PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zhai, C; Li, Y; Mascarenhas, C; Lin, Q; Li, K; Vyrides, I; Grant, CM; Panaretou, B				Zhai, C.; Li, Y.; Mascarenhas, C.; Lin, Q.; Li, K.; Vyrides, I.; Grant, C. M.; Panaretou, B.			The function of ORAOV1/LTO1, a gene that is overexpressed frequently in cancer: essential roles in the function and biogenesis of the ribosome	ONCOGENE			English	Article						ribosome biogenesis; translation; Fe - S cluster; squamous cell carcinoma	YEAST SACCHAROMYCES-CEREVISIAE; SQUAMOUS-CELL CARCINOMAS; NUCLEAR EXPORT; OXIDATIVE-STRESS; GLOBAL ANALYSIS; PROTEIN RLI1; ORAL-CANCER; TRANSLATION; 11Q13; ABCE1	ORAOV1 (oral cancer overexpressed) is overexpressed in many solid tumours, making a key contribution to the development of cancer, but the cellular role of ORAOV1 is unknown. The yeast orthologue of this protein is encoded by the hitherto uncharacterized essential gene, YNL260c. Expression of ORAOV1 restores viability to yeast cells lacking YNL260c. Under nonpermissive conditions, our conditional mutants of YNL260c are defective in the maturation of the 60S ribosomal subunit, whereas maturation of the 40S subunit is unaffected. Also, initiation of translation is abrogated when YNL260c function is lost. YNL260c is indispensible for life in oxygen, but is nonessential under anaerobic conditions. Consequently, the toxic affects of aerobic metabolism on biogenesis and function of the ribosome are alleviated by YNL260c, hence, we rename YNL260c as LTO1; required for biogenesis of the large ribosomal subunit and initiation of translation in oxygen. Lto1 is found in a complex with Rli1/ABCE1, an ATP-binding cassette (ABC)-ATPase bearing N-terminal [4Fe - 4S] clusters. Like Lto1, the Rli1/ABCE1 [4Fe - 4S] clusters are not required for viability under anaerobic conditions, but are essential in the presence of oxygen. Loss of Lto1 function renders cells susceptible to hydroperoxide pro-oxidants, though this type of sensitivity is specific to certain types of oxidative stress as the lto1 mutants are not sensitive to an agent that oxidizes thiols. These findings reflect a functional interaction between Lto1 and the Rli1/ABCE1 [4Fe - 4S] clusters, as part of a complex, which relieves the toxic effects of reactive oxygen species (ROS) on biogenesis and function of the ribosome. This complex also includes Yae1, which bridges the interaction between Lto1 and Rli1/ABCE1. Interactions between members of this complex were demonstrated both in vivo and in vitro. An increased generation of ROS is a feature shared by many cancers. The ORAOV1 complex could prevent ROS-induced ribosomal damage, explaining why overexpression of ORAOV1 is so common in solid tumours.	[Zhai, C.; Li, Y.; Lin, Q.; Li, K.; Vyrides, I.; Panaretou, B.] Kings Coll London, Inst Pharmaceut Sci, London SE1 9NH, England; [Mascarenhas, C.; Grant, C. M.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Li, K.] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Peoples R China	University of London; King's College London; University of Manchester; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Panaretou, B (corresponding author), Kings Coll London, Inst Pharmaceut Sci, Franklin Wilkins Bldg,150 Stamford St, London SE1 9NH, England.	barry.panaretou@kcl.ac.uk	; Vyrides, Ioannis/D-1625-2016	Grant, Chris/0000-0002-0616-6576; Vyrides, Ioannis/0000-0001-8316-4577	National Natural Science Foundation of China [31100057]; BBSRC [BB/E00623X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E00623X/1] Funding Source: researchfish	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	CZ was partly supported by the National Natural Science Foundation of China (grant No.31100057). We thank Ed Hurt (University of Heidelberg, Germany) for providing ribosomal subunit reporter plasmids.	AKERVALL JA, 1995, CANCER, V76, P853, DOI 10.1002/1097-0142(19950901)76:5<853::AID-CNCR2820760520>3.0.CO;2-6; Alhebshi A, 2012, MOL BIOL CELL, V23, P3582, DOI 10.1091/mbc.E12-05-0413; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Barthelme D, 2007, J BIOL CHEM, V282, P14598, DOI 10.1074/jbc.M700825200; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Boal AK, 2005, BIOCHEMISTRY-US, V44, P8397, DOI 10.1021/bi047494n; Boal AK, 2009, P NATL ACAD SCI USA, V106, P15237, DOI 10.1073/pnas.0908059106; Chen ZQ, 2006, J BIOL CHEM, V281, P7452, DOI 10.1074/jbc.M510603200; Dong JS, 2004, J BIOL CHEM, V279, P42157, DOI 10.1074/jbc.M404502200; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gollin SM, 2001, HEAD NECK-J SCI SPEC, V23, P238, DOI 10.1002/1097-0347(200103)23:3<238::AID-HED1025>3.0.CO;2-H; Hawle P, 2007, EUKARYOT CELL, V6, P521, DOI 10.1128/EC.00343-06; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; Hu B, 2005, MOL MICROBIOL, V55, P1735, DOI 10.1111/j.1365-2958.2005.04531.x; Huang X, 2006, GENE CHROMOSOME CANC, V45, P1058, DOI 10.1002/gcc.20371; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; James P, 1996, GENETICS, V144, P1425; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jiang L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-20; Jin YS, 1998, GENE CHROMOSOME CANC, V22, P312, DOI 10.1002/(SICI)1098-2264(199808)22:4<312::AID-GCC7>3.0.CO;2-Y; Khoshnevis S, 2010, EMBO REP, V11, P214, DOI 10.1038/embor.2009.272; Kispal G, 2005, EMBO J, V24, P589, DOI 10.1038/sj.emboj.7600541; KOSOWER NS, 1995, METHOD ENZYMOL, V251, P123, DOI 10.1016/0076-6879(95)51116-4; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; LESE CM, 1995, GENE CHROMOSOME CANC, V12, P288, DOI 10.1002/gcc.2870120409; Li ZH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000213; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mascarenhas C, 2008, MOL BIOL CELL, V19, P2995, DOI 10.1091/mbc.E07-11-1173; Mollapour M, 2007, MOL CELL BIOL, V27, P6446, DOI 10.1128/MCB.02205-06; Mroczek S, 2008, NUCLEIC ACIDS RES, V36, P2874, DOI 10.1093/nar/gkm1100; Pisarev AV, 2010, MOL CELL, V37, P196, DOI 10.1016/j.molcel.2009.12.034; Rose MD., 1990, METHODS YEAST GENETI; Shoemaker CJ, 2011, P NATL ACAD SCI USA, V108, pE1392, DOI 10.1073/pnas.1113956108; Snoek ISI, 2006, FEMS YEAST RES, V6, P393, DOI 10.1111/j.1567-1364.2005.00007.x; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Thorpe GW, 2004, P NATL ACAD SCI USA, V101, P6564, DOI 10.1073/pnas.0305888101; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Trotter EW, 2008, BIOCHEM J, V412, P73, DOI 10.1042/BJ20071634; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Yao W, 2007, MOL CELL, V26, P51, DOI 10.1016/j.molcel.2007.02.018; Yarunin A, 2005, EMBO J, V24, P580, DOI 10.1038/sj.emboj.7600540; Zhai C, 2008, BIOCHEM J, V415, P455, DOI 10.1042/BJ20080209	44	28	30	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 23	2014	33	4					484	494		10.1038/onc.2012.604	http://dx.doi.org/10.1038/onc.2012.604			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	296VX	23318452				2022-12-25	WOS:000330214600009
J	Meyer, DS; Aceto, N; Sausgruber, N; Brinkhaus, H; Muller, U; Pallen, CJ; Bentires-Alj, M				Meyer, D. S.; Aceto, N.; Sausgruber, N.; Brinkhaus, H.; Mueller, U.; Pallen, C. J.; Bentires-Alj, M.			Tyrosine phosphatase PTP alpha contributes to HER2-evoked breast tumor initiation and maintenance	ONCOGENE			English	Article						phosphatases; breast cancer; HER2	CANCER CELL-LINES; EPITHELIAL-CELLS; MAMMARY-TUMORS; IN-VITRO; SRC; 1B; ACTIVATION; IDENTIFICATION; TRANSFORMATION; KINASES	Protein tyrosine phosphatase alpha (PTP alpha/PTPRA) was shown previously to be overexpressed in human primary breast cancers, and to suppress apoptosis in estrogen receptor-negative breast cancer cells in vitro. However, it is not known whether PTP alpha is important for mammary tumor initiation, maintenance and/or progression. We have used a combination of three-dimensional cultures, a transgenic mouse model of breast cancer lacking PTP alpha as well as xenografts of human breast cancer cell lines to address these questions. We found that PTP alpha knockdown after overt tumor development reduced the growth of HER2-positive human breast cancer cell lines, and that this effect was accompanied by a reduction in AKT phosphorylation. However, PTP alpha knockdown did not affect invasiveness of HER2-positive human breast cancer cells grown in three-dimensional cultures. Moreover, in MMTV-NeuNT/PTP alpha(-/-) mice, PTP alpha ablation did not affect NeuNT-evoked tumor onset or metastasis but decreased the number of tumors per mouse. Thus, we demonstrate that PTP alpha contributes to both HER2/Neu-mediated mammary tumor initiation and maintenance. Our results suggest that inhibition of PTP alpha can have a beneficial effect on HER2-positive breast cancers, but that inhibition of additional targets is needed to block breast tumorigenesis.	[Meyer, D. S.; Aceto, N.; Sausgruber, N.; Brinkhaus, H.; Mueller, U.; Bentires-Alj, M.] Friedrich Miescher Inst Biomed Res FMI, Basel, Switzerland; [Pallen, C. J.] Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada; [Pallen, C. J.] Univ British Columbia, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada	Friedrich Miescher Institute for Biomedical Research; University of British Columbia; Child & Family Research Institute; University of British Columbia	Bentires-Alj, M (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	bentires@fmi.ch	Mohamed, Bentires-Alj/F-4484-2015; Aceto, Nicola/O-2484-2014	Mohamed, Bentires-Alj/0000-0001-6344-1127; Pallen, Catherine/0000-0002-3576-5295; Aceto, Nicola/0000-0001-9579-6918	Novartis Research Foundation; European Research Council (ERC starting grant) [243211-PTPsBDC]; Swiss Cancer League; Krebsliga Beider Basel	Novartis Research Foundation; European Research Council (ERC starting grant)(European Research Council (ERC)); Swiss Cancer League; Krebsliga Beider Basel	We thank members of the Bentires-Alj laboratory for advice and discussions. Research in the laboratory of MBA is supported by the Novartis Research Foundation, the European Research Council (ERC starting grant 243211-PTPsBDC), the Swiss Cancer League and the Krebsliga Beider Basel.	Aceto N, 2012, NAT MED, V18, P529, DOI 10.1038/nm.2645; Ardini E, 2000, ONCOGENE, V19, P4979, DOI 10.1038/sj.onc.1203869; Arias-Romero LE, 2009, CANCER RES, V69, P4582, DOI 10.1158/0008-5472.CAN-08-4001; Balavenkatraman KK, 2011, MOL CANCER RES, V9, P1377, DOI 10.1158/1541-7786.MCR-11-0198; Bentires-Alj M, 2007, CANCER RES, V67, P2420, DOI 10.1158/0008-5472.CAN-06-4610; Bjorge JD, 2000, J BIOL CHEM, V275, P41439, DOI 10.1074/jbc.M004852200; Di Cosimo S, 2010, NAT REV CLIN ONCOL, V7, P139, DOI 10.1038/nrclinonc.2009.234; Elson A, 1999, ONCOGENE, V18, P7535, DOI 10.1038/sj.onc.1203098; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Julien SG, 2007, NAT GENET, V39, P338, DOI 10.1038/ng1963; Lin G, 2011, GENE DEV, V25, P1412, DOI 10.1101/gad.2018911; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Pallen CJ, 2003, CURR TOP MED CHEM, V3, P821, DOI 10.2174/1568026033452320; Perou CM, 2011, COLD SPRING HARB PER, V3; Ponniah S, 1999, CURR BIOL, V9, P535, DOI 10.1016/S0960-9822(99)80238-3; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Yip SC, 2010, TRENDS BIOCHEM SCI, V35, P442, DOI 10.1016/j.tibs.2010.03.004; Zheng X, 2008, INT J CANCER, V122, P1999, DOI 10.1002/ijc.23321; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0	20	13	14	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 16	2014	33	3					398	402		10.1038/onc.2012.585	http://dx.doi.org/10.1038/onc.2012.585			5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	296VR	23318421				2022-12-25	WOS:000330214000014
J	Yeung, CL; Ngo, VN; Grohar, PJ; Arnaldez, FI; Asante, A; Wan, X; Khan, J; Hewitt, SM; Khanna, C; Staudt, LM; Helman, LJ				Yeung, C. L.; Ngo, V. N.; Grohar, P. J.; Arnaldez, F. I.; Asante, A.; Wan, X.; Khan, J.; Hewitt, S. M.; Khanna, C.; Staudt, L. M.; Helman, L. J.			Loss-of-function screen in rhabdomyosarcoma identifies CRKL-YES as a critical signal for tumor growth	ONCOGENE			English	Article						rhabdomyosarcoma; CRKL; SRC; YES; dasatinib	CHRONIC MYELOGENOUS LEUKEMIA; ALVEOLAR RHABDOMYOSARCOMA; CHROMOSOMAL LOCALIZATION; CELLS; CANCER; GENE; PATHWAY; PROTEIN; FUSION; FAMILY	To identify novel signaling pathways necessary for rhabdomyosarcoma (RMS) survival, we performed a loss-of-function screen using an inducible small hairpin RNA (shRNA) library in an alveolar and an embryonal RMS cell line. This screen identified CRKL expression as necessary for growth of alveolar RMS and embryonal RMS both in vitro and in vivo. We also found that CRKL was uniformly highly expressed in both RMS cell lines and tumor tissue. As CRKL is a member of the CRK adapter protein family that contains an SH2 and two SH3 domains and is involved in signal transduction from multiple tyrosine kinase receptors, we evaluated CRKL interaction with multiple tyrosine kinase receptor signaling pathways in RMS cells. While we saw no interaction of CRKL with IGFIR, MET or PI3KAKT/mTOR pathways, we determined that CRKL signaling was associated with SRC family kinase (SFK) signaling, specifically with YES kinase. Inhibition of SFK signaling with dasatinib or another SFK inhibitor, sarcatinib, suppressed RMS cell growth in vitro and in vivo. These data identify CRKL as a novel critical component of RMS growth. This study also demonstrates the use of functional screening to identify a potentially novel therapeutic target and treatment approach for these highly aggressive pediatric cancers.	[Yeung, C. L.; Grohar, P. J.; Arnaldez, F. I.; Asante, A.; Wan, X.; Khan, J.; Khanna, C.; Helman, L. J.] NCI, Pediat Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Ngo, V. N.] City Hope Natl Med Ctr, Beckman Res Inst, Div Hematopoiet Stem Cell & Leukemia Res, Duarte, CA 91010 USA; [Hewitt, S. M.] NCI, Ctr Canc Res, Pathol Lab, Bethesda, MD 20892 USA; [Staudt, L. M.] NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); City of Hope; Beckman Research Institute of City of Hope; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Helman, LJ (corresponding author), NCI, Pediat Oncol Branch, Ctr Canc Res, Bldg 31,Room 3A11, Bethesda, MD 20892 USA.	helmanl@nih.gov	Staudt, Louis/AAC-5324-2019; Grohar, Patrick/V-2557-2018; Khan, Javed/P-9157-2014	Hewitt, Stephen/0000-0001-8283-1788; Ngo, Vu/0000-0002-9501-6990	National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC011007, ZIABC010999, ZICBC010923, ZIABC010806, ZIASC006892] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported through funding to the Intramural Research Program of the National Cancer Institute. We would also like to thank the many patients and their families who continue to contribute to and inform our research. We thank Dr Su Young Kim experiments, Elena Kuznetsova, Dr Arnulfo Mendoza, and Dr Melinda G Hollings-head for advice and help with xenograft experiment. We also thank the Children's Oncology Group Soft-Tissue Sarcoma Committee for providing the tissue microarrays for analysis of CRKL expression. We thank Joan Massague for the sharing the Addgene plasmid 26 980.	Arai A, 2006, CELL SIGNAL, V18, P2162, DOI 10.1016/j.cellsig.2006.05.001; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Cheung HW, 2011, CANCER DISCOV, V1, P608, DOI 10.1158/2159-8290.CD-11-0046; DAVIS RJ, 1994, CANCER RES, V54, P2869; Feller SM, 2001, ONCOGENE, V20, P6348, DOI 10.1038/sj.onc.1204779; Guris DL, 2001, NAT GENET, V27, P293, DOI 10.1038/85855; Koval AP, 1998, J BIOL CHEM, V273, P14780, DOI 10.1074/jbc.273.24.14780; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; MARKOWITZ D, 1988, J VIROL, V62, P1120, DOI 10.1128/JVI.62.4.1120-1124.1988; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; NICHOLS GL, 1994, BLOOD, V84, P2912; Oberlin O, 2008, J CLIN ONCOL, V26, P2384, DOI 10.1200/JCO.2007.14.7207; ODA T, 1994, J BIOL CHEM, V269, P22925; Sakkab D, 2000, J BIOL CHEM, V275, P10772, DOI 10.1074/jbc.275.15.10772; SCRABLE HJ, 1987, NATURE, V329, P645, DOI 10.1038/329645a0; SHAPIRO DN, 1993, CANCER RES, V53, P5108; Taulli R, 2006, CANCER RES, V66, P4742, DOI 10.1158/0008-5472.CAN-05-4292; TENHOEVE J, 1994, BLOOD, V84, P1731; TENHOEVE J, 1993, ONCOGENE, V8, P2469; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017	20	33	33	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 21	2013	32	47					5429	5438		10.1038/onc.2012.590	http://dx.doi.org/10.1038/onc.2012.590			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	254PM	23318429	Green Published, hybrid			2022-12-25	WOS:000327177600006
J	Guo, L; Chen, C; Shi, M; Wang, F; Chen, X; Diao, D; Hu, M; Yu, M; Qian, L; Guo, N				Guo, L.; Chen, C.; Shi, M.; Wang, F.; Chen, X.; Diao, D.; Hu, M.; Yu, M.; Qian, L.; Guo, N.			Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition	ONCOGENE			English	Article						OSM; EMT; Stat3; let-7; miR-200	DOUBLE-EDGED-SWORD; NF-KAPPA-B; SELF-RENEWAL; FEEDBACK LOOP; CELL MOTILITY; TGF-BETA; CANCER; INFLAMMATION; EXPRESSION; EMT	Inflammation can act as a crucial mediator of epithelial-to-mesenchymal transition (EMT). In this study, we show that oncostatin M (OSM) is expressed in an autocrine/paracrine fashion in invasive breast carcinoma. OSM stimulation promotes spontaneous lung metastasis of MCF-7 xenografts in nude mice. A conspicuous epigenetic transition was induced by OSM stimulation not only in breast cancer cell lines but also in MCF-7 xenografts in nude mice. The expression of miR-200 and let-7 family members in response to OSM stimulation was downregulated in a signal transducer and activator of transcription factor 3 (Stat3)-dependent manner, resulting in comprehensive alterations of the transcription factors and oncoproteins targeted by these microRNAs. Inhibition of Stat3 activation or the ectopic expression of let-7 and miR-200 effectively reversed the mesenchymal phenotype of breast cancer cells. Stat3 promotes the transcription of Lin-28 by directly binding to the Lin-28 promoter, resulting in the repression of let-7 expression and concomitant upregulation of the let-7 target, high-mobility group A protein 2 (HMGA2). Knock down of HMGA2 significantly impairs OSM-driven EMT. Our data indicate that downregulation of let-7 and miR-200 levels initiates and maintains OSM-induced EMT phenotypes, and HMGA2 acts as a master switch of OSM-induced EMT. These findings highlight the importance of Stat3-coordinated Lin-28B-let-7-HMGA2 and miR-200-ZEB1 circuits in the cytokine-mediated phenotypic reprogramming of breast cancer cells.	[Guo, L.; Chen, C.; Shi, M.; Diao, D.; Hu, M.; Yu, M.; Qian, L.; Guo, N.] Beijing Inst Basic Med Sci, Dept Mol Immunol, Beijing, Peoples R China; [Wang, F.] Inst Basic Med Sci, Dept Brain Protect & Plast Res, Beijing 100850, Peoples R China; [Chen, X.] 307 Hosp, Beijing, Peoples R China; [Diao, D.] Henan Univ, Lab Cellular & Mol Immunol, Sch Med, Kaifeng, Peoples R China	Academy of Military Medical Sciences - China; Fifth Medical Center of Chinese PLA General Hospital; Henan University	Qian, L (corresponding author), Inst Basic Med Sci, Dept Mol Immunol, Beijing 100850, Peoples R China.	qianlubj@sohu.com; ningguo@nic.bmi.ac.cn		, Liang/0000-0002-8748-5770	National Basic Research Program of China (973 Program) [2010CB911904]; National Natural Science Foundation of China [30972690, 31271440, 81272232]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We are grateful to Dr Xuemin Zhang (National Center of Biomedical Analysis, Beijing) for kindly providing us the plasmids pRc/CMV-Stat3C-Flag and luciferase reporter vectors containing the binding sequences for Stat3, NF-kappa B, AP-1 and Smad. We also thank Dr Xiaofei Zheng (Beijing Institute of Radiation Medicine, Beijing) for the gift of the modified pGL3-control plasmid. This work is supported by National Basic Research Program of China (973 Program, No. 2010CB911904) and National Natural Science Foundation of China (Nos. 30972690, 31271440 and 81272232).	Azare J, 2007, MOL CELL BIOL, V27, P4444, DOI 10.1128/MCB.02404-06; Bhaumik D, 2009, CELL CYCLE, V8, P1822; Biddle A, 2012, CANCER METAST REV, V31, P285, DOI 10.1007/s10555-012-9345-0; Boyerinas B, 2008, CANCER RES, V68, P2587, DOI 10.1158/0008-5472.CAN-08-0264; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Chen JJW, 2005, J CLIN ONCOL, V23, P953, DOI 10.1200/JCO.2005.12.172; Cheng GZ, 2008, J BIOL CHEM, V283, P14665, DOI 10.1074/jbc.M707429200; Chiappetta G, 1996, ONCOGENE, V13, P2439; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; Douglas AM, 1998, INT J CANCER, V75, P64, DOI 10.1002/(SICI)1097-0215(19980105)75:1<64::AID-IJC11>3.0.CO;2-D; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Fernando RI, 2011, CANCER RES, V71, P5296, DOI 10.1158/0008-5472.CAN-11-0156; Gomez-Lechon MJ, 1999, LIFE SCI, V65, P2019, DOI 10.1016/S0024-3205(99)00296-9; Grant SL, 1999, MOL MED TODAY, V5, P406, DOI 10.1016/S1357-4310(99)01540-3; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Jarnicki A, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-14; Jorcyk CL, 2006, CYTOKINE, V33, P323, DOI 10.1016/j.cyto.2006.03.004; Jun C, 2007, PROG BIOCHEM BIOPHYS, V34, P389; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Lopez-Novoa JM, 2009, EMBO MOL MED, V1, P303, DOI 10.1002/emmm.200900043; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Nightingale J, 2004, J AM SOC NEPHROL, V15, P21, DOI 10.1097/01.ASN.0000102479.92582.43; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Pfannkuche K, 2009, STEM CELL REV REP, V5, P224, DOI 10.1007/s12015-009-9078-9; Pollack V, 2007, AM J PHYSIOL-RENAL, V293, pF1714, DOI 10.1152/ajprenal.00130.2007; Queen MM, 2005, CANCER RES, V65, P8896, DOI 10.1158/0008-5472.CAN-05-1734; Rokavec M, 2012, MOL CELL, V45, P777, DOI 10.1016/j.molcel.2012.01.015; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Shi M, 2011, BREAST CANCER RES TR, V125, P351, DOI 10.1007/s10549-010-0822-2; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; Strippoli R, 2010, J CELL SCI, V123, P4321, DOI 10.1242/jcs.071647; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Tan EJ, 2012, J BIOL CHEM, V287, P7134, DOI 10.1074/jbc.M111.291385; Thuault S, 2008, J BIOL CHEM, V283, P33437, DOI 10.1074/jbc.M802016200; Winder DM, 2011, J PATHOL, V225, P448, DOI 10.1002/path.2968; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Xiong H, 2012, J BIOL CHEM, V287, P5819, DOI 10.1074/jbc.M111.295964; Yang L, 2010, CANCER METAST REV, V29, P263, DOI 10.1007/s10555-010-9226-3; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zentner MD, 2001, J BIOL CHEM, V276, P29805, DOI 10.1074/jbc.M103153200; Zhao SJ, 2008, CANCER RES, V68, P4221, DOI 10.1158/0008-5472.CAN-07-5123	53	152	158	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 7	2013	32	45					5272	5282		10.1038/onc.2012.573	http://dx.doi.org/10.1038/onc.2012.573			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	251IS	23318420	hybrid			2022-12-25	WOS:000326922100003
J	Gosalia, N; Leir, SH; Harris, A				Gosalia, Nehal; Leir, Shih-Hsing; Harris, Ann			Coordinate Regulation of the Gel-forming Mucin Genes at Chromosome 11p15.5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULATOR PROTEIN CTCF; DEVELOPMENTAL EXPRESSION; DNA METHYLATION; UP-REGULATION; CELL LINE; MUC5AC; IDENTIFICATION; ORGANIZATION; CARCINOMA; SEQUENCE	Four of the genes that encode gel-forming mucins, which are major components of the mucus layer protecting many epithelial surfaces, are clustered at chromosome 11p15.5 and show both cell-and tissue-specific expression patterns. We aimed to determine whether the individual genes were coordinately regulated by mechanisms involving higher order chromatin structure. CCCTC-binding factor (CTCF) sites were predicted in silico and CTCF occupancy then evaluated by chromatin immunoprecipitation. CTCF was found at many sites across the gene cluster, and its binding was correlated with mucin gene expression. Next, siRNA-mediated depletion of CTCF was shown to increase MUC2 expression in A549 lung carcinoma cells and both MUC6 and MUC5AC expression in LS180 colon carcinoma cells. These changes correlated with loss of CTCF binding at multiple sites, although others retained occupancy. In cells actively expressing the mucins, the gene cluster was shown by chromosome conformation capture to form looped three-dimensional structures with direct interactions between the MUC2 promoter region, regions 30 kb 5' to it, close to the MUC6 promoter and others near the 3' end of MUC5AC, >170 kb away. Finally, to demonstrate the importance of CTCF binding to mucin gene expression, Calu-3 lung carcinoma cells were exposed to lipopolysaccharide (LPS). LPS increased the expression of MUC2 and MUC5AC and reduced MUC5B. CTCF occupancy was concurrently depleted at specific binding sites close to these genes. These data suggest that CTCF binding and cell type-specific long-range interactions across the 11p15.5 gene cluster are critical mechanisms for coordinating gel-forming mucin gene expression.	[Gosalia, Nehal; Leir, Shih-Hsing; Harris, Ann] Northwestern Univ, Human Mol Genet Program, Childrens Mem Res Ctr, Feinberg Sch Med, Chicago, IL 60614 USA; [Gosalia, Nehal; Leir, Shih-Hsing; Harris, Ann] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60614 USA; [Harris, Ann] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60614 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Harris, A (corresponding author), Northwestern Univ, Human Mol Genet Program, Childrens Mem Res Ctr, Feinberg Sch Med, Chicago, IL 60614 USA.	ann-harris@northwestern.edu	Leir, Shih-Hsing/AAG-1086-2019; Leir, Shih-Hsing/O-6739-2019	Leir, Shih-Hsing/0000-0001-9524-3379; Gosalia, Nehal/0000-0002-1444-5786	National Institutes of Health [R01 HL094585, R01 HD068901]; Cystic Fibrosis Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068901] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the National Institutes of Health Grants R01 HL094585 and R01 HD068901 and the Cystic Fibrosis Foundation.	BALAGUE C, 1995, GASTROENTEROLOGY, V109, P953, DOI 10.1016/0016-5085(95)90406-9; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Blackledge NP, 2009, NUCLEIC ACIDS RES, V37, P1086, DOI 10.1093/nar/gkn1056; Boyle AP, 2011, GENOME RES, V21, P456, DOI 10.1101/gr.112656.110; Copin MC, 2000, INT J CANCER, V86, P162, DOI 10.1002/(SICI)1097-0215(20000415)86:2<162::AID-IJC3>3.3.CO;2-I; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Desseyn JL, 2000, MOL BIOL EVOL, V17, P1175, DOI 10.1093/oxfordjournals.molbev.a026400; Dohrman A, 1998, BBA-MOL BASIS DIS, V1406, P251, DOI 10.1016/S0925-4439(98)00010-6; DUPERAT VG, 1995, BIOCHEM J, V305, P211, DOI 10.1042/bj3050211; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Fogh J., 1975, HUMAN TUMOR CELLS IN, VVolume 1, P115, DOI [10.1007/978-1-4757-1647-4_5, DOI 10.1007/978-1-4757-1647-4_5]; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GUM JR, 1989, J BIOL CHEM, V264, P6480; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hauber HP, 2007, AM J RESP CELL MOL, V37, P606, DOI 10.1165/rcmb.2006-0404OC; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Krivega I, 2012, CURR OPIN GENET DEV, V22, P79, DOI 10.1016/j.gde.2011.11.001; Leir SH, 2011, EXP CELL RES, V317, P2408, DOI 10.1016/j.yexcr.2011.07.021; LESUFFLEUR T, 1995, J BIOL CHEM, V270, P13665, DOI 10.1074/jbc.270.23.13665; Li DZ, 1998, J BIOL CHEM, V273, P6812, DOI 10.1074/jbc.273.12.6812; Li JD, 1997, P NATL ACAD SCI USA, V94, P967, DOI 10.1073/pnas.94.3.967; Li T, 2008, MOL CELL BIOL, V28, P6473, DOI 10.1128/MCB.00204-08; Lidell ME, 2003, BIOCHEM J, V372, P335, DOI 10.1042/BJ20030003; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Lutz M, 2000, NUCLEIC ACIDS RES, V28, P1707, DOI 10.1093/nar/28.8.1707; Majumder P, 2008, J EXP MED, V205, P785, DOI 10.1084/jem.20071843; Majumder P, 2010, MOL CELL BIOL, V30, P4211, DOI 10.1128/MCB.00327-10; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Ott CJ, 2009, P NATL ACAD SCI USA, V106, P19934, DOI 10.1073/pnas.0900946106; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pigny P, 1996, GENOMICS, V38, P340, DOI 10.1006/geno.1996.0637; PORCHET N, 1991, AM REV RESPIR DIS, V144, pS15, DOI 10.1164/ajrccm/144.3_pt_2.S15; Reid CJ, 1998, GUT, V42, P220, DOI 10.1136/gut.42.2.220; Reid CJ, 1997, AM J RESP CELL MOL, V17, P592, DOI 10.1165/ajrcmb.17.5.2798; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; Roy MG, 2011, AM J RESP CELL MOL, V44, P755, DOI 10.1165/rcmb.2010-0020OC; Shen B. Q., 1994, AM J PHYSIOL, V266, pL439; Smirnova MG, 2003, CELL IMMUNOL, V221, P42, DOI 10.1016/S0008-8749(03)00059-5; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Sproul D, 2005, NAT REV GENET, V6, P775, DOI 10.1038/nrg1688; Tam Anthony, 2011, Ther Adv Respir Dis, V5, P255, DOI 10.1177/1753465810396539; TAN MH, 1986, CANCER INVEST, V4, P15, DOI 10.3109/07357908609039823; Thai P, 2008, ANNU REV PHYSIOL, V70, P405, DOI 10.1146/annurev.physiol.70.113006.100441; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; TOM BH, 1976, IN VITRO CELL DEV B, V12, P180; TORIBARA NW, 1993, J BIOL CHEM, V268, P5879; Van Seuningen I, 2001, FRONT BIOSCI-LANDMRK, V6, pD1216; Vernimmen D, 2007, EMBO J, V26, P2041, DOI 10.1038/sj.emboj.7601654; Vincent A, 2007, ONCOGENE, V26, P6566, DOI 10.1038/sj.onc.1210479; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Yamada N, 2006, INT J CANCER, V119, P1850, DOI 10.1002/ijc.22047; Yamada N, 2011, CLIN EPIGENETICS, V2, P85, DOI 10.1007/s13148-011-0037-3	57	14	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6717	6725		10.1074/jbc.M112.437400	http://dx.doi.org/10.1074/jbc.M112.437400			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23303185	Green Published, hybrid			2022-12-25	WOS:000315820700069
J	van Sorge, NM; Beasley, FC; Gusarov, I; Gonzalez, DJ; von Kockritz-Blickwede, M; Anik, S; Borkowski, AW; Dorrestein, PC; Nudler, E; Nizet, V				van Sorge, Nina M.; Beasley, Federico C.; Gusarov, Ivan; Gonzalez, David J.; von Koeckritz-Blickwede, Maren; Anik, Sabina; Borkowski, Andrew W.; Dorrestein, Pieter C.; Nudler, Evgeny; Nizet, Victor			Methicillin-resistant Staphylococcus aureus Bacterial Nitric-oxide Synthase Affects Antibiotic Sensitivity and Skin Abscess Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDE LL-37; SOFT-TISSUE INFECTIONS; BACILLUS-SUBTILIS; SUPEROXIDE-DISMUTASE; INNATE IMMUNITY; HOST-DEFENSE; VIRULENCE; PROTEIN; STRESS; IRON	Staphylococcus aureus infections present an enormous global health concern complicated by an alarming increase in antibiotic resistance. S. aureus is among the few bacterial species that express nitric-oxide synthase(bNOS) and thus can catalyze NO production from L-arginine. Here we generate an isogenic bNOS-deficient mutant in the epidemic community-acquired methicillin-resistant S. aureus (MRSA) USA300 clone to study its contribution to virulence and antibiotic susceptibility. Loss of bNOS increased MRSA susceptibility to reactive oxygen species and host cathelicidin antimicrobial peptides, which correlated with increased MRSA killing by human neutrophils and within neutrophil extracellular traps. bNOS also promoted resistance to the pharmaceutical antibiotics that act on the cell envelope such as vancomycin and daptomycin. Surprisingly, bNOS-deficient strains gained resistance to aminoglycosides, suggesting that the role of bNOS in antibiotic susceptibility is more complex than previously observed in Bacillus species. Finally, the MRSA bNOS mutant showed reduced virulence with decreased survival and smaller abscess generation in a mouse subcutaneous infection model. Together, these data indicate that bNOS contributes to MRSA innate immune and antibiotic resistance phenotypes. Future development of specific bNOS inhibitors could be an attractive option to simultaneously reduce MRSA pathology and enhance its susceptibility to commonly used antibiotics.	[van Sorge, Nina M.; Beasley, Federico C.; Gonzalez, David J.; von Koeckritz-Blickwede, Maren; Anik, Sabina; Borkowski, Andrew W.; Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Gonzalez, David J.; Dorrestein, Pieter C.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Dorrestein, Pieter C.; Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Gusarov, Ivan; Nudler, Evgeny] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; New York University	Nizet, V (corresponding author), Univ Calif San Diego, Dept Pediat, 9500 Gilman Dr,Mail Code 0687, La Jolla, CA 92093 USA.	vnizet@ucsd.edu	Gusarov, Ivan/AAJ-6282-2020; Dorrestein, Pieter/ABF-2930-2020; Nizet, Victor/AAF-3190-2019; van Sorge, Nina/E-3290-2017	van Sorge, Nina/0000-0002-2695-5863; Nudler, Evgeny/0000-0002-8811-3071; Nizet, Victor/0000-0003-3847-0422	National Institutes of Health [AI077780, HD071600, AI057153]; National Institutes of Health; National Institutes of Health/UCSD Immunology Training Grant [5T32AI060536]; A.P. Giannini Foundation Postdoctoral Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD071600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052453, T32AI060536, R37AI052453, U54AI057153, R01AI093451, R01AI077780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM068524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/UCSD Immunology Training Grant; A.P. Giannini Foundation Postdoctoral Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI077780, HD071600, and AI057153 (to V. N.). This work was also supported by a National Institutes of Health Director's Pioneer award (to E. N.).; Supported National Institutes of Health/UCSD Immunology Training Grant 5T32AI060536.; Recipient of an A.P. Giannini Foundation Postdoctoral Fellowship.	Alalwani SM, 2010, EUR J IMMUNOL, V40, P1118, DOI 10.1002/eji.200939275; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BEST GK, 1965, ARCH BIOCHEM BIOPHYS, V111, P685, DOI 10.1016/0003-9861(65)90250-X; Bird LE, 2002, STRUCTURE, V10, P1687, DOI 10.1016/S0969-2126(02)00911-5; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Chaffin DO, 1998, GENE, V219, P91, DOI 10.1016/S0378-1119(98)00396-5; Chakravortty D, 2003, MICROBES INFECT, V5, P621, DOI 10.1016/S1286-4579(03)00096-0; CHAMBERS HF, 1984, J INFECT DIS, V149, P894, DOI 10.1093/infdis/149.6.894; Choi WS, 1997, BIOCHEM BIOPH RES CO, V237, P554, DOI 10.1006/bbrc.1997.7189; Clarke SR, 2007, CELL HOST MICROBE, V1, P199, DOI 10.1016/j.chom.2007.04.005; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Eckman C, 2010, EUR J MED RES, V15, P554; Escaich S, 2010, EXPERT OPIN THER PAT, V20, P1401, DOI 10.1517/13543776.2010.511176; Gusarov I, 2005, P NATL ACAD SCI USA, V102, P13855, DOI 10.1073/pnas.0504307102; Gusarov I, 2008, J BIOL CHEM, V283, P13140, DOI 10.1074/jbc.M710178200; Gusarov I, 2009, SCIENCE, V325, P1380, DOI 10.1126/science.1175439; Hachmann AB, 2009, ANTIMICROB AGENTS CH, V53, P1598, DOI 10.1128/AAC.01329-08; Hochgrafe F, 2008, J BACTERIOL, V190, P4997, DOI 10.1128/JB.01846-07; Hong IS, 2003, FEMS MICROBIOL LETT, V222, P177, DOI 10.1016/S0378-1097(03)00254-4; Jin T, 2004, J IMMUNOL, V172, P1169, DOI 10.4049/jimmunol.172.2.1169; Kers JA, 2004, NATURE, V429, P79, DOI 10.1038/nature02504; Kohler J, 2011, MICROBES INFECT, V13, P914, DOI 10.1016/j.micinf.2011.05.004; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kristian SA, 2003, J INFECT DIS, V188, P414, DOI 10.1086/376533; Lauth X, 2009, J INNATE IMMUN, V1, P202, DOI 10.1159/000203645; Lemaire S, 2009, ANTIMICROB AGENTS CH, V53, P2289, DOI 10.1128/AAC.01135-08; Lim MH, 2006, INORG CHEM, V45, P8980, DOI 10.1021/ic0609913; Liu GY, 2005, J EXP MED, V202, P209, DOI 10.1084/jem.20050846; MANDELL GL, 1975, J CLIN INVEST, V55, P561, DOI 10.1172/JCI107963; McCollister BD, 2011, ANTIMICROB AGENTS CH, V55, P2189, DOI 10.1128/AAC.01203-10; Moet GJ, 2007, DIAGN MICR INFEC DIS, V57, P7, DOI 10.1016/j.diagmicrobio.2006.05.009; Molne L, 2000, INFECT IMMUN, V68, P6162, DOI 10.1128/IAI.68.11.6162-6167.2000; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Nizet V, 2003, SCAND J INFECT DIS, V35, P670, DOI 10.1080/00365540310015629; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Nizet V, 2007, J ALLERGY CLIN IMMUN, V120, P13, DOI 10.1016/j.jaci.2007.06.005; Ouhara K, 2008, J ANTIMICROB CHEMOTH, V61, P1266, DOI 10.1093/jac/dkn106; Palazzolo-Ballance AM, 2008, J IMMUNOL, V180, P500, DOI 10.4049/jimmunol.180.1.500; Pant K, 2006, BIOCHEMISTRY-US, V45, P2537, DOI 10.1021/bi0518848; Pant K, 2002, BIOCHEMISTRY-US, V41, P11071, DOI 10.1021/bi0263715; Park B, 2008, J BACTERIOL, V190, P2275, DOI 10.1128/JB.00006-08; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Peters BM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001067; Pilsczek FH, 2010, J IMMUNOL, V185, P7413, DOI 10.4049/jimmunol.1000675; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; REPINE JE, 1981, J BIOL CHEM, V256, P7094; Richardson AR, 2008, SCIENCE, V319, P1672, DOI 10.1126/science.1155207; Richardson AR, 2006, MOL MICROBIOL, V61, P927, DOI 10.1111/j.1365-2958.2006.05290.x; Robertson CM, 2008, J SURG RES, V150, P278, DOI 10.1016/j.jss.2008.02.009; Salard I, 2006, J INORG BIOCHEM, V100, P2024, DOI 10.1016/j.jinorgbio.2006.09.017; Sasaki S, 1998, INFECT IMMUN, V66, P1017, DOI 10.1128/IAI.66.3.1017-1022.1998; Shatalin K, 2008, P NATL ACAD SCI USA, V105, P1009, DOI 10.1073/pnas.0710950105; Sieprawska-Lupa M, 2004, ANTIMICROB AGENTS CH, V48, P4673, DOI 10.1128/AAC.48.12.4673-4679.2004; Soehnlein O, 2009, J MOL MED-JMM, V87, P1157, DOI 10.1007/s00109-009-0508-6; Tenover FC, 2009, J ANTIMICROB CHEMOTH, V64, P441, DOI 10.1093/jac/dkp241; Tomasinsig L, 2005, CURR PROTEIN PEPT SC, V6, P23, DOI 10.2174/1389203053027520; van den Berg JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005234; von Kockritz-Blickwede M, 2008, AM J PATHOL, V173, P1657, DOI 10.2353/ajpath.2008.080337; von Kockritz-Blickwede M, 2009, J MOL MED, V87, P775, DOI 10.1007/s00109-009-0481-0; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Wink DA, 2011, J LEUKOCYTE BIOL, V89, P873, DOI 10.1189/jlb.1010550; Yeom J, 2010, J BIOL CHEM, V285, P22689, DOI 10.1074/jbc.M110.127456; Zheng Y, 2007, BRIT J DERMATOL, V157, P1124, DOI 10.1111/j.1365-2133.2007.08196.x	66	73	74	3	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6417	6426		10.1074/jbc.M112.448738	http://dx.doi.org/10.1074/jbc.M112.448738			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23322784	Green Published, hybrid			2022-12-25	WOS:000315820700036
J	Al Lawati, A; Ali, I; Al Barwani, M				Al Lawati, Afaf; Ali, Issam; Al Barwani, Muataz			Effect of Temperature and Capsid Tail on the Packing and Ejection of Viral DNA	PLOS ONE			English	Article							DOUBLE-STRANDED DNA; BACTERIOPHAGE; DYNAMICS; FORCES; TWIST	We use a simulation technique based on molecular dynamics and stochastic rotation model to present the effect of temperature and capsid tail on the packaging and ejection processes of semiflexible polymers. We consider two types of solvents, a good solvent, where the polymer is neutral and repulsion interactions among its various sections are favored, and one where the polymer is charged, giving rise to extra electrostatic reaction. For tailless capsids, we find that packing a neutral polymer is slightly slower at higher temperatures whereas its ejection is slightly slower at lower temperatures. We find the same trend for a charged polymer but the effect is noticeably larger. At a high enough temperature, we notice that packing a charged polymer can be stopped. On the other hand, at fixed temperature and regardless whether the polymer is charged, packing is much easier for a capsid with a tail whereas ejection is much slower. The effect of including the tail on the dynamics of a charged polymer, in particular, is rather significant: more packing fraction is facilitated at higher temperatures due to more ordered polymer configuration inside the capsid. In contrast, during ejection the tail traps the last remaining beads for quite some time before allowing full ejection. We interpret these results in terms of entropic and electrostatic forces.	[Al Lawati, Afaf; Ali, Issam; Al Barwani, Muataz] Sultan Qaboos Univ, Coll Sci, Dept Phys, Al Khoud, Oman	Sultan Qaboos University	Ali, I (corresponding author), Sultan Qaboos Univ, Coll Sci, Dept Phys, Al Khoud, Oman.	issam@squ.edu.om	Al Barwani, Muataz/H-5721-2017	Al Barwani, Muataz/0000-0003-2568-0228				Ali I, 2008, BIOPHYS J, V94, P4159, DOI 10.1529/biophysj.107.111963; Ali I, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.208102; Ali I, 2004, J CHEM PHYS, V121, P8635, DOI 10.1063/1.1798052; Ali I, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3617416; Arsuaga J, 2002, BIOPHYS CHEM, V101, P475, DOI 10.1016/S0301-4622(02)00197-7; de Frutos M, 2005, BIOPHYS J, V88, P1364, DOI 10.1529/biophysj.104.048785; Forrey C, 2006, BIOPHYS J, V91, P25, DOI 10.1529/biophysj.105.073429; Fuller DN, 2007, P NATL ACAD SCI USA, V104, P11245, DOI 10.1073/pnas.0701323104; GABASHVILI IS, 1992, J BIOMOL STRUCT DYN, V9, P911, DOI 10.1080/07391102.1992.10507966; Grayson P, 2007, P NATL ACAD SCI USA, V104, P14652, DOI 10.1073/pnas.0703274104; Kindt J, 2001, P NATL ACAD SCI USA, V98, P13671, DOI 10.1073/pnas.241486298; LaMarque JC, 2004, BIOPOLYMERS, V73, P348, DOI 10.1002/bip.10529; Lof D, 2007, J MOL BIOL, V368, P55, DOI 10.1016/j.jmb.2007.01.076; Malevanets A, 1999, J CHEM PHYS, V110, P8605, DOI 10.1063/1.478857; Marenduzzo D, 2009, P NATL ACAD SCI USA, V106, P22269, DOI [10.1073/pnas.0907524106, 10.1073/pnas.0907S24106]; Matthews R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.088101; Petrov AS, 2007, J STRUCT BIOL, V160, P241, DOI 10.1016/j.jsb.2007.08.012; Rollins GC, 2008, BIOPHYS J, V94, pL38, DOI 10.1529/biophysj.107.126698; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Spakowitz AJ, 2005, BIOPHYS J, V88, P3912, DOI 10.1529/biophysj.104.052738	21	8	9	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e52958	10.1371/journal.pone.0052958	http://dx.doi.org/10.1371/journal.pone.0052958			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320080	Green Published, gold, Green Submitted			2022-12-25	WOS:000313429800022
J	Garcia-Robledo, C; Erickson, DL; Staines, CL; Erwin, TL; Kress, WJ				Garcia-Robledo, Carlos; Erickson, David L.; Staines, Charles L.; Erwin, Terry L.; Kress, W. John			Tropical Plant-Herbivore Networks: Reconstructing Species Interactions Using DNA Barcodes	PLOS ONE			English	Article							INSECT HERBIVORES; HISPINE BEETLES; LEAF BEETLES; HOST PLANTS; GINGERS; CHRYSOMELIDAE; GENERALIST; SPECIALIST; DEMOGRAPHY; PHYLOGENY	Plants and their associated insect herbivores, represent more than 50% of all known species on earth. The first step in understanding the mechanisms generating and maintaining this important component of biodiversity is to identify plant-herbivore associations. In this study we determined insect-host plant associations for an entire guild of insect herbivores using plant DNA extracted from insect gut contents. Over two years, in a tropical rain forest in Costa Rica (La Selva Biological Station), we recorded the full diet breadth of rolled-leaf beetles, a group of herbivores that feed on plants in the order Zingiberales. Field observations were used to determine the accuracy of diet identifications using a three-locus DNA barcode (rbcL, trnH-psbA and ITS2). Using extraction techniques for ancient DNA, we obtained high-quality sequences for two of these loci from gut contents (rbcL and ITS2). Sequences were then compared to a comprehensive DNA barcode library of the Zingiberales. The rbcL locus identified host plants to family (success/sequence = 58.8%) and genus (success/sequence = 47%). For all Zingiberales except Heliconiaceae, ITS2 successfully identified host plants to genus (success/sequence = 67.1%) and species (success/sequence = 61.6%). Kindt's sampling estimates suggest that by collecting ca. four individuals representing each plant-herbivore interaction, 99% of all host associations included in this study can be identified to genus. For plants that amplified ITS2, 99% of the hosts can be identified to species after collecting at least four individuals representing each interaction. Our study demonstrates that host plant identifications at the species-level using DNA barcodes are feasible, cost-effective, and reliable, and that reconstructing plant-herbivore networks with these methods will become the standard for a detailed understanding of these interactions.	[Garcia-Robledo, Carlos; Erickson, David L.; Kress, W. John] Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, Washington, DC 20560 USA; [Garcia-Robledo, Carlos; Staines, Charles L.; Erwin, Terry L.] Smithsonian Inst, Dept Entomol, Natl Museum Nat Hist, Washington, DC 20560 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian National Museum of Natural History	Garcia-Robledo, C (corresponding author), Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, Washington, DC 20560 USA.	garciac@si.edu			Smithsonian Postdoctoral Fellowship; National Geographic-Waitt Institute [W149-11]; Heliconia Society; Rubenstein Fellowship - Encyclopedia of Life	Smithsonian Postdoctoral Fellowship(Smithsonian Institution); National Geographic-Waitt Institute(National Geographic Society); Heliconia Society; Rubenstein Fellowship - Encyclopedia of Life	This research was funded by the Smithsonian Postdoctoral Fellowship, the National Geographic-Waitt Institute grant (W149-11), Heliconia Society Grant and the Rubenstein Fellowship - Encyclopedia of Life to CG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Baldwin BG, 1996, ANN MO BOT GARD, V83, P151, DOI 10.2307/2399971; Barone JA, 1998, J ANIM ECOL, V67, P400, DOI 10.1046/j.1365-2656.1998.00197.x; CHAZDON RL, 1984, J ECOL, V72, P553, DOI 10.2307/2260066; Coissac E, 2012, MOL ECOL, V21, P1834, DOI 10.1111/j.1365-294X.2012.05550.x; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; FRY B, 1978, ECOLOGY, V59, P498, DOI 10.2307/1936580; Futuyma D.J., 1983, COEVOLUTION; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; Garcia-Robledo C, 2012, J EVOLUTION BIOL, V25, P38, DOI 10.1111/j.1420-9101.2011.02401.x; Garcia-Robledo C, 2008, J PALEONTOL, V82, P1035, DOI 10.1666/07-089.1; Garcia-Robledo C, 2010, ZOOTAXA, P50, DOI 10.11646/zootaxa.2610.1.3; Garcia-Robledo C, 2011, J ANIM ECOL, V80, P976, DOI 10.1111/j.1365-2656.2011.01843.x; Garcia-Robledo C, 2009, ENTOMOL EXP APPL, V131, P115, DOI 10.1111/j.1570-7458.2009.00843.x; GARCIAROBLEDO C, 2010, THESIS U MIAMI; Hartshorn Gary S., 1994, P73; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; HOLDRIDGE LR, 1947, SCIENCE, V105, P367, DOI 10.1126/science.105.2727.367; Ivanova NV, 2008, PLANT MOL BIOL REP, V26, P186, DOI 10.1007/s11105-008-0029-4; JANZEN DH, 1980, EVOLUTION, V34, P611, DOI 10.1111/j.1558-5646.1980.tb04849.x; Johnson DM, 2005, ECOLOGY, V86, P3088, DOI 10.1890/04-1815; Johnson DM, 2004, BIOTROPICA, V36, P352, DOI 10.1111/j.1744-7429.2004.tb00327.x; Johnson DM, 2004, ECOLOGY, V85, P2037, DOI 10.1890/03-0508; Jurado-Rivera JA, 2009, P ROY SOC B-BIOL SCI, V276, P639, DOI 10.1098/rspb.2008.1264; Kindt R, 2006, BIODIVERS CONSERV, V15, P3235, DOI 10.1007/s10531-005-0311-9; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2009, P NATL ACAD SCI USA, V106, P18621, DOI 10.1073/pnas.0909820106; Kress WJ, 2005, AM J BOT, V92, P167, DOI 10.3732/ajb.92.1.167; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; MCDADE L. A., 1994, SELVA ECOLOGY NATURA; Navarro SP, 2010, ECOL ENTOMOL, V35, P18, DOI 10.1111/j.1365-2311.2009.01145.x; OTTE D, 1976, P ACAD NAT SCI PHILA, V128, P89; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Prince LM, 2006, TAXON, V55, P281, DOI 10.2307/25065578; R Development Core Team, 2009, R FDN STAT COMP; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; SMITH JF, 1993, ANN MO BOT GARD, V80, P620, DOI 10.2307/2399850; Staines CL, 2009, ZOOTAXA, P58, DOI 10.11646/zootaxa.2033.1.6; Staines CL, 2011, ZOOKEYS, P45, DOI 10.3897/zookeys.157.1338; Staines CL, 1996, REV BIOL TROP, P3; Staudacher K, 2011, SOIL BIOL BIOCHEM, V43, P346, DOI 10.1016/j.soilbio.2010.10.022; STRONG DR, 1977, BIOTROPICA, V9, P156, DOI 10.2307/2387878; STRONG DR, 1977, EVOLUTION, V31, P854, DOI 10.1111/j.1558-5646.1977.tb01078.x; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Wilf P, 2000, SCIENCE, V289, P291, DOI 10.1126/science.289.5477.291; Yoccoz NG, 2012, MOL ECOL, V21, P2031, DOI 10.1111/j.1365-294X.2012.05505.x	48	114	125	1	153	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e52967	10.1371/journal.pone.0052967	http://dx.doi.org/10.1371/journal.pone.0052967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308128	Green Published, gold, Green Submitted			2022-12-25	WOS:000313429800023
J	Bergmann, R; Kongsbak, K; Sorensen, PL; Sander, T; Balle, T				Bergmann, Rikke; Kongsbak, Kristine; Sorensen, Pernille Louise; Sander, Tommy; Balle, Thomas			A Unified Model of the GABA(A) Receptor Comprising Agonist and Benzodiazepine Binding Sites	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; AMINOBUTYRIC ACID(A) RECEPTORS; ALPHA-SUBUNIT SELECTIVITY; X-RAY-STRUCTURE; CRYSTAL-STRUCTURE; A-RECEPTOR; LIGAND-BINDING; STRUCTURAL REQUIREMENTS; EXTRACELLULAR DOMAIN; DIFFERENT RESIDUES	We present a full-length alpha(1)beta(2)gamma(2) GABA receptor model optimized for agonists and benzodiazepine (BZD) allosteric modulators. We propose binding hypotheses for the agonists GABA, muscimol and THIP and for the allosteric modulator diazepam (DZP). The receptor model is primarily based on the glutamate-gated chloride channel (GluCl) from C. elegans and includes additional structural information from the prokaryotic ligand-gated ion channel ELIC in a few regions. Available mutational data of the binding sites are well explained by the model and the proposed ligand binding poses. We suggest a GABA binding mode similar to the binding mode of glutamate in the GluCl X-ray structure. Key interactions are predicted with residues alpha(1)R66, beta(2)T202, alpha(1)T129, beta(2)E155, beta(2)Y205 and the backbone of beta(2)S156. Muscimol is predicted to bind similarly, however, with minor differences rationalized with quantum mechanical energy calculations. Muscimol key interactions are predicted to be alpha(1)R66, beta(2)T202, alpha(1)T129, beta(2)E155, beta(2)Y205 and beta(2)F200. Furthermore, we argue that a water molecule could mediate further interactions between muscimol and the backbone of beta(2)S156 and beta(2)Y157. DZP is predicted to bind with interactions comparable to those of the agonists in the orthosteric site. The carbonyl group of DZP is predicted to interact with two threonines alpha(1)T206 and gamma(2)T142, similar to the acidic moiety of GABA. The chlorine atom of DZP is placed near the important alpha(1)H101 and the N-methyl group near alpha(1)Y159, alpha(1)T206, and alpha(1)Y209. We present a binding mode of DZP in which the pending phenyl moiety of DZP is buried in the binding pocket and thus shielded from solvent exposure. Our full length GABA(A) receptor is made available as Model S1.	[Bergmann, Rikke; Kongsbak, Kristine; Sorensen, Pernille Louise] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Kongsbak, Kristine] Tech Univ Denmark, Natl Food Inst, Soborg, Denmark; [Sander, Tommy] Novo Nordisk AS, Bagsvaerd, Denmark; [Balle, Thomas] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia	University of Copenhagen; Technical University of Denmark; Novo Nordisk; University of Sydney	Balle, T (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia.	thomas.balle@sydney.edu.au		Bergmann, Rikke/0000-0002-8567-0200; Balle, Thomas/0000-0002-0233-8350	Velux Foundation; NeuroSearch A/S	Velux Foundation(Velux Fonden); NeuroSearch A/S	Financial support was obtained from The Velux Foundation (post doctoral grant to RB) and NeuroSearch A/S (funding ogf research assistant KK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIN J, 1993, NATURE, V366, P565, DOI 10.1038/366565a0; Amin J, 1997, MOL PHARMACOL, V51, P833, DOI 10.1124/mol.51.5.833; [Anonymous], 2011, MACROMODEL V 9 9; [Anonymous], 2011, MAESTR V 9 2; [Anonymous], 2011, JAG V 7 8; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Berezhnoy D, 2005, J NEUROCHEM, V92, P859, DOI 10.1111/j.1471-4159.2004.02913.x; Berezhnoy D, 2004, J BIOL CHEM, V279, P3160, DOI 10.1074/jbc.M311371200; Berezhnoy D, 2009, MOL PHARMACOL, V76, P440, DOI 10.1124/mol.109.054650; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bisson WH, 2008, J MOL MODEL, V14, P891, DOI 10.1007/s00894-008-0340-x; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Boileau AJ, 1999, J NEUROSCI, V19, P4847; Boileau AJ, 2002, J BIOL CHEM, V277, P2931, DOI 10.1074/jbc.M109334200; Bostrom J, 1998, J COMPUT AID MOL DES, V12, P383, DOI 10.1023/A:1008007507641; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Buhr A, 1997, MOL PHARMACOL, V52, P676, DOI 10.1124/mol.52.4.676; Buhr A, 1997, J BIOL CHEM, V272, P11799, DOI 10.1074/jbc.272.18.11799; Buhr A, 1996, MOL PHARMACOL, V49, P1080; Campo-Soria C, 2006, BRIT J PHARMACOL, V148, P984, DOI 10.1038/sj.bjp.0706796; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, J BIOL CHEM, V280, P26457, DOI 10.1074/jbc.M414476200; Chang YC, 2009, ACTA PHARMACOL SIN, V30, P663, DOI 10.1038/aps.2009.51; Cheng J, 2010, EUR J MED CHEM, V45, P3595, DOI 10.1016/j.ejmech.2010.05.004; Ci SQ, 2007, J MOL GRAPH MODEL, V26, P537, DOI 10.1016/j.jmgm.2007.03.007; Ci SQ, 2008, PROTEIN J, V27, P71, DOI 10.1007/s10930-007-9109-9; Clayton T, 2007, CURR MED CHEM, V14, P2755, DOI 10.2174/092986707782360097; Cromer BA, 2002, TRENDS BIOCHEM SCI, V27, P280, DOI 10.1016/S0968-0004(02)02092-3; Davies M, 1998, J NEUROCHEM, V70, P2188; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; DIAZARAUZO H, 1991, LIFE SCI, V49, P207, DOI 10.1016/0024-3205(91)90005-V; Dutertre S, 2007, EMBO J, V26, P3858, DOI 10.1038/sj.emboj.7601785; Ebert B, 1999, NEUROCHEM INT, V34, P427, DOI 10.1016/S0197-0186(99)00038-8; Ernst M, 2003, NEUROSCIENCE, V119, P933, DOI 10.1016/S0306-4522(03)00288-4; FELLEGVARI I, 1989, J LIQ CHROMATOGR, V12, P2719; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Frolund B, 2002, J MED CHEM, V45, P2454, DOI 10.1021/jm020027o; Frolund B, 2000, J MED CHEM, V43, P4930, DOI 10.1021/jm000371q; FROLUND B, 1995, J MED CHEM, V38, P3287, DOI 10.1021/jm00017a014; Gharaghani S, 2011, CHEM BIOL DRUG DES, V78, P612, DOI 10.1111/j.1747-0285.2011.01183.x; Ghoshal N, 2010, EXPERT OPIN DRUG DIS, V5, P441, DOI 10.1517/17460441003789363; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; Grant JAA, 2010, BIOORGAN MED CHEM, V18, P909, DOI 10.1016/j.bmc.2009.11.032; GYNTHER BD, 1986, NEUROSCI LETT, V68, P211, DOI 10.1016/0304-3940(86)90144-8; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hanson SM, 2008, J MED CHEM, V51, P7243, DOI 10.1021/jm800889m; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Harrison NJ, 2006, J MOL MODEL, V12, P317, DOI 10.1007/s00894-005-0034-6; He X, 2000, Drug Des Discov, V17, P131; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Holden JH, 2002, J BIOL CHEM, V277, P18785, DOI 10.1074/jbc.M111778200; Huang Q, 1999, Drug Des Discov, V16, P55; Jansen M, 2008, J MED CHEM, V51, P4430, DOI 10.1021/jm701562x; JOHNSTON GA, 1968, BIOCHEM PHARMACOL, V17, P2488, DOI 10.1016/0006-2952(68)90141-X; Johnston GAR, 2005, CURR PHARM DESIGN, V11, P1867, DOI 10.2174/1381612054021024; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kloda JH, 2007, MOL PHARMACOL, V71, P483, DOI 10.1124/mol.106.028662; Krogsgaard-Larsen P, 2002, CHEM REC, V2, P419, DOI 10.1002/tcr.10040; KROGSGAARDLARSEN P, 1977, NATURE, V268, P53, DOI 10.1038/268053a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Law RJ, 2009, BIOPHYS J, V97, P1586, DOI 10.1016/j.bpj.2009.06.044; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Madsen C, 2007, J MED CHEM, V50, P4147, DOI 10.1021/jm070447j; MAKSAY G, 1991, MOL PHARMACOL, V39, P725; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; Morlock EV, 2011, MOL PHARMACOL, V80, P14, DOI 10.1124/mol.110.069542; Newell JG, 2004, J NEUROSCI, V24, P11226, DOI 10.1523/JNEUROSCI.3746-04.2004; O'Mara M, 2005, BIOPHYS J, V88, P3286, DOI 10.1529/biophysj.104.051664; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Padgett CL, 2007, J NEUROSCI, V27, P886, DOI 10.1523/JNEUROSCI.4791-06.2007; Richter L, 2012, NAT CHEM BIOL, V8, P455, DOI [10.1038/nchembio.917, 10.1038/NCHEMBIO.917]; Rohde LAH, 2012, J BIOL CHEM, V287, P4248, DOI 10.1074/jbc.M111.292243; Rosahl TW, 2000, EUR J NEUROSCI, V12, P514; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sancar F, 2007, MOL PHARMACOL, V71, P38, DOI 10.1124/mol.106.029595; Sander T, 2011, PROTEINS, V79, P1458, DOI 10.1002/prot.22975; Sawyer GW, 2002, J BIOL CHEM, V277, P50036, DOI 10.1074/jbc.M209281200; Schaerer MT, 1998, EUR J PHARMACOL, V354, P283, DOI 10.1016/S0014-2999(98)00456-7; Sharkey LM, 2008, MOL PHARMACOL, V74, P203, DOI 10.1124/mol.108.044891; Sherman W, 2006, CHEM BIOL DRUG DES, V67, P83, DOI 10.1111/j.1747-0285.2005.00327.x; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; SIGEL E, 1992, EMBO J, V11, P2017, DOI 10.1002/j.1460-2075.1992.tb05258.x; Sigel E, 1998, MOL PHARMACOL, V54, P1097, DOI 10.1124/mol.54.6.1097; SIGEL E, 1983, J BIOL CHEM, V258, P6965; SIMONYI M, 1990, ACTA PHARM NORDICA, V2, P145; SIMONYI M, 1990, BIOORG CHEM, V18, P1, DOI 10.1016/0045-2068(90)90010-3; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; STERNBACH LH, 1971, ANGEW CHEM INT EDIT, V10, P34, DOI 10.1002/anie.197100341; STEWARD EG, 1973, ACTA CRYSTALLOGR B, V29, P2825, DOI 10.1107/S0567740873007594; Taliani S, 2009, J MED CHEM, V52, P3723, DOI 10.1021/jm9001154; Tan KR, 2007, FEBS LETT, V581, P4718, DOI 10.1016/j.febslet.2007.08.068; Tan KR, 2007, J BIOL CHEM, V282, P26316, DOI 10.1074/jbc.M702153200; Tan KR, 2009, J NEUROCHEM, V111, P1264, DOI 10.1111/j.1471-4159.2009.06419.x; TANNOR DJ, 1994, J AM CHEM SOC, V116, P11875, DOI 10.1021/ja00105a030; Thompson AJ, 2012, NEUROPHARMACOLOGY, V63, P761, DOI 10.1016/j.neuropharm.2012.05.027; Tomita K., 1965, JAP J BRAIN PHYSIOL, V61, P1; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Venkatachalan SP, 2008, P NATL ACAD SCI USA, V105, P13604, DOI 10.1073/pnas.0801854105; Wagner DA, 2004, J NEUROSCI, V24, P2733, DOI 10.1523/JNEUROSCI.4316-03.2004; Wagner DA, 2001, J NEUROSCI, V21, P67, DOI 10.1523/JNEUROSCI.21-01-00067.2001; Walters RJ, 2000, NAT NEUROSCI, V3, P1274, DOI 10.1038/81800; Westh-Hansen SE, 1999, NEUROREPORT, V10, P2417, DOI 10.1097/00001756-199908020-00036; Wingrove PB, 2002, EUR J PHARMACOL, V437, P31, DOI 10.1016/S0014-2999(02)01279-7; Wingrove PB, 1997, MOL PHARMACOL, V52, P874, DOI 10.1124/mol.52.5.874; YOUNG R, 1984, LIFE SCI, V34, P1977, DOI 10.1016/0024-3205(84)90129-2; Zhang W, 1995, Drug Des Discov, V12, P193	113	90	91	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e52323	10.1371/journal.pone.0052323	http://dx.doi.org/10.1371/journal.pone.0052323			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308109	Green Published, gold			2022-12-25	WOS:000313429100009
J	Foster, NL; Baums, IB; Sanchez, JA; Paris, CB; Chollett, I; Agudelo, CL; Vermeij, MJA; Mumby, PJ				Foster, Nicola L.; Baums, Iliana B.; Sanchez, Juan A.; Paris, Claire B.; Chollett, Iliana; Agudelo, Claudia L.; Vermeij, Mark J. A.; Mumby, Peter J.			Hurricane-Driven Patterns of Clonality in an Ecosystem Engineer: The Caribbean Coral Montastraea annularis	PLOS ONE			English	Article							REEF-BUILDING CORAL; LONG-TERM DECLINE; GENOTYPIC DIVERSITY; ASEXUAL REPRODUCTION; POPULATION-STRUCTURE; PHASE-SHIFTS; RECRUITMENT FAILURE; SEXUAL REPRODUCTION; ACROPORA-PALMATA; LIFE-HISTORIES	K-selected species with low rates of sexual recruitment may utilise storage effects where low adult mortality allows a number of individuals to persist through time until a favourable recruitment period occurs. Alternative methods of recruitment may become increasingly important for such species if the availability of favourable conditions for sexual recruitment decline under rising anthropogenic disturbance and climate change. Here, we test the hypotheses that asexual dispersal is an integral life history strategy not only in branching corals, as previously reported, but also in a columnar, 'K-selected' coral species, and that its prevalence is driven by the frequency of severe hurricane disturbance. Montastraea annularis is a long-lived major frame-work builder of Caribbean coral reefs but its survival is threatened by the consequences of climate induced disturbance, such as bleaching, ocean acidification and increased prevalence of disease. 700 M. annularis samples from 18 reefs within the Caribbean were genotyped using six polymorphic microsatellite loci. We demonstrate that asexual reproduction occurs at varying frequency across the species-range and significantly contributes to the local abundance of M. annularis, with its contribution increasing in areas with greater hurricane frequency. We tested several competing hypotheses that might explain the observed pattern of genotypic diversity. 64% of the variation in genotypic diversity among the sites was explained by hurricane incidence and reef slope, demonstrating that large-scale disturbances combine with local habitat characteristics to shape the balance between sexual and asexual reproduction in populations of M. annularis.	[Foster, Nicola L.; Chollett, Iliana; Mumby, Peter J.] Univ Exeter, Sch BioSci, Marine Spatial Ecol Lab, Exeter, Devon, England; [Baums, Iliana B.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Sanchez, Juan A.; Agudelo, Claudia L.] Univ Los Andes, Fac Ciencias, Dept Ciencias Biol, Lab Biol Mol Marina BIOMMAR, Bogota, Colombia; [Paris, Claire B.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Vermeij, Mark J. A.] Carmabi Fdn, Willemstad, Netherlands; [Vermeij, Mark J. A.] Univ Amsterdam, IBED, Amsterdam, Netherlands	University of Exeter; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Universidad de los Andes (Colombia); University of Miami; University of Amsterdam	Foster, NL (corresponding author), Univ Plymouth, Sch Marine Sci & Engn, Plymouth PL4 8AA, Devon, England.	nicolalouise.foster@gmail.com	Vermeij, Mark/B-2752-2013; sanchez, juan/GSD-8167-2022; Mumby, Peter/F-9914-2010; Baums, Iliana Brigitta/G-6435-2010; Vermeij, Mark/AAR-6757-2020; Foster, Nicola L/A-3885-2012	Vermeij, Mark/0000-0001-9612-9527; Mumby, Peter/0000-0002-6297-9053; Baums, Iliana Brigitta/0000-0001-6463-7308; Vermeij, Mark/0000-0001-9612-9527; Foster, Nicola L/0000-0001-9796-1753; Sanchez, Juan Armando/0000-0001-7149-8369; Chollett, Iliana/0000-0003-0536-499X; Chollett, Iliana/0000-0003-4827-1072; Paris-Limouzy, Claire Beatrix/0000-0002-0637-1334	Royal Society; Natural Environment Research Council;  [007]; NERC [NE/E010393/1] Funding Source: UKRI; Natural Environment Research Council [NE/E010393/1] Funding Source: researchfish; Directorate For Geosciences [0825979] Funding Source: National Science Foundation	Royal Society(Royal Society of London); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by funding from the Royal Society and Natural Environment Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We would like to thank S. Box, K. Kuran, S. Bejarano, A. Grajales, P. Shears and J. Shears for their assistance in the field. We thank K. Sumner and J. Ball for their guidance and assistance in the laboratory in Exeter, A. Harborne for his assistance in estimating site exposure and reef slope and H. Edwards and I. Elliott for their assistance in calculating hurricane incidence. We would also like to thank Glovers Reef Marine Research Station, Belize; Pura Vida Resort, Honduras; COLCIENCIAS, BIOMMAR and La Tortuga Dive Shop, Colombia; Frankie's Dive Shop, Belize and Custom Aquatics, Bahamas for logistical support in the field. Colombia granted access to genetic resources to J.A.S. for the DNA analyses included in this paper (Contract 007, resolution 634, 14 March 2007).	Andrefouet S, 2004, GLOBAL ASSESSMENT MO, P1732; Ayre DJ, 2004, MAR ECOL PROG SER, V277, P95, DOI 10.3354/meps277095; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; BAK RPM, 1979, MAR BIOL, V54, P341, DOI 10.1007/BF00395440; Baums IB, 2006, ECOL MONOGR, V76, P503, DOI 10.1890/0012-9615(2006)076[0503:GVICSI]2.0.CO;2; Baums IB, 2006, LIMNOL OCEANOGR, V51, P1969, DOI 10.4319/lo.2006.51.5.1969; Bries JM, 2004, CORAL REEFS, V23, P297, DOI 10.1007/s00338-004-0379-9; Brown BE, 2000, NATURE, V404, P142, DOI 10.1038/35004657; Burke JM, 2000, EVOLUTION, V54, P137, DOI 10.1111/j.0014-3820.2000.tb00014.x; BURNETT WJ, 1995, MAR BIOL, V122, P665, DOI 10.1007/BF00350688; BYTHELL JC, 1993, CORAL REEFS, V12, P143, DOI 10.1007/BF00334474; Carricart-Ganivet JP, 2004, J EXP MAR BIOL ECOL, V302, P249, DOI 10.1016/j.jembe.2003.10.015; Ceplitis A, 2001, EVOLUTION, V55, P1581, DOI 10.1111/j.0014-3820.2001.tb00677.x; Chassignet EP, 2006, OCEAN WEATHER FORECASTING: AN INTEGRATED VIEW OF OCEANOGRAPHY, P413, DOI 10.1007/1-4020-4028-8_16; Chollett I, LIMNOL OCEA IN PRESS; Coffroth MA, 1998, EVOLUTION, V52, P379, DOI 10.1111/j.1558-5646.1998.tb01639.x; Dollar S.J., 1982, Coral Reefs, V1, P71, DOI 10.1007/BF00301688; Dorken ME, 2001, J ECOL, V89, P339, DOI 10.1046/j.1365-2745.2001.00558.x; Douhovnikoff V, 2005, ECOLOGY, V86, P446, DOI 10.1890/04-0257; Douhovnikoff V, 2004, AM J BOT, V91, P1140, DOI 10.3732/ajb.91.7.1140; DUSTAN P, 1975, MAR BIOL, V33, P101, DOI 10.1007/BF00390714; Edmunds PJ, 2007, ECOL MONOGR, V77, P3, DOI 10.1890/05-1081; Edmunds PJ, 2002, CORAL REEFS, V21, P357, DOI 10.1007/s00338-002-0258-1; Elsner JB, 2008, NATURE, V455, P92, DOI 10.1038/nature07234; Eriksson O, 1996, OIKOS, V77, P248, DOI 10.2307/3546063; Eriksson O, 2000, GLOBAL ECOL BIOGEOGR, V9, P443, DOI 10.1046/j.1365-2699.2000.00215.x; ERIKSSON O, 1989, OIKOS, V55, P231, DOI 10.2307/3565427; Foster NL, 2007, J ANIM ECOL, V76, P384, DOI 10.1111/j.1365-2656.2006.01207.x; Foster NL, 2012, MOL ECOL, V21, P1143, DOI 10.1111/j.1365-294X.2012.05455.x; Gardner SN, 1997, AM NAT, V150, P462, DOI 10.1086/286076; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gardner TA, 2005, ECOLOGY, V86, P174, DOI 10.1890/04-0141; GLADFELTER EH, 1978, B MAR SCI, V28, P728; Goldenberg SB, 2001, SCIENCE, V293, P474, DOI 10.1126/science.1060040; GOREAU TJ, 1990, CORAL REEFS, V8, P211, DOI 10.1007/BF00265013; Gourlay MR, 2005, COAST ENG, V52, P353, DOI 10.1016/j.coastaleng.2004.11.007; Harborne AR, 2006, ECOLOGY, V87, P2871, DOI 10.1890/0012-9658(2006)87[2871:MTBDOC]2.0.CO;2; HARMELINVIVIEN ML, 1986, CORAL REEFS, V5, P55, DOI 10.1007/BF00270353; Harper J. L, 1977, POPULATION BIOL PLAN; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; HIGHSMITH RC, 1982, MAR ECOL PROG SER, V7, P207, DOI 10.3354/meps007207; Hoegh-Guldberg O, 2004, SYMBIOSIS, V37, P1; Holland GJ, 2007, PHILOS T R SOC A, V365, P2695, DOI 10.1098/rsta.2007.2083; Honnay O, 2005, OIKOS, V108, P427, DOI 10.1111/j.0030-1299.2005.13569.x; Hughes R.N., 1985, P153; HUGHES RN, 1990, FUNCTIONAL BIOL CLON; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; HUGHES TP, 1992, TRENDS ECOL EVOL, V7, P292, DOI 10.1016/0169-5347(92)90225-Z; HUNTER CL, 1993, EVOLUTION, V47, P1213, DOI 10.1111/j.1558-5646.1993.tb02148.x; Jackson J.B.C., 1985, P297; JACKSON JBC, 1977, AM NAT, V111, P743, DOI 10.1086/283203; KJERFVE B, 1986, J MAR RES, V44, P119, DOI 10.1357/002224086788460120; Laboute P., 1985, P 5 INT COR REEF S, V3, P323; LASKER HR, 1990, ECOLOGY, V71, P1578, DOI 10.2307/1938293; Le Goff-Vitry MC, 2004, MOL ECOL, V13, P537, DOI 10.1046/j.1365-294X.2004.2079.x; LESSIOS HA, 1988, ANNU REV ECOL SYST, V19, P371, DOI 10.1146/annurev.es.19.110188.002103; Levitan DR, 2004, EVOLUTION, V58, P308, DOI 10.1111/j.0014-3820.2004.tb01647.x; Lirman D, 2003, ECOL MODEL, V161, P169, DOI 10.1016/S0304-3800(02)00346-0; MASSEL SR, 1993, CORAL REEFS, V12, P153, DOI 10.1007/BF00334475; McFadden CS, 1997, EVOLUTION, V51, P112, DOI 10.1111/j.1558-5646.1997.tb02393.x; McManus JW, 2004, PROG OCEANOGR, V60, P263, DOI 10.1016/j.pocean.2004.02.014; Mercado-Molina AE, 2011, J EXP MAR BIOL ECOL, V407, P355, DOI 10.1016/j.jembe.2011.07.018; Miller KJ, 2004, HEREDITY, V92, P557, DOI 10.1038/sj.hdy.6800459; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 1999, MAR ECOL PROG SER, V190, P27, DOI 10.3354/meps190027; Namroud MC, 2006, CONSERV GENET, V7, P415, DOI 10.1007/s10592-005-9051-3; NEIGEL JE, 1983, EVOLUTION, V37, P437, DOI 10.1111/j.1558-5646.1983.tb05561.x; Paris CB, 2007, MAR ECOL PROG SER, V347, P285, DOI 10.3354/meps06985; Pianka ER, 1983, EVOLUTIONARY ECOLOGY; POTTS DC, 1984, PALEOBIOLOGY, V10, P48, DOI 10.1017/S0094837300008010; Prati D, 2000, OIKOS, V90, P442, DOI 10.1034/j.1600-0706.2000.900303.x; Reusch TBH, 2006, MOL ECOL, V15, P277, DOI 10.1111/j.1365-294X.2005.02779.x; Richards CL, 2004, ECOL LETT, V7, P1155, DOI 10.1111/j.1461-0248.2004.00674.x; Severance EG, 2004, MOL ECOL NOTES, V4, P74, DOI 10.1046/j.1471-8286.2003.00573.x; Severance EG, 2006, MAR BIOL, V150, P57, DOI 10.1007/s00227-006-0332-2; Sheppard C, 2005, ESTUAR COAST SHELF S, V64, P223, DOI 10.1016/j.ecss.2005.02.016; Smith LD, 1999, J EXP MAR BIOL ECOL, V235, P147, DOI 10.1016/S0022-0981(98)00178-6; Spalding M. D., 2001, WORLD ATLAS CORAL RE; Stocklin J, 2004, EVOL ECOL, V18, P563, DOI 10.1007/s10682-004-5144-6; STODDART JA, 1988, GENETICS, V118, P705; Stokes KE, 2008, PLANT ECOL, V197, P91, DOI 10.1007/s11258-007-9363-0; SZMANT AM, 1991, MAR ECOL PROG SER, V74, P13, DOI 10.3354/meps074013; Szmant-Froelich A, 1985, P 5 INT COR REEF S, V4, P295; Travis SE, 2005, J ECOL, V93, P417, DOI 10.1111/j.0022-0477.2005.00985.x; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; VANVEGHEL MLJ, 1994, MAR ECOL PROG SER, V109, P221, DOI 10.3354/meps109221; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; WARD S, 1995, J EXP MAR BIOL ECOL, V187, P193, DOI 10.1016/0022-0981(94)00180-L; WARNER RR, 1985, AM NAT, V125, P769, DOI 10.1086/284379; Weppler T, 2006, J ECOL, V94, P869, DOI 10.1111/j.1365-2745.2006.01134.x; Williams DE, 2008, CORAL REEFS, V27, P697, DOI 10.1007/s00338-008-0386-3; Winkler E, 1999, PLANT ECOL, V141, P191, DOI 10.1023/A:1009843619713	95	34	34	2	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53283	10.1371/journal.pone.0053283	http://dx.doi.org/10.1371/journal.pone.0053283			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308185	Green Published, gold			2022-12-25	WOS:000313429100050
J	Musella, V; Verderio, P; Reid, JF; Pizzamiglio, S; Gariboldi, M; Callari, M; Milione, M; De Cecco, L; Veneroni, S; Pierotti, MA; Daidone, MG				Musella, Valeria; Verderio, Paolo; Reid, James Francis; Pizzamiglio, Sara; Gariboldi, Manuela; Callari, Maurizio; Milione, Massimo; De Cecco, Loris; Veneroni, Silvia; Pierotti, Marco Alessandro; Daidone, Maria Grazia			Effects of Warm Ischemic Time on Gene Expression Profiling in Colorectal Cancer Tissues and Normal Mucosa	PLOS ONE			English	Article							RNA INTEGRITY; IMPACT	Background: Genome-wide gene expression analyses of tumors are a powerful tool to identify gene signatures associated with biologically and clinically relevant characteristics and for several tumor types are under clinical validation by prospective trials. However, handling and processing of clinical specimens may significantly affect the molecular data obtained from their analysis. We studied the effects of tissue handling time on gene expression in human normal and tumor colon tissues undergoing routine surgical procedures. Methods: RNA extracted from specimens of 15 patients at four time points (for a total of 180 samples) after surgery was analyzed for gene expression on high-density oligonucleotide microarrays. A mixed-effects model was used to identify probes with different expression means across the four different time points. The p-values of the model were adjusted with the Bonferroni method. Results: Thirty-two probe sets associated with tissue handling time in the tumor specimens, and thirty-one in the normal tissues, were identified. Most genes exhibited moderate changes in expression over the time points analyzed; however four of them were oncogenes, and two confirmed the effect of tissue handling by independent validation. Conclusions: Our results suggest that a critical time point for tissue handling in colon seems to be 60 minutes at room temperature. Although the number of time-dependent genes we identified was low, the three genes that already showed changes at this time point in tumor samples were all oncogenes, hence recommending standardization of tissue-handling protocols and effort to reduce the time from specimen removal to snap freezing accounting for warm ischemia in this tumor type.	[Musella, Valeria; Reid, James Francis; Gariboldi, Manuela; Callari, Maurizio; De Cecco, Loris; Veneroni, Silvia; Daidone, Maria Grazia] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy; [Verderio, Paolo; Pizzamiglio, Sara] Fdn IRCCS Ist Nazl Tumori, Unit Med Stat & Biometry, Milan, Italy; [Reid, James Francis; Gariboldi, Manuela] Fdn Ist FIRC Oncol Mol, Milan, Italy; [Milione, Massimo] Fdn IRCCS Ist Nazl Tumori, Dept Pathol, Milan, Italy; [Pierotti, Marco Alessandro] Fdn IRCCS Ist Nazl Tumori, Sci Directorate, Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; IFOM - FIRC Institute of Molecular Oncology; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan	Daidone, MG (corresponding author), Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy.	mariagrazia.daidone@istitutotumori.mi.it	Daidone, Maria Grazia/E-9232-2017; Verderio, Paolo/B-5034-2017; Veneroni, Silvia/F-3651-2017; Pizzamiglio, Sara/C-1061-2017; De Cecco, Loris/K-7036-2016; Callari, Maurizio/AAF-7089-2019; Milione, Massimo/B-8644-2017; Musella, Valeria/H-4458-2016; Pierotti, Marco Alessandro/AAC-4728-2022; Gariboldi, Manuela/K-4744-2016	Daidone, Maria Grazia/0000-0002-4786-1321; Verderio, Paolo/0000-0002-9231-1281; Veneroni, Silvia/0000-0001-9223-4151; Pizzamiglio, Sara/0000-0002-7759-0550; De Cecco, Loris/0000-0002-7066-473X; Callari, Maurizio/0000-0001-5239-0918; Milione, Massimo/0000-0002-1202-139X; Musella, Valeria/0000-0001-9517-2670; Pierotti, Marco Alessandro/0000-0002-7431-8332; Gariboldi, Manuela/0000-0001-8406-165X	Fondazione Cariplo-Regione Lombardia; Associazione Italiana Ricerca Cancro; Alleanza Contro il Cancro; EurocanPlatform project	Fondazione Cariplo-Regione Lombardia(Fondazione CariploRegione Lombardia); Associazione Italiana Ricerca Cancro(Fondazione AIRC per la ricerca sul cancro); Alleanza Contro il Cancro; EurocanPlatform project	This work was supported by grants from Fondazione Cariplo-Regione Lombardia (project Title: "Biobanca per il carcinoma colorettale"), Associazione Italiana Ricerca Cancro, Alleanza Contro il Cancro, and EurocanPlatform project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bell WC, 2010, METHODS MOL BIOL, V576, P1, DOI 10.1007/978-1-59745-545-9_1; Benjamin D, 2007, EXPERT OPIN BIOL TH, V7, P1515, DOI 10.1517/14712598.7.10.1515; Borgan E, 2011, MOL ONCOL, V5, P564, DOI 10.1016/j.molonc.2011.08.004; Bray SE, 2010, HISTOPATHOLOGY, V56, P240, DOI 10.1111/j.1365-2559.2009.03470.x; De Cecco L, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-409; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dumur CI, 2008, DIAGN MOL PATHOL, V17, P200, DOI 10.1097/PDM.0b013e318169bfaf; Erickson HS, 2010, AM J TRANSL RES, V2, P210; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Florell SR, 2001, MODERN PATHOL, V14, P116, DOI 10.1038/modpathol.3880267; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hatzis C, 2011, JNCI-J NATL CANCER I, V103, P1871, DOI 10.1093/jnci/djr438; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Leek JT, 2006, BIOINFORMATICS, V22, P507, DOI 10.1093/bioinformatics/btk005; McCulloch C. E., 2001, GEN LINEAR MIXED MOD; McHugh SM, 2009, WORLD J SURG ONCOL, V7, DOI 10.1186/1477-7819-7-36; Micke P, 2006, LAB INVEST, V86, P202, DOI 10.1038/labinvest.3700372; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shima Y, 2006, J PEDIATR SURG, V41, P830, DOI 10.1016/j.jpedsurg.2005.12.025; Webster MJ, 2006, PROG BRAIN RES, V158, P3, DOI 10.1016/S0079-6123(06)58001-X	24	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53406	10.1371/journal.pone.0053406	http://dx.doi.org/10.1371/journal.pone.0053406			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308215	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429100063
J	Ross, IL; Levitt, NS				Ross, Ian Louis; Levitt, Naomi S.			Addison's Disease Symptoms - A Cross Sectional Study in Urban South Africa	PLOS ONE			English	Article							HEALTH-CARE; PREVALENCE	Background: Addison's disease is a potentially life-threatening disorder, and prompt diagnosis, and introduction of steroid replacement has resulted in near normal life-expectancy. There are limited data describing the clinical presentation of Addison's disease in South Africa. It is hypothesised that patients may present in advanced state of ill-health, compared to Western countries. Patients: A national database of patients was compiled from primary care, referral centres and private practices. 148 patients were enrolled (97 white, 34 mixed ancestry, 5 Asian and 12 black). Methods: Demographic and clinical data were elicited using questionnaires. Biochemical data were obtained from folder reviews and laboratory archived results. Results: The majority of the cohort was women (62%). The median and inter-quartile age range (IQR) of patients at enrolment was 46.0 (32.0-61.0) years, with a wide range from 2.8-88.0 years. The median and IQR age at initial diagnosis was 34.0 (20.0-45.0) years (range 0.02-77.0) years, indicating that at the time of enrolment, the patients, on average, were diagnosed with Addison's disease 12 years previously. Hyperpigmentation was observed in 76%, nausea and vomiting occurred in more than 40%, and weight loss was noted in 25%. Loss of consciousness as a presenting feature was recorded in 20%. with a 95% confidence interval [CI] of (14-28%) and shock occurred in 5% CI (1.5-8.5%). Case-finding was recorded at 3.1 per million. Conclusions: The usual constellation of hyperpigmentation, nausea, vomiting and weight loss suggests Addison's disease, but a significant proportion present with an advanced state of ill-health and Addisonian crises. A lower prevalence rate, compared to Western countries is suggested.	[Ross, Ian Louis; Levitt, Naomi S.] Univ Cape Town, Dept Med, Groote Schuur Hosp, Div Endocrinol, ZA-7925 Cape Town, South Africa	University of Cape Town	Ross, IL (corresponding author), Univ Cape Town, Dept Med, Groote Schuur Hosp, Div Endocrinol, ZA-7925 Cape Town, South Africa.	ian.ross@uct.ac.za	; Ross, Ian Louis/N-7420-2017	Levitt, Naomi/0000-0001-6480-8066; Ross, Ian Louis/0000-0002-5308-7563	Swedish Research Links [65390/2007]	Swedish Research Links	ILR is the recipient of the Swedish Research Links Grant No: 65390/2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu S, 2009, DIABETOLOGIA, V52, P1842, DOI 10.1007/s00125-009-1433-5; Alkhateeb A, 2003, PIGM CELL RES, V16, P208, DOI 10.1034/j.1600-0749.2003.00032.x; Arlt W, 2003, LANCET, V361, P1881, DOI 10.1016/S0140-6736(03)13492-7; BERGNER GE, 1951, J CLIN ENDOCRINOL, V11, P322, DOI 10.1210/jcem-11-3-322; Bergthorsdottir R, 2006, J CLIN ENDOCR METAB, V91, P4849, DOI 10.1210/jc.2006-0076; Bleicken B, 2010, AM J MED SCI, V339, P525, DOI 10.1097/MAJ.0b013e3181db6b7a; Daviauda E, 2008, B WORLD HEALTH ORGAN, V86, P46, DOI 10.2471/BLT.07.042283; Erichsen MM, 2009, J CLIN ENDOCR METAB, V94, P4882, DOI 10.1210/jc.2009-1368; HOPKINSON ND, 1995, ANN RHEUM DIS, V54, P891, DOI 10.1136/ard.54.11.891; KONG MF, 1994, CLIN ENDOCRINOL, V41, P757, DOI 10.1111/j.1365-2265.1994.tb02790.x; Leelarathna L, 2010, ENDOCRINE, V38, P113, DOI 10.1007/s12020-010-9359-8; Lovas K, 2002, CLIN ENDOCRINOL, V56, P787, DOI 10.1046/j.1365-2265.2002.t01-1-01552.x; Matoussi N, 2008, Tunis Med, V86, P890; MEIKLE AW, 1977, AM J MED, V63, P200, DOI 10.1016/0002-9343(77)90233-9; MENGISTU M, 1991, ETHIOPIAN MED J, V29, P185; Naidoo S, 2012, J PUBLIC HEALTH-UK, V34, P149, DOI 10.1093/pubmed/fds008; NERUP J, 1974, DAN MED BULL, V21, P201; Nieman LK, 2006, CLIN DERMATOL, V24, P276, DOI 10.1016/j.clindermatol.2006.04.006; NOMURA K, 1994, INTERNAL MED, V33, P602, DOI 10.2169/internalmedicine.33.602; Oelkers W, 1996, NEW ENGL J MED, V335, P1206, DOI 10.1056/NEJM199610173351607; PAPADOPOULOS KI, 1990, ACTA ENDOCRINOL-COP, V122, P472, DOI 10.1530/acta.0.1220472; Ross I, 2010, CLIN ENDOCRINOL, V73, P291, DOI 10.1111/j.1365-2265.2010.03807.x; Simm PJ, 2004, J PAEDIATR CHILD H, V40, P596, DOI 10.1111/j.1440-1754.2004.00482.x; Soule S, 1999, CLIN ENDOCRINOL, V50, P115, DOI 10.1046/j.1365-2265.1999.00625.x; Stallwood Lynda, 2005, J Pediatr Health Care, V19, P400, DOI 10.1016/j.pedhc.2005.09.003; Ten S, 2001, J CLIN ENDOCR METAB, V86, P2909, DOI 10.1210/jc.86.7.2909; Vasikaran SD, 2009, CLIN CHEM LAB MED, V47, P963, DOI 10.1515/CCLM.2009.225; Willis AC, 1997, POSTGRAD MED J, V73, P286, DOI 10.1136/pgmj.73.859.286	28	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53526	10.1371/journal.pone.0053526	http://dx.doi.org/10.1371/journal.pone.0053526			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308244	Green Published, gold, Green Submitted			2022-12-25	WOS:000313429100082
J	Smeazzetto, S; Saponaro, A; Young, HS; Moncelli, MR; Thiel, G				Smeazzetto, Serena; Saponaro, Andrea; Young, Howard S.; Moncelli, Maria Rosa; Thiel, Gerhard			Structure-Function Relation of Phospholamban: Modulation of Channel Activity as a Potential Regulator of SERCA Activity	PLOS ONE			English	Article							RELEASE CHANNEL; MUTATION; PHOSPHORYLATION; CA2+-ATPASE; STATE; CONDUCTANCE; ORIENTATION; PROTEINS; BILAYERS; PENTAMER	Phospholamban (PLN) is a small integral membrane protein, which binds and inhibits in a yet unknown fashion the Ca2+-ATPase (SERCA) in the sarcoplasmic reticulum. When reconstituted in planar lipid bilayers PLN exhibits ion channel activity with a low unitary conductance. From the effect of non-electrolyte polymers on this unitary conductance we estimate a narrow pore with a diameter of ca. 2.2 angstrom for this channel. This value is similar to that reported for the central pore in the structure of the PLN pentamer. Hence the PLN pentamer, which is in equilibrium with the monomer, is the most likely channel forming structure. Reconstituted PLN mutants, which either stabilize (K27A and R9C) or destabilize (147A) the PLN pentamer and also phosphorylated PLN still generate the same unitary conductance of the wt/non-phosphorylated PLN. However the open probability of the phosphorylated PLN and of the R9C mutant is significantly lower than that of the respective wt/non-phosphorylated control. In the context of data on PLN/SERCA interaction and on Ca2+ accumulation in the sarcoplasmic reticulum the present results are consistent with the view that PLN channel activity could participate in the balancing of charge during Ca2+ uptake. A reduced total conductance of the K+ transporting PLN by phosphorylation or by the R9C mutation may stimulate Ca2+ uptake in the same way as an inhibition of K+ channels in the SR membrane. The R9C-PLN mutation, a putative cause of dilated cardiomyopathy, might hence affect SERCA activity also via its inherent low open probability.	[Smeazzetto, Serena; Moncelli, Maria Rosa] Univ Florence, Dipartimento Chim, I-50144 Florence, Italy; [Saponaro, Andrea] Univ Milan, Dept Biol, Milan, Italy; [Saponaro, Andrea] Univ Milan, CNR IBF Mi, Milan, Italy; [Young, Howard S.] Univ Alberta, Dept Biochem, Edmonton, AB, Canada; [Thiel, Gerhard] Tech Univ Darmstadt, Darmstadt, Germany	University of Florence; University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Milan; University of Alberta; Technical University of Darmstadt	Thiel, G (corresponding author), Tech Univ Darmstadt, Darmstadt, Germany.	gerhardthiel@me.com	Saponaro, Andrea/AAD-1005-2019	Saponaro, Andrea/0000-0001-5035-5174; Smeazzetto, Serena/0000-0003-3297-569X; Thiel, Gerhard/0000-0002-2335-1351; Young, Howard/0000-0002-5990-8422	Ente Cassa di Risparmio di Firenze; Ministero dell'Istruzione, Universita e Ricerca (PRIN project); Loewe initiative SoftControl	Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); Ministero dell'Istruzione, Universita e Ricerca (PRIN project); Loewe initiative SoftControl	This work was supported by Ente Cassa di Risparmio di Firenze and Ministero dell'Istruzione, Universita e Ricerca (PRIN project) and Loewe initiative SoftControl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLARD B, 1992, FEBS LETT, V314, P81, DOI 10.1016/0014-5793(92)81466-Y; Arkin IT, 1997, ANNU REV BIOPH BIOM, V26, P157, DOI 10.1146/annurev.biophys.26.1.157; ARKIN IT, 1995, J MOL BIOL, V248, P824, DOI 10.1006/jmbi.1995.0263; Brittsan AG, 2000, J MOL CELL CARDIOL, V32, P2131, DOI 10.1006/jmcc.2000.1270; Cabrita LD, 2007, PROTEIN SCI, V16, P2360, DOI 10.1110/ps.072822507; Ceholski DK, 2012, J BIOL CHEM, V287, P16521, DOI 10.1074/jbc.M112.360859; Cornea RL, 1997, BIOCHEMISTRY-US, V36, P2960, DOI 10.1021/bi961955q; Cornea RL, 2000, J BIOL CHEM, V275, P41487, DOI 10.1074/jbc.M008195200; Douglas JL, 2005, PROTEIN EXPRES PURIF, V40, P118, DOI 10.1016/j.pep.2004.11.015; FAVERO TG, 1995, J BIOL CHEM, V270, P25557, DOI 10.1074/jbc.270.43.25557; FINK RHA, 1987, PFLUG ARCH EUR J PHY, V409, P374, DOI 10.1007/BF00583791; Glaves JP, 2011, J MOL BIOL, V405, P707, DOI 10.1016/j.jmb.2010.11.014; Ha KN, 2011, P NATL ACAD SCI USA, V108, P2735, DOI 10.1073/pnas.1013987108; Hille B., 1992, IONIC CHANNELS EXCIT; Hinnah SC, 2002, BIOPHYS J, V83, P899, DOI 10.1016/S0006-3495(02)75216-8; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; KOVACS RJ, 1988, J BIOL CHEM, V263, P18364; KRASILNIKOV OV, 1992, FEMS MICROBIOL IMMUN, V105, P93; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Maffeo C, 2009, BIOPHYS J, V96, P4853, DOI 10.1016/j.bpj.2009.03.053; MONTAL M, 1987, J MEMBRANE BIOL, V98, P101, DOI 10.1007/BF01872123; Oxenoid K, 2005, P NATL ACAD SCI USA, V102, P10870, DOI 10.1073/pnas.0504920102; Reddy LG, 1999, BIOCHEMISTRY-US, V38, P3954, DOI 10.1021/bi981795d; Robia SL, 2007, CIRC RES, V101, P1123, DOI 10.1161/CIRCRESAHA.107.159947; Sansom MSP, 1997, BIOPHYS CHEM, V69, P269, DOI 10.1016/S0301-4622(97)00109-9; Schmidt AG, 2001, CARDIOVASC DRUG THER, V15, P387, DOI 10.1023/A:1013381204658; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Smart OS, 1997, BIOPHYS J, V72, P1109, DOI 10.1016/S0006-3495(97)78760-5; Smeazzetto S, 2011, PHYS CHEM CHEM PHYS, V13, P12935, DOI 10.1039/c1cp20460b; Stokes DL, 2006, BIOPHYS J, V90, P4213, DOI 10.1529/biophysj.105.079640; Tadini-Buoninsegni F, 2006, J BIOL CHEM, V281, P37720, DOI 10.1074/jbc.M606040200; TATULIAN SA, 1995, BIOCHEMISTRY-US, V34, P4448, DOI 10.1021/bi00013a038; Traaseth NJ, 2007, P NATL ACAD SCI USA, V104, P14676, DOI 10.1073/pnas.0701016104; Trieber CA, 2009, BIOCHEMISTRY-US, V48, P9287, DOI 10.1021/bi900852m; Verardi R, 2011, P NATL ACAD SCI USA, V108, P9101, DOI 10.1073/pnas.1016535108; Zamoon J, 2003, BIOPHYS J, V85, P2589, DOI 10.1016/S0006-3495(03)74681-5	36	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e52744	10.1371/journal.pone.0052744	http://dx.doi.org/10.1371/journal.pone.0052744			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308118	Green Published, Green Submitted, gold			2022-12-25	WOS:000313670100012
J	Benoit-Bird, KJ; Battaile, BC; Heppell, SA; Hoover, B; Irons, D; Jones, N; Kuletz, KJ; Nordstrom, CA; Paredes, R; Suryan, RM; Waluk, CM; Trites, AW				Benoit-Bird, Kelly J.; Battaile, Brian C.; Heppell, Scott A.; Hoover, Brian; Irons, David; Jones, Nathan; Kuletz, Kathy J.; Nordstrom, Chad A.; Paredes, Rosana; Suryan, Robert M.; Waluk, Chad M.; Trites, Andrew W.			Prey Patch Patterns Predict Habitat Use by Top Marine Predators with Diverse Foraging Strategies	PLOS ONE			English	Article							SEALS CALLORHINUS-URSINUS; PRIBILOF ISLANDS; SPATIAL SCALE; FUR SEALS; ANTARCTIC KRILL; BERING-SEA; SEABIRDS; DENSITY; MODELS; FOOD	Spatial coherence between predators and prey has rarely been observed in pelagic marine ecosystems. We used measures of the environment, prey abundance, prey quality, and prey distribution to explain the observed distributions of three co-occurring predator species breeding on islands in the southeastern Bering Sea: black-legged kittiwakes (Rissa tridactyla), thick-billed murres (Uria lomvia), and northern fur seals (Callorhinus ursinus). Predictions of statistical models were tested using movement patterns obtained from satellite-tracked individual animals. With the most commonly used measures to quantify prey distributions - areal biomass, density, and numerical abundance - we were unable to find a spatial relationship between predators and their prey. We instead found that habitat use by all three predators was predicted most strongly by prey patch characteristics such as depth and local density within spatial aggregations. Additional prey patch characteristics and physical habitat also contributed significantly to characterizing predator patterns. Our results indicate that the small-scale prey patch characteristics are critical to how predators perceive the quality of their food supply and the mechanisms they use to exploit it, regardless of time of day, sampling year, or source colony. The three focal predator species had different constraints and employed different foraging strategies - a shallow diver that makes trips of moderate distance (kittiwakes), a deep diver that makes trip of short distances (murres), and a deep diver that makes extensive trips (fur seals). However, all three were similarly linked by patchiness of prey rather than by the distribution of overall biomass. This supports the hypothesis that patchiness may be critical for understanding predator-prey relationships in pelagic marine systems more generally.	[Benoit-Bird, Kelly J.; Waluk, Chad M.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Heppell, Scott A.; Paredes, Rosana; Suryan, Robert M.] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Battaile, Brian C.; Nordstrom, Chad A.; Trites, Andrew W.] Univ British Columbia, Marine Mammal Res Unit, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada; [Battaile, Brian C.; Nordstrom, Chad A.; Trites, Andrew W.] Univ British Columbia, Dept Zool, Vancouver, BC V5Z 1M9, Canada; [Hoover, Brian; Jones, Nathan] Univ Calif, Moss Landing Marine Labs, Moss Landing, CA USA; [Irons, David; Kuletz, Kathy J.] US Fish & Wildlife Serv, Anchorage, AK USA	Oregon State University; Oregon State University; University of British Columbia; University of British Columbia; Moss Landing Marine Laboratories; United States Department of the Interior; US Fish & Wildlife Service	Benoit-Bird, KJ (corresponding author), Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA.	kbenoit@coas.oregonstate.edu	Trites, Andrew/K-5648-2012	Hoover, Brian/0000-0003-1603-6932; Trites, Andrew/0000-0003-0342-5322	North Pacific Research Board	North Pacific Research Board	Funding was provided by the North Pacific Research Board as part of the Bering Sea Project [http://bsierp.nprb.org/]. The funders facilitated indersciplinary partnerships as part of the program but had no role in the specifics of the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley DG, 2003, ECOLOGY, V84, P709, DOI 10.1890/0012-9658(2003)084[0709:PRCAGS]2.0.CO;2; Antonelis GA, 1997, J ZOOL, V242, P435, DOI 10.1111/j.1469-7998.1997.tb03847.x; BARANGE M, 1994, S AFR J MARINE SCI, V14, P333; Barnett A, 2012, OIKOS, V121, P882, DOI 10.1111/j.1600-0706.2011.20000.x; Baumgartner MF, 2003, MAR ECOL PROG SER, V264, P66; Belsey DA, 1980, REGRESSION DIAGNOSTI; Benoit-Bird KJ, 2012, BIOL LETTERS, V8, P813, DOI 10.1098/rsbl.2012.0232; Benoit-Bird KJ, 2011, MAR ECOL PROG SER, V443, P217, DOI 10.3354/meps09408; Benoit-Bird KJ, 2010, CONT SHELF RES, V30, P17, DOI 10.1016/j.csr.2009.08.001; Benoit-Bird KJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P364, DOI 10.1007/s00265-003-0585-4; Benoit-Bird KJ, 2009, MAR ECOL PROG SER; Beyer JE, 1995, ICES COUNC M COP DEN; Boyd IL, 1996, ECOLOGY, V77, P426, DOI 10.2307/2265619; Brierley AS, 1996, MAR ECOL PROG SER, V138, P51, DOI 10.3354/meps138051; Byrd GV, 2008, DEEP-SEA RES PT II, V55, P1846, DOI 10.1016/j.dsr2.2008.04.004; COLWELL MA, 1993, CONDOR, V95, P94, DOI 10.2307/1369390; Croll DA, 2005, MAR ECOL PROG SER, V289, P117, DOI 10.3354/meps289117; CROLL DA, 1992, ECOLOGY, V73, P344, DOI 10.2307/1938746; De Robertis A, 2010, CAN J FISH AQUAT SCI, V67, P1459, DOI 10.1139/F10-075; Decker MB, 1996, MAR ECOL PROG SER, V139, P1, DOI 10.3354/meps139001; DIEKMANN O, 1988, EXP APPL ACAROL, V5, P319, DOI 10.1007/BF02366100; Diner N, 2001, AQUAT LIVING RESOUR, V14, P211, DOI 10.1016/S0990-7440(01)01121-4; Doniol-Valcroze T, 2011, BEHAV ECOL, V22, P880, DOI 10.1093/beheco/arr038; Fauchald P, 2000, ECOLOGY, V81, P773, DOI 10.1890/0012-9658(2000)081[0773:SDPPIT]2.0.CO;2; Fauchald P, 2009, MAR ECOL PROG SER, V391, P139, DOI 10.3354/meps07818; FOOTE KG, 1988, J ACOUST SOC AM, V83, P9, DOI 10.1121/1.396190; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Friedlaender AS, 2009, MAR MAMMAL SCI, V25, P402, DOI 10.1111/j.1748-7692.2008.00263.x; Gaston A.J., 1998, AUKS ALCIDAE; GODIN JGJ, 1984, ANIM BEHAV, V32, P120, DOI 10.1016/S0003-3472(84)80330-9; GOEBEL ME, 1991, FISH B-NOAA, V89, P171; Goss C, 1997, MAR ECOL PROG SER, V154, P41, DOI 10.3354/meps154041; GOSSCUSTARD JD, 1977, J APPL ECOL, V14, P681, DOI 10.2307/2402803; Greco NM, 1999, EXP APPL ACAROL, V23, P567, DOI 10.1023/A:1006125103981; Greene C. H., 1994, OCEANOGRAPHY, V7, P4; GREENE CH, 1991, NATURE, V349, P110, DOI 10.1038/349110a0; Grunbaum D, 2003, ECOLOGY, V84, P3265, DOI 10.1890/01-4098; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hammond JI, 2007, ECOLOGY, V88, P1525, DOI 10.1890/06-1236; Hatch SA, 2009, BIRDS N AM; Hazen EL, 2009, MAR ECOL PROG SER, V395, P75, DOI 10.3354/meps08108; Hickey JJ, 1977, ENV ASSESSMENT ALASK, V2, P96; Hines AH, 1997, J EXP MAR BIOL ECOL, V216, P191, DOI 10.1016/S0022-0981(97)00096-8; Hunt G.L.J., 1990, STUD AVIAN BIOL, V14, P7; Hunt GL, 2011, ICES J MAR SCI, V68, P1230, DOI 10.1093/icesjms/fsr036; IVES AR, 1993, ECOLOGY, V74, P1929, DOI 10.2307/1940836; Johnston DW, 2005, MAR ECOL PROG SER, V295, P279, DOI 10.3354/meps295279; Kitaysky AS, 2000, MAR ECOL PROG SER, V206, P283, DOI 10.3354/meps206283; Krebs J.R., 1978, P23; LASKER R, 1975, FISH B-NOAA, V73, P453; Leising AW, 2001, MAR ECOL PROG SER, V216, P167, DOI 10.3354/meps216167; Lewis S, 2001, NATURE, V412, P816, DOI 10.1038/35090566; Lima SL, 2002, TRENDS ECOL EVOL, V17, P70, DOI 10.1016/S0169-5347(01)02393-X; Logerwell EA, 1998, ECOGRAPHY, V21, P212, DOI 10.1111/j.1600-0587.1998.tb00674.x; LOUGHLIN TR, 1989, ARCTIC, V42, P368; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; MacLennan D.N., 1992, SPRINGER SCI BUS MED; Mason DM, 1996, ENVIRON BIOL FISH, V45, P283, DOI 10.1007/BF00003098; MAYO CA, 1990, CAN J ZOOL, V68, P2214, DOI 10.1139/z90-308; McIntosh NE, 2011, THESIS OREGON STATE; Milne BT, 1989, LANDSCAPE ECOL, V2, P102; Mizobata K, 2008, DEEP-SEA RES PT II, V55, P1717, DOI 10.1016/j.dsr2.2008.03.002; Morgan RA, 1997, ECOLOGY, V78, P1087, DOI 10.1890/0012-9658(1997)078[1087:TEOSSO]2.0.CO;2; MUOTKA T, 1994, CAN J FISH AQUAT SCI, V51, P2210, DOI 10.1139/f94-223; Nordstrom CA, DEEP SEA RES 2, DOI [10.1016/j.dsr1012.2012.1007.1010, DOI 10.1016/J.DSR1012.2012.1007.1010]; Orians G.H., 1979, P155; Paredes R, 2012, MAR ECOL PR IN PRESS; Piatt J.F., 1990, Studies in Avian Biology, P36; Renner HM, 2012, DEEP SEA RES 2; ROSE GA, 1990, ECOLOGY, V71, P33, DOI 10.2307/1940245; RUSSELL RW, 1992, LANDSCAPE ECOL, V7, P195, DOI 10.1007/BF00133310; Sigler MF, 2012, DEEP SEA RES 2; Sinclair EH, 2008, DEEP-SEA RES PT II, V55, P1897, DOI 10.1016/j.dsr2.2008.04.031; Steele J. H., 1978, NATO C SERIES, V3, P470; Stewart BD, 2001, MAR BIOL, V138, P383, DOI 10.1007/s002270000468; Suryan RM, 2002, MAR ECOL PROG SER, V236, P273, DOI 10.3354/meps236273; Takahashi A, 2008, DEEP-SEA RES PT II, V55, P1837, DOI 10.1016/j.dsr2.2008.04.005; TASKER ML, 1984, AUK, V101, P567, DOI 10.1093/auk/101.3.567; TISELIUS P, 1993, B MAR SCI, V53, P247; Traynor JJ, 1996, ICES J MAR SCI, V53, P253, DOI 10.1006/jmsc.1996.0031; Veit RR, 1999, ARDEA, V87, P41; Whitman L, 2010, THESIS OREGON STATE; Wiese FK, 2012, DEEP SEA RES 2; Wirsing AJ, 2010, ANIM BEHAV, V79, P531, DOI 10.1016/j.anbehav.2009.12.014; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Zeppelin TK, 2006, J ZOOL, V270, P565, DOI 10.1111/j.1469-7998.2006.00122.x; ZHANG ZQ, 1993, OECOLOGIA, V96, P24, DOI 10.1007/BF00318026	87	135	136	1	128	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53348	10.1371/journal.pone.0053348	http://dx.doi.org/10.1371/journal.pone.0053348			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301063	Green Published, gold			2022-12-25	WOS:000313480000051
J	Bortoletto, M; Mattingley, JB; Cunnington, R				Bortoletto, Marta; Mattingley, Jason B.; Cunnington, Ross			Effects of Context on Visuomotor Interference Depends on the Perspective of Observed Actions	PLOS ONE			English	Article							MIRROR NEURON SYSTEM; AUTOMATIC IMITATION; MOTOR FACILITATION; SELF; ATTENTION; REPRESENTATIONS; SPECIFICITY; PERCEPTION; MECHANISMS; MOVEMENTS	Visuomotor interference occurs when the execution of an action is facilitated by the concurrent observation of the same action and hindered by the concurrent observation of a different action. There is evidence that visuomotor interference can be modulated top-down by higher cognitive functions, depending on whether own performed actions or observed actions are selectively attended. Here, we studied whether these effects of cognitive context on visuomotor interference are also dependent on the point-of-view of the observed action. We employed a delayed go/no-go task known to induce visuomotor interference. Static images of hand gestures in either egocentric or allocentric perspective were presented as "go'' stimuli after participants were pre-cued to prepare either a matching (congruent) or non-matching (incongruent) action. Participants performed this task in two different cognitive contexts: In one, they focused on the visual image of the hand gesture shown as the go stimulus (image context), whereas in the other they focused on the hand gesture they performed (action context). We analyzed reaction times to initiate the prepared action upon presentation of the gesture image and found evidence of visuomotor interference in both contexts and for both perspectives. Strikingly, results show that the effect of cognitive context on visuomotor interference also depends on the perspective of observed actions. When focusing on own-actions, visuomotor interference was significantly less for gesture images in allocentric perspective than in egocentric perspective; when focusing on observed actions, visuomotor interference was present regardless of the perspective of the gesture image. Overall these data suggest that visuomotor interference may be modulated by higher cognitive processes, so that when we are specifically attending to our own actions, images depicting others' actions (allocentric perspective) have much less interference on our own actions.	[Bortoletto, Marta] IRCCS San Giovanni di Dio Fatebenefratelli, Cognit Neurosci Unit, Brescia, Italy; [Mattingley, Jason B.; Cunnington, Ross] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia; [Mattingley, Jason B.; Cunnington, Ross] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia	IRCCS Fatebenefratelli; University of Queensland; University of Queensland	Bortoletto, M (corresponding author), IRCCS San Giovanni di Dio Fatebenefratelli, Cognit Neurosci Unit, Brescia, Italy.	marta.bortoletto@cognitiveneuroscience.it	Bortoletto, Marta/A-9403-2012; Mattingley, Jason/J-1537-2014	Bortoletto, Marta/0000-0002-8489-8043; Mattingley, Jason/0000-0003-0929-9216; Cunnington, Ross/0000-0002-7423-4809	Australian Research Council [DP110103285]	Australian Research Council(Australian Research Council)	This work was supported by a grant from the Australian Research Council (DP110103285). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaerts K, 2009, NEUROPSYCHOLOGIA, V47, P415, DOI 10.1016/j.neuropsychologia.2008.09.012; Bach P, 2007, EXP BRAIN RES, V178, P509, DOI 10.1007/s00221-006-0756-4; Bertenthal BI, 2006, J EXP PSYCHOL HUMAN, V32, P210, DOI 10.1037/0096-1523.32.2.210; Bortoletto M, 2011, NEUROPSYCHOLOGIA, V49, P2097, DOI 10.1016/j.neuropsychologia.2011.04.004; Bruzzo A, 2008, NEUROSCI LETT, V441, P61, DOI 10.1016/j.neulet.2008.06.020; Buccino G, 2006, COGN BEHAV NEUROL, V19, P55, DOI 10.1097/00146965-200603000-00007; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Catmur C, 2011, J EXP PSYCHOL HUMAN, V37, P409, DOI 10.1037/a0019325; Cattaneo L, 2010, SOCIAL COGNITIVE AFF; Chong TTJ, 2008, CURR BIOL, V18, P1576, DOI 10.1016/j.cub.2008.08.068; Chong TTJ, 2009, NEUROPSYCHOLOGIA, V47, P786, DOI 10.1016/j.neuropsychologia.2008.12.008; Craighero L, 2002, NEUROPSYCHOLOGIA, V40, P492, DOI 10.1016/S0028-3932(01)00134-8; David N, 2006, J COGNITIVE NEUROSCI, V18, P898, DOI 10.1162/jocn.2006.18.6.898; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Friston KJ, 2011, BIOL CYBERN, V104, P137, DOI 10.1007/s00422-011-0424-z; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Halasz V, 2012, BRAIN SCI, V2, P130, DOI 10.3390/brainsci2020130; Hesse MD, 2009, J COGNITIVE NEUROSCI, V21, P776, DOI 10.1162/jocn.2009.21058; Hetu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024728; Heyes C, 2011, PSYCHOL BULL, V137, P463, DOI 10.1037/a0022288; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Jackson PL, 2006, NEUROIMAGE, V31, P429, DOI 10.1016/j.neuroimage.2005.11.026; James W., 1890, PRINCIPLES PSYCHOL; Kilner James M, 2007, Cogn Process, V8, P159, DOI 10.1007/s10339-007-0170-2; Kilner JM, 2009, J NEUROSCI, V29, P10153, DOI 10.1523/JNEUROSCI.2668-09.2009; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; Lingnau A, 2009, P NATL ACAD SCI USA, V106, P9925, DOI 10.1073/pnas.0902262106; Longo MR, 2008, J EXP PSYCHOL HUMAN, V34, P489, DOI 10.1037/0096-1523.34.2.489; Longo MR, 2009, EXP BRAIN RES, V192, P739, DOI 10.1007/s00221-008-1649-5; Maeda F, 2002, J NEUROPHYSIOL, V87, P1329, DOI 10.1152/jn.00773.2000; Molenberghs P, 2012, NEUROSCI BIOBEHAV R, V36, P341, DOI 10.1016/j.neubiorev.2011.07.004; Molenberghs P, 2012, NEUROIMAGE, V59, P608, DOI 10.1016/j.neuroimage.2011.07.080; Mulder T, 2007, J NEURAL TRANSM, V114, P1265, DOI 10.1007/s00702-007-0763-z; Oberman LM, 2007, SOC COGN AFFECT NEUR, V2, P62, DOI 10.1093/scan/nsl022; Obhi SS, 2011, J NEUROSCI, V31, P14531, DOI 10.1523/JNEUROSCI.3186-11.2011; Ocampo B, 2010, EXP BRAIN RES, V201, P743, DOI 10.1007/s00221-009-2089-6; Ogawa K, 2011, NEUROIMAGE, V56, P728, DOI 10.1016/j.neuroimage.2010.10.043; Oosterhof NN, 2012, J COGNITIVE NEUROSCI, V24, P975, DOI 10.1162/jocn_a_00195; Perry A, 2011, NEUROIMAGE, V58, P895, DOI 10.1016/j.neuroimage.2011.06.060; Pomeroy VM, 2005, NEUROREHAB NEURAL RE, V19, P4, DOI 10.1177/1545968304274351; Press C, 2008, BRAIN COGNITION, V67, P44, DOI 10.1016/j.bandc.2007.11.001; Press C, 2010, J COGNITIVE NEUROSCI, V22, P2198, DOI 10.1162/jocn.2009.21409; Prinz W., 2005, PERSPECT IMITATION N, V1, P141; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Schuch S, 2010, EXP BRAIN RES, V205, P235, DOI 10.1007/s00221-010-2358-4; Schutz-Bosbach S, 2009, J COGNITIVE NEUROSCI, V21, P1215, DOI 10.1162/jocn.2009.21068; Schutz-Bosbach S, 2006, CURR BIOL, V16, P1830, DOI 10.1016/j.cub.2006.07.048; Spengler S, 2010, CONSCIOUS COGN, V19, P98, DOI 10.1016/j.concog.2009.12.014; Strafella AP, 2000, NEUROREPORT, V11, P2289, DOI 10.1097/00001756-200007140-00044; Vogt S, 2003, NEUROPSYCHOLOGIA, V41, P941, DOI 10.1016/S0028-3932(02)00319-6; Watanabe R, 2011, NEUROSCI LETT, V503, P100, DOI 10.1016/j.neulet.2011.08.016; Wolpert DM, 1997, TRENDS COGN SCI, V1, P209, DOI 10.1016/S1364-6613(97)01070-X	53	18	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53248	10.1371/journal.pone.0053248	http://dx.doi.org/10.1371/journal.pone.0053248			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070BE	23301050	Green Submitted, gold, Green Published			2022-12-25	WOS:000313480000043
J	Frangoulidis, D; Splettstoesser, WD; Landt, O; Dehnhardt, J; Henning, K; Hilbert, A; Bauer, T; Antwerpen, M; Meyer, H; Walter, MC; Knobloch, JKM				Frangoulidis, Dimitrios; Splettstoesser, Wolf D.; Landt, Olfert; Dehnhardt, Jasmin; Henning, Klaus; Hilbert, Angela; Bauer, Tilman; Antwerpen, Markus; Meyer, Hermann; Walter, Mathias C.; Knobloch, Johannes K. -M.			Microevolution of the Chromosomal Region of Acute Disease Antigen A (adaA) in the Query (Q) Fever Agent Coxiella burnetii	PLOS ONE			English	Article							PLASMID BASED DIFFERENTIATION; MOLECULAR CHARACTERIZATION; ENDOCARDITIS; SEQUENCE; IDENTIFICATION; DIVERSITY; EVOLUTION; SAMPLES; FRANCE; GENE	The acute disease antigen A (adaA) gene is believed to be associated with Coxiella burnetii strains causing acute Q fever. The detailed analysis of the adaA genomic region of 23 human- and 86 animal-derived C. burnetii isolates presented in this study reveals a much more polymorphic appearance and distribution of the adaA gene, resulting in a classification of C. burnetii strains of better differentiation than previously anticipated. Three different genomic variants of the adaA gene were identified which could be detected in isolates from acute and chronic patients, rendering the association of adaA positive strains with acute Q fever disease disputable. In addition, all adaA positive strains in humans and animals showed the occurrence of the QpH1 plasmid. All adaA positive isolates of acute human patients except one showed a distinct SNP variation at position 431, also predominant in sheep strains, which correlates well with the observation that sheep are a major source of human infection. Furthermore, the phylogenetic analysis of the adaA gene revealed three deletion events and supported the hypothesis that strain Dugway 5J108-111 might be the ancestor of all known C. burnetii strains. Based on our findings, we could confirm the QpDV group and we were able to define a new genotypic cluster. The adaA gene polymorphisms shown here improve molecular typing of Q fever, and give new insights into microevolutionary adaption processes in C. burnetii.	[Frangoulidis, Dimitrios; Splettstoesser, Wolf D.; Antwerpen, Markus; Meyer, Hermann] Bundeswehr Inst Microbiol, Munich, Germany; [Landt, Olfert; Dehnhardt, Jasmin] TIB MOLBIOL GmbH, Berlin, Germany; [Henning, Klaus; Hilbert, Angela] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Wusterhausen, Germany; [Walter, Mathias C.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Walter, Mathias C.] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, Dept Genome Oriented Bioinformat, Freising Weihenstephan, Germany; [Knobloch, Johannes K. -M.] Med Univ Lubeck, Inst Med Microbiol & Hyg, D-23538 Lubeck, Germany	Bundeswehr Institute of Microbiology (IMB); Friedrich Loeffler Institute; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Lubeck	Frangoulidis, D (corresponding author), Bundeswehr Inst Microbiol, Munich, Germany.	DimitriosFrangoulidis@Bundeswehr.org	Walter, Mathias/B-8837-2013; Walter, Mathias/AGP-4944-2022; Knobloch, Johannes K./D-6456-2011	Walter, Mathias/0000-0003-3012-2626; Walter, Mathias/0000-0003-3012-2626; Knobloch, Johannes K./0000-0002-2591-6387; Antwerpen, Markus/0000-0003-4013-8808; Frangoulidis, Dimitrios/0000-0002-2864-3820	German Ministry of Education and Research (BMBF) [01KI0731, 01KI1001]	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported in part by the German Ministry of Education and Research (BMBF) under contract No. 01KI0731 and 01KI1001 (http://www.gesundheitsforschung-bmbf.de/de/1721.php#zoonosen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	AlHajjar S, 1997, PEDIATR INFECT DIS J, V16, P911, DOI 10.1097/00006454-199709000-00020; Beare PA, 2006, J BACTERIOL, V188, P2309, DOI 10.1128/JB.188.7.2309-2324.2006; Beare PA, 2009, INFECT IMMUN, V77, P642, DOI 10.1128/IAI.01141-08; Bena G, 1998, MOL PHYLOGENET EVOL, V9, P552, DOI 10.1006/mpev.1998.0493; Cao W, 2003, CANCER DETECT PREV, V27, P397, DOI 10.1016/S0361-090X(03)00103-X; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Fernandes I, 2009, CLIN MICROBIOL INFEC, V15, P163, DOI 10.1111/j.1469-0691.2008.02209.x; Fournier PE, 1998, J CLIN MICROBIOL, V36, P1823, DOI 10.1128/JCM.36.7.1823-1834.1998; Frangoulidis D, 2012, FEMS IMMUNOL MED MIC, V64, P134, DOI 10.1111/j.1574-695X.2011.00900.x; Guy L, 2010, BIOINFORMATICS, V26, P2334, DOI 10.1093/bioinformatics/btq413; Hatchette TF, 2001, CLIN INFECT DIS, V33, P1347, DOI 10.1086/323031; HENDRIX LR, 1991, J GEN MICROBIOL, V137, P269, DOI 10.1099/00221287-137-2-269; HOOVER TA, 1992, J BACTERIOL, V174, P5540, DOI 10.1128/JB.174.17.5540-5548.1992; Jado I, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-91; Jager C, 1998, EPIDEMIOL INFECT, V120, P157, DOI 10.1017/S0950268897008510; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; MALLAVIA LP, 1991, EUR J EPIDEMIOL, V7, P213, DOI 10.1007/BF00145669; Massung RF, 2012, ADV EXP MED BIOL, V984, P381, DOI 10.1007/978-94-007-4315-1_19; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Muller Kai, 2005, Appl Bioinformatics, V4, P65; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Porten K, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-147; RAOULT D, 1987, J INFECT DIS, V155, P570, DOI 10.1093/infdis/155.3.570; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; SAMUEL JE, 1985, INFECT IMMUN, V49, P775, DOI 10.1128/IAI.49.3.775-779.1985; SAMUEL JE, 1983, INFECT IMMUN, V41, P488, DOI 10.1128/IAI.41.2.488-493.1983; SAVINELLI EA, 1990, ANN NY ACAD SCI, V590, P523, DOI 10.1111/j.1749-6632.1990.tb42262.x; SAWYER LA, 1987, REV INFECT DIS, V9, P935; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Seshadri R, 2006, EMBL GENBANK D UNPUB; STEIN A, 1993, MICROB PATHOGENESIS, V15, P177, DOI 10.1006/mpat.1993.1068; Stein A, 1998, CLIN INFECT DIS, V27, P592, DOI 10.1086/514698; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; THIELE D, 1994, EUR J EPIDEMIOL, V10, P427, DOI 10.1007/BF01719667; To H, 1998, MICROBIOL IMMUNOL, V42, P81, DOI 10.1111/j.1348-0421.1998.tb02255.x; Tomaso H, 2005, MOL CELL PROBE, V19, P9, DOI 10.1016/j.mcp.2004.08.001; VALKOVA D, 1995, FEMS MICROBIOL LETT, V125, P275, DOI 10.1111/j.1574-6968.1995.tb07368.x; Willems H, 1998, J BACTERIOL, V180, P3816, DOI 10.1128/JB.180.15.3816-3822.1998; WILLEMS H, 1993, EUR J EPIDEMIOL, V9, P411, DOI 10.1007/BF00157399; Zhang GQ, 2005, INFECT IMMUN, V73, P1561, DOI 10.1128/IAI.73.3.1561-1567.2005	40	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53440	10.1371/journal.pone.0053440	http://dx.doi.org/10.1371/journal.pone.0053440			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301072	Green Published, gold, Green Submitted			2022-12-25	WOS:000313480000058
J	Gutschow, MV; Hughey, JJ; Ruggero, NA; Bajar, BT; Valle, SD; Covert, MW				Gutschow, Miriam V.; Hughey, Jacob J.; Ruggero, Nicholas A.; Bajar, Bryce T.; Valle, Sean D.; Covert, Markus W.			Single-Cell and Population NF-kappa B Dynamic Responses Depend on Lipopolysaccharide Preparation	PLOS ONE			English	Article							GENE-EXPRESSION; ACTIVATION; LPS; OSCILLATIONS; TRANSCRIPTION; DETERMINES; SIGNAL; TLR4; MICE	Background: Lipopolysaccharide (LPS), found in the outer membrane of gram-negative bacteria, elicits a strong response from the transcription factor family Nuclear factor (NF)-kappa B via Toll-like receptor (TLR) 4. The cellular response to lipopolysaccharide varies depending on the source and preparation of the ligand, however. Our goal was to compare single-cell NF-kappa B dynamics across multiple sources and concentrations of LPS. Methodology/Principal Findings: Using live-cell fluorescence microscopy, we determined the NF-kappa B activation dynamics of hundreds of single cells expressing a p65-dsRed fusion protein. We used computational image analysis to measure the nuclear localization of the fusion protein in the cells over time. The concentration range spanned up to nine orders of magnitude for three E. coli LPS preparations. We find that the LPS preparations induce markedly different responses, even accounting for potency differences. We also find that the ability of soluble TNF receptor to affect NF-kappa B dynamics varies strikingly across the three preparations. Conclusions/Significance: Our work strongly suggests that the cellular response to LPS is highly sensitive to the source and preparation of the ligand. We therefore caution that conclusions drawn from experiments using one preparation may not be applicable to LPS in general.	[Gutschow, Miriam V.; Hughey, Jacob J.; Bajar, Bryce T.; Valle, Sean D.; Covert, Markus W.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Ruggero, Nicholas A.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA	Stanford University; Stanford University	Covert, MW (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	mcovert@stanford.edu		Hughey, Jacob/0000-0002-1558-6089; Bajar, Bryce/0000-0002-0169-0870; Covert, Markus/0000-0002-5993-8912	NCI Pathway Independence Award [K99/R00 CA125994]; National Institutes of Health (NIH) Director's Pioneer Award [DP1OD006413]; Bio-X; ARCS Graduate Student Fellowship; National Science Foundation Graduate Student Fellowship; NATIONAL CANCER INSTITUTE [K99CA125994, R00CA125994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI104305] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006413] Funding Source: NIH RePORTER	NCI Pathway Independence Award; National Institutes of Health (NIH) Director's Pioneer Award; Bio-X; ARCS Graduate Student Fellowship; National Science Foundation Graduate Student Fellowship(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors were supported by an NCI Pathway Independence Award (K99/R00 CA125994) and a National Institutes of Health (NIH) Director's Pioneer Award (DP1OD006413) to MWC; a Bio-X and an ARCS Graduate Student Fellowship to JJH; and an National Science Foundation Graduate Student Fellowship to NAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bowen WS, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001963; Cheong R, 2006, J BIOL CHEM, V281, P2945, DOI 10.1074/jbc.M510085200; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Erridge C, 2004, J MED MICROBIOL, V53, P735, DOI 10.1099/jmm.0.45598-0; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Krishna S, 2006, P NATL ACAD SCI USA, V103, P10840, DOI 10.1073/pnas.0604085103; Lee TK, 2010, CURR OPIN GENET DEV, V20, P677, DOI 10.1016/j.gde.2010.08.005; Lee TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000599; Li YY, 2012, P NATL ACAD SCI USA, V109, P8716, DOI 10.1073/pnas.1202908109; Lipniacki T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-376; Lipniacki T, 2007, CARDIOVASC TOXICOL, V7, P215, DOI 10.1007/s12012-007-9003-x; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nelson G, 2002, J CELL SCI, V115, P1137; Netea MG, 2002, TRENDS IMMUNOL, V23, P135, DOI 10.1016/S1471-4906(01)02169-X; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Sillitoe K, 2007, BIOCHEM SOC T, V35, P263, DOI 10.1042/BST0350263; Sung MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007163; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145	24	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53222	10.1371/journal.pone.0053222	http://dx.doi.org/10.1371/journal.pone.0053222			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301045	gold, Green Published, Green Submitted			2022-12-25	WOS:000313480000040
J	Klenovics, KS; Boor, P; Somoza, V; Celec, P; Fogliano, V; Sebekova, K				Klenovics, Kristina Simon; Boor, Peter; Somoza, Veronika; Celec, Peter; Fogliano, Vincenzo; Sebekova, Katarina			Advanced Glycation End Products in Infant Formulas Do Not Contribute to Insulin Resistance Associated with Their Consumption	PLOS ONE			English	Article							VASCULAR ADHESION PROTEIN-1; NONDIABETIC SUBJECTS; GLUCOSE-METABOLISM; SOLUBLE RECEPTOR; RISK-FACTORS; HUMAN HEALTH; HUMAN-MILK; BREAST; RAGE; AGES	Introduction: Infant formula-feeding is associated with reduced insulin sensitivity. In rodents and healthy humans, advanced glycation end product (AGE)-rich diets exert diabetogenic effects. In comparison with human breast-milk, infant formulas contain high amounts of AGEs. We assessed the role of AGEs in infant-formula-consumption-associated insulin resistance. Methods: Total plasma levels of N-epsilon-(carboxymethyl)lysine (CML), AGEs-associated fluorescence (lambda(ex) = 370 nm/lambda(em) = 445 nm), soluble adhesion molecules, markers of micro-binflammation (hsCRP), oxidative stress (malondialdehyde, 8-isoprostanes) and leptinemia were determined, and correlated with insulin sensitivity in a cross-sectional study in 166 healthy term infants aged 3-to-14 months, subdivided according to feeding regimen (breast-milk- vs. infant formula-fed) and age (3-to-6-month-olds, 7-to-10-month-olds, and 11-to-14-month-old infants). Effects of the consumption of low- vs. high-CML-containing formulas were assessed. 36 infants aged 5.8 +/- 0.3 months were followed-up 7.5 +/- 0.3 months later. Results: Cross-sectional study: 3-to-6-month-olds and 7-to-10-month-old formula-fed infants presented higher total plasma CML levels and AGEs-associated fluorescence (p<0.01, both), while only the 3-to-6-month-olds displayed lower insulin sensitivity (p<0.01) than their breast-milk-fed counterparts. 3-to-6-month-olds fed low-CML-containing formulas presented lower total plasma CML levels (p<0.01), but similar insulin sensitivity compared to those on high-CML-containing formulas. Markers of oxidative stress and inflammation, levels of leptin and adhesion molecules did not differ significantly between the groups. Follow-up study: at initial investigation, the breast-milk-consuming infants displayed lower total plasma CML levels (p<0.01) and AGEs-associated fluorescence (p<0.05), but higher insulin sensitivity (p<0.05) than the formulas-consuming infants. At follow-up, the groups did not differ significantly in either determined parameter. Conclusions: In healthy term infants, high dietary load with CML does not play a pathophysiological role in the induction of infant formula-associated insulin resistance. Whether a high load of AGEs in early childhood affects postnatal programming remains to be elucidated.	[Klenovics, Kristina Simon; Sebekova, Katarina] Slovak Med Univ, Fac Med, Dept Clin & Expt Pharmacotherapy, Bratislava, Slovakia; [Klenovics, Kristina Simon] Comenius Univ, Inst Physiol, Fac Med, Bratislava, Slovakia; [Boor, Peter; Celec, Peter; Sebekova, Katarina] Comenius Univ, Inst Mol BioMed, Fac Med, Bratislava, Slovakia; [Boor, Peter] Rhein Westfal TH Aachen, Div Nephrol, Aachen, Germany; [Boor, Peter] Rhein Westfal TH Aachen, Inst Pathol, Aachen, Germany; [Somoza, Veronika] German Res Ctr Food Chem, Garching, Germany; [Somoza, Veronika] Univ Vienna, Dept Nutr & Physiol Chem, Vienna, Austria; [Fogliano, Vincenzo] Univ Naples Federico II, Dept Food Sci, Naples, Italy	Comenius University Bratislava; Slovak Medical University Bratislava; Comenius University Bratislava; Slovak Academy of Sciences; Comenius University Bratislava; RWTH Aachen University; RWTH Aachen University; Leibniz-Institute for Food Systems Biology at the Technical University of Munich; University of Vienna; University of Naples Federico II	Sebekova, K (corresponding author), Slovak Med Univ, Fac Med, Dept Clin & Expt Pharmacotherapy, Bratislava, Slovakia.	kata.sebekova@gmail.com	Celec, Peter/I-7103-2012; fogliano, vincenzo/W-6885-2019; Somoza, Veronika/D-4141-2013; fogliano, vincenzo/A-1419-2009; Boor, Peter/C-7707-2011; Sebekova, Katarina/H-4906-2016; Sebekova, Katarina/GSD-7056-2022; Fogliano, Vincenzo/M-8166-2019	Celec, Peter/0000-0001-5883-3580; fogliano, vincenzo/0000-0001-8786-9355; Somoza, Veronika/0000-0003-2456-9245; fogliano, vincenzo/0000-0001-8786-9355; Boor, Peter/0000-0001-9921-4284; Sebekova, Katarina/0000-0002-9641-9265; Sebekova, Katarina/0000-0002-9641-9265; Mericq, Veronica/0000-0003-2287-0181	EC of EU [COLL-CT-2005-516415]; Slovak Research and Development Agency [VMSP-II-0027-09]	EC of EU; Slovak Research and Development Agency(Slovak Research and Development Agency)	This study was supported by the grant from 6th FP of EC of EU (ICARE, No. COLL-CT-2005-516415), and from Slovak Research and Development Agency (No. VMSP-II-0027-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella A, 2003, DIABETES, V52, P1004, DOI 10.2337/diabetes.52.4.1004; Agostoni C, 1999, ARCH DIS CHILD, V81, P395, DOI 10.1136/adc.81.5.395; Ames JM, 2007, MOL NUTR FOOD RES, V51, P1085, DOI 10.1002/mnfr.200600304; Basta G, 2006, J CLIN ENDOCR METAB, V91, P4628, DOI 10.1210/jc.2005-2559; Bergmann R, 2001, NAHRUNG, V45, P182, DOI 10.1002/1521-3803(20010601)45:3&lt;182::AID-FOOD182&gt;3.0.CO;2-Q; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Birlouez-Aragon I, 2004, FOOD CHEM, V87, P253, DOI 10.1016/j.foodchem.2003.11.019; Birlouez-Aragon I, 2010, AM J CLIN NUTR, V91, P1220, DOI 10.3945/ajcn.2009.28737; Boor P, 2010, CLIN CHIM ACTA, V411, P1034, DOI 10.1016/j.cca.2010.03.033; Buetler TM, 2008, MOL NUTR FOOD RES, V52, P370, DOI 10.1002/mnfr.200700101; Buetler TM, 2011, MOL NUTR FOOD RES, V55, P291, DOI 10.1002/mnfr.201000140; Bulk-Bunschoten AMW, 2002, PAEDIATR PERINAT EP, V16, P361, DOI 10.1046/j.1365-3016.2002.00440.x; Cassese A, 2008, J BIOL CHEM, V283, P36088, DOI 10.1074/jbc.M801698200; Dabelea D, 2009, LANCET, V373, P1999, DOI 10.1016/S0140-6736(09)60874-6; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Das UN, 2002, PROSTAG LEUKOTR ESS, V67, P1, DOI 10.1054/plef.2002.0374; DaVeiga SP, 2012, ALLERGY ASTHMA PROC, V33, P227, DOI 10.2500/aap.2012.33.3569; Delatour T, 2009, J CHROMATOGR A, V1216, P2371, DOI 10.1016/j.chroma.2009.01.011; Erkekoglu P, 2010, NUTR RES REV, V23, P323, DOI 10.1017/S0954422410000211; Fabricius-Bjerre S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020595; Felton JS, 2007, MUTAT RES-FUND MOL M, V616, P90, DOI 10.1016/j.mrfmmm.2006.11.010; Fohgelberg P, 2005, FOOD CHEM TOXICOL, V43, P951, DOI 10.1016/j.fct.2005.02.001; GINSBURG BE, 1984, ACTA PAEDIATR SCAND, V73, P213, DOI 10.1111/j.1651-2227.1984.tb09931.x; Gupta M, 2010, INDIAN J PEDIATR, V77, P509, DOI 10.1007/s12098-010-0065-6; Havel PJ, 1998, AM J CLIN NUTR, V67, P355, DOI 10.1093/ajcn/67.3.355; Heird WC, 2007, J NUTR, V137, p499S, DOI 10.1093/jn/137.2.499S; Heizmann CW, 2007, MOL NUTR FOOD RES, V51, P1116, DOI 10.1002/mnfr.200600284; JENNESS R, 1979, SEMIN PERINATOL, V3, P225; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kerkhof GF, 2012, J CLIN ENDOCR METAB, V97, P2637, DOI 10.1210/jc.2012-1426; Klenovicsova K, 2011, CLIN CHIM ACTA, V412, P1842, DOI 10.1016/j.cca.2011.06.019; Koyama H, 2007, BIOMARK INSIGHTS, V2, P331; Lack G, 2012, J ALLERGY CLIN IMMUN, V129, P1187, DOI 10.1016/j.jaci.2012.02.036; Leung AKC, 2005, J NATL MED ASSOC, V97, P1010; Li HY, 2009, CLIN CHIM ACTA, V404, P149, DOI 10.1016/j.cca.2009.03.041; Li HY, 2009, CLIN CHIM ACTA, V403, P97, DOI 10.1016/j.cca.2009.01.027; Lonnerdal B, 2000, AM J CLIN NUTR, V72, P484; LUCAS A, 1981, ACTA PAEDIATR SCAND, V70, P195, DOI 10.1111/j.1651-2227.1981.tb05541.x; LYLES GA, 1992, BIOCHEM PHARMACOL, V43, P1409, DOI 10.1016/0006-2952(92)90196-P; Madsen AL, 2010, DIABETIC MED, V27, P1350, DOI 10.1111/j.1464-5491.2010.03134.x; Meltretter J, 2008, ANN NY ACAD SCI, V1126, P134, DOI 10.1196/annals.1433.022; Mericq V, 2005, DIABETOLOGIA, V48, P2609, DOI 10.1007/s00125-005-0036-z; Mericq V, 2010, DIABETES CARE, V33, P2232, DOI 10.2337/dc10-1058; Miele C, 2003, J BIOL CHEM, V278, P47376, DOI 10.1074/jbc.M301088200; Miyata T, 2000, KIDNEY INT, V58, pS120, DOI 10.1046/j.1523-1755.2000.07615.x; Mueller WM, 1998, ENDOCRINOLOGY, V139, P551, DOI 10.1210/en.139.2.551; Munch G, 1997, EUR J CLIN CHEM CLIN, V35, P669; Nakamura K, 2007, CLIN EXP MED, V7, P188, DOI 10.1007/s10238-007-0146-7; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Pischetsrieder M, 2012, AMINO ACIDS, V42, P1111, DOI 10.1007/s00726-010-0775-0; Puddu A, 2010, BIOCHEM BIOPH RES CO, V395, P122, DOI 10.1016/j.bbrc.2010.03.152; Savino F, 2009, CLIN ENDOCRINOL, V71, P757, DOI 10.1111/j.1365-2265.2009.03585.x; Schack-Nielsen L, 2007, J NUTR, V137, p503S, DOI 10.1093/jn/137.2.503S; Sebekova K, 2001, EUR J NUTR, V40, P275, DOI 10.1007/s394-001-8356-3; Sebekova K, 2008, ANN NY ACAD SCI, V1126, P177, DOI 10.1196/annals.1433.049; Sebekova K, 2007, MOL NUTR FOOD RES, V51, P1079, DOI 10.1002/mnfr.200700035; Shu TT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018782; Smith DJ, 1998, J EXP MED, V188, P17, DOI 10.1084/jem.188.1.17; Tahara N, 2012, CARDIOVASC THER, V30, P42, DOI 10.1111/j.1755-5922.2010.00177.x; Tan KCB, 2011, DIABETES-METAB RES, V27, P488, DOI 10.1002/dmrr.1188; Unoki H, 2007, DIABETES RES CLIN PR, V76, P236, DOI 10.1016/j.diabres.2006.09.016; Uribarri J, 2005, ANN NY ACAD SCI, V1043, P461, DOI 10.1196/annals.1333.052; Uribarri J, 2011, DIABETES CARE, V34, P1610, DOI 10.2337/dc11-0091; Van Nguyen C, 2006, MOL NUTR FOOD RES, V50, P1140, DOI 10.1002/mnfr.200600144; Vlassara Helen, 2007, Curr Diab Rep, V7, P235, DOI 10.1007/s11892-007-0037-z; WONG SHY, 1987, CLIN CHEM, V33, P214; Yan SF, 2003, CIRC RES, V93, P1159, DOI 10.1161/01.RES.0000103862.26506.3D; Yonekura H, 2003, BIOCHEM J, V370, P1097, DOI 10.1042/BJ20021371; Zhang L, 2008, J BIOL CHEM, V283, P35507, DOI 10.1074/jbc.M806948200; Zhao ZS, 2009, ENDOCRINOLOGY, V150, P2569, DOI 10.1210/en.2008-1342	70	21	21	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53056	10.1371/journal.pone.0053056	http://dx.doi.org/10.1371/journal.pone.0053056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301020	Green Published, Green Submitted, gold			2022-12-25	WOS:000313320900056
J	Mavila, N; James, D; Utley, S; Cu, N; Coblens, O; Mak, K; Rountree, CB; Kahn, M; Wang, KS				Mavila, Nirmala; James, David; Utley, Sarah; Nguyen Cu; Coblens, Orly; Mak, Katrina; Rountree, C. Bart; Kahn, Michael; Wang, Kasper S.			Fibroblast Growth Factor Receptor-Mediated Activation of AKT-beta-Catenin-CBP Pathway Regulates Survival and Proliferation of Murine Hepatoblasts and Hepatic Tumor Initiating Stem Cells	PLOS ONE			English	Article							LIVER PROGENITOR CELLS; CREB-BINDING PROTEIN; WNT/BETA-CATENIN; SELF-RENEWAL; CANCER; P300; PHOSPHORYLATION; DIFFERENTIATION; COACTIVATORS; EXPRESSION	Fibroblast Growth Factor (FGF)-10 promotes the proliferation and survival of murine hepatoblasts during early stages of hepatogenesis through a Wnt-beta-catenin dependent pathway. To determine the mechanism by which this occurs, we expanded primary culture of hepatoblasts enriched for progenitor markers CD133 and CD49f from embryonic day (E) 12.5 fetal liver and an established tumor initiating stem cell line from Mat1a(-/-) livers in media conditioned with recombinant (r) FGF10 or rFGF7. FGF Receptor (R) activation resulted in the downstream activation of MAPK, PI3K-AKT, and beta-catenin pathways, as well as cellular proliferation. Additionally, increased levels of nuclear beta-catenin phosphorylated at Serine-552 in cultured primary hepatoblasts, Mat1a(-/-) cells, and also in ex vivo embryonic liver explants indicate AKT-dependent activation of beta-catenin downstream of FGFR activation; conversely, the addition of AKT inhibitor Ly294002 completely abrogated beta-catenin activation. FGFR activation-induced cell proliferation and survival were also inhibited by the compound ICG-001, a small molecule inhibitor of beta-catenin-CREB Binding Protein (CBP) in hepatoblasts, further indicating a CBP-dependent regulatory mechanism of beta-catenin activity. Conclusion: FGF signaling regulates the proliferation and survival of embryonic and transformed progenitor cells in part through AKT-mediated activation of beta-catenin and downstream interaction with the transcriptional co-activator CBP. Citation: Mavila N, James D, Utley S, Cu N, Coblens O, et al. (2012) Fibroblast Growth Factor Receptor-Mediated Activation of AKT-beta-Catenin-CBP Pathway Regulates Survival and Proliferation of Murine Hepatoblasts and Hepatic Tumor Initiating Stem Cells. PLoS ONE 7(11): e50401. doi:10.1371/journal.pone.0050401	[Mavila, Nirmala; James, David; Utley, Sarah; Coblens, Orly; Mak, Katrina; Wang, Kasper S.] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; [Nguyen Cu; Kahn, Michael] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Nguyen Cu; Kahn, Michael] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Rountree, C. Bart] Bon Secours St Marys Hosp, Richmond, VA USA	Children's Hospital Los Angeles; University of Southern California; University of Southern California	Wang, KS (corresponding author), Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA.	kwang@chla.usc.edu	Mavila, Nirmala/AAH-6140-2021		National Institutes of Health Grants [K08 AAA01690]; American College of Surgeons Franklin Martin Award; NIH [HL073722]; USC Norris Comprehensive Cancer Center Support Grant [P30 CA014089]; American Cancer Society [MGO-116519]; Penn State Hershey Four Diamonds Fund; California Institute for Regenerative Medicine Bridges to Stem Cell Research Award; NATIONAL CANCER INSTITUTE [P30CA014089] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K08AA016290] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American College of Surgeons Franklin Martin Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USC Norris Comprehensive Cancer Center Support Grant; American Cancer Society(American Cancer Society); Penn State Hershey Four Diamonds Fund; California Institute for Regenerative Medicine Bridges to Stem Cell Research Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by in part by the National Institutes of Health Grants K08 AAA01690 (to KW), the American College of Surgeons Franklin Martin Award (to KW), NIH HL073722 (to MK), USC Norris Comprehensive Cancer Center Support Grant P30 CA014089 (to MK), American Cancer Society, MGO-116519 (to CBR), and The Penn State Hershey Four Diamonds Fund (to CBR) and the California Institute for Regenerative Medicine Bridges to Stem Cell Research Award (to KM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; Berg T, 2007, HEPATOLOGY, V46, P1187, DOI 10.1002/hep.21814; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Cairo S, 2008, CANCER CELL, V14, P471, DOI 10.1016/j.ccr.2008.11.002; Calmont A, 2006, DEV CELL, V11, P339, DOI 10.1016/j.devcel.2006.06.015; Cardinale V, 2011, HEPATOLOGY, V54, P2159, DOI 10.1002/hep.24590; Chan WI, 2011, MOL CELL BIOL, V31, P5046, DOI 10.1128/MCB.05830-11; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fiegel HC, 2004, J HISTOCHEM CYTOCHEM, V52, P1495, DOI 10.1369/jhc.4A6297.2004; Goodman RH, 2000, GENE DEV, V14, P1553; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; Hoppo T, 2004, HEPATOLOGY, V39, P1362, DOI 10.1002/hep.20180; HU ZY, 1995, CELL GROWTH DIFFER, V6, P1019; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; Kahn M, 2011, FUTURE MED CHEM, V3, P1745, DOI [10.4155/FMC.11.126, 10.4155/fmc.11.126]; Lade AG, 2011, DEV DYNAM, V240, P486, DOI 10.1002/dvdy.22522; Laurson J, 2007, CELLS TISSUES ORGANS, V186, P180, DOI 10.1159/000106360; Levy L, 2004, MOL CELL BIOL, V24, P3404, DOI 10.1128/MCB.24.8.3404-3414.2004; Ma H, 2005, ONCOGENE, V24, P3619, DOI 10.1038/sj.onc.1208433; Micsenyi A, 2004, GASTROENTEROLOGY, V126, P1134, DOI 10.1053/j.gastro.2003.12.047; Miki T, 2011, STEM CELL REV; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Monga SPS, 2003, GASTROENTEROLOGY, V124, P202, DOI 10.1053/gast.2003.50000; Nejak-Bowen Kari, 2008, Organogenesis, V4, P92; Ponce DP, 2011, MOL CELL BIOCHEM, V356, P127, DOI 10.1007/s11010-011-0965-4; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rountree CB, 2008, HEPATOLOGY, V47, P1288, DOI 10.1002/hep.22141; Rountree CB, 2007, STEM CELLS, V25, P2419, DOI 10.1634/stemcells.2007-0176; Sokol SY, 2011, DEVELOPMENT, V138, P4341, DOI 10.1242/dev.066209; Tanimizu N, 2007, MOL BIOL CELL, V18, P1472, DOI 10.1091/mbc.E06-09-0848; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Taurin S, 2008, AM J PHYSIOL-CELL PH, V294, pC1169, DOI 10.1152/ajpcell.00096.2008; Teo JL, 2010, ADV DRUG DELIVER REV, V62, P1149, DOI 10.1016/j.addr.2010.09.012; Teo JL, 2005, P NATL ACAD SCI USA, V102, P12171, DOI 10.1073/pnas.0504600102; Thompson MD, 2007, HEPATOLOGY, V45, P1298, DOI 10.1002/hep.21651; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Volckaert T, 2011, J CLIN INVEST, V121, P4409, DOI 10.1172/JCI58097; Wolf D, 2002, J BIOL CHEM, V277, P25562, DOI 10.1074/jbc.M201196200; Yang W, 2008, CANCER RES, V68, P4287, DOI 10.1158/0008-5472.CAN-07-6691; Yeh BK, 2003, P NATL ACAD SCI USA, V100, P2266, DOI 10.1073/pnas.0436500100; Zaret KS, 2000, MECH DEVELOP, V92, P83, DOI 10.1016/S0925-4773(99)00326-3; Zaret KS, 2001, CURR OPIN GENET DEV, V11, P568, DOI 10.1016/S0959-437X(00)00234-3; Zhang LL, 2008, HEPATOLOGY, V48, P1598, DOI 10.1002/hep.22516; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	48	33	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50401	10.1371/journal.pone.0050401	http://dx.doi.org/10.1371/journal.pone.0050401			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23308088	Green Published, Green Submitted, gold			2022-12-25	WOS:000312376100089
J	Thu, KL; Radulovich, N; Becker-Santos, DD; Pikor, LA; Pusic, A; Lockwood, WW; Lam, WL; Tsao, MS				Thu, K. L.; Radulovich, N.; Becker-Santos, D. D.; Pikor, L. A.; Pusic, A.; Lockwood, W. W.; Lam, W. L.; Tsao, M-S			SOX15 is a candidate tumor suppressor in pancreatic cancer with a potential role in Wnt/beta-catenin signaling	ONCOGENE			English	Article						SOX15; integrative genomics; tumor suppressor; pancreatic cancer; Wnt pathway	FREQUENT EPIGENETIC INACTIVATION; PROMOTER METHYLATION; WNT PATHWAY; GENE; MUTATIONS; ONCOGENE; BIOLOGY; PROLIFERATION; ANTAGONISTS; EVOLUTION	Pancreatic cancer is among the top five deadliest cancers in developed countries. Better knowledge of the molecular mechanisms contributing to its tumorigenesis is imperative to improve patient prognosis. Identification of novel tumor suppressor genes (TSGs) in pancreatic cancer will reveal new mechanisms of pathway deregulation and will ultimately help improve our understanding of this aggressive disease. According to Knudson's two-hit model, TSGs are classically disrupted by two concerted genetic events. In this study, we combined DNA methylation profiling with copy number and mRNA expression profiling to identify novel TSGs in a set of 20 pancreatic cancer cell lines. These data sets were integrated for each of similar to 12000 genes in each cell line enabling the elucidation of those genes that undergo DNA hypermethylation, copy-number loss and mRNA downregulation simultaneously in multiple cell lines. Using this integrative genomics strategy, we identified SOX15 (sex determining region Y-box 15) as a candidate TSG in pancreatic cancer. Expression of SOX15 in pancreatic cancer cell lines with undetectable expression resulted in reduced viability of cancer cells both in vitro and in vivo demonstrating its tumor suppressive capability. We also found reduced expression, homozygous deletion and aberrant DNA methylation of SOX15 in clinical pancreatic tumor data sets. Furthermore, we deduced a novel role for SOX15 in suppressing the Wnt/b-catenin signaling pathway, which we hypothesize is a pathway through which SOX15 may exert its tumor suppressive effects in pancreatic cancer.	[Thu, K. L.; Becker-Santos, D. D.; Pikor, L. A.; Pusic, A.; Lockwood, W. W.; Lam, W. L.] BC Canc Res Ctr, Vancouver, BC, Canada; [Radulovich, N.; Tsao, M-S] Univ Toronto, Ontario Canc Inst, Princess Margaret Hosp, Univ Hlth Network, Toronto, ON M5S 1A1, Canada; [Radulovich, N.; Tsao, M-S] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	British Columbia Cancer Agency; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Lam, WL (corresponding author), BC Canc Res Ctr, Vancouver, BC, Canada.	wanlam@bccrc.ca; Ming.Tsao@uhn.ca	Tsao, Ming-Sound/M-3503-2017; Tsao, Ming Sound/AFQ-7332-2022	Tsao, Ming Sound/0000-0002-9160-5405; Thu, Kelsie/0000-0001-9262-7238	Vanier Canada Graduate Scholarships; University of British Columbia 4YF scholarship; CIHR Jean-Francois Saint Denis Fellowship in Cancer Research; Canadian Cancer Society Research Institute [700809]; Canadian Institutes for Health Research; PMH Foundation; Ontario Ministry of Health and Long Term Care; M Qasim Choksi Chair in Lung Cancer Translational Research	Vanier Canada Graduate Scholarships; University of British Columbia 4YF scholarship; CIHR Jean-Francois Saint Denis Fellowship in Cancer Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); PMH Foundation; Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); M Qasim Choksi Chair in Lung Cancer Translational Research	KLT, NR and LAP are supported by Vanier Canada Graduate Scholarships, DDBS by University of British Columbia 4YF scholarship and WWL by a CIHR Jean-Francois Saint Denis Fellowship in Cancer Research. This work was supported by grants from the Canadian Cancer Society Research Institute (#700809), the Canadian Institutes for Health Research, PMH Foundation and Ontario Ministry of Health and Long Term Care. MST is the M Qasim Choksi Chair in Lung Cancer Translational Research.	Andreeva AV, 2010, GENE CHROMOSOME CANC, V49, P775, DOI 10.1002/gcc.20787; Bachman KE, 1999, CANCER RES, V59, P798; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Beranger F, 2000, J BIOL CHEM, V275, P16103, DOI 10.1074/jbc.275.21.16103; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; Bernard P, 2010, INT J BIOCHEM CELL B, V42, P400, DOI 10.1016/j.biocel.2009.10.017; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Birnbaum DJ, 2011, GENE CHROMOSOME CANC, V50, P456, DOI 10.1002/gcc.20870; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Coe BP, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq548; di Magliano MP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001155; Dihlmann S, 2005, INT J CANCER, V113, P515, DOI 10.1002/ijc.20609; Drew BA, 2012, BBA-REV CANCER, V1825, P37, DOI 10.1016/j.bbcan.2011.10.002; Du YC, 2009, GASTROENTEROLOGY, V137, P1346, DOI 10.1053/j.gastro.2009.06.041; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gumz ML, 2007, CLIN CANCER RES, V13, P4740, DOI 10.1158/1078-0432.CCR-07-0143; Gustavsson E, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-187; Harada T, 2008, ONCOGENE, V27, P1951, DOI 10.1038/sj.onc.1210832; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hong SM, 2012, CLIN CANCER RES, V18, P700, DOI 10.1158/1078-0432.CCR-11-1718; Ishkanian AS, 2004, NAT GENET, V36, P299, DOI 10.1038/ng1307; Ito M, 2010, INT J BIOCHEM CELL B, V42, P449, DOI 10.1016/j.biocel.2009.10.023; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jia Y, 2010, EPIGENETICS-US, V5, P743, DOI 10.4161/epi.5.8.13104; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Joergensen MT, 2011, PANCREAS, V40, P540, DOI 10.1097/MPA.0b013e3182152fdf; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Khojasteh M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-274; Klarmann GJ, 2008, EPIGENETICS-US, V3, P59, DOI 10.4161/epi.3.2.5899; Kongkham PN, 2010, ONCOGENE, V29, P3017, DOI 10.1038/onc.2010.32; Kormish JD, 2010, DEV DYNAM, V239, P56, DOI 10.1002/dvdy.22046; Lee HJ, 2004, MOL CELL BIOL, V24, P8428, DOI 10.1128/MCB.24.19.8428-8436.2004; Licchesi JDF, 2008, CARCINOGENESIS, V29, P895, DOI 10.1093/carcin/bgn017; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Lochhead PA, 2012, BIOCHEM SOC T, V40, P251, DOI 10.1042/BST20110663; Lockwood WW, 2012, CLIN CANCER RES, V18, P1936, DOI 10.1158/1078-0432.CCR-11-1431; MacGrogan D, 1996, GENOMICS, V35, P55, DOI 10.1006/geno.1996.0322; Mak AB, 2010, MOL CELL PROTEOMICS, V9, P811, DOI 10.1074/mcp.M000002-MCP201; Mann KM, 2012, P NATL ACAD SCI USA, V109, P5934, DOI 10.1073/pnas.1202490109; McCleary-Wheeler AL, 2012, MOL CARCINOGEN, V51, P25, DOI 10.1002/mc.20827; Medina PP, 2009, HUM MOL GENET, V18, P1343, DOI 10.1093/hmg/ddp034; Meeson AP, 2007, EMBO J, V26, P1902, DOI 10.1038/sj.emboj.7601635; Moon Randall T, 2004, Nat Rev Genet, V5, P691, DOI 10.1038/nrg1427; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Polakis P, 2012, EMBO J, V31, P2737, DOI 10.1038/emboj.2012.126; Qin YR, 2011, CLIN CANCER RES, V17, P46, DOI 10.1158/1078-0432.CCR-10-1155; Radutovich N, 2008, METHOD ENZYMOL, V439, P1, DOI 10.1016/S0076-6879(07)00401-6; Rajan N, 2011, J PATHOL, V224, P309, DOI 10.1002/path.2896; Rubin JS, 2006, FRONT BIOSCI, V11, P2093, DOI 10.2741/1952; Sakai M, 2004, CANCER SCI, V95, P588, DOI 10.1111/j.1349-7006.2004.tb02491.x; Samuel N, 2012, NAT REV GASTRO HEPAT, V9, P77, DOI 10.1038/nrgastro.2011.215; Sato H, 2007, CARCINOGENESIS, V28, P2459, DOI 10.1093/carcin/bgm178; Savage J, 2009, STEM CELLS, V27, P1231, DOI 10.1002/stem.57; Simon R, 2007, CANCER INFORM, V3, P11; Singh P, 2011, PANCREAS, V40, P644, DOI 10.1097/MPA.0b013e31821ff741; Suzuki H, 2008, BRIT J CANCER, V98, P1147, DOI 10.1038/sj.bjc.6604259; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Tan AC, 2009, MOL ONCOL, V3, P425, DOI 10.1016/j.molonc.2009.03.004; Tennis MA, 2012, P AM THORAC SOC, V9, P83; Tennis MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032921; Thu KL, 2011, J THORAC ONCOL, V6, P1521, DOI 10.1097/JTO.0b013e3182289479; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Vincent A, 2011, CLIN CANCER RES, V17, P4341, DOI 10.1158/1078-0432.CCR-10-3431; White BD, 2012, GASTROENTEROLOGY, V142, P219, DOI 10.1053/j.gastro.2011.12.001; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yan HT, 2007, MOL CELLS, V24, P323; Yao H, 2011, EXPERT OPIN THER TAR, V15, P873, DOI 10.1517/14728222.2011.577418; Ye YW, 2011, CANCER LETT, V307, P124, DOI 10.1016/j.canlet.2011.03.024; Zhang W, 2008, CANCER RES, V68, P2764, DOI 10.1158/0008-5472.CAN-07-6349	72	47	48	0	24	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 16	2014	33	3					279	288		10.1038/onc.2012.595	http://dx.doi.org/10.1038/onc.2012.595			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	296VR	23318427				2022-12-25	WOS:000330214000002
J	Valladares, R; Bojilova, L; Potts, AH; Cameron, E; Gardner, C; Lorca, G; Gonzalez, CF				Valladares, Ricardo; Bojilova, Lora; Potts, Anastasia H.; Cameron, Evan; Gardner, Christopher; Lorca, Graciela; Gonzalez, Claudio F.			Lactobacillus johnsonii inhibits indoleamine 2,3-dioxygenase and alters tryptophan metabolite levels in BioBreeding rats	FASEB JOURNAL			English	Article						kynurenine; hydrogen peroxide; intestinal epithelial cell; 5-hydroxytryptamine	INTESTINAL MICROBIOME; NADH OXIDASE; EXPRESSION; CELLS; CONTRIBUTES; RESPONSES; SAMPLES; BRAIN; ONSET; GAMMA	In our previous work, we found that feeding Lactobacillus johnsonii to BioBreeding diabetes-prone (BBDP) rats decreased the incidence of diabetes development. The aim of this study was to investigate host pathways affected by L. johnsonii, with specific focus on the rate-limiting enzyme of tryptophan catabolism, indoleamine 2,3-dioxygenase (IDO). Suspensions of L. johnsonii or an equal volume of vehicle were orally administered to BBDP rats. Tissue IDO was investigated using quantitative RT-PCR and Western blot, whereas tryptophan, kynurenine, and 5-hydroxytryptamine (5-HT) concentrations were quantified by HPLC and ELISA. IDO activity was also investigated using L. johnsonii culture cell-free supernatant (CFS) with affinity-purified IDO and HT-29 intestinal epithelial cells. L. johnsonii feeding resulted in a 17% reduction in serum kynurenine compared with that in vehicle-fed controls, correlating with a 1.4-fold elevation in 5-HT levels. H2O2 produced by L. johnsonii abolished IDO activity in vitro, and L. johnsonii feeding resulted in a 3.9-fold increase in ileum lumen H2O2. L. johnsonii CFS significantly reduced IDO activity in HT-29 intestinal epithelial cells (47% reduction) compared with that in vehicle-treated controls, an effect abolished by catalase treatment. These data support the role of H2O2 in commensal bacteria-host interactions and highlight the influence of commensal bacteria-derived H2O2 on host physiology.-Valladares, R., Bojilova, L., Potts, A. H., Cameron, E., Gardner, C., Lorca, G., Gonzalez, C. F. Lactobacillus johnsonii inhibits indoleamine 2,3-dioxygenase and alters tryptophan metabolite levels in BioBreeding rats. FASEB J. 27, 1711-1720 (2013). www.fasebj.org	[Valladares, Ricardo; Bojilova, Lora; Potts, Anastasia H.; Cameron, Evan; Gardner, Christopher; Lorca, Graciela; Gonzalez, Claudio F.] Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Genet Inst, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Gonzalez, CF (corresponding author), Univ Florida, Genet Inst 325G, 2033 Mowry Rd,POB 103610, Gainesville, FL 32610 USA.	cfgonzalez@ufl.edu		Gardner, Christopher/0000-0001-6416-8476	University of Florida Opportunity Fund; U.S. National Science Foundation [DGE-0802270]	University of Florida Opportunity Fund; U.S. National Science Foundation(National Science Foundation (NSF))	The authors thank Dr. Yoshitsugu Shiro (RIKEN Center, Hyogo, Japan) for the human IDO cDNA, Beverly Driver for her continuous assistance in the laboratory, and Dr. Sixiue Chen and the Proteomics Core at the Interdisciplinary Center for Biotechnological Research (University of Florida, Gainesville, FL, USA) for their technical assistance with the mass spectrometry work. This work was funded by the University of Florida Opportunity Fund and the U.S. National Science Foundation under grant DGE-0802270. The authors declare no conflicts of interest.	Badawy AAB, 2010, INT J TRYPTOPHAN RES, V3, P175, DOI 10.4137/IJTR.S6225; Bell LV, 2011, PARASITE IMMUNOL, V33, P244, DOI 10.1111/j.1365-3024.2010.01272.x; Boerner BP, 2011, ANN NY ACAD SCI, V1243, P103, DOI 10.1111/j.1749-6632.2011.06340.x; Corona AW, 2013, BRAIN BEHAV IMMUN, V31, P134, DOI 10.1016/j.bbi.2012.08.008; Dai XC, 2010, J HISTOCHEM CYTOCHEM, V58, P17, DOI 10.1369/jhc.2009.953604; Denou E, 2007, J BACTERIOL, V189, P8109, DOI 10.1128/JB.00991-07; Forouhar F, 2007, P NATL ACAD SCI USA, V104, P473, DOI 10.1073/pnas.0610007104; Godbout JP, 2008, NEUROPSYCHOPHARMACOL, V33, P2341, DOI 10.1038/sj.npp.1301649; GUBERSKI DL, 1993, DIABETOLOGIA, V36, P912, DOI 10.1007/BF02374472; Harrington L, 2008, INFECT IMMUN, V76, P3045, DOI 10.1128/IAI.00193-08; Holodniy M, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014764, 10.1371/journal.pone.0025792]; Jez JM, 2004, J BIOL CHEM, V279, P33463, DOI 10.1074/jbc.M405127200; Kaszaki J, 2012, J NEURAL TRANSM, V119, P211, DOI 10.1007/s00702-011-0658-x; Kingma SDK, 2011, J NUTR, V141, P1023, DOI 10.3945/jn.110.135517; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; Kudo Y, 2000, MOL HUM REPROD, V6, P369, DOI 10.1093/molehr/6.4.369; Kumar A, 2007, EMBO J, V26, P4457, DOI 10.1038/sj.emboj.7601867; Lai KK, 2009, APPL ENVIRON MICROB, V75, P5018, DOI 10.1128/AEM.02837-08; Lau K, 2011, J IMMUNOL, V186, P3538, DOI 10.4049/jimmunol.1001864; LEWIS UJ, 1954, J BIOL CHEM, V206, P109; Lin PW, 2009, FREE RADICAL BIO MED, V47, P1205, DOI 10.1016/j.freeradbiomed.2009.07.033; Mandi Y, 2012, J NEURAL TRANSM, V119, P197, DOI 10.1007/s00702-011-0681-y; Marty-Teysset C, 2000, APPL ENVIRON MICROB, V66, P262, DOI 10.1128/AEM.66.1.262-267.2000; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Neu J, 2005, J PEDIATR GASTR NUTR, V40, P589, DOI 10.1097/01.MPG.0000159636.19346.C1; Neu J, 2010, ENDOCRIN METAB CLIN, V39, P563, DOI 10.1016/j.ecl.2010.05.008; O'Connor JC, 2009, MOL PSYCHIATR, V14, P511, DOI 10.1038/sj.mp.4002148; Poljak A, 2006, ARCH BIOCHEM BIOPHYS, V450, P9, DOI 10.1016/j.abb.2006.03.003; Resta SC, 2009, J PHYSIOL-LONDON, V587, P4169, DOI 10.1113/jphysiol.2009.176370; Rhee SJ, 2005, J IMMUNOL, V175, P1127, DOI 10.4049/jimmunol.175.2.1127; Roesch LFW, 2009, ISME J, V3, P536, DOI 10.1038/ismej.2009.5; Rosell FI, 2011, J BIOL CHEM, V286, P29273, DOI 10.1074/jbc.M111.262139; Salazar A, 2012, HORM BEHAV, V62, P202, DOI 10.1016/j.yhbeh.2012.03.010; Swanson PA, 2011, P NATL ACAD SCI USA, V108, P8803, DOI 10.1073/pnas.1010042108; Terentis AC, 2010, BIOCHEMISTRY-US, V49, P591, DOI 10.1021/bi901546e; Thebault P, 2009, J IMMUNOL, V183, P3099, DOI 10.4049/jimmunol.0803767; Torres MI, 2007, CLIN EXP IMMUNOL, V148, P419, DOI 10.1111/j.1365-2249.2007.03365.x; Valladares R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010507; Visser JTJ, 2010, DIABETOLOGIA, V53, P2621, DOI 10.1007/s00125-010-1903-9; Voltan S, 2008, GASTROENTEROLOGY, V135, P1216, DOI 10.1053/j.gastro.2008.07.007; Wang B, 2011, ENDOCRINOLOGY, V152, P4984, DOI 10.1210/en.2011-0278; WEEKLEY LB, 1984, FOOD CHEM TOXICOL, V22, P65, DOI 10.1016/0278-6915(84)90055-3; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; YOSHIDA R, 1980, ARCH BIOCHEM BIOPHYS, V203, P343, DOI 10.1016/0003-9861(80)90185-X; Zhou J, 2005, J CEREBR BLOOD F MET, V25, P878, DOI 10.1038/sj.jcbfm.9600082	47	82	87	3	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2013	27	4					1711	1720		10.1096/fj.12-223339	http://dx.doi.org/10.1096/fj.12-223339			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23303207				2022-12-25	WOS:000316940800040
J	Santosa, V; Martha, S; Hirose, N; Tanaka, K				Santosa, Venny; Martha, Sabrina; Hirose, Noriaki; Tanaka, Katsunori			The Fission Yeast Minichromosome Maintenance (MCM)-binding Protein (MCM-BP), Mcb1, Regulates MCM Function during Prereplicative Complex Formation in DNA Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-PHASE; CELL-CYCLE; GENE; IDENTIFICATION; CHECKPOINT; ORIGINS; LOCALIZATION; INITIATION; PROMOTES; FAMILY	The minichromosome maintenance (MCM) complex is a replicative helicase, which is essential for chromosome DNA replication. In recent years, the identification of a novel MCM-binding protein (MCM-BP) in most eukaryotes has led to numerous studies investigating its function and its relationship to the MCM complex. However, the mechanisms by which MCM-BP functions and associates with MCM complexes are not well understood; in addition, the functional role of MCM-BP remains controversial and may vary between model organisms. The present study aims to elucidate the nature and biological function of the MCM-BP ortholog, Mcb1, in fission yeast. The Mcb1 protein continuously interacts with MCM proteins during the cell cycle in vivo and can interact with any individual MCM subunit in vitro. To understand the detailed characteristics of mcb1(+), two temperature-sensitive mcb1 gene mutants (mcb1(ts)) were isolated. Extensive genetic analysis showed that the mcb1(ts) mutants were suppressed by a mcm5(+) multicopy plasmid and displayed synthetic defects with many S-phase-related gene mutants. Moreover, cyclin-dependent kinase modulation by Cig2 repression or Rum1 overproduction suppressed the mcb1(ts) mutants, suggesting the involvement of Mcb1 in pre-RC formation during DNA replication. These data are consistent with the observation that Mcm7 loading onto replication origins is reduced and S-phase progression is delayed in mcb1(ts) mutants. Furthermore, the mcb1(ts) mutation led to the redistribution of MCM subunits to the cytoplasm, and this redistribution was dependent on an active nuclear export system. These results strongly suggest that Mcb1 promotes efficient pre-RC formation during DNA replication by regulating the MCM complex.	[Santosa, Venny; Martha, Sabrina; Hirose, Noriaki; Tanaka, Katsunori] Kwansei Gakuin Univ, Sch Sci & Technol, Dept Biosci, Sanda, Hyogo 6691337, Japan; [Santosa, Venny; Tanaka, Katsunori] Kwansei Gakuin Univ, Sch Sci & Technol, Res Ctr Environm Biosci, Sanda, Hyogo 6691337, Japan	Kwansei Gakuin University; Kwansei Gakuin University	Tanaka, K (corresponding author), Kwansei Gakuin Univ, Sch Sci & Technol, Dept Biosci, 2-1 Gakuen, Sanda, Hyogo 6691337, Japan.	katsunori@kwansei.ac.jp	Tanaka, Katsunori/F-8086-2010	Tanaka, Katsunori/0000-0001-9692-0968	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research from the Japan Society for the Promotion of Science and the Support Project to Assist Private Universities in Developing Bases for Research by the Ministry of Education, Culture, Sports, Science, and Technology (to K. T.).	Bailis JM, 2008, MOL CELL BIOL, V28, P1724, DOI 10.1128/MCB.01717-07; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Benito J, 1998, EMBO J, V17, P482, DOI 10.1093/emboj/17.2.482; Bochman ML, 2010, NUCLEIC ACIDS RES, V38, P6078, DOI 10.1093/nar/gkq422; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Ding L, 2011, J BIOL CHEM, V286, P32918, DOI 10.1074/jbc.M111.282541; Ferguson RL, 2010, J CELL SCI, V123, P2743, DOI 10.1242/jcs.073098; Forbes KC, 1998, GENETICS, V150, P1361; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Fukuura M, 2011, MOL BIOL CELL, V22, P2620, DOI 10.1091/mbc.E10-12-0995; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Gozuacik D, 2003, NUCLEIC ACIDS RES, V31, P570, DOI 10.1093/nar/gkg136; Grallert B, 2000, J CELL SCI, V113, P1447; Hayashi M, 2007, EMBO J, V26, P1327, DOI 10.1038/sj.emboj.7601585; HIRAOKA Y, 1984, CELL, V39, P349, DOI 10.1016/0092-8674(84)90013-8; Hubbi ME, 2011, MOL CELL, V42, P700, DOI 10.1016/j.molcel.2011.03.029; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Jagannathan M, 2012, J CELL SCI, V125, P133, DOI 10.1242/jcs.089938; Jallepalli PV, 1997, GENE DEV, V11, P2767, DOI 10.1101/gad.11.21.2767; Johnson EM, 2003, NUCLEIC ACIDS RES, V31, P2915, DOI 10.1093/nar/gkg395; Kanter DM, 2008, J BIOL CHEM, V283, P31172, DOI 10.1074/jbc.M804686200; Kato H, 2008, CELL CYCLE, V7, P1085; Kawabata T, 2011, MOL CELL, V41, P543, DOI 10.1016/j.molcel.2011.02.006; Kawamukai M, 1999, BBA-GENE STRUCT EXPR, V1446, P93, DOI 10.1016/S0167-4781(99)00071-8; Krawchuk MD, 1999, YEAST, V15, P1419, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1419::AID-YEA466>3.0.CO;2-Q; Kumada K, 1996, MOL GEN GENET, V250, P59, DOI 10.1007/s004380050051; Kunnev D, 2010, ONCOGENE, V29, P3630, DOI 10.1038/onc.2010.125; LABIB K, 1995, J CELL SCI, V108, P3285; Li JJ, 2011, FEBS LETT, V585, P3850, DOI 10.1016/j.febslet.2011.10.033; Liang DT, 1999, J CELL SCI, V112, P559; Lopez-Girona A, 1998, MOL BIOL CELL, V9, P63, DOI 10.1091/mbc.9.1.63; Lutzmann M, 2005, GENE, V362, P51, DOI 10.1016/j.gene.2005.07.031; Lutzmann M, 2012, MOL CELL, V47, P523, DOI 10.1016/j.molcel.2012.05.048; Maiorano D, 2006, CURR OPIN CELL BIOL, V18, P130, DOI 10.1016/j.ceb.2006.02.006; Maki K, 2011, J BIOL CHEM, V286, P41701, DOI 10.1074/jbc.M111.285619; Martin-Castellanos C, 1996, Prog Cell Cycle Res, V2, P29; Mondesert O, 1996, MOL CELL BIOL, V16, P1527; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakajima R, 2002, MOL BIOL CELL, V13, P1462, DOI 10.1091/mbc.02-01-0006; Nakamura T, 2001, MOL BIOL CELL, V12, P3955, DOI 10.1091/mbc.12.12.3955; Nishimura K, 2012, MOL CELL, V47, P511, DOI 10.1016/j.molcel.2012.05.047; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Nishiyama A, 2011, GENE DEV, V25, P165, DOI 10.1101/gad.614411; Nitani N, 2006, GENETICS, V174, P155, DOI 10.1534/genetics.106.060053; Ogawa Y, 1999, MOL CELL BIOL, V19, P7228; Pasion SG, 1999, MOL BIOL CELL, V10, P4043, DOI 10.1091/mbc.10.12.4043; Pommier Y, 2006, PROG NUCLEIC ACID RE, V81, P179, DOI 10.1016/S0079-6603(06)81005-6; Prokhorova TA, 2000, J BIOL CHEM, V275, P2491, DOI 10.1074/jbc.275.4.2491; Remus D, 2009, CURR OPIN CELL BIOL, V21, P771, DOI 10.1016/j.ceb.2009.08.002; Sabatinos SA, 2010, METHOD ENZYMOL, V470, P759, DOI 10.1016/S0076-6879(10)70032-X; Sakwe AM, 2007, MOL CELL BIOL, V27, P3044, DOI 10.1128/MCB.02384-06; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; SAZER S, 1990, J CELL SCI, V97, P509; Shimmoto M, 2009, GENES CELLS, V14, P669, DOI 10.1111/j.1365-2443.2009.01300.x; Takahashi N, 2008, EMBO J, V27, P1840, DOI 10.1038/emboj.2008.107; Takahashi N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000817; Takeda T, 1999, MOL CELL BIOL, V19, P5535; Nguyen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035931; Tsao CC, 2004, EMBO J, V23, P4660, DOI 10.1038/sj.emboj.7600463; WOODS A, 1989, J CELL SCI, V93, P491; Yamada Y, 2004, MOL BIOL CELL, V15, P3740, DOI 10.1091/mbc.E04-04-0292; Yoshida K, 2005, BIOCHEM BIOPH RES CO, V331, P669, DOI 10.1016/j.bbrc.2005.03.222	65	11	11	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6864	6880		10.1074/jbc.M112.432393	http://dx.doi.org/10.1074/jbc.M112.432393			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23322785	Green Published, hybrid			2022-12-25	WOS:000316002400008
J	Cheriyan, M; Pedamallu, CS; Tori, K; Perler, F				Cheriyan, Manoj; Pedamallu, Chandra Sekhar; Tori, Kazuo; Perler, Francine			Faster Protein Splicing with the Nostoc punctiforme DnaE Intein Using Non-native Extein Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL CLEAVAGE ACTIVITY; TUBERCULOSIS-RECA INTEIN; SPLIT INTEINS; MYCOBACTERIUM-TUBERCULOSIS; HIGHLY EFFICIENT; SYSTEM; COMMON	Inteins are naturally occurring intervening sequences that catalyze a protein splicing reaction resulting in intein excision and concatenation of the flanking polypeptides (exteins) with a native peptide bond. Inteins display a diversity of catalytic mechanisms within a highly conserved fold that is shared with hedgehog autoprocessing proteins. The unusual chemistry of inteins has afforded powerful biotechnology tools for controlling enzyme function upon splicing and allowing peptides of different origins to be coupled in a specific, time-defined manner. The extein sequences immediately flanking the intein affect splicing and can be defined as the intein substrate. Because of the enormous potential complexity of all possible flanking sequences, studying intein substrate specificity has been difficult. Therefore, we developed a genetic selection for splicing-dependent kanamycin resistance with no significant bias when six amino acids that immediately flanked the intein insertion site were randomized. We applied this selection to examine the sequence space of residues flanking the Nostoc punctiforme Npu DnaE intein and found that this intein efficiently splices a much wider range of sequences than previously thought, with little N-extein specificity and only two important C-extein positions. The novel selected extein sequences were sufficient to promote splicing in three unrelated proteins, confirming the generalizable nature of the specificity data and defining new potential insertion sites for any target. Kinetic analysis showed splicing rates with the selected exteins that were as fast or faster than the native extein, refuting past assumptions that the naturally selected flanking extein sequences are optimal for splicing.	[Cheriyan, Manoj; Pedamallu, Chandra Sekhar; Tori, Kazuo; Perler, Francine] New England Biolabs Inc, Ipswich, MA 01938 USA	New England Biolabs	Perler, F (corresponding author), New England Biolabs Inc, Ipswich, MA 01938 USA.	pcs.murali@gmail.com; hiris5211@yahoo.co.jp; perler@neb.com	Pedamallu, Chandra Sekhar/AAV-6745-2020; Pedamallu, Chandra Sekhar/AAV-6723-2020					Amitai G, 2009, P NATL ACAD SCI USA, V106, P11005, DOI 10.1073/pnas.0904366106; Appleby-Tagoe JH, 2011, J BIOL CHEM, V286, P34440, DOI 10.1074/jbc.M111.277350; Carvajal-Vallejos P, 2012, J BIOL CHEM, V287, P28686, DOI 10.1074/jbc.M112.372680; Chong SR, 1998, NUCLEIC ACIDS RES, V26, P5109, DOI 10.1093/nar/26.22.5109; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dalgaard JZ, 1997, J COMPUT BIOL, V4, P193, DOI 10.1089/cmb.1997.4.193; Daugelat S, 1999, PROTEIN SCI, V8, P644; Flavell RR, 2009, ACCOUNTS CHEM RES, V42, P107, DOI 10.1021/ar800129c; Fong BA, 2010, TRENDS BIOTECHNOL, V28, P272, DOI 10.1016/j.tibtech.2010.02.003; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; Gangopadhyay JP, 2003, BBA-GEN SUBJECTS, V1619, P193, DOI 10.1016/S0304-4165(02)00495-6; Iwai H, 2006, FEBS LETT, V580, P1853, DOI 10.1016/j.febslet.2006.02.045; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; Lew BM, 2002, GENE, V282, P169, DOI 10.1016/S0378-1119(01)00836-8; Lockless SW, 2009, P NATL ACAD SCI USA, V106, P10999, DOI 10.1073/pnas.0902964106; Martin DD, 2001, BIOCHEMISTRY-US, V40, P1393, DOI 10.1021/bi001786g; Mootz HD, 2009, CHEMBIOCHEM, V10, P2579, DOI 10.1002/cbic.200900370; Nurizzo D, 2003, J MOL BIOL, V327, P491, DOI 10.1016/S0022-2836(03)00121-9; Oeemig JS, 2012, J MOL BIOL, V421, P85, DOI 10.1016/j.jmb.2012.04.029; Oeemig JS, 2009, FEBS LETT, V583, P1451, DOI 10.1016/j.febslet.2009.03.058; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; Shah NH, 2012, J AM CHEM SOC, V134, P11338, DOI 10.1021/ja303226x; Shemella PT, 2011, BIOPHYS J, V100, P2217, DOI 10.1016/j.bpj.2011.02.037; Shi JX, 2005, J AM CHEM SOC, V127, P6198, DOI 10.1021/ja042287w; Tori K, 2012, BIOCHEMISTRY-US, V51, P2496, DOI 10.1021/bi201840k; Tori K, 2010, J BIOL CHEM, V285, P2515, DOI 10.1074/jbc.M109.069567; Volkmann G, 2010, MOL BIOSYST, V6, P2110, DOI 10.1039/c0mb00034e; Zettler J, 2009, FEBS LETT, V583, P909, DOI 10.1016/j.febslet.2009.02.003	28	73	79	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6202	6211		10.1074/jbc.M112.433094	http://dx.doi.org/10.1074/jbc.M112.433094			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23306197	hybrid, Green Published			2022-12-25	WOS:000315820700016
J	Zhang, T; Zhu, QQ; Xie, ZH; Chen, YF; Qiao, YB; Li, LY; Jing, NH				Zhang, Ting; Zhu, Qingqing; Xie, Zhihui; Chen, Yongfeng; Qiao, Yunbo; Li, Lingyu; Jing, Naihe			The Zinc Finger Transcription Factor Ovol2 Acts Downstream of the Bone Morphogenetic Protein Pathway to Regulate the Cell Fate Decision between Neuroectoderm and Mesendoderm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; IN-SITU HYBRIDIZATION; NEURAL PLATE; DROSOPHILA-OVO; GENE-EXPRESSION; AXIS FORMATION; CHICK-EMBRYOS; AVIAN EMBRYOS; MOUSE HOMOLOG; NESTIN GENE	During early embryonic development, bone morphogenetic protein (BMP) signaling is essential for neural/non-neural cell fate decisions. BMP signaling inhibits precocious neural differentiation and allows for proper differentiation of mesoderm, endoderm, and epidermis. However, the mechanisms underlying the BMP pathway-mediated cell fate decision remain largely unknown. Here, we show that the expression of Ovol2, which encodes an evolutionarily conserved zinc finger transcription factor, is down-regulated during neural differentiation of mouse embryonic stem cells. Knockdown of Ovol2 in embryonic stem cells facilitates neural conversion and inhibits mesendodermal differentiation, whereas Ovol2 overexpression gives rise to the opposite phenotype. Moreover, Ovol2 knockdown partially rescues the neural inhibition and mesendodermal induction by BMP4. Mechanistic studies further show that BMP4 directly regulates Ovol2 expression through the binding of Smad1/5/8 to the second intron of the Ovol2 gene. In the chick embryo, cOvol2 expression is specifically excluded from neural territory and is up-regulated by BMP4. In addition, ectopic expression of cOvol2 in the prospective neural plate represses the expression of the definitive neural plate marker cSox2. Taken together, these results indicate that Ovol2 acts downstream of the BMP pathway in the cell fate decision between neuroectoderm and mesendoderm to ensure proper germ layer development.	[Zhang, Ting; Zhu, Qingqing; Xie, Zhihui; Chen, Yongfeng; Qiao, Yunbo; Li, Lingyu; Jing, Naihe] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Jing, NH (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	njing@sibcb.ac.cn		Zhang, Ting/0000-0001-6330-8473	Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01010201]; National Key Basic Research and Development Program of China [2009CB941100]; National Natural Science Foundation of China [30830034, 90919046, 91219303]; Council of Shanghai Municipal Government for Science and Technology [11ZR1443200]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Key Basic Research and Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Council of Shanghai Municipal Government for Science and Technology	This work was supported in part by Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDA01010201; National Key Basic Research and Development Program of China Grant 2009CB941100; National Natural Science Foundation of China Grants 30830034, 90919046, and 91219303; and Council of Shanghai Municipal Government for Science and Technology Grant 11ZR1443200.	Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; Chapman SC, 2002, DEV BIOL, V245, P187, DOI 10.1006/dbio.2002.0641; Chng ZZ, 2010, CELL STEM CELL, V6, P59, DOI 10.1016/j.stem.2009.11.015; Dai X, 1998, GENE DEV, V12, P3452, DOI 10.1101/gad.12.21.3452; Di-Gregorio A, 2007, DEVELOPMENT, V134, P3359, DOI 10.1242/dev.005967; Feledy JA, 1999, DEV BIOL, V212, P455, DOI 10.1006/dbio.1999.9374; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gadue P, 2005, EXP HEMATOL, V33, P955, DOI 10.1016/j.exphem.2005.06.009; Gao X, 2001, BIOCHEM BIOPH RES CO, V284, P1098, DOI 10.1006/bbrc.2001.5089; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Ishimura A, 2000, DEV GROWTH DIFFER, V42, P307; Jin ZG, 2009, J BIOL CHEM, V284, P8160, DOI 10.1074/jbc.M805632200; Johnson AD, 2001, DEVELOPMENT, V128, P2857; Kimelman D, 2000, CURR OPIN GENET DEV, V10, P350, DOI 10.1016/S0959-437X(00)00095-2; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Levi G, 2006, MECH DEVELOP, V123, P3, DOI 10.1016/j.mod.2005.10.007; Li B, 2002, GENOMICS, V80, P319, DOI 10.1006/geno.2002.6831; Li BA, 2002, P NATL ACAD SCI USA, V99, P6064, DOI 10.1073/pnas.092137099; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Linker C, 2004, DEVELOPMENT, V131, P5671, DOI 10.1242/dev.01445; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Lu CC, 2001, CURR OPIN GENET DEV, V11, P384, DOI 10.1016/S0959-437X(00)00208-2; Mackay DR, 2006, DEV BIOL, V291, P38, DOI 10.1016/j.ydbio.2005.12.003; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; MEVELNINIO M, 1991, EMBO J, V10, P2259, DOI 10.1002/j.1460-2075.1991.tb07762.x; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Okada Y, 2004, DEV BIOL, V275, P124, DOI 10.1016/j.ydbio.2004.07.038; OLIVER B, 1987, GENE DEV, V1, P913, DOI 10.1101/gad.1.9.913; Park C, 2004, DEVELOPMENT, V131, P2749, DOI 10.1242/dev.01130; Patthey C, 2009, DEVELOPMENT, V136, P73, DOI 10.1242/dev.025890; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; Pearson S, 2008, DEVELOPMENT, V135, P1525, DOI 10.1242/dev.011767; Pera E, 1999, DEVELOPMENT, V126, P63; Qiao YB, 2012, CELL RES, V22, P1546, DOI 10.1038/cr.2012.122; Rex M, 1997, DEV DYNAM, V209, P323, DOI 10.1002/(SICI)1097-0177(199707)209:3<323::AID-AJA7>3.3.CO;2-B; Rodaway A, 2001, CELL, V105, P169, DOI 10.1016/S0092-8674(01)00307-5; Schroeder IS, 2006, NAT PROTOC, V1, P495, DOI 10.1038/nprot.2006.71; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Stern CD, 1998, CURR TOP DEV BIOL, V36, P223; Streit A, 1998, DEVELOPMENT, V125, P507; Streit A, 1999, MECH DEVELOP, V82, P51, DOI 10.1016/S0925-4773(99)00013-1; Streit A, 2001, METHODS, V23, P339, DOI 10.1006/meth.2000.1146; Suzuki A, 1997, DEVELOPMENT, V124, P3037; Takemoto T, 2011, NATURE, V470, P394, DOI 10.1038/nature09729; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tanaka S, 2004, MOL CELL BIOL, V24, P8834, DOI 10.1128/MCB.24.20.8834-8846.2004; Tang SJ, 1998, DEVELOPMENT, V125, P1877; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Unezaki S, 2004, GENE, V336, P47, DOI 10.1016/j.gene.2004.03.013; Unezaki S, 2007, GENES CELLS, V12, P773, DOI 10.1111/j.1365-2443.2007.01084.x; Voiculescu O, 2008, NAT PROTOC, V3, P419, DOI 10.1038/nprot.2008.10; Wang C, 2006, MOL BIOL CELL, V17, P3075, DOI 10.1091/mbc.E05-11-1087; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Yang L, 1998, J NEUROSCI, V18, P8322; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang KJ, 2010, DEVELOPMENT, V137, P2095, DOI 10.1242/dev.049494	63	24	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6166	6177		10.1074/jbc.M112.418376	http://dx.doi.org/10.1074/jbc.M112.418376			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23319585	Green Published, hybrid			2022-12-25	WOS:000315820700013
J	Blas, MM; Menacho, LA; Alva, IE; Cabello, R; Orellana, ER				Blas, Magaly M.; Menacho, Luis A.; Alva, Isaac E.; Cabello, Robinson; Orellana, E. Roberto			Motivating Men Who Have Sex with Men to Get Tested for HIV through the Internet and Mobile Phones: A Qualitative Study	PLOS ONE			English	Article							HEALTH-PROMOTION; PERU; RISK; PERCEPTIONS; ACCESS; TOOL	Background: Men who have sex with men (MSM) have the highest HIV prevalence in Peru, yet they are underserved by traditional preventive programs. In Peru, the Internet and mobile phones have emerged as an effective and convenient tool to reach this population. Methods and Findings: From October 2010 to February 2011, we conducted eight focus groups with gay identified MSM (closeted and out-of-the-closet) and with self-identified heterosexual MSM in order to identify key features and preferences to be used to tailor culturally-appropriate messages that could be delivered through Internet and mobile phones to motivate MSM to get tested for HIV. Participants reported that in order to motivate HIV testing among MSM, interventions need to be based on motivational messages that encourage participants to overcome the fear of getting tested. Messages should increase the HIV risk perception (of participants who do not consider themselves at risk) by eliciting risky situations experienced by MSM. Messages should emphasize confidentiality, respect and the professionalism of the personnel conducting the counseling and testing. A thorough explanation of the process of HIV testing and the steps to follow after receiving the results should be provided. Messages should also contain information about the venue where the test will be conducted in terms of client characteristics, location, hours of operation and personnel. Finally, stigmatizing and stereotyping messages or images about "being gay" should not be included, as they act as deterrents for getting tested. Conclusions: Interventions aimed at motivating HIV testing among MSM should include motivational messages that reduce the fear of getting tested and increase the risk perception of participants. They should also market the venue where the testing will be conducted, the professionals who will perform the tests, and the type of tests available. Stigmatizing messages or images should be avoided.	[Blas, Magaly M.; Menacho, Luis A.; Alva, Isaac E.] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, STD & HIV Unit, Lima, Peru; [Menacho, Luis A.] Epictr, Lima, Peru; [Orellana, E. Roberto] Portland State Univ, Sch Social Work, Portland, OR 97207 USA; [Orellana, E. Roberto] Portland State Univ, Dept Community Hlth, Portland, OR 97207 USA	Universidad Peruana Cayetano Heredia; Portland State University; Portland State University	Blas, MM (corresponding author), Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, STD & HIV Unit, Lima, Peru.	magaly.blas@upch.pe	Orellana, E. Roberto/K-8633-2012; Orellana, E. Roberto/ABD-5735-2021	Orellana, E. Roberto/0000-0003-4444-2321; Orellana, E. Roberto/0000-0003-4444-2321	Fogarty International Center/National Institutes of Health (FIC/NIH) [R01 TW008398]; QUIPU: The Andean Global Health Informatics Research and Training Center; FIC/NIH [D43TW008438-0109]; FOGARTY INTERNATIONAL CENTER [D43TW008438, R01TW008398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH080665] Funding Source: NIH RePORTER	Fogarty International Center/National Institutes of Health (FIC/NIH); QUIPU: The Andean Global Health Informatics Research and Training Center; FIC/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the Fogarty International Center/National Institutes of Health (FIC/NIH) grant R01 TW008398 to Magaly Blas and QUIPU: The Andean Global Health Informatics Research and Training Center, a FIC/NIH funded grant D43TW008438-0109. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blas MM, 2007, SEX TRANSM INFECT, V83, P567, DOI 10.1136/sti.2007.027276; Blas MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027334; Blas MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010448; Curioso WH, 2007, BMC MED INFORM DECIS, V7, DOI 10.1186/1472-6947-7-24; Curioso WH, 2009, AMIA ANN S P, P129; Dowson L, 2012, AIDS CARE, V24, P204, DOI 10.1080/09540121.2011.597711; Glaser B, 1978, DISCOV GROUNDED THEO; Grier S, 2005, ANNU REV PUBL HEALTH, V26, P319, DOI 10.1146/annurev.publhealth.26.021304.144610; Lapinski MK, 2008, HEALTH COMMUN, V23, P403, DOI 10.1080/10410230802342093; OSIPTEL, 2012, STAT RES PUBL; Padgett D.K., 2016, QUALITATIVE METHODS, V36; Peinado J, 2007, J SEX RES, V44, P233, DOI 10.1080/00224490701443676; Plant A, 2010, HEALTH PROMOT PRACT, V11, P23, DOI 10.1177/1524839907309376; Rimal RN, 2009, AM J PUBLIC HEALTH, V99, P2224, DOI 10.2105/AJPH.2008.155234; Sanchez J, 2007, JAIDS-J ACQ IMM DEF, V44, P578, DOI 10.1097/QAI.0b013e318033ff82; UNAIDS, 2010, UNAIDS REP GLOB AIDS; UNGASS, 2012, COUNTR PROGR REP PER	17	33	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e54012	10.1371/journal.pone.0054012	http://dx.doi.org/10.1371/journal.pone.0054012			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	069IY	23320116	gold, Green Published			2022-12-25	WOS:000313429800083
J	Lusk, RW; Eisen, MB				Lusk, Richard W.; Eisen, Michael B.			Spatial Promoter Recognition Signatures May Enhance Transcription Factor Specificity in Yeast	PLOS ONE			English	Article							FACTOR-BINDING-SITES; DNA-BINDING; SACCHAROMYCES-CEREVISIAE; ENVIRONMENTAL-CHANGES; QUANTITATIVE-ANALYSIS; NUCLEOTIDE-SEQUENCES; REGULATORY ELEMENTS; IN-VIVO; GENOME; ACTIVATION	The short length and high degeneracy of sites recognized by DNA-binding transcription factors limit the amount of information they can carry, and individual sites are rarely sufficient to mediate the regulation of specific targets. Computational analysis of microbial genomes has suggested that many factors function optimally when in a particular orientation and position with respect to their target promoters. To investigate this further, we developed and trained spatial models of binding site positioning and applied them to the genome of the yeast Saccharomyces cerevisiae. We found evidence of non-random organization of sites within promoters, differences in binding site density, or both for thirty-eight transcription factors. We show that these signatures allow transcription factors with substantial differences in binding site specificity to share similar promoter specificities. We illustrate how spatial information dictating the positioning and density of binding sites can in principle increase the information available to the organism for differentiating a transcription factor's true targets, and we indicate how this information could potentially be leveraged for the same purpose in bioinformatic analyses.	[Lusk, Richard W.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Eisen, Michael B.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Eisen, Michael B.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of Michigan System; University of Michigan; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Eisen, MB (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	mbeisen@berkeley.edu		Eisen, Michael/0000-0002-7528-738X	HHMI; NIH [HG002779]; NSF; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002779] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by an HHMI investigator award to M. B. E., an NIH grant HG002779 to M. B. E., and an NSF graduate research fellowship to R. W. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Blaiseau PL, 1998, EMBO J, V17, P6327, DOI 10.1093/emboj/17.21.6327; Bulyk ML, 2002, NUCLEIC ACIDS RES, V30, P1255, DOI 10.1093/nar/30.5.1255; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Elemento O, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r18; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Erb I., 2006, IEEE P ICCSB, V1, P111; Erb I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024279; Felenbok B, 2001, PROG NUCLEIC ACID RE, V69, P149, DOI 10.1016/S0079-6603(01)69047-0; Foat BC, 2006, BIOINFORMATICS, V22, pE141, DOI 10.1093/bioinformatics/btl223; Fordyce PM, 2010, NAT BIOTECHNOL, V28, P970, DOI 10.1038/nbt.1675; Frith MC, 2003, NUCLEIC ACIDS RES, V31, P3666, DOI 10.1093/nar/gkg540; Frith MC, 2002, NUCLEIC ACIDS RES, V30, P3214, DOI 10.1093/nar/gkf438; Frith MC, 2001, BIOINFORMATICS, V17, P878, DOI 10.1093/bioinformatics/17.10.878; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; Gordan R, 2009, GENOME RES, V19, P2090, DOI 10.1101/gr.094144.109; Gough B., 2009, GNU SCI LIB REFERENC; Granlund T., 2012, GNU MP GNU MULTIPLE, V5th; Gropp W, 1996, PARALLEL COMPUT, V22, P789, DOI 10.1016/0167-8191(96)00024-5; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Idrissi FZ, 2001, J BIOL CHEM, V276, P26090, DOI 10.1074/jbc.M101746200; Kim J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000652; Kim JH, 2009, BIOCHIMIE, V91, P300, DOI 10.1016/j.biochi.2008.09.002; Kim JH, 2003, MOL CELL BIOL, V23, P5208, DOI 10.1128/MCB.23.15.5208-5216.2003; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Lin ZG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-581; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; Miller JA, 2003, MOL CELL BIOL, V23, P1623, DOI 10.1128/MCB.23.5.1623-1632.2003; Mirny LA, 2010, P NATL ACAD SCI USA, V107, P22534, DOI 10.1073/pnas.0913805107; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nguyen DH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100054; Orzechowski J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-484; Pina B, 2003, MOL GENET GENOMICS, V268, P791, DOI 10.1007/s00438-002-0801-3; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Rajewsky N, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-30; SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8; Sharon E, 2012, NAT BIOTECHNOL, V30, P521, DOI 10.1038/nbt.2205; Shultzaberger RK, 2007, NUCLEIC ACIDS RES, V35, P771, DOI 10.1093/nar/gkl956; Shultzaberger RK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001199; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; STORMO GD, 1986, NUCLEIC ACIDS RES, V14, P6661, DOI 10.1093/nar/14.16.6661; Tanaka M, 1996, P NATL ACAD SCI USA, V93, P4311, DOI 10.1073/pnas.93.9.4311; Tomovic A, 2007, BIOINFORMATICS, V23, P933, DOI 10.1093/bioinformatics/btm055; Wunderlich Z, 2009, TRENDS GENET, V25, P434, DOI 10.1016/j.tig.2009.08.003; Zhao Y, 2012, GENETICS, V191, P781, DOI 10.1534/genetics.112.138685; Zhao Y, 2011, NAT BIOTECHNOL, V29, P480, DOI 10.1038/nbt.1893; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	53	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53778	10.1371/journal.pone.0053778	http://dx.doi.org/10.1371/journal.pone.0053778			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320104	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429800069
J	Rochat, MK; Laubender, RP; Kuster, D; Braendli, O; Moeller, A; Mansmann, U; von Mutius, E; Wildhaber, J				Rochat, Mascha K.; Laubender, Ruediger P.; Kuster, Daniela; Braendli, Otto; Moeller, Alexander; Mansmann, Ulrich; von Mutius, Erika; Wildhaber, Johannes			Spirometry Reference Equations for Central European Populations from School Age to Old Age	PLOS ONE			English	Article							REFERENCE VALUES; LUNG-FUNCTION; REFERENCE RANGES; ADULTS; OVERWEIGHT; STANDARDS; VOLUMES; OBESITY; CURVES	Background: Spirometry reference values are important for the interpretation of spirometry results. Reference values should be updated regularly, derived from a population as similar to the population for which they are to be used and span across all ages. Such spirometry reference equations are currently lacking for central European populations. Objective: To develop spirometry reference equations for central European populations between 8 and 90 years of age. Materials: We used data collected between January 1993 and December 2010 from a central European population. The data was modelled using "Generalized Additive Models for Location, Scale and Shape" (GAMLSS). Results: The spirometry reference equations were derived from 118'891 individuals consisting of 60'624 (51%) females and 58'267 (49%) males. Altogether, there were 18'211 (15.3%) children under the age of 18 years. Conclusion: We developed spirometry reference equations for a central European population between 8 and 90 years of age that can be implemented in a wide range of clinical settings.	[Rochat, Mascha K.; von Mutius, Erika] Univ Munich, Childrens Hosp, D-80539 Munich, Germany; [Laubender, Ruediger P.; Mansmann, Ulrich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Kuster, Daniela; Moeller, Alexander] Univ Zurich, Childrens Hosp, Div Resp Med, Zurich, Switzerland; [Braendli, Otto] Zurich Lung Assoc, Zurich, Switzerland; [Wildhaber, Johannes] Univ Fribourg, Hosp Fribourg, Dept Paediat, CH-1700 Fribourg, Switzerland; [Wildhaber, Johannes] Univ Fribourg, Fac Med, CH-1700 Fribourg, Switzerland; [Rochat, Mascha K.] Univ Lausanne Hosp, Dept Pediat, Lausanne, Switzerland	University of Munich; University of Munich; University Children's Hospital Zurich; University of Zurich; University of Fribourg; University of Fribourg; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Rochat, MK (corresponding author), Univ Munich, Childrens Hosp, D-80539 Munich, Germany.	wehntaler@gmail.com		Moeller, Alexander/0000-0001-7284-4251; von Mutius, Erika/0000-0002-8893-4515	LMUinnovativ project Munich Center of Health Sciences (McHealth); Lung Association Zurich (Switzerland)	LMUinnovativ project Munich Center of Health Sciences (McHealth); Lung Association Zurich (Switzerland)	The work of R. P. Laubender was partially supported by the LMUinnovativ project Munich Center of Health Sciences (McHealth). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge and thank the Lung Association Zurich (Switzerland) for providing the funding for the spirometry data.	American Thoracic Society, 1991, AM REV RESP DIS, V144, P1202; Borghi E, 2006, STAT MED, V25, P247, DOI 10.1002/sim.2227; Brandli O, 1996, THORAX, V51, P277, DOI 10.1136/thx.51.3.277; Brandli O, 2000, THORAX, V55, P173; Cole TJ, 2009, STAT MED, V28, P880, DOI 10.1002/sim.3504; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; EGGER S, 2001, SCHWEIZ RUNDSCH MED, V90, P531; Golshan M, 2009, ARCH IRAN MED, V12, P256; Johannessen A, 2007, THORAX, V62, P792, DOI 10.1136/thx.2006.071480; Jones RL, 2006, CHEST, V130, P827, DOI 10.1378/chest.130.3.827; Koenker R, 2005, QUANTILE REGREESION; Kunzli N, 2005, SWISS MED WKLY, V135, P503; Kuster SP, 2008, EUR RESPIR J, V31, P860, DOI 10.1183/09031936.00091407; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Liou TG, 2009, CLIN REV ALLERGY IMM; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; OSCHERWITZ M, 1972, AM J EPIDEMIOL, V96, P319, DOI 10.1093/oxfordjournals.aje.a121462; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Pistelli F, 2007, RESP MED, V101, P814, DOI 10.1016/j.rmed.2006.06.032; Rigby RA, 2004, STAT MED, V23, P3053, DOI 10.1002/sim.1861; Stanojevic S, 2010, EUR RESPIR J, V36, P12, DOI 10.1183/09031936.00143209; Stanojevic S, 2008, AM J RESP CRIT CARE, V177, P253, DOI 10.1164/rccm.200708-1248OC; Stasinopoulos RARDM, 2007, J STAT SOFTW, V23, P1; STOCKS J, 1995, EUR RESPIR J, V8, P492, DOI 10.1183/09031936.95.08030492; Subbarao P, 2004, PEDIATR PULM, V37, P515, DOI 10.1002/ppul.20015; THOMPSON JE, 1992, MED J AUSTRALIA, V156, P566, DOI 10.5694/j.1326-5377.1992.tb121420.x; 1995, WHO TECH REP SER, V854, P1	28	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e52619	10.1371/journal.pone.0052619	http://dx.doi.org/10.1371/journal.pone.0052619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320075	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429800017
J	Dilernia, DA; Monaco, DC; Cesar, C; Krolewiecki, AJ; Friedman, SR; Cahn, P; Salomon, H				Dilernia, Dario A.; Monaco, Daniela C.; Cesar, Carina; Krolewiecki, Alejandro J.; Friedman, Samuel R.; Cahn, Pedro; Salomon, Horacio			Estimation of HIV-Testing Rates to Maximize Early Diagnosis-Derived Benefits at the Individual and Population Level	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; SUB-SAHARAN AFRICA; HIV-1-INFECTED PATIENTS; COLLABORATIVE ANALYSIS; VIRAL LOAD; 1ST YEAR; MISSED OPPORTUNITIES; EARLY MORTALITY; AIDS DIAGNOSIS	Background: In HIV infection, initiation of treatment is associated with improved clinical outcom and reduced rate of sexual transmission. However, difficulty in detecting infection in early stages impairs those benefits. We determined the minimum testing rate that maximizes benefits derived from early diagnosis. Methods: We developed a mathematical model of HIV infection, diagnosis and treatment that allows studying both diagnosed and undiagnosed populations, as well as determining the impact of modifying time to diagnosis and testing rates. The model's external consistency was assessed by estimating time to AIDS and death in absence of treatment as well as by estimating age-dependent mortality rates during treatment, and comparing them with data previously reported from CASCADE and DHCS cohorts. Results: In our model, life expectancy of patients diagnosed before 8 years post infection is the same as HIV-negative population. After this time point, age at death is significantly dependent on diagnosis delay but initiation of treatment increases life expectancy to similar levels as HIV-negative population. Early mortality during HAART is dependent on treatment CD4 threshold until 6 years post infection and becomes dependent on diagnosis delay after 6 years post infection. By modifying testing rates, we estimate that an annual testing rate of 20% leads to diagnosis of 90% of infected individuals within the first 8.2 years of infection and that current testing rate in middle-high income settings stands close to 10%. In addition, many differences between low-income and middle-high incomes can be predicted by solely modifying the diagnosis delay. Conclusions: To increase testing rate of undiagnosed HIV population by two-fold in middle-high income settings will minimize early mortality during initiation of treatment and global mortality rate as well as maximize life expectancy. Our results highlight the impact of achieving early diagnosis and the importance of strongly work on improving HIV testing rates.	[Dilernia, Dario A.; Monaco, Daniela C.; Salomon, Horacio] Univ Buenos Aires, Fac Med, Ctr Nacl Referencia SIDA, Buenos Aires, DF, Argentina; [Cesar, Carina; Krolewiecki, Alejandro J.; Cahn, Pedro] Fdn Huesped, Buenos Aires, DF, Argentina; [Friedman, Samuel R.] Natl Dev & Res Inst Inc, New York, NY USA	University of Buenos Aires; National Development & Research Institutes, Inc	Salomon, H (corresponding author), Univ Buenos Aires, Fac Med, Ctr Nacl Referencia SIDA, Buenos Aires, DF, Argentina.	hsalomon@fmed.uba.ar	Krolewiecki, Alejandro/AAK-2047-2021; Cesar, Carina/H-2831-2019	Krolewiecki, Alejandro/0000-0001-9054-1211; Friedman, Sam/0000-0003-2083-1226	Fogarty International Center/National Institutes of Health through the AIDS International Training and Research Program at Mount Sinai School of Medicine-Argentina Program [D43 TW 001037]; FOGARTY INTERNATIONAL CENTER [D43TW001037] Funding Source: NIH RePORTER	Fogarty International Center/National Institutes of Health through the AIDS International Training and Research Program at Mount Sinai School of Medicine-Argentina Program; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research has been partially funded by a Fogarty International Center/National Institutes of Health grant through the AIDS International Training and Research Program at Mount Sinai School of Medicine-Argentina Program (Grant # D43 TW 001037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dilernia DA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003429; Ameal F, 2005, ACTUALIZACIONES SIDA, V13, P150; Badri M, 2004, AIDS, V18, P1159, DOI 10.1097/00002030-200405210-00009; Badri M, 2006, LANCET, V368, P1254, DOI 10.1016/S0140-6736(06)69117-4; Bassett IV, 2010, CLIN INFECT DIS, V50, pS77, DOI 10.1086/651477; Bhattacharya T, 2007, SCIENCE, V315, P1583, DOI 10.1126/science.1131528; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brannstrom J, 2005, INT J STD AIDS, V16, P702, DOI 10.1258/095646205774357262; Castilla J, 2002, AIDS, V16, P1945, DOI 10.1097/00002030-200209270-00012; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P581; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Deeks SG, 1999, AIDS, V13, pF35, DOI 10.1097/00002030-199904160-00001; Delpierre C, 2007, INT J STD AIDS, V18, P312, DOI 10.1258/095646207780749709; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Socias ME, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-40; Fisher M, 2008, CURR OPIN INFECT DIS, V21, P1, DOI 10.1097/QCO.0b013e3282f2d8fb; French N, 1999, J ACQ IMMUN DEF SYND, V22, P509; Girardi E, 2004, JAIDS-J ACQ IMM DEF, V36, P951, DOI 10.1097/00126334-200408010-00009; Girardi E, 2007, JAIDS-J ACQ IMM DEF, V46, pS3, DOI 10.1097/01.qai.0000286597.57066.2b; Gupta P, 1997, J VIROL, V71, P6271, DOI 10.1128/JVI.71.8.6271-6275.1997; Hocking JS, 2000, INT J STD AIDS, V11, P503, DOI 10.1258/0956462001916407; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Krentz HB, 2004, HIV MED, V5, P93, DOI 10.1111/j.1468-1293.2004.00193.x; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Le Moing V, 2002, AIDS, V16, P21, DOI 10.1097/00002030-200201040-00004; Liddicoat RV, 2004, J GEN INTERN MED, V19, P349, DOI 10.1111/j.1525-1497.2004.21251.x; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Manavi K, 2004, INT J STD AIDS, V15, P811, DOI 10.1258/0956462042563585; Marazzi MC, 2008, AIDS RES HUM RETROV, V24, P555, DOI 10.1089/aid.2007.0217; May M, 2007, AIDS, V21, P1185, DOI 10.1097/QAD.0b013e328133f285; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; McDonald AM, 2003, AUST NZ J PUBL HEAL, V27, P608, DOI 10.1111/j.1467-842X.2003.tb00607.x; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Mocroft A, 2005, AIDS RES HUM RETROV, V21, P527, DOI 10.1089/aid.2005.21.527; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; ROSENBERG PS, 1995, SCIENCE, V270, P1372, DOI 10.1126/science.270.5240.1372; Sabin CA, 2004, AIDS, V18, P2145, DOI 10.1097/00002030-200411050-00006; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Schneider MF, 2005, AIDS, V19, P2009, DOI 10.1097/01.aids.0000189864.90053.22; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; Stanley B, 2003, BMJ-BRIT MED J, V326, P1174, DOI 10.1136/bmj.326.7400.1174; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Sullivan AK, 2005, BRIT MED J, V330, P1301, DOI 10.1136/bmj.38398.590602.E0; Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: A collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action, 2000, RAP ADV ANT THER HIV, V355, P1131; Tuboi SH, 2007, JAIDS-J ACQ IMM DEF, V45, P52, DOI 10.1097/QAI.0b013e318042e1c3; Tuboi SH, 2009, JAIDS-J ACQ IMM DEF, V51, P615, DOI 10.1097/QAI.0b013e3181a44f0a; van der Loeff MFS, 2002, AIDS, V16, P1775, DOI 10.1097/00002030-200209060-00010; Walensky RP, 2002, ARCH INTERN MED, V162, P887, DOI 10.1001/archinte.162.8.887; White DAE, 2009, AIDS PATIENT CARE ST, V23, P245, DOI 10.1089/apc.2008.0198; World Health Organization, 2008, UN ACC SCAL PRIOR HI; Zala Carlos, 2008, Medscape J Med, V10, P78, DOI 10.1186/1758-2652-10-4-78	56	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53193	10.1371/journal.pone.0053193	http://dx.doi.org/10.1371/journal.pone.0053193			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308161	Green Published, gold, Green Submitted			2022-12-25	WOS:000313429100037
J	Duan, JH; Hu, CH; Chen, H				Duan, Jinghao; Hu, Chunhong; Chen, Hua			High-Resolution Micro-CT for Morphologic and Quantitative Assessment of the Sinusoid in Human Cavernous Hemangioma of the Liver	PLOS ONE			English	Article							RAY PHASE-CONTRAST; IMAGE-RECONSTRUCTION; RETRIEVAL; VISUALIZATION; TOMOGRAPHY	Hepatic sinusoid plays a vital role in human cavernous hemangioma of the liver (CHL), and its morphologic investigation facilitates the understanding of microcirculation mechanism and pathological change of CHL. However, precise anatomical view of the hepatic sinusoid has been limited by the resolution and contrast available from existing imaging techniques. While liver biopsy has traditionally been the reliable method for the assessment of hepatic sinusoids, the invasiveness and sampling error are its inherent limitations. In this study, imaging of CHL samples was performed using in-line phase-contrast imaging (ILPCI) technique with synchrotron radiation. ILPCI allowed clear visualization of soft tissues and revealed structural details that were invisible to conventional radiography. Combining the computed tomography (CT) technique, ILPCI-CT was used to acquire the high-resolution micro-CT images of CHL, and three dimensional (3D) microstructures of hepatic sinusoids were provided for the morphologic depiction and quantitative assessment. Our study demonstrated that ILPCI-CT could substantially improve the radiographic contrast of CHL tissues in vitro with no contrast agent. ILPCI-CT yielded high-resolution micro-CT image of CHL sample at the micron scale, corresponding to information on actual structures revealed at histological section. The 3D visualization provided an excellent view of the hepatic sinusoid. The accurate view of individual hepatic sinusoid was achieved. The valuable morphological parameters of hepatic sinusoids, such as thrombi, diameters, surface areas and volumes, were measured. These parameters were of great importance in the evaluation of CHL, and they provided quantitative descriptors that characterized anatomical properties and pathological features of hepatic sinusoids. The results highlight the high degree of sensitivity of the ILPCI-CT technique and demonstrate the feasibility of accurate visualization of hepatic sinusoids. Moreover, there is a correlation between the CHL and the size or morphology of hepatic sinusoids, which offers a potential use in noninvasive study and analysis of CHL.	[Duan, Jinghao; Hu, Chunhong] Tianjin Med Univ, Coll Biomed Engn, Tianjin, Peoples R China; [Chen, Hua] Tianjin Med Univ, Canc Hosp, Dept Hepatobiliary Surg, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Hu, CH (corresponding author), Tianjin Med Univ, Coll Biomed Engn, Tianjin, Peoples R China.	chunhong_hu@hotmail.com			National Natural Science Foundation of China [30900333]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants 30900333 (to C. H.) from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arhatari BD, 2011, PHYS MED BIOL, V56, P5265, DOI 10.1088/0031-9155/56/16/012; Beltran MA, 2011, PHYS MED BIOL, V56, P7353, DOI 10.1088/0031-9155/56/23/002; BORNMAN PC, 1987, SURGERY, V101, P445; Burvall A, 2011, OPT EXPRESS, V19, P10359, DOI 10.1364/OE.19.010359; DAVIS TJ, 1995, NATURE, V373, P595, DOI 10.1038/373595a0; Debbaut C, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4005545; Hu JZ, 2012, PHYS MED BIOL, V57, pN55, DOI 10.1088/0031-9155/57/5/N55; ISHAK KG, 1975, MED CLIN N AM, V59, P995, DOI 10.1016/S0025-7125(16)31998-8; Laperle CM, 2008, PHYS MED BIOL, V53, P6911, DOI 10.1088/0031-9155/53/23/017; Larsson DH, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3664870; Lewis RA, 2004, PHYS MED BIOL, V49, P3573, DOI 10.1088/0031-9155/49/16/005; Liu XX, 2010, PHYS MED BIOL, V55, P2399, DOI 10.1088/0031-9155/55/8/017; Lundstrom U, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/9/2603; Mani H, 2001, Clin Liver Dis, V5, P219, DOI 10.1016/S1089-3261(05)70162-8; Momose A, 1996, NAT MED, V2, P473, DOI 10.1038/nm0496-473; OCHSNER JL, 1958, SURGERY, V43, P577; Oda M, 2003, CLIN HEMORHEOL MICRO, V29, P167; Papafragkakis H, 2011, INT J HEPATOL, V2011, DOI 10.4061/2011/942360; Parsons DW, 2008, J ANAT, V213, P217, DOI 10.1111/j.1469-7580.2008.00950.x; Pogany A, 1997, REV SCI INSTRUM, V68, P2774, DOI 10.1063/1.1148194; Sidky EY, 2006, J X-RAY SCI TECHNOL, V14, P119; Sidky EY, 2010, OPT EXPRESS, V18, P10404, DOI 10.1364/OE.18.010404; Spanne P, 1999, PHYS MED BIOL, V44, P741, DOI 10.1088/0031-9155/44/3/016; TUNG GA, 1994, AM J ROENTGENOL, V162, P1113, DOI 10.2214/ajr.162.5.8165993; Vagefi PA, 2011, J GASTROINTEST SURG, V15, P209, DOI 10.1007/s11605-010-1248-1; Weitkamp T, 2011, J SYNCHROTRON RADIAT, V18, P617, DOI 10.1107/S0909049511002895; Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0; Wu XZ, 2003, MED PHYS, V30, P2169, DOI 10.1118/1.1593836; Zhang L, 2011, PLOS ONE, V6, DOI DOI 10.1371/JOURNAL.PONE.0017400	29	15	18	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53507	10.1371/journal.pone.0053507	http://dx.doi.org/10.1371/journal.pone.0053507			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308240	Green Submitted, gold, Green Published			2022-12-25	WOS:000313429100078
J	Richter, M; Zolal, A; Ganslandt, O; Buchfelder, M; Nimsky, C; Merhof, D				Richter, Mirco; Zolal, Amir; Ganslandt, Oliver; Buchfelder, Michael; Nimsky, Christopher; Merhof, Dorit			Evaluation of Diffusion-Tensor Imaging-Based Global Search and Tractography for Tumor Surgery Close to the Language System	PLOS ONE			English	Article							ANATOMO-FUNCTIONAL CONNECTIVITY; WHITE-MATTER TRACTOGRAPHY; DTI-FIBER TRACKING; BRAIN; FASCICULUS; RECONSTRUCTION; VISUALIZATION; DISSECTION; PATHWAYS; INSIGHTS	Pre-operative planning and intra-operative guidance in neurosurgery require detailed information about the location of functional areas and their anatomo-functional connectivity. In particular, regarding the language system, post-operative deficits such as aphasia can be avoided. By combining functional magnetic resonance imaging and diffusion tensor imaging, the connectivity between functional areas can be reconstructed by tractography techniques that need to cope with limitations such as limited resolution and low anisotropic diffusion close to functional areas. Tumors pose particular challenges because of edema, displacement effects on brain tissue and infiltration of white matter. Under these conditions, standard fiber tracking methods reconstruct pathways of insufficient quality. Therefore, robust global or probabilistic approaches are required. In this study, two commonly used standard fiber tracking algorithms, streamline propagation and tensor deflection, were compared with a previously published global search, Gibbs tracking and a connection-oriented probabilistic tractography approach. All methods were applied to reconstruct neuronal pathways of the language system of patients undergoing brain tumor surgery, and control subjects. Connections between Broca and Wernicke areas via the arcuate fasciculus (AF) and the inferior fronto-occipital fasciculus (IFOF) were validated by a clinical expert to ensure anatomical feasibility, and compared using distance-and diffusion-based similarity metrics to evaluate their agreement on pathway locations. For both patients and controls, a strong agreement between all methods was observed regarding the location of the AF. In case of the IFOF however, standard fiber tracking and Gibbs tracking predominantly identified the inferior longitudinal fasciculus that plays a secondary role in semantic language processing. In contrast, global search resolved connections in almost every case via the IFOF which could be confirmed by probabilistic fiber tracking. The results show that regarding the language system, our global search is superior to clinically applied conventional fiber tracking strategies with results similar to time-consuming global or probabilistic approaches.	[Richter, Mirco; Merhof, Dorit] Univ Konstanz, Constance, Germany; [Zolal, Amir] Univ JE Purkyn, Dept Neurosurg, Usti Nad Labem, Czech Republic; [Zolal, Amir] Masaryk Hosp, Usti Nad Labem, Czech Republic; [Ganslandt, Oliver; Buchfelder, Michael] Univ Erlangen Nurnberg, Dept Neurosurg, D-91054 Erlangen, Germany; [Nimsky, Christopher] Univ Marburg, Dept Neurosurg, Marburg, Germany	University of Konstanz; Masaryk Hospital; University of Erlangen Nuremberg; Philipps University Marburg	Richter, M (corresponding author), Univ Konstanz, Constance, Germany.	mirco.richter@uni-konstanz.de	Nimsky, Christopher/E-3702-2014; Merhof, Dorit/AAV-7892-2021; Zolal, Amir/R-5830-2019	Nimsky, Christopher/0000-0002-8216-9410; Zolal, Amir/0000-0003-3729-2513	DFG Research Training Group at the University of Konstanz [GK-1042]	DFG Research Training Group at the University of Konstanz	This study was supported by the DFG Research Training Group GK-1042 "Explorative Analysis and Visualization of Large Information Spaces" at the University of Konstanz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aganj I, 2009, I S BIOMED IMAGING, P1398, DOI 10.1109/ISBI.2009.5193327; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Basser PJ, 1998, MAGNET RESON MED, V39, P928, DOI 10.1002/mrm.1910390610; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bello L, 2008, NEUROIMAGE, V39, P369, DOI 10.1016/j.neuroimage.2007.08.031; Bertani G, 2012, J NEUROSURG SCI, V56, P137; Brun A, 2003, LECT NOTES COMPUT SC, V2809, P518; Cheng P, 2006, NEUROIMAGE, V31, P1075, DOI 10.1016/j.neuroimage.2006.01.028; Corouge I, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 and 2, P344; DECHTER R, 1985, J ACM, V32, P505, DOI 10.1145/3828.3830; Ding ZH, 2001, IEEE VISUAL, P453, DOI 10.1109/VISUAL.2001.964549; Duffau H, 2005, BRAIN, V128, P797, DOI 10.1093/brain/awh423; Duffau H, 2008, NEUROPSYCHOLOGIA, V46, P927, DOI 10.1016/j.neuropsychologia.2007.10.025; Fillard P, 2011, NEUROIMAGE, V56, P220, DOI 10.1016/j.neuroimage.2011.01.032; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Golby AJ, 2011, NEUROSURGERY, V68, P496, DOI 10.1227/NEU.0b013e3182061ebb; Hasan KM, 2001, J MAGN RESON IMAGING, V13, P769, DOI 10.1002/jmri.1107; Jackowski M, 2005, MED IMAGE ANAL, V9, P427, DOI 10.1016/j.media.2005.05.008; Jones D, 2008, PISTE PHANTOM IMAGES; Kier EL, 2004, AM J NEURORADIOL, V25, P677; Kreher B., 2006, P ISMRM 14 INT SCI M; Kreher BW, 2008, NEUROIMAGE, V43, P81, DOI 10.1016/j.neuroimage.2008.06.023; Kuhnt D, 2012, NEUROSURGERY, V70, P911, DOI 10.1227/NEU.0b013e318237a807; Lagana` M, 2010, COMPUTATIONAL INTELL, V2010; Lazar M, 2003, NEUROIMAGE, V20, P1140, DOI 10.1016/S1053-8119(03)00277-5; Lebel C, 2012, MAGN RESON MED, V68, P474, DOI 10.1002/mrm.23254; Maesawa S, 2010, WORLD NEUROSURG, V74, P153, DOI 10.1016/j.wneu.2010.03.022; Mandonnet E, 2007, BRAIN, V130, P623, DOI 10.1093/brain/awl361; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Martino J, 2010, CORTEX, V46, P691, DOI 10.1016/j.cortex.2009.07.015; McDonald CR, 2008, NEUROLOGY, V71, P1869, DOI 10.1212/01.wnl.0000327824.05348.3b; Merhof D, 2006, LECT NOTES COMPUT SC, V4191, P225; Mohades S, 2012, BRAIN RES, V1435, P137; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Neher P, 2012, P SPIE MED IMAGING, V8314; Nimsky C, 2005, RADIOLOGY, V234, P218, DOI 10.1148/radiol.2341031984; Nimsky C, 2007, NEUROSURGERY, V61, P178, DOI [10.1227/01.neu.0000279214.00139.3b, 10.1227/01.NEU.0000144842.18771.30]; Ozarslan E, 2003, MAGN RESON MED, V50, P955, DOI 10.1002/mrm.10596; Parker GJM, 2005, NEUROIMAGE, V24, P656, DOI 10.1016/j.neuroimage.2004.08.047; Parker GJM, 2002, IEEE T MED IMAGING, V21, P505, DOI 10.1109/TMI.2002.1009386; Parker GJM, 2003, J MAGN RESON IMAGING, V18, P242, DOI 10.1002/jmri.10350; Pinotsis DA, 2012, NEUROIMAGE, V59, P1261, DOI [10.1016/j.neuroimage.2011.08.020, 10.1016/j.neuroimage.2010.12.039]; Reisert M, 2009, P MICCAI DIFF MOD WO; Reisert M, 2011, NEUROIMAGE, V54, P955, DOI 10.1016/j.neuroimage.2010.09.016; Saur D, 2010, NEUROIMAGE, V49, P3187, DOI 10.1016/j.neuroimage.2009.11.009; Schmahmann J, 2006, FIBER PATHWAYS BRAIN; Schonberg T, 2006, NEUROIMAGE, V30, P1100, DOI 10.1016/j.neuroimage.2005.11.015; Thesen S, 2000, MAGNET RESON MED, V44, P457, DOI 10.1002/1522-2594(200009)44:3<457::AID-MRM17>3.0.CO;2-R; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Turken AU, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00001; Vandermosten M, 2012, BRAIN, V135, P935, DOI 10.1093/brain/awr363; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Voineskos AN, 2010, BRAIN, V133, P1494, DOI 10.1093/brain/awq040; Westin CF, 1997, ISMRM 97, P1742; Zalesky A, 2008, IEEE T MED IMAGING, V27, P1458, DOI 10.1109/TMI.2008.923644; Zhang S, 2002, CS0218	56	11	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e50132	10.1371/journal.pone.0050132	http://dx.doi.org/10.1371/journal.pone.0050132			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308093	Green Published, gold, Green Submitted			2022-12-25	WOS:000313429100002
J	Stanton, MC; Bockarie, MJ; Kelly-Hope, LA				Stanton, Michelle C.; Bockarie, Moses J.; Kelly-Hope, Louise A.			Geographical Factors Affecting Bed Net Ownership, a Tool for the Elimination of Anopheles-Transmitted Lymphatic Filariasis in Hard-to-Reach Communities	PLOS ONE			English	Article							INSECTICIDE TREATED NETS; PREGNANT-WOMEN; LOA-LOA; POPULATION; AFRICA; TRANSMISSION; POSSESSION; COVERAGE; MOSQUITO; CHILDREN	Vector control, including the use of bed nets, is recommended as a possible strategy for eliminating lymphatic filariasis (LF) in post-conflict countries such as the Democratic Republic of Congo (DRC). This study examined the geographical factors that influence bed net ownership in DRC in order to identify hard-to-reach communities that need to be better targeted. In particular, urban/rural differences and the influence of population density, proximity to cities and health facilities, plus access to major transport networks were investigated. Demographic and Health Survey geo-referenced cluster level data were used to map bed net coverage (proportion of households with at least one of any type of bed net or at least one insecticide-treated net (ITN)), and ITN density (ITNs per person) for 260 clusters. Bivariate and multiple logistic or Poisson regression analyses were used to determine significant relationships. Overall, bed net (30%) and ITN (9%) coverage were very low with significant differences found between urban and rural clusters. In rural clusters, ITN coverage/density was positively correlated with population density (r = 0.25, 0.27 respectively, p < 0.01), and negatively with the distance to the two largest cities, Kinshasa or Lubumbashi (r = -0.28, -0.30 respectively, p < 0.0001). Further, ownership was significantly negatively correlated with distance to primary national roads and railways (all three measures), distance to main rivers (any bed net only) and distance to the nearest health facility (ITNs only). Logistic and Poisson regression models fitted to the rural cluster data indicated that, after controlling for measured covariates, ownership levels in the Bas-Congo province close to Kinshasa were much larger than that of other provinces. This was most noticeable when considering ITN coverage (odds ratio: 5.3, 95% CI: 3.67-7.70). This analysis provides key insights into the barriers of bed net ownership, which will help inform both LF and malaria bed net distribution campaigns as part of an integrated vector management strategy.	[Stanton, Michelle C.; Bockarie, Moses J.; Kelly-Hope, Louise A.] Univ Liverpool, Liverpool Sch Trop Med, Ctr Neglected Trop Dis, Liverpool L3 5QA, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool	Stanton, MC (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Ctr Neglected Trop Dis, Liverpool L3 5QA, Merseyside, England.	michelle.stanton@liv.ac.uk	Bockarie, Moses/AAV-4578-2020; Bockarie, Moses/AAW-3130-2021	Kelly-Hope, Louise/0000-0002-3330-7629	Department for International Development (DFID); GlaxoSmithKline (GSK); GlaxoSmithKline	Department for International Development (DFID); GlaxoSmithKline (GSK)(GlaxoSmithKline); GlaxoSmithKline(GlaxoSmithKline)	The study was supported through a grant from the Department for International Development (DFID) and GlaxoSmithKline (GSK) for research on the elimination of lymphatic filariasis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partially supported through a grant from the commercial funder GlaxoSmithKline. This does not alter the authors' adherence to all of the PLOS ONE policies on sharing data and materials.	African Programme for Onchocerciasis Control, 2010, WHO YEAR 2010 PROGR; Agresti A, 2007, INTRO CATEGORICAL DA; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P121; [Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; [Anonymous], GLOB MAL ACT PLAN MA; Ashton RA, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-134; Balk DL, 2006, ADV PARASIT, V62, P119, DOI 10.1016/S0065-308X(05)62004-0; Beier JC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S4; Belay M, 2008, TROP MED INT HEALTH, V13, P1303, DOI 10.1111/j.1365-3156.2008.02159.x; Blackburn BG, 2006, AM J TROP MED HYG, V75, P650, DOI 10.4269/ajtmh.2006.75.650; Bockarie MJ, 2002, MED VET ENTOMOL, V16, P116, DOI 10.1046/j.0269-283x.2002.00352.x; Burkot T R, 2006, Filaria J, V5, P10, DOI 10.1186/1475-2883-5-10; Demographic and Health Survey, 2007, DEM REP CONG; Department for International Development, 2011, MAL COUNTR PROF; Eisele TP, 2009, AM J TROP MED HYG, V80, P209, DOI 10.4269/ajtmh.2009.80.209; Gardon J, 1997, LANCET, V350, P18, DOI 10.1016/S0140-6736(96)11094-1; Global Malaria Programme, 2007, INS TREAT MOSQ NETS; Graves PM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-354; Hawking F, 1977, Trop Dis Bull, V74, P649; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Ichimori K, 2012, PROV STRAT INT LYMPH; Kelly-Hope LA, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-178; Khan S, 2008, WHO USES INSECTICIDE; Korenromp EL, 2003, TROP MED INT HEALTH, V8, P693, DOI 10.1046/j.1365-3156.2003.01084.x; Larson PS, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-18; Macintyre K, 2006, TROP MED INT HEALTH, V11, P824, DOI 10.1111/j.1365-3156.2006.01637.x; Messina JP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-161; Ministere du Plan, 2007, ENQ DEM SANT REP DEM; Molyneux DH, 2006, ADV PARASIT, V61, P1, DOI 10.1016/S0065-308X(05)61001-9; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142; Noor AM, 2009, LANCET, V373, P58, DOI 10.1016/S0140-6736(08)61596-2; O'Meara WP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025949; Ouattara AF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-288; Pedersen EM, 2002, ANN TROP MED PARASIT, V96, pS91, DOI 10.1179/000349802125002437; President's Malaria Initiative, 2011, MAL OP PLAN FISC YEA; Rutstein SO, 2006, GUID DHS STAT; Sexton AR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-157; Socioeconomic Data and Application Center (SEDAC) Columbia University, GLOB RUR URB MAPP PR; Socioeconomic Data and Application Center (SEDAC) Columbia University, GRIDD POP WORLD VERS; Sutton P, 2001, INT J REMOTE SENS, V22, P3061, DOI 10.1080/01431160010007015; Taylor SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016420; United Nations' Children's Fund (UNICEF), 2011, MUULT IND CLUST SURV; Van den Berg H, 2012, LANCET INFECT DIS, V3099, P1; Wacira DG, 2007, TROP MED INT HEALTH, V12, P140, DOI 10.1111/j.1365-3156.2006.01759.x; World Bank Group, 2010, DEM REP CONG MULT TR; World Health Organization, 2009, LF PROGR REP STRAT P; Zoure HGM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001210	48	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53755	10.1371/journal.pone.0053755	http://dx.doi.org/10.1371/journal.pone.0053755			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308281	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000313429100113
J	Svedruzic, ZM; Popovic, K; Sendula-Jengic, V				Svedruzic, Zeljko M.; Popovic, Katarina; Sendula-Jengic, Vesna			Modulators of gamma-Secretase Activity Can Facilitate the Toxic Side-Effects and Pathogenesis of Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; APP LOCUS DUPLICATION; C-TERMINAL FRAGMENT; A-BETA; INTRAMEMBRANE CLEAVAGE; TRANSMEMBRANE DOMAIN; CEREBROSPINAL-FLUID; MOUSE MODEL; INHIBITOR; SITE	Background: Selective modulation of different A beta products of an intramembrane protease gamma-secretase, could be the most promising strategy for development of effective therapies for Alzheimer's disease. We describe how different drug-candidates can modulate gamma-secretase activity in cells, by studying how DAPT affects changes in gamma-secretase activity caused by gradual increase in A beta metabolism. Results: A beta 1-40 secretion in the presence of DAPT shows biphasic activation-inhibition dose-response curves. The biphasic mechanism is a result of modulation of gamma-secretase activity by multiple substrate and inhibitor molecules that can bind to the enzyme simultaneously. The activation is due to an increase in gamma-secretase's kinetic affinity for its substrate, which can make the enzyme increasingly more saturated with otherwise sub-saturating substrate. The noncompetitive inhibition that prevails at the saturating substrate can decrease the maximal activity. The synergistic activation-inhibition effects can drastically reduce gamma-secretase's capacity to process its physiological substrates. This reduction makes the biphasic inhibitors exceptionally prone to the toxic side-effects and potentially pathogenic. Without the modulation, gamma-secretase activity on it physiological substrate in cells is only 14% of its maximal activity, and far below the saturation. Significance: Presented mechanism can explain why moderate inhibition of gamma-secretase cannot lead to effective therapies, the pharmacodynamics of A beta-rebound phenomenon, and recent failures of the major drug-candidates such as semagacestat. Novel improved drug-candidates can be prepared from competitive inhibitors that can bind to different sites on gamma-secretase simultaneously. Our quantitative analysis of the catalytic capacity can facilitate the future studies of the therapeutic potential of gamma-secretase and the pathogenic changes in A beta metabolism.	[Svedruzic, Zeljko M.; Sendula-Jengic, Vesna] Univ Rijeka, Fac Med, PB Rab, Rab, Croatia; [Svedruzic, Zeljko M.] Univ Rijeka, Dept Biotechnol, Rijeka, Croatia	University of Rijeka; University of Rijeka	Svedruzic, ZM (corresponding author), Univ Rijeka, Fac Med, PB Rab, Rab, Croatia.	zsvedruz@biol.pmf.hr	Svedruzic, Zeljko M/R-3281-2018; Sendula Jengic, Vesna/U-2499-2018	Svedruzic, Zeljko M/0000-0002-0736-6182; Sendula Jengic, Vesna/0000-0003-2126-3793	Croatian Ministry of Health	Croatian Ministry of Health	The authors are funded by the Croatian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelsen PH, 2011, PHYSIOLOGY, V26, P54, DOI 10.1152/physiol.00024.2010; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Beel AJ, 2009, BIOCHEMISTRY-US, V48, P11837, DOI 10.1021/bi901839d; Beher D, 2004, J BIOL CHEM, V279, P43419, DOI 10.1074/jbc.M404937200; Benilova I, 2011, NAT NEUROSCI, V14, P949, DOI 10.1038/nn.2871; Berezovska O, 2003, J NEUROSCI, V23, P4560; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Bulic B, 2011, CURR NEUROPHARMACOL, V9, P598, DOI 10.2174/157015911798376352; Burton CR, 2008, J BIOL CHEM, V283, P22992, DOI 10.1074/jbc.M804175200; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; Chau DM, 2012, J BIOL CHEM; Chavez-Gutierrez L, 2012, EMBO J; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Comery TA, 2005, J NEUROSCI, V25, P8898, DOI 10.1523/JNEUROSCI.2693-05.2005; Coric V., 2012, ARCH NEUROL-CHICAGO, V69, P1430, DOI [10.1001/archneurol.2012.2194, DOI 10.1001/ARCHNEUROL.2012.2194]; Das C, 2003, J AM CHEM SOC, V125, P11794, DOI 10.1021/ja037131v; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Eggert S, 2009, J BIOL CHEM, V284, P28943, DOI 10.1074/jbc.M109.038646; Fersht A., 1999, STRUCTURE MECH PROTE; Fukumoto H, 2004, AM J PATHOL, V164, P719, DOI 10.1016/S0002-9440(10)63159-8; German DC, 2004, REV NEUROSCIENCE, V15, P353, DOI 10.1515/REVNEURO.2004.15.5.353; Guyant-Marechal L, 2007, NEUROLOGY, V68, P684, DOI 10.1212/01.wnl.0000255938.33739.46; Henley DB, 2009, EXPERT OPIN PHARMACO, V10, P1657, DOI 10.1517/14656560903044982; Henley DB, 2011, ALZHEIMERS DEMENT; Holsinger RMD, 2004, ANN NEUROL, V55, P898, DOI 10.1002/ana.20144; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Kornilova AY, 2003, J BIOL CHEM, V278, P16470, DOI 10.1074/jbc.C300019200; Kreft AF, 2009, J MED CHEM, V52, P6169, DOI 10.1021/jm900188z; Lanz TA, 2004, J PHARMACOL EXP THER, V309, P49, DOI 10.1124/jpet.103.060715; Lanz TA, 2006, J PHARMACOL EXP THER, V319, P924, DOI 10.1124/jpet.106.110700; Lauritzen I, 2012, J NEUROSCI, V32, P16243, DOI 10.1523/JNEUROSCI.2775-12.2012; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Marlow L, 2003, BIOCHEM BIOPH RES CO, V305, P502, DOI 10.1016/S0006-291X(03)00797-6; Mitani Y, 2012, J NEUROSCI, V32, P2037, DOI 10.1523/JNEUROSCI.4264-11.2012; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Nalbantoglu J, 1997, NATURE, V387, P500, DOI 10.1038/387500a0; Nelson DL, 2008, LEHINGER PRINCIPLES; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Oehlrich D, 2010, J MED CHEM; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Refolo LM, 1999, J NEUROCHEM, V73, P2383, DOI 10.1046/j.1471-4159.1999.0732383.x; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Rovelet-Lecrux A, 2007, J NEUROL NEUROSUR PS, V78, P1158, DOI 10.1136/jnnp.2006.113514; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Sambamurti K, 2011, J NEUROCHEM, V117, P359, DOI 10.1111/j.1471-4159.2011.07213.x; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; SCHULZ AR, 1994, ENZYME KINETICS DIAS; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Suh YH, 2000, J NEURAL TRANSM-SUPP, P65; Sun AY, 2002, EXP NEUROL, V175, P10, DOI 10.1006/exnr.2002.7875; Svedruzic ZM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032293; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Tamayev R, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-19; Thathiah A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.293re8; Tian GC, 2003, J BIOL CHEM, V278, P28968, DOI 10.1074/jbc.M300905200; Tian GC, 2002, J BIOL CHEM, V277, P31499, DOI 10.1074/jbc.M112328200; Tomita T, 2009, EXPERT REV NEUROTHER, V9, P661, DOI [10.1586/ern.09.24, 10.1586/ERN.09.24]; Tong G, 2012, CLIN THER, V34, P654, DOI 10.1016/j.clinthera.2012.01.022; Uemura K, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-15; Uemura K, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1129; Uemura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007893; Yagishita S, 2006, BIOCHEMISTRY-US, V45, P3952, DOI 10.1021/bi0521846; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Yin YI, 2007, J BIOL CHEM, V282, P23639, DOI 10.1074/jbc.M704601200; Zhang LL, 2001, BIOCHEMISTRY-US, V40, P5049, DOI 10.1021/bi0028800; Zhao B, 2008, J BIOL CHEM, V283, P2927, DOI 10.1074/jbc.M708870200	76	22	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e50759	10.1371/journal.pone.0050759	http://dx.doi.org/10.1371/journal.pone.0050759			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308095	gold, Green Published, Green Submitted			2022-12-25	WOS:000313429100003
J	Bucchi, A; Baruscotti, M; Nardini, M; Barbuti, A; Micheloni, S; Bolognesi, M; DiFrancesco, D				Bucchi, Annalisa; Baruscotti, Mirko; Nardini, Marco; Barbuti, Andrea; Micheloni, Stefano; Bolognesi, Martino; DiFrancesco, Dario			Identification of the Molecular Site of Ivabradine Binding to HCN4 Channels	PLOS ONE			English	Article							ACTIVATED CATION CHANNELS; POTASSIUM CHANNEL; STRUCTURAL BASIS; BLOCK; TOPOLOGY; MODEL; PREDICTION; CURRENTS	Ivabradine is a specific heart rate-reducing agent approved as a treatment of chronic stable angina. Its mode of action involves a selective and specific block of HCN channels, the molecular components of sinoatrial "funny" (f)-channels. Different studies suggest that the binding site of ivabradine is located in the inner vestibule of HCN channels, but the molecular details of ivabradine binding are unknown. We thus sought to investigate by mutagenesis and in silico analysis which residues of the HCN4 channel, the HCN isoform expressed in the sinoatrial node, are involved in the binding of ivabradine. Using homology modeling, we verified the presence of an inner cavity below the channel pore and identified residues lining the cavity; these residues were replaced with alanine (or valine) either alone or in combination, and WT and mutant channels were expressed in HEK293 cells. Comparison of the block efficiency of mutant vs WT channels, measured by patch-clamp, revealed that residues Y506, F509 and I510 are involved in ivabradine binding. For each mutant channel, docking simulations correctly explain the reduced block efficiency in terms of proportionally reduced affinity for ivabradine binding. In summary our study shows that ivabradine occupies a cavity below the channel pore, and identifies specific residues facing this cavity that interact and stabilize the ivabradine molecule. This study provides an interpretation of known properties of f/HCN4 channel block by ivabradine such as the "open channel block", the current-dependence of block and the property of "trapping" of drug molecules in the closed configuration.	[Bucchi, Annalisa; Baruscotti, Mirko; Barbuti, Andrea; Micheloni, Stefano; DiFrancesco, Dario] Univ Milan, Dept Life Sci, PaceLab, Milan, Italy; [Bucchi, Annalisa; Baruscotti, Mirko; Barbuti, Andrea; DiFrancesco, Dario] Univ Milan, Ctr Interuniv Med Mol & Biofis Appicata, Milan, Italy; [Nardini, Marco; Bolognesi, Martino] Univ Milan, Dept Life Sci, Lab Prot Biochem, Milan, Italy	University of Milan; University of Milan; University of Milan	DiFrancesco, D (corresponding author), Univ Milan, Dept Life Sci, PaceLab, Milan, Italy.	dario.difrancesco@unimi.it	Bolognesi, Martino/B-7924-2017; Nardini, Marco/B-7842-2017; Bucchi, Annalisa/B-1882-2017; Barbuti, Andrea/N-9805-2013; DiFrancesco, Dario/G-8408-2017; BARUSCOTTI, MIRKO/D-7017-2017	Bolognesi, Martino/0000-0002-9253-5170; Nardini, Marco/0000-0002-3718-2165; Bucchi, Annalisa/0000-0002-5303-4242; Barbuti, Andrea/0000-0002-4521-4913; DiFrancesco, Dario/0000-0002-7322-1790; BARUSCOTTI, MIRKO/0000-0002-6155-8388	Institut de Recherches Internationales Servier	Institut de Recherches Internationales Servier(Servier)	The authors thank the Institut de Recherches Internationales Servier for providing support for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare C, 2001, J GEN PHYSIOL, V117, P519, DOI 10.1085/jgp.117.6.519; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Bois P, 1996, BRIT J PHARMACOL, V118, P1051, DOI 10.1111/j.1476-5381.1996.tb15505.x; Bucchi A, 2002, J GEN PHYSIOL, V120, P1, DOI 10.1085/jgp.20028593; Bucchi A, 2006, J PHYSIOL-LONDON, V572, P335, DOI 10.1113/jphysiol.2005.100776; Chan YC, 2009, PFLUG ARCH EUR J PHY, V459, P25, DOI 10.1007/s00424-009-0719-2; Cheng L, 2007, J PHARMACOL EXP THER, V322, P931, DOI 10.1124/jpet.107.121467; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; DiFrancesco JC, 2011, J NEUROSCI, V31, P17327, DOI 10.1523/JNEUROSCI.3727-11.2011; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Emery EC, 2011, SCIENCE, V333, P1462, DOI 10.1126/science.1206243; Fernandez D, 2004, J BIOL CHEM, V279, P10120, DOI 10.1074/jbc.M310683200; Giorgetti A, 2005, BIOPHYS J, V89, P932, DOI 10.1529/biophysj.104.045286; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Postea O, 2011, NAT REV DRUG DISCOV, V10, P903, DOI 10.1038/nrd3576; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Roncaglia P, 2002, BIOPHYS J, V83, P1953, DOI 10.1016/S0006-3495(02)73957-X; Rothberg BS, 2003, J GEN PHYSIOL, V122, P501, DOI 10.1085/jgp.200308928; Rothberg BS, 2002, J GEN PHYSIOL, V119, P83, DOI 10.1085/jgp.119.1.83; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanchez-Chapula JA, 2003, MOL PHARMACOL, V63, P1051, DOI 10.1124/mol.63.5.1051; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shin KS, 2001, J GEN PHYSIOL, V117, P91, DOI 10.1085/jgp.117.2.91; Stansfeld PJ, 2007, PROTEINS, V68, P568, DOI 10.1002/prot.21400; Thollon C, 2010, ADV PHARMACOL, V59, P53, DOI 10.1016/S1054-3589(10)59003-3; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849	33	45	45	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53132	10.1371/journal.pone.0053132	http://dx.doi.org/10.1371/journal.pone.0053132			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308150	Green Published, gold, Green Submitted			2022-12-25	WOS:000313670100020
J	Postnova, S; Robinson, PA; Postnov, DD				Postnova, Svetlana; Robinson, Peter A.; Postnov, Dmitry D.			Adaptation to Shift Work: Physiologically Based Modeling of the Effects of Lighting and Shifts' Start Time	PLOS ONE			English	Article							ASCENDING AROUSAL SYSTEM; QUANTITATIVE MODEL; SLEEP-DEPRIVATION; FATIGUE; ENTRAINMENT; SCHEDULES; EXPOSURE; DARKNESS; HUMANS; PERIOD	Shift work has become an integral part of our life with almost 20% of the population being involved in different shift schedules in developed countries. However, the atypical work times, especially the night shifts, are associated with reduced quality and quantity of sleep that leads to increase of sleepiness often culminating in accidents. It has been demonstrated that shift workers' sleepiness can be improved by a proper scheduling of light exposure and optimizing shifts timing. Here, an integrated physiologically-based model of sleep-wake cycles is used to predict adaptation to shift work in different light conditions and for different shift start times for a schedule of four consecutive days of work. The integrated model combines a model of the ascending arousal system in the brain that controls the sleep-wake switch and a human circadian pacemaker model. To validate the application of the integrated model and demonstrate its utility, its dynamics are adjusted to achieve a fit to published experimental results showing adaptation of night shift workers (n = 8) in conditions of either bright or regular lighting. Further, the model is used to predict the shift workers' adaptation to the same shift schedule, but for conditions not considered in the experiment. The model demonstrates that the intensity of shift light can be reduced fourfold from that used in the experiment and still produce good adaptation to night work. The model predicts that sleepiness of the workers during night shifts on a protocol with either bright or regular lighting can be significantly improved by starting the shift earlier in the night, e.g.; at 21:00 instead of 00:00. Finally, the study predicts that people of the same chronotype, i.e. with identical sleep times in normal conditions, can have drastically different responses to shift work depending on their intrinsic circadian and homeostatic parameters.	[Postnova, Svetlana; Robinson, Peter A.] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; [Postnova, Svetlana; Robinson, Peter A.] Univ Sydney, CIRUS, Sydney, NSW 2006, Australia; [Postnova, Svetlana; Robinson, Peter A.] Univ Sydney, Brain Dynam Ctr, Sydney, NSW 2006, Australia; [Postnov, Dmitry D.] Saratov NG Chernyshevskii State Univ, Sch Phys, Saratov, Russia	University of Sydney; University of Sydney; University of Sydney; Saratov State University	Postnova, S (corresponding author), Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia.	postnova@physics.usyd.edu.au	Postnov, Dmitry E/D-4316-2013	Postnova, Svetlana/0000-0002-1224-0779; Postnov, Dmitry D/0000-0002-9708-8453; Robinson, Peter/0000-0002-5050-9804	Australian Research Council (ARC); National Health and Medical Research Council (NHMRC); Westmead Millennium Institute	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Westmead Millennium Institute	This work is supported by the Australian Research Council (ARC), the National Health and Medical Research Council (NHMRC), and Westmead Millennium Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstedt T, 1995, J SLEEP RES, V4, P15, DOI 10.1111/j.1365-2869.1995.tb00221.x; ASCHOFF J, 1979, Z TIERPSYCHOL, V49, P225; Boivin DB, 2002, J BIOL RHYTHM, V17, P556, DOI 10.1177/0748730402238238; Boivin DB, 2007, SLEEP MED, V8, P578, DOI 10.1016/j.sleep.2007.03.015; Borbely A A, 1982, Hum Neurobiol, V1, P195; BORBELY AA, 1992, J SLEEP RES, V1, P63, DOI 10.1111/j.1365-2869.1992.tb00013.x; CZEISLER CA, 1990, NEW ENGL J MED, V322, P1253, DOI 10.1056/NEJM199005033221801; Czeisler CA, 1999, SCIENCE, V284, P2177, DOI 10.1126/science.284.5423.2177; Deco G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000092; Dinges DF, 1995, J SLEEP RES, V4, P4, DOI 10.1111/j.1365-2869.1995.tb00220.x; Duffy JE, 2002, J BIOL RHYTHM, V17, P4, DOI 10.1177/074873002129002294; Folkard S, 2005, IND HEALTH, V43, P20, DOI 10.2486/indhealth.43.20; Fulcher BD, 2010, J THEOR BIOL, V264, P407, DOI 10.1016/j.jtbi.2010.02.028; GLASS L, 1984, AM J PHYSIOL, V246, pR251, DOI 10.1152/ajpregu.1984.246.2.R251; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Hilaire MAS, 2007, J THEOR BIOL, V247, P583, DOI 10.1016/j.jtbi.2007.04.001; Hursh SR, 2004, AVIAT SPACE ENVIR MD, V75, pA44; Jewett ME, 1999, J BIOL RHYTHM, V14, P588, DOI 10.1177/074873099129000920; Landolt HP, 2008, BIOCHEM PHARMACOL, V75, P2070, DOI 10.1016/j.bcp.2008.02.024; Mallis MM, 2004, AVIAT SPACE ENVIR MD, V75, pA4; MINORS DS, 1991, NEUROSCI LETT, V133, P36, DOI 10.1016/0304-3940(91)90051-T; Moore RY, 2007, SLEEP MED, V8, pS27, DOI 10.1016/j.sleep.2007.10.003; Olofsen E., 2010, OPEN SLEEP J, V3, P24; Philip P, 2005, IND HEALTH, V43, P30, DOI 10.2486/indhealth.43.30; Phillips AJK, 2007, J BIOL RHYTHM, V22, P167, DOI 10.1177/0748730406297512; Phillips AJK, 2008, J THEOR BIOL, V255, P413, DOI 10.1016/j.jtbi.2008.08.022; Phillips AJK, 2011, J BIOL RHYTHM, V26, P441, DOI 10.1177/0748730411414163; Postnova S, 2012, J BIOL RHYTHM, V27, P91, DOI 10.1177/0748730411419934; Postnova S, 2009, J BIOL RHYTHM, V24, P523, DOI 10.1177/0748730409346655; Rajaratnam SM, 2001, LANCET, V358, P999, DOI 10.1016/S0140-6736(01)06108-6; REFINETTI R, 1992, PHYSIOL BEHAV, V51, P613, DOI 10.1016/0031-9384(92)90188-8; Roenneberg T, 2007, SLEEP MED REV, V11, P429, DOI 10.1016/j.smrv.2007.07.005; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Tononi G., 2009, J CLIN SLEEP MED, V5, P16	34	25	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53379	10.1371/journal.pone.0053379	http://dx.doi.org/10.1371/journal.pone.0053379			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308206	gold, Green Published			2022-12-25	WOS:000313670100034
J	Bandyopadhyay, U; Cotney, J; Nagy, M; Oh, S; Leng, J; Mahajan, M; Mane, S; Fenton, WA; Noonan, JP; Horwich, AL				Bandyopadhyay, Urmi; Cotney, Justin; Nagy, Maria; Oh, Sunghee; Leng, Jing; Mahajan, Milind; Mane, Shrikant; Fenton, Wayne A.; Noonan, James P.; Horwich, Arthur L.			RNA-Seq Profiling of Spinal Cord Motor Neurons from a Presymptomatic SOD1 ALS Mouse	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; G-ASSOCIATED KINASE; SUPEROXIDE-DISMUTASE; MESSENGER-RNA; HEXANUCLEOTIDE REPEAT; GENE-EXPRESSION; KNOCKOUT MICE; FAMILIAL ALS; MUTATIONS; TDP-43	Mechanisms involved with degeneration of motor neurons in amyotrophic lateral sclerosis (ALS; Lou Gehrig's Disease) are poorly understood, but genetically inherited forms, comprising similar to 10% of the cases, are potentially informative. Recent observations that several inherited forms of ALS involve the RNA binding proteins TDP43 and FUS raise the question as to whether RNA metabolism is generally disturbed in ALS. Here we conduct whole transcriptome profiling of motor neurons from a mouse strain, transgenic for a mutant human SOD1 (G85R SOD1-YFP), that develops symptoms of ALS and paralyzes at 5-6 months of age. Motor neuron cell bodies were laser microdissected from spinal cords at 3 months of age, a time when animals were presymptomatic but showed aggregation of the mutant protein in many lower motor neuron cell bodies and manifested extensive neuromuscular junction morphologic disturbance in their lower extremities. We observed only a small number of transcripts with altered expression levels or splicing in the G85R transgenic compared to age-matched animals of a wild-type SOD1 transgenic strain. Our results indicate that a major disturbance of polyadenylated RNA metabolism does not occur in motor neurons of mutant SOD1 mice, suggesting that the toxicity of the mutant protein lies at the level of translational or post-translational effects.	[Bandyopadhyay, Urmi; Cotney, Justin; Nagy, Maria; Oh, Sunghee; Leng, Jing; Mahajan, Milind; Mane, Shrikant; Fenton, Wayne A.; Noonan, James P.; Horwich, Arthur L.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Bandyopadhyay, Urmi; Nagy, Maria; Horwich, Arthur L.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Noonan, James P.; Horwich, Arthur L.] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT USA; [Leng, Jing; Noonan, James P.] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Horwich, AL (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.	arthur.horwich@yale.edu	Noonan, James/ABF-1320-2021; Bandyopadhyay, Urmi/A-3944-2015; Cotney, Justin L/ABE-8500-2021	Bandyopadhyay, Urmi/0000-0003-3438-8923; Cotney, Justin L/0000-0001-8230-2157	Howard Hughes Medical Institute; NIH [GM094780]; Andersen Foundation Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094780] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Andersen Foundation Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute (A.L.H.), NIH GM094780 (J.P.N.), and an Andersen Foundation Fellowship (J.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoub AE, 2011, P NATL ACAD SCI USA, V108, P14950, DOI 10.1073/pnas.1112213108; Cotney J, 2012, GENOME RES, V22, P1069, DOI 10.1101/gr.129817.111; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; Farr GW, 2011, PROTEIN SCI, V20, P1692, DOI 10.1002/pro.700; Ferraiuolo L, 2007, J NEUROSCI, V27, P9201, DOI 10.1523/JNEUROSCI.1470-07.2007; Greener T, 2000, J BIOL CHEM, V275, P1365, DOI 10.1074/jbc.275.2.1365; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Halawani D, 2006, MOL CELL, V22, P713, DOI 10.1016/j.molcel.2006.06.003; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Hart PJ, 2006, CURR OPIN CHEM BIOL, V10, P131, DOI 10.1016/j.cbpa.2006.02.034; Hedlund E, 2010, BRAIN, V133, P2313, DOI 10.1093/brain/awq167; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; Kawahara Y, 2006, NEUROSCI RES, V54, P11, DOI 10.1016/j.neures.2005.09.006; Ko HS, 2004, FEBS LETT, V566, P110, DOI 10.1016/j.febslet.2004.04.031; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lee D, 2008, MOL BIOL CELL, V19, P2766, DOI 10.1091/mbc.E07-11-1115; Lindberg MJ, 2005, P NATL ACAD SCI USA, V102, P9754, DOI 10.1073/pnas.0501957102; Lobsiger CS, 2007, P NATL ACAD SCI USA, V104, P7319, DOI 10.1073/pnas.0702230104; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Ohto T, 2005, J BIOL CHEM, V280, P24576, DOI 10.1074/jbc.M413711200; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wang J, 2009, P NATL ACAD SCI USA, V106, P1392, DOI 10.1073/pnas.0813045106; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Yim YI, 2010, P NATL ACAD SCI USA, V107, P4412, DOI 10.1073/pnas.1000738107	37	41	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53575	10.1371/journal.pone.0053575	http://dx.doi.org/10.1371/journal.pone.0053575			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301088	Green Published, Green Submitted, gold			2022-12-25	WOS:000313480000067
J	Coxon, GD; Craig, D; Corrales, RM; Vialla, E; Gannoun-Zaki, L; Kremer, L				Coxon, Geoffrey D.; Craig, Derek; Corrales, Rosa Milagros; Vialla, Emilie; Gannoun-Zaki, Laila; Kremer, Laurent			Synthesis, Antitubercular Activity and Mechanism of Resistance of Highly Effective Thiacetazone Analogues	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MYCOLIC ACIDS; MULTIDRUG-RESISTANT; DRUG-TREATMENT; ETHIONAMIDE; ACTIVATION; CYCLOPROPANATION; PHOSPHORYLATION; IMMUNOCOMPETENT; BIOSYNTHESIS	Defining the pharmacological target(s) of currently used drugs and developing new analogues with greater potency are both important aspects of the search for agents that are effective against drug-sensitive and drug-resistant Mycobacterium tuberculosis. Thiacetazone (TAC) is an anti-tubercular drug that was formerly used in conjunction with isoniazid, but removed from the antitubercular chemotherapeutic arsenal due to toxic side effects. However, several recent studies have linked the mechanisms of action of TAC to mycolic acid metabolism and TAC-derived analogues have shown increased potency against M. tuberculosis. To obtain new insights into the molecular mechanisms of TAC resistance, we isolated and analyzed 10 mutants of M. tuberculosis that were highly resistant to TAC. One strain was found to be mutated in the methyltransferase MmaA4 at Gly101, consistent with its lack of oxygenated mycolic acids. All remaining strains harbored missense mutations in either HadA (at Cys61) or HadC (at Val85, Lys157 or Thr123), which are components of the beta-hydroxyacyl-ACP dehydratase complex that participates in the mycolic acid elongation step. Separately, a library of 31 new TAC analogues was synthesized and evaluated against M. tuberculosis. Two of these compounds, 15 and 16, exhibited minimal inhibitory concentrations 10-fold lower than the parental molecule, and inhibited mycolic acid biosynthesis in a dose-dependent manner. Moreover, overexpression of HadAB HadBC or HadABC in M. tuberculosis led to high level resistance to these compounds, demonstrating that their mode of action is similar to that of TAC. In summary, this study uncovered new mutations associated with TAC resistance and also demonstrated that simple structural optimization of the TAC scaffold was possible and may lead to a new generation of TAC-derived drug candidates for the potential treatment of tuberculosis as mycolic acid inhibitors.	[Coxon, Geoffrey D.; Craig, Derek] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Corrales, Rosa Milagros; Vialla, Emilie; Gannoun-Zaki, Laila; Kremer, Laurent] Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, Montpellier, France; [Corrales, Rosa Milagros; Vialla, Emilie; Gannoun-Zaki, Laila; Kremer, Laurent] Univ Montpellier I, CNRS, UMR 5235, Montpellier, France; [Kremer, Laurent] DIMNP, INSERM, Montpellier, France	University of Strathclyde; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Coxon, GD (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland.	geoff.coxon@strath.ac.uk; laurent.kremer@univ-montp2.fr	Kremer, Laurent/M-4935-2017	Kremer, Laurent/0000-0002-6604-4458; Gannoun, Laila/0000-0002-9644-1083	InfectioPole Sud	InfectioPole Sud	This work was supported by the InfectioPole Sud (to RMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alahari A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001343; Alahari A, 2009, MOL MICROBIOL, V71, P1263, DOI 10.1111/j.1365-2958.2009.06604.x; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Baulard AR, 2000, J BIOL CHEM, V275, P28326; Belardinelli JM, 2012, MOL MICROBIOL, V86, P568, DOI 10.1111/mmi.12005; Bermudez LE, 2003, ANTIMICROB AGENTS CH, V47, P2685, DOI 10.1128/AAC.47.8.2685-2687.2003; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; Bugg TDH, 2011, TRENDS BIOTECHNOL, V29, P167, DOI 10.1016/j.tibtech.2010.12.006; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Cantaloube S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029564; Corrales RM, 2012, J BIOL CHEM, V287, P26187, DOI 10.1074/jbc.M112.373209; DAVIDSON PT, 1992, DRUGS, V43, P651, DOI 10.2165/00003495-199243050-00003; DeBarber AE, 2000, P NATL ACAD SCI USA, V97, P9677, DOI 10.1073/pnas.97.17.9677; Dover LG, 2007, ANTIMICROB AGENTS CH, V51, P1055, DOI 10.1128/AAC.01063-06; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; Espinal MA, 2003, TUBERCULOSIS, V83, P44, DOI 10.1016/S1472-9792(02)00058-6; FEGAN D, 1994, T ROY SOC TROP MED H, V88, P714, DOI 10.1016/0035-9203(94)90246-1; FEGAN D, 1995, LANCET, V345, P63; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Grzegorzewicz AE, 2012, J BIOL CHEM, V287, P38434, DOI 10.1074/jbc.M112.400994; Kremer L, 2002, EXPERT OPIN INV DRUG, V11, P1033; Kremer L, 2002, BIOCHEM J, V364, P423, DOI 10.1042/BJ20011628; Kremer L, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P173; Lutfalla G, 2006, METHOD ENZYMOL, V410, P386, DOI 10.1016/S0076-6879(06)10019-1; Mondal R, 2007, EMERG INFECT DIS, V13, P1429, DOI 10.3201/eid1309.070443; NUNN P, 1993, T ROY SOC TROP MED H, V87, P578, DOI 10.1016/0035-9203(93)90096-9; Ojha AK, 2010, J BIOL CHEM, V285, P17380, DOI 10.1074/jbc.M110.112813; Rao V, 2005, J EXP MED, V201, P535, DOI 10.1084/jem.20041668; Rombouts Y, 2012, J BIOL CHEM, V287, P11060, DOI 10.1074/jbc.M111.327387; Sacco E, 2007, P NATL ACAD SCI USA, V104, P14628, DOI 10.1073/pnas.0704132104; Sambandamurthy VK, 2006, VACCINE, V24, P6309, DOI 10.1016/j.vaccine.2006.05.097; Shahab FM, 2010, XENOBIOTICA, V40, P225, DOI 10.3109/00498250903461411; Slama N, 2011, BIOCHEM BIOPH RES CO, V412, P401, DOI 10.1016/j.bbrc.2011.07.051; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Veyron-Churlet R, 2005, J MOL BIOL, V353, P847, DOI 10.1016/j.jmb.2005.09.016; Veyron-Churlet R, 2004, MOL MICROBIOL, V54, P1161, DOI 10.1111/j.1365-2958.2004.04334.x; Vilcheze C, 2006, NAT MED, V12, P1027, DOI 10.1038/nm1466; Wang F, 2007, J EXP MED, V204, P73, DOI 10.1084/jem.20062100; Wei JR, 2011, P NATL ACAD SCI USA, V108, P4176, DOI 10.1073/pnas.1018301108	40	50	53	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53162	10.1371/journal.pone.0053162	http://dx.doi.org/10.1371/journal.pone.0053162			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301038	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000313480000036
J	Liu, JX; Cheng, X; Guo, ZR; Wang, ZH; Li, D; Kang, FB; Li, HJ; Li, BS; Cao, ZC; Nassal, M; Sun, DX				Liu, Jinxia; Cheng, Xin; Guo, Zhengrong; Wang, Zihua; Li, Dong; Kang, Fubiao; Li, Haijun; Li, Baosheng; Cao, Zhichen; Nassal, Michael; Sun, Dianxing			Truncated Active Human Matrix Metalloproteinase-8 Delivered by a Chimeric Adenovirus-Hepatitis B Virus Vector Ameliorates Rat Liver Cirrhosis	PLOS ONE			English	Article							HEPATOMA-CELL LINES; LARGE SURFACE-ANTIGEN; CLOSED CIRCULAR DNA; GENE DELIVERY; TRANSCRIPTIONAL ACTIVATOR; PREGENOME ENCAPSIDATION; TUPAIA HEPATOCYTES; FIBROSIS; INFECTION; COLLAGEN	Background: Liver cirrhosis is a potentially life-threatening disease caused by progressive displacement of functional hepatocytes by fibrous tissue. The underlying fibrosis is often driven by chronic infection with hepatitis B virus (HBV). Matrix metalloproteinases including MMP-8 are crucial for excess collagen degradation. In a rat model of liver cirrhosis, MMP-8 delivery by an adenovirus (Ad) vector achieved significant amelioration of fibrosis but application of Ad vectors in humans is subject to various issues, including a lack of intrinsic liver specificity. Methods: HBV is highly liver-specific and its principal suitability as liver-specific gene transfer vector is established. HBV vectors have a limited insertion capacity and are replication-defective. Conversely, in an HBV infected cell vector replication may be rescued in trans by the resident virus, allowing conditional vector amplification and spreading. Capitalizing on a resident pathogen to help in its elimination and/or in treating its pathogenic consequences would provide a novel strategy. However, resident HBV may also reduce susceptibility to HBV vector superinfection. Thus a size-compatible truncated MMP-8 (tMMP8) gene was cloned into an HBV vector which was then used to generate a chimeric Ad-HBV shuttle vector that is not subject to superinfection exclusion. Rats with thioacetamide-induced liver cirrhosis were injected with the chimera to evaluate therapeutic efficacy. Results: Our data demonstrate that infectious HBV vector particles can be obtained via trans-complementation by wild-type virus, and that the tMMP8 HBV vector can efficiently be shuttled by an Ad vector into cirrhotic rat livers. There it exerted a comparable beneficial effect on fibrosis and hepatocyte proliferation markers as a conventional full-length MMP-8Ad vector. Conclusions: Though the rat cirrhosis model does not allow assessing in vivo HBV vector amplification these results advocate the further development of Ad-HBV vectors for liver-specific gene therapy, including and perhaps particularly for HBV-related disease.	Bethune Int Peace Hosp, Liver Dis Diag & Treatment Ctr PLA, Shijiazhuang, Peoples R China; [Cao, Zhichen] Hebei Med Univ, Affiliated Hosp 3, Dept Tradit Chinese Med & Liver Dis, Shijiazhuang, Peoples R China; [Nassal, Michael] Univ Hosp Freiburg, Freiburg, Germany	Hebei Medical University; University of Freiburg	Nassal, M (corresponding author), Univ Hosp Freiburg, Freiburg, Germany.	nassal2@ukl.uni-freiburg.de; sundianxing@hotmail.com	Nassal, Michael/U-4529-2019; Wang, Zhiquan/HHS-6768-2022	Nassal, Michael/0000-0003-2204-9158; 	National Natural Science Foundation of China [30872255, 30571667]; Wang Baoen Liver Fibrosis Foundation [20070001]; Chinese Foundation for Hepatitis Prevention and Control	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wang Baoen Liver Fibrosis Foundation; Chinese Foundation for Hepatitis Prevention and Control	This work was supported by National Natural Science Foundation of China (grant numbers: 30872255; 30571667, URL of the funder's website, http://isisn.nsfc.gov.cn/egrantweb/) and Chinese Foundation for Hepatitis Prevention and Control, Wang Baoen Liver Fibrosis Foundation (grant number: 20070001, URL of funder's website, http://www.wbelff.org/keti.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONY PP, 1978, J CLIN PATHOL, V31, P395, DOI 10.1136/jcp.31.5.395; BARTENSCHLAGER R, 1990, J VIROL, V64, P5324, DOI 10.1128/JVI.64.11.5324-5332.1990; Beck J, 2007, WORLD J GASTROENTERO, V13, P48, DOI 10.3748/wjg.v13.i1.48; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; Bruck R, 2007, J GASTROEN HEPATOL, V22, P2189, DOI 10.1111/j.1440-1746.2006.04777.x; Dandri M, 2005, J HEPATOL, V42, P54, DOI 10.1016/j.jhep.2004.09.021; Descamps D, 2009, CURR GENE THER, V9, P115, DOI 10.2174/156652309787909544; Ellis EL, 2012, J HEPATOL, V56, P1171, DOI 10.1016/j.jhep.2011.09.024; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Ganem D, 1999, P NATL ACAD SCI USA, V96, P11696, DOI 10.1073/pnas.96.21.11696; Garcia-Tsao G, 2010, HEPATOLOGY, V51, P1445, DOI 10.1002/hep.23478; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Goyal N, 2009, CLIN RADIOL, V64, P1056, DOI 10.1016/j.crad.2009.05.010; GRESSNER AM, 1991, EUR J CLIN CHEM CLIN, V29, P293; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Guo HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043270; Hantz O, 2009, J GEN VIROL, V90, P127, DOI 10.1099/vir.0.004861-0; Hemmann S, 2007, J HEPATOL, V46, P955, DOI 10.1016/j.jhep.2007.02.003; Hildt E, 1996, VIROLOGY, V225, P235, DOI 10.1006/viro.1996.0594; HILDT E, 1995, ONCOGENE, V11, P2055; Hildt E, 1998, RECENT RES CANCER, V154, P315; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Iimuro Y, 2003, GASTROENTEROLOGY, V124, P445, DOI 10.1053/gast.2003.50063; Iimuro Y, 2008, PHARM RES-DORDR, V25, P249, DOI 10.1007/s11095-007-9311-7; Iredale JP, 2004, GASTROENTEROLOGY, V126, P1199, DOI 10.1053/j.gastro.2004.01.060; JUNKERNIEPMANN M, 1990, EMBO J, V9, P3389, DOI 10.1002/j.1460-2075.1990.tb07540.x; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Li D, 2011, J BIOCHEM, V150, P371, DOI 10.1093/jb/mvr086; Liu Jin-Xia, 2009, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V23, P316; Lucifora J, 2011, J HEPATOL, V55, P996, DOI 10.1016/j.jhep.2011.02.015; MONTFORT I, 1978, AM J PATHOL, V92, P411; Moore CS, 2012, AM J PATHOL, V180, P12, DOI 10.1016/j.ajpath.2011.09.008; Mormone E, 2011, CHEM-BIOL INTERACT, V193, P225, DOI 10.1016/j.cbi.2011.07.001; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; NASSAL M, 1992, J VIROL, V66, P4107, DOI 10.1128/JVI.66.7.4107-4116.1992; Nassal M, 2008, VIRUS RES, V134, P235, DOI 10.1016/j.virusres.2007.12.024; Ni SH, 2005, HUM GENE THER, V16, P664, DOI 10.1089/hum.2005.16.664; Nicholson P, 2010, CELL MOL LIFE SCI, V67, P677, DOI 10.1007/s00018-009-0177-1; Oren R, 1996, HEPATOLOGY, V24, P419; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Paranjpe S, 2007, HEPATOLOGY, V45, P1471, DOI 10.1002/hep.21570; Pelman GR, 2005, J BIOL CHEM, V280, P2370, DOI 10.1074/jbc.M409603200; PEREZTAMAYO R, 1987, EXP MOL PATHOL, V47, P300, DOI 10.1016/0014-4800(87)90015-3; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Protzer U, 1999, P NATL ACAD SCI USA, V96, P10818, DOI 10.1073/pnas.96.19.10818; RANEY AK, 1990, J VIROL, V64, P2360, DOI 10.1128/JVI.64.5.2360-2368.1990; Ren ST, 2001, J VIROL, V75, P1104, DOI 10.1128/JVI.75.3.1104-1116.2001; ROJKIND M, 1974, ANAL BIOCHEM, V57, P1, DOI 10.1016/0003-2697(74)90043-8; ROJKIND M, 1979, GASTROENTEROLOGY, V76, P710; SCHALLER H, 1991, CURR TOP MICROBIOL, V168, P21; Schulze A, 2012, HEPATOLOGY, V55, P373, DOI 10.1002/hep.24707; SCHUPPAN D, 1990, SEMIN LIVER DIS, V10, P1, DOI 10.1055/s-2008-1040452; Siller-Lopez F, 2004, GASTROENTEROLOGY, V126, P1122, DOI 10.1053/j.gastro.2003.12.045; Siller-Lopez F, 2000, J HEPATOL, V33, P758, DOI 10.1016/S0168-8278(00)80307-4; Sprinzl MF, 2001, J VIROL, V75, P5108, DOI 10.1128/JVI.75.11.5108-5118.2001; Sun DX, 2006, J HEPATOL, V45, P636, DOI 10.1016/j.jhep.2006.05.019; Sun DX, 2010, J HEPATOL, V52, P817, DOI 10.1016/j.jhep.2009.10.038; TSUKAMOTO H, 1990, SEMIN LIVER DIS, V10, P56, DOI 10.1055/s-2008-1040457; Untergasser A, 2004, HUM GENE THER, V15, P203, DOI 10.1089/104303404772680001; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Walters KA, 2004, J VIROL, V78, P7925, DOI 10.1128/JVI.78.15.7925-7937.2004; Wang TaiLing, 1998, Chinese Journal of Hepatology, V6, P195; Zoulim F, 2009, LIVER INT, V29, P108, DOI 10.1111/j.1478-3231.2008.01939.x	65	17	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53392	10.1371/journal.pone.0053392	http://dx.doi.org/10.1371/journal.pone.0053392			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301066	gold, Green Published			2022-12-25	WOS:000313480000053
J	Louvanto, K; Rautava, J; Willberg, J; Wideman, L; Syrjanen, K; Grenman, S; Syrjanen, S				Louvanto, Karolina; Rautava, Jaana; Willberg, Jaana; Wideman, Lilli; Syrjanen, Kari; Grenman, Seija; Syrjanen, Stina			Genotype-Specific Incidence and Clearance of Human Papillomavirus in Oral Mucosa of Women: A Six-Year Follow-Up Study	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HPV INFECTIONS; RISK-FACTORS; BLOT HYBRIDIZATION; NATURAL-HISTORY; PREGNANT-WOMEN; PREVALENCE; DNA; SEROLOGY; HEAD	Background: There are no previous longitudinal studies on genotype-specific natural history of human papillomavirus (HPV) infections in oral mucosa of women. Methods: In the Finnish Family HPV Study, 329 pregnant women were enrolled and followed up. HPV-genotyping of oral scrapings was performed with nested PCR and Multimetrix (R) test (Progen, Heidelberg, Germany). Incidence and clearance times and rates for each HPV-genotype identified in oral mucosa were determined. Predictors for incident and cleared HPV infections for species 7/9 genotypes were analyzed using Poisson regression model. Results: Altogether, 115 baseline HPV-negative women acquired incident oral HPV infection, and 79 women cleared their infection. HPV16 and multiple HPVs most frequently caused incident infections (65% and 12%) in 13.3 and 17.1 months respectively, followed by HPV58, HPV18 and HPV6 (close to 5% each) in 11-24 months. HPV58, HPV18 and HPV66 were the most common to clear. HPV6 and HPV11 had the shortest clearance times, 4.6 months and 2.5 months, and the highest clearance rates, 225.5/1000 wmr and 400/1000 wmr, respectively. The protective factors for incident oral HPV-species 7/9 infections were 1) new pregnancy during follow-up and 2) having the same sexual partner during FU. Increased clearance was related with older age and a history of atopic reactions, whereas previous sexually transmitted disease and new pregnancy were associated with decreased clearance. Conclusions: HPV16 was the most frequent genotype to cause an incident oral HPV-infection. Low risk HPV genotypes cleared from oral mucosa more quickly than high risk HPV genotypes. Pregnancy affected the outcome of oral HPV infection.	[Louvanto, Karolina; Rautava, Jaana; Willberg, Jaana; Wideman, Lilli; Syrjanen, Stina] Univ Turku, Fac Med, Inst Dent, Dept Oral Pathol, Turku, Finland; [Louvanto, Karolina; Rautava, Jaana; Willberg, Jaana; Wideman, Lilli; Syrjanen, Stina] Univ Turku, Med Res Lab, Turku, Finland; [Louvanto, Karolina; Grenman, Seija] Univ Turku, Turku Univ Hosp, Dept Obstet & Gynecol, Turku, Finland; [Syrjanen, Kari] Turku Univ Hosp, Dept Radiotherapy & Oncol, FIN-20520 Turku, Finland; [Syrjanen, Kari] Barretos Canc Hosp, Teaching & Res Inst, Barretos, SP, Brazil	University of Turku; University of Turku; University of Turku; University of Turku; Hospital de Cancer de Barretos	Rautava, J (corresponding author), Univ Turku, Fac Med, Inst Dent, Dept Oral Pathol, Turku, Finland.	jaana.rautava@utu.fi	Louvanto, Karolina/GXG-3296-2022	Louvanto, Karolina/0000-0002-1172-363X; Syrjanen, Kari/0000-0001-7180-7491; Syrjanen, Stina/0000-0003-0738-5698	Academy of Finland [116438/2006, 130204/2008]; Finnish Cancer Foundation; Sohlberg Foundation; Finnish Dental Society; Government Special Foundation (EVO)	Academy of Finland(Academy of Finland); Finnish Cancer Foundation; Sohlberg Foundation; Finnish Dental Society; Government Special Foundation (EVO)	This work was supported by the Academy of Finland (#116438/2006, #130204/2008), Finnish Cancer Foundation, Sohlberg Foundation, Finnish Dental Society, and the Government Special Foundation (EVO) to Turku University Hospital. The funders had no role in the study design and data analysis, decision to publish, or preparation of the manuscript.	Anttila M, 1999, GYNECOL ONCOL, V72, P337, DOI 10.1006/gyno.1998.5264; D'Souza G, 2007, INT J CANCER, V121, P143, DOI 10.1002/ijc.22667; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Diggle PJ, 2002, ANAL LONGITUDINAL DA; Fife KH, 1999, AM J OBSTET GYNECOL, V180, P1110, DOI 10.1016/S0002-9378(99)70602-2; Franco EL, 1999, J INFECT DIS, V180, P1415, DOI 10.1086/315086; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Goodman MT, 2008, CANCER RES, V68, P8813, DOI 10.1158/0008-5472.CAN-08-1380; Hardin J., 2003, GEN ESTIMATING EQUAT; Hernandez-Giron C, 2005, SEX TRANSM DIS, V32, P613, DOI 10.1097/01.olq.0000179888.47309.db; KELLOKOSKI J, 1992, ORAL MICROBIOL IMMUN, V7, P19, DOI 10.1111/j.1399-302X.1992.tb00014.x; KELLOKOSKI JK, 1992, J ORAL PATHOL MED, V21, P459, DOI 10.1111/j.1600-0714.1992.tb00975.x; Kreimer AR, 2004, J INFECT DIS, V189, P686, DOI 10.1086/381504; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Louvanto K, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-179; Louvanto K, 2010, J INFECT DIS, V202, P436, DOI 10.1086/653826; Miller CS, 1996, ORAL SURG ORAL MED O, V82, P57, DOI 10.1016/S1079-2104(96)80378-7; Miller CS, 2001, ORAL SURG ORAL MED O, V91, P622, DOI 10.1067/moe.2001.115392; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Montgomery SM, 2002, BRIT J CANCER, V87, P989, DOI 10.1038/sj.bjc.6600585; Munoz N, 2004, J INFECT DIS, V190, P2077, DOI 10.1086/425907; Nobbenhuis MAE, 2002, BRIT J CANCER, V87, P75, DOI 10.1038/sj.bjc.6600367; Paaso AE, 2011, J GEN VIROL, V92, P2034, DOI 10.1099/vir.0.032011-0; Rautava J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042171; Rintala M, 2006, J CLIN VIROL, V35, P89, DOI 10.1016/j.jcv.2005.05.012; Rintala MAM, 2005, CLIN INFECT DIS, V41, P1728, DOI 10.1086/498114; Rintala MAM, 2005, J CLIN MICROBIOL, V43, P376, DOI 10.1128/JCM.43.1.376-381.2005; Safaeian M, 2008, CANCER EPIDEM BIOMAR, V17, P1300, DOI 10.1158/1055-9965.EPI-07-2678; Sanders AE, 2012, ORAL DIS, V18, P430, DOI 10.1111/j.1601-0825.2011.01892.x; Sarkola ME, 2009, GYNECOL OBSTET INVES, V67, P208, DOI 10.1159/000209204; Schmitt M, 2006, J CLIN MICROBIOL, V44, P504, DOI 10.1128/JCM.44.2.504-512.2006; Smith EM, 2007, PEDIATR INFECT DIS J, V26, P836, DOI 10.1097/INF.0b013e318124a4ae; SNIJDERS PJF, 1990, J GEN VIROL, V71, P173, DOI 10.1099/0022-1317-71-1-173; Syrjanen S, 2007, NEW ENGL J MED, V356, P1993, DOI 10.1056/NEJMe078004; Syrjanen S., 2000, PAPILLOMAVIRUS INFEC; Syrjanen S, 2009, J GEN VIROL, V90, P1515, DOI 10.1099/vir.0.007823-0; Tenti P, 1997, J INFECT DIS, V176, P277, DOI 10.1086/517266; Terai M, 1999, ORAL MICROBIOL IMMUN, V14, P201, DOI 10.1034/j.1399-302X.1999.140401.x; Trottier H, 2008, J INFECT DIS, V197, P1436, DOI 10.1086/587698; Waterboer T, 2006, J IMMUNOL METHODS, V309, P200, DOI 10.1016/j.jim.2005.11.008; Waterboer T, 2005, CLIN CHEM, V51, P1845, DOI 10.1373/clinchem.2005.052381; WILLIAMS H, 1993, ARCH DERMATOL, V129, P717, DOI 10.1001/archderm.129.6.717; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180	43	38	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53413	10.1371/journal.pone.0053413	http://dx.doi.org/10.1371/journal.pone.0053413			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301068	Green Published, gold, Green Submitted			2022-12-25	WOS:000313480000055
J	Shintani, N; Siebenrock, KA; Hunziker, EB				Shintani, Nahoko; Siebenrock, Klaus A.; Hunziker, Ernst B.			TGF-beta 1 Enhances the BMP-2-Induced Chondrogenesis of Bovine Synovial Explants and Arrests Downstream Differentiation at an Early Stage of Hypertrophy	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HUMAN BONE-MARROW; FIBROBLAST GROWTH FACTOR-2; ARTICULAR-CARTILAGE REPAIR; MUSCLE-DERIVED CELLS; STROMAL CELLS; X COLLAGEN; ADIPOSE-TISSUE; IN-VITRO; MORPHOGENETIC PROTEIN-2	Background: Synovial explants furnish an in-situ population of mesenchymal stem cells for the repair of articular cartilage. Although bone morphogenetic protein 2 (BMP-2) induces the chondrogenesis of bovine synovial explants, the cartilage formed is neither homogeneously distributed nor of an exclusively hyaline type. Furthermore, the downstream differentiation of chondrocytes proceeds to the stage of terminal hypertrophy, which is inextricably coupled with undesired matrix mineralization. With a view to optimizing BMP-2-induced chondrogenesis, the modulating influences of fibroblast growth factor 2 (FGF-2) and transforming growth factor beta 1 (TGF-beta 1) were investigated. Methodology/Principal Findings: Explants of bovine calf metacarpal synovium were exposed to BMP-2 (200 ng/ml) for 4 (or 6) weeks. FGF-2 (10 ng/ml) or TGF-beta 1 (10 ng/ml) was introduced at the onset of incubation and was present either during the first week of culturing alone or throughout its entire course. FGF-2 enhanced the BMP-2-induced increase in metachromatic staining for glycosaminoglycans (GAGs) only when it was present during the first week of culturing alone. TGF-beta 1 enhanced not only the BMP-2- induced increase in metachromasia (to a greater degree than FGF-2), but also the biochemically-assayed accumulation of GAGs, when it was present throughout the entire culturing period; in addition, it arrested the downstream differentiation of cells at an early stage of hypertrophy. These findings were corroborated by an analysis of the gene- and protein-expression levels of key cartilaginous markers and by an estimation of individual cell volume. Conclusions/Significance: TGF-beta 1 enhances the BMP-2-induced chondrogenesis of bovine synovial explants, improves the hyaline-like properties of the neocartilage, and arrests the downstream differentiation of cells at an early stage of hypertrophy. With the prospect of engineering a mature, truly articular type of cartilage in the context of clinical repair, our findings will be of importance in fine-tuning the stimulation protocol for the optimal chondrogenic differentiation of synovial explants.	[Hunziker, Ernst B.] Univ Bern, Dept Orthopaed Surg, Ctr Regenerat Med Skeletal Tissues, Bern, Switzerland; Univ Bern, Dept Clin Res, Ctr Regenerat Med Skeletal Tissues, Bern, Switzerland	University of Bern; University of Bern	Hunziker, EB (corresponding author), Univ Bern, Dept Orthopaed Surg, Ctr Regenerat Med Skeletal Tissues, Bern, Switzerland.	ernst.hunziker@dkf.unibe.ch	Hunziker, Ernst B/GYA-1015-2022	Siebenrock, Klaus Arno/0000-0003-3627-4313; Shintani, Nahoko/0000-0002-5722-5134	National Institutes of Health (NIH), USA (National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)) [5 R01 AR052766]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052766] Funding Source: NIH RePORTER	National Institutes of Health (NIH), USA (National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by the National Institutes of Health (NIH), USA (National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), grant number: 5 R01 AR052766, www.niams.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsalameh S, 2004, ARTHRITIS RHEUM-US, V50, P1522, DOI 10.1002/art.20269; Archer Charles W., 2003, Birth Defects Research, V69, P144, DOI 10.1002/bdrc.10015; BALLOCK RT, 1993, DEV BIOL, V158, P414, DOI 10.1006/dbio.1993.1200; Banfi A, 2000, EXP HEMATOL, V28, P707, DOI 10.1016/S0301-472X(00)00160-0; Berg E, 1999, Orthop Nurs, V18, P55; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Chen FH, 2006, NAT CLIN PRACT RHEUM, V2, P373, DOI 10.1038/ncprheum0216; Chiou M, 2006, BIOCHEM BIOPH RES CO, V343, P644, DOI 10.1016/j.bbrc.2006.02.171; De Bari C, 2006, ARTHRITIS RHEUM, V54, P1209, DOI 10.1002/art.21753; De Bari C, 2001, ARTHRITIS RHEUM-US, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P; Deasy BM, 2002, STEM CELLS, V20, P50, DOI 10.1634/stemcells.20-1-50; Debiais F, 1998, J BONE MINER RES, V13, P645, DOI 10.1359/jbmr.1998.13.4.645; EGGLI PS, 1988, ANAT REC, V222, P217, DOI 10.1002/ar.1092220302; ELFORD PR, 1992, CYTOKINE, V4, P232, DOI 10.1016/1043-4666(92)90061-U; Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; FASSLER R, 1994, P NATL ACAD SCI USA, V91, P5070, DOI 10.1073/pnas.91.11.5070; Fowler MR, 2002, ARCH PATHOL LAB MED, V126, P727; FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381; Gelber AC, 2000, ANN INTERN MED, V133, P321, DOI 10.7326/0003-4819-133-5-200009050-00007; Getgood A, 2009, J BONE JOINT SURG BR, V91B, P565, DOI 10.1302/0301-620X.91B5.21832; GOSPODAROWICZ D, 1986, CELL DIFFER DEV, V19, P1, DOI 10.1016/0045-6039(86)90021-7; Gualtieri G, 1978, Chir Ital, V30, P642; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hagg R, 1997, J BIOL CHEM, V272, P20650, DOI 10.1074/jbc.272.33.20650; Halasz K, 2007, J BIOL CHEM, V282, P31166, DOI 10.1074/jbc.M705735200; Hanada K, 2001, J CELL BIOCHEM, V81, P284, DOI 10.1002/1097-4644(20010501)81:2<284::AID-JCB1043>3.0.CO;2-D; Hellingman CA, 2010, TISSUE ENG PT A, V16, P545, DOI [10.1089/ten.tea.2008.0551, 10.1089/ten.TEA.2008.0551]; Hennig T, 2007, J CELL PHYSIOL, V211, P682, DOI 10.1002/jcp.20977; Hildner F, 2010, J BIOMED MATER RES A, V94A, P978, DOI 10.1002/jbm.a.32761; Holden P, 2001, J BIOL CHEM, V276, P6046, DOI 10.1074/jbc.M009507200; HUNZIKER EB, 1989, J PHYSIOL-LONDON, V414, P55, DOI 10.1113/jphysiol.1989.sp017676; Hunziker EB, 1999, OSTEOARTHR CARTILAGE, V7, P15, DOI 10.1053/joca.1998.0159; HUNZIKER EB, 1987, J BONE JOINT SURG AM, V69A, P162, DOI 10.2106/00004623-198769020-00002; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P564, DOI 10.1053/joca.2002.0814; HUNZIKER EB, 1983, J HISTOCHEM CYTOCHEM, V31, P717, DOI 10.1177/31.6.6341460; KATO Y, 1988, P NATL ACAD SCI USA, V85, P9552, DOI 10.1073/pnas.85.24.9552; KIELTY CM, 1985, BIOCHEM J, V227, P545, DOI 10.1042/bj2270545; Kim HJ, 2009, TISSUE ENG PT A, V15, P1543, DOI 10.1089/ten.tea.2008.0368; Kim JH, 2011, TISSUE ENG PT A, V17, P991, DOI [10.1089/ten.tea.2010.0277, 10.1089/ten.TEA.2010.0277]; KIRSCH T, 1991, EUR J BIOCHEM, V196, P575, DOI 10.1111/j.1432-1033.1991.tb15852.x; KIRSCH T, 1991, FEBS LETT, V294, P149, DOI 10.1016/0014-5793(91)81363-D; Kurth T, 2007, OSTEOARTHR CARTILAGE, V15, P1178, DOI 10.1016/j.joca.2007.03.015; Lammi PE, 2002, BONE, V31, P690, DOI 10.1016/S8756-3282(02)00904-3; Lee S, 2009, TISSUE ENG PT A, V15, P3401, DOI [10.1089/ten.tea.2008.0466, 10.1089/ten.TEA.2008.0466]; Li GH, 2009, TISSUE ENG PT A, V15, P2123, DOI 10.1089/ten.tea.2008.0214; Manek NJ, 2003, ARTHRITIS RHEUM-US, V48, P1024, DOI 10.1002/art.10884; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456; Mastrogiacomo M, 2005, J CELL PHYSIOL, V204, P594, DOI 10.1002/jcp.20325; Mastrogiacomo M, 2001, OSTEOARTHR CARTILAGE, V9, pS36, DOI 10.1053/joca.2001.0442; MAURICE H, 1988, J BONE JOINT SURG BR, V70, P807, DOI 10.1302/0301-620X.70B5.3192585; Miyamoto C, 2007, J ORTHOP SCI, V12, P555, DOI 10.1007/s00776-007-1176-4; MULLERGLAUSER W, 1986, J CELL BIOL, V102, P1931, DOI 10.1083/jcb.102.5.1931; Nishimura K, 1999, ARTHRITIS RHEUM, V42, P2631, DOI 10.1002/1529-0131(199912)42:12<2631::AID-ANR18>3.0.CO;2-H; Noth U, 2002, J ORTHOP RES, V20, P1060, DOI 10.1016/S0736-0266(02)00018-9; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Park Y, 2005, OSTEOARTHR CARTILAGE, V13, P527, DOI 10.1016/j.joca.2005.02.006; Roche S, 2001, BIOMATERIALS, V22, P9, DOI 10.1016/S0142-9612(00)00084-3; Roos EM, 2005, CURR OPIN RHEUMATOL, V17, P195, DOI 10.1097/01.bor.0000151406.64393.00; Rosenberg K, 1998, J BIOL CHEM, V273, P20397, DOI 10.1074/jbc.273.32.20397; Roth R D, 1993, Clin Podiatr Med Surg, V10, P137; Rui YF, 2010, CHINESE MED J-PEKING, V123, P3040, DOI 10.3760/cma.j.issn.0366-6999.2010.21.017; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; SCHMID TM, 1983, J BIOL CHEM, V258, P9504; Sekiya I, 2001, BIOCHEM BIOPH RES CO, V284, P411, DOI 10.1006/bbrc.2001.4898; Sheehan D, 1980, THEORY PRACTICE HIST, Vsecond, P226; Shen BJ, 2010, J CELL BIOCHEM, V109, P406, DOI 10.1002/jcb.22412; Shen BJ, 2009, TISSUE ENG PT A, V15, P1311, DOI 10.1089/ten.tea.2008.0132; Shintani N, 2011, Eur Cell Mater, V22, P302; Shintani N, 2007, ARTHRITIS RHEUM, V56, P1869, DOI 10.1002/art.22701; Shintani N, 2007, J ORTHOP RES, V25, P813, DOI 10.1002/jor.20345; Sinanan ACM, 2004, BIOTECHNOL APPL BIOC, V40, P25, DOI 10.1042/BA20030185; Solchaga LA, 2005, J CELL PHYSIOL, V203, P398, DOI 10.1002/jcp.20238; Stevens MM, 2004, J ORTHOP RES, V22, P1114, DOI 10.1016/j.orthres.2003.12.021; STOCKWELL RA, 1979, BIOL CARTILAGE CELLS; Theoret CL, 1996, VET SURG, V25, P142, DOI 10.1111/j.1532-950X.1996.tb01390.x; Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200; Tsutsumi S, 2001, BIOCHEM BIOPH RES CO, V288, P413, DOI 10.1006/bbrc.2001.5777; van der Kraan PM, 2001, OSTEOARTHR CARTILAGE, V9, P92, DOI 10.1053/joca.2000.0364; WARDALE RJ, 1993, J CELL SCI, V105, P975; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	85	43	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53086	10.1371/journal.pone.0053086	http://dx.doi.org/10.1371/journal.pone.0053086			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301025	Green Published, Green Submitted, gold			2022-12-25	WOS:000313480000030
J	Maltha, J; Gillet, P; Heutmekers, M; Bottieau, E; Van Gompel, A; Jacobs, J				Maltha, Jessica; Gillet, Philippe; Heutmekers, Marloes; Bottieau, Emmanuel; Van Gompel, Alfons; Jacobs, Jan			Self-Diagnosis of Malaria by Travelers and Expatriates: Assessment of Malaria Rapid Diagnostic Tests Available on the Internet	PLOS ONE			English	Article							ACCURACY; QUALITY; PLDH	Introduction: In the past malaria rapid diagnostic tests (RDTs) for self-diagnosis by travelers were considered suboptimal due to poor performance. Nowadays RDTs for self-diagnosis are marketed and available through the internet. The present study assessed RDT products marketed for self-diagnosis for diagnostic accuracy and quality of labeling, content and instructions for use (IFU). Methods: Diagnostic accuracy of eight RDT products was assessed with a panel of stored whole blood samples comprising the four Plasmodium species (n = 90) as well as Plasmodium negative samples (n = 10). IFUs were assessed for quality of description of procedure and interpretation and for lay-out and readability level. Errors in packaging and content were recorded. Results: Two products gave false-positive test lines in 70% and 80% of Plasmodium negative samples, precluding their use. Of the remaining products, 4/6 had good to excellent sensitivity for the diagnosis of Plasmodium falciparum (98.2%-100.0%) and Plasmodium vivax (93.3%-100.0%). Sensitivity for Plasmodium ovale and Plasmodium malariae diagnosis was poor (6.7%-80.0%). All but one product yielded false-positive test lines after reading beyond the recommended reading time. Problems with labeling (not specifying target antigens (n = 3), and content (desiccant with no humidity indicator (n = 6)) were observed. IFUs had major shortcomings in description of test procedure and interpretation, poor readability and layout and user-unfriendly typography. Strategic issues (e.g. the need for repeat testing and reasons for false-negative tests) were not addressed in any of the IFUs. Conclusion: Diagnostic accuracy of RDTs for self-diagnosis was variable, with only 4/8 RDT products being reliable for the diagnosis of P. falciparum and P. vivax, and none for P. ovale and P. malariae. RDTs for self-diagnosis need improvements in IFUs (content and user-friendliness), labeling and content before they can be considered for self-diagnosis by the traveler.	[Maltha, Jessica; Gillet, Philippe; Heutmekers, Marloes; Bottieau, Emmanuel; Van Gompel, Alfons; Jacobs, Jan] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Maltha, Jessica] Univ Louvain, Ctr Mol & Vasc Biol, Louvain, Belgium	Institute of Tropical Medicine (ITM)	Maltha, J (corresponding author), Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium.	jmaltha@itg.be	Heutmekers, Marloes/P-6140-2015; Jacobs, Jan/GRX-7316-2022	Heutmekers, Marloes/0000-0003-0880-409X; gillet, philippe/0000-0001-5878-6446	Steunfonds Marguerite-Marie Delacroix	Steunfonds Marguerite-Marie Delacroix	J.M. holds a grant of the 'Steunfonds Marguerite-Marie Delacroix.' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Causer LM, 2004, CLIN INFECT DIS, V39, P1583, DOI 10.1086/425311; Cnops L, 2011, CLIN MICROBIOL INFEC, V17, P1101, DOI 10.1111/j.1469-0691.2010.03344.x; European Commission, 1998, EUR STAND IN VITR DI; Funk M, 1999, T ROY SOC TROP MED H, V93, P268, DOI 10.1016/S0035-9203(99)90018-4; Gillet P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-39; Gillet P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-359; Gillet P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-215; Grobusch MP, 2002, EUR J CLIN MICROBIOL, V21, P818, DOI 10.1007/s10096-002-0831-0; Hopkins H, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-30; Jelinek T, 1999, LANCET, V354, P1609, DOI 10.1016/S0140-6736(99)01969-8; Magill Alan J, 2006, Curr Infect Dis Rep, V8, P35, DOI 10.1007/s11908-006-0033-5; Maltha J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043094; Maltha J, 2011, EUR J PEDIATR, V170, P821, DOI 10.1007/s00431-011-1451-4; Maltha J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-7; Maltha J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-198; Maltha J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-171; Mayxay M, 2001, T ROY SOC TROP MED H, V95, P179, DOI 10.1016/S0035-9203(01)90156-7; Miller RS, 2001, BRIT J HAEMATOL, V113, P558, DOI 10.1046/j.1365-2141.2001.02782.x; Mudanyali O, 2012, LAB CHIP, V12, P2678, DOI [10.1039/c2lc40235a, 10.1039/c21c40235a]; Mueller I, 2007, J CLIN MICROBIOL, V45, P627, DOI 10.1128/JCM.00816-06; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; Rennie W, 2007, T ROY SOC TROP MED H, V101, P9, DOI 10.1016/j.trstmh.2006.03.011; Roukens AH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-128; Schlagenhauf P, 2008, CLIN MICROBIOL REV, V21, P466, DOI 10.1128/CMR.00059-07; Schlagenhauf P, 2012, EXPERT REV ANTI-INFE, V10, P537, DOI [10.1586/ERI.12.42, 10.1586/eri.12.42]; Trachsler M, 1999, TROP MED INT HEALTH, V4, P442, DOI 10.1046/j.1365-3156.1999.00419.x; Van der Palen M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-90; van Dijk DPJ, 2010, EUR J CLIN MICROBIOL, V29, P577, DOI 10.1007/s10096-010-0898-y; Wallace LS, 2009, J WOMENS HEALTH, V18, P363, DOI 10.1089/jwh.2008.0985; Whitty CJM, 2000, AM J TROP MED HYG, V63, P295, DOI 10.4269/ajtmh.2000.63.295; World Health Organization, 2003, M 20 23 JAN 2003 MAN; World Health Organization, 2012, INT TRAV HLTH	32	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53102	10.1371/journal.pone.0053102	http://dx.doi.org/10.1371/journal.pone.0053102			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301027	Green Published, gold			2022-12-25	WOS:000313320900060
J	Terahara, K; Ishige, M; Ikeno, S; Mitsuki, Y; Okada, S; Kobayashi, K; Tsunetsugu-Yokota, Y				Terahara, Kazutaka; Ishige, Masayuki; Ikeno, Shota; Mitsuki, Yu-ya; Okada, Seiji; Kobayashi, Kazuo; Tsunetsugu-Yokota, Yasuko			Expansion of Activated Memory CD4(+) T Cells Affects Infectivity of CCR5-Tropic HIV-1 in Humanized NOD/SCID/JAK3(null) Mice	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BLOOD CD34(+) CELLS; DENDRITIC CELLS; IMMUNE-SYSTEM; HOMEOSTATIC PROLIFERATION; TRANSMISSION; MATURE; NAIVE; RECONSTITUTION; PATHOGENESIS	Humanized mice reconstituted with human hematopoietic cells have been developed as an experimental animal model for human immunodeficiency virus type 1 (HIV-1) infection. Myeloablative irradiation is usually performed to augment the engraftment of donor hematopoietic stem cells (HSCs) in recipient mice; however, some mouse strains are susceptible to irradiation, making longitudinal analysis difficult. We previously attempted to construct humanized NOD/SCID/JAK3(null) (hNOJ) mice, which were not irradiated prior to human HSC transplantation. We found that, over time, many of the reconstituted CD4(+) T cells expanded with an activated effector memory phenotype. Therefore, the present study used hNOJ mice that were irradiated (hNOJ (IR+)) or not (hNOJ (IR-)) prior to human HSC transplantation to examine whether the development and cellularity of the reconstituted CD4(+) T cells were influenced by the degree of chimerism, and whether they affected HIV-1 infectivity. Indeed, hNOJ (IR+) mice showed a greater degree of chimerism than hNOJ (IR-) mice. However, the conversion of CD4(+) T cells to an activated effector memory phenotype, with a high percentage of cells showing Ki-67 expression, occurred in both hNOJ (IR+) and hNOJ (IR-) mice, probably as a result of lymphopenia-induced homeostatic expansion. Furthermore, when hNOJ (IR+) and hNOJ (IR-) mice, which were selected as naive- and memory CD4(+) T cell subset-rich groups, respectively, were infected with CCR5-tropic HIV-1 in vivo, virus replication (as assessed by the plasma viral load) was delayed; however, the titer subsequently reached a 1-log higher level in memory-rich hNOJ (IR-) mice than in naive-rich hNOJ (IR+) mice, indicating that virus infectivity in hNOJ mice was affected by the different status of the reconstituted CD4(+) T cells. Therefore, the hNOJ mouse model should be used selectively, i.e., according to the specific experimental objectives, to gain an appropriate understanding of HIV-1 infection/pathogenesis.	[Terahara, Kazutaka; Ishige, Masayuki; Ikeno, Shota; Mitsuki, Yu-ya; Kobayashi, Kazuo; Tsunetsugu-Yokota, Yasuko] Natl Inst Infect Dis, Dept Immunol, Tokyo, Japan; [Ishige, Masayuki; Okada, Seiji] Kumamoto Univ, Ctr AIDS Res, Div Hematopoiesis, Kumamoto, Japan; [Ikeno, Shota] Kitasato Univ, Kitasato Inst Life Sci, Lab Viral Infect 2, Tokyo, Japan	National Institute of Infectious Diseases (NIID); Kumamoto University; Kitasato University	Tsunetsugu-Yokota, Y (corresponding author), Natl Inst Infect Dis, Dept Immunol, Tokyo, Japan.	yyokota@nih.go.jp	Okada, Seiji/F-5785-2013	Terahara, Kazutaka/0000-0001-9876-4356	Ministry of Education, Science, Sports and Culture of Japan; Ministry of Health, Labour and Welfare of Japan; Grants-in-Aid for Scientific Research [23790453] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Science, Sports and Culture of Japan (K. T.), and the Ministry of Health, Labour and Welfare of Japan (K.T. and Y.T.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkina R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020169; Andre MC, 2010, J IMMUNOL, V185, P2710, DOI 10.4049/jimmunol.1000583; Baenziger S, 2006, P NATL ACAD SCI USA, V103, P15951, DOI 10.1073/pnas.0604493103; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Berges BK, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-65; Berges BK, 2010, VIROLOGY, V397, P100, DOI 10.1016/j.virol.2009.10.034; Boyman O, 2009, EUR J IMMUNOL, V39, P2088, DOI 10.1002/eji.200939444; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Dai JH, 2009, J VIROL, V83, P4528, DOI 10.1128/JVI.01910-08; David SA, 2001, AIDS RES HUM RETROV, V17, P59, DOI 10.1089/088922201750056799; Goldstein Harris, 2008, AIDS Res Ther, V5, P3, DOI 10.1186/1742-6405-5-3; Gorantla S, 2007, J VIROL, V81, P2700, DOI 10.1128/JVI.02010-06; Goronzy JJ, 2007, EXP GERONTOL, V42, P400, DOI 10.1016/j.exger.2006.11.016; Granelli-Piperno A, 1998, J VIROL, V72, P2733, DOI 10.1128/JVI.72.4.2733-2737.1998; Hiramatsu H, 2003, BLOOD, V102, P873, DOI 10.1182/blood-2002-09-2755; Ito R, 2012, CELL MOL IMMUNOL, V9, P208, DOI 10.1038/cmi.2012.2; Kemp K, 2001, J INTERF CYTOK RES, V21, P503, DOI 10.1089/10799900152434376; Langeveld M, 2006, EUR J CLIN INVEST, V36, P250, DOI 10.1111/j.1365-2362.2006.01626.x; Legrand N, 2006, BLOOD, V108, P238, DOI 10.1182/blood-2006-01-0190; Legrand N, 2006, J IMMUNOL, V176, P2053, DOI 10.4049/jimmunol.176.4.2053; Legrand N, 2009, CELL HOST MICROBE, V6, P5, DOI 10.1016/j.chom.2009.06.006; Lipman M, 2006, CURR OPIN INFECT DIS, V19, P20, DOI 10.1097/01.qco.0000200543.80712.01; Liu CX, 2010, BLOOD, V116, P5518, DOI 10.1182/blood-2009-12-260810; Manz MG, 2007, IMMUNITY, V26, P537, DOI 10.1016/j.immuni.2007.05.001; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; MCCLURE MO, 1987, NATURE, V330, P487, DOI 10.1038/330487a0; Min B, 2005, J IMMUNOL, V174, P6039, DOI 10.4049/jimmunol.174.10.6039; Nie CY, 2009, VIROLOGY, V394, P64, DOI 10.1016/j.virol.2009.08.011; Nischang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038853; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Okada R, 2008, INT IMMUNOL, V20, P1189, DOI 10.1093/intimm/dxn075; Okada S, 2008, INT J HEMATOL, V88, P476, DOI 10.1007/s12185-008-0215-z; Okoye A, 2007, J EXP MED, V204, P2171, DOI 10.1084/jem.20070567; Onoe T, 2010, J IMMUNOL, V184, P6756, DOI 10.4049/jimmunol.0901711; Park SY, 1995, IMMUNITY, V3, P771, DOI 10.1016/1074-7613(95)90066-7; Picker LJ, 2005, NAT IMMUNOL, V6, P430, DOI 10.1038/ni0505-430; Ponnappan S, 2011, ANTIOXID REDOX SIGN, V14, P1551, DOI 10.1089/ars.2010.3228; Saito A, 2011, MICROBES INFECT, V13, P58, DOI 10.1016/j.micinf.2010.10.001; Sato K, 2011, EXP BIOL MED MAYWOOD; Sato Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042776; Sato Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013109; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Shacklett BL, 2008, PLOS MED, V5, P16, DOI 10.1371/journal.pmed.0050013; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Simon V, 2003, NAT REV MICROBIOL, V1, P181, DOI 10.1038/nrmicro772; Singh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038491; Stevenson M, 2003, NAT MED, V9, P853, DOI 10.1038/nm0703-853; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Suzuki M, 2012, INT IMMUNOL, V24, P243, DOI 10.1093/intimm/dxs045; Terahara K, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2011.00280; Tobiume M, 2003, J VIROL, V77, P10645, DOI 10.1128/JVI.77.19.10645-10650.2003; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Tsunetsugu-Yokota Y, 1997, VIROLOGY, V239, P259, DOI 10.1006/viro.1997.8895; Tsunetsugu-Yokota Y., 2008, AIDS VACCINES HIV RE, P117; Watanabe S, 2007, J VIROL, V81, P13259, DOI 10.1128/JVI.01353-07; Wege AK, 2008, CURR TOP MICROBIOL, V324, P149; Woodland DL, 2006, TRENDS IMMUNOL, V27, P303, DOI 10.1016/j.it.2006.05.002; Yahata T, 2002, J IMMUNOL, V169, P204, DOI 10.4049/jimmunol.169.1.204; Yamamoto T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000279; Yue FY, 2004, J IMMUNOL, V172, P2476, DOI 10.4049/jimmunol.172.4.2476; Zhang LG, 2007, BLOOD, V109, P2978, DOI 10.1182/blood-2006-07-033159	62	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53495	10.1371/journal.pone.0053495	http://dx.doi.org/10.1371/journal.pone.0053495			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301078	Green Published, gold, Green Submitted			2022-12-25	WOS:000313320900080
J	Kuchenreuther, MJ; Weber, JD				Kuchenreuther, M. J.; Weber, J. D.			The ARF tumor-suppressor controls Drosha translation to prevent Ras-driven transformation	ONCOGENE			English	Article						ARF; Drosha; translation; tumor suppression; rRNA	RIBOSOMAL-RNA; PROTEIN; P53; EXPRESSION; P19(ARF); COMPLEX; DICER; MDM2; BIOGENESIS; MICRORNAS	ARF is a multifunctional tumor suppressor that acts as both a sensor of oncogenic stimuli and as a key regulator of ribosome biogenesis. Recently, our group established the DEAD-box RNA helicase and microRNA (miRNA) microprocessor accessory subunit, DDX5, as a critical target of basal ARF function. To identify other molecular targets of ARF, we focused on known interacting proteins of DDX5 in the microprocessor complex. Drosha, the catalytic core of the microprocessor complex, has a critical role in the maturation of specific non-coding RNAs, including miRNAs and ribosomal RNAs (rRNAs). Here, we report that chronic or acute loss of Arf enhanced Drosha protein expression. This induction did not involve Drosha mRNA transcription or protein stability but rather relied on the increased translation of existing Drosha mRNAs. Enhanced Drosha expression did not alter global miRNA production but rather modified expression of a subset of miRNAs in the absence of Arf. Elevated Drosha protein levels were required to maintain the increased rRNA synthesis and cellular proliferation observed in the absence of Arf. Arf-deficient cells transformed by oncogenic RasV12 were dependent on increased Drosha expression as Drosha knockdown was sufficient to inhibit Ras-dependent cellular transformation. Thus, we propose that ARF regulates Drosha mRNA translation to prevent aberrant cell proliferation and Ras-dependent transformation.	[Kuchenreuther, M. J.; Weber, J. D.] Washington Univ, Sch Med, BRIGHT Inst, St Louis, MO 63110 USA; [Kuchenreuther, M. J.; Weber, J. D.] Washington Univ, Sch Med, Dept Internal Med, Div Mol Oncol, St Louis, MO 63110 USA; [Weber, J. D.] Washington Univ, Sch Med, Dept Cell Biol, Siteman Canc Ctr, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	Weber, JD (corresponding author), Washington Univ, Sch Med, Dept Internal Med, BRIGHT Inst,Div Mol Oncol, 660 South Euclid Ave,Campus 8069, St Louis, MO 63110 USA.	jweber@dom.wustl.edu		Weber, Jason/0000-0002-1069-6983	Siteman Cancer Center, Cancer Biology Pathway Training Grant [T32 CA113275]; National Institutes of Health [R01 CA120436]; Department of Defense Era of Hope Scholar Award [BC075004]; NATIONAL CANCER INSTITUTE [R01CA120436, T32CA113275] Funding Source: NIH RePORTER	Siteman Cancer Center, Cancer Biology Pathway Training Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Era of Hope Scholar Award(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the members of the Weber lab for their technical input and suggestions. The Children's Discovery Institute and the Genome Institute at Washington University provided lentiviral knockdown constructs. MJK was supported by the Siteman Cancer Center, Cancer Biology Pathway Training Grant (T32 CA113275). Grants from the National Institutes of Health (R01 CA120436) and Department of Defense Era of Hope Scholar Award (BC075004) to JDW supported this work.	Apicelli AJ, 2008, MOL CELL BIOL, V28, P1068, DOI 10.1128/MCB.00484-07; Ayrault O, 2004, ONCOGENE, V23, P8097, DOI 10.1038/sj.onc.1207968; Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; Brady SN, 2004, MOL CELL BIOL, V24, P9327, DOI 10.1128/MCB.24.21.9327-9338.2004; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Han J, 2009, CELL, V136, P75, DOI 10.1016/j.cell.2008.10.053; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kawagishi H, 2010, CANCER RES, V70, P4749, DOI 10.1158/0008-5472.CAN-10-0368; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lessard F, 2010, MOL CELL, V38, P539, DOI 10.1016/j.molcel.2010.03.015; Lin RJ, 2010, CANCER RES, V70, P7841, DOI 10.1158/0008-5472.CAN-10-0970; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maggi LB, 2008, MOL CELL BIOL, V28, P7050, DOI 10.1128/MCB.01548-07; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Miceli AP, 2012, MOL CELL BIOL, V32, P348, DOI 10.1128/MCB.06030-11; Muralidhar B, 2011, J PATHOL, V224, P496, DOI 10.1002/path.2898; Olanich ME, 2011, ONCOGENE, V30, P77, DOI 10.1038/onc.2010.404; Oskowitz AZ, 2011, INT J BIOCHEM CELL B, V43, P1563, DOI 10.1016/j.biocel.2011.07.005; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; QUELLE DE, 1995, CELL, V83, P993; ROUSSEL MF, 1995, P NATL ACAD SCI USA, V92, P6837, DOI 10.1073/pnas.92.15.6837; Sand M, 2010, CANCER INVEST, V28, P649, DOI 10.3109/07357901003630918; Saporita AJ, 2011, CANCER RES, V71, P6708, DOI 10.1158/0008-5472.CAN-11-1472; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Shiohama A, 2007, EXP CELL RES, V313, P4196, DOI 10.1016/j.yexcr.2007.07.020; Strezoska Z, 2000, MOL CELL BIOL, V20, P5516, DOI 10.1128/MCB.20.15.5516-5528.2000; Sugimoto M, 2003, MOL CELL, V11, P415, DOI 10.1016/S1097-2765(03)00057-1; Sugito N, 2006, CLIN CANCER RES, V12, P7322, DOI 10.1158/1078-0432.CCR-06-0515; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Wu HJ, 2000, J BIOL CHEM, V275, P36957, DOI 10.1074/jbc.M005494200; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4	41	11	11	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 16	2014	33	3					300	307		10.1038/onc.2012.601	http://dx.doi.org/10.1038/onc.2012.601			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	296VR	23318441	Green Accepted			2022-12-25	WOS:000330214000004
J	Xiang, Y; Ma, N; Wang, D; Zhang, Y; Zhou, J; Wu, G; Zhao, R; Huang, H; Wang, X; Qiao, Y; Li, F; Han, D; Wang, L; Zhang, G; Gao, X				Xiang, Y.; Ma, N.; Wang, D.; Zhang, Y.; Zhou, J.; Wu, G.; Zhao, R.; Huang, H.; Wang, X.; Qiao, Y.; Li, F.; Han, D.; Wang, L.; Zhang, G.; Gao, X.			MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine	ONCOGENE			English	Article						cisplatin resistance; microRNA; DNMT1; decitabine; ovarian cancer	DNA METHYLTRANSFERASE 1; GENE-EXPRESSION; IN-VITRO; HEPATOCELLULAR-CARCINOMA; ENDOMETRIAL CANCER; PLATINUM-RESISTANT; DRUG-RESISTANCE; BREAST-CANCER; LINES; METHYLATION	Epithelial ovarian cancer (EOC) is a highly lethal gynaecological malignancy. Cisplatin is the basal chemotherapeutic agent used to treat EOC, but resistance to cisplatin leads to chemotherapy failure. MicroRNAs are a novel class of regulators that function by controlling gene expression at the post-transcriptional level. Several recent reports have identified some microRNAs that are related to chemotherapy sensitivity. In this study, we found two microRNAs miR-152 and miR-185 that were significantly downregulated in the cisplatin-resistant ovarian cell lines SKOV3/DDP and A2780/DDP, compared with their sensitive parent line SKOV3 and A2780, respectively. Subsequently, the roles of miR-152 and miR-185 were evaluated in vitro and in vivo. The overexpression of miR-152 or miR-185 increased cisplatin sensitivity of SKOV3/DDP and A2780/DDP cells by inhibiting proliferation and promoting apoptosis, then we further confirmed that these miRNAs functioned through suppressing DNA methyltransferase 1 (DNMT1) directly. Concordantly, CD-1/CD-1 nude mice that were injected intraperitoneally with SKOV3/DDP cells transfected with miR-152 mimics exhibited upregulated cisplatin sensitivity in vivo. Interestingly, we found that there were no significant changes in the expression of these two microRNAs after treatment with decitabine (DAC), a traditional epigenetic therapeutic agent, suggesting these miRNAs represented two new regulators independent of DAC. Finally, the survival assay in A549 and HepG2 cells revealed that the two microRNAs involved in cisplatin sensitivity were related to cell types. Our results indicated that miR-152 and miR-185 were involved in ovarian cancer cisplatin resistance in vitro and in vivo by targeting DNMT1 directly. These molecules may serve as potential epigenetic therapeutic targets in other cancers.	[Xiang, Y.; Ma, N.; Wang, D.; Zhou, J.; Wu, G.; Zhao, R.; Huang, H.; Wang, X.; Qiao, Y.; Li, F.; Han, D.; Wang, L.; Gao, X.] Harbin Med Univ, Dept Biochem & Mol Biol, Harbin 150086, Peoples R China; [Zhang, Y.] Harbin Med Univ, Dept Lab Diag, Affiliated Hosp 1, Harbin 150086, Peoples R China; [Zhang, G.] Harbin Med Univ, Dept Obstet & Gynecol, Affiliated Hosp 1, Harbin 150086, Peoples R China; [Gao, X.] Minist Educ, Key Lab Cardiovasc Med Res, Harbin, Peoples R China; [Gao, X.] Harbin Med Univ, State Prov Key Labs Biomed Pharmaceut China, Harbin 150086, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Zhang, G (corresponding author), Harbin Med Univ, Dept Obstet & Gynecol, Affiliated Hosp 1, Harbin 150086, Peoples R China.	zhangguangmei@126.com; gaoxu_671227@yahoo.com.cn	gao, xu/U-4765-2019	Xiang, Ying/0000-0002-4879-2751	Natural Science Foundation of Heilongjiang Province for youth and for outstanding youth [QC2010002, JC201110]; Natural Science Foundation of China [81101373, 81270511, 81001033]; Science Foundation of Health Department of Heilongjiang Province [2012-525]; Science Foundation of the First Affiliated Hospital of Harbin Medical University [2009Y24]	Natural Science Foundation of Heilongjiang Province for youth and for outstanding youth; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Health Department of Heilongjiang Province; Science Foundation of the First Affiliated Hospital of Harbin Medical University	This work was supported by the Natural Science Foundation of Heilongjiang Province for youth (QC2010002) and for outstanding youth (JC201110), the Natural Science Foundation of China (81101373/81270511/81001033), the Science Foundation of Health Department of Heilongjiang Province(2012-525) and the Science Foundation of the First Affiliated Hospital of Harbin Medical University (2009Y24).	Akcakaya P, 2011, INT J ONCOL, V39, P311, DOI 10.3892/ijo.2011.1043; Barabas K, 2008, VET COMP ONCOL, V6, P1, DOI 10.1111/j.1476-5829.2007.00142.x; Basu A., 2010, J NUCL ACIDS, V2010; Blum KA, 2010, BRIT J HAEMATOL, V150, P189, DOI 10.1111/j.1365-2141.2010.08213.x; Blum W, 2012, BLOOD, V119, P6025, DOI 10.1182/blood-2012-03-413898; Chan TA, 2008, PLOS MED, V5, P823, DOI 10.1371/journal.pmed.0050114; Chen Huaping, 2011, Frontiers in Genetics, V2, P67, DOI 10.3389/fgene.2011.00067; Chen Y, 2010, J GASTROINTEST SURG, V14, P1170, DOI 10.1007/s11605-010-1202-2; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; Fan H, 2009, WORLD J GASTROENTERO, V15, P2020, DOI 10.3748/wjg.15.2020; Fang F, 2010, CANCER-AM CANCER SOC, V116, P4043, DOI 10.1002/cncr.25204; Fu X, 2012, FEBS LETT, V586, P1279, DOI 10.1016/j.febslet.2012.03.006; Fung-Kee-Fung M, 2007, Curr Oncol, V14, P195; Glasspool RM, 2006, BRIT J CANCER, V94, P1087, DOI 10.1038/sj.bjc.6603024; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; Holleman A, 2011, ONCOGENE, V30, P4386, DOI 10.1038/onc.2011.148; Huang JF, 2010, HEPATOLOGY, V52, P60, DOI 10.1002/hep.23660; Imam JS, 2010, ONCOGENE, V29, P4971, DOI 10.1038/onc.2010.233; Ishida S, 2002, P NATL ACAD SCI USA, V99, P14298, DOI 10.1073/pnas.162491399; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kantarjian HM, 2005, SEMIN HEMATOL, V42, pS17, DOI 10.1053/j.seminhematol.2005.05.006; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kovalchuk O, 2008, MOL CANCER THER, V7, P2152, DOI 10.1158/1535-7163.MCT-08-0021; Kwon MJ, 2011, INT J MOL SCI, V12, P983, DOI 10.3390/ijms12020983; LENZI R, 1994, ANTICANCER RES, V14, P247; Li M, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-34; Liao JM, 2011, J BIOL CHEM, V286, P33901, DOI 10.1074/jbc.M111.262030; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Luszczek W, 2010, MOL CANCER THER, V9, P2309, DOI 10.1158/1535-7163.MCT-10-0309; Malizia AP, 2011, WIRES SYST BIOL MED, V3, P183, DOI 10.1002/wsbm.111; Matei D, 2012, CANCER RES, V72, P2197, DOI 10.1158/0008-5472.CAN-11-3909; Matei DE, 2010, GYNECOL ONCOL, V116, P195, DOI 10.1016/j.ygyno.2009.09.043; Myatt SS, 2010, CANCER RES, V70, P367, DOI 10.1158/0008-5472.CAN-09-1891; OZOLS RF, 1991, SEMIN ONCOL, V18, P222; Plumb JA, 2000, CANCER RES, V60, P6039; Qin TC, 2009, BLOOD, V113, P659, DOI 10.1182/blood-2008-02-140038; Saito Y, 2009, BIOCHEM BIOPH RES CO, V379, P726, DOI 10.1016/j.bbrc.2008.12.098; Sangodkar J, 2012, J CLIN INVEST, V122, P2637, DOI 10.1172/JCI62058; Selvakumaran M, 2003, CANCER RES, V63, P1311; Selvakumaran M, 2001, CANCER RES, V61, P1291; Singh RK, 2008, GYNECOL ONCOL, V109, P240, DOI 10.1016/j.ygyno.2008.01.042; Takahashi Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006677; Tang MQ, 2009, CURR GENOMICS, V10, P336, DOI 10.2174/138920209788920994; Tohyama K, 2012, CURR PHARM DESIGN, V18, P3190, DOI 10.2174/1381612811209023190; Tsai KW, 2011, INT J CANCER, V129, P2600, DOI 10.1002/ijc.25919; Tsuruta T, 2011, CANCER RES, V71, P6450, DOI 10.1158/0008-5472.CAN-11-0364; Yang DF, 2012, J IMMUNOL, V188, P4441, DOI 10.4049/jimmunol.1103035; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yang N, 2008, CANCER RES, V68, P10307, DOI 10.1158/0008-5472.CAN-08-1954; Yi TZ, 2012, CHEMOTHERAPY, V58, P19, DOI 10.1159/000333077; Zhang JQ, 2012, GASTROENTEROLOGY, V143, P246, DOI 10.1053/j.gastro.2012.03.045; Zhang ZP, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-124; Zhao JJ, 2008, J BIOL CHEM, V283, P31079, DOI 10.1074/jbc.M806041200; Zhao ZW, 2012, BIOCHEM J, V444, P291, DOI 10.1042/BJ20111855; Zhou X, 2012, ONCOL REP, V27, P447, DOI 10.3892/or.2011.1482	56	165	177	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 16	2014	33	3					378	386		10.1038/onc.2012.575	http://dx.doi.org/10.1038/onc.2012.575			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	296VR	23318422				2022-12-25	WOS:000330214000012
J	Kapilashrami, K; Bommineni, GR; Machutta, CA; Kim, P; Lai, CT; Simmerling, C; Picart, F; Tonge, PJ				Kapilashrami, Kanishk; Bommineni, Gopal R.; Machutta, Carl A.; Kim, Pilho; Lai, Cheng-Tsung; Simmerling, Carlos; Picart, Francis; Tonge, Peter J.			Thiolactomycin-based beta-Ketoacyl-AcpM Synthase A (KasA) Inhibitors FRAGMENT-BASED INHIBITOR DISCOVERY USING TRANSIENT ONE-DIMENSIONAL NUCLEAR OVERHAUSER EFFECT NMR SPECTROSCOPY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; MYCOBACTERIUM-TUBERCULOSIS; CONDENSING ENZYMES; NOE EXPERIMENTS; BIOSYNTHESIS; NMR; IDENTIFICATION; ANTIMALARIAL; DERIVATIVES; ANALOGS	Thiolactomycin (TLM) is a natural product inhibitor of KasA, the beta-ketoacyl synthase A from Mycobacterium tuberculosis. To improve the affinity of TLM for KasA, a series of TLM analogs have been synthesized based on interligand NOEs between TLM and a pantetheine analog when both are bound simultaneously to the enzyme. Kinetic binding data reveal that position 3 of the thiolactone ring is a suitable position for elaboration of the TLM scaffold, and the structure-activity relationship studies provide information on the molecular features that govern time-dependent inhibition in this enzyme system. These experiments also exemplify the utility of transient one-dimensional NOE spectroscopy for obtaining interligand NOEs compared with traditional steady state two-dimensional NOESY spectroscopy.	[Kapilashrami, Kanishk; Bommineni, Gopal R.; Machutta, Carl A.; Lai, Cheng-Tsung; Simmerling, Carlos; Tonge, Peter J.] SUNY Stony Brook, Dept Chem, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA; [Kapilashrami, Kanishk; Bommineni, Gopal R.; Picart, Francis; Tonge, Peter J.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Lai, Cheng-Tsung; Simmerling, Carlos] SUNY Stony Brook, Dept Biochem, Biochem & Struct Biol Grad Program, Stony Brook, NY 11794 USA; [Simmerling, Carlos] SUNY Stony Brook, Laufer Ctr Phys & Quantitat Biol, Stony Brook, NY 11794 USA; [Kim, Pilho] Korea Res Inst Chem Technol, Ctr Canc & Infect Dis, Bioorgan Sci Div, Taejon 305600, South Korea	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Korea Research Institute of Chemical Technology (KRICT)	Picart, F (corresponding author), SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA.	francis.picart@sunysb.edu; peter.tonge@sunysb.edu	Lai, Cheng-Tsung/H-6728-2013; Tonge, Peter J/A-7443-2009	Lai, Cheng-Tsung/0000-0002-1192-2815; Tonge, Peter J/0000-0003-1606-3471	National Institutes of Health [GM102864, AI044639]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044639, R21AI044639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102864] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM102864 and AI044639 (to P. J. T.).	Al-Balas Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005617; Becattini B, 2006, CHEM-EUR J, V12, P2658, DOI 10.1002/chem.200500636; Bhatt A, 2005, J BACTERIOL, V187, P7596, DOI 10.1128/JB.187.22.7596-7606.2005; Brown MS, 2003, J AM CHEM SOC, V125, P10166, DOI 10.1021/ja034540i; Chen JH, 2007, ACS CHEM BIOL, V2, P329, DOI 10.1021/cb700025j; Copeland R. A., 2004, ENZYMES PRACTICAL IN; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; EDZES HT, 1977, NATURE, V265, P521, DOI 10.1038/265521a0; Hu HT, 2006, J MAGN RESON, V182, P173, DOI 10.1016/j.jmr.2006.06.009; Jones AL, 2000, BIOCHEM J, V347, P205, DOI 10.1042/0264-6021:3470205; Jones SM, 2004, BIOORGAN MED CHEM, V12, P683, DOI 10.1016/j.bmc.2003.11.023; Kim P, 2006, J MED CHEM, V49, P159, DOI 10.1021/jm050825p; Lang PT, 2009, RNA, V15, P1219, DOI 10.1261/rna.1563609; Lee PJ, 2009, J MED CHEM, V52, P952, DOI 10.1021/jm8008103; Lu H, 2010, CURR OPIN CHEM BIOL, V14, P467, DOI 10.1016/j.cbpa.2010.06.176; Luckner SR, 2009, STRUCTURE, V17, P1004, DOI 10.1016/j.str.2009.04.012; Machutta CA, 2010, J BIOL CHEM, V285, P6161, DOI 10.1074/jbc.M109.077909; MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2; McFadden JM, 2005, J MED CHEM, V48, P946, DOI 10.1021/jm049389h; MIYAKAWA S, 1982, J ANTIBIOT, V35, P411, DOI 10.7164/antibiotics.35.411; Mukherjee S, 2010, J CHEM INF MODEL, V50, P1986, DOI 10.1021/ci1001982; NOTO T, 1982, J ANTIBIOT, V35, P401, DOI 10.7164/antibiotics.35.401; Omura S, 1981, Methods Enzymol, V72, P520; Price AC, 2001, J BIOL CHEM, V276, P6551, DOI 10.1074/jbc.M007101200; SASAKI H, 1982, J ANTIBIOT, V35, P396, DOI 10.7164/antibiotics.35.396; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Singh S, 2008, EUR J MED CHEM, V43, P1071, DOI 10.1016/j.ejmech.2007.06.018; Spry C, 2005, ANTIMICROB AGENTS CH, V49, P4649, DOI 10.1128/AAC.49.11.4649-4657.2005; STOTT K, 1995, J AM CHEM SOC, V117, P4199, DOI 10.1021/ja00119a048; Stott K, 1997, J MAGN RESON, V125, P302, DOI 10.1006/jmre.1997.1110; Swinney DC, 2004, NAT REV DRUG DISCOV, V3, P801, DOI 10.1038/nrd1500; Szabo A, 1999, TETRAHEDRON-ASYMMETR, V10, P61, DOI 10.1016/S0957-4166(98)00499-6; WANG CLJ, 1984, TETRAHEDRON LETT, V25, P5243; Wang J, 2006, NATURE, V441, P358, DOI 10.1038/nature04784; Witkowski A, 1999, BIOCHEMISTRY-US, V38, P11643, DOI 10.1021/bi990993h	36	26	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6045	6052		10.1074/jbc.M112.414516	http://dx.doi.org/10.1074/jbc.M112.414516			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23306195	hybrid, Green Published			2022-12-25	WOS:000315820700002
J	Yang, FC; Tan, BCM; Chen, WH; Lin, YH; Huang, JY; Chang, HY; Sun, HY; Hsu, PH; Liou, GG; Shen, J; Chang, CJ; Han, CC; Tsai, MD; Lee, SC				Yang, Fu-Chia; Tan, Bertrand Chin-Ming; Chen, Wei-Hao; Lin, Ya-Huei; Huang, Jing-Yi; Chang, Hsin-Yun; Sun, Hui-Yu; Hsu, Pang-Hung; Liou, Gunn-Guang; Shen, James; Chang, Ching-Jin; Han, Chau-Chung; Tsai, Ming-Daw; Lee, Sheng-Chung			Reversible Acetylation Regulates Salt-inducible Kinase (SIK2) and Its Function in Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATION; EXPRESSION; TDP-43; POLYGLUTAMINE; INVOLVEMENT; INHIBITION; EXPANSIONS; DISEASE; CAMP	Salt-inducible kinase 2 (SIK2) is a serine/threonine protein kinase belonging to the AMP-activated protein kinase (AMPK) family. SIK2 has been shown to function in the insulin-signaling pathway during adipocyte differentiation and to modulate CREB-mediated gene expression in response to hormones and nutrients. However, molecular mechanisms underlying the regulation of SIK2 kinase activity remains largely elusive. Here we report a dynamic, post-translational regulation of its kinase activity that is coordinated by an acetylation-deaceytlation switch, p300/CBP-mediated Lys-53 acetylation inhibits SIK2 kinase activity, whereas HDAC6-mediated deacetylation restores the activity. Interestingly, overexpression of acetylation-mimetic mutant of SIK2 (SIK2-K53Q), but not the nonacetylatable K53R variant, resulted in accumulation of autophagosomes. Further consistent with a role in autophagy, knockdown of SIK2 abrogated autophagosome and lysosome fusion. Consequently, SIK2 and its kinase activity are indispensable for the removal of TDP-43 Delta inclusion bodies. Our findings uncover SIK2 as a critical determinant in autophagy progression and further suggest a mechanism in which the interplay among kinase and deacetylase activities contributes to cellular protein pool homeostasis.	[Yang, Fu-Chia; Chen, Wei-Hao; Lin, Ya-Huei; Huang, Jing-Yi; Chang, Hsin-Yun; Sun, Hui-Yu; Lee, Sheng-Chung] Natl Taiwan Univ, Inst Mol Med, Taipei 100, Taiwan; [Yang, Fu-Chia; Chang, Ching-Jin] Natl Taiwan Univ, Inst Biochem Sci, Taipei 100, Taiwan; [Lee, Sheng-Chung] Natl Taiwan Univ, Inst Clin Med, Taipei 100, Taiwan; [Tan, Bertrand Chin-Ming] Chang Gung Univ, Dept Biomed Sci, Tao Yuan 33302, Taiwan; [Yang, Fu-Chia] Acad Sinica, Inst Biol Chem, Taiwan Int Grad Program, Chem Biol & Mol Biophys Program, Taipei 11529, Taiwan; [Hsu, Pang-Hung; Tsai, Ming-Daw] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan; [Shen, James] Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan; [Chang, Ching-Jin; Tsai, Ming-Daw; Lee, Sheng-Chung] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Han, Chau-Chung] Acad Sinica, Inst Mol & Atom Sci, Taipei 11529, Taiwan; [Liou, Gunn-Guang] Natl Hlth Res Inst, Div Mol & Genom Med, Miaoli 35053, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; Chang Gung University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Health Research Institutes - Taiwan	Lee, SC (corresponding author), Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei 10051, Taiwan.	slee@ntu.edu.tw	shen, Che-Kun James/L-1343-2015; Liou, Gunn‐Guang/AAI-9787-2020; Chang, Ching-Jin/G-4511-2019; Hsu, Pang-Hung/C-5587-2018; Tsai, Ming-Daw/G-4689-2019; Han, Chau-Chung/F-7930-2012; Liou, Gan-Guang/E-3976-2010	Hsu, Pang-Hung/0000-0001-6873-6434; Tsai, Ming-Daw/0000-0003-1374-0414; Chang, Ching-Jin/0000-0001-7129-8092; Tan, Bertrand/0000-0002-2218-7115; Liou, Gan-Guang/0000-0002-2619-8516	National Science Council [NSC96-2321-B-002-008, NSC100-2320-B-002-008, NSC99-2632-B-182-011-MY3, NSC101-2320-B-182-036-MY3, NSC101-2321-B-182-009]; Academia Sinica; Institute of Biological Chemistry, Academia Sinica; Department of Medical Research, National Taiwan University Hospital	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan); Institute of Biological Chemistry, Academia Sinica(Academia Sinica - Taiwan); Department of Medical Research, National Taiwan University Hospital	This work was supported by National Science Council Grants NSC96-2321-B-002-008 and NSC100-2320-B-002-008 (to S.-C. L.), NSC99-2632-B-182-011-MY3, NSC101-2320-B-182-036-MY3, and NSC101-2321-B-182-009 (to B. C-M. T.), and grants from the Academia Sinica (to M.-D. T.) and the Institute of Biological Chemistry, Academia Sinica (to S.-C. L).; We thank Drs. Tso-Pang Yao for HDAC6 and Mitsuhiro Okamoto for SIK2 and GST-Syntide plasmids. We are indebted to Dr. Yeu-Kuang Hwu of Academia Sinica and the National Synchrotron Radiation Research Center for kindly providing a Jeol 2100F EM, to the Institute of Molecular Biology, Academia Sinica, for the FEI Tecnai G<SUP>2</SUP> EM service, and Hsiao-Hsuian Shen, Shu-Ping Tsai, Wen-Li Peng, Sue-Ping Lee, and Yi-Yun Chen for EM technical assistance. We appreciate Yi-Li Liu and I-Ching Huang for their technical expertise on DNA sequencing, supported in part by the Department of Medical Research, National Taiwan University Hospital.	Ahmed AA, 2010, CANCER CELL, V18, P109, DOI 10.1016/j.ccr.2010.06.018; Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Bricambert J, 2010, J CLIN INVEST, V120, P4316, DOI 10.1172/JCI41624; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Henriksson E, 2012, BIOCHEM J, V444, P503, DOI 10.1042/BJ20111932; Horike N, 2003, J BIOL CHEM, V278, P18440, DOI 10.1074/jbc.M211770200; Horike N, 2010, PIGM CELL MELANOMA R, V23, P809, DOI 10.1111/j.1755-148X.2010.00760.x; Huang JY, 2006, NUCLEIC ACIDS RES, V34, P2398, DOI 10.1093/nar/gkl241; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Knaevelsrud H, 2010, FEBS LETT, V584, P2635, DOI 10.1016/j.febslet.2010.04.041; Kumagai A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026148; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Lee IH, 2009, J BIOL CHEM, V284, P6322, DOI 10.1074/jbc.M807135200; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Liu Y, 2012, ENDOCRINOLOGY, V153, P223, DOI 10.1210/en.2011-1404; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Muraoka M, 2009, AM J PHYSIOL-ENDOC M, V296, pE1430, DOI 10.1152/ajpendo.00024.2009; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Rohn TT, 2008, BRAIN RES, V1228, P189, DOI 10.1016/j.brainres.2008.06.094; Sasaki T, 2011, NEURON, V69, P106, DOI 10.1016/j.neuron.2010.12.004; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Tsay YG, 2000, ANAL BIOCHEM, V287, P55, DOI 10.1006/abio.2000.4837; Wang IF, 2008, TRENDS MOL MED, V14, P479, DOI 10.1016/j.molmed.2008.09.001; Yi C, 2012, AUTOPHAGY, V8, P1529, DOI 10.4161/auto.21156; Yi C, 2012, SCIENCE, V336, P474, DOI 10.1126/science.1216990; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007	31	26	34	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6227	6237		10.1074/jbc.M112.431239	http://dx.doi.org/10.1074/jbc.M112.431239			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23322770	Green Published, hybrid			2022-12-25	WOS:000315820700018
J	Teo, AKK; Windmueller, R; Johansson, BB; Dirice, E; Njolstad, PR; Tjora, E; Raeder, H; Kulkarni, RN				Teo, Adrian K. K.; Windmueller, Rebecca; Johansson, Bente B.; Dirice, Ercument; Njolstad, Pal R.; Tjora, Erling; Raeder, Helge; Kulkarni, Rohit N.			Derivation of Human Induced Pluripotent Stem Cells from Patients with Maturity Onset Diabetes of the Young	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEFINED FACTORS	Maturity onset diabetes of the young (MODY) is an autosomal dominant disease. Despite extensive research, the mechanism by which a mutant MODY gene results in monogenic diabetes is not yet clear due to the inaccessibility of patient samples. Induced pluripotency and directed differentiation toward the pancreatic lineage are now viable and attractive methods to uncover the molecular mechanisms underlying MODY. Here we report, for the first time, the derivation of human induced pluripotent stem cells (hiPSCs) from patients with five types of MODY: MODY1 (HNF4A), MODY2 (GCK), MODY3 (HNF1A), MODY5 (HNF1B), and MODY8 (CEL) with a polycistronic lentiviral vector expressing a Cre-excisable human "stem cell cassette" containing the four reprogramming factors OCT4, KLF4, SOX2, and CMYC. These MODY-hiPSCs morphologically resemble human pluripotent stem cells (hPSCs), express pluripotency markers OCT4, SOX2, NANOG, SSEA-4, and TRA-1-60, give rise to derivatives of the three germ layers in a teratoma assay, and are karyotypically normal. Overall, our MODYhiPSCs serve as invaluable tools to dissect the role of MODY genes in the development of pancreas and islet cells and to evaluate their significance in regulating beta cell function. This knowledge will aid future attempts aimed at deriving functional mature beta cells from hPSCs.	[Teo, Adrian K. K.; Windmueller, Rebecca; Dirice, Ercument; Kulkarni, Rohit N.] Brigham & Womens Hosp, Dept Med, Joslin Diabet Ctr, Sect Islet Cell & Regenerat Biol, Boston, MA 02215 USA; [Teo, Adrian K. K.; Windmueller, Rebecca; Dirice, Ercument; Kulkarni, Rohit N.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Njolstad, Pal R.; Tjora, Erling; Raeder, Helge] Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway; [Johansson, Bente B.] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Johansson, Bente B.; Njolstad, Pal R.; Raeder, Helge] Univ Bergen, Dept Med 2, KG Jebsen Ctr Diabet Res, N-5021 Bergen, Norway	Harvard University; Brigham & Women's Hospital; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen	Kulkarni, RN (corresponding author), Brigham & Womens Hosp, Dept Med, Joslin Diabet Ctr, Sect Islet Cell & Regenerat Biol, 1 Joslin Pl, Boston, MA 02215 USA.	rohit.kulkarni@joslin.harvard.edu	Raeder, Helge/ABE-3601-2020; Raeder, Helge/AFQ-6279-2022; Dirice, Ercument/B-2825-2017; Johansson, Bente Berg/AAE-7666-2022; Teo, Adrian Kee Keong/A-4009-2013	Teo, Adrian Kee Keong/0000-0001-5901-7075; Johansson, Bente Berg/0000-0001-8893-1915; Dirice, Ercument/0000-0003-2792-7204	Harvard Stem Cell Institute [SG-0078-12-00]; National Institutes of Health [RO1 DK 67536]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067536] Funding Source: NIH RePORTER	Harvard Stem Cell Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by a grant from the Harvard Stem Cell Institute Agreement SG-0078-12-00 (to R.N.K.) and in part by National Institutes of Health Grant RO1 DK 67536 (to R.N.K.).	Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lombardo D, 2001, BBA-MOL CELL BIOL L, V1533, P1, DOI 10.1016/S1388-1981(01)00130-5; Maehr R, 2009, P NATL ACAD SCI USA, V106, P15768, DOI 10.1073/pnas.0906894106; Maestro MA, 2007, ENDOCR DEV, V12, P33, DOI 10.1159/000109603; Osbak KK, 2009, HUM MUTAT, V30, P1512, DOI 10.1002/humu.21110; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Park In-Hyun, 2009, Curr Protoc Stem Cell Biol, VChapter 4, DOI 10.1002/9780470151808.sc04a01s8; Sommer CA, 2010, STEM CELLS, V28, P64, DOI 10.1002/stem.255; Steck AK, 2011, CURR OPIN ENDOCRINOL, V18, P252, DOI 10.1097/MED.0b013e3283488275; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019	11	85	89	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5353	5356		10.1074/jbc.C112.428979	http://dx.doi.org/10.1074/jbc.C112.428979			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23306198	Green Published, hybrid			2022-12-25	WOS:000315342500009
J	Furukawa, H; Oka, S; Shimada, K; Sugii, S; Hashimoto, A; Komiya, A; Fukui, N; Nagai, T; Hirohata, S; Setoguchi, K; Okamoto, A; Chiba, N; Suematsu, E; Miyashita, T; Migita, K; Suda, A; Nagaoka, S; Tsuchiya, N; Tohma, S				Furukawa, Hiroshi; Oka, Shomi; Shimada, Kota; Sugii, Shoji; Hashimoto, Atsushi; Komiya, Akiko; Fukui, Naoshi; Nagai, Tatsuo; Hirohata, Shunsei; Setoguchi, Keigo; Okamoto, Akira; Chiba, Noriyuki; Suematsu, Eiichi; Miyashita, Taiichiro; Migita, Kiyoshi; Suda, Akiko; Nagaoka, Shouhei; Tsuchiya, Naoyuki; Tohma, Shigeto			Association of Increased Frequencies of HLA-DPB1*05:01 with the Presence of Anti-Ro/SS-A and Anti-La/SS-B Antibodies in Japanese Rheumatoid Arthritis and Systemic Lupus Erythematosus Patients	PLOS ONE			English	Article							PRIMARY SJOGRENS-SYNDROME; HLA CLASS-II; RO SSA ANTIBODIES; AUTOANTIBODY PRODUCTION; CLINICAL-SIGNIFICANCE; REVISED CRITERIA; CLASSIFICATION; EPITOPES; MARKER	Introduction: Autoantibodies to ribonucleoprotein are associated with a variety of autoimmune diseases, including rheumatoid arthritis (RA). Many studies on associations between human leukocyte antigen (HLA) alleles and RA have been reported, but few have been validated in RA subpopulations with anti-La/SS-B or anti-Ro/SS-A antibodies. Here, we investigated associations of HLA class II alleles with the presence of anti-Ro/SS-A or anti-La/SS-B antibodies in RA. Methods: An association study was conducted for HLA-DRB1, DQB1, and DPB1 in Japanese RA and systemic lupus erythematosus (SLE) patients that were positive or negative for anti-Ro/SS-A and/or anti-La/SS-B antibodies. Results: An increased prevalence of certain class II alleles was associated with the presence of anti-Ro/SS-A antibodies as follows:DRB1*08:03 (Pc = 3.79x10(-5), odds ratio [OR] 3.06, 95% confidence interval [CI] 1.98-4.73), DQB1*06:01 (Pc = 0.0106, OR 1.70, 95% CI 1.26-2.31), and DPB1*05:01 (Pc = 0.0040, OR 1.55, 95% CI 1.23-1.96). On the other hand, DRB1*15:01 (Pc = 0.0470, OR 3.14, 95% CI 1.63-6.05), DQB1*06:02 (Pc = 0.0252,OR 3.14, 95% CI 1.63-6.05), and DPB1*05:01 (Pc = 0.0069, OR 2.27, 95% CI 1.44-3.57) were associated with anti-La/SS-B antibodies. The DPB1*05:01 allele was associated with anti-Ro/SS-A (Pc = 0.0408, OR 1.69, 95% CI 1.19-2.41) and anti-La/SS-B antibodies (Pc = 2.48x10(-5), OR 3.31, 95% CI 2.02-5.43) in SLE patients. Conclusion: HLA-DPB1*05:01 was the only allele associated with the presence of both anti-Ro/SS-A and anti-La/SS-B antibodies in Japanese RA and SLE patients.	[Furukawa, Hiroshi; Oka, Shomi; Komiya, Akiko; Fukui, Naoshi; Tohma, Shigeto] Natl Hosp Org, Sagamihara Hosp, Clin Res Ctr Allergy & Rheumatol, Sagamihara, Kanagawa, Japan; [Shimada, Kota; Sugii, Shoji] Tokyo Metropolitan Tama Med Ctr, Dept Rheumatol, Fuchu, Tokyo, Japan; [Hashimoto, Atsushi] Natl Hosp Org, Sagamihara Hosp, Dept Rheumatol, Sagamihara, Kanagawa, Japan; [Nagai, Tatsuo; Hirohata, Shunsei] Kitasato Univ, Sch Med, Dept Rheumatol & Infect Dis, Sagamihara, Kanagawa 228, Japan; [Setoguchi, Keigo] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan; [Okamoto, Akira] Natl Hosp Org, Himeji Med Ctr, Dept Rheumatol, Himeji, Hyogo, Japan; [Chiba, Noriyuki] Natl Hosp Org, Morioka Hosp, Dept Rheumatol, Morioka, Iwate, Japan; [Suematsu, Eiichi] Natl Hosp Org, Kyushu Med Ctr, Clin Res Inst, Dept Internal Med & Rheumatol, Fukuoka, Japan; [Miyashita, Taiichiro; Migita, Kiyoshi] Natl Hosp Org, Nagasaki Med Ctr, Omura, Japan; [Suda, Akiko; Nagaoka, Shouhei] Yokohama Minami Kyosai Hosp, Dept Rheumatol, Yokohama, Kanagawa, Japan; [Tsuchiya, Naoyuki] Univ Tsukuba, Fac Med, Mol & Genet Epidemiol Lab, Tsukuba, Ibaraki, Japan	Kitasato University; Tokyo Metropolitan Cancer & Infectious Diseases Center Komagome Hospital; University of Tsukuba	Furukawa, H (corresponding author), Natl Hosp Org, Sagamihara Hosp, Clin Res Ctr Allergy & Rheumatol, Sagamihara, Kanagawa, Japan.	h-furukawa@sagamihara-hosp.gr.jp	Tsuchiya, Naoyuki/CAA-4545-2022	Tsuchiya, Naoyuki/0000-0002-6776-5580	Japan Society for the Promotion of Science, Health and Labour Science Research [22390199, 22591090, 24791018]; Ministry of Health, Labour, and Welfare of Japan; National Hospital Organization; Daiwa Securities Health Foundation; Japan Research Foundation for Clinical Pharmacology; Nakatomi Foundation; Takeda Science Foundation; Abbott Japan Co., Ltd.; Astellas Pharma Inc.; Chugai Pharmaceutical Co., Ltd.; Eisai Co., Ltd.; Mitsubishi Tanabe Pharma Corporation; Merck Sharp and Dohme Inc.; Pfizer Japan Inc.; Takeda Pharmaceutical Company Limited; Teijin Pharma Limited; Takeda Pharmaceutical Company; Astellas Pharma Inc.,; Hisamitsu Pharmaceutical Co., Inc.	Japan Society for the Promotion of Science, Health and Labour Science Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Hospital Organization; Daiwa Securities Health Foundation; Japan Research Foundation for Clinical Pharmacology; Nakatomi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Abbott Japan Co., Ltd.(Abbott Laboratories); Astellas Pharma Inc.(Astellas Pharmaceuticals); Chugai Pharmaceutical Co., Ltd.; Eisai Co., Ltd.(Eisai Co Ltd); Mitsubishi Tanabe Pharma Corporation(Mitsubishi Tanabe Pharma Corporation); Merck Sharp and Dohme Inc.(Merck & Company); Pfizer Japan Inc.(Pfizer); Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd); Teijin Pharma Limited(Teijin Pharma Limited); Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Astellas Pharma Inc.,(Astellas Pharmaceuticals); Hisamitsu Pharmaceutical Co., Inc.	This work was supported by Grants-in-Aid for Scientific Research (B, C) (22390199, 22591090) and for Young Scientists (24791018) from the Japan Society for the Promotion of Science, Health and Labour Science Research, Grants from the Ministry of Health, Labour, and Welfare of Japan, Grants-in-Aid for Clinical Research from National Hospital Organization, Research Grants from Daiwa Securities Health Foundation, Research Grants from Japan Research Foundation for Clinical Pharmacology, Research Grants from The Nakatomi Foundation, Research Grants from the Takeda Science Foundation, and research grants from pharmaceutical companies: Abbott Japan Co., Ltd., Astellas Pharma Inc., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Merck Sharp and Dohme Inc., Pfizer Japan Inc., Takeda Pharmaceutical Company Limited and Teijin Pharma Limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparing the manuscript.; HF has the following conflicts. The following funders are supported in whole or in part by the indicated pharmaceutical companies. The Japan Research Foundation for Clinical Pharmacology is run by Daiichi Sankyo, the Takeda Science Foundation is supported by an endowment from Takeda Pharmaceutical Company and the Nakatomi Foundation was established by Hisamitsu Pharmaceutical Co., Inc. The Daiwa Securities Health Foundation was established by Daiwa Securities Group Inc. ST was supported by research grants from nine pharmaceutical companies: Abbott Japan Co., Ltd., Astellas Pharma Inc., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Merck Sharp and Dohme Inc., Pfizer Japan Inc., Takeda Pharmaceutical Company Limited, and Teijin Pharma Limited. NT is supported by the Takeda Science Foundation, which is supported by an endowment from the Takeda Pharmaceutical Company. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The other authors declare no financial or commercial conflicts of interest.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; BOIRE G, 1993, J RHEUMATOL, V20, P1654; BOIRE G, 1988, J RHEUMATOL, V15, P391; Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; Furukawa H, 2012, ANN RHEUM D IN PRESS; Furukawa H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033133; Gottenberg JE, 2003, ARTHRITIS RHEUM, V48, P2240, DOI 10.1002/art.11103; Hernandez-Molina G, 2011, AUTOIMMUN REV, V10, P123, DOI 10.1016/j.autrev.2010.09.001; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; Kamada N, 2006, J DERMATOL, V33, P616, DOI 10.1111/j.1346-8138.2006.00142.x; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kominami S, 2009, J HUM GENET, V54, P108, DOI 10.1038/jhg.2008.15; Lewis SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027175; Lyons PA, 2012, NEW ENGL J MED, V367, P214, DOI 10.1056/NEJMoa1108735; McCormack M, 2011, NEW ENGL J MED, V364, P1134, DOI 10.1056/NEJMoa1013297; Miyagawa S, 1998, ARTHRITIS RHEUM-US, V41, P927, DOI 10.1002/1529-0131(199805)41:5<927::AID-ART21>3.0.CO;2-R; Noguchi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002170; Oka S, 2012, TISSUE ANTIGENS, V80, P386, DOI 10.1111/j.1399-0039.2012.01921.x; Perricone C, 2011, AUTOIMMUN REV, V10, P599, DOI 10.1016/j.autrev.2011.04.021; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Reveille John D., 1998, Current Opinion in Rheumatology, V10, P187, DOI 10.1097/00002281-199805000-00007; Rischmueller M, 1998, CLIN EXP IMMUNOL, V111, P365; Schneeberger E, 2008, CLIN RHEUMATOL, V27, P517, DOI 10.1007/s10067-007-0812-x; Scott IC, 2011, BEST PRACT RES CL RH, V25, P447, DOI 10.1016/j.berh.2011.10.010; Tishler M, 1997, RHEUMATOL INT, V17, P133, DOI 10.1007/s002960050023; TISHLER M, 1994, J RHEUMATOL, V21, P1040; TISHLER M, 1992, J RHEUMATOL, V19, P234; Tsuboi H, 2010, CLIN EXP IMMUNOL, V162, P53, DOI 10.1111/j.1365-2249.2010.04188.x; Tzioufas AG, 2002, ANN RHEUM DIS, V61, P398, DOI 10.1136/ard.61.5.398	30	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53910	10.1371/journal.pone.0053910	http://dx.doi.org/10.1371/journal.pone.0053910			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320107	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429800072
J	Iuso, D; Czernik, M; Di Egidio, F; Sampino, S; Zacchini, F; Bochenek, M; Smorag, Z; Modlinski, JA; Ptak, G; Loi, P				Iuso, Domenico; Czernik, Marta; Di Egidio, Fiorella; Sampino, Silvestre; Zacchini, Federica; Bochenek, Michal; Smorag, Zdzislaw; Modlinski, Jacek A.; Ptak, Grazyna; Loi, Pasqualino			Genomic Stability of Lyophilized Sheep Somatic Cells before and after Nuclear Transfer	PLOS ONE			English	Article							DESICCATION TOLERANCE; FREEZE TOLERANCE; DNA; SURVIVAL; EMBRYOS; REPAIR; DAMAGE	The unprecedented decline of biodiversity worldwide is urging scientists to collect and store biological material from seriously threatened animals, including large mammals. Lyophilization is being explored as a low-cost system for storage in bio-banks of cells that might be used to expand or restore endangered or extinct species through the procedure of Somatic Cell Nuclear Transfer (SCNT). Here we report that the genome is intact in about 60% of lyophylized sheep lymphocytes, whereas DNA damage occurs randomly in the remaining 40%. Remarkably, lyophilized nuclei injected into enucleated oocytes are repaired by a robust DNA repairing activity of the oocytes, and show normal developmental competence. Cloned embryos derived from lyophylized cells exhibited chromosome and cellular composition comparable to those of embryos derived from fresh donor cells. These findings support the feasibility of lyophylization as a storage procedure of mammalian cells to be used for SCNT.	[Iuso, Domenico; Czernik, Marta; Di Egidio, Fiorella; Sampino, Silvestre; Zacchini, Federica; Ptak, Grazyna; Loi, Pasqualino] Univ Teramo, Dept Comparat Biomed Sci, Teramo, Italy; [Bochenek, Michal; Smorag, Zdzislaw] Natl Res Inst Anim Prod, Balice, Poland; [Modlinski, Jacek A.] Polish Acad Sci, Inst Genet & Anim Breeding, Dept Expt Embryol, Jastrzebiec, Poland	University of Teramo; National Research Institute of Animal Production; Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences	Ptak, G (corresponding author), Univ Teramo, Dept Comparat Biomed Sci, Teramo, Italy.	gptak@unite.it; ploi@unite.it	Zacchini, Federica/GQY-5276-2022; Sampino, Silvestre/K-5033-2012	Zacchini, Federica/0000-0001-7942-2625; Sampino, Silvestre/0000-0001-8266-5062; CZERNIK, Marta Teresa/0000-0002-4535-4932; Iuso, Domenico/0000-0001-5946-2793; Ptak, Grazyna/0000-0003-1437-4698	European Research Council under the European Community [210103]; GP: PRIN [2007MY2M92]; EU FP7-KBBE-2009-3 Programme [244356]; NextGen; PRIN MIUR [2009JE3CHM]; Bank Foundation Tercas (Teramo, Italy)	European Research Council under the European Community(European Research Council (ERC)); GP: PRIN; EU FP7-KBBE-2009-3 Programme; NextGen; PRIN MIUR(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Bank Foundation Tercas (Teramo, Italy)	The research leading to these results received funding from the European Research Council under the European Community Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no 210103; GP: PRIN 2007, no 2007MY2M92 to GP. PL acknowledges the support of the EU FP7-KBBE-2009-3 Programme, project no 244356, NextGen, and PRIN MIUR funding (protocol no 2009JE3CHM). Funds from the Bank Foundation Tercas (Teramo, Italy) are also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker JP, 2004, LIFE IN THE FROZEN STATE, P563, DOI 10.1201/9780203647073.ch20; Baatout S, 2007, IN VIVO, V21, P571; BLACKMAN SA, 1991, PLANT PHYSIOL, V96, P868, DOI 10.1104/pp.96.3.868; Buchanan SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012518; Buitink J, 2004, CRYOBIOLOGY, V48, P215, DOI 10.1016/j.cryobiol.2004.02.011; COLLAS P, 1991, BIOL REPROD, V45, P455, DOI 10.1095/biolreprod45.3.455; COSTANZO JP, 1993, J EXP BIOL, V181, P245; Crowe JH, 2005, INTEGR COMP BIOL, V45, P810, DOI 10.1093/icb/45.5.810; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; Dutta R, 2011, THERIOGENOLOGY, V76, P851, DOI 10.1016/j.theriogenology.2011.03.025; Franklin Rosalind E, 2003, Nature, V421, P400; Guo N, 2000, NAT BIOTECHNOL, V18, P168, DOI 10.1038/72616; Hand SC, 2011, ANNU REV PHYSIOL, V73, P115, DOI 10.1146/annurev-physiol-012110-142203; KEILIN D, 1959, PROC R SOC SER B-BIO, V150, P149, DOI 10.1098/rspb.1959.0013; LEHMAN CW, 1993, MOL CELL BIOL, V13, P6897, DOI 10.1128/MCB.13.11.6897; Leibo SP, 2011, FERTIL STERIL, V96, P269, DOI 10.1016/j.fertnstert.2011.06.065; Loi P, 2011, THERIOGENOLOGY, V76, P217, DOI 10.1016/j.theriogenology.2011.01.016; Loi P, 2002, BIOL REPROD, V67, P126, DOI 10.1095/biolreprod67.1.126; Loi P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002978; Menezo Y, 2007, J ASSIST REPROD GEN, V24, P513, DOI 10.1007/s10815-007-9167-0; Miyamoto K, 2011, GENE DEV, V25, P946, DOI 10.1101/gad.615211; Mu XF, 2011, BIOL REPROD, V85, P524, DOI 10.1095/biolreprod.110.089334; Muriel L, 2004, MOL HUM REPROD, V10, P203, DOI 10.1093/molehr/gah029; Natan D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005240; Ono T, 2008, J REPROD DEVELOP, V54, P486, DOI 10.1262/jrd.20112; Podhorecka M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/920161; Resch GP, 2002, J STRUCT BIOL, V137, P305, DOI 10.1016/S1047-8477(02)00005-9; REY L, 1975, PROC R SOC SER B-BIO, V191, P9, DOI 10.1098/rspb.1975.0110; Ryder OA, 2000, SCIENCE, V288, P275, DOI 10.1126/science.288.5464.275; Sakkas D, 2010, FERTIL STERIL, V93, P1027, DOI 10.1016/j.fertnstert.2009.10.046; SCHMID WD, 1982, SCIENCE, V215, P697, DOI 10.1126/science.7058335; SMALL JV, 1994, J STRUCT BIOL, V113, P135, DOI 10.1006/jsbi.1994.1043; STOREY KB, 1988, PHYSIOL REV, V68, P27, DOI 10.1152/physrev.1988.68.1.27; T'Joen V, 2012, STEM CELLS DEV, V21, P721, DOI 10.1089/scd.2011.0192; The Practice Committee of the American Society for reproduction Medicine, 2008, FERTIL STERIL, V86, P35; Turinetto V, 2012, STEM CELLS, V30, P1414, DOI 10.1002/stem.1133; Wang W, 2000, INT J PHARMACEUT, V203, P1, DOI 10.1016/S0378-5173(00)00423-3; Weinstein R, 1995, TRANSFUS CLIN BIOL, V2, P427, DOI 10.1016/S1246-7820(05)80067-9; Welnicz W, 2011, J INSECT PHYSIOL, V57, P577, DOI 10.1016/j.jinsphys.2011.03.019; Wessman P, 2011, J SCI FOOD AGR, V91, P2518, DOI 10.1002/jsfa.4343; Whelan DR, 2001, NUCLEIC ACIDS RES, V39, P5439; Wossidlo M, 2010, EMBO J, V29, P1877, DOI 10.1038/emboj.2010.80	42	15	15	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e51317	10.1371/journal.pone.0051317	http://dx.doi.org/10.1371/journal.pone.0051317			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308098	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429800007
J	Gelman, JS; Sironi, J; Berezniuk, I; Dasgupta, S; Castro, LM; Gozzo, FC; Ferro, ES; Fricker, LD				Gelman, Julia S.; Sironi, Juan; Berezniuk, Iryna; Dasgupta, Sayani; Castro, Leandro M.; Gozzo, Fabio C.; Ferro, Emer S.; Fricker, Lloyd D.			Alterations of the Intracellular Peptidome in Response to the Proteasome Inhibitor Bortezomib	PLOS ONE			English	Article							THIMET OLIGOPEPTIDASE; PROTEIN INTERACTIONS; NATURAL REGULATORS; MASS-SPECTROMETRY; MULTIPLE-MYELOMA; CELLS; SPECIFICITY; DEGRADATION; IDENTIFICATION; SELECTIVITY	Bortezomib is an antitumor drug that competitively inhibits proteasome beta-1 and beta-5 subunits. While the impact of bortezomib on protein stability is known, the effect of this drug on intracellular peptides has not been previously explored. A quantitative peptidomics technique was used to examine the effect of treating human embryonic kidney 293T (HEK293T) cells with 5-500 nM bortezomib for various lengths of time (30 minutes to 16 hours), and human neuroblastoma SH-SY5Y cells with 500 nM bortezomib for 1 hour. Although bortezomib treatment decreased the levels of some intracellular peptides, the majority of peptides were increased by 50-500 nM bortezomib. Peptides requiring cleavage at acidic and hydrophobic sites, which involve beta-1 and -5 proteasome subunits, were among those elevated by bortezomib. In contrast, the proteasome inhibitor epoxomicin caused a decrease in the levels of many of these peptides. Although bortezomib can induce autophagy under certain conditions, the rapid bortezomib-mediated increase in peptide levels did not correlate with the induction of autophagy. Taken together, the present data indicate that bortezomib alters the balance of intracellular peptides, which may contribute to the biological effects of this drug.	[Gelman, Julia S.; Sironi, Juan; Berezniuk, Iryna; Dasgupta, Sayani; Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [Gelman, Julia S.; Berezniuk, Iryna; Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA; [Castro, Leandro M.; Ferro, Emer S.] Univ Sao Paulo, Dept Cell Biol & Dev, Sao Paulo, Brazil; [Gozzo, Fabio C.] Univ Estadual Campinas, Inst Chem, Sao Paulo, Brazil	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Universidade de Sao Paulo; Universidade Estadual de Campinas	Fricker, LD (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA.	Lloyd.fricker@einstein.yu.edu	Castro, Leandro M/E-5654-2014; Castro, Leandro/ABI-5520-2020; Gozzo, Fabio/F-8123-2010; Castro, Leandro/O-6762-2019; Ferro, Emer S/D-3908-2012	Castro, Leandro/0000-0002-7156-2006; Castro, Leandro/0000-0002-7156-2006; Ferro, Emer S/0000-0003-1651-9192; Dasgupta, Sayani/0000-0003-4782-7956	National Institutes of Health [R01 DA-004494]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [559698/2009-7]; University of Sao Paulo [2011.1.9333.1.3]; CNPq; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); University of Sao Paulo; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was primarily supported by National Institutes of Health grant R01 DA-004494 (L. D. F.), and by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; grant 559698/2009-7, Rede GENOPROT) and partially supported by the University of Sao Paulo (grants 2011.1.9333.1.3, NAPNA). LMC, FCG and ESF are fellowship recipients from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 1999, CANCER RES, V59, P2615; Adams J, 2002, CURR OPIN CHEM BIOL, V6, P493, DOI 10.1016/S1367-5931(02)00343-5; Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Arastu-Kapur S, 2011, CLIN CANCER RES, V17, P2734, DOI 10.1158/1078-0432.CCR-10-1950; Arkin MR, 2009, CURR OPIN CHEM BIOL, V13, P284, DOI 10.1016/j.cbpa.2009.05.125; Baggerman G, 2002, J BIOL CHEM, V277, P40368, DOI 10.1074/jbc.M206257200; BARRETT AJ, 1995, METHOD ENZYMOL, V248, P529; Berkers CR, 2005, NAT METHODS, V2, P357, DOI 10.1038/nmeth759; Berti DA, 2012, PROTEOMICS, V12, P2668, DOI 10.1002/pmic.201200051; Berti DA, 2009, J BIOL CHEM, V284, P14105, DOI 10.1074/jbc.M807916200; Chauhan D, 2005, CANCER CELL, V8, P407, DOI 10.1016/j.ccr.2005.10.013; Che FY, 2007, J PROTEOME RES, V6, P4667, DOI 10.1021/pr060690r; Che FY, 2005, J MASS SPECTROM, V40, P238, DOI 10.1002/jms.743; Crawford LJA, 2006, CANCER RES, V66, P6379, DOI 10.1158/0008-5472.CAN-06-0605; Cunha FM, 2008, J BIOL CHEM, V283, P24448, DOI 10.1074/jbc.M801252200; DENAULT JB, 2002, CURR PROTOC PROTEIN, pCH21; Ferro ES, 2004, J NEUROCHEM, V91, P769, DOI 10.1111/j.1471-4159.2004.02757.x; Fontanini A, 2009, J BIOL CHEM, V284, P8369, DOI 10.1074/jbc.M806113200; Fricker LD, 2006, MASS SPECTROM REV, V25, P327, DOI 10.1002/mas.20079; Fricker LD, 2012, J PROTEOME RES, V11, P1981, DOI 10.1021/pr2012076; Fricker LD, 2010, MOL BIOSYST, V6, P1355, DOI 10.1039/c003317k; Gass J, 2007, CELL MOL LIFE SCI, V64, P345, DOI 10.1007/s00018-006-6317-y; Gelman JS, 2011, J PROTEOME RES, V10, P1583, DOI 10.1021/pr100952f; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Grasso G, 2009, JMASS SPECTROM; Groll M, 2000, J AM CHEM SOC, V122, P1237, DOI 10.1021/ja993588m; Gucinski AC, 2010, METHODS MOL BIOL, V604, P73, DOI 10.1007/978-1-60761-444-9_6; Harada M, 2008, HEPATOLOGY, V47, P2026, DOI 10.1002/hep.22294; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; Kessler JH, 2011, NAT IMMUNOL, V12, P45, DOI 10.1038/ni.1974; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Kondo T, 2010, SCIENCE, V329, P336, DOI 10.1126/science.1188158; Kravtsova-Ivantsiv Y, 2009, MOL CELL, V33, P496, DOI 10.1016/j.molcel.2009.01.023; Li CY, 2010, J BIOL CHEM, V285, P16096, DOI 10.1074/jbc.M109.072694; Lightcap ES, 2000, CLIN CHEM, V46, P673; Lioni M, 2008, MOL CANCER THER, V7, P2866, DOI 10.1158/1535-7163.MCT-08-0391; Matsui M, 2006, BIOL CHEM, V387, P1535, DOI 10.1515/BC.2006.191; Milani M, 2009, CANCER RES, V69, P4415, DOI 10.1158/0008-5472.CAN-08-2839; Moore HE, 2009, MOL CANCER THER, V8, P762, DOI 10.1158/1535-7163.MCT-08-0735; Morano C, 2008, ANAL CHEM, V80, P9298, DOI 10.1021/ac801654h; Moravec RA, 2009, ANAL BIOCHEM, V387, P294, DOI 10.1016/j.ab.2009.01.016; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nickeleit I, 2008, CANCER CELL, V14, P23, DOI 10.1016/j.ccr.2008.05.016; ORLOWSKI M, 1989, BIOCHEM J, V261, P951, DOI 10.1042/bj2610951; Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3; Rioli V, 1998, BIOCHEM BIOPH RES CO, V250, P5, DOI 10.1006/bbrc.1998.8941; Rubakhin SS, 2006, ANAL CHEM, V78, P7267, DOI 10.1021/ac0607010; Rubinstein M, 2009, BIOPOLYMERS, V91, P505, DOI 10.1002/bip.21164; Russo LC, 2012, PROTEOMICS, V12, P2641, DOI 10.1002/pmic.201200032; Saric T, 2004, J BIOL CHEM, V279, P46723, DOI 10.1074/jbc.M406537200; Schulz-Knappe P, 2001, COMB CHEM HIGH T SCR, V4, P207; Svensson M, 2003, J PROTEOME RES, V2, P213, DOI 10.1021/pr020010u; Terpos E, 2008, EXPERT OPIN DRUG MET, V4, P639, DOI [10.1517/17425255.4.5.639, 10.1517/17425255.4.5.639 ]; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Utecht KN, 2008, AM J HEALTH-SYST PH, V65, P1221, DOI 10.2146/ajhp070272; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Zhang X, 2008, J NEUROCHEM, V107, P1596, DOI 10.1111/j.1471-4159.2008.05722.x	58	59	62	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53263	10.1371/journal.pone.0053263	http://dx.doi.org/10.1371/journal.pone.0053263			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308178	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429100047
J	Yeoh, CC; Balcerowicz, M; Zhang, LL; Jaudal, M; Brocard, L; Ratet, P; Putterill, J				Yeoh, Chin Chin; Balcerowicz, Martin; Zhang, Lulu; Jaudal, Mauren; Brocard, Lysiane; Ratet, Pascal; Putterill, Joanna			Fine Mapping Links the FTa1 Flowering Time Regulator to the Dominant Spring1 Locus in Medicago	PLOS ONE			English	Article							GENETIC-CONTROL; T HOMOLOG; ARABIDOPSIS; TRUNCATULA; PEA; GENOME; FLORIGEN; ROLES	To extend our understanding of flowering time control in eudicots, we screened for mutants in the model legume Medicago truncatula (Medicago). We identified an early flowering mutant, spring1, in a T-DNA mutant screen, but spring1 was not tagged and was deemed a somaclonal mutant. We backcrossed the mutant to wild type R108. The F1 plants and the majority of F2 plants were early flowering like spring1, strongly indicating that spring1 conferred monogenic, dominant early flowering. We hypothesized that the spring1 phenotype resulted from over expression of an activator of flowering. Previously, a major QTL for flowering time in different Medicago accessions was located to an interval on chromosome 7 with six candidate flowering-time activators, including a CONSTANS gene, MtCO, and three FLOWERING LOCUS T (FT) genes. Hence we embarked upon linkage mapping using 29 markers from the MtCO/FT region on chromosome 7 on two populations developed by crossing spring1 with Jester. Spring1 mapped to an interval of similar to 0.5 Mb on chromosome 7 that excluded MtCO, but contained 78 genes, including the three FT genes. Of these FT genes, only FTa1 was up-regulated in spring1 plants. We then investigated global gene expression in spring1 and R108 by microarray analysis. Overall, they had highly similar gene expression and apart from FTa1, no genes in the mapping interval were differentially expressed. Two MADS transcription factor genes, FRUITFULLb (FULb) and SUPPRESSOR OF OVER EXPRESSION OF CONSTANS1a (SOC1a), that were up-regulated in spring1, were also up-regulated in transgenic Medicago over-expressing FTa1. This suggested that their differential expression in spring1 resulted from the increased abundance of FTa1. A 6255 bp genomic FTa1 fragment, including the complete 5' region, was sequenced, but no changes were observed indicating that the spring1 mutation is not a DNA sequence difference in the FTa1 promoter or introns.	[Yeoh, Chin Chin; Balcerowicz, Martin; Zhang, Lulu; Jaudal, Mauren; Putterill, Joanna] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Brocard, Lysiane; Ratet, Pascal] CNRS, Inst Sci Vegetal, Gif Sur Yvette, France	University of Auckland; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Putterill, J (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.	J.Putterill@auckland.ac.nz	Ratet, Pascal/GPP-3654-2022; Balcerowicz, Martin/AAF-9638-2020	Ratet, Pascal/0000-0002-8621-1495; Balcerowicz, Martin/0000-0001-9462-4436; Jaudal, Mauren/0000-0002-5760-2497; Brocard, Lysiane/0000-0002-9397-1660	New Zealand Foundation for Research Science and Technology [C10X0816 MeriNET, C10X0704]; New Zealand Marsden Fund [10-UOA-200]	New Zealand Foundation for Research Science and Technology(New Zealand Foundation for Research, Science and Technology); New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	The research was funded by the New Zealand Foundation for Research Science and Technology (www.msi.govt.nz/) contract numbers C10X0816 MeriNET and C10X0704 and by the New Zealand Marsden Fund (www.royalsociety.org.nz/programmes/funds/marsden/) contract 10-UOA-200. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amasino RM, 2010, PLANT PHYSIOL, V154, P516, DOI 10.1104/pp.110.161653; Brocard L, 2006, CAB REV, P23; Chabaud M., 2008, HDB NEW TECHNOLOGIES, P45; Chabaud M., 2006, MEDICAGO TRUNCATULA; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Gibeaut DM, 1997, PLANT PHYSIOL, V115, P317, DOI 10.1104/pp.115.2.317; Graham PH, 2003, PLANT PHYSIOL, V131, P872, DOI 10.1104/pp.017004; Greenup A, 2009, ANN BOT-LONDON, V103, P1165, DOI 10.1093/aob/mcp063; Hecht V, 2005, PLANT PHYSIOL, V137, P1420, DOI 10.1104/pp.104.057018; Hecht V, 2007, PLANT PHYSIOL, V144, P648, DOI 10.1104/pp.107.096818; Hecht V, 2011, PLANT CELL, V23, P147, DOI 10.1105/tpc.110.081042; Higgins JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010065; Hill J.R., 2000, PLANT VARIETIES J, V13, P40; Julier B, 2007, THEOR APPL GENET, V114, P1391, DOI 10.1007/s00122-007-0525-1; Espinoza LDL, 2012, THEOR APPL GENET, V124, P739, DOI 10.1007/s00122-011-1743-0; Laurie RE, 2011, PLANT PHYSIOL, V156, P2207, DOI 10.1104/pp.111.180182; Liew LC, 2009, PLANT CELL, V21, P3198, DOI 10.1105/tpc.109.067223; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Mun JH, 2006, GENETICS, V172, P2541, DOI 10.1534/genetics.105.054791; Ovchinnikova E, 2011, MOL PLANT MICROBE IN, V24, P1333, DOI 10.1094/MPMI-01-11-0013; Pierre JB, 2008, THEOR APPL GENET, V117, P609, DOI 10.1007/s00122-008-0805-4; Pierre JB, 2011, MOL BREEDING, V28, P25, DOI 10.1007/s11032-010-9457-6; Putterill J, 2004, BIOESSAYS, V26, P363, DOI 10.1002/bies.20021; Rakocevic A, 2009, PLANT PHYSIOL, V151, P1250, DOI 10.1104/pp.109.138024; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Scholte M, 2002, MOL BREEDING, V10, P203, DOI 10.1023/A:1020564612093; Shalit A, 2009, P NATL ACAD SCI USA, V106, P8392, DOI 10.1073/pnas.0810810106; Simon R, 1996, SEMIN CELL DEV BIOL, V7, P419, DOI 10.1006/scdb.1996.0052; Smykal P, 2009, HEREDITY, V103, P157, DOI 10.1038/hdy.2009.45; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; Tadege M, 2009, PLANT PHYSIOL, V151, P978, DOI 10.1104/pp.109.144097; Teper-Bamnolker P, 2005, PLANT CELL, V17, P2661, DOI 10.1105/tpc.105.035766; Trinh TH, 1998, PLANT CELL REP, V17, P345, DOI 10.1007/s002990050405; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Turnbull C, 2011, J EXP BOT, V62, P4399, DOI 10.1093/jxb/err191; Weller JL, 2009, J EXP BOT, V60, P2493, DOI 10.1093/jxb/erp120; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yeoh CC, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-36; Yoo SK, 2005, PLANT PHYSIOL, V139, P770, DOI 10.1104/pp.105.066928; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625	41	25	25	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53467	10.1371/journal.pone.0053467	http://dx.doi.org/10.1371/journal.pone.0053467			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308229	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429100072
J	Birky, CW				Birky, C. William, Jr.			Species Detection and Identification in Sexual Organisms Using Population Genetic Theory and DNA Sequences	PLOS ONE			English	Article							DELIMITATION; SELECTION; CORVUS	Phylogenetic trees of DNA sequences of a group of specimens may include clades of two kinds: those produced by stochastic processes (random genetic drift) within a species, and clades that represent different species. The ratio of the mean pairwise sequence difference between a pair of clades (K) to the mean pairwise sequence difference within a clade (theta) can be used to determine whether the clades are samples from different species (K/theta >= 4) or the same species (K/theta<4) with probability >= 0.95. Previously I applied this criterion to delimit species of asexual organisms. Here I use data from the literature to show how it can also be applied to delimit sexual species using four groups of sexual organisms as examples: ravens, spotted leopards, sea butterflies, and liverworts. Mitochondrial or chloroplast genes are used because these segregate earlier during speciation than most nuclear genes and hence detect earlier stages of speciation. In several cases the K/theta ratio was greater than 4, confirming the original authors' intuition that the clades were sufficiently different to be assigned to different species. But the K/theta ratio split each of two liverwort species into two evolutionary species, and showed that support for the distinction between the common and Chihuahuan raven species is weak. I also discuss some possible sources of error in using the K/theta ratio; the most significant one would be cases where males migrate between different populations but females do not, making the use of maternally inherited organelle genes problematic. The K/theta ratio must be used with some caution, like all other methods for species delimitation. Nevertheless, it is a simple theory-based quantitative method for using DNA sequences to make rigorous decisions about species delimitation in sexual as well as asexual eukaryotes.	Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	University of Arizona	Birky, CW (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	birky@u.arizona.edu						Avise J.C., 1990, Oxford Surveys in Evolutionary Biology, V7, P45; Avise John C., 1994, pi; Birky CW, 2008, CURR BIOL, V18, pR692, DOI 10.1016/j.cub.2008.06.049; Birky CW, 2011, ZOOL J LINN SOC-LOND, V161, P723, DOI 10.1111/j.1096-3642.2010.00674.x; Birky CW, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P201, DOI 10.1007/978-90-481-2770-2_10; Birky CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010609; Birky CW, 2005, HYDROBIOLOGIA, V546, P29, DOI 10.1007/s10750-005-4097-2; BIRKY CW, 1991, EVOLUTION AT THE MOLECULAR LEVEL, P112; Buckley-Beason VA, 2006, CURR BIOL, V16, P2371, DOI 10.1016/j.cub.2006.08.066; Carnargo A, 2012, EVOLUTION, V66-9, P2834; Cook LG, 2010, INVERTEBR SYST, V24, P322, DOI 10.1071/IS10011; Coyne JA, 2004, SPECIATION, V37; Darwin G., 1871, P423; Darwin C., 1872, ORIGIN SPECIES MEANS, V144, P971; Ence DD, 2011, MOL ECOL RESOUR, V11, P473, DOI 10.1111/j.1755-0998.2010.02947.x; Feldman CR, 2005, ZOOL SCR, V34, P145, DOI 10.1111/j.1463-6409.2005.00182.x; Grassman LI, 2005, J MAMMAL, V86, P29, DOI 10.1644/1545-1542(2005)086&lt;0029:EOTSFI&gt;2.0.CO;2; Hausdorf B, 2010, SYST BIOL, V59, P491, DOI 10.1093/sysbio/syq039; Hedrick PW, 2007, EVOLUTION, V61, P2750, DOI 10.1111/j.1558-5646.2007.00250.x; HEINRICH B, 1994, CONDOR, V96, P545, DOI 10.2307/1369334; Heinrichs J, 2010, MOL PHYLOGENET EVOL, V56, P1105, DOI 10.1016/j.ympev.2010.05.004; Huelsenbeck JP, 2011, EVOL BIOINFORM, V7, P55, DOI 10.4137/EBO.S6761; Hunt Brian, 2010, PLoS ONE, V5, P1, DOI 10.1371/journal.pone.0009835; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Lim GS, 2012, SYST BIOL, V61, P165, DOI 10.1093/sysbio/syr030; Maddison WP, 2001, MACCLADE 4 ANAL PHYL; Marrone F, 2010, HYDROBIOLOGIA, V644, P115, DOI 10.1007/s10750-010-0101-6; May RM, 2009, SCIENCE, V323, P687, DOI 10.1126/science.1170937; MYERS GS, 1952, SYST ZOOL, V1, P106, DOI 10.2307/2411812; Nei M., 2000, MOL EVOLUTION PHYLOG; O'Meara BC, 2010, SYST BIOL, V59, P59, DOI 10.1093/sysbio/syp077; Omland KE, 2006, MOL ECOL, V15, P795, DOI 10.1111/j.1365-294X.2005.02827.x; Omland KE, 2000, P ROY SOC B-BIOL SCI, V267, P2475, DOI 10.1098/rspb.2000.1308; Osada N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025549; Pacak A, 2003, J MOL EVOL, V56, P11, DOI 10.1007/s00239-002-2375-4; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rodrigo A, 2008, PHILOS T R SOC B, V363, P3893, DOI 10.1098/rstb.2008.0173; Rosenberg NA, 2003, EVOLUTION, V57, P1465, DOI 10.1554/03-012; Schon I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039844; SIMPSON GEORGE GAYLORD, 1961; SIMPSON GG, 1951, EVOLUTION, V5, P285, DOI 10.2307/2405675; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tang CQ, 2012, P NATL ACAD SCI USA, V109, P16208, DOI 10.1073/pnas.1209160109	45	53	54	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e52544	10.1371/journal.pone.0052544	http://dx.doi.org/10.1371/journal.pone.0052544			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308113	Green Published, gold, Green Submitted			2022-12-25	WOS:000313670100010
J	Friedrich, RM; Friederici, AD				Friedrich, Roland M.; Friederici, Angela D.			Mathematical Logic in the Human Brain: Semantics	PLOS ONE			English	Article							LATERAL PREFRONTAL CORTEX; COGNITIVE CONTROL; WORKING-MEMORY; PARIETAL CORTEX; ORGANIZATION; INFORMATION; REPRESENTATION; INTEGRATION; ACTIVATION; RETRIEVAL	As a higher cognitive function in humans, mathematics is supported by parietal and prefrontal brain regions. Here, we give an integrative account of the role of the different brain systems in processing the semantics of mathematical logic from the perspective of macroscopic polysynaptic networks. By comparing algebraic and arithmetic expressions of identical underlying structure, we show how the different subparts of a fronto-parietal network are modulated by the semantic domain, over which the mathematical formulae are interpreted. Within this network, the prefrontal cortex represents a system that hosts three major components, namely, control, arithmetic-logic, and short-term memory. This prefrontal system operates on data fed to it by two other systems: a premotor-parietal top-down system that updates and transforms (external) data into an internal format, and a hippocampal bottom-up system that either detects novel information or serves as an access device to memory for previously acquired knowledge.	[Friedrich, Roland M.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Friedrich, Roland M.; Friederici, Angela D.] Humboldt Univ, Inst Math, D-10099 Berlin, Germany	Max Planck Society; Humboldt University of Berlin	Friedrich, RM (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	rolandf@mathematik.hu-berlin.de	Nishihara, Gregory N/GNM-5370-2022; Nishihara, Greg/H-6808-2019; Manda, Atsuyoshi/AAH-1228-2021	Nishihara, Gregory N/0000-0003-2543-1301; Nishihara, Greg/0000-0003-2543-1301; Manda, Atsuyoshi/0000-0001-7065-7751	Max Planck Institute for Human Cognitive and Brain Sciences	Max Planck Institute for Human Cognitive and Brain Sciences	The work was funded by Max Planck Institute for Human Cognitive and Brain Sciences, www.cbs.mpg.de/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Aminoff E, 2007, CEREB CORTEX, V17, P1493, DOI 10.1093/cercor/bhl078; Anderson JR, 2008, TRENDS COGN SCI, V12, P136, DOI 10.1016/j.tics.2008.01.006; Ansari D, 2008, NAT REV NEUROSCI, V9, P278, DOI 10.1038/nrn2334; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Badre D, 2005, NEURON, V47, P907, DOI 10.1016/j.neuron.2005.07.023; Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; Badre D, 2009, NAT REV NEUROSCI, V10, P659, DOI 10.1038/nrn2667; Bledowski C, 2009, J NEUROSCI, V29, P13735, DOI 10.1523/JNEUROSCI.2547-09.2009; Brass M, 2005, TRENDS COGN SCI, V9, P314, DOI 10.1016/j.tics.2005.05.001; Butterworth B, 2005, J CHILD PSYCHOL PSYC, V46, P3, DOI 10.1111/j.1469-7610.2004.00374.x; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; Caplan D, 1999, BEHAV BRAIN SCI, V22, P77; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cusack R, 2010, J COGNITIVE NEUROSCI, V22, P32, DOI 10.1162/jocn.2009.21194; De Pisapia N, 2007, CEREB CORTEX, V17, P993, DOI 10.1093/cercor/bhl010; Dehaene S, 2004, CURR OPIN NEUROBIOL, V14, P218, DOI 10.1016/j.conb.2004.03.008; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; Desrochers TM, 2012, TRENDS COGN SCI, V16, P407, DOI 10.1016/j.tics.2012.06.009; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Fiebach CJ, 2005, HUM BRAIN MAPP, V24, P79, DOI 10.1002/hbm.20070; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Friedrich R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005599; Goel V, 2007, TRENDS COGN SCI, V11, P435, DOI 10.1016/j.tics.2007.09.003; Gruber O, 2003, NEUROIMAGE, V19, P797, DOI 10.1016/S1053-8119(03)00089-2; Hanakawa T, 2002, CEREB CORTEX, V12, P1157, DOI 10.1093/cercor/12.11.1157; Jubault T, 2007, J NEUROSCI, V27, P11028, DOI 10.1523/JNEUROSCI.1986-07.2007; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Kouneiher F, 2009, NAT NEUROSCI, V12, P939, DOI 10.1038/nn.2321; Lohmann G, 2001, COMPUT MED IMAG GRAP, V25, P449, DOI 10.1016/S0895-6111(01)00008-8; Lohmann G, 2010, CEREB CORTEX, V20, P1286, DOI 10.1093/cercor/bhp190; Makuuchi M, 2009, P NATL ACAD SCI USA, V106, P8362, DOI 10.1073/pnas.0810928106; Menon V, 2000, NEUROIMAGE, V12, P357, DOI 10.1006/nimg.2000.0613; Mestres-Misse A, 2012, NEUROIMAGE, V62, P41, DOI 10.1016/j.neuroimage.2012.05.021; Montojo CA, 2008, NEURON, V59, P173, DOI 10.1016/j.neuron.2008.05.012; Nieder A, 2009, ANNU REV NEUROSCI, V32, P185, DOI 10.1146/annurev.neuro.051508.135550; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Sakai K, 2002, NAT NEUROSCI, V5, P479, DOI 10.1038/nn846; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Talairach J., 1988, COPLANAR STEREOTAXIC; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Verstynen TD, 2012, J NEUROPHYSIOL, V107, P2984, DOI 10.1152/jn.00995.2011; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Wendelken C, 2008, NEUROPSYCHOLOGIA, V46, P665, DOI 10.1016/j.neuropsychologia.2007.09.015; Yoshida W, 2006, NEURON, V50, P781, DOI 10.1016/j.neuron.2006.05.006	50	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53699	10.1371/journal.pone.0053699	http://dx.doi.org/10.1371/journal.pone.0053699			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070BE	23301101	gold, Green Published, Green Submitted			2022-12-25	WOS:000313480000076
J	Perez-Bercoff, A; Hudson, CM; Conant, GC				Perez-Bercoff, Asa; Hudson, Corey M.; Conant, Gavin C.			A Conserved Mammalian Protein Interaction Network	PLOS ONE			English	Article							EVOLUTIONARY RATE; INTERACTION PARTNERS; MOLECULAR EVOLUTION; MAXIMUM-LIKELIHOOD; GENOME DUPLICATION; SIMPLE DEPENDENCE; YEAST; COEVOLUTION; GENE; CONSTRAINT	Physical interactions between proteins mediate a variety of biological functions, including signal transduction, physical structuring of the cell and regulation. While extensive catalogs of such interactions are known from model organisms, their evolutionary histories are difficult to study given the lack of interaction data from phylogenetic outgroups. Using phylogenomic approaches, we infer a upper bound on the time of origin for a large set of human protein-protein interactions, showing that most such interactions appear relatively ancient, dating no later than the radiation of placental mammals. By analyzing paired alignments of orthologous and putatively interacting protein-coding genes from eight mammals, we find evidence for weak but significant co-evolution, as measured by relative selective constraint, between pairs of genes with interacting proteins. However, we find no strong evidence for shared instances of directional selection within an interacting pair. Finally, we use a network approach to show that the distribution of selective constraint across the protein interaction network is non-random, with a clear tendency for interacting proteins to share similar selective constraints. Collectively, the results suggest that, on the whole, protein interactions in mammals are under selective constraint, presumably due to their functional roles.	[Perez-Bercoff, Asa] Univ Dublin Trinity Coll, Smurfit Inst Genet, Dublin 2, Ireland; [Hudson, Corey M.; Conant, Gavin C.] Univ Missouri, Inst Informat, Columbia, MO 65211 USA; [Conant, Gavin C.] Univ Missouri, Div Anim Sci, Columbia, MO USA	Trinity College Dublin; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Conant, GC (corresponding author), Univ Missouri, Inst Informat, Columbia, MO 65211 USA.	conantg@missouri.edu	Hudson, Corey M./I-1283-2019; Conant, Gavin/R-7022-2019	Hudson, Corey M./0000-0003-4796-538X; Conant, Gavin/0000-0002-8677-4933	Galostiftelsen Stipendium for hogre utlandsstudier; National Library of Medicine Biomedical and Health Informatics Training Fellowship [LM007089-19]; Reproductive Biology Group of the Food for the 21st Century program at the University of Missouri; NATIONAL LIBRARY OF MEDICINE [T15LM007089] Funding Source: NIH RePORTER	Galostiftelsen Stipendium for hogre utlandsstudier; National Library of Medicine Biomedical and Health Informatics Training Fellowship; Reproductive Biology Group of the Food for the 21st Century program at the University of Missouri; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	A.P.B. is supported by Galostiftelsen Stipendium for hogre utlandsstudier. C.M.H. is supported by a National Library of Medicine Biomedical and Health Informatics Training Fellowship [LM007089-19]. G.C.C. is supported by the Reproductive Biology Group of the Food for the 21st Century program at the University of Missouri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beltrao P, 2007, PLOS COMPUT BIOL, V3, P258, DOI 10.1371/journal.pcbi.0030025; Bloom JD, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-21; Bloom JD, 2006, MOL BIOL EVOL, V23, P1751, DOI 10.1093/molbev/msl040; Bustamante CD, 2000, MOL BIOL EVOL, V17, P301, DOI 10.1093/oxfordjournals.molbev.a026310; Campos PRA, 2004, J THEOR BIOL, V231, P197, DOI 10.1016/j.jtbi.2004.06.014; Choi SS, 2006, MOL BIOL EVOL, V23, P2131, DOI 10.1093/molbev/msl086; Clark NL, 2010, MOL BIOL EVOL, V27, P1152, DOI 10.1093/molbev/msp324; Conant GC, 2009, TRENDS GENET, V25, P377, DOI 10.1016/j.tig.2009.07.004; Conant GC, 2006, PLOS BIOL, V4, P545, DOI 10.1371/journal.pbio.0040109; Conant GC, 2002, NUCLEIC ACIDS RES, V30, P3378, DOI 10.1093/nar/gkf449; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Drummond DA, 2006, MOL BIOL EVOL, V23, P327, DOI 10.1093/molbev/msj038; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fares MA, 2006, BIOINFORMATICS, V22, P2821, DOI 10.1093/bioinformatics/btl493; Fares MA, 2006, GENETICS, V173, P9, DOI 10.1534/genetics.105.053249; Fernandez A, 2011, NATURE, V474, P502, DOI 10.1038/nature09992; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Fraser HB, 2004, P NATL ACAD SCI USA, V101, P9033, DOI 10.1073/pnas.0402591101; Fraser HB, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-11; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; Guan YF, 2007, GENETICS, V175, P933, DOI 10.1534/genetics.106.064329; Hahn MW, 2004, J MOL EVOL, V58, P203, DOI 10.1007/s00239-003-2544-0; Hakes L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r209; Hakes L, 2007, P NATL ACAD SCI USA, V104, P7999, DOI 10.1073/pnas.0609962104; Hudson CM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-89; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jordan IK, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-1; Juan D, 2008, FEBS LETT, V582, P1225, DOI 10.1016/j.febslet.2008.02.017; Julenius K, 2006, MOL BIOL EVOL, V23, P2039, DOI 10.1093/molbev/msl081; Kann MG, 2009, J MOL BIOL, V385, P91, DOI 10.1016/j.jmb.2008.09.078; Kim WK, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000232; KORBER BTM, 1993, P NATL ACAD SCI USA, V90, P7176, DOI 10.1073/pnas.90.15.7176; Kunin V, 2004, MOL BIOL EVOL, V21, P1171, DOI 10.1093/molbev/msh085; Li L, 2006, MOL BIOL EVOL, V23, P2467, DOI 10.1093/molbev/msl121; Liang Z, 2010, FEBS LETT, V584, P4237, DOI 10.1016/j.febslet.2010.09.014; Liao BY, 2010, GENOME BIOL EVOL, V2, P39, DOI 10.1093/gbe/evp058; Lin YS, 2007, MOL BIOL EVOL, V24, P1005, DOI 10.1093/molbev/msm019; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Mathivanan S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S19; Mintseris J, 2005, P NATL ACAD SCI USA, V102, P10930, DOI 10.1073/pnas.0502667102; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; Pal C, 2001, GENETICS, V158, P927; Pazos F, 2001, PROTEIN ENG, V14, P609, DOI 10.1093/protein/14.9.609; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Perez-Bercoff A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-160; Pollock DD, 1999, J MOL BIOL, V287, P187, DOI 10.1006/jmbi.1998.2601; Qian WF, 2011, P NATL ACAD SCI USA, V108, P8725, DOI 10.1073/pnas.1104695108; Rambaut A., 2006, TREE FIGURE DRAWING; Saeed R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-128; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Travers SAA, 2007, MOL BIOL EVOL, V24, P2787, DOI 10.1093/molbev/msm213; Vinogradov AE, 2010, P ROY SOC B-BIOL SCI, V277, P1403, DOI 10.1098/rspb.2009.1865; Wagner A, 2001, MOL BIOL EVOL, V18, P1283, DOI 10.1093/oxfordjournals.molbev.a003913; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707	59	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52581	10.1371/journal.pone.0052581	http://dx.doi.org/10.1371/journal.pone.0052581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23320073	gold, Green Published, Green Submitted			2022-12-25	WOS:000313320900032
J	Chauvin, C; Koka, V; Nouschi, A; Mieulet, V; Hoareau-Aveilla, C; Dreazen, A; Cagnard, N; Carpentier, W; Kiss, T; Meyuhas, O; Pende, M				Chauvin, C.; Koka, V.; Nouschi, A.; Mieulet, V.; Hoareau-Aveilla, C.; Dreazen, A.; Cagnard, N.; Carpentier, W.; Kiss, T.; Meyuhas, O.; Pende, M.			Ribosomal protein S6 kinase activity controls the ribosome biogenesis transcriptional program	ONCOGENE			English	Article						signal transduction; ribosome biogenesis; mTOR	MESSENGER-RNA TRANSLATION; CELL-SIZE; PHOSPHORYLATION; MTOR; REVEALS; TARGET; GROWTH; GENES; YEAST; IDENTIFICATION	S6 kinases (S6Ks) are mechanistic target of rapamycin substrates that participate in cell growth control. S6Ks phosphorylate ribosomal protein S6 (rpS6) and additional proteins involved in the translational machinery, although the functional roles of these modifications remain elusive. Here we analyze the S6K-dependent transcriptional and translational regulation of gene expression by comparing whole-genome microarray of total and polysomal mouse liver RNA after feeding. We show that tissue lacking S6Ks 1 and 2 (S6K1 and S6K2), displays a defect in the ribosome biogenesis (RiBi) transcriptional program after feeding. Over 75% of RiBi factors are controlled by S6K, including Nop56, Nop14, Gar1, Rrp9, Rrp15, Rrp12 and Pwp2 nucleolar proteins. Importantly, the reduced activity of RiBi transcriptional promoters in S6K1;S6K2(-/-) cells is also observed in rpS6 knock-in mutants that cannot be phosphorylated. As ribosomal protein synthesis is not affected by these mutations, our data reveal a distinct and specific aspect of RiBi under the control of rpS6 kinase activity, that is, the RiBi transcriptional program.	[Chauvin, C.; Koka, V.; Nouschi, A.; Mieulet, V.; Pende, M.] INSERM, U845, F-75015 Paris, France; [Chauvin, C.; Koka, V.; Nouschi, A.; Mieulet, V.; Cagnard, N.; Pende, M.] Univ Paris 05, Sorbonne Paris Cite, Fac Med, UMRS 845, Paris, France; [Hoareau-Aveilla, C.; Kiss, T.] Univ Toulouse UPS, Lab Biol Mol Eucaryote, Toulouse, France; [Hoareau-Aveilla, C.; Kiss, T.] CNRS, Toulouse, France; [Dreazen, A.; Meyuhas, O.] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Dept Biochem & Mol Biol, IL-91010 Jerusalem, Israel; [Carpentier, W.] Univ Paris 06, Grp Hosp Pitie Salpetriere, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite Federale Toulouse Midi-Pyrenees (ComUE); Centre National de la Recherche Scientifique (CNRS); Hebrew University of Jerusalem; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Pende, M (corresponding author), INSERM, U845, 156 Rue Vaugirard, F-75015 Paris, France.	mario.pende@inserm.fr	MIEULET, Virginie/F-1195-2017; Hoareau-Aveilla, Coralie/G-3787-2017; Pende, Mario/AFR-1348-2022; Cagnard, Nicolas/K-2754-2014	MIEULET, Virginie/0000-0001-5104-639X; Hoareau-Aveilla, Coralie/0000-0001-5506-4552; Pende, Mario/0000-0002-7864-8937; Cagnard, Nicolas/0000-0002-9051-1896; Kiss, Tamas/0000-0003-0293-3093	European Research Council; Fondation de la Recherche Medicale; Fondation Schlumberger pour l'Education et la Recherche; ANR; US-Israel Binational Science Foundation [2009054]; Israel Cancer Research Fund; Ministry of Health; Coddim Ile de France	European Research Council(European Research Council (ERC)European Commission); Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation Schlumberger pour l'Education et la Recherche; ANR(French National Research Agency (ANR)); US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Cancer Research Fund; Ministry of Health; Coddim Ile de France	We thank the Novartis Foundation and George Thomas laboratory for the use of S6K mutant mice. We are grateful to the members of INSERM-U845 for support, and to Stefano Fumagalli and Olivier Jean-Jean for helpful discussions and sharing reagents. We thank Sophie Berissi, Ana Diaz and Sylvie Fabrega for excellent technical support. We thank Pfizer for the generous gift of Temsirolimus. This work was supported by grants to MP from the European Research Council, from Fondation de la Recherche Medicale, from Fondation Schlumberger pour l'Education et la Recherche and from ANR and by grants to OM from the US-Israel Binational Science Foundation (2009054), Israel Cancer Research Fund and Ministry of Health. CC received a fellowship from the Coddim Ile de France.	Bernstein KA, 2006, MOL CELL BIOL, V26, P1195, DOI 10.1128/MCB.26.4.1195-1208.2006; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Dai MS, 2010, J BIOL CHEM, V285, P12587, DOI 10.1074/jbc.M109.056259; De Marchis ML, 2005, RNA, V11, P495, DOI 10.1261/rna.7200205; De S, 2010, BIOCHEM SOC T, V38, P1543, DOI 10.1042/BST0381543; De S, 2011, RNA, V17, P1713, DOI 10.1261/rna.2808411; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Dosil M, 2004, J BIOL CHEM, V279, P37385, DOI 10.1074/jbc.M404909200; Espeillac C, 2011, J CLIN INVEST, V121, P2821, DOI 10.1172/JCI44203; Gautier T, 1997, MOL CELL BIOL, V17, P7088, DOI 10.1128/MCB.17.12.7088; Ge JP, 2010, MOL CELL BIOL, V30, P413, DOI 10.1128/MCB.01128-09; GIRARD JP, 1992, EMBO J, V11, P673, DOI 10.1002/j.1460-2075.1992.tb05099.x; GROVE JR, 1991, MOL CELL BIOL, V11, P5541, DOI 10.1128/MCB.11.11.5541; Guertin DA, 2006, CURR BIOL, V16, P958, DOI 10.1016/j.cub.2006.03.084; Hannan KM, 2003, MOL CELL BIOL, V23, P8862, DOI 10.1128/MCB.23.23.8862-8877.2003; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Huber A, 2011, EMBO J, V30, P3052, DOI 10.1038/emboj.2011.221; Iadevaia V, 2012, NUCLEIC ACIDS RES, V40, P2527, DOI 10.1093/nar/gkr1040; Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kiss T, 2010, MOL CELL, V37, P597, DOI 10.1016/j.molcel.2010.01.032; KOZMA SC, 1990, P NATL ACAD SCI USA, V87, P7365, DOI 10.1073/pnas.87.19.7365; KRIEG J, 1988, J BIOL CHEM, V263, P11473; Laplante M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011593; Lempiainen H, 2009, MOL CELL, V33, P704, DOI 10.1016/j.molcel.2009.01.034; Lempiainen H, 2009, CURR OPIN CELL BIOL, V21, P855, DOI 10.1016/j.ceb.2009.09.002; Liu PCC, 2001, MOL BIOL CELL, V12, P3644, DOI 10.1091/mbc.12.11.3644; Malygin AA, 2007, NUCLEIC ACIDS RES, V35, P6414, DOI 10.1093/nar/gkm701; Mariappan MM, 2011, AM J PHYSIOL-RENAL, V300, pF219, DOI 10.1152/ajprenal.00207.2010; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504; Mieulet V, 2007, AM J PHYSIOL-CELL PH, V293, pC712, DOI 10.1152/ajpcell.00499.2006; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Patursky-Polischuk I, 2009, MOL CELL BIOL, V29, P640, DOI 10.1128/MCB.00980-08; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Pende M, 2000, NATURE, V408, P994, DOI 10.1038/35050135; Powley IR, 2009, GENE DEV, V23, P1207, DOI 10.1101/gad.516509; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; THOMAS G, 1980, CELL, V19, P1015, DOI 10.1016/0092-8674(80)90092-6; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Venema J, 2000, RNA, V6, P1660, DOI 10.1017/S1355838200001369; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835	52	172	179	4	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 23	2014	33	4					474	483		10.1038/onc.2012.606	http://dx.doi.org/10.1038/onc.2012.606			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	296VX	23318442				2022-12-25	WOS:000330214600008
J	Bojja, RS; Andrake, MD; Merkel, G; Weigand, S; Dunbrack, RL; Skalka, AM				Bojja, Ravi Shankar; Andrake, Mark D.; Merkel, George; Weigand, Steven; Dunbrack, Roland L., Jr.; Skalka, Anna Marie			Architecture and Assembly of HIV Integrase Multimers in the Absence of DNA Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 INTEGRASE; VIRAL-DNA; PROTEIN; DOMAIN; MODEL; OLIGOMERIZATION; CONFORMATIONS; INTASOME; MONOMER; BINDING	We have applied small angle x-ray scattering and protein cross-linking coupled with mass spectrometry to determine the architectures of full-length HIV integrase (IN) dimers in solution. By blocking interactions that stabilize either a core-core domain interface or N-terminal domain intermolecular contacts, we show that full-length HIV IN can form two dimer types. One is an expected dimer, characterized by interactions between two catalytic core domains. The other dimer is stabilized by interactions of the N-terminal domain of one monomer with the C-terminal domain and catalytic core domain of the second monomer as well as direct interactions between the two C-terminal domains. This organization is similar to the "reaching dimer" previously described for wild type ASV apoIN and resembles the inner, substrate binding dimer in the crystal structure of the PFV intasome. Results from our small angle x-ray scattering and modeling studies indicate that in the absence of its DNA substrate, the HIV IN tetramer assembles as two stacked reaching dimers that are stabilized by core-core interactions. These models of full-length HIV IN provide new insight into multimer assembly and suggest additional approaches for enzyme inhibition.	[Bojja, Ravi Shankar; Andrake, Mark D.; Merkel, George; Weigand, Steven; Dunbrack, Roland L., Jr.; Skalka, Anna Marie] Fox Chase Canc Ctr, Inst Canc Res, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Skalka, AM (corresponding author), 333 Cottman Ave, Philadelphia, PA 19111 USA.	AM_Skalka@fccc.edu	Dunbrack, Roland/ABG-7141-2020; Weigand, Steven/G-6181-2015	Weigand, Steven/0000-0003-3137-0672; Dunbrack, Roland/0000-0001-7674-6667	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; National Institutes of Health [AI40385, CA71515, CA006927]; NATIONAL CANCER INSTITUTE [P30CA006927, R01CA071515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084453] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank our colleagues Drs. Richard A. Katz, Eileen Jaffe, and Heinrich Roder for helpful comments regarding the experiments reported in this manuscript and Marie Estes for assistance in its preparation. Use of Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences (DE-AC02-06CH11357) under general user proposal access. Our studies also benefited from access to the following shared Cancer Center Support Grant facilities: Molecular Modeling, Organic synthesis, DNA sequencing, and Cell Culture. Dr. Anthony Young generously provided access to his mass spectrometry suite, and Dr. Hong Chen assisted with CD spectral analysis.; This work was supported, in whole or in part, by National Institutes of Health Grants AI40385, CA71515, and CA006927.	Al-Mawsawi LQ, 2008, VIROLOGY, V377, P353, DOI 10.1016/j.virol.2008.04.030; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Asante-Appiah E, 1998, J BIOL CHEM, V273, P35078, DOI 10.1074/jbc.273.52.35078; AsanteAppiah E, 1997, J BIOL CHEM, V272, P16196, DOI 10.1074/jbc.272.26.16196; Bojja RS, 2011, J BIOL CHEM, V286, P17047, DOI 10.1074/jbc.M110.212571; BUSHMAN FD, 1993, P NATL ACAD SCI USA, V90, P3428, DOI 10.1073/pnas.90.8.3428; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; CRAIGIE R, 1991, NUCLEIC ACIDS RES, V19, P2729, DOI 10.1093/nar/19.10.2729; Craigie R, 2012, FUTURE VIROL, V7, P679, DOI 10.2217/FVL.12.56; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241; GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D; Gronenborn AM, 2009, CURR OPIN STRUC BIOL, V19, P39, DOI 10.1016/j.sbi.2008.12.002; Guiot E, 2006, J BIOL CHEM, V281, P22707, DOI 10.1074/jbc.M602198200; Gupta K, 2012, STRUCTURE, V20, P1918, DOI 10.1016/j.str.2012.08.023; Gupta K, 2010, J BIOL CHEM, V285, P20303, DOI 10.1074/jbc.M110.114413; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000515; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; Ilavsky J, 2009, J APPL CRYSTALLOGR, V42, P347, DOI 10.1107/S0021889809002222; Jaffe EK, 2005, TRENDS BIOCHEM SCI, V30, P490, DOI 10.1016/j.tibs.2005.07.003; Kessl JJ, 2011, NUCLEIC ACIDS RES, V39, P9009, DOI 10.1093/nar/gkr581; Kessl JJ, 2009, MOL PHARMACOL, V76, P824, DOI 10.1124/mol.109.058883; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Krishnan L, 2010, P NATL ACAD SCI USA, V107, P15910, DOI 10.1073/pnas.1002346107; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee SP, 1997, BIOCHEMISTRY-US, V36, P173, DOI 10.1021/bi961849o; LevyMintz P, 1996, J VIROL, V70, P8821, DOI 10.1128/JVI.70.12.8821-8832.1996; Li M, 2005, J BIOL CHEM, V280, P29334, DOI 10.1074/jbc.M505367200; Lutzke RAP, 1998, J VIROL, V72, P4841, DOI 10.1128/JVI.72.6.4841-4848.1998; Mckee CJ, 2008, J BIOL CHEM, V283, P31802, DOI 10.1074/jbc.M805843200; Merkel G, 2009, METHODS, V47, P243, DOI 10.1016/j.ymeth.2008.10.024; Pandey KK, 2011, BIOCHEMISTRY-US, V50, P9788, DOI 10.1021/bi201247f; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Powers ET, 2003, BIOPHYS J, V85, P3587, DOI 10.1016/S0006-3495(03)74777-8; Selwood T, 2012, ARCH BIOCHEM BIOPHYS, V519, P131, DOI 10.1016/j.abb.2011.11.020; Serrao E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045177; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Taltynov O., 2012, MOL BIOL INT; Tintori C, 2012, BIOORG MED CHEM LETT, V22, P3109, DOI 10.1016/j.bmcl.2012.03.064; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Xu QF, 2011, NUCLEIC ACIDS RES, V39, pD761, DOI 10.1093/nar/gkq1059	44	23	24	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7373	7386		10.1074/jbc.M112.434431	http://dx.doi.org/10.1074/jbc.M112.434431			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23322775	hybrid, Green Published			2022-12-25	WOS:000316002400056
J	Demissie, ZA; Erland, LAE; Rheault, MR; Mahmoud, SS				Demissie, Zerihun A.; Erland, Lauren A. E.; Rheault, Mark R.; Mahmoud, Soheil S.			The Biosynthetic Origin of Irregular Monoterpenes in Lavandula ISOLATION AND BIOCHEMICAL CHARACTERIZATION OF A NOVEL cis-PRENYL DIPHOSPHATE SYNTHASE GENE, LAVANDULYL DIPHOSPHATE SYNTHASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GERANYL DIPHOSPHATE; CHRYSANTHEMUM-CINERARIAEFOLIUM; FUNCTIONAL-CHARACTERIZATION; SOPHORA-FLAVESCENS; TERPENE SYNTHASES; CLONING; PYROPHOSPHATE; PRENYLTRANSFERASES; CONSTITUENTS; EXPRESSION	Lavender essential oils are constituted predominantly of regular monoterpenes, for example linalool, 1,8-cineole, and camphor. However, they also contain irregular monoterpenes including lavandulol and lavandulyl acetate. Although the majority of genes responsible for the production of regular monoterpenes in lavenders are now known, enzymes (including lavandulyl diphosphate synthase (LPPS)) catalyzing the biosynthesis of irregular monoterpenes in these plants have not been described. Here, we report the isolation and functional characterization of a novel cis-prenyl diphosphate synthase cDNA, termed Lavandula x intermedia lavandulyl diphosphate synthase (LiLPPS), through a homology-based cloning strategy. The LiLPPS ORF, encoding for a 305-amino acid long protein, was expressed in Escherichia coli, and the recombinant protein was purified by nickel-nitrilotriacetic acid affinity chromatography. The approximately 34.5-kDa bacterially produced protein specifically catalyzed the head-to-middle condensation of two dimethylallyl diphosphate units to LPP in vitro with apparent K-m and k(cat) values of 208 +/- 12 mu M and 0.1 s(-1), respectively. LiLPPS is a homodimeric enzyme with a sigmoidal saturation curve and Hill coefficient of 2.7, suggesting a positive co-operative interaction among its catalytic sites. LiLPPS could be used to modulate the production of lavandulol and its derivatives in plants through metabolic engineering.	[Demissie, Zerihun A.; Erland, Lauren A. E.; Rheault, Mark R.; Mahmoud, Soheil S.] Univ British Columbia, Dept Biol, Kelowna, BC V1V 1V7, Canada	University of British Columbia	Mahmoud, SS (corresponding author), Univ British Columbia, Dept Biol, 3333 Univ Way, Kelowna, BC V1V 1V7, Canada.	soheil.mahmoud@ubc.ca	Rheault, Mark/K-6252-2012; Erland, Lauren/I-8415-2019	Rheault, Mark/0000-0002-7290-4565; Erland, Lauren/0000-0003-3157-0535	University of British Columbia Okanagan; Investment Agriculture Foundation of British Columbia; National Research Council Plant Biotechnology Institute through the NAPGEN program; Genome British Columbia; Natural Sciences and Engineering Research Council of Canada; British Columbia through the Ministry of Advanced Education	University of British Columbia Okanagan; Investment Agriculture Foundation of British Columbia; National Research Council Plant Biotechnology Institute through the NAPGEN program; Genome British Columbia; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); British Columbia through the Ministry of Advanced Education	This work was supported through grants or in-kind contributions by the University of British Columbia Okanagan, Investment Agriculture Foundation of British Columbia, National Research Council Plant Biotechnology Institute through the NAPGEN program, and Genome British Columbia (to S. S. M.) and by the Natural Sciences and Engineering Research Council of Canada (to S. S. M. and M. R. R.).; Supported by the Pacific Century Graduate Scholarships from the province of British Columbia through the Ministry of Advanced Education.	Bouvier F, 2000, PLANT J, V24, P241, DOI 10.1046/j.1365-313x.2000.00875.x; Burke C, 2002, ARCH BIOCHEM BIOPHYS, V405, P130, DOI 10.1016/S0003-9861(02)00335-1; Burke CC, 1999, P NATL ACAD SCI USA, V96, P13062, DOI 10.1073/pnas.96.23.13062; Chang TH, 2010, PLANT CELL, V22, P454, DOI 10.1105/tpc.109.071738; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Christianson DW, 2008, CURR OPIN CHEM BIOL, V12, P141, DOI 10.1016/j.cbpa.2007.12.008; CROTEAU R, 1979, ARCH BIOCHEM BIOPHYS, V198, P512, DOI 10.1016/0003-9861(79)90526-5; Croteau R., 2000, BIOCH MOL BIOL PLANT, P1250, DOI DOI 10.1201/B11003-3; Degenhardt J, 2009, PHYTOCHEMISTRY, V70, P1621, DOI 10.1016/j.phytochem.2009.07.030; Demissie ZA, 2012, PLANT MOL BIOL, V79, P393, DOI 10.1007/s11103-012-9920-3; Demissie ZA, 2011, PLANTA, V233, P685, DOI 10.1007/s00425-010-1332-5; Dewick P.M., 2009, MED NATURAL PRODUCTS; EPSTEIN WW, 1991, J ORG CHEM, V56, P4451, DOI 10.1021/jo00014a023; Falk L, 2009, J ESSENT OIL RES, V21, P225, DOI 10.1080/10412905.2009.9700154; Franco JC, 2009, BIORATIONAL CONTROL OF ARTHROPOD PESTS: APPLICATION AND RESISTANCE MANAGEMENT, P233, DOI 10.1007/978-90-481-2316-2_10; Gao Y, 2012, NAT PROD REP, V29, P1153, DOI 10.1039/c2np20059g; Haug-Schifferdecker E, 2010, J BIOL CHEM, V285, P16487, DOI 10.1074/jbc.M110.113720; Hemmerlin A, 2003, J BIOL CHEM, V278, P32132, DOI 10.1074/jbc.M213045200; Kharel Y, 2003, NAT PROD REP, V20, P111, DOI 10.1039/b108934j; Ko WG, 2000, TOXICOL IN VITRO, V14, P429, DOI 10.1016/S0887-2333(00)00041-2; Landmann C, 2007, ARCH BIOCHEM BIOPHYS, V465, P417, DOI 10.1016/j.abb.2007.06.011; Lane A., 2010, LAVENDER GENUS LAVEN, P117; Lee HS, 1997, PLANTA MED, V63, P266, DOI 10.1055/s-2006-957670; Liang PH, 2002, EUR J BIOCHEM, V269, P3339, DOI 10.1046/j.1432-1033.2002.03014.x; Lis-Balchin M., 2002, LAVENDER, P117, DOI [10.1201/9780203216521-16, DOI 10.1201/9780203216521-16]; Ma YMA, 2012, J EXP BOT, V63, P2809, DOI 10.1093/jxb/err466; Matsuda K, 2005, PHYTOCHEMISTRY, V66, P1529, DOI 10.1016/j.phytochem.2005.05.005; Matsuda K, 2012, TOP CURR CHEM, V314, P73, DOI 10.1007/128_2011_271; Rivera SB, 2001, P NATL ACAD SCI USA, V98, P4373, DOI 10.1073/pnas.071543598; Sallaud C, 2009, PLANT CELL, V21, P301, DOI 10.1105/tpc.107.057885; Schilmiller AL, 2009, P NATL ACAD SCI USA, V106, P10865, DOI 10.1073/pnas.0904113106; Schmidt A, 2008, PHYTOCHEMISTRY, V69, P49, DOI 10.1016/j.phytochem.2007.06.022; Sugiyama A, 2011, METAB ENG, V13, P629, DOI 10.1016/j.ymben.2011.07.003; Tholl D, 2004, PLANT CELL, V16, P977, DOI 10.1105/tpc.020156; Thulasiram HV, 2008, J AM CHEM SOC, V130, P1966, DOI 10.1021/ja0771282; Thulasiram HV, 2007, SCIENCE, V316, P73, DOI 10.1126/science.1137786; Walsh CT, 2007, ACS CHEM BIOL, V2, P296, DOI 10.1021/cb700094s; Walton VM, 2006, J ECON ENTOMOL, V99, P1280, DOI 10.1603/0022-0493-99.4.1280; Wang GD, 2009, P NATL ACAD SCI USA, V106, P9914, DOI 10.1073/pnas.0904069106; Woronuk G, 2011, PLANTA MED, V77, P7, DOI 10.1055/s-0030-1250136; Zhao P, 2003, PLANT PHYSIOL, V133, P1306, DOI 10.1104/pp.103.025213	41	62	63	1	67	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6333	6341		10.1074/jbc.M112.431171	http://dx.doi.org/10.1074/jbc.M112.431171			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23306202	hybrid, Green Published			2022-12-25	WOS:000315820700028
J	Otani, J; Arita, K; Kato, T; Kinoshita, M; Kimura, H; Suetake, I; Tajima, S; Ariyoshi, M; Shirakawa, M				Otani, Junji; Arita, Kyohei; Kato, Tsuyoshi; Kinoshita, Mariko; Kimura, Hironobu; Suetake, Isao; Tajima, Shoji; Ariyoshi, Mariko; Shirakawa, Masahiro			Structural Basis of the Versatile DNA Recognition Ability of the Methyl-CpG Binding Domain of Methyl-CpG Binding Domain Protein 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-DEMETHYLATION; GLYCOSYLASE MBD4; THYMINE; REPLICATION; 5-CARBOXYLCYTOSINE; 5-METHYLCYTOSINE; DEAMINATION; EXCISION; PRODUCT; ERASURE	The methyl-CpG binding domain (MBD) protein MBD4 participates in DNA repair as a glycosylase that excises mismatched thymine bases in CpG sites and also functions in transcriptional repression. Unlike other MBD proteins, MBD4 recognizes not only methylated CpG dinucleotides ((5m)CG/(5m)CG) but also T/G mismatched sites generated by spontaneous deamination of 5-methylcytosine ((5m)CG/TG). The glycosylase activity of MBD4 is also implicated in active DNA demethylation initiated by the deaminase-catalyzed conversion of 5-methylcytosine to thymine. Here, we report the crystal structures of the MBD of MBD4(MBDMBD4) complexed with (5m)CG/(5m)CG and (5m)CG/TG. The crystal structures show that the DNA interface of MBD4 has flexible structural features and harbors an extensive water network that supports its dual base specificities. Combined with the results of biochemical analyses, the crystal structure of MBD4 bound to 5-hydroxymethylcytosine further demonstrates that MBDMBD4 is able to recognize a wide range of 5-methylcytosine modifications through the unique water network. The versatile base recognition ability of MBDMBD4 implies multifunctional roles for MBD4 in the regulation of dynamic DNA methylation patterns coupled with deamination and/or oxidation of 5-methylcytosine.	[Otani, Junji; Arita, Kyohei; Kato, Tsuyoshi; Kinoshita, Mariko; Shirakawa, Masahiro] Kyoto Univ, Grad Sch Engn, Kyoto 6158510, Japan; [Kimura, Hironobu; Suetake, Isao; Tajima, Shoji] Inst Prot Res, Suita, Osaka 5650871, Japan; [Ariyoshi, Mariko] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto 6158501, Japan; [Ariyoshi, Mariko] JST, PREST, Kawaguchi, Saitama 3320012, Japan; [Shirakawa, Masahiro] JST, CREST, Kawaguchi, Saitama 3320012, Japan; [Shirakawa, Masahiro] RIKEN, Yokohama Inst, Kanagawa 2300045, Japan	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); RIKEN	Ariyoshi, M (corresponding author), Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto 6158501, Japan.	ariyoshi@moleng.kyoto-u.ac.jp; shirakawa@moleng.kyoto-u.ac.jp	Kimura, Hironobu/B-3731-2010; Suetake, Isao/G-3144-2013; Arita, Kyohei/AAJ-6402-2020; Suetake, Isao/D-4326-2009	Arita, Kyohei/0000-0002-9762-8405; Suetake, Isao/0000-0002-1246-8474	Ministry of Education, Culture, Sports, Science and Technology; Japan Science and Technology Agency (MEXT); JST, PRESTO; Global COE Program "International Center for Integrated Research and Advanced Education in Materials Science" of MEXT of Japan [B-09]; Grants-in-Aid for Scientific Research [24113711, 24570153, 24116515] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (MEXT); JST, PRESTO(Japan Science & Technology Agency (JST)); Global COE Program "International Center for Integrated Research and Advanced Education in Materials Science" of MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology and the Japan Science and Technology Agency (MEXT) (to M. S.) and by JST, PRESTO (to M. A.) and the Global COE Program "International Center for Integrated Research and Advanced Education in Materials Science" (No. B-09) of MEXT of Japan, administered by the Japan Society for the Promotion of Science.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aziz MA, 2009, CANCER BIOL THER, V8, P1156, DOI 10.4161/cbt.8.12.8536; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bogdanovic O, 2009, CHROMOSOMA, V118, P549, DOI 10.1007/s00412-009-0221-9; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P4841, DOI 10.1093/nar/gks155; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; HUNTER WN, 1987, J BIOL CHEM, V262, P9962; Inomata K, 2008, BIOCHEMISTRY-US, V47, P3266, DOI 10.1021/bi7019029; Inoue A, 2011, CELL RES, V21, P1670, DOI 10.1038/cr.2011.189; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Jin SG, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq223; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Kondo E, 2005, MOL CELL BIOL, V25, P4388, DOI 10.1128/MCB.25.11.4388-4396.2005; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Liu PF, 2003, DNA REPAIR, V2, P199, DOI 10.1016/S1568-7864(02)00198-2; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Manvilla BA, 2012, J MOL BIOL, V420, P164, DOI 10.1016/j.jmb.2012.04.028; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Millar CB, 2002, SCIENCE, V297, P403, DOI 10.1126/science.1073354; Morera S, 2012, NUCLEIC ACIDS RES, V40, P9917, DOI 10.1093/nar/gks714; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Ohki I, 2001, CELL, V105, P487, DOI 10.1016/S0092-8674(01)00324-5; Olson WK, 2001, J MOL BIOL, V313, P229, DOI 10.1006/jmbi.2001.4987; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Riccio A, 1999, NAT GENET, V23, P266, DOI 10.1038/15443; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; Scarsdale JN, 2011, NUCLEIC ACIDS RES, V39, P6741, DOI 10.1093/nar/gkr262; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Thillainadesan G, 2012, MOL CELL, V46, P636, DOI 10.1016/j.molcel.2012.03.027; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950	42	53	53	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6351	6362		10.1074/jbc.M112.431098	http://dx.doi.org/10.1074/jbc.M112.431098			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23316048	Green Published, hybrid			2022-12-25	WOS:000315820700030
J	Verissimo, AF; Mohtar, MA; Daldal, F				Verissimo, Andreia F.; Mohtar, Mohamad A.; Daldal, Fevzi			The Heme Chaperone ApoCcmE Forms a Ternary Complex with CcmI and Apocytochrome c	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C; RHODOBACTER-CAPSULATUS; RHODOPSEUDOMONAS-CAPSULATA; LIGATION COMPLEX; MATURATION; BIOGENESIS; PROTEINS; BIOSYNTHESIS; MITOCHONDRIA; TRAFFICKING	Cytochrome c maturation (Ccm) is a post-translational process that occurs after translocation of apocytochromes c to the positive (p) side of energy-transducing membranes. Ccm is responsible for the formation of covalent bonds between the thiol groups of two cysteines residues at the heme-binding sites of the apocytochromes and the vinyl groups of heme b (protoporphyrin IX-Fe). Among the proteins (CcmABCDEFGHI and CcdA) required for this process, CcmABCD are involved in loading heme b to apoCcmE. The holoCcmE thus formed provides heme b to the apocytochromes. Catalysis of the thioether bonds between the apocytochromes c and heme b is mediated by the heme ligation core complex, which in Rhodobacter capsulatus contains at least the CcmF, CcmH, and CcmI components. In this work we show that the heme chaperone apoCcmE binds to the apocytochrome c and the apocytochrome c chaperone CcmI to yield stable binary and ternary complexes in the absence of heme in vitro. We found that during these protein-protein interactions, apoCcmE favors the presence of a disulfide bond at the apocytochrome c heme-binding site. We also establish using detergent-dispersed membranes that apoCcmE interacts directly with CcmI and CcmH of the heme ligation core complex CcmFHI. Implications of these findings are discussed with respect to heme transfer from CcmE to the apocytochromes c during heme ligation assisted by the core complex CcmFHI.	[Verissimo, Andreia F.; Mohtar, Mohamad A.; Daldal, Fevzi] Univ Penn, Dept Biol, Philadelphia, PA 19014 USA	University of Pennsylvania	Daldal, F (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19014 USA.	fdaldal@sas.upenn.edu	Mohtar, M. Aiman/ABB-8253-2020; Mohtar, M. Aiman/B-8129-2018	Mohtar, M. Aiman/0000-0002-9015-9802; Mohtar, M. Aiman/0000-0002-9015-9802	National Institutes of Health [GM 38237]; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy [DE-FG02-91ER20052]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 38237 (to F.D.). This work was also supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy through Grant DE-FG02-91ER20052 for the production, purification, and assay of the proteins and their mutant variants (to F.D.).	Ahuja U, 2005, J BIOL CHEM, V280, P236, DOI 10.1074/jbc.M410912200; Ahuja U, 2003, J BIOL CHEM, V278, P52061, DOI 10.1074/jbc.M310077200; AMBLER RP, 1991, BIOCHIM BIOPHYS ACTA, V1058, P42, DOI 10.1016/S0005-2728(05)80266-X; Arcus V, 2002, CURR OPIN STRUC BIOL, V12, P794, DOI 10.1016/S0959-440X(02)00392-5; Arnesano F, 2002, BIOCHEMISTRY-US, V41, P13587, DOI 10.1021/bi026362w; BENNING MM, 1991, J MOL BIOL, V220, P673, DOI 10.1016/0022-2836(91)90109-J; Bertini I, 2006, CHEM REV, V106, P90, DOI 10.1021/cr050241v; BHAGWAT AS, 1986, J BACTERIOL, V166, P751, DOI 10.1128/jb.166.3.751-755.1986; Bowman SEJ, 2008, NAT PROD REP, V25, P1118, DOI 10.1039/b717196j; Christensen O, 2007, FEBS J, V274, P2322, DOI 10.1111/j.1742-4658.2007.05769.x; DALDAL F, 1986, P NATL ACAD SCI USA, V83, P2012, DOI 10.1073/pnas.83.7.2012; Daltrop O, 2002, P NATL ACAD SCI USA, V99, P7872, DOI 10.1073/pnas.132259099; Deshmukh M, 2000, MOL MICROBIOL, V35, P123, DOI 10.1046/j.1365-2958.2000.01683.x; Deshmukh M, 2002, MOL MICROBIOL, V46, P1069, DOI 10.1046/j.1365-2958.2002.03212.x; Di Matteo A, 2007, J BIOL CHEM, V282, P27012, DOI 10.1074/jbc.M702702200; Enggist E, 2002, STRUCTURE, V10, P1551, DOI 10.1016/S0969-2126(02)00885-7; Feissner RE, 2006, MOL MICROBIOL, V61, P219, DOI 10.1111/j.1365-2958.2006.05221.x; Francisco BS, 2011, BIOCHEMISTRY-US, V50, P10974, DOI 10.1021/bi201508t; Giege P, 2004, FEBS LETT, V563, P165, DOI 10.1016/S0014-5793(04)00291-1; Goldman BS, 1997, J MOL BIOL, V268, P724, DOI 10.1006/jmbi.1997.0992; Hasegawa J, 1998, BIOCHEMISTRY-US, V37, P9641, DOI 10.1021/bi9803067; HOLDEN HM, 1987, J MOL BIOL, V195, P229, DOI 10.1016/0022-2836(87)90341-X; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang SE, 1996, J BACTERIOL, V178, P5279, DOI 10.1128/jb.178.17.5279-5290.1996; Lee DH, 2005, J AM CHEM SOC, V127, P3716, DOI 10.1021/ja044658e; Lee JH, 2007, BBA-BIOMEMBRANES, V1768, P2164, DOI 10.1016/j.bbamem.2007.04.022; Marino SM, 2012, J BIOL CHEM, V287, P4419, DOI 10.1074/jbc.R111.275578; Marino SM, 2010, J MOL BIOL, V404, P902, DOI 10.1016/j.jmb.2010.09.027; Mavridou DAI, 2012, J BIOL CHEM, V287, P2342, DOI 10.1074/jbc.M111.313692; Meyer EH, 2005, P NATL ACAD SCI USA, V102, P16113, DOI 10.1073/pnas.0503473102; Rayapuram N, 2008, J BIOL CHEM, V283, P25200, DOI 10.1074/jbc.M802621200; Ren Q, 2002, J BIOL CHEM, V277, P7657, DOI 10.1074/jbc.M110979200; Ren Q, 2001, J BIOL CHEM, V276, P32591, DOI 10.1074/jbc.M103058200; Richard-Fogal C, 2010, J MOL BIOL, V401, P350, DOI 10.1016/j.jmb.2010.06.041; Richard-Fogal CL, 2008, J BACTERIOL, V190, P3489, DOI 10.1128/JB.00146-08; Richard-Fogal CL, 2009, EMBO J, V28, P2349, DOI 10.1038/emboj.2009.189; Roos G, 2013, ANTIOXID REDOX SIGN, V18, P94, DOI 10.1089/ars.2012.4521; Sambongi Y, 2002, EUR J BIOCHEM, V269, P3355, DOI 10.1046/j.1432-1033.2002.03045.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sanders C, 2005, J BACTERIOL, V187, P4245, DOI 10.1128/JB.187.12.4245-4256.2005; Sanders C, 2008, J BIOL CHEM, V283, P29715, DOI 10.1074/jbc.M805413200; Sanders C, 2007, J BACTERIOL, V189, P789, DOI 10.1128/JB.01441-06; Sanders C, 2010, TRENDS MICROBIOL, V18, P266, DOI 10.1016/j.tim.2010.03.006; Schulz H, 2000, J BACTERIOL, V182, P6831, DOI 10.1128/JB.182.23.6831-6833.2000; Stevens JM, 2011, FEBS J, V278, P4170, DOI 10.1111/j.1742-4658.2011.08376.x; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; Thony-Meyer L, 2003, BIOCHEMISTRY-US, V42, P13099, DOI 10.1021/bi035598c; Turkarslan S, 2008, MOL MICROBIOL, V70, P652, DOI 10.1111/j.1365-2958.2008.06441.x; Verissimo AF, 2011, J BIOL CHEM, V286, P40452, DOI 10.1074/jbc.M111.277764	50	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6272	6283		10.1074/jbc.M112.440024	http://dx.doi.org/10.1074/jbc.M112.440024			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23319598	Green Published, hybrid			2022-12-25	WOS:000315820700022
J	Tabares, LC; Un, S				Tabares, Leandro C.; Un, Sun			In Situ Determination of Manganese(II) Speciation in Deinococcus radiodurans by High Magnetic Field EPR DETECTION OF HIGH LEVELS OF Mn(II) BOUND TO PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS RESISTANCE; SUPEROXIDE DISMUTASES; BINDING; RESONANCE; MN(II)	High magnetic field high frequency electron paramagnetic resonance techniques were used to measure in situ Mn(II) speciation in Deinococcus radiodurans, a radiation-resistant bacteria capable of accumulating high concentrations of Mn(II). It was possible to identify and quantify the evolution of Mn(II) species in intact cells at various stages of growth. Aside from water, 95-GHz high field electron nuclear double resonance showed that the Mn(II) ions are bound to histidines and phosphate groups, mostly from fructose-1,6-bisphosphate but also inorganic phosphates and nucleotides. During stationary growth phase, 285-GHz continuous wave EPR measurements showed that histidine is the most common ligand to Mn(II) and that significant amounts of cellular Mn(II) in D. radiodurans are bound to peptides and proteins. As much as 40% of the total Mn(II) was in manganese superoxide dismutase, and it is this protein and not smaller manganese complexes, as has been suggested recently, that is probably the primary defense against superoxide.	[Tabares, Leandro C.; Un, Sun] CEA Saclay, Inst Biol & Technol Saclay, Serv Bioenerget Biol Struct & Mecanismes, CNRS,UMR 8221, F-91191 Gif Sur Yvette, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Tabares, LC (corresponding author), CEA Saclay, Inst Biol & Technol Saclay, Serv Bioenerget Biol Struct & Mecanismes, CNRS,UMR 8221, F-91191 Gif Sur Yvette, France.	leandro.tabares@cea.fr; sun.un@cea.fr	Tabares, Leandro C/A-6368-2009	Tabares, Leandro C/0000-0002-8906-6430	Agence Nationale de la Recherche [2011 BSV5 013 01]; CNRS; Region Ile-de-France; CEA	Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Ile-de-France(Region Ile-de-France); CEA(French Atomic Energy Commission)	This work was partially financed by the Agence Nationale de la Recherche it has been possible to measure Mn(II) speciation in situ at (Contract Number 2011 BSV5 013 01) and CNRS (Programme "Interface PCB") and the spectrometers were funded by the Region Ile-de-France (Programme Sesame), CEA, and CNRS.	ARCHIBALD FS, 1981, J BACTERIOL, V145, P442, DOI 10.1128/JB.145.1.442-451.1981; Barnese K, 2008, J AM CHEM SOC, V130, P4604, DOI 10.1021/ja710162n; Barnese K, 2012, P NATL ACAD SCI USA, V109, P6892, DOI 10.1073/pnas.1203051109; Bennati M, 2005, REP PROG PHYS, V68, P411, DOI 10.1088/0034-4885/68/2/R05; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; BERLETT BS, 1990, P NATL ACAD SCI USA, V87, P389, DOI 10.1073/pnas.87.1.389; Blasius M, 2008, CRIT REV BIOCHEM MOL, V43, P221, DOI [10.1080/10409230802122274, 10.1080/10409230802122274 ]; Chen HA, 2010, BIOCHEM BIOPH RES CO, V396, P413, DOI 10.1016/j.bbrc.2010.04.106; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; Daly MJ, 2007, PLOS BIOL, V5, P769, DOI 10.1371/journal.pbio.0050092; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Daly MJ, 2009, NAT REV MICROBIOL, V7, P237, DOI 10.1038/nrmicro2073; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Davey CA, 2002, P NATL ACAD SCI USA, V99, P11169, DOI 10.1073/pnas.172271399; DAVIES ER, 1974, PHYS LETT A, VA 47, P1, DOI 10.1016/0375-9601(74)90078-4; de Almeida CB, 2002, MOL GENET GENOMICS, V268, P28, DOI 10.1007/s00438-002-0718-x; Horsburgh MJ, 2002, TRENDS MICROBIOL, V10, P496, DOI 10.1016/S0966-842X(02)02462-9; IMLAY JA, 1991, J BIOL CHEM, V266, P6957; Kruger A, 2011, ANTIOXID REDOX SIGN, V15, P311, DOI 10.1089/ars.2010.3797; LEIBOWITZ PJ, 1976, PHOTOCHEM PHOTOBIOL, V23, P45; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Markillie LM, 1999, J BACTERIOL, V181, P666, DOI 10.1128/JB.181.2.666-669.1999; McNaughton RL, 2010, P NATL ACAD SCI USA, V107, P15335, DOI 10.1073/pnas.1009648107; Millonig H, 2009, J INORG BIOCHEM, V103, P876, DOI 10.1016/j.jinorgbio.2009.03.004; MIMS WB, 1965, PROC R SOC LON SER-A, V283, P452, DOI 10.1098/rspa.1965.0034; Mounicou S, 2009, CHEM SOC REV, V38, P1119, DOI 10.1039/b713633c; Potapov A, 2006, APPL MAGN RESON, V30, P461, DOI 10.1007/BF03166212; Robinson CK, 2011, J BACTERIOL, V193, P1653, DOI 10.1128/JB.01310-10; Schiemann O, 2007, APPL MAGN RESON, V31, P543, DOI 10.1007/BF03166601; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Sun HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035057; Tabares LC, 2010, BBA-PROTEINS PROTEOM, V1804, P308, DOI 10.1016/j.bbapap.2009.09.027; Tabares LC, 2009, J PHYS CHEM B, V113, P9016, DOI 10.1021/jp9021807; Un S, 2004, J AM CHEM SOC, V126, P2720, DOI 10.1021/ja036503x; Un S, 2001, APPL MAGN RESON, V21, P341, DOI 10.1007/BF03162413; Volkmer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023126	36	32	33	1	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5050	5055		10.1074/jbc.C112.444992	http://dx.doi.org/10.1074/jbc.C112.444992			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23303180	Green Published, hybrid			2022-12-25	WOS:000315340400052
J	Caballero, I; Al Ghareeb, S; Basatvat, S; Sanchez-Lopez, JA; Montazeri, M; Maslehat, N; Elliott, S; Chapman, NR; Fazeli, A				Caballero, Ignacio; Al Ghareeb, Sumiah; Basatvat, Shaghayegh; Sanchez-Lopez, Javier A.; Montazeri, Mehrnaz; Maslehat, Nasim; Elliott, Sarah; Chapman, Neil R.; Fazeli, Alireza			Human Trophoblast Cells Modulate Endometrial Cells Nuclear Factor kappa B Response to Flagellin In Vitro	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; UTERINE RECEPTIVITY; ENDOGENOUS LIGANDS; IMPLANTATION; ACTIVATION; PREGNANCY; TRANSCRIPTION; ATTACHMENT; EXPRESSION; EPITHELIUM	Background: Implantation is a complex process that requires a delicate cooperation between the immune and reproductive system. Any interference in the fine balance could result in embryo loss and infertility. We have recently shown that Toll-like receptor 5 activation results in a decrease of trophoblast cells binding to endometrial cells in an in vitro model of human implantation. However, little is known about the downstream signalling leading to the observed failure in implantation and the factors that modulate this immune response. Methods and Principal Findings: An in vitro model of embryo implantation was used to evaluate the effect of trophoblasts and flagellin on the activation of NF-kappa B in endometrial cells and whether TLR5-related in vitro implantation failure is signalled through NF-kappa B. We generated two different NF-kappa B reporting cell lines by transfecting either an immortalized endometrial epithelial cell line (hTERT-EECs) or a human endometrial carcinoma cell line (Ishikawa 3-H-12) with a plasmid containing the secreted alkaline phosphatase (SEAP) under the control of five NF-kappa B sites. The presence of trophoblast cells as well as flagellin increased NF-kappa B activity when compared to controls. The NF-kappa B activation induced by flagellin was further increased by the addition of trophoblast cells. Moreover, blocking NF-kappa B signalling with a specific inhibitor (BAY11-7082) was able to restore the binding ability of our trophoblast cell line to the endometrial monolayer. Conclusions: These are the first results showing a local effect of the trophoblasts on the innate immune response of the endometrial epithelium. Moreover, we show that implantation failure caused by intrauterine infections could be associated with abnormal levels of NF-kappa B activation. Further studies are needed to evaluate the target genes through which NF-kappa B activation after TLR5 stimulation lead to failure in implantation and the effect of the embryo on those genes. Understanding these pathways could help in the diagnosis and treatment of implantation failure cases.	[Caballero, Ignacio; Al Ghareeb, Sumiah; Basatvat, Shaghayegh; Sanchez-Lopez, Javier A.; Montazeri, Mehrnaz; Maslehat, Nasim; Elliott, Sarah; Chapman, Neil R.; Fazeli, Alireza] Univ Sheffield, Sch Med, Dept Human Metab, Acad Unit Reprod & Dev Med, Sheffield, S Yorkshire, England	University of Sheffield	Fazeli, A (corresponding author), Univ Sheffield, Sch Med, Dept Human Metab, Acad Unit Reprod & Dev Med, Sheffield, S Yorkshire, England.	A.Fazeli@Sheffield.ac.uk	Fazeli, Alireza/G-3679-2010	Fazeli, Alireza/0000-0003-0870-9914; Basatvat, Shaghayegh/0000-0001-6201-4588; Chapman, Neil/0000-0002-4853-2909; Sanchez-Lopez, Javier Arturo/0000-0003-4684-1238; Caballero, Ignacio/0000-0002-0628-4134	Marie Curie [IIF-253948]	Marie Curie(European Commission)	This research was supported by Marie Curie IIF-253948. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboussahoud W, 2010, HUM REPROD, V25, P2217, DOI 10.1093/humrep/deq185; Aboussahoud W, 2010, J REPROD IMMUNOL, V84, P41, DOI 10.1016/j.jri.2009.09.008; Aflatoonian R, 2007, HUM REPROD, V22, P586, DOI 10.1093/humrep/del388; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Carvalho FA, 2011, MUCOSAL IMMUNOL, V4, P102, DOI 10.1038/mi.2010.57; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Fazleabas AT, 2004, PLACENTA, V25, pS26, DOI 10.1016/j.placenta.2004.01.014; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; GRUMMER R, 1994, PLACENTA, V15, P411, DOI 10.1016/0143-4004(94)90008-6; Guimond MJ, 1998, J EXP MED, V187, P217, DOI 10.1084/jem.187.2.217; Hohn HP, 2000, MOL REPROD DEV, V57, P135; Hombach-Klonisch S, 2005, J MOL ENDOCRINOL, V34, P517, DOI 10.1677/jme.1.01550; Jarvis JN, 1998, PEDIATR RES, V43, P509, DOI 10.1203/00006450-199804000-00012; JOHN NJ, 1993, IN VITRO CELL DEV-AN, V29A, P461, DOI 10.1007/BF02639380; Kalkhoven E, 1996, J BIOL CHEM, V271, P6217, DOI 10.1074/jbc.271.11.6217; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Klein C, 2006, BIOL REPROD, V74, P253, DOI 10.1095/biolreprod.105.046748; Koga K, 2009, J OBSTET GYNAECOL RE, V35, P191, DOI 10.1111/j.1447-0756.2008.00963.x; Korch C, 2012, GYNECOL ONCOL, V127, P241, DOI 10.1016/j.ygyno.2012.06.017; Kwak-Kim J, 2010, AM J REPROD IMMUNOL, V63, P611, DOI 10.1111/j.1600-0897.2010.00847.x; Ledee-Bataille N, 2002, HUM REPROD, V17, P213, DOI 10.1093/humrep/17.1.213; Lessey BA, 1996, FERTIL STERIL, V65, P477, DOI 10.1016/S0015-0282(16)58140-0; LIBRACH CL, 1994, J BIOL CHEM, V269, P17125; Meter RA, 2007, FERTIL STERIL, V88, pS40, DOI 10.1016/j.fertnstert.2007.07.144; Nakamura H, 2004, BIOCHEM BIOPH RES CO, V321, P886, DOI 10.1016/j.bbrc.2004.07.045; Nakamura H, 2004, AM J REPROD IMMUNOL, V51, P16, DOI 10.1046/j.8755-8920.2003.00116.x; Piccinini AM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/672395; Robertson SA, 2011, AM J REPROD IMMUNOL, V66, P2, DOI 10.1111/j.1600-0897.2011.01039.x; Ross JW, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-39; Ross JW, 2003, BIOL REPROD, V69, P1251, DOI 10.1095/biolreprod.103.015842; SHYAMALA G, 1992, P NATL ACAD SCI USA, V89, P10628, DOI 10.1073/pnas.89.22.10628; Simon C, 1998, FERTIL STERIL, V70, P896, DOI 10.1016/S0015-0282(98)00275-1; Singh M, 2011, J ENDOCRINOL, V210, P5, DOI 10.1530/JOE-10-0461; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; SMITH MF, 1994, J IMMUNOL, V153, P3584; Staun-Ram E, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-56; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Teklenburg G, 2010, MOL HUM REPROD, V16, P886, DOI 10.1093/molehr/gaq079; Thie M, 1998, HUM REPROD, V13, P3211, DOI 10.1093/humrep/13.11.3211; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Walker CG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-474; Zhang JH, 2007, J REPROD IMMUNOL, V74, P61, DOI 10.1016/j.jri.2006.10.005	45	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e39441	10.1371/journal.pone.0039441	http://dx.doi.org/10.1371/journal.pone.0039441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320062	Green Published, gold			2022-12-25	WOS:000313429800001
J	Makarov, V; Rakitina, D; Protopopova, A; Yaminsky, I; Arutiunian, A; Love, AJ; Taliansky, M; Kalinina, N				Makarov, Valentine; Rakitina, Daria; Protopopova, Anna; Yaminsky, Igor; Arutiunian, Alexander; Love, Andrew J.; Taliansky, Michael; Kalinina, Natalia			Plant Coilin: Structural Characteristics and RNA-Binding Properties	PLOS ONE			English	Article							CIRCULAR-DICHROISM SPECTRA; CAJAL BODIES; SECONDARY STRUCTURE; BODY FORMATION; PROTEIN; PHOSPHORYLATION; SNRNPS; DOMAIN; SMN; INTERMEDIATE	Cajal bodies (CBs) are dynamic subnuclear compartments involved in the biogenesis of ribonucleoproteins. Coilin is a major structural scaffolding protein necessary for CB formation, composition and activity. The predicted secondary structure of Arabidopsis thaliana coilin (Atcoilin) suggests that the protein is composed of three main domains. Analysis of the physical properties of deletion mutants indicates that Atcoilin might consist of an N-terminal globular domain, a central highly disordered domain and a C-terminal domain containing a presumable Tudor-like structure adjacent to a disordered C terminus. Despite the low homology in amino acid sequences, a similar type of domain organization is likely shared by human and animal coilin proteins and coilin-like proteins of various plant species. Atcoilin is able to bind RNA effectively and in a non-specific manner. This activity is provided by three RNA-binding sites: two sets of basic amino acids in the N-terminal domain and one set in the central domain. Interaction with RNA induces the multimerization of the Atcoilin molecule, a consequence of the structural alterations in the N-terminal domain. The interaction with RNA and subsequent multimerization may facilitate coilin's function as a scaffolding protein. A model of the N-terminal domain is also proposed.	[Makarov, Valentine; Arutiunian, Alexander; Kalinina, Natalia] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia; [Makarov, Valentine; Rakitina, Daria] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia; [Protopopova, Anna; Yaminsky, Igor] Moscow MV Lomonosov State Univ, Fac Phys, Moscow, Russia; [Love, Andrew J.; Taliansky, Michael] James Hutton Inst, Dundee, Scotland	Lomonosov Moscow State University; Lomonosov Moscow State University; Lomonosov Moscow State University; James Hutton Institute	Rakitina, D (corresponding author), Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia.	rakitina@genebee.msu.ru; kalinina@genebee.msu.ru	Protopopova, Anna D/J-4764-2013; Taliansky, Michael/H-8483-2013; Yaminsky, Igor/H-7857-2013	Protopopova, Anna D/0000-0003-3729-4922; Yaminsky, Igor/0000-0001-8731-3947; Rakitina, Daria/0000-0003-3554-7690	RFBR [10-04-0522a]; Scottish Government Rural and Environmental Science and Analytical Services Division	RFBR(Russian Foundation for Basic Research (RFBR)); Scottish Government Rural and Environmental Science and Analytical Services Division	This work was supported by RFBR grant 10-04-0522a. The work of A.J.L. and M. T. was supported by funding from Scottish Government Rural and Environmental Science and Analytical Services Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRADE LEC, 1991, J EXP MED, V173, P1407, DOI 10.1084/jem.173.6.1407; [Anonymous], [No title captured]; Barilla D, 2005, EMBO J, V24, P1453, DOI 10.1038/sj.emboj.7600619; Bellini M, 1998, MOL BIOL CELL, V9, P2987, DOI 10.1091/mbc.9.10.2987; Broome HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036300; CARMOFONSECA M, 1993, J CELL BIOL, V120, P841, DOI 10.1083/jcb.120.4.841; Carrero ZI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025743; Collier S, 2006, MOL BIOL CELL, V17, P2942, DOI 10.1091/mbc.E05-12-1157; Hearst SM, 2009, J CELL SCI, V122, P1872, DOI 10.1242/jcs.044040; Hebert MD, 2002, DEV CELL, V3, P329, DOI 10.1016/S1534-5807(02)00222-8; Hebert MD, 2001, GENE DEV, V15, P2720, DOI 10.1101/gad.908401; Hebert MD, 2000, MOL BIOL CELL, V11, P4159, DOI 10.1091/mbc.11.12.4159; Hebert MD, 2010, ARCH BIOCHEM BIOPHYS, V496, P69, DOI 10.1016/j.abb.2010.02.012; JOHNSON WC, 1988, ANNU REV BIOPHYS BIO, V17, P145, DOI 10.1146/annurev.bb.17.060188.001045; Kaiser TE, 2008, SCIENCE, V322, P1713, DOI 10.1126/science.1165216; Lam YW, 2002, MOL BIOL CELL, V13, P2461, DOI 10.1091/mbc.02-03-0034; Lemm I, 2006, MOL BIOL CELL, V17, P3221, DOI 10.1091/mbc.E06-03-0247; Liu JL, 2009, MOL BIOL CELL, V20, P1661, DOI 10.1091/mbc.E08-05-0525; Makalowski W, 1998, P NATL ACAD SCI USA, V95, P9407, DOI 10.1073/pnas.95.16.9407; Matera AG, 1998, J CELL BIOCHEM, V70, P181; Nizami Z, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000653; OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Rea AM, 2008, BIOCHEMISTRY-US, V47, P8225, DOI 10.1021/bi800722d; Roy S, 1995, Subcell Biochem, V24, P101; Royer CA, 2006, CHEM REV, V106, P1769, DOI 10.1021/cr0404390; Shanbhag R, 2010, FEBS LETT, V584, P4351, DOI 10.1016/j.febslet.2010.09.034; Shpargel KB, 2003, J CELL SCI, V116, P303, DOI 10.1242/jcs.00211; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; Stanek D, 2006, CHROMOSOMA, V115, P343, DOI 10.1007/s00412-006-0056-6; Strzelecka M, 2010, NUCLEUS-PHILA, V1, P96, DOI 10.4161/nucl.1.1.10680; Toyota CG, 2010, CHROMOSOMA, V119, P205, DOI 10.1007/s00412-009-0249-x; Tucker KE, 2000, J STRUCT BIOL, V129, P269, DOI 10.1006/jsbi.2000.4234; Tucker KE, 2001, J CELL BIOL, V154, P293, DOI 10.1083/jcb.200104083; TUMA RS, 1993, J CELL BIOL, V122, P767, DOI 10.1083/jcb.122.4.767; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Vallee-Belisle A, 2007, J MOL BIOL, V374, P791, DOI 10.1016/j.jmb.2007.09.018; Velma V, 2010, FEBS LETT, V584, P4735, DOI 10.1016/j.febslet.2010.11.004; Walker MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006171; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Whittom AA, 2008, CELL MOL LIFE SCI, V65, P1256, DOI 10.1007/s00018-008-7587-3; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; Xu HZ, 2005, CHROMOSOMA, V114, P155, DOI 10.1007/s00412-005-0003-y; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200	46	22	25	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53571	10.1371/journal.pone.0053571	http://dx.doi.org/10.1371/journal.pone.0053571			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320094	Green Submitted, gold, Green Published			2022-12-25	WOS:000313429800059
J	Schumacher, J; Gautier, A; Morgant, G; Studt, L; Ducrot, PH; Le Pecheur, P; Azeddine, S; Fillinger, S; Leroux, P; Tudzynski, B; Viaud, M				Schumacher, Julia; Gautier, Angelique; Morgant, Guillaume; Studt, Lena; Ducrot, Paul-Henri; Le Pecheur, Pascal; Azeddine, Saad; Fillinger, Sabine; Leroux, Pierre; Tudzynski, Bettina; Viaud, Muriel			A Functional Bikaverin Biosynthesis Gene Cluster in Rare Strains of Botrytis cinerea Is Positively Controlled by VELVET	PLOS ONE			English	Article							BOTRYOTINIA-FUCKELIANA; SECONDARY METABOLISM; MOLECULAR PHYLOGENY; HORIZONTAL TRANSFER; GRAY MOLD; FUNGAL; ACID; EVOLUTION; MELANIN; IDENTIFICATION	The gene cluster responsible for the biosynthesis of the red polyketidic pigment bikaverin has only been characterized in Fusarium ssp. so far. Recently, a highly homologous but incomplete and nonfunctional bikaverin cluster has been found in the genome of the unrelated phytopathogenic fungus Botrytis cinerea. In this study, we provided evidence that rare B. cinerea strains such as 1750 have a complete and functional cluster comprising the six genes orthologous to Fusarium fujikuroi ffbik1-ffbik6 and do produce bikaverin. Phylogenetic analysis confirmed that the whole cluster was acquired from Fusarium through a horizontal gene transfer (HGT). In the bikaverin-nonproducing strain B05.10, the genes encoding bikaverin biosynthesis enzymes are nonfunctional due to deleterious mutations (bcbik2-3) or missing (bcbik1) but interestingly, the genes encoding the regulatory proteins BcBIK4 and BcBIK5 do not harbor deleterious mutations which suggests that they may still be functional. Heterologous complementation of the F. fujikuroi Delta ffbik4 mutant confirmed that bcbik4 of strain B05.10 is indeed fully functional. Deletion of bcvel1 in the pink strain 1750 resulted in loss of bikaverin and overproduction of melanin indicating that the VELVET protein BcVEL1 regulates the biosynthesis of the two pigments in an opposite manner. Although strain 1750 itself expresses a truncated BcVEL1 protein (100 instead of 575 aa) that is nonfunctional with regard to sclerotia formation, virulence and oxalic acid formation, it is sufficient to regulate pigment biosynthesis (bikaverin and melanin) and fenhexamid HydR2 type of resistance. Finally, a genetic cross between strain 1750 and a bikaverin-nonproducing strain sensitive to fenhexamid revealed that the functional bikaverin cluster is genetically linked to the HydR2 locus.	[Schumacher, Julia; Studt, Lena; Tudzynski, Bettina] Univ Munster, Inst Biol & Biotechnol Plants, D-48149 Munster, Germany; [Gautier, Angelique; Morgant, Guillaume; Le Pecheur, Pascal; Azeddine, Saad; Fillinger, Sabine; Leroux, Pierre; Viaud, Muriel] INRA, UR BIOGER CPP, F-78850 Thiverval Grignon, France; [Studt, Lena] Univ Munster, Inst Food Chem, D-48149 Munster, Germany; [Ducrot, Paul-Henri] INRA, IJPB, F-78026 Versailles, France	University of Munster; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Munster; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Tudzynski, B (corresponding author), Univ Munster, Inst Biol & Biotechnol Plants, D-48149 Munster, Germany.	bettina.tudzynski@uni-muenster.de; viaud@versailles.inra.fr	Schumacher, Julia/B-9142-2019; Studt, Lena/AAE-3991-2021	Schumacher, Julia/0000-0001-9120-9675; Studt-Reinhold, Lena/0000-0002-8738-2106; Fillinger, Sabine/0000-0003-4683-0803				Albertini C, 2004, EUR J PLANT PATHOL, V110, P723, DOI 10.1023/B:EJPP.0000041567.94140.05; Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; BALAN J, 1970, Folia Microbiologica, V15, P479, DOI 10.1007/BF02880192; Barnes B, 1930, ANN BOT-LONDON, V44, P825, DOI 10.1093/oxfordjournals.aob.a090252; Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Bayram O, 2012, FEMS MICROBIOL REV, V36, P1, DOI 10.1111/j.1574-6976.2011.00285.x; Butler MJ, 1998, CAN J MICROBIOL, V44, P1115, DOI 10.1139/cjm-44-12-1115; Campbell MA, 2012, GENOME BIOL EVOL, V4, P289, DOI 10.1093/gbe/evs011; Limon MC, 2010, APPL MICROBIOL BIOT, V87, P21, DOI 10.1007/s00253-010-2551-1; Choi YE, 2008, MYCOLOGIA, V100, P701, DOI 10.3852/08-015; Choi YE, 2011, APPL ENVIRON MICROB, V77, P942, DOI 10.1128/AEM.01830-10; CORNFORTH JW, 1971, J CHEM SOC C, P2786, DOI 10.1039/j39710002786; DARKEN MA, 1959, APPL MICROBIOL, V7, P301, DOI 10.1128/AEM.7.5.301-303.1959; Debieu D, 2001, PEST MANAG SCI, V57, P1060, DOI 10.1002/ps.394; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Doss RP, 2003, PHYTOCHEMISTRY, V63, P687, DOI 10.1016/S0031-9422(03)00323-6; FARETRA F, 1988, J GEN MICROBIOL, V134, P2543; Fillinger S, 2008, ANTIMICROB AGENTS CH, V52, P3933, DOI 10.1128/AAC.00615-08; Fox EM, 2008, CURR OPIN MICROBIOL, V11, P481, DOI 10.1016/j.mib.2008.10.007; Gao Q, 2011, NAT REV MICROBIOL, V9, P791, DOI 10.1038/nrmicro2649; GEISSMAN TA, 1966, PHYTOCHEMISTRY, V5, P933, DOI 10.1016/S0031-9422(00)82790-9; GRINDLE M, 1979, J GEN MICROBIOL, V111, P109, DOI 10.1099/00221287-111-1-109; He S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028291, 10.1371/journal.pone.0020107]; Hearld FD, 1926, PHYTOPATHOLOGY, V16, P485; HEWITT TG, 1971, J CHEM SOC A, P817, DOI 10.1039/j19710000817; Hoffmeister D, 2007, NAT PROD REP, V24, P393, DOI 10.1039/b603084j; Khaldi N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r18; Kohut G, 2010, J BASIC MICROB, V50, P59, DOI 10.1002/jobm.200900113; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Lawrence DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028231; Leroux P, 2002, PEST MANAG SCI, V58, P876, DOI 10.1002/ps.566; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Linnemannstons P, 2002, FUNGAL GENET BIOL, V37, P134, DOI 10.1016/S1087-1845(02)00501-7; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Malz S, 2005, FUNGAL GENET BIOL, V42, P420, DOI 10.1016/j.fgb.2005.01.010; Merhej J, 2012, MOL PLANT PATHOL, V13, P363, DOI 10.1111/j.1364-3703.2011.00755.x; Mukherjee PK, 2010, APPL ENVIRON MICROB, V76, P2345, DOI 10.1128/AEM.02391-09; Musavi M., 1991, APPL BIOCH MICROBIOL, V27, P255; Osbourn A, 2010, TRENDS GENET, V26, P449, DOI 10.1016/j.tig.2010.07.001; Palmer JM, 2010, CURR OPIN MICROBIOL, V13, P431, DOI 10.1016/j.mib.2010.04.008; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Quidde T, 1999, EUR J PLANT PATHOL, V105, P273, DOI 10.1023/A:1008796006051; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schumacher J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047840; Schumacher J, 2012, FUNGAL GENET BIOL, V49, P483, DOI 10.1016/j.fgb.2012.03.005; Siewers V, 2004, APPL ENVIRON MICROB, V70, P3868, DOI 10.1128/AEM.70.7.3868-3876.2004; Slot JC, 2011, CURR BIOL, V21, P134, DOI 10.1016/j.cub.2010.12.020; Soanes DM, 2007, PLANT CELL, V19, P3318, DOI 10.1105/tpc.107.056663; Son SW, 2008, J APPL MICROBIOL, V104, P692, DOI 10.1111/j.1365-2672.2007.03581.x; Staats M, 2005, MOL BIOL EVOL, V22, P333, DOI 10.1093/molbev/msi020; Studt L, 2012, APPL ENVIRON MICROB, V78, P4468, DOI 10.1128/AEM.00823-12; Tudzynski B, 1999, MOL GEN GENET, V261, P106, DOI 10.1007/s004380050950; Walker AS, 2011, PHYTOPATHOLOGY, V101, P1433, DOI 10.1094/PHYTO-04-11-0104; Walton JD, 2000, FUNGAL GENET BIOL, V30, P167, DOI 10.1006/fgbi.2000.1224; Watanabe M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-322; Wiemann P, 2009, MOL MICROBIOL, V72, P931, DOI 10.1111/j.1365-2958.2009.06695.x; Wu DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002542; ZEUN R, 1985, PHYTOPATHOL Z, V112, P259	59	51	51	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53729	10.1371/journal.pone.0053729	http://dx.doi.org/10.1371/journal.pone.0053729			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308280	gold, Green Published, Green Submitted			2022-12-25	WOS:000313429100112
J	Siddique, HR; Parray, A; Zhong, WX; Karnes, RJ; Bergstralh, EJ; Koochekpour, S; Rhim, JS; Konety, BR; Saleem, M				Siddique, Hifzur Rahman; Parray, Aijaz; Zhong, Weixiong; Karnes, R. Jeffery; Bergstralh, Eric J.; Koochekpour, Shahriar; Rhim, Johng S.; Konety, Badrinath R.; Saleem, Mohammad			BMI1, Stem Cell Factor Acting as Novel Serum-biomarker for Caucasian and African-American Prostate Cancer	PLOS ONE			English	Article							ANTIGEN; MEN; TRANSFORMATION; EXPRESSION; ESTABLISHMENT; MANAGEMENT; SURROGACY; INHIBITOR; PROGNOSIS; CARCINOMA	Background: Lack of reliable predictive biomarkers is a stumbling block in the management of prostate cancer (CaP). Prostate-specific antigen (PSA) widely used in clinics has several caveats as a CaP biomarker. African-American CaP patients have poor prognosis than Caucasians, and notably the serum-PSA does not perform well in this group. Further, some men with low serum-PSA remain unnoticed for CaP until they develop disease. Thus, there is a need to identify a reliable diagnostic and predictive biomarker of CaP. Here, we show that BMI1 stem-cell protein is secretory and could be explored for biomarker use in CaP patients. Methodology/Principal Findings: Semi-quantitative analysis of BMI1 was performed in prostatic tissues of TRAMP (autochthonous transgenic mouse model), human CaP patients, and in cell-based models representing normal and different CaP phenotypes in African-American and Caucasian men, by employing immunohistochemistry, immunoblotting and Slot-blotting. Quantitative analysis of BMI1 and PSA were performed in blood and culture-media of siRNA-transfected and non-transfected cells by employing ELISA. BMI1 protein is (i) secreted by CaP cells, (ii) increased in the apical region of epithelial cells and stromal region in prostatic tumors, and (iii) detected in human blood. BMI1 is detectable in blood of CaP patients in an order of increasing tumor stage, exhibit a positive correlation with serum-PSA and importantly is detectable in patients which exhibit low serum-PSA. The clinical significance of BMI1 as a biomarker could be ascertained from observation that CaP cells secrete this protein in higher levels than cells representative of benign prostatic hyperplasia (BPH). Conclusions/Significance: BMI1 could be developed as a dual bio-marker (serum and biopsy) for the diagnosis and prognosis of CaP in Caucasian and African-American men. Though compelling these data warrant further investigation in a cohort of African-American patients.	[Siddique, Hifzur Rahman; Parray, Aijaz; Saleem, Mohammad] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Zhong, Weixiong] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [Karnes, R. Jeffery] Mayo Clin & Mayo Fdn, Mayo Med Sch, Dept Urol, Rochester, MN 55905 USA; [Karnes, R. Jeffery; Bergstralh, Eric J.] Mayo Clin, Rochester, MN USA; [Bergstralh, Eric J.] Mayo Clin & Mayo Fdn, Mayo Med Sch, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Koochekpour, Shahriar] Roswell Pk Canc Inst, Ctr Genet & Pharmacol, Buffalo, NY 14263 USA; [Rhim, Johng S.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [Konety, Badrinath R.; Saleem, Mohammad] Univ Minnesota, Dept Urol, Minneapolis, MN USA; [Saleem, Mohammad] Univ Minnesota, Dept Lab Med Pathol, Minneapolis, MN USA	University of Minnesota System; University of Wisconsin System; University of Wisconsin Madison; Mayo Clinic; Mayo Clinic; Mayo Clinic; Roswell Park Cancer Institute; Uniformed Services University of the Health Sciences - USA; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Saleem, M (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	msbhat@umn.edu	Saleem, Mohammad/GVS-9221-2022; Siddique, Hifzur R/H-4049-2019	Saleem, Mohammad/0000-0002-7422-7967; Siddique, Hifzur R/0000-0001-8736-0487	Department of Defense CDMRP [W81XWH-08-1-0605]	Department of Defense CDMRP(United States Department of Defense)	This work was in part supported by the Department of Defense CDMRP grant W81XWH-08-1-0605 to the corresponding author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong AJ, 2007, J CLIN ONCOL, V25, P3965, DOI 10.1200/JCO.2007.11.4769; Armstrong AJ, 2012, EUR UROL, V61, P549, DOI 10.1016/j.eururo.2011.11.009; Asbell SO, 2000, J NATL MED ASSOC, V92, P445; Balk SP, 2003, J CLIN ONCOL, V21, P383, DOI 10.1200/JCO.2003.02.083; Bickers B, 2009, ANTICANCER RES, V29, P3289; Bigler SA, 2011, PROSTATE CANCER, V2011, DOI 10.1155/2011/239460; Campbell PM, 2007, CANCER RES, V67, P2098, DOI 10.1158/0008-5472.CAN-06-3752; Casanova-Salas I, 2012, CLIN TRANSL ONCOL; Cenci T, 2012, AM J CLIN PATHOL, V138, P390, DOI 10.1309/AJCPRXHNJQLO09QA; Fowler JE, 2002, CANCER, V94, P1661, DOI 10.1002/cncr.10446; Fradet Y, 2009, CURR OPIN UROL, V19, P243, DOI 10.1097/MOU.0b013e32832a08b5; Gaston KE, 2003, J UROLOGY, V170, P990, DOI 10.1097/01.ju.0000079761.56154.e5; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Hayward SW, 2001, CANCER RES, V61, P8135; Kang MK, 2007, BRIT J CANCER, V96, P126, DOI 10.1038/sj.bjc.6603529; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Koochekpour S, 2004, PROSTATE, V60, P141, DOI 10.1002/pros.20053; Levy David A, 2011, Curr Urol Rep, V12, P197, DOI 10.1007/s11934-011-0177-1; Madu CO, 2010, J CANCER, V1, P150; Meulenbeld HJ, 2013, BJU INT, V111, P44, DOI 10.1111/j.1464-410X.2012.11404.x; Parray A, 2012, BIOL-TARGETS THER, V6, P267, DOI 10.2147/BTT.S23954; Petrylak DP, 2006, J NATL CANCER I, V98, P516, DOI 10.1093/jnci/djj129; Saleem M, 2006, CANCER EPIDEM BIOMAR, V15, P217, DOI 10.1158/1055-9965.EPI-05-0737; Sasaki T, 2005, EUR UROL, V48, P224, DOI 10.1016/j.eururo.2005.03.017; Shariat SF, 2011, ACTA ONCOL, V50, P61, DOI 10.3109/0284186X.2010.542174; Siddique HR, 2012, INT J CANCER, V131, P1720, DOI 10.1002/ijc.27409; Siddique HR, 2012, STEM CELLS, V30, P372, DOI 10.1002/stem.1035; Siddique HR, 2011, CLIN CANCER RES, V17, P5379, DOI 10.1158/1078-0432.CCR-11-0916; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Smith DS, 1998, J UROLOGY, V160, P1734, DOI 10.1016/S0022-5347(01)62395-4; Spiess PE, 2007, CANCER-AM CANCER SOC, V110, P1729, DOI 10.1002/cncr.22971; Taplin ME, 2005, UROLOGY, V66, P386, DOI 10.1016/j.urology.2005.03.040; Theodore S, 2010, INT J ONCOL, V37, P1477, DOI 10.3892/ijo_00000800; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918	34	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e52993	10.1371/journal.pone.0052993	http://dx.doi.org/10.1371/journal.pone.0052993			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308129	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429100022
J	Condren, AB; Kumar, A; Mettu, P; Liang, KJ; Zhao, L; Tsai, JY; Fariss, RN; Wong, WT				Condren, Audrey B.; Kumar, Anil; Mettu, Pradeep; Liang, Katharine J.; Zhao, Lian; Tsai, Jen-yue; Fariss, Robert N.; Wong, Wai T.			Perivascular Mural Cells of the Mouse Choroid Demonstrate Morphological Diversity That Is Correlated to Vasoregulatory Function	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; SMOOTH-MUSCLE-CELLS; MACULAR DEGENERATION; BLOOD-FLOW; HUMAN EYE; MORPHOMETRIC-ANALYSIS; CILIARY GANGLION; BRUCHS MEMBRANE; NITRIC-OXIDE; PERICYTES	Objective: Perivascular mural cells of the choroid have been implicated in physiological functioning as well as in retinal disease pathogenesis. However details regarding their form and function are not well understood. We aim to characterize choroidal mural cells in the adult mouse choroid in terms of their distribution and morphology, and correlate these to their contractile behavior. Methods: Sclerochoroidal flat-mounted explants were prepared from albino transgenic mice in which the a-smooth muscle actin (alpha-SMA) promoter drives the expression of green fluorescent protein (GFP). alpha-SMA-expressing smooth muscle cells and pericytes in the living choroid were thereby rendered fluorescent and imaged with confocal microscopy and live-cell imaging in situ. Results: Choroidal perivascular mural cells demonstrate significant diversity in terms of their distribution and morphology at different levels of the vasculature. They range from densely-packed circumferentially-oriented cells that provide complete vascular coverage in primary arteries to widely-spaced stellate-shaped cells that are distributed sparsely over terminal arterioles. Mural cells at each level are immunopositive for contractile proteins alpha-SMA and desmin and demonstrate vasoconstrictory contractile movements in response to endothelin-1 and the calcium ionophore, A23187, and vasodilation in response to the calcium chelator, BAPTA. The prominence of vasoregulatory contractile responses varies with mural cell morphology and density, and is greater in vessels with dense coverage of mural cells with circumferential cellular morphologies. In the choriocapillaris, pericytes demonstrate a sparse, horizontal distribution and are selectively distributed only to the scleral surface of the choriocapillaris. Conclusions: Diversity and regional specialization of perivascular mural cells may subserve varying requirements for vasoregulation in the choroid. The model of the alpha-SMA-GFP transgenic albino mouse provides a useful and intact system for the morphological and functional study of choroidal mural cells.	[Condren, Audrey B.; Kumar, Anil; Mettu, Pradeep; Liang, Katharine J.; Zhao, Lian; Wong, Wai T.] NEI, Unit Neuron Glia Interact Retinal Dis, NIH, Bethesda, MD 20892 USA; [Tsai, Jen-yue; Fariss, Robert N.] NEI, Biol Imaging Core, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Wong, WT (corresponding author), NEI, Unit Neuron Glia Interact Retinal Dis, NIH, Bethesda, MD 20892 USA.	wongw@nei.nih.gov	Fariss, Robert/ABI-1771-2020; Wong, Wai/B-6118-2017	Wong, Wai/0000-0003-0681-4016; Fariss, Robert/0000-0003-3227-7170	National Eye Institute Intramural Research Program; NATIONAL EYE INSTITUTE [ZICEY000459] Funding Source: NIH RePORTER	National Eye Institute Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by the National Eye Institute Intramural Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Berenberg TL, 2012, RETINA-J RET VIT DIS, V32, P25, DOI 10.1097/IAE.0b013e3182150483; Boltz A, 2010, INVEST OPHTH VIS SCI, V51, P4220, DOI 10.1167/iovs.09-4968; Chan-Ling T, 2011, INVEST OPHTH VIS SCI, V52, P399, DOI 10.1167/iovs.10-5403; Ciulla TA, 2002, BRIT J OPHTHALMOL, V86, P209, DOI 10.1136/bjo.86.2.209; Ciulla TA, 2001, ACTA OPHTHALMOL SCAN, V79, P108, DOI 10.1034/j.1600-0420.2001.079002108.x; COGAN DG, 1967, ARCH OPHTHALMOL-CHIC, V78, P133; Curtis TM, 2001, J PHYSIOL-LONDON, V532, P609, DOI 10.1111/j.1469-7793.2001.0609e.x; DAS A, 1988, EXP EYE RES, V46, P349, DOI 10.1016/S0014-4835(88)80025-3; Delaey C, 2000, OPHTHALMIC RES, V32, P249, DOI 10.1159/000055622; Dimitrova G, 2001, EYE, V15, P602, DOI 10.1038/eye.2001.193; EPSTEIN ML, 1988, NEUROSCIENCE, V25, P1053, DOI 10.1016/0306-4522(88)90058-9; FERRARIDILEO G, 1989, INVEST OPHTH VIS SCI, V30, P473; FLUGEL C, 1994, INVEST OPHTH VIS SCI, V35, P592; Grunwald JE, 1998, INVEST OPHTH VIS SCI, V39, P385; Grunwald JE, 2005, INVEST OPHTH VIS SCI, V46, P1033, DOI 10.1167/iovs.04-1050; Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6; Hlushchuk R, 2007, MICROCIRCULATION, V14, P813, DOI 10.1080/10739680701370021; ISHIBASHI T, 1995, ARCH OPHTHALMOL-CHIC, V113, P227, DOI 10.1001/archopht.1995.01100020111041; Jo N, 2006, AM J PATHOL, V168, P2036, DOI 10.2353/ajpath.2006.050588; KELLEY C, 1987, J CELL BIOL, V104, P483, DOI 10.1083/jcb.104.3.483; KILLINGSWORTH MC, 1995, GRAEF ARCH CLIN EXP, V233, P313, DOI 10.1007/BF00200479; Kur J, 2012, PROG RETIN EYE RES, V31, P377, DOI 10.1016/j.preteyeres.2012.04.004; Ladewig MS, 2005, PROSTAG LEUKOTR ESS, V72, P251, DOI 10.1016/j.plefa.2004.11.006; LATIES AM, 1967, ARCH OPHTHALMOL-CHIC, V77, P405, DOI 10.1001/archopht.1967.00980020407021; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; MANCHE EE, 1990, ACTA ANAT, V138, P89; Mata NL, 2010, CURR OPIN OPHTHALMOL, V21, P190, DOI 10.1097/ICU.0b013e32833866c8; May CA, 2004, INVEST OPHTH VIS SCI, V45, P361, DOI 10.1167/iovs.03-0624; MERINEY SD, 1987, J NEUROSCI, V7, P3840; Metelitsina TI, 2008, INVEST OPHTH VIS SCI, V49, P358, DOI 10.1167/iovs.07-0526; Motiejunaite R, 2008, EXP EYE RES, V86, P171, DOI 10.1016/j.exer.2007.10.013; Muir ER, 2012, INVEST OPHTHALMOL VI; Nagaoka T, 2004, BRIT J OPHTHALMOL, V88, P1060, DOI 10.1136/bjo.2003.035345; Nickla DL, 2010, PROG RETIN EYE RES, V29, P144, DOI 10.1016/j.preteyeres.2009.12.002; Nilsson SFE, 1996, INVEST OPHTH VIS SCI, V37, P2110; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Sarks JP, 1997, EYE, V11, P515, DOI 10.1038/eye.1997.137; Schmetterer L, 1998, GRAEF ARCH CLIN EXP, V236, P160, DOI 10.1007/s004170050058; Schocket Lisa S., 2004, International Ophthalmology, V25, P89, DOI 10.1023/B:INTE.0000031744.93778.60; Scholfield CN, 2007, MICROCIRCULATION, V14, P11, DOI 10.1080/10739680601072115; Schrodl F, 2003, INVEST OPHTH VIS SCI, V44, P3705, DOI 10.1167/iovs.03-0232; Seeliger MW, 2005, VISION RES, V45, P3512, DOI 10.1016/j.visres.2005.08.014; Sims DE, 2000, CLIN EXP PHARMACOL P, V27, P842, DOI 10.1046/j.1440-1681.2000.03343.x; SKALLI O, 1989, J HISTOCHEM CYTOCHEM, V37, P315, DOI 10.1177/37.3.2918221; Spraul CW, 1999, SURV OPHTHALMOL, V44, pS10, DOI 10.1016/S0039-6257(99)00086-7; Spraul CW, 1996, INVEST OPHTH VIS SCI, V37, P2724; Wu DM, 2003, AM J PHYSIOL-HEART C, V284, pH2083, DOI 10.1152/ajpheart.01007.2002; YAMAMOTO R, 1993, NEUROSCIENCE, V54, P189, DOI 10.1016/0306-4522(93)90393-T; YE XO, 1990, INVEST OPHTH VIS SCI, V31, P1731; Yokota T, 2006, STEM CELLS, V24, P13, DOI 10.1634/stemcells.2004-0346	51	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53386	10.1371/journal.pone.0053386	http://dx.doi.org/10.1371/journal.pone.0053386			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308209	gold, Green Submitted, Green Published			2022-12-25	WOS:000313670100035
J	Guensch, DP; Fischer, K; Flewitt, JA; Friedrich, MG				Guensch, Dominik P.; Fischer, Kady; Flewitt, Jacqueline A.; Friedrich, Matthias G.			Impact of Intermittent Apnea on Myocardial Tissue Oxygenation-A Study Using Oxygenation-Sensitive Cardiovascular Magnetic Resonance	PLOS ONE			English	Article							CORONARY BLOOD-FLOW; ARTERY-DISEASE INSIGHTS; SIGNAL RESPONSE; CARBON-DIOXIDE; 3 TESLA; HYPERCAPNIA; PERFUSION; MODEL; STATE; HYPOXIA	Background: Carbon dioxide (CO2) is a recognized vasodilator of myocardial blood vessels that leads to changes in myocardial oxygenation through the recruitment of the coronary flow reserve. Yet, it is unknown whether changes of carbon dioxide induced by breathing maneuvers can be used to modify coronary blood flow and thus myocardial oxygenation. Oxygenation-sensitive cardiovascular magnetic resonance (CMR) using the blood oxygen level-dependent (BOLD) effect allows for non-invasive monitoring of changes of myocardial tissue oxygenation. We hypothesized that mild hypercapnia induced by long breath-holds leads to changes in myocardial oxygenation that can be detected by oxygenation-sensitive CMR. Methods and Results: In nine anaesthetized and ventilated pigs, 60s breath-holds were induced. Left ventricular myocardial and blood pool oxygenation changes, as monitored by oxygenation-sensitive CMR using a T2*-weighted steady-state-free-precession (SSFP) sequence at 1.5T, were compared to changes of blood gas levels obtained immediately prior to and after the breath-hold. Long breath-holds resulted in an increase of paCO(2), accompanied by a decrease of paO(2) and pH. There was a significant decrease of blood pressure, while heart rate did not change. A decrease in the left ventricular blood pool oxygenation was observed, which was similar to drop in SaO(2). Oxygenation in the myocardial tissue however, was maintained throughout the period. Changes in myocardial oxygenation were strongly correlated with the change in paCO(2) during the breath-hold (r = 0.90, p = 0.010). Conclusion: Despite a drop in blood oxygen levels, myocardial oxygenation is maintained throughout long breath-holds and is linearly correlated with the parallel increase of arterial CO2, a known coronary vasodilator. Breathing maneuvers in combination with oxygenation-sensitive CMR may be useful as a diagnostic test for coronary artery function.	[Guensch, Dominik P.; Fischer, Kady; Flewitt, Jacqueline A.; Friedrich, Matthias G.] Univ Calgary, Stephenson Cardiovasc MR Ctr, Libin Cardiovasc Inst Alberta, Dept Cardiac Sci & Radiol, Calgary, AB, Canada; [Fischer, Kady; Friedrich, Matthias G.] Univ Montreal, CMR Res Ctr, Montreal Heart Inst, Montreal, PQ, Canada	Libin Cardiovascular Institute Of Alberta; University of Calgary; Universite de Montreal	Friedrich, MG (corresponding author), Univ Calgary, Stephenson Cardiovasc MR Ctr, Libin Cardiovasc Inst Alberta, Dept Cardiac Sci & Radiol, Calgary, AB, Canada.	mgwfriedrich@gmail.com	Friedrich, Matthias/H-8474-2015	Friedrich, Matthias/0000-0003-1204-5647; Gunsch, Dominik/0000-0003-4127-4086; Fischer, Kady/0000-0002-7765-4550	The Husky Energy Inc.	The Husky Energy Inc.	The Husky Energy Inc., as part of the Husky Energy Program for the Early Detection of Cardiovascular Disease, sponsored this investigation, yet did not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainslie PN, 2004, J APPL PHYSIOL, V97, P149, DOI 10.1152/japplphysiol.01385.2003; ALELLA A, 1955, AM J PHYSIOL, V183, P570, DOI 10.1152/ajplegacy.1955.183.3.570; Arellano R, 1999, CRIT CARE MED, V27, P2729, DOI 10.1097/00003246-199912000-00021; Arnold JR, 2012, J AM COLL CARDIOL, V59, P1954, DOI 10.1016/j.jacc.2012.01.055; ATALAY MK, 1995, MAGNET RESON MED, V34, P623, DOI 10.1002/mrm.1910340420; Bauer WR, 1999, PHYS REV LETT, V83, P4215, DOI 10.1103/PhysRevLett.83.4215; Bauer WR, 1999, MAGN RESON MED, V42, P1004, DOI 10.1002/(SICI)1522-2594(199912)42:6<1004::AID-MRM2>3.0.CO;2-M; Beaudin AE, 2011, AM J PHYSL HEART CIR; BROTEN TP, 1991, CIRC RES, V68, P531, DOI 10.1161/01.RES.68.2.531; CASE RB, 1976, CIRC RES, V39, P558, DOI 10.1161/01.RES.39.4.558; Dharmakumar R, 2006, MAGN RESON MED, V55, P1372, DOI 10.1002/mrm.20911; ELIADES D, 1986, CARDIOVASC RES, V20, P127, DOI 10.1093/cvr/20.2.127; Fieno DS, 2004, CIRCULATION, V110, P1284, DOI 10.1161/01.CIR.0000140673.13057.34; Friedrich MG, 2003, CIRCULATION, V108, P2219, DOI 10.1161/01.CIR.0000095271.08248.EA; Gauthier CJ, 2012, NEUROIMAGE, V60, P1212, DOI 10.1016/j.neuroimage.2011.12.056; Hsu YY, 2010, J MAGN RESON IMAGING, V31, P78, DOI 10.1002/jmri.22015; Kannurpatti SS, 2002, MAGN RESON MED, V47, P864, DOI 10.1002/mrm.10131; Karamitsos TD, 2010, CIRC-CARDIOVASC IMAG, V3, P32, DOI 10.1161/CIRCIMAGING.109.860148; KASSAB GS, 1994, AM J PHYSIOL-HEART C, V267, pH2100, DOI 10.1152/ajpheart.1994.267.6.H2100; KELMAN GR, 1966, J APPL PHYSIOL, V21, P1375, DOI 10.1152/jappl.1966.21.4.1375; KETY SS, 1948, J CLIN INVEST, V27, P484, DOI 10.1172/JCI101995; KOEHLER RC, 1980, AM J PHYSIOL, V239, pH545, DOI 10.1152/ajpheart.1980.239.4.H545; KUO L, 1995, AM J PHYSIOL-HEART C, V269, pH541, DOI 10.1152/ajpheart.1995.269.2.H541; Li DB, 1996, MAGNET RESON MED, V36, P16, DOI 10.1002/mrm.1910360105; MANKA R, 2010, J CARDIOVASC MAGN R, V12, DOI DOI 10.1186/1532-429X-12-54; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Rioja E, 2010, AM J VET RES, V71, P24, DOI 10.2460/ajvr.71.1.24; ROTHE CF, 1985, AM J PHYSIOL, V249, P1061; SEVERINGHAUS JW, 1979, J APPL PHYSIOL, V46, P599, DOI 10.1152/jappl.1979.46.3.599; Shea SM, 2005, RADIOLOGY, V236, P503, DOI 10.1148/radiol.2362040149; VARJAVAND N, 2000, MAGN RESON MED, DOI DOI 10.1002/MRM.20911; Vohringer M, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-20; Wacker CM, 2003, J AM COLL CARDIOL, V41, P834, DOI 10.1016/S0735-1097(02)02931-5	33	19	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53282	10.1371/journal.pone.0053282	http://dx.doi.org/10.1371/journal.pone.0053282			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301055	Green Published, Green Submitted, gold			2022-12-25	WOS:000313480000046
J	Somekh, J; Choder, M; Dori, D				Somekh, Judith; Choder, Mordechai; Dori, Dov			Conceptual Model-Based Systems Biology: Mapping Knowledge and Discovering Gaps in the mRNA Transcription Cycle	PLOS ONE			English	Article							TERMINAL DOMAIN PHOSPHATASE; SIMULATION; INITIATION; MEDIATOR; EXECUTION; NETWORK; TFIIB	We propose a Conceptual Model-based Systems Biology framework for qualitative modeling, executing, and eliciting knowledge gaps in molecular biology systems. The framework is an adaptation of Object-Process Methodology (OPM), a graphical and textual executable modeling language. OPM enables concurrent representation of the system's structure-the objects that comprise the system, and behavior-how processes transform objects over time. Applying a top-down approach of recursively zooming into processes, we model a case in point-the mRNA transcription cycle. Starting with this high level cell function, we model increasingly detailed processes along with participating objects. Our modeling approach is capable of modeling molecular processes such as complex formation, localization and trafficking, molecular binding, enzymatic stimulation, and environmental intervention. At the lowest level, similar to the Gene Ontology, all biological processes boil down to three basic molecular functions: catalysis, binding/dissociation, and transporting. During modeling and execution of the mRNA transcription model, we discovered knowledge gaps, which we present and classify into various types. We also show how model execution enhances a coherent model construction. Identification and pinpointing knowledge gaps is an important feature of the framework, as it suggests where research should focus and whether conjectures about uncertain mechanisms fit into the already verified model.	[Somekh, Judith; Dori, Dov] Technion Israel Inst Technol, Fac Ind Engn & Management, IL-32000 Haifa, Israel; [Dori, Dov] MIT, Engn Syst Div, Cambridge, MA 02139 USA; [Choder, Mordechai] Technion Israel Inst Technol, Fac Med, Haifa, Israel	Technion Israel Institute of Technology; Massachusetts Institute of Technology (MIT); Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Somekh, J (corresponding author), Technion Israel Inst Technol, Fac Ind Engn & Management, IL-32000 Haifa, Israel.	yuditol@technion.ac.il		Dori, Dov/0000-0002-2393-3124	Israeli Ministry of Science [38221]; European Union [262044 - VISIONAIR]; Gordon Center for Systems Engineering at the Technion; Israel Science Foundation	Israeli Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel); European Union(European Commission); Gordon Center for Systems Engineering at the Technion; Israel Science Foundation(Israel Science Foundation)	This work was funded in part by a grant agreement No. 38221 for Promoting Women in Science by the Israeli Ministry of Science to JS. The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement No. 262044 - VISIONAIR and from Gordon Center for Systems Engineering at the Technion. This work was partially supported by a grant from Israel Science Foundation to MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 2010, MOL BIOL CELL; [Anonymous], 2011, ENCY KNOWLEDGE MANAG; Calzone L, 2006, BIOINFORMATICS, V22, P1805, DOI 10.1093/bioinformatics/btl172; Cannata N, 2005, LECT NOTES COMPUT SC, V3737, P105; Chaouiya C, 2007, BRIEF BIOINFORM, V8, P210, DOI 10.1093/bib/bbm029; Chen HT, 2004, CELL, V119, P169, DOI 10.1016/j.cell.2004.09.028; Dori D, 2004, VLDB J, V13, P120, DOI 10.1007/s00778-004-0120-x; Dori D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000872; Efroni S, 2003, GENOME RES, V13, P2485, DOI 10.1101/gr.1215303; Faeder JR, 2005, COMPLEXITY, V10, P22, DOI 10.1002/cplx.20074; Fisher J, 2005, P NATL ACAD SCI USA, V102, P1951, DOI 10.1073/pnas.0409433102; Fisher J, 2007, NAT BIOTECHNOL, V25, P1239, DOI 10.1038/nbt1356; Friedl EM, 2003, P NATL ACAD SCI USA, V100, P2328, DOI 10.1073/pnas.2628049100; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Harel D, 2008, ELECTRON NOTES THEOR, V194, P119, DOI 10.1016/j.entcs.2007.12.009; Harel-Sharvit L, 2010, CELL, V143, P552, DOI 10.1016/j.cell.2010.10.033; Jansson A, 2010, DRUG DISCOV TODAY, V15, P365, DOI 10.1016/j.drudis.2010.02.012; Kam N, 2003, LECT NOTES COMPUT SC, V2602, P4; Kielbassa J, 2009, COMPUT BIOL CHEM, V33, P46, DOI 10.1016/j.compbiolchem.2008.07.022; Kobor MS, 2000, MOL CELL BIOL, V20, P7438, DOI 10.1128/MCB.20.20.7438-7449.2000; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Machado D, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-45; MELTON J, 2006, QUERYING XML XQUERY; Moraru II, 2008, IET SYST BIOL, V2, P352, DOI 10.1049/iet-syb:20080102; Peleg M, 2002, BIOINFORMATICS, V18, P825, DOI 10.1093/bioinformatics/18.6.825; Peleg M, 2000, IEEE T SOFTWARE ENG, V26, P742, DOI 10.1109/32.879812; Perelman L, 2011, THESIS TECHNION ISRA; Perelman V, 2011, SIMUL SERIES, V43, P140; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Rani PG, 2004, MOL CELL BIOL, V24, P1709, DOI 10.1128/MCB.24.4.1709-1720.2004; Reddy VN, 1993, P INT C INTELL SYST, V1; Regev A, 2001, Pac Symp Biocomput, P459; Sadot A, 2008, IEEE ACM T COMPUT BI, V5, P223, DOI 10.1109/TCBB.2007.1076; Shmulevich I, 2003, P NATL ACAD SCI USA, V100, P10734, DOI 10.1073/pnas.1534782100; Smith Barry, 2003, AMIA Annu Symp Proc, P609; Svejstrup JQ, 2004, BBA-GENE STRUCT EXPR, V1677, P64, DOI 10.1016/j.bbaexp.2003.10.012; Svejstrup JQ, 1997, P NATL ACAD SCI USA, V94, P6075, DOI 10.1073/pnas.94.12.6075; Takahashi K, 2003, BIOINFORMATICS, V19, P1727, DOI 10.1093/bioinformatics/btg221; Wang YM, 2010, CURR BIOL, V20, P548, DOI 10.1016/j.cub.2010.01.052; Webb K, 2004, LECT NOTES COMPUT SC, V3029, P128; Yaroker Y, 2012, SYSTEMS ENG IN PRESS; Yudkovsky N, 2000, NATURE, V408, P225, DOI 10.1038/35041603; ZAWEL L, 1995, GENE DEV, V9, P1479, DOI 10.1101/gad.9.12.1479	45	12	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51430	10.1371/journal.pone.0051430	http://dx.doi.org/10.1371/journal.pone.0051430			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23308089	gold, Green Submitted, Green Published			2022-12-25	WOS:000312794500029
J	Zeilstra, J; Joosten, SPJ; van Andel, H; Tolg, C; Berns, A; Snoek, M; van de Wetering, MV; Spaargaren, M; Clevers, H; Pals, ST				Zeilstra, J.; Joosten, S. P. J.; van Andel, H.; Tolg, C.; Berns, A.; Snoek, M.; van de Wetering, M.; Spaargaren, M.; Clevers, H.; Pals, S. T.			Stem cell CD44v isoforms promote intestinal cancer formation in Apc(min) mice downstream of Wnt signaling	ONCOGENE			English	Article						CD44; colorectal cancer; stem cell; Wnt signaling	HUMAN COLORECTAL-CANCER; PROTEOGLYCAN FORMS; BETA-CATENIN; COLON-CANCER; C-MET; EXPRESSION; APC; DIFFERENTIATION; PROGRESSION; METASTASIS	A gene signature specific for intestinal stem cells (ISCs) has recently been shown to predict relapse in colorectal cancer (CRC) but the tumorigenic role of individual signature genes remains poorly defined. A prominent ISC-signature gene is the cancer stem cell marker CD44, which encodes various splice variants comprising a diverse repertoire of adhesion and signaling molecules. Using Lgr5 as ISC marker, we have fluorescence-activated cell sorting-purified ISCs to define their CD44 repertoire. ISCs display a specific set of CD44 variant isoforms (CD44v), but remarkably lack the CD44 standard (CD44s) isoform. These CD44v also stand-out in transformed human ISCs isolated from microadenomas of familial adenomatous polyposis patients. By employing knock-in mice expressing either CD44v4-10 or CD44s, we demonstrate that the CD44v isoform, but not CD44s, promotes adenoma initiation in Apc(Min/+) mice. Our data identify CD44v as component of the ISCs program critical for tumor initiation, and as potential treatment target in CRC.	[Zeilstra, J.; Joosten, S. P. J.; van Andel, H.; Spaargaren, M.; Pals, S. T.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Tolg, C.; Berns, A.; Snoek, M.] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [van de Wetering, M.; Clevers, H.] Hubrecht Inst, Utrecht, Netherlands; [van de Wetering, M.; Clevers, H.] Univ Med Ctr Utrecht, Utrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Netherlands Cancer Institute; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Pals, ST (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pathol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	s.t.pals@amc.uva.nl	Spaargaren, Marcel/AAU-1298-2021	Spaargaren, Marcel/0000-0002-3135-5109; Joosten, Sander/0000-0002-6699-3717; Pals, Steven/0000-0002-1419-0939	Dutch Cancer Society	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by a grant from the Dutch Cancer Society. The authors declare no competing financial interests.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; BENNETT KL, 1995, J CELL BIOL, V131, P1623, DOI 10.1083/jcb.131.6.1623; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Boon EMJ, 2002, CANCER RES, V62, P5126; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; DIRENZO MF, 1995, CLIN CANCER RES, V1, P147; HEIDER KH, 1993, J CELL BIOL, V120, P227, DOI 10.1083/jcb.120.1.227; JACKSON DG, 1995, J CELL BIOL, V128, P673, DOI 10.1083/jcb.128.4.673; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McCart AE, 2008, PATHOL RES PRACT, V204, P479, DOI 10.1016/j.prp.2008.03.004; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; MULDER JWR, 1994, LANCET, V344, P1470, DOI 10.1016/S0140-6736(94)90290-9; Noah TK, 2011, EXP CELL RES, V317, P2702, DOI 10.1016/j.yexcr.2011.09.006; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Schmits R, 1997, BLOOD, V90, P2217, DOI 10.1182/blood.V90.6.2217.2217_2217_2233; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; van der Voort R, 1999, J BIOL CHEM, V274, P6499, DOI 10.1074/jbc.274.10.6499; vanderNeut R, 1996, NAT GENET, V13, P366, DOI 10.1038/ng0796-366; VANDERVOORT R, 1995, BIOCHEM BIOPH RES CO, V214, P137, DOI 10.1006/bbrc.1995.2267; VANWEERING DHJ, 1993, PCR METH APPL, V3, P100; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Wielenga VJM, 1999, AM J PATHOL, V154, P515, DOI 10.1016/S0002-9440(10)65297-2; WIELENGA VJM, 1993, CANCER RES, V53, P4754; Wielenga VJM, 2000, ADV CANCER RES, V77, P169; Wielenga VJM, 2000, AM J PATHOL, V157, P1563, DOI 10.1016/S0002-9440(10)64793-1; Zeilstra J, 2008, CANCER RES, V68, P3655, DOI 10.1158/0008-5472.CAN-07-2940; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	39	94	94	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 30	2014	33	5					665	670		10.1038/onc.2012.611	http://dx.doi.org/10.1038/onc.2012.611			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AA5GW	23318432				2022-12-25	WOS:000331125100014
J	Marcos-Villar, L; Gallego, P; Munoz-Fontela, C; de la Cruz-Herrera, CF; Campagna, M; Gonzalez, D; Lopitz-Otsoa, F; Rodriguez, MS; Rivas, C				Marcos-Villar, L.; Gallego, P.; Munoz-Fontela, C.; de la Cruz-Herrera, C. F.; Campagna, M.; Gonzalez, D.; Lopitz-Otsoa, F.; Rodriguez, M. S.; Rivas, C.			Kaposi's sarcoma-associated herpesvirus lana2 protein interacts with the pocket proteins and inhibits their sumoylation	ONCOGENE			English	Article						pocket proteins; KSHV; LANA2; pocket proteins; sumoylation; LXCXE domain	RETINOBLASTOMA TUMOR-SUPPRESSOR; LARGE T-ANTIGEN; INTERFERON-REGULATORY FACTOR-3; PRIMARY EFFUSION LYMPHOMA; C-MYC; CELL-CYCLE; TRANSCRIPTIONAL REPRESSION; DISTINCT MECHANISMS; FAMILY-MEMBERS; GENE RB2/P130	The pocket proteins retinoblastoma protein (pRb), p107 and p130 are the key targets of oncoproteins expressed by DNA tumor viruses. Some of these viral proteins contain an LXCXE motif that mediates the interaction with the three pocket proteins and the inhibition of the pRb SUMOylation. Kaposi's sarcoma herpesvirus (KSHV) contains at least two proteins that can regulate pRb function but, so far, a KSHV-encoded protein targeting p107 and p130 has not been identified. Here, we show that the KSHV latent protein LANA2 binds to pRb, p107 and p130. LANA2 contains an LXCXE motif that is required for bypassing pRb-mediated cell-cycle arrest and for inhibiting pRb SUMOylation. Finally, we demonstrate that, in addition to pRb, both p107 and p130 can be SUMOylated, and this modification is also inhibited by LANA2 in an LXCXE-dependent manner. These results demonstrate, for the first time, the SUMOylation of p107 or p130 and, so far, they represent the first example of a KSHV protein able to interact with the three pocket proteins and to inhibit their conjugation to SUMO.	[Marcos-Villar, L.; Gallego, P.; de la Cruz-Herrera, C. F.; Campagna, M.; Gonzalez, D.; Rivas, C.] CSIC, Ctr Nacl Biotecnol, Madrid 28049, Spain; [Munoz-Fontela, C.] Heinrich Pette Inst, Leibniz Inst Expt Virol, Hamburg, Germany; [Lopitz-Otsoa, F.; Rodriguez, M. S.] CIBERehd, CIC BioGUNE, Prote Unit, Buildin Derio, Spain; [Rodriguez, M. S.] Inbiomed, Ubiquitylat & Canc Mol Biol Lab, San Sebastian, Gipuzkoa, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Heinrich Pette Institute; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIC bioGUNE	Rivas, C (corresponding author), CSIC, Ctr Nacl Biotecnol, Campus Univ Autonoma Madrid, Madrid 28049, Spain.	crivas@cnb.csic.es	Rivas, Carmen/AAB-6278-2019; MARCOS-VILLAR, LAURA/L-8444-2014; de Llano, Dolores González/F-2219-2013; Lopitz-Otsoa, Fernando/A-1966-2017; Rivas, Carmen/L-3162-2017	Rivas, Carmen/0000-0002-0518-7199; MARCOS-VILLAR, LAURA/0000-0002-8635-6432; de Llano, Dolores González/0000-0001-8140-7045; Lopitz-Otsoa, Fernando/0000-0001-8452-6939; Rivas, Carmen/0000-0002-0518-7199; de la Cruz-Herrera, Carlos/0000-0002-7493-5154; Munoz-Fontela, Cesar/0000-0002-7725-2586	Juan de la Cierva Program; JAE predoctoral fellowship from CSIC; La Caixa fellowship;  [BFU-2008-03784];  [BFU-2011-27064]	Juan de la Cierva Program; JAE predoctoral fellowship from CSIC; La Caixa fellowship(La Caixa Foundation); ; 	This project has been possible thanks to the generous support from Patrick Moore and Yuan Chang (Pittsburg University, USA) in the initial experiments and to the reagents they provided. This work was supported by BFU-2008-03784 and BFU-2011-27064. MC and LM-V are supported by Juan de la Cierva Program. PG is supported by JAE predoctoral fellowship from CSIC. CFC-H is supported by La Caixa fellowship.	Araki K, 2008, CLIN CANCER RES, V14, P3514, DOI 10.1158/1078-0432.CCR-07-4538; BARBEAU D, 1994, ONCOGENE, V9, P359; Baresova P, 2012, J BIOL CHEM, V287, P16199, DOI 10.1074/jbc.M111.335216; BEIJERSBERGEN RL, 1994, EMBO J, V13, P4080, DOI 10.1002/j.1460-2075.1994.tb06725.x; BEIJERSBERGEN RL, 1995, GENE DEV, V9, P1340, DOI 10.1101/gad.9.11.1340; Benetti R, 2008, NAT STRUCT MOL BIOL, V15, P268, DOI 10.1038/nsmb.1399; Bowen C, 1998, CANCER RES, V58, P3275; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Campagna M, 2011, CELL DEATH DIFFER, V18, P72, DOI 10.1038/cdd.2010.77; Chan HM, 2001, NAT CELL BIOL, V3, P667, DOI 10.1038/35083062; Chang Y, 1996, NATURE, V382, P410, DOI 10.1038/382410a0; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; CHRISTENSEN JB, 1995, J VIROL, V69, P3945, DOI 10.1128/JVI.69.6.3945-3948.1995; Claudio PP, 2000, CANCER RES, V60, P372; Claudio PP, 2000, CANCER RES, V60, P8; Claudio PP, 1996, CANCER RES, V56, P2003; CLAUDIO PP, 1994, CANCER RES, V54, P5556; DeGregori J, 2006, CURR MOL MED, V6, P739; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; DYSON N, 1992, J VIROL, V66, P4606, DOI 10.1128/JVI.66.7.4606-4611.1992; DYSON N, 1992, CANCER SURV, V12, P161; Esteban M, 2003, J GEN VIROL, V84, P1463, DOI 10.1099/vir.0.19014-0; EWEN ME, 1991, CELL, V66, P1155, DOI 10.1016/0092-8674(91)90038-Z; Fan SJ, 2001, ONCOGENE, V20, P4827, DOI 10.1038/sj.onc.1204666; GoddenKent D, 1997, J VIROL, V71, P4193, DOI 10.1128/JVI.71.6.4193-4198.1997; GOODRICH DW, 1991, CELL, V67, P293, DOI 10.1016/0092-8674(91)90181-W; GU W, 1994, SCIENCE, V264, P251, DOI 10.1126/science.8146655; HANNON GJ, 1993, GENE DEV, V7, P2378, DOI 10.1101/gad.7.12a.2378; Howard CM, 2000, CANCER RES, V60, P2737; Hsieh JK, 1999, MOL CELL, V3, P181, DOI 10.1016/S1097-2765(00)80309-3; Joo CH, 2007, J VIROL, V81, P8282, DOI 10.1128/JVI.00235-07; JUNG JU, 1994, MOL CELL BIOL, V14, P7235, DOI 10.1128/MCB.14.11.7235; Kim HY, 2001, EMBO J, V20, P295, DOI 10.1093/emboj/20.1.295; Knudsen KE, 1999, ONCOGENE, V18, P5239, DOI 10.1038/sj.onc.1202910; Ledl A, 2005, ONCOGENE, V24, P3810, DOI 10.1038/sj.onc.1208539; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; Lemaire C, 2005, ONCOGENE, V24, P3297, DOI 10.1038/sj.onc.1208493; Li MT, 1997, J VIROL, V71, P1984, DOI 10.1128/JVI.71.3.1984-1991.1997; Li TW, 2006, J BIOL CHEM, V281, P36221, DOI 10.1074/jbc.M608236200; LI Y, 1993, GENE DEV, V7, P2366, DOI 10.1101/gad.7.12a.2366; Lu F, 2010, J VIROL, V84, P2697, DOI 10.1128/JVI.01997-09; Lubyova B, 2004, J BIOL CHEM, V279, P7643, DOI 10.1074/jbc.M309485200; Lubyova B, 2007, J BIOL CHEM, V282, P31944, DOI 10.1074/jbc.M706430200; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Marcos-Villar L, J GEN VIROL 1, V92, P188; Marcos-Villar L, 2009, J VIROL, V83, P8849, DOI 10.1128/JVI.00339-09; MAYOL X, 1993, ONCOGENE, V8, P2561; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Miller G, 2007, ADV CANCER RES, V97, P81, DOI 10.1016/S0065-230X(06)97004-3; MORAN E, 1986, MOL CELL BIOL, V6, P3470, DOI 10.1128/MCB.6.10.3470; Pantry SN, 2009, SEMIN CANCER BIOL, V19, P153, DOI 10.1016/j.semcancer.2009.02.010; Platt G, 2002, ONCOGENE, V21, P1823, DOI 10.1038/sj.onc.1205360; Radkov SA, 2000, NAT MED, V6, P1121, DOI 10.1038/80459; Rivas C, 2001, J VIROL, V75, P429, DOI 10.1128/JVI.75.1.429-438.2001; Scambia G, 2006, ONCOGENE, V25, P5302, DOI 10.1038/sj.onc.1209620; Schwarze F, 2010, ONCOGENE, V29, P5755, DOI 10.1038/onc.2010.311; Seo T, 2004, ONCOGENE, V23, P6146, DOI 10.1038/sj.onc.1207807; Shin YC, 2008, CANCER RES, V68, P1751, DOI 10.1158/0008-5472.CAN-07-2766; Smith EJ, 1998, CELL GROWTH DIFFER, V9, P297; Starostik P, 1996, MOL CELL BIOL, V16, P3606; Sullivan CS, 2000, MOL CELL BIOL, V20, P6233, DOI 10.1128/MCB.20.17.6233-6243.2000; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; WEINBERG RA, 1995, ANN NY ACAD SCI, V758, P331, DOI 10.1111/j.1749-6632.1995.tb24838.x; Wies E, 2008, BLOOD, V111, P320, DOI 10.1182/blood-2007-05-092288; Wies E, 2009, J BIOL CHEM, V284, P8525, DOI 10.1074/jbc.M809252200; Wirt SE, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-9; Xiao ZX, 1996, P NATL ACAD SCI USA, V93, P4633, DOI 10.1073/pnas.93.10.4633; YEUNG RS, 1993, ONCOGENE, V8, P3465; Zalvide J, 1998, MOL CELL BIOL, V18, P1408, DOI 10.1128/MCB.18.3.1408; Zhang BY, 2006, P NATL ACAD SCI USA, V103, P437, DOI 10.1073/pnas.0510012103; Zhao X, 2001, UROLOGY, V57, P860, DOI 10.1016/S0090-4295(01)00946-3; ZHU L, 1993, GENE DEV, V7, P1111, DOI 10.1101/gad.7.7a.1111	73	17	17	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 23	2014	33	4					495	503		10.1038/onc.2012.603	http://dx.doi.org/10.1038/onc.2012.603			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	296VX	23318443				2022-12-25	WOS:000330214600010
J	Solga, AC; Gianino, SM; Gutmann, DH				Solga, A. C.; Gianino, S. M.; Gutmann, D. H.			NG2-cells are not the cell of origin for murine neurofibromatosis-1 (Nf1) optic glioma	ONCOGENE			English	Article						genetically-engineered mice; NG2+; optic glioma; neurofibromatosis type 1	CENTRAL-NERVOUS-SYSTEM; GLIAL PROGENITORS; NG2 PROTEOGLYCAN; GROWTH-FACTOR; OLIGODENDROCYTE PRECURSORS; MALIGNANT GLIOMAS; PATHWAY GLIOMAS; CLONAL ANALYSIS; WHITE-MATTER; CHILDREN	Low-grade glial neoplasms (astrocytomas) represent one of the most common brain tumors in the pediatric population. These tumors frequently form in the optic pathway (optic pathway gliomas, OPGs), especially in children with the neurofibromatosis type 1 (NF1)-inherited tumor predisposition syndrome. To model these tumors in mice, we have previously developed several Nf1 genetically-engineered mouse strains that form optic gliomas. However, there are three distinct macroglial cell populations in the optic nerve (astrocytes, NG2 + (nerve/glial antigen 2) cells and oligodendrocytes). The presence of NG2 + cells in the optic nerve raises the intriguing possibility that these cells could be the tumor-initiating cells, as has been suggested for adult glioma. In this report, we used a combination of complementary in vitro and novel genetically-engineered mouse strains in vivo to determine whether NG2 + cells could give rise to Nf1 optic glioma. First, we show that Nf1 inactivation results in a cell-autonomous increase in glial fibrillary acidic protein + (GFAP + ), but not in NG2 + , cell proliferation in vitro. Second, similar to the GFAP-Cre transgenic strain that drives Nf1 optic gliomagenesis, NG2-expressing cells also give rise to all three macroglial lineages in vivo. Third, in contrast to the GFAP-Cre strain, Nf1 gene inactivation in NG2 + cells is not sufficient for optic gliomagenesis in vivo. Collectively, these data demonstrate that NG2 + cells are not the cell of origin for mouse optic glioma, and support a model in which gliomagenesis requires Nf1 loss in specific neuroglial progenitors during embryogenesis.	[Solga, A. C.; Gianino, S. M.; Gutmann, D. H.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Washington University (WUSTL)	Gutmann, DH (corresponding author), Washington Univ, Sch Med, Dept Neurol, Box 8111,660 South Euclid Ave, St Louis, MO 63110 USA.	gutmannd@neuro.wustl.edu		Gutmann, David/0000-0002-3127-5045	National Cancer Institute [U01-CA141549]; National Eye Institute [EY02687]; NATIONAL CANCER INSTITUTE [U01CA141549] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY002687] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We appreciate the excellent technical assistance of Angela Petti and Belinda McMahan in the Ophthalmology Core Facility for preparing the optic nerve sections. This work was funded by a grant from the National Cancer Institute (U01-CA141549 to DHG), whereas the Ophthalmology Core Facility is funded by a grant from the National Eye Institute EY02687).	Abel TW, 2009, MOL CANCER RES, V7, P645, DOI 10.1158/1541-7786.MCR-08-0477; Al-Mayhani MTF, 2011, NEURO-ONCOLOGY, V13, P830, DOI 10.1093/neuonc/nor088; Assanah M, 2006, J NEUROSCI, V26, P6781, DOI 10.1523/JNEUROSCI.0514-06.2006; Bajenaru ML, 2002, MOL CELL BIOL, V22, P5100, DOI 10.1128/MCB.22.14.5100-5113.2002; Bajenaru ML, 2003, CANCER RES, V63, P8573; Baracskay KL, 2007, GLIA, V55, P1001, DOI 10.1002/glia.20519; Blazo MA, 2004, AM J MED GENET A, V127A, P224, DOI 10.1002/ajmg.a.20650; BRANNAN CI, 1994, GENE DEV, V8, P1019, DOI 10.1101/gad.8.9.1019; Czyzyk E, 2003, J CHILD NEUROL, V18, P471, DOI 10.1177/08830738030180070401; Dahiya S, 2011, J NEUROPATH EXP NEUR, V70, P622, DOI 10.1097/NEN.0b013e31822200aa; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Ellis JA, 2012, NEUROSURGERY, V70, P198, DOI 10.1227/NEU.0b013e31822ce963; Gao LM, 2006, J NEUROSCI, V26, P7619, DOI 10.1523/JNEUROSCI.0855-06.2006; Hegedus B, 2008, CANCER RES, V68, P1520, DOI 10.1158/0008-5472.CAN-07-5916; Ju PJ, 2012, CYTOTHERAPY, V14, P608, DOI 10.3109/14653249.2011.651528; Kwon CH, 2008, CANCER RES, V68, P3286, DOI 10.1158/0008-5472.CAN-07-6867; Lee DY, 2012, CANCER CELL, V22, P131, DOI 10.1016/j.ccr.2012.05.036; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; Listernick R, 1997, ANN NEUROL, V41, P143, DOI 10.1002/ana.410410204; LISTERNICK R, 1995, J PEDIATR-US, V127, P718, DOI 10.1016/S0022-3476(95)70159-1; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; LUND AM, 1991, EUR J PEDIATR, V150, P835, DOI 10.1007/BF01955002; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Masui K, 2010, GLIA, V58, P1050, DOI 10.1002/glia.20986; MILLER RH, 1985, DEV BIOL, V111, P35, DOI 10.1016/0012-1606(85)90432-4; Mokry J, 2008, STEM CELLS DEV, V17, P333, DOI 10.1089/scd.2007.0091; Neymeyer V, 1997, BRAIN RES, V766, P195, DOI 10.1016/S0006-8993(97)00528-3; Ogden AT, 2008, NEUROSURGERY, V62, P505, DOI 10.1227/01.neu.0000316019.28421.95; Ono K, 1997, NEURON, V19, P283, DOI 10.1016/S0896-6273(00)80939-3; Ozerdem U, 2001, DEV DYNAM, V222, P218, DOI 10.1002/dvdy.1200; RAFF MC, 1984, DEV BIOL, V106, P53, DOI 10.1016/0012-1606(84)90060-5; RAFF MC, 1983, J NEUROSCI, V3, P1289; SCHRAPPE M, 1991, CANCER RES, V51, P4986; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; STALLCUP WB, 1987, J NEUROSCI, V7, P2737; Tchoghandjian A, 2010, BRAIN PATHOL, V20, P211, DOI 10.1111/j.1750-3639.2009.00269.x; Tchoghandjian A, 2009, BRAIN, V132, P1523, DOI 10.1093/brain/awp048; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023062; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Wiranowska M, 2006, BRAIN CELL BIOL, V35, P159, DOI 10.1007/s11068-007-9009-0; Yeh TH, 2009, GLIA, V57, P1239, DOI 10.1002/glia.20845; Yoo S, 2007, DEV NEUROBIOL, V67, P860, DOI 10.1002/dneu.20369; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895; Zhu Y, 2005, DEVELOPMENT, V132, P5577, DOI 10.1242/dev.02162; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	47	16	16	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 16	2014	33	3					289	299		10.1038/onc.2012.580	http://dx.doi.org/10.1038/onc.2012.580			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	296VR	23318450	Green Accepted			2022-12-25	WOS:000330214000003
J	Streppel, MM; Lata, S; DelaBastide, M; Montgomery, EA; Wang, JS; Canto, MI; Macgregor-Das, AM; Pai, S; Morsink, FHM; Offerhaus, GJ; Antoniou, E; Maitra, A; McCombie, WR				Streppel, M. M.; Lata, S.; DelaBastide, M.; Montgomery, E. A.; Wang, J. S.; Canto, M. I.; Macgregor-Das, A. M.; Pai, S.; Morsink, F. H. M.; Offerhaus, G. J.; Antoniou, E.; Maitra, A.; McCombie, W. R.			Next-generation sequencing of endoscopic biopsies identifies ARID1A as a tumor-suppressor gene in Barrett's esophagus	ONCOGENE			English	Article						next-generation sequencing; endoscopic mucosal biopsies; Barrett's esophagus; esophageal adenocarcinoma; ARID1A	CALCIUM-BINDING PROTEIN; CARCINOEMBRYONIC ANTIGEN; FREQUENT MUTATIONS; SOMATIC MUTATIONS; CANCER; ADENOCARCINOMA; PROGRESSION; BREAST; TARGET; EXPRESSION	The incidence of Barrett's esophagus (BE)-associated esophageal adenocarcinoma (EAC) is increasing. Next-generation sequencing (NGS) provides an unprecedented opportunity to uncover genomic alterations during BE pathogenesis and progression to EAC, but treatment-naive surgical specimens are scarce. The objective of this study was to establish the feasibility of using widely available endoscopic mucosal biopsies for successful NGS, using samples obtained from a BE 'progressor'. Paired-end whole-genome NGS was performed on the Illumina platform using libraries generated from mucosal biopsies of normal squamous epithelium (NSE), BE and EAC obtained from a patient who progressed to adenocarcinoma during endoscopic surveillance. Selective validation studies, including Sanger sequencing, immunohistochemistry and functional assays, were performed to confirm the NGS findings. NGS identified somatic nonsense mutations of AT-rich interactive domain 1A (SWI like) (ARID1A) and PPIE and an additional 37 missense mutations in BE and/or EAC, which were confirmed by Sanger sequencing. ARID1A mutations were detected in 15% (3/20) high-grade dysplasia (HGD)/EAC patients. Immunohistochemistry performed on an independent archival cohort demonstrated ARID1A protein loss in 0% (0/76), 4.9% (2/40), 14.3% (4/28), 16.0% (8/50) and 12.2% (12/98) of NSE, BE, low-grade dysplasia, HGD and EAC tissues, respectively, and was inversely associated with nuclear p53 accumulation (P - 0.028). Enhanced cell growth, proliferation and invasion were observed on ARID1A knockdown in EAC cells. In addition, genes downstream of ARID1A that potentially contribute to the ARID1A knockdown phenotype were identified. Our studies establish the feasibility of using mucosal biopsies for NGS, which should enable the comparative analysis of larger 'progressor' versus 'non-progressor' cohorts. Further, we identify ARID1A as a novel tumor-suppressor gene in BE pathogenesis, reiterating the importance of aberrant chromatin in the metaplasiadysplasia sequence.	[Streppel, M. M.; Montgomery, E. A.; Macgregor-Das, A. M.; Pai, S.; Maitra, A.] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD USA; [Streppel, M. M.] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Streppel, M. M.; Morsink, F. H. M.; Offerhaus, G. J.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Lata, S.; DelaBastide, M.; Antoniou, E.; McCombie, W. R.] Cold Spring Harbor Lab, Stanley Inst Cognit Genom, Woodbury, NY USA; [Wang, J. S.] Washington Univ, Sch Med, Dept Med, Div Gastroenterol, St Louis, MO 63110 USA; [Canto, M. I.] Johns Hopkins Med Inst, Dept Med, Div Gastroenterol & Hepatol, Baltimore, MD USA; [Macgregor-Das, A. M.] Johns Hopkins Med Inst, Pathobiol Program, Baltimore, MD USA; [Maitra, A.] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD USA; [Maitra, A.] Johns Hopkins Med Inst, Dept Med Genet, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Cold Spring Harbor Laboratory; Washington University (WUSTL); Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Maitra, A (corresponding author), Johns Hopkins Med Inst, Dept Pathol, CRBII Bldg,Room 341,1550 Orleans St, Baltimore, MD 21231 USA.	amaitra1@jhmi.edu; mccombie@cshl.edu		McCombie, W. Richard/0000-0003-1899-0682	Jerry D'Amato foundation; NIH [1K23DK068149, S10 RR023702-01]; NCI [CA045508]; Fulbright/the Netherland America Foundation; Rene Vogels Foundation; NATIONAL CANCER INSTITUTE [P30CA045508, R01CA113669] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK068149] Funding Source: NIH RePORTER	Jerry D'Amato foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fulbright/the Netherland America Foundation; Rene Vogels Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work at Johns Hopkins Medical Institutions was funded by the Jerry D'Amato foundation and the NIH (1K23DK068149) and the work at WRM's laboratory was supported by a Cancer Center Support Grant (CA045508) from the NCI and NIH Shared Instrument grant S10 RR023702-01. MMS has been sponsored by Fulbright/the Netherland America Foundation and the Rene Vogels Foundation.	Agrawal N, 2012, CANCER DISCOV, V2, P899, DOI 10.1158/2159-8290.CD-12-0189; Alvarez H, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001356; Alvarez H, 2010, CANCER BIOL THER, V10, P1009, DOI 10.4161/cbt.10.10.13248; Alvarez H, 2008, CANCER BIOL THER, V7, P1753; Ashworth A, 2011, CELL, V145, P30, DOI 10.1016/j.cell.2011.03.020; Berinstein NL, 2002, J CLIN ONCOL, V20, P2197, DOI 10.1200/JCO.2002.08.017; Birnbaum DJ, 2011, GENE CHROMOSOME CANC, V50, P456, DOI 10.1002/gcc.20870; Camacho-Leal P, 2008, ONCOGENE, V27, P1545, DOI 10.1038/sj.onc.1210789; Clark MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000832; Cornen S, 2012, ONCOGENE, V31, P4255, DOI 10.1038/onc.2011.598; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; di Pietro M, 2012, P NATL ACAD SCI USA, V109, P9077, DOI 10.1073/pnas.1116933109; Fair K, 2001, MOL CELL BIOL, V21, P3589, DOI 10.1128/MCB.21.10.3589-3597.2001; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Galipeau PC, 2007, PLOS MED, V4, P342, DOI 10.1371/jourmal.pmed.0040067; Gilbert EW, 2011, J GASTROINTEST SURG, V15, P708, DOI 10.1007/s11605-011-1485-y; Goh XY, 2011, GUT, V60, P1317, DOI 10.1136/gut.2010.234179; GRIFFIN M, 1987, HISTOPATHOLOGY, V11, P53; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Gupta S, 2012, CLIN CANCER RES, V18, P280, DOI 10.1158/1078-0432.CCR-11-2165; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang JM, 2007, GENE CHROMOSOME CANC, V46, P745, DOI 10.1002/gcc.20459; Hvid-Jensen F, 2011, NEW ENGL J MED, V365, P1375, DOI 10.1056/NEJMoa1103042; Jin Z, 2009, CANCER RES, V69, P4112, DOI 10.1158/0008-5472.CAN-09-0028; Jones S, 2012, HUM MUTAT, V33, P100, DOI 10.1002/humu.21633; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kaz AM, CANC LETT; Kumar A, 2011, P NATL ACAD SCI USA, V108, P17087, DOI 10.1073/pnas.1108745108; Lee OJ, 2006, GASTROENTEROLOGY, V130, pA273; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Li XH, 2008, CANCER PREV RES, V1, P413, DOI 10.1158/1940-6207.CAPR-08-0121; Link DC, 2011, JAMA-J AM MED ASSOC, V305, P1568, DOI 10.1001/jama.2011.473; Luby TM, 2008, EXPERT REV VACCINES, V7, P995, DOI 10.1586/14760584.7.7.995; Mamo A, 2012, ONCOGENE, V31, P2090, DOI 10.1038/onc.2011.386; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Martinez VG, 2008, BRIT J CANCER, V98, P564, DOI 10.1038/sj.bjc.6604195; McFadyen MCE, 2004, MOL CANCER THER, V3, P363; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mishra SK, 2012, CANCER METAST REV, V31, P163, DOI 10.1007/s10555-011-9338-4; Nik-Zainal S, 2012, CELL, V149, P5; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Ordonez C, 2000, CANCER RES, V60, P3419; Park S, 2010, BIOCHEMISTRY-US, V49, P6576, DOI 10.1021/bi1009387; Paulson TG, 2009, CLIN CANCER RES, V15, P3305, DOI 10.1158/1078-0432.CCR-08-2494; Paulson TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003809; Reid BJ, 2001, AM J GASTROENTEROL, V96, P1321; Reid BJ, 2010, NAT REV CANCER, V10, P87, DOI 10.1038/nrc2773; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rozen S, 2000, Methods Mol Biol, V132, P365; Sato F, 2006, CANCER-AM CANCER SOC, V106, P483, DOI 10.1002/cncr.21657; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sherbet GV, 1998, ANTICANCER RES, V18, P2415; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Streppel MM, 2012, HUM PATHOL, V43, P1755, DOI 10.1016/j.humpath.2012.01.005; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wang Kenneth K, 2005, Gastroenterology, V128, P1468, DOI 10.1053/j.gastro.2005.03.076; Wang S, 2006, ONCOGENE, V25, P3346, DOI 10.1038/sj.onc.1209357; Wang ZX, 2010, CELL, V141, P1183, DOI 10.1016/j.cell.2010.05.016; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543; Yates LR, 2012, NAT REV GENET, V13, P795, DOI 10.1038/nrg3317; Yousef F, 2008, AM J EPIDEMIOL, V168, P237, DOI 10.1093/aje/kwn121; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246	67	62	69	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 16	2014	33	3					347	357		10.1038/onc.2012.586	http://dx.doi.org/10.1038/onc.2012.586			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	296VR	23318448	Green Accepted			2022-12-25	WOS:000330214000009
J	Gravells, P; Hoh, L; Solovieva, S; Patil, A; Dudziec, E; Rennie, IG; Sisley, K; Bryant, HE				Gravells, P.; Hoh, L.; Solovieva, S.; Patil, A.; Dudziec, E.; Rennie, I. G.; Sisley, K.; Bryant, H. E.			Reduced FANCD2 influences spontaneous SCE and RAD51 foci formation in uveal melanoma and Fanconi anaemia	ONCOGENE			English	Article						FANCD2; homologous recombination; non-homologous end-joining; uveal melanoma; sister chromatid exchange; RAD51	SISTER-CHROMATID EXCHANGE; DNA-DAMAGING AGENTS; BREAST-CANCER; HOMOLOGOUS RECOMBINATION; CHROMOSOME-DAMAGE; REPLICATION FORKS; ALKYLATING-AGENTS; GENE CONVERSION; MCL-1 PROMOTER; STRAND BREAKS	Uveal melanoma (UM) is unique among cancers in displaying reduced endogenous levels of sister chromatid exchange (SCE). Here we demonstrate that FANCD2 expression is reduced in UM and that ectopic expression of FANCD2 increased SCE. Similarly, FANCD2-deficient fibroblasts (PD20) derived from Fanconi anaemia patients displayed reduced spontaneous SCE formation relative to their FANCD2-complemented counterparts, suggesting that this observation is not specific to UM. In addition, spontaneous RAD51 foci were reduced in UM and PD20 cells compared with FANCD2-proficient cells. This is consistent with a model where spontaneous SCEs are the end product of endogenous recombination events and implicates FANCD2 in the promotion of recombination-mediated repair of endogenous DNA damage and in SCE formation during normal DNA replication. In both UM and PD20 cells, low SCE was reversed by inhibiting DNA-PKcs (DNA-dependent protein kinase, catalytic subunit). Finally, we demonstrate that both PD20 and UM are sensitive to acetaldehyde, supporting a role for FANCD2 in repair of lesions induced by such endogenous metabolites. Together, these data suggest FANCD2 may promote spontaneous SCE by influencing which double-strand break repair pathway predominates during normal S-phase progression.	[Gravells, P.; Hoh, L.; Solovieva, S.; Patil, A.; Dudziec, E.; Bryant, H. E.] Univ Sheffield, Fac Med Dent & Hlth Sci, Dept Oncol, Inst Canc Studies, Sheffield S10 2RX, Yorks, England; [Hoh, L.; Rennie, I. G.; Sisley, K.] Univ Sheffield, Acad Unit Ophthalmol & Orthopt, Dept Oncol, Fac Med Dent & Hlth Sci,Royal Hallamshire Hosp, Sheffield S10 2RX, Yorks, England	University of Sheffield; University of Sheffield	Bryant, HE (corresponding author), Univ Sheffield, Sch Med, Inst Canc studies, Beech Hill Rd, Sheffield S10 2RX, Yorks, England.	h.bryant@sheffield.ac.uk	bryant, helen/AHB-1139-2022; Sisley, Karen/B-7296-2019	bryant, helen/0000-0003-2720-7020; Sisley, Karen/0000-0002-5565-2618	RCUK fellowship; MRC studentship; Weston Park Hospital Cancer Appeal [CA95]; Sarcoma Trust; Yorkshire Eye Research and Yorkshire Cancer Research [S305PA]	RCUK fellowship(UK Research & Innovation (UKRI)); MRC studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Weston Park Hospital Cancer Appeal; Sarcoma Trust; Yorkshire Eye Research and Yorkshire Cancer Research	We thank Professors Toshiyasu Taniguchi and Alan D'Andrea for providing cells, the FANCD2-expressing retroviral vectors and for their technical advice. They also thank Professors Tomas Lindahl and Mark Meuth and Dr Spencer Collis for critical reading of the manuscript and discussion. We are grateful for funding from an RCUK fellowship to HB and MRC studentship to PG and for general funding from Weston Park Hospital Cancer Appeal (CA95), The Sarcoma Trust, Yorkshire Eye Research and Yorkshire Cancer Research (S305PA).	Abraham J, 2011, ALCOHOL CLIN EXP RES, V35, P2113, DOI 10.1111/j.1530-0277.2011.01563.x; Adamo A, 2010, MOL CELL, V39, P25, DOI 10.1016/j.molcel.2010.06.026; AUERBACH AD, 1976, NATURE, V261, P494, DOI 10.1038/261494a0; Barroso E, 2006, CARCINOGENESIS, V27, P1930, DOI 10.1093/carcin/bgl062; BUERSTEDDE JM, 1990, EMBO J, V9, P921, DOI 10.1002/j.1460-2075.1990.tb08190.x; Campanero MR, 2000, P NATL ACAD SCI USA, V97, P6481, DOI 10.1073/pnas.100340697; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Croxton R, 2002, ONCOGENE, V21, P1359, DOI 10.1038/sj.onc.1205157; Croxton R, 2002, ONCOGENE, V21, P1563, DOI 10.1038/sj.onc.1205232; Damato B, 2009, INVEST OPHTH VIS SCI, V50, P3048, DOI 10.1167/iovs.08-3165; Dronkert MLG, 2000, MOL CELL BIOL, V20, P3147, DOI 10.1128/MCB.20.9.3147-3156.2000; Eischen CM, 2001, ONCOGENE, V20, P6983, DOI 10.1038/sj.onc.1204892; Garcia CL, 2009, MUTAT RES-FUND MOL M, V662, P3, DOI 10.1016/j.mrfmmm.2008.11.008; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; GEBHART E, 1985, HUM GENET, V69, P309, DOI 10.1007/BF00291647; Godthelp BC, 2002, NUCLEIC ACIDS RES, V30, P2172, DOI 10.1093/nar/30.10.2172; Goyanes V., 1994, Cytobios, V77, P67; Gravells P, 2011, BRIT J CANCER, V104, P1098, DOI 10.1038/bjc.2011.56; Harbour JW, 2009, AM J OPHTHALMOL, V148, P823, DOI 10.1016/j.ajo.2009.07.004; HAYASHI K, 1975, HUMANGENETIK, V29, P201, DOI 10.1007/BF00297624; Hoh L, 2011, GENE CHROMOSOME CANC, V50, P34, DOI 10.1002/gcc.20829; Houghtaling S, 2003, GENE DEV, V17, P2021, DOI 10.1101/gad.1103403; HOWELL RT, 1991, J MED GENET, V28, P468, DOI 10.1136/jmg.28.7.468; KATO H, 1976, NATURE, V260, P447, DOI 10.1038/260447a0; Kim MK, 2004, CANCER LETT, V210, P85, DOI 10.1016/j.canlet.2004.01.014; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; LATT SA, 1975, P NATL ACAD SCI USA, V72, P4066, DOI 10.1073/pnas.72.10.4066; Lyakhovich A, 2006, CANCER LETT, V232, P99, DOI 10.1016/j.canlet.2005.07.038; Miranda M, 1997, MUTAGENESIS, V12, P233, DOI 10.1093/mutage/12.4.233; NAGASAWA H, 1983, MUTAT RES, V107, P315, DOI 10.1016/0027-5107(83)90173-2; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Neveling K, 2007, CYTOGENET GENOME RES, V118, P166, DOI 10.1159/000108297; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; NOVOTNA B, 1979, HUM GENET, V49, P41; Pace P, 2010, SCIENCE, V329, P219, DOI 10.1126/science.1192277; Pang QS, 2009, MUTAT RES-FUND MOL M, V668, P42, DOI 10.1016/j.mrfmmm.2009.03.013; Patel KA, 2001, BRIT J OPHTHALMOL, V85, P1440, DOI 10.1136/bjo.85.12.1440; Phillips AC, 1999, MOL CELL, V4, P771, DOI 10.1016/S1097-2765(00)80387-1; PORFIRIO B, 1983, HUM GENET, V63, P117, DOI 10.1007/BF00291529; Rosado IV, 2011, NAT STRUCT MOL BIOL, V18, P1432, DOI 10.1038/nsmb.2173; Rudland PS, 2010, AM J PATHOL, V176, P2935, DOI 10.2353/ajpath.2010.090779; Saleh-Gohari N, 2005, MOL CELL BIOL, V25, P7158, DOI 10.1128/MCB.25.16.7158-7169.2005; Sisley K, 1997, GENE CHROMOSOME CANC, V19, P22, DOI 10.1002/(SICI)1098-2264(199705)19:1<22::AID-GCC4>3.0.CO;2-2; Smiraldo PG, 2005, CANCER RES, V65, P2089, DOI 10.1158/0008-5472.CAN-04-2079; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; SPERLING K, 1975, HUMANGENETIK, V27, P227, DOI 10.1007/BF00278349; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; Tanaka H, 2002, MOL CELL, V9, P1017, DOI 10.1016/S1097-2765(02)00522-1; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Taniguchi T, 2003, NAT MED, V9, P568, DOI 10.1038/nm852; Tian X, 2011, CELL SIGNAL, V23, P193, DOI 10.1016/j.cellsig.2010.09.003; Timmers C, 2001, MOL CELL, V7, P241, DOI 10.1016/S1097-2765(01)00172-1; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; van der Groep P, 2008, BREAST CANCER RES TR, V107, P41, DOI 10.1007/s10549-007-9534-7; Wang LC, 2008, DNA REPAIR, V7, P1973, DOI 10.1016/j.dnarep.2008.08.005; Wilson JB, 2001, CARCINOGENESIS, V22, P1939, DOI 10.1093/carcin/22.12.1939; Wojcik A, 2004, CYTOGENET GENOME RES, V104, P304, DOI 10.1159/000077507; Yamamoto K, 2005, MOL CELL BIOL, V25, P34, DOI 10.1128/MCB.25.1.34-43.2005	58	7	9	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 14	2013	32	46					5338	5346		10.1038/onc.2012.627	http://dx.doi.org/10.1038/onc.2012.627			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	251IU	23318456	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000326922400004
J	Zhang, L; Wu, H; Lu, D; Li, G; Sun, C; Song, H; Li, J; Zhai, T; Huang, L; Hou, C; Wang, W; Zhou, B; Chen, S; Lu, B; Zhang, X				Zhang, L.; Wu, H.; Lu, D.; Li, G.; Sun, C.; Song, H.; Li, J.; Zhai, T.; Huang, Lv; Hou, C.; Wang, W.; Zhou, B.; Chen, S.; Lu, B.; Zhang, X.			The costimulatory molecule B7-H4 promote tumor progression and cell proliferation through translocating into nucleus	ONCOGENE			English	Article						B7-H4; nuclear localization sequence (NLS); tumor infiltrated lymphocyte (TIL); renal cell carcinoma (RCC); cell cycle; cell proliferation	B7 FAMILY-MEMBER; BREAST-CANCER; PROTEIN EXPRESSION; PANCREATIC-CANCER; OVARIAN-CANCER; CARCINOMA; LOCALIZATION; SURVIVAL; IMMUNORESISTANCE; ACTIVATION	B7-H4, a member of B7 family, is a transmembrane protein and inhibits T-cells immunity. However, in a variety of tumor cells, B7-H4 was detected predominantly in intracellular compartments with unknown mechanism and functions. In this study, we analyzed B7-H4 expression and subcellular distribution by immunohistochemistry in renal cell carcinoma (RCC) tissues. B7-H4 protein was detected on the membrane, in the cytosol and/or in the nucleus in tumor tissues. The membrane and nuclear expression of B7-H4 was significantly correlated with the tumor stages of RCC. Moreover, the membrane localization of B7-H4 was inversely correlated with the intensity of tumor infiltrates lymphocyte (TILs), whereas no association was observed between nuclear expression of B7-H4 and the density of TILs status. We further identified that B7-H4 is a cytoplasmic-nuclear shuttling protein containing a functional nuclear localization sequence (NLS) motif. A point mutation of B7-H4 NLS motif blocked the leptomycin B -induced nuclear accumulation of B7-H4. HEK293 cells stably expressing B7-H4 NLS mutant exhibited more potent inhibition in T-cell proliferation and cytokine production through increasing its surface expression compared with wild-type B7-H4 transfected cells owing to their increased surface expression. Most importantly, overexpression of wild-type B7-H4 in HEK293 cells enhanced tumor cell proliferation in vitro and tumorigenicity in vivo, promoted G1/S phase transition. The regulation of cell cycle by wild-type B7-H4 was partialy due to upregulation of Cyclin D 1 and Cyclin E. A mutation of B7-H4 NLS motif abolished the B7-H4-mediated cell proliferation and cell cycle regulation. Furthermore, B7-H4 wild-type confers chemoresistance activity to RCC cell lines including Caki-1 and ACHN. Our study provides a new insight into the functional implication of B7-H4 in its subcellular localization.	[Zhang, L.; Lu, D.; Zhang, X.] Soochow Univ, Coll Med, Inst Med Biotechnol, Jiangsu Stem Cell Res Lab, Suzhou 215006, Peoples R China; [Zhang, L.; Song, H.; Li, J.; Zhai, T.; Huang, Lv; Wang, W.; Chen, S.] Soochow Univ, Dept Pharm, Coll Pharmaceut Sci, Suzhou 215006, Peoples R China; [Wu, H.; Zhou, B.] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Clin Immunol, Suzhou 215006, Peoples R China; [Li, G.; Lu, B.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA USA; [Sun, C.; Hou, C.] Soochow Univ, Affiliated Hosp 2, Dept Urol, Suzhou 215006, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Soochow University - China	Zhang, X (corresponding author), Soochow Univ, Coll Med, Inst Med Biotechnol, Jiangsu Stem Cell Res Lab, Renmin Rd 178, Suzhou 215006, Peoples R China.	xueguangzh@yahoo.com.cn	Zhai, Tianhang/HGD-2935-2022	Lu, Desheng/0000-0002-0314-5649; Zhang, Liang/0000-0002-5041-8005	National Nature Science Foundation of China [30901361]; Natural Science Fund for Colleges and Universities in Jiangsu Province [09KJB310013]; National Program on Key Basic Research Project (973 Program) [2013CB530501]; Program for Changjiang Scholars and Innovative Research Team [IRT0849]; National Natural Science Foundation of China [30930085]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Planned Projects for Postdoctoral Research Funds [0702053]; National University Student Innovation of Soochow University	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund for Colleges and Universities in Jiangsu Province; National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China); Program for Changjiang Scholars and Innovative Research Team(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Planned Projects for Postdoctoral Research Funds; National University Student Innovation of Soochow University	We are grateful to Yu-ming Hu for his assistant in animal experiment; Wei Sun for collecting the clinical specimens; Ying Chen for her help in immunohistochemical analysis; and Kehua Yu as well as Yu Shen for their technical assistance in flow cytometry. This work was supported by National Nature Science Foundation of China (Grant No. 30901361); Natural Science Fund for Colleges and Universities in Jiangsu Province (Grant No. 09KJB310013); National Program on Key Basic Research Project (973 Program, Grant No. 2013CB530501); Program for Changjiang Scholars and Innovative Research Team (Grant No. IRT0849); National Natural Science Foundation of China (Grants No. 30930085); A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Planned Projects for Postdoctoral Research Funds (No. 0702053); National University Student Innovation of Soochow University.	ALLRED DC, 1993, J NATL CANCER I, V85, P200, DOI 10.1093/jnci/85.3.200; Arigami T, 2011, WORLD J SURG, V35, P2051, DOI 10.1007/s00268-011-1186-4; Arnoys EJ, 2007, ACTA HISTOCHEM, V109, P89, DOI 10.1016/j.acthis.2006.10.002; Awadallah NS, 2008, PANCREAS, V36, P200, DOI 10.1097/MPA.0b013e318150e4e0; Azuma T, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000166; Boucher MJ, 2000, J CELL BIOCHEM, V79, P355, DOI 10.1002/1097-4644(20001201)79:3<355::AID-JCB20>3.3.CO;2-S; Chen LJ, 2011, CANCER IMMUNOL IMMUN, V60, P1047, DOI 10.1007/s00262-011-1017-3; Chen YW, 2011, INFLAMMATION, V34, P688, DOI 10.1007/s10753-010-9280-6; Cheng L, 2009, INT J GYNECOL CANCER, V19, P1481, DOI 10.1111/IGC.0b013e3181ad0fa2; Crane CA, 2009, ONCOGENE, V28, P306, DOI 10.1038/onc.2008.384; Fei F, 2008, EXP HEMATOL, V36, P1297, DOI 10.1016/j.exphem.2008.05.002; Flies DB, 2007, J IMMUNOTHER, V30, P251, DOI 10.1097/CJI.0b013e31802e085a; Ghebeh H, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2605; Guida M, 2007, ANN ONCOL, V18, P149, DOI 10.1093/annonc/mdm245; Huang WC, 2011, J BIOL CHEM, V286, P20558, DOI 10.1074/jbc.M111.240796; Jiang JT, 2010, CANCER IMMUNOL IMMUN, V59, P1707, DOI 10.1007/s00262-010-0900-7; Kamimura Y, 2009, BIOCHEM BIOPH RES CO, V389, P349, DOI 10.1016/j.bbrc.2009.08.144; KIEFER P, 1994, EMBO J, V13, P4126, DOI 10.1002/j.1460-2075.1994.tb06730.x; Krambeck AE, 2006, P NATL ACAD SCI USA, V103, P10391, DOI 10.1073/pnas.0600937103; Kryczek I, 2006, J EXP MED, V203, P871, DOI 10.1084/jem.20050930; Kurebayashi Y, 2012, CELL REP, V1, P360, DOI 10.1016/j.celrep.2012.02.007; MICKISCH GH, 1994, WORLD J UROL, V12, P214; Miyatake T, 2007, GYNECOL ONCOL, V106, P119, DOI 10.1016/j.ygyno.2007.03.039; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; Prasad DVR, 2003, IMMUNITY, V18, P863, DOI 10.1016/S1074-7613(03)00147-X; Quandt D, 2011, CLIN CANCER RES, V17, P3100, DOI 10.1158/1078-0432.CCR-10-2268; Salceda S, 2005, EXP CELL RES, V306, P128, DOI 10.1016/j.yexcr.2005.01.018; Sica GL, 2003, IMMUNITY, V18, P849, DOI 10.1016/S1074-7613(03)00152-3; Simon I, 2006, CANCER RES, V66, P1570, DOI 10.1158/0008-5472.CAN-04-3550; Tan DSW, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-17; Thompson RH, 2008, CANCER RES, V68, P6054, DOI 10.1158/0008-5472.CAN-08-0869; Tringler B, 2006, GYNECOL ONCOL, V100, P44, DOI 10.1016/j.ygyno.2005.08.060; Tringler B, 2005, CLIN CANCER RES, V11, P1842, DOI 10.1158/1078-0432.CCR-04-1658; Vasko R, 2011, EUR J PHARMACOL, V670, P50, DOI 10.1016/j.ejphar.2011.08.030; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028232; Zang XX, 2003, P NATL ACAD SCI USA, V100, P10388, DOI 10.1073/pnas.1434299100	37	67	82	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 14	2013	32	46					5347	5358		10.1038/onc.2012.600	http://dx.doi.org/10.1038/onc.2012.600			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	251IU	23318460	hybrid, Green Published			2022-12-25	WOS:000326922400005
J	Cieslik, KA; Trial, J; Carlson, S; Taffet, GE; Entman, ML				Cieslik, Katarzyna A.; Trial, JoAnn; Carlson, Signe; Taffet, George E.; Entman, Mark L.			Aberrant differentiation of fibroblast progenitors contributes to fibrosis in the aged murine heart: role of elevated circulating insulin levels	FASEB JOURNAL			English	Article						mesenchymal stem cell; collagen	MESENCHYMAL STEM-CELLS; HUMAN-SKIN FIBROBLASTS; GROWTH-FACTOR-BETA; TGF-BETA; MYOFIBROBLAST FORMATION; MEDIATED ACTIVATION; PULMONARY-FIBROSIS; SIGNALING PATHWAYS; LUNG FIBROBLASTS; AGING HEART	With age, the collagen content of the heart increases, leading to interstitial fibrosis. We have shown that CD44(pos) fibroblasts derived from aged murine hearts display reduced responsiveness to TGF-beta but, paradoxically, have increased collagen expression in vivo and in vitro. We postulated that this phenomenon was due to the defect in mesenchymal stem cell (MSC) differentiation in a setting of elevated circulating insulin levels and production that we observed in aging mice. We discovered that cultured fibroblasts derived from aged but not young cardiac MSCs of nonhematopoietic lineage displayed increased basal and insulin-induced (1 nM) collagen expression (2-fold), accompanied by increased farnesyltransferase (FTase) and Erk activities. In a quest for a possible mechanism, we found that a chronic pathophysiologic insulin concentration (1 nM) caused abnormal fibroblast differentiation of MSCs isolated from young hearts. Fibroblasts derived from these MSCs responded to insulin by elevating collagen expression as seen in untreated aged fibroblast cultures, suggesting a causal link between increased insulin levels and defective MSC responses. Here we report an insulin-dependent pathway that specifically targets collagen type I transcriptional activation leading to a unique mechanism of fibrosis that is TGF-beta and inflammation-independent in the aged heart.-Cieslik, K. A., Trial, J., Carlson, S., Taffet, G. E., Entman, M. L. Aberrant differentiation of fibroblast progenitors contributes to fibrosis in the aged murine heart: role of elevated circulating insulin levels. FASEB J. 27, 1761-1771 (2013). www.fasebj.org	[Cieslik, Katarzyna A.; Trial, JoAnn; Taffet, George E.; Entman, Mark L.] Baylor Coll Med, Div Cardiovasc Sci, Houston, TX 77030 USA; [Cieslik, Katarzyna A.; Trial, JoAnn; Taffet, George E.; Entman, Mark L.] Baylor Coll Med, DeBakey Heart Ctr, Dept Med, Houston, TX 77030 USA; [Carlson, Signe] Univ Washington, Dept Med, Seattle, WA USA	Baylor College of Medicine; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; University of Washington; University of Washington Seattle	Cieslik, KA (corresponding author), Baylor Coll Med, Div Cardiovasc Sci, Dept Med, 1 Baylor Plaza,Mail Stn BCM620, Houston, TX 77030 USA.	cieslik@bcm.edu	Cieslik, Katarzyna/AAO-1982-2021	Cieslik, Katarzyna/0000-0002-2167-7921; Trial, JoAnn/0000-0001-7145-7786	U.S. National Institutes of Health [R01HL089792, T32HL07816]; Medallion Foundation; Hankamer Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007816, R01HL022512, R01HL089792] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medallion Foundation; Hankamer Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health grants R01HL089792 (M. L. E.) and T32HL07816 (S. C.), a Medallion Foundation grant (J.T.), and the Hankamer Foundation. The authors are grateful to Dr. Heinrich Taegtmeyer for critical reading of this manuscript. The authors also thank Dorellyn B. Lee and Hao Zhang for excellent technical assistance. The authors declare no conflicts of interest.	Barzilai N, 1998, J CLIN INVEST, V101, P1353, DOI 10.1172/JCI485; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carlson S, 2011, CARDIOVASC RES, V91, P99, DOI 10.1093/cvr/cvr061; Chen SJ, 1999, J INVEST DERMATOL, V112, P49, DOI 10.1046/j.1523-1747.1999.00477.x; Chiao YA, 2012, CARDIOVASC RES, V96, P444, DOI 10.1093/cvr/cvs275; Cieslik KA, 2011, AM J PATHOL, V179, P1792, DOI 10.1016/j.ajpath.2011.06.022; Cieslik KA, 2011, J MOL CELL CARDIOL, V50, P248, DOI 10.1016/j.yjmcc.2010.10.019; Debessa CRG, 2001, MECH AGEING DEV, V122, P1049; Draznin B, 2000, ENDOCRINOLOGY, V141, P1310, DOI 10.1210/en.141.4.1310; FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908; FRAZE E, 1987, J AM GERIATR SOC, V35, P224, DOI 10.1111/j.1532-5415.1987.tb02313.x; Fukasawa H, 2004, KIDNEY INT, V65, P63, DOI 10.1111/j.1523-1755.2004.00393.x; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; Gagliano N, 2000, J GERONTOL A-BIOL, V55, pB365, DOI 10.1093/gerona/55.8.B365; Gagliano N, 2007, DIGEST DIS, V25, P118, DOI 10.1159/000099475; Glaser J, 2000, GERONTOLOGY, V46, P93, DOI 10.1159/000022141; Goalstone M, 1997, ENDOCRINOLOGY, V138, P5119, DOI 10.1210/en.138.12.5119; Goalstone M. L., 2004, DIABETES MELLITUS FU, P422; Grammer TC, 1997, ONCOGENE, V14, P1635, DOI 10.1038/sj.onc.1201000; HINTON DE, 1968, J GERONTOL, V23, P205, DOI 10.1093/geronj/23.2.205; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Jones DL, 2011, NAT CELL BIOL, V13, P506, DOI 10.1038/ncb0511-506; Kang HR, 2007, J BIOL CHEM, V282, P7723, DOI 10.1074/jbc.M610764200; KJELLSTROM T, 1984, HORM METAB RES, V16, P168, DOI 10.1055/s-2007-1014734; Klemm DJ, 2001, J BIOL CHEM, V276, P28430, DOI 10.1074/jbc.M103382200; Krupsky M, 1996, CONNECT TISSUE RES, V34, P53, DOI 10.3109/03008209609028893; Lakatta EG, 2003, CIRCULATION, V107, P346, DOI 10.1161/01.CIR.0000048893.62841.F7; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Lin TH, 1997, J CELL BIOL, V136, P1385, DOI 10.1083/jcb.136.6.1385; Liu TG, 2007, AM J RESP CELL MOL, V37, P507, DOI 10.1165/rcmb.2007-0077OC; Mizushige K, 2000, CIRCULATION, V101, P899, DOI 10.1161/01.CIR.101.8.899; Moerman EJ, 2004, AGING CELL, V3, P379, DOI 10.1111/j.1474-9728.2004.00127.x; Nakamura T, 2000, HEPATOLOGY, V32, P247, DOI 10.1053/jhep.2000.9109; Peyret N, 2000, THESIS WAYNE STATE U; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; SEABRA MC, 1991, CELL, V65, P429, DOI 10.1016/0092-8674(91)90460-G; Shih DTB, 2005, STEM CELLS, V23, P1012, DOI 10.1634/stemcells.2004-0125; Song YX, 1999, FORENSIC SCI INT, V104, P133, DOI 10.1016/S0379-0738(99)00103-6; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Takeji M, 2006, J BIOL CHEM, V281, P40193, DOI 10.1074/jbc.M602182200; Tang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025320; Teekakirikul P, 2010, J CLIN INVEST, V120, P3520, DOI 10.1172/JCI42028; Watts KL, 2005, AM J RESP CELL MOL, V32, P290, DOI 10.1165/rcmb.2004-0127OC; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Zhou XP, 2008, P NATL ACAD SCI USA, V105, P17181, DOI 10.1073/pnas.0800846105; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	47	37	38	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2013	27	4					1761	1771		10.1096/fj.12-220145	http://dx.doi.org/10.1096/fj.12-220145			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23303205	Green Published			2022-12-25	WOS:000316940800044
J	Hammadi, M; Oulidi, A; Gackiere, F; Katsogiannou, M; Slomianny, C; Roudbaraki, M; Dewailly, E; Delcourt, P; Lepage, G; Lotteau, S; Ducreux, S; Prevarskaya, N; Van Coppenolle, F				Hammadi, Mehdi; Oulidi, Agathe; Gackiere, Florian; Katsogiannou, Maria; Slomianny, Christian; Roudbaraki, Morad; Dewailly, Etienne; Delcourt, Philippe; Lepage, Gilbert; Lotteau, Sabine; Ducreux, Sylvie; Prevarskaya, Natalia; Van Coppenolle, Fabien			Modulation of ER stress and apoptosis by endoplasmic reticulum calcium leak via translocon during unfolded protein response: involvement of GRP78	FASEB JOURNAL			English	Article						cancer; Bip	STORE-OPERATED CHANNELS; BIP; CHAPERONE; CELLS; COMPONENTS; REGULATOR; DEPLETION; ROLES; PORE	The endoplasmic reticulum (ER) is involved in many cellular functions, including protein folding and Ca2+ homeostasis. The ability of cells to respond to the ER stress is critical for cell survival, and disruption in such regulation can lead to apoptosis. ER stress is accompanied by alterations in Ca2+ homeostasis, and the ER Ca2+ store depletion by itself can induce ER stress and apoptosis. Despite that, the ER Ca2+ leak channels activated in response to the ER stress remain poorly characterized. Here we demonstrate that ER Ca2+ depletion during the ER stress occurs via translocon, the ER protein complex involved in translation. Numerous ER stress inducers stimulate the ER Ca2+ leak that can be prevented by translocon inhibitor, anisomycin. Expression of GRP78, an ER stress marker, increased following treatment with puromycin (a translocon opener) and was suppressed by anisomycin, confirming a primary role of translocon in ER stress induction. Inhibition of ER store depletion by anisomycin significantly reduces apoptosis stimulated by the ER stress inducers. We suggest that translocon opening is physiologically modulated by GRP78, particularly during the ER stress. The ability to modulate the ER Ca2+ permeability and subsequent ER stress can lead to development of a novel therapeutic approach.-Hammadi, M., Oulidi, A., Gackiere, F., Katsogiannou, M., Slomianny, C., Roudbaraki, M., Dewailly, E., Delcourt, P., Lepage, G., Lotteau, S., Ducreux, S., Prevarskaya, N., Van Coppenolle, F. Modulation of ER stress and apoptosis by endoplasmic reticulum calcium leak via translocon during unfolded protein response: involvement of GRP78. FASEB J. 27, 1600-1609 (2013). www.fasebj.org	[Hammadi, Mehdi; Oulidi, Agathe; Slomianny, Christian; Roudbaraki, Morad; Dewailly, Etienne; Delcourt, Philippe; Lepage, Gilbert; Prevarskaya, Natalia] Univ Lille 1, INSERM, U1003, Cellular Physiol Lab, F-59655 Villeneuve Dascq, France; [Gackiere, Florian] Aix Marseille Univ, Inst Neurosci Timone, Marseille, France; [Gackiere, Florian] Aix Marseille Univ, CNRS, UMR 7289, Marseille, France; [Katsogiannou, Maria] Aix Marseille Univ, INSERM, Mol Oncol U1068, Marseille, France; [Katsogiannou, Maria] Aix Marseille Univ, CNRS, UMR 7258, Marseille, France; [Katsogiannou, Maria] Inst J Paoli I Calmettes, CRCM, F-13009 Marseille, France; [Lotteau, Sabine; Ducreux, Sylvie; Van Coppenolle, Fabien] Univ Lyon 1, CNRS, UMR 5534, Ctr Genet & Physiol Mol & Cellulaires, F-69622 Villeurbanne, France; [Lotteau, Sabine; Ducreux, Sylvie; Van Coppenolle, Fabien] Univ Lyon, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Van Coppenolle, F (corresponding author), Univ Lyon 1, INSERM, U1060, CarMeN,Equipe 5, 8 Ave Rockefeller, F-69373 Lyon 08, France.	fabien.van-coppenolle@univ-lyon1.fr	Slomianny, Christian/L-8285-2018; DUCREUX, SYLVIE/D-6257-2013	DUCREUX, SYLVIE/0000-0003-3207-9537; Morad, Roudbaraki/0000-0001-5751-3323; Prevarskaya, natacha/0000-0003-0316-197X	Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS); Ligue Nationale Contre le Cancer, Association pour la Recherche contre le Cancer (ARC); Ministere de l'Enseignement Superieur et de la Recherche	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Ligue Nationale Contre le Cancer, Association pour la Recherche contre le Cancer (ARC); Ministere de l'Enseignement Superieur et de la Recherche	This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Ligue Nationale Contre le Cancer, Association pour la Recherche contre le Cancer (ARC), and Ministere de l'Enseignement Superieur et de la Recherche. The authors declare no conflicts of interest.	Alder NN, 2005, J CELL BIOL, V168, P389, DOI 10.1083/jcb.200409174; Austin RC, 2009, ANTIOXID REDOX SIGN, V11, P2279, DOI [10.1089/ars.2009.2686, 10.1089/ARS.2009.2686]; Benedetti C, 2000, BIOCHEM BIOPH RES CO, V278, P530, DOI 10.1006/bbrc.2000.3838; Chami M, 2008, MOL CELL, V32, P641, DOI 10.1016/j.molcel.2008.11.014; Chung KT, 2002, J BIOL CHEM, V277, P47557, DOI 10.1074/jbc.M208377200; Cunard R, 2011, AM J PHYSIOL-RENAL, V300, pF1054, DOI 10.1152/ajprenal.00021.2011; Erdmann F, 2011, EMBO J, V30, P17, DOI 10.1038/emboj.2010.284; Flourakis M, 2006, FASEB J, V20, P1215, DOI 10.1096/fj.05-5254fje; Fu M, 2011, CELL DEATH DIFFER, V18, P1057, DOI 10.1038/cdd.2010.181; Fu Y, 2007, CANCER RES, V67, P3734, DOI 10.1158/0008-5472.CAN-06-4594; Gackiere F, 2006, CELL CALCIUM, V39, P357, DOI 10.1016/j.ceca.2005.12.003; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Haigh NG, 2002, J CELL BIOL, V156, P261, DOI 10.1083/jcb.200110074; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Hoseki J, 2010, J BIOCHEM, V147, P19, DOI 10.1093/jb/mvp194; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Kaneko M, 2003, LIFE SCI, V74, P199, DOI 10.1016/j.lfs.2003.09.007; Kim SW, 2001, Z NATURFORSCH C, V56, P1169; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lomax RB, 2002, J BIOL CHEM, V277, P26479, DOI 10.1074/jbc.M201845200; Mandic A, 2003, J BIOL CHEM, V278, P9100, DOI 10.1074/jbc.M210284200; Matus S, 2011, CURR OPIN CELL BIOL, V23, P239, DOI 10.1016/j.ceb.2011.01.003; Minamino T, 2010, CIRC RES, V107, P1071, DOI 10.1161/CIRCRESAHA.110.227819; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Parkash J, 2010, LIFE SCI, V87, P587, DOI 10.1016/j.lfs.2010.09.013; Peters LR, 2011, J IMMUNOL, V187, P919, DOI 10.4049/jimmunol.1100690; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Rasheva VI, 2009, APOPTOSIS, V14, P996, DOI 10.1007/s10495-009-0341-y; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Schauble N, 2012, EMBO J, V31, P3282, DOI 10.1038/emboj.2012.189; Skryma R, 2000, J PHYSIOL-LONDON, V527, P71, DOI 10.1111/j.1469-7793.2000.00071.x; Tsai Yien Che, 2010, Genes Cancer, V1, P764; Van Coppenolle F, 2004, J CELL SCI, V117, P4135, DOI 10.1242/jcs.01274; Vanden Abeele F, 2002, CANCER CELL, V1, P169; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang LH, 2010, J CELL BIOCHEM, V110, P1299, DOI 10.1002/jcb.22679	39	129	141	4	37	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2013	27	4					1600	1609		10.1096/fj.12-218875	http://dx.doi.org/10.1096/fj.12-218875			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23322163				2022-12-25	WOS:000316940800030
J	Zheng, ZQ; Li, AM; Holmes, BB; Marasa, JC; Diamond, MI				Zheng, Zhiqiang; Li, Aimin; Holmes, Brandon B.; Marasa, Jayne C.; Diamond, Marc I.			An N-terminal Nuclear Export Signal Regulates Trafficking and Aggregation of Huntingtin (Htt) Protein Exon 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; MUTANT HUNTINGTIN; POLYGLUTAMINE AGGREGATION; SUBCELLULAR-LOCALIZATION; ANDROGEN RECEPTOR; REDUCES TOXICITY; CASPASE CLEAVAGE; DISEASE; FRAGMENTS; MODULATE	Huntington disease is a dominantly inherited neurodegenerative condition caused by polyglutamine expansion in the N terminus of the huntingtin protein (Htt). The first 17 amino acids (N17) of Htt play a key role in regulating its toxicity and aggregation. Both nuclear export and cytoplasm retention functions have been ascribed to N17. We have determined that N17 acts as a nuclear export sequence (NES) within Htt exon and when fused to yellow fluorescent protein. We have defined amino acids within N17 that constitute the nuclear export sequence (NES). Mutation of any of the conserved residues increases nuclear accumulation of Htt exon 1. Nuclear export of Htt is sensitive to leptomycin B and is reduced by knockdown of exportin 1. In HEK293 cells, NES mutations decrease overall Htt aggregation but increase the fraction of cells with nuclear inclusions. In primary cultured neurons, NES mutations increase nuclear accumulation and increase overall aggregation. This work defines a bona fide nuclear export sequence within N17 and links it to effects on protein aggregation. This may help explain the important role of N17 in controlling Htt toxicity.	[Zheng, Zhiqiang; Li, Aimin; Holmes, Brandon B.; Diamond, Marc I.] Washington Univ, Dept Neurol, St Louis, MO 63110 USA; [Marasa, Jayne C.] Washington Univ, Dept Radiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Diamond, MI (corresponding author), Washington Univ, Sch Med, Dept Neurol, Box 8111,660 S Euclid Ave, St Louis, MO 63110 USA.	diamondm@neuro.wustl.edu		Holmes, Brandon/0000-0002-1153-840X	National Institutes of Health through the NINDS [R21NS076116]; Hope Center for Neurological Disorders; National Institutes of Health predoctoral fellowship through the NINDS; Molecular Imaging Center [P50 CA94056]; Siteman Cancer Center at Washington University School of Medicine [P30 CA091842]; NATIONAL CANCER INSTITUTE [P30CA091842, P50CA094056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS079039, R21NS076116] Funding Source: NIH RePORTER	National Institutes of Health through the NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Hope Center for Neurological Disorders; National Institutes of Health predoctoral fellowship through the NINDS; Molecular Imaging Center; Siteman Cancer Center at Washington University School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R21NS076116 through the NINDS. This work was also supported by Hope Center for Neurological Disorders (to M. I. D.); a National Institutes of Health predoctoral fellowship through the NINDS (to B. B. H.), Molecular Imaging Center Grant P50 CA94056, the Siteman Cancer Center at Washington University School of Medicine Grant P30 CA091842, and an Anheuser-Busch/Emerson challenge gift (High Throughput Screening Core).	ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Angeli S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009053; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Atwal RS, 2011, NAT CHEM BIOL, V7, P453, DOI [10.1038/NCHEMBIO.582, 10.1038/nchembio.582]; Ben-Efraim I, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-74; Benn CL, 2005, HUM MOL GENET, V14, P3065, DOI 10.1093/hmg/ddi340; Cornett J, 2005, NAT GENET, V37, P198, DOI 10.1038/ng1503; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DeRooij KE, 1996, HUM MOL GENET, V5, P1093, DOI 10.1093/hmg/5.8.1093; Desai UA, 2006, HUM MOL GENET, V15, P2114, DOI 10.1093/hmg/ddl135; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Havel LS, 2011, HUM MOL GENET, V20, P1424, DOI 10.1093/hmg/ddr023; Huang TT, 2000, P NATL ACAD SCI USA, V97, P1014, DOI 10.1073/pnas.97.3.1014; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Kim JE, 2000, P NATL ACAD SCI USA, V97, P14340, DOI 10.1073/pnas.011511898; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Li SH, 1998, HUM MOL GENET, V7, P777, DOI 10.1093/hmg/7.5.777; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Pollitt SK, 2003, NEURON, V40, P685, DOI 10.1016/S0896-6273(03)00697-4; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; Schaufele F, 2005, P NATL ACAD SCI USA, V102, P9802, DOI 10.1073/pnas.0408819102; Schilling G, 2004, HUM MOL GENET, V13, P1599, DOI 10.1093/hmg/ddh175; Shao JY, 2008, MOL CELL BIOL, V28, P5196, DOI 10.1128/MCB.00079-08; Shao J, 2008, FEBS LETT, V582, P1637, DOI 10.1016/j.febslet.2008.04.009; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Tao T, 2001, TRAFFIC, V2, P385, DOI 10.1034/j.1600-0854.2001.002006385.x; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Thompson LM, 2009, J CELL BIOL, V187, P1083, DOI 10.1083/jcb.200909067; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Williamson TE, 2010, J MOL BIOL, V396, P1295, DOI 10.1016/j.jmb.2009.12.017; Xia JR, 2003, HUM MOL GENET, V12, P1393, DOI 10.1093/hmg/ddg156	40	53	55	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6063	6071		10.1074/jbc.M112.413575	http://dx.doi.org/10.1074/jbc.M112.413575			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23319588	Green Published, hybrid			2022-12-25	WOS:000315820700004
J	Greene, MJ; Pinter-Wollman, N; Gordon, DM				Greene, Michael J.; Pinter-Wollman, Noa; Gordon, Deborah M.			Interactions with Combined Chemical Cues Inform Harvester Ant Foragers' Decisions to Leave the Nest in Search of Food	PLOS ONE			English	Article							CUTICULAR HYDROCARBONS; GEOGRAPHIC VARIATIONS; FORAGING ACTIVITY; FATTY-ACIDS; HYMENOPTERA; ACTIVATION; DISPERSAL; PLANT	Social insect colonies operate without central control or any global assessment of what needs to be done by workers. Colony organization arises from the responses of individuals to local cues. Red harvester ants (Pogonomyrmex barbatus) regulate foraging using interactions between returning and outgoing foragers. The rate at which foragers return with seeds, a measure of food availability, sets the rate at which outgoing foragers leave the nest on foraging trips. We used mimics to test whether outgoing foragers inside the nest respond to the odor of food, oleic acid, the odor of the forager itself, cuticular hydrocarbons, or a combination of both with increased foraging activity. We compared foraging activity, the rate at which foragers passed a line on a trail, before and after the addition of mimics. The combination of both odors, those of food and of foragers, is required to stimulate foraging. The addition of blank mimics, mimics coated with food odor alone, or mimics coated with forager odor alone did not increase foraging activity. We compared the rates at which foragers inside the nest interacted with other ants, blank mimics, and mimics coated with a combination of food and forager odor. Foragers inside the nest interacted more with mimics coated with combined forager/seed odors than with blank mimics, and these interactions had the same effect as those with other foragers. Outgoing foragers inside the nest entrance are stimulated to leave the nest in search of food by interacting with foragers returning with seeds. By using the combined odors of forager cuticular hydrocarbons and of seeds, the colony captures precise information, on the timescale of seconds, about the current availability of food.	[Greene, Michael J.] Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA; [Pinter-Wollman, Noa; Gordon, Deborah M.] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	University of Colorado System; University of Colorado Denver; Stanford University	Greene, MJ (corresponding author), Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA.	michael.greene@ucdenver.edu			NSF [IOS-0718631]	NSF(National Science Foundation (NSF))	NSF grant IOS-0718631 to DMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler FR, 2003, AM NAT, V162, P529, DOI 10.1086/378856; Beverly BD, 2009, BEHAV ECOL, V20, P633, DOI 10.1093/beheco/arp041; Biesmeijer JC, 1998, BEHAV ECOL SOCIOBIOL, V42, P107, DOI 10.1007/s002650050418; Bollazzi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017667; Boulay R, 2007, NATURWISSENSCHAFTEN, V94, P242, DOI 10.1007/s00114-006-0185-z; Boulay R, 2006, CHEMOECOLOGY, V16, P1, DOI 10.1007/s00049-005-0322-8; CAMAZINE S, 1993, BEHAV ECOL SOCIOBIOL, V32, P265, DOI 10.1007/BF00166516; Copeland LO, 2001, PRINCIPLES SEED SCI, P48; Fernandez PC, 2003, BEHAV ECOL SOCIOBIOL, V54, P80, DOI 10.1007/s00265-003-0607-2; Gordon DM, 2008, BEHAV ECOL, V19, P217, DOI 10.1093/beheco/arm125; Gordon DM, 2007, NATURE, V446, P143, DOI 10.1038/446143a; Gordon DM, 2011, BEHAV ECOL, V22, P429, DOI 10.1093/beheco/arq218; GORDON DM, 1983, J CHEM ECOL, V9, P105, DOI 10.1007/BF00987774; Gordon DM, 1996, ECOLOGY, V77, P2393, DOI 10.2307/2265741; GORDON DM, 1995, ANIM BEHAV, V49, P649, DOI 10.1016/0003-3472(95)80198-7; GORDON DM, 1991, AM NAT, V138, P379, DOI 10.1086/285223; Gordon DM, 2002, AM NAT, V159, P509, DOI 10.1086/339461; GORDON DM, 1993, OECOLOGIA, V95, P479, DOI 10.1007/BF00317431; Greene MJ, 2007, AM NAT, V170, P943, DOI 10.1086/522843; Greene MJ, 2007, J EXP BIOL, V210, P897, DOI 10.1242/jeb.02706; Greene MJ, 2007, BEHAV ECOL, V18, P451, DOI 10.1093/beheco/arl105; Greene MJ, 2003, NATURE, V423, P32, DOI 10.1038/423032a; Gruter C, 2008, P R SOC B, V275, P1321, DOI 10.1098/rspb.2008.0186; Helmy O, 2003, INSECT SOC, V50, P32, DOI 10.1007/s000400300005; Ichinose K, 2005, INSECT SOC, V57, P453; Kanchanamayoon Wanna, 2007, Chiang Mai Journal of Science, V34, P249; Laffargue A, 2007, PLANT PHYSIOL BIOCH, V45, P250, DOI 10.1016/j.plaphy.2007.01.012; Martin SJ, 2009, BIOL J LINN SOC, V96, P732, DOI 10.1111/j.1095-8312.2008.01158.x; Nelson D.R., 1995, WAXES CHEM MOL BIOL, P1; Nelson DR, 2001, COMP BIOCHEM PHYS B, V128, P575, DOI 10.1016/S1096-4959(00)00354-7; O'Donnell S, 2001, BEHAV ECOL, V12, P353, DOI 10.1093/beheco/12.3.353; Pinter-Wollman N, 2011, J R SOC INTERFACE, V8, P1562, DOI 10.1098/rsif.2011.0059; Schafer RJ, 2006, ANIM BEHAV, V71, P815, DOI 10.1016/j.anbehav.2005.05.024; Steck K, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-5; Sturgis SJ, 2011, J CHEM ECOL, V37, P514, DOI 10.1007/s10886-011-9947-y; Vioque J, 2003, J CHEM ECOL, V70, P1157; Wagner D, 2000, J CHEM ECOL, V26, P2245, DOI 10.1023/A:1005529224856; Wagner D, 1998, J CHEM ECOL, V24, P2021, DOI 10.1023/A:1020781508889; WILSON EDWARD O., 1958, PSYCHE, V65, P108, DOI 10.1155/1958/69391	39	37	38	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e52219	10.1371/journal.pone.0052219	http://dx.doi.org/10.1371/journal.pone.0052219			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308106	Green Published, gold			2022-12-25	WOS:000313429800013
J	Hamlin, AS; Windels, F; Boskovic, Z; Sah, P; Coulson, EJ				Hamlin, Adam S.; Windels, Francois; Boskovic, Zoran; Sah, Pankaj; Coulson, Elizabeth J.			Lesions of the Basal Forebrain Cholinergic System in Mice Disrupt Idiothetic Navigation	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; HIPPOCAMPAL THETA; SPATIAL MEMORY; NEURONS; ACETYLCHOLINE; DEMENTIA; RATS; NEUROTRANSMITTER; INVOLVEMENT	Loss of integrity of the basal forebrain cholinergic neurons is a consistent feature of Alzheimer's disease, and measurement of basal forebrain degeneration by magnetic resonance imaging is emerging as a sensitive diagnostic marker for prodromal disease. It is also known that Alzheimer's disease patients perform poorly on both real space and computerized cued (allothetic) or uncued (idiothetic) recall navigation tasks. Although the hippocampus is required for allothetic navigation, lesions of this region only mildly affect idiothetic navigation. Here we tested the hypothesis that the cholinergic medial septo-hippocampal circuit is important for idiothetic navigation. Basal forebrain cholinergic neurons were selectively lesioned in mice using the toxin saporin conjugated to a basal forebrain cholinergic neuronal marker, the p75 neurotrophin receptor. Control animals were able to learn and remember spatial information when tested on a modified version of the passive place avoidance test where all extramaze cues were removed, and animals had to rely on idiothetic signals. However, the exploratory behaviour of mice with cholinergic basal forebrain lesions was highly disorganized during this test. By contrast, the lesioned animals performed no differently from controls in tasks involving contextual fear conditioning and spatial working memory (Y maze), and displayed no deficits in potentially confounding behaviours such as motor performance, anxiety, or disturbed sleep/wake cycles. These data suggest that the basal forebrain cholinergic system plays a specific role in idiothetic navigation, a modality that is impaired early in Alzheimer's disease.	[Hamlin, Adam S.; Windels, Francois; Boskovic, Zoran; Sah, Pankaj; Coulson, Elizabeth J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Hamlin, Adam S.] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW, Australia	University of Queensland; Charles Sturt University	Coulson, EJ (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	e.coulson@uq.edu.au	Windels, Francois/G-5432-2010; Sah, Pankaj/C-8175-2009; Boskovic, Zoran/Y-2764-2018; Coulson, Elizabeth J./C-8766-2009	Boskovic, Zoran/0000-0002-9867-1827; Coulson, Elizabeth J./0000-0003-3783-6197; Sah, Pankaj/0000-0001-5063-1589; Windels, Francois/0000-0001-5341-2197; Hamlin, Adam/0000-0003-0495-1973	National Health and Medical Research Council of Australia [569507, 569886, 569601]; Mason Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Mason Foundation	This work was supported by the National Health and Medical Research Council of Australia (Project Grant 569507; Postdoctoral Fellowship 569886 to A. S. H.; Career Development Fellowship 569601 to E.J.C.) and a Mason Foundation grant [http://www.nhmrc.gov.au/, http://www.anz.com/personal/private-bank-trustees/trustees/granting/granting-programs/health-medical/#NMP] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger-Sweeney J, 2001, J NEUROSCI, V21, P8164, DOI 10.1523/JNEUROSCI.21-20-08164.2001; Blokland A, 1995, BRAIN RES REV, V21, P285, DOI 10.1016/0165-0173(95)00016-X; Cimadevilla JM, 2000, J NEUROSCI METH, V102, P155, DOI 10.1016/S0165-0270(00)00288-0; Craig LA, 2011, NEUROSCI BIOBEHAV R, V35, P1397, DOI 10.1016/j.neubiorev.2011.03.001; Czeh B, 2001, NEUROBIOL LEARN MEM, V75, P190, DOI 10.1006/nlme.2000.3975; Feigenbaum JD, 2004, NEUROPSYCHOLOGY, V18, P462, DOI 10.1037/0894-4105.18.3.462; FOSTER TC, 1989, SCIENCE, V244, P1580, DOI 10.1126/science.2740902; Franklin K., 2007, MOUSE BRAIN STEREOTA; Gallistel C. R., 1990, ORG LEARNING; Gorny JH, 2002, LEARN MEMORY, V9, P387, DOI 10.1101/lm.53002; Grothe M, 2012, BIOL PSYCHIAT, V71, P805, DOI 10.1016/j.biopsych.2011.06.019; Grothe M, 2010, CEREB CORTEX, V20, P1685, DOI 10.1093/cercor/bhp232; Hall JR, 2008, INT J GERIATR PSYCH, V23, P314, DOI 10.1002/gps.1881; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; Henny P, 2008, EUR J NEUROSCI, V27, P654, DOI 10.1111/j.1460-9568.2008.06029.x; Hort J, 2007, P NATL ACAD SCI USA, V104, P4042, DOI 10.1073/pnas.0611314104; Hunter CL, 2004, EUR J NEUROSCI, V19, P3305, DOI 10.1111/j.0953-816X.2004.03439.x; Laczo J, 2010, NEURODEGENER DIS, V7, P148, DOI 10.1159/000289226; Laczo J, 2011, NEURODEGENER DIS, V8, P169, DOI 10.1159/000321581; Laczo J, 2009, BEHAV BRAIN RES, V202, P252, DOI 10.1016/j.bbr.2009.03.041; LEE MG, 1994, NEUROSCIENCE, V62, P1033, DOI 10.1016/0306-4522(94)90341-7; Levey AI, 1996, P NATL ACAD SCI USA, V93, P13541, DOI 10.1073/pnas.93.24.13541; Mapstone M, 2003, NEUROLOGY, V60, P802, DOI 10.1212/01.WNL.0000049471.76799.DE; Martin MM, 2007, PHYSIOL BEHAV, V90, P412, DOI 10.1016/j.physbeh.2006.10.007; Mesulam M, 2004, LEARN MEMORY, V11, P43, DOI 10.1101/lm.69204; Monacelli AM, 2003, NEUROLOGY, V61, P1491, DOI 10.1212/WNL.61.11.1491; Moreau PH, 2008, HIPPOCAMPUS, V18, P610, DOI 10.1002/hipo.20422; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Muth K, 2010, BIOL PSYCHIAT, V67, P588, DOI 10.1016/j.biopsych.2009.02.026; Nag N, 2009, NEUROSCI LETT, V452, P247, DOI 10.1016/j.neulet.2009.01.006; Nordberg A, 2001, BIOL PSYCHIAT, V49, P200, DOI 10.1016/S0006-3223(00)01125-2; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Perry E, 1999, TRENDS NEUROSCI, V22, P273, DOI 10.1016/S0166-2236(98)01361-7; PERRY EK, 1981, LANCET, V2, P149, DOI 10.1016/S0140-6736(81)90327-5; Pinto T, 2011, AGEING RES REV, V10, P404, DOI 10.1016/j.arr.2011.01.003; Schliebs R, 2006, J NEURAL TRANSM, V113, P1625, DOI 10.1007/s00702-006-0579-2; Tai SK, 2012, HIPPOCAMPUS, V22, P914, DOI 10.1002/hipo.20955; Taube JS, 1998, PROG NEUROBIOL, V55, P225, DOI 10.1016/S0301-0082(98)00004-5; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Vanderwolf CH, 1977, CIBA F SYMP, P199; Whishaw IQ, 2001, BEHAV BRAIN RES, V127, P49, DOI 10.1016/S0166-4328(01)00359-X; Yoder RM, 2005, HIPPOCAMPUS, V15, P381, DOI 10.1002/hipo.20062	42	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53472	10.1371/journal.pone.0053472	http://dx.doi.org/10.1371/journal.pone.0053472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320088	gold, Green Published, Green Submitted			2022-12-25	WOS:000313429800052
J	Swidsinski, A; Verstraelen, H; Loening-Baucke, V; Swidsinski, S; Mendling, W; Halwani, Z				Swidsinski, Alexander; Verstraelen, Hans; Loening-Baucke, Vera; Swidsinski, Sonja; Mendling, Werner; Halwani, Zaher			Presence of a Polymicrobial Endometrial Biofilm in Patients with Bacterial Vaginosis	PLOS ONE			English	Article							VAGINAL MICROFLORA; ASSOCIATION; WOMEN; COLONIZATION; MISCARRIAGE; STERILITY	Objective: To assess whether the bacterial vaginosis biofilm extends into the upper female genital tract. Study Design: Endometrial samples obtained during curettage and fallopian tube samples obtained during salpingectomy were collected. Endometrial and fallopian tube samples were analyzed for the presence of bacteria with fluorescence-in-situ-hybridisation (FISH) analysis with probes targeting bacterial vaginosis-associated and other bacteria. Results: A structured polymicrobial Gardnerella vaginalis biofilm could be detected in part of the endometrial and fallopian tube specimens. Women with bacterial vaginosis had a 50.0% (95% CI 24.0-76.0) risk of presenting with an endometrial Gardnerella vaginalis biofilm. Pregnancy (AOR = 41.5, 95% CI 5.0-341.9, p<0.001) and the presence of bacterial vaginosis (AOR = 23.2, 95% CI 2.6-205.9, p<0.001) were highly predictive of the presence of uterine or fallopian bacterial colonisation when compared to non-pregnant women without bacterial vaginosis. Conclusion: Bacterial vaginosis is frequently associated with the presence of a structured polymicrobial Gardnerella vaginalis biofilm attached to the endometrium. This may have major implications for our understanding of the pathogenesis of adverse pregnancy outcome in association with bacterial vaginosis.	[Swidsinski, Alexander; Loening-Baucke, Vera] Univ Med Berlin, Lab Mol Genet Polymicrobial Infect & Bacterial Bi, Charite Hosp, CCM, Berlin, Germany; [Swidsinski, Alexander; Loening-Baucke, Vera] Univ Med Berlin, Dept Med, Berlin, Germany; [Verstraelen, Hans] Univ Ghent, Dept Obstet & Gynaecol, B-9000 Ghent, Belgium; [Swidsinski, Sonja] Lab Berlin, Dept Microbiol, Berlin, Germany; [Mendling, Werner] German Ctr Infect Obstet & Gynaecol, Wuppertal, Germany; [Halwani, Zaher] DRK Kliniken Berlin Westend, Klin Gynakol & Geburtshilfe, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ghent University	Verstraelen, H (corresponding author), Univ Ghent, Dept Obstet & Gynaecol, B-9000 Ghent, Belgium.	hans.verstraelen@ugent.be	Verstraelen, Hans/AAA-8694-2019; Verstraelen, Hans/A-5602-2008; Mendling, Werner/ABF-9498-2021	Verstraelen, Hans/0000-0002-4070-1587; Swidsinski, Alexander/0000-0002-7071-0417				Andrews WW, 2006, AM J OBSTET GYNECOL, V195, P1611, DOI 10.1016/j.ajog.2006.04.010; ANSBACHE.R, 1967, AM J OBSTET GYNECOL, V99, P394, DOI 10.1016/S0002-9378(16)34549-5; COWLING P, 1992, EUR J CLIN MICROBIOL, V11, P204, DOI 10.1007/BF01967084; DUFF P, 1983, OBSTET GYNECOL, V61, P217; El Aila NA, 2011, RES MICROBIOL, V162, P506, DOI 10.1016/j.resmic.2011.04.004; Espinoza J, 2006, AM J OBSTET GYNECOL, V194, P630, DOI 10.1016/j.ajog.2005.11.050; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Leitich H, 2007, BEST PRACT RES CL OB, V21, P375, DOI 10.1016/j.bpobgyn.2006.12.005; MOLLER BR, 1995, ACTA OBSTET GYN SCAN, V74, P216, DOI 10.3109/00016349509008942; NELSON LH, 1986, J REPROD MED, V31, P473; Oakeshott P, 2002, BRIT MED J, V325, P1334, DOI 10.1136/bmj.325.7376.1334; Ralph SG, 1999, BRIT MED J, V319, P220, DOI 10.1136/bmj.319.7204.220; Swidsinski A, 2005, OBSTET GYNECOL, V106, P1013, DOI 10.1097/01.AOG.0000183594.45524.d2; Swidsinski A, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.039; Swidsinski A, 2010, GYNECOL OBSTET INVES, V70, P256, DOI 10.1159/000314015; Swidsinski A, 2010, ANAEROBE, V16, P478, DOI 10.1016/j.anaerobe.2010.06.011; Tita ATN, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.028; Verhelst R, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-16; Verstraelen H, 2004, AM J OBSTET GYNECOL, V191, P1130, DOI 10.1016/j.ajog.2004.04.013; Verstraelen H, 2009, EXPERT REV ANTI-INFE, V7, P1109, DOI [10.1586/eri.09.87, 10.1586/ERI.09.87]; Wilson JD, 2002, BJOG-INT J OBSTET GY, V109, P714, DOI 10.1016/S1470-0328(02)01297-1	21	96	115	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53997	10.1371/journal.pone.0053997	http://dx.doi.org/10.1371/journal.pone.0053997			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320114	Green Submitted, gold, Green Published			2022-12-25	WOS:000313429800080
J	Buades, JM; Rodriguez, V; Terrasa, B; Perez-Mellado, V; Brown, RP; Castro, JA; Picornell, A; Ramon, MM				Buades, Joana M.; Rodriguez, Virginia; Terrasa, Barbara; Perez-Mellado, Valentin; Brown, Richard P.; Castro, Jose A.; Picornell, Antonia; Ramon, M. M.			Variability of the mc1r Gene in Melanic and Non-Melanic Podarcis lilfordi and Podarcis pityusensis from the Balearic Archipelago	PLOS ONE			English	Article							HAPLOTYPE RECONSTRUCTION; PHENOTYPIC ASSOCIATIONS; STATISTICAL-METHOD; CLADISTIC-ANALYSIS; SEQUENCE VARIATION; DNA POLYMORPHISM; PLUMAGE COLOR; LIZARDS; MUTATIONS; CONSERVATION	The association between polymorphism at the mc1r locus and colour variation was studied in two wall lizard species (Podarcis lilfordi and P. pityusensis) from the Balearic archipelago. Podarcis lilfordi comprises several deep mitochondrial lineages, the oldest of which originated in the Pliocene, while much shallower mitochondrial lineages are found in P. pityusensis. Here, we examined whether specific substitutions were associated with the melanic colouration found in islet populations of these species. Homologous nuclear sequences covering most of the mc1r gene were obtained from 73 individuals from melanic and non-melanic Podarcis from different populations (the entire gene was also sequenced in six selected individuals). MtDNA gene trees were also constructed and used as a framework to assess mc1r diversity. Mc1r showed greater polymorphism in P. lilfordi than in P. pityusensis. However, we observed no substitutions that were common to all melanic individuals across the two species. Only one significant association was detected in the mc1r partial sequence, but this was a synonymous A/G mutation with A alleles being more abundant in melanic populations. In addition, there were no associations between the main dominant phenotypes (green and brown, blue and yellow spots and ventral colour) and synonymous or non-synonymous substitutions in the mc1r gene. There was no statistical evidence of selection on mc1r. This study suggests no relationship between mc1r polymorphism and colour variation in Balearic Podarcis.	[Buades, Joana M.; Rodriguez, Virginia; Terrasa, Barbara; Castro, Jose A.; Picornell, Antonia; Ramon, M. M.] Univ Illes Balears, Genet Lab, Palma De Mallorca, Spain; [Perez-Mellado, Valentin] Univ Salamanca, Dept Biol Anim, E-37008 Salamanca, Spain; [Brown, Richard P.] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool L3 5UX, Merseyside, England	Universitat de les Illes Balears; University of Salamanca; Liverpool John Moores University	Ramon, MM (corresponding author), Univ Illes Balears, Genet Lab, Palma De Mallorca, Spain.	cori.ramon@uib.es	Pont, Barbara Terrasa/AAA-7194-2019; Picornell, Antonia/H-5072-2017; Castro, Jose A./J-9192-2014; RAMON, M MISERICORDIA/Y-2497-2018; Perez-Mellado, Valentin/G-3476-2015	Picornell, Antonia/0000-0003-4454-5304; Castro, Jose A./0000-0001-8262-560X; RAMON, M MISERICORDIA/0000-0003-1234-3337; Perez-Mellado, Valentin/0000-0002-7137-4945; Brown, Richard P./0000-0003-2401-6077	Spanish Ministerio de Ciencia e Innovacion and European Union FEDER funds [CGL2006-10893, CGL2009-12926]; Direccio General URT (Govern de les Illes Balears); European Union FSE	Spanish Ministerio de Ciencia e Innovacion and European Union FEDER funds; Direccio General URT (Govern de les Illes Balears); European Union FSE(European Social Fund (ESF))	This work has been financed by the research funds CGL2006-10893 and CGL2009-12926 of the Spanish Ministerio de Ciencia e Innovacion and European Union FEDER funds. VR is supported by a grant from Direccio General URT (Govern de les Illes Balears) and European Union FSE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TM, 2009, SCIENCE, V323, P1339, DOI 10.1126/science.1165448; Arnold EN, 2007, ZOOTAXA, P1, DOI 10.11646/zootaxa.1430.1.1; Bagnara JT, 2007, PIGM CELL RES, V20, P14, DOI 10.1111/j.1600-0749.2006.00360.x; Brown RP, 2008, MOL PHYLOGENET EVOL, V48, P350, DOI 10.1016/j.ympev.2008.04.013; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Corso J, 2012, GENET MOL BIOL, V35, P81, DOI 10.1590/S1415-47572012005000015; Daniels SR, 2004, J ZOOL, V263, P373, DOI 10.1017/S0952836904005424; Eisentraut M., 1954, Zoologischer Anzeiger, V152, P317; Eisentraut M., 1949, Mitt zool Mus Berlin1949, V26, P1; FU YX, 1993, GENETICS, V133, P693; Garcia-Borron JC, 2005, PIGM CELL RES, V18, P393, DOI 10.1111/j.1600-0749.2005.00278.x; Gross JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000326; Guo XL, 2010, BRIT POULTRY SCI, V51, P734, DOI 10.1080/00071668.2010.518408; Harris DJ, 1999, COPEIA, P749; HARTMANN M., 1953, ZOOL JAHRB ABT ALLG ZOOL U PHYSIOL TIERE, V64, P86; Herczeg G, 2010, ANN ZOOL FENN, V47, P37, DOI 10.5735/086.047.0104; Hubbard JK, 2010, TRENDS GENET, V26, P231, DOI 10.1016/j.tig.2010.02.002; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kerje S, 2003, ANIM GENET, V34, P241, DOI 10.1046/j.1365-2052.2003.00991.x; Kijas JMH, 1998, GENETICS, V150, P1177; KRAMER G, 1949, Z INDUKT ABSTAMM VER, V83, P157, DOI 10.1007/BF00309280; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; McRobie H, 2009, J HERED, V100, P709, DOI 10.1093/jhered/esp059; Micheletti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047694; Nachman MW, 2003, P NATL ACAD SCI USA, V100, P5268, DOI 10.1073/pnas.0431157100; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nunes VL, 2011, J EVOLUTION BIOL, V24, P2289, DOI 10.1111/j.1420-9101.2011.02359.x; Parker AR, 1998, J EXP BIOL, V201, P2343; Perez-Mellado V, 1988, BALEARIC LIZARD PODA, V1; Pinho C, 2010, CONSERV GENET RESOUR, V2, P181, DOI 10.1007/s12686-009-9126-4; Raia P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-289; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; Rosenblum EB, 2010, P NATL ACAD SCI USA, V107, P2113, DOI 10.1073/pnas.0911042107; Salvador A, 1984, BIOGEOGRAPHY ECOLOGY, P429; Schioth HB, 2005, PEPTIDES, V26, P1886, DOI 10.1016/j.peptides.2004.11.034; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; Takeuchi S, 1996, BBA-GENE STRUCT EXPR, V1306, P122, DOI 10.1016/0167-4781(96)00026-7; TEMPLETON AR, 1992, GENETICS, V132, P619; TEMPLETON AR, 1993, GENETICS, V134, P659; Terrasa B, 2009, DIVERS DISTRIB, V15, P207, DOI 10.1111/j.1472-4642.2008.00520.x	43	20	21	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53088	10.1371/journal.pone.0053088	http://dx.doi.org/10.1371/journal.pone.0053088			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308144	gold, Green Published			2022-12-25	WOS:000313429100028
J	Desel, C; Werninghaus, K; Ritter, M; Jozefowski, K; Wenzel, J; Russkamp, N; Schleicher, U; Christensen, D; Wirtz, S; Kirschning, C; Agger, EM; da Costa, CP; Lang, R				Desel, Christiane; Werninghaus, Kerstin; Ritter, Manuel; Jozefowski, Katrin; Wenzel, Jens; Russkamp, Norman; Schleicher, Ulrike; Christensen, Dennis; Wirtz, Stefan; Kirschning, Carsten; Agger, Else Marie; da Costa, Clarissa Prazeres; Lang, Roland			The Mincle-Activating Adjuvant TDB Induces MyD88-Dependent Th1 and Th17 Responses through IL-1R Signaling	PLOS ONE			English	Article							IFN-GAMMA PRODUCTION; T-CELLS; INFLAMMASOME ACTIVATION; ANTIBODY-RESPONSES; CRUCIAL ROLE; CASPASE-1; CYTOKINE; MYD88; IL-1-BETA; INDUCTION	Successful vaccination against intracellular pathogens requires the generation of cellular immune responses. Trehalose-6,6-dibehenate (TDB), the synthetic analog of the mycobacterial cord factor trehalose-6,6-dimycolate (TDM), is a potent adjuvant inducing strong Th1 and Th17 immune responses. We previously identified the C-type lectin Mincle as receptor for these glycolipids that triggers the FcR gamma-Syk-Card9 pathway for APC activation and adjuvanticity. Interestingly, in vivo data revealed that the adjuvant effect was not solely Mincle-dependent but also required MyD88. Therefore, we dissected which MyD88-dependent pathways are essential for successful immunization with a tuberculosis subunit vaccine. We show here that antigen-specific Th1/Th17 immune responses required IL-1 receptor-mediated signals independent of IL-18 and IL-33-signaling. ASC-deficient mice had impaired IL-17 but intact IFN gamma responses, indicating partial independence of TDB adjuvanticity from inflammasome activation. Our data suggest that the glycolipid adjuvant TDB triggers Mincle-dependent IL-1 production to induce MyD88-dependent Th1/Th17 responses in vivo.	[Desel, Christiane; Werninghaus, Kerstin; Jozefowski, Katrin; Wenzel, Jens; Russkamp, Norman; Schleicher, Ulrike; Lang, Roland] Univ Hosp Erlangen, Inst Clin Microbiol Immunol & Hyg, Erlangen, Germany; [Ritter, Manuel; da Costa, Clarissa Prazeres] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-80290 Munich, Germany; [Christensen, Dennis; Agger, Else Marie] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark; [Wirtz, Stefan] Univ Hosp Erlangen, Med Clin 1, Erlangen, Germany; [Kirschning, Carsten] Inst Med Mikrobiol, Essen, Germany	University of Erlangen Nuremberg; Technical University of Munich; Statens Serum Institut; University of Erlangen Nuremberg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Desel, C (corresponding author), Univ Hosp Erlangen, Inst Clin Microbiol Immunol & Hyg, Erlangen, Germany.	christiane.desel@uk-erlangen.de; roland.lang@uk-erlangen.de	Ritter, Manuel/ABE-7747-2020; Christensen, Dennis/C-6378-2008	Ritter, Manuel/0000-0001-8667-2067; Christensen, Dennis/0000-0003-2382-8639; Desel, Christiane/0000-0003-2029-3851; Lang, Roland/0000-0003-0502-3677; Wirtz, Stefan/0000-0001-6936-7431	Deutsche Forschungsgemeinschaft [SFB796, SFB/TR22]; European Union	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB796 to RL and SFB/TR22 to CPdP) and the European Union (FP6 NEWTBVAC to EMA, DC and RL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Agger EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003116; Brereton CF, 2011, J IMMUNOL, V186, P5896, DOI 10.4049/jimmunol.1003789; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Davidsen J, 2005, BBA-BIOMEMBRANES, V1718, P22, DOI 10.1016/j.bbamem.2005.10.011; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Geisel RE, 2005, J IMMUNOL, V174, P5007, DOI 10.4049/jimmunol.174.8.5007; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Gross O, 2012, IMMUNITY, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Ippagunta SK, 2012, NAT IMMUNOL, V13, P701, DOI 10.1038/ni.2389; Ippagunta SK, 2011, NAT IMMUNOL, V12, P1010, DOI 10.1038/ni.2095; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Kaufmann SHE, 2010, LANCET, V375, P2110, DOI 10.1016/S0140-6736(10)60393-5; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Lalor SJ, 2011, J IMMUNOL, V186, P5738, DOI 10.4049/jimmunol.1003597; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Lindenstrom T, 2012, INFECT IMMUN, V80, P3533, DOI 10.1128/IAI.00550-12; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masumoto M, 1999, J IMMUNOL, V163, P5039; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Ottenhoff TH, 2010, HUM VACCINES, V6, P1007, DOI 10.4161/hv.6.12.13143; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013; Schweneker K, 2012, IMMUNOBIOLOGY, DOI [10.1016/j.imbio.2012.07.029, DOI 10.1016/J.IM-BI0.2012.07.029]; Sun DX, 2006, NAT IMMUNOL, V7, P375, DOI 10.1038/ni1308; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Wenzel J, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00071; Werninghaus K, 2009, J EXP MED, V206, P89, DOI 10.1084/jem.20081445; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1	37	98	100	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53531	10.1371/journal.pone.0053531	http://dx.doi.org/10.1371/journal.pone.0053531			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308247	Green Published, gold			2022-12-25	WOS:000313429100085
J	Hou, DJ; Li, GH; Fang, L; Li, B				Hou, Dianju; Li, Gehong; Fang, Lin; Li, Bing			Frontalis Muscle Flap Suspension for the Correction of Congenital Blepharoptosis in Early Age Children	PLOS ONE			English	Article							AUTOGENOUS FASCIA-LATA; SEVERE PTOSIS	Background: We aimed to report our successful use of frontalis muscle flap suspension for the correction of congenital blepharoptosis in early age children. Methods: This retrospective study included 61 early age children (41 boys, 20 girls) with an average age of 6 years (range, 3-10 years) with congenital blepharoptosis who received surgery during the period from March 2007 to January 2011. There were 39 cases of unilateral blepharoptosis and 22 cases of bilateral blepharoptosis, thus a total of 83 eyes were affected. If patient had bilateral blepharoptosis, both eyes were operated on in the same surgery. Patients were followed for 3 months to 5 years. The procedure was performed without complications in all cases. Results: The postoperative healing grade was good in 81 eyes (97.6%); the correction of blepharoptosis was satisfactory, the double eyelid folds were natural and aesthetic, the eyelid position and the curvature were ideal, and the eyes were bilaterally symmetrical. The postoperative healing grade was fair in 2 eyes (2.4%); blepharoptosis was improved compared with that before surgery. At discharge, lagophthalmos was noted in 10 eyes of which 4 cases resolved by the last follow-up. The remaining 6 cases were mild. Eleven eyes received reoperation for residual ptosis after the first surgery. The curvature of the palpebral margin was not natural in 4 eyes. These unnatural curvature possibly was caused by an excessively low lateral fixation point or postoperative avulsion. Conclusion: Frontalis muscle flap suspension under general anesthesia for the correction of congenital blepharoptosis in early age children can achieve good surgical results.	[Hou, Dianju; Fang, Lin; Li, Bing] Peking Union Med Coll, Plast Surg Hosp, Dept Microinvas Plasit Surg Ctr, Beijing 100021, Peoples R China; [Hou, Dianju; Li, Gehong; Fang, Lin; Li, Bing] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Li, Gehong] Peking Union Med Coll, Plast Surg Hosp, Dept Hosp Infect Control, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Plastic Surgery Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Plastic Surgery Hospital - CAMS	Li, GH (corresponding author), Peking Union Med Coll, Plast Surg Hosp, Dept Hosp Infect Control, Beijing 100021, Peoples R China.	hglabcde@163.com						Allard FD, 2010, MIDDLE EAST AFR J OP, V17, P129, DOI 10.4103/0974-9233.63073; Allen RC, 2012, BRIT J OPHTHALMOL, V96, P841, DOI 10.1136/bjophthalmol-2011-300667; Arajy ZY, 2012, J CRANIO MAXILL SURG, V40, P129, DOI 10.1016/j.jcms.2011.03.002; Baroody Michael, 2005, Curr Opin Ophthalmol, V16, P351, DOI 10.1097/01.icu.0000186647.00413.21; Beard C, 1981, PTOSIS, V3rd, P39; Berry-Brincat A, 2009, EYE, V23, P1554, DOI 10.1038/eye.2008.311; Bhiromekraibhak Keerapat, 2010, J Med Assoc Thai, V93 Suppl 2, pS15; Bleyen I, 2009, OPHTHAL PLAST RECONS, V25, P359, DOI 10.1097/IOP.0b013e3181b1e67a; Cetinkaya A, 2008, CURR OPIN OPHTHALMOL, V19, P428, DOI 10.1097/ICU.0b013e32830b88eb; Deenstra W, 1996, ANN PLAS SURG, V36, P348, DOI 10.1097/00000637-199604000-00004; Evereklioglu C, 2012, BRIT J OPHTHALMOL, V96, P570, DOI 10.1136/bjophthalmol-2011-300400; Friedhofer H, 2012, PLAST RECONSTR SURG, V129, p453E, DOI 10.1097/PRS.0b013e3182402deb; Han X, 2007, CHIN COSMETIC MED, V16, P522; Kim CY, 2012, AM J OPHTHALMOL, V153, P334, DOI 10.1016/j.ajo.2011.07.023; Leibovitch I, 2003, AM J OPHTHALMOL, V136, P866, DOI 10.1016/S0002-9394(03)00466-5; Lin MC, 2006, CHIN COSMETIC MED, V15, P46; Luo J, 1994, CHIN J PLAST SURG, V10, P466; Pan Y, 2008, AESTHET PLAST SURG, V32, P604, DOI 10.1007/s00266-008-9125-y; Philandrianos C, 2010, J PLAST RECONSTR AES, V63, P782, DOI 10.1016/j.bjps.2009.01.083; Qiu SS, 2011, ANN PLAS SURG, V67, P129, DOI 10.1097/SAP.0b013e3181f3e5eb; Ramirez OM, 2004, PLAST RECONSTR SURG, V113, P1841, DOI 10.1097/01.PRS.0000117664.07831.48; Sakol P J, 1999, Curr Opin Ophthalmol, V10, P335, DOI 10.1097/00055735-199910000-00010; Small RG, 2000, OPHTHALMIC PLAST REC, V16, P81, DOI 10.1097/00002341-200003000-00001; Sokol JA, 2011, OPHTHAL PLAST RECONS, V27, P211, DOI 10.1097/IOP.0b013e3181ef72cd; Tong JT, 2000, J AAPOS, V4, P186, DOI 10.1067/mpa.2000.105275; Zhang HM, 1999, BRIT J PLAST SURG, V52, P524, DOI 10.1054/bjps.1999.3149	26	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53185	10.1371/journal.pone.0053185	http://dx.doi.org/10.1371/journal.pone.0053185			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308158	Green Published, gold, Green Submitted			2022-12-25	WOS:000313429100034
J	Liu, ZJ; Chen, LJ; Liu, KW; Li, LQ; Rao, WH; Zhang, YT; Tang, GD; Huang, LQ				Liu, Zhong-Jian; Chen, Li-Jun; Liu, Ke-Wei; Li, Li-Qiang; Rao, Wen-Hui; Zhang, Yu-Ting; Tang, Guang-Da; Huang, Lai-Qiang			Adding Perches for Cross-Pollination Ensures the Reproduction of a Self-Incompatible Orchid	PLOS ONE			English	Article							FERTILIZATION; EVOLUTION	Background: Outcrossing is known to carry genetic advantages in comparison with inbreeding. In many cases, flowering plants develop a self-incompatibility mechanism, along with a floral component adaptation mechanism, to avoid self-pollination and to promote outbreeding. Orchids commonly have a lip in their flower that functions as the a visiting plate for insect pollinators. Aside from the lip, however, many species (including Coelogyne rigida) have sheaths around the axis of inflorescence. The function of these sheaths remains unknown, and has long been a puzzle to researchers. Methodology/Principal Findings: We investigated the function of these sheaths in relation to the lip and the pollinators, as well as their role in the modes of pollination and reproduction of Coelogyne rigida in 30 flowering populations of orchids in the limestone area of Southeast Yunnan, China. We found that self-incompatible C. rigida developed specialized bird perches around the basal axis of inflorescence to attract sunbirds and to complement their behavioral tendency to change foraging locations frequently. This self-incompatibility mechanism operates separately from the floral component adaptation mechanism. This mechanism thus prevents bees from repeatedly visiting the floral lip of the same plant which, in turn, results in autogamy. In this way, instead of preventing autogamy, C. rigida responds to these negative effects through a highly efficient cross-pollination method that successfully transfers pollen to different plants. Conclusions: The proposed method ensures reproductive success, while offsetting the infertile self-pollination by insects, thereby reducing mating costs and addressing the lack of cross-pollination. The adaptation provides a novel and striking example of structural adaptation that promotes cross-pollination in angiosperms.	[Liu, Zhong-Jian; Chen, Li-Jun; Liu, Ke-Wei; Li, Li-Qiang; Rao, Wen-Hui; Zhang, Yu-Ting] Natl Orchid Conservat Ctr China, Shenzhen Key Lab Orchid Conservat & Utilizat, Shenzhen, Peoples R China; [Liu, Zhong-Jian; Chen, Li-Jun; Liu, Ke-Wei; Li, Li-Qiang; Rao, Wen-Hui; Zhang, Yu-Ting] Orchid Conservat & Res Ctr Shenzhen, Shenzhen, Peoples R China; [Liu, Zhong-Jian; Liu, Ke-Wei; Huang, Lai-Qiang] Tsinghua Univ, Grad Sch Shenzhen, Ctr Biotechnol & BioMed, Shenzhen 518057, Peoples R China; [Liu, Zhong-Jian; Tang, Guang-Da; Huang, Lai-Qiang] S China Agr Univ, Coll Forestry, Guangzhou, Guangdong, Peoples R China	Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; South China Agricultural University	Liu, ZJ (corresponding author), Natl Orchid Conservat Ctr China, Shenzhen Key Lab Orchid Conservat & Utilizat, Shenzhen, Peoples R China.	liuzj@sinicaorchid.org; huanglq@mail.tsinghua.edu.cn		Liu, Zhong-Jian/0000-0003-4390-3878	State Forestry Administration, China [2011-4-53]; State Forestry Administration of China [2010-240]; Forestry Construction Program of Guangdong Province, China [2010-317]	State Forestry Administration, China; State Forestry Administration of China; Forestry Construction Program of Guangdong Province, China	This work was supported by fellowships from the 948 Program of State Forestry Administration, China (No. 2011-4-53), the Forestry Construction Program of State Forestry Administration of China (No. 2010-240), and the Forestry Construction Program of Guangdong Province, China (No. 2010-317). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson B, 2005, NATURE, V435, P41, DOI 10.1038/435041a; Anderson B, 2010, EVOLUTION, V64, P960, DOI 10.1111/j.1558-5646.2009.00880.x; BAKER HG, 1955, EVOLUTION, V9, P347, DOI 10.2307/2405656; Barrett SCH, 1996, PHILOS T R SOC B, V351, P1271, DOI 10.1098/rstb.1996.0110; Chen LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037478; Chen S.C., 2009, FLORA CHINA, VVol. 25, P315; Cheng J, 2009, ANN BOT-LONDON, V104, P565, DOI 10.1093/aob/mcp029; CONNER JK, 1995, OECOLOGIA, V104, P234, DOI 10.1007/BF00328588; Darwin C, 1916, EFFECTS CROSS AND SE; Dressler RL, 1993, PHYLOGENY CLASSIFICA; Fleming PA, 2002, OECOLOGIA, V132, P361, DOI 10.1007/s00442-002-0921-9; Herlihy CR, 2002, NATURE, V416, P320, DOI 10.1038/416320a; HOLSINGER KE, 1991, TRENDS ECOL EVOL, V6, P307, DOI 10.1016/0169-5347(91)90033-T; Johnson SD, 2004, PLANT SYST EVOL, V244, P181, DOI 10.1007/s00606-003-0106-y; [刘仲健 LIU ZhongJian], 2008, [生态学报, Acta Ecologica Sinica], V28, P111; Ollerton J, 1998, NATURE, V394, P726, DOI 10.1038/29409; Richards RJ, 1997, PLANT BREEDING SYSTE; Sahli HF, 2011, EVOLUTION, V65, P1457, DOI 10.1111/j.1558-5646.2011.01229.x; SMITH R M, 1990, Edinburgh Journal of Botany, V47, P1; Stebbins G.L., 1974, FLOWERING PLANTS EVO, DOI 10.4159/harvard.9780674864856; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; Takebayashi N, 2001, AM J BOT, V88, P1143, DOI 10.2307/3558325; WESTERKAMP C, 1990, BOT ACTA, V103, P366, DOI 10.1111/j.1438-8677.1990.tb00176.x; Zhang DY, 2004, HIST EVOLUTION REPRO	24	6	6	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53695	10.1371/journal.pone.0053695	http://dx.doi.org/10.1371/journal.pone.0053695			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308277	Green Published, gold			2022-12-25	WOS:000313429100109
J	Nagarajan, R; Jonkman, JN				Nagarajan, Radhakrishnan; Jonkman, Jeffrey N.			A Neural Network Model to Translate Brain Developmental Events across Mammalian Species	PLOS ONE			English	Article								Translating the timing of brain developmental events across mammalian species using suitable models has provided unprecedented insights into neural development and evolution. More importantly, these models can prove to be useful abstractions and predict unknown events across species from known empirical event timing data retrieved from published literature. Such predictions can be especially useful since the distribution of the event timing data is skewed with a majority of events documented only across a few selected species. The present study investigates the choice of single hidden layer feed-forward neural networks (FFNN) for predicting the unknown events from the empirical data. A leave-one-out cross-validation approach is used to determine the optimal number of units in the hidden layer and the decay parameter for the FFNN. It is shown that unlike the present Finlay-Darlington (FD) model, FFNN does not impose any constraints on the functional form of the model and falls under the class of semiparametric regression models that can approximate any continuous function. The results from FFNN as well as FD model also indicate that a majority of events with large absolute prediction errors correspond to those of primates and late events comprising the tail of event timing data distribution with minimal representation in the empirical data. These results also indicate that accurate prediction of primate events may be challenging.	[Nagarajan, Radhakrishnan] Univ Kentucky, Coll Publ Hlth, Dept Biostat, Div Biomed Informat, Lexington, KY 40506 USA; [Jonkman, Jeffrey N.] Grinnell Coll, Dept Math & Stat, Grinnell, IA 50112 USA	University of Kentucky	Nagarajan, R (corresponding author), Univ Kentucky, Coll Publ Hlth, Dept Biostat, Div Biomed Informat, Lexington, KY 40506 USA.	rnagarajan@uky.edu			National Science Foundation [NSF DBI-0849684]	National Science Foundation(National Science Foundation (NSF))	RK acknowledges funding from the National Science Foundation (NSF DBI-0849684). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop C.M., 2006, PATTERN RECOGNITION; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Clancy B, 2007, NEUROINFORMATICS, V5, P79, DOI 10.1385/NI:5:1:79; Clancy B, 2000, DEVELOPMENTAL SCI, V3, P57, DOI 10.1111/1467-7687.00100; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Efron B., 1994, INTRO BOOTSTRAP; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Gybenko G, 1989, MATH CONTROL SIGNAL, V2, P303, DOI DOI 10.1007/BF02551274; Harrell FE, 2001, REGRESSION MODELING; Hassoun MH., 1995, FUNDAMENTALS ARTIFIC, DOI 10.1109/JPROC.1996.503146; Hastie T., 2003, ELEMENTS STAT LEARNI; HORNIK K, 1991, NEURAL NETWORKS, V4, P251, DOI 10.1016/0893-6080(91)90009-T; Ingrassia S, 2005, TECHNOMETRICS, V47, P297, DOI 10.1198/004017005000000058; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02459570; Nagarajan R, 2008, NEUROINFORMATICS, V6, P71, DOI 10.1007/s12021-008-9013-2; Nagarajan R, 2010, NEUROINFORMATICS, V8, P201, DOI 10.1007/s12021-010-9081-y; Ripley B. D., 1996, PATTERN RECOGNITION; Rojas R., 1996, NEURAL NETWORKS SYST, DOI [10.1007/978-3-642-61068-4{\_}7, DOI 10.1007/978-3-642-61068-4]; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2	19	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53225	10.1371/journal.pone.0053225	http://dx.doi.org/10.1371/journal.pone.0053225			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308165	Green Published, gold, Green Submitted			2022-12-25	WOS:000313429100040
J	Takamatsu, S; Onoguchi, K; Onomoto, K; Narita, R; Takahasi, K; Ishidate, F; Fujiwara, TK; Yoneyama, M; Kato, H; Fujita, T				Takamatsu, Shiori; Onoguchi, Kazuhide; Onomoto, Koji; Narita, Ryo; Takahasi, Kiyohiro; Ishidate, Fumiyoshi; Fujiwara, Takahiro K.; Yoneyama, Mitsutoshi; Kato, Hiroki; Fujita, Takashi			Functional Characterization of Domains of IPS-1 Using an Inducible Oligomerization System	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; ANTIVIRAL SIGNALING PROTEIN; HEPATITIS-C-VIRUS; NF-KAPPA-B; RIG-I; INNATE IMMUNITY; ADAPTER PROTEIN; IFN-BETA; MAVS; RESPONSES	The innate immune system recognizes viral nucleic acids and stimulates cellular antiviral responses. Intracellular detection of viral RNA is mediated by the Retinoic acid inducible gene (RIG)-I Like Receptor (RLR), leading to production of type I interferon (IFN) and pro-inflammatory cytokines. Once cells are infected with a virus, RIG-I and MDA5 bind to viral RNA and undergo conformational change to transmit a signal through direct interaction with downstream CARD-containing adaptor protein, IFN-beta promoter stimulator-1 (IPS-1, also referred as MAVS/VISA/Cardif). IPS-1 is composed of N-terminal Caspase Activation and Recruitment Domain (CARD), proline-rich domain, intermediate domain, and C-terminal transmembrane (TM) domain. The TM domain of IPS-1 anchors it to the mitochondrial outer membrane. It has been hypothesized that activated RLR triggers the accumulation of IPS-1, which forms oligomer as a scaffold for downstream signal proteins. However, the exact mechanisms of IPS-1-mediated signaling remain controversial. In this study, to reveal the details of IPS-1 signaling, we used an artificial oligomerization system to induce oligomerization of IPS-1 in cells. Artificial oligomerization of IPS-1 activated antiviral signaling without a viral infection. Using this system, we investigated the domain-requirement of IPS-1 for its signaling. We discovered that artificial oligomerization of IPS-1 could overcome the requirement of CARD and the TM domain. Moreover, from deletion- and point-mutant analyses, the C-terminal Tumor necrosis factor Receptor-Associated Factor (TRAF) binding motif of IPS-1 (aa. 453-460) present in the intermediate domain is critical for downstream signal transduction. Our results suggest that IPS-1 oligomerization is essential for the formation of a multiprotein signaling complex and enables downstream activation of transcription factors, Interferon Regulatory Factor 3 (IRF3) and Nuclear Factor-kappa B (NF-kappa B), leading to type I IFN and pro-inflammatory cytokine production.	[Takamatsu, Shiori; Onoguchi, Kazuhide; Narita, Ryo; Takahasi, Kiyohiro; Kato, Hiroki; Fujita, Takashi] Kyoto Univ, Inst Virus Res, Mol Genet Lab, Kyoto 606, Japan; [Takamatsu, Shiori; Kato, Hiroki; Fujita, Takashi] Kyoto Univ, Grad Sch Biostudies, Mol Cell Biol Lab, Kyoto, Japan; [Onomoto, Koji; Yoneyama, Mitsutoshi] Chiba Univ, Med Mycol Res Ctr, Div Mol Immunol, Chuo Ku, Chiba, Japan; [Takahasi, Kiyohiro] Kyoto Univ, Grad Sch Pharmaceut Sci, Inst Innovat NanoBio Drug Discovery & Dev, Kyoto, Japan; [Ishidate, Fumiyoshi; Fujiwara, Takahiro K.] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Ctr Meso Bio Single Mol Imaging CeMI, Kyoto, Japan	Kyoto University; Kyoto University; Chiba University; Kyoto University; Kyoto University	Fujita, T (corresponding author), Kyoto Univ, Inst Virus Res, Mol Genet Lab, Kyoto 606, Japan.	tfujita@virus.kyoto-u.ac.jp	Yoneyama, Mitsutoshi/D-8244-2017; Fujiwara, Takahiro/G-2755-2012	Yoneyama, Mitsutoshi/0000-0001-9512-0408; Fujiwara, Takahiro/0000-0001-5576-759X	Ministry of Education, Culture, Sports, Science and Technology in Japan [24115004, 23249023]; Ministry of Health, Labor and Welfare of Japan; PRESTO Japan Science and Technology Agency; Uehara Memorial Foundation; Takaeda Science Foundation; Naito Foundation; Nippon Boehringer Ingelheim; Grants-in-Aid for Scientific Research [23249023, 24115004] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); PRESTO Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Uehara Memorial Foundation(Uehara Memorial Foundation); Takaeda Science Foundation; Naito Foundation(Naito Memorial Foundation); Nippon Boehringer Ingelheim(Boehringer Ingelheim); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The Ministry of Education, Culture, Sports, Science and Technology in Japan (Innovative Areas "Infection competency" (No.24115004), Scientific Research "A"(23249023) (http://www.mext.go.jp/english/), the Ministry of Health, Labor and Welfare of Japan (http://www.mhlw.go.jp/english/index.html), the PRESTO Japan Science and Technology Agency (http://www.jst.go.jp/kisoken/presto/index_e.html), the Uehara Memorial Foundation (http://www.ueharazaidan.com/), the Takaeda Science Foundation (http://www.takeda-sci.or.jp/index.html), the Naito Foundation (http://www.naito-f.or.jp/), and Nippon Boehringer Ingelheim (http://www.boehringer-ingelheim.co.jp/com/Home/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belgnaoui SM, 2011, CURR OPIN IMMUNOL, V23, P564, DOI 10.1016/j.coi.2011.08.001; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; DALY C, 1993, MOL CELL BIOL, V13, P3756, DOI 10.1128/MCB.13.6.3756; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Koshiba T, 2012, BIOCH BIOPHYS ACTA; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Mao AP, 2010, J BIOL CHEM, V285, P9470, DOI 10.1074/jbc.M109.071043; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; Onoguchi K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001012; Ouda R, 2011, J BIOL CHEM, V286, P26210, DOI 10.1074/jbc.M111.229856; Paz S, 2011, CELL RES, V21, P895, DOI 10.1038/cr.2011.2; Paz S, 2009, MOL CELL BIOL, V29, P3401, DOI 10.1128/MCB.00880-08; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Sambhara S, 2012, NUCL ACID SENSORS AN; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Tang ED, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009172; Tang ED, 2009, J VIROL, V83, P3420, DOI 10.1128/JVI.02623-08; Ueyama T, 2008, J IMMUNOL, V181, P629, DOI 10.4049/jimmunol.181.1.629; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Yoshida R, 2008, J BIOL CHEM, V283, P36211, DOI 10.1074/jbc.M806576200	35	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53578	10.1371/journal.pone.0053578	http://dx.doi.org/10.1371/journal.pone.0053578			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308256	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429100092
J	Tarradas, A; Selga, E; Beltran-Alvarez, P; Perez-Serra, A; Riuro, H; Pico, F; Iglesias, A; Campuzano, O; Castro-Urda, V; Fernandez-Lozano, I; Perez, GJ; Scornik, FS; Brugada, R				Tarradas, Anna; Selga, Elisabet; Beltran-Alvarez, Pedro; Perez-Serra, Alexandra; Riuro, Helena; Pico, Ferran; Iglesias, Anna; Campuzano, Oscar; Castro-Urda, Victor; Fernandez-Lozano, Ignacio; Perez, Guillermo J.; Scornik, Fabiana S.; Brugada, Ramon			A Novel Missense Mutation, I890T, in the Pore Region of Cardiac Sodium Channel Causes Brugada Syndrome	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; SCN5A MUTATIONS; GENETIC-BASIS; CHANNELOPATHIES; POLYMORPHISM; MODULATION; EXPRESSION; DISEASE	Brugada syndrome (BrS) is a life-threatening, inherited arrhythmogenic syndrome associated with autosomal dominant mutations in SCN5A, the gene encoding the cardiac Na+ channel alpha subunit (Na(v)1.5). The aim of this work was to characterize the functional alterations caused by a novel SCN5A mutation, I890T, and thus establish whether this mutation is associated with BrS. The mutation was identified by direct sequencing of SCN5A from the proband's DNA. Wild-type (WT) or I890T Na(v)1.5 channels were heterologously expressed in human embryonic kidney cells. Sodium currents were studied using standard whole cell patch-clamp protocols and immunodetection experiments were performed using an antibody against human Na(v)1.5 channel. A marked decrease in current density was observed in cells expressing the I890T channel (from -52.0 +/- 6.5 pA/pF, n=15 to -35.9 +/- 3.4 pA/pF, n = 22, at -20 mV, WT and I890T, respectively). Moreover, a positive shift of the activation curve was identified (V-1/2 = -32.0 +/- 0.3 mV, n = 18, and -27.3 +/- 0.3 mV, n = 22, WT and I890T, respectively). No changes between WT and I890T currents were observed in steady-state inactivation, time course of inactivation, slow inactivation or recovery from inactivation parameters. Cell surface protein biotinylation analyses confirmed that Na(v)1.5 channel membrane expression levels were similar in WT and I890T cells. In summary, our data reveal that the I890T mutation, located within the pore of Na(v)1.5, causes an evident loss-of-function of the channel. Thus, the BrS phenotype observed in the proband is most likely due to this mutation.	[Tarradas, Anna; Selga, Elisabet; Beltran-Alvarez, Pedro; Perez-Serra, Alexandra; Riuro, Helena; Pico, Ferran; Iglesias, Anna; Campuzano, Oscar; Perez, Guillermo J.; Scornik, Fabiana S.; Brugada, Ramon] Inst Invest Biomed Girona IDIBGi, Cardiovasc Genet Ctr, Girona, Spain; [Tarradas, Anna; Selga, Elisabet; Beltran-Alvarez, Pedro; Perez-Serra, Alexandra; Riuro, Helena; Pico, Ferran; Iglesias, Anna; Campuzano, Oscar; Perez, Guillermo J.; Scornik, Fabiana S.; Brugada, Ramon] Univ Girona UdG, Sch Med, Girona, Spain; [Castro-Urda, Victor; Fernandez-Lozano, Ignacio] Hosp Puerta de Hierro, Arrhythmia Unit, Madrid, Spain	Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Universitat de Girona; Hospital Puerta de Hierro-Majadahonda	Brugada, R (corresponding author), Inst Invest Biomed Girona IDIBGi, Cardiovasc Genet Ctr, Girona, Spain.	rbrugada@idibgi.org	campuzano, oscar/J-1968-2014; Selga, Elisabet/H-9007-2015; Perez, Guillermo J/D-5932-2013; Beltran-Alvarez, Pedro/AAU-5826-2021; Scornik, Fabiana S/I-1516-2014	campuzano, oscar/0000-0001-5298-5276; Selga, Elisabet/0000-0002-4290-8370; Perez, Guillermo J/0000-0003-0237-2150; Scornik, Fabiana S/0000-0002-0477-1924; Beltran-Alvarez, Pedro/0000-0001-8136-8963; Fernandez Lozano, Ignacio/0000-0002-3092-8761; Castro, Victor/0000-0002-8325-1379	Fundacio Obra social "La Caixa", Centro Nacional de Investigaciones Cardiovasculares [CNIC-03-2008]; Instituto de Salud Carlos III [FIS-PI08/1800]	Fundacio Obra social "La Caixa", Centro Nacional de Investigaciones Cardiovasculares; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by Fundacio Obra social "La Caixa", Centro Nacional de Investigaciones Cardiovasculares [CNIC-03-2008] and Instituto de Salud Carlos III [FIS-PI08/1800]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin AS, 2010, PFLUG ARCH EUR J PHY, V460, P223, DOI 10.1007/s00424-009-0761-0; Antzelevitch C, 2005, CIRCULATION, V111, P659, DOI 10.1161/01.CIR.0000152479.54298.51; Antzelevitch C, 2002, CIRC RES, V91, P1114, DOI 10.1161/01.RES.0000046046.53721.90; Antzelevitch Charles, 2008, Curr Cardiol Rep, V10, P376, DOI 10.1007/s11886-008-0060-y; Brugada J, 1998, CIRCULATION, V97, P457; Campuzano O, 2009, REV ESP CARDIOL, V62, P422, DOI 10.1016/S0300-8932(09)70899-1; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; GELLENS ME, 1992, P NATL ACAD SCI USA, V89, P554, DOI 10.1073/pnas.89.2.554; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hilber K, 2001, J BIOL CHEM, V276, P27831, DOI 10.1074/jbc.M101933200; Itoh H, 2005, J CARDIOVASC ELECTR, V16, P378, DOI 10.1046/j.1540-8167.2005.40606.x; Jung C, 2011, CARDIOVASC RES, V91, P465, DOI 10.1093/cvr/cvr083; Kapplinger JD, 2010, HEART RHYTHM, V7, P33, DOI 10.1016/j.hrthm.2009.09.069; Keller DI, 2005, CARDIOVASC RES, V67, P510, DOI 10.1016/j.cardiores.2005.03.024; Lizotte E, 2009, J CARDIOVASC ELECTR, V20, P1137, DOI 10.1111/j.1540-8167.2009.01508.x; Makita N, 2008, J CLIN INVEST, V118, P2219, DOI [10.1172/JCl34057, 10.1172/JCI34057]; Marangoni S, 2011, CARDIOVASC RES, V91, P606, DOI 10.1093/cvr/cvr142; Meregalli PG, 2009, HEART RHYTHM, V6, P341, DOI 10.1016/j.hrthm.2008.11.009; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Probst V, 2009, CIRC-CARDIOVASC GENE, V2, P552, DOI 10.1161/CIRCGENETICS.109.853374; Shirai N, 2002, CARDIOVASC RES, V53, P348, DOI 10.1016/S0008-6363(01)00494-1; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Tan BH, 2006, AM J PHYSIOL-HEART C, V291, pH1822, DOI 10.1152/ajpheart.00101.2006; Wang Q, 1996, GENOMICS, V34, P9, DOI 10.1006/geno.1996.0236; Wilde AAM, 2011, CIRC RES, V108, P884, DOI 10.1161/CIRCRESAHA.110.238469; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054; Zimmer T, 2008, PROG BIOPHYS MOL BIO, V98, P120, DOI 10.1016/j.pbiomolbio.2008.10.005	27	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53220	10.1371/journal.pone.0053220	http://dx.doi.org/10.1371/journal.pone.0053220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308164	gold, Green Submitted, Green Published			2022-12-25	WOS:000313429100039
J	Zhou, ZH; Zhu, HM; Chen, L				Zhou, Zhenhe; Zhu, Hongmei; Chen, Lin			Effect of Aripiprazole on Mismatch Negativity (MMN) in Schizophrenia	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; SPECTRUM DISORDERS; COGNITIVE DEFICITS; HEALTHY-VOLUNTEERS; PARTIAL AGONIST; ATTENTION; MEMORY; 1ST-EPISODE; RISPERIDONE; GENERATION	Background: Cognitive deficits are considered core symptoms of the schizophrenia. Cognitive function has been found to be a better predictor of functional outcome than symptom levels. Changed mismatch negativity (MMN) reflects abnormalities of early auditory processing in schizophrenia. Up to now, no studies for the effects of aripiprazole on MMN in schizophrenia have been reported. Methodology/Principal Findings: Subjects included 26 patients with schizophrenia, and 26 controls. Psychopathology was rated in patients with the Positive and Negative Syndrome Scale (PANSS) at baseline, after 4- and 8-week treatments with aripiprazole. Auditory stimuli for ERP consisted of 100 millisecond/1000 Hz standards, intermixed with 100 millisecond/1500 Hz frequency deviants and 250 millisecond/1000 Hz duration deviants. EEG was recorded at Fz. BESA 5.1.8 was used to perform data analysis. MMN waveforms were obtained by subtracting waveforms elicited by standards from waveforms elicited by frequency-or duration-deviant stimuli. Aripiprazole decreased all PANSS. Patients showed smaller mean amplitudes of frequency and duration MMN at baseline than did controls. A repeated measure ANOVA with sessions (i.e., baseline, 4- and 8-week treatments) and MMN type (frequency vs. duration) as within-subject factors revealed no significant MMN type or MMN type x session main effect for MMN amplitudes. Session main effect was significant. LSD tests demonstrated significant differences between MMN amplitudes at 8 weeks and those at both baseline and 4 weeks. There was significant negative correlation between changes in amplitudes of frequency and duration MMN and changes in PANSS total scores at baseline and follow-up periods. Conclusions: Aripiprazole improved the amplitudes of MMN. MMN offers objective evidence that treatment with the aripiprazole may ameliorate preattentive deficits in schizophrenia.	[Zhou, Zhenhe; Zhu, Hongmei; Chen, Lin] Nanjing Med Univ, Wuxi Mental Hlth Ctr, Dept Psychiat, Wuxi, Jiangsu, Peoples R China	Nanjing Medical University	Zhou, ZH (corresponding author), Nanjing Med Univ, Wuxi Mental Hlth Ctr, Dept Psychiat, Wuxi, Jiangsu, Peoples R China.	wuxich102@sohu.com			Medical Research Foundation of Department of Public Health, Jiangsu Province, China [H201043]	Medical Research Foundation of Department of Public Health, Jiangsu Province, China	This study was supported by the Medical Research Foundation of Department of Public Health, Jiangsu Province, China (No.H201043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdede BBK, 2005, PROG NEURO-PSYCHOPH, V29, P233, DOI 10.1016/j.pnpbp.2004.11.005; Alain C, 1997, PSYCHOPHYSIOLOGY, V34, P534, DOI 10.1111/j.1469-8986.1997.tb01740.x; ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Bramon E, 2004, SCHIZOPHR RES, V67, P1, DOI 10.1016/S0920-9964(03)00132-4; Brockhaus-Dumke A, 2005, SCHIZOPHR RES, V73, P297, DOI 10.1016/j.schres.2004.05.016; Burris KD, 2002, J PHARMACOL EXP THER, V302, P381, DOI 10.1124/jpet.102.033175; Dittmann BA, 2001, NEUROSCI LETT, V308, P119; Dittmann-Balcar A, 1999, NEUROREPORT, V10, P3749, DOI 10.1097/00001756-199912160-00005; Domjan N, 2012, SCHIZOPHR RES, V139, P253, DOI 10.1016/j.schres.2012.06.002; Evans JD, 2004, SCHIZOPHR RES, V70, P331, DOI 10.1016/j.schres.2004.01.011; GOLD JM, 1993, PSYCHIAT CLIN N AM, V16, P295; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; Hori H, 2012, J PSYCHIATR RES, V46, P757, DOI 10.1016/j.jpsychires.2012.02.013; Javitt DC, 2000, ARCH GEN PSYCHIAT, V57, P1131, DOI 10.1001/archpsyc.57.12.1131; Jordan S, 2002, EUR J PHARMACOL, V441, P137, DOI 10.1016/S0014-2999(02)01532-7; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kern RS, 2006, PSYCHOPHARMACOLOGY, V187, P312, DOI 10.1007/s00213-006-0428-x; Kishi T, 2010, NEUROSCI RES, V66, P340, DOI 10.1016/j.neures.2009.12.007; Korostenskaja M, 2005, PROG NEURO-PSYCHOPH, V29, P543, DOI 10.1016/j.pnpbp.2005.01.019; Lavoie AS, 2007, PROGR NEUROPSYCHOPHA, V11, P1; LAVOIE S, 2007, NEUROPSYCHOPHARMACOL, V33, P1; Light GA, 2005, AM J PSYCHIAT, V162, P1741, DOI 10.1176/appi.ajp.162.9.1741; Malhi GS, 2008, ACTA PSYCHIAT SCAND, V117, P100, DOI 10.1111/j.1600-0447.2007.01111.x; Michie PT, 2002, BIOL PSYCHIAT, V52, P749, DOI 10.1016/S0006-3223(02)01379-3; Murphy A, 2009, EUR NEUROPSYCHOPHARM, V19, pS188, DOI 10.1016/S0924-977X(09)70226-3; NAATANEN R, 1995, EAR HEARING, V16, P6; Riedel M, 2010, PHARMACOPSYCHIATRY, V43, P50, DOI 10.1055/s-0029-1239539; Salisbury DF, 2002, ARCH GEN PSYCHIAT, V59, P686, DOI 10.1001/archpsyc.59.8.686; Sato Y, 2000, NEUROREPORT, V11, P3703, DOI 10.1097/00001756-200011270-00023; SAYKIN AJ, 1991, ARCH GEN PSYCHIAT, V48, P618; Stip E, 2010, CLIN THER, V32, pS3, DOI 10.1016/j.clinthera.2010.01.021; Tamo N, 2011, FRONTIERS PSYCHOL, V2, P367; Umbricht D, 2000, ARCH GEN PSYCHIAT, V57, P1139, DOI 10.1001/archpsyc.57.12.1139; Umbricht D, 1998, BIOL PSYCHIAT, V44, P716, DOI 10.1016/S0006-3223(97)00524-6; Umbricht D, 2005, SCHIZOPHR RES, V76, P1, DOI 10.1016/j.schres.2004.12.002; Umbricht D, 2003, BIOL PSYCHIAT, V53, P1120, DOI 10.1016/S0006-3223(02)01642-6; Umbricht D, 1999, INT J NEUROPSYCHOP, V2, P299, DOI 10.1017/S1461145799001595; Umbricht DSG, 2006, BIOL PSYCHIAT, V59, P762, DOI 10.1016/j.biopsych.2005.08.030; Velligan DI, 1997, SCHIZOPHR RES, V25, P21, DOI 10.1016/S0920-9964(97)00010-8; Woldorff MG, 1998, PSYCHOPHYSIOLOGY, V35, P283, DOI 10.1017/S0048577298961601; Yago E, 2001, NEUROREPORT, V12, P2583, DOI 10.1097/00001756-200108080-00058; Yiting L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034454, DOI 10.1371/JOURNAL.PONE.0034454]; Zhang MY, 1998, MANUAL RATING SCALE, P150	43	25	26	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e52186	10.1371/journal.pone.0052186	http://dx.doi.org/10.1371/journal.pone.0052186			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308105	Green Published, gold, Green Submitted			2022-12-25	WOS:000313429100008
J	Baysal, O; Lai, D; Xu, HH; Siragusa, M; Caliskan, M; Carimi, F; da Silva, JAT; Tor, M				Baysal, Omur; Lai, Duo; Xu, Han-Hong; Siragusa, Mirko; Caliskan, Mikail; Carimi, Francesco; da Silva, Jaime A. Teixeira; Toer, Mahmut			A Proteomic Approach Provides New Insights into the Control of Soil-Borne Plant Pathogens by Bacillus Species	PLOS ONE			English	Article							SYSTEMIC RESISTANCE; FUSARIC ACID; LIPOPEPTIDE; BIOCONTROL; GROWTH; ANTIBIOTICS; PROTEINS; SUBTILIS; DISEASE	Beneficial microorganisms (also known as biopesticides) are considered to be one of the most promising methods for more rational and safe crop management practices. We used Bacillus strains EU07, QST713 and FZB24, and investigated their inhibitory effect on Fusarium. Bacterial cell cultures, cell-free supernatants and volatiles displayed varying degrees of suppressive effect. Proteomic analysis of secreted proteins from EU07 and FZB24 revealed the presence of lytic enzymes, cellulases, proteases, 1,4-beta-glucanase and hydrolases, all of which contribute to degradation of the pathogen cell wall. Further proteomic investigations showed that proteins involved in metabolism, protein folding, protein degradation, translation, recognition and signal transduction cascade play an important role in the control of Fusarium oxysporum. Our findings provide new knowledge on the mechanism of action of Bacillus species and insight into biocontrol mechanisms.	[Baysal, Omur] Mugla Sitki Kocman Univ, Fac Life Sci, Dept Mol Biol & Genet, Mugla, Turkey; [Lai, Duo; Xu, Han-Hong] S China Agr Univ, Minist Educ, Key Lab Nat Pesticide & Chem Biol, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China; [Siragusa, Mirko; Carimi, Francesco] CNR, Inst Plant Genet, Res Div Palermo, Palermo, Italy; [Caliskan, Mikail] Turkish Minist Food Agr & Livestock, Cent Res Inst Field Crops, Ankara, Turkey; [da Silva, Jaime A. Teixeira] Kagawa Univ, Fac Agr, Miki, Ikenobe 76107, Japan; [da Silva, Jaime A. Teixeira] Kagawa Univ, Grad Sch Agr, Miki, Ikenobe 76107, Japan; [Toer, Mahmut] Univ Worcester, NPARU, Henwick Grove, Worcester, England	Mugla Sitki Kocman University; South China Agricultural University; Consiglio Nazionale delle Ricerche (CNR); Gida Tarim Ve Hayvancilik Bakanligi; Ministry of Food, Agriculture & Livestock - Turkey; Kagawa University; Kagawa University; University of Worcester	Baysal, O (corresponding author), Mugla Sitki Kocman Univ, Fac Life Sci, Dept Mol Biol & Genet, Mugla, Turkey.	omurbaysal@mu.edu.tr; hhxu@scau.edu.cn	Biology and Genetics / Molecular Microbiology and Genetics, Ömür Baysal Ph.D. Professor on Molecular/C-8869-2013; Carimi, Francesco/E-2954-2016; Baysal, Ömür/AAC-8891-2022; Tor, Mahmut/AAF-6449-2020; Carimi, Francesco/GYU-0312-2022; Tor, Mahmut/AAU-4624-2020	Carimi, Francesco/0000-0002-7700-9527; Baysal, Ömür/0000-0001-5104-0983; Tor, Mahmut/0000-0002-4416-5048; Xu, Han-Hong/0000-0001-7841-2396; Teixeira da Silva, Jaime A./0000-0003-3299-2772	The Leverhulme Trust	The Leverhulme Trust(Leverhulme Trust)	The authors acknowledge Dr. Kunhua Hu (Protemics Research Center, SUN Yat-sen University, China) and Dr. QS Yang (BGI-Shenzhen, China) for their technical support. Work in Mahmut Tor's laboratory is supported by The Leverhulme Trust.	Ahn IP, 2002, MOL CELLS, V13, P302; Alonso JM, 2004, SCIENCE, V306, P1513, DOI 10.1126/science.1104812; Amani H, 2010, APPL BIOCHEM BIOTECH, V162, P510, DOI 10.1007/s12010-009-8889-0; Bacon CW, 2004, CAN J BOT, V82, P878, DOI [10.1139/b04-067, 10.1139/B04-067]; Bacon CW, 2002, BIOL CONTROL, V23, P274, DOI 10.1006/bcon.2001.1016; Baysal O, 2009, PHYSIOL MOL PLANT P, V74, P68, DOI 10.1016/j.pmpp.2009.09.008; Baysal O, 2008, PHYSIOL MOL PLANT P, V73, P25, DOI 10.1016/j.pmpp.2008.11.002; Bent AF, 1999, ADV AGRON, V66, P251, DOI 10.1016/S0065-2113(08)60429-0; Bland JM, 1996, J ORG CHEM, V61, P5663, DOI 10.1021/jo960452n; Blumer C, 2000, MICROBIOL-SGM, V146, P2417, DOI 10.1099/00221287-146-10-2417; Boissier F, 2006, J BIOL CHEM, V281, P4434, DOI 10.1074/jbc.M510250200; Bouizgarne B, 2006, MOL PLANT MICROBE IN, V19, P550, DOI 10.1094/MPMI-19-0550; Carvalho FP, 2006, ENVIRON SCI POLICY, V9, P685, DOI 10.1016/j.envsci.2006.08.002; Chevallet M, 2007, PROTEOMICS, V7, P1757, DOI 10.1002/pmic.200601024; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Earl AM, 2008, TRENDS MICROBIOL, V16, P269, DOI 10.1016/j.tim.2008.03.004; EEA, 2005, 10 EEA; Fravel DR, 2005, ANNU REV PHYTOPATHOL, V43, P337, DOI 10.1146/annurev.phyto.43.032904.092924; Godsey MH, 2007, PROTEIN SCI, V16, P1285, DOI 10.1110/ps.062674007; Grove TL, 2011, SCIENCE, V332, P604, DOI 10.1126/science.1200877; Han SH, 2006, MOL PLANT MICROBE IN, V19, P924, DOI 10.1094/MPMI-19-0924; Ivanova I, 1998, INT J FOOD MICROBIOL, V42, P147, DOI 10.1016/S0168-1605(98)00067-1; JARVIS WR, 1983, PLANT DIS, V67, P38, DOI 10.1094/PD-67-38; Katan T, 1999, PLANT PATHOL, V48, P541, DOI 10.1046/j.1365-3059.1999.00362.x; Kim PI, 2004, J APPL MICROBIOL, V97, P942, DOI 10.1111/j.1365-2672.2004.02356.x; Kloepper JW, 2004, PHYTOPATHOLOGY, V94, P1259, DOI 10.1094/PHYTO.2004.94.11.1259; Luo Y, 2010, J AM SOC MASS SPECTR, V21, P34, DOI 10.1016/j.jasms.2009.08.026; Marten P, 2000, J APPL MICROBIOL, V89, P463, DOI 10.1046/j.1365-2672.2000.01136.x; Mattow J, 2003, ELECTROPHORESIS, V24, P3405, DOI 10.1002/elps.200305601; Munimbazi C, 1998, J APPL MICROBIOL, V84, P959, DOI 10.1046/j.1365-2672.1998.00431.x; Pacwa-Plociniczak M, 2011, INT J MOL SCI, V12, P633, DOI 10.3390/ijms12010633; Pare PW, 2005, PHOTOSYNTH RES, V85, P149, DOI 10.1007/s11120-005-1001-x; Ravishankar KV, 2011, ACTA HORTIC, V897, P363; Rohlf F.J., 1994, NTSYS NUMERICAL TAXO; Ryu CM, 2004, PLANT PHYSIOL, V134, P1017, DOI 10.1104/pp.103.026583; Saleem M, 2007, J IND MICROBIOL BIOT, V34, P635, DOI 10.1007/s10295-007-0240-6; Stein T, 2005, MOL MICROBIOL, V56, P845, DOI 10.1111/j.1365-2958.2005.04587.x; TAGG JR, 1971, APPL MICROBIOL, V21, P943, DOI 10.1128/AEM.21.5.943-943.1971; THIMON L, 1995, FEMS MICROBIOL LETT, V128, P101, DOI 10.1111/j.1574-6968.1995.tb07507.x; Todorov SD, 2005, FOOD TECHNOL BIOTECH, V43, P165; Urbanczyk H, 2007, INT J SYST EVOL MICR, V57, P2823, DOI 10.1099/ijs.0.65081-0; Van Loon LC, 2004, ECOL STU AN, V170, P177; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; Wang YQ, 2010, PESTIC BIOCHEM PHYS, V98, P224, DOI 10.1016/j.pestbp.2010.06.011; Zhao J., 2006, Floriculture, ornamental and plant biotechnology, P344; Zuber Peter, 1993, P897	46	55	59	0	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53182	10.1371/journal.pone.0053182	http://dx.doi.org/10.1371/journal.pone.0053182			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301041	Green Published, Green Submitted, gold			2022-12-25	WOS:000313480000038
J	Kim, E; Sun, L; Gabel, CV; Fang-Yen, C				Kim, Eric; Sun, Lin; Gabel, Christopher V.; Fang-Yen, Christopher			Long-Term Imaging of Caenorhabditis elegans Using Nanoparticle-Mediated Immobilization	PLOS ONE			English	Article							DYNAMIC-RANGE; SENSITIVITY; NEURONS; CA2+	One advantage of the nematode Caenorhabditis elegans as a model organism is its suitability for in vivo optical microscopy. Imaging C. elegans often requires animals to be immobilized to avoid movement-related artifacts. Immobilization has been performed by application of anesthetics or by introducing physical constraints using glue or specialized microfluidic devices. Here we present a method for immobilizing C. elegans using polystyrene nanoparticles and agarose pads. Our technique is technically simple, does not expose the worm to toxic substances, and allows recovery of animals. We evaluate the method and show that the polystyrene beads increase friction between the worm and agarose pad. We use our method to quantify calcium transients and long-term regrowth in single neurons following axotomy by a femtosecond laser.	[Kim, Eric; Fang-Yen, Christopher] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Sun, Lin; Gabel, Christopher V.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA	University of Pennsylvania; Boston University	Fang-Yen, C (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.	fangyen@seas.upenn.edu	Fang-Yen, Christopher/AAY-9017-2020	Fang-Yen, Christopher/0000-0002-4568-3218; Gabel, Christopher/0000-0002-2763-3938	Penn Undergraduate Research Mentorship program; Massachusetts Life Science Center New Investigator Matching Grant	Penn Undergraduate Research Mentorship program; Massachusetts Life Science Center New Investigator Matching Grant	EK was partly supported by the Penn Undergraduate Research Mentorship program. CVG was partly supported by the Massachusetts Life Science Center New Investigator Matching Grant. (http://www.masslifesciences.com/grants/invest.html) No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulin Thomas, 2006, WormBook, P1, DOI 10.1895/wormbook.1.106.1; Chokshi TV, 2009, LAB CHIP, V9, P151, DOI 10.1039/b807345g; Chu GKT, 2001, NEUROSCIENCE, V102, P945, DOI 10.1016/S0306-4522(00)00514-5; Fang-Yen C, 2011, METHODS CELL BIOL; Fang-Yen C, 2010, P NATL ACAD SCI USA, V107, P20323, DOI 10.1073/pnas.1003016107; Gabel CV, 2008, DEVELOPMENT, V135, P1129, DOI 10.1242/dev.013995; Gabel CV, 2008, CONTEMP PHYS, V49, P391, DOI 10.1080/00107510802628263; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Guo SX, 2008, NAT METHODS, V5, P531, DOI 10.1038/NMETH.1203; Hart A. C., 2006, WORMBOOK; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Hulme SE, 2007, LAB CHIP, V7, P1515, DOI 10.1039/b707861g; Kamber D, 2009, EXP NEUROL, V219, P112, DOI 10.1016/j.expneurol.2009.05.004; Keane J, 2003, GENETICS, V164, P153; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Pinan-Lucarre B, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001331; Rohde CB, 2007, P NATL ACAD SCI USA, V104, P13891, DOI 10.1073/pnas.0706513104; Shaham S., 2006, WORMBOOK; Stiernagle Theresa, 2006, WormBook, P1; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Szlufarska I, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/12/123001	22	184	188	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53419	10.1371/journal.pone.0053419	http://dx.doi.org/10.1371/journal.pone.0053419			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301069	Green Published, gold			2022-12-25	WOS:000313480000056
J	Kriangkum, J; Warkinton, A; Belch, AR; Pilarski, LM				Kriangkum, Jitra; Warkinton, Amanda; Belch, Andrew R.; Pilarski, Linda M.			Alteration of Introns in a Hyaluronan Synthase 1 (HAS1) Minigene Convert Pre-Mrna Splicing to the Aberrant Pattern in Multiple Myeloma (MM): MM Patients Harbor Similar Changes	PLOS ONE			English	Article							WALDENSTROMS MACROGLOBULINEMIA; SILENT MUTATIONS; BREAST-CANCER; MSH2 MISSENSE; G-RUNS; GENE; VARIANTS; EXON; PROTEIN; SITE	Aberrant pre-mRNA splice variants of hyaluronan synthase 1 (HAS1) have been identified in malignant cells from cancer patients. Bioinformatic analysis suggests that intronic sequence changes can underlie aberrant splicing. Deletions and mutations were introduced into HAS1 minigene constructs to identify regions that can influence aberrant intronic splicing, comparing the splicing pattern in transfectants with that in multiple myeloma (MM) patients. Introduced genetic variations in introns 3 and 4 of HAS1 as shown here can promote aberrant splicing of the type detected in malignant cells from MM patients. HAS1Vd is a novel intronic splice variant first identified here. HAS1Vb, an intronic splice variant previously identified in patients, skips exon 4 and utilizes the same intron 4 alternative 3'splice site as HAS1Vd. For transfected constructs with unaltered introns 3 and 4, HAS1Vd transcripts are readily detectable, frequently to the exclusion of HAS1Vb. In contrast, in MM patients, HAS1Vb is more frequent than HAS1Vd. In the HAS1 minigene, combining deletion in intron 4 with mutations in intron 3 leads to a shift from HAS1Vd expression to HAS1Vb expression. The upregulation of aberrant splicing, exemplified here by the expression of HAS1Vb, is shown here to be influenced by multiple genetic changes in intronic sequences. For HAS1Vb, this includes enhanced exon 4 skipping and increased usage of alternative 3' splice sites. Thus, the combination of introduced mutations in HAS1 intron3 with introduced deletions in HAS1 intron 4 promoted a shift to an aberrant splicing pattern previously shown to be clinically significant. Most MM patients harbor genetic variations in intron 4, and as shown here, nearly half harbor recurrent mutations in HAS1 intron 3. Our work suggests that aberrant intronic HAS1 splicing in MM patients may rely on intronic HAS1 deletions and mutations that are frequent in MM patients but absent from healthy donors.	[Kriangkum, Jitra; Warkinton, Amanda; Belch, Andrew R.; Pilarski, Linda M.] Univ Alberta, Dept Oncol, Cross Canc Inst, Edmonton, AB, Canada	University of Alberta	Kriangkum, J (corresponding author), Univ Alberta, Dept Oncol, Cross Canc Inst, Edmonton, AB, Canada.	jitra@ualberta.ca; lpilarsk@ualberta.ca			Alberta Cancer Foundation; Canadian Institutes of Health Research	Alberta Cancer Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work is funded by Alberta Cancer Foundation and Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscripts.	Adamia S, 2005, CLIN LYMPHOMA, V5, P253, DOI 10.3816/CLM.2005.n.010; Adamia S, 2005, BLOOD, V105, P4836, DOI 10.1182/blood-2004-10-3825; Adamia S, 2003, SEMIN ONCOL, V30, P165, DOI 10.1053/sonc.2003.50042; Adamia S, 2009, CLIN LYMPHOMA MYELOM, V9, P30, DOI 10.3816/CLM.2009.n.006; Adamia S, 2008, BLOOD, V112, P5111, DOI 10.1182/blood-2008-02-141770; Agrawal S, 2005, HUM MOL GENET, V14, P2459, DOI 10.1093/hmg/ddi246; Auclair J, 2006, HUM MUTAT, V27, P145, DOI 10.1002/humu.20280; Bechtel Jason M, 2008, BMC Res Notes, V1, P4, DOI 10.1186/1756-0500-1-4; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Buratti E, 2006, NUCLEIC ACIDS RES, V34, P3494, DOI 10.1093/nar/gkl498; Carlo T, 2000, MOL CELL BIOL, V20, P3988, DOI 10.1128/MCB.20.11.3988-3995.2000; Carlo T, 1996, RNA, V2, P342; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Colgin L M, 1999, Hum Mutat, V14, P92, DOI 10.1002/(SICI)1098-1004(1999)14:1<92::AID-HUMU24>3.0.CO;2-#; Durocher F, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-230; Ghosh A, 2009, J BIOL CHEM, V284, P18840, DOI 10.1074/jbc.M109.013813; Han K, 2005, PLOS BIOL, V3, P843, DOI 10.1371/journal.pbio.0030158; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Kalnina Z, 2005, GENE CHROMOSOME CANC, V42, P342, DOI 10.1002/gcc.20156; Lamolle G, 2006, MUTAT RES-FUND MOL M, V600, P102, DOI 10.1016/j.mrfmmm.2006.03.004; Lastella P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-243; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Ludes-Meyers JH, 2003, CYTOGENET GENOME RES, V100, P101, DOI 10.1159/000072844; Marcucci R, 2007, NUCLEIC ACIDS RES, V35, P132, DOI 10.1093/nar/gkl965; McCullough AJ, 1997, MOL CELL BIOL, V17, P4562, DOI 10.1128/MCB.17.8.4562; Moon SD, 2005, J CLIN ENDOCR METAB, V90, P878, DOI 10.1210/jc.2004-0991; NUSSINOV R, 1987, BIOCHIM BIOPHYS ACTA, V910, P261, DOI 10.1016/0167-4781(87)90119-9; NUSSINOV R, 1989, J BIOMOL STRUCT DYN, V6, P985, DOI 10.1080/07391102.1989.10506526; Pagani F, 2004, NAT REV GENET, V5, P389, DOI 10.1038/nrg1327; Pagenstecher C, 2006, HUM GENET, V119, P9, DOI 10.1007/s00439-005-0107-8; SIRANDPUGNET P, 1995, NUCLEIC ACIDS RES, V23, P3501, DOI 10.1093/nar/23.17.3501; Staalesen V, 2004, ONCOGENE, V23, P8535, DOI 10.1038/sj.onc.1207928; TAKAHASHI T, 1990, J CLIN INVEST, V86, P363, DOI 10.1172/JCI114710; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; Venables JP, 2006, BIOESSAYS, V28, P378, DOI 10.1002/bies.20390; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010	36	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53469	10.1371/journal.pone.0053469	http://dx.doi.org/10.1371/journal.pone.0053469			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301075	gold, Green Published, Green Submitted			2022-12-25	WOS:000313480000059
J	Liu, GX; Li, YQ; Huang, XR; Wei, LH; Chen, HY; Shi, YJ; Heuchel, RL; Lan, HY				Liu, Guan-Xian; Li, You-Qi; Huang, Xiao R.; Wei, Lihua; Chen, Hai-Yong; Shi, Yong-Jun; Heuchel, Rainer L.; Lan, Hui Y.			Disruption of Smad7 Promotes ANG II-Mediated Renal Inflammation and Fibrosis via Sp1-TGF-beta/Smad3-NF center dot kappa B-Dependent Mechanisms in Mice	PLOS ONE			English	Article							ANGIOTENSIN-ALDOSTERONE SYSTEM; COLLAGEN EXPRESSION; LATENT TGF-BETA-1; GENE-EXPRESSION; KIDNEY; RECEPTOR; SP1; NEPHROPATHY; PATHWAY; SPECIFICITY	Smad7 is an inhibitory Smad and plays a protective role in obstructive and diabetic kidney disease. However, the role and mechanisms of Smad7 in hypertensive nephropathy remains unexplored. Thus, the aim of this study was to investigate the role and regulatory mechanisms of Smad7 in ANG II-induced hypertensive nephropathy. Smad7 gene knockout (KO) and wild-type (WT) mice received a subcutaneous infusion of ANG II or control saline for 4 weeks via osmotic mini-pumps. ANG II infusion produced equivalent hypertension in Smad7 KO and WT mice; however, Smad7 KO mice exhibited more severe renal functional injury as shown by increased proteinuria and reduced renal function (both p < 0.05) when compared with Smad7 WT mice. Enhanced renal injury in Smad7 KO mice was associated with more progressive renal fibrosis with elevated TGF-beta/Smad3 signalling. Smad7 KO mice also showed more profound renal inflammation including increased macrophage infiltration, enhanced IL-1 beta and TNF-alpha expression, and a marked activation of NF-kappa B signaling (all p < 0.01). Further studies revealed that enhanced ANG II-mediated renal inflammation and fibrosis in Smad7 KO mice were also associated with upregulation of Sp1 but downregulation of miR-29b expression. Taken together, the present study revealed that enhanced Sp1-TGF-beta 1/Smad3-NF-kappa B signaling and loss of miR-29 may be mechanisms by which deletion of Smad7 promotes ANG II-mediated renal fibrosis and inflammation. Thus, Smad7 may play a protective role in ANG II-induced hypertensive kidney disease.	[Liu, Guan-Xian; Li, You-Qi; Shi, Yong-Jun] Cent Municipal Hosp Huizhou, Dept Nephrol, Huizhou, Guangdong, Peoples R China; [Huang, Xiao R.; Wei, Lihua; Chen, Hai-Yong; Lan, Hui Y.] CUHK Res Inst, Shenzhen, Guangdong, Peoples R China; [Huang, Xiao R.; Heuchel, Rainer L.; Lan, Hui Y.] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Huang, Xiao R.; Heuchel, Rainer L.; Lan, Hui Y.] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; Karolinska Inst, CLINTEC, Stockholm, Sweden	Chinese University of Hong Kong; Chinese University of Hong Kong; Karolinska Institutet	Liu, GX (corresponding author), Cent Municipal Hosp Huizhou, Dept Nephrol, Huizhou, Guangdong, Peoples R China.	liyouqi0330@163.com; hylan@cuhk.edu.hk	CHEN, Hai-Yong/K-5853-2019; Heuchel, Rainer/P-7875-2019; CHEN, Hai-Yong/B-1424-2013; Chen, Haiyong/G-6787-2014; Lan, Hui Yao/C-9734-2015	CHEN, Hai-Yong/0000-0002-4889-2752; Heuchel, Rainer/0000-0002-2782-585X; CHEN, Hai-Yong/0000-0002-4706-9596; Chen, Haiyong/0000-0002-4889-2752; Lan, Hui Yao/0000-0003-4283-9755	Major State Basic Research Development Program of China (973) [2012CB517700]; The Shenzhen Basic Research Program (SZSITC) [JC201104220290A]; Research Grant Council of Hong Kong [RGC GRF 469110, N_CUHK404/10, CUHK5/CRF/09]; Focused Investment Scheme B from the Chinese University of Hong Kong [1902061]	Major State Basic Research Development Program of China (973)(National Basic Research Program of China); The Shenzhen Basic Research Program (SZSITC); Research Grant Council of Hong Kong(Hong Kong Research Grants Council); Focused Investment Scheme B from the Chinese University of Hong Kong	This work was supported by grants from Major State Basic Research Development Program of China (973, No. 2012CB517700); The Shenzhen Basic Research Program (SZSITC, JC201104220290A), the Research Grant Council of Hong Kong (RGC GRF 469110, N_CUHK404/10, CUHK5/CRF/09); and the Focused Investment Scheme B (1902061) from the Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carvajal G, 2008, KIDNEY INT, V74, P585, DOI 10.1038/ki.2008.213; Chung ACK, 2009, NEPHROL DIAL TRANSPL, V24, P1443, DOI 10.1093/ndt/gfn699; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Fukasawa H, 2004, P NATL ACAD SCI USA, V101, P8687, DOI 10.1073/pnas.0400035101; Hart PD, 2010, EXPERT OPIN PHARMACO, V11, P2675, DOI 10.1517/14656566.2010.485612; Hou CC, 2005, AM J PATHOL, V166, P761, DOI 10.1016/S0002-9440(10)62297-3; Huang XR, 2008, AM J PHYSIOL-RENAL, V295, pF118, DOI 10.1152/ajprenal.00021.2008; Huang XR, 2008, J AM SOC NEPHROL, V19, P233, DOI 10.1681/ASN.2007040484; Huang XR, 2010, HYPERTENSION, V55, P1165, DOI 10.1161/HYPERTENSIONAHA.109.147611; Ka SM, 2007, J AM SOC NEPHROL, V18, P1777, DOI 10.1681/ASN.2006080901; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kopp JB, 1996, LAB INVEST, V74, P991; Lan HY, 2008, FRONT BIOSCI-LANDMRK, V13, P4984, DOI 10.2741/3057; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Lan HY, 2003, J AM SOC NEPHROL, V14, P1535, DOI 10.1097/01.ASN.0000067632.04658.B8; Leelahavanichkul A, 2010, KIDNEY INT, V78, P1136, DOI 10.1038/ki.2010.287; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Li N, 2012, INVEST OPHTH VIS SCI, V53, P1670, DOI 10.1167/iovs.11-8670; Li RG, 2006, J IMMUNOL, V176, P6777, DOI 10.4049/jimmunol.176.11.6777; Liu FY, 2007, AM J NEPHROL, V27, P176, DOI 10.1159/000100518; Liu SJ, 2010, CANCER CELL, V17, P333, DOI 10.1016/j.ccr.2010.03.008; Liu Z, 2012, AM J PHYSIOL-RENAL, V302, pF986, DOI 10.1152/ajprenal.00595.2011; Luna C, 2011, INVEST OPHTH VIS SCI, V52, P3567, DOI 10.1167/iovs.10-6448; Meng XM, 2010, J AM SOC NEPHROL, V21, P1477, DOI 10.1681/ASN.2009121244; Motojima M, 2000, BIOCHEM J, V349, P435, DOI 10.1042/0264-6021:3490435; Ng YY, 2005, KIDNEY INT, V67, pS83, DOI 10.1111/j.1523-1755.2005.09421.x; PERKINS ND, 1994, MOL CELL BIOL, V14, P6570, DOI 10.1128/MCB.14.10.6570; Poncelet AC, 2001, J BIOL CHEM, V276, P6983, DOI 10.1074/jbc.M006442200; Qin W, 2011, J AM SOC NEPHROL, V22, P1462, DOI 10.1681/ASN.2010121308; Remuzzi G, 2005, KIDNEY INT, V68, P57; Rodriguez-Vita J, 2005, CIRCULATION, V111, P2509, DOI 10.1161/01.CIR.0000165133.84978.E2; Ruiz-Ortega M, 2006, NEPHROL DIAL TRANSPL, V21, P16, DOI 10.1093/ndt/gfi265; Tan RY, 2008, AM J PHYSIOL-RENAL, V294, pF1076, DOI 10.1152/ajprenal.00323.2007; Traylor A, 2007, AM J PHYSIOL-RENAL, V293, pF885, DOI 10.1152/ajprenal.00519.2006; Udani S, 2011, NAT REV NEPHROL, V7, P11, DOI 10.1038/nrneph.2010.154; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang WS, 2005, J AM SOC NEPHROL, V16, P1371, DOI 10.1681/ASN.2004121070; Wang WS, 2006, CIRC RES, V98, P1032, DOI 10.1161/01.RES.0000218782.52610.dc; Wolf G, 2006, KIDNEY INT, V70, P1914, DOI 10.1038/sj.ki.5001846; Yang FY, 2010, J PATHOL, V221, P390, DOI 10.1002/path.2721; Yang FY, 2009, HYPERTENSION, V54, P877, DOI 10.1161/HYPERTENSIONAHA.109.136531; Yang YZ, 2010, DIABETES, V59, pA590; Zhao X, 2001, BBA-GENE STRUCT EXPR, V1522, P195, DOI 10.1016/S0167-4781(01)00341-4; Zhuo JL, 2011, PEPTIDES, V32, P1551, DOI 10.1016/j.peptides.2011.05.012	46	78	82	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53573	10.1371/journal.pone.0053573	http://dx.doi.org/10.1371/journal.pone.0053573			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301086	Green Submitted, Green Published, gold			2022-12-25	WOS:000313480000066
J	Lopacinska, JM; Emneus, J; Dufva, M				Lopacinska, Joanna M.; Emneus, Jenny; Dufva, Martin			Poly(Dimethylsiloxane) (PDMS) Affects Gene Expression in PC12 Cells Differentiating into Neuronal-Like Cells	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; PHEOCHROMOCYTOMA CELLS; CULTURE MODELS; BIOCOMPATIBILITY; MICROARRAY; RECEPTORS; OUTGROWTH; DISEASES; ASSAYS; LEVEL	Introduction: Microfluidics systems usually consist of materials like PMMA - poly(methyl methacrylate) and PDMS - poly(dimethylsiloxane) and not polystyrene (PS), which is usually used for cell culture. Cellular and molecular responses in cells grown on PS are well characterized due to decades of accumulated research. In contrast, the experience base is limited for materials used in microfludics chip fabrication. Methods: The effect of different materials (PS, PMMA and perforated PMMA with a piece of PDMS underneath) on the growth and differentiation of PC12 (adrenal phaeochromocytoma) cells into neuronal-like cells was investigated using cell viability, cell cycle distribution, morphology, and gene expression analysis. Results/Conclusions: After differentiation, the morphology, viability and cell cycle distribution of PC12 cells grown on PS, PMMA with and without PDMS underneath was the same. By contrast, 41 genes showed different expression for PC12 cells differentiating on PMMA as compared to on PS. In contrast, 677 genes showed different expression on PMMA with PDMS underneath as compared with PC12 cells on PS. The differentially expressed genes are involved in neuronal cell development and function. However, there were also many markers for neuronal cell development and functions that were expressed similarly in cells differentiating on PS, PMMA and PMMA with PDMS underneath. In conclusion, it was shown that PMMA has a minor impact and PDMS a major impact on gene expression in PC12 cells.	[Lopacinska, Joanna M.; Emneus, Jenny; Dufva, Martin] Tech Univ Denmark, Dept Micro & Nanotechnol, Kongens Lyngby, Denmark	Technical University of Denmark	Dufva, M (corresponding author), Tech Univ Denmark, Dept Micro & Nanotechnol, Kongens Lyngby, Denmark.	martin.dufva@nanotech.dtu.dk	Emneus, Jenny/A-5763-2012; Dufva, Martin/V-9469-2019; Lopacinska-Jørgensen, Joanna/AGO-3187-2022; Dufva, Martin/D-1873-2012	Emneus, Jenny/0000-0002-8061-201X; Lopacinska-Jørgensen, Joanna/0000-0001-7803-425X; Dufva, Martin/0000-0001-5449-0189	EU [NMP4-SL-2008-214706, CP-FP 214566-2]	EU(European Commission)	The authors would like to acknowledge two EU funded FP7 projects: NMP4-SL-2008-214706 Excell and CP-FP 214566-2 NanoScale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelastro JM, 2000, P NATL ACAD SCI USA, V97, P10424, DOI 10.1073/pnas.97.19.10424; Bontoux N, 2008, LAB CHIP, V8, P443, DOI 10.1039/b716543a; Bournat JC, 2001, MOL BRAIN RES, V90, P149, DOI 10.1016/S0169-328X(01)00097-3; Carvalho B, 2010, ANAL NIMBLEGEN EXPRE; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; CHEN TK, 1994, ANAL CHEM, V66, P3031, DOI 10.1021/ac00091a007; Das KP, 2004, NEUROTOXICOL TERATOL, V26, P397, DOI 10.1016/j.ntt.2004.02.006; DIMAGGIO DA, 1994, ENDOCRINOLOGY, V134, P719, DOI 10.1210/en.134.2.719; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Gao YD, 2011, BIOMED MICRODEVICES, V13, P539, DOI 10.1007/s10544-011-9523-9; Gentelmen R, 2005, BIOINFORMATICS COMPU; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GUNNING PW, 1981, J NEUROSCI, V1, P368; Hardy J, 2001, J ALZHEIMERS DIS, V3, P109, DOI 10.3233/JAD-2001-3115; Heiskanen A, 2010, NATO SCI PEACE SEC A, P399, DOI 10.1007/978-90-481-9029-4_19; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jeon JS, 2011, BIOMED MICRODEVICES, V13, P325, DOI 10.1007/s10544-010-9496-0; Kartalov EP, 2006, J NANOSCI NANOTECHNO, V6, P2265, DOI 10.1166/jnn.2006.504; Kim L, 2007, LAB CHIP, V7, P681, DOI 10.1039/b704602b; Koike T, 2006, NEUROSCI LETT, V410, P212, DOI 10.1016/j.neulet.2006.10.008; Leclerc E, 2004, BIOTECHNOL PROGR, V20, P750, DOI 10.1021/bp0300568; Leclerc E, 2006, BIOMATERIALS, V27, P586, DOI 10.1016/j.biomaterials.2005.06.002; Lopacinska JM, 2012, NANOSCALE, V4, P3739, DOI 10.1039/c2nr11455k; Marek L, 2004, J CELL PHYSIOL, V201, P459, DOI 10.1002/jcp.20087; Meyvantsson I, 2008, ANNU REV ANAL CHEM, V1, P423, DOI 10.1146/annurev.anchem.1.031207.113042; Miller CM, 2008, DEVELOPMENT, V135, P95, DOI 10.1242/dev.011072; Millet LJ, 2007, LAB CHIP, V7, P987, DOI 10.1039/b705266a; Ni M, 2009, INT J MOL SCI, V10, P5411, DOI 10.3390/ijms10125411; Ostrovidov S, 2004, BIOMED MICRODEVICES, V6, P279, DOI 10.1023/B:BMMD.0000048560.96140.ca; Paguirigan AL, 2008, BIOESSAYS, V30, P811, DOI 10.1002/bies.20804; Paguirigan AL, 2009, INTEGR BIOL, V1, P182, DOI 10.1039/b814565b; Rajakumar PA, 1998, REGUL PEPTIDES, V73, P123, DOI 10.1016/S0167-0115(97)01072-0; Regehr KJ, 2009, LAB CHIP, V9, P2132, DOI 10.1039/b903043c; Sabourin D, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/3/035021; Sabourin D, 2010, P 14 INT C MIN SYST, P1433; Sabourin D, 2012, J LAB AUTOM; Sabourin D, 2010, MICROFLUID NANOFLUID, V9, P87, DOI 10.1007/s10404-009-0520-8; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Skafte-Pedersen P, 2012, BIOMED MICRODEVICES, V14, P385, DOI 10.1007/s10544-011-9615-6; Skafte-Pedersen P, 2009, LAB CHIP, V9, P3003, DOI 10.1039/b906156h; Skovronsky DM, 2006, ANNU REV PATHOL-MECH, V1, P151, DOI 10.1146/annurev.pathol.1.110304.100113; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stangegaard M, 2005, THESIS TU DENMARK KO; Stangegaard M, 2006, LAB CHIP, V6, P1045, DOI 10.1039/b603379b; Stangegaard M, 2006, MOL BIOSYST, V2, P421, DOI 10.1039/b608239d; Takino T, 2006, EXP CELL RES, V312, P1381, DOI 10.1016/j.yexcr.2006.01.008; Tang BL, 2008, MOL ASPECTS MED, V29, P187, DOI 10.1016/j.mam.2007.02.001; Urdiales JL, 1998, J NEUROSCI, V18, P6767; van Midwoud PM, 2012, ANAL CHEM, V84, P3938, DOI 10.1021/ac300771z; vanGrunsven LA, 1996, ONCOGENE, V12, P855; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Westerink RHS, 2008, ACTA PHYSIOL, V192, P273, DOI 10.1111/j.1748-1716.2007.01805.x; Yuan H, 2010, SPINAL CORD, V48, P850, DOI 10.1038/sc.2010.47	56	28	28	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53107	10.1371/journal.pone.0053107	http://dx.doi.org/10.1371/journal.pone.0053107			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301028	Green Published, gold, Green Submitted			2022-12-25	WOS:000313480000031
J	Ng, EKO; Li, RFN; Shin, VY; Jin, HC; Leung, CPH; Ma, ESK; Pang, R; Chua, D; Chu, KM; Law, WL; Law, SYK; Poon, RTP; Kwong, A				Ng, Enders K. O.; Li, Rufina; Shin, Vivian Y.; Jin, Hong Chuan; Leung, Candy P. H.; Ma, Edmond S. K.; Pang, Roberta; Chua, Daniel; Chu, Kent-Man; Law, W. L.; Law, Simon Y. K.; Poon, Ronnie T. P.; Kwong, Ava			Circulating microRNAs as Specific Biomarkers for Breast Cancer Detection	PLOS ONE			English	Article							BLOOD-BASED MARKERS; CELL LUNG-CANCER; TUMOR-SUPPRESSOR; EXPRESSION; SERUM; PROLIFERATION; PROGNOSIS; LEUKEMIA; MIR-16	Background: We previously showed microRNAs (miRNAs) in plasma are potential biomarkers for colorectal cancer detection. Here, we aimed to develop specific blood-based miRNA assay for breast cancer detection. Methodology/Principal Findings: TaqMan-based miRNA profiling was performed in tumor, adjacent non-tumor, corresponding plasma from breast cancer patients, and plasma from matched healthy controls. All putative markers identified were verified in a training set of breast cancer patients. Selected markers were validated in a case-control cohort of 170 breast cancer patients, 100 controls, and 95 other types of cancers and then blindly validated in an independent set of 70 breast cancer patients and 50 healthy controls. Profiling results showed 8 miRNAs were concordantly up-regulated and 1 miRNA was concordantly down-regulated in both plasma and tumor tissue of breast cancer patients. Of the 8 up-regulated miRNAs, only 3 were significantly elevated (p<0.0001) before surgery and reduced after surgery in the training set. Results from the validation cohort showed that a combination of miR-145 and miR-451 was the best biomarker (p<0.0001) in discriminating breast cancer from healthy controls and all other types of cancers. In the blind validation, these plasma markers yielded Receiver Operating Characteristic (ROC) curve area of 0.931. The positive predictive value was 88% and the negative predictive value was 92%. Altered levels of these miRNAs in plasma have been detected not only in advanced stages but also early stages of tumors. The positive predictive value for ductal carcinoma in situ (DCIS) cases was 96%. Conclusions: These results suggested that these circulating miRNAs could be a potential specific biomarker for breast cancer screening.	[Ng, Enders K. O.; Li, Rufina; Shin, Vivian Y.; Leung, Candy P. H.; Pang, Roberta; Chu, Kent-Man; Law, W. L.; Law, Simon Y. K.; Poon, Ronnie T. P.; Kwong, Ava] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Chua, Daniel] Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Ng, Enders K. O.; Ma, Edmond S. K.; Kwong, Ava] Hong Kong Sanat & Hosp, Dept Mol Pathol, Hong Kong, Hong Kong, Peoples R China; [Jin, Hong Chuan] Zhejiang Univ, Sch Med, Sir Runrun Shaw Hosp, Biomed Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China	University of Hong Kong; University of Hong Kong; Zhejiang University	Ng, EKO (corresponding author), Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China.	ngko@hku.hk; akwong@asiabreastregistry.com	Jin, Hongchuan/C-3686-2009; Ma, Shiu Kwan Edmond/AAZ-7637-2021; Kwong, Ava/D-8005-2013; Law, Simon/C-4324-2009; Ng, Enders/T-3881-2019; Ng, Enders K.O./F-2787-2010	Ma, Shiu Kwan Edmond/0000-0002-1259-2205; Kwong, Ava/0000-0002-6968-9489; Law, Simon/0000-0002-6518-5806; Ng, Enders/0000-0002-6955-0030; Ng, Enders K.O./0000-0002-6955-0030; Wang, Xian/0000-0003-0041-7589; Jin, Hongchuan/0000-0002-6697-3097; Shin, Vivian Yvonne/0000-0003-1282-7593; Ng, Enders Kai-on/0000-0002-5293-3529	Hong Kong Hereditary Breast Cancer Family Registry	Hong Kong Hereditary Breast Cancer Family Registry	The authors sincerely thank Hong Kong Hereditary Breast Cancer Family Registry for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We sincerely thank to Hong Kong Hereditary Breast Cancer Family Registry for their support. We also like to thank Dr Dacita Suen, Dr Catherine Choi and Ms. Wong Ling for helping in patient recruitment.	Asaga S, 2011, CLIN CHEM, V57, P84, DOI 10.1373/clinchem.2010.151845; Bandi N, 2009, CANCER RES, V69, P5553, DOI 10.1158/0008-5472.CAN-08-4277; Bandres E, 2009, CLIN CANCER RES, V15, P2281, DOI 10.1158/1078-0432.CCR-08-1818; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Duffy MJ, 1999, ANN CLIN BIOCHEM, V36, P579, DOI 10.1177/000456329903600503; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kaddar T, 2009, LEUKEMIA RES, V33, P1217, DOI 10.1016/j.leukres.2008.12.015; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Kovalchuk O, 2008, MOL CANCER THER, V7, P2152, DOI 10.1158/1535-7163.MCT-08-0021; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Ng EKO, 2010, GUT, V59, P1004, DOI 10.1136/gut.2010.208082; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Resnick KE, 2009, GYNECOL ONCOL, V112, P55, DOI 10.1016/j.ygyno.2008.08.036; Roth C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2766; Sachdeva M, 2010, CANCER RES, V70, P378, DOI 10.1158/0008-5472.CAN-09-2021; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Shi B, 2007, J BIOL CHEM, V282, P32582, DOI 10.1074/jbc.M702806200; Wang R, 2011, ONCOGENE, V30, P2644, DOI 10.1038/onc.2010.642; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Yu T, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-64; Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735; Zhu Weizhu, 2009, BMC Res Notes, V2, P89, DOI 10.1186/1756-0500-2-89	36	199	211	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53141	10.1371/journal.pone.0053141	http://dx.doi.org/10.1371/journal.pone.0053141			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301032	Green Published, gold			2022-12-25	WOS:000313480000032
J	Rolland, AD; Lardenois, A; Goupil, AS; Lareyre, JJ; Houlgatte, R; Chalmel, F; Le Gac, F				Rolland, Antoine D.; Lardenois, Aurelie; Goupil, Anne-Sophie; Lareyre, Jean-Jacques; Houlgatte, Remi; Chalmel, Frederic; Le Gac, Florence			Profiling of Androgen Response in Rainbow Trout Pubertal Testis: Relevance to Male Gonad Development and Spermatogenesis	PLOS ONE			English	Article							CATFISH CLARIAS-GARIEPINUS; EEL ANGUILLA-JAPONICA; ONCORHYNCHUS-MYKISS; GENE-EXPRESSION; JAPANESE EEL; HYPOPHYSECTOMIZED RAT; HORMONAL-REGULATION; SERTOLI-CELLS; SEX STEROIDS; COHO SALMON	The capacity of testicular somatic cells to promote and sustain germ cell differentiation is largely regulated by sexual steroids and notably androgens. In fish species the importance of androgens is emphasized by their ability to induce sex reversal of the developing fries and to trigger spermatogenesis. Here we studied the influence of androgens on testicular gene expression in trout testis using microarrays. Following treatment of immature males with physiological doses of testosterone or 11-ketotestosterone, 418 genes that exhibit changes in expression were identified. Interestingly, the activity of testosterone appeared stronger than that of 11-ketotestosterone. Expression profiles of responsive genes throughout testis development and in isolated germ cells confirmed androgens to mainly affect gene expression in somatic cells. Furthermore, specific clusters of genes that exhibit regulation coincidently with changes in the natural circulating levels of androgens during the reproductive cycle were highlighted, reinforcing the physiological significance of these data. Among somatic genes, a phylogenetic footprinting study identified putative androgen response elements within the proximal promoter regions of 42 potential direct androgen target genes. Finally, androgens were also found to alter the germ line towards meiotic expression profiles, supporting the hypothesis of a role for the somatic responsive genes in driving germ cell fate. This study significantly increases our understanding of molecular pathways regulated by androgens in vertebrates. The highly cyclic testicular development in trout together with functions associated with regulated genes reveal potential mechanisms for androgen actions in tubule formation, steroid production, germ cell development and sperm secretion.	[Rolland, Antoine D.; Goupil, Anne-Sophie; Lareyre, Jean-Jacques; Le Gac, Florence] Biogenouest, INRA, LPGP UR1037, SFR Biosit, Rennes, France; [Lardenois, Aurelie; Chalmel, Frederic] Univ Rennes 1, INSERM, U1085, IRSET, Rennes, France; [Houlgatte, Remi] Inst Thorax IRT UN, INSERM, UMR1087, Nantes, France; [Houlgatte, Remi] Univ Nantes, Nantes, France	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite	Le Gac, F (corresponding author), Biogenouest, INRA, LPGP UR1037, SFR Biosit, Campus Beaulieu, Rennes, France.	legac@rennes.inra.fr	Lardenois, Aurélie/AAA-8961-2020; ROLLAND, Antoine D/B-2611-2012; Houlgatte, Remi/P-3020-2017; Chalmel, Frédéric/AAM-1079-2021; Rolland, Antoine/A-6263-2011; Chalmel, Frédéric/L-5360-2018; Chalmel, Frederic/M-1297-2016	ROLLAND, Antoine D/0000-0002-9758-4406; Chalmel, Frédéric/0000-0002-0535-3628; Chalmel, Frédéric/0000-0002-0535-3628; 	AGENAE program; INRA-CIPA-OFIMER European community IFOP grant; French National Research Agency [ANR-06-GANI-014]; European Community's Seventh Framework Programme (FP7), project LIFECYCLE [222719]; SIGENAE informatics team	AGENAE program; INRA-CIPA-OFIMER European community IFOP grant; French National Research Agency(French National Research Agency (ANR)); European Community's Seventh Framework Programme (FP7), project LIFECYCLE; SIGENAE informatics team	This work was supported by the AGENAE program (www.agenae.fr), INRA-CIPA-OFIMER European community IFOP grant. This research received funding from the French National Research Agency (ANR-06-GANI-014 "Spermgen") and from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no222719, project LIFECYCLE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the SIGENAE informatics team for their support, the PEIMA experimental fish farming facilities for the experimental animals and the INRA-Rennes/BIOSIT functional genomic platform for advice.	Adams IR, 2002, DEVELOPMENT, V129, P1155; ADLER AJ, 1991, MOL ENDOCRINOL, V5, P1587, DOI 10.1210/mend-5-11-1587; Alavi SMH, 2006, CELL BIOL INT, V30, P1, DOI 10.1016/j.cellbi.2005.06.004; Amer MA, 2001, BIOL REPROD, V65, P1057, DOI 10.1095/biolreprod65.4.1057; Barbulescu K, 2001, MOL ENDOCRINOL, V15, P1803, DOI 10.1210/me.15.10.1803; Baron D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-357; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BORG B, 1994, COMP BIOCHEM PHYS C, V109, P219, DOI 10.1016/0742-8413(94)00063-G; Cavaco JEB, 1998, AM J PHYSIOL-REG I, V275, pR1793, DOI 10.1152/ajpregu.1998.275.6.R1793; Cavaco JEB, 2001, BIOL REPROD, V65, P1807, DOI 10.1095/biolreprod65.6.1807; Chalmel F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-86; Chang CS, 2004, P NATL ACAD SCI USA, V101, P6876, DOI 10.1073/pnas.0307306101; COCHRAN RC, 1992, J EXP ZOOL, V261, P143, DOI 10.1002/jez.1402610205; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; de Waal PP, 2008, REPRODUCTION, V136, P225, DOI 10.1530/REP-08-0055; DECLERCQ L, 1977, IN VITRO CELL DEV B, V13, P85; Dickey JT, 1998, J MOL ENDOCRINOL, V21, P291, DOI 10.1677/jme.0.0210291; Douard V, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-336; El Shennawy A, 1998, J ANDROL, V19, P320; ELKINGTON JS, 1974, AUST J BIOL SCI, V27, P47, DOI 10.1071/BI9740047; FITZPATRICK MS, 1994, GEN COMP ENDOCR, V95, P399, DOI 10.1006/gcen.1994.1139; FOSTIER A, 1982, GEN COMP ENDOCR, V46, P428, DOI 10.1016/0016-6480(82)90096-X; Galas JE, 2009, ANN NY ACAD SCI, V1163, P398, DOI 10.1111/j.1749-6632.2008.03663.x; GHARIB SD, 1990, ENDOCR REV, V11, P177, DOI 10.1210/edrv-11-1-177; Gomez JM, 1999, GEN COMP ENDOCR, V113, P413, DOI 10.1006/gcen.1998.7222; Gomez JM, 1998, BIOL REPROD, V58, P483, DOI 10.1095/biolreprod58.2.483; Haywood M, 2003, ENDOCRINOLOGY, V144, P509, DOI 10.1210/en.2002-220710; Holdcraft RW, 2004, INT J ANDROL, V27, P335, DOI 10.1111/j.1365-2605.2004.00502.x; Johnston DS, 2001, ENDOCRINOLOGY, V142, P2405, DOI 10.1210/en.142.6.2405; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Khan IA, 1999, BIOL REPROD, V61, P834, DOI 10.1095/biolreprod61.3.834; KOBAYASHI M, 1991, ZOOL SCI, V8, P389; Lareyre JJ, 2000, BIOL REPROD, V63, P1881, DOI 10.1095/biolreprod63.6.1881; Leal MC, 2009, GEN COMP ENDOCR, V162, P134, DOI 10.1016/j.ygcen.2009.03.003; Loir M, 1999, MOL REPROD DEV, V53, P422, DOI 10.1002/(SICI)1098-2795(199908)53:4&lt;422::AID-MRD8&gt;3.0.CO;2-V; MARSHALL WS, 1993, GEN COMP ENDOCR, V90, P232, DOI 10.1006/gcen.1993.1078; MATHER JP, 1990, ENDOCRINOLOGY, V127, P3206, DOI 10.1210/endo-127-6-3206; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Meachem SJ, 2005, J ENDOCRINOL, V186, P429, DOI 10.1677/joe.1.06121; MIURA T, 1995, FISHERIES SCI, V61, P434, DOI 10.2331/fishsci.61.434; MIURA T, 1991, P NATL ACAD SCI USA, V88, P5774, DOI 10.1073/pnas.88.13.5774; Miura T, 2002, DEVELOPMENT, V129, P2689; ORTH JM, 1988, ENDOCRINOLOGY, V122, P787, DOI 10.1210/endo-122-3-787; Rescan PY, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-438; Rolland AD, 2008, ADV EXP MED BIOL, V636, P16, DOI 10.1007/978-0-387-09597-4_2; Rolland AD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-546; Schulz RW, 2010, GEN COMP ENDOCR, V165, P390, DOI 10.1016/j.ygcen.2009.02.013; Schulz RW, 2001, COMP BIOCHEM PHYS B, V129, P407, DOI 10.1016/S1096-4959(01)00339-6; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; SINGH J, 1995, ENDOCRINOLOGY, V136, P5311, DOI 10.1210/en.136.12.5311; Skaar KS, 2011, ENDOCRINOLOGY, V152, P3527, DOI 10.1210/en.2010-1469; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Takeo J, 1999, J BIOL CHEM, V274, P5674, DOI 10.1074/jbc.274.9.5674; Taranger GL, 2010, GEN COMP ENDOCR, V165, P483, DOI 10.1016/j.ygcen.2009.05.004; Vizziano D, 2007, DEV DYNAM, V236, P2198, DOI 10.1002/dvdy.21212; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965; Woods M, 2009, MOL CELL ENDOCRINOL, V303, P57, DOI 10.1016/j.mce.2008.12.014; Wu Y, 2007, ENDOCRINOLOGY, V148, P2984, DOI 10.1210/en.2006-1653; Zhou Q, 2002, J ANDROL, V23, P870	60	32	32	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53302	10.1371/journal.pone.0053302	http://dx.doi.org/10.1371/journal.pone.0053302			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301058	gold, Green Published			2022-12-25	WOS:000313480000048
J	Zeng, Q; Dong, SY; Wu, LX; Li, H; Sun, ZJ; Li, JB; Jiang, HX; Chen, ZH; Wang, QB; Chen, WW				Zeng, Qiang; Dong, Sheng-Yong; Wu, Liu-Xin; Li, Hong; Sun, Zhi-Jian; Li, Jing-Bo; Jiang, Hong-Xia; Chen, Zhi-Heng; Wang, Qi-Bin; Chen, Wei-Wei			Variable Food-Specific IgG Antibody Levels in Healthy and Symptomatic Chinese Adults	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; IMMUNOGLOBULIN-G; GENE POLYMORPHISMS; MILK PROTEIN; DOUBLE-BLIND; ALLERGY; PREVALENCE; PEANUT; ELIMINATION; RESPONSES	Background: The presence of food-specific IgG antibodies in human serum may be useful for diagnosis of adverse food reactions. However, the clinical utility of tesing for such antibodies remains very controversial. The aim of this study was to evaluate the serum levels and population distribution of food-specific IgGs and their association with chronic symptoms in a large-scale Chinese population. Methodology/Principal Findings: A total of 21305 adult participants from different regions of China had 14 type of food-specific serum IgG antibodies that were measured by enzyme-linked immunosorbent assay. Amongthese, 5,394 participants were randomly chosen to complete follow-up questionnaire surveys on their dietary characteristics and chronic symptoms. The concentrations of food-specific IgGs against 14 foods ranged from a median (interquartile range) of 7.3 (3.8, 12.6) U/mL of pork-specfic IgG to 42.3 (28.8, 60.2) U/mL of crab-specific IgG. The concentration of food-specific IgGs was closely related to gender; after adjustment for region and age, women had higher concentrations of food-specific IgGs against all of the 14 foods except chicken (regression coefficient (95% CI): 0.01 (-0.003, 0.023); P = 0.129) and corn (0.002 (-0.013, 0.016); P = 0.825). Similar results were also found in the relationship of geographic region to the food-specific IgG concentrations for the 14 foods. Chronic symptoms were negatively associated with the concentrations of a few food-specific IgGs, and were positively associated with the concentrations of other food-specific IgGs. Conclusions: The levels of food-specific IgGs were variable both in healthy and in symptomatic Chinese adults. These findings raise awareness that demographic factors, the type of food and specific chronic symptoms should be considered before food elimination treatment based on IgG testing in patients with chronic symptoms is used in clinical practice.	[Zeng, Qiang; Dong, Sheng-Yong] Chinese Peoples Liberat Army Gen Hosp, Int Med Ctr, Beijing, Peoples R China; [Wu, Liu-Xin] PLA AF Inst Aviat Med, Lab 2, Beijing, Peoples R China; [Li, Hong] Fujian Prov Hosp, Hlth Management Ctr, Fuzhou, Fujian, Peoples R China; [Sun, Zhi-Jian] Shandong Prov Hosp, Hlth Management Ctr, Jinan, Shandong, Peoples R China; [Li, Jing-Bo] Third Mil Med Univ, Southwest Hosp, Hlth Management Ctr, Chongqing, Peoples R China; [Jiang, Hong-Xia] Cent S Univ, Xiangya Hosp, Hlth Management Ctr, Changsha, Hunan, Peoples R China; [Chen, Zhi-Heng] Cent S Univ, Xiangya Hosp 3, Hlth Management Ctr, Changsha, Hunan, Peoples R China; [Wang, Qi-Bin] Shandong Elect Power Ctr Hosp, Hlth Management Ctr, Jinan, Shandong, Peoples R China; [Chen, Wei-Wei] 302 Hosp PLA, Treatment & Res Ctr Infect Dis, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Fujian Provincial Hospital; Shandong First Medical University & Shandong Academy of Medical Sciences; Army Medical University; Central South University; Central South University; Fifth Medical Center of Chinese PLA General Hospital	Zeng, Q (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Int Med Ctr, Beijing, Peoples R China.	zq301@hotmail.com; cww302@126.com		Dong, Sheng-Yong/0000-0002-8395-4269	State Science and Technology Support Program [2012BAI37B04]	State Science and Technology Support Program	This study was supported by the State Science and Technology Support Program (No. 2012BAI37B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens B, 2010, ALLERGY, V65, P1554, DOI 10.1111/j.1398-9995.2010.02429.x; Alberto EJC, 2008, PEDIAT ALLERG IMM-UK, V19, P716, DOI 10.1111/j.1399-3038.2007.00709.x; Alpay K, 2010, CEPHALALGIA, V30, P829, DOI 10.1177/0333102410361404; [Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; Antico A, 2011, INT ARCH ALLERGY IMM, V155, P52, DOI 10.1159/000318736; Atkinson W, 2004, GUT, V53, P1459, DOI 10.1136/gut.2003.037697; Babu BNH, 2008, CLIN EXP ALLERGY, V38, P1795, DOI 10.1111/j.1365-2222.2008.03076.x; Battais F, 2003, CLIN EXP ALLERGY, V33, P962, DOI 10.1046/j.1365-2222.2003.01592.x; Carvalho RVB, 2010, DIGEST DIS SCI, V55, P60, DOI 10.1007/s10620-008-0698-8; Chafen JJS, 2010, JAMA-J AM MED ASSOC, V303, P1848, DOI 10.1001/jama.2010.582; Chen Y, 2003, J CLIN EPIDEMIOL, V56, P180, DOI 10.1016/S0895-4356(02)00593-0; CROWE SE, 1992, GASTROENTEROLOGY, V103, P1075, DOI 10.1016/0016-5085(92)90047-3; Dreskin SC, 2010, CLIN IMMUNOL, V137, P366, DOI 10.1016/j.clim.2010.08.009; Harduar-Morano L, 2011, J ALLERGY CLIN IMMUN, V128, P594, DOI 10.1016/j.jaci.2011.04.049; Hochwallner H, 2011, ALLERGY, V66, P1201, DOI 10.1111/j.1398-9995.2011.02635.x; Hong XM, 2011, J ALLERGY CLIN IMMUN, V128, P374, DOI 10.1016/j.jaci.2011.05.007; HOST A, 1992, ALLERGY, V47, P218, DOI 10.1111/j.1398-9995.1992.tb00654.x; Hunter JO, 2005, GUT, V54, P1203; Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591; Kanagawa Y, 2009, PEDIATR ALLERGY IMMU, V20, P347, DOI 10.1111/j.1399-3038.2008.00791.x; Pelsser LM, 2011, LANCET, V377, P494, DOI 10.1016/S0140-6736(10)62227-1; Penard-Morand C, 2005, ALLERGY, V60, P1165, DOI 10.1111/j.1398-9995.2005.00860.x; Poulos LM, 2007, J ALLERGY CLIN IMMUN, V120, P878, DOI 10.1016/j.jaci.2007.07.040; Sampson HA, 2004, J ALLERGY CLIN IMMUN, V113, P805, DOI 10.1016/j.jaci.2004.03.014; Satoguina JS, 2005, J IMMUNOL, V174, P4718, DOI 10.4049/jimmunol.174.8.4718; Schafer T, 2001, ALLERGY, V56, P1172, DOI 10.1034/j.1398-9995.2001.00196.x; Scott-Taylor TH, 2010, PEDIAT ALLERG IMM-UK, V21, P935, DOI 10.1111/j.1399-3038.2010.01025.x; Shreffler WG, 2005, J ALLERGY CLIN IMMUN, V116, P893, DOI 10.1016/j.jaci.2005.06.033; Sicherer SH, 2011, J ALLERGY CLIN IMMUN, V127, P594, DOI 10.1016/j.jaci.2010.11.044; Sicherer SH, 2003, J ALLERGY CLIN IMMUN, V112, P1203, DOI 10.1016/S0091-6749(03)02026-8; Skripak JM, 2008, J ALLERGY CLIN IMMUN, V122, P1154, DOI 10.1016/j.jaci.2008.09.030; Stapel SO, 2008, ALLERGY, V63, P793, DOI 10.1111/j.1398-9995.2008.01705.x; Tay SS, 2007, CLIN EXP ALLERGY, V37, P1512, DOI 10.1111/j.1365-2222.2007.02802.x; YOUNG E, 1994, LANCET, V343, P1127, DOI 10.1016/S0140-6736(94)90234-8; Zaitsu M, 2007, MOL IMMUNOL, V44, P1977, DOI 10.1016/j.molimm.2006.09.030; Zar S, 2005, AM J GASTROENTEROL, V100, P1550, DOI 10.1111/j.1572-0241.2005.41348.x; Zuberbier T, 2004, ALLERGY, V59, P338, DOI 10.1046/j.1398-9995.2003.00403.x; Zuo XL, 2007, CLIN EXP ALLERGY, V37, P823, DOI 10.1111/j.1365-2222.2007.02727.x	38	22	28	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53612	10.1371/journal.pone.0053612	http://dx.doi.org/10.1371/journal.pone.0053612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301096	Green Published, Green Submitted, gold			2022-12-25	WOS:000313480000072
J	Ramirez-Garcia, A; Arteta, B; Abad-Diaz-de-Cerio, A; Pellon, A; Antoran, A; Marquez, J; Rementeria, A; Hernando, FL				Ramirez-Garcia, Andoni; Arteta, Beatriz; Abad-Diaz-de-Cerio, Ana; Pellon, Aize; Antoran, Aitziber; Marquez, Joana; Rementeria, Aitor; Hernando, Fernando L.			Candida albicans Increases Tumor Cell Adhesion to Endothelial Cells In Vitro: Intraspecific Differences and Importance of the Mannose Receptor	PLOS ONE			English	Article							HEPATIC MELANOMA METASTASIS; CYTOKINE PRODUCTION; PROINFLAMMATORY RESPONSE; SINUSOIDAL ENDOTHELIUM; FILAMENTOUS FORMS; EXPRESSION; INFECTION; INTERLEUKIN-18; IDENTIFICATION; INFLAMMATION	The dimorphic fungus Candida albicans is able to trigger a cytokine-mediated pro-inflammatory response that increases tumor cell adhesion to hepatic endothelium and metastasis. To check the intraspecific differences in this effect, we used an in vitro murine model of hepatic response against C. albicans, which made clear that tumor cells adhered more to endothelium incubated with blastoconidia, both live and killed, than germ tubes. This finding was related to the higher carbohydrate/protein ratio found in blastoconidia. In fact, destruction of mannose ligand residues on the cell surface by metaperiodate treatment significantly reduced tumor cell adhesion induced. Moreover, we also noticed that the effect of clinical strains was greater than that of the reference one. This finding could not be explained by the carbohydrate/protein data, but to explain these differences between strains, we analyzed the expression level of ten genes (ADH1, APE3, IDH2, ENO1, FBA1, ILV5, PDI1, PGK1, QCR2 and TUF1) that code for the proteins identified previously in a mannoprotein-enriched pro-metastatic fraction of C. albicans. The results corroborated that their expression was higher in clinical strains than the reference one. To confirm the importance of the mannoprotein fraction, we also demonstrate that blocking the mannose receptor decreases the effect of C. albicans and its mannoproteins, inhibiting IL-18 synthesis and tumor cell adhesion increase by around 60%. These findings could be the first step towards a new treatment for solid organ cancers based on the role of the mannose receptor in C. albicans-induced tumor progression and metastasis.	[Ramirez-Garcia, Andoni; Abad-Diaz-de-Cerio, Ana; Pellon, Aize; Antoran, Aitziber; Rementeria, Aitor; Hernando, Fernando L.] Univ Basque Country UPV EHU, Fac Sci & Technol, Dept Immunol Microbiol & Parasitol, Leioa, Spain; [Ramirez-Garcia, Andoni] Univ Basque Country UPV EHU, Fac Pharm, Dept Immunol Microbiol & Parasitol, Vitoria, Spain; [Arteta, Beatriz; Marquez, Joana] Univ Basque Country UPV EHU, Fac Med & Dent, Dept Cell Biol & Histol, Leioa, Spain	University of Basque Country; University of Basque Country; University of Basque Country	Ramirez-Garcia, A (corresponding author), Univ Basque Country UPV EHU, Fac Sci & Technol, Dept Immunol Microbiol & Parasitol, Leioa, Spain.	andoni.ramirez@ehu.es	Pellon, Aize/I-2870-2015; Arteta, Beatriz/I-4161-2019; Pellon, Aize/K-6083-2019; Ramirez-Garcia, Andoni/I-1697-2015; Antoran, Aitziber/AAA-4435-2019; Hernando, Fernando/I-2763-2015; Arteta, Beatriz/N-4353-2015; Rementeria, Aitor/B-3936-2008; ABAD DIAZ DE CERIO, ANA/Z-1039-2018	Pellon, Aize/0000-0003-0415-6566; Arteta, Beatriz/0000-0003-3253-3162; Pellon, Aize/0000-0003-0415-6566; Ramirez-Garcia, Andoni/0000-0003-2696-162X; Antoran, Aitziber/0000-0003-2594-8220; Hernando, Fernando/0000-0002-7151-9083; Rementeria, Aitor/0000-0003-0478-1038; ABAD DIAZ DE CERIO, ANA/0000-0001-6022-1751; MARQUEZ CLAVIJO, JOANA/0000-0002-6429-615X	SAIOTEK [S-PE09UN41, S-PE11UN070]; Basque Government [IT343/10]; University of the Basque Country [UE 03/04, UE 08/14]; UFI Grant from the University of the Basque Country UPV/EHU [UFI11/25]; Government of the Basque Country	SAIOTEK; Basque Government(Basque Government); University of the Basque Country; UFI Grant from the University of the Basque Country UPV/EHU; Government of the Basque Country	This work was supported by two SAIOTEK grants (S-PE09UN41 and S-PE11UN070) and a consolidated research group IT343/10 of Basque Government, two grants from the University of the Basque Country (UE 03/04 and UE 08/14) and a UFI Grant (UFI11/25) from the University of the Basque Country UPV/EHU. Andoni Ramirez-Garcia was supported by a fellowship from the Government of the Basque Country. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolopoulos V., 2001, Current Molecular Medicine (Hilversum), V1, P469, DOI 10.2174/1566524013363645; Asumendi A, 1996, HEPATOLOGY, V23, P1521, DOI 10.1002/hep.510230632; Bendel CM, 2003, CRIT CARE MED, V31, P501, DOI 10.1097/01.CCM.0000049954.48239.A1; Blackwell TS, 1997, J IMMUNOL, V158, P5934; Cannom RRM, 2002, J INFECT DIS, V186, P389, DOI 10.1086/341660; Carrascal MT, 2003, CANCER RES, V63, P491; CHUNG CW, 1954, J BIOL CHEM, V208, P395; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Filler SG, 1996, INFECT IMMUN, V64, P2609, DOI 10.1128/IAI.64.7.2609-2617.1996; Gil ML, 2006, MICROBES INFECT, V8, P2299, DOI 10.1016/j.micinf.2006.03.014; Gil ML, 2006, FEMS IMMUNOL MED MIC, V46, P1, DOI 10.1111/j.1574-695X.2005.00018.x; Grubb SEW, 2009, INFECT IMMUN, V77, P3872, DOI 10.1128/IAI.00518-09; Hernando FL, 2007, INT MICROBIOL, V10, P103, DOI 10.2436/20.1501.01.15; HERNANDO FL, 1993, J MED VET MYCOL, V31, P227; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Murciano C, 2011, INFECT IMMUN, V79, P4902, DOI 10.1128/IAI.05591-11; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Orozco AS, 2000, INFECT IMMUN, V68, P1134, DOI 10.1128/IAI.68.3.1134-1141.2000; Phan QT, 2000, INFECT IMMUN, V68, P3485, DOI 10.1128/IAI.68.6.3485-3490.2000; Ramirez-Garcia A, 2011, APPL MICROBIOL BIOT, V92, P133, DOI 10.1007/s00253-011-3540-8; Rodriguez-Cuesta J, 2010, CLIN EXP METASTAS, V27, P35, DOI 10.1007/s10585-009-9300-9; Saville SP, 2003, EUKARYOT CELL, V2, P1053, DOI 10.1128/EC.2.5.1053-1060.2003; SAWYER RT, 1976, INFECT IMMUN, V14, P1348, DOI 10.1128/IAI.14.6.1348-1355.1976; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; Strober W., 2001, CURR PROTOC IMMUNOL, DOI [10.1002/0471142735.ima03bs21, DOI 10.1002/0471142735.IMA03BS111]; van der Graaf CAA, 2005, INFECT IMMUN, V73, P7458, DOI 10.1128/IAI.73.11.7458-7464.2005; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vidal-Vanaclocha F, 2000, P NATL ACAD SCI USA, V97, P734, DOI 10.1073/pnas.97.2.734; Vidal-Vanaclocha F, 2006, CANCER METAST REV, V25, P417, DOI 10.1007/s10555-006-9013-3; Villar CC, 2005, INFECT IMMUN, V73, P4588, DOI 10.1128/IAI.73.8.4588-4595.2005	30	17	28	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53584	10.1371/journal.pone.0053584	http://dx.doi.org/10.1371/journal.pone.0053584			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301091	Green Published, gold			2022-12-25	WOS:000313320900085
J	Wang, ML; Wang, JP; Wang, TP; Li, J; Hui, L; Ha, XQ				Wang, Meiliang; Wang, Jiuping; Wang, Tianping; Li, Jing; Hui, Ling; Ha, Xiaoqin			Thrombocytopenia as a Predictor of Severe Acute Kidney Injury in Patients with Hantaan Virus Infections	PLOS ONE			English	Article							PUUMALA HANTAVIRUS INFECTION; CONGO HEMORRHAGIC-FEVER; RENAL SYNDROME; DISEASE SEVERITY; DENGUE SEVERITY; NICARAGUA; DIAGNOSIS; FATALITY; FAILURE; PROTEIN	Background: Hematological abnormalities often occur several days before kidney injury in patients with hemorrhagic fever with renal syndrome (HFRS). We aimed to investigate the prevalence and prognostic value of the early hematological markers in patients with HFRS caused by Hantaan virus (HTNV) infection. Methods: In a retrospective cohort study, we analyzed the case records of 112 patients with acute HTNV infection and evaluated the hematological markers for early prediction and risk stratification of HFRS patients with acute kidney injury (AKI). Results: Of 112 patients analyzed, 66 (59%) developed severe AKI, defined as either receipt of acute dialysis or increased serum creatinine >= 354 mu mol/L. The prognostic accuracy of hematological markers, as quantified by the area under the receiver-operating-characteristic curve (AUC), was highest with the nadir platelet count (AUC, 0.89; 95% CI, 0.83-0.95), as compared with the admission platelet count (AUC, 0.84; 95% CI, 0.77-0.92), and the admission and peak leukocyte counts. The nadir platelet count correlated moderately with the levels of peak blood urea nitrogen (r = -0.616) and serum creatinine (r = -0.589), the length of hospital stay (r = -0.599), and the number of dialysis sessions that each patient received during hospital stay (r = -0.625). By multivariate analysis, decreased nadir platelet count remained independently associated with the development of severe AKI (odds ratio, 27.57; 95% CI, 6.96-109.16; P<0.0001). Conclusions: Thrombocytopenia, rather than leukocytosis, is independently associated with subsequent severe AKI among patients with acute HTNV infection.	[Wang, Meiliang; Hui, Ling; Ha, Xiaoqin] Lanzhou Gen Hosp, Ctr Med Expt, Lanzhou Mil Command, Lanzhou, Gansu, Peoples R China; [Wang, Jiuping; Wang, Tianping; Li, Jing] Fourth Mil Med Univ, Tangdu Hosp, Dept Infect Dis, Xian 710032, Shaanxi, Peoples R China; [Hui, Ling; Ha, Xiaoqin] Gansu Key Lab Stem Cell & Gene Therapy, Lanzhou, Gansu, Peoples R China	Air Force Military Medical University	Wang, ML (corresponding author), Lanzhou Gen Hosp, Ctr Med Expt, Lanzhou Mil Command, Lanzhou, Gansu, Peoples R China.	mlwang_2003@yahoo.com						Balmaseda A, 2005, AM J TROP MED HYG, V73, P1059, DOI 10.4269/ajtmh.2005.73.1059; Denecke B, 2010, MAYO CLIN PROC, V85, P1016, DOI 10.4065/mcp.2009.0040; Evika MA, 2008, INT J INFECT DIS, V12, P374, DOI [10.1016/j.ijid.2007.09.010, 10.1016/j.ijid.2007.09.01]; Fisgin NT, 2009, TROP DOCT, V39, P158, DOI 10.1258/td.2008.080092; Geisbert TW, 2004, NAT MED, V10, pS110, DOI 10.1038/nm1142; Hammond SN, 2005, AM J TROP MED HYG, V73, P1063; Kim YO, 2003, J KOREAN MED SCI, V18, P696, DOI 10.3346/jkms.2003.18.5.696; Kim YK, 2007, J INFECTION, V54, P381, DOI 10.1016/j.jinf.2006.07.006; Klein SL, 2011, CLIN INFECT DIS, V52, P1414, DOI 10.1093/cid/cir232; Laine O, 2010, THROMB RES, V126, P154, DOI 10.1016/j.thromres.2010.05.025; Libraty DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035402; Liu KD, 2006, CLIN J AM SOC NEPHRO, V1, P915, DOI 10.2215/CJN.01430406; Onguru P, 2010, J CLIN LAB ANAL, V24, P163, DOI 10.1002/jcla.20383; Outinen TK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-132; Pozner RG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000847; Rasche FM, 2004, EMERG INFECT DIS, V10, P1420, DOI 10.3201/eid1008.031069; Sane J, 2012, ANN MED, V44, P468, DOI 10.3109/07853890.2011.573500; Sundberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021134; Takala A, 2000, J INFECT DIS, V181, P1964, DOI 10.1086/315522; Tanner L, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000196; Wang ML, 2009, J INFECT DIS, V199, P188, DOI 10.1086/595834	21	31	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53236	10.1371/journal.pone.0053236	http://dx.doi.org/10.1371/journal.pone.0053236			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301047	Green Submitted, gold, Green Published			2022-12-25	WOS:000313320900070
J	Theesfeld, CL; Hampton, RY				Theesfeld, Chandra L.; Hampton, Randolph Y.			Insulin-induced Gene Protein (INSIG)-dependent Sterol Regulation of Hmg2 Endoplasmic Reticulum-associated Degradation (ERAD) in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE DEGRADATION; SACCHAROMYCES-CEREVISIAE; COA REDUCTASE; MEMBRANE-PROTEIN; (HMG)-COA REDUCTASE; UBIQUITIN LIGASE; INSIG; CHOLESTEROL; SIGNAL; IDENTIFICATION	Insulin-induced gene proteins (INSIGs) function in control of cellular cholesterol. Mammalian INSIGs exert control by directly interacting with proteins containing sterol-sensing domains (SSDs) when sterol levels are elevated. Mammalian 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase (HMGR) undergoes sterol-dependent, endoplasmic-reticulum (ER)-associated degradation (ERAD) that is mediated by INSIG interaction with the HMGR SSD. The yeast HMGR isozyme Hmg2 also undergoes feedback-regulated ERAD in response to the early pathway-derived isoprene gernanylgeranyl pyrophosphate (GGPP). Hmg2 has an SSD, and its degradation is controlled by the INSIG homologue Nsg1. However, yeast Nsg1 promotes Hmg2 stabilization by inhibiting GGPP-stimulated ERAD. We have proposed that the seemingly disparate INSIG functions can be unified by viewing INSIGs as sterol-dependent chaperones of SSD clients. Accordingly, we tested the role of sterols in the Nsg1 regulation of Hmg2. We found that both Nsg1-mediated stabilization of Hmg2 and the Nsg1-Hmg2 interaction required the early sterol lanosterol. Lowering lanosterol in the cell allowed GGPP-stimulated Hmg2 ERAD. Thus, Hmg2-regulated degradation is controlled by a two-signal logic; GGPP promotes degradation, and lanosterol inhibits degradation. These data reveal that the sterol dependence of INSIG-client interaction has been preserved for over 1 billion years. We propose that the INSIGs are a class of sterol-dependent chaperones that bind to SSD clients, thus harnessing ER quality control in the homeostasis of sterols.	[Theesfeld, Chandra L.; Hampton, Randolph Y.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Hampton, RY (corresponding author), Univ Calif San Diego, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rhampton@ucsd.edu			National Institutes of Health, NIGMS, National Research Service [5F32GM82195, 5R01DK051996]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051996, R37DK051996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM082195] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS, National Research Service; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, National Research Service Award 5F32GM82195 (to C. L. T.) and Grant 5R01DK051996 (to R. Y. H.).	BASSON ME, 1986, P NATL ACAD SCI USA, V83, P5563, DOI 10.1073/pnas.83.15.5563; BROWN MS, 1980, J LIPID RES, V21, P505; Carroll SM, 2010, J BIOL CHEM, V285, P5146, DOI 10.1074/jbc.M109.067876; Crowley JH, 1998, CURR GENET, V34, P93, DOI 10.1007/s002940050371; Flury I, 2005, EMBO J, V24, P3917, DOI 10.1038/sj.emboj.7600855; Gardner R, 1998, MOL BIOL CELL, V9, P2611, DOI 10.1091/mbc.9.9.2611; Gardner RG, 1999, J BIOL CHEM, V274, P31671, DOI 10.1074/jbc.274.44.31671; Gardner RG, 2001, J BIOL CHEM, V276, P8681, DOI 10.1074/jbc.M007888200; Garza RM, 2009, J BIOL CHEM, V284, P35368, DOI 10.1074/jbc.M109.023994; Garza RM, 2009, J BIOL CHEM, V284, P14710, DOI 10.1074/jbc.M809607200; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; HAMPTON RY, 1994, J CELL BIOL, V125, P299, DOI 10.1083/jcb.125.2.299; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hughes AL, 2008, J LIPID RES, V49, P2001, DOI 10.1194/jlr.M800207-JLR200; Jo Y, 2010, CRIT REV BIOCHEM MOL, V45, P185, DOI 10.3109/10409238.2010.485605; Jones GM, 2008, NAT METHODS, V5, P239, DOI 10.1038/NMETH.1181; Lai LC, 2006, EUKARYOT CELL, V5, P1468, DOI 10.1128/EC.00107-06; Lee JN, 2006, J BIOL CHEM, V281, P39308, DOI 10.1074/jbc.M608999200; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Motamed M, 2011, J BIOL CHEM, V286, P18002, DOI 10.1074/jbc.M111.238311; NEAL WD, 1977, J BACTERIOL, V129, P1375, DOI 10.1128/JB.129.3.1375-1378.1977; Nguyen AD, 2007, J BIOL CHEM, V282, P27436, DOI 10.1074/jbc.M704976200; Nguyen AD, 2009, J BIOL CHEM, V284, P26778, DOI 10.1074/jbc.M109.032342; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Shearer AG, 2005, EMBO J, V24, P149, DOI 10.1038/sj.emboj.7600498; SIKORSKI RS, 1989, GENETICS, V122, P19; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Ter Linde JJM, 2002, YEAST, V19, P825, DOI 10.1002/yea.879; Theesfeld CL, 2011, J BIOL CHEM, V286, P26298, DOI 10.1074/jbc.M111.244798; Wilhovsky S, 2000, MOL BIOL CELL, V11, P1697, DOI 10.1091/mbc.11.5.1697	36	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8519	8530		10.1074/jbc.M112.404517	http://dx.doi.org/10.1074/jbc.M112.404517			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23306196	Green Published, hybrid			2022-12-25	WOS:000316564500048
J	Bae, JS; Koo, NY; Namkoong, E; Davies, AJ; Choi, SK; Shin, Y; Jin, M; Hwang, SM; Mikoshiba, K; Park, K				Bae, Jun-Seok; Koo, Na-Youn; Namkoong, Eun; Davies, Alexander J.; Choi, Seul-Ki; Shin, Yonghwan; Jin, Meihong; Hwang, Sung-Min; Mikoshiba, Katsuhiko; Park, Kyungpyo			Chaperone Stress 70 Protein (STCH) Binds and Regulates Two Acid/Base Transporters NBCe1-B and NHE1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGER ISOFORM 1; NA+/H+ EXCHANGER; SALIVARY-GLANDS; ATPASE DOMAIN; PH REGULATION; COTRANSPORTER; EXPRESSION; CANCER; CALCIUM; CELLS	Regulation of intracellular pH is critical for the maintenance of cell homeostasis in response to stress. We used yeast two-hybrid screening to identify novel interacting partners of the pH-regulating transporter NBCe1-B. We identified Hsp70-like stress 70 protein chaperone (STCH) as interacting with NBCe1-B at the N-terminal (amino acids 96-440) region. Co-injection of STCH and NBCe1-B cRNA into Xenopus oocytes significantly increased surface expression of NBCe1-B and enhanced bicarbonate conductance compared with NBCe1-B cRNA alone. STCH siRNA decreased the rate of Na+-dependent pH(i) recovery from NH4+ pulse-induced acidification in an HSG (human submandibular gland ductal) cell line. We observed that in addition to NBCe1-B, Na+/H+ exchanger (NHE)-dependent pHi recovery was also impaired by STCH siRNA and further confirmed the interaction of STCH with NHE1 but not plasma membrane Ca2+ ATPase. Both NBCe1-B and NHE1 interactions were dependent on a specific 45-amino acid region of STCH. In conclusion, we identify a novel role of STCH in the regulation of pHi through site-specific interactions with NBCe1-B and NHE1 and subsequent modulation of membrane transporter expression. We propose STCH may play a role in pHi regulation at times of cellular stress by enhancing the recovery from intracellular acidification.	[Bae, Jun-Seok; Koo, Na-Youn; Namkoong, Eun; Davies, Alexander J.; Choi, Seul-Ki; Shin, Yonghwan; Jin, Meihong; Hwang, Sung-Min; Park, Kyungpyo] Seoul Natl Univ, Sch Dent, Dept Physiol, Seoul 110749, South Korea; [Bae, Jun-Seok; Koo, Na-Youn; Namkoong, Eun; Davies, Alexander J.; Choi, Seul-Ki; Shin, Yonghwan; Jin, Meihong; Hwang, Sung-Min; Park, Kyungpyo] Dent Res Inst, Seoul 110749, South Korea; [Mikoshiba, Katsuhiko] RIKEN Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan	Seoul National University (SNU); RIKEN	Park, K (corresponding author), Seoul Natl Univ, Sch Dent, Dept Oral Physiol, Yeongeon Dong 28, Seoul 110749, South Korea.	kppark@snu.ac.kr	Mikoshiba, Katsuhiko/N-7943-2015	Davies, Alexander/0000-0003-0072-1708	National Research Foundation of Korea through the Oromaxillofacial Dysfunction Research Center for the Elderly at Seoul National University in Korea [2011-0028231]	National Research Foundation of Korea through the Oromaxillofacial Dysfunction Research Center for the Elderly at Seoul National University in Korea(National Research Foundation of Korea)	This work was supported by a National Research Foundation of Korea grant through the Oromaxillofacial Dysfunction Research Center for the Elderly (2011-0028231) at Seoul National University in Korea.	Aoki M, 2005, BIOCHEM BIOPH RES CO, V335, P566, DOI 10.1016/j.bbrc.2005.07.110; Boedtkjer E, 2012, CURR PHARM DESIGN, V18, P1345, DOI 10.2174/138161212799504830; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Choi SY, 2006, J DENT RES, V85, P839, DOI 10.1177/154405910608500912; Corsi AK, 1997, J CELL BIOL, V137, P1483, DOI 10.1083/jcb.137.7.1483; DYCK JRB, 1995, CARDIOVASC RES, V29, P203, DOI 10.1016/S0008-6363(96)88571-3; Groet J, 1998, GENOME RES, V8, P385, DOI 10.1101/gr.8.4.385; Han Pu, 2011, Zhonghua Yi Xue Za Zhi, V91, P2314; He PJ, 2008, J BIOL CHEM, V283, P33544, DOI 10.1074/jbc.M805534200; Heimel JA, 2008, GENES BRAIN BEHAV, V7, P915, DOI 10.1111/j.1601-183X.2008.00431.x; HOHFELD J, 1995, CELL, V83, P589; Homann V, 2006, HISTOCHEM CELL BIOL, V125, P583, DOI 10.1007/s00418-005-0100-2; Hwang SM, 2011, J BIOL CHEM, V286, P1719, DOI 10.1074/jbc.M109.090951; Iurov I Iu, 2010, Genetika, V46, P1348; Kaye FJ, 2000, FEBS LETT, V467, P348, DOI 10.1016/S0014-5793(00)01135-2; Kemp G, 2008, CHANNELS, V2, P329, DOI 10.4161/chan.2.5.6898; Kim YB, 2003, BIOCHEM BIOPH RES CO, V304, P593, DOI 10.1016/S0006-291X(03)00632-6; Lee MG, 2012, PHYSIOL REV, V92, P39, DOI 10.1152/physrev.00011.2011; Lee SK, 2012, AM J PHYSIOL-CELL PH, V302, pC518, DOI 10.1152/ajpcell.00352.2011; Li J, 2006, AM J PHYSIOL-GASTR L, V291, pG1031, DOI 10.1152/ajpgi.00483.2005; Loo SY, 2012, CURR PHARM DESIGN, V18, P1372; Matsushita M, 2011, AM J PHYSIOL-CELL PH, V301, pC280, DOI 10.1152/ajpcell.00404.2010; McClellan AJ, 1998, MOL BIOL CELL, V9, P3533, DOI 10.1091/mbc.9.12.3533; Neri D, 2011, NAT REV DRUG DISCOV, V10, P767, DOI 10.1038/nrd3554; OTTERSON GA, 1994, EMBO J, V13, P1216, DOI 10.1002/j.1460-2075.1994.tb06371.x; Otterson GA, 1997, GENE, V199, P287, DOI 10.1016/S0378-1119(97)00383-1; Park K, 2002, ARCH ORAL BIOL, V47, P1, DOI 10.1016/S0003-9969(01)00098-X; Putney LK, 2003, J BIOL CHEM, V278, P44645, DOI 10.1074/jbc.M308099200; RAO GN, 1993, AM J PHYSIOL, V264, pC1278, DOI 10.1152/ajpcell.1993.264.5.C1278; Reshkin SJ, 2000, FASEB J, V14, P2185, DOI 10.1096/fj.00-0029com; Roussa E, 2001, HISTOCHEM J, V33, P337, DOI 10.1023/A:1012471023913; Shirakabe K, 2006, P NATL ACAD SCI USA, V103, P9542, DOI 10.1073/pnas.0602250103; SILVA NLCL, 1995, BIOCHEMISTRY-US, V34, P10412, DOI 10.1021/bi00033a013; TOMBAUGH GC, 1993, J NEUROCHEM, V61, P793, DOI 10.1111/j.1471-4159.1993.tb03589.x; Wanamaker CP, 2007, J BIOL CHEM, V282, P31113, DOI 10.1074/jbc.M705369200; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; Worsham MJ, 2012, J ONCOL, V2012, DOI 10.1155/2012/752860; Xue J, 2007, AM J PHYSIOL-REG I, V292, pR2406, DOI 10.1152/ajpregu.00859.2006; Yamagata N, 2008, BIOCHEM BIOPH RES CO, V376, P499, DOI 10.1016/j.bbrc.2008.09.013; Yang DK, 2011, J CLIN INVEST, V121, P956, DOI 10.1172/JCI43475; Yao H, 2004, CELL CALCIUM, V36, P247, DOI 10.1016/j.ceca.2004.02.013	41	20	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6295	6305		10.1074/jbc.M112.392001	http://dx.doi.org/10.1074/jbc.M112.392001			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23303189	Green Published, hybrid			2022-12-25	WOS:000315820700024
J	Chapman, ALP; Mocatta, TJ; Shiva, S; Seidel, A; Chen, B; Khalilova, I; Paumann-Page, ME; Jameson, GNL; Winterbourn, CC; Kettle, AJ				Chapman, Anna L. P.; Mocatta, Tessa J.; Shiva, Sruti; Seidel, Antonia; Chen, Brian; Khalilova, Irada; Paumann-Page, Martina E.; Jameson, Guy N. L.; Winterbourn, Christine C.; Kettle, Anthony J.			Ceruloplasmin Is an Endogenous Inhibitor of Myeloperoxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; LOW-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-A-I; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; CATALYZED OXIDATION; COMPOUND-I; PROTEIN; KINETICS; ASSOCIATION	Myeloperoxidase is a neutrophil enzyme that promotes oxidative stress in numerous inflammatory pathologies. It uses hydrogen peroxide to catalyze the production of strong oxidants including chlorine bleach and free radicals. A physiological defense against the inappropriate action of this enzyme has yet to be identified. We found that myeloperoxidase oxidized 75% of the ascorbate in plasma from ceruloplasmin knock-out mice, but there was no significant loss in plasma from wild type animals. When myeloperoxidase was added to human plasma it became bound to other proteins and was reversibly inhibited. Ceruloplasmin was the predominant protein associated with myeloperoxidase. When the purified proteins were mixed, they became strongly but reversibly associated. Ceruloplasmin was a potent inhibitor of purified myeloperoxidase, inhibiting production of hypochlorous acid by 50% at 25 nM. Ceruloplasmin rapidly reduced Compound I, the FeV redox intermediate of myeloperoxidase, to Compound II, which has Fe-IV in its heme prosthetic groups. It also prevented the fast reduction of Compound II by tyrosine. In the presence of chloride and hydrogen peroxide, ceruloplasmin converted myeloperoxidase to Compound II and slowed its conversion back to the ferric enzyme. Collectively, our results indicate that ceruloplasmin inhibits myeloperoxidase by reducing Compound I and then trapping the enzyme as inactive Compound II. We propose that ceruloplasmin should provide a protective shield against inadvertent oxidant production by myeloperoxidase during inflammation.	[Chapman, Anna L. P.; Mocatta, Tessa J.; Chen, Brian; Khalilova, Irada; Paumann-Page, Martina E.; Winterbourn, Christine C.; Kettle, Anthony J.] Univ Otago, Ctr Free Rad Res, Dept Pathol, Christchurch 8140, New Zealand; [Seidel, Antonia; Jameson, Guy N. L.] Univ Otago, Dept Chem, Dunedin, New Zealand; [Shiva, Sruti] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA 15261 USA	University of Otago; University of Otago; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kettle, AJ (corresponding author), Univ Otago, Ctr Free Rad Res, POB 4345, Christchurch 8140, New Zealand.	tony.kettle@otago.ac.nz	Jameson, Guy N. L./J-3258-2015; Khalilova, Irada/AGF-0824-2022; Khalilova, Irada/I-5103-2015	Jameson, Guy N. L./0000-0001-9416-699X; Khalilova, Irada/0000-0002-4238-3113; Kettle, Tony/0000-0002-8218-7766	Health Research Council of New Zealand; University of Otago	Health Research Council of New Zealand(Health Research Council of New Zealand); University of Otago	This work was supported by the Health Research Council of New Zealand.; Supported by a University of Otago doctoral scholarship.	Auchere F, 2001, EUR J BIOCHEM, V268, P2889, DOI 10.1046/j.1432-1327.2001.02175.x; Auchere F, 1999, BIOCHEM J, V343, P603, DOI 10.1042/0264-6021:3430603; Bakhautdin B, 2013, GUT, V62, P209, DOI 10.1136/gutjnl-2011-300694; Baldus S, 2003, CIRCULATION, V108, P1440, DOI 10.1161/01.CIR.0000090690.67322.51; Bielli P, 2002, CELL MOL LIFE SCI, V59, P1413, DOI 10.1007/s00018-002-8519-2; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; Buss IH, 2003, PEDIATR RES, V53, P455, DOI 10.1203/01.PDR.0000050655.25689.CE; Carr AC, 2000, FEBS LETT, V487, P176, DOI 10.1016/S0014-5793(00)02227-4; CHESNEY JA, 1991, ANAL BIOCHEM, V196, P262, DOI 10.1016/0003-2697(91)90463-4; Da Costa LA, 2013, J NUTR BIOCHEM, V24, P396, DOI 10.1016/j.jnutbio.2012.08.012; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; Dunford HB, 1999, BIOCHEM CELL BIOL, V77, P449, DOI 10.1139/bcb-77-5-449; Dypbukt JM, 2005, FREE RADICAL BIO MED, V39, P1468, DOI 10.1016/j.freeradbiomed.2005.07.008; EHRENWALD E, 1994, J CLIN INVEST, V93, P1493, DOI 10.1172/JCI117127; Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017; Griffin SV, 1999, KIDNEY INT, V55, P917, DOI 10.1046/j.1523-1755.1999.055003917.x; Gruys E, 2005, J Zhejiang Univ Sci B, V6, P1045, DOI 10.1631/jzus.2005.B1045; GUTTERIDGE JMC, 1980, MED LAB SCI, V37, P267; HARRIS ZL, 1995, P NATL ACAD SCI USA, V92, P2539, DOI 10.1073/pnas.92.7.2539; HARRISON JE, 1980, BIOCHEM BIOPH RES CO, V94, P34, DOI 10.1016/S0006-291X(80)80183-5; Heinecke JW, 2002, TOXICOLOGY, V177, P11, DOI 10.1016/S0300-483X(02)00192-0; Jantschko W, 2005, BIOCHEM PHARMACOL, V69, P1149, DOI 10.1016/j.bcp.2005.02.006; Jennette JC, 2011, CURR OPIN NEPHROL HY, V20, P263, DOI 10.1097/MNH.0b013e3283456731; Kettle AJ, 1997, BIOCHEM J, V321, P503, DOI 10.1042/bj3210503; KETTLE AJ, 1991, BIOCHEM PHARMACOL, V41, P1485, DOI 10.1016/0006-2952(91)90565-M; KETTLE AJ, 1989, BIOCHEM J, V263, P823, DOI 10.1042/bj2630823; Kettle AJ, 1997, REDOX REP, V3, P3, DOI 10.1080/13510002.1997.11747085; KETTLE AJ, 1994, METHOD ENZYMOL, V233, P502; Kim IG, 1998, FEBS LETT, V431, P473, DOI 10.1016/S0014-5793(98)00817-5; Klebanoff S. J., 2013, J LEUKOC BI IN PRESS; MANTTARI M, 1994, EUR HEART J, V15, P1599; MARQUEZ LA, 1993, ARCH BIOCHEM BIOPHYS, V305, P414, DOI 10.1006/abbi.1993.1440; MARQUEZ LA, 1994, BIOCHEMISTRY-US, V33, P1447, DOI 10.1021/bi00172a022; Marquez LA, 1995, J BIOL CHEM, V270, P30434, DOI 10.1074/jbc.270.51.30434; Meotti FC, 2011, J BIOL CHEM, V286, P12901, DOI 10.1074/jbc.M110.172460; Meotti FC, 2008, FREE RADICAL BIO MED, V44, P109, DOI 10.1016/j.freeradbiomed.2007.09.017; Mocatta TJ, 2007, J AM COLL CARDIOL, V49, P1993, DOI 10.1016/j.jacc.2007.02.040; Naito Y, 2007, J GASTROENTEROL, V42, P787, DOI 10.1007/s00535-007-2096-y; Nicholls SJ, 2009, J LIPID RES, V50, pS346, DOI 10.1194/jlr.R800086-JLR200; Northrop DB, 1998, J CHEM EDUC, V75, P1153, DOI 10.1021/ed075p1153; Ochs RS, 2000, J CHEM EDUC, V77, P1453, DOI 10.1021/ed077p1453; Park YS, 2000, FREE RADICAL RES, V33, P261, DOI 10.1080/10715760000301421; Prutz WA, 2000, ARCH BIOCHEM BIOPHYS, V380, P181, DOI 10.1006/abbi.2000.1914; Pullar JM, 2000, IUBMB LIFE, V50, P259, DOI 10.1080/15216540051080958; SCHRAUFSTATTER IU, 1990, J CLIN INVEST, V85, P554, DOI 10.1172/JCI114472; Segelmark M, 1997, CLIN EXP IMMUNOL, V108, P167, DOI 10.1046/j.1365-2249.1997.d01-992.x; Shao BH, 2012, J BIOL CHEM, V287, P6375, DOI 10.1074/jbc.M111.337345; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Shiva S, 2006, NAT CHEM BIOL, V2, P486, DOI 10.1038/nchembio813; Sokolov AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P409, DOI 10.1134/S0006297907040074; Sokolov AV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1225, DOI 10.1134/S0006297909110078; Sokolov AV, 2010, CHEM PHYS LIPIDS, V163, P347, DOI 10.1016/j.chemphyslip.2010.02.002; Sokolov AV, 2008, FREE RADICAL RES, V42, P989, DOI 10.1080/10715760802566574; Stamp LK, 2012, RHEUMATOLOGY, V51, P1796, DOI 10.1093/rheumatology/kes193; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Tang WHW, 2012, ARTERIOSCL THROM VAS, V32, P516, DOI 10.1161/ATVBAHA.111.237040; TAYLOR JC, 1982, AM REV RESPIR DIS, V126, P476; Thomson E, 2010, FREE RADICAL BIO MED, V49, P1354, DOI 10.1016/j.freeradbiomed.2010.07.010; Tiden AK, 2011, J BIOL CHEM, V286, P37578, DOI 10.1074/jbc.M111.266981; Tien M, 1999, ARCH BIOCHEM BIOPHYS, V367, P61, DOI 10.1006/abbi.1999.1226; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; Vasilyev VB, 2010, BIOCHEM SOC T, V38, P947, DOI 10.1042/BST0380947; Vile GF, 2000, ARCH BIOCHEM BIOPHYS, V377, P122, DOI 10.1006/abbi.2000.1706; Vissers MCM, 2001, J BIOL CHEM, V276, P46835, DOI 10.1074/jbc.M107664200; WALKER FJ, 1990, J BIOL CHEM, V265, P1834; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; Winterbourn CC, 2000, CRIT CARE MED, V28, P143, DOI 10.1097/00003246-200001000-00024; Winterbourn CC, 2003, BIOCHEM BIOPH RES CO, V305, P729, DOI 10.1016/S0006-291X(03)00810-6; WINTERBOURN CC, 1985, BIOCHIM BIOPHYS ACTA, V840, P204, DOI 10.1016/0304-4165(85)90120-5; Winterbourn CC, 2013, ANTIOXID REDOX SIGN, V18, P642, DOI 10.1089/ars.2012.4827; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Ximenes VF, 2010, BIOCHEM J, V425, P285, DOI 10.1042/BJ20090776; Zhang ZL, 2001, JAMA-J AM MED ASSOC, V286, P2136, DOI 10.1001/jama.286.17.2136; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	74	86	88	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6465	6477		10.1074/jbc.M112.418970	http://dx.doi.org/10.1074/jbc.M112.418970			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23306200	Green Published, hybrid			2022-12-25	WOS:000315820700040
J	Connolly, DJ; O'Neill, LAJ; McGettrick, AF				Connolly, Dympna J.; O'Neill, Luke A. J.; McGettrick, Anne F.			The GOLD Domain-containing Protein TMED1 Is Involved in Interleukin-33 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR ACCESSORY PROTEIN; SUBCELLULAR-LOCALIZATION; P24 PROTEINS; SOLUBLE ST2; IL-33; PATHWAY; FAMILY; INFLAMMATION; TRANSPORT; CLONING	The proinflammatory danger signal IL-33, which is released from damaged or dying cells, achieves its effects via the IL-1R family member ST2L. The detection of IL-33 by ST2L initiates downstream signaling pathways that result in the activation of MAPKs and NF-kappa B. Here, we show that TMED1 associates with ST2L. Using a series of mutation and deletion constructs, we demonstrate that this interaction is mediated by the GOLD domain of TMED1 and the TIR domain of ST2L. Our findings also demonstrate that TMED1 is required for optimal IL-33-induced IL-8 and IL-6 production. This discovery provides additional support to the concept that the TMED family members are important players in innate immune signaling.	[Connolly, Dympna J.; O'Neill, Luke A. J.; McGettrick, Anne F.] Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland	Trinity College Dublin	Connolly, DJ (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Pearse St, Dublin 2, Ireland.	connoldj@tcd.ie		O'Neill, Luke/0000-0002-4333-2748	Science Foundation Ireland	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Science Foundation Ireland.	Anantharaman V, 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002-3-5-RESEARCH0023; Boltz KA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-212; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Bulek K, 2009, J IMMUNOL, V182, P2601, DOI 10.4049/jimmunol.0802729; Carney GE, 2004, BIOL CELL, V96, P271, DOI 10.1016/j.biolcel.2004.01.004; Chackerian AA, 2007, J IMMUNOL, V179, P2551, DOI 10.4049/jimmunol.179.4.2551; Doyle SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1706; Emery G, 2000, J CELL SCI, V113, P2507; Funakoshi-Tago M, 2008, CELL SIGNAL, V20, P1679, DOI 10.1016/j.cellsig.2008.05.013; Gayle MA, 1996, J BIOL CHEM, V271, P5784, DOI 10.1074/jbc.271.10.5784; Hayakawa H, 2007, J BIOL CHEM, V282, P26369, DOI 10.1074/jbc.M704916200; Jenne N, 2002, J BIOL CHEM, V277, P46504, DOI 10.1074/jbc.M206989200; Jun Y, 2011, BMB REP, V44, P369, DOI 10.5483/BMBRep.2011.44.6.369; Li HJ, 2000, GENOMICS, V67, P284, DOI 10.1006/geno.2000.6269; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Mirchandani AS, 2012, TRENDS IMMUNOL, V33, P389, DOI 10.1016/j.it.2012.04.005; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Oboki Keisuke, 2010, Allergology International, V59, P143, DOI 10.2332/allergolint.10-RAI-0186; Palmer G, 2008, CYTOKINE, V42, P358, DOI 10.1016/j.cyto.2008.03.008; Palsson-McDermott EM, 2009, NAT IMMUNOL, V10, P579, DOI 10.1038/ni.1727; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Strating JRPM, 2009, BIOL CELL, V101, P495, DOI 10.1042/BC20080233; Tago K, 2001, BIOCHEM BIOPH RES CO, V285, P1377, DOI 10.1006/bbrc.2001.5306; Talabot-Ayer D, 2009, J BIOL CHEM, V284, P19420, DOI 10.1074/jbc.M901744200; Zhao J, 2012, NAT IMMUNOL, V13, P651, DOI 10.1038/ni.2341	28	26	26	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5616	5623		10.1074/jbc.M112.403899	http://dx.doi.org/10.1074/jbc.M112.403899			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23319592	Green Published, hybrid			2022-12-25	WOS:000315342500035
J	Mesquita, FS; Holden, DW; Rolhion, N				Mesquita, Francisco S.; Holden, David W.; Rolhion, Nathalie			Lack of Effect of the Salmonella Deubiquitinase SseL on the NF-kappa B Pathway	PLOS ONE			English	Article							AVRA; TYPHIMURIUM; INNATE; REPLICATION; IMMUNE; MAPK	Intracellular replication of Salmonella enterica requires effector proteins translocated across the Salmonella-containing vacuolar membrane by Salmonella pathogenicity island-2 (SPI-2) encoded type III secretion system (T3SS). The SPI-2 T3SS effector SseL is a deubiquitinase that contributes to virulence in mice. Previous work has produced conflicting evidence as to the involvement of SseL in interference with the NF-kappa B pathway. To attempt to clarify these discrepancies, we compared mRNA levels in mouse primary bone marrow-derived macrophages infected with wild-type or sseL mutant strains using a genome-wide microarray. There was no detectable effect of loss of SseL on mRNA levels corresponding to any known NF-kappa B-regulated gene. In addition, there was no effect of SseL on (i) the activation or levels of both the canonical inhibitor of the NF-kappa B pathway (I kappa B alpha and phospho-I kappa B alpha), and the non-canonical NF-kappa B precursor p100/p52, (ii) the translocation of the NF-kappa B transcription factor p65 to the nucleus of infected macrophages and (iii) pro-inflammatory cytokines secretion. Furthermore, ectopic expression of SseL did not affect NF-kappa B activation in reporter cell lines. These results fail to support a role for SseL in the down-regulation of the host immune response and in particular the NF-kappa B pathway.	[Mesquita, Francisco S.; Holden, David W.; Rolhion, Nathalie] Univ London Imperial Coll Sci Technol & Med, Microbiol Sect, MRC Ctr Mol Bacteriol & Infect, London, England	Imperial College London	Rolhion, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Microbiol Sect, MRC Ctr Mol Bacteriol & Infect, London, England.	n.rolhion@imperial.ac.uk	Mesquita, Francisco/AAF-7557-2019; Mesquita, Francisco/K-5869-2013	Mesquita, Francisco/0000-0002-3777-825X; Mesquita, Francisco/0000-0002-3777-825X; ROLHION, nathalie/0000-0002-2946-4808	European Union Marie Curie Actions [MEST-CT-2005-020311]; Medical Research Council [G0800148]; European Molecular Biology Organization [ALTF 1177-2007]; Wellcome Trust (UK) [092686/Z/10/Z]; MRC [MR/J006874/1, G0800148] Funding Source: UKRI	European Union Marie Curie Actions(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Wellcome Trust (UK)(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the European Union Marie Curie Actions (MEST-CT-2005-020311) (http://www.eimid.org/), the Medical Research Council (G0800148) (http://www.mrc.ac.uk/), the European Molecular Biology Organization (ALTF 1177-2007) and the Wellcome Trust (UK) (092686/Z/10/Z) (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arena ET, 2011, INFECT IMMUN, V79, P4392, DOI 10.1128/IAI.05478-11; Auweter SD, 2012, MICROBES INFECT, V14, P148, DOI 10.1016/j.micinf.2011.09.003; Auweter SD, 2011, J BIOL CHEM, V286, P24023, DOI 10.1074/jbc.M111.224600; Basak S, 2008, CYTOKINE GROWTH F R, V19, P187, DOI 10.1016/j.cytogfr.2008.04.005; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Bruno VM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000538; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; Collier-Hyams LS, 2002, J IMMUNOL, V169, P2846, DOI 10.4049/jimmunol.169.6.2846; Coombes BK, 2007, INFECT IMMUN, V75, P574, DOI 10.1128/IAI.00985-06; Denecker G, 2001, J BIOL CHEM, V276, P19706, DOI 10.1074/jbc.M101573200; Du FY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000595; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Gotoh Y, 2004, BIOCHEM BIOPH RES CO, V314, P688, DOI 10.1016/j.bbrc.2003.12.148; Hansen-Wester I, 2001, MICROBES INFECT, V3, P549, DOI 10.1016/S1286-4579(01)01411-3; Haraga A, 2006, CELL MICROBIOL, V8, P837, DOI 10.1111/j.1462-5822.2005.00670.x; Helaine S, 2010, P NATL ACAD SCI USA, V107, P3746, DOI 10.1073/pnas.1000041107; Jones RM, 2008, CELL HOST MICROBE, V3, P233, DOI 10.1016/j.chom.2008.02.016; Kanarek N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000166; Kato T, 2008, GENES CELLS, V13, P509, DOI 10.1111/j.1365-2443.2008.01182.x; Le Negrate G, 2008, J IMMUNOL, V180, P5045, DOI 10.4049/jimmunol.180.7.5045; Le Negrate G, 2012, CELL MICROBIOL, V14, P155, DOI 10.1111/j.1462-5822.2011.01719.x; Mesquita FS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002743; Mukherjee S, 2008, METHOD ENZYMOL, V438, P343, DOI 10.1016/S0076-6879(07)38024-5; Newton HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000898; Niemann GS, 2011, INFECT IMMUN, V79, P33, DOI 10.1128/IAI.00771-10; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; RACOOSIN EL, 1989, J EXP MED, V170, P1635, DOI 10.1084/jem.170.5.1635; Rahman MM, 2011, NAT REV MICROBIOL, V9, P291, DOI 10.1038/nrmicro2539; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Ruland J, 2011, NAT IMMUNOL, V12, P709, DOI 10.1038/ni.2055; Rytkonen A, 2007, P NATL ACAD SCI USA, V104, P3502, DOI 10.1073/pnas.0610095104; Schesser K, 2000, MICROB PATHOGENESIS, V28, P59, DOI 10.1006/mpat.1999.0324; Sun SC, 2008, TRENDS IMMUNOL, V29, P469, DOI 10.1016/j.it.2008.07.003; Sweet CR, 2007, CELL MICROBIOL, V9, P2700, DOI 10.1111/j.1462-5822.2007.00990.x; Ye ZD, 2007, AM J PATHOL, V171, P882, DOI 10.2353/ajpath.2007.070220	40	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53064	10.1371/journal.pone.0053064	http://dx.doi.org/10.1371/journal.pone.0053064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308136	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429800026
J	Ouedraogo, A; Tiono, AB; Diarra, A; Sanon, S; Yaro, JB; Ouedraogo, E; Bougouma, EC; Soulama, I; Gansane, A; Ouedraogo, A; Konate, AT; Nebie, I; Watson, NL; Sanza, M; Dube, TJT; Sirima, SB				Ouedraogo, Alphonse; Tiono, Alfred B.; Diarra, Amidou; Sanon, Souleymane; Yaro, Jean Baptiste; Ouedraogo, Esperance; Bougouma, Edith C.; Soulama, Issiaka; Gansane, Adama; Ouedraogo, Amathe; Konate, Amadou T.; Nebie, Issa; Watson, Nora L.; Sanza, Megan; Dube, Tina J. T.; Sirima, Sodiomon Bienvenu			Malaria Morbidity in High and Seasonal Malaria Transmission Area of Burkina Faso	PLOS ONE			English	Article							CLINICAL MALARIA; CASE DEFINITIONS; WEST-AFRICA; CHILDREN; EFFICACY; VACCINES	Background: Malariometric parameters are often primary endpoints of efficacy trials of malaria vaccine candidates. This study aims to describe the epidemiology of malaria prior to the conduct of a series of drug and vaccine trials in a rural area of Burkina Faso. Methods: Malaria incidence was prospectively evaluated over one year follow-up among two cohorts of children aged 0-5 years living in the Sapone health district. The parents of 1089 children comprising a passive case detection cohort were encouraged to seek care from the local health clinic at any time their child felt sick. Among this cohort, 555 children were randomly selected for inclusion in an active surveillance sub-cohort evaluated for clinical malaria during twice weekly home visits. Malaria prevalence was evaluated by cross-sectional survey during the low and high transmission seasons. Results: Number of episodes per child ranged from 0 to 6 per year. Cumulative incidence was 67.4% in the passive and 86.2% in the active cohort and was highest among children 0-1 years. Clinical malaria prevalence was 9.8% in the low and 13.0% in the high season (p>0.05). Median days to first malaria episode ranged from 187 (95% CI 180-193) among children 0-1 years to 228 (95% CI 212, 242) among children 4-5 years. The alternative parasite thresholds for the malaria case definition that achieved optimal sensitivity and specificity (70-80%) were 3150 parasites/mu l in the high and 1350 parasites/mu l in the low season. Conclusion: Clinical malaria burden was highest among the youngest age group children, who may represent the most appropriate target population for malaria vaccine candidate development. The pyrogenic threshold of parasitaemia varied markedly by season, suggesting a value for alternative parasitaemia levels in the malaria case defintion. Regional epidemiology of malaria described, Sapone area field centers are positioned for future conduct of malaria vaccine trials.	[Ouedraogo, Alphonse; Tiono, Alfred B.; Diarra, Amidou; Sanon, Souleymane; Yaro, Jean Baptiste; Ouedraogo, Esperance; Bougouma, Edith C.; Soulama, Issiaka; Gansane, Adama; Ouedraogo, Amathe; Konate, Amadou T.; Nebie, Issa; Sirima, Sodiomon Bienvenu] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; [Watson, Nora L.; Sanza, Megan; Dube, Tina J. T.] EMMES Corp, Rockville, MD USA; [Sirima, Sodiomon Bienvenu] Grp Act & Rech Sante, Ouagadougou, Burkina Faso	Emmes Corporation	Sirima, SB (corresponding author), Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso.	s.sirima.cnlp@fasonet.bf	OUEDRAOGO, Alphonse/F-7859-2019; SOULAMA, Issiaka/Z-1254-2019	SOULAMA, Issiaka/0000-0002-0993-0525; Tiono, B. Alfred/0000-0002-5104-3946; SIRIMA, Sodiomon Bienvenu/0000-0002-0972-4211; Ouedraogo, Alphonse/0000-0002-3520-6637; Nebie, Issa/0000-0003-3051-3600	NIAID/DMID [HHSN266200416C]	NIAID/DMID	Sources of funding NIAID/DMID (subcontract No HHSN266200416C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUDON D, 1985, T ROY SOC TROP MED H, V79, P283, DOI 10.1016/0035-9203(85)90361-X; Breman JG, 2007, AM J TROP MED HYG, V77, P36; Dicko A, 2005, TROP MED INT HEALTH, V10, P550, DOI 10.1111/j.1365-3156.2005.01418.x; Dicko A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023390; Greenwood B, 2005, ACTA TROP, V95, P298, DOI 10.1016/j.actatropica.2005.04.017; Indepth N, 2006, SIT D; Konate AT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023391; Ministere de la sante DGISS, 2009, ANN STAT 2009 ANN ST, P178; Moorthy VS, 2009, VACCINE, V27, P624, DOI 10.1016/j.vaccine.2008.11.034; Nebie I, 2008, INFECT IMMUN, V76, P759, DOI 10.1128/IAI.01147-07; Olotu A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015569; Ouedraogo A, 2010, TROP MED INT HEALTH, V15, P1315, DOI 10.1111/j.1365-3156.2010.02618.x; Owusu-Agyei S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-220; Rogers WO, 2006, J INFECT DIS, V193, P467, DOI 10.1086/499314; Sabatinelli G, 1986, Parassitologia, V28, P17; SANTE MDL, 2008, ANN STAT 2008; Saute F, 2003, T ROY SOC TROP MED H, V97, P655, DOI 10.1016/S0035-9203(03)80097-4; Schellenberg DM, 2003, T ROY SOC TROP MED H, V97, P647, DOI 10.1016/S0035-9203(03)80096-2; SCHELLENBERG JRMA, 1994, T ROY SOC TROP MED H, V88, P429, DOI 10.1016/0035-9203(94)90416-2; SMITH T, 1994, STAT MED, V13, P2345, DOI 10.1002/sim.4780132206; WHO, 2009, WHO MAL REP MALARIA; YE Y, 2009, GLOB HLTH ACTION, V2; [No title captured]	23	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e50036	10.1371/journal.pone.0050036	http://dx.doi.org/10.1371/journal.pone.0050036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320064	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429800003
J	Turner, C; Turner, P; Carrara, V; Burgoine, K; Htoo, STL; Watthanaworawit, W; Day, NP; White, NJ; Goldblatt, D; Nosten, F				Turner, Claudia; Turner, Paul; Carrara, Verena; Burgoine, Kathy; Htoo, Saw Tha Ler; Watthanaworawit, Wanitda; Day, Nicholas P.; White, Nicholas J.; Goldblatt, David; Nosten, Francois			High Rates of Pneumonia in Children under Two Years of Age in a South East Asian Refugee Population	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; ETIOLOGY; EPIDEMIOLOGY; INFANTS	Background: There are an estimated 150 million episodes of childhood pneumonia per year, with 11-20 million hospital admissions and 1.575 million deaths. Refugee children are particularly vulnerable, with poorly defined pneumonia epidemiology. Methods: We followed a birth cohort of 955 refugee infants, born over a one-year period, until two years of age. Clinical and radiographic pneumonia were diagnosed according to WHO criteria. Detailed characteristics were collected to determine risk factors for clinical, radiological and multiple episodes of pneumonia. Investigations were taken during a pneumonia episode to help determine or to infer an aetiological diagnosis. Findings: The incidence of clinical pneumonia was 0.73 (95% CI 0.70-0.75) episodes per child year (/CY) and of radiological primary endpoint pneumonia (PEP) was 0.22/CY (95% CI 0.20-0.24). The incidence of pneumonia without severe signs was 0.50/CY (95% CI 0.48-0.53), severe pneumonia 0.15/CY (95% CI 0.13-0.17) and very severe pneumonia 0.06/CY (0.05-0.07). Virus was detected, from a nasopharyngeal aspirate, in 61.3% of episodes. A reduced volume of living space per person (IRR 0.99, 95% CI 0.99-1.0, p = 0.003) and young maternal age (IRR 1.59, 95% CI 1.12-2.27, p = 0.01) were risk factors for developing pneumonia. The risk of a child having >1 episode of pneumonia was increased by having a shorter distance to the next house (IRR 0.86, 95% CI 0.74-1.00, p = 0.04). Infants were at risk of having an episode of PEP if there was a shorter distance from stove to bed (IRR 0.89, 95% CI 0.80-0.99, p = 0.03). Raised CRP and neutrophil values were associated with PEP. Conclusions: There was a high incidence of pneumonia in young children in this SE Asian refugee population. Viral infections were important, however CXR and non-specific marker findings suggested that bacteria may be involved in up to a third of cases.	[Turner, Claudia; Turner, Paul; Carrara, Verena; Burgoine, Kathy; Htoo, Saw Tha Ler; Watthanaworawit, Wanitda; Nosten, Francois] Shoklo Malaria Res Unit, Mae Sot, Thailand; [Turner, Claudia; Turner, Paul; Watthanaworawit, Wanitda; Day, Nicholas P.; White, Nicholas J.; Nosten, Francois] Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Turner, Claudia; Turner, Paul; Day, Nicholas P.; White, Nicholas J.; Nosten, Francois] Univ Oxford, Ctr Trop Med, Oxford, England; [Goldblatt, David] UCL, Inst Child Hlth, Immunobiol Unit, London, England	Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); University of Oxford; University of London; University College London	Turner, C (corresponding author), Shoklo Malaria Res Unit, Mae Sot, Thailand.	claudia@tropmedres.ac	Goldblatt, David/C-5972-2008; Carrara, Verena/R-6492-2019; White, Nick/AAC-6527-2019; Nosten, Francois/AAC-5509-2019	Goldblatt, David/0000-0002-0769-5242; Carrara, Verena/0000-0002-2758-0872; White, Nick/0000-0002-1897-1978; Nosten, Francois/0000-0002-7951-0745; Burgoine, Kathy/0000-0001-7975-745X; Turner, Paul/0000-0002-1013-7815	Wellcome Trust of Great Britain [077166/Z/05]; Wellcome Trust [083735]; National Institute for Health Research [NF-SI-0611-10066] Funding Source: researchfish	Wellcome Trust of Great Britain(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	CT and FN are supported by the Wellcome Trust of Great Britain (Grant No. 077166/Z/05). PT is also supported by the Wellcome Trust (Grant 083735). SMRU is part of the Mahidol-Oxford University Tropical Medicine Research Program and is supported by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEGBOLA RA, 1994, PEDIATR INFECT DIS J, V13, P975, DOI 10.1097/00006454-199411000-00008; Bellos Anna, 2010, Confl Health, V4, P3, DOI 10.1186/1752-1505-4-3; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Cashat-Cruz Miguel, 2005, Semin Pediatr Infect Dis, V16, P84, DOI 10.1053/j.spid.2005.12.005; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; CRUZ JR, 1990, REV INFECT DIS, V12, pS1029; Dherani M, 2008, B WORLD HEALTH ORGAN, V86, P390, DOI 10.2471/BLT.07.044529; Ferrero F, 2010, PEDIATR PULM, V45, P1009, DOI 10.1002/ppul.21287; HORTAL M, 1990, REV INFECT DIS, V12, pS966; Korppi M, 2004, PEDIATR INT, V46, P545, DOI 10.1111/j.1442-200x.2004.01947.x; Levine OS, 2012, CLIN INFECT DIS, V54, pS93, DOI 10.1093/cid/cir1052; Madhi SA, 2006, PEDIATR INFECT DIS J, V25, P30, DOI 10.1097/01.inf.0000195787.99199.4a; Madhi SA, 2004, NAT MED, V10, P811, DOI 10.1038/nm1077; Neil McIntosh PH, 2008, FORFAR ARNEILS TXB P; Nokes DJ, 2008, CLIN INFECT DIS, V46, P50, DOI 10.1086/524019; Rudan I, 2004, B WORLD HEALTH ORGAN, V82, P895; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Scott JAG, 2008, B WORLD HEALTH ORGAN, V86, P494, DOI 10.2471/BLT.08.052753; Thorn LKAM, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-180; Turner P, 2010, EMERG INFECT DIS, V16, P1366, DOI 10.3201/eid1609.100220; UNHCR, 2011, UNHCR 2011 GLOB TREN; Wardlaw T, 2006, LANCET, V368, P1048, DOI 10.1016/S0140-6736(06)69334-3; WHO, 2007, INT MAN CHILDH ILL; WHO, 2005, PCK BOOK HOSP CAR CH; WHO U, 2006, PNEUM FORG KILL CHIL; World Health Organization, 2001, WHOVB0135	28	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e54026	10.1371/journal.pone.0054026	http://dx.doi.org/10.1371/journal.pone.0054026			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320118	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429800085
J	Golec, DP; Dower, NA; Stone, JC; Baldwin, TA				Golec, Dominic P.; Dower, Nancy A.; Stone, James C.; Baldwin, Troy A.			RasGRP1, but Not RasGRP3, Is Required for Efficient Thymic beta-Selection and ERK Activation Downstream of CXCR4	PLOS ONE			English	Article							T-CELL DEVELOPMENT; ADAPTER PROTEIN SLP-76; GAMMA-DELTA; RAS ACTIVATION; THYMOCYTE DIFFERENTIATION; TCR SIGNALS; IN-VIVO; RECEPTOR; PROLIFERATION; MEMBRANE	T cell development is a highly dynamic process that is driven by interactions between developing thymocytes and the thymic microenvironment. Upon entering the thymus, the earliest thymic progenitors, called CD4(-) CD8(-) 'double negative' (DN) thymocytes, pass through a checkpoint termed "beta-selection" before maturing into CD4(+) CD8(+) 'double positive' (DP) thymocytes. beta-selection is an important developmental checkpoint during thymopoiesis where developing DN thymocytes that successfully express the pre-T cell receptor (TCR) undergo extensive proliferation and differentiation towards the DP stage. Signals transduced through the pre-TCR, chemokine receptor CXCR4 and Notch are thought to drive beta-selection. Additionally, it has long been known that ERK is activated during beta-selection; however the pathways regulating ERK activation remain unknown. Here, we performed a detailed analysis of the beta-selection events in mice lacking RasGRP1, RasGRP3 and RasGRP1 and 3. We report that RasGRP1 KO and RasGRP1/3 DKO deficient thymi show a partial developmental block at the early DN3 stage of development. Furthermore, DN3 thymocytes from RasGRP1 and RasGRP1/3 double knockout thymi show significantly reduced proliferation, despite expression of the TCR beta chain. As a result of impaired beta-selection, the pool of TCR beta(+) DN4 is significantly diminished, resulting in inefficient DN to DP development. Also, we report that RasGRP1 is required for ERK activation downstream of CXCR4 signaling, which we hypothesize represents a potential mechanism of RasGRP1 regulation of beta-selection. Our results demonstrate that RasGRP1 is an important regulator of proliferation and differentiation at the beta-selection checkpoint and functions downstream of CXCR4 to activate the Ras/MAPK pathway.	[Golec, Dominic P.; Baldwin, Troy A.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Stone, James C.] Univ Alberta, Dept Biochem, Edmonton, AB, Canada; [Dower, Nancy A.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Baldwin, TA (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.	tbaldwin@ualberta.ca		Golec, Dominic/0000-0002-2741-3302	Canadian Institutes of Health Research (CIHR) grant [MOP-86595]; National Sciences and Engineering Research Council of Canada CGS M; Alberta Innovates [201300120] Funding Source: researchfish	Canadian Institutes of Health Research (CIHR) grant(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Research Council of Canada CGS M; Alberta Innovates	This work was supported by Canadian Institutes of Health Research (CIHR) grant MOP-86595 (to TAB). TAB is an Alberta Innovates - Health Solutions Scholar and CIHR New Investigator. A National Sciences and Engineering Research Council of Canada CGS M scholarship award supports DPG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balagopalan L, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005512; Beaulieu N, 2007, MOL BIOL CELL, V18, P3156, DOI 10.1091/mbc.E06-10-0932; Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Chen Y, 2012, J IMMUNOL, V189, P61, DOI 10.4049/jimmunol.1103272; Cheng AM, 1997, P NATL ACAD SCI USA, V94, P9797, DOI 10.1073/pnas.94.18.9797; Ciofani M, 2010, NAT REV IMMUNOL, V10, P657, DOI 10.1038/nri2820; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; Coughlin JJ, 2005, J IMMUNOL, V175, P7179, DOI 10.4049/jimmunol.175.11.7179; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; Dose M, 2006, BLOOD, V108, P2669, DOI 10.1182/blood-2006-02-005900; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Dumont C, 2009, BLOOD, V113, P3990, DOI 10.1182/blood-2008-09-181180; Fuller DM, 2012, J IMMUNOL, V189, P4005, DOI 10.4049/jimmunol.1201380; Gomez M, 2000, NAT IMMUNOL, V1, P348, DOI 10.1038/79808; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Haks MC, 2005, IMMUNITY, V22, P595, DOI 10.1016/j.immuni.2005.04.003; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Holmes R., 2009, COLD SPRING HARB PRO; Innocenti M, 2002, J CELL BIOL, V156, P125, DOI 10.1083/jcb.200108035; Janas ML, 2011, J IMMUNOL, V187, P4667, DOI 10.4049/jimmunol.1101949; Janas ML, 2010, TRENDS IMMUNOL, V31, P370, DOI 10.1016/j.it.2010.07.002; Janas ML, 2010, J EXP MED, V207, P247, DOI 10.1084/jem.20091430; Johnson JE, 2007, BIOCHEM J, V406, P223, DOI 10.1042/BJ20070294; Kortum RL, 2012, MOL CELL BIOL, V32, P2748, DOI 10.1128/MCB.00317-12; Kortum RL, 2011, P NATL ACAD SCI USA, V108, P12407, DOI 10.1073/pnas.1104295108; Lee T, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000013; Limnander A, 2011, NAT IMMUNOL, V12, P425, DOI 10.1038/ni.2016; Michie AM, 1999, J EXP MED, V190, P1647, DOI 10.1084/jem.190.11.1647; Michie AM, 2002, SEMIN IMMUNOL, V14, P311, DOI 10.1016/S1044-5323(02)00064-7; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Priatel JJ, 2002, IMMUNITY, V17, P617, DOI 10.1016/S1074-7613(02)00451-X; Rincon M, 2001, ONCOGENE, V20, P2490, DOI 10.1038/sj.onc.1204382; Roose JP, 2007, MOL CELL BIOL, V27, P2732, DOI 10.1128/MCB.01882-06; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; Shen SD, 2011, J IMMUNOL, V187, P4467, DOI 10.4049/jimmunol.1003798; Sommers CL, 2005, J EXP MED, V201, P1125, DOI 10.1084/jem.20041869; Sugawara T, 1998, J IMMUNOL, V161, P2888; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Thompson PK, 2011, SEMIN IMMUNOL, V23, P350, DOI 10.1016/j.smim.2011.08.007; Trampont PC, 2010, NAT IMMUNOL, V11, P162, DOI 10.1038/ni.1830; Zahedi B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.189605; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zheng Y, 2005, BLOOD, V105, P3648, DOI 10.1182/blood-2004-10-3916; Zhu MH, 2012, J BIOL CHEM, V287, P8135, DOI 10.1074/jbc.M111.320580	48	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53300	10.1371/journal.pone.0053300	http://dx.doi.org/10.1371/journal.pone.0053300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308188	gold, Green Published, Green Submitted			2022-12-25	WOS:000313429100052
J	Hansen, BH; Holme, I; Anderssen, SA; Kolle, E				Hansen, Bjorge Herman; Holme, Ingar; Anderssen, Sigmund Alfred; Kolle, Elin			Patterns of Objectively Measured Physical Activity in Normal Weight, Overweight, and Obese Individuals (20-85 Years): A Cross-Sectional Study	PLOS ONE			English	Article							MIDDLE-AGED WOMEN; BODY-MASS INDEX; SELF-REPORT; UNITED-STATES; ADULTS; MEN; ACCELEROMETER; POPULATION; DIET; ASSOCIATIONS	Background: The magnitude of the association between physical activity (PA) and obesity has been difficult to establish using questionnaires. The aim of the study was to evaluate patterns of PA across BMI-defined weight categories and to examine the independent contribution of PA on weight status, using accelerometers. Methods: The study was a cross-sectional population-based study of 3,867 adults and older people aged 20-85 years, living in Norway. PA was assessed for seven consecutive days using the ActiGraph GT1M accelerometer. Anthropometrical data was self-reported and overweight and obesity was defined as having a body mass index (BMI) of 25-<30 and >= 30 kg/m(2), respectively. Results: Overweight and obese participants performed less overall PA and PA of at least moderate intensity and took fewer steps, compared to normal weight participants. Although overall PA did not differ between weekdays and weekends, an interaction between BMI category and type of day was present, indicating a larger difference in overall PA between BMI categories on weekends compared to weekdays. Obese participants displayed 19% and 25% lower overall physical activity compared to normal weight participants, on weekdays and weekends, respectively. Participants in the most active quintile of overall PA had a 53% lower risk (OR 0.47, 95% CI: 0.37 to 0.60) for having a BMI above or below 25 kg/m(2), and a 71% lower risk (OR: 0.29, 95% CI: 0.20 to 0.44) for having a BMI above or below 30 kg/m(2). Conclusions: Overweight and obese participants engaged in less overall PA and moderate and vigorous PA compared with normal weight individuals. The weight related differences in overall PA were most pronounced on the weekend and the risk of being overweight or obese decreases across quintiles of PA.	[Hansen, Bjorge Herman; Holme, Ingar; Anderssen, Sigmund Alfred; Kolle, Elin] Norwegian Sch Sport Sci, Dept Sports Med, Oslo, Norway	Norwegian School of Sport Sciences	Hansen, BH (corresponding author), Norwegian Sch Sport Sci, Dept Sports Med, Oslo, Norway.	bjorge.herman.hansen@nih.no			Norwegian Directorate of Health; Norwegian School of Sport Sciences	Norwegian Directorate of Health; Norwegian School of Sport Sciences	The study was funded by the Norwegian Directorate of Health and the Norwegian School of Sport Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderssen SA, 2008, SCAND J MED SCI SPOR, V18, P309, DOI 10.1111/j.1600-0838.2007.00645.x; Anderssen SA, 2004, NORDIC NUTR RECOMMEN; Ball K, 2001, INT J OBESITY, V25, P914, DOI 10.1038/sj.ijo.0801622; Bernstein MS, 2004, PREV MED, V38, P94, DOI 10.1016/j.ypmed.2003.09.032; Cooper AR, 2000, EUR J CLIN NUTR, V54, P887, DOI 10.1038/sj.ejcn.1601116; Corder K, 2007, CURR OPIN CLIN NUTR, V10, P597, DOI 10.1097/MCO.0b013e328285d883; Corder K, 2010, AM J EPIDEMIOL, V171, P1065, DOI 10.1093/aje/kwq068; Davis JN, 2006, OBESITY, V14, P2259, DOI 10.1038/oby.2006.265; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Droyvold WB, 2004, INT J OBESITY, V28, P410, DOI 10.1038/sj.ijo.0802569; FORBES GB, 1993, NUTR REV, V51, P296, DOI 10.1111/j.1753-4887.1993.tb03058.x; Frankenfield DC, 2001, NUTRITION, V17, P26, DOI 10.1016/S0899-9007(00)00471-8; Haapanen N, 1997, INT J OBESITY, V21, P288, DOI 10.1038/sj.ijo.0800403; Hagstromer M, 2010, AM J EPIDEMIOL, V171, P1055, DOI 10.1093/aje/kwq069; Hansen BH, 2012, MED SCI SPORT EXER, V44, P266, DOI 10.1249/MSS.0b013e31822cb354; JACOBSEN BK, 1988, SCAND J SOC MED, V16, P101, DOI 10.1177/140349488801600207; James PT, 2004, CLIN DERMATOL, V22, P276, DOI 10.1016/j.clindermatol.2004.01.010; Katzmarzyk PT, 2009, J PHYS ACT HEALTH, V6, P269, DOI 10.1123/jpah.6.3.269; Lopes VP, 2009, J PHYS ACT HEALTH, V6, pS133, DOI 10.1123/jpah.6.s1.s133; Meyer HE, 2005, PROSTAG LEUKOTR ESS, V73, P3, DOI 10.1016/j.plefa.2005.04.003; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Norum KR, 2005, PREVENTITIVE NUTR CO; Nyholm M, 2007, OBESITY, V15, P197, DOI 10.1038/oby.2007.536; PRENTICE AM, 1995, BRIT MED J, V311, P437, DOI 10.1136/bmj.311.7002.437; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; Sogaard Anne Johanne, 2004, Int J Equity Health, V3, P3; SONNEHOLM S, 1989, J EPIDEMIOL COMMUN H, V43, P369, DOI 10.1136/jech.43.4.369; Strandhagen E, 2010, EUR J EPIDEMIOL, V25, P163, DOI 10.1007/s10654-010-9427-7; Strath Scott J, 2008, Prev Chronic Dis, V5, pA131; Thompson DL, 2004, MED SCI SPORT EXER, V36, P911, DOI 10.1249/01.MSS.0000126787.14165.B3; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tucker LA, 2003, OBES RES, V11, P1581, DOI 10.1038/oby.2003.210; Tudor-Locke C, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-60; Tudor-Locke C, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-39; Van Loon AJM, 2003, ANN EPIDEMIOL, V13, P105, DOI 10.1016/S1047-2797(02)00257-0; Wareham NJ, 1998, INT J OBESITY, V22, pS30; Weinsier RL, 1998, AM J MED, V105, P145, DOI 10.1016/S0002-9343(98)00190-9; Westerterp KR, 2009, EUR J APPL PHYSIOL, V105, P823, DOI 10.1007/s00421-009-1000-2; WHO, 2000, OB PREV MAN GLOB EP; Wyatt HR, 2005, MED SCI SPORT EXER, V37, P724, DOI 10.1249/01.MSS.0000161750.84096.D4; Yoshioka M, 2005, INT J OBESITY, V29, P502, DOI 10.1038/sj.ijo.0802891	43	39	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53044	10.1371/journal.pone.0053044	http://dx.doi.org/10.1371/journal.pone.0053044			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308135	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429100025
J	Knowlton, AE; Fowler, LJ; Patel, RK; Wallet, SM; Grieshaber, SS				Knowlton, Andrea E.; Fowler, Larry J.; Patel, Rahul K.; Wallet, Shannon M.; Grieshaber, Scott S.			Chlamydia Induces Anchorage Independence in 3T3 Cells and Detrimental Cytological Defects in an Infection Model	PLOS ONE			English	Article							INVASIVE CERVICAL-CANCER; TRACHOMATIS INFECTION; INTRAEPITHELIAL NEOPLASIA; CELL-TRANSFORMATION; RISK; MICE; VITRO; DNA; INSTABILITY; SEGREGATION	Chlamydia are Gram negative, obligate intracellular bacterial organisms with different species causing a multitude of infections in both humans and animals. Chlamydia trachomatis is the causative agent of the sexually transmitted infection (STI) Chlamydia, the most commonly acquired bacterial STI in the United States. Chlamydial infections have also been epidemiologically linked to cervical cancer in women co-infected with the human papillomavirus (HPV). We have previously shown chlamydial infection results in centrosome amplification and multipolar spindle formation leading to chromosomal instability. Many studies indicate that centrosome abnormalities, spindle defects, and chromosome segregation errors can lead to cell transformation. We hypothesize that the presence of these defects within infected dividing cells identifies a possible mechanism for Chlamydia as a cofactor in cervical cancer formation. Here we demonstrate that infection with Chlamydia trachomatis is able to transform 3T3 cells in soft agar resulting in anchorage independence and increased colony formation. Additionally, we show for the first time Chlamydia infects actively replicating cells in vivo. Infection of mice with Chlamydia results in significantly increased cell proliferation within the cervix, and in evidence of cervical dysplasia. Confocal examination of these infected tissues also revealed elements of chlamydial induced chromosome instability. These results contribute to a growing body of data implicating a role for Chlamydia in cervical cancer development and suggest a possible molecular mechanism for this effect.	[Knowlton, Andrea E.; Patel, Rahul K.; Grieshaber, Scott S.] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA; [Wallet, Shannon M.] Univ Florida, Coll Dent, Dept Periodontol Biol, Gainesville, FL USA; [Fowler, Larry J.] Univ Florida, Coll Med, Dept Pathol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Grieshaber, SS (corresponding author), Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA.	sgriesha@ufl.edu			National Institutes of Allergy and Infectious Disease, National Institutes of Health [R01 AI077583]; NIDCR, National Institutes of Health [5 T32 DE007200, T90 DE021990]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007200] Funding Source: NIH RePORTER	National Institutes of Allergy and Infectious Disease, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The research presented here was funded by the National Institutes of Allergy and Infectious Disease, National Institutes of Health R01 AI077583. AEK was supported by fellowships from the NIDCR, National Institutes of Health, 5 T32 DE007200 and T90 DE021990. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anttila T, 2001, JAMA-J AM MED ASSOC, V285, P47, DOI 10.1001/jama.285.1.47; Autier P, 1996, BRIT J CANCER, V74, P488, DOI 10.1038/bjc.1996.388; BEbEar C, 2009, CLIN MICROBIOL INFEC, V15, P4, DOI 10.1111/j.1469-0691.2008.02647.x; BERWALD Y, 1963, NATURE, V200, P1182, DOI 10.1038/2001182a0; Brake T, 2005, P NATL ACAD SCI USA, V102, P2490, DOI 10.1073/pnas.0409883102; Brown HM, 2012, CELL MICROBIOL, V14, P1554, DOI 10.1111/j.1462-5822.2012.01820.x; CAMPBELL S, 1989, J GEN MICROBIOL, V135, P2379; Collingro A, 2011, MOL BIOL EVOL, V28, P3253, DOI 10.1093/molbev/msr161; COTTER TW, 1995, INFECT IMMUN, V63, P4704, DOI 10.1128/IAI.63.12.4704-4714.1995; Datta SD, 2012, SEX TRANSM DIS, V39, P92, DOI 10.1097/OLQ.0b013e31823e2ff7; DIPAOLO JA, 1969, SCIENCE, V165, P917, DOI 10.1126/science.165.3896.917; Duensing S, 2002, ONCOGENE, V21, P6241, DOI 10.1038/sj.onc.1205709; Duensing S, 2001, CANCER RES, V61, P2356; Elson DA, 2000, CANCER RES, V60, P1267; Farris CM, 2011, INFECT IMMUN, V79, P986, DOI 10.1128/IAI.00881-10; Fenech M, 2011, MUTAGENESIS, V26, P43, DOI 10.1093/mutage/geq050; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gisselsson D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001871; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Greene W, 2003, J INFECTION, V47, P45, DOI 10.1016/S0163-4453(03)00039-2; Grieshaber SS, 2006, TRAFFIC, V7, P940, DOI 10.1111/j.1600-0854.2006.00439.x; Heinzen RA, 1999, TRENDS MICROBIOL, V7, P149, DOI 10.1016/S0966-842X(99)01475-4; Herber R, 1996, J VIROL, V70, P1873, DOI 10.1128/JVI.70.3.1873-1881.1996; Hinkula M, 2004, BRIT J CANCER, V90, P1025, DOI 10.1038/sj.bjc.6601650; HOWARD L, 1974, APPL MICROBIOL, V27, P102, DOI 10.1128/AEM.27.1.102-106.1974; Johnson KA, 2009, CELL MICROBIOL, V11, P1064, DOI 10.1111/j.1462-5822.2009.01307.x; KirschVolders M, 1997, MUTAT RES-GEN TOX EN, V392, P19, DOI 10.1016/S0165-1218(97)00042-6; Knowlton AE, 2011, TRAFFIC, V12, P854, DOI 10.1111/j.1600-0854.2011.01204.x; Koskela P, 2000, INT J CANCER, V85, P35, DOI 10.1002/(SICI)1097-0215(20000101)85:1&lt;35::AID-IJC6&gt;3.0.CO;2-A; LASNE C, 1974, NATURE, V247, P490, DOI 10.1038/247490a0; Leppert PC, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.112.099283; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Madeleine MM, 2007, INT J CANCER, V120, P650, DOI 10.1002/ijc.22325; Matsumoto K, 2003, BRIT J CANCER, V89, P831, DOI 10.1038/sj.bjc.6601220; Miller WC, 2004, JAMA-J AM MED ASSOC, V291, P2229, DOI 10.1001/jama.291.18.2229; Nigg EA, 2006, INT J CANCER, V119, P2717, DOI 10.1002/ijc.22245; Ohman H, 2009, J INFECT DIS, V199, P1353, DOI 10.1086/597620; PATTON DL, 1989, J INFECT DIS, V159, P1105, DOI 10.1093/infdis/159.6.1105; Pihan G, 2003, CANCER CELL, V4, P89, DOI 10.1016/S1535-6108(03)00195-8; Pihan GA, 1998, CANCER RES, V58, P3974; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Riley RR, 2003, CANCER RES, V63, P4862; Roden R, 2006, NAT REV CANCER, V6, P753, DOI 10.1038/nrc1973; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sasaki K, 2012, MUTAT RES-GEN TOX EN, V744, P30, DOI 10.1016/j.mrgentox.2011.12.014; SCHWARZ E, 1985, NATURE, V314, P111, DOI 10.1038/314111a0; Shah AA, 2005, SEX TRANSM DIS, V32, P49, DOI 10.1097/01.olq.0000148299.14513.11; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; Smith JS, 2004, INT J CANCER, V111, P431, DOI 10.1002/ijc.20257; Smith JS, 2002, J INFECT DIS, V185, P324, DOI 10.1086/338569; Steenbergen RDM, 2005, J CLIN VIROL, V32, pS25, DOI 10.1016/j.jcv.2004.11.019; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Walboomers JM, 1999, AID PATH431 3 0 CO 2; Wallin KL, 2002, INT J CANCER, V101, P371, DOI 10.1002/ijc.10639; WHO, 2001, GUIDELINES STANDARDS, P1; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798; zurHausen H, 1996, BBA-REV CANCER, V1288, pF55; Zyss D, 2009, TRENDS CELL BIOL, V19, P334, DOI 10.1016/j.tcb.2009.04.001	61	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e54022	10.1371/journal.pone.0054022	http://dx.doi.org/10.1371/journal.pone.0054022			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308295	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429100126
J	Salazar, CR; Sun, JH; Li, YH; Francois, F; Corby, P; Perez-Perez, G; Dasanayake, A; Pei, ZH; Chen, Y				Salazar, Christian R.; Sun, Jinghua; Li, Yihong; Francois, Fritz; Corby, Patricia; Perez-Perez, Guillermo; Dasanayake, Ananda; Pei, Zhiheng; Chen, Yu			Association between Selected Oral Pathogens and Gastric Precancerous Lesions	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; CHRONIC ATROPHIC GASTRITIS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; PORPHYROMONAS-GINGIVALIS; STREPTOCOCCUS-MUTANS; PERIODONTAL-DISEASE; TOOTH LOSS; AGGREGATIBACTER-ACTINOMYCETEMCOMITANS; INTESTINAL METAPLASIA; SUBGINGIVAL PLAQUE	We examined whether colonization of selected oral pathogens is associated with gastric precancerous lesions in a cross-sectional study. A total of 119 participants were included, of which 37 were cases of chronic atrophic gastritis, intestinal metaplasia, or dysplasia. An oral examination was performed to measure periodontal indices. Plaque and saliva samples were tested with real-time quantitative PCR for DNA levels of pathogens related to periodontal disease (Porphyromonas gingivalis, Tannerella forsythensis, Treponema denticola, Actinobacillus actinomycetemcomitans) and dental caries (Streptococcus mutans and S. sobrinus). There were no consistent associations between DNA levels of selected bacterial species and gastric precancerous lesions, although an elevated but non-significant odds ratio (OR) for gastric precancerous lesions was observed in relation to increasing colonization of A. actinomycetemcomitans (OR = 1.36 for one standard deviation increase, 95% Confidence Interval = 0.87-2.12), P. gingivalis (OR = 1.12, 0.67-1.88) and T. denticola (OR = 1.34, 0.83-2.12) measured in plaque. To assess the influence of specific long-term infection, stratified analyses by levels of periodontal indices were conducted. A. actinomycetemcomitans was significantly associated with gastric precancerous lesions (OR = 2.51, 1.13-5.56) among those with >= median of percent tooth sites with PD >= 3 mm, compared with no association among those below the median (OR = 0.86, 0.43-1.72). A significantly stronger relationship was observed between the cumulative bacterial burden score of periodontal disease-related pathogens and gastric precancerous lesions among those with higher versus lower levels of periodontal disease indices (p-values for interactions: 0.03-0.06). Among individuals with periodontal disease, high levels of colonization of periodontal pathogens are associated with an increased risk of gastric precancerous lesions.	[Salazar, Christian R.; Dasanayake, Ananda] NYU, Coll Dent, Dept Epidemiol & Hlth Promot, New York, NY USA; [Salazar, Christian R.] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Sun, Jinghua; Li, Yihong] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10003 USA; [Francois, Fritz; Pei, Zhiheng; Chen, Yu] NYU, Sch Med, Dept Med, New York, NY USA; [Francois, Fritz; Chen, Yu] NYU, Sch Med, Inst Canc, New York, NY USA; [Corby, Patricia] NYU, Coll Dent, Dept Periodontol & Implant Dent, New York, NY USA; [Chen, Yu] NYU, Sch Med, Div Epidemiol, Dept Environm Med, New York, NY USA; [Perez-Perez, Guillermo] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Pei, Zhiheng] NYU, Sch Med, Dept Pathol, New York, NY USA	New York University; Columbia University; New York University; New York University; New York University; New York University; New York University; New York University; New York University	Li, YH (corresponding author), NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10003 USA.	yihong.li@hyu.edu; yu.chen@nyumc.org	Perez, Guillermo Perez/AAJ-3761-2020; Salazar, Christian/I-1096-2013	Li, Yihong/0000-0002-5476-1943; Perez Perez, Guillermo/0000-0002-0131-5798; Chen, Yu/0000-0002-1519-4894; Salazar, Christian/0000-0003-3755-275X; Francois, Fritz/0000-0003-4491-2637; Pei, Zhiheng/0000-0001-8570-6747	U.S. National Institute [R21DE018438, P30CA016087, ES000260, K23CA107123, T32-DE007255]; NATIONAL CANCER INSTITUTE [P30CA016087, K23CA107123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE018438, T32DE007255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	U.S. National Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by U.S. National Institute grants R21DE018438, P30CA016087, ES000260, K23CA107123, and T32-DE007255. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2005, SCAND J GASTROENTERO, V40, P681, DOI 10.1080/00365520510015430; Abnet CC, 2001, CANCER CAUSE CONTROL, V12, P847, DOI 10.1023/A:1012290009545; [Anonymous], 1996, Ann Periodontol, V1, P926; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blaser MJ, 2010, P NATL ACAD SCI USA, V107, P6125, DOI 10.1073/pnas.1002112107; BLASER MJ, 1995, CANCER RES, V55, P2111; Breslow N, 1980, IARC SCI PUBL, V32, P227; Buchmann R, 2000, J PERIODONTOL, V71, P444, DOI 10.1902/jop.2000.71.3.444; Casarin RCV, 2010, J PERIODONTAL RES, V45, P635, DOI 10.1111/j.1600-0765.2010.01278.x; CORREA P, 1975, LANCET, V2, P58; CORREA P, 1988, CANCER RES, V48, P3554; Correa Pelayo, 2004, Gastric Cancer, V7, P9, DOI 10.1007/s10120-003-0265-0; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; da Silva-Boghossian CM, 2011, ARCH ORAL BIOL, V56, P899, DOI 10.1016/j.archoralbio.2011.02.009; DEMIRER T, 1990, CANCER, V65, P2344, DOI 10.1002/1097-0142(19900515)65:10&lt;2344::AID-CNCR2820651030&gt;3.0.CO;2-H; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Dye BA, 2005, J CLIN PERIODONTOL, V32, P1189, DOI 10.1111/j.1600-051X.2005.00856.x; Engel LS, 2003, J NATL CANCER I, V95, P1404, DOI 10.1093/jnci/djg047; FARINATI F, 1995, EUR J CANCER PREV, V4, P181, DOI 10.1097/00008469-199504000-00009; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fives-Taylor PM, 1999, PERIODONTOL 2000, V20, P136, DOI 10.1111/j.1600-0757.1999.tb00161.x; FONTHAM E, 1986, JNCI-J NATL CANCER I, V76, P621, DOI 10.1093/jnci/76.4.621; FONTHAM ETH, 1995, AM J GASTROENTEROL, V90, P1094; FOXMAN B, 2008, INTERDISCIP PERSPECT, P1; Francois F, 2008, GUT, V57, P16, DOI 10.1136/gut.2007.131672; HAMADA S, 1980, MICROBIOL REV, V44, P331, DOI 10.1128/MMBR.44.2.331-384.1980; Kato I, 2004, CANCER EPIDEM BIOMAR, V13, P468; KIGURE T, 1995, J PERIODONTAL RES, V30, P332, DOI 10.1111/j.1600-0765.1995.tb01284.x; Kuper H, 2000, J INTERN MED, V248, P171, DOI 10.1046/j.1365-2796.2000.00742.x; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Li Y, 2006, ORAL MICROBIOL IMMUN, V21, P333, DOI 10.1111/j.1399-302X.2006.00301.x; LOE H, 1967, J PERIODONTOL, V38, P610, DOI 10.1902/jop.1967.38.6.610; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Michaud DS, 2008, LANCET ONCOL, V9, P550, DOI 10.1016/S1470-2045(08)70106-2; National Institute of Dental Research, 1987, EP OR DIS PREV PROGR; Nibali L, 2007, J DENT RES, V86, P416, DOI 10.1177/154405910708600505; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Peleteiro B, 2007, CANCER EPIDEM BIOMAR, V16, P322, DOI 10.1158/1055-9965.EPI-06-0885; PEREZPEREZ GI, 1988, ANN INTERN MED, V109, P11, DOI 10.7326/0003-4819-109-1-11; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Pritchard DM, 2006, CURR OPIN GASTROEN, V22, P620, DOI 10.1097/01.mog.0000245539.50765.f6; Psoter WJ, 2011, CLIN ORAL INVEST, V15, P461, DOI 10.1007/s00784-010-0413-y; Salazar CR, 2012, CARCINOGENESIS, V33, P399, DOI 10.1093/carcin/bgr284; Slots J, 1999, PERIODONTOL 2000, V20, P82, DOI 10.1111/j.1600-0757.1999.tb00159.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; TALLEY NJ, 1991, J NATL CANCER I, V83, P1734, DOI 10.1093/jnci/83.23.1734; Terry MB, 2002, SEMIN RADIAT ONCOL, V12, P111, DOI 10.1053/srao.30814; Watabe K, 1998, ONCOL REP, V5, P1191; Weck MN, 2006, CANCER EPIDEM BIOMAR, V15, P1083, DOI 10.1158/1055-9965.EPI-05-0931; Whiley RA, 1998, ORAL MICROBIOL IMMUN, V13, P195, DOI 10.1111/j.1399-302X.1998.tb00698.x; Yano A, 2002, FEMS MICROBIOL LETT, V217, P23, DOI 10.1111/j.1574-6968.2002.tb11451.x; Zadeh HH, 1999, PERIODONTOL 2000, V20, P239, DOI 10.1111/j.1600-0757.1999.tb00163.x	52	39	43	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e51604	10.1371/journal.pone.0051604	http://dx.doi.org/10.1371/journal.pone.0051604			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308100	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429100005
J	Cullen, JA; Maie, T; Schoenfuss, HL; Blob, RW				Cullen, Joshua A.; Maie, Takashi; Schoenfuss, Heiko L.; Blob, Richard W.			Evolutionary Novelty versus Exaptation: Oral Kinematics in Feeding versus Climbing in the Waterfall-Climbing Hawaiian Goby Sicyopterus stimpsoni	PLOS ONE			English	Article							EXTREME ENVIRONMENTS; GOBIID FISHES; PERFORMANCE; SUCTION; RECRUITMENT; SIMULATION; CHALLENGES; MORPHOLOGY; PROPULSION; DIVERSITY	Species exposed to extreme environments often exhibit distinctive traits that help meet the demands of such habitats. Such traits could evolve independently, but under intense selective pressures of extreme environments some existing structures or behaviors might be coopted to meet specialized demands, evolving via the process of exaptation. We evaluated the potential for exaptation to have operated in the evolution of novel behaviors of the waterfall-climbing gobiid fish genus Sicyopterus. These fish use an "inching'' behavior to climb waterfalls, in which an oral sucker is cyclically protruded and attached to the climbing surface. They also exhibit a distinctive feeding behavior, in which the premaxilla is cyclically protruded to scrape diatoms from the substrate. Given the similarity of these patterns, we hypothesized that one might have been coopted from the other. To evaluate this, we filmed climbing and feeding in Sicyopterus stimpsoni from Hawai'i, and measured oral kinematics for two comparisons. First, we compared feeding kinematics of S. stimpsoni with those for two suction feeding gobiids (Awaous guamensis and Lentipes concolor), assessing what novel jaw movements were required for algal grazing. Second, we quantified the similarity of oral kinematics between feeding and climbing in S. stimpsoni, evaluating the potential for either to represent an exaptation from the other. Premaxillary movements showed the greatest differences between scraping and suction feeding taxa. Between feeding and climbing, overall profiles of oral kinematics matched closely for most variables in S. stimpsoni, with only a few showing significant differences in maximum values. Although current data cannot resolve whether oral movements for climbing were coopted from feeding, or feeding movements coopted from climbing, similarities between feeding and climbing kinematics in S. stimpsoni are consistent with evidence of exaptation, with modifications, between these behaviors. Such comparisons can provide insight into the evolutionary mechanisms facilitating exploitation of extreme habitats.	[Cullen, Joshua A.; Maie, Takashi; Blob, Richard W.] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Schoenfuss, Heiko L.] St Cloud State Univ, Aquat Toxicol Lab, St Cloud, MN 56301 USA	Clemson University; Minnesota State Colleges & Universities; Saint Cloud State University	Blob, RW (corresponding author), Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA.	rblob@clemson.edu		Schoenfuss, Heiko/0000-0001-5464-992X; Cullen, Joshua/0000-0002-6935-9340; Blob, Richard/0000-0001-5026-343X	US National Science foundation [IOS-0817911, IOS-0817794]; St. Cloud State University Faculty Research Grant; Clemson University Creative Inquiry Grant [479]; Direct For Biological Sciences [0817794, 0817911] Funding Source: National Science Foundation	US National Science foundation(National Science Foundation (NSF)); St. Cloud State University Faculty Research Grant; Clemson University Creative Inquiry Grant; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was funded by the US National Science foundation (http://www.nsf.gov) IOS-0817911 (HLS) and IOS-0817794 (RWB), a St. Cloud State University Faculty Research Grant (HLS), and Clemson University Creative Inquiry Grant #479 (RWB, JAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blob RW, 2007, J ZOOL, V273, P200, DOI 10.1111/j.1469-7998.2007.00315.x; Blob RW, 2010, INTEGR COMP BIOL, V50, P1185, DOI 10.1093/icb/icq070; Blob RW, 2008, INTEGR COMP BIOL, V48, P734, DOI 10.1093/icb/icn086; Blob RW, 2006, J ZOOL, V268, P315, DOI 10.1111/j.1469-7998.2005.00034.x; FITZSIMONS JM, 1995, ENVIRON BIOL FISH, V43, P39, DOI 10.1007/BF00001816; FUKUI S, 1979, JPN J ICHTHYOL, V26, P84; GERARD JF, 1993, REV ECOL-TERRE VIE, V48, P239; Gerstner CL, 2007, CAN J ZOOL, V85, P133, DOI 10.1139/Z06-199; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Hamilton AG, 1989, LINEAR ALGEBRA; Hankison SJ, 2006, J FISH BIOL, V68, P1610, DOI 10.1111/j.0022-1112.2006.001051.x; Julius ML, 2005, AQUAT ECOL, V39, P473, DOI 10.1007/s10452-005-9007-1; Keith P, 2008, MAR FRESHWATER RES, V59, P876, DOI 10.1071/MF08116; Keith P, 2011, MAR BIOL, V158, P311, DOI 10.1007/s00227-010-1560-z; Keith P, 2003, J FISH BIOL, V63, P831, DOI 10.1046/j.1095-8649.2003.00197.x; Kido Michael H., 1996, Pacific Science, V50, P184; Lauder George V., 1996, P55; LAUDER GV, 1980, J EXP BIOL, V88, P49; Legreneur P, 2012, ADAPT BEHAV, V20, P67, DOI 10.1177/1059712311426797; Maie T, 2012, J EXP BIOL, V215, P3925, DOI 10.1242/jeb.072967; Maie T, 2009, J MORPHOL, V270, P976, DOI 10.1002/jmor.10737; Maie T, 2009, J MORPHOL, V270, P344, DOI 10.1002/jmor.10695; McDowall RM, 2004, FISH FISH, V5, P75, DOI 10.1111/j.1467-2960.2004.00138.x; McDowall RM, 2003, J BIOGEOGR, V30, P703, DOI 10.1046/j.1365-2699.2003.00851.x; Nishimoto Robert T., 1997, Micronesica, V30, P41; Patek SN, 2006, P NATL ACAD SCI USA, V103, P12787, DOI 10.1073/pnas.0604290103; RADTKE RL, 1988, ENVIRON BIOL FISH, V23, P205, DOI 10.1007/BF00004911; Rivera ARV, 2013, J EXP BIOL, V216, P668, DOI 10.1242/jeb.079715; SCHAEFER SA, 1986, SYST ZOOL, V35, P489, DOI 10.2307/2413111; Schoenfuss Heiko L., 2007, Bishop Museum Bulletin in Cultural and Environmental Studies, V3, P125; Schoenfuss HL, 2011, CYBIUM, V35, P361; Schoenfuss Heiko L., 1997, Micronesica, V30, P93; Schoenfuss HL, 2003, J ZOOL, V261, P191, DOI 10.1017/S0952836903004102; Sokal RR, 1995, BIOMETRY; Tobalske BW, 2007, J EXP BIOL, V210, P1742, DOI 10.1242/jeb.001701; Van Wassenbergh S, 2009, J EXP BIOL, V212, P116, DOI 10.1242/jeb.023929; Voegtle B., 2002, B FRANCAIS PECHE PIS, V364, P109, DOI DOI 10.1051/KMAE:2002006; Vogel S., 2003, COMP BIOMECHANICS LI; Walker JA, 1998, J EXP BIOL, V201, P981; Waterman TH, 1999, J EXP ZOOL, V285, P326, DOI 10.1002/(SICI)1097-010X(19991215)285:4<326::AID-JEZ3>3.3.CO;2-K; Waterman TH, 2001, J EXP ZOOL, V291, P130, DOI 10.1002/jez.1065	41	15	15	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53274	10.1371/journal.pone.0053274	http://dx.doi.org/10.1371/journal.pone.0053274			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308184	Green Published, Green Submitted, gold			2022-12-25	WOS:000313670100030
J	Fujikura, K; Setsu, T; Tanigaki, K; Abe, T; Kiyonari, H; Terashima, T; Sakisaka, T				Fujikura, Kohei; Setsu, Tomiyoshi; Tanigaki, Kenji; Abe, Takaya; Kiyonari, Hiroshi; Terashima, Toshio; Sakisaka, Toshiaki			Kif14 Mutation Causes Severe Brain Malformation and Hypomyelination	PLOS ONE			English	Article							MUTANT MICE; MOUSE GENOME; NEURAL-TUBE; OLIGODENDROCYTE; PROTEINS; MYELIN; NEUROGENESIS; CYTOKINESIS; MECHANISMS; DEFECTS	We describe a novel spontaneous mouse mutant, laggard (lag), characterized by a flat head, motor impairment and growth retardation. The mutation is inherited as an autosomal recessive trait, and lag/lag mice suffer from cerebellar ataxia and die before weaning. lag/lag mice exhibit a dramatic reduction in brain size and slender optic nerves. By positional cloning, we identify a splice site mutation in Kif14. Transgenic complementation with wild-type Kif14-cDNA alleviates ataxic phenotype in lag/lag mice. To further confirm that the causative gene is Kif14, we generate Kif14 knockout mice and find that all of the phenotypes of Kif14 knockout mice are similar to those of lag/lag mice. The main morphological abnormality of lag/lag mouse is severe hypomyelination in central nervous system. The lag/lag mice express an array of myelin-related genes at significantly reduced levels. The disrupted cytoarchitecture of the cerebellar and cerebral cortices appears to result from apoptotic cell death. Thus, we conclude that Kif14 is essential for the generation and maturation of late-developing structures such as the myelin sheath, cerebellar and cerebral cortices. So far, no Kif14-deficient mice or mutation in Kif14 has ever been reported and we firstly define the biological function of Kif14 in vivo. The discovery of mammalian models, laggard, has opened up horizons for researchers to add more knowledge regarding the etiology and pathology of brain malformation.	[Fujikura, Kohei; Sakisaka, Toshiaki] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Membrane Dynam, Kobe, Hyogo 657, Japan; [Setsu, Tomiyoshi; Terashima, Toshio] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Dev Neurobiol, Kobe, Hyogo 657, Japan; [Tanigaki, Kenji] Shiga Med Ctr, Res Inst, Moriyama, Shiga, Japan; [Abe, Takaya; Kiyonari, Hiroshi] RIKEN, Ctr Dev Biol, Lab Anim Resources & Genet Engn, Kobe, Hyogo, Japan	Kobe University; Kobe University; RIKEN	Sakisaka, T (corresponding author), Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Membrane Dynam, Kobe, Hyogo 657, Japan.	sakisaka@med.kobe-u.ac.jp	Kiyonari, Hiroshi/N-7936-2015		Ministry of Education, Culture, Sports, Science and Technology, Japan [22500334]; Japan Epilepsy Research Foundation; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Epilepsy Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (number 22500334), by a grant provided by The Japan Epilepsy Research Foundation, and by the grant provided by Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Corson TW, 2005, ONCOGENE, V24, P4741, DOI 10.1038/sj.onc.1208641; Di Cunto F, 2000, NEURON, V28, P115, DOI 10.1016/S0896-6273(00)00090-8; Eggenschwiler JT, 2001, NATURE, V412, P194, DOI 10.1038/35084089; Flores AI, 2008, J NEUROSCI, V28, P7174, DOI 10.1523/JNEUROSCI.0150-08.2008; Goldowitz D, 1997, J NEUROSCI, V17, P8767; Gruneberg U, 2006, J CELL BIOL, V172, P363, DOI 10.1083/jcb.200511061; GUNTHER T, 1994, DEVELOPMENT, V120, P3119; Harrington EP, 2010, ANN NEUROL, V68, P703, DOI 10.1002/ana.22090; HERRUP K, 1979, BRAIN RES, V178, P443, DOI 10.1016/0006-8993(79)90705-4; HERRUP K, 1995, DEVELOPMENT, V121, P2385; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Jejeli M, 2003, NEUROSCI RES, V47, P309, DOI 10.1016/S0168-0102(03)00224-4; Kiyonari H, 2010, GENESIS, V48, P317, DOI 10.1002/dvg.20614; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lyons DA, 2009, NAT GENET, V41, P854, DOI 10.1038/ng.376; Nakagawa T, 1997, P NATL ACAD SCI USA, V94, P9654, DOI 10.1073/pnas.94.18.9654; Nakahira E, 2005, J COMP NEUROL, V483, P329, DOI 10.1002/cne.20441; Narayanan SP, 2009, J NEUROSCI, V29, P6860, DOI 10.1523/JNEUROSCI.0232-09.2009; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; Ponting C, 2005, CURR OPIN GENET DEV, V15, P241, DOI 10.1016/j.gde.2005.04.009; RAKIC P, 1973, J COMP NEUROL, V152, P103, DOI 10.1002/cne.901520202; Rhodes M, 1998, GENOME RES, V8, P531, DOI 10.1101/gr.8.5.531; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; SIDMAN RL, 1964, SCIENCE, V144, P309, DOI 10.1126/science.144.3616.309; Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	33	32	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53490	10.1371/journal.pone.0053490	http://dx.doi.org/10.1371/journal.pone.0053490			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308235	gold, Green Published, Green Submitted			2022-12-25	WOS:000313670100045
J	Kamtekar, N; Pandey, A; Agrawal, N; Pissurlenkar, RRS; Borana, M; Ahmad, B				Kamtekar, Nayana; Pandey, Anita; Agrawal, Neeraj; Pissurlenkar, Raghuvir R. S.; Borana, Mohanish; Ahmad, Basir			Interaction of Multimicrobial Synthetic Inhibitor 1,2-Bis(2-Benzimidazolyl)-1,2-Ethanediol with Serum Albumin: Spectroscopic and Computational Studies	PLOS ONE			English	Article							TARGET RESIDENCE TIME; ACCURATE DOCKING; LIGAND-BINDING; BOVINE; FLUORESCENCE; GLIDE; BENZIMIDAZOLE; AGGREGATION; SPECIFICITY; DERIVATIVES	The molecule, 1,2-Bis(2-benzimidazolyl)-1,2-ethanediol (BBE) is known to act as a selective inhibitor of poliovirus, rhinovirus, Candida albicans, several bacterial species, and is easily synthesized by Phillips reaction. The interaction of BBE with BSA and the effects of its binding on the conformation and unfolding/refolding pathways of the protein were investigated using multispectroscopic techniques and molecular modeling. The binding studies indicate that BSA has one high affinity BBE binding site with association constant 6.02 +/- 0.05x10(4) M-1 at 298 K. By measuring binding at different temperatures, we determined the changes in enthalpy (Delta H = -15.13 +/- 2.15 kJ mol(-1)), entropy (Delta S = 40.87 +/- 7.25 J mol(-1) K-1) and free energy (Delta G = 26.78 +/- 1.02) of interaction, which indicate that the binding was spontaneous and both enthalpically and entropically driven. Based on molecular modeling and thermodynamic parameters, we proposed that the complex formation involved mainly hydrophilic interaction such as hydrogen bonding between hydroxyl groups of ethane-1,2-diol fragment with Tyr410 and benzimidazole sp(2) nitrogen atom with Ser488 and hydrophobic interaction between phenyl ring of one benzimidazole of the ligand and hydrophobic residues namely, Ile387, Cys391, Phe402, Val432 and Cys437. The sequential unfolding mechanism of BSA, site-specific marker displacement experiments and molecular modeling showed that the molecule preferably binds in subdomain IIIA. The BBE binding to BSA was found to cause both secondary and tertiary structural alterations in the protein as studied by intrinsic fluorescence, near-UV and far-UV circular dichroism results. The unfolding/refolding study showed that BBE stabilized native to intermediate states (N reversible arrow I) transition of the protein by similar to 2 kJ mol(-1) without affecting the intermediate to unfolded states (I reversible arrow U) transition and general mechanism of unfolding of BSA.	[Kamtekar, Nayana; Pandey, Anita; Agrawal, Neeraj; Borana, Mohanish; Ahmad, Basir] Univ Mumbai, UM DAE Ctr Excellence Basic Sci, Mumbai, Maharashtra, India; [Pissurlenkar, Raghuvir R. S.] Bombay Coll Pharm, Pharmaceut Chem Div, Mumbai, Maharashtra, India	UM-DAE Centre for Excellence in Basic Sciences; University of Mumbai	Ahmad, B (corresponding author), Univ Mumbai, UM DAE Ctr Excellence Basic Sci, Kalina Campus, Mumbai, Maharashtra, India.	basir.ahmad@cbs.ac.in	Ahmad, Basir/O-9344-2017; Pissurlenkar, Raghuvir R/H-7621-2017	Ahmad, Basir/0000-0002-0120-5097; Pissurlenkar, Raghuvir R/0000-0002-1983-1336	UM-DAE Centre for Excellence in Basic Sciences	UM-DAE Centre for Excellence in Basic Sciences	Financial Support was provided by UM-DAE Centre for Excellence in Basic Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043814; Ahmad B, 2006, BIOMACROMOLECULES, V7, P1350, DOI 10.1021/bm050996b; Ahmad B, 2004, BIOCHEM BIOPH RES CO, V314, P166, DOI 10.1016/j.bbrc.2003.12.069; Ahmad B, 2012, J BIOL CHEM, V287, P9193, DOI 10.1074/jbc.M111.325548; Ahmad E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038372; AKIHAMA S, 1968, NATURE, V217, P562, DOI 10.1038/217562a0; Bagatolli LA, 1996, J PHARM SCI, V85, P1131, DOI 10.1021/js960142k; Bourassa P, 2010, J PHYS CHEM B, V114, P3348, DOI 10.1021/jp9115996; Charbonneau DM, 2010, J PHYS CHEM B, V114, P1148, DOI 10.1021/jp910077h; Coan KED, 2008, J AM CHEM SOC, V130, P9606, DOI 10.1021/ja802977h; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Copeland RA, 2010, EXPERT OPIN DRUG DIS, V5, P305, DOI 10.1517/17460441003677725; Creighton T. E., 1993, PROTEINS STRUCTURE M; de Azevedo WF, 2008, CURR DRUG TARGETS, V9, P1071, DOI 10.2174/138945008786949441; Dubeau S, 2010, BIOMACROMOLECULES, V11, P1507, DOI 10.1021/bm100144v; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Han XL, 2012, J PHOTOCH PHOTOBIO B, V109, P1, DOI 10.1016/j.jphotobiol.2011.12.010; Hung HC, 2012, ANAL CHEM, V84, P6391, DOI 10.1021/ac2022426; Isele K, 2002, J CHEM SOC DALTON, P3899, DOI 10.1039/b203229e; Kang J, 2004, BBA-GEN SUBJECTS, V1674, P205, DOI 10.1016/j.bbagen.2004.06.021; Kume S, 2012, BIOCHEM J, V446, P279, DOI 10.1042/BJ20120324; Lakowicz J.R., 2004, PRINCIPLES FLUORESCE, V2nd ed.; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Majorek KA, 2012, MOL IMMUNOL, V52, P174, DOI 10.1016/j.molimm.2012.05.011; Narazaki R, 1997, BBA-PROTEIN STRUCT M, V1338, P275, DOI 10.1016/S0167-4838(96)00221-X; OSULLIVAN DG, 1963, NATURE, V198, P1270, DOI 10.1038/1981270a0; Owen SC, 2012, ACS CHEM BIOL, V7, P1429, DOI 10.1021/cb300189b; Patel AB, 1999, J BIOL CHEM, V274, P21755, DOI 10.1074/jbc.274.31.21755; PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0; Peters T., 1996, ALL ALBUMIN BIOCH GE; Ryan CW, 2004, CLIN CANCER RES, V10, P4406, DOI 10.1158/1078-0432.CCR-04-0083; Schmidt S, 2008, ANTIMICROB AGENTS CH, V52, P3994, DOI 10.1128/AAC.00427-08; Seeliger D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000634; SHIPKOWITZ NL, 1972, APPL MICROBIOL, V23, P117, DOI 10.1128/AEM.23.1.117-122.1972; SJOHOLM I, 1979, MOL PHARMACOL, V16, P767; Strunk JJ, 2008, J MOL BIOL, V377, P725, DOI 10.1016/j.jmb.2008.01.017; SUDLOW G, 1975, MOL PHARMACOL, V11, P824; TANFORD C, 1968, ADVANCES PROTEIN CHE, V23, P122; Tavman A, 2005, FOLIA MICROBIOL, V50, P467, DOI 10.1007/BF02931431; Tayyab S, 2002, INT J BIOL MACROMOL, V30, P17, DOI 10.1016/S0141-8130(01)00185-4; Thomas GL, 2011, CURR OPIN CHEM BIOL, V15, P516, DOI 10.1016/j.cbpa.2011.05.022; Tummino PJ, 2008, BIOCHEMISTRY-US, V47, P5481, DOI 10.1021/bi8002023; Waldron TT, 2003, BIOCHEMISTRY-US, V42, P5058, DOI 10.1021/bi034212v; WALLEVIK K, 1973, J BIOL CHEM, V248, P2650; WARE WR, 1962, J PHYS CHEM-US, V66, P455, DOI 10.1021/j100809a020; Zhang R, 2009, CURR OPIN DRUG DISC, V12, P488	50	21	21	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53499	10.1371/journal.pone.0053499	http://dx.doi.org/10.1371/journal.pone.0053499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308237	Green Submitted, Green Published, gold			2022-12-25	WOS:000313670100046
J	Elbroch, LM; Wittmer, HU				Elbroch, L. Mark; Wittmer, Heiko U.			Nuisance Ecology: Do Scavenging Condors Exact Foraging Costs on Pumas in Patagonia?	PLOS ONE			English	Article							DOGS LYCAON-PICTUS; PREDATION RISK; HOME-RANGE; PREY; KLEPTOPARASITISM; FEAR; LANDSCAPES; SURVIVAL; SYSTEMS; ENERGY	Predation risk describes the energetic cost an animal suffers when making a trade off between maximizing energy intake and minimizing threats to its survival. We tested whether Andean condors (Vultur gryphus) influenced the foraging behaviors of a top predator in Patagonia, the puma (Puma concolor), in ways comparable to direct risks of predation for prey to address three questions: 1) Do condors exact a foraging cost on pumas?; 2) If so, do pumas exhibit behaviors indicative of these risks?; and 3) Do pumas display predictable behaviors associated with prey species foraging in risky environments? Using GPS location data, we located 433 kill sites of 9 pumas and quantified their kill rates. Based upon time pumas spent at a carcass, we quantified handling time. Pumas abandoned > 10% of edible meat at 133 of 266 large carcasses after a single night, and did so most often in open grasslands where their carcasses were easily detected by condors. Our data suggested that condors exacted foraging costs on pumas by significantly decreasing puma handling times at carcasses, and that pumas increased their kill rates by 50% relative to those reported for North America to compensate for these losses. Finally, we determined that the relative risks of detection and associated harassment by condors, rather than prey densities, explained puma "giving up times'' (GUTs) across structurally variable risk classes in the study area, and that, like many prey species, pumas disproportionately hunted in high-risk, high-resource reward areas.	[Elbroch, L. Mark; Wittmer, Heiko U.] Univ Calif Davis, Davis, CA 95616 USA; [Wittmer, Heiko U.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand	University of California System; University of California Davis; Victoria University Wellington	Elbroch, LM (corresponding author), Univ Calif Davis, Davis, CA 95616 USA.	lmelbroch@ucdavis.edu	Wittmer, Heiko U/D-4172-2015	Wittmer, Heiko U/0000-0002-8861-188X	National Science Foundation (USA) Graduate Fellowship; National Geographic Society Explorer Grant; Felidae Conservation Fund; Conservacion Patagonica; Oregon Zoo Future for Wildlife Program; Pacific Rim Research Program; University of California, Davis; Hemispheric Institute on the Americas; The American Society of Mammalogists Grants in Aid of Research Program; Stockton Sportsman's Club	National Science Foundation (USA) Graduate Fellowship; National Geographic Society Explorer Grant; Felidae Conservation Fund; Conservacion Patagonica; Oregon Zoo Future for Wildlife Program; Pacific Rim Research Program; University of California, Davis(University of California System); Hemispheric Institute on the Americas; The American Society of Mammalogists Grants in Aid of Research Program; Stockton Sportsman's Club(Mukai Science and Technology Foundation)	Funding for this research was generously provided through a National Science Foundation (USA) Graduate Fellowship, National Geographic Society Explorer Grant, Felidae Conservation Fund, Conservacion Patagonica, Oregon Zoo Future for Wildlife Program, Pacific Rim Research Program, University of California, Davis, the Hemispheric Institute on the Americas, The American Society of Mammalogists Grants in Aid of Research Program, the Stockton Sportsman's Club, Charles and Elizabeth Gorst, Fred Vanderbeck, Nancy Birtwell and Carole Bell. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AE, 1984, MAMMALIAN SPECIES, V219; Anderson CR, 2003, J WILDLIFE MANAGE, V67, P307, DOI 10.2307/3802772; Bellati J, 1990, P 14 VERT PEST C U C, P163; Birdlife International, 2008, IUCN 2011 IUCN RED L; Broom M, 2003, BEHAV ECOL, V14, P23, DOI 10.1093/beheco/14.1.23; Brown Joel S., 2007, P437; BROWN JS, 1994, AUST J ZOOL, V42, P435, DOI 10.1071/ZO9940435; Carbone C, 2005, J ZOOL, V266, P153, DOI 10.1017/s0952836905006710; Caro T., 1994, CHEETAHS SERENGETI P; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; Elbroch L. M., 2012, ORYX IN PRESS; Elbroch LM, 2012, MAMM BIOL, V77, P377, DOI 10.1016/j.mambio.2012.02.010; Elbroch LM, 2012, BIOL LETTERS, V8, P776, DOI 10.1098/rsbl.2012.0423; Elbroch LM, 2013, J MAMMAL IN PRESS, V94; Elbroch M, 2011, CONSERV BIOL, V25, P1195, DOI 10.1111/j.1523-1739.2011.01740.x; Elbroch M, 2009, REV CHIL HIST NAT, V82, P459; Evans JW, 2009, J WILDLIFE MANAGE, V73, P426, DOI 10.2193/2007-514; Flueck Werner T., 2005, Mastozool. neotrop., V12, P245; Fryxell JM, 2007, NATURE, V449, P1041, DOI 10.1038/nature06177; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Holling C. S., 1959, Canadian Entomologist, V91, P385; Hooge P. M., 2000, ANIMAL MOVEMENT EXTE, P2; HOUSTON AI, 1993, PHILOS T ROY SOC B, V341, P375, DOI 10.1098/rstb.1993.0123; HOUSTON D C, 1975, Journal of Wildlife Diseases, V11, P306; Houston D.C., 1994, HDB BIRDS WORLD, V2; Iriarte A., 2008, MAMMIFEROS CHILE; Kaczensky P, 2005, WILDLIFE BIOL, V11, P101, DOI 10.2981/0909-6396(2005)11[101:EORCCS]2.0.CO;2; Knopff KH, 2010, J WILDLIFE MANAGE, V74, P1435, DOI 10.2193/2009-314; Krofel M, 2012, BEHAV ECOL SOCIOBIOL, V66, P1297, DOI 10.1007/s00265-012-1384-6; Lambertucci SA, 2009, ANIM CONSERV, V12, P338, DOI 10.1111/j.1469-1795.2009.00258.x; Lank DB, 2003, J AVIAN BIOL, V34, P225, DOI 10.1034/j.1600-048X.2003.03250.x; Laundre J.W., 2010, OPEN ECOL J, V3, P1, DOI [10.2174/1874213001003030001, DOI 10.2174/1874213001003030001]; Laundre JW, 2001, CAN J ZOOL, V79, P1401, DOI 10.1139/cjz-79-8-1401; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; LOTKA ALFRED J., 1932, JOUR WASHINGTON ACAD SCI, V22, P461; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; McLellan BN, 2010, ECOLOGY, V91, P286, DOI 10.1890/09-0286.1; Mukherjee S, 2009, OECOLOGIA, V159, P661, DOI 10.1007/s00442-008-1243-3; Murphy Kerry, 2010, P118; Putnam R., 1988, NATURAL HIST DEER; Raedeke KJ, 1979, THESIS U WASHINGTON; Ruth TK, 2011, J WILDLIFE MANAGE, V75, P1381, DOI 10.1002/jwmg.190; Ruth Toni K., 2010, P163; Sarno RJ, 1999, BEHAV ECOL, V10, P41, DOI 10.1093/beheco/10.1.41; SCHOENER TW, 1983, AM NAT, V122, P240, DOI 10.1086/284133; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Searle KR, 2008, BEHAV ECOL, V19, P475, DOI 10.1093/beheco/arn004; Steel R., 1997, PRINCIPLES PROCEDURE; Thaker M, 2011, ECOLOGY, V92, P398, DOI 10.1890/10-0126.1; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Todd, 1996, NATURAL HIST WATERFO; van der Meer E, 2011, BEHAV ECOL, V22, P985, DOI 10.1093/beheco/arr079; Verdolin JL, 2006, BEHAV ECOL SOCIOBIOL, V60, P457, DOI 10.1007/s00265-006-0172-6; Walker Susan, 2010, P91; Willems EP, 2009, ECOLOGY, V90, P546, DOI 10.1890/08-0765.1; Wilson EE, 2011, TRENDS ECOL EVOL, V26, P129, DOI 10.1016/j.tree.2010.12.011; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	58	28	30	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53595	10.1371/journal.pone.0053595	http://dx.doi.org/10.1371/journal.pone.0053595			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301093	gold, Green Published, Green Submitted			2022-12-25	WOS:000313480000070
J	Hilbers, F; Junge, W; Sielaff, H				Hilbers, Florian; Junge, Wolfgang; Sielaff, Hendrik			The Torque of Rotary F-ATPase Can Unfold Subunit Gamma If Rotor and Stator Are Cross-Linked	PLOS ONE			English	Article							ELASTIC POWER TRANSMISSION; ESCHERICHIA-COLI; F-1-ATPASE; SYNTHASE; ROTATION; DYNAMICS; ENERGY; F0F1-ATPASE; REGION; ASSAY	During ATP hydrolysis by F-1-ATPase subunit gamma rotates in a hydrophobic bearing, formed by the N-terminal ends of the stator subunits (alpha beta)(3). If the penultimate residue at the alpha-helical C-terminal end of subunit gamma is artificially cross-linked (via an engineered disulfide bridge) with the bearing, the rotary function of F-1 persists. This observation has been tentatively interpreted by the unfolding of the alpha-helix and swiveling rotation in some dihedral angles between lower residues. Here, we screened the domain between rotor and bearing where an artificial disulfide bridge did not impair the rotary ATPase activity. We newly engineered three mutants with double cysteines farther away from the C-terminus of subunit gamma, while the results of three further mutants were published before. We found ATPase and rotary activity for mutants with cross-links in the single alpha-helical, C-terminal portion of subunit gamma (from gamma 285 to gamma 276 in E. coli), and virtually no activity when the cross-link was placed farther down, where the C-terminal alpha-helix meets its N-terminal counterpart to form a supposedly stable coiled coil. In conclusion, only the C-terminal singular alpha-helix is prone to unwinding and can form a swivel joint, whereas the coiled coil portion seems to resist the enzyme's torque.	[Hilbers, Florian] MPI Biophys, Dept Mol Membrane Biol, Frankfurt, Germany; [Junge, Wolfgang] Univ Osnabruck, Div Biophys, Osnabruck, Germany; [Sielaff, Hendrik] Jena Univ Hosp, Single Mol Microscopy Grp, Jena, Germany	Max Planck Society; University Osnabruck; Friedrich Schiller University of Jena	Sielaff, H (corresponding author), Jena Univ Hosp, Single Mol Microscopy Grp, Jena, Germany.	hendrik.sielaff@med.uni-jena.de		Sielaff, Hendrik/0000-0001-5231-7286	DFG [SFB 431]; Volkswagen-Stiftung; Fonds der Chemischen Industrie	DFG(German Research Foundation (DFG)); Volkswagen-Stiftung(Volkswagen); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	The project was funded by DFG (SFB 431), Volkswagen-Stiftung, and Fonds der Chemischen Industrie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cherepanov DA, 1999, FEBS LETT, V449, P1, DOI 10.1016/S0014-5793(99)00386-5; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Czub J, 2011, P NATL ACAD SCI USA, V108, P7408, DOI 10.1073/pnas.1018686108; Furuike S, 2008, SCIENCE, V319, P955, DOI 10.1126/science.1151343; Gumbiowski K, 2001, J BIOL CHEM, V276, P42287, DOI 10.1074/jbc.M106884200; Hossain MD, 2008, BIOPHYS J, V95, P4837, DOI 10.1529/biophysj.108.140061; Junge W, 2001, FEBS LETT, V504, P152, DOI 10.1016/S0014-5793(01)02745-4; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; Kuo PH, 1998, FEBS LETT, V426, P217, DOI 10.1016/S0014-5793(98)00337-8; LEBEL D, 1978, ANAL BIOCHEM, V85, P86, DOI 10.1016/0003-2697(78)90277-4; Masaike T, 2008, NAT STRUCT MOL BIOL, V15, P1326, DOI 10.1038/nsmb.1510; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Mnatsakanyan N, 2009, J BIOL CHEM, V284, P26519, DOI 10.1074/jbc.M109.030528; Muller M, 2004, EUR J BIOCHEM, V271, P3914, DOI 10.1111/j.1432-1033.2004.04328.x; Muller M, 2002, J BIOL CHEM, V277, P23308, DOI 10.1074/jbc.M201998200; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Noji H, 1999, BIOCHEM BIOPH RES CO, V260, P597, DOI 10.1006/bbrc.1999.0885; Panke O, 1999, BBA-BIOENERGETICS, V1412, P118, DOI 10.1016/S0005-2728(99)00059-6; Panke O, 2001, BIOPHYS J, V81, P1220, DOI 10.1016/S0006-3495(01)75780-3; Rees DM, 2009, P NATL ACAD SCI USA, V106, P21597, DOI 10.1073/pnas.0910365106; Sabbert D, 1996, NATURE, V381, P623, DOI 10.1038/381623a0; Sabbert D, 1997, P NATL ACAD SCI USA, V94, P4401, DOI 10.1073/pnas.94.9.4401; SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6; Sielaff H, 2008, P NATL ACAD SCI USA, V105, P17760, DOI 10.1073/pnas.0807683105; Sokolov M, 1999, J BIOL CHEM, V274, P13824, DOI 10.1074/jbc.274.20.13824; von Ballmoos C, 2008, ANNU REV BIOPHYS, V37, P43, DOI 10.1146/annurev.biophys.37.032807.130018; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Wachter A, 2011, P NATL ACAD SCI USA, V108, P3924, DOI 10.1073/pnas.1011581108; WISE JG, 1990, J BIOL CHEM, V265, P10403	33	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53754	10.1371/journal.pone.0053754	http://dx.doi.org/10.1371/journal.pone.0053754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301103	Green Published, gold			2022-12-25	WOS:000313480000078
J	Brouxhon, SM; Kyrkanides, S; Teng, X; Athar, M; Ghazizadeh, S; Simon, M; O'Banion, MK; Ma, L				Brouxhon, S. M.; Kyrkanides, S.; Teng, X.; Athar, M.; Ghazizadeh, S.; Simon, M.; O'Banion, M. K.; Ma, L.			Soluble E-cadherin: a critical oncogene modulating receptor tyrosine kinases, MAPK and PI3K/Akt/mTOR signaling	ONCOGENE			English	Article						squamous cell carcinomas; UV-irradiation; soluble E-cadherin; HER/ErbB receptors; IGF-1R; oncogenecity	GROWTH-FACTOR RECEPTOR; CELL CARCINOMA PROGRESSION; BREAST-CANCER CELLS; TRANSGENIC MICE; FACTOR-I; ULTRAVIOLET-IRRADIATION; PROSTATE-CANCER; TUMOR PROMOTION; DOWN-REGULATION; GASTRIC-CANCER	E-cadherin, a cell-cell adhesion glycoprotein, is frequently downregulated with tumorigenic progression. The extracellular domain of E-cadherin is cleaved by proteases to generate a soluble ectodomain fragment, termed sEcad, which is elevated in the urine or serum of cancer patients. In this study, we explored the functional role of sEcad in the progression of skin squamous cell carcinomas (SCCs). We found that full-length E-cadherin expression was decreased and sEcad increased in human clinical tumor samples as well as in ultraviolet (UV)-induced SCCs in mice. Interestingly, sEcad associated with members of the human epidermal growth factor receptor (HER) and insulin-like growth factor-1 (IGF-1R) family of receptors in human and UV-induced mouse tumors. Moreover, in both E-cadherin-positive (E-cadherin(+)) and -negative (E-cadherin(-)) cells in vitro, sEcad activated downstream mitogen-activated protein (MAP) kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) signaling and enhanced tumor growth, motility and invasion, the latter via activation of matrix metalloproteinase-2 (MMP-2) and MMP-9. To this end, HER, PI3K or MEK inhibitors suppressed sEcad's tumorigenic effects, including proliferation, migration and invasion. Taken together, our data suggest that sEcad contributes to skin carcinogenesis via association with the HER/IGF-1R-family of receptors and subsequent activation of the MAPK and PI3K/Akt/mTOR pathways, thereby implicating sEcad as a putative therapeutic target in cutaneous SCCs.	[Brouxhon, S. M.; Kyrkanides, S.; Teng, X.; Ghazizadeh, S.; Simon, M.; Ma, L.] SUNY Stony Brook, Hlth Sci Ctr, Dept Emergency Med, Stony Brook, NY 11794 USA; [Athar, M.] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA; [O'Banion, M. K.] Univ Rochester, Sch Med & Dent, Dept Neurobiol, Rochester, NY USA; [O'Banion, M. K.] Univ Rochester, Sch Med & Dent, Dept Anat, Rochester, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Alabama System; University of Alabama Birmingham; University of Rochester; University of Rochester	Brouxhon, SM (corresponding author), SUNY Stony Brook, Hlth Sci Ctr, Sch Med, Westchester Hall,Room 154, Stony Brook, NY 11794 USA.	Sabine.Brouxhon@stonybrook.edu	Ma, Li/AAG-4109-2020	Ma, Li/0000-0001-8470-0378; O'Banion, M. Kerry/0000-0003-1246-3363	NIH [K08CA133910, R21ES015832, R01CA138998]; NATIONAL CANCER INSTITUTE [R01CA138998, K08CA133910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES015832] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Dr Yuspa (NCI) and Dr Klein-Szanto (Fox Chase Cancer Center) for the PAM212 and CC4A cells, respectively. This work was supported by NIH grants K08CA133910 (NCI) and R21ES015832 (NIEHS) to SMB as well as NIH grant R01CA138998 (NCI) to MA.	Batistatou A, 2006, VIRCHOWS ARCH, V448, P763, DOI 10.1007/s00428-006-0183-8; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Bol D, 1998, MOL CARCINOGEN, V21, P2, DOI 10.1002/(SICI)1098-2744(199801)21:1<2::AID-MC2>3.3.CO;2-7; Bol DK, 1997, ONCOGENE, V14, P1725, DOI 10.1038/sj.onc.1201011; BONGIORNO PF, 1995, BRIT J CANCER, V71, P166, DOI 10.1038/bjc.1995.34; Brouxhon S, 2007, CANCER RES, V67, P7654, DOI 10.1158/0008-5472.CAN-06-4415; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chan ACO, 2003, J CLIN ONCOL, V21, P2288, DOI 10.1200/JCO.2003.08.078; Davies G, 2001, CLIN CANCER RES, V7, P3289; DiGiovanni J, 2000, CANCER RES, V60, P1561; Dlugosz AA, 1997, CANCER RES, V57, P3180; El-Abaseri TB, 2006, CARCINOGENESIS, V27, P225, DOI 10.1093/carcin/bgi220; El-Abaseri TB, 2005, CANCER RES, V65, P3958, DOI 10.1158/0008-5472.CAN-04-2204; Esch TR, 2000, J AUTOIMMUN, V15, P387, DOI 10.1006/jaut.2000.0451; Fong KP, 2011, BLOOD, V117, pE15, DOI 10.1182/blood-2010-05-283838; Fujii K, 1996, EXP CELL RES, V223, P50, DOI 10.1006/excr.1996.0057; Galer CE, 2011, HEAD NECK-J SCI SPEC, V33, P189, DOI 10.1002/hed.21419; GAMALLO C, 1993, AM J PATHOL, V142, P987; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hazan RB, 1998, J BIOL CHEM, V273, P9078, DOI 10.1074/jbc.273.15.9078; Higgins MJ, 2011, J CLIN INVEST, V121, P3797, DOI 10.1172/JCI57152; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Inge LJ, 2011, EXP CELL RES, V317, P838, DOI 10.1016/j.yexcr.2010.12.025; KATAYAMA M, 1994, BRIT J CANCER, V69, P580, DOI 10.1038/bjc.1994.106; Kim AL, 2002, PHOTOCHEM PHOTOBIOL, V75, P58, DOI 10.1562/0031-8655(2002)075<0058:SSAOCE>2.0.CO;2; Kuefer R, 2003, CLIN CANCER RES, V9, P6447; Kyrkanides S, 2007, J NEUROIMMUNOL, V188, P39, DOI 10.1016/j.jneuroim.2007.05.010; Madson JG, 2007, MOL CARCINOGEN, V46, P624, DOI 10.1002/mc.20335; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Maretzky T, 2008, J INVEST DERMATOL, V128, P1737, DOI 10.1038/sj.jid.5701242; Margulis A, 2005, CANCER RES, V65, P1783, DOI 10.1158/0008-5472.CAN-04-3399; MAYER B, 1993, CANCER RES, V53, P1690; MOLL R, 1993, AM J PATHOL, V143, P1731; Nahta R, 2005, CANCER RES, V65, P11118, DOI 10.1158/0008-5472.CAN-04-3841; Najy AJ, 2008, J BIOL CHEM, V283, P18393, DOI 10.1074/jbc.M801329200; Nawrocki-Raby B, 2003, INT J CANCER, V105, P790, DOI 10.1002/ijc.11168; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Saha B, 2007, ANTICANCER RES, V27, P3903; Symowicz J, 2007, CANCER RES, V67, P2030, DOI 10.1158/0008-5472.CAN-06-2808; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; Uchida Y, 2011, J IMMUNOL, V186, P6945, DOI 10.4049/jimmunol.1003853; Van den Bossche J, 2012, BLOOD, V119, P1623, DOI 10.1182/blood-2011-10-384289; VASSAR R, 1991, GENE DEV, V5, P714, DOI 10.1101/gad.5.5.714; Wan YS, 2001, INT J ONCOL, V18, P461; Wilding J, 1996, CANCER RES, V56, P5285; Wilker E, 2005, MOL CARCINOGEN, V44, P137, DOI 10.1002/mc.20132; Yang Jun, 2005, Zhonghua Zhong Liu Za Zhi, V27, P25	47	70	74	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 9	2014	33	2					225	235		10.1038/onc.2012.563	http://dx.doi.org/10.1038/onc.2012.563			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	286BY	23318419	Green Accepted			2022-12-25	WOS:000329440700010
J	Violante, S; IJlst, L; Brinke, HT; de Almeida, IT; Wanders, RJA; Ventura, FV; Houten, SM				Violante, Sara; IJlst, Lodewijk; Brinke, Heleen te; de Almeida, Isabel Tavares; Wanders, Ronald J. A.; Ventura, Fatima V.; Houten, Sander M.			Carnitine palmitoyltransferase 2 and carnitine/acylcarnitine translocase are involved in the mitochondrial synthesis and export of acylcarnitines	FASEB JOURNAL			English	Article						mitochondrial fatty acid beta-oxidation; Acyl-CoA metabolites	RAT-LIVER MITOCHONDRIA; FATTY-ACID OXIDATION; ORGANIC CATION/CARNITINE TRANSPORTER; ADENINE-NUCLEOTIDE TRANSLOCASE; BETA-OXIDATION; COENZYME-A; OCTN2; INHIBITION; DIAGNOSIS; LONG	Acylcarnitines are commonly used in the diagnosis of mitochondrial fatty acid beta-oxidation disorders (mFAODs). It is generally assumed that this plasma acylcarnitine profile reflects the mitochondrial accumulation of acyl-CoAs. The identity of the enzymes and the mitochondrial and plasmalemmal transporters involved in the synthesis and export of these metabolites have remained undefined. We used lentiviral shRNA to knock down the expression of medium-chain acyl-CoA dehydrogenase (MCAD) in control and carnitine palmitoyltransferase 2 (CPT2)-, carnitine/acylcarnitine translocase (CACT)-, and plasmalemmal carnitine transporter (OCTN2)-deficient human fibroblasts. These cell lines, including mock-transduced controls, were loaded with decanoic acid and carnitine, followed by the measurement of the acylcarnitine profile in the extracellular medium. In control fibroblasts, MCAD knockdown markedly increased the production of octanoylcarnitine (3-fold, P<0.01). OCTN2-deficient cell lines also showed extracellular accumulation of octanoylcarnitine (2.8-fold, P<0.01), suggesting that the cellular export of acylcarnitines does not depend on OCTN2. In contrast, in CPT2- and CACT-deficient cells, the accumulation of octanoylcarnitine in the medium did not significantly increase in the MCAD knockdown. Similar results were obtained using pharmacological inhibition of CPT2 in fibroblasts from MCAD-deficient individuals. This shows that CPT2 and CACT are crucial for mitochondrial acylcarnitine formation and export to the extracellular fluids in mFAOD.	[Violante, Sara; de Almeida, Isabel Tavares; Ventura, Fatima V.] Univ Lisbon, Fac Farm, Metab & Genet Grp, Res Inst Med & Pharmaceut Sci IMed UL, P-1649003 Lisbon, Portugal; [Violante, Sara; IJlst, Lodewijk; Brinke, Heleen te; Wanders, Ronald J. A.; Houten, Sander M.] Univ Amsterdam, Dept Clin Chem & Pediat, Lab Genet Metab Dis, Amsterdam, Netherlands	Universidade de Lisboa; University of Amsterdam	Ventura, FV (corresponding author), Univ Lisbon, Fac Farm, Av Prof Gama Pinto, P-1649003 Lisbon, Portugal.	fatima.ventura@ff.ul.pt	de Almeida, Isabel Tavares/F-8319-2014; Houten, Sander/Y-3599-2019; iMed.ULisboa, MetGen/B-5293-2014; Ventura, Fátima/F-7211-2015	Houten, Sander/0000-0002-6167-9147; Ventura, Fátima/0000-0002-5699-0387; Tavares de Almeida, Isabel/0000-0002-4024-8305	Fundacao para a Ciencia e Tecnologia (Lisbon, Portugal); Netherlands Organization for Scientific Research (VIDI grant) [016.086.336];  [SFRH/BD/38074/2007]	Fundacao para a Ciencia e Tecnologia (Lisbon, Portugal)(Portuguese Foundation for Science and Technology); Netherlands Organization for Scientific Research (VIDI grant); 	The authors gratefully acknowledge Jos Ruiter for the assistance with the HPLC measurements and helpful discussions and Prof. Marinus Duran for his valuable comments and suggestions throughout the development of the experimental work. Part of this work was financially supported by Fundacao para a Ciencia e Tecnologia (Lisbon, Portugal), by a grant awarded to S.V. (SFRH/BD/38074/2007), and by the Netherlands Organization for Scientific Research (VIDI grant 016.086.336 to S.M.H.).	BELL FP, 1980, ATHEROSCLEROSIS, V37, P21, DOI 10.1016/0021-9150(80)90090-8; Chegary M, 2008, MOL GENET METAB, V93, P403, DOI 10.1016/j.ymgme.2007.11.001; FRITZ IB, 1963, ADV LIPID RES, V1, P285; Hamilton JA, 1999, DIABETES, V48, P2255, DOI 10.2337/diabetes.48.12.2255; Houten SM, 2010, J INHERIT METAB DIS, V33, P469, DOI 10.1007/s10545-010-9061-2; Indiveri C, 1998, BIOCHEM BIOPH RES CO, V249, P589, DOI 10.1006/bbrc.1998.9197; Indiveri C, 2011, MOL ASPECTS MED, V32, P223, DOI 10.1016/j.mam.2011.10.008; JENKINS DL, 1985, J BIOL CHEM, V260, P4748; Longo N, 2006, AM J MED GENET C, V142C, P77, DOI 10.1002/ajmg.c.30087; MALOY SR, 1981, J BIOL CHEM, V256, P3735; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Ohashi R, 2002, J PHARMACOL EXP THER, V302, P1286, DOI 10.1124/jpet.102.036004; Pasquali M, 2006, AM J MED GENET C, V142C, P64, DOI 10.1002/ajmg.c.30086; Pochini L, 2004, BBA-BIOMEMBRANES, V1661, P78, DOI 10.1016/j.bbamem.2003.12.001; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ramsay RR, 2001, BBA-PROTEIN STRUCT M, V1546, P21, DOI 10.1016/S0167-4838(01)00147-9; Rinaldo P, 2008, GENET MED, V10, P151, DOI 10.1097/GIM.0b013e3181614289; Schaefer J, 1997, J NEUROL NEUROSUR PS, V62, P169, DOI 10.1136/jnnp.62.2.169; Sim KG, 2002, CLIN CHIM ACTA, V323, P37, DOI 10.1016/S0009-8981(02)00182-1; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Tamai I, 1998, J BIOL CHEM, V273, P20378, DOI 10.1074/jbc.273.32.20378; VAARTJES WJ, 1972, FEBS LETT, V23, P303, DOI 10.1016/0014-5793(72)80302-8; Ventura FV, 2007, BIOCHEM BIOPH RES CO, V352, P873, DOI 10.1016/j.bbrc.2006.11.109; Ventura FV, 2005, MOL GENET METAB, V86, P344, DOI 10.1016/j.ymgme.2005.07.030; Ventura FV, 1998, EUR J BIOCHEM, V253, P614, DOI 10.1046/j.1432-1327.1998.2530614.x; Violante S, 2010, BBA-MOL BASIS DIS, V1802, P728, DOI 10.1016/j.bbadis.2010.06.002; Vreken P, 1999, J INHERIT METAB DIS, V22, P302, DOI 10.1023/A:1005587617745; WOLDEGIORGIS G, 1982, J BIOL CHEM, V257, P4783; Wu X, 1998, BIOCHEM BIOPH RES CO, V246, P589, DOI 10.1006/bbrc.1998.8669; Wu X, 1999, J PHARMACOL EXP THER, V290, P1482	30	42	44	1	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2013	27	5					2039	2044		10.1096/fj.12-216689	http://dx.doi.org/10.1096/fj.12-216689			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	134PU	23322164				2022-12-25	WOS:000318226100023
J	Raines, SM; Rane, HS; Bernardo, SM; Binder, JL; Lee, SA; Parra, KJ				Raines, Summer M.; Rane, Hallie S.; Bernardo, Stella M.; Binder, Jessica L.; Lee, Samuel A.; Parra, Karlett J.			Deletion of Vacuolar Proton-translocating ATPase V(o)a Isoforms Clarifies the Role of Vacuolar pH as a Determinant of Virulence-associated Traits in Candida albicans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST V-ATPASE; H+-ATPASE; AMINO-ACIDS; PHOSPHATIDYLINOSITOL 3-KINASE; ANTIFUNGAL SUSCEPTIBILITY; SACCHAROMYCES-CEREVISIAE; CRYPTOCOCCUS-NEOFORMANS; MEMBRANE-VESICLES; GENE ENCODES; SUBUNIT	Vacuolar proton-translocating ATPase (V-ATPase) is a central regulator of cellular pH homeostasis, and inactivation of all V-ATPase function has been shown to prevent infectivity in Candida albicans. V-ATPase subunit a of the V-o domain (V(o)a) is present as two fungal isoforms: Stv1p (Golgi) and Vph1p (vacuole). To delineate the individual contribution of Stv1p and Vph1p to C. albicans physiology, we created stv1 Delta/Delta and vph1 Delta/Delta mutants and compared them to the corresponding reintegrant strains (stv1 Delta/Delta R and vph1 Delta/Delta R). V-ATPase activity, vacuolar physiology, and in vitro virulence-related phenotypes were unaffected in the stv1 Delta/Delta mutant. The vph1 Delta/Delta mutant exhibited defective V1Vo assembly and a 90% reduction in concanamycin A-sensitive ATPase activity and proton transport in purified vacuolar membranes, suggesting that the Vph1p isoform is essential for vacuolar V-ATPase activity in C. albicans. The vph1 Delta/Delta cells also had abnormal endocytosis and vacuolar morphology and an alkalinized vacuolar lumen (pH(vph1)Delta/Delta = 6.8 versus pH(vph1) Delta/Delta(R) = 5.8) in both yeast cells and hyphae. Secreted protease and lipase activities were significantly reduced, and M199-induced filamentation was impaired in the vph1 Delta/Delta mutant. However, the vph1 Delta/Delta cells remained competent for filamentation induced by Spider media and YPD, 10% FCS, and biofilm formation and macrophage killing were unaffected in vitro. These studies suggest that different virulence mechanisms differentially rely on acidified vacuoles and that the loss of both vacuolar (Vph1p) and non-vacuolar (Stv1p) V-ATPase activity is necessary to affect in vitro virulence-related phenotypes. As a determinant of C. albicans pathogenesis, vacuolar pH alone may prove less critical than originally assumed.	[Raines, Summer M.; Binder, Jessica L.; Parra, Karlett J.] Univ New Mexico, Dept Biochem & Mol Biol, Hlth Sci Ctr, Sch Med, Albuquerque, NM 87131 USA; [Bernardo, Stella M.; Lee, Samuel A.] Univ New Mexico, Dept Internal Med, Hlth Sci Ctr, Sch Med, Albuquerque, NM 87131 USA; [Rane, Hallie S.; Bernardo, Stella M.; Lee, Samuel A.; Parra, Karlett J.] New Mexico Vet Healthcare Syst, Infect Dis Sect, Albuquerque, NM 87108 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center	Parra, KJ (corresponding author), Univ New Mexico, Dept Biochem & Mol Biol, MSC08 4670, Albuquerque, NM 87131 USA.	kjparra@salud.unm.edu		Binder, Jessica/0000-0003-2091-3950	National Institutes of Health [5R01GM086495, K12GM088021, 5T32AI007538-13]; Department of Veterans Affairs MERIT Award; Biomedical Research Institute of New Mexico; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM088021, R01GM086495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs MERIT Award(US Department of Veterans Affairs); Biomedical Research Institute of New Mexico; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01GM086495 (to K. J. P.), K12GM088021 (to S. M. R.), and 5T32AI007538-13 (to S. M. B.). The work was also supported by a Department of Veterans Affairs MERIT Award (to S. A. L.) and a Biomedical Research Institute of New Mexico grant (to S. A. L.).	Augsten M, 2002, INFECT IMMUN, V70, P4462, DOI 10.1128/IAI.70.8.4462-4470.2002; Bayer MJ, 2003, J CELL BIOL, V162, P211, DOI 10.1083/jcb.200212004; Bernardo SM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-133; Bruckmann A, 2000, MICROBIOL-SGM, V146, P2755, DOI 10.1099/00221287-146-11-2755; Chan CY, 2012, J BIOL CHEM, V287, P10236, DOI 10.1074/jbc.M111.321133; CRANDALL M, 1987, J GEN MICROBIOL, V133, P2817; Davis D, 2000, MOL CELL BIOL, V20, P971, DOI 10.1128/MCB.20.3.971-978.2000; Davis DA, 2009, CURR OPIN MICROBIOL, V12, P365, DOI 10.1016/j.mib.2009.05.006; DOHERTY RD, 1993, J BIOL CHEM, V268, P16845; Eck R, 2005, INT J MED MICROBIOL, V295, P57, DOI 10.1016/j.ijmm.2004.12.007; Efeyan A, 2012, TRENDS MOL MED, V18, P524, DOI 10.1016/j.molmed.2012.05.007; Erickson T, 2001, MOL MICROBIOL, V42, P1121, DOI 10.1046/j.1365-2958.2001.02712.x; Finnigan GC, 2012, J BIOL CHEM, V287, P19487, DOI 10.1074/jbc.M112.343814; FORGAC M, 1983, P NATL ACAD SCI-BIOL, V80, P1300, DOI 10.1073/pnas.80.5.1300; Fu Y, 1997, MICROBIOL-UK, V143, P331, DOI 10.1099/00221287-143-2-331; GRAHAM LA, 1994, J BIOL CHEM, V269, P25974; Gustavsson M, 2008, MOL GENET GENOMICS, V280, P233, DOI 10.1007/s00438-008-0359-9; Hilty J, 2008, MOL MICROBIOL, V70, P127, DOI 10.1111/j.1365-2958.2008.06395.x; Horn DL, 2009, CLIN INFECT DIS, V48, P1695, DOI 10.1086/599039; Huang CJ, 2011, J BIOL CHEM, V286, P10058, DOI 10.1074/jbc.M110.197889; Ishimoto M, 2012, BIOSCI BIOTECH BIOCH, V76, P1802, DOI 10.1271/bbb.120372; Jia N, 2002, ANTIMICROB AGENTS CH, V46, P947, DOI 10.1128/AAC.46.4.947-957.2002; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Karkowska-Kuleta J, 2009, ACTA BIOCHIM POL, V56, P211; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Kawasaki-Nishi S, 2001, P NATL ACAD SCI USA, V98, P12397, DOI 10.1073/pnas.221291798; Kretschmar M, 2002, MICROB PATHOGENESIS, V32, P61, DOI 10.1006/mpat.2001.0478; Lee SA, 2009, MYCOPATHOLOGIA, V167, P55, DOI 10.1007/s11046-008-9155-7; Lin M, 2012, EUKARYOT CELL, V11, P442, DOI 10.1128/EC.05286-11; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; MANOLSON MF, 1992, J EXP BIOL, V172, P105; MANOLSON MF, 1992, J BIOL CHEM, V267, P14294; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; Mavor AL, 2005, CURR DRUG TARGETS, V6, P863, DOI 10.2174/138945005774912735; Michel V, 2013, INT J CANCER, V132, pE1, DOI 10.1002/ijc.27811; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Owegi MA, 2005, J BIOL CHEM, V280, P18393, DOI 10.1074/jbc.M412567200; Owegi MA, 2006, J BIOL CHEM, V281, P30001, DOI 10.1074/jbc.M605006200; Palanisamy SKA, 2010, EUKARYOT CELL, V9, P266, DOI 10.1128/EC.00295-09; Palmer GE, 2005, EUKARYOT CELL, V4, P1677, DOI 10.1128/EC.4.10.1677-1686.2005; Palmer Glen E, 2011, Commun Integr Biol, V4, P240, DOI 10.4161/cib.4.2.14717; Palmer GE, 2010, EUKARYOT CELL, V9, P1755, DOI 10.1128/EC.00029-10; Parra K. J., 2012, EMERGING STRATEGIES, P89; Perzov N, 2002, J EXP BIOL, V205, P1209; Perzov N, 2000, J BIOL CHEM, V275, P40088, DOI 10.1074/jbc.M007011200; Plant PJ, 1999, J BIOL CHEM, V274, P37270, DOI 10.1074/jbc.274.52.37270; Poltermann S, 2005, MICROBIOL-SGM, V151, P1645, DOI 10.1099/mic.0.27505-0; Ramage G, 2005, METH MOLEC MED, V118, P71; Richardson MD, 2005, J ANTIMICROB CHEMOTH, V56, P5, DOI 10.1093/jac/dki218; SATO T, 1984, J BIOL CHEM, V259, P1505; Shoji JY, 2006, EUKARYOT CELL, V5, P411, DOI 10.1128/EC.5.2.411-421.2006; STEWART E, 1988, J GEN MICROBIOL, V134, P1079; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; Tarsio M, 2011, J BIOL CHEM, V286, P28089, DOI 10.1074/jbc.M111.251363; Tobudic S, 2012, MYCOSES, V55, P199, DOI 10.1111/j.1439-0507.2011.02076.x; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; van de Veerdonk FL, 2010, CURR OPIN CRIT CARE, V16, P453, DOI 10.1097/MCC.0b013e32833e046e; Veses V, 2008, CURR OPIN MICROBIOL, V11, P503, DOI 10.1016/j.mib.2008.09.017; Weissman Z, 2008, MOL MICROBIOL, V69, P201, DOI 10.1111/j.1365-2958.2008.06277.x; Wilson RB, 2000, YEAST, V16, P65, DOI 10.1002/(SICI)1097-0061(20000115)16:1&lt;65::AID-YEA508&gt;3.0.CO;2-M; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Zhang Yong-Qiang, 2010, Virulence, V1, P551, DOI 10.4161/viru.1.6.13802; Zhang YQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000939	65	28	31	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6190	6201		10.1074/jbc.M112.426197	http://dx.doi.org/10.1074/jbc.M112.426197			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23316054	hybrid, Green Published			2022-12-25	WOS:000315820700015
J	Dumurgier, J; Mouton-Liger, F; Lapalus, P; Prevot, M; Laplanche, JL; Hugon, J; Paquet, C				Dumurgier, Julien; Mouton-Liger, Francois; Lapalus, Pauline; Prevot, Magali; Laplanche, Jean-Louis; Hugon, Jacques; Paquet, Claire		Grp Invest Liquide Cephalorachidie	Cerebrospinal Fluid PKR Level Predicts Cognitive Decline in Alzheimer's Disease	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; CSF BIOMARKERS PREDICT; PHOSPHORYLATION; ASSOCIATION; PROGRESSION; ACTIVATION	The cerebrospinal fluid (CSF) levels of the proapoptotic kinase R (PKR) and its phosphorylated PKR (pPKR) are increased in Alzheimer's disease (AD), but whether CSF PKR concentrations are associated with cognitive decline in AD patients remain unknown. In this study, 41 consecutive patients with AD and 11 patients with amnestic mild cognitive impairment (aMCI) from our Memory Clinic were included. A lumbar puncture was performed during the following month of the clinical diagnosis and Mini-Mental State Examination (MMSE) evaluations were repeated every 6 months during a mean follow-up of 2 years. In AD patients, linear mixed models adjusted for age and sex were used to assess the cross-sectional and longitudinal associations between MMSE scores and baseline CSF levels of A beta peptide (A beta 1-42), Tau, phosphorylated Tau (p-Tau 181), PKR and pPKR. The mean (SD) MMSE at baseline was 20.5 (6.1) and MMSE scores declined over the follow-up (-0.12 point/month, standard error [SE] = 0.03). A lower MMSE at baseline was associated with lower levels of CSF A beta 1-42 and p-Tau 181/Tau ratio. pPKR level was associated with longitudinal MMSE changes over the follow-up, higher pPKR levels being related with an exacerbated cognitive deterioration. Other CSF biomarkers were not associated with MMSE changes over time. In aMCI patients, mean CSF biomarker levels were not different in patients who converted to AD from those who did not convert. These results suggest that at the time of AD diagnosis, a higher level of CSF pPKR can predict a faster rate of cognitive decline.	[Dumurgier, Julien; Lapalus, Pauline; Prevot, Magali; Hugon, Jacques; Paquet, Claire] Univ Paris Diderot, Paris Nord Ile France St Louis Lariboisiere Ferna, AP HP, Clin & Res Memory Ctr, Paris, France; [Dumurgier, Julien; Mouton-Liger, Francois; Hugon, Jacques; Paquet, Claire] Inserm, UMR S 839, Inst Fer Moulin, Paris, France; [Laplanche, Jean-Louis] Univ Paris Diderot, St Louis Lariboisiere Fernand Hosp, AP HP, Dept Biochem, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Hugon, J (corresponding author), Univ Paris Diderot, Paris Nord Ile France St Louis Lariboisiere Ferna, AP HP, Clin & Res Memory Ctr, Paris, France.	jacques.hugon@lrb.aphp.fr	LAPLANCHE, Jean-Louis/S-8707-2016; Dumurgier, Julien/G-2400-2017; Peoc'h, Katell/V-1604-2017; Mouton-Liger, Francois/A-3234-2016	Dumurgier, Julien/0000-0003-2070-9706; Peoc'h, Katell/0000-0002-8203-1243; Mouton-Liger, Francois/0000-0001-8172-6548; LAPLANCHE, Jean-Louis/0000-0003-2836-2903	Assistance publique hopitaux de Paris and Inserm	Assistance publique hopitaux de Paris and Inserm	This study was supported by Assistance publique hopitaux de Paris and Inserm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Bose A, 2011, BRAIN PATHOL, V21, P189, DOI 10.1111/j.1750-3639.2010.00437.x; Burns A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b158; Chang RCC, 2002, J NEUROCHEM, V83, P1215, DOI 10.1046/j.1471-4159.2002.01237.x; Chui HC, 2006, ANN NEUROL, V60, P677, DOI 10.1002/ana.21009; Dumurgier J, 2010, NEUROBIOL DIS, V40, P456, DOI 10.1016/j.nbd.2010.07.007; Duyckaerts C, 2009, ACTA NEUROPATHOL, V118, P5, DOI 10.1007/s00401-009-0532-1; Fjell AM, 2010, J NEUROSCI, V30, P2088, DOI 10.1523/JNEUROSCI.3785-09.2010; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Henneman WJP, 2009, NEUROLOGY, V73, P935, DOI 10.1212/WNL.0b013e3181b879ac; Hugon J, 2009, EXPERT REV NEUROTHER, V9, P1455, DOI [10.1586/ern.09.92, 10.1586/ERN.09.92]; Ill-Raga G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021456; Ito K, 2010, ALZHEIMERS DEMENT, V6, P39, DOI 10.1016/j.jalz.2009.05.665; Jack CR, 2012, ANN NEUROL, V71, P765, DOI 10.1002/ana.22628; Kester MI, 2009, NEUROLOGY, V73, P1353, DOI 10.1212/WNL.0b013e3181bd8271; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mouton-Liger F, 2012, BBA-MOL BASIS DIS, V1822, P885, DOI 10.1016/j.bbadis.2012.01.009; Mouton-Liger F, 2012, BIOL PSYCHIAT, V71, P829, DOI 10.1016/j.biopsych.2011.11.031; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Seppala TT, 2012, NEUROLOGY, V78, P1568, DOI 10.1212/WNL.0b013e3182563bd0; Tapiola T, 2000, NEUROBIOL AGING, V21, P735, DOI 10.1016/S0197-4580(00)00164-0; Tarawneh R, 2012, NEUROLOGY, V78, P709, DOI 10.1212/WNL.0b013e318248e568; Tarawneh R, 2011, ANN NEUROL, V70, P274, DOI 10.1002/ana.22448; Vemuri P, 2010, ANN NEUROL, V67, P308, DOI 10.1002/ana.21953; Wallin AK, 2010, NEUROLOGY, V74, P1531, DOI 10.1212/WNL.0b013e3181dd4dd8; Wang L, 2011, ALZHEIMER DIS ASS DI; Zamanian-Daryoush M, 2000, MOL CELL BIOL, V20, P1278, DOI 10.1128/MCB.20.4.1278-1290.2000	27	45	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53587	10.1371/journal.pone.0053587	http://dx.doi.org/10.1371/journal.pone.0053587			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320095	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429800060
J	Teixido, C; Mares, R; Aracil, M; Cajal, SRY; Hernandez-Losa, J				Teixido, Cristina; Mares, Roso; Aracil, Miguel; Ramon y Cajal, Santiago; Hernandez-Losa, Javier			Epithelial-Mesenchymal Transition Markers and HER3 Expression Are Predictors of Elisidepsin Treatment Response in Breast and Pancreatic Cancer Cell Lines	PLOS ONE			English	Article							KAHALALIDE-F; E-CADHERIN; TUMOR PROGRESSION; STRUCTURAL BASIS; PROSTATE-CANCER; ERBB3; ADHESION; MECHANISM; COMPOUND; PM02734	Elisidepsin (elisidepsin trifluoroacetate, Irvalec(R), PM02734) is a new synthetic depsipeptide, a result of the PharmaMar Development Program that seeks synthetic products of marine origin-derived compounds. Elisidepsin is a drug with antiproliferative activity in a wide range of tumors. In the present work we studied and characterized the mechanisms associated with sensitivity and resistance to elisidepsin treatment in a broad panel of tumor cell lines from breast and pancreas carcinomas, focusing on different factors involved in epithelial-mesenchymal transition (EMT) and the use of HER family receptors in predicting the in vitro drug response. Interestingly, we observed that the basal protein expression levels of EMT markers show a significant correlation with cell viability in response to elisidepsin treatment in a panel of 12 different breast and pancreatic cancer cell lines. In addition, we generated three elisidepsin treatment-resistant cell lines (MCF-7, HPAC and AsPC-1) and analyzed the pattern of expression of different EMT markers in these cells, confirming that acquired resistance to elisidepsin is associated with a switch to the EMT state. Furthermore, a direct correlation between basal HER3 expression and sensitivity to elisidepsin was observed; moreover, modulation of HER3 expression levels in different cancer cell lines alter their sensitivities to the drug, making them more resistant when HER3 expression is downregulated by a HER3-specific short hairpin RNA and more sensitive when the receptor is overexpressed. These results show that HER3 expression is an important marker of sensitivity to elisidepsin treatment.	[Teixido, Cristina; Mares, Roso] Univ Autonoma Barcelona, Vall Hebron Univ Inst, Mol Pathol Grp, E-08193 Barcelona, Spain; [Aracil, Miguel] Pharmamar, Madrid, Spain; [Ramon y Cajal, Santiago; Hernandez-Losa, Javier] Univ Autonoma Barcelona, Vall Hebron Univ Hosp, Dept Pathol, E-08193 Barcelona, Spain	Autonomous University of Barcelona; PharmaMar; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron	Hernandez-Losa, J (corresponding author), Univ Autonoma Barcelona, Vall Hebron Univ Hosp, Dept Pathol, E-08193 Barcelona, Spain.	jahernan@vhebron.net	Javier, Hernandez Losa/C-1173-2008; Ramon y Cajal, Santiago/H-4955-2016; Teixido, Cristina/I-4505-2019	Javier, Hernandez Losa/0000-0003-1526-3201; Ramon y Cajal, Santiago/0000-0002-3867-1390; Teixido, Cristina/0000-0002-7226-6567; mares, Roso/0000-0002-7339-0172	Pharmamar Company; CENIT [CEN-2009-1016]	Pharmamar Company; CENIT	This work has been partially funded by Pharmamar Company and by CENIT grant (CEN-2009-1016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; CIARDIELLO F, 1991, P NATL ACAD SCI USA, V88, P7792, DOI 10.1073/pnas.88.17.7792; Friess H, 1995, CLIN CANCER RES, V1, P1413; GarciaRocha M, 1996, CANCER LETT, V99, P43, DOI 10.1016/0304-3835(95)04036-6; Gomez SG, 2003, EXP HEMATOL, V31, P1104, DOI 10.1016/j.exphem.2003.07.004; Hama H, 2000, FEBS LETT, V478, P26, DOI 10.1016/S0014-5793(00)01821-4; Hamann MT, 1996, J ORG CHEM, V61, P6594, DOI 10.1021/jo960877+; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Herrero AB, 2008, CANCER RES, V68, P9779, DOI 10.1158/0008-5472.CAN-08-1981; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Janmaat ML, 2005, MOL PHARMACOL, V68, P502, DOI 10.1124/mol.105.011361; Koumakpayi IH, 2006, CLIN CANCER RES, V12, P2730, DOI 10.1158/1078-0432.CCR-05-2242; Kountourakis P, 2006, CANCER J, V12, P229, DOI 10.1097/00130404-200605000-00012; LEMOINE NR, 1992, BRIT J CANCER, V66, P1116, DOI 10.1038/bjc.1992.420; Ling YH, 2009, EUR J CANCER, V45, P1855, DOI 10.1016/j.ejca.2009.03.003; Lozano JJ, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-109; Molina-Guijarro JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019042; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; NAGAFUCHI A, 1987, NATURE, V329, P341, DOI 10.1038/329341a0; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; Naidu R, 1998, BRIT J CANCER, V78, P1385, DOI 10.1038/bjc.1998.689; NYHOLM PG, 1990, CHEM PHYS LIPIDS, V52, P1, DOI 10.1016/0009-3084(90)90002-9; PATEL DJ, 1995, NATURE, V374, P306, DOI 10.1038/374306a0; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Sewell JM, 2005, EUR J CANCER, V41, P1637, DOI 10.1016/j.ejca.2005.04.015; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Shilabin AG, 2007, J MED CHEM, V50, P4340, DOI 10.1021/jm061288r; Suarez Y, 2003, MOL CANCER THER, V2, P863; Tanner B, 2006, J CLIN ONCOL, V24, P4317, DOI 10.1200/JCO.2005.04.8397; Teixido C, 2012, INT J ONCOL; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Varadi T, 2011, EUR J PHARMACOL, V667, P91, DOI 10.1016/j.ejphar.2011.05.064; Wosikowski K, 1997, JNCI-J NATL CANCER I, V89, P1505, DOI 10.1093/jnci/89.20.1505; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545	41	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53645	10.1371/journal.pone.0053645	http://dx.doi.org/10.1371/journal.pone.0053645			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320098	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429800063
J	Zhou, D; Li, ST; Zhang, XH; Cai, D				Zhou, Douglas; Li, Songting; Zhang, Xiao-hui; Cai, David			Phenomenological Incorporation of Nonlinear Dendritic Integration Using Integrate-and-Fire Neuronal Frameworks	PLOS ONE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; SHUNTING INHIBITION; SUPRALINEAR SUMMATION; SPIKING NEURONS; MODEL; CORTEX; CELLS; OSCILLATIONS; POTENTIALS; EXCITATION	It has been discovered recently in experiments that the dendritic integration of excitatory glutamatergic inputs and inhibitory GABAergic inputs in hippocampus CA1 pyramidal neurons obeys a simple arithmetic rule as V-S(Exp) approximate to V-E(Exp) + V-I(Exp) + kV(E)(Exp) V-I(Exp), where V-S(Exp), V-E(Exp) and V-I(Exp) are the respective voltage values of the summed somatic potential, the excitatory postsynaptic potential (EPSP) and the inhibitory postsynaptic potential measured at the time when the EPSP reaches its peak value. Moreover, the shunting coefficient k in this rule only depends on the spatial location but not the amplitude of the excitatory or inhibitory input on the dendrite. In this work, we address the theoretical issue of how much the above dendritic integration rule can be accounted for using subthreshold membrane potential dynamics in the soma as characterized by the conductance-based integrate-and-fire (I&F) model. Then, we propose a simple I&F neuron model that incorporates the spatial dependence of the shunting coefficient k by a phenomenological parametrization. Our analytical and numerical results show that this dendritic-integration-rule-based I&F (DIF) model is able to capture many experimental observations and it also yields predictions that can be used to verify the validity of the DIF model experimentally. In addition, the DIF model incorporates the dendritic integration effects dynamically and is applicable to more general situations than those in experiments in which excitatory and inhibitory inputs occur simultaneously in time. Finally, we generalize the DIF neuronal model to incorporate multiple inputs and obtain a similar dendritic integration rule that is consistent with the results obtained by using a realistic neuronal model with multiple compartments. This generalized DIF model can potentially be used to study network dynamics that may involve effects arising from dendritic integrations.	[Zhou, Douglas; Li, Songting; Cai, David] Shanghai Jiao Tong Univ, Dept Math, MOE LSC, Shanghai 200030, Peoples R China; [Zhou, Douglas; Li, Songting; Cai, David] Shanghai Jiao Tong Univ, Inst Nat Sci, Shanghai 200030, Peoples R China; [Zhang, Xiao-hui] Chinese Acad Sci, Inst Neurosci, Shanghai, Peoples R China; [Zhang, Xiao-hui] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Shanghai, Peoples R China; [Cai, David] NYU, Courant Inst Math Sci, New York, NY USA; [Cai, David] NYU, Ctr Neural Sci, New York, NY 10003 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; New York University; New York University	Cai, D (corresponding author), Shanghai Jiao Tong Univ, Dept Math, MOE LSC, Shanghai 200030, Peoples R China.	sdcai@sjtu.edu.cn	Zhou, Douglas/E-5428-2019	Zhou, Douglas/0000-0001-6631-2961	Shanghai Pujiang Program [10PJ1406300]; NSFC [11101275]; 973 Program [2011CBA00403]; SA-SIBS Scholarship Program; NSF [DMS-1009575]; Shanghai Jiao Tong University	Shanghai Pujiang Program(Shanghai Pujiang Program); NSFC(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); SA-SIBS Scholarship Program; NSF(National Science Foundation (NSF)); Shanghai Jiao Tong University	This work was supported by Shanghai Pujiang Program (Grant No. 10PJ1406300), NSFC (Grant No. 11101275), 973 Program (2011CBA00403) and the SA-SIBS Scholarship Program, NSF grant DMS-1009575, an R&D Grant from Shanghai Jiao Tong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel M, 2005, J NEUROPHYSIOL, V93, P1959, DOI 10.1152/jn.00214.2004; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Badel L, 2008, BIOL CYBERN, V99, P361, DOI 10.1007/s00422-008-0259-4; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; BURKE RE, 1967, J NEUROPHYSIOL, V30, P1114, DOI 10.1152/jn.1967.30.5.1114; Carandini M, 1996, J NEUROPHYSIOL, V76, P3425, DOI 10.1152/jn.1996.76.5.3425; Carnevale NT, 2006, NEURON BOOK; Cash S, 1998, J NEUROSCI, V18, P10; Chacron MJ, 2006, J NEUROPHYSIOL, V95, P2933, DOI 10.1152/jn.01296.2005; David F, 2008, J COMPUT NEUROSCI, V25, P25, DOI 10.1007/s10827-007-0063-5; Dayan P., 2001, THEORETICAL NEUROSCI; Feng HF, 2001, NEURAL NETWORKS, V14, P955, DOI 10.1016/S0893-6080(01)00074-0; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Hao J, 2009, P NATL ACAD SCI USA, V106, P21906, DOI 10.1073/pnas.0912022106; Hausser M, 2003, CURR OPIN NEUROBIOL, V13, P372, DOI 10.1016/S0959-4388(03)00075-8; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Koch C, 2005, BIOPHYSICS COMPUTATI; KUNO M, 1969, J PHYSIOL-LONDON, V201, P465, DOI 10.1113/jphysiol.1969.sp008767; Lapicque L., 1907, J PHYSIOL PATH GEN, V9, P620, DOI DOI 10.1007/S00422-007-0189-6; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Margulis M, 1998, J NEUROPHYSIOL, V79, P2809, DOI 10.1152/jn.1998.79.5.2809; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; Nettleton JS, 2000, J NEUROPHYSIOL, V83, P3310, DOI 10.1152/jn.2000.83.6.3310; Poirazi P, 2003, NEURON, V37, P977, DOI 10.1016/S0896-6273(03)00148-X; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Rall W., 1995, THEORETICAL FDN DEND; Rall W, 1964, NEURAL THEORY MODELI, P122; ROSE RM, 1989, PROC R SOC SER B-BIO, V237, P267, DOI 10.1098/rspb.1989.0049; Schwindt PC, 1998, J NEUROPHYSIOL, V79, P2432, DOI 10.1152/jn.1998.79.5.2432; Smith GD, 2000, J NEUROPHYSIOL, V83, P588, DOI 10.1152/jn.2000.83.1.588; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Vida I, 2006, NEURON, V49, P107, DOI 10.1016/j.neuron.2005.11.036; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wilson HR, 1999, J THEOR BIOL, V200, P375, DOI 10.1006/jtbi.1999.1002	41	9	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53508	10.1371/journal.pone.0053508	http://dx.doi.org/10.1371/journal.pone.0053508			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308241	gold, Green Published			2022-12-25	WOS:000313429100079
J	Zou, ZW; Ishida, M; Li, F; Kakizaki, T; Suzuki, S; Kitashiba, H; Nishio, T				Zou, Zhongwei; Ishida, Masahiko; Li, Feng; Kakizaki, Tomohiro; Suzuki, Sho; Kitashiba, Hiroyasu; Nishio, Takeshi			QTL Analysis Using SNP Markers Developed by Next-Generation Sequencing for Identification of Candidate Genes Controlling 4-Methylthio-3-Butenyl Glucosinolate Contents in Roots of Radish, Raphanus sativus L	PLOS ONE			English	Article							CHAIN ELONGATION; BRASSICA-JUNCEA; LINKAGE MAP; BIOSYNTHESIS; TRAIT; LOCI; BIOAVAILABILITY; RESISTANCE; CATALYZES; DENSITY	SNP markers for QTL analysis of 4-MTB-GSL contents in radish roots were developed by determining nucleotide sequences of bulked PCR products using a next-generation sequencer. DNA fragments were amplified from two radish lines by multiplex PCR with six primer pairs, and those amplified by 2,880 primer pairs were mixed and sequenced. By assembling sequence data, 1,953 SNPs in 750 DNA fragments, 437 of which have been previously mapped in a linkage map, were identified. A linkage map of nine linkage groups was constructed with 188 markers, and five QTLs were detected in two F-2 populations, three of them accounting for more than 50% of the total phenotypic variance being repeatedly detected. In the identified QTL regions, nine SNP markers were newly produced. By synteny analysis of the QTLs regions with Arabidopsis thaliana and Brassica rapa genome sequences, three candidate genes were selected, i.e., RsMAM3 for production of aliphatic glucosinolates linked to GSL-QTL-4, RsIPMDH1 for leucine biosynthesis showing strong co-expression with glucosinolate biosynthesis genes linked to GSL-QTL-2, and RsBCAT4 for branched-chain amino acid aminotransferase linked to GSL-QTL-1. Nucleotide sequences and expression of these genes suggested their possible function in 4MTB-GSL biosynthesis in radish roots.	[Zou, Zhongwei; Li, Feng; Suzuki, Sho; Kitashiba, Hiroyasu; Nishio, Takeshi] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 980, Japan; [Ishida, Masahiko; Kakizaki, Tomohiro] NARO Inst Vegetable & Tea Sci, Tsu, Mie, Japan	Tohoku University	Nishio, T (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 980, Japan.	nishio@bios.tohoku.ac.jp	Zou, Zhongwei/AAE-9108-2020; KAKIZAKI, Tomohiro/E-6304-2011	KAKIZAKI, Tomohiro/0000-0002-3636-6616; Zou, Zhongwei/0000-0002-8955-1153	Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (BRAIN), Japan	Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (BRAIN), Japan	This work was supported by the Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (BRAIN), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bett KE, 2003, GENOME, V46, P423, DOI [10.1139/g03-026, 10.1139/G03-026]; Bisht NC, 2009, THEOR APPL GENET, V118, P413, DOI 10.1007/s00122-008-0907-z; Bjerg B, 1987, GLUCOSINOLATES RAPES, P125; Brader G, 2006, PLANT J, V46, P758, DOI 10.1111/j.1365-313X.2006.02743.x; Brautigam A, 2010, PLANT BIOLOGY, V12, P831, DOI 10.1111/j.1438-8677.2010.00373.x; Budahn H, 2009, THEOR APPL GENET, V118, P775, DOI 10.1007/s00122-008-0937-6; CARLSON DG, 1985, J AM SOC HORTIC SCI, V110, P634; Chen SX, 2003, PLANT J, V33, P923, DOI 10.1046/j.1365-313X.2003.01679.x; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Field B, 2004, PLANT PHYSIOL, V135, P828, DOI 10.1104/pp.104.039347; Gigolashvili T, 2009, PLANT CELL, V21, P1813, DOI 10.1105/tpc.109.066399; Grubb CD, 2006, TRENDS PLANT SCI, V11, P89, DOI 10.1016/j.tplants.2005.12.006; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hansen CH, 2001, J BIOL CHEM, V276, P11078, DOI 10.1074/jbc.M010123200; He Y, 2009, PLANT J, V60, P679, DOI 10.1111/j.1365-313X.2009.03990.x; Hemm MR, 2003, PLANT CELL, V15, P179, DOI 10.1105/tpc.006544; Hirai MY, 2007, P NATL ACAD SCI USA, V104, P6478, DOI 10.1073/pnas.0611629104; Holst B, 2004, NAT PROD REP, V21, P425, DOI 10.1039/b204039p; Ishida M, 2012, BREEDING SCI, V62, P63, DOI 10.1270/jsbbs.62.63; Ishida M, 2011, BREEDING SCI, V61, P208, DOI 10.1270/jsbbs.61.208; ISHII G, 1987, J JPN SOC HORTIC SCI, V56, P313, DOI 10.2503/jjshs.56.313; Kamei A, 2010, THEOR APPL GENET, V120, P1021, DOI 10.1007/s00122-009-1230-z; Kaplinski L, 2005, BIOINFORMATICS, V21, P1701, DOI 10.1093/bioinformatics/bti219; Kroymann J, 2003, P NATL ACAD SCI USA, V100, P14587, DOI 10.1073/pnas.1734046100; Kroymann J, 2001, PLANT PHYSIOL, V127, P1077, DOI 10.1104/pp.010416; Li F, 2011, DNA RES, V18, P401, DOI 10.1093/dnares/dsr027; Lou P, 2008, NEW PHYTOL, V179, P1017, DOI 10.1111/j.1469-8137.2008.02530.x; Mithen RF, 2000, J SCI FOOD AGR, V80, P967, DOI [10.1002/(SICI)1097-0010(20000515)80:7<967::AID-JSFA597>3.0.CO;2-V, 10.1002/(SICI)1097-0010(20000515)80:7&lt;967::AID-JSFA597&gt;3.0.CO;2-V]; Naur P, 2003, PLANT PHYSIOL, V133, P63, DOI 10.1104/pp.102.019240; Ramchiary N, 2007, THEOR APPL GENET, V116, P77, DOI 10.1007/s00122-007-0648-4; Sawada Y, 2009, PLANT CELL PHYSIOL, V50, P1181, DOI 10.1093/pcp/pcp079; Schuster J, 2006, PLANT CELL, V18, P2664, DOI 10.1105/tpc.105.039339; Shiokai S, 2010, PLANT CELL REP, V29, P829, DOI 10.1007/s00299-010-0867-z; Shiokai S, 2010, MOL BREEDING, V25, P179, DOI 10.1007/s11032-009-9315-6; Shirasawa K, 2011, DNA RES, V18, P221, DOI 10.1093/dnares/dsr013; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Textor S, 2007, PLANT PHYSIOL, V144, P60, DOI 10.1104/pp.106.091579; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; Tsuro M, 2005, BREEDING SCI, V55, P107, DOI 10.1270/jsbbs.55.107; Van Ooijen J.W., 2006, JOINMAP 4 0 SOFTWARE; Wang H, 2011, GENE, V487, P135, DOI 10.1016/j.gene.2011.07.021; Wang S., 2007, WINDOWS QTL CARTOGRA; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wittstock U, 2002, TRENDS PLANT SCI, V7, P263, DOI 10.1016/S1360-1385(02)02273-2; Zang YX, 2009, FEBS J, V276, P3559, DOI 10.1111/j.1742-4658.2009.07076.x	46	31	35	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53541	10.1371/journal.pone.0053541	http://dx.doi.org/10.1371/journal.pone.0053541			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308250	gold, Green Published, Green Submitted			2022-12-25	WOS:000313429100087
J	Auburn, S; Marfurt, J; Maslen, G; Campino, S; Rubio, VR; Manske, M; MacHunter, B; Kenangalem, E; Noviyanti, R; Trianty, L; Sebayang, B; Wirjanata, G; Sriprawat, K; Alcock, D; MacInnis, B; Miotto, O; Clark, TG; Russell, B; Anstey, NM; Nosten, F; Kwiatkowski, DP; Price, RN				Auburn, Sarah; Marfurt, Jutta; Maslen, Gareth; Campino, Susana; Rubio, Valentin Ruano; Manske, Magnus; MacHunter, Barbara; Kenangalem, Enny; Noviyanti, Rintis; Trianty, Leily; Sebayang, Boni; Wirjanata, Grennady; Sriprawat, Kanlaya; Alcock, Daniel; MacInnis, Bronwyn; Miotto, Olivo; Clark, Taane G.; Russell, Bruce; Anstey, Nicholas M.; Nosten, Francois; Kwiatkowski, Dominic P.; Price, Ric N.			Effective Preparation of Plasmodium vivax Field Isolates for High-Throughput Whole Genome Sequencing	PLOS ONE			English	Article							HUMAN MALARIA PARASITE; CHLOROQUINE RESISTANCE; FALCIPARUM; AMPLIFICATION; SAMPLES; BLOOD; INFECTIONS; SELECTION; DISEASE; BENIGN	Whole genome sequencing (WGS) of Plasmodium vivax is problematic due to the reliance on clinical isolates which are generally low in parasitaemia and sample volume. Furthermore, clinical isolates contain a significant contaminating background of host DNA which confounds efforts to map short read sequence of the target P. vivax DNA. Here, we discuss a methodology to significantly improve the success of P. vivax WGS on natural (non-adapted) patient isolates. Using 37 patient isolates from Indonesia, Thailand, and travellers, we assessed the application of CF11-based white blood cell filtration alone and in combination with short term ex vivo schizont maturation. Although CF11 filtration reduced human DNA contamination in 8 Indonesian isolates tested, additional short-term culture increased the P. vivax DNA yield from a median of 0.15 to 6.2 ng mu l(-1) packed red blood cells (pRBCs) (p = 0.001) and reduced the human DNA percentage from a median of 33.9% to 6.22% (p = 0.008). Furthermore, post-CF11 and culture samples from Thailand gave a median P. vivax DNA yield of 2.34 ng mu l(-1) pRBCs, and 2.65% human DNA. In 22 P. vivax patient isolates prepared with the 2-step method, we demonstrate high depth (median 654X coverage) and breadth (>= 89%) of coverage on the Illumina GAII and HiSeq platforms. In contrast to the A+T-rich P. falciparum genome, negligible bias was observed in coverage depth between coding and non-coding regions of the P. vivax genome. This uniform coverage will greatly facilitate the detection of SNPs and copy number variants across the genome, enabling unbiased exploration of the natural diversity in P. vivax populations.	[Auburn, Sarah; Marfurt, Jutta; MacHunter, Barbara; Wirjanata, Grennady; Anstey, Nicholas M.; Price, Ric N.] Charles Darwin Univ, Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT 0909, Australia; [Maslen, Gareth; Campino, Susana; Rubio, Valentin Ruano; Manske, Magnus; Alcock, Daniel; MacInnis, Bronwyn; Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Hinxton, England; [Maslen, Gareth; Campino, Susana; Rubio, Valentin Ruano; Manske, Magnus; Alcock, Daniel; MacInnis, Bronwyn; Miotto, Olivo; Kwiatkowski, Dominic P.] Univ Oxford, Ctr Genom & Global Hlth, MRC, Oxford, England; [Kenangalem, Enny; Noviyanti, Rintis; Trianty, Leily; Sebayang, Boni] Papuan Hlth & Community Dev Fdn, Timika Malaria Res Programme, Timika, Papua, Indonesia; [Noviyanti, Rintis; Trianty, Leily; Sebayang, Boni] Eijkman Inst Mol Biol, Jakarta, Indonesia; [Sriprawat, Kanlaya; Nosten, Francois] Shoklo Malaria Res Unit, Mae Sot, Tak Province, Thailand; [Miotto, Olivo; Nosten, Francois] Mahidol Univ, Fac Trop Med, Mahidol Oxford Res Unit, Bangkok, Thailand; [Clark, Taane G.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Clark, Taane G.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Russell, Bruce] Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hlth Syst, Singapore 117595, Singapore; [Anstey, Nicholas M.; Price, Ric N.] Royal Darwin Hosp, Div Med, Darwin, NT, Australia; [Nosten, Francois; Price, Ric N.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England	Charles Darwin University; Menzies School of Health Research; Wellcome Trust Sanger Institute; University of Oxford; Eijkman Institute; Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; National University of Singapore; University of Oxford	Auburn, S (corresponding author), Charles Darwin Univ, Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT 0909, Australia.	sarah.auburn@menzies.edu.au	Miotto, Olivo/AAE-7124-2019; Clark, Taane G./AAM-2570-2020; Campino, Susana/AAM-2577-2020; Mead, Daniel/AAE-6629-2019; Nosten, Francois/AAC-5509-2019; Russell, Bruce/A-9240-2011; Auburn, Sarah/N-2266-2013	Miotto, Olivo/0000-0001-8060-6771; Clark, Taane G./0000-0001-8985-9265; Campino, Susana/0000-0003-1403-6138; Mead, Daniel/0000-0001-7717-4330; Nosten, Francois/0000-0002-7951-0745; Russell, Bruce/0000-0003-2333-4348; Price, Richard/0000-0003-2000-2874; Kwiatkowski, Dominic/0000-0002-5023-0176; Maslen, Gareth/0000-0001-7318-3678; Trianty, Leily/0000-0002-4368-476X; Wirjanata, Grennady/0000-0002-6858-8547; Auburn, Sarah/0000-0002-4638-536X; Sebayang, Boni/0000-0002-7264-2366; Noviyanti, Rintis/0000-0003-1383-3274; Manske, Magnus/0000-0001-5916-0947	Wellcome Trust Senior Research Fellowship in Clinical Science; Asia Pacific Malaria Elimination Network; Wellcome Trust; Bill and Melinda Gates Foundation; Medical Research Council United Kingdom; National Health and Medical Research Council, Australia; Swiss National Science Foundation Career Development Fellowship; Wellcome Trust of Great Britain; Medical Research Council [G19/9, G0600718B] Funding Source: researchfish; MRC [G19/9] Funding Source: UKRI	Wellcome Trust Senior Research Fellowship in Clinical Science(Wellcome Trust); Asia Pacific Malaria Elimination Network; Wellcome Trust(Wellcome TrustEuropean Commission); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Swiss National Science Foundation Career Development Fellowship(Swiss National Science Foundation (SNSF)); Wellcome Trust of Great Britain(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded in part by a Wellcome Trust Senior Research Fellowship in Clinical Science awarded RP (RP, SA) and part by the Asia Pacific Malaria Elimination Network (RP, SA), the Wellcome Trust (DK, GM, SC, VRR, MM, DA, B. MacInnis, OM), the Bill and Melinda Gates Foundation (DK, GM, SC, VRR, MM, DA, B. MacInnis, OM), the Medical Research Council United Kingdom (DK, GM, SC, VRR, MM, DA, B. MacInnis, OM), the National Health and Medical Research Council, Australia (NA, JM), and a Swiss National Science Foundation Career Development Fellowship (JM). The Shoklo Malaria Research Unit (KS, FN) is part of the Mahidol-Oxford-University Research Unit, supported by the Wellcome Trust of Great Britain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arisue N, 2012, MOL BIOL EVOL, V29, P2095, DOI 10.1093/molbev/mss082; Auburn S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022213; Baird JK, 2009, ANN TROP PAEDIATR, V29, P251, DOI 10.1179/027249309X12547917868808; Baird JK, 2009, CLIN MICROBIOL REV, V22, P508, DOI 10.1128/CMR.00008-09; BARNES DA, 1992, EMBO J, V11, P3067, DOI 10.1002/j.1460-2075.1992.tb05378.x; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Boissiere A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-163; Bright AT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-262; Carlton J, 2003, TRENDS PARASITOL, V19, P227, DOI 10.1016/S1471-4922(03)00066-7; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Carlton JM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001160; Dharia NV, 2010, P NATL ACAD SCI USA, V107, P20045, DOI 10.1073/pnas.1003776107; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; KEMP DJ, 1992, MEM I OSWALDO CRUZ, V87, P85, DOI 10.1590/S0074-02761992000700011; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD28, DOI 10.1093/nar/gkq967; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mangold KA, 2005, J CLIN MICROBIOL, V43, P2435, DOI 10.1128/JCM.43.5.2435-2440.2005; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mason DP, 1999, AM J TROP MED HYG, V61, P367, DOI 10.4269/ajtmh.1999.61.367; Mayxay M, 2004, TROP MED INT HEALTH, V9, P325, DOI 10.1111/j.1365-3156.2004.01199.x; Melnikov A, 2011, GENOME BIOL, V12, DOI [10.1186/gb-2011-12-8-R73, 10.1186/gb-2011-12-8-r73]; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; Padley D, 2003, ANN TROP MED PARASIT, V97, P131, DOI 10.1179/000349803125002977; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Price RN, 2009, CURR OPIN INFECT DIS, V22, P430, DOI 10.1097/QCO.0b013e32832f14c1; Russell B, 2008, ANTIMICROB AGENTS CH, V52, P1040, DOI 10.1128/AAC.01334-07; Russell B, 2012, INT J PARASITOL; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Sriprawat K, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-115; Tao ZY, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-115; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Venkatesan M, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-41; WILSON CM, 1989, SCIENCE, V244, P1184, DOI 10.1126/science.2658061	38	24	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53160	10.1371/journal.pone.0053160	http://dx.doi.org/10.1371/journal.pone.0053160			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308154	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000313670100023
J	Gao, WJ; Peng, Y; Liang, GY; Liang, AJ; Ye, W; Zhang, LM; Sharma, S; Su, PQ; Huang, DS				Gao, Wenjie; Peng, Yan; Liang, Guoyan; Liang, Anjing; Ye, Wei; Zhang, Liangming; Sharma, Swarkar; Su, Peiqiang; Huang, Dongsheng			Association between Common Variants near LBX1 and Adolescent Idiopathic Scoliosis Replicated in the Chinese Han Population	PLOS ONE			English	Article							RECEPTOR GENE POLYMORPHISMS; GENOME-WIDE ASSOCIATION; DORSAL SPINAL-CORD; CURVE SEVERITY; TRANSMITTER PHENOTYPES; EVOKED-POTENTIALS; SUSCEPTIBILITY; LOCUS; ASSIGNMENT; OSTEOPENIA	Background: Adolescent idiopathic scoliosis (AIS) is one of the most common spinal deformities found in adolescent populations. Recently, a genome-wide association study (GWAS) in a Japanese population indicated that three single nucleotide polymorphisms (SNPs), rs11190870, rs625039 and rs11598564, all located near the LBX1 gene, may be associated with AIS susceptibility [1]. This study suggests a novel AIS predisposition candidate gene and supports the hypothesis that somatosensory functional disorders could contribute to the pathogenesis of AIS. These findings warrant replication in other populations. Methodology/Principal Findings: First, we conducted a case-control study consisting of 953 Chinese Han individuals from southern China (513 patients and 440 healthy controls), and the three SNPs were all found to be associated with AIS predisposition. The ORs were observed as 1.49 (95% CI 1.23-1.80, P = 5.09E-5), 1.70 (95% CI 1.42-2.04, P = 1.17E-8) and 1.52 (95% CI 1.27-1.83, P = 5.54E-6) for rs625039, rs11190870 and rs11598564, respectively. Second, a case-only study including a subgroup of AIS patients (N = 234) was performed to determine the effects of these variants on the severity of the condition. However, we did not find any association between these variants and the severity of curvature. Conclusion: This study shows that the genetic variants near the LBX1 gene are associated with AIS susceptibility in Chinese Han population. It successfully replicates the results of the GWAS, which was performed in a Japanese population.	[Gao, Wenjie; Su, Peiqiang] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Orthoped Surg, Guangzhou 510275, Guangdong, Peoples R China; [Gao, Wenjie; Peng, Yan; Liang, Guoyan; Liang, Anjing; Ye, Wei; Zhang, Liangming; Huang, Dongsheng] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Orthoped Surg, Guangzhou 510275, Guangdong, Peoples R China; [Sharma, Swarkar] Texas Scottish Rite Hosp Children, Seay Ctr Musculoskeletal Res, Dallas, TX 75219 USA; [Sharma, Swarkar] Shri Mata Vaishno Devi Univ, Sch Biol & Chem, Katra, India	Sun Yat Sen University; Sun Yat Sen University; Texas Scottish Rite Hospital for Children; Shri Mata Vaishno Devi University	Su, PQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Orthoped Surg, Guangzhou 510275, Guangdong, Peoples R China.	spq88007@yahoo.com.cn; huangdongshen18@hotmail.com	Liang, Guoyan/AEL-4482-2022; SHARMA, SWARKAR/B-8096-2008; zhang, liangming/Q-9967-2016	SHARMA, SWARKAR/0000-0001-8857-5906; zhang, liangming/0000-0003-2282-4687	National Natural Science Foundation of China [81171674, 81071703]; Research Fund of Social Development of Guangdong Province [2010B031900023]; Research Fund of Popular Science of Guangzhou City [2011KP012]; Fundamental Research Funds for the Central Universities [11ykzd10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund of Social Development of Guangdong Province; Research Fund of Popular Science of Guangzhou City; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (No. 81171674 and No. 81071703), Research Fund of Social Development of Guangdong Province (No. 2010B031900023), Research Fund of Popular Science of Guangzhou City (No. 2011KP012) and the Fundamental Research Funds for the Central Universities (No. 11ykzd10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alden KJ, 2006, SPINE, V31, P1815, DOI 10.1097/01.brs.0000227264.23603.dc; Asher MA, 2006, SCOLIOSIS SPINAL DIS, V1, DOI 10.1186/1748-7161-1-2; Aulisa L, 2007, SPINE, V32, P2700, DOI 10.1097/BRS.0b013e31815a5943; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BARRIOS C, 1987, SPINE, V12, P433, DOI 10.1097/00007632-198706000-00003; Buetow KH, 2001, P NATL ACAD SCI USA, V98, P581, DOI 10.1073/pnas.021506298; Chan V, 2002, AM J HUM GENET, V71, P401, DOI 10.1086/341607; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chen ZJ, 2009, EUR J HUM GENET, V17, P525, DOI 10.1038/ejhg.2008.203; Cheng JCY, 2007, CLIN ORTHOP RELAT R, P38, DOI 10.1097/BLO.0b013e3180d09dcc; Cheng JCY, 1998, SPINE, V23, P332, DOI 10.1097/00007632-199802010-00009; Cheng JCY, 1999, SPINE, V24, P1679, DOI 10.1097/00007632-199908150-00009; Cheng LP, 2005, NAT NEUROSCI, V8, P1510, DOI 10.1038/nn1569; Cobb J., 1948, AM ACADEMY ORTHOPAED, V5, P261; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Fan YH, 2012, J HUM GENET, V57, P244, DOI 10.1038/jhg.2012.11; Gao XC, 2007, AM J HUM GENET, V80, P957, DOI 10.1086/513571; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Guo X, 2006, SPINE, V31, pE437, DOI 10.1097/01.brs.0000222048.47010.bf; Gurnett CA, 2009, SPINE, V34, pE94, DOI 10.1097/BRS.0b013e31818b88a5; Huang MG, 2008, DEV BIOL, V322, P394, DOI 10.1016/j.ydbio.2008.06.031; Hung VWY, 2005, J BONE JOINT SURG AM, V87A, P2709, DOI 10.2106/JBJS.D.02782; Inoue M, 2002, SPINE, V27, P2357, DOI 10.1097/00007632-200211010-00009; JAGLA K, 1995, MECH DEVELOP, V53, P345, DOI 10.1016/0925-4773(95)00450-5; Jiang H, 2012, EUR SPINE J; Jiang J, 1976, SPINE PHILA PA 1976; Justice CM, 2003, SPINE, V28, P589, DOI 10.1097/00007632-200303150-00014; Karachalios T, 1999, SPINE, V24, P2318, DOI 10.1097/00007632-199911150-00006; Kim H, 2010, RADIOGRAPHICS, V30, P1823, DOI 10.1148/rg.307105061; Kouwenhoven JWM, 2008, SPINE, V33, P2898, DOI 10.1097/BRS.0b013e3181891751; LONSTEIN JE, 1994, J BONE JOINT SURG AM, V76A, P1207, DOI 10.2106/00004623-199408000-00011; Mao SH, 2011, EUR SPINE J, V20, P260, DOI 10.1007/s00586-010-1649-6; Miller MR, 2010, OBESITY, V18, P555, DOI 10.1038/oby.2009.303; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Nelson LM, 2011, SPINE, V36, P37, DOI 10.1097/BRS.0b013e3181e8755b; Ocaka L, 2008, J MED GENET, V45, P87, DOI 10.1136/jmg.2007.051896; Oestreich AE, 1998, SKELETAL RADIOL, V27, P591, DOI 10.1007/s002560050445; Ott J, 2004, NEUROLOGY, V63, P955, DOI 10.1212/WNL.63.6.955; PINCOTT JR, 1984, J BONE JOINT SURG BR, V66, P27; PINCOTT JR, 1982, J BONE JOINT SURG BR, V64, P503; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qiu XS, 2007, SPINE, V32, P1748, DOI 10.1097/BRS.0b013e3180b9f0ff; Qiu Y, 2011, SPINE PHILA PA 1976; Reamy BV, 2001, AM FAM PHYSICIAN, V64, P111; RISSER J C, 1958, Clin Orthop, V11, P111; Risser JC, 1936, J BONE JOINT SURG, V18, P667; Salehi LB, 2002, HUM GENET, V111, P401, DOI 10.1007/s00439-002-0785-4; Sharma S, 2011, HUM MOL GENET, V20, P1456, DOI 10.1093/hmg/ddq571; Sieber MA, 2007, J NEUROSCI, V27, P4902, DOI 10.1523/JNEUROSCI.0717-07.2007; SUK SI, 1989, SPINE, V14, P692, DOI 10.1097/00007632-198907000-00008; Takahashi Y, 2011, NAT GENET, V43, P1237, DOI 10.1038/ng.974; Takahashi Y, 2011, J ORTHOP RES, V29, P1055, DOI 10.1002/jor.21347; Takahashi Y, 2011, J ORTHOP RES, V29, P834, DOI 10.1002/jor.21322; Tang NLS, 2006, SPINE, V31, P2463, DOI 10.1097/01.brs.0000239179.81596.2b; Wang H, 2008, SPINE, V33, P2199, DOI 10.1097/BRS.0b013e31817c03f9; Weinstein SL, 1999, SPINE, V24, P2592, DOI 10.1097/00007632-199912150-00006; Weinstein SL, 2008, LANCET, V371, P1527, DOI 10.1016/S0140-6736(08)60658-3; Wise CA, 2000, SPINE, V25, P2372, DOI 10.1097/00007632-200009150-00017; Wu J, 2006, SPINE, V31, P1131, DOI 10.1097/01.brs.0000216603.91330.6f; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Yeung HY, 2006, STUD HEALTH TECHNOL, V123, P18; Zhang HQ, 2009, SPINE, V34, P760, DOI 10.1097/BRS.0b013e31818ad5ac	66	38	42	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53234	10.1371/journal.pone.0053234	http://dx.doi.org/10.1371/journal.pone.0053234			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308168	Green Submitted, gold, Green Published			2022-12-25	WOS:000313670100025
J	Colbert, CL; Agar, NYR; Kumar, P; Chakko, MN; Sinha, SC; Powlowski, JB; Eltis, LD; Bolin, JT				Colbert, Christopher L.; Agar, Nathalie Y. R.; Kumar, Pravindra; Chakko, Mathew N.; Sinha, Sangita C.; Powlowski, Justin B.; Eltis, Lindsay D.; Bolin, Jeffrey T.			Structural Characterization of Pandoraea pnomenusa B-356 Biphenyl Dioxygenase Reveals Features of Potent Polychlorinated Biphenyl-Degrading Enzymes	PLOS ONE			English	Article							TERMINAL OXYGENASE COMPONENT; CRYSTAL-STRUCTURE; NAPHTHALENE DIOXYGENASE; 3-DIMENSIONAL STRUCTURE; CLASSIFICATION-SYSTEM; FUNCTIONAL-ANALYSIS; ENCODING BIPHENYL; GENE-CLUSTER; DEGRADATION; CRYSTALLIZATION	The oxidative degradation of biphenyl and polychlorinated biphenyls (PCBs) is initiated in Pandoraea pnomenusa B-356 by biphenyl dioxygenase (BPDOB356). BPDOB356, a heterohexameric (alpha beta)(3) Rieske oxygenase (RO), catalyzes the insertion of dioxygen with stereo- and regioselectivity at the 2,3-carbons of biphenyl, and can transform a broad spectrum of PCB congeners. Here we present the X-ray crystal structures of BPDOB356 with and without its substrate biphenyl 1.6-angstrom resolution for both structures. In both cases, the Fe(II) has five ligands in a square pyramidal configuration: H233 N epsilon 2, H239 N epsilon 2, D386 O delta 1 and O delta 2, and a single water molecule. Analysis of the active sites of BPDOB356 and related ROs revealed structural features that likely contribute to the superior PCB-degrading ability of certain BPDOs. First, the active site cavity readily accommodates biphenyl with minimal conformational rearrangement. Second, M231 was predicted to sterically interfere with binding of some PCBs, and substitution of this residue yielded variants that transform 2,2'-dichlorobiphenyl more effectively. Third, in addition to the volume and shape of the active site, residues at the active site entrance also apparently influence substrate preference. Finally, comparison of the conformation of the active site entrance loop among ROs provides a basis for a structure-based classification consistent with a phylogeny derived from amino acid sequence alignments.	[Colbert, Christopher L.; Sinha, Sangita C.] N Dakota State Univ, Dept Chem & Biochem, Fargo, ND 58105 USA; [Agar, Nathalie Y. R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurosurg & Radiol, Boston, MA 02115 USA; [Kumar, Pravindra] Indian Inst Technol, Dept Biotechnol, Roorkee, Uttarakhand, India; [Chakko, Mathew N.] Providence Hosp & Med Ctr, Dept Diagnost Radiol, Southfield, MI USA; [Agar, Nathalie Y. R.; Powlowski, Justin B.] Concordia Univ, Dept Chem & Biochem, Montreal, PQ H3G 1M8, Canada; [Eltis, Lindsay D.] Univ British Columbia, Inst Life Sci, Dept Microbiol, Vancouver, BC, Canada; [Eltis, Lindsay D.] Univ British Columbia, Dept Biochem, Inst Life Sci, Vancouver, BC, Canada; [Colbert, Christopher L.; Kumar, Pravindra; Chakko, Mathew N.; Bolin, Jeffrey T.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Colbert, Christopher L.; Kumar, Pravindra; Chakko, Mathew N.; Bolin, Jeffrey T.] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA	North Dakota State University Fargo; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; Concordia University - Canada; University of British Columbia; University of British Columbia; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Colbert, CL (corresponding author), N Dakota State Univ, Dept Chem & Biochem, Fargo, ND 58105 USA.	christopher.colbert@ndsu.edu	KUMAR, PRAVINDRA/AAF-2859-2020; Eltis, Lindsay D/J-8272-2015	KUMAR, PRAVINDRA/0000-0003-2128-7736; Eltis, Lindsay D/0000-0002-6774-8158	Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC Discovery grant; National Institutes of Health (NIH) [R01-GM52381]; NIH award [P20 RR015566]; NSF ND EPSCoR [EPS-0814442]; NIH training grant [T32-GM008296]; NSERC; Fonds FCAR postgraduate scholarships; National Center for Research Resources [5P41RR007707]; National Institute of General Medical Sciences from the National Institutes of Health [8P41GM103543]; U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; Office Of The Director [0814442] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015566, P41RR007707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103332, P41GM103543, R01GM052381, T32GM008296] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF ND EPSCoR; NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds FCAR postgraduate scholarships; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Discovery and Strategic grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) to LDE, a NSERC Discovery grant to JP, and National Institutes of Health (NIH) award R01-GM52381 to JTB. CLC and SCS were supported by NIH award P20 RR015566 and NSF ND EPSCoR EPS-0814442. CLC was supported in part by an NIH training grant, T32-GM008296. NYRA was the recipient of NSERC and Fonds FCAR postgraduate scholarships. Use of the BioCARS Sector 14 was supported by grants from the National Center for Research Resources (5P41RR007707) and the National Institute of General Medical Sciences (8P41GM103543) from the National Institutes of Health. Results shown in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by UChicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki H, 1996, J FERMENT BIOENG, V81, P187, DOI 10.1016/0922-338X(96)82207-0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barriault D, 2002, J BACTERIOL, V184, P3794, DOI 10.1128/JB.184.14.3794-3800.2002; BOYINGTON JC, 1993, SCIENCE, V260, P1482, DOI 10.1126/science.8502991; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carpenter David O., 2006, Reviews on Environmental Health, V21, P1; Chebrou H, 1999, J BACTERIOL, V181, P4805, DOI 10.1128/JB.181.16.4805-4811.1999; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Dai SD, 2002, NAT STRUCT BIOL, V9, P934, DOI 10.1038/nsb866; Dodson E, 1996, REF PROT STRUCT P DA; Dong XS, 2005, J BACTERIOL, V187, P2483, DOI 10.1128/JB.187.7.2483-2490.2005; ERICKSON BD, 1993, APPL ENVIRON MICROB, V59, P3858, DOI 10.1128/AEM.59.11.3858-3862.1993; ERICKSON BD, 1992, J BACTERIOL, V174, P2903, DOI 10.1128/JB.174.9.2903-2912.1992; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Ferraro DJ, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-10; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; FURUKAWA K, 1986, J BACTERIOL, V166, P392, DOI 10.1128/jb.166.2.392-398.1986; Furukawa K, 2004, J BACTERIOL, V186, P5189, DOI 10.1128/JB.186.16.5189-5196.2004; Furukawa K, 2000, J GEN APPL MICROBIOL, V46, P283, DOI 10.2323/jgam.46.283; Furusawa Y, 2004, J MOL BIOL, V342, P1041, DOI 10.1016/j.jmb.2004.07.062; GIBSON DT, 1993, J BACTERIOL, V175, P4561, DOI 10.1128/JB.175.14.4561-4564.1993; Gomez-Gil L, 2007, J BACTERIOL, V189, P5705, DOI 10.1128/JB.01476-06; Goodwill KE, 1997, NAT STRUCT BIOL, V4, P578, DOI 10.1038/nsb0797-578; Habe H, 2003, APPL MICROBIOL BIOT, V61, P44, DOI 10.1007/s00253-002-1166-6; HAN S, 1995, SCIENCE, V270, P976, DOI 10.1126/science.270.5238.976; HIROSE J, 1994, GENE, V138, P27; HOWELLS ER, 1950, ACTA CRYSTALLOGR, V3, P210, DOI 10.1107/S0365110X50000513; Hurtubise Y, 1998, J BACTERIOL, V180, P5828, DOI 10.1128/JB.180.22.5828-5835.1998; Imbeault NYR, 2000, J BIOL CHEM, V275, P12430, DOI 10.1074/jbc.275.17.12430; Iwasaki T, 2007, BIOSCI BIOTECH BIOCH, V71, P993, DOI 10.1271/bbb.60663; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karlsson A, 2003, SCIENCE, V299, P1039, DOI 10.1126/science.1078020; Kauppi B, 1998, STRUCTURE, V6, P571, DOI 10.1016/S0969-2126(98)00059-8; Kim E, 1999, J IND MICROBIOL BIOT, V23, P294, DOI 10.1038/sj.jim.2900724; Kimura N, 1997, J BACTERIOL, V179, P3936, DOI 10.1128/jb.179.12.3936-3943.1997; Kweon Ohgew, 2008, BMC Biochemistry, V9, P11, DOI 10.1186/1471-2091-9-11; Martins BM, 2005, STRUCTURE, V13, P817, DOI 10.1016/j.str.2005.03.008; Mondello FJ, 1997, APPL ENVIRON MICROB, V63, P3096, DOI 10.1128/AEM.63.8.3096-3103.1997; Nam JW, 2001, BIOSCI BIOTECH BIOCH, V65, P254, DOI 10.1271/bbb.65.254; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parales RE, 2005, APPL ENVIRON MICROB, V71, P3806, DOI 10.1128/AEM.71.7.3806-3814.2005; Parales RE, 1998, J BACTERIOL, V180, P2337, DOI 10.1128/JB.180.9.2337-2344.1998; Parales RE, 1999, J BACTERIOL, V181, P1831, DOI 10.1128/JB.181.6.1831-1837.1999; REES DC, 1980, ACTA CRYSTALLOGR A, V36, P578, DOI 10.1107/S0567739480001234; SETO M, 1995, APPL ENVIRON MICROB, V61, P3353, DOI 10.1128/AEM.61.9.3353-3358.1995; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Suenaga H, 2002, J BACTERIOL, V184, P3682, DOI 10.1128/JB.184.13.3682-3688.2002; Suenaga H, 2001, J BACTERIOL, V183, P5441, DOI 10.1128/JB.183.18.5441-5444.2001; SUGIYAMA K, 1995, P JPN ACAD B-PHYS, V71, P32, DOI 10.2183/pjab.71.32; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vezina J, 2008, J MOL MICROB BIOTECH, V15, P139, DOI 10.1159/000121326; Yeates TO, 1997, METHOD ENZYMOL, V276, P344, DOI 10.1016/S0076-6879(97)76068-3; Zielinski M, 2003, J BACTERIOL, V185, P6976, DOI 10.1128/JB.185.23.6976-6980.2003	54	24	25	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52550	10.1371/journal.pone.0052550	http://dx.doi.org/10.1371/journal.pone.0052550			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23308114	Green Published, gold, Green Accepted			2022-12-25	WOS:000313480000010
J	Frana, TS; Beahm, AR; Hanson, BM; Kinyon, JM; Layman, LL; Karriker, LA; Ramirez, A; Smith, TC				Frana, Timothy S.; Beahm, Aleigh R.; Hanson, Blake M.; Kinyon, Joann M.; Layman, Lori L.; Karriker, Locke A.; Ramirez, Alejandro; Smith, Tara C.			Isolation and Characterization of Methicillin-Resistant Staphylococcus aureus from Pork Farms and Visiting Veterinary Students	PLOS ONE			English	Article							SLAUGHTER PIGS; UNITED-STATES; ANTIBIOTIC-RESISTANCE; NASAL COLONIZATION; PORCINE ORIGIN; HIGH-RISK; ST398; PREVALENCE; MRSA; SWINE	In the last decade livestock-associated methicillin-resistant S. aureus (LA-MRSA) has become a public health concern in many parts of the world. Sequence type 398 (ST398) has been the most commonly reported type of LA-MRSA. While many studies have focused on long-term exposure experienced by swine workers, this study focuses on short-term exposures experienced by veterinary students conducting diagnostic investigations. The objectives were to assess the rate of MRSA acquisition and longevity of carriage in students exposed to pork farms and characterize the recovered MRSA isolates. Student nasal swabs were collected immediately before and after farm visits. Pig nasal swabs and environmental sponge samples were also collected. MRSA isolates were identified biochemically and molecularly including spa typing and antimicrobial susceptibility testing. Thirty (30) veterinary students were enrolled and 40 pork farms were visited. MRSA was detected in 30% of the pork farms and in 22% of the students following an exposure to a MRSA-positive pork farm. All students found to be MRSA-positive initially following farm visit were negative for MRSA within 24 hours post visit. Most common spa types recovered were t002 (79%), t034 (16%) and t548 (4%). Spa types found in pork farms closely matched those recovered from students with few exceptions. Resistance levels to antimicrobials varied, but resistance was most commonly seen for spectinomycin, tetracyclines and neomycin. Non-ST398 MRSA isolates were more likely to be resistant to florfenicol and neomycin as well as more likely to be multidrug resistant compared to ST398 MRSA isolates. These findings indicate that MRSA can be recovered from persons visiting contaminated farms. However, the duration of carriage was very brief and most likely represents contamination of nasal passages rather than biological colonization. The most common spa types found in this study were associated with ST5 and expands the range of livestock-associated MRSA types.	[Frana, Timothy S.; Beahm, Aleigh R.; Kinyon, Joann M.; Layman, Lori L.; Karriker, Locke A.; Ramirez, Alejandro] Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA 50011 USA; [Hanson, Blake M.; Smith, Tara C.] Univ Iowa, Coll Publ Hlth, Ctr Emerging Infect Dis, Dept Epidemiol, Iowa City, IA USA	Iowa State University; University of Iowa	Frana, TS (corresponding author), Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA 50011 USA.	tfrana@iastate.edu	Hanson, Blake/AAL-8522-2021	Hanson, Blake/0000-0003-2949-7818; Smith, Tara C./0000-0003-3747-1116	National Institute for Occupational Safety and Health [K01OH009793]; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [K01OH009793] Funding Source: NIH RePORTER	National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	TCS is partially supported through research funding from The National Institute for Occupational Safety and Health K01OH009793 (http://www.cdc.gov/niosh/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Battisti A, 2010, VET MICROBIOL, V142, P361, DOI 10.1016/j.vetmic.2009.10.008; Bootsma MCJ, 2011, J R SOC INTERFACE, V8, P578, DOI 10.1098/rsif.2010.0349; CLSI, 2008, PERFORMANCE STANDARD; Crombe F, 2012, MICROB DRUG RESIST, V18, P125, DOI 10.1089/mdr.2011.0138; Cui SH, 2009, J ANTIMICROB CHEMOTH, V64, P680, DOI 10.1093/jac/dkp275; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; Denis O, 2009, EMERG INFECT DIS, V15, P1098, DOI 10.3201/eid1507.080652; Dressler AE, 2012, VET REC, V170, P495, DOI 10.1136/vr.100570; EFSA, 2009, AN BAS SURV PREV M B; Garcia-Graells C, 2012, EPIDEMIOL INFECT, V140, P383, DOI 10.1017/S0950268811002263; Gordoncillo MJ, 2012, ZOONOSES PUBLIC HLTH, V59, P212, DOI 10.1111/j.1863-2378.2011.01437.x; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Graveland H, 2011, INT J MED MICROBIOL, V301, P630, DOI 10.1016/j.ijmm.2011.09.004; Graveland H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016830; Guardabassi L, 2007, VET MICROBIOL, V122, P384, DOI 10.1016/j.vetmic.2007.03.021; Guardabassi L, 2009, EMERG INFECT DIS, V15, P1998, DOI 10.3201/eid1512.090378; Hanson B M, 2011, J Infect Public Health, V4, P169, DOI 10.1016/j.jiph.2011.06.001; Horgan M, 2011, VET J, V190, P255, DOI 10.1016/j.tvjl.2010.10.025; Huber H, 2010, EURO SURVEILL, V15; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; Jamrozy DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040458; Kadlec K, 2009, J ANTIMICROB CHEMOTH, V64, P1156, DOI 10.1093/jac/dkp350; Kehrenberg C, 2009, ANTIMICROB AGENTS CH, V53, P779, DOI 10.1128/AAC.01376-08; Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kock R, 2009, EUR J CLIN MICROBIOL, V28, P1375, DOI 10.1007/s10096-009-0795-4; Lewis HC, 2008, EMERG INFECT DIS, V14, P1383, DOI 10.3201/eid1409.071576; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Louie L, 2002, J CLIN MICROBIOL, V40, P2786, DOI 10.1128/JCM.40.8.2786-2790.2002; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Meeniken D, 2008, DEUT TIERARZTL WOCH, V115, P132, DOI 10.2377/0341-6593-115-132; Mendes RE, 2011, DIAGN MICR INFEC DIS, V71, P177, DOI 10.1016/j.diagmicrobio.2011.06.009; Molla B, 2012, J CLIN MICROBIOL, V50, P3687, DOI 10.1128/JCM.01971-12; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Moodley A, 2008, SCAND J WORK ENV HEA, V34, P151, DOI 10.5271/sjweh.1219; Morcillo A, 2012, FOODBORNE PATHOG DIS, V9, P207, DOI 10.1089/fpd.2011.0982; Neela V, 2009, J CLIN MICROBIOL, V47, P4138, DOI 10.1128/JCM.01363-09; O'Brien AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030092; Overesch G, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-30; Pomba CA, 2009, INT J ANTIMICROB AG, V34, P193, DOI 10.1016/j.ijantimicag.2009.02.019; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Riesen A, 2009, SCHWEIZ ARCH TIERH, V151, P425, DOI 10.1024/0036-7281.151.9.425; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258; Smith TC, 2010, EMERGENCE STAPHYLOCO; Strommenger B, 2008, J CLIN MICROBIOL, V46, P574, DOI 10.1128/JCM.01599-07; Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12; van Cleef BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009385; van Cleef BAGL, 2011, J CLIN MICROBIOL, V49, P1030, DOI 10.1128/JCM.00493-10; Van Den Broek IVF, 2009, EPIDEMIOL INFECT, V137, P700, DOI 10.1017/S0950268808001507; van Duijkeren E, 2008, VET MICROBIOL, V126, P383, DOI 10.1016/j.vetmic.2007.07.021; Van Hoecke H, 2009, LARYNGOSCOPE, V119, P137, DOI 10.1002/lary.20030; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Wagenaar JA, 2009, VET MICROBIOL, V139, P405, DOI 10.1016/j.vetmic.2009.06.014; Wassenberg MWM, 2011, CLIN MICROBIOL INFEC, V17, P316, DOI 10.1111/j.1469-0691.2010.03260.x; Weese JS, 2011, ZOONOSES PUBLIC HLTH, V58, P238, DOI 10.1111/j.1863-2378.2010.01340.x; Wulf MWH, 2008, CLIN MICROBIOL INFEC, V14, P29, DOI 10.1111/j.1469-0691.2007.01873.x; Wulf M, 2006, EMERG INFECT DIS, V12, P1939	61	105	108	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53738	10.1371/journal.pone.0053738	http://dx.doi.org/10.1371/journal.pone.0053738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301102	Green Published, gold			2022-12-25	WOS:000313480000077
J	Li, JC; Li, XD; Li, Y; Yang, H; Wang, LJ; Qin, YR; Liu, HB; Fu, L; Guan, XY				Li, Jiangchao; Li, Xiaodong; Li, Yan; Yang, Hong; Wang, Lijing; Qin, Yanru; Liu, Haibo; Fu, Li; Guan, Xin-Yuan			Cell-Specific Detection of miR-375 Downregulation for Predicting the Prognosis of Esophageal Squamous Cell Carcinoma by miRNA In Situ Hybridization	PLOS ONE			English	Article							LUNG-CANCER; SIGNAL AMPLIFICATION; EXPRESSION; MICRORNAS; ESTABLISHMENT; SURVIVAL	MicroRNAs (miRNAs) play important roles in the regulation of genes associated with cancer development and progression. By the more deeply characterization of miRNAs' effect in cancer development, it requires a useful tool to investigate expression and distribution of a miRNA in cancer cells and tissues. To fulfill this application demand, we developed a miRNA in situ hybridization (MISH) approach using the 2'-Fluoro modified miRNA probe in combination with enzyme-labeled fluorescence (ELF) signal amplification approach. MISH was used to study expression of miR-375 in esophageal squamous cell carcinoma (ESCC) cell lines and tissues using a tissue microarray (TMA) containing 300 cases. The results showed that our MISH approach is a practical way to detect expression and distribution of a tested miRNA in both cultured cells and archive tissue sections. MISH results also showed that miR-375 was frequently downregulated in ESCCs, which was significantly associated with advanced clinical stage (p = 0.003) tumor metastasis (p = 0.04) and poor outcome (p = 0.04) of ESCC. Moreover, the accuracy of MISH results could be confirmed by QRT-PCR. Our results demonstrated that MISH is a useful and reliable tool to study miRNA expression in solid tumors. Downregulation of miR-375 can be used as a biomarker to predict the outcome of ESCC.	[Li, Jiangchao; Li, Yan; Liu, Haibo; Guan, Xin-Yuan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China; [Li, Jiangchao; Wang, Lijing] Guangdong Pharmaceut Univ, Vasc Biol Res Inst, Guangzhou, Guangdong, Peoples R China; [Li, Xiaodong; Yang, Hong] Sun Yat Sen Univ, Ctr Canc, Dept Thorac Surg, Guangzhou 510275, Guangdong, Peoples R China; [Qin, Yanru] Zhengzhou Univ, Affiliated Hosp 1, Dept Oncol, Zhengzhou, Peoples R China; [Fu, Li; Guan, Xin-Yuan] Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China	Sun Yat Sen University; Guangdong Pharmaceutical University; Sun Yat Sen University; Zhengzhou University; University of Hong Kong	Guan, XY (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China.	xyguan@hkucc.hku.hk	Fu, Li/F-7182-2010; Li, Jiangchao/AAF-4515-2021; /A-3639-2009; Guan, Xin-Yuan/A-3639-2009	Fu, Li/0000-0003-2643-6278; Li, Jiangchao/0000-0002-0947-7580; /0000-0003-1874-9805; Guan, Xin-Yuan/0000-0002-4485-6017	National Natural Science Foundation of China [30971606, 81172338, 81000863]; Sun Yat-Sen University "Hundred Talents Program'' [85000-3171311]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sun Yat-Sen University "Hundred Talents Program''	This work was supported by grants from the National Natural Science Foundation of China (30971606 and 81172338), the Sun Yat-Sen University "Hundred Talents Program'' (85000-3171311) and the National Natural Science Foundation of China (81000863). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop JA, 2010, CLIN CANCER RES, V16, P610, DOI 10.1158/1078-0432.CCR-09-2638; Fu L, 2011, DIS ESOPHAGUS; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hu YC, 2000, CANCER GENET CYTOGEN, V118, P112, DOI 10.1016/S0165-4608(99)00193-4; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Kong KL, 2012, GUT, V61, P33, DOI 10.1136/gutjnl-2011-300178; Landi MT, 2010, CLIN CANCER RES, V16, P430, DOI 10.1158/1078-0432.CCR-09-1736; Li JC, 2012, MOL MED REP, V5, P114, DOI 10.3892/mmr.2011.613; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp482; Neely LA, 2006, NAT METHODS, V3, P41, DOI 10.1038/NMETH825; Pallan PS, 2011, NUCLEIC ACIDS RES, V39, P3482, DOI 10.1093/nar/gkq1270; Paragas VB, 1997, J HISTOCHEM CYTOCHEM, V45, P345, DOI 10.1177/002215549704500302; Raponi M, 2009, CANCER RES, V69, P5776, DOI 10.1158/0008-5472.CAN-09-0587; Silahtaroglu AN, 2007, NAT PROTOC, V2, P2520, DOI 10.1038/nprot.2007.313; Sirotkin AV, 2010, J CELL PHYSIOL, V223, P49, DOI 10.1002/jcp.21999	17	53	57	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53582	10.1371/journal.pone.0053582	http://dx.doi.org/10.1371/journal.pone.0053582			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301089	Green Published, Green Submitted, gold			2022-12-25	WOS:000313480000068
J	Rueda, A; Fernandez-Velasco, M; Benitah, JP; Gomez, AM				Rueda, Angelica; Fernandez-Velasco, Maria; Benitah, Jean-Pierre; Gomez, Ana Maria			Abnormal Ca2+ Spark/STOC Coupling in Cerebral Artery Smooth Muscle Cells of Obese Type 2 Diabetic Mice	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; SMALL MESENTERIC-ARTERIES; RYANODINE RECEPTORS; OXIDATIVE STRESS; DOWN-REGULATION; CALCIUM SPARKS; RETICULUM CA2+; DYSFUNCTION; RELEASE; STROKE	Diabetes is a major risk factor for stroke. However, the molecular mechanisms involved in cerebral artery dysfunction found in the diabetic patients are not completely elucidated. In cerebral artery smooth muscle cells (CASMCs), spontaneous and local increases of intracellular Ca2+ due to the opening of ryanodine receptors (Ca2+ sparks) activate large conductance Ca2+-activated K+ (BK) channels that generate spontaneous transient outward currents (STOCs). STOCs have a key participation in the control of vascular myogenic tone and blood pressure. Our goal was to investigate whether alterations in Ca2+ spark and STOC activities, measured by confocal microscopy and patch-clamp technique, respectively, occur in isolated CASMCs of an experimental model of type-2 diabetes (db/db mouse). We found that mean Ca2+ spark amplitude, duration, size and rate-of-rise were significantly smaller in Fluo-3 loaded db/db compared to control CASMCs, with a subsequent decrease in the total amount of Ca2+ released through Ca2+ sparks in db/db CASMCs, though Ca2+ spark frequency remained. Interestingly, the frequency of large-amplitude Ca2+ sparks was also significantly reduced in db/db cells. In addition, the frequency and amplitude of STOCs were markedly reduced at all voltages tested (from -50 to 0 mV) in db/db CASMCs. The latter correlates with decreased BK channel beta 1/alpha subunit ratio found in db/db vascular tissues. Taken together, Ca2+ spark alterations lead to inappropriate BK channels activation in CASMCs of db/db mice and this condition is aggravated by the decrease in the BK beta 1 subunit/alpha subunit ratio which underlies the significant reduction of Ca2+ spark/STOC coupling in CASMCs of diabetic animals.	[Rueda, Angelica] Ctr Invest & Estudios Avanzados IPN, Dept Bioquim, Mexico City, DF, Mexico; [Rueda, Angelica; Fernandez-Velasco, Maria] Univ Montpellier 2, Univ Montpellier 1, U637, INSERM, Montpellier, France; [Fernandez-Velasco, Maria] Inst Invest Hosp Univ La Paz IdiPAZ, Madrid, Spain; [Benitah, Jean-Pierre; Gomez, Ana Maria] Univ Paris 11, INSERM, U769, IFR141, Chatenay Malabry, France	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Hospital Universitario La Paz; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Rueda, A (corresponding author), Ctr Invest & Estudios Avanzados IPN, Dept Bioquim, Mexico City, DF, Mexico.	arueda@cinvestav.mx; ana-maria.gomez@inserm.fr	Gomez, Ana M./B-5376-2013; Rueda, Angelica/G-4055-2012; velasco, maria fernandez/AAO-5062-2021; Benitah, Jean-Pierre/L-6060-2018; Rueda, Angelica/A-1394-2009; Rueda, Angelica/AAW-4621-2020	Gomez, Ana M./0000-0003-0009-2884; Rueda, Angelica/0000-0001-8749-8494; Benitah, Jean-Pierre/0000-0002-9866-9081; Rueda, Angelica/0000-0001-8749-8494	Conacyt [80960]; ICyTDF [331/2010]; Agence National de la Recherche [Geno-09-HyperEpac, Geno-09-Carythm]; Region Ile de France [CODDIM: COD100256]; European Union (CONTICA) [018802]; FRM (Fondation pour la Recherche medicale)	Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); ICyTDF; Agence National de la Recherche(French National Research Agency (ANR)); Region Ile de France(Region Ile-de-France); European Union (CONTICA); FRM (Fondation pour la Recherche medicale)(Fondation pour la Recherche Medicale)	This work was funded by Conacyt (No. 80960), ICyTDF No.331/2010), Agence National de la Recherche (Geno-09-HyperEpac and Geno-09-Carythm), Region Ile de France (CODDIM: COD100256), European Union (2005 No018802, CONTICA) and FRM (Fondation pour la Recherche medicale). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Air EL, 2007, DIABETES CARE, V30, P3131, DOI 10.2337/dc06-1537; Amberg GC, 2003, CIRC RES, V93, P965, DOI 10.1161/01.RES.0000100068.43006.36; Asfandiyarova Nailya, 2006, Diab Vasc Dis Res, V3, P57, DOI 10.3132/dvdr.2006.009; Bagi Z, 2005, ARTERIOSCL THROM VAS, V25, P1610, DOI 10.1161/01.ATV.0000172688.26838.9f; Bagi Z, 2003, AM J PHYSIOL-HEART C, V285, pH1404, DOI 10.1152/ajpheart.00235.2003; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Cheranov SY, 2002, J PHYSIOL-LONDON, V544, P71, DOI 10.1113/jphysiol.2002.025197; Didion SP, 2007, AM J PHYSIOL-HEART C, V292, pH1579, DOI 10.1152/ajpheart.00939.2006; Didion SP, 2005, STROKE, V36, P342, DOI 10.1161/01.STR.0000152952.42730.92; Dong L, 2008, J CEREBR BLOOD F MET, V28, P377, DOI 10.1038/sj.jcbfm.9600536; Erdei N, 2007, AM J PHYSIOL-HEART C, V292, pH649, DOI 10.1152/ajpheart.00596.2006; Ergul A, 2009, VASC PHARMACOL, V51, P44, DOI 10.1016/j.vph.2009.02.004; Essin K, 2007, J PHYSIOL-LONDON, V584, P205, DOI 10.1113/jphysiol.2007.138982; Gollasch M, 2000, Z KARDIOL, V89, P15; Gollasch M, 1998, CIRC RES, V83, P1104, DOI 10.1161/01.RES.83.11.1104; Gomez AM, 2009, CIRCULATION, V119, P2179, DOI 10.1161/CIRCULATIONAHA.108.805804; Gomez-Viquez L, 2003, BIOPHYS J, V85, P370, DOI 10.1016/S0006-3495(03)74481-6; Guo ZH, 2005, CARDIOVASC RES, V67, P723, DOI 10.1016/j.cardiores.2005.04.008; Jaggar JH, 1998, ACTA PHYSIOL SCAND, V164, P577; Jaggar JH, 2000, AM J PHYSIOL-CELL PH, V278, pC235, DOI 10.1152/ajpcell.2000.278.2.C235; Janghorbani M, 2007, DIABETES CARE, V30, P1730, DOI 10.2337/dc06-2363; JORGENSEN HS, 1994, STROKE, V25, P1977, DOI 10.1161/01.STR.25.10.1977; Knot HJ, 1998, J PHYSIOL-LONDON, V508, P211, DOI 10.1111/j.1469-7793.1998.211br.x; Lagaud GJL, 2001, J VASC RES, V38, P578, DOI 10.1159/000051094; Liao Y, 2008, DIABETES-METAB RES, V21, P554; Lu T, 2008, BIOPHYS J, V95, P5165, DOI 10.1529/biophysj.108.138339; Lu T, 2006, CIRC RES, V99, P607, DOI 10.1161/01.RES.0000243147.41792.93; Mankovsky BN, 1996, J DIABETES COMPLICAT, V10, P228, DOI 10.1016/S1056-8727(96)90006-9; McGahon MK, 2007, CIRC RES, V100, P703, DOI 10.1161/01.RES.0000260182.36481.c9; McGahon Mary K, 2007, Channels (Austin), V1, P141; MCVEIGH GE, 1992, DIABETOLOGIA, V35, P771; Miike T, 2008, N-S ARCH PHARMACOL, V377, P401, DOI 10.1007/s00210-008-0261-3; Navedo MF, 2010, AM J PHYSIOL-CELL PH, V298, pC211, DOI 10.1152/ajpcell.00267.2009; Pannirselvam M, 2005, BRIT J PHARMACOL, V144, P953, DOI 10.1038/sj.bjp.0706121; Pannirselvam M, 2002, BRIT J PHARMACOL, V136, P255, DOI 10.1038/sj.bjp.0704683; Perez GJ, 1999, J GEN PHYSIOL, V113, P229, DOI 10.1085/jgp.113.2.229; Piercy V, 1998, PHARMACOLOGY, V56, P267, DOI 10.1159/000028208; Rueda A, 2002, CELL CALCIUM, V31, P161, DOI 10.1054/ceca.2002.0270; Rueda A, 2006, J PHYSIOL-LONDON, V576, P887, DOI 10.1113/jphysiol.2006.113951; Shen JX, 2004, BIOPHYS J, V86, P182, DOI 10.1016/S0006-3495(04)74095-3; Su J, 2008, ARTERIOSCL THROM VAS, V28, P1432, DOI 10.1161/ATVBAHA.108.167205; Tureyen K, 2010, J NEUROCHEM; Vannucci SJ, 2001, J CEREBR BLOOD F MET, V21, P52, DOI 10.1097/00004647-200101000-00007; Wang Y, 2010, CURR NEUROVASC RES, V7, P75, DOI 10.2174/156720210791184925; Williams SB, 1996, J AM COLL CARDIOL, V27, P567, DOI 10.1016/0735-1097(95)00522-6; Yeung CM, 2010, J NEUROSCI RES, V88, P2026, DOI 10.1002/jnr.22349	48	31	31	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53321	10.1371/journal.pone.0053321	http://dx.doi.org/10.1371/journal.pone.0053321			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301060	Green Published, Green Submitted, gold			2022-12-25	WOS:000313480000049
J	Weingarten-Gabbay, S; Khan, D; Liberman, N; Yoffe, Y; Bialik, S; Das, S; Oren, M; Kimchi, A				Weingarten-Gabbay, S.; Khan, D.; Liberman, N.; Yoffe, Y.; Bialik, S.; Das, S.; Oren, M.; Kimchi, A.			The translation initiation factor DAP5 promotes IRES-driven translation of p53 mRNA	ONCOGENE			English	Article						p53; Delta 40p53; DAP5; IRES; translational control	RIBOSOME ENTRY SITE; ENDOPLASMIC-RETICULUM STRESS; PROGRAMMED CELL-DEATH; MEDIATED TRANSLATION; EXPRESSION ANALYSIS; CASPASE CLEAVAGE; FACTOR 4G; ISOFORMS; IDENTIFICATION; INDUCTION	Translational regulation of the p53 mRNA can determine the ratio between p53 and its N-terminal truncated isoforms and therefore has a significant role in determining p53-regulated signaling pathways. Although its importance in cell fate decisions has been demonstrated repeatedly, little is known about the regulatory mechanisms that determine this ratio. Two internal ribosome entry sites (IRESs) residing within the 5'UTR and the coding sequence of p53 mRNA drive the translation of full-length p53 and Delta 40p53 isoform, respectively. Here, we report that DAP5, a translation initiation factor shown to positively regulate the translation of various IRES containing mRNAs, promotes IRES-driven translation of p53 mRNA. Upon DAP5 depletion, p53 and Delta 40p53 protein levels were decreased, with a greater effect on the N-terminal truncated isoform. Functional analysis using bicistronic vectors driving the expression of a reporter gene from each of these two IRESs indicated that DAP5 preferentially promotes translation from the second IRES residing in the coding sequence. Furthermore, p53 mRNA expressed from a plasmid carrying this second IRES was selectively shifted to lighter polysomes upon DAP5 knockdown. Consequently, Delta 40p53 protein levels and the subsequent transcriptional activation of the 14-3-3 sigma gene, a known target of Delta 40p53, were strongly reduced. In addition, we show here that DAP5 interacts with p53 IRES elements in in vitro and in vivo binding studies, proving for the first time that DAP5 directly binds a target mRNA. Thus, through its ability to regulate IRES-dependent translation of the p53 mRNA, DAP5 may control the ratio between different p53 isoforms encoded by a single mRNA.	[Weingarten-Gabbay, S.; Liberman, N.; Yoffe, Y.; Bialik, S.; Kimchi, A.] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Khan, D.; Das, S.] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Oren, M.] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Indian Institute of Science (IISC) - Bangalore; Weizmann Institute of Science	Kimchi, A (corresponding author), Weizmann Inst Sci, Dept Mol Genet, 234 Herzl St, IL-76100 Rehovot, Israel.	adi.kimchi@weizmann.ac.il		Khan, Debjit/0000-0001-5568-3361; Oren, Moshe/0000-0003-4311-7172	Flight Attendant Medical Research Institute; European Union FP7 APO-SYS; Indo French Centre for the Promotion of Advanced Research; Department of Biotechnology, India; Council of Scientific and Industrial Research, India	Flight Attendant Medical Research Institute; European Union FP7 APO-SYS; Indo French Centre for the Promotion of Advanced Research; Department of Biotechnology, India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	We gratefully acknowledge Dr Robin Fahraeus and Dr Jean-Christophe Bourdon for the p53 cDNA constructs, the Israel Structure Proteomic Center (ISPC) at the Weizmann Institute for supplying recombinant DAP5 protein and Sylvia Wilder for technical help. This work was supported by grants from the Flight Attendant Medical Research Institute (to AK and MO), the European Union FP7 APO-SYS (to AK), the Indo French Centre for the Promotion of Advanced Research (to SD), the Department of Biotechnology, India (to SD), and a pre-doctoral fellowship from the Council of Scientific and Industrial Research, India (to DK). AK and MO are incumbents of the Helena Rubinstein Chair of Cancer Research and the Andre Lwoff Chair in Molecular Biology, respectively.	Bourougaa K, 2010, MOL CELL, V38, P78, DOI 10.1016/j.molcel.2010.01.041; Candeias MM, 2006, ONCOGENE, V25, P6936, DOI 10.1038/sj.onc.1209996; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; Courtois S, 2002, ONCOGENE, V21, P6722, DOI 10.1038/sj.onc.1205874; Grover R, 2008, CELL CYCLE, V7, P2189, DOI 10.4161/cc.7.14.6271; Grover R, 2011, RNA BIOL, V8, P132, DOI 10.4161/rna.8.1.14260; Henis-Korenblit S, 2002, P NATL ACAD SCI USA, V99, P5400, DOI 10.1073/pnas.082102499; Henis-Korenblit S, 2000, MOL CELL BIOL, V20, P496, DOI 10.1128/MCB.20.2.496-506.2000; Herbreteau CH, 2005, NAT STRUCT MOL BIOL, V12, P1001, DOI 10.1038/nsmb1011; Imataka H, 1997, EMBO J, V16, P817, DOI 10.1093/emboj/16.4.817; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; LevyStrumpf N, 1997, MOL CELL BIOL, V17, P1615, DOI 10.1128/MCB.17.3.1615; Lewis SM, 2008, NUCLEIC ACIDS RES, V36, P168, DOI 10.1093/nar/gkm1007; Liberman N, 2008, J MOL BIOL, V383, P539, DOI 10.1016/j.jmb.2008.08.013; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Marash L, 2005, CELL DEATH DIFFER, V12, P554, DOI 10.1038/sj.cdd.4401609; Marash L, 2008, MOL CELL, V30, P447, DOI 10.1016/j.molcel.2008.03.018; Marcel V, 2011, CELL DEATH DIFFER, V18, P1815, DOI 10.1038/cdd.2011.120; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Nevins TA, 2003, J BIOL CHEM, V278, P3572, DOI 10.1074/jbc.M206781200; Ohki R, 2007, CANCER SCI, V98, P189, DOI 10.1111/j.1349-7006.2006.00375.x; Powell DJ, 2008, CELL CYCLE, V7, P950, DOI 10.4161/cc.7.7.5626; Pudi R, 2003, J BIOL CHEM, V278, P12231, DOI 10.1074/jbc.M210287200; Ray PS, 2006, EMBO REP, V7, P404, DOI 10.1038/sj.embor.7400623; Shaughnessy JD, 1997, GENOMICS, V39, P192, DOI 10.1006/geno.1996.4502; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Warnakulasuriyarachchi D, 2004, J BIOL CHEM, V279, P17148, DOI 10.1074/jbc.M308737200; Yamanaka S, 1997, GENE DEV, V11, P321, DOI 10.1101/gad.11.3.321; Yang DQ, 2006, ONCOGENE, V25, P4613, DOI 10.1038/sj.onc.1209483; Yin YL, 2002, NAT CELL BIOL, V4, P462, DOI 10.1038/ncb801	30	47	48	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 30	2014	33	5					611	618		10.1038/onc.2012.626	http://dx.doi.org/10.1038/onc.2012.626			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AA5GW	23318444				2022-12-25	WOS:000331125100009
J	Huang, LS; Berdyshev, E; Mathew, B; Fu, PF; Gorshkova, IA; He, DH; Ma, WL; Noth, I; Ma, SF; Pendyala, S; Reddy, SP; Zhou, T; Zhang, W; Garzon, SA; Garcia, JGN; Natarajan, V				Huang, Long Shuang; Berdyshev, Evgeny; Mathew, Biji; Fu, Panfeng; Gorshkova, Irina A.; He, Donghong; Ma, Wenli; Noth, Imre; Ma, Shwu-Fan; Pendyala, Srikanth; Reddy, Sekhar P.; Zhou, Tong; Zhang, Wei; Garzon, Steven A.; Garcia, Joe G. N.; Natarajan, Viswanathan			Targeting sphingosine kinase 1 attenuates bleomycin-induced pulmonary fibrosis	FASEB JOURNAL			English	Article						TGF-beta; S1P; S1P lyase	GROWTH-FACTOR-BETA; VASCULAR LEAK; LUNG INJURY; 1-PHOSPHATE; FIBROBLASTS; MURINE; SPHINGOSINE-1-PHOSPHATE; DIFFERENTIATION; INFLAMMATION; INHIBITION	Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive interstitial lung disease, wherein transforming growth factor beta (TGF-beta) and sphingosine-1-phosphate (S1P) contribute to the pathogenesis of fibrosis. However, the in vivo contribution of sphingosine kinase (SphK) in fibrotic processes has not been documented. Microarray analysis of blood mononuclear cells from patients with IPF and SphK1- or SphK2-knockdown mice and SphK inhibitor were used to assess the role of SphKs in fibrogenesis. The expression of SphK1/2 negatively correlated with lung function and survival in patients with IPF. Also, the expression of SphK1 was increased in lung tissues from patients with IPF and bleomycin-challenged mice. Knockdown of SphK1, but not SphK2, increased survival and resistance to pulmonary fibrosis in bleomycin-challenged mice. Administration of SphK inhibitor reduced bleomycin-induced mortality and pulmonary fibrosis in mice. Knockdown of SphK1 or treatment with SphK inhibitor attenuated S1P generation and TGF-beta secretion in a bleomycin-induced lung fibrosis mouse model that was accompanied by reduced phosphorylation of Smad2 and MAPKs in lung tissue. In vitro, bleomycin-induced expression of SphK1 in lung fibroblast was found to be TGF-beta dependent. Taken together, these data indicate that SphK1 plays a critical role in the pathology of lung fibrosis and is a novel therapeutic target.-Huang, L. S., Berdyshev, E., Mathew, B., Fu, P., Gorshkova, I. A., He, D., Ma, W., Noth, I., Ma, S.-F., Pendyala, S., Reddy, S. P., Zhou, T., Zhang, W., Garzon, S. A., Garcia, J. G. N., Natarajan, V. Targeting sphingosine kinase 1 attenuates bleomycin-induced pulmonary fibrosis. FASEB J. 27, 1749-1760 (2013). www.fasebj.org	[Huang, Long Shuang; Fu, Panfeng; He, Donghong; Ma, Wenli; Pendyala, Srikanth; Natarajan, Viswanathan] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; [Huang, Long Shuang; Berdyshev, Evgeny; Mathew, Biji; Fu, Panfeng; Gorshkova, Irina A.; He, Donghong; Ma, Wenli; Pendyala, Srikanth; Zhou, Tong; Garcia, Joe G. N.; Natarajan, Viswanathan] Univ Illinois, Inst Personalized Resp Med, Chicago, IL 60612 USA; [Berdyshev, Evgeny; Mathew, Biji; Gorshkova, Irina A.; Zhou, Tong; Garcia, Joe G. N.; Natarajan, Viswanathan] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Reddy, Sekhar P.; Zhang, Wei] Univ Illinois, Dept Pediat, Chicago, IL 60612 USA; [Zhang, Wei] Univ Illinois, Inst Human Genet, Chicago, IL 60612 USA; [Garzon, Steven A.] Univ Illinois, Dept Pathol, Chicago, IL 60612 USA; [Noth, Imre; Ma, Shwu-Fan] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago	Natarajan, V (corresponding author), Univ Illinois, Dept Pharmacol, E403 Med Sci Bldg MC868,835 South Wolcott Ave, Chicago, IL 60612 USA.	visnatar@uic.edu	Fu, Panfeng/F-7345-2015; Huang, Longshuang/H-9553-2016	Fu, Panfeng/0000-0001-8813-9258; 	U.S. National Institutes of Health (NIH) [HL P01 98050, P01 58064, HL66109, ES11863]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066109, P01HL098050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011863] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by U.S. National Institutes of Health (NIH) grants HL P01 98050 and P01 58064 to V.N. and J.G.N.G, and HL66109 and ES11863 to S.P.R.. The authors thank Dr. Prasad Kanteti for helpful discussion and manuscript preparation. The authors thank Dr. Richard L Proia (NIH/National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA) for providing breeding pairs of the SphK1<SUP>-/-</SUP> and SphK2<SUP>-/-</SUP> mice. The authors declare no conflicts of interest.	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Aoki J, 2008, BBA-MOL CELL BIOL L, V1781, P513, DOI 10.1016/j.bbalip.2008.06.005; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Bartram U, 2004, CHEST, V125, P754, DOI 10.1378/chest.125.2.754; Berdyshev EV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016571; Cencetti F, 2010, MOL BIOL CELL, V21, P1111, DOI 10.1091/mbc.E09-09-0812; Chiba Y, 2010, J PHARMACOL SCI, V114, P304, DOI 10.1254/jphs.10202FP; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; Dhami R, 2010, CELL PHYSIOL BIOCHEM, V26, P749, DOI 10.1159/000322342; Di AK, 2010, J BIOL CHEM, V285, P15848, DOI 10.1074/jbc.M109.075549; Duan SW, 2008, BIOINFORMATION, V2, P469, DOI 10.6026/97320630002469; Dudek SM, 2004, J BIOL CHEM, V279, P24692, DOI 10.1074/jbc.M313969200; French KJ, 2006, J PHARMACOL EXP THER, V318, P596, DOI 10.1124/jpet.106.101345; French KJ, 2003, CANCER RES, V63, P5962; Funke M, 2012, AM J RESP CELL MOL, V46, P355, DOI 10.1165/rcmb.2010-0155OC; Gao P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044543; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Ghosh M, 2004, AM J RESP CELL MOL, V30, P91, DOI 10.1165/rcmb.2003-0005OC; Gorshkova I, 2012, J LIPID RES, V53, P1553, DOI 10.1194/jlr.M026039; Hamada K, 2007, CHEST, V131, P650, DOI 10.1378/chest.06-1466; Hla T, 2004, SEMIN CELL DEV BIOL, V15, P513, DOI 10.1016/j.semcdb.2004.05.002; Huebner RH, 2008, BIOTECHNIQUES, V44, P507, DOI 10.2144/000112729; Inage M, 2009, INT J BIOL SCI, V5, P304; KHALIL N, 1991, AM J RESP CELL MOL, V5, P155, DOI 10.1165/ajrcmb/5.2.155; Kharel Y, 2012, BIOCHEM J, V447, P149, DOI 10.1042/BJ20120609; Kharel Y, 2011, ANAL BIOCHEM, V411, P230, DOI 10.1016/j.ab.2011.01.003; King TE, 1998, ANN INTERN MED, V129, P806, DOI 10.7326/0003-4819-129-10-199811150-00012; Kono Y, 2007, AM J RESP CELL MOL, V37, P395, DOI 10.1165/rcmb.2007-0065OC; LIMPER AH, 1991, CHEST, V99, pS55, DOI 10.1378/chest.99.3_Supplement.55S; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Liu L, 2009, J ENVIRON PATHOL TOX, V28, P99, DOI 10.1615/JEnvironPatholToxicolOncol.v28.i2.20; McVerry BJ, 2004, AM J RESP CRIT CARE, V170, P987, DOI 10.1164/rccm.200405-684oc; Milara J, 2012, THORAX, V67, P147, DOI 10.1136/thoraxjnl-2011-200026; Mouratis MA, 2011, CURR OPIN PULM MED, V17, P355, DOI 10.1097/MCP.0b013e328349ac2b; Oskouian B, 2007, CELL CYCLE, V6, P522, DOI 10.4161/cc.6.5.3903; Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC; Phan SH, 2002, CHEST, V122, p286S, DOI 10.1378/chest.122.6_suppl.286S; SAPPINO AP, 1990, LAB INVEST, V63, P144; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Shea BS, 2010, AM J RESP CELL MOL, V43, P662, DOI 10.1165/rcmb.2009-0345OC; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Takuwa N, 2010, CARDIOVASC RES, V85, P484, DOI 10.1093/cvr/cvp312; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VASKOVSKY VE, 1975, J CHROMATOGR, V114, P129, DOI 10.1016/S0021-9673(00)85249-8; Zemann B, 2007, IMMUNOL LETT, V109, P56, DOI 10.1016/j.imlet.2007.01.001	45	69	75	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2013	27	4					1749	1760		10.1096/fj.12-219634	http://dx.doi.org/10.1096/fj.12-219634			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23315259	Green Published			2022-12-25	WOS:000316940800043
J	Zou, CB; Chen, Y; Smith, RM; Snavely, C; Li, J; Coon, TA; Chen, BB; Zhao, YT; Mallampalli, RK				Zou, Chunbin; Chen, Yan; Smith, Rebecca M.; Snavely, Courtney; Li, Jin; Coon, Tiffany A.; Chen, Bill B.; Zhao, Yutong; Mallampalli, Rama K.			SCFFbxw15 Mediates Histone Acetyltransferase Binding to Origin Recognition Complex (HBO1) Ubiquitin-Proteasomal Degradation to Regulate Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; F-BOX; BETA-TRCP; ACTIVATION; LIPOPOLYSACCHARIDE; PHOSPHORYLATION; RECRUITMENT; ACETYLASE; LIGASES; TRANSCRIPTION	Histone acetyltransferase binding to origin recognition complex (HBO1) plays a crucial role in DNA replication licensing and cell proliferation, yet its molecular regulation in cells is relatively unknown. Here an uncharacterized protein, Fbxw15, directly interacts with HBO1, a labile protein (t(1/2) = similar to 3 h), to mediate its ubiquitination (Lys(338)) and degradation in the cytoplasm. Fbxw15-mediated HBO1 depletion required mitogen-activated protein kinase 1 (Mek1), which was sufficient to trigger HBO1 phosphorylation and degradation in cells. Mek1 ability to produce HBO1 degradation was blocked by Fbxw15 silencing. Lipopolysaccharide induced HBO1 degradation, an effect abrogated by Fbxw15 or Mek1 cellular depletion. Modulation of Fbxw15 levels was able to differentially regulate histone H3K14 acetylation and cellular proliferation by altering HBO1 levels. These studies authenticate Fbxw15 as a ubiquitin E3 ligase subunit that mediates endotoxin-induced HBO1 depletion in cells, thereby controlling cell replicative capacity.	[Zou, Chunbin; Chen, Yan; Smith, Rebecca M.; Snavely, Courtney; Li, Jin; Coon, Tiffany A.; Chen, Bill B.; Zhao, Yutong; Mallampalli, Rama K.] Univ Pittsburgh, Acute Lung Injury Ctr Excellence, Dept Med, Pittsburgh, PA 15213 USA; [Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv Line, Pittsburgh, PA 15240 USA; [Mallampalli, Rama K.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15260 USA; [Chen, Yan] Cent South Univ, Xiangya Hosp 2, Dept Internal Med, Div Resp Dis, Changsha 410011, Hunan, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Central South University	Mallampalli, RK (corresponding author), Dept Med, Div Pulm Allergy & Crit Care Med, 628 NW Montefiore,3459 5th Ave, Pittsburgh, PA 15213 USA.	mallampallirk@upmc.edu	Zou, Chunbin/L-7488-2019	Zou, Chunbin/0000-0003-1355-4726	National Institutes of Health [HL096376, HL097376, HL098174, HL116472, HL01916]; United States Department of Veterans Affairs; Veterans Health Administration; Office of Research and Development; Biomedical Laboratory Research and Development; American Heart Association [12SDG12040330]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097376, R01HL112791, R01HL098174, R01HL116472, R01HL096376] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Health Administration(US Department of Veterans Affairs); Office of Research and Development; Biomedical Laboratory Research and Development(US Department of Veterans Affairs); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants HL096376, HL097376, and HL098174 (to R. K. M.), HL116472 (to B. B. C.), and HL01916 (to Y. Z.). This work was also supported in part by the United States Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development, a Merit Review Award from the United States Department of Veterans Affairs, and American Heart Association Award 12SDG12040330 (to C. Z.).	Avvakumov N, 2012, MOL CELL BIOL, V32, P689, DOI 10.1128/MCB.06455-11; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Burgermeister E, 2007, MOL CELL BIOL, V27, P803, DOI 10.1128/MCB.00601-06; Carter AB, 1998, AM J RESP CELL MOL, V18, P384, DOI 10.1165/ajrcmb.18.3.2972; Chadha GS, 2010, MOL CELL, V37, P5, DOI 10.1016/j.molcel.2009.12.028; Chen BB, 2011, MOL CELL BIOL, V31, P1905, DOI 10.1128/MCB.00723-10; Coles AH, 2010, P NATL ACAD SCI USA, V107, P11423, DOI 10.1073/pnas.0912116107; De La Chesnaye E, 2008, BIOL REPROD, V78, P714, DOI 10.1095/biolreprod.107.063826; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Haller D, 2003, J BIOL CHEM, V278, P23851, DOI 10.1074/jbc.M300075200; HAMILTON JA, 1992, J IMMUNOL, V148, P4028; Ho MS, 2008, CELL MOL LIFE SCI, V65, P1977, DOI 10.1007/s00018-008-7592-6; Iizuka M, 2006, MOL CELL BIOL, V26, P1098, DOI 10.1128/MCB.26.3.1098-1108.2006; Iizuka M, 1999, J BIOL CHEM, V274, P23027, DOI 10.1074/jbc.274.33.23027; Inuzuka H, 2012, CELL, V150, P179, DOI 10.1016/j.cell.2012.05.038; Jain S, 2012, BREAST CANCER RES TR, V135, P103, DOI 10.1007/s10549-012-2069-6; Jo C, 2011, J BIOL CHEM, V286, P18903, DOI 10.1074/jbc.M111.225128; Karabinova P, 2011, CELL TISSUE RES, V346, P1, DOI 10.1007/s00441-011-1235-1; Kim CO, 2012, ARCH GERONTOL GERIAT, V54, pE35, DOI 10.1016/j.archger.2011.07.016; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Lau AW, 2012, FRONT BIOSCI-LANDMRK, V17, P2197, DOI 10.2741/4045; Li YM, 2011, J BIOL CHEM, V286, P41344, DOI 10.1074/jbc.M111.290767; Maki K, 2008, J IMMUNOL, V181, P494, DOI 10.4049/jimmunol.181.1.494; Miotto B, 2008, GENE DEV, V22, P2633, DOI 10.1101/gad.1674108; Miotto B, 2011, MOL CELL, V44, P62, DOI 10.1016/j.molcel.2011.06.021; Miotto B, 2010, MOL CELL, V37, P57, DOI 10.1016/j.molcel.2009.12.012; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Potoka DA, 2003, AM J PHYSIOL-GASTR L, V285, pG861, DOI 10.1152/ajpgi.00412.2002; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; Ruemmele FM, 2002, GUT, V51, P842, DOI 10.1136/gut.51.6.842; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Saksouk N, 2009, MOL CELL, V33, P257, DOI 10.1016/j.molcel.2009.01.007; Shima Y, 2008, MOL CELL BIOL, V28, P7126, DOI 10.1128/MCB.00897-08; Silverman JS, 2012, TRENDS BIOCHEM SCI, V37, P66, DOI 10.1016/j.tibs.2011.10.004; Starostina NG, 2012, TRENDS CELL BIOL, V22, P33, DOI 10.1016/j.tcb.2011.10.004; Takada Y, 2005, BLOOD, V106, P641, DOI 10.1182/blood-2004-12-4589; Tan MKM, 2011, MOL CELL BIOL, V31, P3687, DOI 10.1128/MCB.05746-11; Wong PG, 2010, CELL CYCLE, V9, P4351, DOI 10.4161/cc.9.21.13596; Wu ZQ, 2008, P NATL ACAD SCI USA, V105, P1919, DOI 10.1073/pnas.0712063105; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Yang LN, 2011, CELL IMMUNOL, V271, P173, DOI 10.1016/j.cellimm.2011.06.017; Zhao J, 2012, J BIOL CHEM, V287, P19105, DOI 10.1074/jbc.M112.339507; Zou CB, 2011, J BIOL CHEM, V286, P28019, DOI 10.1074/jbc.M111.253385; Zou CB, 2011, J BIOL CHEM, V286, P2719, DOI 10.1074/jbc.M110.192377	46	30	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6306	6316		10.1074/jbc.M112.426882	http://dx.doi.org/10.1074/jbc.M112.426882			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23319590	hybrid, Green Published			2022-12-25	WOS:000315820700025
J	Battivelli, E; Lecossier, D; Clavel, F; Hance, AJ				Battivelli, Emilie; Lecossier, Denise; Clavel, Francois; Hance, Allan J.			Delaying Reverse Transcription Does Not Increase Sensitivity of HIV-1 to Human TRIM5 alpha	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CYCLOPHILIN-A; HUMAN-CELLS; RETROVIRAL RESTRICTION; PREINTEGRATION COMPLEX; RHESUS TRIM5-ALPHA; ANTIVIRAL ACTIVITY; TRIM5 PROTEINS; RING DOMAIN; DNA FLAP	Background: Because uncoating of the capsid is linked to reverse transcription, modifications that delay this process lead to the persistence in the cytoplasm of capsids susceptible to recognition by the human restriction factor TRIM5 alpha (hTRIM5 alpha). It is unknown, however, if increasing the time available for capsid-hTRIM5 alpha interactions would actually render viruses more sensitive to hTRIM5 alpha. Results: Viral sensitivity to hTRIM5 alpha was evaluated by comparing their replication in human U373-X4 cells in which hTRIM5 alpha activity had or had not been inhibited by overexpression of human TRIM5 gamma. No differences were observed comparing wildtype HIV-1 and variants carrying mutations in reverse transcriptase or the central polypurine tract that delayed the completion of reverse transcription. In addition, the effect of delaying the onset of reverse transcription for several hours by treating target cells with nevirapine was evaluated using viral isolates with different sensitivities to hTRIM5 alpha. Delaying reverse transcription led to a time-dependent loss in viral infectivity that was increased by inhibiting capsid-cyclophilin A interactions, but did not result in increased viral sensitivity to hTRIM5 alpha, regardless of their intrinsic sensitivity to this restriction factor. Conclusions: Consistent with prior studies, the HIV-1 capsid can be targeted for destruction by hTRIM5 alpha, but different strains display considerable variability in their sensitivity to this restriction factor. Capsids can also be lost more slowly through a TRIM5 alpha-independent process that is accelerated when capsid-cyclophilin A interactions are inhibited, an effect that may reflect changes in the intrinsic stability of the capsid. Blocking the onset or delaying reverse transcription does not, however, increase viral sensitivity to hTRIM5 alpha, indicating that the recognition of the capsids by hTRIM5 alpha is completed rapidly following entry into the cytoplasm, as previously observed for the simian restriction factors TRIM-Cyp and rhesus TRIM5 alpha.	[Battivelli, Emilie; Lecossier, Denise; Clavel, Francois; Hance, Allan J.] INSERM, U941, Paris, France; [Battivelli, Emilie; Lecossier, Denise; Clavel, Francois; Hance, Allan J.] Univ Paris Diderot, Inst Univ Hematol, Hop St Louis, Paris, France; [Hance, Allan J.] Hop Bichat Claude Bernard, Assistance Publ Hop Paris, Serv Malad Infect & Trop, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Hance, AJ (corresponding author), INSERM, U941, Paris, France.	allan.hance@inserm.fr			INSERM, Agence Nationale de Recherche sur le Sida et les Hepatites (ANRS), Sidaction	INSERM, Agence Nationale de Recherche sur le Sida et les Hepatites (ANRS), Sidaction	INSERM, Agence Nationale de Recherche sur le Sida et les Hepatites (ANRS), Sidaction. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2006, J VIROL, V80, P9754, DOI 10.1128/JVI.01052-06; Arhel N, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-96; Arhel NJ, 2007, EMBO J, V26, P3025, DOI 10.1038/sj.emboj.7601740; Battivelli E, 2011, J VIROL, V85, P11846, DOI 10.1128/JVI.05201-11; Battivelli E, 2011, J VIROL, V85, P7828, DOI 10.1128/JVI.00648-11; Battivelli E, 2010, J VIROL, V84, P11010, DOI 10.1128/JVI.00758-10; Berube J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-68; BILLICH A, 1995, J VIROL, V69, P2451, DOI 10.1128/JVI.69.4.2451-2461.1995; Bouchonnet F, 2005, J VIROL, V79, P812, DOI 10.1128/JVI.79.2.812-822.2005; Campbell EM, 2008, J CELL BIOL, V180, P549, DOI 10.1083/jcb.200706154; CHARNEAU P, 1992, J VIROL, V66, P2814, DOI 10.1128/JVI.66.5.2814-2820.1992; Diaz-Griffero F, 2007, VIROLOGY, V369, P400, DOI 10.1016/j.virol.2007.08.032; Diaz-Griffero F, 2007, J VIROL, V81, P10362, DOI 10.1128/JVI.00703-07; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Ganser-Pornillos BK, 2011, P NATL ACAD SCI USA, V108, P534, DOI 10.1073/pnas.1013426108; Hatziioannou T, 2005, J VIROL, V79, P176, DOI 10.1128/JVI.79.1.176-183.2005; Hulme AE, 2011, P NATL ACAD SCI USA, V108, P9975, DOI 10.1073/pnas.1014522108; Javanbakht H, 2005, J BIOL CHEM, V280, P26933, DOI 10.1074/jbc.M502145200; Keckesova Z, 2006, J VIROL, V80, P4683, DOI 10.1128/JVI.80.10.4683-4690.2006; Kim J, 2011, J VIROL, V85, P8116, DOI 10.1128/JVI.00341-11; Kratovac Z, 2008, J VIROL, V82, P6772, DOI 10.1128/JVI.00410-08; Labrosse B, 1998, J VIROL, V72, P6381, DOI 10.1128/JVI.72.8.6381-6388.1998; Leschonsky B, 2007, J GEN VIROL, V88, P207, DOI 10.1099/vir.0.81894-0; Li Y, 2009, J VIROL, V83, P10951, DOI 10.1128/JVI.00682-09; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Luban J., 2012, MOL BIOL INT, V2012; Luban J, 2007, J VIROL, V81, P1054, DOI 10.1128/JVI.01519-06; Maegawa H, 2008, J VIROL METHODS, V151, P249, DOI 10.1016/j.jviromet.2008.04.012; Maegawa H, 2010, VIROLOGY, V399, P212, DOI 10.1016/j.virol.2010.01.003; Matsuoka S, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-21; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Nisole S, 2004, P NATL ACAD SCI USA, V101, P13324, DOI 10.1073/pnas.0404640101; Passerini LD, 2006, J VIROL, V80, P2100, DOI 10.1128/JVI.80.5.2100-2105.2006; Perez-Caballero D, 2005, J VIROL, V79, P15567, DOI 10.1128/JVI.79.24.15567-15572.2005; Perez-Caballero D, 2005, J VIROL, V79, P8969, DOI 10.1128/JVI.79.14.8969-8978.2005; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Ptak RG, 2008, ANTIMICROB AGENTS CH, V52, P1302, DOI 10.1128/AAC.01324-07; Rold CJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000074; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Sokolskaja E, 2006, J VIROL, V80, P2855, DOI 10.1128/JVI.80.6.2855-2862.2006; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Stremlau M, 2006, VIROLOGY, V351, P112, DOI 10.1016/j.virol.2006.03.015; THALI M, 1994, NATURE, V372, P363, DOI 10.1038/372363a0; Thomas DC, 2007, J VIROL, V81, P4798, DOI 10.1128/JVI.02471-06; Towers GJ, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-40; Wu XL, 2006, P NATL ACAD SCI USA, V103, P7465, DOI 10.1073/pnas.0510483103; Yap MW, 2006, J VIROL, V80, P4061, DOI 10.1128/JVI.80.8.4061-4067.2006; Yin L, 1998, J VIROL, V72, P6430, DOI 10.1128/JVI.72.8.6430-6436.1998; Ylinen LMJ, 2005, J VIROL, V79, P11580, DOI 10.1128/JVI.79.18.11580-11587.2005; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zhao GP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002009	53	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e52434	10.1371/journal.pone.0052434	http://dx.doi.org/10.1371/journal.pone.0052434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320071	Green Published, gold, Green Submitted			2022-12-25	WOS:000313429800014
J	Chisti, MJ; Salam, MA; Ashraf, H; Faruque, ASG; Bardhan, PK; Shahid, ASMSB; Shahunja, KM; Das, SK; Ahmed, T				Chisti, Mohammod Jobayer; Salam, Mohammed Abdus; Ashraf, Hasan; Faruque, Abu S. G.; Bardhan, Pradip Kumar; Shahid, Abu S. M. S. B.; Shahunja, K. M.; Das, Sumon Kumar; Ahmed, Tahmeed			Predictors and Outcome of Hypoxemia in Severely Malnourished Children under Five with Pneumonia: A Case Control Design	PLOS ONE			English	Article							PAPUA-NEW-GUINEA; LOWER RESPIRATORY-INFECTION; DEVELOPING-COUNTRIES; UNDER-5 CHILDREN; OXYGEN PROGRAM; DIARRHEA; BANGLADESH; HYPERNATREMIA; EPIDEMIOLOGY; HOSPITALS	Background: There is lack of information in the medical literature on predictors of hypoxemia in severely malnourished children with pneumonia, although hypoxemia is common and is often associated with fatal outcome in this population. We explored the predictors of hypoxemia in under-five children who were hospitalized for the management of pneumonia and severe acute malnutrition (SAM). Methods: In this unmatched case-control design, SAM children of both sexes, aged 0-59 months, admitted to the Dhaka Hospital of the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr, b) with radiological pneumonia and hypoxemia during April 2011 to April 2012 were studied. SAM children with pneumonia and hypoxemia (SpO(2)<90%) constituted the cases (n = 37), and randomly selected SAM children with pneumonia but without hypoxemia constituted controls (n = 111). Results: The case-fatality was significantly higher among the cases than the controls (30% vs. 4%; p<0.001). In logistic regression analysis, after adjusting for potential confounders such as nasal flaring, head nodding, inability to drink, and crackles in lungs, fast breathing (95% CI = 1.09-13.55), lower chest wall in-drawing (95% CI = 2.48-43.41), and convulsion at admission (95% CI = 3.14-234.01) were identified as independent predictors of hypoxemia in this population. The sensitivity of fast breathing, lower chest wall in-drawing and convulsion at admission and their 95% confidence intervals (CI) to predict hypoxemia were 84 (67-93)%, 89 (74-96)%, and 19 (9-36)% respectively, and their specificity were 53 (43-63)%, 60 (51-69)% and 98 (93-100)% respectively. Conclusion and Significance: Fast breathing and lower chest wall in-drawing were the best predictors of hypoxemia in SAM children with pneumonia. There thus, in resources poor settings where pulse oximetry is not available, identification of these simple clinical predictors of hypoxemia in such children could be reliably used for early O-2 supplementation in addition to other appropriate management to reduce morbidity and deaths.	[Chisti, Mohammod Jobayer; Ashraf, Hasan; Faruque, Abu S. G.; Bardhan, Pradip Kumar; Shahid, Abu S. M. S. B.; Shahunja, K. M.; Das, Sumon Kumar; Ahmed, Tahmeed] Int Ctr Diarhoeal Dis Res, Ctr Nutr & Food Secur, Icddr B, Dhaka, Bangladesh; [Chisti, Mohammod Jobayer; Ashraf, Hasan; Bardhan, Pradip Kumar] Icddr B, Clin Serv, Dhaka, Bangladesh; [Salam, Mohammed Abdus] Icddr B, Res Adm Serv, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR)	Chisti, MJ (corresponding author), Int Ctr Diarhoeal Dis Res, Ctr Nutr & Food Secur, Icddr B, Dhaka, Bangladesh.	chisti@icddrb.org	Shahunja, K M/AAR-6229-2020; Das, Sumon Kumar/AAD-1551-2019; Chisti, Mohammod J/A-7216-2018; Das, Sumon Kumar/T-6384-2019	Shahunja, K M/0000-0002-9345-206X; 	Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR, B) [Gr-00233]; Australian Agency for International Development; Government of the People's Republic of Bangladesh; Canadian International Development Agency; Swedish International Development Cooperation Agency; Department for International Development, United Kingdom	Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR, B); Australian Agency for International Development; Government of the People's Republic of Bangladesh; Canadian International Development Agency; Swedish International Development Cooperation Agency; Department for International Development, United Kingdom	This research study was funded by the Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR, B; grant no Gr-00233) and its donors, which provide unrestricted support to ICDDR, B for its operations and research. Current donors providing unrestricted support include: Australian Agency for International Development, Government of the People's Republic of Bangladesh, Canadian International Development Agency, Swedish International Development Cooperation Agency, and the Department for International Development, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrogue HJ, 2000, NEW ENGL J MED, V342, P1493, DOI 10.1056/NEJM200005183422006; Alam Nure H, 2003, Paediatr Drugs, V5, P151, DOI 10.2165/00128072-200305030-00002; Chisti MJ, 2011, TROP MED INT HLTH; Chisti MJ, 2007, ACTA PAEDIATR, V96, P693, DOI 10.1111/j.1651-2227.2007.00192.x; Chisti MJ, 2011, ACTA PAEDIATR, V100, pE275, DOI 10.1111/j.1651-2227.2011.02368.x; Chisti MJ, 2010, PEDIATR INFECT DIS J, V29, P174, DOI 10.1097/INF.0b013e3181b9a4d5; Chisti MJ, 2009, TROP MED INT HEALTH, V14, P1173, DOI 10.1111/j.1365-3156.2009.02364.x; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Duke T, 2001, INT J TUBERC LUNG D, V5, P511; Duke T, 2002, ARCH DIS CHILD, V86, P108, DOI 10.1136/adc.86.2.108; DYKE T, 1995, J TROP PEDIATRICS, V41, P196, DOI 10.1093/tropej/41.4.196; Lodha Rakesh, 2004, Indian Pediatr, V41, P129; Lozano JM, 2001, INT J TUBERC LUNG D, V5, P496; Matai S, 2008, ANN TROP PAEDIATR, V28, P71, DOI 10.1179/146532808X270716; Morgan G, 1997, LANCET, V349, P1693, DOI 10.1016/S0140-6736(96)12038-9; ONYANGO FE, 1993, BRIT MED J, V306, P612, DOI 10.1136/bmj.306.6878.612; Rahman M M, 1997, Bangladesh Med Res Counc Bull, V23, P47; REDD SC, 1994, T ROY SOC TROP MED H, V88, P307, DOI 10.1016/0035-9203(94)90092-2; SAMADI AR, 1983, BRIT MED J, V286, P671, DOI 10.1136/bmj.286.6366.671; Smyth A, 1998, ANN TROP PAEDIATR, V18, P31, DOI 10.1080/02724936.1998.11747923; Subhi R, 2009, LANCET INFECT DIS, V9, P219, DOI 10.1016/S1473-3099(09)70071-4; Suskind DMK, 1990, MALNOURISHED CHILD; Terborg C, MED KLIN INTENSIVMED; Wandi F, 2006, ANN TROP PAEDIATR, V26, P277, DOI 10.1179/146532806X152791; Weber MW, 1997, ARCH DIS CHILD, V76, P310, DOI 10.1136/adc.76.4.310; West JB., 2008, WESTS RESP PHYSL ESS, V9th; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C	27	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e51376	10.1371/journal.pone.0051376	http://dx.doi.org/10.1371/journal.pone.0051376			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320066	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429800008
J	Gustafsson, E; Almonte-Becerril, M; Bloch, W; Costell, M				Gustafsson, Erika; Almonte-Becerril, Maylin; Bloch, Wilhelm; Costell, Mercedes			Perlecan Maintains Microvessel Integrity In Vivo and Modulates Their Formation In Vitro	PLOS ONE			English	Article							MUSCLE-CELL PROLIFERATION; FIBROBLAST-GROWTH-FACTOR; SCHWARTZ-JAMPEL-SYNDROME; HEPARAN-SULFATE; BASEMENT-MEMBRANES; ALPHA-2-BETA-1 INTEGRIN; ENDOTHELIAL-CELLS; DEFICIENT MICE; TUMOR-GROWTH; ANGIOGENESIS	Perlecan is a heparan sulfate proteoglycan assembled into the vascular basement membranes (BMs) during vasculogenesis. In the present study we have investigated vessel formation in mice, teratomas and embryoid bodies (EBs) in the absence of perlecan. We found that perlecan was dispensable for blood vessel formation and maturation until embryonic day (E) 12.5. At later stages of development 40% of mutant embryos showed dilated microvessels in brain and skin, which ruptured and led to severe bleedings. Surprisingly, teratomas derived from perlecan-null ES cells showed efficient contribution of perlecan-deficient endothelial cells to an apparently normal tumor vasculature. However, in perlecan-deficient EBs the area occupied by an endothelial network and the number of vessel branches were significantly diminished. Addition of FGF-2 but not VEGF(165) rescued the in vitro deficiency of the mutant ES cells. Furthermore, in the absence of perlecan in the EB matrix lower levels of FGFs are bound, stored and available for cell surface presentation. Altogether these findings suggest that perlecan supports the maintenance of brain and skin subendothelial BMs and promotes vasculo- and angiogenesis by modulating FGF-2 function.	[Gustafsson, Erika] Lund Univ, Dept Expt Pathol, Lund, Sweden; [Almonte-Becerril, Maylin; Costell, Mercedes] Univ Valencia, Dept Biochem & Mol Biol, Valencia, Spain; [Almonte-Becerril, Maylin] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Infect & Patogenesis Mol, Mexico City, DF, Mexico; [Bloch, Wilhelm] Dept Mol & Cellular Sport Med, Cologne, Germany	Lund University; University of Valencia; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Costell, M (corresponding author), Univ Valencia, Dept Biochem & Mol Biol, Valencia, Spain.	Mercedes.Costell@uv.es	ALMONTE-BECERRIL, MAYLIN/F-2830-2019; Costell, Mercedes/H-7850-2015	Costell, Mercedes/0000-0001-6146-996X; ALMONTE-BECERRIL, MAYLIN/0000-0003-1552-5961	Universitat de Valencia; University of Lund; Deutsche Forschungsgemeinschaft [DFG419/2]	Universitat de Valencia; University of Lund; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Universitat de Valencia (to M. C.) and the University of Lund (to E. G.). W. B. was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG419/2). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adatia R, 1997, ANN ONCOL, V8, P1257, DOI 10.1023/A:1008243115385; Arikawa-Hirasawa E, 2002, AM J HUM GENET, V70, P1368, DOI 10.1086/340390; Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354, DOI 10.1038/15537; AVIEZER D, 1994, CELL, V79, P1005, DOI 10.1016/0092-8674(94)90031-0; Bader BL, 1998, CELL, V95, P507, DOI 10.1016/S0092-8674(00)81618-9; Baker AB, 2008, CIRC RES, V103, P289, DOI 10.1161/CIRCRESAHA.108.179465; Bix G, 2004, J CELL BIOL, V166, P97, DOI 10.1083/jcb.200401150; Bix G, 2008, MICROSC RES TECHNIQ, V71, P339, DOI 10.1002/jemt.20562; Bloch W, 1997, J CELL BIOL, V139, P265, DOI 10.1083/jcb.139.1.265; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chadderton NS, 2003, INT J BIOCHEM CELL B, V35, P1052, DOI 10.1016/S1357-2725(02)00299-6; Costell M, 2002, CIRC RES, V91, P158, DOI 10.1161/01.RES.0000026056.81424.DA; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; Dono R, 1998, EMBO J, V17, P4213, DOI 10.1093/emboj/17.15.4213; Eberhard A, 2000, CANCER RES, V60, P1388; Eklund L, 2001, P NATL ACAD SCI USA, V98, P1194, DOI 10.1073/pnas.031444798; Feitsma K, 2000, J BIOL CHEM, V275, P9396, DOI 10.1074/jbc.275.13.9396; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; Garl PJ, 2004, CIRC RES, V94, P175, DOI 10.1161/01.RES.0000109791.69181.B6; Giros A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-29; Gohring W, 1998, EUR J BIOCHEM, V255, P60, DOI 10.1046/j.1432-1327.1998.2550060.x; Goyal A, 2011, J BIOL CHEM, V286, P25947, DOI 10.1074/jbc.M111.243626; Handler M, 1997, AIDAJA630CO2H; Henry MD, 2001, J CELL SCI, V114, P1137; Ishijima M, 2012, MATRIX BIOL, V31, P234, DOI 10.1016/j.matbio.2012.02.006; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kazemi S, 2002, CELL PHYSIOL BIOCHEM, V12, P55, DOI 10.1159/000063781; Kinsella MG, 2003, ARTERIOSCL THROM VAS, V23, P608, DOI 10.1161/01.ATV.0000063109.94810.EE; Kostka G, 2001, MOL CELL BIOL, V21, P7025, DOI 10.1128/MCB.21.20.7025-7034.2001; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Mathiak M, 1997, CANCER RES, V57, P2130; Miosge N, 2003, J HISTOCHEM CYTOCHEM, V51, P285, DOI 10.1177/002215540305100303; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; Montanez E, 2007, METHOD ENZYMOL, V426, P239, DOI 10.1016/S0076-6879(07)26012-4; MURDOCH AD, 1994, J HISTOCHEM CYTOCHEM, V42, P239, DOI 10.1177/42.2.7507142; Nicole S, 2000, NAT GENET, V26, P480, DOI 10.1038/82638; Peng HB, 1999, J CELL BIOL, V145, P911, DOI 10.1083/jcb.145.4.911; RISAU W, 1988, DEVELOPMENT, V102, P471; RISAU W, 1988, DEV BIOL, V125, P441, DOI 10.1016/0012-1606(88)90225-4; Rossi M, 2003, EMBO J, V22, P236, DOI 10.1093/emboj/cdg019; Sakai K, 2009, J BIOL CHEM, V284, P22491, DOI 10.1074/jbc.M109.025148; SAKSELA O, 1988, J CELL BIOL, V107, P743, DOI 10.1083/jcb.107.2.743; Sasse P, 2008, CARDIOVASC RES, V80, P435, DOI 10.1093/cvr/cvn225; Segev A, 2004, CARDIOVASC RES, V63, P603, DOI 10.1016/j.cardiores.2004.03.028; Sharma B, 1998, J CLIN INVEST, V102, P1599, DOI 10.1172/JCI3793; Stratman AN, 2012, MICROSC MICROANAL, V18, P68, DOI 10.1017/S1431927611012402; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; Thyboll J, 2002, MOL CELL BIOL, V22, P1194, DOI 10.1128/MCB.22.4.1194-1202.2002; Tran PK, 2004, CIRC RES, V94, P550, DOI 10.1161/01.RES.0000117772.86853.34; Wickstrom SA, 2003, CANCER CELL, V3, P513, DOI 10.1016/S1535-6108(03)00143-0; Yu K, 2000, P NATL ACAD SCI USA, V97, P14536, DOI 10.1073/pnas.97.26.14536; Zhou ZJ, 2004, CANCER RES, V64, P4699, DOI 10.1158/0008-5472.CAN-04-0810; Zhu JW, 2002, DEVELOPMENT, V129, P2891; Zoeller JJ, 2008, J CELL BIOL, V181, P381, DOI 10.1083/jcb.200708022; Zoeller JJ, 2009, MATRIX BIOL, V28, P284, DOI 10.1016/j.matbio.2009.04.010	56	30	30	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53715	10.1371/journal.pone.0053715	http://dx.doi.org/10.1371/journal.pone.0053715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320101	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429800066
J	Haselhorst, DS; Moreno, JE; Punyasena, SW				Haselhorst, Derek S.; Enrique Moreno, J.; Punyasena, Surangi W.			Variability within the 10-Year Pollen Rain of a Seasonal Neotropical Forest and Its Implications for Paleoenvironmental and Phenological Research	PLOS ONE			English	Article							EL-NINO; TROPICAL TREES; CLIMATE; VEGETATION; DISPERSAL; PATTERNS; SPECTRA; RECORD; DIFFERENTIATION; REPRESENTATION	Tropical paleoecologists use a combination of mud-water interface and modern pollen rain samples (local samples of airborne pollen) to interpret compositional changes within fossil pollen records. Taxonomic similarities between the composition of modern assemblages and fossil samples are the basis of reconstructing paleoclimates and paleoenvironments. Surface sediment samples reflect a time-averaged accumulation of pollen spanning several years or more. Due to experimental constraints, modern pollen rain samples are generally collected over shorter timeframes (1-3 years) and are therefore less likely to capture the full range of natural variability in pollen rain composition and abundance. This potentially biases paleoenvironmental interpretations based on modern pollen rain transfer functions. To determine the degree to which short-term environmental change affects the composition of the aerial pollen flux of Neotropical forests, we sampled ten years of the seasonal pollen rain from Barro Colorado Island, Panama and compared it to climatic and environmental data over the same ten-year span. We establish that the pollen rain effectively captured the strong seasonality and stratification of pollen flow within the forest canopy and that individual taxa had variable sensitivity to seasonal and annual changes in environmental conditions, manifested as changes in pollen productivity. We conclude that modern pollen rain samples capture the reproductive response of moist tropical plants to short-term environmental change, but that consequently, pollen rain-based calibrations need to include longer sampling periods (>= 7 years) to reflect the full range of natural variability in the pollen output of a forest and simulate the time-averaging present in sediment samples. Our results also demonstrate that over the long-term, pollen traps placed in the forest understory are representative samples of the pollen output of both canopy and understory vegetation. Aerial pollen traps, therefore, also represent an underutilized means of monitoring the pollen productivity and reproductive behavior of moist tropical forests.	[Haselhorst, Derek S.; Punyasena, Surangi W.] Univ Illinois, Program Ecol Evolut & Conservat Biol, Urbana, IL 61801 USA; [Enrique Moreno, J.] Smithsonian Trop Res Inst, Ctr Trop Paleoecol & Archaeol, Panama City, Panama; [Punyasena, Surangi W.] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Illinois System; University of Illinois Urbana-Champaign	Punyasena, SW (corresponding author), Univ Illinois, Program Ecol Evolut & Conservat Biol, Urbana, IL 61801 USA.	punyasena@life.illinois.edu	Punyasena, Surangi/C-9134-2011	Punyasena, Surangi/0000-0003-2110-5840	University of Illinois Campus Research Board [09236, 11239]; University of Illinois Center for Latin American and Caribbean Studies Tinker Travel Grant; U.S. National Science Foundation [NSF EF-1137396]; Direct For Biological Sciences [1137396] Funding Source: National Science Foundation	University of Illinois Campus Research Board; University of Illinois Center for Latin American and Caribbean Studies Tinker Travel Grant; U.S. National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by the University of Illinois Campus Research Board (Grants #09236 and #11239) to SWP and a University of Illinois Center for Latin American and Caribbean Studies Tinker Travel Grant to DSH. SWP acknowledges additional support from the U.S. National Science Foundation (NSF EF-1137396). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler GH, 2000, BIOTROPICA, V32, P686, DOI 10.1646/0006-3606(2000)032[0686:RPOATC]2.0.CO;2; [Anonymous], 1976, J BIOGEOGR, DOI DOI 10.2307/3038013; Behling H, 1998, REV PALAEOBOT PALYNO, V99, P143, DOI 10.1016/S0034-6667(97)00044-4; Behling H, 1997, REV PALAEOBOT PALYNO, V97, P287, DOI 10.1016/S0034-6667(96)00073-5; BORCHERT R, 1980, ECOLOGY, V61, P1065, DOI 10.2307/1936825; Brando PM, 2010, P NATL ACAD SCI USA, V107, P14685, DOI 10.1073/pnas.0908741107; Burn MJ, 2010, PALAEOGEOGR PALAEOCL, V295, P1, DOI 10.1016/j.palaeo.2010.05.009; Bush M.B., 1991, HOLOCENE, V1, P162, DOI DOI 10.1177/095968369100100209; Bush MB, 1998, GLOBAL ECOL BIOGEOGR, V7, P379, DOI 10.2307/2997685; BUSH MB, 1992, J VEG SCI, V3, P275, DOI 10.2307/3235691; Bush MB, 2000, QUATERNARY RES, V54, P132, DOI 10.1006/qres.2000.2138; BUSH MB, 1995, AM NAT, V145, P594, DOI 10.1086/285757; Bush MB, 2001, GLOBAL ECOL BIOGEOGR, V10, P359, DOI 10.1046/j.1466-822X.2001.00247.x; Bush NB, 2001, J TROP ECOL, V17, P729, DOI 10.1017/S0266467401001547; Colinvaux P., 1999, AMAZON POLLEN MANUAL; Colinvaux PA, 1996, SCIENCE, V274, P85, DOI 10.1126/science.274.5284.85; Colinvaux PA, 2001, PALAEOGEOGR PALAEOCL, V166, P51, DOI 10.1016/S0031-0182(00)00201-7; Condit R, 1998, CLIMATIC CHANGE, V39, P413, DOI 10.1023/A:1005395806800; Condit R, 2004, J TROP ECOL, V20, P51, DOI 10.1017/S0266467403001081; Correa-Metrio A, 2011, HOLOCENE, V21, P681, DOI 10.1177/0959683610391321; Croat T.B., 1978, FLORA BARRO COLORADO; DAVIS MB, 1960, ECOLOGY, V41, P346, DOI 10.2307/1930226; Faegri K., 1898, J BIOGEOGR, V12, P238; FRANKIE GW, 1974, J ECOL, V62, P881, DOI 10.2307/2258961; Gonzalez C, 2006, PALAEOGEOGR PALAEOCL, V234, P62, DOI 10.1016/j.palaeo.2005.10.019; Gosling WD, 2005, QUATERNARY RES, V64, P284, DOI 10.1016/j.yqres.2005.08.008; Gosling WD, 2003, HOLOCENE, V13, P613, DOI 10.1191/0959683603hl649rr; Gosling WD, 2009, REV PALAEOBOT PALYNO, V153, P70, DOI 10.1016/j.revpalbo.2008.06.007; GRANT PR, 1987, OIKOS, V49, P55, DOI 10.2307/3565554; Jackson ST, 1999, BOT REV, V65, P39, DOI 10.1007/BF02856557; Jones HT, 2011, REV PALAEOBOT PALYNO, V164, P223, DOI 10.1016/j.revpalbo.2011.01.001; KERSHAW AP, 1990, REV PALAEOBOT PALYNO, V64, P281, DOI 10.1016/0034-6667(90)90143-7; KERSHAW AP, 1994, REV PALAEOBOT PALYNO, V83, P83, DOI 10.1016/0034-6667(94)90060-4; LEIGH EG, 1999, TROPICAL FOREST ECOL; Lobo JA, 2003, AM J BOT, V90, P1054, DOI 10.3732/ajb.90.7.1054; MACHADO JL, 1994, TREE PHYSIOL, V14, P219, DOI 10.1093/treephys/14.3.219; MORI S A, 1976, Biotropica, V8, P184, DOI 10.2307/2989684; Muller-Landau HC, 2008, J ECOL, V96, P653, DOI 10.1111/j.1365-2745.2008.01399.x; OPLER P A, 1975, Biotropica, V7, P234, DOI 10.2307/2989736; Paton S, METEOROLOGICAL HYDRO; PUTZ FE, 1984, ECOLOGY, V65, P1713, DOI 10.2307/1937767; Rodgers JC, 1996, PALAEOGEOGR PALAEOCL, V124, P53, DOI 10.1016/0031-0182(96)00004-1; Roubik D.W., 1991, POLLEN SPORES BARRO; Seppa H, 2004, J BIOGEOGR, V31, P251, DOI 10.1111/j.1365-2699.2004.00923.x; STOCKMARR J, 1971, Pollen et Spores, V13, P615; TISSUE DT, 1995, FUNCT ECOL, V9, P518, DOI 10.2307/2390018; Travers SE, 1999, BIOTROPICA, V31, P159; Valderrama MJ, 2010, BIOMETRICS, V66, P578, DOI 10.1111/j.1541-0420.2009.01293.x; Wright SJ, 2006, ECOL LETT, V9, P35, DOI 10.1111/j.1461-0248.2005.00851.x; WRIGHT SJ, 1994, AM NAT, V143, P192, DOI 10.1086/285600; WRIGHT SJ, 1991, ECOLOGY, V72, P1643, DOI 10.2307/1940964; Wright SJ, 2004, ECOLOGY, V85, P484, DOI 10.1890/02-0757; Zimmerman JK, 2007, J TROP ECOL, V23, P231, DOI 10.1017/S0266467406003890	53	21	22	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53485	10.1371/journal.pone.0053485	http://dx.doi.org/10.1371/journal.pone.0053485			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320089	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429800054
J	Sawicka, M; Pawlikowski, J; Wilson, S; Ferdinando, D; Wu, H; Adams, PD; Gunn, DA; Parish, W				Sawicka, Magdalena; Pawlikowski, Jeffrey; Wilson, Stephen; Ferdinando, Dudley; Wu, Hong; Adams, Peter David; Gunn, David Andrew; Parish, William			The Specificity and Patterns of Staining in Human Cells and Tissues of p16INK4a Antibodies Demonstrate Variant Antigen Binding	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; LUNG-CANCER; CERVICAL BIOPSIES; EPITHELIAL-CELLS; P16; P16(INK4A); EXPRESSION; MARKER; INHIBITION; MUTATIONS	The validity of the identification and classification of human cancer using antibodies to detect biomarker proteins depends upon antibody specificity. Antibodies that bind to the tumour-suppressor protein p16INK4a are widely used for cancer diagnosis and research. In this study we examined the specificity of four commercially available anti-p16INK4a antibodies in four immunological applications. The antibodies H-156 and JC8 detected the same 16 kDa protein in western blot and immunoprecipitation tests, whereas the antibody F-12 did not detect any protein in western blot analysis or capture a protein that could be recognised by the H-156 antibody. In immunocytochemistry tests, the antibodies JC8 and H-156 detected a predominately cytoplasmic localised antigen, whose signal was depleted in p16INK4a siRNA experiments. F-12, in contrast, detected a predominately nuclear located antigen and there was no noticeable reduction in this signal after siRNA knockdown. Furthermore in immunohistochemistry tests, F-12 generated a different pattern of staining compared to the JC8 and E6H4 antibodies. These results demonstrate that three out of four commercially available p16INK4a antibodies are specific to, and indicate a mainly cytoplasmic localisation for, the p16INK4a protein. The F-12 antibody, which has been widely used in previous studies, gave different results to the other antibodies and did not demonstrate specificity to human p16INK4a. This work emphasizes the importance of the validation of commercial antibodies, aside to the previously reported use, for the full verification of immunoreaction specificity.	[Sawicka, Magdalena; Wilson, Stephen; Ferdinando, Dudley; Gunn, David Andrew; Parish, William] Unilever Discover, Sharnbrook, Beds, England; [Pawlikowski, Jeffrey; Adams, Peter David] Univ Glasgow, Inst Canc Sci, CR UK Beatson Labs, Glasgow, Lanark, Scotland; [Wu, Hong] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Unilever; University of Glasgow; Fox Chase Cancer Center	Sawicka, M (corresponding author), Unilever Discover, Colworth Sci Pk, Sharnbrook, Beds, England.	Magdalena.Sawicka@unilever.com; David.Gunn@unilever.com		Adams, Peter/0000-0002-0684-1770; Gunn, David/0000-0001-9866-3221	Unilever PLC; CRUK program [C10652/A10250]; Biotechnology and Biological Sciences Research Council [BB/H021019/1] Funding Source: researchfish; BBSRC [BB/H021019/1] Funding Source: UKRI	Unilever PLC(Unilever); CRUK program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by Unilever PLC and work in the lab of PDA was funded by CRUK program grant C10652/A10250. Authors MS, SW, DF, DG and WP were employees of Unilever at the time of the study and were involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Chen JT, 2001, LUNG CANCER, V31, P163, DOI 10.1016/S0169-5002(00)00191-4; Cheng YL, 2003, EUR J CARDIO-THORAC, V23, P221, DOI 10.1016/S1010-7940(02)00749-2; Cuschieri K, 2008, CANCER EPIDEM BIOMAR, V17, P2536, DOI 10.1158/1055-9965.EPI-08-0306; Dray M, 2005, PATHOLOGY, V37, P112, DOI 10.1080/00313020500058607; Groeger AM, 1999, J THORAC CARDIOV SUR, V118, P529, DOI 10.1016/S0022-5223(99)70192-3; Haller F, 2008, J PATHOL, V215, P253, DOI 10.1002/path.2352; Haller F, 2010, HISTOPATHOLOGY, V56, P305, DOI 10.1111/j.1365-2559.2010.03478.x; Klaes R, 2001, INT J CANCER, V92, P276, DOI 10.1002/ijc.1174; Liggett WH, 1998, J CLIN ONCOL, V16, P1197, DOI 10.1200/JCO.1998.16.3.1197; Lin H, 2006, WORLD J SURG ONCOL, V7, P1; LUKAS J, 1995, NATURE, V375, P503, DOI 10.1038/375503a0; Marra DE, 2000, CIRCULATION, V102, P2124, DOI 10.1161/01.CIR.102.17.2124; McKenzie HA, 2010, HUM MUTAT, V31, P692, DOI 10.1002/humu.21245; Melck A, 2007, ANN SURG ONCOL, V14, P3403, DOI 10.1245/s10434-007-9572-8; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Nilsson K, 2006, INT J CANCER, V118, P1120, DOI 10.1002/ijc.21466; OKAMOTO A, 1994, P NATL ACAD SCI USA, V91, P11045, DOI 10.1073/pnas.91.23.11045; Pavey S, 1999, CANCER RES, V59, P4185; Pilon C, 1999, J CLIN ENDOCR METAB, V84, P2776, DOI 10.1210/jc.84.8.2776; Rocco JW, 2001, EXP CELL RES, V264, P42, DOI 10.1006/excr.2000.5149; Rothberg BEG, 2009, J CLIN ONCOL, V27, P5772, DOI 10.1200/JCO.2009.22.8239; Schutte M, 1997, CANCER RES, V57, P3126; de Sa BCS, 2009, MELANOMA RES, V19, P135, DOI 10.1097/CMR.0b013e32831993f3; Volgareva G, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-58; Wang SS, 2004, CANCER EPIDEM BIOMAR, V13, P1355; Zhu CQ, 2006, J CLIN PATHOL, V59, P790, DOI 10.1136/jcp.2005.031351	26	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53313	10.1371/journal.pone.0053313	http://dx.doi.org/10.1371/journal.pone.0053313			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308192	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000313429800037
J	Borgeaud, S; Blokesch, M				Borgeaud, Sandrine; Blokesch, Melanie			Overexpression of the tcp Gene Cluster Using the T7 RNA Polymerase/Promoter System and Natural Transformation-Mediated Genetic Engineering of Vibrio cholerae	PLOS ONE			English	Article							TOXIN-COREGULATED PILUS; MANNOSE-SENSITIVE HEMAGGLUTININ; GRAM-NEGATIVE BACTERIA; EL-TOR; MICROCOLONY FORMATION; CULTURE-CONDITIONS; ESCHERICHIA-COLI; CLONED GENES; DNA-SEQUENCE; BACTERIOPHAGE-T7	The human pathogen and aquatic bacterium Vibrio cholerae belongs to the group of naturally competent bacteria. This developmental program allows the bacterium to take up free DNA from its surrounding followed by a homologous recombination event, which allows integration of the transforming DNA into the chromosome. Taking advantage of this phenomenon we genetically engineered V. cholerae using natural transformation and FLP recombination. More precisely, we adapted the T7 RNA polymerase/promoter system in this organism allowing expression of genes in a T7 RNA polymerase-dependent manner. We naturally transformed V. cholerae by adding a T7-specific promoter sequence upstream the toxin-coregulated pilus (tcp) gene cluster. In a V. cholerae strain, which concomitantly produced the T7 RNA polymerase, this genetic manipulation resulted in the overexpression of downstream genes. The phenotypes of the strain were also in line with the successful production of TCP pili. This provides a proof-of-principle that the T7 RNA polymerase/promoter system is functional in V. cholerae and that genetic engineering of this organism by natural transformation is a straightforward and efficient approach.	[Borgeaud, Sandrine; Blokesch, Melanie] Ecole Polytech Fed Lausanne, Global Hlth Inst, Sch Life Sci, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Blokesch, M (corresponding author), Ecole Polytech Fed Lausanne, Global Hlth Inst, Sch Life Sci, Lausanne, Switzerland.	melanie.blokesch@epfl.ch	Blokesch, Melanie/A-4057-2013	Blokesch, Melanie/0000-0002-7024-1489	Swiss National Science Foundation [31003A_127029]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation grant 31003A_127029. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1982, MOL CLONING LAB MANU; BAO Y, 1991, GENE, V109, P167, DOI 10.1016/0378-1119(91)90604-A; Beyhan S, 2006, J BACTERIOL, V188, P3600, DOI 10.1128/JB.188.10.3600-3613.2006; Blokesch M, 2012, MOB GENET ELEMENTS, V2, P5; Blokesch M, 2007, PLOS PATHOG, V3, P733, DOI 10.1371/journal.ppat.0030081; Blokesch M, 2012, JOVE-J VIS EXP, DOI 10.3791/3761; Blokesch M, 2012, ENVIRON MICROBIOL, V14, P1898, DOI 10.1111/j.1462-2920.2011.02689.x; BROWN RC, 1995, MOL MICROBIOL, V16, P425, DOI 10.1111/j.1365-2958.1995.tb02408.x; CHAMBERL.M, 1970, NATURE, V228, P227, DOI 10.1038/228227a0; DAVANLOO P, 1984, P NATL ACAD SCI-BIOL, V81, P2035, DOI 10.1073/pnas.81.7.2035; De Souza Silva O, 2010, PLASMID, V64, P186, DOI 10.1016/j.plasmid.2010.08.001; DiRita VJ, 1996, P NATL ACAD SCI USA, V93, P7991, DOI 10.1073/pnas.93.15.7991; DUNN JJ, 1983, J MOL BIOL, V166, P477, DOI 10.1016/S0022-2836(83)80282-4; Faruque SM, 2003, INFECT IMMUN, V71, P2993, DOI 10.1128/IAI.71.6.2993-2999.2003; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; HERRINGTON DA, 1988, J EXP MED, V168, P1487, DOI 10.1084/jem.168.4.1487; IKEDA RA, 1992, NUCLEIC ACIDS RES, V20, P2517, DOI 10.1093/nar/20.10.2517; IWANAGA M, 1986, MICROBIOL IMMUNOL, V30, P1075, DOI 10.1111/j.1348-0421.1986.tb03037.x; Jude BA, 2011, J STRUCT BIOL, V175, P1, DOI 10.1016/j.jsb.2011.04.008; Judson N, 2000, NAT BIOTECHNOL, V18, P740, DOI 10.1038/77305; Karaolis DKR, 1998, P NATL ACAD SCI USA, V95, P3134, DOI 10.1073/pnas.95.6.3134; Kirn TJ, 2000, MOL MICROBIOL, V35, P896, DOI 10.1046/j.1365-2958.2000.01764.x; Krebs SJ, 2011, J BACTERIOL, V193, P5260, DOI 10.1128/JB.00378-11; Lambertsen L, 2004, ENVIRON MICROBIOL, V6, P726, DOI 10.1111/j.1462-2920.2004.00605.x; Li J, 2012, J MOL BIOL, V418, P47, DOI 10.1016/j.jmb.2012.02.017; Lim MS, 2010, MOL MICROBIOL, V77, P755, DOI 10.1111/j.1365-2958.2010.07244.x; Lo Scrudato M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002778; Marvig RL, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-155; Matson JS, 2007, INFECT IMMUN, V75, P5542, DOI 10.1128/IAI.01094-07; Medrano AI, 1999, INFECT IMMUN, V67, P2178, DOI 10.1128/IAI.67.5.2178-2183.1999; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; Nielsen AT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001102; OAKLEY JL, 1977, P NATL ACAD SCI USA, V74, P4266, DOI 10.1073/pnas.74.10.4266; PANAYOTATOS N, 1979, NATURE, V280, P35, DOI 10.1038/280035a0; ROSA MD, 1979, CELL, V16, P815, DOI 10.1016/0092-8674(79)90097-7; Schleif R, 2010, FEMS MICROBIOL REV, V34, P779, DOI 10.1111/j.1574-6976.2010.00226.x; Seitz P, 2013, FEMS MICROBIOL REV, V37, P336, DOI 10.1111/j.1574-6976.2012.00353.x; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; STUDIER FW, 1991, J MOL BIOL, V219, P37, DOI 10.1016/0022-2836(91)90855-Z; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Suckow G, 2011, J BACTERIOL, V193, P4914, DOI 10.1128/JB.05396-11; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Tacket CO, 1998, INFECT IMMUN, V66, P692, DOI 10.1128/IAI.66.2.692-695.1998; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Thelin KH, 1996, INFECT IMMUN, V64, P2853, DOI 10.1128/IAI.64.7.2853-2856.1996; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yildiz FH, 1998, J BACTERIOL, V180, P773, DOI 10.1128/JB.180.4.773-784.1998	47	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53952	10.1371/journal.pone.0053952	http://dx.doi.org/10.1371/journal.pone.0053952			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308292	Green Submitted, gold, Green Published			2022-12-25	WOS:000313429100124
J	Mehtala, ML; Lensink, MF; Pietikainen, LP; Hiltunen, JK; Glumoff, T				Mehtala, Maija L.; Lensink, Marc F.; Pietikainen, Laura P.; Hiltunen, J. Kalervo; Glumoff, Tuomo			On the Molecular Basis of D-Bifunctional Protein Deficiency Type III	PLOS ONE			English	Article							PEROXISOMAL MULTIFUNCTIONAL ENZYME; CRYSTAL-STRUCTURE; BETA-OXIDATION; DEHYDROGENASE; YEAST; RESOLUTION; SIMULATIONS; RESIDUES; DYNAMICS; SPECTRUM	Molecular basis of D-bifunctional protein (D-BP) deficiency was studied with wild type and five disease-causing variants of 3R-hydroxyacyl-CoA dehydrogenase fragment of the human MFE-2 (multifunctional enzyme type 2) protein. Complementation analysis in vivo in yeast and in vitro enzyme kinetic and stability determinants as well as in silico stability and structural fluctuation calculations were correlated with clinical data of known patients. Despite variations not affecting the catalytic residues, enzyme kinetic performance (K-m, V-max and k(cat)) of the recombinant protein variants were compromised to a varying extent and this can be judged as the direct molecular cause for D-BP deficiency. Protein stability plays an additional role in producing non-functionality of MFE-2 in case structural variations affect cofactor or substrate binding sites. Structure-function considerations of the variant proteins matched well with the available data of the patients.	[Mehtala, Maija L.; Pietikainen, Laura P.; Hiltunen, J. Kalervo; Glumoff, Tuomo] Univ Oulu, Dept Biochem, Oulu, Finland; [Mehtala, Maija L.; Pietikainen, Laura P.; Hiltunen, J. Kalervo; Glumoff, Tuomo] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Lensink, Marc F.] Univ Lille 1, Ctr Hyperfrequences & Semicond, CNRS, Interdisciplinary Res Inst, F-59655 Villeneuve Dascq, France	Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille	Glumoff, T (corresponding author), Univ Oulu, Dept Biochem, Oulu, Finland.	tuomo.glumoff@oulu.fi	Lensink, Marc F/A-1678-2008	Lensink, Marc F/0000-0003-3957-9470; Hiltunen, Kalervo/0000-0002-3073-9602	Academy of Finland [1122531, 138690]; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by the Academy of Finland (grant number 1122531 (to T.G.)); and the Sigrid Juselius Foundation and the Academy of Finland (grant number 138690 (to K.H.)). URL of funders: www.aka.fi and www.sigridjuselius.fi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanen HI, 2003, J BIOL CHEM, V278, P28912, DOI 10.1074/jbc.M304598200; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; CHANDRASEKHAR J, 1984, J AM CHEM SOC, V106, P903, DOI 10.1021/ja00316a012; Churchill CDM, 2009, J PHYS CHEM B, V113, P16046, DOI 10.1021/jp907887y; Copeland KL, 2008, J PHYS CHEM B, V112, P14291, DOI 10.1021/jp805528v; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Emekli U, 2008, PROTEINS, V70, P1219, DOI 10.1002/prot.21613; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; Ferdinandusse S, 2006, ANN NEUROL, V59, P92, DOI 10.1002/ana.20702; Ferdinandusse S, 2006, AM J HUM GENET, V78, P112, DOI 10.1086/498880; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; FILPPULA SA, 1995, J BIOL CHEM, V270, P27453, DOI 10.1074/jbc.270.46.27453; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gronborg S, 2010, AM J MED GENET A, V152A, P2845, DOI 10.1002/ajmg.a.33677; Gurvitz A, 1997, J BIOL CHEM, V272, P22140, DOI 10.1074/jbc.272.35.22140; Haapalainen AM, 2003, STRUCTURE, V11, P87, DOI 10.1016/S0969-2126(02)00931-0; Haapalainen AM, 2001, J MOL BIOL, V313, P1127, DOI 10.1006/jmbi.2001.5084; Haataja TJK, 2011, BIOCHEM J, V435, P771, DOI 10.1042/BJ20101661; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HILTUNEN JK, 1989, J BIOL CHEM, V264, P13536; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kashiwayama Y, 2010, J BIOL CHEM, V285, P26315, DOI 10.1074/jbc.M110.104547; Koski MK, 2005, J MOL BIOL, V345, P1157, DOI 10.1016/j.jmb.2004.11.009; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lukacik P, 2005, PDB ID 1ZBQ CRYSTAL; Mayer S, 2007, J MOL BIOL, V372, P268, DOI 10.1016/j.jmb.2007.06.044; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Qin YM, 1999, J BIOL CHEM, V274, P28619, DOI 10.1074/jbc.274.40.28619; Qin YM, 2000, J BIOL CHEM, V275, P4965, DOI 10.1074/jbc.275.7.4965; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Russell DW, 2009, J LIPID RES, V50, pS120, DOI 10.1194/jlr.R800026-JLR200; Schulz G. E., 1979, PRINCIPLES PROTEIN S; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Grunsven EG, 1998, P NATL ACAD SCI USA, V95, P2128, DOI 10.1073/pnas.95.5.2128; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Wanders R.J., 2001, METABOLIC MOL BASES, P3219; Wanders RJA, 2010, BBA-MOL CELL BIOL L, V1801, P272, DOI 10.1016/j.bbalip.2010.01.001; Ylianttila MS, 2006, J MOL BIOL, V358, P1286, DOI 10.1016/j.jmb.2006.03.001	43	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53688	10.1371/journal.pone.0053688	http://dx.doi.org/10.1371/journal.pone.0053688			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308274	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429100106
J	Pham, LL; Lemaire, P; Harroche, A; Souberbielle, JC; Brauner, R				Pham, Luu-Ly; Lemaire, Pierre; Harroche, Annie; Souberbielle, Jean-Claude; Brauner, Raja			Pituitary Stalk Interruption Syndrome in 53 Postpubertal Patients: Factors Influencing the Heterogeneity of Its Presentation	PLOS ONE			English	Article							GROWTH-HORMONE DEFICIENCY; MAGNETIC-RESONANCE; CHILDREN; HYPOPITUITARISM; MUTATIONS; MORTALITY	Background: Pituitary stalk interruption syndrome (PSIS) may induce an isolated growth hormone (GH) deficiency or multiple hypothalamic-pituitary (HP) deficiencies. Patients with multiple HP deficiencies, primarily those with adrenocorticotropin (ACTH) deficiency, are at increased risk of morbidity and mortality. Our objective was to identify the factors influencing each symptom and the MRI features of the syndrome to enhance its diagnosis and genetic analysis. Methods: This study was a retrospective, single-center, case-cohort study of 53 patients with PSIS who had reached pubertal age. Results: Patients were classified as having an isolated GH deficiency (n = 24, Group 1) or HP deficiencies (n = 29, Group 2); of these, 19 had complete HP deficiency, and 10 had GH deficiency associated with TSH (n = 4), TSH and ACTH (n = 3), TSH and gonadotropin (n = 1) deficiencies or amenorrhea (n = 2). The following features were less frequent in Group 1 than in Group 2: breech presentation (4% vs 35%, P = 0.008), hypoglycemia (0% vs 59%, P<0.00001), micropenis (13% vs 69%, P<0.003), hypothalamic origin (0% vs 52%, P<0.000001), ophthalmic malformation (8% vs 38%, P<0.02) and psychomotor delay (0% vs 31%, P<0.004). The frequencies of all other malformations were similar in both groups (37% vs 59%). A visible pituitary stalk was characteristic of patients belonging to Group 1 (P<0.0002). The GH peak was greater in Group 1 than in Group 2 (P<0.0003), as was the anterior pituitary height (P = 0.01). Conclusion: The factors that best discriminate patients with multiple HP deficiencies from those with an isolated GH deficiency are breech presentation, hypoglycemia, and micropenis. No patient with an isolated GH deficiency had psychomotor delay, but associated malformations and/or syndromes, with the exception of ophthalmic disorders, occurred with similar frequencies in both groups. We have also shown that each of the above characteristics is associated with a given HP deficiency and/or malformation/syndrome in the majority of cases.	[Pham, Luu-Ly; Harroche, Annie; Brauner, Raja] Univ Paris 05, Paris, France; [Pham, Luu-Ly; Harroche, Annie; Brauner, Raja] Fdn Ophtalmol Adolphe Rothschild, Paris, France; [Lemaire, Pierre] UJF Grenoble 1, G SCOP UMR5272, Grenoble INP, CNRS, Grenoble, France; [Souberbielle, Jean-Claude] Hop Necker Enfants Malad, AP HP, Serv Explorat Fonct, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Fondation Adolphe de Rothschild; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Brauner, R (corresponding author), Univ Paris 05, Paris, France.	raja.brauner@wanadoo.fr						Albertsson-Wikland K, 1990, ACTA PAEDIATR SC   S, V370, P121; ALBERTSSONWIKLAND K, 1990, ACTA PAEDIATR SCAND, P115; ARGYROPOULOU M, 1991, PEDIATR RADIOL, V21, P247, DOI 10.1007/BF02018614; ARGYROPOULOU M, 1992, J PEDIATR-US, V120, P886, DOI 10.1016/S0022-3476(05)81955-9; Beukhof CM, 2007, CLASSIC TRIAD VARIAN, P69; Carayol M, 2004, J Gynecol Obstet Biol Reprod (Paris), V33, pS37; CRAFT WH, 1980, J PEDIATR-US, V96, P397, DOI 10.1016/S0022-3476(80)80680-9; Dupuis-Girod S, 2001, J PEDIATR-US, V138, P129, DOI 10.1067/mpd.2001.109200; Gascoin-Lachambre G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016367; Groisne C, 2002, HORM RES, V58, P94, DOI 10.1159/000064660; Israel E, 2000, J CLIN ENDOCR METAB, V85, P3990; Le Ray C, 2006, OBSTET GYNECOL, V107, P1269; Leblanc T, 2003, J PEDIATR-US, V142, P358, DOI 10.1067/mpd.2003.57; Leroy B, 1971, Rev Fr Gynecol Obstet, V66, P391; Pham LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026516; Machinis K, 2001, AM J HUM GENET, V69, P961, DOI 10.1086/323764; Mcnay DEG, 2007, J CLIN ENDOCR METAB, V92, P691, DOI 10.1210/jc.2006-1609; Melo ME, 2007, CLIN ENDOCRINOL, V66, P95, DOI 10.1111/j.1365-2265.2006.02692.x; Mills JL, 2004, J PEDIATR-US, V144, P430, DOI 10.1016/j.jpeds.2003.12.036; Murray PG, 2008, CLIN ENDOCRINOL, V69, P597, DOI 10.1111/j.1365-2265.2008.03236.x; Pinto G, 1997, J CLIN ENDOCR METAB, V82, P3450, DOI 10.1210/jc.82.10.3450; Rayl J, 1996, AM J OBSTET GYNECOL, V174, P28, DOI 10.1016/S0002-9378(96)70368-X; Reynaud R, 2011, EUR J ENDOCRINOL, V164, P457, DOI 10.1530/EJE-10-0892; Reynaud R, 2012, J CLIN ENDOCR METAB, V97, pE1068, DOI 10.1210/jc.2011-3056; RONA RJ, 1977, ARCH DIS CHILD, V52, P197, DOI 10.1136/adc.52.3.197; ROOT AW, 1989, AM J DIS CHILD, V143, P366, DOI 10.1001/archpedi.1989.02150150124031; Rottembourg D, 2008, CLIN ENDOCRINOL, V69, P105, DOI 10.1111/j.1365-2265.2007.03155.x; Simon D, 2006, CLIN ENDOCRINOL, V64, P416, DOI 10.1111/j.1365-2265.2006.02484.x; Baquedano MS, 2010, J CLIN ENDOCR METAB, V95, pE98, DOI 10.1210/jc.2010-0223; STEENDIJK R, 1980, HELV PAEDIATR ACTA, V35, P129; Taback SP, 1996, J CLIN ENDOCR METAB, V81, P1693, DOI 10.1210/jc.81.5.1693; TRIULZI F, 1994, PEDIATRICS, V93, P409; Trivin C, 2007, GROWTH HORM IGF RES, V17, P122, DOI 10.1016/j.ghir.2006.12.007; Woods KS, 2005, AM J HUM GENET, V76, P833, DOI 10.1086/430134	34	14	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53189	10.1371/journal.pone.0053189	http://dx.doi.org/10.1371/journal.pone.0053189			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308160	gold, Green Submitted, Green Published			2022-12-25	WOS:000313429100036
J	Zhang, X; Reinhardt, JD; Gosney, JE; Li, JN				Zhang, Xia; Reinhardt, Jan D.; Gosney, James E.; Li, Jianan			The NHV Rehabilitation Services Program Improves Long-Term Physical Functioning in Survivors of the 2008 Sichuan Earthquake: A Longitudinal Quasi Experiment	PLOS ONE			English	Article							WENCHUAN EARTHQUAKE; DISASTER RELIEF; RESCUE EFFORTS; HEALTH; INJURY; CHINA; DISABILITY; EMERGENCY; OUTCOMES; VICTIMS	Background: Long-term disability following natural disasters significantly burdens survivors and the impacted society. Nevertheless, medical rehabilitation programming has been historically neglected in disaster relief planning. 'NHV' is a rehabilitation services program comprised of non-governmental organizations (NGOs) (N), local health departments (H), and professional rehabilitation volunteers (V) which aims to improve long-term physical functioning in survivors of the 2008 Sichuan earthquake. We aimed to evaluate the effectiveness of the NHV program. Methods/Findings: 510 of 591 enrolled earthquake survivors participated in this longitudinal quasi-experimental study (86.3%). The early intervention group (NHV-E) consisted of 298 survivors who received institutional-based rehabilitation (IBR) followed by community-based rehabilitation (CBR); the late intervention group (NHV-L) was comprised of 101 survivors who began rehabilitation one year later. The control group of 111 earthquake survivors did not receive IBR/CBR. Physical functioning was assessed using the Barthel Index (BI). Data were analyzed with a mixed-effects Tobit regression model. Physical functioning was significantly increased in the NHV-E and NHV-L groups at follow-up but not in the control group after adjustment for gender, age, type of injury, and time to measurement. We found significant effects of both NHV (11.14, 95% CI 9.0-13.3) and sponaneaous recovery (5.03; 95% CI 1.73-8.34). The effect of NHV-E (11.3, 95% CI 9.0-13.7) was marginally greater than that of NHV-L (10.7, 95% CI 7.9-13.6). It could, however, not be determined whether specific IBR or CBR program components were effective since individual component exposures were not evaluated. Conclusion: Our analysis shows that the NHV improved the long-term physical functioning of Sichuan earthquake survivors with disabling injuries. The comprehensive rehabilitation program benefitted the individual and society, rehabilitation services in China, and international rehabilitation disaster relief planning. Similar IBR/CBR programs should therefore be considered for future large-scale rehabilitation disaster relief efforts.	[Zhang, Xia; Li, Jianan] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Zhang, Xia; Reinhardt, Jan D.; Gosney, James E.; Li, Jianan] WHO, Liaison Subcomm Rehabil Disaster Relief, Int Soc Phys & Rehabil Med, CH-1211 Geneva, Switzerland; [Reinhardt, Jan D.] Swiss Parapleg Res, Nottwil, Switzerland; [Reinhardt, Jan D.] Univ Lucerne, Dept Hlth Sci & Hlth Policy, Luzern, Switzerland	Nanjing Medical University; World Health Organization; Swiss Paraplegic Research; University of Lucerne	Li, JN (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	lijianan@carm.org.cn			Hong Kong Caring for Children Foundation; Chinese Association of Rehabilitation Medicine; Nanjing Medical University; Handicap International; Sichuan Province and Mianzhu County Government; Mianzhu County People's Hospital; Anxian Traditional Chinese Medicine Hospital; Hong Kong Rehabilitation Society	Hong Kong Caring for Children Foundation; Chinese Association of Rehabilitation Medicine; Nanjing Medical University; Handicap International; Sichuan Province and Mianzhu County Government; Mianzhu County People's Hospital; Anxian Traditional Chinese Medicine Hospital; Hong Kong Rehabilitation Society	This study was funded by the Hong Kong Caring for Children Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the support of the Hong Kong Caring For Children Foundation, the Chinese Association of Rehabilitation Medicine, the Nanjing Medical University, Handicap International, the Sichuan Province and Mianzhu County Government, the Mianzhu County People's Hospital, the Anxian Traditional Chinese Medicine Hospital, and the Hong Kong Rehabilitation Society. We deeply thank the rehabilitation volunteers who participated in this study. The investigation would not have been possible without the significant contributions of Xiaorong Hu, Sijing Chen, and Shouguo Liu, who were intimately involved in NHV design and data collection. Carolina Ballert, Nandini Devi, Bernd Fellinghauer, Per von Groote, Andrew Pennycott, and Sheng Cai are kindly acknowledged as well for their technical contributions.	Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Burns AS, 2012, J REHABIL MED, V44, P414, DOI 10.2340/16501977-0974; Chan EYY, 2011, EUR J EMERG MED, V18, P111, DOI 10.1097/MEJ.0b013e32833dba19; Chen Jin, 2009, J Evid Based Med, V2, P270, DOI 10.1111/j.1756-5391.2009.01053.x; CRED, 2012, EM DAT INT DIS DAT; Dong ZH, 2009, NEW ENGL J MED, V361, P636, DOI 10.1056/NEJMc0903047; Garnett GP, 2011, LANCET, V378, P515, DOI 10.1016/S0140-6736(10)61505-X; Gong P, 2012, LANCET, V379, P843, DOI 10.1016/S0140-6736(11)61878-3; Gosney J, 2011, J REHABIL MED, V43, P965, DOI 10.2340/16501977-0890; Gu JW, 2010, EMERG MED J, V27, P216, DOI 10.1136/emj.2008.065342; Kett M, 2009, LANCET, V374, P1801, DOI 10.1016/S0140-6736(09)62024-9; Knowlton LM, 2011, PREHOSP DISASTER MED, V26, P438, DOI 10.1017/S1049023X12000076; Landry MD, 2010, DISABIL REHABIL, V32, P1616, DOI 10.3109/09638288.2010.500345; Leung SOC, 2007, CLIN REHABIL, V21, P912, DOI 10.1177/0269215507077286; Li YQ, 2012, J REHABIL MED, V44, P534, DOI 10.2340/16501977-1005; Li Yuanfeng, 2009, J Evid Based Med, V2, P258, DOI 10.1111/j.1756-5391.2009.01045.x; [宁宁 NING Ning], 2008, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V8, P496; Rabe-Hesketh S, 2004, TOBIT GLLAMM; Rabe-Hesketh S.S.A., 2005, MULTILEVEL LONGITUDI; Rathore FA, 2012, ARCH PHYS MED REHABI; Rathore FA, 2012, ARCH PHYS MED REHAB, V93, P1875, DOI 10.1016/j.apmr.2012.05.018; Redmond AD, 2011, EMERG MED J, V28, P516, DOI 10.1136/emj.2009.089920; Redmond AD, 2011, PREHOSP DISASTER MED, V26, P449, DOI 10.1017/S1049023X12000088; Redmond AD, 2011, LANCET, V377, P1054, DOI 10.1016/S0140-6736(11)60319-X; Reinhardt JD, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.7191; Roy N, 2011, DISASTER MED PUBLIC, V5, P112, DOI 10.1001/dmp.2011.35; Twisk J, 2009, J CLIN EPIDEMIOL, V62, P953, DOI 10.1016/j.jclinepi.2008.10.003; WAECKERLE JF, 1991, NEW ENGL J MED, V324, P815; WHO, 2011, WORLD REPORT ON DISABILITY, P1; WHO, 2001, WHO INT CLASS FUNCT; Wong CNC, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-43; World Health Organisation (WHO), 2005, DIS DIS REH; World Health Organization, 2010, COMM BAS REH CBR GUI; Xiao MY, 2011, J REHABIL MED, V43, P515, DOI 10.2340/16501977-0813; You CM, 2009, J PUBLIC HEALTH POL, V30, P379, DOI 10.1057/jphp.2009.30; Zhang LL, 2012, LANCET, V379, P853, DOI 10.1016/S0140-6736(11)61876-X; Zhang LL, 2011, EMERG MED J, V28, P618, DOI 10.1136/emj.2009.087296; Zhang X, 2012, J REHABIL MED, V44, P206, DOI 10.2340/16501977-0945	38	23	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53995	10.1371/journal.pone.0053995	http://dx.doi.org/10.1371/journal.pone.0053995			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308293	Green Published, gold			2022-12-25	WOS:000313429100125
J	Etich, J; Bergmeier, V; Frie, C; Kreft, S; Bengestrate, L; Eming, S; Mauch, C; Eckes, B; Ulus, H; Lund, FE; Rappl, G; Abken, H; Paulsson, M; Brachvogel, B				Etich, Julia; Bergmeier, Vera; Frie, Christian; Kreft, Sandra; Bengestrate, Lena; Eming, Sabine; Mauch, Cornelia; Eckes, Beate; Ulus, Hikmet; Lund, Frances E.; Rappl, Gunter; Abken, Hinrich; Paulsson, Mats; Brachvogel, Bent			PECAM1(+)/Sca1(+)/CD38(+) Vascular Cells Transform into Myofibroblast-Like Cells in Skin Wound Repair	PLOS ONE			English	Article							SURFACE ANTIGEN CD38; ENDOTHELIAL PRECURSORS; PERIVASCULAR CELLS; PROGENITOR CELLS; POPULATION; ACTIVATION; EXPRESSION; CONTRIBUTE; TISSUE; LIVER	Skin injury induces the formation of new blood vessels by activating the vasculature in order to restore tissue homeostasis. Vascular cells may also differentiate into matrix-secreting contractile myofibroblasts to promote wound closure. Here, we characterize a PECAM1(+)/Sca1(+) vascular cell population in mouse skin, which is highly enriched in wounds at the peak of neoangiogenesis and myofibroblast formation. These cells express endothelial and perivascular markers and present the receptor CD38 on their surface. PECAM1(+)/Sca1(+)/CD38(+) cells proliferate upon wounding and could give rise to alpha-SMA(+) myofibroblast-like cells. CD38 stimulation in immunodeficient mice reduced the wound size at the peak of neoangiogenesis and myofibroblast formation. In humans a corresponding cell population was identified, which was enriched in sprouting vessels of basal cell carcinoma biopsies. The results indicate that PECAM1(+)/Sca1(+)/CD38(+) vascular cells could proliferate and differentiate into myofibroblast-like cells in wound repair. Moreover, CD38 signaling modulates PECAM1(+)/Sca1(+)/CD38(+) cell activation in the healing process implying CD38 as a target for anti-angiogenic therapies in human basal cell carcinoma.	[Etich, Julia; Bergmeier, Vera; Frie, Christian; Kreft, Sandra; Bengestrate, Lena; Paulsson, Mats; Brachvogel, Bent] Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, North Rhine Wes, Germany; [Eming, Sabine; Rappl, Gunter; Abken, Hinrich; Paulsson, Mats; Brachvogel, Bent] Univ Cologne, Fac Med, Ctr Mol Med Cologne, D-50931 Cologne, North Rhine Wes, Germany; [Eming, Sabine; Mauch, Cornelia; Eckes, Beate] Univ Cologne, Dept Dermatol, D-50931 Cologne, North Rhine Wes, Germany; [Ulus, Hikmet] Clin Paediat Surg, D-50931 Cologne, North Rhine Wes, Germany; [Lund, Frances E.] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA; [Rappl, Gunter; Abken, Hinrich] Univ Cologne, Fac Med, Dept Internal Med 1, D-50931 Cologne, North Rhine Wes, Germany; [Paulsson, Mats] Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, North Rhine Wes, Germany	University of Cologne; University of Cologne; University of Cologne; University of Rochester; University of Cologne; University of Cologne	Brachvogel, B (corresponding author), Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, North Rhine Wes, Germany.	bent.brachvogel@uni-koeln.de		Etich, Julia/0000-0003-3238-6692; Brachvogel, Bent/0000-0002-3923-0554	DFG [SFB829-B04]; BMBF [01-GN-0823]; Wilhelm Sander-Stiftung; Deutsche Krebshilfe	DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); Wilhelm Sander-Stiftung; Deutsche Krebshilfe(Deutsche Krebshilfe)	This project was supported by the DFG (SFB829-B04), BMBF (01-GN-0823); Wilhelm Sander-Stiftung and the Deutsche Krebshilfe to H.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brachvogel B, 2005, DEVELOPMENT, V132, P2657, DOI 10.1242/dev.01846; Brachvogel B, 2007, EXP CELL RES, V313, P2730, DOI 10.1016/j.yexcr.2007.04.031; de Weers M, 2011, J IMMUNOL, V186, P1840, DOI 10.4049/jimmunol.1003032; Deaglio S, 2010, MOL MED, V16, P87, DOI 10.2119/molmed.2009.00146; Eming SA, 2007, PROG HISTOCHEM CYTO, V42, P115, DOI 10.1016/j.proghi.2007.06.001; Gerharz M, 2007, WOUND REPAIR REGEN, V15, P105, DOI 10.1111/j.1524-475X.2006.00191.x; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Grenier G, 2007, STEM CELLS, V25, P3101, DOI 10.1634/stemcells.2006-0795; Hara-Yokoyama M, 2008, INT IMMUNOPHARMACOL, V8, P59, DOI 10.1016/j.intimp.2007.10.010; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hoofnagle MH, 2004, J CLIN INVEST, V113, P1249, DOI 10.1172/JCI200421761; Luna G, 2004, STEM CELLS DEV, V13, P528, DOI 10.1089/scd.2004.13.528; Mack JA, 2003, FASEB J, V17, P1352, DOI 10.1096/fj.02-0959fje; McQualter JL, 2009, STEM CELLS, V27, P623, DOI 10.1634/stemcells.2008-0866; NISHINA H, 1994, BIOCHEM BIOPH RES CO, V203, P1318, DOI 10.1006/bbrc.1994.2326; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Petroll WM, 1997, EXP EYE RES, V64, P257, DOI 10.1006/exer.1996.0211; Rajkumar VS, 2006, AM J PATHOL, V169, P2254, DOI 10.2353/ajpath.2006.060196; Rasband W., 2006, IMAGEJ; Sundberg C, 1996, LAB INVEST, V74, P452; Torsney E, 2011, J MOL CELL CARDIOL, V50, P304, DOI 10.1016/j.yjmcc.2010.09.006; Tsuchiya A, 2008, BIOCHEM BIOPH RES CO, V365, P595, DOI 10.1016/j.bbrc.2007.10.150; WATSON JV, 1987, CYTOMETRY, V8, P1, DOI 10.1002/cyto.990080101; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613	25	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53262	10.1371/journal.pone.0053262	http://dx.doi.org/10.1371/journal.pone.0053262			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308177	gold, Green Published, Green Submitted			2022-12-25	WOS:000313670100028
J	Joers, P; Jacobs, HT				Joers, Priit; Jacobs, Howard T.			Analysis of Replication Intermediates Indicates That Drosophila melanogaster Mitochondrial DNA Replicates by a Strand-Coupled Theta Mechanism	PLOS ONE			English	Article							2-DIMENSIONAL GEL-ELECTROPHORESIS; SACCHAROMYCES-CEREVISIAE; LAGGING-STRAND; FORK MOVEMENT; ORIGINS; MUTATIONS; MOLECULES; DIRECTION; PLASMID; DISEASE	Mitochondrial DNA synthesis is necessary for the normal function of the organelle and for the eukaryotic organism as a whole. Here we demonstrate, using two-dimensional agarose gel electrophoresis to analyse replication intermediates, that unidirectional, strand-coupled DNA synthesis is the prevalent mode of mtDNA replication in Drosophila melanogaster. Commencing within the single, extended non-coding region (NCR), replication proceeds around the circular genome, manifesting an irregular rate of elongation, and pausing frequently in specific regions. Evidence for a limited contribution of strand-asynchronous DNA synthesis was found in a subset of mtDNA molecules, but confined to the ribosomal RNA gene region, just downstream of the NCR. Our findings imply that strand-coupled replication is widespread amongst metazoans, and should inform future research on mtDNA metabolism in D. melanogaster.	[Jacobs, Howard T.] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland; Univ Tampere, Tampere Univ Hosp, FIN-33101 Tampere, Finland	Tampere University; Tampere University; Tampere University Hospital	Jacobs, HT (corresponding author), Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland.	Howard.T.Jacobs@uta.fi	Jacobs, Howard T/G-2434-2011	Jacobs, Howard/0000-0003-1895-6003; Joers, Priit/0000-0002-9248-1774	Academy of Finland; Sigrid Juselius Foundation; Tampere University Hospital Medical Research Fund	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Tampere University Hospital Medical Research Fund	Funding for this work was provided by Academy of Finland, Sigrid Juselius Foundation and Tampere University Hospital Medical Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azvolinsky A, 2009, MOL CELL, V34, P722, DOI 10.1016/j.molcel.2009.05.022; Belanger KG, 1996, NUCLEIC ACIDS RES, V24, P2166, DOI 10.1093/nar/24.11.2166; BELL L, 1983, ANAL BIOCHEM, V130, P527, DOI 10.1016/0003-2697(83)90628-0; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; BREWER BJ, 1992, CELL, V71, P267, DOI 10.1016/0092-8674(92)90355-G; Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; Ermakova OV, 1996, J BIOL CHEM, V271, P33009, DOI 10.1074/jbc.271.51.33009; Fernandez-Ayala DJM, 2009, CELL METAB, V9, P449, DOI 10.1016/j.cmet.2009.03.004; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; GARESSE R, 1988, GENETICS, V118, P649; GODDARD JM, 1980, NUCLEIC ACIDS RES, V8, P741; GODDARD JM, 1978, P NATL ACAD SCI USA, V75, P3886, DOI 10.1073/pnas.75.8.3886; GREENFEDER SA, 1992, MOL CELL BIOL, V12, P4056, DOI 10.1128/MCB.12.9.4056; Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1; Huberman JA, 1997, METHODS, V13, P247, DOI 10.1006/meth.1997.0524; Krasilnikova Maria M., 2004, V277, P19; KRYSAN PJ, 1991, MOL CELL BIOL, V11, P1464, DOI 10.1128/MCB.11.3.1464; Kuzminov A, 1997, J MOL BIOL, V268, P1, DOI 10.1006/jmbi.1997.0955; LINDSEY JC, 1989, J MOL BIOL, V206, P779, DOI 10.1016/0022-2836(89)90584-6; Makovets S, 2004, MOL CELL BIOL, V24, P4019, DOI 10.1128/MCB.24.9.4019-4031.2004; MATSUMOTO L, 1974, J CELL BIOL, V63, P146, DOI 10.1083/jcb.63.1.146; Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024; Pohjoismaki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029; Pohlhaus JR, 2006, METHOD ENZYMOL, V409, P477, DOI 10.1016/S0076-6879(05)09028-2; RAO BS, 1994, GENE, V140, P233, DOI 10.1016/0378-1119(94)90549-5; Reyes A, 2009, METHODS MOL BIOL, V554, P15, DOI 10.1007/978-1-59745-521-3_2; RUBENSTEIN JLR, 1977, CELL, V12, P471, DOI 10.1016/0092-8674(77)90123-4; Saito S, 2005, GENETICS, V171, P1695, DOI 10.1534/genetics.105.046243; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Schvartzman JB, 2010, PLASMID, V63, P1, DOI 10.1016/j.plasmid.2009.11.001; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; WEISMANSHOMER P, 1989, BIOCHEM BIOPH RES CO, V164, P1149, DOI 10.1016/0006-291X(89)91789-0; Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9; Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392	35	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53249	10.1371/journal.pone.0053249	http://dx.doi.org/10.1371/journal.pone.0053249			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308172	gold, Green Published, Green Submitted			2022-12-25	WOS:000313670100026
J	Li, Y; Teo, WL; Low, MJ; Meijer, L; Sanderson, I; Pettersson, S; Greicius, G				Li, Y.; Teo, W. L.; Low, M. J.; Meijer, L.; Sanderson, I.; Pettersson, S.; Greicius, G.			Constitutive TLR4 signalling in intestinal epithelium reduces tumor load by increasing apoptosis in APC(Min/+) mice	ONCOGENE			English	Article						TLR4; APC(Min/+); Cox-2; apoptosis; Paneth cells; tumorigenesis	HUMAN COLON-CANCER; FAMILIAL ADENOMATOUS POLYPOSIS; CELLS IN-VITRO; CYCLOOXYGENASE-2 INHIBITOR; TRANSGENIC MICE; GROWTH; EXPRESSION; PROTEIN; VIVO; LIPOPOLYSACCHARIDE	The microbial pattern-recognizing Toll-like receptors (TLRs) are major signal transducers known to shape and influence the postnatal maturation of host intestinal epithelium. Perturbations in this intricate host-microbe cross-talk have been reported to be associated with uncontrolled epithelial cell growth and thus potential cancer development by mechanisms which are largely unknown. We therefore generated transgenic mice carrying a constitutively active TLR4 (CD4-TLR4) linked to an intestinal epithelial cell-specific promoter. Ex vivo analysis of transgenic crypt-villus organoid cultures revealed an increased proliferative capacity and a lowered cyclooxygenase 2 (Cox-2) expression in these organoids compared with wild-type control cultures. Introducing the CD4-TLR4 transgene into APC(Min/+) mice (CD4-TLR4-APC(Min/+)), a model of colorectal carcinoma, resulted in a dramatic drop in tumor load as compared with control APC(Min/+) mice. Intestinal tumors from CD4-TLR4-APC(Min/+) mice displayed reduced Cox-2 protein, elevated interferon beta expression and increased caspase-3 activity, which correlated with increased apoptosis in vivo. Thus, our data reveal that host microbiota-mediated signal transduction via TLR4 in intestinal epithelial cells is far more complex than what is previously reported.	[Li, Y.; Meijer, L.; Pettersson, S.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, S-17177 Stockholm, Sweden; [Li, Y.] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore; [Teo, W. L.; Low, M. J.; Pettersson, S.; Greicius, G.] Natl Canc Ctr, Singapore, Singapore; [Sanderson, I.] Barts & London Queen Marys Sch Med & Dent, Digest Dis Clin Acad Unit, London, England; [Pettersson, S.] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	Karolinska Institutet; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National Cancer Centre Singapore (NCCS); University of London; Queen Mary University London; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Pettersson, S (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Theorells Vag 3, S-17177 Stockholm, Sweden.	Sven.Pettersson@ki.se	Pettersson, Sven/F-9511-2015; Li, Yinghui/K-8253-2018	Li, Yinghui/0000-0002-9023-9466; Greicius, Gediminas/0000-0001-8333-787X; Sanderson, Ian/0000-0002-9814-0161	Singapore Immunology Network [(SIgN)-SIgN 10-038]	Singapore Immunology Network(Agency for Science Technology & Research (A*STAR))	Our research work was funded by a grant from Singapore Immunology Network (SIgN)-SIgN 10-038. We would like to thank Dr Robert Wallin for his great expertise and assistance in using the deconvolution microscope for anti-CD4 fluorescence imaging. We thank Velmurugesan Arulampalam for valuable discussions regarding our study. We also thank Arlaine Anne Bautista Amoyo, Jieshun Wong and Annika Samuelsson for their technical support with animal care and handling.	Andreani V, 2007, CANCER RES, V67, P10519, DOI 10.1158/0008-5472.CAN-07-0079; ARULAMPALAM V, 1994, EUR J IMMUNOL, V24, P1671, DOI 10.1002/eji.1830240732; Bohnhorst J, 2006, LEUKEMIA, V20, P1138, DOI 10.1038/sj.leu.2404225; Brown SL, 2007, J CLIN INVEST, V117, P258, DOI 10.1172/JCI29159; Chicoine MR, 2007, NEUROSURGERY, V60, P372, DOI 10.1227/01.NEU.0000249280.61761.2E; COHN SM, 1992, J CELL BIOL, V119, P27, DOI 10.1083/jcb.119.1.27; Cursio R, 2008, TRANSPL P, V40, P2038, DOI 10.1016/j.transproceed.2008.05.039; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Fukata M, 2011, INFLAMM BOWEL DIS, V17, P1464, DOI 10.1002/ibd.21527; Garay RP, 2007, EUR J PHARMACOL, V563, P1, DOI 10.1016/j.ejphar.2007.02.018; Nunez NG, 2012, CANCER RES, V72, P592, DOI 10.1158/0008-5472.CAN-11-0534; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Harmey JH, 2002, INT J CANCER, V101, P415, DOI 10.1002/ijc.10632; KARGMAN SL, 1995, CANCER RES, V55, P2556; Klampfer L, 2007, ONCOGENE, V26, P2071, DOI 10.1038/sj.onc.1210015; Kutchera W, 1996, P NATL ACAD SCI USA, V93, P4816, DOI 10.1073/pnas.93.10.4816; Li YH, 2012, CARCINOGENESIS, V33, P1231, DOI 10.1093/carcin/bgs137; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; MAEHARA Y, 1994, AM J SURG, V168, P36, DOI 10.1016/S0002-9610(05)80068-6; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Muller-Decker K, 2002, P NATL ACAD SCI USA, V99, P12483, DOI 10.1073/pnas.192323799; Nakamoto N, 2006, INT J ONCOL, V29, P625; Ohtsuka Y, 2001, GUT, V49, P526, DOI 10.1136/gut.49.4.526; Otto F, 1996, EUR J CANCER, V32A, P1712, DOI 10.1016/0959-8049(96)00186-4; Pidgeon GP, 1999, BRIT J CANCER, V81, P1311, DOI 10.1038/sj.bjc.6694369; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Razack AHA, 2007, ASIAN J SURG, V30, P302, DOI 10.1016/S1015-9584(08)60045-7; Sato M, 1997, APOPTOSIS, V2, P227, DOI 10.1023/A:1026428918301; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sheng HM, 1997, J CLIN INVEST, V99, P2254, DOI 10.1172/JCI119400; Singh B, 2005, INT J ONCOL, V26, P1393; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; Swamy MV, 2006, CANCER RES, V66, P7370, DOI 10.1158/0008-5472.CAN-05-4619; SWEETSER DA, 1988, P NATL ACAD SCI USA, V85, P9611, DOI 10.1073/pnas.85.24.9611; Trifan OC, 2003, J CELL MOL MED, V7, P207, DOI 10.1111/j.1582-4934.2003.tb00222.x; Wang D, 2006, GUT, V55, P115, DOI 10.1136/gut.2004.047100; Yokota S, 2010, INFECT IMMUN, V78, P468, DOI 10.1128/IAI.00903-09	41	15	16	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 16	2014	33	3					369	377		10.1038/onc.2012.581	http://dx.doi.org/10.1038/onc.2012.581			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	296VR	23318418	Green Submitted			2022-12-25	WOS:000330214000011
J	Kumari, U; Jun, WY; Bay, BH; Lyakhovich, A				Kumari, U.; Jun, W. Ya; Bay, B. Huat; Lyakhovich, A.			Evidence of mitochondrial dysfunction and impaired ROS detoxifying machinery in Fanconi Anemia cells	ONCOGENE			English	Article						Fanconi Anemia; reactive oxygen species; mitochondria	INTERSTRAND CROSS-LINK; OXIDATIVE STRESS; REACTIVE OXYGEN; SUPEROXIDE-DISMUTASE; SKELETAL-MUSCLE; DNA-REPAIR; PATHWAY; MUTATION; DAMAGE; FANCD2	Fanconi Anemia (FA) is a rare genetic disorder associated with a bone-marrow failure, cancer predisposition and hypersensitivity to DNA crosslinking agents. Majority of the 15 FA genes and encoded proteins characterized so far are integrated into DNA repair pathways, however, other important functions cannot be excluded. FA cells are sensitive to oxidants, and accumulation of oxidized proteins has been characterized for several FA subgroups. Clinical phenotypes of both FA and other closely related diseases suggest altered functions of mitochondria, organelles responsible for cellular energetic metabolism, and also serving as an important producer and the most susceptible target from reactive oxidative species (ROS). In this study, we have shown that elevated level of mitochondrial ROS in FA cells is in parallel with the decrease of mitochondrial membrane potential, the decrease of ATP production, impaired oxygen uptake and pathological changes in the morphology of mitochondria. This is accompanied by inactivation of enzymes that are essential for the energy production (F1F0ATPase and cytochrome C oxidase) and detoxification of ROS (superoxide dismutase, SOD1). In turn, overexpression of SOD1 could rescue oxygen consumption rate in FA-deficient cells. Importantly, the depletion of mitochondria improved survival rate of mitomycin C treated FA cells suggesting that hypersensitivity of FA cells to chemotherapeutic drugs could be in part due to the mitochondria-mediated oxidative stress. On the basis of our results, we propose that deficiency in FA genes lead to disabling mitochondrial ROS-scavenging machinery further affecting mitochondrial functions and suppressing cell respiration.	[Kumari, U.; Lyakhovich, A.] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore 169857, Singapore; [Jun, W. Ya; Bay, B. Huat] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117595, Singapore	National University of Singapore; National University of Singapore	Lyakhovich, A (corresponding author), Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Coll Rd,Level 6, Singapore 169857, Singapore.	lyakhovich@gmail.com	Lyakhovich, Alex/B-4410-2008	Lyakhovich, Alex/0000-0002-8279-4697				Ali SS, 2010, J BIOL CHEM, V285, P32522, DOI 10.1074/jbc.M110.155432; Allan AC, 1997, PLANT CELL, V9, P1559, DOI 10.1105/tpc.9.9.1559; AMANO F, 1995, FEBS LETT, V368, P425, DOI 10.1016/0014-5793(95)00700-J; Bogliolo M, 2002, MUTAGENESIS, V17, P25, DOI 10.1093/mutage/17.1.25; Bogliolo M, 2007, EMBO J, V26, P1340, DOI 10.1038/sj.emboj.7601574; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Cossarizza A., 2001, CURR PROTOC CYTOM, DOI [10.1002/0471142956.cy0914s13, DOI 10.1002/0471142956.CY0914S13]; Cuccarolo P, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-63; DALLAPICCOLA B, 1985, HUM GENET, V69, P62, DOI 10.1007/BF00295530; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; DEGAN P, 1995, CARCINOGENESIS, V16, P735, DOI 10.1093/carcin/16.4.735; Dirmeier R, 2002, J BIOL CHEM, V277, P34773, DOI 10.1074/jbc.M203902200; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Du W, 2012, BLOOD, V119, P4142, DOI 10.1182/blood-2011-09-381970; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Fridlyand LE, 2005, ANN NY ACAD SCI, V1066, P136, DOI 10.1196/annals.1363.019; Hadjur S, 2001, BLOOD, V98, P1003, DOI 10.1182/blood.V98.4.1003; Hutter E, 2007, AGING CELL, V6, P245, DOI 10.1111/j.1474-9726.2007.00282.x; JOENJE H, 1981, NATURE, V290, P142, DOI 10.1038/290142a0; Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505; Kim Y, 2011, NAT GENET, V43, P142, DOI 10.1038/ng.750; Kumar B, 2008, CANCER RES, V68, P1777, DOI 10.1158/0008-5472.CAN-07-5259; Li RC, 2008, BRAIN RES, V1190, P159, DOI 10.1016/j.brainres.2007.11.022; Lyakhovich A, 2010, MOL CANCER RES, V8, P46, DOI 10.1158/1541-7786.MCR-09-0373; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Miller SW, 1996, J NEUROCHEM, V67, P1897; Moldovan GL, 2009, CELL, V139, P1222, DOI 10.1016/j.cell.2009.12.006; Mukhopadhyay SS, 2006, J CELL BIOL, V175, P225, DOI 10.1083/jcb.200607061; NORDENSON I, 1977, HEREDITAS, V86, P147; O'Neill HC, 2011, AM J RESP CELL MOL, V45, P323, DOI 10.1165/rcmb.2010-0214OC; Pagano G, 2004, CARCINOGENESIS, V25, P1899, DOI 10.1093/carcin/bgh194; Pagano G, 1997, BLOOD, V89, P1111, DOI 10.1182/blood.V89.3.1111; Pagano G, 2012, BIOL CHEM, V393, P11, DOI 10.1515/BC-2011-227; Pallardo FV, 2010, BIOGERONTOLOGY, V11, P401, DOI 10.1007/s10522-010-9269-4; Petrovic S, 2011, BIOL CHEM, V392, P625, DOI 10.1515/BC.2011.064; Ponte F, 2011, TOXICOLOGY, V289, P52, DOI 10.1016/j.tox.2011.07.009; Rachek LI, 2007, ENDOCRINOLOGY, V148, P293, DOI 10.1210/en.2006-0998; Rani R, 2008, CANCER RES, V68, P9693, DOI 10.1158/0008-5472.CAN-08-1790; RICHTER C, 1991, CHEM-BIOL INTERACT, V77, P1, DOI 10.1016/0009-2797(91)90002-O; Rousset S, 2002, PHOTOCHEM PHOTOBIOL, V75, P159, DOI 10.1562/0031-8655(2002)075<0159:MAIFAF>2.0.CO;2; ROUSSET S, 1990, CANCER RES, V50, P2443; Ruppitsch W, 1997, HUM GENET, V99, P710, DOI 10.1007/s004390050437; Saadatzadeh MR, 2004, J BIOL CHEM, V279, P16805, DOI 10.1074/jbc.M313721200; SCHINDLER D, 1988, AM J HUM GENET, V43, P429; TAKEUCHI T, 1993, CARCINOGENESIS, V14, P1115, DOI 10.1093/carcin/14.6.1115; Talbot DA, 2004, FEBS LETT, V556, P111, DOI 10.1016/S0014-5793(03)01386-3; Tobaben S, 2011, CELL DEATH DIFFER, V18, P282, DOI 10.1038/cdd.2010.92; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Vandenberg CJ, 2003, MOL CELL, V12, P247, DOI 10.1016/S1097-2765(03)00281-8; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; Wu YL, 2010, BLOOD, V116, P3780, DOI 10.1182/blood-2009-11-256016; Xue YT, 2008, HUM MOL GENET, V17, P1641, DOI 10.1093/hmg/ddn054; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103	53	74	75	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 9	2014	33	2					165	172		10.1038/onc.2012.583	http://dx.doi.org/10.1038/onc.2012.583			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	286BY	23318445				2022-12-25	WOS:000329440700004
J	Ko, JY; Yoo, KH; Song, SA; Kim, DY; Kong, HK; Ahn, C; Lee, HW; Kang, DH; Oh, GT; Park, JH				Ko, Je Yeong; Yoo, Kyung Hyun; Song, Seon Ah; Kim, Do Yeon; Kong, Hyun Kyung; Ahn, Curie; Lee, Han Woong; Kang, Duk-Hee; Oh, Goo Taeg; Park, Jong Hoon			Inactivation of Max-interacting Protein 1 Induces Renal Cilia Disassembly through Reduction in Levels of Intraflagellar Transport 20 in Polycystic Kidney	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL HEART-DISEASE; AUTOSOMAL-DOMINANT; MITOTIC SPINDLE; CELL-LINES; MXI1; COMPLEX; GROWTH; MISORIENTATION; DYSKINESIA; MOUSE	Cilia in ciliated cells consist of protruding structures that sense mechanical and chemical signals from the extracellular environment. Cilia are assembled with variety molecules via a process known as intraflagellar transport (IFT). What controls the length of cilia in ciliated cells is critical to understand ciliary disease such as autosomal dominant polycystic kidney disease, which involves abnormally short cilia. But this control mechanism is not well understood. Previously, multiple tubular cysts have been observed in the kidneys of max-interacting protein 1 (Mxi1)-deficient mice aged 6 months or more. Here, we clarified the relationship between Mxi1 inactivation and cilia disassembly. Cilia phenotypes were observed in kidneys of Mxi1-deficient mice using scanning electron microscopy to elucidate the effect of Mxi1 on renal cilia phenotype, and cilia disassembly was observed in Mxi1-deficient kidney. In addition, genes related to cilia were validated in vitro and in vivo using quantitative PCR, and Ift20 was selected as a candidate gene in this study. The length of cilium decreased, and p-ERK level induced by a cilia defect increased in kidneys of Mxi1-deficient mice. Ciliogenesis of Mxi1-deficient mouse embryonic fibroblasts (MEFs) decreased, and this abnormality was restored by Mxi1 transfection in Mxi1-deficient MEFs. We confirmed that ciliogenesis and Ift20 expression were regulated by Mxi1 in vitro. We also determined that Mxi1 regulates Ift20 promoter activity via Ets-1 binding to the Ift20 promoter. These results indicate that inactivating Mxi1 induces ciliary defects in polycystic kidney.	[Ko, Je Yeong; Yoo, Kyung Hyun; Song, Seon Ah; Kim, Do Yeon; Kong, Hyun Kyung; Park, Jong Hoon] Sookmyung Womens Univ, Dept Biol Sci, Seoul 140742, South Korea; [Ahn, Curie] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul 110744, South Korea; [Lee, Han Woong] Yonsei Univ, Dept Biochem, Seoul 120749, South Korea; [Kang, Duk-Hee] Ewha Womans Univ, Dept Internal Med, Sch Med, Seoul 120750, South Korea; [Oh, Goo Taeg] Ewha Womans Univ, Dept Biol Sci, Seoul 120750, South Korea	Sookmyung Women's University; Seoul National University (SNU); Yonsei University; Ewha Womans University; Ewha Womans University	Park, JH (corresponding author), Sookmyung Womens Univ, Dept Biol Sci, Seoul 140742, South Korea.	parkjh@sookmyung.ac.kr	Oh, Goo Taeg/AAQ-9995-2021		Bio and Medical Technology Development Program of the National Research Foundation of Korea [2011-0031220, 2011-0019452]	Bio and Medical Technology Development Program of the National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by Grants 2011-0031220 and 2011-0019452 from the Bio and Medical Technology Development Program of the National Research Foundation of Korea.	Al-Bhalal L, 2005, ADV ANAT PATHOL, V12, P126, DOI 10.1097/01.pap.0000163959.29032.1f; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Blacque OE, 2008, FRONT BIOSCI-LANDMRK, V13, P2633, DOI 10.2741/2871; Brueckner M, 2007, CIRCULATION, V115, P2793, DOI 10.1161/CIRCULATIONAHA.107.699256; Cowley BD, 2008, KIDNEY INT, V73, P251, DOI 10.1038/sj.ki.5002695; Henriksson M, 1996, ADV CANCER RES, V68, P109, DOI 10.1016/S0065-230X(08)60353-X; Jonassen JA, 2008, J CELL BIOL, V183, P377, DOI 10.1083/jcb.200808137; Jonassen JA, 2012, J AM SOC NEPHROL, V23, P641, DOI 10.1681/ASN.2011080829; Kawamata N, 2005, INT J ONCOL, V26, P1369; Keady BT, 2012, DEV CELL, V22, P940, DOI 10.1016/j.devcel.2012.04.009; Kennedy MP, 2007, CIRCULATION, V115, P2814, DOI 10.1161/CIRCULATIONAHA.106.649038; Ko JY, 2011, BIOCHEM BIOPH RES CO, V415, P36, DOI 10.1016/j.bbrc.2011.10.005; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Ong ACM, 2005, KIDNEY INT, V67, P1234, DOI 10.1111/j.1523-1755.2005.00201.x; Park EY, 2011, BMB REP, V44, P359, DOI 10.5483/BMBRep.2011.44.6.359; Pazour GJ, 2004, J AM SOC NEPHROL, V15, P2528, DOI 10.1097/01.ASN.0000141055.57643.E0; Pazour GJ, 2002, TRENDS CELL BIOL, V12, P551, DOI 10.1016/S0962-8924(02)02410-8; Pedersen LB, 2008, DEV DYNAM, V237, P1993, DOI 10.1002/dvdy.21521; Puri S, 2006, BIOCHEM BIOPH RES CO, V342, P1005, DOI 10.1016/j.bbrc.2006.02.045; REEDERS ST, 1992, NAT GENET, V1, P235, DOI 10.1038/ng0792-235; Salem H, 2010, ONCOGENE, V29, P4046, DOI 10.1038/onc.2010.162; Satir P, 2008, HISTOCHEM CELL BIOL, V129, P687, DOI 10.1007/s00418-008-0416-9; Schreiber-Agus N, 1998, BIOESSAYS, V20, P808, DOI 10.1002/(SICI)1521-1878(199810)20:10<808::AID-BIES6>3.0.CO;2-U; Schreiber-Agus N, 1998, NATURE, V393, P483, DOI 10.1038/31008; Serra R, 2008, ANAT REC, V291, P1049, DOI 10.1002/ar.20634; Takiar V, 2011, BBA-MOL BASIS DIS, V1812, P1337, DOI 10.1016/j.bbadis.2010.11.014; Torres VE, 2006, NAT CLIN PRACT NEPHR, V2, P40, DOI 10.1038/ncpneph0070; Veland IR, 2009, NEPHRON PHYSIOL, V111, P39, DOI 10.1159/000208212; Wagner CA, 2008, J NEPHROL, V21, P14; Wang DY, 2000, PATHOL INT, V50, P373, DOI 10.1046/j.1440-1827.2000.01057.x; Watnick T, 2003, NAT GENET, V34, P355, DOI 10.1038/ng0803-355; Yoo KH, 2007, BIOCHEM BIOPH RES CO, V356, P85, DOI 10.1016/j.bbrc.2007.02.103; Yoo KH, 2009, PROTEOMICS, V9, P3824, DOI 10.1002/pmic.200800753; Zaucke F, 2010, HUM MOL GENET, V19, P1985, DOI 10.1093/hmg/ddq077; Zuo XF, 2011, J BIOL CHEM, V286, P22469, DOI 10.1074/jbc.M111.238469	35	3	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6488	6497		10.1074/jbc.M112.413302	http://dx.doi.org/10.1074/jbc.M112.413302			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23316056	hybrid, Green Published			2022-12-25	WOS:000315820700042
J	Vitrac, H; Bogdanov, M; Dowhan, W				Vitrac, Heidi; Bogdanov, Mikhail; Dowhan, William			Proper Fatty Acid Composition Rather than an Ionizable Lipid Amine Is Required for Full Transport Function of Lactose Permease from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYTOPIC MEMBRANE-PROTEIN; MONOCLONAL-ANTIBODY 4B1; GALACTOSE-SPECIFIC PROTEINS; TOPOLOGICAL ORGANIZATION; PHOSPHOLIPID-COMPOSITION; MULTIDRUG TRANSPORTER; STRUCTURAL FEATURES; PHOSPHATIDYLETHANOLAMINE; TOPOGENESIS; BINDING	Energy-dependent uphill transport but not energy-independent downhill transport by lactose permease (LacY) is impaired when expressed in Escherichia coli cells or reconstituted in liposomes lacking phosphatidylethanolamine (PE) and containing only anionic phospholipids. The absence of PE results in inversion of the N-terminal half and misfolding of periplasmic domain P7, which are required for uphill transport of substrates. Replacement of PE in vitro by lipids with no net charge (phosphatidylcholine (PC), monoglucosyl diacylglycerol (GlcDAG), or diglucosyl diacylglycerol (GlcGlcDAG)) supported wild type transmembrane topology of the N-terminal half of LacY. The restoration of uphill transport in vitro was dependent on LacY native topology and proper folding of P7. Support of uphill transport by net neutral lipids in vitro (PE > PC >> GlcDAG not equal GlcGlcDAG provided that PE or PC contained one saturated fatty acid) paralleled the results observed previously in vivo (PE = PC > GlcDAG not equal GlcGlcDAG). Therefore, a free amino group is not required for uphill transport as previously concluded based on the lack of in vitro uphill transport when fully unsaturated PC replaced E. coli-derived PE. A close correlation was observed in vivo and in vitro between the ability of LacY to carry out uphill transport, the native conformation of P7, and the lipid headgroup and fatty acid composition. Therefore, the headgroup and the fatty acid composition of lipids are important for defining LacY topological organization and catalytically important structural features, further illustrating the direct role of lipids, independent of other cellular factors, in defining membrane protein structure/function.	[Vitrac, Heidi; Bogdanov, Mikhail; Dowhan, William] Univ Texas Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Dowhan, William] Univ Texas Med Sch, Ctr Membrane Biol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Bogdanov, M (corresponding author), Univ Texas Med Sch Houston, Dept Biochem & Mol Biol, 6431 Fannin St,Suite 6-200, Houston, TX 77030 USA.	Mikhail.V.Bogdanov@uth.tmc.edu; William.Dowhan@uth.tmc.edu	Bogdanov, Mikhail/J-3695-2017; Vitrac, Heidi/R-7117-2018	Vitrac, Heidi/0000-0002-8858-4914	National Institutes of Health Grant [GM R37 20478]; John Dunn Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020478] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Dunn Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM R37 20478 (to W. D.). This work was also supported by a grant from the John Dunn Research Foundation (to W. D.).	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Andersson M, 2012, STRUCTURE, V20, P1893, DOI 10.1016/j.str.2012.08.021; Bogdanov M, 2002, EMBO J, V21, P2107, DOI 10.1093/emboj/21.9.2107; Bogdanov M, 1999, J BIOL CHEM, V274, P36827, DOI 10.1074/jbc.274.52.36827; Bogdanov M, 2005, METHODS, V36, P148, DOI 10.1016/j.ymeth.2004.11.002; Bogdanov M, 1998, EMBO J, V17, P5255, DOI 10.1093/emboj/17.18.5255; Bogdanov M, 1999, J BIOL CHEM, V274, P12339, DOI 10.1074/jbc.274.18.12339; Bogdanov M, 1996, J BIOL CHEM, V271, P11615, DOI 10.1074/jbc.271.20.11615; BOGDANOV M, 1995, J BIOL CHEM, V270, P732, DOI 10.1074/jbc.270.2.732; Bogdanov M, 2008, J CELL BIOL, V182, P925, DOI 10.1083/jcb.200803097; Bogdanov M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.404103; Bogdanov M, 2010, P NATL ACAD SCI USA, V107, P15057, DOI 10.1073/pnas.1006286107; Bogdanov M, 2010, METHODS MOL BIOL, V619, P79, DOI 10.1007/978-1-60327-412-8_5; Bogdanov M, 2009, J BIOL CHEM, V284, P9637, DOI 10.1074/jbc.R800081200; CHEN CC, 1984, J BIOL CHEM, V259, P150; CHEN CC, 1986, J BIOL CHEM, V261, P2599; DECHAVIGNY A, 1991, J BIOL CHEM, V266, P5323; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Dowhan W, 2012, BBA-BIOMEMBRANES, V1818, P1097, DOI 10.1016/j.bbamem.2011.09.013; Dowhan W, 2011, BIOCHEM SOC T, V39, P767, DOI 10.1042/BST0390767; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; DRIESSEN AJM, 1988, BIOCHEMISTRY-US, V27, P865, DOI 10.1021/bi00403a005; Fendler K, 1996, BIOCHEMISTRY-US, V35, P8009, DOI 10.1021/bi960175e; Fernandez MD, 2005, J AM CHEM SOC, V127, P7379, DOI 10.1021/ja051020+; Frillingos S, 1997, BIOCHEMISTRY-US, V36, P6408, DOI 10.1021/bi970233b; Frillingos S, 1996, BIOCHEMISTRY-US, V35, P10166, DOI 10.1021/bi960995r; Gbaguidi B, 2007, CELL MOL LIFE SCI, V64, P1571, DOI 10.1007/s00018-007-7031-0; Gustot A, 2010, J BIOL CHEM, V285, P14144, DOI 10.1074/jbc.M109.079673; Hakizimana P, 2008, J BIOL CHEM, V283, P9369, DOI 10.1074/jbc.M708427200; Lee AG, 2011, TRENDS BIOCHEM SCI, V36, P493, DOI 10.1016/j.tibs.2011.06.007; Nagamori S, 2004, J CELL BIOL, V165, P53, DOI 10.1083/jcb.200402067; PAGE MGP, 1988, J BIOL CHEM, V263, P15897; Roderick SL, 2002, NAT STRUCT BIOL, V9, P507, DOI 10.1038/nsb812; Sanders CR, 2011, BIOCHEMISTRY-US, V50, P7858, DOI 10.1021/bi2011527; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Suarez-Germa C, 2012, J PHYS CHEM B, V116, P2438, DOI 10.1021/jp2105665; Sujatha MS, 2004, PROTEINS, V55, P44, DOI 10.1002/prot.10612; Sujatha MS, 2004, PROTEIN SCI, V13, P2502, DOI 10.1110/ps.04812804; Sun JZ, 1996, BIOCHEMISTRY-US, V35, P990, DOI 10.1021/bi952166w; Toyomizu M, 2002, BBA-BIOMEMBRANES, V1558, P54, DOI 10.1016/S0005-2736(01)00422-9; URATANI Y, 1986, J BIOL CHEM, V261, P5450; Vitrac H, 2011, J BIOL CHEM, V286, P15182, DOI 10.1074/jbc.M110.214387; Voss J, 1997, BIOCHEMISTRY-US, V36, P15055, DOI 10.1021/bi971726j; Wang XY, 2002, EMBO J, V21, P5673, DOI 10.1093/emboj/cdf571; Wikstrom M, 2004, J BIOL CHEM, V279, P10484, DOI 10.1074/jbc.M310183200; Wikstrom M, 2009, J BIOL CHEM, V284, P954, DOI 10.1074/jbc.M804482200; Xie J, 2006, J BIOL CHEM, V281, P19172, DOI 10.1074/jbc.M602565200; Zhang W, 2005, J BIOL CHEM, V280, P26032, DOI 10.1074/jbc.M504929200; Zhang W, 2003, J BIOL CHEM, V278, P50128, DOI 10.1074/jbc.M309840200	49	24	24	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5873	5885		10.1074/jbc.M112.442988	http://dx.doi.org/10.1074/jbc.M112.442988			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23322771	Green Published, hybrid			2022-12-25	WOS:000315342500057
J	Balakrishnan, B; Sen, D; Hareendran, S; Roshini, V; David, S; Srivastava, A; Jayandharan, GR				Balakrishnan, Balaji; Sen, Dwaipayan; Hareendran, Sangeetha; Roshini, Vaani; David, Sachin; Srivastava, Alok; Jayandharan, Giridhara R.			Activation of the Cellular Unfolded Protein Response by Recombinant Adeno-Associated Virus Vectors	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; INNATE IMMUNE-RESPONSES; KAPPA-B PATHWAY; VIRAL VECTORS; GENE-THERAPY; INTRACELLULAR TRAFFICKING; TRANSCRIPTION FACTOR; METABOLIC DISEASE; AIRWAY EPITHELIA; MESSENGER-RNA	The unfolded protein response (UPR) is a stress-induced cyto-protective mechanism elicited towards an influx of large amount of proteins in the endoplasmic reticulum (ER). In the present study, we evaluated if AAV manipulates the UPR pathways during its infection. We first examined the role of the three major UPR axes, namely, endoribonuclease inositol-requiring enzyme-1 (IRE1 alpha), activating transcription factor 6 (ATF6) and PKR-like ER kinase (PERK) in AAV infected cells. Total RNA from mock or AAV infected HeLa cells were used to determine the levels of 8 different ER-stress responsive transcripts from these pathways. We observed a significant up-regulation of IRE1 alpha (up to 11 fold) and PERK (up to 8 fold) genes 12-48 hours after infection with self-complementary (sc)AAV2 but less prominent with single-stranded (ss) AAV2 vectors. Further studies demonstrated that scAAV1 and scAAV6 also induce cellular UPR in vitro, with AAV1 vectors activating the PERK pathway (3 fold) while AAV6 vectors induced a significant increase on all the three major UPR pathways [6-16 fold]. These data suggest that the type and strength of UPR activation is dependent on the viral capsid. We then examined if transient inhibition of UPR pathways by RNA interference has an effect on AAV transduction. siRNA mediated silencing of PERK and IRE1 alpha had a modest effect on AAV2 and AAV6 mediated gene expression (similar to 1.5-2 fold) in vitro. Furthermore, hepatic gene transfer of scAAV2 vectors in vivo, strongly elevated IRE1 alpha and PERK pathways (2 and 3.5 fold, respectively). However, when animals were pre-treated with a pharmacological UPR inhibitor (metformin) during scAAV2 gene transfer, the UPR signalling and its subsequent inflammatory response was attenuated concomitant to a modest 2.8 fold increase in transgene expression. Collectively, these data suggest that AAV vectors activate the cellular UPR pathways and their selective inhibition may be beneficial during AAV mediated gene transfer.	[Balakrishnan, Balaji; Sen, Dwaipayan; Roshini, Vaani; David, Sachin; Srivastava, Alok; Jayandharan, Giridhara R.] Christian Med Coll & Hosp, Dept Hematol, Vellore, Tamil Nadu, India; [Hareendran, Sangeetha; Srivastava, Alok; Jayandharan, Giridhara R.] Christian Med Coll & Hosp, Ctr Stem Cell Res, Vellore, Tamil Nadu, India	Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore	Jayandharan, GR (corresponding author), Christian Med Coll & Hosp, Dept Hematol, Vellore, Tamil Nadu, India.	jay@cmcvellore.ac.in	Hareendran, Sangeetha/AAE-6392-2019; Balakrishnan, Balaji/AAW-7251-2020	Balakrishnan, Balaji/0000-0003-4852-3022; Sen, Dwaipayan/0000-0002-3485-494X; Hareendran, Sangeetha/0000-0002-9070-8023	Department of Science of Technology, Government of India; Department of Biotechnology (DBT), Government of India [BT/03/IYBA/2010, BT/PR14748/MED/12/491/2010, BT/01/COE/08/03]; Bayer Inc, USA; University Grants Commission, New Delhi, India	Department of Science of Technology, Government of India; Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Bayer Inc, USA; University Grants Commission, New Delhi, India(University Grants Commission, India)	GRJ is supported by research grants from Department of Science of Technology, Government of India (Swarnajayanti Fellowship 2011), Department of Biotechnology (DBT), Government of India (Innovative Young Biotechnologist award 2010: BT/03/IYBA/2010; Grant: BT/PR14748/MED/12/491/2010; Grant: BT/01/COE/08/03) and an early career investigator award-2010 from Bayer Hemophilia Awards program, Bayer Inc, USA. BB is supported by a junior research fellowship from University Grants Commission, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNS KI, 1995, BIOESSAYS, V17, P237, DOI 10.1002/bies.950170310; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Clavarino G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002708; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; Ding W, 2003, J VIROL, V77, P7361, DOI 10.1128/JVI.77.13.7361-7366.2003; Ding W, 2005, GENE THER, V12, P873, DOI 10.1038/sj.gt.3302527; Douar AM, 2001, J VIROL, V75, P1824, DOI 10.1128/JVI.75.4.1824-1833.2001; Duan DS, 2000, J CLIN INVEST, V105, P1573, DOI 10.1172/JCI8317; Duan DS, 1999, J VIROL, V73, P10371, DOI 10.1128/JVI.73.12.10371-10376.1999; Engel A, 2010, NAT IMMUNOL, V11, P365, DOI 10.1038/ni0510-365; Erles K, 1999, J MED VIROL, V59, P406, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;406::AID-JMV22&gt;3.0.CO;2-N; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Gu F, 2001, CELL MOL LIFE SCI, V58, P1067, DOI 10.1007/PL00000922; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hassan IH, 2012, J BIOL CHEM, V287, P4679, DOI 10.1074/jbc.M111.284695; Hauck B, 2004, J VIROL, V78, P13678, DOI 10.1128/JVI.78.24.13678-13686.2004; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; Hiramatsu N, 2011, METHOD ENZYMOL, V491, P183, DOI 10.1016/B978-0-12-385928-0.00011-0; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Isler JA, 2005, J VIROL, V79, P6890, DOI 10.1128/JVI.79.11.6890-6899.2005; Jayandharan GR, 2011, P NATL ACAD SCI USA, V108, P3743, DOI 10.1073/pnas.1012753108; Johnson JS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002053; Kaneko M, 2003, BIOL PHARM BULL, V26, P931, DOI 10.1248/bpb.26.931; Kazemi S, 2004, MOL CELL BIOL, V24, P3415, DOI 10.1128/MCB.24.8.3415-3429.2004; Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474; Kourelis TV, 2012, MED ONCOL, V29, P1314, DOI 10.1007/s12032-011-9846-7; Kube DM, 1997, NUCLEIC ACIDS RES, V25, P3375, DOI 10.1093/nar/25.16.3375; Lazar C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034169; Lee DY, 2009, J VIROL, V83, P1168, DOI 10.1128/JVI.01358-08; Li BZ, 2007, VIRUS RES, V124, P44, DOI 10.1016/j.virusres.2006.09.011; Li SS, 2009, VIROLOGY, V391, P257, DOI 10.1016/j.virol.2009.06.039; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Martino AT, 2011, BLOOD, V117, P6459, DOI 10.1182/blood-2010-10-314518; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07; Merquiol E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024660; Minakshi R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008342; Mingozzi F, 2007, NAT MED, V13, P419, DOI 10.1038/nm1549; Nonnenmacher M, 2012, GENE THER, V19, P649, DOI 10.1038/gt.2012.6; Nonnenmacher M, 2012, GENE THER; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Pien GC, 2009, J CLIN INVEST, V119, P1688, DOI 10.1172/JCI36891; Rogers GL, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00194; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Sanlioglu S., 2001, Current Gene Therapy, V1, P137, DOI 10.2174/1566523013348788; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Theriault JR, 2011, BIOCHEM BIOPH RES CO, V409, P500, DOI 10.1016/j.bbrc.2011.05.034; Trujillo-Alonso V, 2011, J VIROL, V85, P12594, DOI 10.1128/JVI.05620-11; Xia LM, 2012, J IMMUNOL, V188, P753, DOI 10.4049/jimmunol.1101652; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhu JG, 2009, J CLIN INVEST, V119, P2388, DOI 10.1172/JCI37607	56	29	30	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53845	10.1371/journal.pone.0053845	http://dx.doi.org/10.1371/journal.pone.0053845			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320106	gold, Green Submitted, Green Published			2022-12-25	WOS:000313429800071
J	Pinne, M; Haake, DA				Pinne, Marija; Haake, David A.			LipL32 Is a Subsurface Lipoprotein of Leptospira interrogans: Presentation of New Data and Reevaluation of Previous Studies	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; SURFACE-EXPOSED LIPOPROTEIN; PATHOGENIC LEPTOSPIRA; MONOCLONAL-ANTIBODIES; MOLECULAR-CLONING; SEQUENCE-ANALYSIS; EPIDEMIC; ANTIGEN; BINDS; OMPL1	The agents of leptospirosis, a zoonosis with worldwide distribution, are pathogenic spirochetes belonging to the genus Leptospira. The leptospiral life cycle involves transmission via fresh water and colonization of the renal tubules of their reservoir hosts. Infection of accidental hosts, including humans, may result in life-threatening sequelae. Bacterial outer membrane proteins (OMPs), particularly those with surface-exposed regions, play crucial roles in pathogen virulence mechanisms and adaptation to environmental conditions, including those found in the mammalian host. Therefore, elucidation and characterization of the surface-exposed OMPs of Leptospira spp. is of great interest in the leptospirosis field. A thorough, multi-pronged approach for assessing surface exposure of leptospiral OMPs is essential. Herein, we present evidence for a sub-surface location for most or all of the major leptospiral lipoprotein, LipL32, based on surface immunofluorescence utilizing three different types of antibodies and four different permeabilization methods, as well as surface proteolysis of intact and lysed leptospires. We reevaluate prior evidence presented in support of LipL32 surface-exposure and present a novel perspective on a protein whose location has been misleading researchers, due in large part to its extraordinary abundance in leptospiral cells.	[Pinne, Marija] Vet Affairs Greater Los Angeles Healthcare Syst, Res Serv, Los Angeles, CA USA; [Haake, David A.] Vet Affairs Greater Los Angeles Healthcare Syst, Div Infect Dis, Los Angeles, CA USA; [Pinne, Marija; Haake, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Haake, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA; [Haake, David A.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Pinne, M (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Res Serv, Los Angeles, CA USA.	mpinne@ucla.edu			VA Medical Research Funds; National Institute of Allergy and Infectious Diseases [AI-034431]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034431] Funding Source: NIH RePORTER	VA Medical Research Funds(US Department of Veterans Affairs); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by VA Medical Research Funds (to D. A. H.) and grant AI-034431 (to D. A. H.) from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Cao XJ, 2010, CELL RES, V20, P197, DOI 10.1038/cr.2009.127; Cullen PA, 2005, INFECT IMMUN, V73, P4853, DOI 10.1128/IAI.73.8.4853-4863.2005; Cullen PA, 2004, FEMS MICROBIOL REV, V28, P291, DOI 10.1016/j.femsre.2003.10.004; Cullen PA, 2002, INFECT IMMUN, V70, P2311, DOI 10.1128/IAI.70.5.2311-2318.2002; Domingos RF, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-50; Eshghi A, 2011, MICROBIOLOGY, V158, P622; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Fernandes CPH, 2007, HYBRIDOMA, V26, P35, DOI 10.1089/hyb.2006.033; Flannery B, 2001, J CLIN MICROBIOL, V39, P3303, DOI 10.1128/JCM.39.9.3303-3310.2001; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Ganoza CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000612; Guerreiro H, 2001, INFECT IMMUN, V69, P4958, DOI 10.1128/IAI.69.8.4958-4968.2001; Haake DA, 2000, MICROBIOL-SGM, V146, P1491, DOI 10.1099/00221287-146-7-1491; Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000; Haake DA, 2004, J BACTERIOL, V186, P2818, DOI 10.1128/JB.186.9.2818-2828.2004; HAAKE DA, 1993, J BACTERIOL, V175, P4225, DOI 10.1128/JB.175.13.4225-4234.1993; Haake DA, 2002, INFECT IMMUN, V70, P4936, DOI 10.1128/IAI.70.9.4936-4945.2002; HAAKE DA, 1991, INFECT IMMUN, V59, P1131, DOI 10.1128/IAI.59.3.1131-1140.1991; Habarta A, 2011, CURR MICROBIOL, V62, P526, DOI 10.1007/s00284-010-9739-6; Hauk P, 2008, INFECT IMMUN, V76, P2642, DOI 10.1128/IAI.01639-07; Hoke DE, 2008, INFECT IMMUN, V76, P2063, DOI 10.1128/IAI.01643-07; ITO K, 1991, MOL MICROBIOL, V5, P2243, DOI 10.1111/j.1365-2958.1991.tb02154.x; Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lucas DSD, 2011, VACCINE, V29, P3413, DOI 10.1016/j.vaccine.2011.02.084; Ludtke CB, 2003, BRAZ J MICROBIOL, V34, P1, DOI 10.1590/S1517-83822003000500001; Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184; Matsunaga J, 2002, INFECT IMMUN, V70, P323, DOI 10.1128/IAI.70.1.323-334.2002; Matsunaga J, 2006, MICROBIOL-SGM, V152, P3777, DOI 10.1099/mic.0.29162-0; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; Mendes RS, 2011, INFECT IMMUN, V79, P4657, DOI 10.1128/IAI.05583-11; Murray GL, 2009, INFECT IMMUN, V77, P952, DOI 10.1128/IAI.01370-08; Nally JE, 2007, INFECT IMMUN, V75, P766, DOI 10.1128/IAI.00741-06; Nally JE, 2005, PROTEOMICS, V5, P144, DOI 10.1002/pmic.200400880; Nally JE, 2001, INFECT IMMUN, V69, P7616, DOI 10.1128/IAI.69.12.7616-7624.2001; Oliveira R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021962; Pinne M, 2011, JOVE-J VIS EXP, DOI 10.3791/2805; Pinne M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006071; Seixas FK, 2007, VACCINE, V26, P88, DOI 10.1016/j.vaccine.2007.10.052; Setubal JC, 2006, MICROBIOL-SGM, V152, P113, DOI 10.1099/mic.0.28317-0; SHANG ES, 1995, INFECT IMMUN, V63, P3174, DOI 10.1128/IAI.63.8.3174-3181.1995; Shang ES, 1996, INFECT IMMUN, V64, P2322, DOI 10.1128/IAI.64.6.2322-2330.1996; STADER J, 1988, J BACTERIOL, V170, P1973, DOI 10.1128/jb.170.4.1973-1974.1988; Trevejo RT, 1998, J INFECT DIS, V178, P1457, DOI 10.1086/314424; Tung JY, 2010, J BIOL CHEM, V285, P3245, DOI 10.1074/jbc.M109.006320; Vivian JP, 2009, J MOL BIOL, V387, P1229, DOI 10.1016/j.jmb.2009.02.038; WILSKE B, 1993, INFECT IMMUN, V61, P2182, DOI 10.1128/IAI.61.5.2182-2191.1993; ZUERNER RL, 1991, MICROB PATHOGENESIS, V10, P311, DOI 10.1016/0882-4010(91)90014-2	50	48	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e51025	10.1371/journal.pone.0051025	http://dx.doi.org/10.1371/journal.pone.0051025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23323152	gold, Green Published, Green Submitted			2022-12-25	WOS:000313429800006
J	Bai, Y; Wang, MY; Han, YH; Dou, SW; Lin, Q; Guo, Y; Li, W; Ding, DG; Dai, JP; Qin, W; Shi, DP; Tian, J; Dai, YM				Bai, Yan; Wang, Mei-Yun; Han, Yan-Hong; Dou, She-Wei; Lin, Qing; Guo, Ying; Li, Wei; Ding, De-Gang; Dai, Jian-Ping; Qin, Wei; Shi, Da-Peng; Tian, Jie; Dai, Yong-Ming			Susceptibility Weighted Imaging: A New Tool in the Diagnosis of Prostate Cancer and Detection of Prostatic Calcification	PLOS ONE			English	Article							GROWTH-FACTOR VEGF; CEREBRAL MICROBLEEDS; MR; BRAIN; INJURY; TUMOR; CT	Background: Susceptibility weighted imaging (SWI) is a new MRI technique which has been proved very useful in the diagnosis of brain diseases, but few study was performed on its value in prostatic diseases. The aim of the present study was to investigate the value of SWI in distinguishing prostate cancer from benign prostatic hyperplasia and detecting prostatic calcification. Methodology/Principal Findings: 23 patients with prostate cancer and 53 patients with benign prostatic hyperplasia proved by prostate biopsy were scanned on a 3.0T MR and a 16-row CT scanner. High-resolution SWI, conventional MRI and CT were performed on all patients. The MRI and CT findings, especially SWI, were analyzed and compared. The analyses revealed that 19 out of 23 patients with prostate cancer presented hemorrhage within tumor area on SWI. However, in 53 patients with benign prostatic hyperplasia, hemorrhage was detected only in 1 patient in prostate by SWI. When comparing SWI, conventional MRI and CT in detecting prostate cancer hemorrhage, out of the 19 patients with prostate cancer who had prostatic hemorrhage detected by SWI, the prostatic hemorrhage was detected in only 7 patients by using conventional MRI, and none was detected by CT. In addition, CT demonstrated calcifications in 22 patients which were all detected by SWI whereas only 3 were detected by conventional MRI. Compared to CT, SWI showed 100% in the diagnostic sensitivity, specificity, accuracy, positive predictive value(PPV) and negative predictive value(NPV) in detecting calcifications in prostate but conventional MRI demonstrated 13.6% in sensitivity, 100% in specificity, 75% in accuracy, 100% in PPV and 74% in NPV. Conclusions: More apparent prostate hemorrhages were detected on SWI than on conventional MRI or CT. SWI may provide valuable information for the differential diagnosis between prostate cancer and prostatic hyperplasia. Filtered phase images can identify prostatic calcifications as well as CT.	[Bai, Yan; Wang, Mei-Yun; Han, Yan-Hong; Dou, She-Wei; Lin, Qing; Guo, Ying; Li, Wei; Dai, Jian-Ping; Shi, Da-Peng] Henan Prov Peoples Hosp, Dept Radiol, Zhengzhou, Henan, Peoples R China; [Ding, De-Gang] Henan Prov Peoples Hosp, Dept Urinary Surg, Zhengzhou, Henan, Peoples R China; [Dai, Yong-Ming] Siemens Healthcare, MRI, Shanghai, Peoples R China; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China; [Li, Wei] Xidian Univ, Sch Sci & Technol, Life Sci Res Ctr, Xian, Shanxi, Peoples R China	Zhengzhou University; Zhengzhou University; Siemens AG; Chinese Academy of Sciences; Institute of Automation, CAS; Xidian University	Wang, MY (corresponding author), Henan Prov Peoples Hosp, Dept Radiol, Zhengzhou, Henan, Peoples R China.	meiyun9999@gmail.com; cjr.shidapeng@vip.163.com; tian@ieee.org	Tian, Jie/H-1190-2011; tian, jie/M-6336-2013	Tian, Jie/0000-0003-0498-0432; 	National Natural Science Foundation of China [81271565]; Distinguished Young Scholar in Scientific and Technical Innovation Foundation of Henan Province [124100510016]; Science and Technology Foundation of Public Health of Henan Province [201202018, 201003095]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Distinguished Young Scholar in Scientific and Technical Innovation Foundation of Henan Province; Science and Technology Foundation of Public Health of Henan Province	This study was supported by the National Natural Science Foundation of China under Grant Nos. 81271565, the Distinguished Young Scholar in Scientific and Technical Innovation Foundation of Henan Province under Grant No. 124100510016, and the Science and Technology Foundation of Public Health of Henan Province under Grant Nos. 201202018 and 201003095. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akter M, 2007, ACAD RADIOL, V14, P1011, DOI 10.1016/j.acra.2007.05.013; Al Sayyari A, 2010, AM J NEURORADIOL, V31, P1049, DOI 10.3174/ajnr.A2011; AVRAHAMI E, 1994, J NEUROL, V241, P381, DOI 10.1007/BF02033355; Barth PJ, 1996, HUM PATHOL, V27, P1306, DOI 10.1016/S0046-8177(96)90342-1; CARTER HB, 1991, RADIOLOGY, V178, P523, DOI 10.1148/radiology.178.2.1987620; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gao TL, 2008, NEUROL RES, V30, P272, DOI 10.1179/016164107X251556; Geramoutsos L, 2004, EUR UROL, V45, P333; Haacke EM, 2011, J MAGN RESON IMAGING, V33, P1527, DOI 10.1002/jmri.22578; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Ikonen S, 2001, ACTA RADIOL, V42, P348, DOI 10.1034/j.1600-0455.2001.420402.x; INABA T, 1992, J UROLOGY, V148, P1457, DOI 10.1016/S0022-5347(17)36939-2; Kim JK, 2009, KOREAN J RADIOL, V10, P535, DOI 10.3348/kjr.2009.10.6.535; Kim WB, 2011, UROLOGY, V78, P447, DOI 10.1016/j.urology.2010.12.056; KUCHARCZYK W, 1994, AM J NEURORADIOL, V15, P1145; Li H, 2006, AM J ROENTGENOL, V186, P729, DOI 10.2214/AJR.04.0775; Ling MT, 2005, CARCINOGENESIS, V26, P1668, DOI 10.1093/carcin/bgi128; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Nandigam RNK, 2009, AM J NEURORADIOL, V30, P338, DOI 10.3174/ajnr.A1355; Park MJ, 2009, AM J NEURORADIOL, V30, P1402, DOI 10.3174/ajnr.A1593; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; Santhosh K, 2009, CLIN RADIOL, V64, P74, DOI 10.1016/j.crad.2008.04.022; Stefanou D, 2004, IN VIVO, V18, P155; Tang J, 2013, MAGN RESON MED, V69, P1396, DOI 10.1002/mrm.24384; Tempany C, 2008, J MAGN RESON IMAGING, V27, P356, DOI 10.1002/jmri.21259; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; TSUCHIYA K, 1993, NEURORADIOLOGY, V35, P341, DOI 10.1007/BF00588364; Wang MY, 2011, MAGN RESON IMAGING, V29, P365, DOI 10.1016/j.mri.2010.10.016; Wu Z, 2009, J MAGN RESON IMAGING, V29, P177, DOI 10.1002/jmri.21617; Yang J, 2006, ASIAN J ANDROL, V8, P169, DOI 10.1111/j.1745-7262.2006.00120.x; Zhu WZ, 2008, CHINESE MED J-PEKING, V121, P2021, DOI 10.1097/00029330-200810020-00014	31	34	39	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53237	10.1371/journal.pone.0053237	http://dx.doi.org/10.1371/journal.pone.0053237			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308170	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429100044
J	Cui, XL; Witalison, EE; Chumanevich, AP; Chumanevich, AA; Poudyal, D; Subramanian, V; Schetter, AJ; Harris, CC; Thompson, PR; Hofseth, LJ				Cui, Xiangli; Witalison, Erin E.; Chumanevich, Alena P.; Chumanevich, Alexander A.; Poudyal, Deepak; Subramanian, Venkataraman; Schetter, Aaron J.; Harris, Curtis C.; Thompson, Paul R.; Hofseth, Lorne J.			The Induction of microRNA-16 in Colon Cancer Cells by Protein Arginine Deiminase Inhibition Causes a p53-Dependent Cell Cycle Arrest	PLOS ONE			English	Article							PEPTIDYLARGININE DEIMINASE; GENE-EXPRESSION; DOWN-REGULATION; MIR-16 FAMILY; ULCERATIVE-COLITIS; PAD4; P53; SUPPRESSION; CITRULLINATION; INACTIVATORS	Protein Arginine Deiminases (PADs) catalyze the post-translational conversion of peptidyl-Arginine to peptidyl-Citrulline in a calcium-dependent, irreversible reaction. Evidence is emerging that PADs play a role in carcinogenesis. To determine the cancer-associated functional implications of PADs, we designed a small molecule PAD inhibitor (called Chor-amidine or Cl-amidine), and tested the impact of this drug on the cell cycle. Data derived from experiments in colon cancer cells indicate that Cl-amidine causes a G1 arrest, and that this was p53-dependent. In a separate set of experiments, we found that Cl-amidine caused a significant increase in microRNA-16 (miRNA-16), and that this increase was also p53-dependent. Because miRNA-16 is a putative tumor suppressor miRNA, and others have found that miRNA-16 suppresses proliferation, we hypothesized that the p53-dependent G1 arrest associated with PAD inhibition was, in turn, dependent on miRNA-16 expression. Results are consistent with this hypothesis. As well, we found the G1 arrest is at least in part due to the ability of Cl-amidine-mediated expression of miRNA-16 to suppress its' G1-associated targets: cyclins D1, D2, D3, E1, and cdk6. Our study sheds light into the mechanisms by which PAD inhibition can protect against or treat colon cancer.	[Cui, Xiangli; Witalison, Erin E.; Chumanevich, Alena P.; Chumanevich, Alexander A.; Poudyal, Deepak; Hofseth, Lorne J.] Univ S Carolina, S Carolina Coll Pharm, Dept Drug Discovery & Biomed Sci, Columbia, SC 29208 USA; [Subramanian, Venkataraman; Thompson, Paul R.] Scripps Florida, Scripps Res Inst, Dept Chem, Jupiter, FL USA; [Schetter, Aaron J.; Harris, Curtis C.] NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Scripps Research Institute; State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hofseth, LJ (corresponding author), Univ S Carolina, S Carolina Coll Pharm, Dept Drug Discovery & Biomed Sci, Columbia, SC 29208 USA.	hofseth@cop.sc.edu			National Institutes of Health [5R01CA151304]; NATIONAL CANCER INSTITUTE [R01CA151304, ZIABC011496] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [P01AT003961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079357] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the following grants: National Institutes of Health grant 5R01CA151304 to LJH and PRT (http://projectreporter.nih.gov/reporter_searchresults.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan A, 2010, EXP CELL RES, V316, P3512, DOI 10.1016/j.yexcr.2010.07.007; Bandi N, 2009, CANCER RES, V69, P5553, DOI 10.1158/0008-5472.CAN-08-4277; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Biggar KK, 2012, CELL CYCLE, V11, P1705, DOI 10.4161/cc.19790; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Cai CK, 2012, ONCOL REP, V28, P1764, DOI 10.3892/or.2012.1995; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Causey CP, 2008, TETRAHEDRON LETT, V49, P4383, DOI 10.1016/j.tetlet.2008.05.021; Chang XT, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-40; Chang XT, 2006, MOL CARCINOGEN, V45, P183, DOI 10.1002/mc.20169; Chen C, 2008, CANCER EPIDEM BIOMAR, V17, P2152, DOI 10.1158/1055-9965.EPI-07-2893; Cherrington BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041242; Chumanevich AA, 2011, AM J PHYSIOL-GASTR L, V300, pG929, DOI 10.1152/ajpgi.00435.2010; Chumanevich AA, 2010, CARCINOGENESIS, V31, P1787, DOI 10.1093/carcin/bgq158; Cui XL, 2010, CANCER PREV RES, V3, P549, DOI 10.1158/1940-6207.CAPR-09-0117; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; FUJISAKI M, 1981, J BIOCHEM, V89, P257, DOI 10.1093/oxfordjournals.jbchem.a133189; Guo CJ, 2009, APOPTOSIS, V14, P1331, DOI 10.1007/s10495-009-0401-3; Guo Q, 2011, J BIOL CHEM, V286, P17069, DOI 10.1074/jbc.M111.230961; Jones JE, 2009, CURR OPIN DRUG DISC, V12, P616; Katsanos KH, 2007, DIGESTION, V75, P113, DOI 10.1159/000104731; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; Knuckley B, 2010, BIOCHEMISTRY-US, V49, P4852, DOI 10.1021/bi100363t; LENNARDJONES JE, 1983, LANCET, V2, P149, DOI 10.1016/S0140-6736(83)90129-0; Lerner M, 2009, EXP CELL RES, V315, P2941, DOI 10.1016/j.yexcr.2009.07.001; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li P, 2010, ONCOGENE, V29, P3153, DOI 10.1038/onc.2010.51; Li PX, 2008, MOL CELL BIOL, V28, P4745, DOI 10.1128/MCB.01747-07; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Luo Y, 2006, BIOCHEMISTRY-US, V45, P11727, DOI 10.1021/bi061180d; Makrygiannakis D, 2006, ANN RHEUM DIS, V65, P1219, DOI 10.1136/ard.2005.049403; Mohanan S, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/895343; Ofir M, 2011, MOL CANCER RES, V9, P440, DOI 10.1158/1541-7786.MCR-10-0344; Porkka KP, 2011, GENE CHROMOSOME CANC, V50, P499, DOI 10.1002/gcc.20873; Pothof J, 2009, EMBO J, V28, P2090, DOI 10.1038/emboj.2009.156; RANSOHOFF DF, 1988, GASTROENTEROLOGY, V94, P1089, DOI 10.1016/0016-5085(88)90573-2; Rissland OS, 2011, MOL CELL, V43, P993, DOI 10.1016/j.molcel.2011.08.021; Rivas MA, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3187; Slack JL, 2011, CELL MOL LIFE SCI, V68, P709, DOI 10.1007/s00018-010-0480-x; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Takeshita F, 2010, MOL THER, V18, P181, DOI 10.1038/mt.2009.207; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Wang F, 2009, BMB REP, V42, P725, DOI 10.5483/BMBRep.2009.42.11.725; Wang KH, 2011, J BIOL CHEM, V286, P9468, DOI 10.1074/jbc.M110.178335; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Wu G, 2011, BRIT J CANCER, V105, P146, DOI 10.1038/bjc.2011.190; Wu WKK, 2011, CARCINOGENESIS, V32, P247, DOI 10.1093/carcin/bgq243; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546; Ying L, 2007, CANCER RES, V67, P9286, DOI 10.1158/0008-5472.CAN-07-2238; Young LE, 2012, MOL CANCER RES, V10, P167, DOI 10.1158/1541-7786.MCR-11-0337	52	30	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53791	10.1371/journal.pone.0053791	http://dx.doi.org/10.1371/journal.pone.0053791			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308284	Green Published, gold			2022-12-25	WOS:000313429100116
J	Lefebvre, R; Legrand, C; Groom, L; Dirksen, RT; Jacquemond, V				Lefebvre, Romain; Legrand, Claude; Groom, Linda; Dirksen, Robert T.; Jacquemond, Vincent			Ca2+ Release in Muscle Fibers Expressing R4892W and G4896V Type 1 Ryanodine Receptor Disease Mutants	PLOS ONE			English	Article							CENTRAL CORE DISEASE; PORE-FORMING SEGMENT; SKELETAL-MUSCLE; MALIGNANT HYPERTHERMIA; CALCIUM HOMEOSTASIS; CHANNEL FUNCTION; ION PERMEATION; MUTATIONS; MOUSE; RYR1	The large and rapidly increasing number of potentially pathological mutants in the type 1 ryanodine receptor (RyR1) prompts the need to characterize their effects on voltage-activated sarcoplasmic reticulum (SR) Ca2+ release in skeletal muscle. Here we evaluated the function of the R4892W and G4896V RyR1 mutants, both associated with central core disease (CCD) in humans, in myotubes and in adult muscle fibers. For both mutants expressed in RyR1-null (dyspedic) myotubes, voltage-gated Ca2+ release was absent following homotypic expression and only partially restored following heterotypic expression with wild-type (WT) RyR1. In muscle fibers from adult WT mice, both mutants were expressed in restricted regions of the fibers with a pattern consistent with triadic localization. Voltage-clamp-activated confocal Ca2+ signals showed that fiber regions endowed with G4896V-RyR1s exhibited an similar to 30% reduction in the peak rate of SR Ca2+ release, with no significant change in SR Ca2+ content. Immunostaining revealed no associated change in the expression of either alpha 1S subunit (Cav1.1) of the dihydropyridine receptor (DHPR) or type 1 sarco(endo) plasmic reticulum Ca2+ ATPase (SERCA1), indicating that the reduced Ca2+ release resulted from defective RyR1 function. Interestingly, in spite of robust localized junctional expression, the R4892W mutant did not affect SR Ca2+ release in adult muscle fibers, consistent with a low functional penetrance of this particular CCD-associated mutant.	[Lefebvre, Romain; Legrand, Claude; Jacquemond, Vincent] Univ Lyon 1, CNRS UMR 5534, Ctr Genet & Physiol Mol & Cellulaire, F-69622 Villeurbanne, France; [Groom, Linda; Dirksen, Robert T.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Rochester	Jacquemond, V (corresponding author), Univ Lyon 1, CNRS UMR 5534, Ctr Genet & Physiol Mol & Cellulaire, F-69622 Villeurbanne, France.	vincent.jacquemond@univ-lyon1.fr		Jacquemond, Vincent/0000-0003-4944-270X	Centre National de la Recherche Scientifique (CNRS), Universite Lyon 1; Association Francaise contre les Myopathies (AFM); NIH [AR055349]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053349] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique (CNRS), Universite Lyon 1; Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from Centre National de la Recherche Scientifique (CNRS), Universite Lyon 1, Association Francaise contre les Myopathies (AFM) and NIH (AR055349 to R. T. D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila G, 2003, J GEN PHYSIOL, V121, P277, DOI 10.1085/jgp.200308791; Avila G, 2001, P NATL ACAD SCI USA, V98, P4215, DOI 10.1073/pnas.071048198; Avila G, 2001, J GEN PHYSIOL, V118, P277, DOI 10.1085/jgp.118.3.277; Balshaw D, 1999, P NATL ACAD SCI USA, V96, P3345, DOI 10.1073/pnas.96.7.3345; Boncompagni S, 2010, AGING CELL, V9, P958, DOI 10.1111/j.1474-9726.2010.00623.x; Boncompagni S, 2009, P NATL ACAD SCI USA, V106, P21996, DOI 10.1073/pnas.0911496106; Chelu MG, 2006, FASEB J, V20, P329, DOI 10.1096/fj.05-4497fje; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Collet C, 2004, CELL BIOCHEM BIOPHYS, V40, P225, DOI 10.1385/CBB:40:2:225; Dirksen RT, 2004, BIOPHYS J, V87, P3193, DOI 10.1529/biophysj.104.049447; Du GG, 2004, BIOCHEM J, V382, P557, DOI 10.1042/BJ20040580; Ducreux S, 2004, J BIOL CHEM, V279, P43838, DOI 10.1074/jbc.M403612200; Gao L, 2000, BIOPHYS J, V79, P828, DOI 10.1016/S0006-3495(00)76339-9; Jacquemond V, 1997, BIOPHYS J, V73, P920, DOI 10.1016/S0006-3495(97)78124-4; Jungbluth H, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-25; Kimura T, 2009, CELL CALCIUM, V45, P264, DOI 10.1016/j.ceca.2008.11.005; Kossugue PM, 2007, MUSCLE NERVE, V35, P670, DOI 10.1002/mus.20715; Lefebvre R, 2011, J PHYSIOL-LONDON, V589, P5361, DOI 10.1113/jphysiol.2011.216408; Legrand C, 2008, J PHYSIOL-LONDON, V586, P441, DOI 10.1113/jphysiol.2007.145862; Loy RE, 2011, J GEN PHYSIOL, V137, P43, DOI 10.1085/jgp.201010523; Lyfenko AD, 2004, BIOCHEM BIOPH RES CO, V322, P1256, DOI 10.1016/j.bbrc.2004.08.031; Lynch PJ, 1999, P NATL ACAD SCI USA, V96, P4164, DOI 10.1073/pnas.96.7.4164; Monnier N, 2001, HUM MOL GENET, V10, P2581, DOI 10.1093/hmg/10.22.2581; Muntoni F, 2003, BRAIN, V126, P2339, DOI 10.1093/brain/awg288; Pouvreau S, 2006, BIOPHYS J, V91, P2206, DOI 10.1529/biophysj.105.078089; Ramachandran S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000367; Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356; Rosenberg H, 2010, GENE REV; Treves S, 2005, NEUROMUSCULAR DISORD, V15, P577, DOI 10.1016/j.nmd.2005.06.008; Treves S, 2008, CURR OPIN PHARMACOL, V8, P319, DOI 10.1016/j.coph.2008.01.005; Vega AV, 2011, J PHYSIOL-LONDON, V589, P4649, DOI 10.1113/jphysiol.2011.210765; Wang Y, 2005, BIOPHYS J, V89, P256, DOI 10.1529/biophysj.104.056002; Weiss N, 2010, J PHYSIOL-LONDON, V588, P2945, DOI 10.1113/jphysiol.2010.191593; Xu L, 2008, J BIOL CHEM, V283, P6321, DOI 10.1074/jbc.M707353200; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971; Zvaritch E, 2007, P NATL ACAD SCI USA, V104, P18537, DOI 10.1073/pnas.0709312104; Zvaritch E, 2009, P NATL ACAD SCI USA, V106, P21813, DOI 10.1073/pnas.0912126106	37	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e54042	10.1371/journal.pone.0054042	http://dx.doi.org/10.1371/journal.pone.0054042			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308296	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429100127
J	Mizrahi-Man, O; Davenport, ER; Gilad, Y				Mizrahi-Man, Orna; Davenport, Emily R.; Gilad, Yoav			Taxonomic Classification of Bacterial 16S rRNA Genes Using Short Sequencing Reads: Evaluation of Effective Study Designs	PLOS ONE			English	Article							HUMAN GUT MICROBIOME; SPECIES LIVING TREE; PAIRED-END; COMMUNITY; DIVERSITY; PROJECT; TOOLS; GENERATION; PRIMERS; SEARCH	Massively parallel high throughput sequencing technologies allow us to interrogate the microbial composition of biological samples at unprecedented resolution. The typical approach is to perform high-throughout sequencing of 16S rRNA genes, which are then taxonomically classified based on similarity to known sequences in existing databases. Current technologies cause a predicament though, because although they enable deep coverage of samples, they are limited in the length of sequence they can produce. As a result, high-throughout studies of microbial communities often do not sequence the entire 16S rRNA gene. The challenge is to obtain reliable representation of bacterial communities through taxonomic classification of short 16S rRNA gene sequences. In this study we explored properties of different study designs and developed specific recommendations for effective use of short-read sequencing technologies for the purpose of interrogating bacterial communities, with a focus on classification using naive Bayesian classifiers. To assess precision and coverage of each design, we used a collection of similar to 8,500 manually curated 16S rRNA gene sequences from cultured bacteria and a set of over one million bacterial 16S rRNA gene sequences retrieved from environmental samples, respectively. We also tested different configurations of taxonomic classification approaches using short read sequencing data, and provide recommendations for optimal choice of the relevant parameters. We conclude that with a judicious selection of the sequenced region and the corresponding choice of a suitable training set for taxonomic classification, it is possible to explore bacterial communities at great depth using current technologies, with only a minimal loss of taxonomic resolution.	[Mizrahi-Man, Orna; Davenport, Emily R.; Gilad, Yoav] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago	Gilad, Y (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	gilad@uchicago.edu		Davenport, Emily R./0000-0002-6938-4933	NIH [HL092206]; DDRC grant (Digestive Diseases Research Core Center); DDRCC;  [P30DK42086]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DDRC grant (Digestive Diseases Research Core Center); DDRCC; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grant HL092206 to YG, and by a pilot and feasibility DDRC grant (Digestive Diseases Research Core Center) to YG, funded by P30DK42086. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank members of the Gilad lab for helpful discussions and C. Ober and Z. Gauhar for comments on the manuscript. This work was supported by NIH grant HL092206 to YG, and by a pilot and feasibility DDRCC grant to YG, funded by P30DK42086.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Charlson ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042786; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Degnan PH, 2012, ISME J, V6, P183, DOI 10.1038/ismej.2011.74; DeSantis Todd Z., 2011, BMC Ecology, V11, P11, DOI 10.1186/1472-6785-11-11; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fagen Jennie R, 2012, Open Microbiol J, V6, P29, DOI 10.2174/1874285801206010029; Finkel OM, 2011, APPL ENVIRON MICROB, V77, P7647, DOI 10.1128/AEM.05565-11; Garrity GM, 2007, TAXONOMIC OUTLINE BA; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P3132, DOI 10.1111/j.1462-2920.2009.02017.x; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Hackl E, 2004, APPL ENVIRON MICROB, V70, P5057, DOI 10.1128/AEM.70.9.5057-5065.2004; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Hummelen R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026602; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Kohler T, 2012, APPL ENVIRON MICROB, V78, P4691, DOI 10.1128/AEM.00683-12; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Munoz R, 2011, SYST APPL MICROBIOL, V34, P169, DOI 10.1016/j.syapm.2011.03.001; Nakayama J, 2011, FEMS IMMUNOL MED MIC, V63, P397, DOI 10.1111/j.1574-695X.2011.00872.x; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shepherd ML, 2012, FEMS MICROBIOL LETT, V326, P62, DOI 10.1111/j.1574-6968.2011.02434.x; Soergel DAW, 2012, ISME J; Sundquist A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-108; Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109; Werner JJ, 2012, ISME J, V6, P1273, DOI 10.1038/ismej.2011.186; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09; Zhang XJ, 2011, APPL MICROBIOL BIOT, V91, P425, DOI 10.1007/s00253-011-3296-1	52	192	199	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53608	10.1371/journal.pone.0053608	http://dx.doi.org/10.1371/journal.pone.0053608			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308262	Green Published, gold, Green Submitted			2022-12-25	WOS:000313429100095
J	Zhang, J; Yang, JM; Wang, HJ; Ru, GQ; Fan, DM				Zhang, Jun; Yang, Jian-min; Wang, Hui-ju; Ru, Guo-qing; Fan, Dai-ming			Synthesized Multiple Antigenic Polypeptide Vaccine Based on B-Cell Epitopes of Human Heparanase Could Elicit a Potent Antimetastatic Effect on Human Hepatocellular Carcinoma In Vivo (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							CANCER METASTASIS; GROWTH-FACTOR; SULFATE; ANGIOGENESIS; IDENTIFICATION; MIMETICS; INVASION; TRENDS; LINE	Aims: The aim of this study was to investigate the antimetastatic effect of multiple antigenic polypeptide (MAP) vaccine based on B-cell epitopes of heparanase (HPSE) on human hepatocellular carcinoma (HCC) in vivo. Methods: The antiserum against B-cell epitopes of HPSE was isolated, purified and characterized after immunizing white-hair-black-eye (WHBY) rabbit with freshly synthesized MAP vaccine. Tumor-bearing murine models of orthotopic implants using HCC-97H cell line were built in BALB/c nude mice. Anti-MAP polyclonal antibodies induced by MAP vaccine were administrated to the models. The impact on metastasis was assessed, the expressions of VEGF/bFGF in hepatoma tissues and in murine sera were evaluated, and the micro-vessel density (MVD) was counted as well. In addition, the possible impairments of the HPSE MAP vaccine on certain HPSE positive normal organs and blood cells were investigated. Results: The antiserum was harvested, purified and identified. The antibodies induced by MAP vaccine could specifically react with the dominant epitopes of both precursor protein and large subunit monomer of HPSE, markedly decrease HPSE activity, suppress the expressions of both VEGF and bFGF, and reduce the MVD. Pulmonary metastasis was also attenuated significantly by the anti-MAP polyclonal antibodies. In addition, no obvious impairment could be observed in certain HPSE positive organs and cells. Conclusion: MAP vaccine based on B-cell epitopes of HPSE is capable of alleviating HCC metastasis in vivo, mainly through inhibiting the HPSE activity and tumor associated angiogenesis, by virtue of the specific anti-MAP polyclonal antibodies. Furthermore, these HPSE-specific antibodies do not cause obvious abnormalities on certain HPSE positive blood cells and organs. Our study provides theoretical evidences for the clinical use of the synthesized MAP vaccine based on B-cell epitopes of HPSE in preventing HCC metastasis.	[Zhang, Jun; Fan, Dai-ming] Fourth Mil Med Univ, State Key Lab Canc Biol, Xijing Hosp Digest Dis, Xian 710032, Shanxi Province, Peoples R China; [Zhang, Jun; Fan, Dai-ming] Fourth Mil Med Univ, Inst Digest Dis, Xijing Hosp Digest Dis, Xian 710032, Shanxi Province, Peoples R China; [Zhang, Jun; Yang, Jian-min] Zhejiang Prov Peoples Hosp, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China; [Wang, Hui-ju] Key Lab Gastroenterol Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Ru, Guo-qing] Zhejiang Prov Peoples Hosp, Dept Pathol, Hangzhou, Zhejiang, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Zhejiang Provincial People's Hospital; Zhejiang Provincial People's Hospital	Fan, DM (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, Xijing Hosp Digest Dis, Xian 710032, Shanxi Province, Peoples R China.	fandaim@fmmu.edu.cn			National Natural Science Foundation of China [30570816]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 30570816). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An FQ, 2000, J CANCER RES CLIN, V126, P153, DOI 10.1007/s004320050025; Chan A, 2007, ANN ONCOL, V18, P1152, DOI 10.1093/annonc/mdl476; Du Ling, 2008, Zhonghua Weishengwuxue He Mianyixue Zazhi, V28, P869; Ferrara N, 2001, AM J PHYSIOL-CELL PH, V280, pC1358, DOI 10.1152/ajpcell.2001.280.6.C1358; Ferro V, 2007, SEMIN THROMB HEMOST, V33, P557, DOI 10.1055/s-2007-982088; FIDLER IJ, 1994, CELL, V79, P185, DOI 10.1016/0092-8674(94)90187-2; Han Xiao-mei, 2009, Zhonghua Zhongliu Zazhi, V31, P10, DOI 10.3760/cma.j.issn.0253-3766.2009.01.003; Hao XS, 2003, EUR J CANCER PREV, V12, P273, DOI 10.1097/00008469-200308000-00006; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; KATZ M, 1981, INFECT IMMUN, V31, P1125, DOI 10.1128/IAI.31.3.1125-1131.1981; Levy-Adam F, 2005, J BIOL CHEM, V280, P20457, DOI 10.1074/jbc.M414546200; Levy-Adam F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002319; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; Liu Xiaobo, 1999, Journal of West China University of Medical Sciences, V30, P455; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; McKenzie EA, 2007, BRIT J PHARMACOL, V151, P1, DOI 10.1038/sj.bjp.0707182; Miao HQ, 2006, CURR MED CHEM, V13, P2101, DOI 10.2174/092986706777935230; Nasser NJ, 2009, P NATL ACAD SCI USA, V106, P2253, DOI 10.1073/pnas.0812846106; Poon RT, 2011, ANN SURG, V233, P227; Roy M, 2009, J CELL BIOCHEM, V106, P200, DOI 10.1002/jcb.22005; Sawai H, 2008, J SURG RES, V144, P117, DOI 10.1016/j.jss.2007.03.023; Schutte K, 2009, DIGEST DIS, V27, P80, DOI 10.1159/000218339; Shen FG, 2011, J ANHUI AGR SCI, V20, P12264; Shen KK, 2011, J BIOCHEM, V150, P189, DOI 10.1093/jb/mvr060; Sommerfeldt N, 2006, CANCER RES, V66, P7716, DOI 10.1158/0008-5472.CAN-05-2363; Tang ZY, 2004, J CANCER RES CLIN, V130, P187, DOI 10.1007/s00432-003-0511-1; Tian J, 1999, BRIT J CANCER, V81, P814, DOI 10.1038/sj.bjc.6690769; Uchino K, 2011, CANCER-AM CANCER SOC, V117, P4475, DOI 10.1002/cncr.25960; Vlodavsky I, 2002, SEMIN CANCER BIOL, V12, P121, DOI 10.1006/scbi.2001.0420; Vlodavsky I, 2008, CONNECT TISSUE RES, V49, P207, DOI 10.1080/03008200802143281; Vlodavsky I, 2007, CURR PHARM DESIGN, V13, P2057; WEIDNER N, 1995, AM J PATHOL, V147, P9; Xu YZ, 2011, ENDOCRINE, V40, P445, DOI 10.1007/s12020-011-9502-1; Yang JM, 2009, CANCER IMMUNOL IMMUN, V58, P1387, DOI 10.1007/s00262-008-0651-x; Zarour HM, 2011, EUR J IMMUNOL, V41, P1510, DOI 10.1002/eji.201190035; Zhao HJ, 2006, CANCER RES, V66, P8779, DOI 10.1158/0008-5472.CAN-06-1382	37	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e52940	10.1371/journal.pone.0052940	http://dx.doi.org/10.1371/journal.pone.0052940			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308126	Green Published, gold, Green Submitted			2022-12-25	WOS:000313429100021
J	Egli, A; Schafer, J; Osthoff, M; Thiel, S; Mikkelsen, C; Rauch, A; Hirsch, HH; Bucher, HC; Young, J; Jensenius, JC; Battegay, M; Trendelenburg, M				Egli, Adrian; Schaefer, Juliane; Osthoff, Michael; Thiel, Steffen; Mikkelsen, Christina; Rauch, Andri; Hirsch, Hans H.; Bucher, Heiner C.; Young, James; Jensenius, Jens C.; Battegay, Manuel; Trendelenburg, Marten		Swiss HIV Cohort Study	Low Levels of Mannan-Binding Lectin or Ficolins Are Not Associated with an Increased Risk of Cytomegalovirus Disease in HIV-Infected Patients	PLOS ONE			English	Article							GENE POLYMORPHISMS; COMPLEMENT PATHWAY; IMMUNE REGULATION; CMV DISEASE; VIRUS; PROTEIN; DEFICIENCY; TRANSPLANT; RETINITIS; MBL2	Background: In HIV-infected patients, prediction of Cytomegalovirus (CMV) disease remains difficult. A protective role of mannan-binding lectin (MBL) and ficolins against CMV disease has been reported after transplantation, but the impact in HIV-infected patients is unclear. Methods: In a case-control study nested within the Swiss HIV Cohort Study, we investigated associations between plasma levels of MBL/ficolins and CMV disease. We compared HIV-infected patients with CMV disease (cases) to CMV-seropositive patients without CMV disease (controls) matched for CD4 T-cells, sampling time, and use of combination antiretroviral therapy. MBL and M-ficolin, L-ficolin, and H-ficolin were quantified using ELISA. Results: We analysed 105 cases and 105 matched controls. CMV disease was neither associated with MBL (odds ratio [OR] 1.03 per log(10) ng/mL increase (95% CI 0.73-1.45)) nor with ficolins (OR per log(10) ng/mL increase 0.66 (95% CI 0.28-1.52), 2.34 (95% CI 0.44-12.36), and 0.89 (95% CI 0.26-3.03) for M-ficolin, L-ficolin, and H-ficolin, respectively). We found no evidence of a greater association between MBL and CMV disease in patients with low CD4 counts; however in the multivariable analysis, CMV disease was more likely in patients with an increased HIV RNA (OR 1.53 per log(10) copies/mL; 95% CI 1.08-2.16), or a shorter duration of HIV-infection (OR 0.91 per year; 95% CI 0.84-0.98). Conclusions: CMV disease is not associated with low levels of MBL/ficolins, suggesting a lack of a protective role in HIV-infected patients.	[Egli, Adrian; Hirsch, Hans H.; Battegay, Manuel] Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, CH-4031 Basel, Switzerland; [Egli, Adrian; Osthoff, Michael; Trendelenburg, Marten] Univ Basel, Dept Biomed, Clin Immunol Lab, Basel, Switzerland; [Schaefer, Juliane; Bucher, Heiner C.; Young, James] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland; [Thiel, Steffen; Mikkelsen, Christina; Jensenius, Jens C.] Univ Aarhus, Dept Biomed, Aarhus, Denmark; [Rauch, Andri] Univ Hosp Bern, Div Infect Dis, CH-3010 Bern, Switzerland; [Rauch, Andri] Univ Bern, Bern, Switzerland; [Hirsch, Hans H.] Univ Basel, Inst Med Microbiol, Dept Biomed, Basel, Switzerland; [Trendelenburg, Marten] Univ Basel Hosp, Clin Internal Med, CH-4031 Basel, Switzerland	University of Basel; University of Basel; University of Basel; Aarhus University; University of Bern; University Hospital of Bern; University of Bern; University of Basel; University of Basel	Egli, A (corresponding author), Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, CH-4031 Basel, Switzerland.	aegli@ualberta.ca	Trendelenburg, Marten/AAM-1626-2020; Rauch, Andri/E-9948-2017; Pantaleo, Giuseppe/K-6163-2016	Trendelenburg, Marten/0000-0001-7036-8386; Rauch, Andri/0000-0001-5297-6062; Hirsch, Hans H./0000-0003-0883-0423; Thiel, Steffen/0000-0002-4817-155X; Young, Jim/0000-0002-4314-3007; Osthoff, Michael/0000-0001-5439-957X; Mikkelsen, Christina/0000-0002-2945-6197	framework of the Swiss HIV Cohort Study [637]; Swiss National Science Foundation [33CS30_134277]; Swiss National Foundation [3200B0-110040/1]; Astellas Foundation University Hospital of Basel; Novartis Jubilaumsstiftung; Santesuisse; Gottfried and Julia Bangerter-Rhyner-Foundation	framework of the Swiss HIV Cohort Study; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Astellas Foundation University Hospital of Basel; Novartis Jubilaumsstiftung(Novartis); Santesuisse; Gottfried and Julia Bangerter-Rhyner-Foundation	This study was supported by the framework of the Swiss HIV Cohort Study (project # 637), the Swiss National Science Foundation (grant # 33CS30_134277), and through grants from the Swiss National Foundation (grant # 3200B0-110040/1), from the Astellas Foundation University Hospital of Basel, and from the Novartis Jubilaumsstiftung to AE and MT. The Basel Institute for Clinical Epidemiology and Biostatistics is supported by grants from Santesuisse and from the Gottfried and Julia Bangerter-Rhyner-Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battegay M, 2006, LANCET INFECT DIS, V6, P280, DOI 10.1016/S1473-3099(06)70463-7; BENKO DM, 1986, J VIROL, V59, P703, DOI 10.1128/JVI.59.3.703-713.1986; Bouwman LH, 2005, GASTROENTEROLOGY, V129, P408, DOI 10.1053/j.gastro.2005.06.049; Brantsaeter AB, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-127; BRESLOW N, 1982, BIOMETRICS, V38, P661, DOI 10.2307/2530047; Bronke C, 2005, J INFECT DIS, V191, P873, DOI 10.1086/427828; Brown KS, 2010, PROTEIN CELL, V1, P664, DOI 10.1007/s13238-010-0088-9; Cervera C, 2009, TRANSPL P, V41, P2259, DOI 10.1016/j.transproceed.2009.06.056; Cervera C, 2007, TRANSPLANTATION, V83, P1493, DOI 10.1097/01.tp.0000264999.71318.2b; Chow SP, 2011, CLIN EXP OPHTHALMOL, V39, P871, DOI 10.1111/j.1442-9071.2011.02572.x; Cummings KL, 2007, VIRAL IMMUNOL, V20, P505, DOI 10.1089/vim.2007.0061; Cunha AA, 2011, REV INST MED TROP SP, V53, P83, DOI 10.1590/S0036-46652011000100005; de Rooij BJF, 2011, J HEPATOL, V55, P800, DOI 10.1016/j.jhep.2011.01.039; Deayton JR, 2000, SEX TRANSM INFECT, V76, P342, DOI 10.1136/sti.76.5.342; Egli A, 2008, TRANSPL INFECT DIS, V10, P27, DOI 10.1111/j.1399-3062.2007.00285.x; Egli A, 2012, CLIN INFECT DIS, V55, P1678, DOI 10.1093/cid/cis818; EZEKOWITZ RAB, 1989, J EXP MED, V169, P185, DOI 10.1084/jem.169.1.185; Fiane AE, 2005, EUR HEART J, V26, P1660, DOI 10.1093/eurheartj/ehi198; Gadjeva M, 2004, CLIN EXP IMMUNOL, V138, P304, DOI 10.1111/j.1365-2249.2004.02616.x; Gandhi MK, 2004, LANCET INFECT DIS, V4, P725, DOI 10.1016/S1473-3099(04)01202-2; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; GARRED P, 1992, CLIN EXP IMMUNOL, V90, P517; Garred P, 2009, MOL IMMUNOL, V46, P2737, DOI 10.1016/j.molimm.2009.05.005; Henckaerts L, 2009, CRIT CARE MED, V37, P192, DOI 10.1097/CCM.0b013e31819263d8; Herpers BL, 2009, CLIN EXP IMMUNOL, V156, P488, DOI 10.1111/j.1365-2249.2009.03929.x; Hu YZ, 2010, VIRAL IMMUNOL, V23, P443, DOI 10.1089/vim.2009.0109; Ip WKE, 2005, J INFECT DIS, V191, P1697, DOI 10.1086/429631; Jabs DA, 2011, AM J OPHTHALMOL, V151, P198, DOI 10.1016/j.ajo.2010.10.018; Jacobson MA, 2008, CLIN INFECT DIS, V46, P458, DOI 10.1086/525853; Jeon S, 2012, OPHTHALMOLOGY, V119, P1892, DOI 10.1016/j.ophtha.2012.03.032; Kase T, 1999, IMMUNOLOGY, V97, P385; Kwakkel-van Erp JM, 2011, CLIN EXP IMMUNOL, V165, P410, DOI 10.1111/j.1365-2249.2011.04436.x; Lachin JM, 2008, STAT MED, V27, P2509, DOI 10.1002/sim.3057; Liu Y, 2005, J IMMUNOL, V175, P3150, DOI 10.4049/jimmunol.175.5.3150; Ljungman P, 2002, CLIN INFECT DIS, V34, P1094, DOI 10.1086/339329; LUBIN JH, 1984, BIOMETRICS, V40, P63, DOI 10.2307/2530744; Manuel O, 2007, TRANSPLANTATION, V83, P359, DOI 10.1097/01.tp.0000251721.90688.c2; O'Brien KB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017377; Osthoff M, 2010, HAEMATOL-HEMATOL J, V95, P1389, DOI 10.3324/haematol.2009.017863; Perez-Castellano M, 2006, CLIN EXP IMMUNOL, V145, P228, DOI 10.1111/j.1365-2249.2006.03140.x; Sagedal S, 2008, NEPHROL DIAL TRANSPL, V23, P4054, DOI 10.1093/ndt/gfn355; Sarkar N, 2008, LATTICE MULTIVARIATE; Schoeni-Affolter F, 2010, INT J EPIDEMIOL, V39, P1179, DOI 10.1093/ije/dyp321; Seppanen M, 2009, HUM IMMUNOL, V70, P218, DOI 10.1016/j.humimm.2009.01.022; Singh KP, 2007, CLIN IMMUNOL, V124, P200, DOI 10.1016/j.clim.2007.04.018; Somnuke P, 2011, VIROLOGY, V413, P253, DOI 10.1016/j.virol.2011.02.022; Spiller OB, 1998, J INFECT DIS, V178, P1597, DOI 10.1086/314499; Stoermer KA, 2011, VIROLOGY, V411, P362, DOI 10.1016/j.virol.2010.12.045; SUPER M, 1992, NAT GENET, V2, P50, DOI 10.1038/ng0992-50; Szala A, 2011, MOL IMMUNOL, V48, P2203, DOI 10.1016/j.molimm.2011.06.220; TayKearney ML, 1997, J INFECT DIS, V176, P790, DOI 10.1086/517303; Thielens NM, 2002, IMMUNOBIOLOGY, V205, P563, DOI 10.1078/0171-2985-00155; Wittenborn T, 2010, J INNATE IMMUN, V2, P167, DOI 10.1159/000218324; Worthley DL, 2009, CLIN INFECT DIS, V48, P410, DOI 10.1086/596313; Wu W, 2012, APMIS, V120, P675, DOI 10.1111/j.1600-0463.2012.02880.x	55	8	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e51983	10.1371/journal.pone.0051983	http://dx.doi.org/10.1371/journal.pone.0051983			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308103	Green Published, gold, Green Submitted			2022-12-25	WOS:000313670100005
J	Le Coadic, M; Froquet, R; Lima, WC; Dias, M; Marchetti, A; Cosson, P				Le Coadic, Marion; Froquet, Romain; Lima, Wanessa C.; Dias, Marco; Marchetti, Anna; Cosson, Pierre			Phg1/TM9 Proteins Control Intracellular Killing of Bacteria by Determining Cellular Levels of the Kil1 Sulfotransferase in Dictyostelium	PLOS ONE			English	Article							MODEL HOST; ADHESION; DISCOIDEUM; PHAGOCYTOSIS	Dictyostelium discoideum has largely been used to study phagocytosis and intracellular killing of bacteria. Previous studies have shown that Phg1A, Kil1 and Kil2 proteins are necessary for efficient intracellular killing of Klebsiella bacteria. Here we show that in phg1a KO cells, cellular levels of lysosomal glycosidases and lysozyme are decreased, and lysosomal pH is increased. Surprisingly, overexpression of Kil1 restores efficient killing in phg1a KO cells without correcting these lysosomal anomalies. Conversely, kil1 KO cells are defective for killing, but their enzymatic content and lysosomal pH are indistinguishable from WT cells. The killing defect of phg1a KO cells can be accounted for by the observation that in these cells the stability and the cellular amount of Kil1 are markedly reduced. Since Kil1 is the only sulfotransferase characterized in Dictyostelium, an (unidentified) sulfated factor, defective in both phg1a and kil1 KO cells, may play a key role in intracellular killing of Klebsiella bacteria. In addition, Phg1B plays a redundant role with Phg1A in controlling cellular amounts of Kil1 and intracellular killing. Finally, cellular levels of Kil1 are unaffected in kil2 KO cells, and Kil1 overexpression does not correct the killing defect of kil2 KO cells, suggesting that Kil2 plays a distinct role in intracellular killing.	[Le Coadic, Marion; Froquet, Romain; Lima, Wanessa C.; Dias, Marco; Marchetti, Anna; Cosson, Pierre] Ctr Med Univ Geneva, Dept Cell Physiol & Metab, Geneva Fac Med, Geneva, Switzerland	University of Geneva	Cosson, P (corresponding author), Ctr Med Univ Geneva, Dept Cell Physiol & Metab, Geneva Fac Med, Geneva, Switzerland.	Pierre.Cosson@unige.ch		Le Coadic, Marion/0000-0003-4725-9610	Swiss National Science Foundation [31003A-135789]; Doerenkamp-Zbinden foundation; FENRIV foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Doerenkamp-Zbinden foundation; FENRIV foundation	This work was supported by grants from the Swiss National Science Foundation (31003A-135789 to P.C.) and from the Doerenkamp-Zbinden and the FENRIV foundations (E. Naef Fondation pour la recherche in vitro). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benghezal M, 2006, CELL MICROBIOL, V8, P139, DOI 10.1111/j.1462-5822.2005.00607.x; Benghezal M, 2003, MOL BIOL CELL, V14, P2890, DOI 10.1091/mbc.E02-11-0724; Bergeret E, 2008, J CELL SCI, V121, P3325, DOI 10.1242/jcs.030163; Bozzaro S, 2011, CURR DRUG TARGETS, V12, P942, DOI 10.2174/138945011795677782; Cornillon S, 2000, J BIOL CHEM, V275, P34287, DOI 10.1074/jbc.M006725200; Froquet R, 2008, J BIOL CHEM, V283, P6764, DOI 10.1074/jbc.M704484200; Froquet R, 2012, MOL BIOL CELL, V23, P679, DOI 10.1091/mbc.E11-04-0338; Froquet R, 2009, NAT PROTOC, V4, P25, DOI 10.1038/nprot.2008.212; Fukuda M, 2001, J BIOL CHEM, V276, P47747, DOI 10.1074/jbc.R100049200; Gopaldass N, 2012, TRAFFIC, V13, P120, DOI 10.1111/j.1600-0854.2011.01296.x; JACOBS T, 1995, EUR J BIOCHEM, V231, P831, DOI 10.1111/j.1432-1033.1995.0831d.x; Lelong E, 2011, CELL MICROBIOL, V13, P246, DOI 10.1111/j.1462-5822.2010.01532.x; Lozupone F, 2009, EMBO REP, V10, P1348, DOI 10.1038/embor.2009.236; Marchetti Anna, 2009, BMC Res Notes, V2, P7, DOI 10.1186/1756-0500-2-7; Markart P, 2004, AM J RESP CRIT CARE, V169, P454, DOI 10.1164/rccm.200305-669OC; Muller I, 2005, J BIOL CHEM, V280, P10435, DOI 10.1074/jbc.M411445200; Nakimbugwe D, 2006, FEMS MICROBIOL LETT, V259, P41, DOI 10.1111/j.1574-6968.2006.00240.x	17	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53259	10.1371/journal.pone.0053259	http://dx.doi.org/10.1371/journal.pone.0053259			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301051	Green Submitted, Green Published, gold			2022-12-25	WOS:000313320900071
J	Ravilious, GE; Westfall, CS; Jez, JM				Ravilious, Geoffrey E.; Westfall, Corey S.; Jez, Joseph M.			Redox-linked Gating of Nucleotide Binding by the N-terminal Domain of Adenosine 5 '-Phosphosulfate Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-INHIBITION; ADENOSINE-5'-PHOSPHOSULFATE KINASE; PENICILLIUM-CHRYSOGENUM; ESCHERICHIA-COLI; APS-KINASE; ARABIDOPSIS-THALIANA; SULFUR ASSIMILATION; ATP SULFURYLASE; SULFATE ASSIMILATION; CRYSTAL-STRUCTURE	Adenosine 5'-phosphosulfate kinase (APSK) catalyzes the phosphorylation of adenosine 5'-phosphosulfate (APS) to 3'-phosphoadenosine-5'-phosphosulfate (PAPS). Crystallographic studies of APSK from Arabidopsis thaliana revealed the presence of a regulatory intersubunit disulfide bond (Cys(86)Cys(119)). The reduced enzyme displayed improved catalytic efficiency and decreased effectiveness of substrate inhibition by APS compared with the oxidized form. Here we examine the effect of disulfide formation and the role of the N-terminal domain on nucleotide binding using isothermal titration calorimetry (ITC) and steady-state kinetics. Formation of the disulfide bond in A. thaliana APSK (AtAPSK) inverts the binding affinities at the ATP/ADP and APS/PAPS sites from those observed in the reduced enzyme, consistent with initial binding of APS as inhibitory, and suggests a role for the N-terminal domain in guiding nucleotide binding order. To test this, an N-terminal truncation variant (AtAPSK Delta 96) was generated. The resulting protein was completely insensitive to substrate inhibition by APS. ITC analysis of AtAPSK Delta 96 showed decreased affinity for APS binding, although the N-terminal domain does not directly interact with this ligand. Moreover, AtAPSK Delta 96 displayed reduced affinity for ADP, which corresponds to a loss of substrate inhibition by formation of an E.ADP.APS dead end complex. Examination of the AtAPSK crystal structure suggested Arg(93) as important for positioning of the N-terminal domain. ITC and kinetic analysis of the R93A mutant also showed a complete loss of substrate inhibition and altered nucleotide binding affinities, which mimics the effect of the N-terminal deletion. These results show how thiol-linked changes in AtAPSK alter the energetics of binding equilibria to control its activity.	[Ravilious, Geoffrey E.; Westfall, Corey S.; Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Jez, JM (corresponding author), Washington Univ, Dept Biol, 1 Brookings Dr,Campus Box 1137, St Louis, MO 63130 USA.	jjez@biology2.wustl.edu			National Science Foundation [MCB-0904215]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB-0904215.	Amano Y, 2007, P NATL ACAD SCI USA, V104, P18333, DOI 10.1073/pnas.0706403104; Barford D, 2004, CURR OPIN STRUC BIOL, V14, P679, DOI 10.1016/j.sbi.2004.09.012; Gay SC, 2009, ACTA CRYSTALLOGR D, V65, P1021, DOI 10.1107/S0907444909026547; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Klein M, 2004, J EXP BOT, V55, P1809, DOI 10.1093/jxb/erh183; Lansdon EB, 2002, BIOCHEMISTRY-US, V41, P13672, DOI 10.1021/bi026556b; LIANG P, 1991, PROTEINS, V9, P28, DOI 10.1002/prot.340090105; Lillig CH, 2001, ARCH BIOCHEM BIOPHYS, V392, P303, DOI 10.1006/abbi.2001.2453; MacRae IJ, 2000, BIOCHEMISTRY-US, V39, P1613, DOI 10.1021/bi9924157; MacRae IJ, 1999, ARCH BIOCHEM BIOPHYS, V361, P277, DOI 10.1006/abbi.1998.0993; Marzluf GA, 1997, ANNU REV MICROBIOL, V51, P73, DOI 10.1146/annurev.micro.51.1.73; Mugford SG, 2010, FEBS LETT, V584, P119, DOI 10.1016/j.febslet.2009.11.014; Mugford SG, 2009, PLANT CELL, V21, P910, DOI 10.1105/tpc.109.065581; Paget MSB, 2003, ANNU REV GENET, V37, P91, DOI 10.1146/annurev.genet.37.110801.142538; Patron NJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-39; Phartiyal P, 2006, ARCH BIOCHEM BIOPHYS, V450, P20, DOI 10.1016/j.abb.2006.03.033; Ravilious GE, 2012, NAT PROD REP, V29, P1138, DOI 10.1039/c2np20009k; Ravilious GE, 2012, J BIOL CHEM, V287, P30385, DOI 10.1074/jbc.M112.387001; Ravilious GE, 2012, P NATL ACAD SCI USA, V109, P309, DOI 10.1073/pnas.1115772108; RENOSTO F, 1991, ARCH BIOCHEM BIOPHYS, V284, P30, DOI 10.1016/0003-9861(91)90258-K; RENOSTO F, 1985, J BIOL CHEM, V260, P1903; Satishchandran C, 2000, ARCH BIOCHEM BIOPHYS, V378, P210, DOI 10.1006/abbi.2000.1841; Sekowska A, 2000, J MOL MICROB BIOTECH, V2, P145; Sekulic N, 2007, J BIOL CHEM, V282, P22112, DOI 10.1074/jbc.M701713200; Sekulic N, 2007, J MOL BIOL, V367, P488, DOI 10.1016/j.jmb.2007.01.025; Sinev MA, 1996, FEBS LETT, V397, P273, DOI 10.1016/S0014-5793(96)01195-7; Takahashi H, 2011, ANNU REV PLANT BIOL, V62, P157, DOI 10.1146/annurev-arplant-042110-103921; Yatusevich R, 2010, PLANT J, V62, P1, DOI 10.1111/j.1365-313X.2009.04118.x; Yi H, 2010, AMINO ACIDS, V39, P963, DOI 10.1007/s00726-010-0572-9; Yi H, 2010, MOL PLANT, V3, P269, DOI 10.1093/mp/ssp112; Yu ZH, 2007, J MOL BIOL, V365, P732, DOI 10.1016/j.jmb.2006.10.035; Zhang M, 2012, J AM CHEM SOC, V134, P16979, DOI 10.1021/ja3078522	33	14	16	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6107	6115		10.1074/jbc.M112.439414	http://dx.doi.org/10.1074/jbc.M112.439414			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23322773	Green Published, hybrid			2022-12-25	WOS:000315820700008
J	Krycer, JR; Brown, AJ				Krycer, James Robert; Brown, Andrew John			Does Changing Androgen Receptor Status during Prostate Cancer Development Impact upon Cholesterol Homeostasis?	PLOS ONE			English	Article							CELL-LINE; DEPRIVATION THERAPY; PROLONGED TREATMENT; GENE AMPLIFICATION; TUMOR PROGRESSION; EXPRESSION; LNCAP; BICALUTAMIDE; CARCINOMA; CASTRATION	Background: Recent evidence associates prostate cancer with high cholesterol levels, with cholesterol being an important raw material for cell-growth. Within the cell, cholesterol homeostasis is maintained by two master transcription factors: sterol-regulatory element-binding protein 2 (SREBP-2) and liver X receptor (LXR). We previously showed that the androgen receptor, a major player in prostate cell physiology, toggles these transcription factors to promote cholesterol accumulation. Given that prostate cancer therapy targets the androgen receptor, selecting for cells with altered androgen receptor activity, how would this affect SREBP-2 and LXR activity? Using a novel prostate cancer progression model, we explored how this crosstalk between the androgen receptor and cholesterol homeostasis changes during prostate cancer development. Methodology/Principal Findings: Firstly, we characterised our progression model, which involved 1) culturing LNCaP cells at physiological testosterone levels to generate androgen-tolerant LNCaP-305 cells, and 2) culturing LNCaP-305 with the anti-androgen casodex to generate castration-resistant LNCaP-364 cells. This progression was accompanied by upregulated androgen receptor expression, typically seen clinically, and a reduction in androgen receptor activity. Although this influenced how SREBP-2 and LXR target genes responded to androgen treatment, cellular cholesterol levels and their response to changing sterol status was similar in all LNCaP sub-lines. Conclusion/Significance: Overall cholesterol homeostasis is unaffected by changing androgen receptor activity in prostate cancer cells. This does not negate the relationship between androgens and cholesterol homeostasis, but rather suggests that other factors compensate for altered androgen receptor activity. Given that cholesterol regulation is maintained during progression, this supports the growing idea that cholesterol metabolism is a suitable target for prostate cancer.	[Krycer, James Robert; Brown, Andrew John] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia	University of New South Wales Sydney	Brown, AJ (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	aj.brown@unsw.edu.au		Krycer, James/0000-0003-1536-7270; Migliaccio, Antimo/0000-0002-4197-2055	Prostate Cancer Foundation of Australia [PG2710]; Petre Foundation	Prostate Cancer Foundation of Australia; Petre Foundation	AJB's research is supported by a grant from the Prostate Cancer Foundation of Australia (PG2710, http://www.prostate.org.au). JRK is the recipient of the Petre Foundation scholarship (http://www.petrefoundation.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaza H, 2011, CANCER SCI, V102, P51, DOI 10.1111/j.1349-7006.2010.01774.x; Brown AJ, 2007, CLIN EXP PHARMACOL P, V34, P135, DOI 10.1111/j.1440-1681.2007.04565.x; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Culig Z, 1999, BRIT J CANCER, V81, P242, DOI 10.1038/sj.bjc.6690684; Dai JL, 1996, MOL ENDOCRINOL, V10, P1582, DOI 10.1210/me.10.12.1582; Ettinger SL, 2004, CANCER RES, V64, P2212, DOI 10.1158/0008-5472.CAN-2148-2; Ford OH, 2003, J UROLOGY, V170, P1817, DOI 10.1097/01.ju.0000091873.09677.f4; Fukuchi J, 2004, CANCER RES, V64, P7682, DOI 10.1158/0008-5472.CAN-04-2647; Fuse H, 2007, PROSTATE, V67, P630, DOI 10.1002/pros.20269; Galea AM, 2009, FREE RADICAL BIO MED, V47, P880, DOI 10.1016/j.freeradbiomed.2009.06.027; Hara T, 2003, CANCER RES, V63, P149; Heemers HV, 2006, MOL ENDOCRINOL, V20, P2265, DOI 10.1210/me.2005-0479; Hobisch A, 2006, PROSTATE, V66, P413, DOI 10.1002/pros.20365; Holzbeierlein J, 2004, AM J PATHOL, V164, P217, DOI 10.1016/S0002-9440(10)63112-4; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Huggins C, 1941, CANCER RES, V1, P293; Ishikura N, 2010, PROSTATE, V70, P457, DOI 10.1002/pros.21079; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kawata H, 2010, PROSTATE, V70, P745, DOI 10.1002/pros.21107; Koivisto P, 1997, CANCER RES, V57, P314; KOKONTIS J, 1994, CANCER RES, V54, P1566; Kokontis JM, 2005, PROSTATE, V65, P287, DOI 10.1002/pros.20285; Krycer JR, 2012, BIOCHEM J, V446, P191, DOI 10.1042/BJ20120545; Krycer JR, 2010, TRENDS ENDOCRIN MET, V21, P268, DOI 10.1016/j.tem.2010.01.001; Krycer JR, 2011, J BIOL CHEM, V286, P20637, DOI 10.1074/jbc.M111.227082; Krycer JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008496; Leon CG, 2010, PROSTATE, V70, P390, DOI 10.1002/pros.21072; Litvinov IV, 2006, P NATL ACAD SCI USA, V103, P15085, DOI 10.1073/pnas.0603057103; Luu W, 2012, BBA-MOL CELL RES, V1823, P458, DOI 10.1016/j.bbamcr.2011.09.017; Malerod L, 2002, BIOCHEM BIOPH RES CO, V299, P916, DOI 10.1016/S0006-291X(02)02760-2; Murillo H, 2001, ENDOCRINOLOGY, V142, P4795, DOI 10.1210/en.142.11.4795; Olsson M, 2011, PROSTATE, V71, P909, DOI 10.1002/pros.21307; Pagler TA, 2006, J BIOL CHEM, V281, P11193, DOI 10.1074/jbc.M510261200; RAGO R, 1990, ANAL BIOCHEM, V191, P31; Rudolfsson SH, 2009, EXPERT OPIN THER TAR, V13, P219, DOI [10.1517/14728220802626249 , 10.1517/14728220802626249]; Schaffner C P, 1981, Prog Clin Biol Res, V75A, P279; Schrijvers Dirk, 2007, Recent Results Cancer Res, V175, P239; Sedelaar JPM, 2009, PROSTATE, V69, P1724, DOI 10.1002/pros.21028; Sharifi N, 2010, ENDOCR-RELAT CANCER, V17, pR305, DOI 10.1677/ERC-10-0187; Sobel RE, 2005, J UROLOGY, V173, P342, DOI 10.1097/01.ju.0000141580.30910.57; Solomon KR, 2008, TRENDS ENDOCRIN MET, V19, P113, DOI 10.1016/j.tem.2007.12.004; Soto AM, 1995, ONCOL RES, V7, P545; Swinnen JV, 1996, ENDOCRINOLOGY, V137, P4468, DOI 10.1210/en.137.10.4468; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Twiddy AL, 2011, PHARM RES-DORDR, V28, P423, DOI 10.1007/s11095-010-0210-y; Vander Griend DJ, 2007, CELL CYCLE, V6, P647, DOI 10.4161/cc.6.6.4028; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Wako K, 2008, J CLIN PATHOL, V61, P448, DOI 10.1136/jcp.2007.050906	50	13	13	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e54007	10.1371/journal.pone.0054007	http://dx.doi.org/10.1371/journal.pone.0054007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320115	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429800081
J	Mestre, O; Hurtado-Ortiz, R; Dos Vultos, T; Namouchi, A; Cimino, M; Pimentel, M; Neyrolles, O; Gicquel, B				Mestre, Olga; Hurtado-Ortiz, Raquel; Dos Vultos, Tiago; Namouchi, Amine; Cimino, Mena; Pimentel, Madalena; Neyrolles, Olivier; Gicquel, Brigitte			High Throughput Phenotypic Selection of Mycobacterium tuberculosis Mutants with Impaired Resistance to Reactive Oxygen Species Identifies Genes Important for Intracellular Growth	PLOS ONE			English	Article							TAGGED TRANSPOSON MUTAGENESIS; PHAGOSOME MATURATION; HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; DRUG-RESISTANCE; SURVIVAL; VIRULENCE; MACROPHAGES; REQUIREMENTS; COMPLEX	Mycobacterium tuberculosis has the remarkable capacity to survive within the hostile environment of the macrophage, and to resist potent antibacterial molecules such as reactive oxygen species (ROS). Thus, understanding mycobacterial resistance mechanisms against ROS may contribute to the development of new anti-tuberculosis therapies. Here we identified genes involved in such mechanisms by screening a high-density transposon mutant library, and we show that several of them are involved in the intracellular lifestyle of the pathogen. Many of these genes were found to play a part in cell envelope functions, further strengthening the important role of the mycobacterial cell envelope in protection against aggressions such as the ones caused by ROS inside host cells.	[Mestre, Olga; Hurtado-Ortiz, Raquel; Dos Vultos, Tiago; Namouchi, Amine; Cimino, Mena; Gicquel, Brigitte] Inst Pasteur, Unite Genet Mycobacterienne, Paris, France; [Pimentel, Madalena] Univ Lisbon, Fac Farm, Unidade Retrovirus & Infeccoes Associadas, Ctr Patogenese Mol, P-1699 Lisbon, Portugal; [Neyrolles, Olivier] CNRS, Inst Pharmacol & Biol Struct, Toulouse, France; [Neyrolles, Olivier] Univ Toulouse 3, Inst Pharmacol & Biol Struct, Toulouse, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universidade de Lisboa; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Mestre, O (corresponding author), Inst Pasteur, Unite Genet Mycobacterienne, Paris, France.	olga.mestre@pasteur.fr	Pimentel, Madalena/AAZ-5857-2021; iMed.ULisboa, M2B/B-5277-2014; Neyrolles, Olivier/AAG-3692-2019; Pimentel, Madalena/C-3582-2014; Mestre, Olga/D-7418-2013	Pimentel, Madalena/0000-0002-4598-1290; iMed.ULisboa, M2B/0000-0002-1245-3715; Neyrolles, Olivier/0000-0003-0047-5885; Pimentel, Madalena/0000-0002-4598-1290; Hurtado-Ortiz, Raquel/0000-0002-7650-2993; Mestre, Olga/0000-0002-0993-2248	European NEWTBVAC FP7 241745 Project; Fundacao para a Ciencia e Tecnologia [SFRH/BD/39079/2007]	European NEWTBVAC FP7 241745 Project; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the European NEWTBVAC FP7 241745 Project. OM is a recipient of a Fellowship from Fundacao para a Ciencia e Tecnologia (SFRH/BD/39079/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter Y, 2012, BIOCHIMIE, V94, P110, DOI 10.1016/j.biochi.2011.09.026; Bange F.-C., 1999, Tubercle and Lung Disease, V79, P171, DOI 10.1054/tuld.1998.0201; Baranov PV, 2001, NUCLEIC ACIDS RES, V29, P264, DOI 10.1093/nar/29.1.264; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Boshoff HIM, 2003, CELL, V113, P183, DOI 10.1016/S0092-8674(03)00270-8; Brodin P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001100; Bustamante J, 2007, J ALLERGY CLIN IMMUN, V120, P32, DOI 10.1016/j.jaci.2007.04.034; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; Dutta NK, 2010, J INFECT DIS, V201, P1743, DOI 10.1086/652497; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Ezraty B, 2005, J BACTERIOL, V187, P231, DOI 10.1128/JB.187.1.231-237.2005; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Fontan P, 2008, INFECT IMMUN, V76, P717, DOI 10.1128/IAI.00974-07; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; IMLAY JA, 1986, J BACTERIOL, V166, P519, DOI 10.1128/jb.166.2.519-527.1986; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jain M, 2005, PLOS PATHOG, V1, P12, DOI 10.1371/journal.ppat.0010002; Lamichhane G, 2005, INFECT IMMUN, V73, P2533, DOI 10.1128/IAI.73.4.2533-2540.2005; LEE MH, 1991, P NATL ACAD SCI USA, V88, P3111, DOI 10.1073/pnas.88.8.3111; MacGurn JA, 2007, INFECT IMMUN, V75, P2668, DOI 10.1128/IAI.01872-06; Malaga W, 2008, J BIOL CHEM, V283, P15177, DOI 10.1074/jbc.M710275200; Malm S, 2009, MICROBIOL-SGM, V155, P1332, DOI 10.1099/mic.0.023275-0; Manca C, 1999, INFECT IMMUN, V67, P74, DOI 10.1128/IAI.67.1.74-79.1999; Manganelli R, 2002, MOL MICROBIOL, V45, P365, DOI 10.1046/j.1365-2958.2002.03005.x; McAdam RA, 2002, MICROBIOL-SGM, V148, P2975, DOI 10.1099/00221287-148-10-2975; Namouchi A, 2012, GENOME RES, V22, P721, DOI 10.1101/gr.129544.111; Ng VH, 2004, MOL MICROBIOL, V52, P1291, DOI 10.1111/j.1365-2958.2004.04078.x; Parish T, 1998, METH MOL B, V101, P129, DOI 10.1385/0-89603-471-2:129; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Pethe K, 2004, P NATL ACAD SCI USA, V101, P13642, DOI 10.1073/pnas.0401657101; Philips JA, 2008, CELL MICROBIOL, V10, P2408, DOI 10.1111/j.1462-5822.2008.01239.x; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rosas-Magallanes V, 2007, INFECT IMMUN, V75, P504, DOI 10.1128/IAI.00058-06; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Sohaskey CD, 2003, J BACTERIOL, V185, P7247, DOI 10.1128/JB.185.24.7247-7256.2003; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Tekaia F., 1999, Tubercle and Lung Disease, V79, P329, DOI 10.1054/tuld.1999.0220; Vandal OH, 2008, NAT MED, V14, P849, DOI 10.1038/nm.1795; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Voskuil MI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00105; Voskuil MI, 2004, TUBERCULOSIS, V84, P256, DOI 10.1016/j.tube.2003.12.014; WALKER L, 1981, NATURE, V293, P69, DOI 10.1038/293069a0; Williams MJ, 2011, J BACTERIOL, V193, P98, DOI 10.1128/JB.00774-10; Zahrt TC, 2002, ANTIOXID REDOX SIGN, V4, P141, DOI 10.1089/152308602753625924	52	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53486	10.1371/journal.pone.0053486	http://dx.doi.org/10.1371/journal.pone.0053486			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320090	gold, Green Published, Green Submitted			2022-12-25	WOS:000313429800055
J	Armstrong, N; Ramamoorthy, M; Lyon, D; Jones, K; Duttaroy, A				Armstrong, Najealicka; Ramamoorthy, Malaisamy; Lyon, Delina; Jones, Kimberly; Duttaroy, Atanu			Mechanism of Silver Nanoparticles Action on Insect Pigmentation Reveals Intervention of Copper Homeostasis	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; IN-VITRO; OXIDE NANOPARTICLES; ZEBRAFISH EMBRYOS; NULL MUTATION; TOXICITY; CELLS; CYTOTOXICITY; TRANSPORTER; GOLD	Silver nanoparticles (AgNPs), like almost all nanoparticles, are potentially toxic beyond a certain concentration because the survival of the organism is compromised due to scores of pathophysiological abnormalities past that concentration. However, the mechanism of AgNP toxicity remains undetermined. Instead of applying a toxic dose, we attempted to monitor the effects of AgNPs at a nonlethal concentration on wild type Drosophila melanogaster by exposing them throughout their development. All adult flies raised in AgNP doped food showed that up to 50 mg/L concentration AgNP has no negative influence on median survival; however, these flies appeared uniformly lighter in body color due to the loss of melanin pigments in their cuticle. Additionally, fertility and vertical movement ability were compromised due to AgNP feeding. Determination of the amount of free ionic silver (Ag+) led us to claim that the observed biological effects have resulted from the AgNPs and not from Ag+. Biochemical analysis suggests that the activity of copper dependent enzymes, namely tyrosinase and Cu-Zn superoxide dismutase, are decreased significantly following the consumption of AgNPs, despite the constant level of copper present in the tissue. Consequently, we propose a mechanism whereby consumption of excess AgNPs in association with membrane bound copper transporter proteins cause sequestration of copper, thus creating a condition that resembles copper starvation. This model also explains the cuticular demelanization effect resulting from AgNP since tyrosinase activity is essential for melanin biosynthesis. Finally, we claim that Drosophila, an established genetic model system, can be well utilized for further understanding of the biological effects of nanoparticles.	[Armstrong, Najealicka; Duttaroy, Atanu] Howard Univ, Dept Biol, Washington, DC 20059 USA; [Ramamoorthy, Malaisamy; Lyon, Delina; Jones, Kimberly] Howard Univ, Dept Civil & Environm Engn, Washington, DC 20059 USA	Howard University; Howard University	Duttaroy, A (corresponding author), Howard Univ, Dept Biol, Washington, DC 20059 USA.	aduttaroy@howard.edu	Lyon, Delina/ABD-7121-2021	Lyon, Delina/0000-0002-2291-9048	Center for Environmental Implications of Nanotechnology (CEINT) at Duke University; Howard University; National Science Foundation	Center for Environmental Implications of Nanotechnology (CEINT) at Duke University; Howard University; National Science Foundation(National Science Foundation (NSF))	This work is supported by the Center for Environmental Implications of Nanotechnology (CEINT) at Duke University with Howard University as a partner. CEINT is funded by the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed M, 2010, TOXICOL APPL PHARM, V242, P263, DOI 10.1016/j.taap.2009.10.016; Ahamed M, 2008, TOXICOL APPL PHARM, V233, P404, DOI 10.1016/j.taap.2008.09.015; Arora S, 2008, TOXICOL LETT, V179, P93, DOI 10.1016/j.toxlet.2008.04.009; AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w; Balamurugan K, 2007, EMBO J, V26, P1035, DOI 10.1038/sj.emboj.7601543; Balamurugan K, 2006, BBA-MOL CELL RES, V1763, P737, DOI 10.1016/j.bbamcr.2006.05.001; Bar-Ilan O, 2009, SMALL, V5, P1897, DOI 10.1002/smll.200801716; Bertinato J, 2010, J TRACE ELEM MED BIO, V24, P178, DOI 10.1016/j.jtemb.2010.01.009; Braydich-Stolle L, 2005, TOXICOL SCI, V88, P412, DOI 10.1093/toxsci/kfi256; Brisson JA, 2005, EVOLUTION, V59, P1046; Cha K, 2008, BIOTECHNOL LETT, V30, P1893, DOI 10.1007/s10529-008-9786-2; Demir ER, 2011, NANOTOXICOLOGY, V5, P417, DOI 10.3109/17435390.2010.529176; Di Stefano HS, 1943, AM NAT, V77, P94, DOI 10.1086/281108; Duttaroy A, 2003, GENETICS, V165, P2295; Falugi C, 2012, MAR ENVIRON RES, V76, P114, DOI 10.1016/j.marenvres.2011.10.003; Foldbjerg R, 2009, TOXICOL LETT, V190, P156, DOI 10.1016/j.toxlet.2009.07.009; Hackenberg S, 2011, TOXICOL LETT, V201, P27, DOI 10.1016/j.toxlet.2010.12.001; HOPKINS TL, 1992, ANNU REV ENTOMOL, V37, P273, DOI 10.1146/annurev.en.37.010192.001421; Huang N, 2012, NANOTOXICOLOGY; Johnston HJ, 2010, CRIT REV TOXICOL, V40, P328, DOI 10.3109/10408440903453074; Kuo YM, 2001, P NATL ACAD SCI USA, V98, P6836, DOI 10.1073/pnas.111057298; Lee HY, 2007, CHEM COMMUN, P2959, DOI 10.1039/b703034g; Lee J, 2002, J BIOL CHEM, V277, P40253, DOI 10.1074/jbc.M208002200; Lee KJ, 2007, ACS NANO, V1, P133, DOI 10.1021/nn700048y; Lee LW, 2001, P NATL ACAD SCI USA, V98, P6842, DOI 10.1073/pnas.111058698; LEE PC, 1982, J PHYS CHEM-US, V86, P3391, DOI 10.1021/j100214a025; Li PW, 2010, TOXICOL LETT, V197, P82, DOI 10.1016/j.toxlet.2010.05.003; Nalabotu SK, 2011, INT J NANOMED, V6, P2327, DOI 10.2147/IJN.S25119; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Ostrowski AD, 2009, J NANOPART RES, V11, P251, DOI 10.1007/s11051-008-9579-5; Panacek A, 2011, ENVIRON SCI TECHNOL, V45, P4974, DOI 10.1021/es104216b; Park EJ, 2010, TOXICOL IN VITRO, V24, P872, DOI 10.1016/j.tiv.2009.12.001; PHILLIPS JP, 1989, P NATL ACAD SCI USA, V86, P2761, DOI 10.1073/pnas.86.8.2761; Prohaska JR, 2004, J NUTR, V134, P1003, DOI 10.1093/jn/134.5.1003; Prota G., 1992, MELANINS MELANOGENES; Roh JY, 2009, ENVIRON SCI TECHNOL, V43, P3933, DOI 10.1021/es803477u; Selvaraj A, 2005, GENE DEV, V19, P891, DOI 10.1101/gad.1301805; Song JE, 2011, ENVIRON SCI TECHNOL, V45, P5988, DOI 10.1021/es200547c; Srivastava M, 2012, ENVIRON HEALTH PERSP, V120, P56, DOI 10.1289/ehp.1103928; Turski ML, 2007, J BIOL CHEM, V282, P24017, DOI 10.1074/jbc.M703792200; Vanwinkle BA, 2009, NANOTOXICOLOGY, V3, P307, DOI 10.3109/17435390903121949; Vecchio G, 2012, NANOMED-NANOTECHNOL, V8, P1, DOI 10.1016/j.nano.2011.11.001; Vigneshwaran N, 2007, J NANOSCI NANOTECHNO, V7, P1893, DOI 10.1166/jnn.2007.737; WINDER AJ, 1991, EUR J BIOCHEM, V198, P317, DOI 10.1111/j.1432-1033.1991.tb16018.x; Wittkopp PJ, 2009, SEMIN CELL DEV BIOL, V20, P65, DOI 10.1016/j.semcdb.2008.10.002; WRIGHT TRF, 1987, ADV GENET, V24, P127, DOI 10.1016/s0065-2660(08)60008-5; Zhou H, 2003, J BIOL CHEM, V278, P48210, DOI 10.1074/jbc.M309820200; Zhu SQ, 2006, MAR ENVIRON RES, V62, pS5, DOI 10.1016/j.marenvres.2006.04.059	48	84	85	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53186	10.1371/journal.pone.0053186	http://dx.doi.org/10.1371/journal.pone.0053186			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308159	gold, Green Published, Green Submitted			2022-12-25	WOS:000313429100035
J	Bashir, MEH; Ward, JM; Cummings, M; Karrar, EE; Root, M; Mohamed, AA; Naclerio, RM; Preuss, D				Bashir, Mohamed Elfatih H.; Ward, Jason M.; Cummings, Matthew; Karrar, Eltayeb E.; Root, Michael; Mohamed, Abu Bekr A.; Naclerio, Robert M.; Preuss, Daphne			Dual Function of Novel Pollen Coat (Surface) Proteins: IgE-binding Capacity and Proteolytic Activity Disrupting the Airway Epithelial Barrier	PLOS ONE			English	Article							BERMUDA GRASS-POLLEN; GROUP-I ALLERGENS; CYNODON-DACTYLON POLLEN; MAJOR ALLERGEN; STRUCTURAL-CHARACTERIZATION; IDENTIFICATION; CLONING; PURIFICATION; ISOALLERGENS; EXPRESSION	Background: The pollen coat is the first structure of the pollen to encounter the mucosal immune system upon inhalation. Prior characterizations of pollen allergens have focused on water-soluble, cytoplasmic proteins, but have overlooked much of the extracellular pollen coat. Due to washing with organic solvents when prepared, these pollen coat proteins are typically absent from commercial standardized allergenic extracts (i.e., "de-fatted"), and, as a result, their involvement in allergy has not been explored. Methodology/Principal Findings: Using a unique approach to search for pollen allergenic proteins residing in the pollen coat, we employed transmission electron microscopy (TEM) to assess the impact of organic solvents on the structural integrity of the pollen coat. TEM results indicated that de-fatting of Cynodon dactylon (Bermuda grass) pollen (BGP) by use of organic solvents altered the structural integrity of the pollen coat. The novel IgE-binding proteins of the BGP coat include a cysteine protease (CP) and endoxylanase (EXY). The full-length cDNA that encodes the novel IgE-reactive CP was cloned from floral RNA. The EXY and CP were purified to homogeneity and tested for IgE reactivity. The CP from the BGP coat increased the permeability of human airway epithelial cells, caused a clear concentration-dependent detachment of cells, and damaged their barrier integrity. Conclusions/Significance: Using an immunoproteomics approach, novel allergenic proteins of the BGP coat were identified. These proteins represent a class of novel dual-function proteins residing on the coat of the pollen grain that have IgE-binding capacity and proteolytic activity, which disrupts the integrity of the airway epithelial barrier. The identification of pollen coat allergens might explain the IgE-negative response to available skin-prick-testing proteins in patients who have positive symptoms. Further study of the role of these pollen coat proteins in allergic responses is warranted and could potentially lead to the development of improved diagnostic and therapeutic tools.	[Bashir, Mohamed Elfatih H.; Karrar, Eltayeb E.; Mohamed, Abu Bekr A.; Naclerio, Robert M.] Univ Chicago, Dept Surg, Sect Otolaryngol Head & Neck Surg, Chicago, IL 60637 USA; [Bashir, Mohamed Elfatih H.; Ward, Jason M.; Cummings, Matthew; Root, Michael; Preuss, Daphne] Univ Chicago, Dept Mol Genet & Cell Biol, Div Biol Sci, Chicago, IL 60637 USA; [Ward, Jason M.] Monsanto Co, St Louis, MO USA; [Preuss, Daphne] Chromatin Inc, Chicago, IL USA	University of Chicago; University of Chicago; Monsanto	Bashir, MEH (corresponding author), Univ Chicago, Dept Surg, Sect Otolaryngol Head & Neck Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA.	mbashir@surgery.bsd.uchicago.edu		Bashir, Mohamed Elfatih/0000-0003-0125-1648	The Strategic Program for Asthma Research; National Science Foundation ""Arabidopsis 2010: Functional analysis of pollen exine assembly" [MCB-0520283]; Department of Energy "Cell-Cell Interaction during Pollen Tube Guidance in Arabidopsis" [DE-FG02-96ER20240]; The McHugh Otolaryngology Research Fund	The Strategic Program for Asthma Research; National Science Foundation ""Arabidopsis 2010: Functional analysis of pollen exine assembly"(National Science Foundation (NSF)); Department of Energy "Cell-Cell Interaction during Pollen Tube Guidance in Arabidopsis"(United States Department of Energy (DOE)); The McHugh Otolaryngology Research Fund	The Strategic Program for Asthma Research (www.spar-aaf.org); National Science Foundation, http://www.nsf.gov/ "Arabidopsis 2010: Functional analysis of pollen exine assembly," MCB-0520283; Department of Energy, http://energy.gov/ "Cell-Cell Interaction during Pollen Tube Guidance in Arabidopsis," DE-FG02-96ER20240; The McHugh Otolaryngology Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson K, 2003, INT ARCH ALLERGY IMM, V130, P87, DOI 10.1159/000069013; Asturias JA, 1997, J ALLERGY CLIN IMMUN, V100, P365, DOI 10.1016/S0091-6749(97)70250-1; Bashir MEH, 2002, J IMMUNOL, V169, P3284, DOI 10.4049/jimmunol.169.6.3284; Bass DJ, 2000, ANN ALLERG ASTHMA IM, V85, P374, DOI 10.1016/S1081-1206(10)62549-5; Beers EP, 2004, PHYTOCHEMISTRY, V65, P43, DOI 10.1016/j.phytochem.2003.09.005; Burr ML, 2003, CLIN EXP ALLERGY, V33, P1675, DOI 10.1111/j.1365-2222.2003.01816.x; Cadot P, 2000, J ALLERGY CLIN IMMUN, V105, P286, DOI 10.1016/S0091-6749(00)90078-2; Chow LP, 2005, FEBS J, V272, P6218, DOI 10.1111/j.1742-4658.2005.05000.x; Cosgrove DJ, 1997, P NATL ACAD SCI USA, V94, P6559, DOI 10.1073/pnas.94.12.6559; Dedic A, 2009, MOL IMMUNOL, V46, P416, DOI 10.1016/j.molimm.2008.10.012; Edlund AF, 2004, PLANT CELL, V16, pS84, DOI 10.1105/tpc.015800; Esch RE, 1997, METHODS, V13, P2, DOI 10.1006/meth.1997.0491; FORD SA, 1987, J ALLERGY CLIN IMMUN, V79, P711, DOI 10.1016/0091-6749(87)90201-6; Grobe K, 1999, EUR J BIOCHEM, V263, P33, DOI 10.1046/j.1432-1327.1999.00462.x; Grobe K, 2002, EUR J BIOCHEM, V269, P2083, DOI 10.1046/j.1432-1033.2002.02856.x; Grote M, 1999, INT ARCH ALLERGY IMM, V118, P1, DOI 10.1159/000024024; Honys D, 2003, PLANT PHYSIOL, V132, P640, DOI 10.1104/pp.103.020925; Hurley BP, 2006, AM J PHYSIOL-LUNG C, V290, pL703, DOI 10.1152/ajplung.00390.2005; Johnson CC, 2002, CURR OPIN ALLERGY CL, V2, P133, DOI 10.1097/00130832-200204000-00009; Kao SH, 2005, PROTEOMICS, V5, P3805, DOI 10.1002/pmic.200401229; Li BL, 2001, ADV EXP MED BIOL, V495, P271; Liaw SH, 2001, BIOCHEM BIOPH RES CO, V280, P738, DOI 10.1006/bbrc.2000.4203; MATTHIESEN F, 1991, J ALLERGY CLIN IMMUN, V88, P763, DOI 10.1016/0091-6749(91)90184-P; Mayfield JA, 2000, NAT CELL BIOL, V2, P128, DOI 10.1038/35000084; Mayfield JA, 2001, SCIENCE, V292, P2482, DOI 10.1126/science.1060972; McCormick S, 2004, PLANT CELL, V16, pS142, DOI 10.1105/tpc.016659; Meyers BC, 2004, GENOME RES, V14, P1641, DOI 10.1101/gr.2275604; Minero FJG, 1998, ALLERGY, V53, P266, DOI 10.1111/j.1398-9995.1998.tb03886.x; Nathan RA, 2007, ALLERGY ASTHMA PROC, V28, P3, DOI 10.2500/aap.2007.28.2934; Post S, 2012, THORAX, V67, P488, DOI 10.1136/thoraxjnl-2011-200606; Schubert-Unkmeir A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000874; SHEN HD, 1988, CLIN ALLERGY, V18, P401, DOI 10.1111/j.1365-2222.1988.tb02888.x; Smith GL, 2002, NAT REV IMMUNOL, V2, P521, DOI 10.1038/nri845; SMITH PM, 1994, INT ARCH ALLERGY IMM, V104, P57, DOI 10.1159/000236709; Stingone JA, 2008, J ALLERGY CLIN IMMUN, V122, P748, DOI 10.1016/j.jaci.2008.08.001; Su SN, 1996, J ALLERGY CLIN IMMUN, V98, P486, DOI 10.1016/S0091-6749(96)70080-5; Suphioglu C, 1997, FEBS LETT, V402, P167, DOI 10.1016/S0014-5793(96)01520-7; Suvilehto J, 2007, RHINOLOGY, V45, P286; Swanson R, 2004, ANNU REV GENET, V38, P793, DOI 10.1146/annurev.genet.38.072902.092356; Tao AL, 2005, ACTA PHARMACOL SIN, V26, P1225, DOI 10.1111/j.1745-7254.2005.00194.x; Verdino P, 2006, CLIN REV ALLERG IMMU, V30, P73, DOI 10.1385/CRIAI:30:2:73; Vigh-Conrad KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010174; Vrtala S, 2007, J IMMUNOL, V179, P1730, DOI 10.4049/jimmunol.179.3.1730; Watkins DN, 1997, BRIT J PHARMACOL, V121, P1482; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wilkesman JG, 2007, ELECTROPHORESIS, V28, P429, DOI 10.1002/elps.200600332; Wu WC, 2001, J BIOMED SCI, V8, P342, DOI 10.1007/BF02258376	47	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53337	10.1371/journal.pone.0053337	http://dx.doi.org/10.1371/journal.pone.0053337			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308195	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429100055
J	Gu, YJ; Wang, CF; Zheng, Y; Hou, XH; Mo, YF; Yu, WH; Zhang, L; Hu, C; Nan, HR; Chen, L; Li, J; Liu, YX; Huang, ZZ; Han, M; Bao, YQ; Zhong, WJ; Jia, WP				Gu, Yunjuan; Wang, Chunfang; Zheng, Ying; Hou, Xuhong; Mo, Yifei; Yu, Weihui; Zhang, Lei; Hu, Cheng; Nan, Hairong; Chen, Lei; Li, Jie; Liu, Yuxiang; Huang, Zhezhou; Han, Ming; Bao, Yuqian; Zhong, Weijian; Jia, Weiping			Cancer Incidence and Mortality in Patients with Type 2 Diabetes Treated with Human Insulin: A Cohort Study in Shanghai	PLOS ONE			English	Article							RISK; MALIGNANCIES; CARCINOMA; GLARGINE; MELLITUS; ANALOGS	Aim: The aim was to investigate the association between human insulin and cancer incidence and mortality in Chinese patients with type 2 diabetes. Methods: We recruited 8,774 insulin-naive diabetes patients from the Shanghai Diabetes Registry (SDR). The follow-up rate was 85.4%. All subjects were divided into the insulin use cohort (n = 3,639) and the non-insulin use cohort (n = 5,135). The primary outcome was the first diagnosis of any cancer. The secondary outcome was all-cause mortality. Cox proportional hazards model was used to estimate the relative risk (RR) of cancer and mortality. Results: We observed 98 cancer events in the insulin use cohort and 170 in the non-insulin use cohort. Cancer incidence rates were 78.6 and 74.3 per 10,000 patients per year in the insulin users and the non-insulin users, respectively. No significant difference in cancer risk was observed between the two cohorts (adjusted RR = 1.20, 95% CI 0.89-1.62, P = 0.228). Regarding site-specific cancers, only the risk of liver cancer was significantly higher in the insulin users compared to that in the non-insulin users (adjusted RR = 2.84, 95% CI 1.12-7.17, P = 0.028). The risks of overall mortality (adjusted RR = 1.89, 95% CI 1.47-2.43, P < 0.0001) and death from cancer (adjusted RR = 2.16, 95% CI 1.39-3.35, P = 0.001) were all significantly higher in the insulin users than in the non-insulin users. Conclusion: There was no excess risk of overall cancer in patients with type 2 diabetes who were treated with human insulin. However, a significantly higher risk of liver cancer was found in these patients. Moreover, insulin users showed higher risks of overall and cancer mortality. Considering that individuals treated with insulin were more likely to be advanced diabetic patients, caution should be used in interpreting these results.	[Gu, Yunjuan; Hou, Xuhong; Mo, Yifei; Yu, Weihui; Zhang, Lei; Hu, Cheng; Chen, Lei; Li, Jie; Liu, Yuxiang; Bao, Yuqian; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Clin Ctr Diabet, Shanghai Diabet Inst,Dept Endocrinol & Metab, Shanghai 200030, Peoples R China; [Gu, Yunjuan; Mo, Yifei; Yu, Weihui; Liu, Yuxiang] Shanghai Jiao Tong Univ, Sch Med, Dept Med, Shanghai 200030, Peoples R China; [Gu, Yunjuan; Hou, Xuhong; Mo, Yifei; Yu, Weihui; Zhang, Lei; Hu, Cheng; Chen, Lei; Li, Jie; Liu, Yuxiang; Bao, Yuqian; Jia, Weiping] Shanghai Key Lab Diabet Mellitus, Shanghai, Peoples R China; [Gu, Yunjuan] Nantong Univ, Affiliated Hosp, Dept Endocrinol & Metab, Nantong, Jiangsu, Peoples R China; [Wang, Chunfang; Han, Ming] Shanghai Municipal Ctr Dis Control & Prevent, Dept Vital Stat, Shanghai, Peoples R China; [Zheng, Ying; Huang, Zhezhou] Shanghai Municipal Ctr Dis Control & Prevent, Dept Canc Prevent & Control, Shanghai, Peoples R China; [Nan, Hairong] Univ Hong Kong, Dept Community Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Nantong University; Shanghai Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention; University of Hong Kong	Jia, WP (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Clin Ctr Diabet, Shanghai Diabet Inst,Dept Endocrinol & Metab, Shanghai 200030, Peoples R China.	wpjia@sjtu.edu.cn	Hu, Cheng/C-3346-2008; Jia, Weiping/B-7483-2012	Hu, Cheng/0000-0003-4314-2386; Chen, Lei/0000-0002-6581-0544; Gu, Yunjuan/0000-0002-5840-1494	National 973 Program [2011CB504001]; Shanghai municipal hospitals' project of chronic disease prevention and treatment [SHDC12007316]; Ministry of Health [201002002]	National 973 Program(National Basic Research Program of China); Shanghai municipal hospitals' project of chronic disease prevention and treatment; Ministry of Health	This work was funded by the National 973 Program (2011CB504001); Shanghai municipal hospitals' project of chronic disease prevention and treatment (SHDC12007316); Specific research fund from Ministry of Health (201002002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson C, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000433; Baur DM, 2011, METABOLISM, V60, P1363, DOI 10.1016/j.metabol.2010.09.012; Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; CHANG C, 2011, FILM COMMENT, V47, P6, DOI DOI 10.1371/J0URNAL.P0NE.0021368]; Chang CH, 2012, J CLIN ENDOCR METAB, V97, pE1170, DOI 10.1210/jc.2012-1162; Colhoun HM, 2009, DIABETOLOGIA, V52, P1755, DOI 10.1007/s00125-009-1453-1; Eurich DT, 2007, BMJ-BRIT MED J, V335, P497, DOI 10.1136/bmj.39314.620174.80; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hemkens LG, 2009, DIABETOLOGIA, V52, P1732, DOI 10.1007/s00125-009-1418-4; HEUSON JC, 1972, CANCER RES, V32, P233; Jonasson JM, 2009, DIABETOLOGIA, V52, P1745, DOI 10.1007/s00125-009-1444-2; Lai SW, 2012, AM J GASTROENTEROL, V107, P46, DOI 10.1038/ajg.2011.384; Mannucci E, 2010, DIABETES CARE, V33, P1997, DOI 10.2337/dc10-0476; Nicolucci A, 2010, ACTA DIABETOL, V47, P87, DOI 10.1007/s00592-010-0187-3; Rosenstock J, 2009, DIABETOLOGIA, V52, P1971, DOI 10.1007/s00125-009-1452-2; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Tseng CH, 2012, WORLD J GASTROENTERO, V18, P4182, DOI 10.3748/wjg.v18.i31.4182; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Yamasaki K, 2010, CANCER SCI, V101, P65, DOI 10.1111/j.1349-7006.2009.01345.x; Yang XL, 2010, DIABETES, V59, P1254, DOI 10.2337/db09-1371	22	23	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53411	10.1371/journal.pone.0053411	http://dx.doi.org/10.1371/journal.pone.0053411			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308218	Green Published, gold, Green Submitted			2022-12-25	WOS:000313429100064
J	Qin, W; Liu, Y; Jiang, TZ; Yu, CS				Qin, Wen; Liu, Yong; Jiang, Tianzi; Yu, Chunshui			The Development of Visual Areas Depends Differently on Visual Experience	PLOS ONE			English	Article							LATERAL OCCIPITAL COMPLEX; EARLY BLIND SUBJECTS; STATE FUNCTIONAL CONNECTIVITY; CROSS-MODAL PLASTICITY; SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; MIDDLE TEMPORAL AREA; CONGENITALLY BLIND; AUDITORY SUBSTITUTION; CORTICAL SURFACE	Visual experience plays an important role in the development of the visual cortex; however, recent functional imaging studies have shown that the functional organization is preserved in several higher-tier visual areas in congenitally blind subjects, indicating that maturation of visual areas depend unequally on visual experience. In this study, we aim to validate this hypothesis using a multimodality MRI approach. We found increased cortical thickness in the congenitally blind was present in the early visual areas and absent in the higher-tier ones, suggesting that the structural development of the visual cortex depends hierarchically on visual experience. In congenitally blind subjects, the decreased resting-state functional connectivity with the primary somatosensory cortex was more prominent in the early visual areas than in the higher-tier ones and were more pronounced in the ventral stream than in the dorsal one, suggesting that the development of functional organization of the visual cortex also depends differently on visual experience. Moreover, congenitally blind subjects showed normal or increased functional connectivity between ipsilateral higher-tier and early visual areas, suggesting an indirect corticocortical pathway through which somatosenroy information can reach the early visual areas. These findings support our hypothesis that the development of visual areas depends differently on visual experience.	[Qin, Wen; Yu, Chunshui] Tianjin Med Univ, Gen Hosp, Dept Radiol, Tianjin, Peoples R China; [Liu, Yong; Jiang, Tianzi] Chinese Acad Sci, Natl Lab Pattern Recognit Inst Automat, LIAMA Ctr Computat Med, Beijing, Peoples R China; [Yu, Chunshui] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China	Tianjin Medical University; Chinese Academy of Sciences; Capital Medical University	Jiang, TZ (corresponding author), Chinese Acad Sci, Natl Lab Pattern Recognit Inst Automat, LIAMA Ctr Computat Med, Beijing, Peoples R China.	jiangtz@nlpr.ia.ac.cn; chunshuiyu@yahoo.cn	Liu, Yong/F-2682-2011; QIN, WEN/F-3783-2015; Jiang, Tianzi/I-4256-2012	Liu, Yong/0000-0002-1862-3121; QIN, WEN/0000-0002-9121-8296; Jiang, Tianzi/0000-0001-9531-291X; Yu, Chunshui/0000-0001-5648-5199	National Basic Research Program of China (973 program) [2011CB707800]; Natural Science Foundation of China [30870694, 30900476, 81270020]; Open Projects Program of National Laboratory of Pattern Recognition	National Basic Research Program of China (973 program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Projects Program of National Laboratory of Pattern Recognition	This work was supported by grants from the National Basic Research Program of China (973 program, No. 2011CB707800), Natural Science Foundation of China (Grant Nos. 30870694,30900476 and 81270020), and the Open Projects Program of National Laboratory of Pattern Recognition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amedi A, 2003, NAT NEUROSCI, V6, P758, DOI 10.1038/nn1072; Amedi A, 2002, CEREB CORTEX, V12, P1202, DOI 10.1093/cercor/12.11.1202; Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; Amedi A, 2007, NAT NEUROSCI, V10, P687, DOI 10.1038/nn1912; Amedi A, 2010, RESTOR NEUROL NEUROS, V28, P143, DOI [10.3233/RNN-2010-0503, 10.3233/RNN-2010-0497]; Auvray M, 2007, PERCEPTION, V36, P416, DOI 10.1068/p5631; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Bedny M, 2011, P NATL ACAD SCI USA, V108, P4429, DOI 10.1073/pnas.1014818108; Bedny M, 2010, CURR BIOL, V20, P1900, DOI 10.1016/j.cub.2010.09.044; Bizley JK, 2007, CEREB CORTEX, V17, P2172, DOI 10.1093/cercor/bhl128; Bock AS, 2011, J COMP NEUROL; BOURGEOIS JP, 1989, P NATL ACAD SCI USA, V86, P4297, DOI 10.1073/pnas.86.11.4297; Bourne JA, 2006, CEREB CORTEX, V16, P405, DOI 10.1093/cercor/bhi119; Bridge H, 2009, BRAIN, V132, P3467, DOI 10.1093/brain/awp279; BRONCHTI G, 1991, DEV BRAIN RES, V58, P159, DOI 10.1016/0165-3806(91)90002-Z; Buchel C, 2003, NAT NEUROSCI, V6, P657, DOI 10.1038/nn0703-657; Burton H, 2003, J NEUROPHYSIOL, V90, P1965, DOI 10.1152/jn.00279.2003; Burton H, 2002, J NEUROPHYSIOL, V88, P3359, DOI 10.1152/jn.00129.2002; Burton H, 2002, J NEUROPHYSIOL, V87, P589, DOI 10.1152/jn.00285.2001; CALLAWAY EM, 1991, P NATL ACAD SCI USA, V88, P745, DOI 10.1073/pnas.88.3.745; Chechik G, 1999, NEURAL COMPUT, V11, P2061, DOI 10.1162/089976699300016089; Collignon O, 2007, CEREB CORTEX, V17, P457, DOI 10.1093/cercor/bhj162; Collignon O, 2011, P NATL ACAD SCI USA, V108, P4435, DOI 10.1073/pnas.1013928108; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; den Ouden HEM, 2009, CEREB CORTEX, V19, P1175, DOI 10.1093/cercor/bhn161; DeVolder AG, 1997, BRAIN RES, V750, P235, DOI 10.1016/S0006-8993(96)01352-2; Distler C, 1996, CEREB CORTEX, V6, P184, DOI 10.1093/cercor/6.2.184; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Eckert MA, 2008, HUM BRAIN MAPP, V29, P848, DOI 10.1002/hbm.20560; Falchier A, 2002, J NEUROSCI, V22, P5749; Fiehler K, 2010, RESTOR NEUROL NEUROS, V28, P193, DOI 10.3233/RNN-2010-0500; Fiehler K, 2009, CEREB CORTEX, V19, P1, DOI 10.1093/cercor/bhn067; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fujii T, 2009, NEUROSCI RES, V65, P175, DOI 10.1016/j.neures.2009.06.014; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; INNOCENTI GM, 1995, TRENDS NEUROSCI, V18, P397, DOI 10.1016/0166-2236(95)93936-R; James TW, 2002, NEUROPSYCHOLOGIA, V40, P1706, DOI 10.1016/S0028-3932(02)00017-9; Jiang JF, 2009, J NEUROSCI, V29, P2205, DOI 10.1523/JNEUROSCI.5451-08.2009; Karlen SJ, 2006, NEUROSCIENCE, V142, P843, DOI 10.1016/j.neuroscience.2006.06.055; Kassuba T, 2011, NEUROIMAGE, V56, P1566, DOI 10.1016/j.neuroimage.2011.02.032; Kim JK, 2011, J NEUROSCI, V31, P7848, DOI 10.1523/JNEUROSCI.3399-10.2011; Kim JK, 2008, BRAIN RES, V1242, P263, DOI 10.1016/j.brainres.2008.06.038; Kiorpes L, 2003, VISUAL NEUROSCI, V20, P567, DOI 10.1017/S0952523803205101; Kiorpes L, 2012, VISION RES, V63, P34, DOI 10.1016/j.visres.2012.04.018; Klinge C, 2010, J NEUROSCI, V30, P12798, DOI 10.1523/JNEUROSCI.2384-10.2010; Kovacs I, 1999, P NATL ACAD SCI USA, V96, P12204, DOI 10.1073/pnas.96.21.12204; Kovacs I, 2000, VISION RES, V40, P1301, DOI 10.1016/S0042-6989(00)00055-9; Kupers R, 2006, P NATL ACAD SCI USA, V103, P13256, DOI 10.1073/pnas.0602925103; Kupers R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00019; Kupers R, 2010, P NATL ACAD SCI USA, V107, P12716, DOI 10.1073/pnas.1006199107; Lepore N, 2010, NEUROIMAGE, V49, P134, DOI 10.1016/j.neuroimage.2009.07.048; Lewis TL, 2005, DEV PSYCHOBIOL, V46, P163, DOI 10.1002/dev.20055; Liu C, 2011, NEUROREPORT, V22, P190, DOI 10.1097/WNR.0b013e3283447c09; Liu Y, 2007, BRAIN, V130, P2085, DOI 10.1093/brain/awm121; Mahon BZ, 2009, NEURON, V63, P397, DOI 10.1016/j.neuron.2009.07.012; Matsui T, 2011, CEREB CORTEX; Matteau I, 2010, BRAIN RES BULL, V82, P264, DOI 10.1016/j.brainresbull.2010.05.001; Mishina M, 2003, NEUROIMAGE, V19, P125, DOI 10.1016/S1053-8119(03)00051-X; Noppeney U, 2005, CURR BIOL, V15, pR488, DOI 10.1016/j.cub.2005.06.053; Norman-Haignere SV, 2012, CEREB CORTEX, V22, P391, DOI 10.1093/cercor/bhr118; Pan WJ, 2007, NEUROIMAGE, V37, P212, DOI 10.1016/j.neuroimage.2007.05.014; Park HJ, 2009, NEUROIMAGE, V47, P98, DOI 10.1016/j.neuroimage.2009.03.076; Peltier S, 2007, NEUROPSYCHOLOGIA, V45, P476, DOI 10.1016/j.neuropsychologia.2006.03.003; Pietrini P, 2004, P NATL ACAD SCI USA, V101, P5658, DOI 10.1073/pnas.0400707101; Poirier C, 2006, NEUROIMAGE, V31, P279, DOI 10.1016/j.neuroimage.2005.11.036; Poirier C, 2005, COGNITIVE BRAIN RES, V25, P650, DOI 10.1016/j.cogbrainres.2005.08.015; Proulx MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001840; Ptito M, 2008, EXP BRAIN RES, V184, P193, DOI 10.1007/s00221-007-1091-0; Ptito M, 2008, EXP BRAIN RES, V187, P41, DOI 10.1007/s00221-008-1273-4; Ptito M, 2009, NEUROREPORT, V20, P543, DOI 10.1097/WNR.0b013e3283279909; Raz N, 2005, CEREB CORTEX, V15, P1459, DOI 10.1093/cercor/bhi026; REHKAMPER G, 1994, J COMP NEUROL, V347, P570, DOI 10.1002/cne.903470408; Reich L, 2012, CURR OPIN NEUROL, V25, P86, DOI 10.1097/WCO.0b013e32834ed723; Reich L, 2011, CURR BIOL, V21, P363, DOI 10.1016/j.cub.2011.01.040; Renier L, 2010, DISABIL REHABIL-ASSI, V5, P175, DOI 10.3109/17483100903253936; Renier LA, 2010, NEURON, V68, P138, DOI 10.1016/j.neuron.2010.09.021; Ricciardi E, 2007, CEREB CORTEX, V17, P2933, DOI 10.1093/cercor/bhm018; Rockland KS, 2003, INT J PSYCHOPHYSIOL, V50, P19, DOI 10.1016/S0167-8760(03)00121-1; RODMAN HR, 1993, J NEUROPHYSIOL, V70, P1115, DOI 10.1152/jn.1993.70.3.1115; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Shimony JS, 2006, CEREB CORTEX, V16, P1653, DOI 10.1093/cercor/bhj102; Shu N, 2009, HUM BRAIN MAPP, V30, P220, DOI 10.1002/hbm.20507; Striem-Amit E, 2012, CEREB CORTEX, V22, P1698, DOI 10.1093/cercor/bhr253; Sur M, 2001, NAT REV NEUROSCI, V2, P251, DOI 10.1038/35067562; Talairach J., 1988, COPLANAR STEREOTAXIC; UHL F, 1993, NEUROSCI LETT, V150, P162, DOI 10.1016/0304-3940(93)90526-Q; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; VERAART C, 1990, BRAIN RES, V510, P115, DOI 10.1016/0006-8993(90)90735-T; Wattam-Bell J, 2010, CURR BIOL, V20, P411, DOI 10.1016/j.cub.2009.12.020; Werner S, 2010, J NEUROSCI, V30, P2662, DOI 10.1523/JNEUROSCI.5091-09.2010; Wittenberg GF, 2004, EUR J NEUROSCI, V20, P1923, DOI 10.1111/j.1460-9568.2004.03630.x; Wolbers T, 2011, NEUROIMAGE, V56, P681, DOI 10.1016/j.neuroimage.2010.04.266; Yu CS, 2008, HUM BRAIN MAPP, V29, P533, DOI 10.1002/hbm.20420	98	35	36	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53784	10.1371/journal.pone.0053784	http://dx.doi.org/10.1371/journal.pone.0053784			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308283	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429100115
J	Himeda, T; Hosomi, T; Okuwa, T; Muraki, Y; Ohara, Y				Himeda, Toshiki; Hosomi, Takushi; Okuwa, Takako; Muraki, Yasushi; Ohara, Yoshiro			Saffold Virus Type 3 (SAFV-3) Persists in HeLa Cells	PLOS ONE			English	Article							CHILDREN; CARDIOVIRUSES; INFECTIONS; GROWTH	Saffold virus (SAFV) was identified as a human cardiovirus in 2007. Although several epidemiological studies have been reported, they have failed to provide a clear picture of the relationship between SAFV and human diseases. SAFV genotype 3 has been isolated from the cerebrospinal fluid specimen of patient with aseptic meningitis. This finding is of interest since Theiler's murine encephalomyelitis virus (TMEV), which is the closely related virus, is known to cause a multiple sclerosis-like syndrome in mice. TMEV persistently infects in mouse macrophage cells in vivo and in vitro, and the viral persistence is essential in TMEV-induced demyelinating disease. The precise mechanism(s) of SAFV infection still remain unclear. In order to clarify the SAFV pathogenicity, in the present study, we studied the possibilities of the in vitro persistent infection of SAFV. The two distinct phenotypes of HeLa cells, HeLa-N and HeLa-R, were identified. In these cells, the type of SAFV-3 infection was clearly different. HeLa-N cells were lyticly infected with SAFV-3 and the host suitable for the efficient growth. On the other hand, HeLa-R cells were persistently infected with SAFV-3. In addition, the SAFV persistence in HeLa-R cells is independent of type HFN response of host cells although the TMEV persistence in mouse macrophage cells depends on the response. Furthermore, it was suggested that SAFV persistence may be influenced by the expression of receptor(s) for SAFV infection on the host cells. The present findings on SAFV persistence will provide the important information to encourage the research of SAFV pathogenicity.	[Himeda, Toshiki; Okuwa, Takako; Muraki, Yasushi; Ohara, Yoshiro] Kanazawa Med Univ, Sch Med, Dept Microbiol, Kanazawa, Ishikawa, Japan; [Hosomi, Takushi] Publ Hlth Inst Kochi Prefecture, Kochi, Japan	Kanazawa Medical University	Ohara, Y (corresponding author), Kanazawa Med Univ, Sch Med, Dept Microbiol, Kanazawa, Ishikawa, Japan.	ohara@kanazawa-med.ac.jp			Japan Society for the Promotion of Science [24790449]; Ministry of Education, Culture, Sports, Science and Technology [22590421]; Kanazawa Medical University [S2012-6]; Takeda Science Foundation; Neuroimmunological Research Committee of the Ministry of Health, Labor and Welfare; Ministry of Health, Labour and Welfare, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kanazawa Medical University; Takeda Science Foundation(Takeda Science Foundation (TSF)); Neuroimmunological Research Committee of the Ministry of Health, Labor and Welfare; Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid for Young Scientists (B) from Japan Society for the Promotion of Science (24790449), Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology (22590421), a grant for promoted Research from Kanazawa Medical University (S2012-6), a grant from Takeda Science Foundation, a grant from the Neuroimmunological Research Committee of the Ministry of Health, Labor and Welfare, a Grant-in-Aid for Research on Emerging and Re-emerging Infectious Diseases and a Grant-in-Aid for the Promotion of Polio Eradication from the Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2008, EMERG INFECT DIS, V14, P834, DOI 10.3201/eid1405.071675; Blinkova O, 2009, J CLIN MICROBIOL, V47, P3507, DOI 10.1128/JCM.01062-09; Blinkova O, 2009, J VIROL, V83, P4631, DOI 10.1128/JVI.02085-08; Boldogh I, 1996, MED MICROBIOLOGY; Feuer R, 2002, J VIROL, V76, P4430, DOI 10.1128/JVI.76.9.4430-4440.2002; Hertzler S, 2011, J VIROL, V85, P7411, DOI 10.1128/JVI.00265-11; Himeda T, 2011, CLIN EXP NEUROIMMUNO, V2, P49; Himeda T, 2012, J VIROL, V86, P1292, DOI 10.1128/JVI.06087-11; Himeda T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-110; Himeda T, 2010, J NEUROVIROL, V16, P219, DOI 10.3109/13550284.2010.484040; Jones MS, 2007, J CLIN MICROBIOL, V45, P2144, DOI 10.1128/JCM.00174-07; Masters JR, 2001, P NATL ACAD SCI USA, V98, P8012, DOI 10.1073/pnas.121616198; Nielsen ACY, 2012, EMERG INFECT DIS, V18, P7, DOI 10.3201/eid1801.110725; Pinkert S, 2011, J VIROL, V85, P13409, DOI 10.1128/JVI.00621-11; Sorgeloos F, 2010, EUR 2010, P104; YOSHITAKE Y, 1992, IN VITRO CELL DEV-AN, V28A, P419; Zoll J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000416	17	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53194	10.1371/journal.pone.0053194	http://dx.doi.org/10.1371/journal.pone.0053194			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308162	Green Published, gold, Green Submitted			2022-12-25	WOS:000313670100024
J	Jensen, MM; Erichsen, KD; Johnbeck, CB; Bjorkling, F; Madsen, J; Bzorek, M; Jensen, PB; Hojgaard, L; Sehested, M; Kjaer, A				Jensen, Mette Munk; Erichsen, Kamille Dumong; Johnbeck, Camilla Bardram; Bjorkling, Fredrik; Madsen, Jacob; Bzorek, Michael; Jensen, Peter Buhl; Hojgaard, Liselotte; Sehested, Maxwell; Kjaer, Andreas			[18F]FLT and [18F]FDG PET for Non-invasive Treatment Monitoring of the Nicotinamide Phosphoribosyltransferase Inhibitor APO866 in Human Xenografts	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; IN-VIVO; THYMIDINE KINASE-1; TUMOR RESPONSE; IMAGING PROLIFERATION; THERAPY; MICE; FDG; PHARMACOKINETICS; VALIDATION	Introduction: APO866 is a new anti-tumor compound inhibiting nicotinamide phosphoribosyltransferase (NAMPT). APO866 has an anti-tumor effect in several pre-clinical tumor models and is currently in several clinical phase II studies. 3'-deoxy-3'-[18F]fluorothymidine ([18F]FLT) is a tracer used to assess cell proliferation in vivo. The aim of this study was non-invasively to study effect of APO866 treatment on [18F]FLT and 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) uptake. Methods: In vivo uptake of [18F]FLT and [18F]FDG in human ovary cancer xenografts in mice (A2780) was studied at various time points after APO866 treatment. Baseline [18F]FLT or [18F]FDG scans were made before treatment and repeated after 24 hours, 48 hours and 7 days. Tumor volume was followed with computed tomography (CT). Tracer uptake was quantified using small animal PET/CT. One hour after iv injection of tracer, static PET scans were performed. Imaging results were compared with Ki67 immunohistochemistry. Results: Tumors treated with APO866 had volumes that were 114% (24 h), 128% (48 h) and 130% (Day 7) relative to baseline volumes at Day 0. In the control group tumor volumes were 118% (24 h), 145% (48 h) and 339% (Day 7) relative to baseline volumes Day 0. Tumor volume between the treatment and control group was significantly different at Day 7 (P = 0.001). Compared to baseline, [18F]FLT SUVmax was significantly different at 24 h (P < 0.001), 48 h (P < 0.001) and Day 7 (P < 0.001) in the APO866 group. Compared to baseline, [18F]FDG SUVmax was significantly different at Day 7 (P = 0.005) in the APO866 group. Conclusions: APO866 treatment caused a significant decrease in [18F]FLT uptake 24 and 48 hours after treatment initiation. The early reductions in tumor cell proliferation preceded decrease in tumor volume. The results show the possibility to use [18F]FLT and [18F]FDG to image treatment effect early following treatment with APO866 in future clinical studies.	[Jensen, Mette Munk; Johnbeck, Camilla Bardram; Hojgaard, Liselotte; Kjaer, Andreas] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Jensen, Mette Munk; Johnbeck, Camilla Bardram; Madsen, Jacob; Hojgaard, Liselotte; Kjaer, Andreas] Rigshosp, Dept Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark; [Erichsen, Kamille Dumong; Bjorkling, Fredrik; Jensen, Peter Buhl; Sehested, Maxwell] TopoTarget AS, Copenhagen, Denmark; [Bzorek, Michael] Naestved Hosp, Dept Pathol, Naestved, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; Naestved Hospital	Jensen, MM (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark.	mettemj@sund.ku.dk	Højgaard, Liselotte/AAK-8329-2020; Kjaer, Andreas/E-8932-2015	Bjorkling, Fredrik/0000-0001-7018-8334; Kjaer, Andreas/0000-0002-2706-5547	National Advanced Technology Foundation; John and Birthe Meyer Foundation; Danish Medical Research Council; Rigshospitalets Research Foundation; Svend Andersen Foundation; AP Moller Foundation; Novo Nordisk Foundation; Lundbeck Foundation; Danish Cancer Society	National Advanced Technology Foundation; John and Birthe Meyer Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Rigshospitalets Research Foundation; Svend Andersen Foundation; AP Moller Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Danish Cancer Society(Danish Cancer Society)	Funding came from the National Advanced Technology Foundation, The John and Birthe Meyer Foundation, Danish Medical Research Council, Rigshospitalets Research Foundation, Svend Andersen Foundation, AP Moller Foundation, Novo Nordisk Foundation, Lundbeck Foundation and Danish Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Apisarnthanarax S, 2006, CLIN CANCER RES, V12, P4590, DOI 10.1158/1078-0432.CCR-05-2720; ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Barthel H, 2005, EUR J NUCL MED MOL I, V32, P257, DOI 10.1007/s00259-004-1611-0; Barthel H, 2003, CANCER RES, V63, P3791; Berghmans T, 2008, J THORAC ONCOL, V3, P6, DOI 10.1097/JTO.0b013e31815e6d6b; Borst GR, 2005, EUR J CANCER, V41, P1533, DOI 10.1016/j.ejca.2005.03.026; Brepoels L, 2009, J NUCL MED, V50, P1102, DOI 10.2967/jnumed.109.062208; Buck AK, 2003, J NUCL MED, V44, P1426; Deroose CM, 2007, J NUCL MED, V48, P295; Downey RJ, 2004, J CLIN ONCOL, V22, P3255, DOI 10.1200/JCO.2004.11.109; EVA A, 1982, NATURE, V295, P116, DOI 10.1038/295116a0; Francis DL, 2003, GUT, V52, P1602, DOI 10.1136/gut.52.11.1602; Fueger BJ, 2006, J NUCL MED, V47, P999; Hasmann M, 2003, CANCER RES, V63, P7436; Holen K, 2008, INVEST NEW DRUG, V26, P45, DOI 10.1007/s10637-007-9083-2; Ishimori T, 2005, ACAD RADIOL, V12, P776, DOI 10.1016/j.acra.2005.03.062; Jensen Mette Munk, 2008, BMC Med Imaging, V8, P16, DOI 10.1186/1471-2342-8-16; Jensen MA, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011024, 10.1371/journal.pone.0012965]; KONG XB, 1992, ANTIMICROB AGENTS CH, V36, P808, DOI 10.1128/AAC.36.4.808; Leyton J, 2005, CANCER RES, V65, P4202, DOI 10.1158/0008-5472.CAN-04-4008; Leyton J, 2008, MOL CANCER THER, V7, P3112, DOI 10.1158/1535-7163.MCT-08-0264; Leyton J, 2006, CANCER RES, V66, P7621, DOI 10.1158/0008-5472.CAN-05-3962; Molthoff CFM, 2007, MOL IMAGING BIOL, V9, P340, DOI 10.1007/s11307-007-0104-5; MUNCHPETERSEN B, 1995, ADV ENZYME REGUL, V35, P69, DOI 10.1016/0065-2571(94)00014-T; Nahimana A, 2009, BLOOD, V113, P3276, DOI 10.1182/blood-2008-08-173369; Olesen UH, 2010, MOL CANCER THER, V9, P1609, DOI 10.1158/1535-7163.MCT-09-1130; Oyama N, 2004, J NUCL MED, V45, P519; Rasey JS, 2002, J NUCL MED, V43, P1210; SHERLEY JL, 1988, J BIOL CHEM, V263, P8350; Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337; Sohn HJ, 2008, CLIN CANCER RES, V14, P7423, DOI 10.1158/1078-0432.CCR-08-0312; Vesselle H, 2002, CLIN CANCER RES, V8, P3315; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Waldherr C, 2005, J NUCL MED, V46, P114; Wosikowski K, 2002, CANCER RES, V62, P1057; Yang YJ, 2006, EUR J NUCL MED MOL I, V33, P412, DOI 10.1007/s00259-005-0011-4	36	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53410	10.1371/journal.pone.0053410	http://dx.doi.org/10.1371/journal.pone.0053410			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308217	Green Published, Green Submitted, gold			2022-12-25	WOS:000313670100039
J	Chen, B; Tao, ZX; Zhao, YM; Chen, HW; Yong, YH; Liu, X; Wang, H; Wu, ZZ; Yang, ZJ; Yuan, L				Chen, Bo; Tao, Zhengxian; Zhao, Yingming; Chen, Hongwu; Yong, Yonghong; Liu, Xiang; Wang, Hua; Wu, Zuze; Yang, Zhijian; Yuan, Li			Catheter-Based Intramyocardial Delivery (NavX) of Adenovirus Achieves Safe and Accurate Gene Transfer in Pigs	PLOS ONE			English	Article							HEPATOCYTE-GROWTH-FACTOR; MYOCARDIAL-ISCHEMIA; TRANSENDOCARDIAL DELIVERY; ADENOASSOCIATED VIRUS; HEART FUNCTION; ANGIOGENESIS; THERAPY; CARDIOMYOPATHY; IMPROVEMENT; TACHYCARDIA	Background: Hepatocyte growth factor (HGF) is one of the major angiogenic factors being studied for the treatment of ischemic heart diseases. Our previous study demonstrated adenovirus-HGF was effective in myocardial ischemia models. The first clinical safety study showed a positive effect in patients with severe and diffused triple coronary disease. Methods: 12 Pigs were randomized (1:1) to receive HGF, which was administered as five injections into the infarcted myocardium, or saline (control group). The injections were guided by EnSite NavX left ventricular electroanatomical mapping. Results: The catheter-based injections caused no pericardial effusion, malignant arrhythmia or death. During mapping and injection, alanine aminotransferase, aspartate aminotransferase, blood urea nitrogen, serum creatinine and creatine kinase-MB levels have no significant increase as compared to those before and after the injection in HGF group(P>0.05). HGF group has high HGF expression with Western blot, less myocardial infarct sizes by electroanatomical mapping (HGF group versus after saline group, 5.28 +/- 0.55 cm(2) versus 9.06 +/- 1.06 cm(2), P<0.01), better cardiac function with Gated-Single Photon Emission Computed Tomography compared with those in saline group. Histological, strongly increased lectin-positive microvessels and microvessel density were found in the myocardial ischemic regions in HGF group. Conclusion: Intramyocardial injection guided by NavX system provides a method of feasible and safe percutaneous gene transfer to myocardial infarct regions.	[Chen, Bo; Tao, Zhengxian; Zhao, Yingming; Chen, Hongwu; Yong, Yonghong; Yang, Zhijian] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China; [Liu, Xiang] MicroPort Med Shanghai Co Ltd, Dev Technol Dept, Shanghai, Peoples R China; [Wang, Hua; Wu, Zuze] Acad Mil Med Sci, Beijing Inst Radiat Med China, Dept Expt Hematol, Beijing, Peoples R China; [Yuan, Li] Nanjing Med Univ, Dept Biochem & Mol Biol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Academy of Military Medical Sciences - China; Nanjing Medical University	Yang, ZJ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China.	zhijianyangnj@yahoo.com.cn; Yuanli@njmu.edu.cn			National Nature Science Foundation of China [30971254]; Supporting Program of Science and Technology of Jiangsu [BE2009686]; Innovative Project of Clamber Scholar of Jiangsu [BK2010021]; Chinese National Basic Research and Development Grants '973' [2008CB517303]; National Mega-Project of Science Research of China [2009ZX09301-002]; Chinese High-Tech Grant'863' [2007AA021007]; Priority Acadamic Program Development of Jiangsu Higher Education Institutions	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Supporting Program of Science and Technology of Jiangsu; Innovative Project of Clamber Scholar of Jiangsu; Chinese National Basic Research and Development Grants '973'(National Basic Research Program of China); National Mega-Project of Science Research of China; Chinese High-Tech Grant'863'; Priority Acadamic Program Development of Jiangsu Higher Education Institutions	This work was financially supported by grants from National Nature Science Foundation of China (30971254), Supporting Program of Science and Technology of Jiangsu (Social Development, BE2009686), the Innovative Project of Clamber Scholar of Jiangsu (BK2010021), Chinese National Basic Research and Development Grants '973' (2008CB517303), the National Mega-Project of Science Research of China (No.2009ZX09301-002) and Chinese High-Tech Grant'863'(2007AA021007), and a Project Funded by the Priority Acadamic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki M, 2000, GENE THER, V7, P417, DOI 10.1038/sj.gt.3301104; Azuma J, 2006, GENE THER, V13, P1206, DOI 10.1038/sj.gt.3302740; Bish LT, 2008, MOL THER, V16, P1953, DOI 10.1038/mt.2008.202; Byrne MJ, 2008, GENE THER, V15, P1550, DOI 10.1038/gt.2008.120; Casella M, 2009, HEART RHYTHM, V6, P1598, DOI 10.1016/j.hrthm.2009.07.040; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Chaanine AH, 2010, SEMIN THORAC CARDIOV, V22, P127, DOI 10.1053/j.semtcvs.2010.09.009; Duan HF, 2003, MOL THER, V8, P467, DOI 10.1016/S1525-0016(03)00186-2; Gao GP, 2011, HUM GENE THER, V22, P979, DOI 10.1089/hum.2011.042; Kaspar BK, 2005, J GENE MED, V7, P316, DOI 10.1002/jgm.665; Katz MG, 2010, HUM GENE THER, V21, P371, DOI 10.1089/hum.2009.164; Kiang A, 2006, MOL THER, V14, P588, DOI 10.1016/j.ymthe.2006.03.024; Kornowski R, 2000, J AM COLL CARDIOL, V35, P1031, DOI 10.1016/S0735-1097(99)00642-7; Kornowski R, 1999, CATHETER CARDIO INTE, V48, P447, DOI 10.1002/(SICI)1522-726X(199912)48:4<447::AID-CCD23>3.0.CO;2-Y; Kovoor P, 1998, CIRCULATION, V98, P1534, DOI 10.1161/01.CIR.98.15.1534; Liu Q, 2003, GENE THER, V10, P935, DOI 10.1038/sj.gt.3302036; Losordo DW, 2011, CIRC RES, V109, P428, DOI 10.1161/CIRCRESAHA.111.245993; Madonna R, 2012, THROMB HAEMOSTASIS, V107, P656, DOI 10.1160/TH11-10-0711; Nakamura T, 2000, J CLIN INVEST, V106, P1511, DOI 10.1172/JCI10226; Nguyen PK, 2011, CIRC RES, V109, P962, DOI 10.1161/CIRCRESAHA.111.242909; Poornima IG, 2004, J AM COLL CARDIOL, V43, P194, DOI 10.1016/j.jacc.2003.09.029; Reithmann C, 2009, J CARDIOVASC ELECTR, V20, P841, DOI 10.1111/j.1540-8167.2009.01467.x; Taniyama Y, 2000, CIRCULATION, V102, P246, DOI 10.1161/01.CIR.102.2.246; Tao ZX, 2010, J BIOMED RES, V24, P198, DOI 10.1016/S1674-8301(10)60029-2; Tao ZX, 2011, P NATL ACAD SCI USA, V108, P2064, DOI 10.1073/pnas.1018925108; Tung R, 2011, HEART RHYTHM, V8, P439, DOI 10.1016/j.hrthm.2010.10.044; Vale PR, 2001, CIRCULATION, V103, P2138; Ventura R, 2004, J CARDIOVASC ELECTR, V15, P1157, DOI 10.1046/j.1540-8167.2004.04064.x; Wang W, 2006, ACTA PHARMACOL SIN, V27, P555, DOI 10.1111/j.1745-7254.2006.00306.x; Yang ZJ, 2010, MOL BIOL REP, V37, P2075, DOI 10.1007/s11033-009-9665-5; Yang ZJ, 2009, MOL BIOL REP, V36, P1323, DOI 10.1007/s11033-008-9315-3; Yuan B, 2008, IN VIVO, V22, P629; Yuan B, 2008, SCI CHINA SER C, V51, P537, DOI 10.1007/s11427-008-0073-1; ZhiJian Y, 2007, SCI CHINA SER C, V50, P748, DOI 10.1007/s11427-007-0102-5	34	11	12	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53007	10.1371/journal.pone.0053007	http://dx.doi.org/10.1371/journal.pone.0053007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301013	gold, Green Published, Green Submitted			2022-12-25	WOS:000313480000025
J	Snider, AJ; Ruiz, P; Obeid, LM; Oates, JC				Snider, Ashley J.; Ruiz, Phillip; Obeid, Lina M.; Oates, Jim C.			Inhibition of Sphingosine Kinase-2 in a Murine Model of Lupus Nephritis	PLOS ONE			English	Article							RENAL THROMBOXANE PRODUCTION; MRL/LPR MICE; ERYTHEMATOSUS; SURVIVAL; FTY720; SPHINGOSINE-1-PHOSPHATE; DISEASE; CYCLOOXYGENASE-2; INFLAMMATION; ASSOCIATION	Sphingosine-1-phosphate (S1P), a potent bioactive lipid, is emerging as a central mediator in inflammation and immune responses. We have previously implicated S1P and its synthetic enzyme sphingosine kinase (SK) in inflammatory and autoimmune disorders, including inflammatory bowel disease and rheumatoid arthritis. Generation of S1P requires phosphorylation of sphingosine by SK, of which there are two isoforms. Numerous studies have implicated SK1 in immune cell trafficking, inflammation and autoimmune disorders. In this study, we set out to determine the role of SK and S1P in lupus nephritis (LN). To this end, we examined S1P and dihydro-S1P (dh-S1P) levels in serum and kidney tissues from a mouse model of LN. Interestingly dh-S1P was significantly elevated in serum and kidney tissue from LN mice, which is more readily phosphorylated by SK2. Therefore, we employed the use of the specific SK2 inhibitor, ABC294640 in our murine model of LN. Treatment with ABC294640 did not improve vascular or interstitial pathology associated with LN. However, mice treated with the SK2 inhibitor did demonstrate decreases in glomerular pathology and accumulation of B and T cells in the spleen these were not statistically different from lpr mice treated with vehicle. LN mice treated with ABC294640 did not have improved urine thromboxane levels or urine proteinuria measurements. Both S1P and dh-S1P levels in circulation were significantly reduced with ABC294640 treatment; however, dh-S1P was actually elevated in kidneys from LN mice treated with ABC294640. Together these data demonstrate a role for SKs in LN; however, they suggest that inhibition of SK1 or perhaps both SK isoforms would better prevent elevations in S1P and dh-S1P and potentially better protect against LN.	[Snider, Ashley J.; Obeid, Lina M.; Oates, Jim C.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA; [Snider, Ashley J.; Obeid, Lina M.; Oates, Jim C.] Med Univ S Carolina, Dept Med, Div Rheumatol & Immunol, Charleston, SC 29425 USA; [Ruiz, Phillip] Univ Miami, Miller Sch Med, Dept Pathol, Div Immunopathol, Miami, FL 33136 USA; [Obeid, Lina M.] Med Univ S Carolina, Dept Mol & Cellular Biol & Pathobiol, Charleston, SC 29425 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; University of Miami; Medical University of South Carolina	Oates, JC (corresponding author), Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA.	oatesjc@musc.edu		obeid, lina/0000-0002-0734-0847; Oates, Jim/0000-0002-5426-1359	Alliance for Lupus Research; Veterans Affairs Merit Award; Career Development Award; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER	Alliance for Lupus Research; Veterans Affairs Merit Award(US Department of Veterans Affairs); Career Development Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a grant from the Alliance for Lupus Research (JCO), Veterans Affairs Merit Award (LMO) and Career Development Award (AJS). Lipid analyses provided by the Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina (P30 CA138313) and the Lipidomics Core in the SC Lipidomics and Pathobiology COBRE, Department Biochemistry, MUSC (P20 RR017677). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alperovich G, 2007, LUPUS, V16, P18, DOI 10.1177/0961203306073136; Ando S, 2010, BIOCHEM BIOPH RES CO, V394, P804, DOI 10.1016/j.bbrc.2010.03.078; AUSTIN HA, 1984, KIDNEY INT, V25, P689, DOI 10.1038/ki.1984.75; Baker DA, 2010, J IMMUNOL, V185, P2570, DOI 10.4049/jimmunol.1000644; Bielawski J, 2010, ADV EXP MED BIOL, V688, P46; Budde K, 2006, CLIN TRANSPLANT, V20, P17, DOI 10.1111/j.1399-0012.2006.00596.x; Dooley MA, 1997, KIDNEY INT, V51, P1188, DOI 10.1038/ki.1997.162; French KJ, 2010, J PHARMACOL EXP THER, V333, P129, DOI 10.1124/jpet.109.163444; GILKESON GS, 1989, CLIN IMMUNOL IMMUNOP, V53, P460, DOI 10.1016/0090-1229(89)90008-1; Han TS, 2006, LUPUS, V15, P71, DOI 10.1191/0961203306lu2264oa; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; KELLEY VE, 1986, J CLIN INVEST, V77, P252, DOI 10.1172/JCI112284; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Maines LW, 2008, DIGEST DIS SCI, V53, P997, DOI 10.1007/s10620-007-0133-6; Oates JC, 2007, ARTHRITIS RHEUM, V56, P3738, DOI 10.1002/art.22955; Oates JC, 1997, CLIN IMMUNOL IMMUNOP, V83, P86, DOI 10.1006/clin.1997.4332; Okazaki H, 2002, J RHEUMATOL, V29, P707; Sekine H, 2006, J IMMUNOL, V177, P7423, DOI 10.4049/jimmunol.177.10.7423; Smith CD, 2007, SPHINGOSINE KINASE I; SPURNEY RF, 1991, PROSTAG OTH LIPID M, V42, P15, DOI 10.1016/0090-6980(91)90090-3; Taha TA, 2004, BBA-MOL CELL BIOL L, V1682, P48, DOI 10.1016/S1388-1981(04)00023-X; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; Tomasoni S, 1998, J AM SOC NEPHROL, V9, P1202; Watanabe H, 2000, J IMMUNOL, V164, P786, DOI 10.4049/jimmunol.164.2.786; Watson L, 2012, J CLIN IMMUNOL, V32, P1019, DOI 10.1007/s10875-012-9710-3; Wenderfer SE, 2008, KIDNEY INT, V74, P1319, DOI 10.1038/ki.2008.396; Xin C, 2007, BRIT J PHARMACOL, V150, P943, DOI 10.1038/sj.bjp.0707171; Zeidan YH, 2007, TRENDS MOL MED, V13, P327, DOI 10.1016/j.molmed.2007.06.002; Zhang XK, 2004, J IMMUNOL, V173, P6481, DOI 10.4049/jimmunol.173.10.6481; Zoja C, 2001, KIDNEY INT, V60, P653, DOI 10.1046/j.1523-1755.2001.060002653.x	30	31	32	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53521	10.1371/journal.pone.0053521	http://dx.doi.org/10.1371/journal.pone.0053521			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301082	Green Published, gold, Green Submitted			2022-12-25	WOS:000313480000063
J	Ornelas, IM; Silva, TM; Fragel-Madeira, L; Ventura, ALM				Ornelas, Isis Moraes; Silva, Thayane Martins; Fragel-Madeira, Lucianne; Marques Ventura, Ana Lucia			Inhibition of PI3K/Akt Pathway Impairs G2/M Transition of Cell Cycle in Late Developing Progenitors of the Avian Embryo Retina	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; ATP-INDUCED PROLIFERATION; SIGNAL-REGULATED KINASE; PROTEIN-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOINOSITIDE 3-KINASE; HISTONE H3; DEPENDENT PHOSPHORYLATION; MESSENGER-RNA; MITOSIS	PI3K/Akt is an important pathway implicated in the proliferation and survival of cells in the CNS. Here we investigated the participation of the PI3K/Akt signal pathway in cell cycle of developing retinal progenitors. Immunofluorescence assays performed in cultures of chick embryo retinal cells and intact tissues revealed the presence of phosphorylated Akt and 4E-BP1 in cells with typical mitotic profiles. Blockade of PI3K activity with the chemical inhibitor LY 294002 (LY) in retinal explants blocked the progression of proliferating cells through G2/M transition, indicated by an expressive increase in the number of cells labeled for phosphorylated histone H3 in the ventricular margin of the retina. No significant level of cell death could be detected at this region. Retinal explants treated with LY for 24 h also showed a significant decrease in the expression of phospho-Akt, phospho-GSK-3 and the hyperphosphorylated form of 4E-BP1. Although no change in the expression of cyclin B1 was detected, a significant decrease in CDK1 expression was noticed after 24 h of LY treatment both in retinal explants and monolayer cultures. Our results suggest that PI3K/Akt is an active pathway during proliferation of retinal progenitors and its activity appears to be required for proper CDK1 expression levels and mitosis progression of these cells.	[Ornelas, Isis Moraes; Silva, Thayane Martins; Fragel-Madeira, Lucianne; Marques Ventura, Ana Lucia] Univ Fed Fluminense, Inst Biol, Dept Neurobiol, Neurosci Program, Rio De Janeiro, Brazil	Universidade Federal Fluminense	Ventura, ALM (corresponding author), Univ Fed Fluminense, Inst Biol, Dept Neurobiol, Neurosci Program, Rio De Janeiro, Brazil.	almv@vm.uff.br	Fragel-Madeira, Lucianne/I-2208-2016; Fragel-Madeira, Lucianne/V-1665-2019	Fragel-Madeira, Lucianne/0000-0001-6747-2828	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Pro-Reitoria de Pesquisa e Inovacao (PROPPi-UFF); CAPES	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Pro-Reitoria de Pesquisa e Inovacao (PROPPi-UFF); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Pro-Reitoria de Pesquisa e Inovacao (PROPPi-UFF). Isis M. Ornelas is the recipient of a post-doctoral fellowship from CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler R, 2000, PROG RETIN EYE RES, V19, P529, DOI 10.1016/S1350-9462(00)00008-2; Andersen CB, 1998, J BIOL CHEM, V273, P18705, DOI 10.1074/jbc.273.30.18705; Barton KM, 2008, DEV DYNAM, V237, P672, DOI 10.1002/dvdy.21449; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Boutros R, 2008, CELL CYCLE, V7, P401, DOI 10.4161/cc.7.3.5295; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Campos CBL, 2002, NEUROSCIENCE, V112, P583, DOI 10.1016/S0306-4522(02)00096-9; Nunes PHC, 2007, INT J DEV NEUROSCI, V25, P499, DOI 10.1016/j.ijdevneu.2007.09.007; Choi Kangduk, 2010, Korean Journal of Internal Medicine, V25, P119, DOI 10.3904/kjim.2010.25.2.119; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Espanel X, 1997, INT J DEV BIOL, V41, P469; Fischer AJ, 2005, J COMP NEUROL, V484, P1, DOI 10.1002/cne.20406; Franca GR, 2007, INT J DEV NEUROSCI, V25, P283, DOI 10.1016/j.ijdevneu.2007.05.006; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Graff JR, 2000, J BIOL CHEM, V275, P24500, DOI 10.1074/jbc.M003145200; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; GURLEY LR, 1978, EUR J BIOCHEM, V84, P1, DOI 10.1111/j.1432-1033.1978.tb12135.x; Heesom KJ, 2001, CURR BIOL, V11, P1374, DOI 10.1016/S0960-9822(01)00422-5; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hou HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035665; Kalous J, 2006, BIOL CELL, V98, P111, DOI 10.1042/BC20050020; Katayama K, 2005, MOL CELL BIOL, V25, P5725, DOI 10.1128/MCB.25.13.5725-5737.2005; Kobayashi N, 2003, BLOOD, V102, P3186, DOI 10.1182/blood-2003-02-0567; Li YC, 2012, LIFE SCI, V90, P962, DOI 10.1016/j.lfs.2012.04.044; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Portugal LCL, 2009, NEUROSCI LETT, V466, P35, DOI 10.1016/j.neulet.2009.09.046; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; LIU XJ, 1995, MOL CELL BIOL, V15, P3563; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; MCGOWAN CH, 1990, MOL CELL BIOL, V10, P3847, DOI 10.1128/MCB.10.7.3847; O'Farrell PH, 2001, TRENDS CELL BIOL, V11, P512, DOI 10.1016/S0962-8924(01)02142-0; Okumura E, 2002, NAT CELL BIOL, V4, P111, DOI 10.1038/ncb741; Ornelas IM, 2010, INT J DEV NEUROSCI, V28, P503, DOI 10.1016/j.ijdevneu.2010.06.001; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pearson R, 2002, J NEUROSCI, V22, P7569; Pearson RA, 2005, NEURON, V46, P731, DOI 10.1016/j.neuron.2005.04.024; Pimentel B, 2002, DEV BIOL, V247, P295, DOI 10.1006/dbio.2002.0703; Pines J, 2001, NAT CELL BIOL, V3, pE3, DOI 10.1038/35050676; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; Pyronnet S, 2000, MOL CELL, V5, P607, DOI 10.1016/S1097-2765(00)80240-3; Ramirez-Valle F, 2010, MOL CELL BIOL, V30, P3151, DOI 10.1128/MCB.00322-09; Rehen SK, 2002, BRAIN RES, V947, P78, DOI 10.1016/S0006-8993(02)02909-8; Roberts EC, 2002, MOL CELL BIOL, V22, P7226, DOI 10.1128/MCB.22.20.7226-7241.2002; Sadler KC, 1998, DEV BIOL, V197, P25, DOI 10.1006/dbio.1998.8869; Sanches G, 2002, INT J DEV NEUROSCI, V20, P21, DOI 10.1016/S0736-5748(02)00004-7; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shimada M, 2003, J ENDOCRINOL, V179, P25, DOI 10.1677/joe.0.1790025; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Shin I, 2005, J BIOL CHEM, V280, P6055, DOI 10.1074/jbc.M412367200; Sholl-Franco A, 2010, INT J DEV NEUROSCI, V28, P63, DOI 10.1016/j.ijdevneu.2009.09.004; Shtivelman E, 2002, CURR BIOL, V12, P919, DOI 10.1016/S0960-9822(02)00843-6; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; TASSAN JP, 1994, J CELL BIOL, V127, P467, DOI 10.1083/jcb.127.2.467; Van Hooser A, 1998, J CELL SCI, V111, P3497; Wakefield JG, 2003, J CELL SCI, V116, P637, DOI 10.1242/jcs.00273; WELCH PJ, 1992, P NATL ACAD SCI USA, V89, P3093, DOI 10.1073/pnas.89.7.3093; Wymann MP, 2003, TRENDS PHARMACOL SCI, V24, P366, DOI 10.1016/S0165-6147(03)00163-9	60	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53517	10.1371/journal.pone.0053517	http://dx.doi.org/10.1371/journal.pone.0053517			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301080	gold, Green Published, Green Submitted			2022-12-25	WOS:000313320900082
J	Ramachandran, S; Chakraborty, A; Xu, L; Mei, YW; Samso, M; Dokholyan, NV; Meissner, G				Ramachandran, Srinivas; Chakraborty, Asima; Xu, Le; Mei, Yingwu; Samso, Montserrat; Dokholyan, Nikolay V.; Meissner, Gerhard			Structural Determinants of Skeletal Muscle Ryanodine Receptor Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ RELEASE CHANNEL; DISCRETE MOLECULAR-DYNAMICS; PROTEIN DATABASE SEARCHES; VOLTAGE SENSOR; CRYSTAL-STRUCTURE; S4-S5 LINKER; TOPOLOGY PREDICTION; ACTIVATION GATE; PSI-BLAST; MOVEMENT	Ryanodine receptor type 1 (RyR1) releases Ca2+ from intracellular stores upon nerve impulse to trigger skeletal muscle contraction. Effector binding at the cytoplasmic domain tightly controls gating of the pore domain of RyR1 to release Ca2+. However, the molecular mechanism that links effector binding to channel gating is unknown due to lack of structural data. Here, we used a combination of computational and electrophysiological methods and cryo-EM densities to generate structural models of the open and closed states of RyR1. Using our structural models, we identified an interface between the pore-lining helix (Tyr-4912-Glu-4948) and a linker helix (Val-4830-Val-4841) that lies parallel to the cytoplasmic membrane leaflet. To test the hypothesis that this interface controls RyR1 gating, we designed mutations in the linker helix to stabilize either the open (V4830W and T4840W) or closed (H4832W and G4834W) state and validated them using single channel experiments. To further confirm this interface, we designed mutations in the pore-lining helix to stabilize the closed state (Q4947N, Q4947T, and Q4947S), which we also validated using single channel experiments. The channel conductance and selectivity of the mutations that we designed in the linker and pore-lining helices were indistinguishable from those of WT RyR1, demonstrating our ability to modulate RyR1 gating without affecting ion permeation. Our integrated computational and experimental approach significantly advances the understanding of the structure and function of an unusually large ion channel.	[Ramachandran, Srinivas; Chakraborty, Asima; Xu, Le; Mei, Yingwu; Dokholyan, Nikolay V.; Meissner, Gerhard] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Samso, Montserrat] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23298 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Virginia Commonwealth University	Samso, M (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, Med Coll Virginia Campus, Richmond, VA 23298 USA.	msamso@vcu.edu; dokh@unc.edu; meissner@med.unc.edu	Dokholyan, Nikolay/D-8081-2018; Xu, Le/HDN-9623-2022	Dokholyan, Nikolay/0000-0002-8225-4025; Samso, Montserrat/0000-0002-2788-3283; Ramachandran, Srinivas/0000-0003-2929-1377	National Institutes of Health [AR018687]; American Heart Association Predoctoral Fellowship [09PRE2090068]; Virginia Commonwealth University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR018687, R01AR018687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowship(American Heart Association); Virginia Commonwealth University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR018687 (to G. M. and N. V. D.). This work was also supported by American Heart Association Predoctoral Fellowship 09PRE2090068 (to S. R.) and Virginia Commonwealth University startup funds (to M. S.).	Alam A, 2009, NAT STRUCT MOL BIOL, V16, P30, DOI 10.1038/nsmb.1531; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Balshaw D, 1999, P NATL ACAD SCI USA, V96, P3345, DOI 10.1073/pnas.96.7.3345; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bernsel A, 2008, P NATL ACAD SCI USA, V105, P7177, DOI 10.1073/pnas.0711151105; CALLAWAY C, 1994, J BIOL CHEM, V269, P15876; Caprini M, 2005, J BIOL CHEM, V280, P18253, DOI 10.1074/jbc.M413389200; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Clayton GM, 2008, P NATL ACAD SCI USA, V105, P1511, DOI 10.1073/pnas.0711533105; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; Decher N, 2004, J BIOL CHEM, V279, P13859, DOI 10.1074/jbc.M313704200; Ding F, 2008, STRUCTURE, V16, P1010, DOI 10.1016/j.str.2008.03.013; Ding F, 2006, PLOS COMPUT BIOL, V2, P725, DOI 10.1371/journal.pcbi.0020085; Dokholyan NV, 1998, FOLD DES, V3, P577, DOI 10.1016/S1359-0278(98)00072-8; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Du GG, 2002, P NATL ACAD SCI USA, V99, P16725, DOI 10.1073/pnas.012688999; Du GG, 2004, J BIOL CHEM, V279, P37566, DOI 10.1074/jbc.M406637200; Ferrer T, 2006, J BIOL CHEM, V281, P12858, DOI 10.1074/jbc.M513518200; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Gao L, 2000, BIOPHYS J, V79, P828, DOI 10.1016/S0006-3495(00)76339-9; Gao L, 1997, FEBS LETT, V412, P223, DOI 10.1016/S0014-5793(97)00781-3; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Klein A, 2012, HUM MUTAT, V33, P981, DOI 10.1002/humu.22056; Kota P, 2011, BIOINFORMATICS, V27, P2209, DOI 10.1093/bioinformatics/btr374; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; LEE HB, 1994, J BIOL CHEM, V269, P13305; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Ludtke SJ, 2005, STRUCTURE, V13, P1203, DOI 10.1016/j.str.2005.06.005; Meissner G, 2004, CELL CALCIUM, V35, P621, DOI 10.1016/j.ceca.2004.01.015; Mitaku S, 2002, BIOINFORMATICS, V18, P608, DOI 10.1093/bioinformatics/18.4.608; Murayama T, 2011, J BIOL CHEM, V286, P35571, DOI 10.1074/jbc.M111.255240; Nugent T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-159; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; RADERMACHER M, 1994, J CELL BIOL, V127, P411, DOI 10.1083/jcb.127.2.411; Ramachandran S, 2011, PROTEINS, V79, P261, DOI 10.1002/prot.22879; RIOS E, 1991, PHYSIOL REV, V71, P849, DOI 10.1152/physrev.1991.71.3.849; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Seo MD, 2012, NATURE, V483, P108, DOI 10.1038/nature10751; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Shirvanyants D, 2012, J PHYS CHEM B, V116, P8375, DOI 10.1021/jp2114576; Sutko JL, 1997, PHARMACOL REV, V49, P53; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; Viklund H, 2004, PROTEIN SCI, V13, P1908, DOI 10.1110/ps.04625404; Viklund H, 2008, BIOINFORMATICS, V24, P1662, DOI 10.1093/bioinformatics/btn221; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Wang Y, 2006, J BIOL CHEM, V281, P15572, DOI 10.1074/jbc.M600090200; WILLIAMS AJ, 1992, J MUSCLE RES CELL M, V13, P7, DOI 10.1007/BF01738423; Xu L, 2006, BIOPHYS J, V90, P443, DOI 10.1529/biophysj.105.072538; Yarov-Yarovoy V, 2012, P NATL ACAD SCI USA, V109, pE93, DOI 10.1073/pnas.1118434109; Yin S, 2008, J CHEM INF MODEL, V48, P1656, DOI 10.1021/ci8001167; Yin S, 2007, STRUCTURE, V15, P1567, DOI 10.1016/j.str.2007.09.024; Yin SY, 2007, NAT METHODS, V4, P466, DOI 10.1038/nmeth0607-466; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971	59	41	41	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6154	6165		10.1074/jbc.M112.433789	http://dx.doi.org/10.1074/jbc.M112.433789			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23319589	Green Published, hybrid			2022-12-25	WOS:000315820700012
J	Gonzalez, W; Zuniga, L; Cid, LP; Arevalo, B; Niemeyer, MI; Sepulveda, FV				Gonzalez, Wendy; Zuniga, Leandro; Cid, L. Pablo; Arevalo, Barbara; Niemeyer, Maria Isabel; Sepulveda, Francisco V.			An Extracellular Ion Pathway Plays a Central Role in the Cooperative Gating of a K-2P K+ Channel by Extracellular pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN POTASSIUM CHANNEL; 2-PORE DOMAIN; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; TASK-3; PORE; BLOCK; SENSITIVITY; SELECTIVITY; MECHANISM	Proton-gated TASK-3K(+) channel belongs to the K-2P family of proteins that underlie the K+ leak setting the membrane potential in all cells. TASK-3 is under cooperative gating control by extracellular [H+]. Use of recently solved K-2P structures allows us to explore the molecular mechanism of TASK-3 cooperative pH gating. Tunnel-like side portals define an extracellular ion pathway to the selectivity filter. We use a combination of molecular modeling and functional assays to show that pH-sensing histidine residues and K+ ions mutually interact electrostatically in the confines of the extracellular ion pathway. K+ ions modulate the pK(a) of sensing histidine side chains whose charge states in turn determine the open/closed transition of the channel pore. Cooperativity, and therefore steep dependence of TASK-3 K+ channel activity on extracellular pH, is dependent on an effect of the permeant ion on the channel pH(o) sensors.	[Zuniga, Leandro; Cid, L. Pablo; Niemeyer, Maria Isabel; Sepulveda, Francisco V.] Ctr Estudios Cient, Valdivia 5110466, Chile; [Gonzalez, Wendy; Arevalo, Barbara] Univ Talca, Ctr Bioinformat & Simulac Mol, Talca 3465548, Chile	Universidad de Talca	Niemeyer, MI (corresponding author), Ctr Estudios Cient, Ave Arturo Prat 514, Valdivia 5110466, Chile.	miniemeyer@cecs.cl; fsepulveda@cecs.cl		Sepulveda Valenzuela, Francisco Leandro/0000-0003-0022-6598; Cid, Pablo/0000-0003-0394-0498	Fondecyt [1090478, 11100373]; Conicyt Base Finance Program	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Conicyt Base Finance Program	This work was supported by Fondecyt Grants 1090478 (to M.I.N.) and 11100373 (to W.G.).; We are grateful to Dr. Jurgen Daut (Marburg, Germany) and Donghee Kim (Chicago, IL) for providing TASK-3 and TASK-1 cDNAs and to Dr. Jacques Teulon (Paris, France) for comments on a preliminary version of the paper. CECs is funded by the Conicyt Base Finance Program.	Barel O, 2008, AM J HUM GENET, V83, P193, DOI 10.1016/j.ajhg.2008.07.010; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Carvacho I, 2008, J GEN PHYSIOL, V131, P147, DOI 10.1085/jgp.200709862; Chatelain FC, 2012, P NATL ACAD SCI USA, V109, P5499, DOI 10.1073/pnas.1201132109; Cid LP, 2000, AM J PHYSIOL-CELL PH, V279, pC1198, DOI 10.1152/ajpcell.2000.279.4.C1198; Clarke CE, 2008, J BIOL CHEM, V283, P16985, DOI 10.1074/jbc.M801368200; Clarke CE, 2004, J PHYSIOL-LONDON, V560, P51, DOI 10.1113/jphysiol.2004.070292; Cohen A, 2009, EUR BIOPHYS J BIOPHY, V39, P61, DOI 10.1007/s00249-009-0457-6; Czirjak G, 2003, MOL PHARMACOL, V63, P646, DOI 10.1124/mol.63.3.646; Davies LA, 2008, P NATL ACAD SCI USA, V105, P2203, DOI 10.1073/pnas.0712000105; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Guagliardo NA, 2012, HYPERTENSION, V59, P999, DOI 10.1161/HYPERTENSIONAHA.111.189662; Ho MC, 2009, NATURE, V459, P393, DOI 10.1038/nature07938; HODGKIN AL, 1947, J PHYSIOL-LONDON, V106, P341, DOI 10.1113/jphysiol.1947.sp004216; Niemeyer MI, 2010, J BIOL CHEM, V285, P16467, DOI 10.1074/jbc.M110.107060; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim D, 2009, J PHYSIOL-LONDON, V587, P2963, DOI 10.1113/jphysiol.2009.171181; Kim Y, 2000, J BIOL CHEM, V275, P9340, DOI 10.1074/jbc.275.13.9340; Kollewe A, 2009, J GEN PHYSIOL, V134, P53, DOI 10.1085/jgp.200910235; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lesage F, 2011, PHYSIOLOGY, V26, P424, DOI 10.1152/physiol.00029.2011; Lopes CMB, 2001, J BIOL CHEM, V276, P24449, DOI 10.1074/jbc.C100184200; Lopes CMB, 2000, J BIOL CHEM, V275, P16969, DOI 10.1074/jbc.M001948200; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; Musset B, 2006, J PHYSIOL-LONDON, V572, P639, DOI 10.1113/jphysiol.2006.106898; Niemeyer MI, 2007, P NATL ACAD SCI USA, V104, P666, DOI 10.1073/pnas.0606173104; Niemeyer MI, 2001, J BIOL CHEM, V276, P43166, DOI 10.1074/jbc.M107192200; Pang DSJ, 2009, P NATL ACAD SCI USA, V106, P17546, DOI 10.1073/pnas.0907228106; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piechotta PL, 2011, EMBO J, V30, P3607, DOI 10.1038/emboj.2011.268; Rajan S, 2000, J BIOL CHEM, V275, P16650, DOI 10.1074/jbc.M000030200; Stansfeld PJ, 2008, BIOCHEMISTRY-US, V47, P7414, DOI 10.1021/bi800475j; YON J, 1989, NUCLEIC ACIDS RES, V17, P4895, DOI 10.1093/nar/17.12.4895; Yuill KH, 2007, PFLUG ARCH EUR J PHY, V455, P333, DOI 10.1007/s00424-007-0282-7; Zuniga L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016141	39	30	30	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5984	5991		10.1074/jbc.M112.445528	http://dx.doi.org/10.1074/jbc.M112.445528			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23319597	Green Published, hybrid			2022-12-25	WOS:000315342500066
J	Sarabhai, S; Sharma, P; Capalash, N				Sarabhai, Sajal; Sharma, Prince; Capalash, Neena			Ellagic Acid Derivatives from Terminalia chebula Retz. Downregulate the Expression of Quorum Sensing Genes to Attenuate Pseudomonas aeruginosa PAO1 Virulence	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; BIOFILM FORMATION; MEDICINAL-PLANTS; CYSTIC-FIBROSIS; INHIBITORS; FRUITS; TRANSCRIPTION; STRAINS; TANNINS; GROWTH	Background: Burgeoning antibiotic resistance in Pseudomonas aeruginosa has necessitated the development of anti pathogenic agents that can quench acylhomoserine lactone (AHL) mediated QS with least risk of resistance. This study explores the anti quorum sensing potential of T. chebula Retz. and identification of probable compounds(s) showing anti QS activity and the mechanism of attenuation of P. aeruginosa PAO1 virulence factors. Methods and Results: Methanol extract of T. chebula Retz. fruit showed anti QS activity using Agrobacterium tumefaciens A136. Bioactive fraction (F7), obtained by fractionation of methanol extract using Sephadex LH20, showed significant reduction (p<0.001) in QS regulated production of extracellular virulence factors in P. aeruginosa PAO1. Biofilm formation and alginate were significantly (p<0.05) reduced with enhanced (20%) susceptibility to tobramycin. Real Time PCR of F7 treated P. aeruginosa showed down regulation of autoinducer synthase (lasI and rhlI) and their cognate receptor (lasR and rhlR) genes by 89, 90, 90 and 93%, respectively. Electrospray Ionization Mass Spectrometry also showed 90 and 64% reduction in the production of 3-oxo-C12HSL and C4HSL after treatment. Decrease in AHLs as one of the mechanisms of quorum quenching by F7 was supported by the reversal of inhibited swarming motility in F7-treated P. aeruginosa PAO1 on addition of C4HSL. F7 also showed antagonistic activity against 3-oxo-C12HSL-dependent QS in E. coli bioreporter. C. elegans fed on F7-treated P. aeruginosa showed enhanced survival with LT50 increasing from 24 to 72 h. LC-ESI-MS of F7 revealed the presence of ellagic acid derivatives responsible for anti QS activity in T. chebula extract. Conclusions: This is the first report on anti QS activity of T. chebula fruit linked to EADs which down regulate the expression of lasIR and rhlIR genes with concomitant decrease in AHLs in P. aeruginosa PAO1 causing attenuation of its virulence factors and enhanced sensitivity of its biofilm towards tobramycin.	[Sarabhai, Sajal; Sharma, Prince] Panjab Univ, Dept Microbiol, Chandigarh 160014, India; [Capalash, Neena] Panjab Univ, Dept Biotechnol, Chandigarh 160014, India	Panjab University; Panjab University	Capalash, N (corresponding author), Panjab Univ, Dept Biotechnol, Chandigarh 160014, India.	caplash@pu.ac.in		Capalash, Neena/0000-0002-0197-8428	Council of Scientific and Industrial Research (CSIR) [09/135(0544)/2008-EMR-I]	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	Funding in the form of a fellowship to Sajal Sarabhai from the Council of Scientific and Industrial Research (CSIR) is acknowledged [Grant no: 09/135(0544)/2008-EMR-I]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adonizio A, 2008, ANTIMICROB AGENTS CH, V52, P198, DOI 10.1128/AAC.00612-07; Adonizio AL, 2006, J ETHNOPHARMACOL, V105, P427, DOI 10.1016/j.jep.2005.11.025; Agarwal V, 2008, MYCOPATHOLOGIA, V165, P13, DOI 10.1007/s11046-007-9077-9; Amara N, 2009, J AM CHEM SOC, V131, P10610, DOI 10.1021/ja903292v; Anwesa Bag, 2009, African Journal of Plant Science, V3, P25; Babic F, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-148; Balasubramanian D, 2011, J MED MICROBIOL, V60, P147, DOI 10.1099/jmm.0.021600-0; Bjarnsholt T, 2005, MICROBIOL-SGM, V151, P3873, DOI 10.1099/mic.0.27955-0; Chalise JP, 2010, INT J FOOD SCI NUTR, V61, P425, DOI 10.3109/09637481003591590; Cheng HY, 2002, ANTIVIR RES, V55, P447, DOI 10.1016/S0166-3542(02)00077-3; Chugani SA, 2001, P NATL ACAD SCI USA, V98, P2752, DOI 10.1073/pnas.051624298; Dekimpe V, 2009, MICROBIOL-SGM, V155, P712, DOI 10.1099/mic.0.022764-0; Doring G, 2000, EUR RESPIR J, V16, P749, DOI 10.1034/j.1399-3003.2000.16d30.x; Drewnowski A, 2000, AM J CLIN NUTR, V72, P1424; FRANKLIN MJ, 1993, J BACTERIOL, V175, P5057, DOI 10.1128/JB.175.16.5057-5065.1993; Fuqua C, 1996, J BACTERIOL, V178, P435, DOI 10.1128/jb.178.2.435-440.1996; Gallagher LA, 2001, J BACTERIOL, V183, P6207, DOI 10.1128/JB.183.21.6207-6214.2001; Gao H, 2008, BIOSCI BIOTECH BIOCH, V72, P601, DOI 10.1271/bbb.70591; Haagensen JAJ, 2007, J BACTERIOL, V189, P28, DOI 10.1128/JB.00720-06; Harborne J, 1973, PHYTOCHEMICALS METHO; Hentzer M, 2003, BIODRUGS, V17, P241, DOI 10.2165/00063030-200317040-00003; Hoang TT, 1999, MOL MICROBIOL, V45, P1655; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Huber B, 2003, Z NATURFORSCH C, V58, P879; Jakobsen TH, 2012, ANTIMICROB AGENTS CH, V56, P2314, DOI 10.1128/AAC.05919-11; Jakobsen TH, 2012, APPL ENVIRON MICROB, V78, P2410, DOI 10.1128/AEM.05992-11; Jimenez PN, 2012, MICROBIOL MOL BIOL R, V76, P46, DOI 10.1128/MMBR.05007-11; Juang LJ, 2004, J SEP SCI, V27, P718, DOI 10.1002/jssc.200401741; Kannan P, 2009, AFR J MICROBIOL RES, V3, P180; Kaur Kamaljit, 2002, Journal of Environmental Pathology Toxicology and Oncology, V21, P45; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Kociolek Martin G., 2009, Anti-Infective Agents in Medicinal Chemistry, V8, P315; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; Lee JH, 2006, MOL MICROBIOL, V59, P602, DOI 10.1111/j.1365-2958.2005.04960.x; Makemson J, 2006, LUMINESCENCE, V21, P1, DOI 10.1002/bio.873; Manefield M, 2002, MICROBIOL-SGM, V148, P1119, DOI 10.1099/00221287-148-4-1119; May CO, 2011, APPL ENVIRON MICROB, V77, P3061; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; MCCLURE CD, 1992, J LEUKOCYTE BIOL, V51, P97, DOI 10.1002/jlb.51.2.97; Miller JH., 1972, EXPT MOL GENETICS; Ni NT, 2009, MED RES REV, V29, P65, DOI 10.1002/med.20145; O'Donovan L, 2001, MICROBIOL-SGM, V147, P1025, DOI 10.1099/00221287-147-4-1025; Oncul O, 2009, INDIAN J MED RES, V130, P758; Pesci EC, 1997, J BACTERIOL, V179, P3127, DOI 10.1128/jb.179.10.3127-3132.1997; Pfundstein B, 2010, PHYTOCHEMISTRY, V71, P1132, DOI 10.1016/j.phytochem.2010.03.018; Quave CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028737; Rambaugh KP, 2006, APPL ENVIRON MICROB, V72, P5135; Rasmussen TB, 2006, MICROBIOL-SGM, V152, P895, DOI 10.1099/mic.0.28601-0; Reddy DB, 2009, J ETHNOPHARMACOL, V124, P506, DOI 10.1016/j.jep.2009.05.022; Rudrappa T, 2008, J AGR FOOD CHEM, V56, P1955, DOI 10.1021/jf072591j; Sadlon AE, 2010, ALTERN MED REV, V15, P33; Saleem A, 2002, J ETHNOPHARMACOL, V81, P327, DOI 10.1016/S0378-8741(02)00099-5; Senturk S, 2012, J INFECT DEV COUNTR, V6, P501; Shaw PD, 1997, P NATL ACAD SCI USA, V94, P6036, DOI 10.1073/pnas.94.12.6036; Shin TY, 2001, J ETHNOPHARMACOL, V74, P133, DOI 10.1016/S0378-8741(00)00360-3; Srikumar R, 2005, BIOL PHARM BULL, V28, P1398, DOI 10.1248/bpb.28.1398; Stehling EG, 2008, BRAZ J INFECT DIS, V12, P86, DOI 10.1590/S1413-86702008000100018; Suguna L, 2002, PHYTOTHER RES, V16, P227, DOI 10.1002/ptr.827; Taganna JC, 2011, J ETHNOPHARMACOL, V134, P865, DOI 10.1016/j.jep.2011.01.028; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Vandeputte OM, 2010, APPL ENVIRON MICROB, V76, P243, DOI 10.1128/AEM.01059-09; Vattem DA, 2005, ASIA PAC J CLIN NUTR, V14, P120; Wang EW, 2005, ARCH OTOLARYNGOL, V131, P983, DOI 10.1001/archotol.131.11.983; Yates EA, 2002, INFECT IMMUN, V70, P5635, DOI 10.1128/IAI.70.10.5635-5646.2002; Zahin M, 2010, INDIAN J EXP BIOL, V48, P1219; Zhu H, 2002, J MED MICROBIOL, V51, P1063, DOI 10.1099/0022-1317-51-12-1063	66	139	148	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53441	10.1371/journal.pone.0053441	http://dx.doi.org/10.1371/journal.pone.0053441			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320085	Green Published, gold, Green Submitted			2022-12-25	WOS:000313429800050
J	Vecile, E; Dobrina, A; Salloum, FN; Van Tassell, BW; Falcione, A; Gustini, E; Secchiero, S; Crovella, S; Sinagra, G; Finato, N; Nicklin, MJ; Abbate, A				Vecile, Elena; Dobrina, Aldo; Salloum, Fadi N.; Van Tassell, Benjamin W.; Falcione, Antonella; Gustini, Edoardo; Secchiero, Samuele; Crovella, Sergio; Sinagra, Gianfranco; Finato, Nicoletta; Nicklin, Martin J.; Abbate, Antonio			Intracellular Function of Interleukin-1 Receptor Antagonist in Ischemic Cardiomyocytes	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CYTOCHROME-C RELEASE; IN-VIVO; AUTOINFLAMMATORY DISEASE; CASPASE ACTIVATION; GENE-EXPRESSION; IAP PROTEINS; APOPTOSIS; INHIBITION; CELLS	Background: Loss of cardiac myocytes due to apoptosis is a relevant feature of ischemic heart disease. It has been described in infarct and peri-infarct regions of the myocardium in coronary syndromes and in ischemia-linked heart remodeling. Previous studies have provided protection against ischemia-induced cardiomyocyte apoptosis by the anti-inflammatory cytokine interleukin-1 receptor-antagonist (IL-1Ra). Mitochondria triggering of caspases plays a central role in ischemia-induced apoptosis. We examined the production of IL-1Ra in the ischemic heart and, based on dual intra/extracellular function of some other interleukins, we hypothesized that IL-1Ra may also directly inhibit mitochondria-activated caspases and cardiomyocyte apoptosis. Methodology/Principal Findings: Synthesis of IL-1Ra was evidenced in the hearts explanted from patients with ischemic heart disease. In the mouse ischemic heart and in a mouse cardiomyocyte cell line exposed to long-lasting hypoxia, IL-1Ra bound and inhibited mitochondria-activated caspases, whereas inhibition of caspase activation was not observed in the heart of mice lacking IL-1Ra (Il-1ra-/-) or in siRNA to IL-1Ra-interfered cells. An impressive 6-fold increase of hypoxia-induced apoptosis was observed in cells lacking IL-1Ra. IL-1Ra down-regulated cells were not protected against caspase activation and apoptosis by knocking down of the IL-1 receptor, confirming the intracellular, receptor-independent, antiapoptotic function of IL-1Ra. Notably, the inhibitory effect of IL-1Ra was not influenced by enduring ischemic conditions in which previously described physiologic inhibitors of apoptosis are neutralized. Conclusions/Significance: These observations point to intracellular IL-1Ra as a critical mechanism of the cell self-protection against ischemia-induced apoptosis and suggest that this cytokine plays an important role in the remodeling of heart by promoting survival of cardiomyocytes in the ischemic regions.	[Vecile, Elena; Dobrina, Aldo; Falcione, Antonella; Gustini, Edoardo; Secchiero, Samuele] Univ Trieste, Dept Life Sci, I-34127 Trieste, Italy; [Salloum, Fadi N.; Van Tassell, Benjamin W.; Abbate, Antonio] Virginia Commonwealth Univ, Victoria Johnson Res Lab, Richmond, VA USA; [Salloum, Fadi N.; Van Tassell, Benjamin W.; Abbate, Antonio] Virginia Commonwealth Univ, VCU Pauley Heart Ctr, Richmond, VA USA; [Crovella, Sergio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Sinagra, Gianfranco] Univ Trieste, Cardiovasc Dept, I-34127 Trieste, Italy; [Finato, Nicoletta] Univ Udine, Dept Med & Morphol Res, I-33100 Udine, Italy; [Nicklin, Martin J.] Univ Sheffield, Sir Henry Wellcome Labs Med Res, Div Genom Med, Sheffield S10 2TN, S Yorkshire, England	University of Trieste; Virginia Commonwealth University; Virginia Commonwealth University; IRCCS Burlo Garofolo; University of Trieste; University of Udine; University of Sheffield	Dobrina, A (corresponding author), Univ Trieste, Dept Life Sci, I-34127 Trieste, Italy.	dobrina@units.it	Crovella, Sergio/K-5050-2016; Sinagra, Gianfranco/AAE-3943-2020; sinagra, gianfranco gs/P-7643-2014; Abbate, Antonio/G-8805-2016; Salloum, Fadi N/C-2391-2008; Abbate, Antonio/E-3405-2014	Crovella, Sergio/0000-0001-8493-1168; Abbate, Antonio/0000-0002-1930-785X; Salloum, Fadi N/0000-0002-8947-9315; SINAGRA, GIANFRANCO/0000-0003-2700-8478; Nicklin, Martin/0000-0002-0127-1131; Dobrina, Aldo/0000-0002-8393-1796	Italian Ministero dell'Universita e della Ricerca; American Heart Association;  [KL2RR031989-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000057] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR031989] Funding Source: NIH RePORTER	Italian Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); American Heart Association(American Heart Association); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by funds of the Italian Ministero dell'Universita e della Ricerca and by an American Heart Association Beginning Grant-in-Aid (Mid-Atlantic Affiliate) to AA. FNS is supported by an American Heart Association Scientist Development Grant. BWVT is supported by an institutional KL2RR031989-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2005, EUR HEART J, V26, P2039, DOI 10.1093/eurheartj/ehi419; Abbate A, 2008, CIRCULATION, V117, P2670, DOI 10.1161/CIRCULATIONAHA.107.740233; Abbate A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027923; Aksentijevich I, 2009, NEW ENGL J MED, V360, P2426, DOI 10.1056/NEJMoa0807865; AREND WP, 1991, J CLIN INVEST, V88, P1445, DOI 10.1172/JCI115453; Banda NK, 2005, J IMMUNOL, V174, P3608, DOI 10.4049/jimmunol.174.6.3608; Biasucci LM, 1999, CIRCULATION, V99, P2079, DOI 10.1161/01.CIR.99.16.2079; Boniotto M, 2003, EUR J HISTOCHEM, V47, P177; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cortes A, 2001, BIOCHEM J, V357, P263, DOI 10.1042/0264-6021:3570263; de Moissac D, 2000, J MOL CELL CARDIOL, V32, P53, DOI 10.1006/jmcc.1999.1057; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dinarello CA, 2009, NEW ENGL J MED, V360, P2467, DOI 10.1056/NEJMe0811014; Donath S, 2006, CIRCULATION, V113, P1203, DOI 10.1161/CIRCULATIONAHA.105.576785; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Ekert PG, 1999, CELL DEATH DIFFER, V6, P1081, DOI 10.1038/sj.cdd.4400594; Ekhterae D, 1999, CIRC RES, V85, pE70; Gabay C, 1997, J IMMUNOL, V159, P5905; Gabay C, 1999, CYTOKINE, V11, P561, DOI 10.1006/cyto.1998.0451; Garcia-Calvo M, 1999, CELL DEATH DIFFER, V6, P362, DOI 10.1038/sj.cdd.4400497; Kostin S, 2003, CIRC RES, V92, P715, DOI 10.1161/01.RES.0000067471.95890.5C; Larsen CM, 2009, DIABETES CARE, V32, P1663, DOI 10.2337/dc09-0533; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Narula J, 1999, P NATL ACAD SCI USA, V96, P8144, DOI 10.1073/pnas.96.14.8144; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nicklin MJH, 2000, J EXP MED, V191, P303, DOI 10.1084/jem.191.2.303; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Palmer G, 2011, NAT REV RHEUMATOL, V7, P321, DOI 10.1038/nrrheum.2011.53; Patti G, 2004, J AM COLL CARDIOL, V43, P35, DOI 10.1016/j.jacc.2003.07.032; Recchia AG, 2009, J MOL CELL CARDIOL, V46, P352, DOI 10.1016/j.yjmcc.2008.11.017; Reddy S, 2009, NEW ENGL J MED, V360, P2438, DOI 10.1056/NEJMoa0809568; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Suzuki K, 2001, CIRCULATION, V104, pI308; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Werman A, 2004, P NATL ACAD SCI USA, V101, P2434, DOI 10.1073/pnas.0308705101; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	39	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53265	10.1371/journal.pone.0053265	http://dx.doi.org/10.1371/journal.pone.0053265			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308180	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000313429800035
J	Verdurand, M; Fillman, SG; Weickert, CS; Zavitsanou, K				Verdurand, Mathieu; Fillman, Stu G.; Weickert, Cynthia Shannon; Zavitsanou, Katerina			Increases in [H-3]Muscimol and [H-3]Flumazenil Binding in the Dorsolateral Prefrontal Cortex in Schizophrenia Are Linked to alpha 4 and gamma 2S mRNA Levels Respectively	PLOS ONE			English	Article							BENZODIAZEPINE-RECEPTOR-BINDING; AMINOBUTYRIC ACID(A) RECEPTORS; GABA(A) RECEPTOR; A RECEPTOR; GENE-EXPRESSION; HIPPOCAMPAL-FORMATION; NEUROTROPHIC FACTOR; CORTICAL GABA(A); POSTMORTEM-BRAIN; CINGULATE CORTEX	Background: GABA(A) receptors (GABA(A)R) are composed of several subunits that determine sensitivity to drugs, synaptic localisation and function. Recent studies suggest that agonists targeting selective GABA(A)R subunits may have therapeutic value against the cognitive impairments observed in schizophrenia. In this study, we determined whether GABA(A)R binding deficits exist in the dorsolateral prefrontal cortex (DLPFC) of people with schizophrenia and tested if changes in GABA(A)R binding are related to the changes in subunit mRNAs. The GABA orthosteric and the benzodiazepine allosteric binding sites were assessed autoradiographically using [H-3]Muscimol and [H-3]Flumazenil, respectively, in a large cohort of individuals with schizophrenia (n = 37) and their matched controls (n = 37). We measured, using qPCR, mRNA of beta (beta 1, beta 2, beta 3), gamma (gamma 1, gamma 2, gamma 2S for short and gamma 2L for long isoform, gamma 3) and delta subunits and used our previous measurements of GABA(A)R alpha subunit mRNAs in order to relate mRNAs and binding through correlation and regression analysis. Results: Significant increases in both [H-3]Muscimol (p = 0.016) and [H-3]Flumazenil (p = 0.012) binding were found in the DLPFC of schizophrenia patients. Expression levels of mRNA subunits measured did not show any significant difference in schizophrenia compared to controls. Regression analysis revealed that in schizophrenia, the [H-3]Muscimol binding variance was most related to alpha 4 mRNA levels and the [H-3]Flumazenil binding variance was most related to gamma 2S subunit mRNA levels. [H-3]Muscimol and [H-3]Flumazenil binding were not affected by the lifetime anti-psychotics dose (chlorpromazine equivalent). Conclusions: We report parallel increases in orthosteric and allosteric GABA(A)R binding sites in the DLPFC in schizophrenia that may be related to a "shift" in subunit composition towards alpha 4 and gamma 2S respectively, which may compromise normal GABAergic modulation and function. Our results may have implications for the development of treatment strategies that target specific GABA(A)R receptor subunits.	[Verdurand, Mathieu; Fillman, Stu G.; Weickert, Cynthia Shannon; Zavitsanou, Katerina] Schizophrenia Res Inst, Sydney, NSW, Australia; [Fillman, Stu G.; Weickert, Cynthia Shannon; Zavitsanou, Katerina] Neurosci Res Australia, Sydney, NSW, Australia; [Fillman, Stu G.; Weickert, Cynthia Shannon; Zavitsanou, Katerina] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Verdurand, Mathieu] Australian Nucl Sci & Technol Org, ANSTO LifeSci, Sydney, NSW, Australia	Neuroscience Research Australia; University of New South Wales Sydney; Australian Nuclear Science & Technology Organisation	Zavitsanou, K (corresponding author), Schizophrenia Res Inst, Sydney, NSW, Australia.	k.zavitsanou@neura.edu.au	Zavitsanou, Katerina/G-5936-2012	Shannon Weickert, Cynthia/0000-0002-4560-0259; Verdurand, Mathieu/0000-0003-2619-3907	Schizophrenia Research Institute; NSW Ministry of Health; Macquarie Group Foundation; University of New South Wales, and Neuroscience Research Australia; National Health and Medical Research Council of Australia; National Institute of Alcohol Abuse and Alcoholism [R24AA012725]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA012725, R28AA012725] Funding Source: NIH RePORTER	Schizophrenia Research Institute; NSW Ministry of Health; Macquarie Group Foundation; University of New South Wales, and Neuroscience Research Australia; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by Schizophrenia Research Institute (utilising infrastructure funding from the NSW Ministry of Health and the Macquarie Group Foundation), the University of New South Wales, and Neuroscience Research Australia. The New South Wales Tissue Resource Centre at the University of Sydney is supported by the National Health and Medical Research Council of Australia, Schizophrenia Research Institute, and National Institute of Alcohol Abuse and Alcoholism (grant number R24AA012725). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Dargham A, 1999, NEUROPSYCHOPHARMACOL, V20, P650, DOI 10.1016/S0893-133X(98)00107-9; AKBARIAN S, 1995, ARCH GEN PSYCHIAT, V52, P258, DOI 10.1001/archpsyc.1995.03950160008002; Baer K, 2000, EUR J NEUROSCI, V12, P2639, DOI 10.1046/j.1460-9568.2000.00159.x; Ball S, 1998, BIOL PSYCHIAT, V43, P107, DOI 10.1016/S0006-3223(97)00300-4; Benes FM, 1996, NEUROSCIENCE, V75, P1021, DOI 10.1016/0306-4522(96)00328-4; BENES FM, 1992, J NEUROSCI, V12, P924; Benes FM, 1996, SYNAPSE, V22, P338; Benes FM, 1997, BRAIN RES, V755, P121, DOI 10.1016/S0006-8993(97)00113-3; Beneyto M, 2011, CEREB CORTEX, V21, P999, DOI 10.1093/cercor/bhq169; Boileau AJ, 2010, J NEUROSCI, V30, P4895, DOI 10.1523/JNEUROSCI.5039-09.2010; Busatto GF, 1997, AM J PSYCHIAT, V154, P56; Connolly CN, 1999, MOL CELL NEUROSCI, V13, P259, DOI 10.1006/mcne.1999.0746; Daskalakis ZJ, 2007, BRAIN RES REV, V56, P427, DOI 10.1016/j.brainresrev.2007.09.006; Dean B, 1999, J NEUROCHEM, V72, P1593, DOI 10.1046/j.1471-4159.1999.721593.x; Deng C, 2006, EXP BRAIN RES, V168, P587, DOI 10.1007/s00221-005-0290-9; Duncan CE, 2010, J PSYCHIATR RES, V44, P673, DOI 10.1016/j.jpsychires.2009.12.007; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Fatemi SH, 2010, J AUTISM DEV DISORD, V40, P743, DOI 10.1007/s10803-009-0924-z; Fillman SG, 2010, INT J DEV NEUROSCI, V28, P513, DOI 10.1016/j.ijdevneu.2010.05.004; Flynn G, 2008, SCHIZOPHR RES, V105, P262, DOI 10.1016/j.schres.2008.05.029; Glykys J, 2008, J NEUROSCI, V28, P1421, DOI 10.1523/JNEUROSCI.4751-07.2008; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; HANADA S, 1987, LIFE SCI, V40, P259, DOI 10.1016/0024-3205(87)90341-9; Hand KSP, 1997, BRIT J PHARMACOL, V122, P358, DOI 10.1038/sj.bjp.0701365; Hanson SM, 2008, J NEUROSCI, V28, P3490, DOI 10.1523/JNEUROSCI.5727-07.2008; HARPER CG, 1988, J NEUROL NEUROSUR PS, V51, P124, DOI 10.1136/jnnp.51.1.124; Hashimoto T, 2008, MOL PSYCHIATR, V13, P147, DOI 10.1038/sj.mp.4002011; Hashimoto T, 2005, J NEUROSCI, V25, P372, DOI 10.1523/JNEUROSCI.4035-04.2005; Haw C, 2007, J PSYCHOPHARMACOL, V21, P645, DOI 10.1177/0269881106072386; HERB A, 1992, P NATL ACAD SCI USA, V89, P1433, DOI 10.1073/pnas.89.4.1433; Hevers W, 1998, MOL NEUROBIOL, V18, P35, DOI 10.1007/BF02741459; HillVenning C, 1997, BRIT J PHARMACOL, V120, P749, DOI 10.1038/sj.bjp.0700927; Huntsman MM, 1998, P NATL ACAD SCI USA, V95, P15066, DOI 10.1073/pnas.95.25.15066; Impagnatiello F, 1998, P NATL ACAD SCI USA, V95, P15718, DOI 10.1073/pnas.95.26.15718; Kellendonk C, 2009, TRENDS NEUROSCI, V32, P347, DOI 10.1016/j.tins.2009.02.003; KIUCHI Y, 1989, EUR ARCH PSY CLIN N, V239, P71, DOI 10.1007/BF01759578; Knoflach F, 1996, MOL PHARMACOL, V50, P1253; Lewis DA, 2008, NEUROTOX RES, V14, P237, DOI 10.1007/BF03033813; LUDDENS H, 1994, MOL PHARMACOL, V45, P810; McLeod MC, 2010, PSYCHIAT RES, V179, P139, DOI 10.1016/j.psychres.2009.03.034; Newell KA, 2007, PROG NEURO-PSYCHOPH, V31, P225, DOI 10.1016/j.pnpbp.2006.07.004; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; OWEN F, 1981, ACTA PSYCHIAT SCAND, V63, P20, DOI 10.1111/j.1600-0447.1981.tb02455.x; Pandey GN, 1997, PSYCHIAT RES, V71, P137, DOI 10.1016/S0165-1781(97)00060-7; Rudolph U, 2011, NAT REV DRUG DISCOV, V10, P685, DOI 10.1038/nrd3502; SANNA E, 1995, J PHARMACOL EXP THER, V274, P353; SMITH GB, 1995, TRENDS PHARMACOL SCI, V16, P162, DOI 10.1016/S0165-6147(00)89009-4; Straub RE, 2007, MOL PSYCHIATR, V12, P854, DOI 10.1038/sj.mp.4001988; Strous RD, 2007, PSYCHONEUROENDOCRINO, V32, P96, DOI 10.1016/j.psyneuen.2006.11.002; Vinkers CH, 2010, EXPERT OPIN INV DRUG, V19, P1217, DOI 10.1517/13543784.2010.513382; Volk DW, 2002, CEREB CORTEX, V12, P1063, DOI 10.1093/cercor/12.10.1063; Volk DW, 2000, ARCH GEN PSYCHIAT, V57, P237, DOI 10.1001/archpsyc.57.3.237; Weickert CS, 2010, AUST NZ J PSYCHIAT, V44, P59, DOI 10.3109/00048670903393662; Whittington MA, 2003, TRENDS NEUROSCI, V26, P676, DOI 10.1016/j.tins.2003.09.016; WOLKOWITZ OM, 1991, AM J PSYCHIAT, V148, P714; Wong J, 2010, NEUROSCIENCE, V169, P1071, DOI 10.1016/j.neuroscience.2010.05.037; Woo TU, 1998, P NATL ACAD SCI USA, V95, P5341, DOI 10.1073/pnas.95.9.5341; YMER S, 1990, EMBO J, V9, P3261, DOI 10.1002/j.1460-2075.1990.tb07525.x	58	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e52724	10.1371/journal.pone.0052724	http://dx.doi.org/10.1371/journal.pone.0052724			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320076	gold, Green Published, Green Submitted			2022-12-25	WOS:000313429800018
J	Dillen, S; Zels, S; Verlinden, H; Spit, J; Van Wielendaele, P; Vanden Broeck, J				Dillen, Senne; Zels, Sven; Verlinden, Heleen; Spit, Jornt; Van Wielendaele, Pieter; Vanden Broeck, Jozef			Functional Characterization of the Short Neuropeptide F Receptor in the Desert Locust, Schistocerca gregaria	PLOS ONE			English	Article							PROTEIN COUPLED RECEPTORS; FOOD-INTAKE; NEUROHORMONE GPCRS; GENE-EXPRESSION; BEHAVIOR; PEPTIDES; MOSQUITO; DEPENDS; NEURONS; GENOME	Whereas short neuropeptide F (sNPF) has already been reported to stimulate feeding behaviour in a variety of insect species, the opposite effect was observed in the desert locust. In the present study, we cloned a G protein-coupled receptor (GPCR) cDNA from the desert locust, Schistocerca gregaria. Cell-based functional analysis of this receptor indicated that it is activated by both known isoforms of Schgr-sNPF in a concentration dependent manner, with EC50 values in the nanomolar range. This Schgr-sNPF receptor constitutes the first functionally characterized peptide GPCR in locusts. The in vivo effects of the sNPF signalling pathway on the regulation of feeding in locusts were further studied by knocking down the newly identified Schgr-sNPF receptor by means of RNA interference, as well as by means of peptide injection studies. While injection of sNPF caused an inhibitory effect on food uptake in the desert locust, knocking down the corresponding peptide receptor resulted in an increase of total food uptake when compared to control animals. This is the first comprehensive study in which a clearly negative correlation is described between the sNPF signalling pathway and feeding, prompting a reconsideration of the diverse roles of sNPFs in the physiology of insects.	[Dillen, Senne; Zels, Sven; Verlinden, Heleen; Spit, Jornt; Van Wielendaele, Pieter; Vanden Broeck, Jozef] Katholieke Univ Leuven, Dept Biol, Louvain, Belgium	KU Leuven	Vanden Broeck, J (corresponding author), Katholieke Univ Leuven, Dept Biol, Louvain, Belgium.	jozef.vandenbroeck@bio.kuleuven.be	Verlinden, Heleen/D-1033-2011	Verlinden, Heleen/0000-0001-6721-3973; Van Wielendaele, Pieter/0000-0003-1492-6165; Vanden Broeck, Jozef/0000-0001-7653-0516	KU Leuven Research Foundation [GOA/11/02]; Research Foundation of Flanders (FWO-Flanders); Interuniversity Attraction Poles program (Belgian Science Policy) [IAP P6/14]; Agency for Innovation by Science and Technology (IWT)	KU Leuven Research Foundation; Research Foundation of Flanders (FWO-Flanders)(FWO); Interuniversity Attraction Poles program (Belgian Science Policy)(Belgian Federal Science Policy Office); Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by grants from the KU Leuven Research Foundation (Grant GOA/11/02, www.kuleuven.be/bof), the Research Foundation of Flanders (FWO-Flanders, www.fwo.be) and the Interuniversity Attraction Poles program (Belgian Science Policy, Grant IAP P6/14, www.belspo.be). SZ and JS were supported by a scholarship from the Agency for Innovation by Science and Technology (IWT, www.iwt.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anzi B, 2010, CURR BIOL, V20, P969, DOI 10.1016/j.cub.2010.04.039; Ament SA, 2011, INSECT MOL BIOL, V20, P335, DOI 10.1111/j.1365-2583.2011.01068.x; Badisco L, 2011, PLOS ONE, V6, pe17274; Broeck JV, 2001, PEPTIDES, V22, P241, DOI 10.1016/S0196-9781(00)00376-4; BROWN MR, 1994, J INSECT PHYSIOL, V40, P399, DOI 10.1016/0022-1910(94)90158-9; Chen ME, 2006, ARCH INSECT BIOCHEM, V61, P195, DOI 10.1002/arch.20103; Clynen E, 2009, INSECT BIOCHEM MOLEC, V39, P491, DOI 10.1016/j.ibmb.2009.06.001; Clynen E, 2009, ANN NY ACAD SCI, V1163, P60, DOI 10.1111/j.1749-6632.2008.03624.x; Feng GP, 2003, EUR J NEUROSCI, V18, P227, DOI 10.1046/j.1460-9568.2003.02719.x; Garczynski SF, 2007, PEPTIDES, V28, P109, DOI 10.1016/j.peptides.2006.09.019; Gazi L, 1999, BRIT J PHARMACOL, V128, P613, DOI 10.1038/sj.bjp.0702849; Hauser F, 2008, FRONT NEUROENDOCRIN, V29, P142, DOI 10.1016/j.yfrne.2007.10.003; Hauser F, 2006, PROG NEUROBIOL, V80, P1, DOI 10.1016/j.pneurobio.2006.07.005; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Huang YQ, 2011, PEPTIDES, V32, P483, DOI 10.1016/j.peptides.2010.09.014; Hummon AB, 2006, SCIENCE, V314, P647, DOI 10.1126/science.1124128; Huybrechts J, 2004, BIOCHEM BIOPH RES CO, V317, P909, DOI 10.1016/j.bbrc.2004.03.136; Johard HAD, 2009, J COMP NEUROL, V516, P59, DOI 10.1002/cne.22099; Kahsai L, 2010, J EXP BIOL, V213, P2256, DOI 10.1242/jeb.043190; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Lee KS, 2008, NAT CELL BIOL, V10, P468, DOI 10.1038/ncb1710; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu HL, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-57; McDonald J, 2003, BRIT J PHARMACOL, V140, P61, DOI 10.1038/sj.bjp.0705401; Mertens I, 2002, BIOCHEM BIOPH RES CO, V297, P1140, DOI 10.1016/S0006-291X(02)02351-3; Mikani A, 2012, PEPTIDES, V34, P135, DOI 10.1016/j.peptides.2011.10.028; Nagata Shinji, 2012, Front Endocrinol (Lausanne), V3, P3, DOI 10.3389/fendo.2012.00003; Nagata S, 2011, GEN COMP ENDOCR, V172, P90, DOI 10.1016/j.ygcen.2011.03.004; Nassel DR, 2011, PEPTIDES, V32, P1335, DOI 10.1016/j.peptides.2011.03.013; Nassel DR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-90; Ons S, 2011, INSECT MOL BIOL, V20, P29, DOI 10.1111/j.1365-2583.2010.01050.x; Poels J, 2005, PEPTIDES, V26, P109, DOI 10.1016/j.peptides.2004.07.015; Root CM, 2011, CELL, V145, P133, DOI 10.1016/j.cell.2011.02.008; Schoofs L, 2001, PEPTIDES, V22, P219, DOI 10.1016/S0196-9781(00)00385-5; Spit J, 2012, CAN J ZOOL, V90, P489, DOI 10.1139/Z2012-014; Spit J, 2012, PEPTIDES, V34, P251, DOI 10.1016/j.peptides.2011.06.019; Van Wielendaele P, 2013, INSECT BIOCHEM MOLEC, V43, P102, DOI 10.1016/j.ibmb.2012.10.002; Van Wielendaele P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031425; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veenstra JA, 2012, INSECT BIOCHEM MOLEC, V42, P277, DOI 10.1016/j.ibmb.2011.12.009; Wei Z, 2000, J INSECT PHYSIOL, V46, P1259, DOI 10.1016/S0022-1910(00)00046-9; Yamanaka N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003048	42	42	43	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53604	10.1371/journal.pone.0053604	http://dx.doi.org/10.1371/journal.pone.0053604			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308260	Green Published, gold			2022-12-25	WOS:000313670100050
J	Zhang, F; Gao, B; Xu, LD; Li, CQ; Hao, DP; Zhang, SJ; Zhou, M; Su, F; Chen, X; Zhi, H; Li, X				Zhang, Fan; Gao, Bo; Xu, Liangde; Li, Chunquan; Hao, Dapeng; Zhang, Shaojun; Zhou, Meng; Su, Fei; Chen, Xi; Zhi, Hui; Li, Xia			Allele-Specific Behavior of Molecular Networks: Understanding Small-Molecule Drug Response in Yeast	PLOS ONE			English	Article							LARGE GENE LISTS; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTORS; GENOME ORGANIZATION; EXPRESSION NETWORKS; PLASMA-MEMBRANE; COMPLEX TRAITS; DISEASE; ARABIDOPSIS; DISCOVERY	The study of systems genetics is changing the way the genetic and molecular basis of phenotypic variation, such as disease susceptibility and drug response, is being analyzed. Moreover, systems genetics aids in the translation of insights from systems biology into genetics. The use of systems genetics enables greater attention to be focused on the potential impact of genetic perturbations on the molecular states of networks that in turn affects complex traits. In this study, we developed models to detect allele-specific perturbations on interactions, in which a genetic locus with alternative alleles exerted a differing influence on an interaction. We utilized the models to investigate the dynamic behavior of an integrated molecular network undergoing genetic perturbations in yeast. Our results revealed the complexity of regulatory relationships between genetic loci and networks, in which different genetic loci perturb specific network modules. In addition, significant within-module functional coherence was found. We then used the network perturbation model to elucidate the underlying molecular mechanisms of individual differences in response to 100 diverse small molecule drugs. As a result, we identified sub-networks in the integrated network that responded to variations in DNA associated with response to diverse compounds and were significantly enriched for known drug targets. Literature mining results provided strong independent evidence for the effectiveness of these genetic perturbing networks in the elucidation of small-molecule responses in yeast.	[Li, Xia] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; Harbin Med Univ, Affiliated Hosp 2, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Li, X (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China.	lixia@hrbmu.edu.cn	Li, Chunquan/AAI-1072-2020; li, xia/HHZ-7468-2022; Zhou, Meng/G-7674-2011	Li, Chunquan/0000-0002-4700-5496; Zhou, Meng/0000-0001-9987-9024	National Natural Science Foundation of China [31200998, 61170154, 61073136]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20102307110022, 20102307120027]; Science Foundation of Heilongjiang Province [ZD200816-01]; Science Foundation of Heilongjiang Province Education Department [11541137, 12511273]; Science Foundation of Heilongjiang Provincial Health Department [2011-249]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Science Foundation of Heilongjiang Province; Science Foundation of Heilongjiang Province Education Department; Science Foundation of Heilongjiang Provincial Health Department	This work was supported in part by the National Natural Science Foundation of China (Grant Nos. 31200998, 61170154 and 61073136), the Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant Nos. 20102307110022 and 20102307120027), the Science Foundation of Heilongjiang Province (Grant Nos. ZD200816-01), the Science Foundation of Heilongjiang Province Education Department (Grant Nos. 11541137 and 12511273), and the Science Foundation of Heilongjiang Provincial Health Department (Grant Nos. 2011-249). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamgir Md, 2010, BMC Chemical Biology, V10, P6, DOI 10.1186/1472-6769-10-6; Amoroso F, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.105; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Becker KG, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-61; Benfey PN, 2008, SCIENCE, V320, P495, DOI 10.1126/science.1153716; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beyer A, 2006, PLOS COMPUT BIOL, V2, P615, DOI 10.1371/journal.pcbi.0020070; Bon C, 2007, ANN BIOL CLIN-PARIS, V65, P609, DOI 10.1684/abc.2007.0168; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Chan EKF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001198; Chan SW, 2005, FASEB J, V19, P1510, DOI 10.1096/fj.04-3455fje; Chen JC, 2006, BIOINFORMATICS, V22, P2283, DOI 10.1093/bioinformatics/btl370; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; del Sol A, 2010, CURR OPIN BIOTECH, V21, P566, DOI 10.1016/j.copbio.2010.07.010; Dudley AM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100004; Ertekin-Taner N, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-31; Folmer V, 2008, BBA-BIOMEMBRANES, V1778, P1141, DOI 10.1016/j.bbamem.2007.12.008; Foss EJ, 2007, NAT GENET, V39, P1369, DOI 10.1038/ng.2007.22; Gelis S, 2012, MICROBIOLOGYOPEN, V1, P182, DOI 10.1002/mbo3.23; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ito A, 2011, J RADIAT RES, V52, P342, DOI 10.1269/jrr.10151; Kamolrat T, 2012, EUR J NUTR; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kapitzky L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.107; Kawahata M, 2006, FEMS YEAST RES, V6, P924, DOI 10.1111/j.1567-1364.2006.00089.x; Keurentjes JJB, 2007, P NATL ACAD SCI USA, V104, P1708, DOI 10.1073/pnas.0610429104; Kim HS, 2007, P NATL ACAD SCI USA, V104, P19387, DOI 10.1073/pnas.0708194104; Kim S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000587; Kliebenstein D, 2009, ANNU REV PLANT BIOL, V60, P93, DOI 10.1146/annurev.arplant.043008.092114; Kliebenstein DJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-308; Kliebenstein DJ, 2009, METHODS MOL BIOL, V553, P227, DOI 10.1007/978-1-60327-563-7_11; Kruegel U, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002253; Kuhn M, 2010, NUCLEIC ACIDS RES, V38, pD552, DOI 10.1093/nar/gkp937; Lan H, 2006, PLOS GENET, V2, P51, DOI 10.1371/journal.pgen.0020006; Law BK, 2005, CRIT REV ONCOL HEMAT, V56, P47, DOI 10.1016/j.critrevonc.2004.09.009; Le Morvan V, 2006, PHARMACOGENOMICS, V7, P843, DOI 10.2217/14622416.7.6.843; Lee SI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000358; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Maynard ND, 2008, NAT METHODS, V5, P307, DOI [10.1038/NMETH.1194, 10.1038/nmeth.1194]; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Owsianik G, 2002, MOL MICROBIOL, V43, P1295, DOI 10.1046/j.1365-2958.2002.02823.x; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Pedroso N, 2009, FREE RADICAL BIO MED, V46, P289, DOI 10.1016/j.freeradbiomed.2008.10.039; Perlstein EO, 2006, CHEM BIOL, V13, P319, DOI 10.1016/j.chembiol.2006.01.010; Perlstein EO, 2007, NAT GENET, V39, P496, DOI 10.1038/ng1991; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Rachlin J, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100103; Rowe HC, 2008, PLANT CELL, V20, P1199, DOI 10.1105/tpc.108.058131; Ruderfer DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006907; Saez-Vasquez J, 2010, MOL PLANT, V3, P678, DOI 10.1093/mp/ssq034; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Sharifpoor S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r39; Sieberts SK, 2007, MAMM GENOME, V18, P389, DOI 10.1007/s00335-007-9040-6; Tamura KI, 2004, J BIOSCI BIOENG, V98, P159, DOI 10.1016/S1389-1723(04)00260-9; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Watters JW, 2004, P NATL ACAD SCI USA, V101, P11809, DOI 10.1073/pnas.0404580101; Wentzell AM, 2007, PLOS GENET, V3, P1687, DOI 10.1371/journal.pgen.0030162; Westmoreland TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005830; Wu CL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000070; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Xie MW, 2005, P NATL ACAD SCI USA, V102, P7215, DOI 10.1073/pnas.0500297102; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80; Zimmer C, 2011, J CELL BIOL, V192, P723, DOI 10.1083/jcb.201010058; Zou F, 2010, NEUROLOGY, V74, P480, DOI 10.1212/WNL.0b013e3181d07654; Zunino SJ, 2007, CANCER LETT, V254, P119, DOI 10.1016/j.canlet.2007.03.002	73	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53581	10.1371/journal.pone.0053581	http://dx.doi.org/10.1371/journal.pone.0053581			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308257	Green Published, gold, Green Submitted			2022-12-25	WOS:000313670100049
J	Claverie-Martin, F; Garcia-Nieto, V; Loris, C; Ariceta, G; Nadal, I; Espinosa, L; Fernandez-Maseda, A; Anton-Gamero, M; Avila, A; Madrid, A; Gonzalez-Acosta, H; Cordoba-Lanus, E; Santos, F; Gil-Calvo, M; Espino, M; Garcia-Martinez, E; Sanchez, A; Muley, R				Claverie-Martin, Felix; Garcia-Nieto, Victor; Loris, Cesar; Ariceta, Gema; Nadal, Inmaculada; Espinosa, Laura; Fernandez-Maseda, Angeles; Anton-Gamero, Montserrat; Avila, Africa; Madrid, Alvaro; Gonzalez-Acosta, Hilaria; Cordoba-Lanus, Elizabeth; Santos, Fernando; Gil-Calvo, Marta; Espino, Mar; Garcia-Martinez, Elena; Sanchez, Ana; Muley, Rafael		RenalTube Grp	Claudin-19 Mutations and Clinical Phenotype in Spanish Patients with Familial Hypomagnesemia with Hypercalciuria and Nephrocalcinosis	PLOS ONE			English	Article							THICK ASCENDING LIMB; CLDN19 MUTATIONS; TIGHT JUNCTIONS; DISEASE; GENE; MAGNESIUM; GENOTYPE; FHHNC; SUBSTITUTIONS; PARACELLIN-1	Familial hypomagnesemia with hypercalciuria and nephrocalcinosis is an autosomal recessive tubular disorder characterized by excessive renal magnesium and calcium excretion and chronic kidney failure. This rare disease is caused by mutations in the CLDN16 and CLDN19 genes. These genes encode the tight junction proteins claudin-16 and claudin-19, respectively, which regulate the paracellular ion reabsortion in the kidney. Patients with mutations in the CLDN19 gene also present severe visual impairment. Our goals in this study were to examine the clinical characteristics of a large cohort of Spanish patients with this disorder and to identify the disease causing mutations. We included a total of 31 patients belonging to 27 unrelated families and studied renal and ocular manifestations. We then analyzed by direct DNA sequencing the coding regions of CLDN16 and CLDN19 genes in these patients. Bioinformatic tools were used to predict the consequences of mutations. Clinical evaluation showed ocular defects in 87% of patients, including mainly myopia, nystagmus and macular colobomata. Twenty two percent of patients underwent renal transplantation and impaired renal function was observed in another 61% of patients. Results of the genetic analysis revealed CLDN19 mutations in all patients confirming the clinical diagnosis. The majority of patients exhibited the previously described p.G20D mutation. Haplotype analysis using three microsatellite markers showed a founder effect for this recurrent mutation in our cohort. We also identified four new pathogenic mutations in CLDN19, p.G122R, p.I41T, p.G75C and p.G75S. A strategy based on microsequencing was designed to facilitate the genetic diagnosis of this disease. Our data indicate that patients with CLDN19 mutations have a high risk of progression to chronic renal disease.	[Claverie-Martin, Felix; Gonzalez-Acosta, Hilaria; Cordoba-Lanus, Elizabeth] Hosp Nuestra Senora Candelaria, Unidad Invest, Santa Cruz De Tenerife, Spain; [Loris, Cesar] Hosp Infantil Miguel Servet, Zaragoza, Spain; [Ariceta, Gema] Hosp Cruces, Baracaldo, Spain; [Nadal, Inmaculada] Hosp Virgen Camino, Pamplona, Spain; [Espinosa, Laura] Hosp La Paz, Madrid, Spain; [Fernandez-Maseda, Angeles] Hosp Virgen Salud, Toledo, Spain; [Anton-Gamero, Montserrat; Garcia-Martinez, Elena] Hosp Reina Sofia, Cordoba, Spain; [Avila, Africa] Complejo Hosp Jaen, Jaen, Spain; [Madrid, Alvaro] Hosp Valle De Hebron, Barcelona, Spain; [Santos, Fernando] Univ Oviedo, Hosp Cent Asturias, E-33080 Oviedo, Spain; [Gil-Calvo, Marta] Hosp Clin, Santiago De Compostela, Spain; [Espino, Mar] Hosp Fdn Alcorcon, Madrid, Spain; [Sanchez, Ana] Hosp Univ Virgen Rocio, Seville, Spain; [Muley, Rafael] Hosp 12 Octubre, E-28041 Madrid, Spain	Miguel Servet University Hospital; Hospital Universitario Cruces; Hospital Virgen del Camino; Servicio Navarro de Salud - Osasunbidea; Hospital Universitario La Paz; Complejo Hospitalario de Toledo; Hospital Universitario Reina Sofia - Cordoba; Complejo Hospitalario de Jaen; Hospital Universitari Vall d'Hebron; Central University Hospital Asturias; University of Oviedo; Complexo Hospitalario Universitario de Santiago de Compostela; Alcorcon Foundation University Hospital; Virgen del Rocio University Hospital; Hospital Universitario 12 de Octubre	Claverie-Martin, F (corresponding author), Hosp Nuestra Senora Candelaria, Unidad Invest, Santa Cruz De Tenerife, Spain.	fclamar@gobiernodecanarias.org	ANTON-GAMERO, MONTSERRAT/AAV-3686-2021; Córdoba-Lanús, Elizabeth/B-8573-2014; Madariaga, Leire/B-5220-2019; Ramos-Trujillo, Elena/B-7843-2014; Anton-Gamero, Montserrat/M-8534-2017	ANTON-GAMERO, MONTSERRAT/0000-0002-8515-4900; Madariaga, Leire/0000-0002-4032-9842; Claverie-Martin, Felix/0000-0003-2468-3267; Madrid, Alvaro/0000-0002-5942-8488; Cordoba-Lanus, Elizabeth/0000-0001-5534-8280; Castano, Luis/0000-0003-0437-9401; Perez de Nanclares, Gustavo/0000-0002-1692-8976	Fondo de Investigacion Sanitaria (FIS) [PI09/91009, PI11/00342]; European Regional Development Fund; Fundacion Canaria de Investigacion y Salud FUNCIS [PI24/07]; Sociedad Canaria de Pediatria de Tenerife; FIS [PI09/90758, PI09/90888]	Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); European Regional Development Fund(European Commission); Fundacion Canaria de Investigacion y Salud FUNCIS; Sociedad Canaria de Pediatria de Tenerife; FIS(Instituto de Salud Carlos III)	This work was supported by research grants from Fondo de Investigacion Sanitaria (FIS, PI09/91009 and PI11/00342, cofinanced by the European Regional Development Fund) and Fundacion Canaria de Investigacion y Salud FUNCIS (PI24/07) to FCM, and by a fellowship from the Sociedad Canaria de Pediatria de Tenerife. FS and GA acknowledge funding from FIS (grants PI09/90758 and PI09/90888, respectively). The funding from FIS was granted as coordinated proyect Renaltube. No additional external funding was received for this study. The funders have no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Angelow S, 2007, AM J PHYSIOL-RENAL, V293, pF166, DOI 10.1152/ajprenal.00087.2007; Anton-Gamero M, 2008, J AM SOC NEPHROL, V19, P597; Benigno V, 2000, NEPHROL DIAL TRANSPL, V15, P605, DOI 10.1093/ndt/15.5.605; Blanchard A, 2001, KIDNEY INT, V59, P2206, DOI 10.1046/j.1523-1755.2001.00736.x; Buratti E, 2006, NUCLEIC ACIDS RES, V34, P3494, DOI 10.1093/nar/gkl498; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Claverie-Martin F, 2009, PEDIATR NEPHROL, V24, P1793; Faguer S, 2011, CLIN J AM SOC NEPHRO, V6, P355, DOI 10.2215/CJN.02870310; Godron A, 2012, CLIN J AM SOC NEPHRO, V7, P801, DOI 10.2215/CJN.12841211; Gunzel D, 2009, PFLUG ARCH EUR J PHY, V458, P77, DOI 10.1007/s00424-008-0589-z; Hampson G, 2008, BMC NEPHROL, V9, DOI 10.1186/1471-2369-9-12; Hou JH, 2008, J CLIN INVEST, V118, P619, DOI 10.1172/JCI33970; Hou JH, 2010, CURR OPIN NEPHROL HY, V19, P483, DOI 10.1097/MNH.0b013e32833b7125; Hou JH, 2009, P NATL ACAD SCI USA, V106, P15350, DOI 10.1073/pnas.0907724106; Kang JH, 2005, PEDIATR NEPHROL, V20, P1490, DOI 10.1007/s00467-005-1969-7; Kausalya PJ, 2006, J CLIN INVEST, V116, P878, DOI 10.1172/JCI26323; Khajavi M, 2006, EUR J HUM GENET, V14, P1074, DOI 10.1038/sj.ejhg.5201649; Konrad M, 2008, J AM SOC NEPHROL, V19, P171, DOI 10.1681/ASN.2007060709; Konrad M, 2006, AM J HUM GENET, V79, P949, DOI 10.1086/508617; Lal-Nag M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-235; Loris Pablo C, 2004, An Pediatr (Barc), V61, P502; Miyamoto T, 2005, J CELL BIOL, V169, P527, DOI 10.1083/jcb.200501154; Muller D, 2003, AM J HUM GENET, V73, P1293, DOI 10.1086/380418; Naeem M, 2011, AM J NEPHROL, V34, P241, DOI 10.1159/000330854; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; PRAGA M, 1995, KIDNEY INT, V47, P1419, DOI 10.1038/ki.1995.199; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; RODRIGUEZSORIANO J, 1987, PEDIATR NEPHROL, V1, P465, DOI 10.1007/BF00849255; SCHWARTZ GJ, 1987, PEDIATR CLIN N AM, V34, P571; Simon DB, 1999, SCIENCE, V285, P103, DOI 10.1126/science.285.5424.103; Sunyaev S, 2000, TRENDS GENET, V16, P198, DOI 10.1016/S0168-9525(00)01988-0; Tajima T, 2003, PEDIATR NEPHROL, V18, P1280, DOI 10.1007/s00467-003-1304-0; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Weber S, 2001, J AM SOC NEPHROL, V12, P1872, DOI 10.1681/ASN.V1291872; Weber S, 2000, EUR J HUM GENET, V8, P414, DOI 10.1038/sj.ejhg.5200475	35	35	37	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53151	10.1371/journal.pone.0053151	http://dx.doi.org/10.1371/journal.pone.0053151			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301036	gold, Green Submitted, Green Published			2022-12-25	WOS:000313480000034
J	Mullen, MP; Hanrahan, JP; Howard, DJ; Powell, R				Mullen, Michael P.; Hanrahan, James P.; Howard, Dawn J.; Powell, Richard			Investigation of Prolific Sheep from UK and Ireland for Evidence on Origin of the Mutations in BMP15 (FecX(G), FecX(B)) and GDF9 (FecG(H)) in Belclare and Cambridge Sheep	PLOS ONE			English	Article							INCREASED OVULATION RATE; BOOROOLA FECB; X-CHROMOSOME; GENE; STERILITY; DELETION	This paper concerns the likely origin of three mutations with large effects on ovulation rate identified in the Belclare and Cambridge sheep breeds; two in the BMP15 gene (FecX(G) and FecX(B)) and the third (FecG(H)) in GDF9. All three mutations segregate in Belclare sheep while one, FecX(B), has not been found in the Cambridge. Both Belclare and Cambridge breeds are relatively recently developed composites that have common ancestry through the use of genetic material from the Finnish Landrace and Lleyn breeds. The development of both composites also involved major contributions from exceptionally prolific ewes screened from flocks in Ireland (Belclare) and Britain (Cambridge) during the 1960s. The objective of the current study was to establish the likely origin of the mutations (FecX(G), FecX(B) and FecG(H)) through analysis of DNA from Finnish Landrace and Lleyn sheep, and Galway and Texel breeds which contributed to the development of the Belclare breed. Ewes with exceptionally high prolificacy (hyper-prolific ewes) in current flocks on Irish farms were identified to simulate the screening of ewes from Irish flocks in the 1960s. DNA was obtained from: prolific ewes in extant flocks of Lleyn sheep (n = 44) on the Lleyn peninsula in Wales; hyper-prolific ewes (n = 41); prolific Galway (n = 41) ewes; Finnish Landrace (n = 124) and Texel (n = 19) ewes. The FecX(G) mutation was identified in Lleyn but not in Finnish Landrace, Galway or Texel sheep; FecX(B) was only found among the hyper-prolific ewes. The FecG(H) mutation was identified in the sample of Lleyn sheep. It was concluded from these findings that the Lleyn breed was the most likely source of the FecX(G) and FecG(H) mutations in Belclare and Cambridge sheep and that the FecX(B) mutation came from the High Fertility line that was developed using prolific ewes selected from commercial flocks in Ireland in the 1960's and subsequently used in the genesis of the Belclare.	[Mullen, Michael P.; Powell, Richard] Natl Univ Ireland, Dept Microbiol, Galway, Ireland; [Mullen, Michael P.; Hanrahan, James P.; Howard, Dawn J.] TEAGASC, Anim & Grassland Res & Innovat Ctr, Athenry, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Teagasc	Mullen, MP (corresponding author), Natl Univ Ireland, Dept Microbiol, Galway, Ireland.	michael.mullen@teagasc.ie		Howard, Dawn J/0000-0002-7573-5859	Teagasc Walsh Fellowship Scheme; Genesis Faraday SPARK award (Lleyn survey); Science Foundation Ireland [07/SRC/B1156]	Teagasc Walsh Fellowship Scheme; Genesis Faraday SPARK award (Lleyn survey); Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	Financial support through the Teagasc Walsh Fellowship Scheme, Genesis Faraday SPARK award (Lleyn survey) and Science Foundation Ireland (07/SRC/B1156) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Bodin L, 1998, P WORLD C GEN APPL L, V27, P11; Bodin L, 2007, ENDOCRINOLOGY, V148, P393, DOI 10.1210/en.2006-0764; BRADFORD GE, 1986, J ANIM SCI, V63, P418, DOI 10.2527/jas1986.632418x; Chu Ming-Xing, 2005, Acta Genetica Sinica, V32, P38; Davis G. H., 2001, Proceedings of the Fourteenth Conference of the Association for the Advancement of Animal Breeding and Genetics, Queenstown, New Zealand, 30 July-2 August 2001, P175; Davis GH, 2002, BIOL REPROD, V66, P1869, DOI 10.1095/biolreprod66.6.1869; Davis GH, 2006, ANIM REPROD SCI, V92, P87, DOI 10.1016/j.anireprosci.2005.06.001; DAVIS GH, 1982, NEW ZEAL J AGR RES, V25, P525, DOI 10.1080/00288233.1982.10425216; Davis GH, 2001, BIOL REPROD, V64, P216, DOI 10.1095/biolreprod64.1.216; DAVIS GH, 1991, BIOL REPROD, V44, P620, DOI 10.1095/biolreprod44.4.620; Galloway SM, 2000, NAT GENET, V25, P279, DOI 10.1038/77033; Hanrahan J. P., 1984, Proceedings of the 2nd World Congress on Sheep and Beef Cattle Breeding, 16-19 April 1984, Pretoria, South Africa., P483; Hanrahan JP, 2004, BIOL REPROD, V70, P900, DOI 10.1095/biolreprod.103.023093; HANRAHAN JP, 1985, ANIM PROD, V40, P529; Hanrahan JP, 1990, RES REPORT, P139; Hanrahan JP, 1976, LLEYN SHEEP, P168; Hanrahan JP, 1975, P 29 ANN M EUR ASS A; Hanrahan JP, 2009, BSAS ADV ANIM BIOSCI, V1, P42; Hanrahan JP, 2007, P BRIT SOC AN SCI AN; Jonmundsson J. V., 1985, Genetics of reproduction in sheep., P159; Juengel JL, 2011, BIOL REPROD, V85, P113, DOI 10.1095/biolreprod.110.090514; Lecerf F, 2002, P 7 WORLD C GEN APP, P753; Martinez-Royo A, 2008, ANIM GENET, V39, P294, DOI 10.1111/j.1365-2052.2008.01707.x; Monteagudo LV, 2009, ANIM REPROD SCI, V110, P139, DOI 10.1016/j.anireprosci.2008.01.005; Mullen MP, 2009, IRISH J AGR FOOD RES, V48, P109; Mullen MP, 2011, BSAS ADV ANIM BIOSCI, V2, P212; Mullen MP, 2003, P AGR RES FOR TULL I; Nicol L, 2009, REPRODUCTION, V138, P921, DOI 10.1530/REP-09-0193; Owen John B., 1976, SHEEP PRODUCTION; Piper L. R., 1982, The Booroola Merino. Proceedings of a workshop held at Armidale, N.S.W. 24 August 1980, P9; RADOMSKA MJ, 1988, J AGR SCI FINLAND, V60, P597; Silva BDM, 2011, ANIM GENET, V42, P89, DOI 10.1111/j.1365-2052.2010.02078.x; Timon V, 1963, GENETIC IMPROVEMENT, P78; Vaughan EK, 1997, VET REC, V140, P100, DOI 10.1136/vr.140.4.100; Wilson T, 2001, BIOL REPROD, V64, P1225, DOI 10.1095/biolreprod64.4.1225	37	20	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53172	10.1371/journal.pone.0053172	http://dx.doi.org/10.1371/journal.pone.0053172			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301039	gold, Green Published, Green Submitted			2022-12-25	WOS:000313320900066
J	Kipari, T; Hadoke, PWF; Iqbal, J; Man, TY; Miller, E; Coutinho, AE; Zhang, ZG; Sullivan, KM; Mitic, T; Livingstone, DEW; Schrecker, C; Samuel, K; White, CI; Bouhlel, MA; Chinetti-Gbaguidi, G; Staels, B; Andrew, R; Walker, BR; Savill, JS; Chapman, KE; Seckl, JR				Kipari, Tiina; Hadoke, Patrick W. F.; Iqbal, Javaid; Man, Tak-Yung; Miller, Eileen; Coutinho, Agnes E.; Zhang, Zhenguang; Sullivan, Katie M.; Mitic, Tijana; Livingstone, Dawn E. W.; Schrecker, Christopher; Samuel, Kay; White, Christopher I.; Bouhlel, M. Amine; Chinetti-Gbaguidi, Giulia; Staels, Bart; Andrew, Ruth; Walker, Brian R.; Savill, John S.; Chapman, Karen E.; Seckl, Jonathan R.			11 beta-hydroxysteroid dehydrogenase type 1 deficiency in bone marrow-derived cells reduces atherosclerosis	FASEB JOURNAL			English	Article						atherogenesis; glucocorticoids; inflammation	INDUCED VISCERAL OBESITY; 11-BETA-HSD1 INHIBITION; APOPTOTIC LEUKOCYTES; COLLAGEN-SYNTHESIS; METABOLIC SYNDROME; CUSHINGS-DISEASE; KNOCKOUT MICE; GLUCOCORTICOIDS; MACROPHAGES; EXPRESSION	11 beta-Hydroxysteroid dehydrogenase type-1 (11 beta-HSD1) converts inert cortisone into active cortisol, amplifying intracellular glucocorticoid action. 11 beta-HSD1 deficiency improves cardiovascular risk factors in obesity but exacerbates acute inflammation. To determine the effects of 11 beta-HSD1 deficiency on atherosclerosis and its inflammation, atherosclerosisprone apolipoprotein E-knockout (ApoE-KO) mice were treated with a selective 11 beta-HSD1 inhibitor or crossed with 11 beta-HSD1-KO mice to generate double knockouts (DKOs) and challenged with an atherogenic Western diet. 11 beta-HSD1 inhibition or deficiency attenuated atherosclerosis (74-76%) without deleterious effects on plaque structure. This occurred without affecting plasma lipids or glucose, suggesting independence from classical metabolic risk factors. KO plaques were not more inflamed and indeed had 36% less T-cell infiltration, associated with 38% reduced circulating monocyte chemoattractant protein-1 (MCP-1) and 36% lower lesional vascular cell adhesion molecule-1 (VCAM-1). Bone marrow (BM) cells are key to the atheroprotection, since transplantation of DKO BM to irradiated ApoE-KO mice reduced atherosclerosis by 51%. 11 beta-HSD1- null macrophages show 76% enhanced cholesterol ester export. Thus, 11 beta-HSD1 deficiency reduces atherosclerosis without exaggerated lesional inflammation independent of metabolic risk factors. Selective 11 beta-HSD1 inhibitors promise novel antiatherosclerosis effects over and above their benefits for metabolic risk factors via effects on BM cells, plausibly macrophages.-Kipari, T., Hadoke, P. W. F., Iqbal, J., Man, T. Y., Miller, E., Coutinho, A. E., Zhang, Z., Sullivan, K. M., Mitic, T., Livingstone, D. E. W., Schrecker, C., Samuel, K., White, C. I., Bouhlel, M. A., Chinetti-Gbaguidi, G., Staels, B., Andrew, R., Walker, B. R., Savill, J. S., Chapman, K. E., Seckl, J. R. 11 beta-hydroxysteroid dehydrogenase type 1 deficiency in bone marrow-derived cells reduces atherosclerosis. FASEB J. 27, 1519-1531 (2013). www.fasebj.org	[Kipari, Tiina; Hadoke, Patrick W. F.; Iqbal, Javaid; Man, Tak-Yung; Miller, Eileen; Coutinho, Agnes E.; Zhang, Zhenguang; Sullivan, Katie M.; Mitic, Tijana; Livingstone, Dawn E. W.; Schrecker, Christopher; White, Christopher I.; Andrew, Ruth; Walker, Brian R.; Chapman, Karen E.; Seckl, Jonathan R.] Univ Edinburgh, British Heart Fdn, Ctr Cardiovasc Sci, Edinburgh EH16 4TJ, Midlothian, Scotland; [Savill, John S.] Univ Edinburgh, MRC, Ctr Inflammat Res, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland; [Samuel, Kay] Univ Edinburgh, MRC, Ctr Regenerat Med, Edinburgh EH16 4TJ, Midlothian, Scotland; [Bouhlel, M. Amine; Chinetti-Gbaguidi, Giulia; Staels, Bart] Univ Lille 2, Univ Lille Nord France, INSERM, UMR 1011,Inst Pasteur Lille, Lille, France	University of Edinburgh; University of Edinburgh; University of Edinburgh; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Kipari, T (corresponding author), Univ Edinburgh, Queens Med Res Inst, Endocrinol Unit, BHF Ctr Cardiovasc Sci, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	tkipari@ed.ac.uk	chinetti, giulia/Q-6901-2016; Staels, Bart/N-9497-2016; Andrew, Ruth/C-2727-2008	chinetti, giulia/0000-0001-8048-8138; Staels, Bart/0000-0002-3784-1503; Andrew, Ruth/0000-0002-6916-2994; Miller, Eileen/0000-0003-1566-8217; Chapman, Karen/0000-0001-7777-6817; Iqbal, Javaid/0000-0002-9729-7503	Wellcome Trust [083184/Z/07/Z]; Medical Research Council [86642]; Society for Endocrinology; British Heart Foundation (BHF), Agence Nationale de la Recherche (AlMHA project); Carnegie Trust; MRC [G9900991, G0800235, G0802069] Funding Source: UKRI; British Heart Foundation [RG/11/4/28734] Funding Source: researchfish; Medical Research Council [G9900991, G0802069, G0800235, MR/K026992/1, G0700704B] Funding Source: researchfish; National Institute for Health Research [CL-2009-04-001] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Society for Endocrinology; British Heart Foundation (BHF), Agence Nationale de la Recherche (AlMHA project)(French National Research Agency (ANR)); Carnegie Trust(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors thank Dr. Valerie S. Densmore for generating the original 11 beta-HSD1, ApoE double-knockout line, and Dr. Nicholas Kirkby for help with optical projection tomography. This work was supported by grants from the Wellcome Trust (program grant 083184/Z/07/Z), the Medical Research Council (project grant 86642), the Society for Endocrinology, the British Heart Foundation (BHF), Agence Nationale de la Recherche (AlMHA project), and the Carnegie Trust. The authors acknowledge the support of the BHF Centre of Excellence. Conflict of interest: B. R. W. and J.R.S. hold intellectual property on the concept of 11 beta-HSD1 inhibitors in metabolic and cardiovascular disease.	Alevizaki M, 2007, METABOLISM, V56, P222, DOI 10.1016/j.metabol.2006.09.017; Ayaori M, 2006, ARTERIOSCL THROM VAS, V26, P163, DOI 10.1161/01.ATV.0000193513.29074.52; Blankenberg S, 2003, ATHEROSCLEROSIS, V170, P191, DOI 10.1016/S0021-9150(03)00097-2; CANALIS E, 1983, ENDOCRINOLOGY, V112, P931, DOI 10.1210/endo-112-3-931; Cavalcanti DMH, 2007, BRIT J PHARMACOL, V152, P1291, DOI 10.1038/sj.bjp.0707512; Chapman KE, 2009, MOL CELL ENDOCRINOL, V301, P123, DOI 10.1016/j.mce.2008.09.031; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Combadiere C, 2008, CIRCULATION, V117, P1649, DOI 10.1161/CIRCULATIONAHA.107.745091; Coutinho AE, 2012, ENDOCRINOLOGY, V153, P234, DOI 10.1210/en.2011-1398; Curtiss LK, 2000, ARTERIOSCL THROM VAS, V20, P1852, DOI 10.1161/01.ATV.20.8.1852; CUTRONEO KR, 1975, MOL PHARMACOL, V11, P632; Deuchar G. A., ENDOCRINOLOGY, V152, P236; ETXABE J, 1994, CLIN ENDOCRINOL, V40, P479, DOI 10.1111/j.1365-2265.1994.tb02486.x; Faggiano A, 2003, J CLIN ENDOCR METAB, V88, P2527, DOI 10.1210/jc.2002-021558; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Gilmour JS, 2006, J IMMUNOL, V176, P7605, DOI 10.4049/jimmunol.176.12.7605; Goncharova EA, 2003, AM J RESP CELL MOL, V29, P19, DOI 10.1165/rcmb.2002-0254OC; HADOKE P, 1995, CORONARY ARTERY DIS, V6, P403, DOI 10.1097/00019501-199505000-00008; Hadoke PWF, 2001, CIRCULATION, V104, P2832, DOI 10.1161/hc4801.100077; Hansson G. K., NAT IMMUNOL, V12, P204; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Harris HJ, 2001, ENDOCRINOLOGY, V142, P114, DOI 10.1210/en.142.1.114; Hermanowski-Vosatka A, 2005, J EXP MED, V202, P517, DOI 10.1084/jem.20050119; HOLMAN RL, 1958, LAB INVEST, V7, P42; Kirkby N. S., PLOS ONE, V6; Kotelevtsev Y, 1997, P NATL ACAD SCI USA, V94, P14924, DOI 10.1073/pnas.94.26.14924; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu YQ, 1999, J IMMUNOL, V162, P3639; Livingstone DEW, 2000, ENDOCRINOLOGY, V141, P560, DOI 10.1210/en.141.2.560; Lloyd DJ, 2009, DIABETES OBES METAB, V11, P688, DOI 10.1111/j.1463-1326.2009.01034.x; LONGENECKER JP, 1984, J CELL BIOL, V98, P534, DOI 10.1083/jcb.98.2.534; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; MEISLER N, 1995, J CELL BIOCHEM, V59, P376, DOI 10.1002/jcb.240590309; Morton NM, 2004, DIABETES, V53, P931, DOI 10.2337/diabetes.53.4.931; Morton NM, 2001, J BIOL CHEM, V276, P41293, DOI 10.1074/jbc.M103676200; Packard RRS, 2009, SEMIN IMMUNOPATHOL, V31, P5, DOI 10.1007/s00281-009-0153-8; Peixoto RADS, 2008, ENDOCRINOLOGY, V149, P1861, DOI 10.1210/en.2007-1028; Poon M, 2001, ATHEROSCLEROSIS, V155, P371, DOI 10.1016/S0021-9150(00)00605-5; Rask E, 2001, J CLIN ENDOCR METAB, V86, P1418, DOI 10.1210/jc.86.3.1418; Rigamonti E, 2005, CIRC RES, V97, P682, DOI 10.1161/01.RES.0000184678.43488.9f; Rosenstock J., DIABETES CARE, V33, P1516; SHIOMI M, 1995, ARTERIOSCL THROM VAS, V15, P1938, DOI 10.1161/01.ATV.15.11.1938; Simoncini T, 2000, CIRC RES, V87, P19, DOI 10.1161/01.RES.87.1.19; Small GR, 2005, P NATL ACAD SCI USA, V102, P12165, DOI 10.1073/pnas.0500641102; Souverein PC, 2004, HEART, V90, P859, DOI 10.1136/hrt.2003.020180; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Taleb S., CURR OPIN PHARM, V10, P197; Thieringer R, 2001, J IMMUNOL, V167, P30, DOI 10.4049/jimmunol.167.1.30; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Williams H, 2002, ARTERIOSCL THROM VAS, V22, P788, DOI 10.1161/01.ATV.0000014587.66321.B4; Zhang TY, 2005, J IMMUNOL, V174, P879, DOI 10.4049/jimmunol.174.2.879; Zhu Y., BIOCH J, V428, P47	53	37	37	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2013	27	4					1519	1531		10.1096/fj.12-219105	http://dx.doi.org/10.1096/fj.12-219105			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23303209	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000316940800024
J	Murakami, K; Calero, G; Brown, CR; Liu, X; Davis, RE; Boeger, H; Kornberg, RD				Murakami, Kenji; Calero, Guillermo; Brown, Christopher R.; Liu, Xin; Davis, Ralph E.; Boeger, Hinrich; Kornberg, Roger D.			Formation and Fate of a Complete 31-Protein RNA Polymerase II Transcription Preinitiation Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; INITIATION-FACTORS; PROMOTER DNA; FACTOR TFIIH; IN-VITRO; ELONGATION; YEAST; INTERMEDIATE; REINITIATION; RECRUITMENT	Whereas individual RNA polymerase II (pol II)-general transcription factor (GTF) complexes are unstable, an assembly of pol II with six GTFs and promoter DNA could be isolated in abundant homogeneous form. The resulting complete pol II transcription preinitiation complex (PIC) contained equimolar amounts of all 31 protein components. An intermediate in assembly, consisting of four GTFs and promoter DNA, could be isolated and supplemented with the remaining components for formation of the PIC. Nuclease digestion and psoralen cross-linking mapped the PIC between positions -70 and -9, centered on the TATA box. Addition of ATP to the PIC resulted in quantitative conversion to an open complex, which retained all 31 proteins, contrary to expectation from previous studies. Addition of the remaining NTPs resulted in run-off transcription, with an efficiency that was promoter-dependent and was as great as 17.5% with the promoters tested.	[Murakami, Kenji; Calero, Guillermo; Liu, Xin; Davis, Ralph E.; Kornberg, Roger D.] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; [Brown, Christopher R.; Boeger, Hinrich] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	Stanford University; University of California System; University of California Santa Cruz	Kornberg, RD (corresponding author), Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA.	kornberg@stanford.edu		Brown, Christopher/0000-0001-6076-4035	National Institutes of Health [GM36659, AI21144]; Japan Society for the Promotion of Science (JSPS); Kanae Foundation; Uehara Memorial Foundation; Kazato Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036659, R01GM036659] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kanae Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Kazato Research Foundation(Kazato Research Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM36659 and AI21144 (to R. D. K.).; Supported by the Japan Society for the Promotion of Science (JSPS), the Kanae Foundation, the Uehara Memorial Foundation, and the Kazato Research Foundation.	BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; Cabart P, 2012, J BIOL CHEM, V287, P961, DOI 10.1074/jbc.M111.297572; CAI H, 1987, J BIOL CHEM, V262, P298; CECH T, 1977, BIOCHEMISTRY-US, V16, P5313, DOI 10.1021/bi00643a024; CONAWAY RC, 1993, ANNU REV BIOCHEM, V62, P161; Dvir A, 1996, J BIOL CHEM, V271, P7245, DOI 10.1074/jbc.271.13.7245; Esnault C, 2008, MOL CELL, V31, P337, DOI 10.1016/j.molcel.2008.06.021; FEAVER WJ, 1994, CELL, V79, P1103, DOI 10.1016/0092-8674(94)90040-X; GIARDINA C, 1993, SCIENCE, V261, P759, DOI 10.1126/science.8342041; Gibbons BJ, 2012, P NATL ACAD SCI USA, V109, P1949, DOI 10.1073/pnas.1105266109; Hahn S, 1998, COLD SPRING HARB SYM, V63, P181, DOI 10.1101/sqb.1998.63.181; Iyer V, 1996, P NATL ACAD SCI USA, V93, P5208, DOI 10.1073/pnas.93.11.5208; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Liu Y, 2004, MOL CELL BIOL, V24, P1721, DOI 10.1128/MCB.24.4.1721-1735.2004; LUSE DS, 1987, J BIOL CHEM, V262, P289; Miller G, 2006, NAT STRUCT MOL BIOL, V13, P603, DOI 10.1038/nsmb1117; Murakami K, 2012, P NATL ACAD SCI USA, V109, P4816, DOI 10.1073/pnas.1201448109; OBRIEN T, 1991, MOL CELL BIOL, V11, P5285, DOI 10.1128/MCB.11.10.5285; Ranish JA, 1999, GENE DEV, V13, P49, DOI 10.1101/gad.13.1.49; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; SAYRE MH, 1992, J BIOL CHEM, V267, P23376; Spangler L, 2001, P NATL ACAD SCI USA, V98, P5544, DOI 10.1073/pnas.101004498; SVEJSTRUP JQ, 1994, J BIOL CHEM, V269, P28044; Wade JT, 2008, CURR OPIN GENET DEV, V18, P130, DOI 10.1016/j.gde.2007.12.008; Yudkovsky N, 2000, NATURE, V408, P225, DOI 10.1038/35041603; ZAWEL L, 1995, GENE DEV, V9, P1479, DOI 10.1101/gad.9.12.1479	28	23	23	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6325	6332		10.1074/jbc.M112.433623	http://dx.doi.org/10.1074/jbc.M112.433623			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23303183	hybrid, Green Published			2022-12-25	WOS:000315820700027
J	Panjarian, S; Iacob, RE; Chen, SG; Wales, TE; Engen, JR; Smithgall, TE				Panjarian, Shoghag; Iacob, Roxana E.; Chen, Shugui; Wales, Thomas E.; Engen, John R.; Smithgall, Thomas E.			Enhanced SH3/Linker Interaction Overcomes Abl Kinase Activation by Gatekeeper and Myristic Acid Binding Pocket Mutations and Increases Sensitivity to Small Molecule Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE MASS-SPECTROMETRY; SRC-FAMILY KINASES; REGULATES C-ABL; BCR-ABL; TYROSINE KINASE; SH3 DOMAIN; SH3-LIGAND INTERACTIONS; HYDROGEN-EXCHANGE; STRUCTURAL BASIS; IMATINIB	Multidomain kinases such as c-Src and c-Abl are regulated by complex allosteric interactions involving their noncatalytic SH3 and SH2 domains. Here we show that enhancing natural allosteric control of kinase activity by SH3/linker engagement has long-range suppressive effects on the kinase activity of the c-Abl core. Surprisingly, enhanced SH3/linker interaction also dramatically sensitized the Bcr-Abl tyrosine kinase associated with chronic myelogenous leukemia to small molecule inhibitors that target either the active site or the myristic acid binding pocket in the kinase domain C-lobe. Dynamics analyses using hydrogen exchange mass spectrometry revealed a remarkable allosteric network linking the SH3 domain, the myristic acid binding pocket, and the active site of the c-Abl core, providing a structural basis for the biological observations. These results suggest a rational strategy for enhanced drug targeting of Bcr-Abl and other multidomain kinase systems that use multiple small molecules to exploit natural mechanisms of kinase control.	[Panjarian, Shoghag; Smithgall, Thomas E.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA; [Iacob, Roxana E.; Chen, Shugui; Wales, Thomas E.; Engen, John R.] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northeastern University	Smithgall, TE (corresponding author), Bridgeside Point 2,Suite 523,450 Technol Dr, Pittsburgh, PA 15219 USA.	tsmithga@pitt.edu		Wales, Thomas E./0000-0001-6133-5689; Engen, John R./0000-0002-6918-9476	National Institutes of Health [CA169962, CA101828, GM086507, GM101135]; Waters Corporation; NATIONAL CANCER INSTITUTE [R01CA101828, R21CA169962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101135, R01GM086507] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Waters Corporation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA169962 and CA101828 (to T. E. S.) and GM086507 and GM101135 (to J. R. E.), and a research collaboration with the Waters Corporation (to J. R. E.).	Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Barila D, 1998, NAT GENET, V18, P280, DOI 10.1038/ng0398-280; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Burkitt W, 2008, RAPID COMMUN MASS SP, V22, P3893, DOI 10.1002/rcm.3794; Chen S, 2008, J MOL BIOL, V383, P414, DOI 10.1016/j.jmb.2008.08.040; Chen SG, 2008, BIOCHEMISTRY-US, V47, P5795, DOI 10.1021/bi800446b; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Engen JR, 2008, CELL MOL LIFE SCI, V65, P3058, DOI 10.1007/s00018-008-8122-2; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Filippakopoulos P, 2008, CELL, V134, P793, DOI 10.1016/j.cell.2008.07.047; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Griswold IJ, 2006, MOL CELL BIOL, V26, P6082, DOI 10.1128/MCB.02202-05; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Iacob RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015929; Iacob RE, 2009, P NATL ACAD SCI USA, V106, P1386, DOI 10.1073/pnas.0811912106; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; MCWHIRTER JR, 1993, MOL CELL BIOL, V13, P7587, DOI 10.1128/MCB.13.12.7587; Meyn MA, 2006, J BIOL CHEM, V281, P30907, DOI 10.1074/jbc.M605902200; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Nagar B, 2002, CANCER RES, V62, P4236; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Nardi V, 2004, CURR OPIN HEMATOL, V11, P35, DOI 10.1097/00062752-200401000-00006; Pene-Dumitrescu T, 2008, ONCOGENE, V27, P7055, DOI 10.1038/onc.2008.330; Pene-Dumitrescu T, 2010, J BIOL CHEM, V285, P21446, DOI 10.1074/jbc.M109.090043; Pisabarro MT, 1998, J MOL BIOL, V281, P513, DOI 10.1006/jmbi.1998.1932; Plumb RS, 2006, RAPID COMMUN MASS SP, V20, P1989, DOI 10.1002/rcm.2550; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wales TE, 2008, ANAL CHEM, V80, P6815, DOI 10.1021/ac8008862; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1498, DOI 10.1016/j.jasms.2006.05.014; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675	38	25	25	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6116	6129		10.1074/jbc.M112.431312	http://dx.doi.org/10.1074/jbc.M112.431312			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23303187	hybrid, Green Published			2022-12-25	WOS:000315820700009
J	Yang, GH; Dong, YB; Li, YL; Wang, QL; Shi, QL; Zhou, Q				Yang, Guohu; Dong, Yongbin; Li, Yuling; Wang, Qilei; Shi, Qingling; Zhou, Qiang			Verification of QTL for Grain Starch Content and Its Genetic Correlation with Oil Content Using Two Connected RIL Populations in High-Oil Maize	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ILLINOIS HIGH OIL; KERNEL OIL; PROTEIN; SELECTION; ASSOCIATIONS; CROSS; F-23; IDENTIFICATION; YIELD	Grain oil content is negatively correlated with starch content in maize in general. In this study, 282 and 263 recombinant inbred lines (RIL) developed from two crosses between one high-oil maize inbred and two normal dent maize inbreds were evaluated for grain starch content and its correlation with oil content under four environments. Single-trait QTL for starch content in single-population and joint-population analysis, and multiple-trait QTL for both starch and oil content were detected, and compared with the result obtained in the two related F-2:3 populations. Totally, 20 single-population QTL for grain starch content were detected. No QTL was simultaneously detected across all ten cases. QTL at bins 5.03 and 9.03 were all detected in both populations and in 4 and 5 cases, respectively. Only 2 of the 16 joint-population QTL had significant effects in both populations. Three single-population QTL and 8 joint-population QTL at bins 1.03, 1.04-1.05, 3.05, 8.04-8.05, 9.03, and 9.05 could be considered as fine-mapped. Common QTL across F-2:3 and RIL generations were observed at bins 5.04, 8.04 and 8.05 in population 1 (Pop. 1), and at bin 5.03 in population 2 (Pop. 2). QTL at bins 3.02-3.03, 3.05, 8.04-8.05 and 9.03 should be focused in high-starch maize breeding. In multiple-trait QTL analysis, 17 starch-oil QTL were detected, 10 in Pop. 1 and 7 in Pop. 2. And 22 single-trait QTL failed to show significance in multiple-trait analysis, 13 QTL for starch content and 9 QTL for oil content. However, QTL at bins 1.03, 6.03-6.04 and 8.03-8.04 might increase grain starch content and/or grain oil content without reduction in another trait. Further research should be conducted to validate the effect of these QTL in the simultaneous improvement of grain starch and oil content in maize.	[Yang, Guohu; Dong, Yongbin; Li, Yuling; Wang, Qilei; Shi, Qingling; Zhou, Qiang] Henan Agr Univ, Coll Agr, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China	Henan Agricultural University	Li, YL (corresponding author), Henan Agr Univ, Coll Agr, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China.	yuling_li@126.com			Henan Innovation Project for University Prominent Research Talents [2005HANCET-12]; Henan Scientific Technology Research Project [0623011700]	Henan Innovation Project for University Prominent Research Talents; Henan Scientific Technology Research Project	This study was supported by Henan Innovation Project for University Prominent Research Talents (2005HANCET-12), Henan Scientific Technology Research Project (0623011700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS KL, 1987, ANIM FEED SCI TECH, V17, P201, DOI 10.1016/0377-8401(87)90003-4; ALEXANDER DE, 1968, CROP SCI, V8, P273, DOI 10.2135/cropsci1968.0011183X000800030002x; Arcade A, 2004, BIOINFORMATICS, V20, P2324, DOI 10.1093/bioinformatics/bth230; Austin DF, 1996, THEOR APPL GENET, V92, P817, DOI 10.1007/BF00221893; BERKE TG, 1995, CROP SCI, V35, P1542, DOI 10.2135/cropsci1995.0011183X003500060004x; CHURCHILL GA, 1994, GENETICS, V138, P963; Dudley, 1974, 70 GENERATIONS SELEC, P181; DUDLEY JW, 1992, MAYDICA, V37, P81; Dudley JW, 2004, CROP SCI, V44, P1419, DOI 10.2135/cropsci2004.1419; GOLDMAN IL, 1994, CROP SCI, V34, P908, DOI 10.2135/cropsci1994.0011183X003400040013x; Goss J, 1992, P 47 ANN CORN SORGH, P82; HAN Y, 1987, POULTRY SCI, V66, P103, DOI 10.3382/ps.0660103; HENDERSON CR, 1953, BIOMETRICS, V9, P226, DOI 10.2307/3001853; Hopkins C.G., 1899, ILL AGR EXP STN B, V55, P205; JIANG CJ, 1995, GENETICS, V140, P1111; Jiang HaiYing, 2005, Acta Agronomica Sinica, V31, P361; Kao CH, 1999, GENETICS, V152, P1203; KNAPP SJ, 1985, CROP SCI, V25, P192, DOI 10.2135/cropsci1985.0011183X002500010046x; Lambert R.J., 2001, SPECIALTY CORNS, P131, DOI DOI 10.1201/9781420038569.CH5; Lambert RJ, 1997, MAYDICA, V42, P39; Laurie CC, 2004, GENETICS, V168, P2141, DOI 10.1534/genetics.104.029686; Li HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017573; Li YL, 2009, J GENET, V88, P61, DOI 10.1007/s12041-009-0008-z; Liu YY, 2008, J CEREAL SCI, V48, P625, DOI 10.1016/j.jcs.2008.02.003; Lynch M, 1998, GENETICS ANAL QUANTI, P448; Mangolin CA, 2004, EUPHYTICA, V137, P251, DOI 10.1023/B:EUPH.0000041588.95689.47; Miranda JB., 1981, QUANTITATIVE GENETIC; MISEVIC D, 1989, CROP SCI, V29, P320, DOI 10.2135/cropsci1989.0011183X002900020018x; Piepho HP, 2001, GENETICS, V157, P425; Prioul JL, 1997, J EXP BOT, V48, P1151, DOI 10.1093/jxb/48.6.1151; PRIOUL JL, 1994, PLANT PHYSIOL, V104, P179, DOI 10.1104/pp.104.1.179; PRIOUL JL, 1990, PLANT PHYSIOL BIOCH, V28, P485; Slattery CJ, 2000, TRENDS PLANT SCI, V5, P291, DOI 10.1016/S1360-1385(00)01657-5; Song XF, 2004, MAYDICA, V49, P41; Thevenot C, 2005, J EXP BOT, V56, P945, DOI 10.1093/jxb/eri087; Wang S, 2012, WINDOWS QTL CARTOGRA; Wang YZ, 2010, EUPHYTICA, V174, P239, DOI 10.1007/s10681-010-0123-1; Wassom JJ, 2008, CROP SCI, V48, P243, DOI 10.2135/cropsci2007.04.0205; Watson S. A., 1987, Corn: chemistry and technology., P53; Willmot DB, 2006, MAYDICA, V51, P187; WOODWORTH CM, 1952, AGRON J, V44, P60, DOI 10.2134/agronj1952.00021962004400020002x; Yang GH, 2012, MOL BREEDING, V29, P313, DOI 10.1007/s11032-011-9548-z; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang J, 2008, EUPHYTICA, V162, P335, DOI 10.1007/s10681-007-9500-9; Zheng P, 2008, NAT GENET, V40, P367, DOI 10.1038/ng.85	45	13	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53770	10.1371/journal.pone.0053770	http://dx.doi.org/10.1371/journal.pone.0053770			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320103	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429800068
J	Abbas, A; Kong, XB; Liu, Z; Jing, BY; Gao, X				Abbas, Ahmed; Kong, Xin-Bing; Liu, Zhi; Jing, Bing-Yi; Gao, Xin			Automatic Peak Selection by a Benjamini-Hochberg-Based Algorithm	PLOS ONE			English	Article							NMR; PICKING; DISCOVERY; MUNIN	A common issue in bioinformatics is that computational methods often generate a large number of predictions sorted according to certain confidence scores. A key problem is then determining how many predictions must be selected to include most of the true predictions while maintaining reasonably high precision. In nuclear magnetic resonance (NMR)-based protein structure determination, for instance, computational peak picking methods are becoming more and more common, although expert-knowledge remains the method of choice to determine how many peaks among thousands of candidate peaks should be taken into consideration to capture the true peaks. Here, we propose a Benjamini-Hochberg (BH)-based approach that automatically selects the number of peaks. We formulate the peak selection problem as a multiple testing problem. Given a candidate peak list sorted by either volumes or intensities, we first convert the peaks into p-values and then apply the B-H-based algorithm to automatically select the number of peaks. The proposed approach is tested on the state-of-the-art peak picking methods, including WaVPeak [1] and PICKY [2]. Compared with the traditional fixed number-based approach, our approach returns significantly more true peaks. For instance, by combining WaVPeak or PICKY with the proposed method, the missing peak rates are on average reduced by 20% and 26%, respectively, in a benchmark set of 32 spectra extracted from eight proteins. The consensus of the B-H-selected peaks from both WaVPeak and PICKY achieves 88% recall and 83% precision, which significantly outperforms each individual method and the consensus method without using the B-H algorithm. The proposed method can be used as a standard procedure for any peak picking method and straightforwardly applied to some other prediction selection problems in bioinformatics. The source code, documentation and example data of the proposed method is available at http://sfb.kaust.edu.sa/pages/software.aspx.	[Abbas, Ahmed; Gao, Xin] King Abdullah Univ Sci & Technol, Comp Elect & Math Sci & Engn Div, Thuwal, Saudi Arabia; [Kong, Xin-Bing] Fudan Univ, Dept Stat, Shanghai 200433, Peoples R China; [Liu, Zhi] Univ Macau, Fac Sci & Technol, Dept Math, Taipa, Peoples R China; [Jing, Bing-Yi] Hong Kong Univ Sci & Technol, Dept Math, Kowloon, Hong Kong, Peoples R China	King Abdullah University of Science & Technology; Fudan University; University of Macau; Hong Kong University of Science & Technology	Jing, BY (corresponding author), Hong Kong Univ Sci & Technol, Dept Math, Kowloon, Hong Kong, Peoples R China.	majing@ust.hk; xin.gao@kaust.edu.sa	Gao, Xin/D-5487-2013	Gao, Xin/0000-0002-7108-3574; Jing, Bing-yi/0000-0002-8876-1570	GMSV-OCRF award from King Abdullah University of Science and Technology; Hong Kong Research Grants Council [HKUST6019/10P, HKUST6019/12P];  [GRP-CF-2011-19-P-Gao-Huang]	GMSV-OCRF award from King Abdullah University of Science and Technology; Hong Kong Research Grants Council(Hong Kong Research Grants Council); 	This work was supported by Award No. GRP-CF-2011-19-P-Gao-Huang, a GMSV-OCRF award from King Abdullah University of Science and Technology, and Hong Kong Research Grants Council grants HKUST6019/10P and HKUST6019/12P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alipanahi B, 2011, J BIOINF COMPUT BIOL, V9, P15, DOI 10.1142/S0219720011005276; Alipanahi B, 2009, BIOINFORMATICS, V25, pI268, DOI 10.1093/bioinformatics/btp225; Altieri AS, 2004, CURR OPIN STRUC BIOL, V14, P547, DOI 10.1016/j.sbi.2004.09.003; ANTZ C, 1995, J BIOMOL NMR, V5, P287, DOI 10.1007/BF00211755; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonferroni C., 1936, PUBBL R 1 SUPER SCI, V8, P3; Bonferroni CE, 1935, STUDI ONORE PROFESSO, P13; CARRARA EA, 1993, NEURAL NETWORKS, V6, P1023, DOI 10.1016/S0893-6080(09)80012-9; Coin L, 2003, P NATL ACAD SCI USA, V100, P4516, DOI 10.1073/pnas.0737502100; CORNE SA, 1992, J MAGN RESON, V100, P256, DOI 10.1016/0022-2364(92)90260-E; Daubechies I., 1992, 10 LECT WAVELETS, DOI [10.1137/1.9781611970104.ch1, DOI 10.1137/1.9781611970104.CH1]; Efron B., 2010, LARGE SCALE INFERENC; Forslund K, 2008, BIOINFORMATICS, V24, P1681, DOI 10.1093/bioinformatics/btn312; Gao X, 2009, THESIS U WATERLOO; Gao X., 2012, J APPL COMPUT MATH, V1, P1; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Gronwald W, 2004, PROG NUCL MAG RES SP, V44, P33, DOI 10.1016/j.pnmrs.2003.12.002; Guntert P, 2009, EUR BIOPHYS J BIOPHY, V38, P129, DOI 10.1007/s00249-008-0367-z; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kleywegt G., 1990, J MAGN RESON, V135, P288; Koradi R, 1998, J MAGN RESON, V135, P288, DOI 10.1006/jmre.1998.1570; Korzhnev DM, 2001, J BIOMOL NMR, V21, P263, DOI 10.1023/A:1012982830367; Liu Z, 2012, BIOINFORMATICS, V28, P914, DOI 10.1093/bioinformatics/bts078; Messih MA, 2012, BIOINFORMATICS, V28, pI444, DOI 10.1093/bioinformatics/bts398; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; Orekhov VY, 2001, J BIOMOL NMR, V20, P49, DOI 10.1023/A:1011234126930; ROUH A, 1994, J BIOMOL NMR, V4, P505, DOI 10.1007/BF00156617; Silvescu A., 2004, INTERELEMENT DEPENDE; Wuthrich K, 1986, NMR PROTEINS NUCL AC	29	23	24	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53112	10.1371/journal.pone.0053112	http://dx.doi.org/10.1371/journal.pone.0053112			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308147	Green Submitted, gold, Green Published			2022-12-25	WOS:000313429100030
J	Liaw, C; Tung, CW; Ho, SY				Liaw, Chyn; Tung, Chun-Wei; Ho, Shinn-Ying			Prediction and Analysis of Antibody Amyloidogenesis from Sequences	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; PROTEIN; AGGREGATION; PEPTIDES; IDENTIFICATION; HUMANIZATION; SERVER; IMMUNOGENICITY; DETERMINANTS; CONFORMATION	Antibody amyloidogenesis is the aggregation of soluble proteins into amyloid fibrils that is one of major causes of the failures of humanized antibodies. The prediction and prevention of antibody amyloidogenesis are helpful for restoring and enhancing therapeutic effects. Due to a large number of possible germlines, the existing method is not practical to predict sequences of novel germlines, which establishes individual models for each known germline. This study proposes a first automatic and across-germline prediction method (named AbAmyloid) capable of predicting antibody amyloidogenesis from sequences. Since the amyloidogenesis is determined by a whole sequence of an antibody rather than germline-dependent properties such as mutated residues, this study assess three types of germline-independent sequence features (amino acid composition, dipeptide composition and physicochemical properties). AbAmyloid using a Random Forests classifier with dipeptide composition performs well on a data set of 12 germlines. The within-and across-germline prediction accuracies are 83.10% and 83.33% using Jackknife tests, respectively, and the novel-germline prediction accuracy using a leave-one-germline-out test is 72.22%. A thorough analysis of sequence features is conducted to identify informative properties for further providing insights to antibody amyloidogenesis. Some identified informative physicochemical properties are amphiphilicity, hydrophobicity, reverse turn, helical structure, isoelectric point, net charge, mutability, coil, turn, linker, nuclear protein, etc. Additionally, the numbers of ubiquitylation sites in amyloidogenic and nonamyloidogenic antibodies are found to be significantly different. It reveals that antibodies less likely to be ubiquitylated tend to be amyloidogenic. The method AbAmyloid capable of automatically predicting antibody amyloidogenesis of novel germlines is implemented as a publicly available web server at http://iclab.life.nctu.edu.tw/abamyloid.	[Liaw, Chyn; Ho, Shinn-Ying] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Tung, Chun-Wei] Kaohsiung Med Univ, Coll Pharm, Sch Pharm, Kaohsiung, Taiwan; [Ho, Shinn-Ying] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; Kaohsiung Medical University; National Yang Ming Chiao Tung University	Ho, SY (corresponding author), Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan.	syho@mail.nctu.edu.tw	Ho, Shinn-Ying/AFD-8402-2022; Ho, Shinn-Ying/AAE-9394-2022; Tung, Chun-Wei/B-3749-2008	Ho, Shinn-Ying/0000-0002-1901-8353; Ho, Shinn-Ying/0000-0002-1901-8353; Tung, Chun-Wei/0000-0003-3011-8440	National Science Council of Taiwan [NSC-101-2627-B-009-003-]; "Center for Bioinformatics Research of Aiming for the Top University Program'' of the National Chiao Tung University; Ministry of Education, Taiwan, R.O.C [101W962]; UST-UCSD International Center of Excellence in Advanced Bioengineering; Taiwan National Science Council I-RiCE Program [NSC-101-2911-I-009-101]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); "Center for Bioinformatics Research of Aiming for the Top University Program'' of the National Chiao Tung University; Ministry of Education, Taiwan, R.O.C(Ministry of Education, Taiwan); UST-UCSD International Center of Excellence in Advanced Bioengineering; Taiwan National Science Council I-RiCE Program	This work was supported by National Science Council of Taiwan under the contract number NSC-101-2627-B-009-003-, and "Center for Bioinformatics Research of Aiming for the Top University Program'' of the National Chiao Tung University and Ministry of Education, Taiwan, R.O.C for the project 101W962. This work was also supported in part by the UST-UCSD International Center of Excellence in Advanced Bioengineering sponsored by the Taiwan National Science Council I-RiCE Program under Grant Number: NSC-101-2911-I-009-101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedini A, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/015005; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amaratunga D, 2008, BIOINFORMATICS, V24, P2010, DOI 10.1093/bioinformatics/btn356; Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Bond JP, 2003, J STRUCT BIOL, V141, P156, DOI 10.1016/S1047-8477(02)00625-1; BRACK A, 1975, NATURE, V256, P383, DOI 10.1038/256383a0; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Broome BM, 2000, J MOL BIOL, V296, P961, DOI 10.1006/jmbi.2000.3514; Caflisch A, 2006, CURR OPIN CHEM BIOL, V10, P437, DOI 10.1016/j.cbpa.2006.07.009; Calle M Luz, 2011, Brief Bioinform, V12, P86, DOI 10.1093/bib/bbq011; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Clark M, 2000, IMMUNOL TODAY, V21, P397, DOI 10.1016/S0167-5699(00)01680-7; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Das U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001176; David MPC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-79; de Groot NS, 2012, METHODS MOL BIOL, V819, P199, DOI 10.1007/978-1-61779-465-0_14; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; Es-haghi A, 2012, BBA-PROTEINS PROTEOM, V1824, P468, DOI 10.1016/j.bbapap.2011.12.010; Ewert S, 2004, METHODS, V34, P184, DOI 10.1016/j.ymeth.2004.04.007; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Galzitskaya OV, 2006, PLOS COMPUT BIOL, V2, P1639, DOI 10.1371/journal.pcbi.0020177; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gordon DJ, 2004, BIOPHYS J, V86, P428, DOI 10.1016/S0006-3495(04)74119-3; Huang WL, 2007, BIOSYSTEMS, V90, P573, DOI 10.1016/j.biosystems.2007.01.001; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; HURLE MR, 1994, P NATL ACAD SCI USA, V91, P5446, DOI 10.1073/pnas.91.12.5446; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Kim W, 2006, P NATL ACAD SCI USA, V103, P15824, DOI 10.1073/pnas.0605629103; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; Krebs MRH, 2009, BIOPHYS J, V96, P5013, DOI 10.1016/j.bpj.2009.03.028; Kryszkiewicz MRH, 2011, 19 INT S ISMIS 2011; Lim A, 1998, PROTEIN SCI, V7, P1545, DOI 10.1002/pro.5560070708; Lin N, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-154; Lopes DHJ, 2007, BIOPHYS J, V93, P3132, DOI 10.1529/biophysj.107.110635; Maji SK, 2004, TETRAHEDRON, V60, P3251, DOI 10.1016/j.tet.2004.02.019; Mateo C, 1997, IMMUNOTECHNOLOGY, V3, P71, DOI 10.1016/S1380-2933(97)00065-1; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; PADLAN EA, 1991, MOL IMMUNOL, V28, P489, DOI 10.1016/0161-5890(91)90163-E; Presta LG, 2008, CURR OPIN IMMUNOL, V20, P460, DOI 10.1016/j.coi.2008.06.012; ROGUSKA MA, 1994, P NATL ACAD SCI USA, V91, P969, DOI 10.1073/pnas.91.3.969; SOREGHAN B, 1994, J BIOL CHEM, V269, P28551; Srisailam S, 2002, J BIOL CHEM, V277, P19027, DOI 10.1074/jbc.M110762200; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Tartaglia GG, 2005, PROTEIN SCI, V14, P2723, DOI 10.1110/ps.051471205; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Topilina NI, 2010, BIOMACROMOLECULES, V11, P1721, DOI 10.1021/bm901467a; Trovato A, 2007, PROTEIN ENG DES SEL, V20, P521, DOI 10.1093/protein/gzm042; Tung CW, 2007, BIOINFORMATICS, V23, P942, DOI 10.1093/bioinformatics/btm061; Tung CW, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-446; Tung CW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-310; Vidal R, 1999, AM J PATHOL, V155, P2009, DOI 10.1016/S0002-9440(10)65520-4; Villegas V, 2000, PROTEIN SCI, V9, P1700, DOI 10.1110/ps.9.9.1700; Waldmann H, 2005, PHILOS T ROY SOC B, V360, P1707, DOI 10.1098/rstb.2005.1702; Wang LJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S3-S2; Zavaljevski N, 2002, BIOINFORMATICS, V18, P689, DOI 10.1093/bioinformatics/18.5.689; ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508	58	20	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53235	10.1371/journal.pone.0053235	http://dx.doi.org/10.1371/journal.pone.0053235			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308169	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429100043
J	Nguyen, J; Tang, SY; Nguyen, D; Alliston, T				Nguyen, Jacqueline; Tang, Simon Y.; Nguyen, Daniel; Alliston, Tamara			Load Regulates Bone Formation and Sclerostin Expression through a TGF beta-Dependent Mechanism	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; CANCELLOUS BONE; GENE; INCREASES; SOST; TRANSCRIPTION; RECEPTOR; SMAD3; MASS	Bone continually adapts to meet changing physical and biological demands. Osteoblasts, osteoclasts, and osteocytes cooperate to integrate these physical and biochemical cues to maintain bone homeostasis. Although TGF beta acts on all three of these cell types to maintain bone homeostasis, the extent to which it participates in the adaptation of bone to mechanical load is unknown. Here, we investigated the role of the TGF beta pathway in load-induced bone formation and the regulation of Sclerostin, a mechanosensitive antagonist of bone anabolism. We found that mechanical load rapidly represses the net activity of the TGF beta pathway in osteocytes, resulting in reduced phosphorylation and activity of key downstream effectors, Smad2 and Smad3. Loss of TGF beta sensitivity compromises the anabolic response of bone to mechanical load, demonstrating that the mechanosensitive regulation of TGF beta signaling is essential for load-induced bone formation. Furthermore, sensitivity to TGF beta is required for the mechanosensitive regulation of Sclerostin, which is induced by TGF beta in a Smad3-dependent manner. Together, our results show that physical cues maintain bone homeostasis through the TGF beta pathway to regulate Sclerostin expression and the deposition of new bone.	[Nguyen, Jacqueline; Alliston, Tamara] Univ Calif San Francisco, Grad Program Oral & Craniofacial Sci, San Francisco, CA 94143 USA; [Tang, Simon Y.; Nguyen, Daniel; Alliston, Tamara] Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco, CA USA; [Alliston, Tamara] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Alliston, Tamara] Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA USA; [Alliston, Tamara] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Alliston, T (corresponding author), Univ Calif San Francisco, Grad Program Oral & Craniofacial Sci, San Francisco, CA 94143 USA.	tamara.alliston@ucsf.edu	Tang, Simon/AAZ-1179-2021	Tang, Simon/0000-0002-5570-3921; Alliston, Tamara/0000-0001-9992-2897	National Institutes of Health [F30DE022680, F32AR059497, R01DE019284]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR059497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019284, F30DE022680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was funded by the National Institutes of Health F30DE022680, F32AR059497, and R01DE019284 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajubi NE, 1996, BIOCHEM BIOPH RES CO, V225, P62, DOI 10.1006/bbrc.1996.1131; Alford AI, 2012, CALCIFIED TISSUE INT, V90, P420, DOI 10.1007/s00223-012-9580-y; Allen JL, 2012, MOL BIOL CELL, V23, P3731, DOI 10.1091/mbc.E12-03-0172; Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Balooch G, 2005, P NATL ACAD SCI USA, V102, P18813, DOI 10.1073/pnas.0507417102; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Dabovic B, 2005, BONE, V37, P25, DOI 10.1016/j.bone.2005.02.021; DUNCAN RL, 1995, CALCIFIED TISSUE INT, V57, P344, DOI 10.1007/BF00302070; Filvaroff E, 1999, DEVELOPMENT, V126, P4267; Fox SW, 2005, MOL CELL ENDOCRINOL, V243, P19, DOI 10.1016/j.mce.2005.09.008; Fritton JC, 2005, BONE, V36, P1030, DOI 10.1016/j.bone.2005.02.013; Galea GL, 2011, FEBS LETT, V585, P2450, DOI 10.1016/j.febslet.2011.06.019; Geiser AG, 1998, BONE, V23, P87, DOI 10.1016/S8756-3282(98)00078-7; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Jian HY, 2006, GENE DEV, V20, P666, DOI 10.1101/gad.1388806; Kamiya N, 2008, DEVELOPMENT, V135, P3801, DOI 10.1242/dev.025825; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Kitase Y, 2010, J BONE MINER RES, V25, P2381, DOI 10.1002/jbmr.168; Kramer I, 2010, J BONE MINER RES, V25, P178, DOI 10.1359/jbmr.090730; Leupin O, 2007, J BONE MINER RES, V22, P1957, DOI 10.1359/JBMR.070804; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Lin AH, 2005, J IMMUNOL, V175, P547, DOI 10.4049/jimmunol.175.1.547; Liu D, 2004, EMBO J, V23, P1557, DOI 10.1038/sj.emboj.7600179; Loots GG, 2012, BONE, V50, P663, DOI 10.1016/j.bone.2011.11.016; Moester MJC, 2010, CALCIFIED TISSUE INT, V87, P99, DOI 10.1007/s00223-010-9372-1; Mohammad KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005275; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Price Joanna S, 2011, Curr Osteoporos Rep, V9, P76, DOI 10.1007/s11914-011-0050-7; Qiu T, 2010, NAT CELL BIOL, V12, P224, DOI 10.1038/ncb2022; RAABCULLEN DM, 1994, CALCIFIED TISSUE INT, V55, P473, DOI 10.1007/BF00298562; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Reijnders CMA, 2007, J ENDOCRINOL, V192, P131, DOI 10.1677/joe.1.06880; Rhee Y, 2011, J BONE MINER RES, V26, P1035, DOI 10.1002/jbmr.304; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Sakai K, 1998, CALCIFIED TISSUE INT, V63, P515, DOI 10.1007/s002239900567; SALVESEN H, 1994, CALCIFIED TISSUE INT, V54, P256, DOI 10.1007/BF00295947; Sevetson B, 2004, J BIOL CHEM, V279, P13849, DOI 10.1074/jbc.M306249200; Tian XY, 2011, BONE, V48, P197, DOI 10.1016/j.bone.2010.09.009; van der Meulen MCH, 2006, BONE, V38, P871, DOI 10.1016/j.bone.2005.11.026; van der Meulen MCH, 2009, CLIN ORTHOP RELAT R, V467, P2000, DOI 10.1007/s11999-009-0897-4; Wang YK, 2012, STEM CELLS DEV, V21, P1176, DOI 10.1089/scd.2011.0293; Whitlon DS, 2001, BRAIN RES PROTOC, V6, P159, DOI 10.1016/S1385-299X(00)00048-9; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1	45	57	58	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53813	10.1371/journal.pone.0053813	http://dx.doi.org/10.1371/journal.pone.0053813			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308287	gold, Green Submitted, Green Published			2022-12-25	WOS:000313429100119
J	Wang, ZY; Chai, WD; Burwinkel, M; Twardziok, S; Wrede, P; Palissa, C; Esch, B; Schmidt, MFG				Wang, Zhenya; Chai, Weidong; Burwinkel, Michael; Twardziok, Sven; Wrede, Paul; Palissa, Christiane; Esch, Bettina; Schmidt, Michael F. G.			Inhibitory Influence of Enterococcus faecium on the Propagation of Swine Influenza A Virus In Vitro	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; NITRIC-OXIDE; ROTAVIRUS INFECTION; MACROPHAGES; PROBIOTICS; RESPONSES; CELLS; MODEL; SOWS	The control of infectious diseases such as swine influenza viruses (SwIV) plays an important role in food production both from the animal health and from the public health point of view. Probiotic microorganisms and other health improving food supplements have been given increasing attention in recent years, but, no information on the effects of probiotics on swine influenza virus is available. Here we address this question by assessing the inhibitory potential of the probiotic Enterococcus faecium NCIMB 10415 (E. faecium) on the replication of two porcine strains of influenza virus (H1N1 and H3N2 strain) in a continuous porcine macrophage cell line (3D4/21) and in MDBK cells. Cell cultures were treated with E. faecium at the nontoxic concentration of 1x10(6) CFU/ml in growth medium for 60 to 90 min before, during and after SwIV infection. After further incubation of cultures in probiotic-free growth medium, cell viability and virus propagation were determined at 48 h or 96 h post infection. The results obtained reveal an almost complete recovery of viability of SwIV infected cells and an inhibition of virus multiplication by up to four log units in the E. faecium treated cells. In both 3D4/21- and MDBK-cells a 60 min treatment with E. faecium stimulated nitric oxide (NO) release which is in line with published evidence for an antiviral function of NO. Furthermore, E. faecium caused a modified cellular expression of selected mediators of defence in 3D4-cells: while the expression of TNF-alpha, TLR-3 and IL-6 were decreased in the SwIV-infected and probiotic treated cells, IL-10 was found to be increased. Since we obtained experimental evidence for the direct adsorptive trapping of SwIV through E. faecium, this probiotic microorganism inhibits influenza viruses by at least two mechanisms, direct physical interaction and strengthening of innate defence at the cellular level.	[Wang, Zhenya; Chai, Weidong; Burwinkel, Michael; Palissa, Christiane; Esch, Bettina; Schmidt, Michael F. G.] Free Univ Berlin, Inst Immunol, Berlin, Germany; [Twardziok, Sven; Wrede, Paul] Charite Univ Med Berlin, Berlin, Germany	Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schmidt, MFG (corresponding author), Free Univ Berlin, Inst Immunol, Berlin, Germany.	michael.schmidt3@fu-berlin.de		Twardziok, Sven/0000-0002-0326-5704; Burwinkel, Michael/0000-0003-4811-7323	DFG (German Research Council) [SFB 852]	DFG (German Research Council)(German Research Foundation (DFG))	SFB 852 sub-project A5 funded by the DFG (German Research Council). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boggy GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012355; Breen EC, 2002, PHARMACOL THERAPEUT, V95, P295, DOI 10.1016/S0163-7258(02)00263-2; Chae SY, 2004, BIOMATERIALS, V25, P843, DOI 10.1016/S0142-9612(03)00605-7; Clancy R, 2003, FEMS IMMUNOL MED MIC, V38, P9, DOI 10.1016/S0928-8244(03)00147-0; de Vrese M, 2002, BRIT J NUTR, V88, pS59, DOI 10.1079/BJN2002630; Ducatez MF, 2008, VACCINE, V26, pD67, DOI 10.1016/j.vaccine.2008.07.064; Fineberg HV, 2008, J INFECT DIS, V197, pS14, DOI 10.1086/524989; Hatakka K, 2001, BMJ-BRIT MED J, V322, P1327, DOI 10.1136/bmj.322.7298.1327; Ivec M, 2007, ANTIVIR RES, V75, P266, DOI 10.1016/j.antiviral.2007.03.013; KRAH DL, 1991, BIOLOGICALS, V19, P223, DOI 10.1016/1045-1056(91)90039-M; Kritas SK, 2007, VET MICROBIOL, V119, P248, DOI 10.1016/j.vetmic.2006.09.012; Kumar VJR, 2010, TROP ANIM HEALTH PRO, V42, P1855, DOI 10.1007/s11250-010-9648-5; Liu FN, 2010, VIRAL IMMUNOL, V23, P135, DOI 10.1089/vim.2009.0088; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; MARKWELL MAK, 1984, BIOCHIM BIOPHYS ACTA, V775, P7, DOI 10.1016/0005-2736(84)90228-1; Meyerhoff RR, 2012, COMP IMMUNOL MICROB, V35, P63, DOI [10.1016/j.cimid.2011.10.002, 10.1016/j.cimid.2011.10.001]; Miettinen M, 1996, INFECT IMMUN, V64, P5403, DOI 10.1128/IAI.64.12.5403-5405.1996; Rimmelzwaan GF, 1999, J VIROL, V73, P8880, DOI 10.1128/JVI.73.10.8880-8883.1999; Scharek L, 2005, VET IMMUNOL IMMUNOP, V105, P151, DOI 10.1016/j.vetimm.2004.12.022; Schierack P, 2009, VET IMMUNOL IMMUNOP, V127, P26, DOI 10.1016/j.vetimm.2008.09.002; Schroder M, 2005, TRENDS IMMUNOL, V26, P462, DOI 10.1016/j.it.2005.07.002; Simon O, 2010, J ANIM FEED SCI, V19, P230, DOI 10.22358/jafs/66284/2010; Weingartl HM, 2002, J VIROL METHODS, V104, P203, DOI 10.1016/S0166-0934(02)00085-X; Yasui H, 1999, ANTON LEEUW INT J G, V76, P383, DOI 10.1023/A:1002041616085; Zhang W, 2008, VET IMMUNOL IMMUNOP, V122, P175, DOI 10.1016/j.vetimm.2007.10.003	25	38	40	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53043	10.1371/journal.pone.0053043	http://dx.doi.org/10.1371/journal.pone.0053043			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308134	Green Published, gold, Green Submitted			2022-12-25	WOS:000313429100024
J	Zopf, R; Williams, MA				Zopf, Regine; Williams, Mark A.			Preference for Orientations Commonly Viewed for One's Own Hand in the Anterior Intraparietal Cortex	PLOS ONE			English	Article							EXTRASTRIATE BODY AREA; LATERAL OCCIPITOTEMPORAL CORTEX; FMRI ADAPTATION REVEALS; PARIETAL CORTEX; RESPONSE PROPERTIES; PERIPERSONAL SPACE; POSTERIOR PARIETAL; VISUAL-CORTEX; REPRESENTATION; PERCEPTION	Brain regions in the intraparietal and the premotor cortices selectively process visual and multisensory events near the hands (peri-hand space). Visual information from the hand itself modulates this processing potentially because it is used to estimate the location of one's own body and the surrounding space. In humans specific occipitotemporal areas process visual information of specific body parts such as hands. Here we used an fMRI block-design to investigate if anterior intraparietal and ventral premotor 'peri-hand areas' exhibit selective responses to viewing images of hands and viewing specific hand orientations. Furthermore, we investigated if the occipitotemporal 'hand area' is sensitive to viewed hand orientation. Our findings demonstrate increased BOLD responses in the left anterior intraparietal area when participants viewed hands and feet as compared to faces and objects. Anterior intraparietal and also occipitotemporal areas in the left hemisphere exhibited response preferences for viewing right hands with orientations commonly viewed for one's own hand as compared to uncommon own hand orientations. Our results indicate that both anterior intraparietal and occipitotemporal areas encode visual limb-specific shape and orientation information.	[Zopf, Regine; Williams, Mark A.] Macquarie Univ, Dept Cognit Sci, Sydney, NSW 2109, Australia	Macquarie University	Zopf, R (corresponding author), Macquarie Univ, Dept Cognit Sci, Sydney, NSW 2109, Australia.	regine.zopf@mq.edu.au		Williams, Mark/0000-0002-3897-5167; Zopf, Regine/0000-0002-1375-3832	Macquarie University; Australian Research Council [DP 0984919]; Queen Elizabeth II Fellowship from the Australian Research Council	Macquarie University; Australian Research Council(Australian Research Council); Queen Elizabeth II Fellowship from the Australian Research Council(Australian Research Council)	R.Z. was supported by a Macquarie University Research Excellence Scholarship and M. A. W. by a Queen Elizabeth II Fellowship from the Australian Research Council. This work was supported by the Australian Research Council (DP 0984919). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astafiev SV, 2004, NAT NEUROSCI, V7, P542, DOI 10.1038/nn1241; Avillac M, 2007, J NEUROSCI, V27, P1922, DOI 10.1523/JNEUROSCI.2646-06.2007; Blakemore SJ, 2001, NAT REV NEUROSCI, V2, P561, DOI 10.1038/35086023; Bracci S, 2012, J NEUROPHYSIOL, V107, P1443, DOI 10.1152/jn.00619.2011; Bracci S, 2010, J NEUROPHYSIOL, V103, P3389, DOI 10.1152/jn.00215.2010; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; Brozzoli C, 2011, J NEUROSCI, V31, P9023, DOI 10.1523/JNEUROSCI.1172-11.2011; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Chan AWY, 2004, NEUROREPORT, V15, P2407, DOI 10.1097/00001756-200410250-00021; Chong TTJ, 2008, CURR BIOL, V18, P1576, DOI 10.1016/j.cub.2008.08.068; de Gelder B, 2009, PHILOS T R SOC B, V364, P3475, DOI 10.1098/rstb.2009.0190; Denys K, 2004, J NEUROSCI, V24, P2551, DOI 10.1523/JNEUROSCI.3569-03.2004; Dinstein I, 2008, J NEUROSCI, V28, P11231, DOI 10.1523/JNEUROSCI.3585-08.2008; Dinstein I, 2007, J NEUROPHYSIOL, V98, P1415, DOI 10.1152/jn.00238.2007; Downing PE, 2011, COGN NEUROSCI-UK, V2, P186, DOI 10.1080/17588928.2011.582945; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Duhamel JR, 1998, J NEUROPHYSIOL, V79, P126, DOI 10.1152/jn.1998.79.1.126; Ehrsson H. H., 2012, NEW HDB MULTISENSORY; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Gentile G, 2011, J NEUROPHYSIOL, V105, P910, DOI 10.1152/jn.00840.2010; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; Graziano MSA, 2002, ATTENTION PERFORM, V19, P136; Heed T, 2011, J NEUROSCI, V31, P3066, DOI 10.1523/JNEUROSCI.4370-10.2011; HYVARINEN J, 1981, BRAIN RES, V206, P287, DOI 10.1016/0006-8993(81)90533-3; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Kennett S, 2001, CURR BIOL, V11, P1188, DOI 10.1016/S0960-9822(01)00327-X; Konen CS, 2008, NAT NEUROSCI, V11, P224, DOI 10.1038/nn2036; Longo MR, 2009, J NEUROSCI, V29, P12125, DOI 10.1523/JNEUROSCI.3072-09.2009; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; Makin TR, 2007, J NEUROSCI, V27, P731, DOI 10.1523/JNEUROSCI.3653-06.2007; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McCarthy G, 1999, CEREB CORTEX, V9, P431, DOI 10.1093/cercor/9.5.431; Moseley GL, 2008, CURR BIOL, V18, pR1047, DOI 10.1016/j.cub.2008.09.031; O'Toole AJ, 2011, VISION RES, V51, P74, DOI 10.1016/j.visres.2010.09.035; Orlov T, 2010, NEURON, V68, P586, DOI 10.1016/j.neuron.2010.09.032; Peelen MV, 2007, NAT REV NEUROSCI, V8, P636, DOI 10.1038/nrn2195; Reed CL, 2006, J EXP PSYCHOL HUMAN, V32, P166, DOI 10.1037/0096-1523.32.1.166; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P147, DOI 10.1016/0166-4328(81)90053-X; Sakata H, 1997, TRENDS NEUROSCI, V20, P350, DOI 10.1016/S0166-2236(97)01067-9; Sawamura H, 2005, J NEUROSCI, V25, P4294, DOI 10.1523/JNEUROSCI.0377-05.2005; Saxe R, 2006, CEREB CORTEX, V16, P178, DOI 10.1093/cercor/bhi095; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Sereno ME, 2002, NEURON, V33, P635, DOI 10.1016/S0896-6273(02)00598-6; Shmuelof L, 2008, NAT NEUROSCI, V11, P1267, DOI 10.1038/nn.2196; Weiner KS, 2011, NEUROIMAGE, V56, P2183, DOI 10.1016/j.neuroimage.2011.03.041; Wheaton KJ, 2004, NEUROIMAGE, V22, P277, DOI 10.1016/j.neuroimage.2003.12.043; Whiteley L, 2004, PERCEPTION, V33, P307, DOI 10.1068/p5053; Zopf R, 2011, COGN NEUROSCI-UK, V2, P147, DOI 10.1080/17588928.2011.578208; Zopf R, 2010, NEUROPSYCHOLOGIA, V48, P713, DOI 10.1016/j.neuropsychologia.2009.10.028	50	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53812	10.1371/journal.pone.0053812	http://dx.doi.org/10.1371/journal.pone.0053812			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308286	gold, Green Published			2022-12-25	WOS:000313429100118
J	Naruse, M; Shibasaki, K; Yokoyama, S; Kurachi, M; Ishizaki, Y				Naruse, Masae; Shibasaki, Koji; Yokoyama, Shuichi; Kurachi, Masashi; Ishizaki, Yasuki			Dynamic Changes of CD44 Expression from Progenitors to Subpopulations of Astrocytes and Neurons in Developing Cerebellum	PLOS ONE			English	Article							NEURAL STEM-CELLS; RADIAL GLIA; OLIGODENDROCYTE; IDENTIFICATION; HYALURONAN; PROLIFERATION; MULTIPOTENT; PROGRESSION; MIGRATION; LINEAGE	We previously reported that CD44-positive cells were candidates for astrocyte precursor cells in the developing cerebellum, because cells expressing high levels of CD44 selected by fluorescence-activated cell sorting (FACS) gave rise only to astrocytes in vitro. However, whether CD44 is a specific cell marker for cerebellar astrocyte precursor cells in vivo is unknown. In this study, we used immunohistochemistry, in situ hybridization, and FACS to analyze the spatial and temporal expression of CD44 and characterize the CD44-positive cells in the mouse cerebellum during development. CD44 expression was observed not only in astrocyte precursor cells but also in neural stem cells and oligodendrocyte precursor cells (OPCs) at early postnatal stages. CD44 expression in OPCs was shut off during oligodendrocyte differentiation. Interestingly, during development, CD44 expression was limited specifically to Bergmann glia and fibrous astrocytes among three types of astrocytes in cerebellum, and expression in astrocytes was shut off during postnatal development. CD44 expression was also detected in developing Purkinje and granule neurons but was limited to granule neurons in the adult cerebellum. Thus, at early developmental stages of the cerebellum, CD44 was widely expressed in several types of precursor cells, and over the course of development, the expression of CD44 became restricted to granule neurons in the adult.	[Naruse, Masae; Shibasaki, Koji; Yokoyama, Shuichi; Kurachi, Masashi; Ishizaki, Yasuki] Gunma Univ, Grad Sch Med, Dept Mol & Cellular Neurobiol, Maebashi, Gunma 371, Japan	Gunma University	Shibasaki, K (corresponding author), Gunma Univ, Grad Sch Med, Dept Mol & Cellular Neurobiol, Maebashi, Gunma 371, Japan.	shibasaki@gunma-u.ac.jp; yasukiishizaki@gunma-u.ac.jp	Ishizaki, Yasuki/AAB-1209-2020; Shibasaki, Koji/U-8674-2018	Shibasaki, Koji/0000-0003-2330-1749	Uehara Memorial Foundation; Takeda Science Foundation, Tokyo, Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan [23650159, 21200012, 20399554, 24111507]; Sumitomo Foundation; Brain Science Foundation; Narishige Neuroscience Research Foundation; Salt Science Research Foundation [12C2]	Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation, Tokyo, Japan(Takeda Science Foundation (TSF)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sumitomo Foundation; Brain Science Foundation; Narishige Neuroscience Research Foundation; Salt Science Research Foundation	This research was supported by a grant from Uehara Memorial Foundation (to K.S., Y.I.), by a grant from Takeda Science Foundation, Tokyo, Japan (to K.S., Y.I.) and by a grant from Grants-in-Aid for Scientific Research (Project No. 23650159 to Y.I., 21200012, 20399554, 24111507, Brain Environment. to K.S.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, by a grant from the Sumitomo Foundation (to K.S.), by a grant from the Brain Science Foundation (to K.S.), by a grant from Narishige Neuroscience Research Foundation (to K.S.), by a grant from Salt Science Research Foundation No. 12C2 (to K.S.). The all funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA H, 1993, BRAIN RES, V632, P249, DOI 10.1016/0006-8993(93)91160-T; Alfei L, 1999, EUR J HISTOCHEM, V43, P29; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Avigdor A, 2004, BLOOD, V103, P2981, DOI 10.1182/blood-2003-10-3611; Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279; Baier C, 2007, MATRIX BIOL, V26, P348, DOI 10.1016/j.matbio.2007.02.002; Bausch SB, 2006, NEUROSCIENCE, V143, P339, DOI 10.1016/j.neuroscience.2006.07.037; Bourguignon LYW, 2007, J NEUROCHEM, V101, P1002, DOI 10.1111/j.1471-4159.2007.04485.x; Bouvier-Labit C, 2002, J NEURO-ONCOL, V60, P127, DOI 10.1023/A:1020630732625; Cai N, 2012, CEREBELLUM, V11, P181, DOI 10.1007/s12311-011-0294-x; Chetty C, 2012, CELL SIGNAL, V24, P549, DOI 10.1016/j.cellsig.2011.10.008; De Falco V, 2012, CANCER RES, V72, P1449, DOI 10.1158/0008-5472.CAN-11-3320; GHANDOUR MS, 1979, J HISTOCHEM CYTOCHEM, V27, P1634, DOI 10.1177/27.12.118210; GIRGRAH N, 1991, J NEUROPATH EXP NEUR, V50, P779, DOI 10.1097/00005072-199111000-00009; Glezer I, 2009, J COMP NEUROL, V517, P906, DOI 10.1002/cne.22185; Goodison S, 1999, J CLIN PATHOL-MOL PA, V52, P189; Jaggupilli A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/708036; Kucharova K, 2010, NEUROSCIENCE, V166, P185, DOI 10.1016/j.neuroscience.2009.12.014; KUPPNER MC, 1992, INT J CANCER, V50, P572, DOI 10.1002/ijc.2910500414; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Liu Y, 2004, DEV BIOL, V276, P31, DOI 10.1016/j.ydbio.2004.08.018; Liu Y, 2002, GLIA, V40, P25, DOI 10.1002/glia.10111; Matsumoto T, 2012, NEUROSCI LETT, V520, P115, DOI 10.1016/j.neulet.2012.05.048; Miletti-Gonzalez KE, 2012, J BIOL CHEM, V287, P18995, DOI 10.1074/jbc.M111.318774; Morales D, 2006, J NEUROSCI, V26, P12226, DOI 10.1523/JNEUROSCI.3493-06.2006; MORETTO G, 1993, J NEUROPATH EXP NEUR, V52, P419, DOI 10.1097/00005072-199307000-00009; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; Nagano O, 2004, CANCER SCI, V95, P930, DOI 10.1111/j.1349-7006.2004.tb03179.x; Naor D, 2002, CRIT REV CL LAB SCI, V39, P527, DOI 10.1080/10408360290795574; Negi LM, 2012, J DRUG TARGET, V20, P561, DOI 10.3109/1061186X.2012.702767; Oishi K, 2006, BIOCHEM BIOPH RES CO, V349, P1065, DOI 10.1016/j.bbrc.2006.08.135; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Shibasaki K, 2007, J NEUROSCI, V27, P1566, DOI 10.1523/JNEUROSCI.4284-06.2007; Shinoe T, 2010, J NEUROCHEM, V115, P1633, DOI 10.1111/j.1471-4159.2010.07072.x; Sillitoe RV, 2007, ANNU REV CELL DEV BI, V23, P549, DOI 10.1146/annurev.cellbio.23.090506.123237; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Suzuki DE, 2011, IN VITRO CELL DEV-AN, V47, P492, DOI 10.1007/s11626-011-9426-3; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509; Wingate RJT, 1999, DEVELOPMENT, V126, P4395; Yoshida T, 2012, PATHOL INT, V62, P463, DOI 10.1111/j.1440-1827.2012.02823.x; Zhang L, 1996, NEURON, V16, P47, DOI 10.1016/S0896-6273(00)80022-7	42	50	51	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53109	10.1371/journal.pone.0053109	http://dx.doi.org/10.1371/journal.pone.0053109			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308146	Green Published, Green Submitted, gold			2022-12-25	WOS:000313670100018
J	Vogel, H; Montag, D; Kanzleiter, T; Jonas, W; Matzke, D; Scherneck, S; Chadt, A; Tole, J; Kluge, R; Joost, HG; Schurmann, A				Vogel, Heike; Montag, Dirk; Kanzleiter, Timo; Jonas, Wenke; Matzke, Daniela; Scherneck, Stephan; Chadt, Alexandra; Toele, Jonas; Kluge, Reinhart; Joost, Hans-Georg; Schuermann, Annette			An Interval of the Obesity QTL Nob3.38 within a QTL Hotspot on Chromosome 1 Modulates Behavioral Phenotypes	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENE-EXPRESSION; SUSCEPTIBILITY LOCUS; INSULIN-RESISTANCE; WEIGHT STATUS; DEPRESSION; MOUSE; MICE; MICRODELETION; HYPERGLYCEMIA	A region on mouse distal chromosome 1 (Chr. 1) that is highly enriched in quantitative trait loci (QTLs) controlling neural and behavioral phenotypes overlaps with the peak region of a major obesity QTL (Nob3.38), which we identified in an intercross of New Zealand Obese (NZO) mice with C57BL/6J (B6). By positional cloning we recently identified a microdeletion within this locus causing the disruption of Ifi202b that protects from adiposity by suppressing expression of 11 beta-Hsd1. Here we show that the Nob3.38 segment also corresponds with the QTL rich region (Qrr1) on Chr. 1 and associates with increased voluntary running wheel activity, Rota-rod performance, decreased grip strength, and anxiety-related traits. The characterization of a subcongenic line carrying 14.2 Mbp of Nob3.38 with a polymorphic region of 4.4 Mbp indicates that the microdeletion and/or other polymorphisms in its proximity alter body weight, voluntary activity, and exploration. Since 27 out of 32 QTL were identified in crosses with B6, we hypothesized that the microdeletion and or adjacent SNPs are unique for B6 mice and responsible for some of the complex Qrr1-mediated effects. Indeed, a phylogenic study of 28 mouse strains revealed a NZO-like genotype for 22 and a B6-like genotype for NZW/LacJ and 4 other C57BL strains. Thus, we suggest that a Nob3.38 interval (173.0-177.4 Mbp) does not only modify adiposity but also neurobehavioral traits by a haplotype segregating with C57BL strains.	[Vogel, Heike; Kanzleiter, Timo; Jonas, Wenke; Matzke, Daniela; Scherneck, Stephan; Chadt, Alexandra; Kluge, Reinhart; Joost, Hans-Georg; Schuermann, Annette] German Inst Human Nutr Potsdam Rehbrucke, Dept Pharmacol, Nuthetal, Germany; [Vogel, Heike; Kanzleiter, Timo; Jonas, Wenke; Matzke, Daniela; Scherneck, Stephan; Chadt, Alexandra; Kluge, Reinhart; Joost, Hans-Georg; Schuermann, Annette] German Inst Human Nutr Potsdam Rehbrucke, Dept Expt Diabetol, Nuthetal, Germany; [Montag, Dirk] Leibniz Inst Neurobiol, Res Grp Neurogenet, Magdeburg, Germany; [Chadt, Alexandra] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, D-40225 Dusseldorf, Germany; [Toele, Jonas] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Genet, Nuthetal, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Leibniz Institut fur Neurobiologie (LIN); Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Schurmann, A (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Pharmacol, Nuthetal, Germany.	schuermann@dife.de	Montag, Dirk/D-3925-2014; Joost, Hans-Georg/J-4462-2013	Montag, Dirk/0000-0002-4964-1330; Joost, Hans-Georg/0000-0002-5860-606X; Scherneck, Stephan/0000-0002-2811-5040; Schurmann, Annette/0000-0002-4113-4377	German Ministry of Education and Research [NGFN2: 01GS0487, NGFNplus: 01GS0821, NEUROTARGET: 01GI0847, DZD: 01GI0922]	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Ministry of Education and Research (NGFN2: 01GS0487; NGFNplus: 01GS0821; NEUROTARGET: 01GI0847; DZD: 01GI0922). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bean MK, 2008, J CLIN PSYCHOL MED S, V15, P214, DOI 10.1007/s10880-008-9124-9; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Boeka AG, 2008, ARCH CLIN NEUROPSYCH, V23, P467, DOI 10.1016/j.acn.2008.03.003; Chadt A, 2008, NAT GENET, V40, P1354, DOI 10.1038/ng.244; Chen AY, 2010, OBESITY, V18, P210, DOI 10.1038/oby.2009.185; Choquet H, 2011, CURR GENOMICS, V12, P169, DOI 10.2174/138920211795677895; Derry JMJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014319; Dong C, 2004, INT J OBESITY, V28, P790, DOI 10.1038/sj.ijo.0802626; Duker AL, 2010, EUR J HUM GENET, V18, P1196, DOI 10.1038/ejhg.2010.102; Faith MS, 2002, J PSYCHOSOM RES, V53, P935, DOI 10.1016/S0022-3999(02)00308-2; Gatti DM, 2009, MAMM GENOME, V20, P437, DOI 10.1007/s00335-009-9199-0; Giesen K, 2003, BIOCHEM BIOPH RES CO, V304, P812, DOI 10.1016/S0006-291X(03)00664-8; Goldfield GS, 2010, J SCHOOL HEALTH, V80, P186, DOI 10.1111/j.1746-1561.2009.00485.x; Gribaudo G, 1999, FEBS LETT, V456, P31, DOI 10.1016/S0014-5793(99)00916-3; Heo M, 2006, INT J OBESITY, V30, P513, DOI 10.1038/sj.ijo.0803122; Herva A, 2006, PSYCHOSOM MED, V68, P213, DOI 10.1097/01.psy.0000203172.02305.ea; Heurteaux C, 2006, NAT NEUROSCI, V9, P1134, DOI 10.1038/nn1749; Hillman JB, 2010, CLIN PEDIATR, V49, P671, DOI 10.1177/0009922810363155; Hitzemann R, 2003, MAMM GENOME, V14, P733, DOI 10.1007/s00335-003-2277-9; Johnston E, 2004, CAN J PUBLIC HEALTH, V95, P179, DOI 10.1007/BF03403643; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; Kelly MA, 2003, MAMM GENOME, V14, P692, DOI 10.1007/s00335-003-2273-0; Kluge R, 2000, DIABETOLOGIA, V43, P1565, DOI 10.1007/s001250051570; Kubzansky LD, 2012, ANN BEHAV MED, V43, P219, DOI 10.1007/s12160-011-9323-8; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Milhaud JM, 2002, BEHAV GENET, V32, P69, DOI 10.1023/A:1014412029774; Montag-Sallaz M, 2003, LEARN MEMORY, V10, P99, DOI 10.1101/lm.53403; Montag-Sallaz M, 2003, GENES BRAIN BEHAV, V2, P20, DOI 10.1034/j.1601-183X.2003.00003.x; Montag-Sallaz M, 2002, MOL CELL BIOL, V22, P7967, DOI 10.1128/MCB.22.22.7967-7981.2002; Mozhui K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000260; Nadeau KJ, 2011, NAT REV CARDIOL, V8, P513, DOI 10.1038/nrcardio.2011.86; Patel AJ, 2001, TRENDS NEUROSCI, V24, P339, DOI 10.1016/S0166-2236(00)01810-5; Plum L, 2000, DIABETES, V49, P1590, DOI 10.2337/diabetes.49.9.1590; Plum L, 2002, DIABETOLOGIA, V45, P823, DOI 10.1007/s00125-002-0796-7; Rawana JS, 2010, CLIN CHILD FAM PSYCH, V13, P213, DOI 10.1007/s10567-010-0072-1; Reaven GM, 2011, MED CLIN N AM, V95, P875, DOI 10.1016/j.mcna.2011.06.002; Roberts RE, 2002, ANN BEHAV MED, V24, P169, DOI 10.1207/S15324796ABM2403_02; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Scherneck S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000541; Shinawi M, 2011, AM J MED GENET A, V155A, P1272, DOI 10.1002/ajmg.a.33878; SIEGELBAUM SA, 1982, NATURE, V299, P413, DOI 10.1038/299413a0; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824; Stunkard AJ, 2003, BIOL PSYCHIAT, V54, P330, DOI 10.1016/S0006-3223(03)00608-5; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001; Turri MG, 1999, MAMM GENOME, V10, P1098, DOI 10.1007/s003359901169; Vogel H, 2012, HUM MOL GENET, V21, P3845, DOI 10.1093/hmg/dds213; Vogel H, 2009, PHYSIOL GENOMICS, V38, P226, DOI 10.1152/physiolgenomics.00011.2009; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Whishaw IQ, 1999, MODERN TECHNIQUES NE, P1243, DOI 10.1007/978-3-642-58552-4_44; Wibom R, 2002, ANAL BIOCHEM, V311, P139, DOI 10.1016/S0003-2697(02)00424-4; Wolfer DP, 2001, PHYSIOL BEHAV, V73, P745, DOI 10.1016/S0031-9384(01)00531-5; Wyrwoll CS, 2011, FRONT NEUROENDOCRIN, V32, P265, DOI 10.1016/j.yfrne.2010.12.001; Yalcin B, 2011, NATURE, V477, P326, DOI 10.1038/nature10432; Yang H, 2007, NAT GENET, V39, P1100, DOI 10.1038/ng2087	55	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53025	10.1371/journal.pone.0053025	http://dx.doi.org/10.1371/journal.pone.0053025			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308133	gold, Green Published, Green Submitted			2022-12-25	WOS:000313670100015
J	Lucas, D; Delgado-Garcia, JM; Escudero, B; Albo, C; Aza, A; Acin-Perez, R; Torres, Y; Moreno, P; Enriquez, JA; Samper, E; Blanco, L; Fairen, A; Bernad, A; Gruart, A				Lucas, Daniel; Delgado-Garcia, Jose M.; Escudero, Beatriz; Albo, Carmen; Aza, Ana; Acin-Perez, Rebeca; Torres, Yaima; Moreno, Paz; Antonio Enriquez, Jose; Samper, Enrique; Blanco, Luis; Fairen, Alfonso; Bernad, Antonio; Gruart, Agnes			Increased Learning and Brain Long-Term Potentiation in Aged Mice Lacking DNA Polymerase mu	PLOS ONE			English	Article							RABBIT FOLLOWING STIMULATION; STRAND BREAK REPAIR; SYNAPTIC-TRANSMISSION; POL-MU; HIPPOCAMPAL NEUROGENESIS; LASTING POTENTIATION; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; CA3-CA1 SYNAPSE; TRANSGENIC MICE	A definitive consequence of the aging process is the progressive deterioration of higher cognitive functions. Defects in DNA repair mechanisms mostly result in accelerated aging and reduced brain function. DNA polymerase m is a novel accessory partner for the non-homologous end-joining DNA repair pathway for double-strand breaks, and its deficiency causes reduced DNA repair. Using associative learning and long-term potentiation experiments, we demonstrate that Pol mu(-/-) mice, however, maintain the ability to learn at ages when wild-type mice do not. Expression and biochemical analyses suggest that brain aging is delayed in Pol mu(-/-) mice, being associated with a reduced error-prone DNA oxidative repair activity and a more efficient mitochondrial function. This is the first example in which the genetic ablation of a DNA-repair function results in a substantially better maintenance of learning abilities, together with fewer signs of brain aging, in old mice.	[Lucas, Daniel] Ctr Nacl Biotecnol CSIC, Dept Immunol & Oncol, Madrid, Spain; [Delgado-Garcia, Jose M.; Gruart, Agnes] Univ Pablo Olavide, Div Neurociencias, Seville, Spain; [Escudero, Beatriz; Albo, Carmen; Acin-Perez, Rebeca; Torres, Yaima; Moreno, Paz; Antonio Enriquez, Jose; Samper, Enrique; Bernad, Antonio] Ctr Nacl Invest Cardiovasc, Dept Regenerat Cardiol, Madrid, Spain; [Escudero, Beatriz; Albo, Carmen; Acin-Perez, Rebeca; Torres, Yaima; Antonio Enriquez, Jose; Samper, Enrique; Bernad, Antonio] Ctr Nacl Invest Cardiovasc, Dev & Cardiac Repair Dept, Madrid, Spain; [Aza, Ana; Blanco, Luis] Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Fairen, Alfonso] Univ Miguel Hernandez, CSIC, Inst Neurociencias, Alacant, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Universidad Pablo de Olavide; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Centro Nacional de Investigaciones Cardiovasculares (CNIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Bernad, A (corresponding author), Ctr Nacl Invest Cardiovasc, Dept Regenerat Cardiol, Madrid, Spain.	abernad@cnic.es; agrumas@upo.es	Acin-Perez, Rebeca/AAU-4913-2020; Blanco, Luis/I-1848-2015; Lucas, Daniel/ABB-6893-2021; Moreno-Murciano, Paz/D-7871-2018; Bernad, Antonio/P-8573-2017; Delgado-Garcia, Jose M./V-1567-2019; Acin-Perez, Rebeca/H-6160-2015; Enríquez, J.A./M-8468-2016	Acin-Perez, Rebeca/0000-0001-9553-8337; Lucas, Daniel/0000-0002-0147-5425; Acin-Perez, Rebeca/0000-0001-9553-8337; Enríquez, J.A./0000-0002-3671-2961; Bernad, Antonio/0000-0003-0620-9668	Spanish Ministry of Education and Reserach [BFU2008-03390/BMC/MICINN, BFU2008-00899/MICINN, BFU2007-60263/MICINN, PAC08-0261-1581/JCCM, SAF 2008-02099/MICINN, PLE2009-0147]	Spanish Ministry of Education and Reserach(German Research Foundation (DFG))	This work was supported by grants BFU2008-03390/BMC/MICINN (A.G.), BFU2008-00899/MICINN (J.M.D.-G.), BFU2007-60263/MICINN and PAC08-0261-1581/JCCM (A.F.), and SAF 2008-02099/MICINN and PLE2009-0147 (A.B.) from the Spanish Ministry of Education and Reserach. D.L. was a fellow of the Spanish Fundacion Ramon Areces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 2003, PHILOS T R SOC B, V358, P735, DOI 10.1098/rstb.2002.1222; Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Bertocci B, 2003, IMMUNITY, V19, P203, DOI 10.1016/S1074-7613(03)00203-6; Bertocci B, 2006, IMMUNITY, V25, P31, DOI 10.1016/j.immuni.2006.04.013; Biade S, 1998, J BIOL CHEM, V273, P898, DOI 10.1074/jbc.273.2.898; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonaguidi MA, 2008, J NEUROSCI, V28, P9194, DOI 10.1523/JNEUROSCI.3314-07.2008; Callicott RJ, 2006, COMPARATIVE MED, V56, P17; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Davis BJ, 2008, NUCLEIC ACIDS RES, V36, P3085, DOI 10.1093/nar/gkn164; Deneault E, 2009, CELL, V137, P369, DOI 10.1016/j.cell.2009.03.026; Dominguez O, 2000, EMBO J, V19, P1731, DOI 10.1093/emboj/19.7.1731; Dominguez-del-Toro E, 2004, EUR J NEUROSCI, V20, P1945, DOI 10.1111/j.1460-9568.2004.03643.x; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Eleore L, 2007, BEHAV NEUROSCI, V121, P1203, DOI 10.1037/0735-7044.121.6.1203; Epel E, 2004, ANN NY ACAD SCI, V1032, P208, DOI 10.1196/annals.1314.022; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gobeske KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007506; Gozalbo-Lopez B, 2009, MOL CELL BIOL, V29, P1266, DOI 10.1128/MCB.01518-08; Griffiths LM, 2009, MOL CELL BIOL, V29, P794, DOI 10.1128/MCB.01357-08; Gruart A, 2008, NEUROBIOL DIS, V30, P439, DOI 10.1016/j.nbd.2008.03.001; GRUART A, 1995, J NEUROPHYSIOL, V74, P226, DOI 10.1152/jn.1995.74.1.226; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; Gu JF, 2007, EMBO J, V26, P1010, DOI 10.1038/sj.emboj.7601559; Gureviciene I, 2004, NEUROBIOL DIS, V15, P188, DOI 10.1016/j.nbd.2003.11.011; Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698; Juarez R, 2006, NUCLEIC ACIDS RES, V34, P4572, DOI 10.1093/nar/gkl457; Kappeler L, 2008, PLOS BIOL, V6, P2144, DOI 10.1371/journal.pbio.0060254; Kim HJ, 2011, EXP DERMATOL, V20, P920, DOI 10.1111/j.1600-0625.2011.01354.x; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Kirouac KN, 2011, P NATL ACAD SCI USA, V108, P3210, DOI 10.1073/pnas.1013909108; Lee Y, 2007, NEUROSCIENCE, V145, P1365, DOI 10.1016/j.neuroscience.2006.07.026; Lucas D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000389; LUND RD, 1966, SCIENCE, V151, P1397, DOI 10.1126/science.151.3716.1397; Madronal N, 2007, J NEUROSCI, V27, P12139, DOI 10.1523/JNEUROSCI.3397-07.2007; Maga G, 2007, NATURE, V447, P606, DOI 10.1038/nature05843; McEchron MD, 2003, J NEUROSCI, V23, P1535, DOI 10.1523/JNEUROSCI.23-04-01535.2003; McElhinny SAN, 2005, MOL CELL, V19, P357, DOI 10.1016/j.molcel.2005.06.012; McElhinny SAN, 2003, MOL CELL BIOL, V23, P2309, DOI 10.1128/MCB.23.7.2309-2315.2003; MCNAUGHTON BL, 1978, BRAIN RES, V157, P277, DOI 10.1016/0006-8993(78)90030-6; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; Molina DP, 2012, NEUROBIOL AGING, V33, P1938, DOI 10.1016/j.neurobiolaging.2011.09.014; Moon AF, 2007, NAT STRUCT MOL BIOL, V14, P45, DOI 10.1038/nsmb1180; Moon FA, 2007, DNA REPAIR AMST, V6, P1709; Paradies G, 2011, NEUROCHEM INT, V58, P447, DOI 10.1016/j.neuint.2010.12.016; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Porras-Garcia E, 2005, EUR J NEUROSCI, V21, P979, DOI 10.1111/j.1460-9568.2005.03940.x; Rockwood LD, 2003, MUTAT RES-FUND MOL M, V529, P51, DOI 10.1016/S0027-5107(03)00108-8; Ruiz JF, 2003, NUCLEIC ACIDS RES, V31, P4441, DOI 10.1093/nar/gkg637; Sekiguchi JM, 2006, CELL, V124, P260, DOI 10.1016/j.cell.2006.01.010; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Takatsuki K, 2003, J NEUROSCI, V23, P17; Tang J, 2009, BIOCHEM BIOPH RES CO, V385, P341, DOI 10.1016/j.bbrc.2009.05.067; Uchiyama Y, 2009, BIOCHIMIE, V91, P165, DOI 10.1016/j.biochi.2008.07.005; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wilson IA, 2006, TRENDS NEUROSCI, V29, P662, DOI 10.1016/j.tins.2006.10.002; Yoo EG, 2011, ENDOCRINOLOGY, V152, P3135, DOI 10.1210/en.2010-1122; Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115	66	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53243	10.1371/journal.pone.0053243	http://dx.doi.org/10.1371/journal.pone.0053243			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301049	Green Published, Green Submitted, gold			2022-12-25	WOS:000313480000042
J	Ma, ZL; Li, R; Yu, J; He, Y; Li, J				Ma, Zhenling; Li, Rui; Yu, Jing; He, Yong; Li, Juan			Alterations in Regional Homogeneity of Spontaneous Brain Activity in Late-Life Subthreshold Depression	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; VOXEL-BASED MORPHOMETRY; MAJOR DEPRESSION; BIPOLAR DISORDER; PARKINSONS-DISEASE; FRONTAL-LOBE; ABNORMALITIES; FMRI; CORTEX; ASYMMETRY	The early detection of major depression in elderly individuals who are at risk of developing the disease is of prime importance when it comes to the prevention of geriatric depression. We used resting-state functional magnetic resonance imaging (fMRI) to examine changes in regional homogeneity (ReHo) of spontaneous activity in late-life subthreshold depression (StD), and we evaluated the sensitivity/specificity performance of these changes. Nineteen elderly individuals with StD and 18 elderly controls underwent a resting-state fMRI scan. The ReHo approach was employed to examine whether StD was related to alterations in resting-state neural activity, in the form of abnormal regional synchronization. Receiver operating characteristic curve analysis and the Fisher stepwise discriminant analysis were used to evaluate the sensitivity/specificity characteristics of the ReHo index in discriminating between the StD subjects and normal controls. The results demonstrated that, compared to controls, StD subjects display lower ReHo in the right orbitofrontal cortex (OFC), left dorsolateral prefrontal cortex (DLPFC), left postcentral gyrus (PCG), and left middle frontal and inferior temporal gyri, as well as higher ReHo in the bilateral insula and right DLPFC. The left PCG and the right DLPFC, OFC, and posterior insula, together reported a predictive accuracy of 91.9%. These results suggest that the regional activity coherence was changed in the resting brain of StD subjects, and that these alterations may serve as potential markers for the early detection of StD in late-life depression.	[Ma, Zhenling; Li, Rui; Yu, Jing; Li, Juan] Chinese Acad Sci, Ctr Aging Psychol, Key Lab Mental Hlth, Beijing, Peoples R China; [Ma, Zhenling] Peking Union Med Coll, Sch Nursing, Beijing 100021, Peoples R China; [Li, Rui; Li, Juan] Chinese Acad Sci, Inst Psychol, Magnet Resonance Imaging Res Ctr, Beijing 100101, Peoples R China; [Li, Rui; Li, Juan] Beijing Normal Univ, Res Ctr Emot Regulat, Beijing 100875, Peoples R China; [Yu, Jing] Southwest Univ, Sch Psychol, Chongqing, Peoples R China; [He, Yong] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; School of Nursing - PUMC; Chinese Academy of Sciences; Institute of Psychology, CAS; Beijing Normal University; Southwest University - China; Beijing Normal University	Li, J (corresponding author), Chinese Acad Sci, Ctr Aging Psychol, Key Lab Mental Hlth, Beijing, Peoples R China.	lijuan@psych.ac.cn	He, Yong/Q-5756-2018; Yu, Jing/AAN-1565-2020; He, Yong/C-2161-2009	He, Yong/0000-0002-7039-2850; li, rui/0000-0002-4101-5415	Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning, China Postdoctoral Science Foundation; National Natural Science Foundation of China [30770725, 30911120494, 31070916]; National Science & Technology Pillar Program of China [2009BAI77B03]; Knowledge Innovation Project of the Chinese Academy of Sciences [KSCX2-EW-J-8]; CAS/SAFEA International Partnership Program for Creative Research Team [Y2CX131003]; Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences [Y1CX251005]; Shang Shan Funding	Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning, China Postdoctoral Science Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Pillar Program of China; Knowledge Innovation Project of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); CAS/SAFEA International Partnership Program for Creative Research Team(Chinese Academy of Sciences); Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences(Chinese Academy of Sciences); Shang Shan Funding	This work was supported by the Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning, China Postdoctoral Science Foundation, the National Natural Science Foundation of China (30770725, 30911120494 and 31070916), the National Science & Technology Pillar Program of China (2009BAI77B03), the Knowledge Innovation Project of the Chinese Academy of Sciences (KSCX2-EW-J-8), the CAS/SAFEA International Partnership Program for Creative Research Team (Y2CX131003), Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences (Y1CX251005), and Shang Shan Funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenstein HJ, 2009, AM J GERIAT PSYCHIAT, V17, P30, DOI 10.1097/JGP.0b013e31817b60af; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anand A, 2009, PSYCHIAT RES-NEUROIM, V171, P189, DOI 10.1016/j.pscychresns.2008.03.012; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Blumberg HP, 2003, ARCH GEN PSYCHIAT, V60, P601, DOI 10.1001/archpsyc.60.6.601; Cuijpers P, 2006, INT J GERIATR PSYCH, V21, P811, DOI 10.1002/gps.1565; Damoiseaux JS, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt106; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Drevets WC, 2007, ANN NY ACAD SCI, V1121, P499, DOI 10.1196/annals.1401.029; Exner C, 2009, J AFFECT DISORDERS, V119, P156, DOI 10.1016/j.jad.2009.03.015; Frodl T, 2009, WORLD J BIOL PSYCHIA, V10, P202, DOI 10.1080/15622970701624603; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Grimm S, 2008, BIOL PSYCHIAT, V63, P369, DOI 10.1016/j.biopsych.2007.05.033; Guo WB, 2011, PROG NEURO-PSYCHOPH, V35, P1297, DOI 10.1016/j.pnpbp.2011.02.006; Horn DI, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00033; Hwang JP, 2010, J GERIATR PSYCH NEUR, V23, P171, DOI 10.1177/0891988710363713; Johnson KA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006213; Kendall M.G., 1990, RANK CORRELATION MET, V5th; Kennedy DP, 2008, NEUROIMAGE, V39, P1877, DOI 10.1016/j.neuroimage.2007.10.052; Kenny ER, 2010, AM J GERIAT PSYCHIAT, V18, P643, DOI 10.1097/JGP.0b013e3181cabd0e; Kroes MCW, 2011, J PSYCHIATR NEUROSCI, V36, P256, DOI 10.1503/jpn.100077; Li CT, 2010, NEUROIMAGE, V50, P347, DOI 10.1016/j.neuroimage.2009.11.021; Liu HH, 2006, NEUROREPORT, V17, P19, DOI 10.1097/01.wnr.0000195666.22714.35; Lyoo IK, 2004, BIOL PSYCHIAT, V55, P648, DOI 10.1016/j.biopsych.2003.10.017; Maeda F, 2000, BRIT J PSYCHIAT, V177, P169, DOI 10.1192/bjp.177.2.169; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; MAYBERG HS, 1990, ANN NEUROL, V28, P57, DOI 10.1002/ana.410280111; Morys Joanna M, 2003, Folia Morphol (Warsz), V62, P347; Mourao-Miranda J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029482; Murphy FC, 2003, COGN AFFECT BEHAV NE, V3, P207, DOI 10.3758/CABN.3.3.207; Nitschke JB, 2005, INT REV NEUROBIOL, V67, P73, DOI 10.1016/S0074-7742(05)67003-1; Nugent AC, 2006, NEUROIMAGE, V30, P485, DOI 10.1016/j.neuroimage.2005.09.029; Oakes TR, 2007, NEUROIMAGE, V34, P500, DOI 10.1016/j.neuroimage.2006.10.007; Paakki JJ, 2010, BRAIN RES, V1321, P169, DOI 10.1016/j.brainres.2009.12.081; Peng DH, 2011, CHINESE MED J-PEKING, V124, P369, DOI 10.3760/cma.j.issn.0366-6999.2011.03.009; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Rajkowska G, 1999, BIOL PSYCHIAT, V45, P1085, DOI 10.1016/S0006-3223(99)00041-4; SACKEIM HA, 1982, ARCH NEUROL-CHICAGO, V39, P210, DOI 10.1001/archneur.1982.00510160016003; Taylor WD, 2007, PSYCHOL MED, V37, P1763, DOI 10.1017/S0033291707000128; Tononi G, 1998, NEUROIMAGE, V7, P133, DOI 10.1006/nimg.1997.0313; Ueda K, 2003, NEUROREPORT, V14, P51, DOI 10.1097/00001756-200301200-00010; Veer IM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00041; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8; Walther S, 2012, J AFFECT DISORDERS, V136, P124, DOI 10.1016/j.jad.2011.08.020; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Wu MJ, 2011, PSYCHIAT RES-NEUROIM, V194, P39, DOI 10.1016/j.pscychresns.2011.04.003; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yao ZJ, 2009, J AFFECT DISORDERS, V115, P430, DOI 10.1016/j.jad.2008.10.013; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018	55	36	43	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53148	10.1371/journal.pone.0053148	http://dx.doi.org/10.1371/journal.pone.0053148			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301035	Green Published, gold, Green Submitted			2022-12-25	WOS:000313320900065
J	Murugan, AK; Alzahrani, A; Xing, MZ				Murugan, Avaniyapuram Kannan; Alzahrani, Ali; Xing, Mingzhao			Mutations in Critical Domains Confer the Human mTOR Gene Strong Tumorigenicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CANCER; PHOSPHATIDYLINOSITOL 3-KINASE/AKT; SIGNALING PATHWAY; MAMMALIAN TARGET; PIK3CA MUTATION; THYROID CANCERS; POOR-PROGNOSIS; BREAST-CANCER; S6 KINASE; GROWTH	Mammalian target of rapamycin (mTOR) is a serine/threonine protein kinase that regulates cell growth, proliferation, and survival. mTOR is frequently activated in human cancers and is a commonly sought anticancer therapeutic target. However, whether the human mTOR gene itself is a proto-oncogene possessing tumorigenicity has not been firmly established. To answer this question, we mutated evolutionarily conserved amino acids, generated eight mutants in the HEAT repeats (M938T) and the FAT (W1456R and G1479N) and kinase (P2273S, V2284M, V2291I, T2294I, and E2288K) domains of mTOR, and studied their oncogenicity. On transient expression in HEK293T cells, these mTOR mutants displayed elevated protein kinase activities accompanied by activated mTOR/p70S6K signaling at varying levels, demonstrating the gain of function of the mTOR gene with these mutations. We selected P2273S and E2288K, the two most catalytically active mutants, to further examine their oncogenicity and tumorigenicity. Stable expression of the two mTOR mutants in NIH3T3 cells strongly activated mTOR/p70S6K signaling, induced cell transformation and invasion, and remarkably, caused rapid tumor formation and growth in athymic nude mice after subcutaneous inoculation of the transfected cells. This study confirms the oncogenic potential of mTOR suggested previously and demonstrates for the first time its tumorigenicity. Thus, beyond the pivotal position of mTOR to relay the oncogenic signals from the upstream phosphatidylinositol 3-kinase/Akt pathway in human cancer, mTOR is capable potentially of playing a direct role in human tumorigenesis if mutated. These results also further support the conclusion that mTOR is a major therapeutic target in human cancers.	[Murugan, Avaniyapuram Kannan; Alzahrani, Ali; Xing, Mingzhao] Johns Hopkins Univ, Div Endocrinol & Metab, Sch Med, Lab Cellular & Mol Thyroid Res, Baltimore, MD 21287 USA	Johns Hopkins University	Xing, MZ (corresponding author), Johns Hopkins Univ, Div Endocrinol & Metab, Sch Med, Lab Cellular & Mol Thyroid Res, Suite 333,1830 East Monument St, Baltimore, MD 21287 USA.	mxing1@jhmi.edu	Murugan, Avaniyapuram Kannan/AAI-8222-2020; Alzahrani, Ali S/L-3664-2017	Murugan, Avaniyapuram Kannan/0000-0002-3096-6100; Alzahrani, Ali S/0000-0003-4294-3624	National Institutes of Health [R01CA134225]; NATIONAL CANCER INSTITUTE [R01CA134225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA134225 (to M. X.).	Aleskandarany MA, 2010, BREAST CANCER RES TR, V122, P45, DOI 10.1007/s10549-009-0508-9; Berven LA, 2000, IMMUNOL CELL BIOL, V78, P447, DOI 10.1046/j.1440-1711.2000.00928.x; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dancey J, 2010, NAT REV CLIN ONCOL, V7, P209, DOI 10.1038/nrclinonc.2010.21; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Di Nicolantonio F, 2010, J CLIN INVEST, V120, P2858, DOI 10.1172/JCI37539; Edinger AL, 2004, ONCOGENE, V23, P5654, DOI 10.1038/sj.onc.1207738; Fukui Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014180; Galoian KA, 2011, TUMOR BIOL, V32, P745, DOI 10.1007/s13277-011-0176-3; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hardt M, 2011, GENES CELLS, V16, P141, DOI 10.1111/j.1365-2443.2010.01482.x; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hou P, 2008, CANCER, V113, P2440, DOI 10.1002/cncr.23869; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Liu DX, 2009, CANCER RES, V69, P7311, DOI 10.1158/0008-5472.CAN-09-1077; Liu RX, 2011, J CLIN ENDOCR METAB, V96, pE577, DOI 10.1210/jc.2010-2644; Liu Z, 2008, J CLIN ENDOCR METAB, V93, P3106, DOI 10.1210/jc.2008-0273; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Mavrakis M, 2006, HUM MOL GENET, V15, P2962, DOI 10.1093/hmg/ddl239; Murugan AK, 2011, CANCER RES, V71, P4403, DOI 10.1158/0008-5472.CAN-10-4041; Murugan AK, 2009, CELL CYCLE, V8, P2122, DOI 10.4161/cc.8.13.8710; Nawroth R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027509; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Ogino S, 2009, J CLIN ONCOL, V27, P1477, DOI 10.1200/JCO.2008.18.6544; Ohne Y, 2008, J BIOL CHEM, V283, P31861, DOI 10.1074/jbc.M801546200; Reinke A, 2006, J BIOL CHEM, V281, P31616, DOI 10.1074/jbc.M603107200; Robbins CM, 2011, GENOME RES, V21, P47, DOI 10.1101/gr.107961.110; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sato T, 2010, ONCOGENE, V29, P2746, DOI 10.1038/onc.2010.28; Sekulic A, 2000, CANCER RES, V60, P3504; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Sturgill TW, 2009, ACS CHEM BIOL, V4, P999, DOI 10.1021/cb900193e; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Volante M, 2009, J CLIN ENDOCR METAB, V94, P4735, DOI 10.1210/jc.2009-1233; Weigelt B, 2011, ONCOGENE, V30, P3222, DOI 10.1038/onc.2011.42; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xing MZ, 2010, THYROID, V20, P697, DOI 10.1089/thy.2010.1646; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	45	36	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6511	6521		10.1074/jbc.M112.399485	http://dx.doi.org/10.1074/jbc.M112.399485			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23322780	Green Published, hybrid			2022-12-25	WOS:000315820700044
J	Furuya, Y; Inagaki, A; Khan, M; Mori, K; Penninger, JM; Nakamura, M; Udagawa, N; Aoki, K; Ohya, K; Uchida, K; Yasuda, H				Furuya, Yuriko; Inagaki, Atsushi; Khan, Masud; Mori, Kaoru; Penninger, Josef M.; Nakamura, Midori; Udagawa, Nobuyuki; Aoki, Kazuhiro; Ohya, Keiichi; Uchida, Kohji; Yasuda, Hisataka			Stimulation of Bone Formation in Cortical Bone of Mice Treated with a Receptor Activator of Nuclear Factor-kappa B Ligand (RANKL)-binding Peptide That Possesses Osteoclastogenesis Inhibitory Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTMENOPAUSAL WOMEN; PARATHYROID-HORMONE; RANK LIGAND; OSTEOBLAST DIFFERENTIATION; OSTEOPROTEGERIN LIGAND; IN-VITRO; RESORPTION; OSTEOPOROSIS; MECHANISM; CELLS	To date, parathyroid hormone is the only clinically available bone anabolic drug. The major difficulty in the development of such drugs is the lack of clarification of the mechanisms regulating osteoblast differentiation and bone formation. Here, we report a peptide (W9) known to abrogate osteoclast differentiation in vivo via blocking receptor activator of nuclear factor-kappa B ligand (RANKL)-RANK signaling that we surprisingly found exhibits a bone anabolic effect in vivo. Subcutaneous administration of W9 three times/day for 5 days significantly augmented bone mineral density in mouse cortical bone. Histomorphometric analysis showed a decrease in osteoclastogenesis in the distal femoral metaphysis and a significant increase in bone formation in the femoral diaphysis. Our findings suggest that W9 exerts bone anabolic activity. To clarify the mechanisms involved in this activity, we investigated the effects of W9 on osteoblast differentiation/mineralization in MC3T3-E1 (E1) cells. W9 markedly increased alkaline phosphatase (a marker enzyme of osteoblasts) activity and mineralization as shown by alizarin red staining. Gene expression of several osteogenesis-related factors was increased in W9-treated E1 cells. Addition of W9 activated p38 MAPK and Smad1/5/8 in E1 cells, and W9 showed osteogenesis stimulatory activity synergistically with BMP-2 in vitro and ectopic bone formation. Knockdown of RANKL-expression in E1 cells reduced the effect of W9. Furthermore, W9 showed a weak effect on RANKL-deficient osteoblasts in alkaline phosphatase assay. Taken together, our findings suggest that this peptide may be useful for the treatment of bone diseases, and W9 achieves its bone anabolic activity through RANKL on osteoblasts accompanied by production of several autocrine factors.	[Furuya, Yuriko; Uchida, Kohji; Yasuda, Hisataka] Oriental Yeast Co Ltd, Nagahama Inst Biochem Sci, Nagahama, Shiga 5260804, Japan; [Inagaki, Atsushi; Mori, Kaoru] Oriental Yeast Co Ltd, Biochem Prod & Dev Ctr, Nagahama, Shiga 5260804, Japan; Oriental Yeast Co Ltd, Bioind Div, Itabashi Ku, Tokyo 1748505, Japan; [Khan, Masud; Aoki, Kazuhiro; Ohya, Keiichi] Tokyo Med & Dent Univ, Grad Sch, Dept Biomatrix, Bunkyo Ku, Tokyo 1138549, Japan; [Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Nakamura, Midori; Udagawa, Nobuyuki] Matsumoto Dent Univ, Dept Biochem, Nagano 3990781, Japan	Oriental Yeast Co., Ltd.; Oriental Yeast Co., Ltd.; Oriental Yeast Co., Ltd.; Tokyo Medical & Dental University (TMDU); Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Matsumoto Dental University	Furuya, Y (corresponding author), 50 Kano Cho, Nagahama, Shiga 5260804, Japan.	furuya-y@oyc.co.jp; hyasuda@oyc.co.jp	AOKI, Kazuhiro/GRO-6475-2022; Penninger, Josef M/I-6860-2013	AOKI, Kazuhiro/0000-0001-6643-6315; Penninger, Josef M/0000-0002-8194-3777; Yasuda, Hisataka/0000-0003-3511-609X	Grants-in-Aid for Scientific Research [23593054, 25293377] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Aoki K, 2006, J CLIN INVEST, V116, P1525, DOI 10.1172/JCI22513; Bekker PJ, 2004, J BONE MINER RES, V19, P1059, DOI 10.1359/JBMR.040305; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; CANALIS E, 1989, J CLIN INVEST, V83, P60, DOI 10.1172/JCI113885; Chen NJ, 2001, J IMMUNOL, V166, P270, DOI 10.4049/jimmunol.166.1.270; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Eghbali-Fatourechi G, 2003, J CLIN INVEST, V111, P1221, DOI 10.1172/JCI200317215; Eissner G, 2004, CYTOKINE GROWTH F R, V15, P353, DOI 10.1016/j.cytogfr.2004.03.011; Furuya Y, 2011, J BIOL CHEM, V286, P37023, DOI 10.1074/jbc.M111.246280; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Hu YY, 2003, ENDOCRINOLOGY, V144, P2068, DOI 10.1210/en.2002-220863; ISGAARD J, 1986, AM J PHYSIOL, V250, pE367, DOI 10.1152/ajpendo.1986.250.4.E367; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; McClung MR, 2006, NEW ENGL J MED, V354, P821, DOI 10.1056/NEJMoa044459; Mizuno A, 1998, BIOCHEM BIOPH RES CO, V247, P610, DOI 10.1006/bbrc.1998.8697; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Nakagawa N, 1998, BIOCHEM BIOPH RES CO, V253, P395, DOI 10.1006/bbrc.1998.9788; Nakamura M, 2003, ENDOCRINOLOGY, V144, P5441, DOI 10.1210/en.2003-0717; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Shevde NK, 2000, P NATL ACAD SCI USA, V97, P7829, DOI 10.1073/pnas.130200197; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Takasaki W, 1997, NAT BIOTECHNOL, V15, P1266, DOI 10.1038/nbt1197-1266; TAM CS, 1982, ENDOCRINOLOGY, V110, P506, DOI 10.1210/endo-110-2-506; Tanaka S, 2005, IMMUNOL REV, V208, P30, DOI 10.1111/j.0105-2896.2005.00327.x; Tomimori Y, 2009, J BONE MINER RES, V24, P1194, DOI [10.1359/JBMR.090217, 10.1359/jbmr.090217]; Watts AD, 1999, EMBO J, V18, P2119, DOI 10.1093/emboj/18.8.2119; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yamamoto N, 1997, BIOCHEM BIOPH RES CO, V238, P574, DOI 10.1006/bbrc.1997.7325; Yasuda H, 1998, ENDOCRINOLOGY, V139, P1329, DOI 10.1210/en.139.3.1329; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597	37	56	62	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5562	5571		10.1074/jbc.M112.426080	http://dx.doi.org/10.1074/jbc.M112.426080			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23319583	Green Published, hybrid			2022-12-25	WOS:000315342500030
J	Song, S; Jang, S; Park, J; Bang, S; Choi, S; Kwon, KY; Zhuang, XX; Kim, E; Chung, J				Song, Saera; Jang, Seoyeon; Park, Jeehye; Bang, Sunhoe; Choi, Sekyu; Kwon, Kyum-Yil; Zhuang, Xiaoxi; Kim, Eunjoon; Chung, Jongkyeong			Characterization of PINK1 (PTEN-induced Putative Kinase 1) Mutations Associated with Parkinson Disease in Mammalian Cells and Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY-ONSET PARKINSONISM; MITOCHONDRIAL DYSFUNCTION; DOPAMINERGIC-NEURONS; PROTEASOME; PATHWAY; PHOSPHORYLATION; DEGRADATION; RECRUITMENT; PATHOLOGY; MEMBRANE	Mutations in PINK1 (PTEN-induced putative kinase 1) are tightly linked to autosomal recessive Parkinson disease (PD). Although more than 50 mutations in PINK1 have been discovered, the role of these mutations in PD pathogenesis remains poorly understood. Here, we characterized 17 representative PINK1 pathogenic mutations in both mammalian cells and Drosophila. These mutations did not affect the typical cleavage patterns and subcellular localization of PINK1 under both normal and damaged mitochondria conditions in mammalian cells. However, PINK1 mutations in the kinase domain failed to translocate Parkin to mitochondria and to induce mitochondrial aggregation. Consistent with the mammalian data, Drosophila PINK1 mutants with mutations in the kinase domain (G426D and L464P) did not genetically interact with Parkin. Furthermore, PINK1-null flies expressing the transgenic G426D mutant displayed defective phenotypes with increasing age, whereas L464P mutant-expressing flies exhibited the phenotypes at an earlier age. Collectively, these results strongly support the hypothesis that the kinase activity of PINK1 is essential for its function and for regulating downstream Parkin functions in mitochondria. We believe that this study provides the basis for understanding the molecular and physiological functions of various PINK1 mutations and provides insights into the pathogenic mechanisms of PINK1-linked PD.	[Song, Saera; Choi, Sekyu; Kim, Eunjoon] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Song, Saera; Jang, Seoyeon; Bang, Sunhoe; Choi, Sekyu; Chung, Jongkyeong] Korea Adv Inst Sci & Technol, Inst Mol Biol & Genet, Taejon 305701, South Korea; [Jang, Seoyeon; Bang, Sunhoe; Chung, Jongkyeong] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Song, Saera; Jang, Seoyeon; Park, Jeehye; Bang, Sunhoe; Choi, Sekyu; Kwon, Kyum-Yil; Chung, Jongkyeong] Seoul Natl Univ, Natl Creat Res Initiat Ctr Energy Homeostasis Reg, Seoul 151742, South Korea; [Zhuang, Xiaoxi] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); Seoul National University (SNU); University of Chicago	Chung, J (corresponding author), Seoul Natl Univ, Sch Biol Sci, 1 Gwanak Ro, Seoul 151742, South Korea.	jkc@snu.ac.kr	Kim, Eunjoon/C-1566-2011	Choi, Sekyu/0000-0003-2928-0942	National Creative Research Initiatives Program Grant from the Korean Ministry of Education, Science and Technology [2010-0018291]	National Creative Research Initiatives Program Grant from the Korean Ministry of Education, Science and Technology	This work was supported by National Creative Research Initiatives Program Grant 2010-0018291 from the Korean Ministry of Education, Science and Technology.	Abou-Sleiman PM, 2006, ANN NEUROL, V60, P414, DOI 10.1002/ana.20960; Becker D, 2012, J BIOL CHEM, V287, P22969, DOI 10.1074/jbc.M112.365700; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Bonifati V, 2005, NEUROLOGY, V65, P87, DOI 10.1212/01.wnl.0000167546.39375.82; Brooks J, 2009, J MED GENET, V46, P375, DOI 10.1136/jmg.2008.063917; Cardona F, 2011, HUM MUTAT, V32, P369, DOI 10.1002/humu.21444; Cha GH, 2005, P NATL ACAD SCI USA, V102, P10345, DOI 10.1073/pnas.0500346102; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chishti MA, 2006, ARCH NEUROL-CHICAGO, V63, P1483, DOI 10.1001/archneur.63.10.1483; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Deas E, 2011, HUM MOL GENET, V20, P867, DOI 10.1093/hmg/ddq526; Deas E, 2009, EMBO MOL MED, V1, P152, DOI 10.1002/emmm.200900024; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Gegg ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004756; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Hatano Y, 2004, NEUROLOGY, V63, P1482, DOI 10.1212/01.WNL.0000142258.29304.FE; Hatano Y, 2004, ANN NEUROL, V56, P424, DOI 10.1002/ana.20251; Ibanez P, 2006, BRAIN, V129, P686, DOI 10.1093/brain/awl005; Imai Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001229; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Klein C, 2007, NEUROLOGY, V69, P2093, DOI 10.1212/01.wnl.0000271880.27321.a7; Koh H, 2012, MOL CELLS, V34, P7, DOI 10.1007/s10059-012-0100-8; Koh H, 2012, J BIOL CHEM, V287, P12750, DOI 10.1074/jbc.M111.337907; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Kumazawa R, 2008, ARCH NEUROL-CHICAGO, V65, P802, DOI 10.1001/archneur.65.6.802; Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607; LANGSTON JW, 1983, NEW ENGL J MED, V309, P310; Li Y, 2005, NEUROLOGY, V64, P1955, DOI 10.1212/01.WNL.0000164009.36740.4E; Lin W, 2008, J NEUROCHEM, V106, P464, DOI 10.1111/j.1471-4159.2008.05398.x; Liu S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002537; Liu WC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004597; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; Matenia D, 2012, J BIOL CHEM, V287, P8174, DOI 10.1074/jbc.M111.262287; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; Moriwaki Y, 2008, NEUROSCI RES, V61, P43, DOI 10.1016/j.neures.2008.01.006; Muqit MMK, 2006, J NEUROCHEM, V98, P156, DOI 10.1111/j.1471-4159.2006.03845.x; Murata H, 2011, J BIOL CHEM, V286, P7182, DOI 10.1074/jbc.M110.179390; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8; Nuytemans K, 2010, HUM MUTAT, V31, P763, DOI 10.1002/humu.21277; Okatsu K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2016; Park J, 2009, BIOCHEM BIOPH RES CO, V378, P518, DOI 10.1016/j.bbrc.2008.11.086; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Prestel J, 2008, J NEUROL, V255, P643, DOI 10.1007/s00415-008-0763-4; Sandebring A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005701; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Seibler P, 2011, J NEUROSCI, V31, P5970, DOI 10.1523/JNEUROSCI.4441-10.2011; Sha D, 2010, HUM MOL GENET, V19, P352, DOI 10.1093/hmg/ddp501; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Sim CH, 2006, HUM MOL GENET, V15, P3251, DOI 10.1093/hmg/ddl398; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tanaka Keiji, 2010, Rinsho Shinkeigaku, V50, P867; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang DF, 2006, P NATL ACAD SCI USA, V103, P13244, DOI 10.1073/pnas.0605551103; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Weihofen A, 2008, HUM MOL GENET, V17, P602, DOI 10.1093/hmg/ddm334; Weihofen A, 2009, BIOCHEMISTRY-US, V48, P2045, DOI 10.1021/bi8019178; Whitworth AJ, 2008, DIS MODEL MECH, V1, P168, DOI 10.1242/dmm.000109; Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455; Woodroof HI, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110012; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105	72	52	53	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5660	5672		10.1074/jbc.M112.430801	http://dx.doi.org/10.1074/jbc.M112.430801			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23303188	Green Published, hybrid			2022-12-25	WOS:000315342500039
J	Jefferson, JM; Dolstad, HA; Sivalingam, MD; Snow, JW				Jefferson, Jamal M.; Dolstad, Hilary A.; Sivalingam, Meera D.; Snow, Jonathan W.			Barrier Immune Effectors Are Maintained during Transition from Nurse to Forager in the Honey Bee	PLOS ONE			English	Article							DIVISION-OF-LABOR; APIS-MELLIFERA; ANTIMICROBIAL PEPTIDES; HOST-DEFENSE; DROSOPHILA; INFECTION; BACTERIAL; GENE; AGE; DYNAMICS	Foragers facilitate horizontal pathogen transmission in honey bee colonies, yet their systemic immune function wanes during transition to this life stage. In general, the insect immune system can be categorized into mechanisms operating at both the barrier epithelial surfaces and at the systemic level. As proposed by the intergenerational transfer theory of aging, such immunosenescence may result from changes in group resource allocation. Yet, the relative influence of pathogen transmission and resource allocation on immune function in bees from different stages has not been examined in the context of barrier immunity. We find that expression levels of antimicrobial peptides (AMPs) in honey bee barrier epithelia of the digestive tract do not follow a life stage-dependent decrease. In addition, correlation of AMP transcript abundance with microbe levels reveals a number of microbe-associated changes in AMPs levels that are equivalent between nurses and foragers. These results favor a model in which barrier effectors are maintained in foragers as a first line of defense, while systemic immune effectors are dismantled to optimize hive-level resources. These findings have important implications for our understanding of immunosenescence in honey bees and other social insects.	[Jefferson, Jamal M.; Dolstad, Hilary A.; Sivalingam, Meera D.; Snow, Jonathan W.] Williams Coll, Dept Biol, Williamstown, MA 01267 USA	Williams College	Snow, JW (corresponding author), Williams Coll, Dept Biol, Williamstown, MA 01267 USA.	jsnow@barnard.edu						Amdam GV, 2011, AGING CELL, V10, P18, DOI 10.1111/j.1474-9726.2010.00647.x; Amdam GV, 2005, EXP GERONTOL, V40, P939, DOI 10.1016/j.exger.2005.08.004; Amdam GV, 2005, AGEING RES REV, V4, P398, DOI 10.1016/j.arr.2005.03.007; Amdam GV, 2004, EXP GERONTOL, V39, P767, DOI 10.1016/j.exger.2004.02.010; Ament SA, 2010, WIRES SYST BIOL MED, V2, P566, DOI 10.1002/wsbm.73; Apidianakis Y, 2011, DIS MODEL MECH, V4, P21, DOI 10.1242/dmm.003970; Bedick JC, 2001, COMP BIOCHEM PHYS C, V130, P107, DOI 10.1016/S1532-0456(01)00226-5; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Boughton RK, 2011, FUNCT ECOL, V25, P81, DOI 10.1111/j.1365-2435.2010.01817.x; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; CASTEELSJOSSON K, 1994, J BIOL CHEM, V269, P28569; Chase-Topping M, 2008, NAT REV MICROBIOL, V6, P904, DOI 10.1038/nrmicro2029; Choi NH, 2008, AGING CELL, V7, P318, DOI 10.1111/j.1474-9726.2008.00380.x; Choi YJ, 2008, BBA-GEN SUBJECTS, V1780, P1093, DOI 10.1016/j.bbagen.2008.06.008; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; DeVeale B, 2004, AGING CELL, V3, P195, DOI 10.1111/j.1474-9728.2004.00106.x; DURRER S, 1994, P ROY SOC B-BIOL SCI, V258, P299, DOI 10.1098/rspb.1994.0176; Dussaubat C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037017; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Evans JD, 2006, J INVERTEBR PATHOL, V93, P135, DOI 10.1016/j.jip.2006.04.004; Evans JD, 2011, TRENDS MICROBIOL, V19, P614, DOI 10.1016/j.tim.2011.09.003; Evans JD, 2004, J ECON ENTOMOL, V97, P752, DOI 10.1603/0022-0493(2004)097[0752:BPIAIR]2.0.CO;2; Feldhaar H, 2008, MICROBES INFECT, V10, P1082, DOI 10.1016/j.micinf.2008.07.010; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Fries I, 2001, APIDOLOGIE, V32, P199, DOI 10.1051/apido:2001122; Fujihashi K, 2009, TRENDS IMMUNOL, V30, P334, DOI 10.1016/j.it.2009.04.004; Hartman AL, 2009, P NATL ACAD SCI USA, V106, P17187, DOI 10.1073/pnas.0904847106; Hawley DM, 2011, FUNCT ECOL, V25, P48, DOI 10.1111/j.1365-2435.2010.01753.x; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Imler Jean-Luc, 2005, V86, P1, DOI 10.1159/000086648; Khoury DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018491; Laughton AM, 2011, J INSECT PHYSIOL, V57, P1023, DOI 10.1016/j.jinsphys.2011.04.020; Lee RD, 2003, P NATL ACAD SCI USA, V100, P9637, DOI 10.1073/pnas.1530303100; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li JL, 2011, J ECON ENTOMOL, V104, P732, DOI 10.1603/EC10355; Lindstrom A, 2008, APIDOLOGIE, V39, P515, DOI 10.1051/apido:2008032; Lourenco AP, 2009, ARCH INSECT BIOCHEM, V71, P70, DOI 10.1002/arch.20301; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Martinson VG, 2012, APPL ENVIRON MICROB, V78, P2830, DOI 10.1128/AEM.07810-11; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; Mattila HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032962; Mohr KI, 2006, ENVIRON MICROBIOL, V8, P258, DOI 10.1111/j.1462-2920.2005.00893.x; Moran NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036393; Munch D, 2010, FEBS LETT, V584, P2496, DOI 10.1016/j.febslet.2010.04.007; Omholt Stig W, 2004, Sci Aging Knowledge Environ, V2004, ppe28, DOI 10.1126/sageke.2004.26.pe28; Petney TN, 1998, INT J PARASITOL, V28, P377, DOI 10.1016/S0020-7519(97)00189-6; Ramsden S, 2008, AGING CELL, V7, P225, DOI 10.1111/j.1474-9726.2008.00370.x; Real LA, 2007, CURR TOP MICROBIOL, V315, P33; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Sabree ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041250; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Schmickl T, 2007, ECOL MODEL, V204, P219, DOI 10.1016/j.ecolmodel.2007.01.001; Schmid-Hempel P., 1998, Parasites in social insects.; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; Shanley DP, 2009, TRENDS IMMUNOL, V30, P374, DOI 10.1016/j.it.2009.05.001; Sibley CD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000184; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Toth AL, 2005, J EXP BIOL, V208, P4641, DOI 10.1242/jeb.01956; Toth AL, 2005, ANIM BEHAV, V69, P427, DOI 10.1016/j.anbehav.2004.03.017; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Welch A, 2009, APPL ENVIRON MICROB, V75, P7862, DOI 10.1128/AEM.01319-09; Wilson-Rich N, 2008, J INSECT PHYSIOL, V54, P1392, DOI 10.1016/j.jinsphys.2008.07.016; Youngman MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002082	65	24	25	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e54097	10.1371/journal.pone.0054097	http://dx.doi.org/10.1371/journal.pone.0054097			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320121	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429800088
J	Notomi, S; Hisatomi, T; Murakami, Y; Terasaki, H; Sonoda, S; Asato, R; Takeda, A; Ikeda, Y; Enaida, H; Sakamoto, T; Ishibashi, T				Notomi, Shoji; Hisatomi, Toshio; Murakami, Yusuke; Terasaki, Hiroto; Sonoda, Shozo; Asato, Ryo; Takeda, Atsunobu; Ikeda, Yasuhiro; Enaida, Hiroshi; Sakamoto, Taiji; Ishibashi, Tatsuro			Dynamic Increase in Extracellular ATP Accelerates Photoreceptor Cell Apoptosis via Ligation of P2RX7 in Subretinal Hemorrhage	PLOS ONE			English	Article							BRILLIANT BLUE-G; RETINAL GANGLION-CELLS; MACULAR DEGENERATION; P2X(7) RECEPTORS; INTRACEREBRAL HEMORRHAGE; IN-VIVO; RAT MODEL; CHOROIDAL NEOVASCULARIZATION; MITOCHONDRIAL APOPTOSIS; VITREOUS HEMORRHAGE	Photoreceptor degeneration is the most critical cause of visual impairment in age-related macular degeneration (AMD). In neovascular form of AMD, severe photoreceptor loss develops with subretinal hemorrhage due to choroidal neovascularization (CNV), growth of abnormal blood vessels from choroidal circulation. However, the detailed mechanisms of this process remain elusive. Here we demonstrate that neovascular AMD with subretinal hemorrhage accompanies a significant increase in extracellular ATP, and that extracellular ATP initiates neurodegenerative processes through specific ligation of Purinergic receptor P2X, ligand-gated ion channel, 7 (P2RX7; P2X7 receptor). Increased extracellular ATP levels were found in the vitreous samples of AMD patients with subretinal hemorrhage compared to control vitreous samples. Extravascular blood induced a massive release of ATP and photoreceptor cell apoptosis in co-culture with primary retinal cells. Photoreceptor cell apoptosis accompanied mitochondrial apoptotic pathways, namely activation of caspase-9 and translocation of apoptosis-inducing factor (AIF) from mitochondria to nuclei, as well as TUNEL-detectable DNA fragmentation. These hallmarks of photoreceptor cell apoptosis were prevented by brilliant blue G (BBG), a selective P2RX7 antagonist, which is an approved adjuvant in ocular surgery. Finally, in a mouse model of subretinal hemorrhage, photoreceptor cells degenerated through BBG-inhibitable apoptosis, suggesting that ligation of P2RX7 by extracellular ATP may accelerate photoreceptor cell apoptosis in AMD with subretinal hemorrhage. Our results indicate a novel mechanism that could involve neuronal cell death not only in AMD but also in hemorrhagic disorders in the CNS and encourage the potential application of BBG as a neuroprotective therapy.	[Notomi, Shoji; Hisatomi, Toshio; Murakami, Yusuke; Asato, Ryo; Takeda, Atsunobu; Ikeda, Yasuhiro; Enaida, Hiroshi; Ishibashi, Tatsuro] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka 812, Japan; [Hisatomi, Toshio; Asato, Ryo] Natl Hosp Org, Clin Res Inst, Kyushu Med Ctr, Fukuoka, Japan; [Terasaki, Hiroto; Sonoda, Shozo; Sakamoto, Taiji] Kagoshima Univ, Dept Ophthalmol, Grad Sch Med Sci, Kagoshima 890, Japan	Kyushu University; Kagoshima University	Hisatomi, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka 812, Japan.	hisatomi@med.kyushu-u.ac.jp		Hisatomi, Toshio/0000-0003-2552-9595	Ministry of Education, Culture, Sports, Science, and Technology, Japan [21791690]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-In-Aid for Scientific Research (number 21791690) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBRACCHIO MP, 1994, PHARMACOL THERAPEUT, V64, P445, DOI 10.1016/0163-7258(94)00048-4; Bhisitkul RB, 2008, INVEST OPHTH VIS SCI, V49, P4071, DOI 10.1167/iovs.08-1892; Bressler NM, 2004, OPHTHALMOLOGY, V111, P1993, DOI 10.1016/j.ophtha.2004.07.023; Burnstock G, 2008, PHARMACOL REP, V60, P12; Chused TM, 1996, J IMMUNOL, V157, P1371; Deuchars SA, 2001, J NEUROSCI, V21, P7143, DOI 10.1523/JNEUROSCI.21-18-07143.2001; Diaz-Hernandez M, 2009, FASEB J, V23, P1893, DOI 10.1096/fj.08-122275; DUBYAK GR, 1993, AM J PHYSIOL, V265, pC577, DOI 10.1152/ajpcell.1993.265.3.C577; Dunaief JL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1435, DOI 10.1001/archopht.120.11.1435; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; Enaida H, 2006, RETINA-J RET VIT DIS, V26, P623, DOI 10.1097/00006982-200607000-00006; Enaida H, 2006, RETINA-J RET VIT DIS, V26, P631, DOI 10.1097/00006982-200607000-00007; Farah ME, 2009, AM J OPHTHALMOL, V148, P332, DOI 10.1016/j.ajo.2009.04.003; Ferrari D, 1999, FEBS LETT, V447, P71, DOI 10.1016/S0014-5793(99)00270-7; FERRIS FL, 1984, ARCH OPHTHALMOL-CHIC, V102, P1640; GLATT H, 1982, AM J OPHTHALMOL, V94, P762, DOI 10.1016/0002-9394(82)90301-4; Green DR, 2005, J CLIN INVEST, V115, P2610, DOI 10.1172/JCI26321; Grossniklaus HE, 2004, AM J OPHTHALMOL, V137, P496, DOI 10.1016/j.ajo.2003.09.042; Hisatomi T, 2006, ARCH OPHTHALMOL-CHIC, V124, P514, DOI 10.1001/archopht.124.4.514; Hisatomi T, 2001, AM J PATHOL, V158, P1271, DOI 10.1016/S0002-9440(10)64078-3; Hisatomi T, 2008, J CLIN INVEST, V118, P2025, DOI 10.1172/JCI34267; Holladay JT, 1997, J REFRACT SURG, V13, P388; Hu HL, 2010, EXP EYE RES, V91, P425, DOI 10.1016/j.exer.2010.06.017; Hua Y, 2007, STROKE, V38, P759, DOI 10.1161/01.STR.0000247868.97078.10; Ishibashi T, 1997, GRAEF ARCH CLIN EXP, V235, P159, DOI 10.1007/BF00941723; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Jaremko KM, 2010, J NEUROCHEM, V114, P1063, DOI 10.1111/j.1471-4159.2010.06826.x; Ricatti MJ, 2009, SYNAPSE, V63, P291, DOI 10.1002/syn.20605; Jung JH, 2010, RETINA-J RET VIT DIS, V30, P865, DOI 10.1097/IAE.0b013e3181c969e9; KLEIN R, 1995, OPHTHALMOLOGY, V102, P371; Lee JE, 2003, RETINA-J RET VIT DIS, V23, P675, DOI 10.1097/00006982-200310000-00012; Liu HT, 2008, PURINERG SIGNAL, V4, P147, DOI 10.1007/s11302-007-9077-8; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; McLarnon JG, 2006, J NEUROPATH EXP NEUR, V65, P1090, DOI 10.1097/01.jnen.0000240470.97295.d3; Mehalow AK, 2003, HUM MOL GENET, V12, P2179, DOI 10.1093/hmg/ddg232; Melani A, 2005, NEUROCHEM INT, V47, P442, DOI 10.1016/j.neuint.2005.05.014; Mitchell CH, 2009, PURINERG SIGNAL, V5, P241, DOI 10.1007/s11302-009-9142-6; Murakami Y, 2008, AM J PATHOL, V173, P1326, DOI 10.2353/ajpath.2008.080466; Nakamura T, 2004, J NEUROSURG, V100, P672, DOI 10.3171/jns.2004.100.4.0672; Nakazawa T, 2007, P NATL ACAD SCI USA, V104, P2425, DOI 10.1073/pnas.0608167104; Notomi S, 2011, AM J PATHOL, V179, P2798, DOI 10.1016/j.ajpath.2011.08.035; Oike M, 2000, AM J PHYSIOL-HEART C, V279, pH630, DOI 10.1152/ajpheart.2000.279.2.H630; Pannicke T, 2000, J NEUROSCI, V20, P5965, DOI 10.1523/JNEUROSCI.20-16-05965.2000; Peng WG, 2009, P NATL ACAD SCI USA, V106, P12489, DOI 10.1073/pnas.0902531106; Puthussery T, 2004, J COMP NEUROL, V472, P13, DOI 10.1002/cne.20045; Puthussery T, 2006, EUR J NEUROSCI, V24, P7, DOI 10.1111/j.1460-9568.2006.04895.x; Puthussery T, 2009, J COMP NEUROL, V513, P430, DOI 10.1002/cne.21964; Qureshi AI, 2003, CRIT CARE MED, V31, P1482, DOI 10.1097/01.CCM.0000063047.63862.99; Ralevic V, 1998, PHARMACOL REV, V50, P413; Regan RF, 1996, J NEUROTRAUM, V13, P223, DOI 10.1089/neu.1996.13.223; Rodrigues EB, 2005, GRAEF ARCH CLIN EXP, V243, P291, DOI 10.1007/s00417-004-0992-x; Rodrigues EB, 2010, AM J OPHTHALMOL, V149, P265, DOI 10.1016/j.ajo.2009.08.020; Rosenfeld PJ, 2011, NEW ENGL J MED, V364, P1966, DOI 10.1056/NEJMe1103334; SACCO RL, 1984, NEUROLOGY, V34, P847, DOI 10.1212/WNL.34.7.847; Sakamoto T, 2010, RETINA-J RET VIT DIS, V30, P856, DOI 10.1097/IAE.0b013e3181c969cb; Schulze-Bonsel K, 2006, INVEST OPHTH VIS SCI, V47, P1236, DOI 10.1167/iovs.05-0981; Steel DHW, 2011, BRIT J OPHTHALMOL, V95, P1051, DOI 10.1136/bjo.2010.182253; Sugiyama T, 2010, INVEST OPHTH VIS SCI, V51, P3236, DOI 10.1167/iovs.09-4192; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Trichonas G, 2010, P NATL ACAD SCI US; Ueno A, 2007, RETINA-J RET VIT DIS, V27, P499, DOI 10.1097/IAE.0b013e318030a129; Vessey KA, 2012, PLOS ONE, V7, P290, DOI 10.1371/journal.pone.0029990; Wang QF, 2004, AM J PHYSIOL-CELL PH, V287, pC1349, DOI 10.1152/ajpcell.00256.2004; Wood Rachel E., 2009, BMC Physiology, V9, P24, DOI 10.1186/1472-6793-9-24; Yang DL, 2011, INVEST OPHTH VIS SCI, V52, P1522, DOI 10.1167/iovs.10-6172; Yang L, 2004, INVEST OPHTH VIS SCI, V45, P648, DOI 10.1167/iovs.03-0827; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zacks DN, 2003, INVEST OPHTH VIS SCI, V44, P1262, DOI 10.1167/iovs.02-0492; Zhang XL, 2005, INVEST OPHTH VIS SCI, V46, P2183, DOI 10.1167/iovs.05-0052	70	55	59	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53338	10.1371/journal.pone.0053338	http://dx.doi.org/10.1371/journal.pone.0053338			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308196	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429800040
J	Tsou, HK; Chen, HT; Hung, YH; Chang, CH; Li, TM; Fong, YC; Tang, CH				Tsou, Hsi-Kai; Chen, Hsien-Te; Hung, Ya-Huey; Chang, Chia-Hao; Li, Te-Mao; Fong, Yi-Chin; Tang, Chih-Hsin			HGF and c-Met Interaction Promotes Migration in Human Chondrosarcoma Cells	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; BREAST-CANCER; MATRIX METALLOPROTEINASES; SIGNALING PATHWAY; PARTIAL-PURIFICATION; GENE-EXPRESSION; INVASION; METASTASIS; RECEPTOR; PROGRESSION	Chondrosarcoma is a type of highly malignant tumor with a potent capacity for local invasion and causing distant metastasis. Chondrosarcoma shows a predilection for metastasis to the lungs. Hepatocyte growth factor (HGF) has been demonstrated to stimulate cancer proliferation, migration, and metastasis. However, the effect of HGF on migration activity of human chondrosarcoma cells is not well known. Here, we found that human chondrosarcoma tissues demonstrated significant expression of HGF, which was higher than that in normal cartilage. We also found that HGF increased the migration and expression of matrix metalloproteinase (MMP)-2 in human chondrosarcoma cells. c-Met inhibitor and siRNA reduced HGF-increased cell migration and MMP-2 expression. HGF treatment resulted in activation of the phosphatidylinositol 3'-kinase (PI3K)/Akt/PKC delta/NF-kappa B pathway, and HGF-induced expression of MMP-2 and cell migration was inhibited by specific inhibitors or siRNA-knockdown of PI3K, Akt, PKC delta, and NF-kappa B cascades. Taken together, our results indicated that HGF enhances migration of chondrosarcoma cells by increasing MMP-2 expression through the c-Met receptor/PI3K/Akt/PKC delta/NF-kappa B signal transduction pathway.	[Tsou, Hsi-Kai] Taichung Vet Gen Hosp, Dept Neurosurg, Taichung, Taiwan; [Tsou, Hsi-Kai; Chen, Hsien-Te] Feng Chia Univ, Dept Mat Sci & Engn, Taichung 40724, Taiwan; [Tsou, Hsi-Kai] Jen Teh Jr Coll Med Nursing & Management, Dept Early Childhood Care & Educ, Miaoli Cty, Taiwan; [Chen, Hsien-Te; Li, Te-Mao; Fong, Yi-Chin] China Med Univ, Coll Chinese Med, Sch Chinese Med, Taichung, Taiwan; [Chen, Hsien-Te; Fong, Yi-Chin] China Med Univ Hosp, Dept Orthoped Surg, Taichung, Taiwan; [Hung, Ya-Huey; Tang, Chih-Hsin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Chang, Chia-Hao] Chang Hwa Hosp, Dept Orthoped Surg, Dept Hlth, Executive Yuan, Chang Hwa Count, Taiwan; [Tang, Chih-Hsin] China Med Univ, Sch Med, Dept Pharmacol, Taichung, Taiwan	Taichung Veterans General Hospital; Feng Chia University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan	Tang, CH (corresponding author), China Med Univ, Sch Med, Dept Pharmacol, Taichung, Taiwan.	chtang@mail.cmu.edu.tw	Tang, Chih Hsin/O-5212-2015	Tang, Chih Hsin/0000-0002-7113-8352	National Science Council of Taiwan [NSC99-2320-B-039-003-MY3, NSC100-2320-B-039-028-MY3]; China Medical University Hospital [DMR-102-055]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); China Medical University Hospital	This study was supported by grants from the National Science Council of Taiwan (NSC99-2320-B-039-003-MY3 and NSC100-2320-B-039-028-MY3) and China Medical University Hospital (DMR-102-055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibollet-Bahena O, 2009, J NEUROCHEM, V109, P1440, DOI 10.1111/j.1471-4159.2009.06071.x; Cecchi F, 2010, EUR J CANCER, V46, P1260, DOI 10.1016/j.ejca.2010.02.028; Chen HT, 2010, J CELL PHYSIOL, V223, P737, DOI 10.1002/jcp.22083; Chen YJ, 2009, J CELL PHYSIOL, V221, P98, DOI 10.1002/jcp.21835; DIRENZO MF, 1995, CANCER RES, V55, P1129; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fong YC, 2007, J ORTHOP RES, V25, P1106, DOI 10.1002/jor.20364; Funakoshi H, 2003, CLIN CHIM ACTA, V327, P1, DOI 10.1016/S0009-8981(02)00302-9; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Hahm ER, 2002, CANCER LETT, V184, P89, DOI 10.1016/S0304-3835(02)00170-2; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Hou CH, 2011, BIOCHEM PHARMACOL, V81, P1286, DOI 10.1016/j.bcp.2011.03.016; Hou CH, 2009, BONE, V44, P233, DOI 10.1016/j.bone.2008.09.021; Hsieh MT, 2003, LIFE SCI, V73, P1007, DOI 10.1016/S0024-3205(03)00372-2; Huang CY, 2009, BIOCHEM PHARMACOL, V77, P794, DOI 10.1016/j.bcp.2008.11.014; Huang HC, 2003, J BIOL CHEM, V278, P46750, DOI 10.1074/jbc.M305216200; Jiang WG, 2005, CRIT REV ONCOL HEMAT, V53, P35, DOI 10.1016/j.critrevonc.2004.09.004; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kang JY, 2003, CANCER RES, V63, P1101; Kerkela E, 2003, EXP DERMATOL, V12, P109, DOI 10.1034/j.1600-0625.2003.120201.x; Koh YW, 2011, J NUTR BIOCHEM, V22, P1074, DOI 10.1016/j.jnutbio.2010.09.005; Lesko E, 2008, FRONT BIOSCI-LANDMRK, V13, P1271, DOI 10.2741/2760; LUETTEKE NC, 1985, CANCER RES, V45, P6331; Maemura M, 1998, CANCER LETT, V126, P215, DOI 10.1016/S0304-3835(98)00014-7; Mahtouk K, 2010, BBA-REV CANCER, V1806, P208, DOI 10.1016/j.bbcan.2010.07.006; Martin TA, 2010, ANTI-CANCER AGENT ME, V10, P2, DOI 10.2174/1871520611009010002; Moriya C, 2011, J INVEST DERMATOL, V131, P655, DOI 10.1038/jid.2010.361; NAKAMURA T, 1984, BIOCHEM BIOPH RES CO, V122, P1450, DOI 10.1016/0006-291X(84)91253-1; Ocal IT, 2003, CANCER-AM CANCER SOC, V97, P1841, DOI 10.1002/cncr.11335; Park SK, 2009, CARCINOGENESIS, V30, P1225, DOI 10.1093/carcin/bgp111; Qin L, 2008, MOL CELL BIOL, V28, P5937, DOI 10.1128/MCB.00579-08; Sato H, 2010, CANCER SCI, V101, P843, DOI 10.1111/j.1349-7006.2010.01498.x; Scherer RL, 2008, CANCER METAST REV, V27, P679, DOI 10.1007/s10555-008-9152-9; Scully SP, 2000, CLIN ORTHOP RELAT R, P291; Tang CH, 2012, BIOCHEM PHARMACOL, V83, P335, DOI 10.1016/j.bcp.2011.11.013; Tang CH, 2011, J BIOL CHEM, V286, P11056, DOI 10.1074/jbc.M110.204081; Terek RM, 1998, J ORTHOPAED RES, V16, P585, DOI 10.1002/jor.1100160510; Toi M, 1998, CLIN CANCER RES, V4, P659; Tsai YY, 2010, INVEST OPHTH VIS SCI, V51, P3462, DOI 10.1167/iovs.09-4921; Tseng CP, 2003, FEBS LETT, V541, P21, DOI 10.1016/S0014-5793(03)00281-3; Wang YC, 2003, ANAL BIOCHEM, V319, P206, DOI 10.1016/S0003-2697(03)00330-0; Woodhouse EC, 1997, CANCER-AM CANCER SOC, V80, P1529, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F; Yuan J, 2005, J ORTHOP RES, V23, P1467, DOI 10.1016/j.orthres.2005.04.004	43	28	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53974	10.1371/journal.pone.0053974	http://dx.doi.org/10.1371/journal.pone.0053974			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320110	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429800075
J	Ahmed, MZ; De Barro, PJ; Ren, SX; Greeff, JM; Qiu, BL				Ahmed, Muhammad Z.; De Barro, Paul J.; Ren, Shun-Xiang; Greeff, Jaco M.; Qiu, Bao-Li			Evidence for Horizontal Transmission of Secondary Endosymbionts in the Bemisia tabaci Cryptic Species Complex	PLOS ONE			English	Article							2 WOLBACHIA STRAINS; HEMIPTERA ALEYRODIDAE; BACTERIAL SYMBIONT; REPRODUCTIVE ISOLATION; Q-BIOTYPE; HOST; EVOLUTION; RECOMBINATION; DIVERSITY; PHYLOGENY	Bemisia tabaci (Hemiptera: Aleyrodidae) is a globally distributed pest composed of at least 34 morphologically indistinguishable cryptic species. At least seven species of endosymbiont have been found infecting some or all members of the complex. The origin(s) of the associations between specific endosymbionts and their whitefly hosts is unknown. Infection is normally vertical, but horizontal transmission does occur and is one way for new infections to be introduced into individuals. The relationships between the different members of the cryptic species complex and the endosymbionts have not been well explored. In this study, the phylogenies of different cryptic species of the host with those of their endosymbionts were compared. Of particular interest was whether there was evidence for both coevolution and horizontal transmission. Congruence was observed for the primary endosymbiont, Portiera aleyrodidarum, and partial incongruence in the case of two secondary endosymbionts, Arsenophonus and Cardinium and incongruence for a third, Wolbachia. The patterns observed for the primary endosymbiont supported cospeciation with the host while the patterns for the secondary endosymbionts, and especially Wolbachia showed evidence of host shifts and extinctions through horizontal transmission rather than cospeciation. Of particular note is the observation of several very recent host shift events in China between exotic invader and indigenous members of the complex. These shifts were from indigenous members of the complex to the invader as well as from the invader to indigenous relatives.	[Ahmed, Muhammad Z.; Ren, Shun-Xiang; Qiu, Bao-Li] S China Agr Univ, Dept Entomol, Guangzhou, Guangdong, Peoples R China; [Ahmed, Muhammad Z.; Greeff, Jaco M.] Univ Pretoria, Dept Genet, ZA-0002 Pretoria, South Africa; [De Barro, Paul J.] CSIRO, Ecosyst Sci, Brisbane, Qld, Australia	South China Agricultural University; University of Pretoria; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Qiu, BL (corresponding author), S China Agr Univ, Dept Entomol, Guangzhou, Guangdong, Peoples R China.	baileyqiu@yahoo.com.cn	Greeff, Jaco M/A-5582-2011; Ahmed, Muhammad Z/E-5735-2011; De Barro, Paul J/C-1724-2008	Ahmed, Muhammad Z/0000-0003-2486-157X; Greeff, Jaco/0000-0003-2951-6791	Program for New Century Excellent Talents in University; National Basic Research Program of China (973 Project) [2009CB119203]; China National Natural Science Foundation [31071732]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Basic Research Program of China (973 Project)(National Basic Research Program of China); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This research was funded by the Program for New Century Excellent Talents in University 2011, National Basic Research Program of China (973 Project, 2009CB119203) and the China National Natural Science Foundation (31071732). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MZ, 2012, J APPL ENTOMOL, V136, P510, DOI 10.1111/j.1439-0418.2011.01673.x; Ahmed MZ, 2010, J ECON ENTOMOL, V103, P1848, DOI 10.1603/EC10033; Ahmed MZ, 2010, CURR MICROBIOL, V61, P322, DOI 10.1007/s00284-010-9614-5; [Anonymous], 2012, EVOL BIOINFORM, V8, P1, DOI 10.4137/EBO.S8532; Baldo L, 2006, MOL BIOL EVOL, V23, P437, DOI 10.1093/molbev/msj049; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Baumann L, 2004, CURR MICROBIOL, V48, P77, DOI 10.1007/s00284-003-4132-3; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; BAUMANN P, 2000, PROKARYOTES; Bordenstein SR, 2001, NATURE, V409, P707, DOI 10.1038/35055543; Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998; BREEUWER JAJ, 1990, NATURE, V346, P558, DOI 10.1038/346558a0; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL, P332; Charleston MA, 1998, MATH BIOSCI, V149, P191, DOI 10.1016/S0025-5564(97)10012-8; Chiel E, 2007, B ENTOMOL RES, V97, P407, DOI 10.1017/S0007485307005159; Chiel E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004767; Chu D, 2011, B ENTOMOL RES, V101, P477, DOI 10.1017/S0007485311000083; Chu Dong, 2005, Acta Entomologica Sinica, V48, P518; Chu D, 2006, FLA ENTOMOL, V89, P168, DOI 10.1653/0015-4040(2006)89[168:TIOTEQ]2.0.CO;2; CLARK MA, 1992, CURR MICROBIOL, V25, P119, DOI 10.1007/BF01570970; Costa HS, 1995, PROTOPLASMA, V189, P194, DOI 10.1007/BF01280174; Dalton R, 2006, NATURE, V443, P898, DOI 10.1038/443898a; De Barro P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025579; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Everett KDE, 2005, INT J SYST EVOL MICR, V55, P1581, DOI 10.1099/ijs.0.63454-0; Feldhaar H, 2011, ECOL ENTOMOL, V36, P533, DOI 10.1111/j.1365-2311.2011.01318.x; Ghanim M, 2009, PEST MANAG SCI, V65, P939, DOI 10.1002/ps.1795; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Gueguen G, 2010, MOL ECOL, V19, P4365, DOI 10.1111/j.1365-294X.2010.04775.x; Guo Xiaopeng, 2008, Weishengwu Xuebao, V48, P63; Heath BD, 1999, CURR BIOL, V9, P313, DOI 10.1016/S0960-9822(99)80139-0; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016061; Huelsenbeck JP, 2000, EVOLUTION, V54, P352, DOI 10.1111/j.0014-3820.2000.tb00039.x; Huigens ME, 2004, P ROY SOC B-BIOL SCI, V271, P509, DOI 10.1098/rspb.2003.2640; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Jiggins FM, 2001, P ROY SOC B-BIOL SCI, V268, P1423, DOI 10.1098/rspb.2001.1656; Johnson KP, 2001, ZOOL SCR, V30, P79, DOI 10.1046/j.1463-6409.2001.00057.x; Keller GP, 2004, MOL ECOL, V13, P2405, DOI 10.1111/j.1365-294X.2004.02213.x; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kontsedalov S, 2008, PEST MANAG SCI, V64, P789, DOI 10.1002/ps.1595; LEGENDRE P., 2001, TEST HOST PARASITE C; Leikoski N, 2009, APPL ENVIRON MICROB, V75, P853, DOI 10.1128/AEM.02134-08; Li SJ, 2011, INSECT SCI, V18, P101, DOI 10.1111/j.1744-7917.2010.01395.x; Li ZX, 2007, CURR MICROBIOL, V54, P467, DOI 10.1007/s00284-007-0011-7; Light JE, 2005, THESIS U MICHIGAN; Light JE, 2008, SYST BIOL, V57, P449, DOI 10.1080/10635150802169610; Light JE, 2007, MOL PHYLOGENET EVOL, V45, P997, DOI 10.1016/j.ympev.2007.09.001; Liu SS, 2007, SCIENCE, V318, P1769, DOI 10.1126/science.1149887; Liu SS, 2012, J INTEGR AGR, V11, P176, DOI 10.1016/S2095-3119(12)60002-1; Maydt J, 2006, BIOINFORMATICS, V22, P1064, DOI 10.1093/bioinformatics/btl057; Moran NA, 2000, CURR OPIN MICROBIOL, V3, P270, DOI 10.1016/S1369-5274(00)00088-6; Moran NA, 1998, BIOSCIENCE, V48, P295, DOI 10.2307/1313356; Moreira LA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000568; MUNSON MA, 1991, J BACTERIOL, V173, P6321, DOI 10.1128/jb.173.20.6321-6324.1991; Nirgianaki A, 2003, CURR MICROBIOL, V47, P93, DOI 10.1007/s00284-002-3969-1; PAGE RDM, 1994, CLADISTICS, V10, P155, DOI 10.1006/clad.1994.1010; Page RDM, 1998, TRENDS ECOL EVOL, V13, P356, DOI 10.1016/S0169-5347(98)01438-4; Paterson AM, 2001, INT J PARASITOL, V31, P1012, DOI 10.1016/S0020-7519(01)00199-0; Peek AS, 1998, P NATL ACAD SCI USA, V95, P9962, DOI 10.1073/pnas.95.17.9962; Ronquist F, 1995, CLADISTICS, V11, P73, DOI 10.1111/j.1096-0031.1995.tb00005.x; Ruan Yong-Ming, 2005, Acta Entomologica Sinica, V48, P859; Ruan YM, 2006, ENTOMOL EXP APPL, V121, P159, DOI 10.1111/j.1570-8703.2006.00466.x; Russell JA, 2003, MOL ECOL, V12, P1061, DOI 10.1046/j.1365-294X.2003.01780.x; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shoemaker DD, 2004, GENETICS, V168, P2049, DOI 10.1534/genetics.104.030890; Shoemaker DD, 1999, EVOLUTION, V53, P1157, DOI [10.2307/2640819, 10.1111/j.1558-5646.1999.tb04529.x]; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Sintupachee S, 2006, MICROB ECOL, V51, P294, DOI 10.1007/s00248-006-9036-x; Stahlhut JK, 2010, MOL ECOL, V19, P4102, DOI 10.1111/j.1365-294X.2010.04776.x; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Telschow A, 2005, J THEOR BIOL, V235, P265, DOI 10.1016/j.jtbi.2005.01.008; Telschow A, 2002, INTEGR COMP BIOL, V42, P340, DOI 10.1093/icb/42.2.340; Thao ML, 2000, APPL ENVIRON MICROB, V66, P2898, DOI 10.1128/AEM.66.7.2898-2905.2000; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; Thao MLL, 2004, CURR MICROBIOL, V48, P140, DOI 10.1007/s00284-003-4157-7; Thierry M, 2011, MOL ECOL, V20, P2172, DOI 10.1111/j.1365-294X.2011.05087.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vavre F, 1999, MOL BIOL EVOL, V16, P1711, DOI 10.1093/oxfordjournals.molbev.a026084; Von der Schulenburg JHG, 2000, MOL BIOL EVOL, V17, P584; Wang P, 2011, INSECT SCI, V18, P67, DOI 10.1111/j.1744-7917.2010.01381.x; Weeks AR, 2003, P ROY SOC B-BIOL SCI, V270, P1857, DOI 10.1098/rspb.2003.2425; Werren JH, 2001, CURR BIOL, V11, P431, DOI 10.1016/S0960-9822(01)00101-4; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Werren JH, 1998, ENDLESS FORMS, P245; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Xu J, 2010, B ENTOMOL RES, V100, P359, DOI 10.1017/S0007485310000015; Zchori-Fein E, 2004, MOL ECOL, V13, P2009, DOI 10.1111/j.1365-294X.2004.02203.x; Zchori-Fein E, 2002, ANN ENTOMOL SOC AM, V95, P711, DOI 10.1603/0013-8746(2002)095[0711:DOPAWB]2.0.CO;2; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	94	43	46	3	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53084	10.1371/journal.pone.0053084	http://dx.doi.org/10.1371/journal.pone.0053084			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308142	Green Published, gold, Green Submitted			2022-12-25	WOS:000313429100027
J	Strauss, S; Neumeister, A; Barcikowski, S; Kracht, D; Kuhbier, JW; Radtke, C; Reimers, K; Vogt, PM				Strauss, Sarah; Neumeister, Anne; Barcikowski, Stephan; Kracht, Dietmar; Kuhbier, Joern W.; Radtke, Christine; Reimers, Kerstin; Vogt, Peter M.			Adhesion, Vitality and Osteogenic Differentiation Capacity of Adipose Derived Stem Cells Seeded on Nitinol Nanoparticle Coatings	PLOS ONE			English	Article							HUMAN BONE-MARROW; SHAPE-MEMORY; MEDICAL APPLICATIONS; TISSUE; PROLIFERATION; BIOMATERIALS; REGENERATION; ALLOYS	Autologous cells can be used for a bioactivation of osteoimplants to enhance osseointegration. In this regard, adipose derived stem cells (ASCs) offer interesting perspectives in implantology because they are fast and easy to isolate. However, not all materials licensed for bone implants are equally suited for cell adhesion. Surface modifications are under investigation to promote cytocompatibility and cell growth. The presented study focused on influences of a Nitinol-nanoparticle coating on ASCs. Possible toxic effects as well as influences on the osteogenic differentiation potential of ASCs were evaluated by viability assays, scanning electron microscopy, immunofluorescence and alizarin red staining. It was previously shown that Nitinol-nanoparticles exert no cell toxic effects to ASCs either in soluble form or as surface coating. Here we could demonstrate that a Nitinol-nanoparticle surface coating enhances cell adherence and growth on Nitinol-surfaces. No negative influence on the osteogenic differentiation was observed. Nitinol-nanoparticle coatings offer new possibilities in implantology research regarding bioactivation by autologous ASCs, respectively enhancement of surface attraction to cells.	[Strauss, Sarah; Kuhbier, Joern W.; Radtke, Christine; Reimers, Kerstin; Vogt, Peter M.] Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, Hannover, Germany; [Neumeister, Anne; Barcikowski, Stephan; Kracht, Dietmar] Laser Zentrum Hannover eV, Hannover, Germany; [Barcikowski, Stephan] Univ Duisburg Essen, Ctr Nanointegrat, Essen, Germany	Hannover Medical School; University of Duisburg Essen	Strauss, S (corresponding author), Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, Hannover, Germany.	strauss.sarah@mh-hannover.de	Vogt, Peter M./AAL-1332-2020; Radtke, Christine/M-2927-2013; Barcikowski, Stephan/I-4754-2012; Radtke, Christine/B-8491-2018	Barcikowski, Stephan/0000-0002-9739-7272; Radtke, Christine/0000-0001-6877-5038; Kracht, Dietmar/0000-0003-3473-4814	German Research Foundation within the Collaborative Research Centre TransRegio 'Micro- and Nanosystems in Medicine - Reconstruction of biologic Functions' [37]	German Research Foundation within the Collaborative Research Centre TransRegio 'Micro- and Nanosystems in Medicine - Reconstruction of biologic Functions'	The study has been funded by the German Research Foundation within the Collaborative Research Centre TransRegio 37 'Micro- and Nanosystems in Medicine - Reconstruction of biologic Functions'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2; Bahat O, 2010, CLIN IMPLANT DENT S1, V12, P2; Barcikowski S, 2010, J NANOPART RES, V12, P1733, DOI 10.1007/s11051-009-9834-4; Blackwood DJ, 2003, CORROS REV, V21, P97; Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202; Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X; Gebert A, 1998, J MICROSC-OXFORD, V191, P297, DOI 10.1046/j.1365-2818.1998.00380.x; Habijan T, 2011, ACTA BIOMATER, V7, P2733, DOI 10.1016/j.actbio.2011.02.022; Habijan T, 2009, THESIS RUHR U BOCHUM; Hahn A, 2011, LASERGENERIERTE NANO; Hahn A, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-011-0686-3; Honda M, 2010, J BIOMED MATER RES A, V94A, P937, DOI 10.1002/jbm.a.32779; Jeswani S, 2011, J NEUROINTERV SURG, V3, P2, DOI 10.1136/jnis.2010.003657; Kang JW, 2008, STEM CELLS DEV, V17, P681, DOI 10.1089/scd.2007.0153; Keyser KA, 2007, CELL TRANSPLANT, V16, P555, DOI 10.3727/000000007783464939; Kohl M, 2009, ADV ENG MATER, V11, P959, DOI 10.1002/adem.200900168; Kuhbier JW, 2010, CHIRURG, V81, P826, DOI 10.1007/s00104-010-1962-y; Kuhbier JW, 2010, ADV BIOCHEM ENG BIOT, V123, P55, DOI 10.1007/10_2009_24; Lendeckel S, 2004, J CRANIO MAXILL SURG, V32, P370, DOI 10.1016/j.jcms.2004.06.002; Lu ZF, 2012, NANOMED-NANOTECHNOL, V8, P507, DOI 10.1016/j.nano.2011.07.012; Menendez-Manjon A, 2009, J LASER MICRO NANOEN, V4, P95, DOI 10.2961/jlmn.2009.02.0004; Mizuno Hiroshi, 2009, Journal of Nippon Medical School, V76, P56; Morgan NB, 2004, MAT SCI ENG A-STRUCT, V378, P16, DOI 10.1016/j.msea.2003.10.326; Muhonen V, 2009, J BIOMED MATER RES A, V88A, P787, DOI 10.1002/jbm.a.31953; Palin E, 2005, NANOTECHNOLOGY, V16, P1828, DOI 10.1088/0957-4484/16/9/069; Puissant N, 2005, BRIT J HAEMATOL, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x; Ravichandran Rajeswari, 2009, World J Stem Cells, V1, P55, DOI 10.4252/wjsc.v1.i1.55; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Shabalovskaya S, 2008, ACTA BIOMATER, V4, P447, DOI 10.1016/j.actbio.2008.01.013; Shabalovskaya SA, 1996, BIO-MED MATER ENG, V6, P267; Shabalovskaya SA, 2001, INT MATER REV, V46, P233, DOI 10.1179/095066001771048745; Tran N, 2009, WIRES NANOMED NANOBI, V1, P336, DOI 10.1002/wnan.23; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Wang MJ, 2006, AM J PHYSIOL-REG I, V291, pR880, DOI 10.1152/ajpregu.00280.2006; Yanez R, 2006, STEM CELLS, V24, P2582, DOI 10.1634/stemcells.2006-0228; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	36	21	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53309	10.1371/journal.pone.0053309	http://dx.doi.org/10.1371/journal.pone.0053309			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308190	Green Published, gold, Green Submitted			2022-12-25	WOS:000313429100054
J	Wang, JX; Xu, JX; Wang, QW; Brainard, RE; Watson, LJ; Jones, SP; Epstein, PN				Wang, Jianxun; Xu, Jianxiang; Wang, Qianwen; Brainard, Robert E.; Watson, Lewis J.; Jones, Steven P.; Epstein, Paul N.			Reduced Cardiac Fructose 2,6 Bisphosphate Increases Hypertrophy and Decreases Glycolysis following Aortic Constriction	PLOS ONE			English	Article							SUPEROXIDE-PRODUCTION; PRESSURE-OVERLOAD; OXIDATIVE STRESS; GLUCOSE-UPTAKE; FATTY-ACID; EXPRESSION; INSULIN; OVEREXPRESSION; CARDIOMYOPATHY; METABOLISM	This study was designed to test whether reduced levels of cardiac fructose-2,6-bisphosphate (F-2,6-P-2) exacerbates cardiac damage in response to pressure overload. F-2,6-P-2 is a positive regulator of the glycolytic enzyme phosphofructokinase. Normal and Mb transgenic mice were subject to transverse aortic constriction (TAC) or sham surgery. Mb transgenic mice have reduced F-2,6-P-2 levels, due to cardiac expression of a transgene for a mutant, kinase deficient form of the enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFK-2) which controls the level of F-2,6-P-2. Thirteen weeks following TAC surgery, glycolysis was elevated in FVB, but not in Mb, hearts. Mb hearts were markedly more sensitive to TAC induced damage. Echocardiography revealed lower fractional shortening in Mb-TAC mice as well as larger left ventricular end diastolic and end systolic diameters. Cardiac hypertrophy and pulmonary congestion were more severe in Mb-TAC mice as indicated by the ratios of heart and lung weight to tibia length. Expression of alpha-MHC RNA was reduced more in Mb-TAC hearts than in FVB-TAC hearts. TAC produced a much greater increase in fibrosis of Mb hearts and this was accompanied by 5-fold more collagen 1 RNA expression in Mb-TAC versus FVB-TAC hearts. Mb-TAC hearts had the lowest phosphocreatine to ATP ratio and the most oxidative stress as indicated by higher cardiac content of 4-hydroxynonenal protein adducts. These results indicate that the heart's capacity to increase F-2,6-P-2 during pressure overload elevates glycolysis which is beneficial for reducing pressure overload induced cardiac hypertrophy, dysfunction and fibrosis.	[Wang, Jianxun] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [Wang, Qianwen; Brainard, Robert E.; Watson, Lewis J.; Jones, Steven P.] Univ Louisville, Dept Physiol, Louisville, KY 40292 USA; [Brainard, Robert E.; Watson, Lewis J.; Jones, Steven P.] Univ Louisville, Inst Mol Cardiol, Louisville, KY 40292 USA; [Xu, Jianxiang; Epstein, Paul N.] Univ Louisville, Dept Pediat, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville	Epstein, PN (corresponding author), Univ Louisville, Dept Pediat, Louisville, KY 40292 USA.	paul.epstein@louisville.edu	Watson, Lewis J/F-3688-2011; Jones, Steven P./D-5092-2009	Watson, Lewis J/0000-0002-8273-7676; Jones, Steven P./0000-0001-5376-8089; Epstein, Paul/0000-0002-7006-8954	National Institutes of Health (NIH) [DK073586, HL083320, HL094419]; American Diabetes Association [7-11-BS-37]; American Heart Association [0715389B]; National Center for Research Resources at NIH [P20 RR024489]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024489] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083320, R01HL094419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073586] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); National Center for Research Resources at NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by National Institutes of Health (NIH) grants DK073586, HL083320 and HL094419 (NIH.gov), American Diabetes Association grant 7-11-BS-37 (http://professional.diabetes.org), American Heart Association (http://www.heart.org/HEARTORG/predoctoral fellowship) 0715389B and National Center for Research Resources at NIH P20 RR024489 (NIH.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRES A, 1980, BIOCHEM J, V186, P799, DOI 10.1042/bj1860799; Aon MA, 2010, BBA-BIOENERGETICS, V1797, P865, DOI 10.1016/j.bbabio.2010.02.016; BERNOFSKY C, 1973, ANAL BIOCHEM, V53, P452, DOI 10.1016/0003-2697(73)90094-8; BISHOP SP, 1970, AM J PHYSIOL, V218, P153, DOI 10.1152/ajplegacy.1970.218.1.153; Domenighetti AA, 2010, J MOL CELL CARDIOL, V48, P663, DOI 10.1016/j.yjmcc.2009.11.017; Donthi RV, 2004, J BIOL CHEM, V279, P48085, DOI 10.1074/jbc.M405510200; Du XL, 2000, P NATL ACAD SCI USA, V97, P12222, DOI 10.1073/pnas.97.22.12222; Facundo HT, 2012, AM J PHYSIOL-HEART C, V302, pH2122, DOI 10.1152/ajpheart.00775.2011; Gupte SA, 2006, J MOL CELL CARDIOL, V41, P340, DOI 10.1016/j.yjmcc.2006.05.003; HAMBY RI, 1974, JAMA-J AM MED ASSOC, V229, P1749, DOI 10.1001/jama.229.13.1749; Hue L, 2002, J MOL CELL CARDIOL, V34, P1091, DOI 10.1006/jmcc.2002.2063; KAGAYA Y, 1995, J CLIN INVEST, V95, P2766, DOI 10.1172/JCI117980; KASHIWAYA Y, 1994, J BIOL CHEM, V269, P25502; Kim M, 2012, J MOL CELL CARDIOL, V52, P1066, DOI 10.1016/j.yjmcc.2012.01.016; Kockskamper J, 2005, J PHYSIOL-LONDON, V564, P697, DOI 10.1113/jphysiol.2004.078782; Liang QR, 2002, CARDIOVASC RES, V53, P423, DOI 10.1016/S0008-6363(01)00495-3; Liang QR, 2002, DIABETES, V51, P174, DOI 10.2337/diabetes.51.1.174; Liao RL, 2002, CIRCULATION, V106, P2125, DOI 10.1161/01.CIR.0000034049.61181.F3; Lowry OH, 1993, FLEXIBLE SYSTEM ENZY; Lu ZB, 2010, CIRCULATION, V121, P1474, DOI 10.1161/CIRCULATIONAHA.109.906818; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Nascimben L, 2004, HYPERTENSION, V44, P662, DOI 10.1161/01.HYP.0000144292.69599.0c; NEUBAUER S, 1992, CIRCULATION, V86, P1810, DOI 10.1161/01.CIR.86.6.1810; Neubauer S, 1997, CIRCULATION, V96, P2190; NEWSHOLM EA, 1964, BIOCHEM J, V93, P641, DOI 10.1042/bj0930641; Ritchie RH, 2007, J MOL CELL CARDIOL, V42, P1119, DOI 10.1016/j.yjmcc.2007.03.900; SCHWARTZ K, 1992, AM J PHYSIOL, V262, pR364, DOI 10.1152/ajpregu.1992.262.3.R364; Takimoto E, 2007, HYPERTENSION, V49, P241, DOI 10.1161/01.HYP.0000254415.31362.a7; Tanaki K, 2001, J AM COLL CARDIOL, V37, P676, DOI 10.1016/S0735-1097(00)01123-2; Taylor M, 2001, J NUCL MED, V42, P55; Ussher JR, 2012, CIRC RES, V111, P628, DOI 10.1161/CIRCRESAHA.111.246371; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang JX, 2006, CIRCULATION, V113, P544, DOI 10.1161/CIRCULATIONAHA.105.537894; Wang QW, 2008, AM J PHYSIOL-HEART C, V294, pH2889, DOI 10.1152/ajpheart.91501.2007; Watson LJ, 2010, P NATL ACAD SCI USA, V107, P17797, DOI 10.1073/pnas.1001907107; Wu CD, 2002, DIABETES, V51, pA319; Yamagishi SI, 2001, J BIOL CHEM, V276, P25096, DOI 10.1074/jbc.M007383200; ZEREZ CR, 1987, ANAL BIOCHEM, V164, P367, DOI 10.1016/0003-2697(87)90506-9; Zhang P, 2008, HYPERTENSION, V52, P918, DOI 10.1161/HYPERTENSIONAHA.108.114702	39	15	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53951	10.1371/journal.pone.0053951	http://dx.doi.org/10.1371/journal.pone.0053951			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308291	gold, Green Submitted, Green Published			2022-12-25	WOS:000313429100123
J	Xu, ZY; Jiang, JF; Xu, C; Wang, Y; Sun, L; Guo, XC; Liu, HQ				Xu, Zhenyu; Jiang, Junfeng; Xu, Chen; Wang, Yue; Sun, Lei; Guo, Xiaocan; Liu, Houqi			MicroRNA-181 Regulates CARM1 and Histone Aginine Methylation to Promote Differentiation of Human Embryonic Stem Cells	PLOS ONE			English	Article							POLYCOMB GROUP PROTEINS; EARLY MOUSE EMBRYO; SELF-RENEWAL; CHROMATIN-STRUCTURE; ENDOTHELIAL-CELLS; RNA INTERFERENCE; PLURIPOTENCY; EXPRESSION; MIR-181; IDENTIFICATION	As a novel epigenetic mechanism, histone H3 methylation at R17 and R26, which is mainly catalyzed by coactivator-associated protein arginine methyltransferase 1 (CARM1), has been reported to modulate the transcription of key pluripotency factors and to regulate pluripotency in mouse embryos and mouse embryonic stem cells (mESCs) in previous studies. However, the role of CARM1 in human embryonic stem cells (hESCs) and the regulatory mechanism that controls CARM1 expression during ESCs differentiation are presently unknown. Here, we demonstrate that CARM1 plays an active role in the resistance to differentiation in hESCs by regulating pluripotency genes in response to BMP4. In a functional screen, we identified the miR-181 family as a regulator of CARM1 that is induced during ESC differentiation and show that endogenous miR-181c represses the expression of CARM1. Depletion of CARM1 or enforced expression of miR-181c inhibits the expression of pluripotency genes and induces differentiation independent of BMP4, whereas overexpression of CARM1 or miR-181c inhibitor elevates Nanog and impedes differentiation. Furthermore, expression of CARM1 rescue constructs inhibits the effect of miR-181c overexpression in promoting differentiation. Taken together, our findings demonstrate the importance of a miR-181c-CARM1 pathway in regulating the differentiation of hESCs.	[Xu, Zhenyu; Jiang, Junfeng; Xu, Chen; Wang, Yue; Sun, Lei; Guo, Xiaocan; Liu, Houqi] Second Mil Med Univ, Res Ctr Dev Biol, Shanghai, Peoples R China	Naval Medical University	Wang, Y (corresponding author), Second Mil Med Univ, Res Ctr Dev Biol, Shanghai, Peoples R China.	wangyuesmmu@gmail.com; houqiliu@126.com	Xu, Chen/AAQ-5514-2020; Wang, Yue/AIC-2138-2022; Zhenyu, Xu/AAW-7042-2020	Xu, Chen/0000-0001-8068-2109; Jiang, Junfeng/0000-0003-2696-2032	National Key Basic Research and Development Project (Beijing, China) [2011CB965101]	National Key Basic Research and Development Project (Beijing, China)	This study was supported by the National Key Basic Research and Development Project (Beijing, China) (No. 2011CB965101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Barroso-delJesus A, 2011, FASEB J, V25, P1497, DOI 10.1096/fj.10-172221; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Calvanese V, 2010, P NATL ACAD SCI USA, V107, P13736, DOI 10.1073/pnas.1001399107; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Gan Q, 2007, STEM CELLS, V25, P2, DOI 10.1634/stemcells.2006-0383; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Han MK, 2008, CELL STEM CELL, V2, P241, DOI 10.1016/j.stem.2008.01.002; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hong SH, 2011, CELL STEM CELL, V9, P24, DOI 10.1016/j.stem.2011.06.002; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jain AK, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001268; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kane NM, 2012, STEM CELLS, V30, P643, DOI 10.1002/stem.1026; Kazenwadel J, 2010, BLOOD, V116, P2395, DOI 10.1182/blood-2009-12-256297; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045633; Li HH, 2009, BEHAV BRAIN RES, V205, P32, DOI 10.1016/j.bbr.2009.06.036; Li X, 2012, CELL DEATH DIFFER, V19, P378, DOI 10.1038/cdd.2011.127; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Meng XM, 2012, MOL THER, V20, P408, DOI 10.1038/mt.2011.258; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Naeem H, 2007, MOL CELL BIOL, V27, P120, DOI 10.1128/MCB.00815-06; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Niu ZY, 2011, P NATL ACAD SCI USA, V108, P12740, DOI 10.1073/pnas.1109987108; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; O'Loghlen A, 2012, CELL STEM CELL, V10, P33, DOI 10.1016/j.stem.2011.12.004; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Rugg-Gunn PJ, 2010, P NATL ACAD SCI USA, V107, P10783, DOI 10.1073/pnas.0914507107; Selvi BR, 2010, J BIOL CHEM, V285, P7143, DOI 10.1074/jbc.M109.063933; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Wang YL, 2009, J CELL PHYSIOL, V218, P251, DOI 10.1002/jcp.21607; Whitcomb SJ, 2007, TRENDS GENET, V23, P494, DOI 10.1016/j.tig.2007.08.006; Wu Q, 2009, STEM CELLS, V27, P2637, DOI 10.1002/stem.131; Wu Z, 2011, J GENET GENOMICS, V38, P13, DOI 10.1016/j.jcg.2010.12.006; Wu ZT, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.373092; Yamaguchi S, 2011, ATHEROSCLEROSIS, V219, P468, DOI 10.1016/j.atherosclerosis.2011.09.004; Zaehres H, 2005, STEM CELLS, V23, P299, DOI 10.1634/stemcells.2004-0252	50	29	32	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53146	10.1371/journal.pone.0053146	http://dx.doi.org/10.1371/journal.pone.0053146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301034	Green Submitted, gold, Green Published			2022-12-25	WOS:000313480000033
J	Teng, Y; Mei, Y; Hawthorn, L; Cowell, JK				Teng, Y.; Mei, Y.; Hawthorn, L.; Cowell, J. K.			WASF3 regulates miR-200 inactivation by ZEB1 through suppression of KISS1 leading to increased invasiveness in breast cancer cells	ONCOGENE			English	Article						breast cancer; metastasis; invasion; KISS1; WASF3; ZEB1	EPITHELIAL-MESENCHYMAL TRANSITION; WAVE FAMILY PROTEINS; E-CADHERIN; LAMELLIPODIA FORMATION; FEEDBACK LOOP; METASTASIS; EXPRESSION; INVASION; GENE; MIGRATION	The WASF3 gene promotes invasion and metastasis in breast cancer cells, which have undergone epithelial-to-mesenchyme transition (EMT). Overexpression of WASF3 in cells that do not show EMT increases their invasion potential as a result of increased ZEB1/2 levels, which specifically suppress the anti-invasion chromosome 1 miR-200a/200b/429 cluster. ZEB1/2 upregulation by WASF3 results from downregulation of KISS1, leading to the release of inhibition of nuclear factor (NF) kB by IkBa. We further show that ZEB1 expression is regulated by the NFkB transcription factor. Knockdown of WASF3 in breast cancer cells leads to reduced ZEB1 levels and increased miR-200 and E-cadherin levels, resulting in loss of invasion potential. The central regulation of this interactive pathway by WASF3 accounts for the increased invasion associated with increased WASF3 expression seen in aggressive breast cancer cells. WASF3, therefore, is a potential target to suppress invasion and metastasis in breast cancer cells.	[Teng, Y.; Mei, Y.; Hawthorn, L.; Cowell, J. K.] Georgia Hlth Sci Univ, Ctr Canc, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Teng, Y (corresponding author), Georgia Hlth Sci Univ, Ctr Canc, CN 2133,1120 15th St, Augusta, GA 30912 USA.	yteng@georgiahealth.edu; jcowell@georgiahealth.edu	Teng, Yong/AAK-4160-2020	Teng, Yong/0000-0002-1856-7289; Hawthorn, Lesleyann/0000-0001-8179-0937	Georgia Cancer Coalition; NIH; National Institutes of Health [CA120510]; NATIONAL CANCER INSTITUTE [R01CA120510] Funding Source: NIH RePORTER	Georgia Cancer Coalition; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Dr Leslie Ann Lesoon for the technical assistance and helpful comments during the writing of this manuscript. We also thank the staff of Cancer Center Shared Resources at GHSU for assistance during microarray data collection. Dr Cowell is supported by the Georgia Cancer Coalition as a distinguished cancer scholar and funded by the NIH. This study was supported, in part, by the National Institutes of Health Grant CA120510.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Ahmad A, 2011, CANCER RES, V71, P3400, DOI 10.1158/0008-5472.CAN-10-0965; Almeida MI, 2010, CELL RES, V20, P603, DOI 10.1038/cr.2010.70; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Brabletz S, 2011, EMBO J, V30, P770, DOI 10.1038/emboj.2010.349; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cabanillas AM, 1996, DNA CELL BIOL, V15, P643, DOI 10.1089/dna.1996.15.643; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Chuang TC, 2011, CANCER LETT, V311, P11, DOI 10.1016/j.canlet.2011.06.007; Edwards LA, 2011, JNCI-J NATL CANCER I, V103, P1162, DOI 10.1093/jnci/djr224; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Ghoshal P, 2012, INT J CANCER, V131, pE905, DOI 10.1002/ijc.27631; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hurst DR, 2009, CANCER RES, V69, P7495, DOI 10.1158/0008-5472.CAN-09-2111; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Jechlinger M, 2006, J CLIN INVEST, V116, P1561, DOI 10.1172/JCI24652; Johnson E, 2010, J BIOL CHEM, V285, P29491, DOI 10.1074/jbc.M110.136770; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kurisu S, 2010, CANCER SCI, V101, P2093, DOI 10.1111/j.1349-7006.2010.01654.x; Levy C, 2010, MOL CELL, V40, P841, DOI 10.1016/j.molcel.2010.11.020; Ma L, 2008, CELL CYCLE, V7, P570, DOI 10.4161/cc.7.5.5547; Mazda M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028688; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Png KJ, 2012, NATURE, V481, P190, DOI 10.1038/nature10661; Pollock CB, 2005, CANCER RES, V65, P1244, DOI 10.1158/0008-5472.CAN-04-1911; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Schliekelman MJ, 2011, CANCER RES, V71, P7670, DOI 10.1158/0008-5472.CAN-11-0964; Sossey-Alaoui K, 2005, EXP CELL RES, V308, P135, DOI 10.1016/j.yexcr.2005.04.011; Sossey-Alaoui K, 2005, J BIOL CHEM, V280, P21748, DOI 10.1074/jbc.M500503200; Sossey-Alaoui K, 2002, ONCOGENE, V21, P5967, DOI 10.1038/sj.onc.1205734; Sossey-Alaoui K, 2007, J BIOL CHEM, V282, P26257, DOI 10.1074/jbc.M701484200; Sossey-Alaoui K, 2007, AM J PATHOL, V170, P2112, DOI 10.2353/ajpath.2007.060975; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Steeg Patricia S, 2003, Clin Breast Cancer, V4, P51, DOI 10.3816/CBC.2003.n.012; Takenawa T, 2001, J CELL SCI, V114, P1801; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Teng Y, 2010, BRIT J CANCER, V103, P1066, DOI 10.1038/sj.bjc.6605850; Teng Y, 2012, J BIOL CHEM, V287, P10051, DOI 10.1074/jbc.M111.335000; Teng Y, 2011, INT J CANCER, V129, P2825, DOI 10.1002/ijc.25964; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007	45	62	63	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 9	2014	33	2					203	211		10.1038/onc.2012.565	http://dx.doi.org/10.1038/onc.2012.565			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	286BY	23318438	Green Accepted			2022-12-25	WOS:000329440700008
J	Tsai, HY; Yang, YF; Wu, AT; Yang, CJ; Liu, YP; Jan, YH; Lee, CH; Hsiao, YW; Yeh, CT; Shen, CN; Lu, PJ; Huang, MS; Hsiao, M				Tsai, H-Y; Yang, Y-F; Wu, A. T.; Yang, C-J; Liu, Y-P; Jan, Y-H; Lee, C-H; Hsiao, Y-W; Yeh, C-T; Shen, C-N; Lu, P-J; Huang, M-S; Hsiao, M.			Endoplasmic reticulum ribosome-binding protein 1 (RRBP1) overexpression is frequently found in lung cancer patients and alleviates intracellular stress-induced apoptosis through the enhancement of GRP78	ONCOGENE			English	Article						RRBP1; GRP78; UPR; apoptosis; lung cancer	GLUCOSE-REGULATED PROTEINS; CHAPERONE GRP78/BIP; DRUG-RESISTANCE; ER; INDUCTION; RECEPTOR; IDENTIFICATION; PROLIFERATION; EXPRESSION; CHEMOTHERAPY	Lung cancer is the leading cause of cancer deaths and is the most occurring malignancy worldwide. Unraveling the molecular mechanisms involved in lung tumorigenesis will greatly improve therapy. During early tumorigenesis, rapid proliferating tumor cells require increased activity of endoplasmic reticulum (ER) for protein synthesis, folding and secretion, thereby are subjected to ER stress. Ribosome-binding protein 1 (RRBP1) was originally identified as a ribosome-binding protein located on the rough ER and associated with unfolding protein response (UPR). In this report, we investigated the role of RRBP1 in lung cancer. RRBP1 was highly expressed in lung cancer tissue, as compared with adjacent normal tissues as assessed by immunohistochemistry (IHC) using lung cancer tissue array (n=87). Knockdown of RRBP1 by short-hairpin RNAs caused ER stress and significantly reduced cell viability and tumorigenicity. This effect was associated with a significant reduction in the expression of glucose-regulated protein 78 (GRP78). UPR regulator GRP78, an anti-apoptotic protein that is widely upregulated in cancer, has a critical role in chemotherapy resistance in some cancers. According to our results, cells with a higher level of RRBP1 were more resistant to ER stress. Ectopic expression of RRBP1 alleviated apoptosis that was induced by the ER-stress agent tunicamycin, 2-deoxy-D-glucose (2DG) or doxorubicin via enhancing GRP78 protein expression. A strong correlation was observed between the expression of RRBP1 and GRP78 in tumor biopsies using the database GSE10072. Our results also indicated that RRBP1 may involve in the regulation of mRNA stability of UPR components including ATF6 and GRP78. Taken together, RRBP1 could alleviate ER stress and help cancer cell survive. RRBP1 is critical for tumor cell survival, which may make it a useful target in lung cancer treatment and a candidate for the development of new targeted therapeutics.	[Tsai, H-Y; Yang, Y-F] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Tsai, H-Y; Yang, Y-F; Jan, Y-H; Hsiao, Y-W; Shen, C-N; Hsiao, M.] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Wu, A. T.] Taipei Med Univ, Coll Sci & Technol, PhD Program Translat Med, Taipei, Taiwan; [Yang, C-J; Huang, M-S] Kaohsiung Med Univ, Sch Med, Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Liu, Y-P; Lu, P-J] Natl Cheng Kung Univ, Inst Clin Med, Tainan 70101, Taiwan; [Wu, A. T.] Taipei Med Univ Hosp, Ctr Canc, Translat Res Lab, Taipei, Taiwan; [Lee, C-H] Taipei Tzu Chi Gen Hosp, Dept Pharm, Taipei, Taiwan; [Yeh, C-T; Shen, C-N] Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan; [Yeh, C-T] Taipei Med Univ, Shuang Ho Hosp, Ctr Canc, Taipei, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Taipei Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Cheng Kung University; Taipei Medical University; Taipei Medical University Hospital; Buddhist Tzu Chi General Hospital; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital	Hsiao, M (corresponding author), Acad Sinica, Genom Res Ctr, 128 Acad Rd,Sect 2, Taipei 115, Taiwan.	mhsiao@gate.sinica.edu.tw	Hsiao, Michael/U-6238-2019; SHEN, CHIA-NING/C-6878-2011	Hsiao, Michael/0000-0001-8529-9213; SHEN, CHIA-NING/0000-0002-0747-217X; Jan, Yi-Hua/0000-0001-7344-7602	National Science Council; Academia Sinica	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	We thank Miss Tracy Tsai for assisting in the pathological staining analysis. RRBP1 plasmids were kindly provided by Dr Kiyoko, Japan Institute of Leather Research. The study was supported by grants from the National Science Council and Academia Sinica.	Arcamone F, 1997, PHARMACOL THERAPEUT, V76, P117, DOI 10.1016/S0163-7258(97)00096-X; Bai JZ, 2008, CELL BIOL INT, V32, P473, DOI 10.1016/j.cellbi.2007.10.002; Becker F, 1999, J CELL BIOL, V146, P273, DOI 10.1083/jcb.146.2.273; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Chang J, 2008, J PROTEOMICS, V71, P530, DOI 10.1016/j.jprot.2008.08.003; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; Cui XA, 2012, PLOS BIOL, V10, P1; Dong DZ, 2008, CANCER RES, V68, P498, DOI 10.1158/0008-5472.CAN-07-2950; FIDLER IJ, 1990, CANCER RES, V50, P6130; Fu Y, 2006, CANCER BIOL THER, V5, P741, DOI 10.4161/cbt.5.7.2970; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; Hoffman RM, 2006, NAT PROTOC, V1, P928, DOI 10.1038/nprot.2006.119; Hyde M, 2002, J CELL BIOL, V156, P993, DOI 10.1083/jcb.200112008; Jamora C, 1996, P NATL ACAD SCI USA, V93, P7690, DOI 10.1073/pnas.93.15.7690; Kim YJ, 2000, GENE, V261, P337, DOI 10.1016/S0378-1119(00)00496-0; Kong Q, 1998, MED HYPOTHESES, V51, P405, DOI 10.1016/S0306-9877(98)90036-6; Krasnov GS, 2009, MOL BIOL+, V43, P321, DOI 10.1134/S0026893309020149; Kurtoglu M, 2007, MOL CANCER THER, V6, P3049, DOI 10.1158/1535-7163.MCT-07-0310; Langley R, 1998, DNA CELL BIOL, V17, P449, DOI 10.1089/dna.1998.17.449; LEE A S, 1992, Current Opinion in Cell Biology, V4, P267, DOI 10.1016/0955-0674(92)90042-B; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; Ogawa-Goto K, 2002, J VIROL, V76, P2350, DOI 10.1128/JVI.76.5.2350-2362.2002; Onn A, 2003, CLIN CANCER RES, V9, P5532; Pyrko P, 2007, CANCER RES, V67, P9809, DOI 10.1158/0008-5472.CAN-07-0625; Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; Sasaya H, 2008, J BIOCHEM, V144, P251, DOI 10.1093/jb/mvn063; SAVITZ AJ, 1990, NATURE, V346, P540, DOI 10.1038/346540a0; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Shepherd FA, 2000, J CLIN ONCOL, V18, p35S; Sobin LH, 1997, CANCER, V80, P1803, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9; Spear E, 2001, TRAFFIC, V2, P515, DOI 10.1034/j.1600-0854.2001.20801.x; Strauss GM, 2005, HEMATOL ONCOL CLIN N, V19, P263, DOI 10.1016/j.hoc.2005.02.008; Travis WD, 2002, CLIN CHEST MED, V23, P65, DOI 10.1016/S0272-5231(03)00061-3; Uramoto H, 2005, LUNG CANCER, V49, P55, DOI 10.1016/j.lungcan.2004.12.011; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Virrey JJ, 2008, MOL CANCER RES, V6, P1268, DOI 10.1158/1541-7786.MCR-08-0060; Wang Q, 2005, CANCER DETECT PREV, V29, P544, DOI 10.1016/j.cdp.2005.09.010; WANKER EE, 1995, J CELL BIOL, V130, P29, DOI 10.1083/jcb.130.1.29; Yang M, 1998, CANCER RES, V58, P4217; Yeung BHY, 2008, ONCOGENE, V27, P6782, DOI 10.1038/onc.2008.290	50	62	62	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 10	2013	32	41					4921	4931		10.1038/onc.2012.514	http://dx.doi.org/10.1038/onc.2012.514			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	235KQ	23318453				2022-12-25	WOS:000325717800008
J	Dettmer, U; Newman, AJ; Luth, ES; Bartels, T; Selkoe, D				Dettmer, Ulf; Newman, Andrew J.; Luth, Eric S.; Bartels, Tim; Selkoe, Dennis			In Vivo Cross-linking Reveals Principally Oligomeric Forms of alpha-Synuclein and beta-Synuclein in Neurons and Non-neural Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONSET PARKINSONS-DISEASE; CRYSTAL-STRUCTURE; MOUSE-BRAIN; PROTEIN; DJ-1; AGGREGATION; ASSOCIATION; INHIBITION; PROMOTES; MUTATION	Aggregation of alpha-synuclein (alpha Syn) in neurons produces the hallmark cytopathology of Parkinson disease and related synucleinopathies. Since its discovery, alpha Syn has been thought to exist normally in cells as an unfolded monomer. We recently reported that alpha Syn can instead exist in cells as a helically folded tetramer that resists aggregation and binds lipid vesicles more avidly than unfolded recombinant monomers (Bartels, T., Choi, J. G., and Selkoe, D. J. (2011) Nature 477, 107-110). However, a subsequent study again concluded that cellular alpha Syn is an unfolded monomer (Fauvet, B., Mbefo, M. K., Fares, M. B., Desobry, C., Michael, S., Ardah, M. T., Tsika, E., Coune, P., Prudent, M., Lion, N., Eliezer, D., Moore, D. J., Schneider, B., Aebischer, P., El-Agnaf, O. M., Masliah, E., and Lashuel, H. A. (2012) J. Biol. Chem. 287, 15345-15364). Here we describe a simple in vivo cross-linking method that reveals a major similar to 60-kDa form of endogenous alpha Syn (monomer, 14.5 kDa) in intact cells and smaller amounts of similar to 80- and similar to 100-kDa forms with the same isoelectric point as the 60-kDa species. Controls indicate that the apparent 60-kDa tetramer exists normally and does not arise from pathological aggregation. The pattern of a major 60-kDa and minor 80- and 100-kDa species plus variable amounts of free monomers occurs endogenously in primary neurons and erythroid cells as well as neuroblastoma cells overexpressing alpha Syn. A similar pattern occurs for the homologue, beta-synuclein, which does not undergo pathogenic aggregation. Cell lysis destabilizes the apparent 60-kDa tetramer, leaving mostly free monomers and some 80-kDa oligomer. However, lysis at high protein concentrations allows partial recovery of the 60-kDa tetramer. Together with our prior findings, these data suggest that endogenous alpha Syn exists principally as a 60-kDa tetramer in living cells but is lysis-sensitive, making the study of natural alpha Syn challenging outside of intact cells.	Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Selkoe, D (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, Harvard Inst Med, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	dselkoe@rics.bwh.harvard.edu	Bartels, Tim/AAD-6128-2021	Bartels, Tim/0000-0002-4071-5612; Dettmer, Ulf/0000-0001-6676-0107	Fidelity Biosciences Research Initiative; NATIONAL INSTITUTE ON AGING [T32AG000222] Funding Source: NIH RePORTER	Fidelity Biosciences Research Initiative; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a research grant from the Fidelity Biosciences Research Initiative.	Barbour R, 2008, NEURODEGENER DIS, V5, P55, DOI 10.1159/000112832; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Baulac S, 2004, MOL CELL NEUROSCI, V27, P236, DOI 10.1016/j.mcn.2004.06.014; BENAROUDJ N, 1995, BIOCHEMISTRY-US, V34, P15282, DOI 10.1021/bi00046a037; BUEHNER M, 1973, P NATL ACAD SCI USA, V70, P3052, DOI 10.1073/pnas.70.11.3052; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chang CR, 2010, J BIOL CHEM, V285, P32494, DOI 10.1074/jbc.M110.142430; Dolder M, 1999, J STRUCT BIOL, V127, P64, DOI 10.1006/jsbi.1999.4141; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; Irizarry MC, 1996, J NEUROPATH EXP NEUR, V55, P889, DOI 10.1097/00005072-199608000-00004; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223; Klucken J, 2006, FASEB J, V20, P2050, DOI 10.1096/fj.05-5422com; Lee BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023939; LINDEN M, 1983, BIOCHIM BIOPHYS ACTA, V736, P125, DOI 10.1016/0005-2736(83)90177-3; MARTIN P, 1982, SCIENCE, V216, P1233, DOI 10.1126/science.6177045; Moore DJ, 2005, HUM MOL GENET, V14, P71, DOI 10.1093/hmg/ddi007; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Payton JE, 2001, MOL BRAIN RES, V95, P138, DOI 10.1016/S0169-328X(01)00257-1; Perrin RJ, 2003, NEUROSCI LETT, V349, P133, DOI 10.1016/S0304-3940(03)00781-X; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Scherzer CR, 2008, P NATL ACAD SCI USA, V105, P10907, DOI 10.1073/pnas.0802437105; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tao X, 2003, J BIOL CHEM, V278, P31372, DOI 10.1074/jbc.M304221200; Trexler AJ, 2012, PROTEIN SCI, V21, P601, DOI 10.1002/pro.2056; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; Wang WJ, 2011, APPL CATAL B-ENVIRON, V108, P108, DOI 10.1016/j.apcatb.2011.08.015; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Westphal CH, 2013, J BIOL CHEM, V288, P1829, DOI 10.1074/jbc.M112.418871; Wilson MA, 2003, P NATL ACAD SCI USA, V100, P9256, DOI 10.1073/pnas.1133288100; Zhou Y, 2004, J BIOL CHEM, V279, P39155, DOI 10.1074/jbc.M405456200	36	167	168	1	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6371	6385		10.1074/jbc.M112.403311	http://dx.doi.org/10.1074/jbc.M112.403311			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23319586	Green Published, hybrid			2022-12-25	WOS:000315820700032
J	Liang, Z; Zhang, YL; Agrahari, G; Chandrahas, V; Glinton, K; Donahue, DL; Balsara, RD; Ploplis, VA; Castellino, FJ				Liang, Zhong; Zhang, Yueling; Agrahari, Garima; Chandrahas, Vishwanatha; Glinton, Kristofor; Donahue, Deborah L.; Balsara, Rashna D.; Ploplis, Victoria A.; Castellino, Francis J.			A Natural Inactivating Mutation in the CovS Component of the CovRS Regulatory Operon in a Pattern D Streptococcal pyogenes Strain Influences Virulence-associated Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCI; HYALURONIC-ACID CAPSULE; AFFINITY PLASMINOGEN-BINDING; M-LIKE PROTEIN; SURFACE PROTEIN; STREPTOKINASE EXPRESSION; 2-COMPONENT SYSTEM; RESPONSE REGULATOR; POSITIVE REGULATOR; VIR REGULON	A skin-tropic invasive group A Streptococcus pyogenes (GAS) strain, AP53, contains a natural inactivating mutation in the covS gene (covS(M)) of the two-component responder (CovR)/sensor (CovS) gene regulatory system. The effects of this mutation on specific GAS virulence determinants have been assessed, with emphasis on expression of the extracellular protease, streptococcal pyrogenic exotoxin B (SpeB), capsular hyaluronic acid, and proteins that allow host plasmin assembly on the bacterial surface, viz. a high affinity plasminogen (Pg)/plasmin receptor, Pg-binding group A streptococcal M protein (PAM), and the human Pg activator streptokinase. To further illuminate mechanisms of the functioning of CovRS in the virulence of AP53, two AP53 isogenic strains were generated, one in which the natural covS(M) gene was mutated to WT-covS (AP53/covS(WT)) and a strain that contained an inactivated covR gene (AP53/Delta covR). Two additional strains that do not contain PAM, viz. WT-NS931 and NS931/covS(M), were also employed. SpeB was not measurably expressed in strains containing covR(WT)/covS(M), whereas in strains with natural or engineered covR(WT)/covS(WT), SpeB expression was highly up-regulated. Alternatively, capsule synthesis via the hasABC operon was enhanced in strain AP53/covS(M), whereas streptokinase expression was only slightly affected by the covS inactivation. PAM expression was not substantially influenced by the covS mutation, suggesting that covRS had minimal effects on the mga regulon that controls PAM expression. These results demonstrate that a covS inactivation results in virulence gene alterations and also suggest that the CovR phosphorylation needed for gene up-or down-regulation can occur by alternative pathways to CovS kinase.	[Castellino, Francis J.] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame	Castellino, FJ (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA.	fcastell@nd.edu	Chandrahas, Vishwanatha K./I-8256-2019	Chandrahas, Vishwanatha K./0000-0001-8227-5021; Glinton, Kristofor/0000-0001-9301-7132; Zhang, Yueling/0000-0002-5619-8410	National Institutes of Health [HL013423]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL013423, R37HL013423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL013423 (to F. J. C.).	Alves R, 2003, MOL MICROBIOL, V48, P25, DOI 10.1046/j.1365-2958.2003.03344.x; BENNASR A, 1994, EUR J BIOCHEM, V222, P267, DOI 10.1111/j.1432-1033.1994.tb18865.x; BERGE A, 1993, J BIOL CHEM, V268, P25417; Bernish B, 1999, J BIOL CHEM, V274, P4786, DOI 10.1074/jbc.274.8.4786; Bessen DE, 1996, J INFECT DIS, V173, P896, DOI 10.1093/infdis/173.4.896; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Churchward G, 2007, MOL MICROBIOL, V64, P34, DOI 10.1111/j.1365-2958.2007.05649.x; Churchward G, 2009, MICROBIOL-SGM, V155, P566, DOI 10.1099/mic.0.024620-0; CLEARY PP, 1992, LANCET, V339, P518, DOI 10.1016/0140-6736(92)90339-5; Cnudde SE, 2006, BIOCHEMISTRY-US, V45, P11052, DOI 10.1021/bi060914j; Cole JN, 2006, FASEB J, V20, P1745, DOI 10.1096/fj.06-5804fje; Cole JN, 2010, MBIO, V1, DOI 10.1128/mBio.00191-10; Dalton TL, 2004, J BACTERIOL, V186, P3928, DOI 10.1128/JB.186.12.3928-3937.2004; Engleberg NC, 2001, J INFECT DIS, V183, P1043, DOI 10.1086/319291; Enright MC, 2001, INFECT IMMUN, V69, P2416, DOI 10.1128/IAI.69.4.2416-2427.2001; Federle MJ, 1999, J BACTERIOL, V181, P3649, DOI 10.1128/JB.181.12.3649-3657.1999; Federle MJ, 2002, MOL MICROBIOL, V43, P1161, DOI 10.1046/j.1365-2958.2002.02810.x; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Fu QH, 2008, J BIOL CHEM, V283, P1580, DOI 10.1074/jbc.M705063200; GARDINER D, 1995, PCR METH APPL, V4, P288; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Gryllos I, 2003, P NATL ACAD SCI USA, V100, P4227, DOI 10.1073/pnas.0636231100; HAANES EJ, 1992, J BACTERIOL, V174, P4967, DOI 10.1128/JB.174.15.4967-4976.1992; HAUSER AR, 1991, J CLIN MICROBIOL, V29, P1562, DOI 10.1128/JCM.29.8.1562-1567.1991; Heath A, 1999, INFECT IMMUN, V67, P5298, DOI 10.1128/IAI.67.10.5298-5305.1999; Hondorp ER, 2007, MOL MICROBIOL, V66, P1056, DOI 10.1111/j.1365-2958.2007.06006.x; Hytonen J, 2001, MOL MICROBIOL, V39, P512, DOI 10.1046/j.1365-2958.2001.02269.x; Kalia A, 2004, J BACTERIOL, V186, P110, DOI 10.1128/JB.186.1.110-121.2004; Kondo H, 1997, NAT STRUCT BIOL, V4, P28, DOI 10.1038/nsb0197-28; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Levin JC, 1998, MOL MICROBIOL, V30, P209, DOI 10.1046/j.1365-2958.1998.01057.x; Liang Z, 2008, TRANSGENIC RES, V17, P979, DOI 10.1007/s11248-008-9190-7; MCIVER KS, 1995, J BACTERIOL, V177, P6619, DOI 10.1128/jb.177.22.6619-6624.1995; McKay FC, 2004, INFECT IMMUN, V72, P364, DOI 10.1128/IAI.72.1.364-370.2004; Nilsen SL, 1999, PROTEIN EXPRES PURIF, V16, P136, DOI 10.1006/prep.1999.1045; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; PEREZCASAL J, 1991, J BACTERIOL, V173, P2617, DOI 10.1128/jb.173.8.2617-2624.1991; PODBIELSKI A, 1993, MOL GEN GENET, V237, P287, DOI 10.1007/BF00282810; PODBIELSKI A, 1995, INFECT IMMUN, V63, P9, DOI 10.1128/IAI.63.1.9-20.1995; Rezcallah MS, 2004, MICROBIOL-SGM, V150, P365, DOI 10.1099/mic.0.26826-0; Ribardo DA, 2006, MOL MICROBIOL, V62, P491, DOI 10.1111/j.1365-2958.2006.05381.x; Ringdahl U, 1998, J BIOL CHEM, V273, P6424, DOI 10.1074/jbc.273.11.6424; Roberts SA, 2007, MOL MICROBIOL, V66, P1506, DOI 10.1111/j.1365-2958.2007.06015.x; Roberts SA, 2007, J BACTERIOL, V189, P1459, DOI 10.1128/JB.01026-06; Sanderson-Smith ML, 2008, FASEB J, V22, P2715, DOI 10.1096/fj.07-105643; Sanderson-Smith ML, 2006, J BIOL CHEM, V281, P25965, DOI 10.1074/jbc.M603846200; Schenone MM, 2000, J PEPT RES, V56, P438, DOI 10.1034/j.1399-3011.2000.00810.x; SCHMIDT KH, 1990, ZBL BAKT-INT J MED M, V273, P216; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schrager HM, 1996, J CLIN INVEST, V98, P1954, DOI 10.1172/JCI118998; SIMPSON WJ, 1990, J BACTERIOL, V172, P696, DOI 10.1128/jb.172.2.696-700.1990; Smeesters PR, 2010, TRENDS MICROBIOL, V18, P275, DOI 10.1016/j.tim.2010.02.007; STENBERG L, 1992, MOL MICROBIOL, V6, P1185, DOI 10.1111/j.1365-2958.1992.tb01557.x; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Svensson MD, 1999, INFECT IMMUN, V67, P3915, DOI 10.1128/IAI.67.8.3915-3920.1999; Trevino J, 2009, INFECT IMMUN, V77, P3141, DOI 10.1128/IAI.01560-08; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Winram SB, 1996, MICROBIOL-SGM, V142, P2311, DOI 10.1099/13500872-142-8-2311; Wistedt AC, 1998, J BIOL CHEM, V273, P24420, DOI 10.1074/jbc.273.38.24420; Zhang YL, 2012, J BIOL CHEM, V287, P42093, DOI 10.1074/jbc.M112.417808; Zimmerlein B, 2005, INFECT IMMUN, V73, P859, DOI 10.1128/IAI.73.2.859-864.2005	63	25	26	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6561	6573		10.1074/jbc.M112.442657	http://dx.doi.org/10.1074/jbc.M112.442657			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23316057	Green Published, hybrid			2022-12-25	WOS:000315820700049
J	Ahn, EEY; Higashi, T; Yan, M; Matsuura, S; Hickey, CJ; Lo, MC; Shia, WJ; DeKelver, RC; Zhang, DE				Ahn, Erin Eun-Young; Higashi, Tsunehito; Yan, Ming; Matsuura, Shinobu; Hickey, Christopher J.; Lo, Miao-Chia; Shia, Wei-Jong; DeKelver, Russell C.; Zhang, Dong-Er			SON Protein Regulates GATA-2 through Transcriptional Control of the MicroRNA 23a similar to 27a similar to 24-2 Cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC STEM-CELLS; IN-VIVO; MESSENGER-RNAS; EXPRESSION; DIFFERENTIATION; BINDING; DISRUPTION; REPRESSION; GENES; NF-E2	SON is a DNA-and RNA-binding protein localized in nuclear speckles. Although its function in RNA splicing for effective cell cycle progression and genome stability was recently unveiled, other mechanisms of SON functions remain unexplored. Here, we report that SON regulates GATA-2, a key transcription factor involved in hematopoietic stem cell maintenance and differentiation. SON is highly expressed in undifferentiated hematopoietic stem/progenitor cells and leukemic blasts. SON knockdown leads to significant depletion of GATA-2 protein with marginal down-regulation of GATA-2 mRNA. We show that miR-27a is up-regulated upon SON knockdown and targets the 3'-UTR of GATA-2 mRNA in hematopoietic cells. Up-regulation of miR-27a was due to activation of the promoter of the miR-23a similar to 27a similar to 24-2 cluster, suggesting that SON suppresses this promoter to lower the microRNAs from this cluster. Our data revealed a previously unidentified role of SON in microRNA production via regulating the transcription process, thereby modulating GATA-2 at the protein level during hematopoietic differentiation.	[Ahn, Erin Eun-Young; Higashi, Tsunehito; Yan, Ming; Matsuura, Shinobu; Lo, Miao-Chia; Shia, Wei-Jong; DeKelver, Russell C.; Zhang, Dong-Er] Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA; [Ahn, Erin Eun-Young; Hickey, Christopher J.] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36604 USA; [Zhang, Dong-Er] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [DeKelver, Russell C.; Zhang, Dong-Er] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of South Alabama; University of California System; University of California San Diego; University of California System; University of California San Diego	Zhang, DE (corresponding author), Univ Calif San Diego, Moores UCSD Canc Ctr, Mail Drop 0815,Rm 5328,3855 Hlth Sci Dr, La Jolla, CA 92093 USA.	d7zhang@ucsd.edu		Ahn, Eun-Young Erin/0000-0001-8795-7734; Matsuura, Shinobu/0000-0002-3914-5376	National Institutes of Health [CA096735]; University of South Alabama Mitchell Cancer Institute Startup Fund; NATIONAL CANCER INSTITUTE [R01CA096735] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL091641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of South Alabama Mitchell Cancer Institute Startup Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant CA096735 (to D.-E. Z.) and by the University of South Alabama Mitchell Cancer Institute Startup Fund (to E. E.-Y. A.).	Ahn EY, 2008, P NATL ACAD SCI USA, V105, P17103, DOI 10.1073/pnas.0802696105; Ahn EY, 2011, MOL CELL, V42, P185, DOI 10.1016/j.molcel.2011.03.014; Ben-Ami O, 2009, P NATL ACAD SCI USA, V106, P238, DOI 10.1073/pnas.0811466106; BERDICHEVSKII FB, 1988, MOL BIOL+, V22, P639; Bresnick EH, 2012, NUCLEIC ACIDS RES, V40, P5819, DOI 10.1093/nar/gks281; Chhabra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-232; CHUMAKOV IM, 1991, MOL BIOL+, V25, P592; Eulalio A, 2009, RNA, V15, P21, DOI 10.1261/rna.1399509; Feng J, 2009, BRIT J HAEMATOL, V145, P412, DOI 10.1111/j.1365-2141.2009.07632.x; Fiedler J, 2011, CIRCULATION, V124, P720, DOI 10.1161/CIRCULATIONAHA.111.039008; Fleenor DE, 1996, GENE, V179, P219, DOI 10.1016/S0378-1119(96)00355-1; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Greenhalf W, 1999, YEAST, V15, P1307, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1307::AID-YEA455>3.3.CO;2-V; Jippo T, 1996, BLOOD, V87, P993, DOI 10.1182/blood.V87.3.993.bloodjournal873993; Kasashima K, 2004, BIOCHEM BIOPH RES CO, V322, P403, DOI 10.1016/j.bbrc.2004.07.130; Komori T, 2010, J BIOL CHEM, V285, P37884, DOI 10.1074/jbc.M110.148973; LABBAYE C, 1995, J CLIN INVEST, V95, P2346, DOI 10.1172/JCI117927; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; LEONARD MW, 1993, DEVELOPMENT, V119, P519; Ling KW, 2004, J EXP MED, V200, P871, DOI 10.1084/jem.20031556; MARTIN DIK, 1990, NATURE, V344, P444, DOI 10.1038/344444a0; Minegishi N, 1999, BLOOD, V93, P4196, DOI 10.1182/blood.V93.12.4196.412k23_4196_4207; Oren T, 2005, NUCLEIC ACIDS RES, V33, P4357, DOI 10.1093/nar/gki746; ORLIC D, 1995, P NATL ACAD SCI USA, V92, P4601, DOI 10.1073/pnas.92.10.4601; Pase L, 2009, BLOOD, V113, P1794, DOI 10.1182/blood-2008-05-155812; Rodrigues NP, 2005, BLOOD, V106, P477, DOI 10.1182/blood-2004-08-2989; Sharma A, 2011, J CELL SCI, V124, P4286, DOI 10.1242/jcs.092239; Snow JW, 2011, BLOOD, V117, P4769, DOI 10.1182/blood-2010-10-313031; SPOSI NM, 1992, P NATL ACAD SCI USA, V89, P6353, DOI 10.1073/pnas.89.14.6353; Sun CT, 2001, J BIOL CHEM, V276, P24059, DOI 10.1074/jbc.M101330200; Takahashi S, 1998, BLOOD, V92, P434, DOI 10.1182/blood.V92.2.434.414k24_434_442; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; Vicente C, 2012, CRIT REV ONCOL HEMAT, V82, P1, DOI 10.1016/j.critrevonc.2011.04.007	35	25	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5381	5388		10.1074/jbc.M112.447227	http://dx.doi.org/10.1074/jbc.M112.447227			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23322776	Green Published, hybrid			2022-12-25	WOS:000315342500013
J	Coutu, S; Rossi, L; Barry, DA; Rudaz, S; Vernaz, N				Coutu, Sylvain; Rossi, Luca; Barry, D. A.; Rudaz, Serge; Vernaz, Nathalie			Temporal Variability of Antibiotics Fluxes in Wastewater and Contribution from Hospitals	PLOS ONE			English	Article							ENVIRONMENTAL RISK-ASSESSMENT; HUMAN PHARMACEUTICALS; TREATMENT PLANTS; CONSUMPTION; FATE; EXPOSURE; CONTAMINANTS; EFFLUENTS; RESIDUES	Significant quantities of antibiotics are used in all parts of the globe to treat diseases with bacterial origins. After ingestion, antibiotics are excreted by the patient and transmitted in due course to the aquatic environment. This study examined temporal fluctuations (monthly time scale) in antibiotic sources (ambulatory sales and data from a hospital dispensary) for Lausanne, Switzerland. Source variability (i.e., antibiotic consumption, monthly data for 2006-2010) were examined in detail for nine antibiotics - azithromycin, ciprofloxacin, clarithromycin, clindamycin, metronidazole, norfloxacin, ofloxacin, sulfamethoxazole and trimethoprim, from which two main conclusions were reached. First, some substances - azithromycin, clarithromycin, ciprofloxacin - displayed high seasonality in their consumption, with the winter peak being up to three times higher than the summer minimum. This seasonality in consumption resulted in seasonality in Predicted Environmental Concentrations (PECs). In addition, the seasonality in PECs was also influenced by that in the base wastewater flow. Second, the contribution of hospitals to the total load of antibiotics reaching the Lausanne Wastewater Treatment Plant (WTP) fluctuated markedly on a monthly time scale, but with no seasonal pattern detected. That is, there was no connection between fluctuations in ambulatory and hospital consumption for the substances investigated.	[Coutu, Sylvain; Rossi, Luca; Barry, D. A.] Ecole Polytech Fed Lausanne, ENAC IIE ECOL, CH-1015 Lausanne, Switzerland; [Rudaz, Serge] Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, Geneva, Switzerland; [Rudaz, Serge] Univ Geneva, Swiss Ctr Appl Human Toxicol, Geneva, Switzerland; [Vernaz, Nathalie] Univ Hosp Geneva, Dept Pharm, Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva; University of Lausanne; University of Geneva; University of Geneva	Coutu, S (corresponding author), Ecole Polytech Fed Lausanne, ENAC IIE ECOL, CH-1015 Lausanne, Switzerland.	sylvain.coutu@epfl.ch	Rudaz, Serge/AAB-2861-2021; Barry, D. Andrew/C-6077-2008	Rudaz, Serge/0000-0002-4180-5417; Barry, D. Andrew/0000-0002-8621-0425; Vernaz, Nathalie/0000-0002-1371-5510	FNS [PDFMP2-123021]	FNS(Swiss National Science Foundation (SNSF))	The study was supported by FNS (http://www.snf.ch/) under Grant number: PDFMP2-123021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assainissement Lausanne, 2009, TECHNICAL REPORT; Beier S, 2011, WATER SCI TECHNOL, V63, P66, DOI 10.2166/wst.2011.010; Besse JP, 2008, TOXICOL LETT, V176, P104, DOI 10.1016/j.toxlet.2007.10.012; Bonvin F, 2011, ENVIRON SCI TECHNOL, V45, P4702, DOI 10.1021/es2003588; Calamari D, 2003, ENVIRON SCI TECHNOL, V37, P1241, DOI 10.1021/es020158e; Carballa M, 2008, CHEMOSPHERE, V72, P1118, DOI 10.1016/j.chemosphere.2008.04.034; Conley JM, 2008, CHEMOSPHERE, V73, P1178, DOI 10.1016/j.chemosphere.2008.07.062; Feldmann DF, 2008, CHEMOSPHERE, V71, P1754, DOI 10.1016/j.chemosphere.2007.11.032; Filippini M, 2006, HEALTH POLICY, V78, P77, DOI 10.1016/j.healthpol.2005.09.009; Garrison LP, 2007, VALUE HEALTH, V10, P326, DOI 10.1111/j.1524-4733.2007.00186.x; Gromaire-Mertz MC, 2000, HOUILLE BLANCHE, P66, DOI 10.1051/lhb/2000018; Heberer T, 2005, J HAZARD MATER, V122, P211, DOI 10.1016/j.jhazmat.2005.03.007; Hirsch R, 1999, SCI TOTAL ENVIRON, V225, P109, DOI 10.1016/S0048-9697(98)00337-4; Huschek G, 2004, ENVIRON TOXICOL, V19, P226, DOI 10.1002/tox.20015; Isidori M, 2005, SCI TOTAL ENVIRON, V346, P87, DOI 10.1016/j.scitotenv.2004.11.017; Jones OAH, 2002, WATER RES, V36, P5013, DOI 10.1016/S0043-1354(02)00227-0; Kfimmerer K., 2001, PHARM ENV SOURCES FA; Kummerer K, 2000, CHEMOSPHERE, V40, P701, DOI 10.1016/S0045-6535(99)00439-7; Langford KH, 2009, ENVIRON INT, V35, P766, DOI 10.1016/j.envint.2009.02.007; Lapworth DJ, 2012, ENVIRON POLLUT, V163, P287, DOI 10.1016/j.envpol.2011.12.034; Le Corre KS, 2012, ENVIRON INT, V45, P99, DOI 10.1016/j.envint.2012.03.008; Lissemore L, 2006, CHEMOSPHERE, V64, P717, DOI 10.1016/j.chemosphere.2005.11.015; McArdell CS, 2003, ENVIRON SCI TECHNOL, V37, P5479, DOI 10.1021/es034368i; Musolff A, 2009, ENVIRON POLLUT, V157, P3069, DOI 10.1016/j.envpol.2009.05.037; NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064; Oropesa AL, 2011, ECOTOXICOLOGY, V21, P1; Ort C, 2010, WATER RES, V44, P605, DOI 10.1016/j.watres.2009.08.002; Patrick DM, 2004, CLIN INFECT DIS, V39, P11, DOI 10.1086/420825; Perazzolo C, 2010, ENVIRON TOXICOL CHEM, V29, P1649, DOI 10.1002/etc.221; Pruden A, 2006, ENVIRON SCI TECHNOL, V40, P7445, DOI 10.1021/es060413l; Reinert KH, 2002, ENVIRON TOXICOL CHEM, V21, P1977, DOI [10.1897/1551-5028(2002)021&lt;1977:EAOTVO&gt;2.0.CO;2, 10.1002/etc.5620210928]; Roig B, 2010, PHARM ENV; Santos JL, 2009, J HAZARD MATER, V164, P1509, DOI 10.1016/j.jhazmat.2008.09.073; Stuer-Lauridsen F, 2000, CHEMOSPHERE, V41, P1509, DOI 10.1016/S0045-6535(00)00152-1; Ternes T., 2006, WATER INTELL ONLINE, V5, P1; Thomas KV, 2007, J ENVIRON MONITOR, V9, P1410, DOI 10.1039/b709745j; Tomicic B, 2001, URBAN DRAINAGE MODEL, V80, P180; Vallotton N, 2008, ENVIRON TOXICOL CHEM, V27, P1399, DOI 10.1897/07-197; VanderStichele RH, 2006, J ANTIMICROB CHEMOTH, V58, P159, DOI 10.1093/jac/dkl147; Verlicchi P, 2012, SCI TOTAL ENVIRON, V430, P109, DOI 10.1016/j.scitotenv.2012.04.055; Watanabe N, 2010, ENVIRON SCI TECHNOL, V44, P6591, DOI 10.1021/es100834s; Webb S, 2003, TOXICOL LETT, V142, P157, DOI 10.1016/S0378-4274(03)00071-7	42	37	37	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53592	10.1371/journal.pone.0053592	http://dx.doi.org/10.1371/journal.pone.0053592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320096	Green Published, gold, Green Submitted			2022-12-25	WOS:000313429800061
J	Rosen, DB; Harrington, KH; Cordeiro, JA; Leung, LY; Putta, S; Lacayo, N; Laszlo, GS; Gudgeon, CJ; Hogge, DE; Hawtin, RE; Cesano, A; Walter, RB				Rosen, David B.; Harrington, Kimberly H.; Cordeiro, James A.; Leung, Ling Y.; Putta, Santosh; Lacayo, Norman; Laszlo, George S.; Gudgeon, Chelsea J.; Hogge, Donna E.; Hawtin, Rachael E.; Cesano, Alessandra; Walter, Roland B.			AKT Signaling as a Novel Factor Associated with In Vitro Resistance of Human AML to Gemtuzumab Ozogamicin	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; HUMAN CELL-LINE; INDUCED CYTOTOXICITY; ESTABLISHMENT; SURVIVAL; THERAPY; NETWORK; PATHWAY; CYTOGENETICS	Gemtuzumab ozogamicin (GO), an immunoconjugate between an anti-CD33 antibody and a calicheamicin-gamma(1) derivative, induces remissions and improves survival in a subset of patients with acute myeloid leukemia (AML). As the mechanisms underlying GO and calicheamicin-gamma(1) resistance are incompletely understood, we herein used flow cytometry-based single cell network profiling (SCNP) assays to study cellular responses of primary human AML cells to GO. Our data indicate that the extent of DNA damage is quantitatively impacted by CD33 expression and drug efflux activity. However, although DNA damage is required for GO-induced cytotoxicity, it is not sufficient for effective cell kill, suggesting that downstream antiapoptotic pathways may function as relevant resistance mechanisms. Supporting this notion, we found activated PI3K/AKT signaling to be associated with GO resistance in vitro in primary AML cells. Consistently, the investigational AKT inhibitor MK-2206 significantly sensitized various human AML cells to GO or free calicheamicin-gamma(1) with particularly pronounced effects in otherwise GO or free calicheamicin-gamma(1) -resistant cells. Likewise, MK-2206 also sensitized primary AML cells to calicheamicin-gamma(1). Together, our findings illustrate the capacity of SCNP assays to discover chemotherapy-related biological pathways and signaling networks relevant to GO-induced genotoxic stress. The identification of AKT signaling as being associated with GO resistance in vitro may provide a novel approach to improve the in vivo efficacy of GO/calicheamicin-gamma(1) and, by extrapolation, other DNA damage-based therapeutics.	[Rosen, David B.; Cordeiro, James A.; Leung, Ling Y.; Putta, Santosh; Hawtin, Rachael E.; Cesano, Alessandra] Nodality Inc, San Francisco, CA USA; [Harrington, Kimberly H.; Laszlo, George S.; Gudgeon, Chelsea J.; Walter, Roland B.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Lacayo, Norman] Stanford Univ, Sch Med, Div Pediat Hematol Oncol, Palo Alto, CA 94304 USA; [Hogge, Donna E.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Walter, Roland B.] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA; [Walter, Roland B.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Stanford University; British Columbia Cancer Agency; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Cesano, A (corresponding author), Nodality Inc, San Francisco, CA USA.	alessandra.cesano@nodality.com	Cordeiro, James/AAE-5295-2019; Walter, Roland/C-1064-2008	Walter, Roland/0000-0002-9268-3341; Hogge, Donna/0000-0002-5205-9982	National Cancer Institute/National Institutes of Health [P30-CA015704-35S6, R21-CA159285]; Valvano Foundation; Seattle Genetics Inc.; NATIONAL CANCER INSTITUTE [P30CA015704, R21CA159285] Funding Source: NIH RePORTER	National Cancer Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Valvano Foundation; Seattle Genetics Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Cancer Institute/National Institutes of Health (P30-CA015704-35S6 and R21-CA159285 [RBW]) and the Valvano Foundation (NL). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; DBR, LL, JAC, SP, REH, and AC are employees and stock-holders of Nodality, Inc. Based on these data, two patents entitled METHODS FOR ANALYING DRUG RESPONSE were filed by Nodality Inc. on Oct 19th, 2009 (USPTO Application No: 2/581,536) and May 1st, 2012 (USPTO Application No: 61/640794). RBW is a consultant for and receives research funding from Seattle Genetics Inc. KHH, GSL, NL, and DEH declare no potential conflicts of interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	BENBASSAT H, 1982, LEUKEMIA RES, V6, P743, DOI 10.1016/0145-2126(82)90055-8; Bressanin D, 2012, ONCOTARGET, V3, P811; Burnett AK, 2012, J CLIN ONCOL; Burnett AK, 2011, J CLIN ONCOL, V29, P369, DOI 10.1200/JCO.2010.31.4310; Castaigne S, 2012, LANCET, V379, P1508, DOI 10.1016/S0140-6736(12)60485-1; Cesano A, 2012, CYTOM PART B-CLIN CY, V82B, P158, DOI 10.1002/cyto.b.21007; Cheng Y, 2012, MOL CANCER THER, V11, P154, DOI 10.1158/1535-7163.MCT-11-0606; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; Delaunay J, 2011, BLOOD, V118, P37, DOI 10.1182/blood.V118.21.79.79; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Dowell JA, 2001, J CLIN PHARMACOL, V41, P1206, DOI 10.1177/00912700122012751; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Gallay N, 2009, LEUKEMIA, V23, P1029, DOI 10.1038/leu.2008.395; Goemans BF, 2008, LEUKEMIA, V22, P2284, DOI 10.1038/leu.2008.147; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Jager E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024265; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; KOEFFLER HP, 1978, SCIENCE, V200, P1153, DOI 10.1126/science.306682; Kornblau SM, 2010, CLIN CANCER RES, V16, P3721, DOI 10.1158/1078-0432.CCR-10-0093; LANOTTE M, 1991, BLOOD, V77, P1080; Linenberger ML, 2005, LEUKEMIA, V19, P176, DOI 10.1038/sj.leu.2403598; Liu RX, 2011, J CLIN ENDOCR METAB, V96, pE577, DOI 10.1210/jc.2010-2644; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Martelli AM, 2006, LEUKEMIA, V20, P911, DOI 10.1038/sj.leu.2404245; Martelli AM, 2010, ONCOTARGET, V1, P89, DOI 10.18632/oncotarget.114; Meng JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014124; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Rosen DB, 2012, LEUKEMIA RES, V36, P900, DOI 10.1016/j.leukres.2012.02.022; Rosen DB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013543; Rosen DB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012405; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Stegeman H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-463; Stelzer GT, 2000, IMMUNOPHENOTYPING, P215; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Tai HL, 2000, CURR OPIN MOL THER, V2, P459; Tallman MS, 2005, BLOOD, V106, P1154, DOI 10.1182/blood-2005-01-0178; Walter RB, 2005, BLOOD, V106, P3584, DOI 10.1182/blood-2005-02-0711; Walter RB, 2005, BLOOD, V105, P1295, DOI 10.1182/blood-2004-07-2784; Walter RB, 2004, BLOOD, V103, P4276, DOI 10.1182/blood-2003-11-3825; Walter RB, 2003, BLOOD, V102, P1466, DOI 10.1182/blood-2003-02-0396; Walter RB, 2012, BLOOD, V119, P6198, DOI 10.1182/blood-2011-11-325050	43	35	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53518	10.1371/journal.pone.0053518	http://dx.doi.org/10.1371/journal.pone.0053518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320091	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429800056
J	Song, Y; Wang, HJ; Ma, J; Wang, ZQ				Song, Yi; Wang, Hai-Jun; Ma, Jun; Wang, Zhiqiang			Secular Trends of Obesity Prevalence in Urban Chinese Children from 1985 to 2010: Gender Disparity	PLOS ONE			English	Article							CHILDHOOD OBESITY; NUTRITION TRANSITION; ENERGY-EXPENDITURE; SEX-DIFFERENCES; OVERWEIGHT; EPIDEMIC; FOOD; AGE	Based on the data from six Chinese National Surveys on Students Constitution and Health (CNSSCH) from 1985 to 2010, we explored the secular trend in the prevalence of obesity in urban Chinese children over a period of 25 years. The aim of this study was to examine the gender disparities in the prevalence of childhood obesity over time. The standardized prevalence of obesity in Chinese children increased rapidly during the past 25 years from 0.2% in 1985 to 8.1% in 2010. The increasing trend was significant in all age subgroups (p<0.01). Although the prevalence of obesity continuously increased in both boys and girls, the changing pace in boys was faster than that in girls. Age-specific prevalence odds ratios (PORs) of boys versus girls for obesity increased over time during the 25 year period. The prevalence of obesity in boys was significantly higher than in girls in all age-specific subgroups from 1991 and after. The gradually expanding gender disparity suggests the prevalence of obesity in boys contribute to a large and growing proportion of obese children. Therefore, it is critical for developing and implementing gender-specific preventive guidelines and public health policies in China.	[Song, Yi; Wang, Hai-Jun; Ma, Jun; Wang, Zhiqiang] Peking Univ, Sch Publ Hlth, Inst Child & Adolescent Hlth, Beijing 100871, Peoples R China; [Wang, Zhiqiang] Univ Queensland, Royal Brisbane & Womens Hosp, Sch Med, Ctr Chron Dis, Herston, Qld, Australia	Peking University; Royal Brisbane & Women's Hospital; University of Queensland	Wang, HJ (corresponding author), Peking Univ, Sch Publ Hlth, Inst Child & Adolescent Hlth, Beijing 100871, Peoples R China.	whjun1@bjmu.edu.cn	Wang, Haijun/AAD-1302-2021; Wang, Zhiqiang/A-5835-2010	Wang, Haijun/0000-0003-0849-2903; Wang, Zhiqiang/0000-0002-5839-743X	National Natural Science Foundation of China [81172683]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The data analysis of the present study was supported by grant from National Natural Science Foundation of China (81172683). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babey SH, 2010, AM J PUBLIC HEALTH, V100, P2149, DOI 10.2105/AJPH.2010.192641; BEYDOUN MA, 2008, OBESITY, V0017; Borders TF, 2006, J COMMUN HEALTH, V31, P57, DOI 10.1007/s10900-005-8189-8; Cheng TO, 2005, INT J CARDIOL, V98, P173, DOI 10.1016/j.ijcard.2004.08.019; CNSSCH, 1997, REP 1995 NAT SURV ST; CNSSCH Association, 2007, REP 2005 NAT SURV ST; CNSSCH Association, 1993, REP 1991 NAT SURV ST; CNSSCH Association, 1987, REP 1985 NAT SURV ST; Dehghan M, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-24; DeLany JP, 2004, AM J CLIN NUTR, V79, P268; Du SF, 2002, PUBLIC HEALTH NUTR, V5, P169, DOI 10.1079/PHN2001290; Goyal Ramesh K, 2010, J Assoc Physicians India, V58, P151; Gupta DK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017221; Ji CY, 2008, INT J CARDIOL, V131, P1, DOI 10.1016/j.ijcard.2008.05.078; Ji CY, 2009, INT J CARDIOL, V132, P1, DOI 10.1016/j.ijcard.2008.07.003; Ji CY, 2005, BIOMED ENVIRON SCI, V18, P390; Ji CY., 2007, REPORT 2005 CHINESE; Kirkby J, 2004, AM J CLIN NUTR, V80, P430, DOI 10.1093/ajcn/80.2.430; Kocoglu G., 2003, Pakistan Journal of Nutrition, V2, P292; Lee CMY, 2007, OBES REV, V8, P191, DOI 10.1111/j.1467-789X.2006.00292.x; Lovejoy JC, 2009, OBES REV, V10, P154, DOI 10.1111/j.1467-789X.2008.00529.x; Ma J, 2012, CHIN J PREV MED, V46, P781; Mahfouz AA, 2011, SAUDI J GASTROENTERO, V17, P318, DOI 10.4103/1319-3767.84486; Marsh HW, 2007, DEV PSYCHOL, V43, P647, DOI 10.1037/0012-1649.43.3.647; Martin KS, 2007, J NUTR EDUC BEHAV, V39, P31, DOI 10.1016/j.jneb.2006.08.021; National Bureau of Statistics of China, 2011, CHIN STAT YB 2011; National Obesity Observatory, 2011, INT COMP OB PREV; Song Yi, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P789; The Chinese Students' Physique and Health Research Group, 2002, RES REP CHIN STUD PH; Uauy R., 2004, OBES REV S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Unnithan AG, 2008, INT J NUTR WELLNESS, V6; Wang J, 2012, INT J OBESITY, V36, P542, DOI 10.1038/ijo.2011.218; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Wisniewski AB, 2009, GENDER MED, V6, P76, DOI 10.1016/j.genm.2008.12.001; Zhai FY, 2009, NUTR REV, V67, pS56, DOI 10.1111/j.1753-4887.2009.00160.x; Zhang Xin, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P781	37	85	97	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53069	10.1371/journal.pone.0053069	http://dx.doi.org/10.1371/journal.pone.0053069			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	069IY	23308137	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429800027
J	Abrahams, PW; Davies, TC; Solomon, AO; Trow, AJ; Wragg, J				Abrahams, Peter W.; Davies, Theo C.; Solomon, Abiye O.; Trow, Amanda J.; Wragg, Joanna			Human Geophagia, Calabash Chalk and Undongo: Mineral Element Nutritional Implications	PLOS ONE			English	Article							PREGNANT-WOMEN; TRACE-ELEMENTS; IRON STATUS; SOIL; LEAD; BIOACCESSIBILITY; BIOAVAILABILITY; SUPPLEMENTATION; EXPOSURE; CHILDREN	The prime aim of our work is to report and comment on the bioaccessible concentrations - i.e., the soluble content of chemical elements in the gastrointestinal environment that is available for absorption - of a number of essential mineral nutrients and potentially harmful elements (PHEs) associated with the deliberate ingestion of African geophagical materials, namely Calabash chalk and Undongo. The pseudo-total concentrations of 13 mineral nutrients/PHEs were quantified following a nitric-perchloric acid digestion of nine different Calabash chalk samples, and bioaccessible contents of eight of these chemical elements were determined in simulated saliva/gastric and intestinal solutions obtained via use of the Fed ORganic Estimation human Simulation Test (FOREhST) in vitro procedure. The Calabash chalk pseudo-total content of the chemical elements is often below what may be regarded as average for soils/shales, and no concentration is excessively high. The in vitro leachate solutions had concentrations that were often lower than those of the blanks used in our experimental procedure, indicative of effective adsorption: lead, a PHE about which concern has been previously raised in connection with the consumption of Calabash chalk, was one such chemical element where this was evident. However, some concentrations in the leachate solutions are suggestive that Calabash chalk can be a source of chemical elements to humans in bioaccessible form, although generally the materials appear to be only a modest supplier: this applies even to iron, a mineral nutrient that has often been linked to the benefits of geophagia in previous academic literature. Our investigations indicate that at the reported rates of ingestion, Calabash chalk on the whole is not an important source of mineral nutrients or PHEs to humans. Similarly, although Undongo contains elevated pseudo-total concentrations of chromium and nickel, this soil is not a significant source to humans for any of the bioaccessible elements investigated.	[Abrahams, Peter W.; Trow, Amanda J.] Aberystwyth Univ, Inst Geog & Earth Sci, Ceredigion, Wales; [Davies, Theo C.; Solomon, Abiye O.] Univ Jos, Dept Geol & Min, Jos, Nigeria; [Wragg, Joanna] British Geol Survey, Nottingham NG12 5GG, England	Aberystwyth University; University of Jos; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey	Abrahams, PW (corresponding author), Aberystwyth Univ, Inst Geog & Earth Sci, Ceredigion, Wales.	pwa@aber.ac.uk		Wragg, Joanna/0000-0003-0011-641X	NERC [bgs05010] Funding Source: UKRI; Natural Environment Research Council [bgs05010] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Abrahams PW, 2012, APPL GEOCHEM, V27, P954, DOI 10.1016/j.apgeochem.2011.05.003; Abrahams PW, 2006, APPL GEOCHEM, V21, P98, DOI 10.1016/j.apgeochem.2005.09.015; Abrahams PW, 1996, GEOGR J, V162, P63, DOI 10.2307/3060216; Abrahams PW, 1997, TROP MED INT HEALTH, V2, P617, DOI 10.1046/j.1365-3156.1997.d01-348.x; Al-Rmalli SW, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-79; Bascomb CL, 1974, SOIL SURVEY LABORATO, P14; Basden GT, 1938, CRAVING EARTH UNDERS; Beckett WS, 2007, HANDBOOK ON THE TOXICOLOGY OF METALS, 3RD EDITION, P39, DOI 10.1016/B978-012369413-3/50058-6; Berrow M. L., 1980, Reference Book, Ministry of Agriculture, Fisheries and Food, P159; Casteel SW, 2006, ENVIRON HEALTH PERSP, V114, P1162, DOI 10.1289/ehp.8852; Cave MR, 2011, DEALING WITH CONTAMINATED SITES: FROM THEORY TOWARDS PRACTICAL APPLICATION, P287, DOI 10.1007/978-90-481-9757-6_7; Cave MR, 2010, ENVIRON SCI TECHNOL, V44, P2654, DOI 10.1021/es903258v; Dean JR, 2004, CHEMOSPHERE, V57, P21, DOI 10.1016/j.chemosphere.2004.05.023; Denys S, 2012, ENVIRON SCI TECHNOL, V46, P6252, DOI 10.1021/es3006942; Ellickson KM, 2001, ARCH ENVIRON CON TOX, V40, P128, DOI 10.1007/s002440010155; European Food Safety Authority, 2010, EFSA J, V8, P1570, DOI [10.2903/j.efsa.2010.1570, DOI 10.2903/J.EFSA.2010.1570]; EVM, 2003, SAF UPP LEV VIT MIN; Food Standards Agency, 2002, CAL CHALK YOUR QUEST; Food Standards Agency, 2003, CAL CHALK WARN; Food Standards Agency, 2006, FOOD STAND AG ANN RE; Geissler PW, 1998, TROP MED INT HEALTH, V3, P529, DOI 10.1046/j.1365-3156.1998.00272.x; Geissler PW, 1998, T ROY SOC TROP MED H, V92, P549, DOI 10.1016/S0035-9203(98)90910-5; Gron C, 2003, HUMAN BIOACCESSIBILI; Health Canada, 2007, CAL CHALK MAY POS HL; Hooda PS, 2004, SCI TOTAL ENVIRON, V333, P75, DOI 10.1016/j.scitotenv.2004.04.023; HUNTER JM, 1973, GEOGR REV, V63, P170, DOI 10.2307/213410; Intawongse M, 2006, TRAC-TREND ANAL CHEM, V25, P876, DOI 10.1016/j.trac.2006.03.010; JECFA, 2011, EV CERT FOOD ADD CON; Kutalek R, 2010, T ROY SOC TROP MED H, V104, P787, DOI 10.1016/j.trstmh.2010.09.002; Maddaloni M, 1998, ENVIRON HEALTH PERSP, V106, P1589, DOI 10.1289/ehp.98106s61589; Mascolo N, 2004, APPL CLAY SCI, V25, P23, DOI 10.1016/j.clay.2003.07.001; MIDDLETON JD, 1989, BRIT MED J, V298, P407; Munsell Color Company, 1954, MUNS SOIL COL CHARTS; New York City Department of Health and Mental Hygiene, CAL CHALK CONT LEAD; NIELSEN FH, 1984, B NEW YORK ACAD MED, V60, P177; NIELSEN GD, 1990, BRIT J DERMATOL, V122, P299, DOI 10.1111/j.1365-2133.1990.tb08277.x; Oomen AG, 2002, ENVIRON SCI TECHNOL, V36, P3326, DOI 10.1021/es010204v; Ponka P, 2007, HANDBOOK ON THE TOXICOLOGY OF METALS, 3RD EDITION, P577, DOI 10.1016/B978-012369413-3/50085-9; SCN, 2004, 5 SCN; SHELLSHEAR ID, 1975, NEW ZEAL MED J, V81, P382; Smith B, 2000, J GEOL SOC LONDON, V157, P885, DOI 10.1144/jgs.157.4.885; Sule S, 2001, OBSTET GYNECOL SURV, V66, P452; Thompson M., 1982, ATOMIC ABSORPTION SP, V5, P261; Trow AJ, 2008, THESIS ABERYSTWYTH U; Turekian KK, 1972, CHEM EARTH; Vermeer D., 1979, AFR NOTES, V8, P13; VERMEER DE, 1985, SCIENCE, V227, P634, DOI 10.1126/science.3969552; VERMEER DE, 1966, ANN ASSOC AM GEOGR, V56, P197, DOI 10.1111/j.1467-8306.1966.tb00553.x; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; WEDEEN RP, 1978, ENVIRON RES, V17, P409, DOI 10.1016/0013-9351(78)90044-0; WHO, 1996, TRAC EL HUM NUTR HLT; Wigle DT, 2005, PLOS MED, V2, P1232, DOI 10.1371/journal.pmed.0020350; Wragg J, 2011, SCI TOTAL ENVIRON, V409, P4016, DOI 10.1016/j.scitotenv.2011.05.019; Yanai J, 2009, SOIL SCI PLANT NUTR, V55, P215, DOI 10.1111/j.1747-0765.2008.00346.x	55	17	21	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53304	10.1371/journal.pone.0053304	http://dx.doi.org/10.1371/journal.pone.0053304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308189	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000313429100053
J	Chowdhury, AH; Ramroop, JR; Upadhyay, G; Sengupta, A; Andrzejczyk, A; Saleque, S				Chowdhury, Asif H.; Ramroop, Johnny R.; Upadhyay, Ghanshyam; Sengupta, Ananya; Andrzejczyk, Anna; Saleque, Shireen			Differential Transcriptional Regulation of meis1 by Gfi1b and Its Co-Factors LSD1 and CoREST	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; GROWTH-FACTOR INDEPENDENCE-1; ACUTE MYELOID-LEUKEMIA; ZINC-FINGER PROTEIN; ERYTHROID-DIFFERENTIATION; FACTOR GFI-1; IN-VITRO; GENES; REPRESSOR; HOX	Gfi1b (growth factor independence 1b) is a zinc finger transcription factor essential for development of the erythroid and megakaryocytic lineages. To elucidate the mechanism underlying Gfi1b function, potential downstream transcriptional targets were identified by chromatin immunoprecipitation and expression profiling approaches. The combination of these approaches revealed the oncogene meis1, which encodes a homeobox protein, as a direct and prominent target of Gfi1b. Examination of the meis1 promoter sequence revealed multiple Gfi1/1b consensus binding motifs. Distinct regions of the promoter were occupied by Gfi1b and its cofactors LSD1 and CoREST/Rcor1, in erythroid cells but not in the closely related megakaryocyte lineage. Accordingly, Meis1 was significantly upregulated in LSD1 inhibited erythroid cells, but not in megakaryocytes. This lineage specific upregulation in Meis1 expression was accompanied by a parallel increase in di-methyl histone3 lysine4 levels in the Meis1 promoter in LSD1 inhibited, erythroid cells. Meis1 was also substantially upregulated in gfi1b-/- fetal liver cells along with its transcriptional partners Pbx1 and several Hox messages. Elevated Meis1 message levels persisted in gfi1b mutant fetal liver cells differentiated along the erythroid lineage, relative to wild type. However, cells differentiated along the megakaryocytic lineage, exhibited no difference in Meis1 levels between controls and mutants. Transfection experiments further demonstrated specific repression of meis1 promoter driven reporters by wild type Gfi1b but neither by a SNAG domain mutant nor by a DNA binding deficient one, thus confirming direct functional regulation of this promoter by the Gfi1b transcriptional complex. Overall, our results demonstrate direct yet differential regulation of meis1 transcription by Gfi1b in distinct hematopoietic lineages thus revealing it to be a common, albeit lineage specific, target of both Gfi1b and its paralog Gfi1.	[Saleque, Shireen] CUNY City Coll, Dept Biol, New York, NY 10031 USA; CUNY, Grad Ctr, New York, NY USA	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System	Saleque, S (corresponding author), CUNY City Coll, Dept Biol, 138Th St & Convent Ave, New York, NY 10031 USA.	ssaleque@ccny.cuny.edu			NIMHD [G12RR03060-26A1, 8G12MD007603-27]; NHLBI [5SC1HL104638]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [SC1HL104638] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	NIMHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by grants G12RR03060-26A1 and 8G12MD007603-27 from NIMHD to CCNY and by grant 5SC1HL104638 from NHLBI to S.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai M, 2012, BLOOD; Daga A, 2000, EXP HEMATOL, V28, P569, DOI 10.1016/S0301-472X(00)00135-1; Duan Zhijun, 2003, Hematology, V8, P339, DOI 10.1080/10245330310001612116; Dwivedi PP, 2005, ENDOCR-RELAT CANCER, V12, P351, DOI 10.1677/erc.1.00920; Elmaagacli AH, 2007, BRIT J HAEMATOL, V136, P212, DOI 10.1111/j.1365-2141.2006.06407.x; Fiolka K, 2006, EMBO REP, V7, P326, DOI 10.1038/sj.embor.7400618; FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; Hisa T, 2004, EMBO J, V23, P450, DOI 10.1038/sj.emboj.7600038; Hock H, 2006, CURR OPIN HEMATOL, V13, P1, DOI 10.1097/01.moh.0000190111.85284.8f; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Horman SR, 2009, BLOOD, V113, P5466, DOI 10.1182/blood-2008-09-179747; Huang M, 2010, ACTA HAEMATOL-BASEL, V123, P1, DOI 10.1159/000253856; Huang YS, 2012, BLOOD, V119, P388, DOI 10.1182/blood-2011-03-341081; ISHIDA Y, 1993, EXP HEMATOL, V21, P289; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Karsunky H, 2002, NAT GENET, V30, P295, DOI 10.1038/ng831; Kazanjian A, 2004, CANCER RES, V64, P6874, DOI 10.1158/0008-5472.CAN-04-0633; Khandanpour C., 2012, BLOOD; Khandanpour C, 2010, BLOOD, V116, P5149, DOI 10.1182/blood-2010-04-280305; Khandanpour C, 2010, BLOOD, V115, P2462, DOI 10.1182/blood-2009-08-239822; Laurent B, 2012, J CELL SCI, V125, P993, DOI 10.1242/jcs.095877; Li-Kroeger D, 2008, DEV CELL, V15, P298, DOI 10.1016/j.devcel.2008.06.001; McGhee L, 2003, J CELL BIOCHEM, V89, P1005, DOI 10.1002/jcb.10548; Moroy T, 2011, SEMIN IMMUNOL, V23, P368, DOI 10.1016/j.smim.2011.08.006; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Pineault N, 2003, BLOOD, V101, P4529, DOI 10.1182/blood-2002-08-2484; Sakai I, 2001, INT J HEMATOL, V73, P507, DOI 10.1007/BF02994015; Saleque S, 2002, GENE DEV, V16, P301, DOI 10.1101/gad.959102; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Schmidt T, 1998, ONCOGENE, V17, P2661, DOI 10.1038/sj.onc.1202191; Shen WF, 1997, MOL CELL BIOL, V17, P6448, DOI 10.1128/MCB.17.11.6448; Shin MS, 2004, CANCER RES, V64, P4419, DOI 10.1158/0008-5472.CAN-03-3885; Shroyer NF, 2005, GENE DEV, V19, P2412, DOI 10.1101/gad.1353905; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; Tong B, 1998, MOL CELL BIOL, V18, P2462, DOI 10.1128/MCB.18.5.2462; van der Meer LT, 2010, LEUKEMIA, V24, P1834, DOI 10.1038/leu.2010.195; Vassen L, 2005, NUCLEIC ACIDS RES, V33, P987, DOI 10.1093/nar/gki243; Vassen L, 2006, EMBO J, V25, P2409, DOI 10.1038/sj.emboj.7601124; Vassen L, 2009, INT J HEMATOL, V89, P422, DOI 10.1007/s12185-009-0286-5; Wallis D, 2003, DEVELOPMENT, V130, P221, DOI 10.1242/dev.00190; Wang GG, 2006, MOL CELL BIOL, V26, P3902, DOI 10.1128/MCB.26.10.3902-3916.2006; Zeng H, 2004, EMBO J, V23, P4116, DOI 10.1038/sj.emboj.7600419; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479; Zhu JF, 2002, IMMUNITY, V16, P733, DOI 10.1016/S1074-7613(02)00317-5; ZweidlerMcKay PA, 1996, MOL CELL BIOL, V16, P4024	47	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53666	10.1371/journal.pone.0053666	http://dx.doi.org/10.1371/journal.pone.0053666			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308270	Green Published, gold			2022-12-25	WOS:000313429100103
J	Nieto-Estevez, V; Pignatelli, J; Arauzo-Bravo, MJ; Hurtado-Chong, A; Vicario-Abejon, C				Nieto-Estevez, Vanesa; Pignatelli, Jaime; Arauzo-Bravo, Marcos J.; Hurtado-Chong, Anahi; Vicario-Abejon, Carlos			A Global Transcriptome Analysis Reveals Molecular Hallmarks of Neural Stem Cell Death, Survival, and Differentiation in Response to Partial FGF-2 and EGF Deprivation	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; RADIAL GLIAL-CELLS; OLFACTORY-BULB; IN-VIVO; SUBVENTRICULAR ZONE; PROGENITOR CELLS; CEREBRAL-CORTEX; SELF-RENEWAL; HIPPOCAMPAL NEUROGENESIS	Neurosphere cell culture is a commonly used model to study the properties and potential applications of neural stem cells (NSCs). However, standard protocols to culture NSCs have yet to be established, and the mechanisms underlying NSC survival and maintenance of their undifferentiated state, in response to the growth factors FGF-2 and EGF are not fully understood. Using cultures of embryonic and adult olfactory bulb stem cells (eOBSCs and aOBSCs), we analyzed the consequences of FGF-2 and EGF addition at different intervals on proliferation, cell cycle progression, cell death and differentiation, as well as on global gene expression. As opposed to cultures supplemented daily, addition of FGF-2 and EGF every 4 days significantly reduced the neurosphere volume and the total number of cells in the spheres, mainly due to increased cell death. Moreover, partial FGF-2 and EGF deprivation produced an increase in OBSC differentiation during the proliferative phase. These changes were more evident in aOBSC than eOBSC cultures. Remarkably, these effects were accompanied by a significant upregulation in the expression of endogenous Fgf-2 and genes involved in cell death and survival (Cryab), lipid catabolic processes (Pla2g7), cell adhesion (Dscaml1), cell differentiation (Dscaml1, Gpr17, S100b, Ndrg2) and signal transduction (Gpr17, Ndrg2). These findings support that a daily supply of FGF-2 and EGF is critical to maintain the viability and the undifferentiated state of NSCs in culture, and they reveal novel molecular hallmarks of NSC death, survival and the initiation of differentiation.	[Nieto-Estevez, Vanesa; Pignatelli, Jaime; Hurtado-Chong, Anahi; Vicario-Abejon, Carlos] CSIC, Inst Cajal, E-28002 Madrid, Spain; [Nieto-Estevez, Vanesa; Pignatelli, Jaime; Vicario-Abejon, Carlos] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Arauzo-Bravo, Marcos J.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Lab Computat Biol & Bioinformat, D-48149 Munster, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); CIBERNED; Max Planck Society	Vicario-Abejon, C (corresponding author), CSIC, Inst Cajal, E-28002 Madrid, Spain.	cvicario@cajal.csic.es	pignatelli, jaime/AAY-8734-2021; Marcos, Arauzo-Bravo/A-1706-2011; Vicario-Abejón, Carlos/G-2814-2016; Pignatelli, Jaime/L-3122-2014	pignatelli, jaime/0000-0002-8431-2241; Marcos, Arauzo-Bravo/0000-0002-3264-464X; Vicario-Abejón, Carlos/0000-0002-7060-0250; Pignatelli, Jaime/0000-0002-8431-2241; Nieto-Estevez, Vanesa/0000-0002-7265-0593	Spanish Ministerio de Ciencia e Innovacion and Ministerio de Economia y Competitividad (MICINN and MINECO) [BFU2007-61230, BFU2010-1963]; Comunidad de Madrid [S2011/BMD-2336]; Instituto de Salud Carlos III (ISCIII) [CIBERNED CB06/05/0065]; MICINN; MINECO	Spanish Ministerio de Ciencia e Innovacion and Ministerio de Economia y Competitividad (MICINN and MINECO); Comunidad de Madrid(Comunidad de Madrid); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); MINECO(Spanish Government)	This work was funded by grants from the Spanish Ministerio de Ciencia e Innovacion and Ministerio de Economia y Competitividad (MICINN and MINECO; BFU2007-61230 and BFU2010-1963), the Comunidad de Madrid (S2011/BMD-2336), and the Instituto de Salud Carlos III (ISCIII; CIBERNED CB06/05/0065) to C.V.-A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank M.J. Roman for her technical support. V.N.-E and A.H.-C were supported by FPI Fellowships from the MICINN and MINECO.	Agarwala KL, 2001, BIOCHEM BIOPH RES CO, V285, P760, DOI 10.1006/bbrc.2001.5214; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Andersson O, 2001, GENOMICS, V78, P178, DOI 10.1006/geno.2001.6666; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beckervordersandforth R, 2010, CELL STEM CELL, V7, P744, DOI 10.1016/j.stem.2010.11.017; Bernal GM, 2011, AGING CELL, V10, P466, DOI 10.1111/j.1474-9726.2011.00694.x; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Bousette N, 2010, P NATL ACAD SCI USA, V107, P18481, DOI 10.1073/pnas.1013555107; Brill MS, 2008, J NEUROSCI, V28, P6439, DOI 10.1523/JNEUROSCI.0700-08.2008; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; Ceruti S, 2011, GLIA, V59, P363, DOI 10.1002/glia.21107; Chen R, 2007, J BIOL CHEM, V282, P24842, DOI 10.1074/jbc.M702865200; Chen Y, 2009, NAT NEUROSCI, V12, P1398, DOI 10.1038/nn.2410; Ciccolini F, 1998, J NEUROSCI, V18, P7869; Coles-Takabe BLK, 2008, STEM CELLS, V26, P2938, DOI 10.1634/stemcells.2008-0558; Demos C, 2008, MOL VIS, V14, P1639; Diaz B, 2000, DEVELOPMENT, V127, P1641; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doncel-Perez E, 2009, GLIA, V57, P1393, DOI 10.1002/glia.20858; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Fuerst PG, 2009, CURR OPIN NEUROBIOL, V19, P389, DOI 10.1016/j.conb.2009.07.013; Fukushima N, 2002, NEUROSCI RES, V44, P467, DOI 10.1016/S0168-0102(02)00173-6; Gao JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036516; Giachino C, 2009, EUR J NEUROSCI, V30, P9, DOI 10.1111/j.1460-9568.2009.06798.x; Greber B, 2011, EMBO J, V30, P4874, DOI 10.1038/emboj.2011.407; Gritti A, 1996, J NEUROSCI, V16, P1091; Guillemot F, 2011, NEURON, V71, P574, DOI 10.1016/j.neuron.2011.08.002; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Hurtado-Chong A, 2009, EUR J NEUROSCI, V30, P742, DOI 10.1111/j.1460-9568.2009.06870.x; Ihrie RA, 2011, NEURON, V70, P674, DOI 10.1016/j.neuron.2011.05.004; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lai WT, 2011, STEM CELLS, V29, P1102, DOI 10.1002/stem.661; Larrayoz IM, 2012, INT REV CEL MOL BIO, V297, P175, DOI 10.1016/B978-0-12-394308-8.00005-4; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Le Bras B, 2006, NAT NEUROSCI, V9, P340, DOI 10.1038/nn1646; Lecca D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003579; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li Y, 2011, BRAIN RES, V1382, P252, DOI 10.1016/j.brainres.2011.01.023; Lillien L, 2000, DEVELOPMENT, V127, P4993; Liu LJ, 2012, J MOL HISTOL, V43, P27, DOI 10.1007/s10735-011-9378-7; Lo Sardo V, 2012, NAT NEUROSCI, V15, P713, DOI 10.1038/nn.3080; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Lukaszewicz AS, 2002, J NEUROSCI, V22, P6610; Lyon L, 2008, SYNAPSE, V62, P842, DOI 10.1002/syn.20553; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Maric D, 2007, J NEUROSCI, V27, P1836, DOI 10.1523/JNEUROSCI.5141-06.2007; Martin I, 2009, BRAIN RES, V1284, P22, DOI 10.1016/j.brainres.2009.05.070; Masilamoni JG, 2006, BBA-MOL BASIS DIS, V1762, P284, DOI 10.1016/j.bbadis.2005.11.007; Mason I, 2007, NAT REV NEUROSCI, V8, P583, DOI 10.1038/nrn2189; McIntyre JC, 2010, J NEUROSCI RES, V88, P3243, DOI 10.1002/jnr.22497; Migaud M, 2010, EUR J NEUROSCI, V32, P2042, DOI 10.1111/j.1460-9568.2010.07521.x; Mishra M, 2011, J CELL MOL MED, V15, P1713, DOI 10.1111/j.1582-4934.2010.01134.x; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Ogata H, 2000, NUCLEIC ACIDS RES, V28, P4021, DOI 10.1093/nar/28.20.4021; Okuda T, 2008, J HISTOCHEM CYTOCHEM, V56, P175, DOI 10.1369/jhc.7A7323.2007; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Pappas IS, 1997, EXP NEUROL, V144, P302, DOI 10.1006/exnr.1997.6411; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Raballo R, 2000, J NEUROSCI, V20, P5012; Ren HX, 2012, CELL, V149, P1314, DOI 10.1016/j.cell.2012.04.032; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Roybon L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004779; Schmidt H, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00025; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shetty AK, 2004, J NEUROSCI RES, V78, P520, DOI 10.1002/jnr.20302; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Stefaniuk M, 2010, J NEUROCHEM, V115, P1183, DOI 10.1111/j.1471-4159.2010.07023.x; Storm EE, 2006, DEVELOPMENT, V133, P1831, DOI 10.1242/dev.02324; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Sun YR, 2011, J CELL SCI, V124, P1867, DOI 10.1242/jcs.085506; Taniguchi H, 2006, DEVELOPMENT, V133, P1923, DOI 10.1242/dev.02354; Taupin P, 2002, J NEUROSCI RES, V69, P745, DOI 10.1002/jnr.10378; Tepavcevic V, 2011, J CLIN INVEST, V121, P4722, DOI 10.1172/JCI59145; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Vaccarino FM, 1999, NAT NEUROSCI, V2, P246, DOI 10.1038/6350; Vergano-Vera E, 2009, NEUROSCIENCE, V162, P39, DOI 10.1016/j.neuroscience.2009.03.033; Vergano-Vera E, 2006, DEVELOPMENT, V133, P4367, DOI 10.1242/dev.02601; Vergano-Vera E, 2010, CELL TISSUE RES, V340, P1, DOI 10.1007/s00441-010-0934-3; VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A; Vicario-Abejon C, 2003, J NEUROSCI, V23, P895; VICARIOABEJON C, 1995, NEURON, V15, P105, DOI 10.1016/0896-6273(95)90068-3; Wingerd KL, 2004, DEV DYNAM, V231, P359, DOI 10.1002/dvdy.20120; Young KM, 2010, GLIA, V58, P943, DOI 10.1002/glia.20976	88	26	29	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53594	10.1371/journal.pone.0053594	http://dx.doi.org/10.1371/journal.pone.0053594			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308259	Green Published, gold, Green Submitted			2022-12-25	WOS:000313429100094
J	Wang, L; Chen, H; Liu, DH; Huo, XX; Gao, JM; Song, XR; Xu, XC; Huang, KQ; Liu, WQ; Wang, Y; Lu, FL; Lun, ZR; Luo, QL; Wang, XL; Shen, JL				Wang, Lin; Chen, He; Liu, Daohua; Huo, Xingxing; Gao, Jiangmei; Song, Xiaorong; Xu, Xiucai; Huang, Kaiquan; Liu, Wenqi; Wang, Yong; Lu, Fangli; Lun, Zhao-Rong; Luo, Qingli; Wang, Xuelong; Shen, Jilong			Genotypes and Mouse Virulence of Toxoplasma gondii Isolates from Animals and Humans in China	PLOS ONE			English	Article							GENETIC-CHARACTERIZATION; POPULATION-STRUCTURE; CONGENITAL TOXOPLASMOSIS; CLONAL LINEAGES; HIGH PREVALENCE; NORTH-AMERICA; SOUTH-AMERICA; STRAINS; IDENTIFICATION; CATS	Background: Recent population structure studies of T. gondii revealed that a few major clonal lineages predominated in different geographical regions. T. gondii in South America is genetically and biologically divergent, whereas this parasite is remarkably clonal in North America and Europe with a few major lineages including Types I, II and III. Information on genotypes and mouse virulence of T. gondii isolates from China is scarce and insufficient to investigate its population structure, evolution, and transmission. Methodology/Principal Findings: Genotyping of 23 T. gondii isolates from different hosts using 10 markers for PCR-restriction fragment length polymorphism analyses (SAG1, SAG2, SAG3, BTUB, GRA6, c22-8, c29-2, L358, PK1 and Apico) revealed five genotypes; among them three genotypes were atypical and two were archetypal. Fifteen strains belong to the Chinese 1 lineage, which has been previously reported as a widespread lineage from swine, cats, and humans in China. Two human isolates fall into the type I and II lineages and the remaining isolates belong to two new atypical genotypes (ToxoDB#204 and #205) which has never been reported in China. Our results show that these genotypes of T. gondii isolates are intermediately or highly virulent in mice except for the strain TgCtwh6, which maintained parasitemia in mice for 35 days post infection although it possesses the uniform genotype of Chinese 1. Additionally, phylogenetic network analyses of all isolates of genotype Chinese 1 are identical, and there is no variation based on the sequence data generated for four introns (EF1, HP2, UPRT1 and UPRT7) and two dense granule proteins (GRA6 and GRA7). Conclusion/Significance: A limited genetic diversity was found and genotype Chinese 1 (ToxoDB#9) is dominantly circulating in mainland China. The results will provide a useful profile for deep insight to the population structure, epidemiology and biological characteristics of T. gondii in China.	[Wang, Lin; Song, Xiaorong; Xu, Xiucai; Luo, Qingli; Wang, Xuelong; Shen, Jilong] Anhui Med Univ, Dept Parasitol, Prov Lab Microbiol & Parasitol, Hefei, Anhui, Peoples R China; [Wang, Lin; Song, Xiaorong; Xu, Xiucai; Luo, Qingli; Wang, Xuelong; Shen, Jilong] Anhui Med Univ, Key Lab Zoonoses Anhui, Hefei, Anhui, Peoples R China; [Chen, He; Huo, Xingxing] Anhui Med Univ, Affiliated Hosp 1, Clin Lab, Hefei, Anhui, Peoples R China; [Wang, Lin; Huang, Kaiquan] Anhui Univ Tradit Chinese Med, Affiliated Hosp 1, Clin Lab, Hefei, Peoples R China; [Liu, Daohua] Prov Inst Parasit Dis Control Anhui, Hefei, Anhui, Peoples R China; [Gao, Jiangmei; Lun, Zhao-Rong] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Key Lab Trop Dis Control,Minist Educ, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Wenqi] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Parasitol, Wuhan 430074, Hubei, Peoples R China; [Wang, Yong] Nanjing Med Univ, Dept Pathogen Biol, Nanjing, Jiangsu, Peoples R China; [Lu, Fangli] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Parasitol, Minist Educ, Guangzhou 510275, Guangdong, Peoples R China; [Lu, Fangli] Sun Yat Sen Univ, Zhongshan Sch Med, Key Lab Trop Dis Control, Minist Educ, Guangzhou 510275, Guangdong, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui University of Chinese Medicine; Sun Yat Sen University; Huazhong University of Science & Technology; Nanjing Medical University; Sun Yat Sen University; Sun Yat Sen University	Shen, JL (corresponding author), Anhui Med Univ, Dept Parasitol, Prov Lab Microbiol & Parasitol, Hefei, Anhui, Peoples R China.	shenjilong53@126.com			National Basic Research Program of China (973 Program) [2010CB530001]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (973 Program, No. 2010CB530001) (http://www.973.gov.cn/Default_3.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032489; Ajzenberg D, 2010, FUTURE MICROBIOL, V5, P841, DOI 10.2217/FMB.10.55; Berenreiterova M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028925; Carruthers VB, 2007, SCHIZOPHRENIA BULL, V33, P745, DOI 10.1093/schbul/sbm008; Chen ZW, 2011, VET PARASITOL, V183, P166, DOI 10.1016/j.vetpar.2011.06.013; Coordinating Office of the National Survey on the Important Human Parasitic Diseases, 2005, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V23, P332; CORNELISSEN AWCA, 1981, PARASITOLOGY, V83, P103, DOI 10.1017/S0031182000050071; DEROUIN F, 1991, EXP PARASITOL, V73, P460, DOI 10.1016/0014-4894(91)90070-D; Dubey JP, 2008, INT J PARASITOL, V38, P999, DOI 10.1016/j.ijpara.2007.11.012; Dubey JP, 2007, VET PARASITOL, V146, P347, DOI 10.1016/j.vetpar.2007.03.008; Dubey JP, 2007, VET PARASITOL, V146, P341, DOI 10.1016/j.vetpar.2007.03.009; Dubey JP, 2007, VET PARASITOL, V145, P45, DOI 10.1016/j.vetpar.2006.12.001; Dubey JP, 2007, VET PARASITOL, V145, P352, DOI 10.1016/j.vetpar.2006.12.016; Dubey JP, 2011, INT J PARASITOL, V41, P1139, DOI 10.1016/j.ijpara.2011.06.005; Dubey J.P., 2010, TOXOPLASMOSIS ANIMAL, P313, DOI DOI 10.1186/1756-3305-3-112; Dubey J.P., 1988, TOXOPLASMOSIS ANIMAL; Dubey JP, 1998, VET PARASITOL, V74, P75, DOI 10.1016/S0304-4017(97)00135-0; Elbez-Rubinstein A, 2009, J INFECT DIS, V199, P280, DOI 10.1086/595793; Gao X., 2011, P IEEE VEH TECHN C V, P1; Herrmann DC, 2012, VET PARASITOL, V185, P78, DOI 10.1016/j.vetpar.2011.10.030; Homan WL, 2000, INT J PARASITOL, V30, P69, DOI 10.1016/S0020-7519(99)00170-8; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Howe DK, 1996, INFECT IMMUN, V64, P5193, DOI 10.1128/IAI.64.12.5193-5198.1996; Huang SY, 2012, J PARASITOL; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jamieson SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002285; Khan A, 2007, P NATL ACAD SCI USA, V104, P14872, DOI 10.1073/pnas.0702356104; Khan A, 2011, INT J PARASITOL, V41, P645, DOI 10.1016/j.ijpara.2011.01.005; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; Lehmann T, 2006, P NATL ACAD SCI USA, V103, P11423, DOI 10.1073/pnas.0601438103; Li ZR, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035834, 10.1371/journal.pone.0051597]; Mavin S, 2003, BRIT J BIOMED SCI, V60, P217, DOI 10.1080/09674845.2003.11783702; McLeod R, 2006, PEDIATR INFECT DIS J, V25, P270, DOI 10.1097/01.inf.0000202070.59190.9a; Mercier A, 2011, INFECT GENET EVOL, V11, P1378, DOI 10.1016/j.meegid.2011.05.003; Mercier A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000876; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Pena HFJ, 2008, INT J PARASITOL, V38, P561, DOI 10.1016/j.ijpara.2007.09.004; Qian WF, 2012, VET PARASITOL, V187, P408, DOI 10.1016/j.vetpar.2012.01.026; Rajendran C, 2012, INFECT GENET EVOL, V12, P359, DOI 10.1016/j.meegid.2011.12.010; SIBLEY LD, 1992, NATURE, V359, P82, DOI 10.1038/359082a0; Stillwaggon E, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001333; Su C, 2006, INT J PARASITOL, V36, P841, DOI 10.1016/j.ijpara.2006.03.003; Su C, 2010, PARASITOLOGY, V137, P1, DOI 10.1017/S0031182009991065; Su CL, 2012, P NATL ACAD SCI USA, V109, P5844, DOI 10.1073/pnas.1203190109; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Velmurugan GV, 2008, VET PARASITOL, V155, P314, DOI 10.1016/j.vetpar.2008.04.021; Zeiner GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008742; Zhou P, 2008, TRENDS PARASITOL, V24, P190, DOI 10.1016/j.pt.2008.01.001; Zhou P, 2011, J PARASITOL, V97, P1193, DOI 10.1645/GE-2851.1; Zhou P, 2010, J PARASITOL, V96, P1027, DOI 10.1645/GE-2465.1; Zhou P, 2009, PARASITOL INT, V58, P193, DOI 10.1016/j.parint.2009.01.006	51	87	110	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53483	10.1371/journal.pone.0053483	http://dx.doi.org/10.1371/journal.pone.0053483			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308233	Green Published, gold, Green Submitted			2022-12-25	WOS:000313429100073
J	Xuan, WJ; Vatansever, F; Huang, LY; Wu, QH; Xuan, Y; Dai, TH; Ando, T; Xu, T; Huang, YY; Hamblin, MR				Xuan, Weijun; Vatansever, Fatma; Huang, Liyi; Wu, Qiuhe; Xuan, Yi; Dai, Tianhong; Ando, Takahiro; Xu, Tao; Huang, Ying-Ying; Hamblin, Michael R.			Transcranial Low-Level Laser Therapy Improves Neurological Performance in Traumatic Brain Injury in Mice: Effect of Treatment Repetition Regimen	PLOS ONE			English	Article							BIPHASIC DOSE-RESPONSE; ACUTE ISCHEMIC-STROKE; LIGHT THERAPY; FLUORO-JADE; ADULT BRAIN; NEURONAL DEGENERATION; SUBVENTRICULAR ZONE; STEM-CELLS; DEFICITS; NEUROGENESIS	Low-level laser (light) therapy (LLLT) has been clinically applied around the world for a spectrum of disorders requiring healing, regeneration and prevention of tissue death. One area that is attracting growing interest in this scope is the use of transcranial LLLT to treat stroke and traumatic brain injury (TBI). We developed a mouse model of severe TBI induced by controlled cortical impact and explored the effect of different treatment schedules. Adult male BALB/c mice were divided into 3 broad groups (a) sham-TBI sham-treatment, (b) real-TBI sham-treatment, and (c) real-TBI active-treatment. Mice received active-treatment (transcranial LLLT by continuous wave 810 nm laser, 25 mW/cm(2), 18 J/cm(2), spot diameter 1 cm) while sham-treatment was immobilization only, delivered either as a single treatment at 4 hours post TBI, as 3 daily treatments commencing at 4 hours post TBI or as 14 daily treatments. Mice were sacrificed at 0, 4, 7, 14 and 28 days post-TBI for histology or histomorphometry, and injected with bromodeoxyuridine (BrdU) at days 21-27 to allow identification of proliferating cells. Mice with severe TBI treated with 1-laser Tx (and to a greater extent 3-laser Tx) had significant improvements in neurological severity score (NSS), and wire-grip and motion test (WGMT). However 14-laser Tx provided no benefit over TBI-sham control. Mice receiving 1-and 3-laser Tx had smaller lesion size at 28-days (although the size increased over 4 weeks in all TBI-groups) and less Fluoro-Jade staining for degenerating neurons (at 14 days) than in TBI control and 14-laser Tx groups. There were more BrdU-positive cells in the lesion in 1-and 3-laser groups suggesting LLLT may increase neurogenesis. Transcranial NIR laser may provide benefit in cases of acute TBI provided the optimum treatment regimen is employed.	[Xuan, Weijun; Vatansever, Fatma; Huang, Liyi; Wu, Qiuhe; Xuan, Yi; Dai, Tianhong; Ando, Takahiro; Xu, Tao; Huang, Ying-Ying; Hamblin, Michael R.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Xuan, Weijun; Vatansever, Fatma; Huang, Liyi; Wu, Qiuhe; Dai, Tianhong; Xu, Tao; Huang, Ying-Ying; Hamblin, Michael R.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Xuan, Weijun] Tradit Chinese Med Univ Guangxi, Dept Otolaryngol, Nanning, Peoples R China; [Huang, Liyi] Guangxi Med Univ, Affiliated Coll & Hosp 1, Dept Infect Dis, Nanning, Peoples R China; [Wu, Qiuhe] Jinan Ctr Hosp, Dept Burn, Jinan, Peoples R China; [Xuan, Yi] Tufts Univ, Sch Engn, Medford, MA USA; [Ando, Takahiro] Keio Univ, Dept Elect & Elect Engn, Kohoku Ku, Yokohama, Kanagawa 223, Japan; [Xu, Tao] Shanghai Jiao Tong Univ, Lab Anesthesiol, Shanghai 200030, Peoples R China; [Huang, Ying-Ying] Guangxi Med Univ, Aesthet & Plast Ctr, Nanning, Peoples R China; [Hamblin, Michael R.] Harvard MIT Div Hlth Sci & Technol, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Guangxi Medical University; Tufts University; Keio University; Shanghai Jiao Tong University; Guangxi Medical University; Harvard University	Hamblin, MR (corresponding author), Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA.	hamblin@helix.mgh.harvard.edu	Dai, Tianhong/P-5961-2018; Ando, Takahiro/H-5209-2019; Huang, Ying-ying/G-3153-2011; Huang, yingying/J-7329-2012; Ando, Takahiro/R-8374-2019; Hamblin, Michael R/H-2758-2019; Hamblin, Mike/AAB-2511-2022	Dai, Tianhong/0000-0001-8960-8896; Huang, Ying-ying/0000-0003-3066-6981; Huang, yingying/0000-0002-4038-0277; Hamblin, Michael R/0000-0001-6431-4605; Xu, Tao/0000-0001-5868-4079	NIH [R01AI050875]; Center for Integration of Medicine and Innovative Technology [DAMD17-02-2-0006]; CDMRP Program in TBI [W81XWH-09-1-0514]; Air Force Office of Scientific Research Military Photomedicine Program [FA9550-11-1-0331]; Grants-in-Aid for Scientific Research [10J04881] Funding Source: KAKEN; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050875] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Integration of Medicine and Innovative Technology; CDMRP Program in TBI; Air Force Office of Scientific Research Military Photomedicine Program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH grant R01AI050875, Center for Integration of Medicine and Innovative Technology (DAMD17-02-2-0006), CDMRP Program in TBI (W81XWH-09-1-0514) and Air Force Office of Scientific Research Military Photomedicine Program (FA9550-11-1-0331). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026212; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Barker JM, 2011, EUR J NEUROSCI, V34, P963, DOI 10.1111/j.1460-9568.2011.07823.x; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Chen ACH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022453; Chung H, 2012, ANN BIOMED ENG, V40, P516, DOI 10.1007/s10439-011-0454-7; Davis PJ., 2007, METHODS NUMERICAL IN; DeTaboada L, 2006, LASER SURG MED, V38, P70, DOI 10.1002/lsm.20256; Feeser VR, 2011, J NEUROIMMUNOL, V237, P4, DOI 10.1016/j.jneuroim.2011.06.007; Frenette AJ, 2012, J NEUROTRAUM, V29, P1, DOI 10.1089/neu.2011.1812; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; Heile Anna, 2011, Dialogues Clin Neurosci, V13, P279; Huang YY, 2012, J BIOPHOTONICS, V5, P827, DOI 10.1002/jbio.201200077; Huang YY, 2011, DOSE-RESPONSE, V9, P602, DOI 10.2203/dose-response.11-009.Hamblin; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Karonen JO, 1999, STROKE, V30, P1583, DOI 10.1161/01.STR.30.8.1583; KARU T, 1995, J PHOTOCH PHOTOBIO B, V27, P219, DOI 10.1016/1011-1344(94)07078-3; Karu TI, 2005, LASER SURG MED, V36, P307, DOI 10.1002/lsm.20148; Khuman J, 2012, J NEUROTRAUM, V29, P408, DOI 10.1089/neu.2010.1745; Kokaia Z, 2006, CEREB CORTEX, V16, pI162, DOI 10.1093/cercor/bhj174; Kuo JR, 2011, J TRAUMA, V71, pE87, DOI 10.1097/TA.0b013e31820932e2; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Lampl Yair, 2007, Expert Rev Neurother, V7, P961, DOI 10.1586/14737175.7.8.961; Lapchak PA, 2004, STROKE, V35, P1985, DOI 10.1161/01.STR.0000131808.69640.b7; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; Ling GSF, 2005, NEUROCRIT CARE, V2, P75, DOI 10.1385/NCC:2:1:075; Lulic D, 2011, NEUROSURGERY, V68, P1172, DOI 10.1227/NEU.0b013e31820c6cdc; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; McIntosh TK, 1996, EUR J ANAESTH, V13, P291, DOI 10.1046/j.1365-2346.1996.00981.x; Muller CJ, 2009, EXP NEUROL, V219, P284, DOI 10.1016/j.expneurol.2009.05.035; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P443, DOI 10.1089/pho.2011.9908; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P351, DOI 10.1089/pho.2010.2814; Nichol AD, 2011, LANCET NEUROL, V10, P405, DOI 10.1016/S1474-4422(11)70085-0; Oron A, 2007, J NEUROTRAUM, V24, P651, DOI 10.1089/neu.2006.0198; Oron A, 2006, STROKE, V37, P2620, DOI 10.1161/01.STR.0000242775.14642.b8; Oron A, 2012, J NEUROTRAUM, V29, P401, DOI 10.1089/neu.2011.2062; Pascual JL, 2011, J TRAUMA, V70, P535, DOI 10.1097/TA.0b013e31820b59de; Quirk BJ, 2012, PHOTOMED LASER SURG, V30, P523, DOI 10.1089/pho.2012.3261; Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Sharma SK, 2011, LASER SURG MED, V43, P851, DOI 10.1002/lsm.21100; Stemer Andrew B, 2010, Curr Cardiol Rep, V12, P29, DOI 10.1007/s11886-009-0071-3; Streeter J, 2004, MITOCHONDRION, V4, P569, DOI 10.1016/j.mito.2004.07.037; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wong-Riley MTT, 2005, J BIOL CHEM, V280, P4761, DOI 10.1074/jbc.M409650200; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003; Xiong Y, 2010, DISCOV MED, V10, P434; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhang RL, 2008, NEUROPHARMACOLOGY, V55, P345, DOI 10.1016/j.neuropharm.2008.05.027; Zivin JA, 2009, STROKE, V40, P1359, DOI 10.1161/STROKEAHA.109.547547	55	88	103	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53454	10.1371/journal.pone.0053454	http://dx.doi.org/10.1371/journal.pone.0053454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308226	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429100069
J	Zhang, LJ; Qi, RF; Zhong, JH; Ni, L; Zheng, G; Xu, J; Lu, GM				Zhang, Long Jiang; Qi, Rongfeng; Zhong, Jianhui; Ni, Ling; Zheng, Gang; Xu, Jian; Lu, Guang Ming			Disrupted Functional Connectivity of the Anterior Cingulate Cortex in Cirrhotic Patients without Overt Hepatic Encephalopathy: A Resting State fMRI Study	PLOS ONE			English	Article							HUMAN BRAIN; ATTENTION SYSTEM; NEURAL MECHANISM; IMPAIRMENT; COGNITION; NETWORKS; INSIGHT; DRIVE; GYRUS	Background: To evaluate the changes of functional connectivity of the anterior cingulate cortex (ACC) in patients with cirrhosis without overt hepatic encephalopathy (HE) using resting state functional MRI. Methodology/Principal Findings: Participants included 67 cirrhotic patients (27 minimal hepatic encephalopathy (MHE) and 40 cirrhotic patients without MHE (non-HE)), and 40 age-and gender-matched healthy controls. rsfMRI were performed on 3 Telsa scanners. The pregenual ACC resting-state networks (RSNs) were characterized by using a standard seed-based whole-brain correlation method and compared between cirrhotic patients and healthy controls. Pearson correlation analysis was performed between the ACC RSNs and venous blood ammonia levels, neuropsychological tests (number connection test type A [NCT-A] and digit symbol test [DST]) scores in cirrhotic patients. All thresholds were set at P<0.05, with false discovery rate corrected. Compared with controls, non-HE and MHE patients showed significantly decreased functional connectivity in the bilateral ACC, bilateral middle frontal cortex (MFC), bilateral middle cingulate cortex (MCC), bilateral superior temporal gyri (STG)/middle temporal gyri (MTG), bilateral thalami, bilateral putamen and bilateral insula, and increased functional connectivity of bilateral precuneus and left temporo-occipital lobe and bilateral lingual gyri. Compared with non-HE patients, MHE showed the decreased functional connectivity of right MCC, bilateral STG/MTG and right putamen. This indicates decreased ACC functional connectivity predominated with the increasing severity of HE. NCT-A scores negatively correlated with ACC functional connectivity in the bilateral MCC, right temporal lobe, and DST scores positively correlated with functional connectivity in the bilateral ACC and the right putamen. No correlation was found between venous blood ammonia levels and functional connectivity in ACC in cirrhotic patients. Conclusions/Significance: Disrupted functional connectivity in ACC was found in cirrhotic patients which further deteriorated with the increasing severity of HE and correlated cognitive dysfunction in cirrhotic patients.	[Zhang, Long Jiang; Qi, Rongfeng; Ni, Ling; Zheng, Gang; Xu, Jian; Lu, Guang Ming] Nanjing Univ, Jinling Hosp, Clin Sch Med Coll, Dept Med Imaging, Nanjing 210008, Jiangsu, Peoples R China; [Zhong, Jianhui] Zhejiang Univ, Dept Biomed Engn, Hangzhou 310003, Zhejiang, Peoples R China	Nanjing University; Zhejiang University	Xu, J (corresponding author), Nanjing Univ, Jinling Hosp, Clin Sch Med Coll, Dept Med Imaging, Nanjing 210008, Jiangsu, Peoples R China.	13851656307@163.com; cjr.luguangming@vip.163.com	Zhong, Jianhui/AAE-6061-2020		Natural Scientific Foundation of China [30700194, 81230032, 81101039]; Chinese Key Program [BWS11J063, 10z026]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Key Program	This work was supported by the grants from the Natural Scientific Foundation of China [Grant Nos. 30700194 and 81230032 for Long Jiang Zhang, Grant No. 81101039 for Gang Zheng], and Chinese Key Program (Grant Nos BWS11J063 and 10z026 for Guangming Lu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio P, 2005, METAB BRAIN DIS, V20, P115, DOI 10.1007/s11011-005-4149-3; Bajaj JS, 2008, CLIN GASTROENTEROL H, V6, P1135, DOI 10.1016/j.cgh.2008.05.025; Bajaj JS, 2008, WORLD J GASTROENTERO, V14, P3609, DOI 10.3748/wjg.14.3609; Bajaj JS, 2008, HEPATOLOGY, V47, P596, DOI 10.1002/hep.22032; Bajaj JS, 2009, HEPATOLOGY, V50, P2014, DOI 10.1002/hep.23216; BATES JF, 1993, J COMP NEUROL, V336, P211, DOI 10.1002/cne.903360205; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Ciecko-Michalska I, 2006, Adv Med Sci, V51, P273; Durieux PF, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00040; Dziobek I, 2011, NEUROIMAGE, V57, P539, DOI 10.1016/j.neuroimage.2011.05.005; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Grahn JA, 2009, BEHAV BRAIN RES, V199, P53, DOI 10.1016/j.bbr.2008.11.020; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hsu TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035266; Iwasa M, 2005, METAB BRAIN DIS, V20, P7, DOI 10.1007/s11011-005-2472-3; Kato A, 2000, HEPATOL RES, V17, P237, DOI 10.1016/S1386-6346(99)00080-7; Lin WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036986; Luo J, 2003, HIPPOCAMPUS, V13, P316, DOI 10.1002/hipo.10069; Luo Q, 2007, NEUROIMAGE, V38, P631, DOI 10.1016/j.neuroimage.2007.07.051; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Montoliu C, 2012, NEUROIMAGE, V61, P1165, DOI 10.1016/j.neuroimage.2012.03.041; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Pourtois G, 2010, NEUROPSYCHOLOGIA, V48, P1144, DOI 10.1016/j.neuropsychologia.2009.12.020; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Qi RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037400; Roman E, 2011, AM J GASTROENTEROL, V106, P476, DOI 10.1038/ajg.2010.413; Sohn MH, 2007, P NATL ACAD SCI USA, V104, P10330, DOI 10.1073/pnas.0703225104; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Wein C, 2004, HEPATOLOGY, V39, P739, DOI 10.1002/hep.20095; Weissenborn K, 2001, METAB BRAIN DIS, V16, P13, DOI 10.1023/A:1011654210096; Weissenborn K, 2001, J HEPATOL, V34, P768, DOI 10.1016/S0168-8278(01)00026-5; Yu CS, 2011, NEUROIMAGE, V54, P2571, DOI 10.1016/j.neuroimage.2010.11.018; Zafiris O, 2004, NEUROIMAGE, V22, P541, DOI 10.1016/j.neuroimage.2004.01.038; Zhang LJ, 2012, AJNR AM J NEURORADIO; Zhang LJ, 2007, ACTA RADIOL, V48, P577, DOI 10.1080/02841850701308378; Zhang LJ, 2010, HEPATOL RES, V40, P777, DOI 10.1111/j.1872-034X.2010.00681.x; Zhang LJ, 2012, HUM BRAIN MAPP, V33, P1384, DOI 10.1002/hbm.21295	41	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53206	10.1371/journal.pone.0053206	http://dx.doi.org/10.1371/journal.pone.0053206			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308163	Green Published, gold, Green Submitted			2022-12-25	WOS:000313429100038
J	Carvalho, JG; Leite, AD; Peres-Buzalaf, C; Salvato, F; Labate, CA; Everett, ET; Whitford, GM; Buzalaf, MAR				Carvalho, Juliane Guimaraes; Leite, Aline de Lima; Peres-Buzalaf, Camila; Salvato, Fernanda; Labate, Carlos Alberto; Everett, Eric T.; Whitford, Gary Milton; Rabelo Buzalaf, Marilia Afonso			Renal Proteome in Mice with Different Susceptibilities to Fluorosis	PLOS ONE			English	Article							CYSTATHIONINE GAMMA-LYASE; QUANTITATIVE TRAIT LOCI; DENTAL FLUOROSIS; FLUORIDE METABOLISM; CELLS; PHOSPHATASE; KIDNEY; PHOSPHORYLATION; EXPRESSION; AQUAPORIN-2	A/J and 129P3/J mouse strains have different susceptibilities to dental fluorosis due to their genetic backgrounds. They also differ with respect to several features of fluoride (F) metabolism and metabolic handling of water. This study was done to determine whether differences in F metabolism could be explained by diversities in the profile of protein expression in kidneys. Weanling, male A/J mice (susceptible to dental fluorosis, n = 18) and 129P3/J mice (resistant, n = 18) were housed in pairs and assigned to three groups given low-F food and drinking water containing 0, 10 or 50 ppm [F] for 7 weeks. Renal proteome profiles were examined using 2D-PAGE and LC-MS/MS. Quantitative intensity analysis detected between A/J and 129P3/J strains 122, 126 and 134 spots differentially expressed in the groups receiving 0, 10 and 50 ppmF, respectively. From these, 25, 30 and 32, respectively, were successfully identified. Most of the proteins were related to metabolic and cellular processes, followed by response to stimuli, development and regulation of cellular processes. In F-treated groups, PDZK-1, a protein involved in the regulation of renal tubular reabsorption capacity was down-modulated in the kidney of 129P3/J mice. A/J and 129P3/J mice exhibited 11 and 3 exclusive proteins, respectively, regardless of F exposure. In conclusion, proteomic analysis was able to identify proteins potentially involved in metabolic handling of F and water that are differentially expressed or even not expressed in the strains evaluated. This can contribute to understanding the molecular mechanisms underlying genetic susceptibility to dental fluorosis, by indicating key-proteins that should be better addressed in future studies.	[Carvalho, Juliane Guimaraes; Leite, Aline de Lima; Peres-Buzalaf, Camila; Rabelo Buzalaf, Marilia Afonso] Univ Sao Paulo, Bauru Dent Sch, Dept Biol Sci, Bauru, SP, Brazil; [Salvato, Fernanda; Labate, Carlos Alberto] Univ Sao Paulo, Dept Genet, Escola Super Agr Luiz de Queiros, Piracicaba, SP, Brazil; [Everett, Eric T.] Univ N Carolina, Sch Dent, Dept Pediat Dent, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Whitford, Gary Milton] Med Coll Georgia, Sch Dent, Dept Oral Biol, Augusta, GA 30912 USA	Universidade de Sao Paulo; Universidade de Sao Paulo; University of North Carolina; University of North Carolina Chapel Hill; University System of Georgia; Augusta University	Buzalaf, MAR (corresponding author), Univ Sao Paulo, Bauru Dent Sch, Dept Biol Sci, Bauru, SP, Brazil.	mbuzalaf@fob.usp.br	Leite, Aline/J-9748-2012; Buzalaf, Marilia Afonso Rabelo/C-5228-2012; Labate, Carlos Alberto/L-2183-2015; Salvato, Fernanda/AAR-4373-2020; Buzalaf, Marilia Afonso Rabelo/AAU-2554-2021; Peres-Buzalaf, Camila/C-5109-2012; Everett, Eric/AAP-4459-2021; Salvato, Fernanda/J-6560-2014	Leite, Aline/0000-0002-2112-1309; Buzalaf, Marilia Afonso Rabelo/0000-0002-5985-3951; Labate, Carlos Alberto/0000-0001-7309-1300; Buzalaf, Marilia Afonso Rabelo/0000-0002-5985-3951; Salvato, Fernanda/0000-0003-1650-5399	Sao Paulo State Research Support Foundation (FAPESP) [2005/04671-0]; CNPq [471485/2007-1]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018104] Funding Source: NIH RePORTER	Sao Paulo State Research Support Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Sao Paulo State Research Support Foundation (FAPESP) (grant 2005/04671-0) and CNPq (grant 471485/2007-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggen JB, 2000, CHEM BIOL, V7, pR13, DOI 10.1016/S1074-5521(00)00069-7; Becchetti A, 2002, AM J PHYSIOL-RENAL, V283, pF1030, DOI 10.1152/ajprenal.00011.2002; Beltran-Aguilar Eugenio D., 2005, Morbidity and Mortality Weekly Report, V54, P1; Blaszczyk I, 2010, BIOL TRACE ELEM RES, V133, P60, DOI 10.1007/s12011-009-8412-z; Bond JS, 2005, FEBS LETT, V579, P3317, DOI 10.1016/j.febslet.2005.03.045; Bronckers ALJJ, 2009, J DENT RES, V88, P877, DOI 10.1177/0022034509343280; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Carvalho JG, 2009, J DENT RES, V88, P1054, DOI 10.1177/0022034509347249; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Darman RB, 2001, J BIOL CHEM, V276, P34359, DOI 10.1074/jbc.C100368200; Dynia DW, 2010, AM J PHYSIOL-RENAL, V298, pF745, DOI 10.1152/ajprenal.00182.2009; Everett ET, 2011, J DENT RES, V90, P552, DOI 10.1177/0022034510384626; Everett ET, 2011, EUR J ORAL SCI, V119, P8, DOI 10.1111/j.1600-0722.2011.00868.x; Everett ET, 2009, CELLS TISSUES ORGANS, V189, P212, DOI 10.1159/000151383; Everett ET, 2002, J DENT RES, V81, P794, DOI 10.1177/0810794; Gillmore JD, 1999, THORAX, V54, P444, DOI 10.1136/thx.54.5.444; Huang H, 2008, COMMUNITY DENT ORAL, V36, P517, DOI 10.1111/j.1600-0528.2007.00424.x; Khan A, 2005, SADJ, V60, P418; Kronenberg D, 2010, J INVEST DERMATOL, V130, P2727, DOI 10.1038/jid.2010.202; Levonen AL, 2000, BIOCHEM J, V347, P291, DOI 10.1042/0264-6021:3470291; LI DL, 1995, AM J PHYSIOL-RENAL, V269, pF673, DOI 10.1152/ajprenal.1995.269.5.F673; Moeller HB, 2010, P NATL ACAD SCI USA, V107, P424, DOI 10.1073/pnas.0910683107; Moeller HB, 2009, KIDNEY INT, V75, P295, DOI 10.1038/ki.2008.505; Mori Y, 2001, JPN J PHYSIOL, V51, P371, DOI 10.2170/jjphysiol.51.371; Mousny M, 2008, BONE, V43, P1067, DOI 10.1016/j.bone.2008.07.248; Mousny M, 2006, BONE, V39, P1283, DOI 10.1016/j.bone.2006.06.006; Peraza MA, 2003, CELL BIOL TOXICOL, V19, P253, DOI 10.1023/B:CBTO.0000003970.60896.49; Portilla D, 2000, AM J PHYSIOL-RENAL, V278, pF667, DOI 10.1152/ajprenal.2000.278.4.F667; Buzalaf MAR, 2011, MONOGR ORAL SCI, V22, P1, DOI 10.1159/000325101; Buzalaf MAR, 2011, MONOGR ORAL SCI, V22, P20, DOI 10.1159/000325107; Rison Stuart C. G., 2000, Functional and Integrative Genomics, V1, P56; Roberts MF, 2000, FRONT BIOSCI-LANDMRK, V5, pD796, DOI 10.2741/roberts; SCHIFFL HH, 1980, NEPHRON, V26, P69, DOI 10.1159/000181954; TAVES DR, 1968, TALANTA, V15, P1015, DOI 10.1016/0039-9140(68)80109-2; Thomson RB, 2005, P NATL ACAD SCI USA, V102, P13331, DOI 10.1073/pnas.0506578102; Tilton RG, 2007, PROTEOMICS, V7, P1729, DOI 10.1002/pmic.200700017; Valenti G, 2000, J CELL SCI, V113, P1985; Whitford GM, 1996, MONOGR ORAL SCI, V16, P1; WHITFORD GM, 1976, AM J PHYSIOL, V230, P527, DOI 10.1152/ajplegacy.1976.230.2.527; Yang GD, 2010, CARDIOVASC RES, V86, P487, DOI 10.1093/cvr/cvp420; Zhang DJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE287, DOI 10.1152/ajpendo.00308.2010	41	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53261	10.1371/journal.pone.0053261	http://dx.doi.org/10.1371/journal.pone.0053261			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308176	Green Published, gold, Green Submitted			2022-12-25	WOS:000313670100027
J	Mayan, MD				Mayan, Maria D.			RNAP-II Molecules Participate in the Anchoring of the ORC to rDNA Replication Origins	PLOS ONE			English	Article							BETA-GLOBIN LOCUS; C-TERMINAL DOMAIN; CTD KINASE-I; POLYMERASE-II; DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; RECOGNITION COMPLEX; ALPHA-AMANITIN; GENOME-WIDE; FUNCTIONAL ELEMENTS	The replication of genomic DNA is limited to a single round per cell cycle. The first component, which recognises and remains bound to origins from recognition until activation and replication elongation, is the origin recognition complex. How origin recognition complex (ORC) proteins remain associated with chromatin throughout the cell cycle is not yet completely understood. Several genome-wide studies have undoubtedly demonstrated that RNA polymerase II (RNAP-II) binding sites overlap with replication origins and with the binding sites of the replication components. RNAP-II is no longer merely associated with transcription elongation. Several reports have demonstrated that RNAP-II molecules affect chromatin structure, transcription, mRNA processing, recombination and DNA repair, among others. Most of these activities have been reported to directly depend on the interaction of proteins with the C-terminal domain (CTD) of RNAP-II. Two-dimensional gels results and ChIP analysis presented herein suggest that stalled RNAP-II molecules bound to the rDNA chromatin participate in the anchoring of ORC proteins to origins during the G1 and S-phases. The results show that in the absence of RNAP-II, Orc1p, Orc2p and Cdc6p do not bind to origins. Moreover, co-immunoprecipitation experiments suggest that Ser2P-CTD and hypophosphorylated RNAP-II interact with Orc1p. In the context of rDNA, cryptic transcription by RNAP-II did not negatively interfere with DNA replication. However, the results indicate that RNAP-II is not necessary to maintain the binding of ORCs to the origins during metaphase. These findings highlight for the first time the potential importance of stalled RNAP-II in the regulation of DNA replication.	[Mayan, Maria D.] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, London, England	Imperial College London	Mayan, MD (corresponding author), CHUAC, Biomed Res Ctr INIBIC, Div Rheumatol, La Coruna, Spain.	MA.Dolores.Mayan.Santos@sergas.es	Mayán, María D./AAR-9227-2021; Mayan, Maria D./C-8813-2012	Mayán, María D./0000-0002-5809-9440; Mayan, Maria D./0000-0002-5809-9440	Medical Research Council of the United Kingdom; Xunta de Galicia	Medical Research Council of the United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Xunta de Galicia(Xunta de GaliciaEuropean Commission)	This work was supported by the Medical Research Council of the United Kingdom. Maria D. Mayan is currently funded by the Xunta de Galicia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; ALADJEM MI, 1995, SCIENCE, V270, P815, DOI 10.1126/science.270.5237.815; Antequera F, 2003, CELL MOL LIFE SCI, V60, P1647, DOI 10.1007/s00018-003-3088-6; Beall EL, 2002, NATURE, V420, P833, DOI 10.1038/nature01228; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1993, SCIENCE, V262, P1844, DOI 10.1126/science.8266072; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bodmer-Glavas M, 2001, NUCLEIC ACIDS RES, V29, P4570, DOI 10.1093/nar/29.22.4570; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Bosco G, 2001, NAT CELL BIOL, V3, P289, DOI 10.1038/35060086; Bouchoux C, 2004, NUCLEIC ACIDS RES, V32, P5851, DOI 10.1093/nar/gkh927; BREGMAN DB, 1995, J CELL BIOL, V129, P287, DOI 10.1083/jcb.129.2.287; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; BREWER BJ, 1988, CELL, V55, P637, DOI 10.1016/0092-8674(88)90222-X; Brookes E, 2009, EMBO REP, V10, P1213, DOI 10.1038/embor.2009.221; BUCHMAN AR, 1988, MOL CELL BIOL, V8, P210, DOI 10.1128/MCB.8.1.210; Burkhalter MD, 2004, MOL CELL, V15, P409, DOI 10.1016/j.molcel.2004.06.024; Bushnell DA, 2002, P NATL ACAD SCI USA, V99, P1218, DOI 10.1073/pnas.251664698; Cadoret JC, 2008, P NATL ACAD SCI USA, V105, P15837, DOI 10.1073/pnas.0805208105; Calvi BR, 2007, GENETICS, V177, P1291, DOI 10.1534/genetics.107.070862; Carlson M, 1997, ANNU REV CELL DEV BI, V13, P1, DOI 10.1146/annurev.cellbio.13.1.1; CHAFIN DR, 1995, J BIOL CHEM, V270, P19114, DOI 10.1074/jbc.270.32.19114; Chapman RD, 2008, TRENDS GENET, V24, P289, DOI 10.1016/j.tig.2008.03.010; Cioci F, 2003, MOL CELL, V12, P135, DOI 10.1016/S1097-2765(03)00262-4; Clemente-Blanco A, 2011, NAT CELL BIOL, V13, P1450, DOI 10.1038/ncb2365; Danis E, 2004, NAT CELL BIOL, V6, P721, DOI 10.1038/ncb1149; DePamphilis ML, 2005, CELL CYCLE, V4, P70, DOI 10.4161/cc.4.1.1333; Diffley JFX, 2011, PHILOS T R SOC B, V366, P3545, DOI 10.1098/rstb.2011.0073; Dirks RW, 1999, HISTOCHEM CELL BIOL, V111, P405, DOI 10.1007/s004180050374; Falk MM, 2009, MOL BIOL CELL, V20, P3342, DOI 10.1091/mbc.E09-04-0288; FORRESTER WC, 1990, GENE DEV, V4, P1637, DOI 10.1101/gad.4.10.1637; FOSS M, 1993, SCIENCE, V262, P1838, DOI 10.1126/science.8266071; Ganley ARD, 2005, P NATL ACAD SCI USA, V102, P11787, DOI 10.1073/pnas.0504905102; Gauthier L, 2002, GENETICS, V162, P1117; GOLDMAN MA, 1984, SCIENCE, V224, P686, DOI 10.1126/science.6719109; Gong XQ, 2004, J BIOL CHEM, V279, P27422, DOI 10.1074/jbc.M402163200; GOODENOUGH DA, 1980, J CELL BIOL, V86, P576, DOI 10.1083/jcb.86.2.576; Grenetier S, 2006, NUCLEIC ACIDS RES, V34, P4996, DOI 10.1093/nar/gkl493; Guillou E, GENES DEV, V24, P2812; HATTON KS, 1988, MOL CELL BIOL, V8, P2149, DOI 10.1128/MCB.8.5.2149; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Hirose Y, 2007, J BIOCHEM, V141, P601, DOI 10.1093/jb/mvm090; Houseley J, 2007, EMBO J, V26, P4996, DOI 10.1038/sj.emboj.7601921; Huang J, 2003, GENE DEV, V17, P2162, DOI 10.1101/gad.1108403; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kanaporis G, 2008, J GEN PHYSIOL, V131, P293, DOI 10.1085/jgp.200709934; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Knott SR, CELL, V148, P99; Kobayashi T, 2005, SCIENCE, V309, P1581, DOI 10.1126/science.1116102; Kohzaki H, 2005, BIOESSAYS, V27, P1107, DOI 10.1002/bies.20316; Li CH, 2006, MOL BIOL CELL, V17, P3848, DOI 10.1091/mbc.E06-03-0205; Lin HB, 2005, EXP CELL RES, V308, P53, DOI 10.1016/j.yexcr.2005.04.012; LINSKENS MHK, 1988, MOL CELL BIOL, V8, P4927, DOI 10.1128/MCB.8.11.4927; Maldonado E, 1996, NATURE, V381, P86, DOI 10.1038/381086a0; MARAHRENS Y, 1992, SCIENCE, V255, P817, DOI 10.1126/science.1536007; Margaritis T, 2008, CELL, V133, P581, DOI 10.1016/j.cell.2008.04.027; MARTIN C, 1989, MOL CELL BIOL, V9, P2341, DOI 10.1128/MCB.9.6.2341; MATSUI S, 1979, J CELL BIOL, V80, P451, DOI 10.1083/jcb.80.2.451; Mayan M, 2010, CELL CYCLE, V9, P4328, DOI 10.4161/cc.9.21.13591; Mayan MD, 2010, CURR PROTOC MOL BIOL, p2B; MICKLEM G, 1993, NATURE, V366, P87, DOI 10.1038/366087a0; Minami H, 2006, MOL CELL BIOL, V26, P8770, DOI 10.1128/MCB.00949-06; Muller M, 2000, MOL CELL, V5, P767, DOI 10.1016/S1097-2765(00)80317-2; Neish AS, 1998, NUCLEIC ACIDS RES, V26, P847, DOI 10.1093/nar/26.3.847; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Nguyen VT, 1996, NUCLEIC ACIDS RES, V24, P2924, DOI 10.1093/nar/24.15.2924; Nieduszynski CA, 2006, GENE DEV, V20, P1874, DOI 10.1101/gad.385306; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; Parsons GG, 1997, MOL CELL BIOL, V17, P5791, DOI 10.1128/MCB.17.10.5791; Pasero P, 2002, GENE DEV, V16, P2479, DOI 10.1101/gad.232902; Patturajan M, 1998, J BIOL CHEM, V273, P4689, DOI 10.1074/jbc.273.8.4689; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Prioleau MN, 2003, MOL CELL BIOL, V23, P3536, DOI 10.1128/MCB.23.10.3536-3549.2003; Radonjic M, 2005, MOL CELL, V18, P171, DOI 10.1016/j.molcel.2005.03.010; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Rytkonen AK, 2006, FEBS J, V273, P5535, DOI 10.1111/j.1742-4658.2006.05544.x; SAFFER LD, 1986, MOL CELL BIOL, V6, P1148, DOI 10.1128/MCB.6.4.1148; Sequeira-Mendes J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000446; SHORE D, 1987, CELL, V51, P721, DOI 10.1016/0092-8674(87)90095-X; Shukla A, 2009, CURR ISSUES MOL BIOL, V11, pI65; Stagljar I, 1999, BIOL CHEM, V380, P525, DOI 10.1515/BC.1999.067; Triolo T, 1996, NATURE, V381, P251, DOI 10.1038/381251a0; Van Slyke C, 2003, NUCLEIC ACIDS RES, V31, P4597, DOI 10.1093/nar/gkg638; Vujcic M, 1999, MOL CELL BIOL, V19, P6098; Wyrick JJ, 2001, SCIENCE, V294, P2357, DOI 10.1126/science.1066101; Xie SQ, 2006, MOL BIOL CELL, V17, P1723, DOI 10.1091/mbc.E05-08-0726; Yankulov K, 1999, MOL CELL BIOL, V19, P6154	89	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53405	10.1371/journal.pone.0053405	http://dx.doi.org/10.1371/journal.pone.0053405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308214	Green Published, gold, Green Submitted			2022-12-25	WOS:000313670100038
J	Vermeulen, JF; Kornegoor, R; van der Wall, E; van der Groep, P; van Diest, PJ				Vermeulen, Jeroen F.; Kornegoor, Robert; van der Wall, Elsken; van der Groep, Petra; van Diest, Paul J.			Differential Expression of Growth Factor Receptors and Membrane-Bound Tumor Markers for Imaging in Male and Female Breast Cancer	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; CARCINOMA; EXPERIENCE; HYPOXIA; MEN	Introduction: Male breast cancer accounts for 0.5-1% of all breast cancers and is generally diagnosed at higher stage than female breast cancers and therefore might benefit from earlier detection and targeted therapy. Except for HER2 and EGFR, little is known about expression of growth factor receptors in male breast cancer. We therefore investigated expression profiles of growth factor receptors and membrane-bound tumor markers in male breast cancer and gynecomastia, in comparison with female breast cancer. Methods: Tissue microarrays containing 133 male breast cancer and 32 gynecomastia cases were stained by immunohistochemistry for a panel of membrane-bound targets and compared with data on 266 female breast cancers. Results: Growth factor receptors were variably expressed in 4.5% (MET) up to 38.5% (IGF1-R) of male breast cancers. Compared to female breast cancer, IGF1-R and carbonic anhydrase 12 (CAXII) were more frequently and CD44v6, MET and FGFR2 less frequently expressed in male breast cancer. Expression of EGFR, HER2, CAIX, and GLUT1 was not significantly different between male and female breast cancer. Further, 48.1% of male breast cancers expressed at least one and 18.0% expressed multiple growth factor receptors. Since individual membrane receptors are expressed in only half of male breast cancers, a panel of membrane markers will be required for molecular imaging strategies to reach sensitivity. A potential panel of markers for molecular imaging, consisting of EGFR, IGF1-R, FGFR2, CD44v6, CAXII, GLUT1, and CD44v6 was positive in 77% of male breast cancers, comparable to female breast cancers. Conclusions: Expression patterns of growth factor receptors and hypoxia membrane proteins in male breast cancer are different from female breast cancer. For molecular imaging strategies, a putative panel consisting of markers for EGFR, IGF1-R, FGFR2, GLUT1, CAXII, CD44v6 was positive in 77% of cases and might be considered for development of molecular tracers for male breast cancer.	[Vermeulen, Jeroen F.; Kornegoor, Robert; van der Groep, Petra; van Diest, Paul J.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [van der Wall, Elsken; van der Groep, Petra] Univ Med Ctr Utrecht, Div Internal Med & Dermatol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	van Diest, PJ (corresponding author), Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands.	p.j.vandiest@umcutrecht.nl			AEGON Inc.; MAMmary carcinoma MOlecular imaging for diagnostics and THerapeutics (MAMMOTH) project of the Dutch Center for Translational Molecular Medicine	AEGON Inc.; MAMmary carcinoma MOlecular imaging for diagnostics and THerapeutics (MAMMOTH) project of the Dutch Center for Translational Molecular Medicine	This work was supported by an unrestricted research grant of AEGON Inc. and by the MAMmary carcinoma MOlecular imaging for diagnostics and THerapeutics (MAMMOTH) project of the Dutch Center for Translational Molecular Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WF, 2010, J CLIN ONCOL, V28, P232, DOI 10.1200/JCO.2009.23.8162; Bane AL, 2009, BREAST CANCER RES TR, V117, P183, DOI 10.1007/s10549-008-0087-1; Barnett DH, 2008, CANCER RES, V68, P3505, DOI 10.1158/0008-5472.CAN-07-6151; Brockstein BE, 2011, DRUGS, V71, P1551, DOI 10.2165/11592540-000000000-00000; CCMO, CENTR COMM RES INV H; Ciocca V, 2006, HISTOPATHOLOGY, V49, P365, DOI 10.1111/j.1365-2559.2006.02519.x; Crane LMA, 2011, GYNECOL ONCOL, V120, P291, DOI 10.1016/j.ygyno.2010.10.009; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Evans DGR, 2010, J MED GENET, V47, P710, DOI 10.1136/jmg.2009.075176; Fentiman IS, 2006, LANCET, V367, P595, DOI 10.1016/S0140-6736(06)68226-3; Foerster R, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-335; FOX SB, 1992, J PATHOL, V166, P13, DOI 10.1002/path.1711660104; Garcia-Closas M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000054; Garrett CR, 2011, EXPERT OPIN BIOL TH, V11, P937, DOI 10.1517/14712598.2011.582464; Ge YM, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2258; Gee MS, 2008, RADIOLOGY, V248, P925, DOI 10.1148/radiol.2482071496; Gethins M, 2012, J NATL CANCER I, V104, P436, DOI 10.1093/jnci/djs172; Giordano SH, 2004, CANCER, V101, P51, DOI 10.1002/cncr.20312; Hirche C, 2010, BREAST CANCER RES TR, V121, P373, DOI 10.1007/s10549-010-0760-z; Kornegoor R, 2012, MODERN PATHOL, V25, P1397, DOI 10.1038/modpathol.2012.101; Kornegoor R, 2012, AM J SURG PATHOL, V36, P762, DOI 10.1097/PAS.0b013e31824324e6; Kornegoor R, 2012, MODERN PATHOL, V25, P398, DOI 10.1038/modpathol.2011.174; Lee SB, 2008, CLIN CANCER RES, V14, P3840, DOI 10.1158/1078-0432.CCR-07-4076; Miao H, 2011, J CLIN ONCOL, V29, P4381, DOI 10.1200/JCO.2011.36.8902; Moore J, 1998, Breast J, V4, P261, DOI 10.1046/j.1524-4741.1998.440261.x; PEYRAT JP, 1988, CANCER RES, V48, P6429; Pivot X, 2011, ANTI-CANCER DRUG, V22, P701, DOI 10.1097/CAD.0b013e328345ffa4; Pleijhuis RG, 2011, EJSO-EUR J SURG ONC, V37, P32, DOI 10.1016/j.ejso.2010.10.006; Pleijhuis RG, 2009, ANN SURG ONCOL, V16, P2717, DOI 10.1245/s10434-009-0609-z; Sampath L, 2007, J NUCL MED, V48, P1501, DOI 10.2967/jnumed.107.042234; Shaaban AM, 2012, BREAST CANCER RES TR, V133, P949, DOI 10.1007/s10549-011-1856-9; Stoll BA, 2002, ANN ONCOL, V13, P191, DOI 10.1093/annonc/mdf059; Valachis A, 2011, BREAST, V20, P485, DOI 10.1016/j.breast.2011.06.009; van der Groep P, 2006, J CLIN PATHOL, V59, P611, DOI 10.1136/jcp.2005.032151; van Diest PJ, 2002, BMJ-BRIT MED J, V325, P648, DOI 10.1136/bmj.325.7365.648; Vermeulen JF, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-240; Vermeulen JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037864; Willsher PC, 1997, ANTICANCER RES, V17, P2335; Wykoff CC, 2001, AM J PATHOL, V158, P1011, DOI 10.1016/S0002-9440(10)64048-5	39	14	14	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53353	10.1371/journal.pone.0053353	http://dx.doi.org/10.1371/journal.pone.0053353			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308200	Green Published, Green Submitted, gold			2022-12-25	WOS:000313670100033
J	Miyazaki, Y				Miyazaki, Yuki			Increasing Visual Search Accuracy by Being Watched	PLOS ONE			English	Article							GAZE-DIRECTION; COOPERATION; STARE; CUES; CONTACT; TIME; EYES	In daily life, huge costs can arise from just one incorrect performance on a visual search task (e. g., a fatal accident due to a driver overlooking a pedestrian). One potential way to prevent such drastic accidents would be for people to modify their decision criterion (e. g., placing a greater priority on accuracy rather than speed) during a visual search. The aim of the present study was to manipulate the criterion by creating an awareness of being watched by another person. During a visual search task, study participants were watched (or not watched) via video cameras and monitors. The results showed that, when they believed they were being watched by another person, they searched more slowly and accurately, as measured by reaction times and hit/miss rates. These findings also were obtained when participants were videotaped and they believed their recorded behavior would be watched by another person in the future. The study primarily demonstrated the role of being watched by another on the modulation of the decision criterion for responding during visual searches.	[Miyazaki, Yuki] Chukyo Univ, Sch Psychol, Nagoya, Aichi, Japan; [Miyazaki, Yuki] Kanagawa Univ, Res Inst Visual Sci, Yokohama, Kanagawa, Japan	Chukyo University; Kanagawa University	Miyazaki, Y (corresponding author), Chukyo Univ, Sch Psychol, Nagoya, Aichi, Japan.	y38zaki@lets.chukyo-u.ac.jp	Miyazaki, Yuki/AAD-3241-2022	Miyazaki, Yuki/0000-0003-4790-4368				Bateson M, 2006, BIOL LETTERS, V2, P412, DOI 10.1098/rsbl.2006.0509; Bourrat P, 2011, EVOL PSYCHOL-US, V9, P193, DOI 10.1177/147470491100900206; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Burnham TC, 2007, HUM NATURE-INT BIOS, V18, P88, DOI 10.1007/s12110-007-9012-2; Conty L, 2006, SPATIAL VISION, V19, P529, DOI 10.1163/156856806779194026; Conty L, 2010, COGNITION, V115, P133, DOI 10.1016/j.cognition.2009.12.005; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Doi HK, 2007, PERCEPTION, V36, P773, DOI 10.1068/p5614; Ekstrom M, 2012, EXP ECON, V15, P530, DOI 10.1007/s10683-011-9312-6; Ernest-Jones M, 2011, EVOL HUM BEHAV, V32, P172, DOI 10.1016/j.evolhumbehav.2010.10.006; Francey D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037397; George N, 2008, NEUROPHYSIOL CLIN, V38, P197, DOI 10.1016/j.neucli.2008.03.001; George N, 2001, NEUROIMAGE, V13, P1102, DOI 10.1006/nimg.2001.0769; Haley KJ, 2005, EVOL HUM BEHAV, V26, P245, DOI 10.1016/j.evolhumbehav.2005.01.002; Keller J, 2011, EUR J PERSONALITY, V25, P363, DOI 10.1002/per.797; Li XR, 2010, BEHAV RES METHODS, V42, P212, DOI 10.3758/BRM.42.1.212; Macmillan N. A., 2005, DETECTION THEORY USE; Mason MF, 2004, MEMORY, V12, P637, DOI 10.1080/09658210344000152; Mifune N, 2010, EVOL HUM BEHAV, V31, P109, DOI 10.1016/j.evolhumbehav.2009.09.004; Miyazaki Y, 2012, PERCEPT MOTOR SKILL, V114, P1007, DOI 10.2466/21.07.24.PMS.114.3.1007-1022; Oda R, 2011, EVOL HUM BEHAV, V32, P166, DOI 10.1016/j.evolhumbehav.2010.11.002; Palanica A, 2011, J VISION, V11, DOI 10.1167/11.2.19; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Powell KL, 2012, ETHOLOGY, V118, P1096, DOI 10.1111/eth.12011; Rigdon M, 2009, J ECON PSYCHOL, V30, P358, DOI 10.1016/j.joep.2009.02.002; SCHOUTEN JF, 1967, ACTA PSYCHOL, V27, P143, DOI 10.1016/0001-6918(67)90054-6; Senju A, 2005, VIS COGN, V12, P127, DOI 10.1080/13506280444000157; Senju A, 2006, PSYCHON B REV, V13, P223, DOI 10.3758/BF03193834; Senju A, 2009, TRENDS COGN SCI, V13, P127, DOI 10.1016/j.tics.2008.11.009; vonGrunau M, 1995, PERCEPTION, V24, P1297, DOI 10.1068/p241297; Vuilleumier P, 2005, VIS COGN, V12, P85, DOI 10.1080/13506280444000120; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; WICKELGREN WA, 1977, ACTA PSYCHOL, V41, P67, DOI 10.1016/0001-6918(77)90012-9; Wolfe JM, 2003, TRENDS COGN SCI, V7, P70, DOI 10.1016/S1364-6613(02)00024-4; Woodman GF, 2001, PSYCHOL SCI, V12, P219, DOI 10.1111/1467-9280.00339; Yokoyama T, 2011, PERCEPTION, V40, P785, DOI 10.1068/p7003	36	7	7	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53500	10.1371/journal.pone.0053500	http://dx.doi.org/10.1371/journal.pone.0053500			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	067UP	23301079	gold, Green Submitted, Green Published			2022-12-25	WOS:000313320900081
J	Siika, AM; Yiannoutsos, CT; Wools-Kaloustian, KK; Musick, BS; Mwangi, AW; Diero, LO; Kimaiyo, SN; Tierney, WM; Carter, JE				Siika, Abraham M.; Yiannoutsos, Constantin T.; Wools-Kaloustian, Kara K.; Musick, Beverly S.; Mwangi, Ann W.; Diero, Lameck O.; Kimaiyo, Sylvester N.; Tierney, William M.; Carter, Jane E.			Active Tuberculosis Is Associated with Worse Clinical Outcomes in HIV-Infected African Patients on Antiretroviral Therapy	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; PULMONARY TUBERCULOSIS; DISEASE PROGRESSION; WESTERN KENYA; WEIGHT-LOSS; SURVIVAL; MORTALITY; EPIDEMIOLOGY; PREVALENCE; EXPERIENCE	Objective: This cohort study utilized data from a large HIV treatment program in western Kenya to describe the impact of active tuberculosis (TB) on clinical outcomes among African patients on antiretroviral therapy (ART). Design: We included all patients initiating ART between March 2004 and November 2007. Clinical (signs and symptoms), radiological (chest radiographs) and laboratory (mycobacterial smears, culture and tissue histology) criteria were used to record the diagnosis of TB disease in the program's electronic medical record system. Methods: We assessed the impact of TB disease on mortality, loss to follow-up (LTFU) and incident AIDS-defining events (ADEs) through Cox models and CD4 cell and weight response to ART by non-linear mixed models. Results: We studied 21,242 patients initiating ART-5,186 (24%) with TB; 62% female; median age 37 years. There were proportionately more men in the active TB (46%) than in the non-TB (35%) group. Adjusting for baseline HIV-disease severity, TB patients were more likely to die (hazard ratio - HR = 1.32, 95% CI 1.18-1.47) or have incident ADEs (HR = 1.31, 95% CI: 1.19-1.45). They had lower median CD4 cell counts (77 versus 109), weight (52.5 versus 55.0 kg) and higher ADE risk at baseline (CD4-adjusted odds ratio = 1.55, 95% CI: 1.31-1.85). ART adherence was similarly good in both groups. Adjusting for gender and baseline CD4 cell count, TB patients experienced virtually identical rise in CD4 counts after ART initiation as those without. However, the overall CD4 count at one year was lower among patients with TB (251 versus 269 cells/mu l). Conclusions: Clinically detected TB disease is associated with greater mortality and morbidity despite salutary response to ART. Data suggest that identifying HIV patients co-infected with TB earlier in the HIV-disease trajectory may not fully address TB-related morbidity and mortality.	[Siika, Abraham M.; Diero, Lameck O.; Kimaiyo, Sylvester N.] Moi Univ, Coll Hlth Sci, Sch Med, Eldoret, Kenya; [Siika, Abraham M.; Yiannoutsos, Constantin T.; Wools-Kaloustian, Kara K.; Musick, Beverly S.; Mwangi, Ann W.; Diero, Lameck O.; Kimaiyo, Sylvester N.; Tierney, William M.; Carter, Jane E.] USAID Acad Model Providing Access Healthcare AMPA, Eldoret, Kenya; [Yiannoutsos, Constantin T.; Wools-Kaloustian, Kara K.; Musick, Beverly S.; Tierney, William M.] Indiana Univ Sch Med, Indianapolis, IN USA; [Mwangi, Ann W.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Tierney, William M.; Carter, Jane E.] Regenstrief Inst Inc, Indianapolis, IN USA	Moi University; United States Agency for International Development (USAID); Indiana University System; Indiana University Bloomington; Brown University; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc	Siika, AM (corresponding author), Moi Univ, Coll Hlth Sci, Sch Med, Eldoret, Kenya.	amsiika@africaonline.co.ke			USAID PEPFAR's grant [623-A-00-08-00003-00]; Prevention of Maternal To Child Transmission (MTCT - Plus) Initiative; Bill and Melinda Gates Foundation; Centers for Disease Control and Prevention (CDC); Kenya National AIDS and STI Control Program (NASCOP); National AIDS Control Council (NACC); United States Agency for International Development President's Emergency Program For AIDS Relief (USAID - PEPFAR); National Institutes of Health grant [AI-069911]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069911] Funding Source: NIH RePORTER	USAID PEPFAR's grant(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Prevention of Maternal To Child Transmission (MTCT - Plus) Initiative; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Kenya National AIDS and STI Control Program (NASCOP); National AIDS Control Council (NACC); United States Agency for International Development President's Emergency Program For AIDS Relief (USAID - PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The USAID-AMPATH Partnership clinical care programs are supported by USAID PEPFAR's grant #623-A-00-08-00003-00. The USAID-AMPATH Partnership program has in the past received support from the Prevention of Maternal To Child Transmission (MTCT - Plus) Initiative, Bill and Melinda Gates Foundation, Centers for Disease Control and Prevention (CDC), the Kenya National AIDS and STI Control Program (NASCOP) and National AIDS Control Council (NACC) and is currently funded by the United States Agency for International Development President's Emergency Program For AIDS Relief (USAID - PEPFAR). Dr. Yiannoutsos' and Wools-Kaloustian's research was partially supported by the National Institutes of Health grant AI-069911. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asimos AW, 1996, AM J EMERG MED, V14, P359, DOI 10.1016/S0735-6757(96)90049-2; Badri M, 2001, INT J TUBERC LUNG D, V5, P225; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; CHAISSON RE, 1987, AM REV RESPIR DIS, V136, P570, DOI 10.1164/ajrccm/136.3.570; Chamie G, 2010, INT J TUBERC LUNG D, V14, P1295; Collins Kalonji R., 2002, AIDS Reviews, V4, P165; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Corbett EL, 2001, INT J TUBERC LUNG D, V5, P205; Del Amo J, 1999, AIDS, V13, P1151, DOI 10.1097/00002030-199907090-00002; Division of Leprosy Tuberculosis and Lung disease, 2006, GUID IMPL TB HIV COL; Division of Leprosy Tuberculosis and Lung disease, 2012, ANN REP 2010 GOV KEN; Dragsted UB, 2004, J INFECT DIS, V190, P148, DOI 10.1086/420786; Einterz RM, 2007, ACAD MED, V82, P812, DOI 10.1097/ACM.0b013e3180cc29f1; FLEMING TR, 1995, J ACQ IMMUN DEF SYND, V10, pS9; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Lawn SD, 2011, J INFECT DIS, V204, pS1159, DOI 10.1093/infdis/jir411; Lopez-Gatell H, 2008, AIDS, V22, P1869, DOI 10.1097/QAD.0b013e32830e010c; Makombe SD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000620; Moore D, 2007, AIDS, V21, P713, DOI 10.1097/QAD.0b013e328013f632; Murray EJ, 2012, HLTH POLICY PLAN; National AIDS and STI Control Programme, 2005, GUID ANT DRUG THER K; Odhiambo J, 2008, INT J TUBERC LUNG D, V12, pS63; Pinheiro J, 2001, MIXED EFFECTS MODELS; PITCHENIK AE, 1985, AM REV RESPIR DIS, V131, P393; R Development Core Team, 2009, R FDN STAT COMP; Reid MJA, 2009, LANCET INFECT DIS, V9, P173, DOI 10.1016/S1473-3099(09)70043-X; Siika AM, 2005, INT J MED INFORM, V74, P345, DOI 10.1016/j.ijmedinf.2005.03.002; Tang AM, 2002, JAIDS-J ACQ IMM DEF, V31, P230, DOI 10.1097/00126334-200210010-00014; Tierney WM, 2007, STUD HEALTH TECHNOL, V129, P372; UNAIDS, 2010, UNAIDS REP GLOB AIDS; WHALEN C, 1995, AM J RESP CRIT CARE, V151, P129, DOI 10.1164/ajrccm.151.1.7812542; Wheeler DA, 1998, J ACQ IMMUN DEF SYND, V18, P80, DOI 10.1097/00042560-199805010-00012; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; Wools-Kaloustian K, 2006, AIDS, V20, P41, DOI 10.1097/01.aids.0000196177.65551.ea; World Health Organisation, 2007, WHO CAS DEF HIV SURV; Yiannoutsos CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003843	41	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53022	10.1371/journal.pone.0053022	http://dx.doi.org/10.1371/journal.pone.0053022			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301015	gold, Green Published, Green Submitted			2022-12-25	WOS:000313320900053
J	Burks, J; Reed, RE; Desai, SD				Burks, J.; Reed, R. E.; Desai, S. D.			ISGylation governs the oncogenic function of Ki-Ras in breast cancer	ONCOGENE			English	Article						ISG15; Ki-Ras; UbcH8; ISGylation; breast cancer; oncogenic transformation	UBIQUITIN-LIKE PROTEIN; ISG15 MODIFICATION; DOWN-REGULATION; TUMOR-CELLS; GENE; EXPRESSION; PATHWAY; SYSTEM; ENDOCYTOSIS; TRANSITION	Aberrant expression of the oncogenic Kirsten-Ras (Ki-Ras) and interferon-stimulated gene 15 (ISG15) pathways is common in breast and other cancers. However, whether these dysregulated pathways cooperate to promote malignancy is not known. This study links Ki-Ras and ISG15 in a previously unidentified regulatory loop that may underlie malignant transformation of mammary cells. We show that oncogenic Ki-Ras regulates the expression of the ISG15 pathway (free ISG15 and ISG15 conjugates), and ISG15, in turn, stabilizes Ki-Ras protein by inhibiting its targeted degradation via lysosomes in breast cancer cells. Disruption of this loop by silencing either Ki-Ras or the ISG15 pathway restored the disrupted cellular architecture, a hallmark feature of most cancer cells. We also demonstrate that ISG15 and UbcH8 (ISG15-specific conjugating enzyme) shRNAs reversed Ki-Ras mutation-associated phenotypes of cancer cells, such as increased cell proliferation, colony formation, anchorage-independent growth in soft agar, cell migration, and epithelial-mesenchymal transition. As UbcH8-silenced breast cancer cells are devoid of ISG15 conjugates but have free ISG15, our results using UbcH8-silenced cells suggest that ISG15 conjugates, and not free ISG15, contributes to oncogenic Ki-Ras transformation. We have thus identified the conjugated form of ISG15 as a critical downstream mediator of oncogenic Ki-Ras, providing a potential mechanistic link between ISG15 and Ki-Ras-mediated breast tumorigenesis. Our findings, which show that inhibition of the ISGylation reverses the malignant phenotypes of breast cancer cells expressing oncogenic Ki-Ras, support the development of ISG15 conjugation inhibitors for treating breast and also other cancers expressing oncogenic Ki-Ras.	[Burks, J.; Reed, R. E.; Desai, S. D.] LSU Hlth Sci Center, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA		Desai, SD (corresponding author), LSU Hlth Sci Center, Sch Med, Dept Biochem & Mol Biol, 1901 Perdido St, New Orleans, LA 70112 USA.	sdesai@lsuhsc.edu			LSU-Health Science Center School of Medicine	LSU-Health Science Center School of Medicine	This work was supported by start-up funds from the LSU-Health Science Center School of Medicine to SD.	Andersen JB, 2006, BRIT J CANCER, V94, P1465, DOI 10.1038/sj.bjc.6603099; Andersen JB, 2006, CYTOKINE GROWTH F R, V17, P411, DOI 10.1016/j.cytogfr.2006.10.001; Begum R, 2004, EXP MOL MED, V36, P358, DOI 10.1038/emm.2004.47; Bektas N, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2117; BUESORAMOS CE, 1993, BLOOD, V82, P2617; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Ciechanover A, 2005, CELL DEATH DIFFER, V12, P1167, DOI 10.1038/sj.cdd.4401691; Desai SD, 2006, CANCER RES, V66, P921, DOI 10.1158/0008-5472.CAN-05-1123; Desai SD, 2012, EXP BIOL MED, V237, P38, DOI 10.1258/ebm.2011.011236; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; Eckert LB, 2004, CANCER RES, V64, P4585, DOI 10.1158/0008-5472.CAN-04-0396; Farassati F, 2008, AM J PATHOL, V173, P1861, DOI 10.2353/ajpath.2008.080376; FRIEDMAN E, 1984, CANCER RES, V44, P3040; Giehl K, 2005, BIOL CHEM, V386, P193, DOI 10.1515/BC.2005.025; Guo YL, 2012, MOL CANCER THER, V11, P1968, DOI 10.1158/1535-7163.MCT-12-0248; HAAS AL, 1987, J BIOL CHEM, V262, P11315; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Handschuh G, 1999, ONCOGENE, V18, P4301, DOI 10.1038/sj.onc.1202790; Harty RN, 2009, J INNATE IMMUN, V1, P397, DOI 10.1159/000226245; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; Hollestelle A, 2007, MOL CANCER RES, V5, P195, DOI 10.1158/1541-7786.MCR-06-0263; Hummer BT, 2001, J VIROL, V75, P7774, DOI 10.1128/JVI.75.16.7774-7777.2001; Jacobsen K, 2002, ONCOGENE, V21, P3058, DOI 10.1038/sj.onc.1205423; Kiessling A, 2009, ONCOGENE, V28, P2606, DOI 10.1038/onc.2009.115; Kim SE, 2009, J CELL SCI, V122, P842, DOI 10.1242/jcs.040493; Konishi H, 2007, CANCER RES, V67, P8460, DOI 10.1158/0008-5472.CAN-07-0108; Kuang ZZ, 2011, J VIROL, V85, P7153, DOI 10.1128/JVI.02610-10; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; Lu A, 2009, J CELL BIOL, V184, P863, DOI 10.1083/jcb.200807186; McLaughlin PMJ, 2000, INT J CANCER, V85, P871, DOI 10.1002/(SICI)1097-0215(20000315)85:6<871::AID-IJC22>3.0.CO;2-O; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Myung J, 2001, MED RES REV, V21, P245, DOI 10.1002/med.1009.abs; NIELSCH U, 1992, J VIROL, V66, P1884, DOI 10.1128/JVI.66.4.1884-1890.1992; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Pickart CM, 1997, FASEB J, V11, P1055, DOI 10.1096/fasebj.11.13.9367341; Pincetic A, 2010, J VIROL, V84, P4725, DOI 10.1128/JVI.02478-09; Pitha-Rowe I, 2004, CANCER RES, V64, P8109, DOI 10.1158/0008-5472.CAN-03-3938; Schneider Gunter, 2003, Mol Cancer, V2, P15, DOI 10.1186/1476-4598-2-15; SCOTT N, 1993, GUT, V34, P621, DOI 10.1136/gut.34.5.621; Shim JH, 2006, J CELL BIOL, V172, P1045, DOI 10.1083/jcb.200509041; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Takeuchi T, 2005, J BIOCHEM, V138, P711, DOI 10.1093/jb/mvi172; Takeuchi T, 2005, BIOCHEM BIOPH RES CO, V336, P9, DOI 10.1016/j.bbrc.2005.08.034; Tripathi MK, 2005, BIOCHEM BIOPH RES CO, V328, P43, DOI 10.1016/j.bbrc.2004.12.142; Tsai YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024291; Ward DMV, 2005, J BIOL CHEM, V280, P10548, DOI 10.1074/jbc.M413734200; Wood LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016422; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yin XY, 2009, LUNG CANCER, V63, P194, DOI 10.1016/j.lungcan.2008.05.009; Zou WG, 2007, BIOCHEM BIOPH RES CO, V354, P321, DOI 10.1016/j.bbrc.2006.12.210; Zou WG, 2005, BIOCHEM BIOPH RES CO, V336, P61, DOI 10.1016/j.bbrc.2005.08.038	53	58	58	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 6	2014	33	6					794	803		10.1038/onc.2012.633	http://dx.doi.org/10.1038/onc.2012.633			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AA5IL	23318454				2022-12-25	WOS:000331129200013
J	Lobo, VJSA; Doni, M; Verrecchia, A; Sanulli, S; Faga, G; Piontini, A; Bianchi, M; Conacci-Sorrell, M; Mazzarol, G; Peg, V; Losa, JH; Ronchi, P; Ponzoni, M; Eisenman, RN; Doglioni, C; Amati, B				Lobo, V. J. Sanchez-Arevalo; Doni, M.; Verrecchia, A.; Sanulli, S.; Faga, G.; Piontini, A.; Bianchi, M.; Conacci-Sorrell, M.; Mazzarol, G.; Peg, V.; Losa, J. H.; Ronchi, P.; Ponzoni, M.; Eisenman, R. N.; Doglioni, C.; Amati, B.			Dual regulation of Myc by Abl	ONCOGENE			English	Article						c-Myc; c-Abl; Pin1; CML; Breast Cancer	KINASE C-ABL; TRANSCRIPTIONAL ACTIVITY; TYROSINE KINASE; BREAST-CANCER; APOPTOTIC RESPONSE; ONCOGENE PRODUCT; PHOSPHORYLATION; ACETYLATION; PIN1; ACTIVATION	The tyrosine kinase c-Abl (or Abl) and the prolyl-isomerase Pin1 cooperatively activate the transcription factor p73 by enhancing recruitment of the acetyltransferase p300. As the transcription factor c-Myc (or Myc) is a known target of Pin1 and p300, we hypothesized that it might be regulated in a similar manner. Consistent with this hypothesis, overexpression of Pin1 augmented the interaction of Myc with p300 and transcriptional activity. The action of Abl, however, was more complex than predicted. On one hand, Abl indirectly enhanced phosphorylation of Myc on Ser 62 and Thr 58, its association with Pin1 and p300 and its acetylation by p300. These effects of Abl were exerted through phosphorylation of substrate(s) other than Myc itself. On the other hand, Abl interacted with the C-terminal domain of Myc and phosphorylated up to five tyrosine residues in its N-terminus, the principal of which was Y74. Indirect immunofluorescence or immunohistochemical staining suggested that the Y74-phosphorylated form of Myc (Myc-pY74) localized to the cytoplasm and coexisted either with active Abl in a subset of mammary carcinomas or with Bcr-Abl in chronic myeloid leukemia. In all instances, Myc-pY74 constituted a minor fraction of the cellular Myc protein. Thus, our data unravel two potential effects of Abl on Myc: first, Abl signaling can indirectly augment acetylation of Myc by p300, and most likely also its transcriptional activity in the nucleus; second, Abl can directly phosphorylate Myc on tyrosine: the resulting form of Myc appears to be cytoplasmic, and its presence correlates with Abl activation in cancer.	[Lobo, V. J. Sanchez-Arevalo; Doni, M.; Verrecchia, A.; Sanulli, S.; Faga, G.; Piontini, A.; Mazzarol, G.; Amati, B.] European Inst Oncol IEO, Dept Expt Oncol, Milan, Italy; [Bianchi, M.] FIRC Inst Mol Oncol IFOM, Milan, Italy; [Conacci-Sorrell, M.; Eisenman, R. N.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; [Peg, V.; Losa, J. H.] Hospital Vall de Hebron, Barcelona, Spain; [Ronchi, P.] Ist Sci San Raffaele, Immunohematol & Transfus Med Serv, I-20132 Milan, Italy; [Ronchi, P.; Ponzoni, M.] Ist Sci San Raffaele, Leukemia Unit, I-20132 Milan, Italy; [Ponzoni, M.; Doglioni, C.] Ist Sci San Raffaele, Pathol Unit, I-20132 Milan, Italy; [Amati, B.] Fdn Ist Italiano Tecnol IIT, Ctr Genom Sci IIT SEMM, Milan, Italy	IRCCS European Institute of Oncology (IEO); IFOM - FIRC Institute of Molecular Oncology; Fred Hutchinson Cancer Center; Hospital Universitari Vall d'Hebron; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Istituto Italiano di Tecnologia - IIT	Amati, B (corresponding author), IIT, Via Adamello 16, I-20139 Milan, Italy.	bruno.amati@iit.it	Faga, Giovanni/AAB-5540-2021; Doni, Mirko/ABA-9174-2021; Peg., Vicente/AAC-9447-2020; Amati, Bruno/AAM-3418-2020; Peg, Vicente/E-9160-2018; Lobo, Victor Javier vjsal Sanchez-Arevalo/H-1069-2011; Doni, Mirko/AAN-6027-2020; Verrecchia, Alessandro/AAQ-6454-2020; Sorrell, Maralice/ABD-6764-2021; Lobo, Victor Javier Sanchez-Arevalo/N-8641-2019	Doni, Mirko/0000-0001-7099-2701; Peg., Vicente/0000-0002-5203-6166; Peg, Vicente/0000-0002-5203-6166; Lobo, Victor Javier vjsal Sanchez-Arevalo/0000-0002-4561-1505; Verrecchia, Alessandro/0000-0002-8596-6650; Lobo, Victor Javier Sanchez-Arevalo/0000-0002-4561-1505; Amati, Bruno/0000-0002-2958-1799; DOGLIONI, Claudio/0000-0002-4969-5216	Ministerio de Ciencia e Inovacion; European Commission FP7 Program (EuroSyStem); European Commission FP7 Program (MODHEP); European Research Council; Association for International Cancer Research (AICR); Cariplo Foundation; Italian Health Ministry; Italian Association for Cancer Research (AIRC); NATIONAL CANCER INSTITUTE [R01CA020525] Funding Source: NIH RePORTER	Ministerio de Ciencia e Inovacion(Spanish Government); European Commission FP7 Program (EuroSyStem); European Commission FP7 Program (MODHEP); European Research Council(European Research Council (ERC)European Commission); Association for International Cancer Research (AICR); Cariplo Foundation(Fondazione Cariplo); Italian Health Ministry(Ministry of Health, Italy); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Theresia Kress, Stefano Campaner and Giorgio Scita for critical reading of the manuscript, Gianni Del Sal for scientific discussion and reagents, Warren Pear, Ricardo Sanchez-Prieto, Silvio Gutkind, Michael Cole and Pier-Giuseppe Pelicci for reagents, Celine Ngouenet, Arianna Vino, Lorenzo Spagnuolo and Teresa Moline for technical assistance, and the Antibody facility at the IFOM-IEO Campus. STI571 was supplied by Novartis. VJSAL was supported by a post-doctoral fellowship from the Ministerio de Ciencia e Inovacion. Work in the Amati lab was supported by grants from the European Commission FP7 Program (EuroSyStem and MODHEP), the European Research Council, the Association for International Cancer Research (AICR), the Cariplo Foundation, the Italian Health Ministry and the Italian Association for Cancer Research (AIRC).	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; Agami R, 1999, NATURE, V399, P809; Barila D, 2000, EMBO J, V19, P273, DOI 10.1093/emboj/19.2.273; Bitomsky N, 2004, ONCOGENE, V23, P7484, DOI 10.1038/sj.onc.1208064; BLACKWOOD EM, 1994, MOL BIOL CELL, V5, P597, DOI 10.1091/mbc.5.5.597; Conacci-Sorrell M, 2010, CELL, V142, P480, DOI 10.1016/j.cell.2010.06.037; CRAIG RW, 1993, CELL GROWTH DIFFER, V4, P349; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; Faiola F, 2005, MOL CELL BIOL, V25, P10220, DOI 10.1128/MCB.25.23.10220-10234.2005; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Ganguly SS, 2012, ONCOGENE, V31, P1804, DOI 10.1038/onc.2011.361; Gomez-Casares MT, 2013, ONCOGENE, V32, P2239, DOI 10.1038/onc.2012.246; Gong JG, 1999, NATURE, V399, P806; Greasley PJ, 2000, NUCLEIC ACIDS RES, V28, P446, DOI 10.1093/nar/28.2.446; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Haupt Y, 1996, EMBO J, V15, P1596, DOI 10.1002/j.1460-2075.1996.tb00504.x; Huang CC, 2008, INT J BIOCHEM CELL B, V40, P423, DOI 10.1016/j.biocel.2007.08.002; Kharbanda S, 2000, MOL CELL BIOL, V20, P4979, DOI 10.1128/MCB.20.14.4979-4989.2000; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Lufei C, 2007, ONCOGENE, V26, P7656, DOI 10.1038/sj.onc.1210567; LUGO TG, 1989, MOL CELL BIOL, V9, P1263, DOI 10.1128/MCB.9.3.1263; Mantovani F, 2004, MOL CELL, V14, P625, DOI 10.1016/j.molcel.2004.05.007; Mantovani F, 2007, NAT STRUCT MOL BIOL, V14, P912, DOI 10.1038/nsmb1306; Monje P, 2005, J BIOL CHEM, V280, P35081, DOI 10.1074/jbc.C500353200; Oh AS, 2008, MOL CELL BIOL, V28, P6580, DOI 10.1128/MCB.00118-08; Pandey P, 1996, J BIOL CHEM, V271, P23775, DOI 10.1074/jbc.271.39.23775; Patel JH, 2004, MOL CELL BIOL, V24, P10826, DOI 10.1128/MCB.24.24.10826-10834.2004; Sanchez-Prieto R, 2002, ONCOGENE, V21, P974, DOI 10.1038/sj.onc.1205134; SAWYERS CL, 1992, CELL, V70, P901, DOI 10.1016/0092-8674(92)90241-4; Srinivasan D, 2008, ONCOGENE, V27, P1095, DOI 10.1038/sj.onc.1210714; Srinivasan D, 2006, CANCER RES, V66, P5648, DOI 10.1158/0008-5472.CAN-06-0734; SUNDARESAN V, 1987, J CLIN PATHOL, V40, P1274, DOI 10.1136/jcp.40.11.1274; Vervoorts J, 2003, EMBO REP, V4, P484, DOI 10.1038/sj.embor.embor821; WILLIAMS ARW, 1990, J PATHOL, V160, P287, DOI 10.1002/path.1711600404; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yi P, 2005, MOL CELL BIOL, V25, P9687, DOI 10.1128/MCB.25.21.9687-9699.2005; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zhang KL, 2005, BIOCHEM BIOPH RES CO, V336, P274, DOI 10.1016/j.bbrc.2005.08.075	44	17	17	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 7	2013	32	45					5261	5271		10.1038/onc.2012.621	http://dx.doi.org/10.1038/onc.2012.621			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	251IS	23318434	Green Accepted, hybrid			2022-12-25	WOS:000326922100002
J	Coomans, CP; van den Berg, SAA; Houben, T; van Klinken, JB; van den Berg, R; Pronk, ACM; Havekes, LM; Romijn, JA; van Dijk, KW; Biermasz, NR; Meijer, JH				Coomans, Claudia P.; van den Berg, Sjoerd A. A.; Houben, Thijs; van Klinken, Jan-Bert; van den Berg, Rosa; Pronk, Amanda C. M.; Havekes, Louis M.; Romijn, Johannes A.; van Dijk, Ko Willems; Biermasz, Nienke R.; Meijer, Johanna H.			Detrimental effects of constant light exposure and high-fat diet on circadian energy metabolism and insulin sensitivity	FASEB JOURNAL			English	Article						constant light; SCN; multiunit activity; electrophysiology	HUMAN SKELETAL-MUSCLE; SUPRACHIASMATIC NUCLEUS; MAMMALIAN CLOCK; DAILY RHYTHM; RAT; TIME; DISTURBANCES; DISRUPTION; EXPRESSION; COMPONENTS	Circadian rhythm disturbances are observed in, e. g., aging and neurodegenerative diseases and are associated with an increased incidence of obesity and diabetes. We subjected male C57Bl/6J mice to constant light [12-h light-light (LL) cycle] to examine the effects of a disturbed circadian rhythm on energy metabolism and insulin sensitivity. In vivo electrophysiological recordings in the central pacemaker of the suprachiasmatic nuclei (SCN) revealed an immediate reduction in rhythm amplitude, stabilizing at 44% of normal amplitude values after 4 d LL. Food intake was increased (+26%) and energy expenditure decreased (-13%), and we observed immediate body weight gain (d 4: +2.4%, d 14: +5.0%). Mixed model analysis revealed that weight gain developed more rapidly in response to LL as compared to high fat. After 4 wk in LL, the circadian pattern in feeding and energy expenditure was completely lost, despite continuing low-amplitude rhythms in the SCN and in behavior, whereas weight gain had stabilized. Hyperinsulinemic-euglycemic clamp analysis revealed complete abolishment of normal circadian variation in insulin sensitivity in LL. In conclusion, a reduction in amplitude of the SCN, to values previously observed in aged mice, is sufficient to induce a complete loss of circadian rhythms in energy metabolism and insulin sensitivity.-Coomans, C. P., van den Berg, S. A. A., Houben, T., van Klinken, J.-B., van den Berg, R., Pronk, A. C. M., Havekes, L. M., Romijn, J. A., Willems van Dijk, K., Biermasz, N. R., Meijer, J. H. Detrimental effects of constant light exposure and high-fat diet on circadian energy metabolism and insulin sensitivity. FASEB J. 27, 1721-1732 (2013). www.fasebj.org	[Coomans, Claudia P.; Meijer, Johanna H.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands; [Coomans, Claudia P.; Romijn, Johannes A.; Biermasz, Nienke R.] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Disorders, NL-2300 RC Leiden, Netherlands; [van den Berg, Sjoerd A. A.; Houben, Thijs; van Klinken, Jan-Bert; van den Berg, Rosa; Pronk, Amanda C. M.; Havekes, Louis M.; van Dijk, Ko Willems] Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RC Leiden, Netherlands; [Havekes, Louis M.] Leiden Univ, Med Ctr, Dept Cardiol, NL-2300 RC Leiden, Netherlands; [Havekes, Louis M.] Netherlands Org Appl Sci Res, Gaubius Lab, Leiden, Netherlands; [Romijn, Johannes A.] Amsterdam Med Ctr, Dept Med, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Organization Applied Science Research; University of Amsterdam; Academic Medical Center Amsterdam	Coomans, CP (corresponding author), Leiden Univ, Med Ctr, Dept Mol Cell Biol, Neurophysiol Lab, Bldg 2,Room T5-32,Einthovenweg 20,POB 9600, NL-2300 RC Leiden, Netherlands.	c.p.coomans@lumc.nl	van der Heijde, Désirée/I-6774-2019; van Dijk, Ko Willems/A-1798-2008; van den Berg, Sjoerd A/R-9541-2018; Biermasz, Nienke/ABE-9436-2021; van Dijk, Ko Willems/AAT-4681-2021; Coomans, Claudia/A-4458-2013	van der Heijde, Désirée/0000-0002-5781-158X; van Dijk, Ko Willems/0000-0002-2172-7394; Biermasz, Nienke/0000-0001-5817-3594; van Dijk, Ko Willems/0000-0002-2172-7394; Coomans, Claudia/0000-0003-0883-458X; van den Berg, Sjoerd/0000-0001-5937-7505; van den Berg, Sjoerd/0000-0001-8967-376X	TI Pharma (TIP project) [T2-105]; Netherlands Heart Foundation (NHS project) [2007B81]; Dutch Diabetes Research Foundation (DFN project) [2007.00.010]; Center of Medical Systems Biology (CMSB project); Netherlands Consortium for Systems Biology (NCSB project) established by The Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NGI/NWO); Dutch Organization for Scientific Research [90700195]; NWO ZonMW (Top Go grant) [81802016]	TI Pharma (TIP project); Netherlands Heart Foundation (NHS project); Dutch Diabetes Research Foundation (DFN project); Center of Medical Systems Biology (CMSB project); Netherlands Consortium for Systems Biology (NCSB project) established by The Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NGI/NWO); Dutch Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NWO ZonMW (Top Go grant)	The authors thank H. Duindam [Department of Molecular Cell Biology, Leiden University Medical Center (LUMC), Leiden, the Netherlands] and H. E. Auvinen (Department of Endocrinology, LUMC) for excellent technical support. This work was supported by grants from TI Pharma (TIP project T2-105, to J.A.R. and L. M. H.), the Netherlands Heart Foundation (NHS project 2007B81, to J.A.R.), the Dutch Diabetes Research Foundation (DFN project 2007.00.010, to J.A.R.), the Center of Medical Systems Biology (CMSB project, to K. W. V. D.), the Netherlands Consortium for Systems Biology (NCSB project, to K. W. V. D.) established by The Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NGI/NWO), the Dutch Organization for Scientific Research (Clinical Fellows 90700195, to N.R.B.), and NWO ZonMW (Top Go grant 81802016, to J.H.M.). The authors report no conflicts of interest.	Ancoli-Israel S, 2002, J AM GERIATR SOC, V50, P282, DOI 10.1046/j.1532-5415.2002.50060.x; ASCHOFF J, 1979, Z TIERPSYCHOL, V49, P225; ASCHOFF J, 1960, COLD SPRING HARB SYM, V25, P11, DOI 10.1101/SQB.1960.025.01.004; Buijs RM, 2006, PROG BRAIN RES, V153, P341, DOI 10.1016/S0079-6123(06)53020-1; Cailotto C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005650; Chen RM, 2008, J NEUROSCI, V28, P11839, DOI 10.1523/JNEUROSCI.2191-08.2008; Claustrat B, 2008, HORM METAB RES, V40, P398, DOI 10.1055/s-2008-1065330; Colwell CS, 2011, NAT REV NEUROSCI, V12, P553, DOI 10.1038/nrn3086; Coomans CP, 2013, DIABETES, V62, P1102, DOI 10.2337/db12-0507; Copertaro Alfredo, 2009, Recenti Progressi in Medicina, V100, P502; Corpeleijn E, 2008, OBESITY, V16, P1025, DOI 10.1038/oby.2008.24; Dalm S, 2005, NEUROENDOCRINOLOGY, V81, P372, DOI 10.1159/000089555; Dijk DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030037; DORRSCHEIDT GJ, 1975, J MATH BIOL, V2, P107; Ekmekcioglu C, 2011, OBES REV, V12, P14, DOI 10.1111/j.1467-789X.2010.00716.x; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; Fonken LK, 2009, BEHAV BRAIN RES, V205, P349, DOI 10.1016/j.bbr.2009.07.001; Foster RG, 2007, CURR BIOL, V17, pR746, DOI 10.1016/j.cub.2007.07.007; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; FUKUDA H, 1991, BIOCHIM BIOPHYS ACTA, V1086, P261, DOI 10.1016/0005-2760(91)90168-H; Gale JE, 2011, J BIOL RHYTHM, V26, P423, DOI 10.1177/0748730411416341; GROOS GA, 1985, ANN NY ACAD SCI, V453, P134, DOI 10.1111/j.1749-6632.1985.tb11806.x; Jud C, 2005, BIOL PROCED ONLINE, V7, P101, DOI 10.1251/bpo109; Kalsbeek A, 2012, MOL CELL ENDOCRINOL, V349, P20, DOI 10.1016/j.mce.2011.06.042; Kalsbeek A, 2003, J NEUROENDOCRINOL, V15, P1144, DOI 10.1111/j.1365-2826.2003.01112.x; Kalsbeek A, 2001, ENDOCRINOLOGY, V142, P2677, DOI 10.1210/en.142.6.2677; Kalsbeek A, 2011, FEBS LETT, V585, P1412, DOI 10.1016/j.febslet.2011.03.021; Karasek M, 2004, EXP GERONTOL, V39, P1723, DOI 10.1016/j.exger.2004.04.012; Karlsson BH, 2003, INT ARCH OCC ENV HEA, V76, P424, DOI 10.1007/s00420-003-0440-y; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Klarsfeld A, 1998, J BIOL RHYTHM, V13, P471, DOI 10.1177/074873098129000309; Kohsaka A, 2007, TRENDS ENDOCRIN MET, V18, P4, DOI 10.1016/j.tem.2006.11.005; la Fleur SE, 2001, DIABETES, V50, P1237, DOI 10.2337/diabetes.50.6.1237; LEIGHTON B, 1988, AM J PHYSIOL, V255, pE41, DOI 10.1152/ajpendo.1988.255.1.E41; Meijer JH, 1996, PROG BRAIN RES, V111, P175, DOI 10.1016/S0079-6123(08)60407-0; Nakamura TJ, 2011, J NEUROSCI, V31, P10201, DOI 10.1523/JNEUROSCI.0451-11.2011; Ohta H, 2005, NAT NEUROSCI, V8, P267, DOI 10.1038/nn1395; Ohta H, 2006, PEDIATR RES, V60, P304, DOI 10.1203/01.pdr.0000233114.18403.66; Rimmer DW, 2000, AM J PHYSIOL-REG I, V279, pR1574, DOI 10.1152/ajpregu.2000.279.5.R1574; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Ruiter M, 2003, DIABETES, V52, P1709, DOI 10.2337/diabetes.52.7.1709; Scheer FAJL, 2003, BIOL CHEM, V384, P697, DOI 10.1515/BC.2003.078; Scheer FAJL, 2001, AM J PHYSIOL-HEART C, V280, pH1391, DOI 10.1152/ajpheart.2001.280.3.H1391; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; van Oosterhout F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039693; Van Someren EJW, 2000, EXP GERONTOL, V35, P1229, DOI 10.1016/S0531-5565(00)00191-1; VanSomeren EJW, 1997, J BIOL RHYTHM, V12, P146, DOI 10.1177/074873049701200206; Vinogradova IA, 2009, AGING-US, V1, P855, DOI 10.18632/aging.100092; Wagner, 1999, Curr Treat Options Neurol, V1, P299, DOI 10.1007/s11940-999-0020-x; Wideman CH, 2009, NUTR NEUROSCI, V12, P233, DOI 10.1179/147683009X423436; Wong H, 2010, INT J NURS STUD, V47, P1021, DOI 10.1016/j.ijnurstu.2010.01.001; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Zambon AC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r61	53	168	170	3	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2013	27	4					1721	1732		10.1096/fj.12-210898	http://dx.doi.org/10.1096/fj.12-210898			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23303208				2022-12-25	WOS:000316940800041
J	Raduwan, H; Isola, AL; Belden, WJ				Raduwan, Hamidah; Isola, Allison L.; Belden, William J.			Methylation of Histone H3 on Lysine 4 by the Lysine Methyltransferase SET1 Protein Is Needed for Normal Clock Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROSPORA CIRCADIAN CLOCK; DROSOPHILA-PERIOD; INDUCED TRANSCRIPTION; FEEDBACK LOOP; NEGATIVE LIMB; FREQUENCY; BINDING; PHOSPHORYLATION; DEGRADATION; RECRUITMENT	The circadian oscillator controls time-of-day gene expression by a network of interconnected feedback loops and is reset by light. The requisite for chromatin regulation in eukaryotic transcription necessitates temporal regulation of histone-modifying and chromatin-remodeling enzymes for proper clock function. CHD1is known to bindH3K4me3in mammalian cells, and Neurospora CHD1 is required for proper regulation of the frequency (frq) gene. Based on this, we examined a strain lacking SET1 to determine the role of H3K4 methylation in clock-and lightmediated frq regulation. Expression of frq was altered in strains lacking set1 under both circadian- and light-regulated gene expression. There is a delay in the phasing of H3K4me3 relative to the peak in frq expression. White Collar 2 (WC-2) association with the frq promoter persists longer in Delta set1, suggesting a more permissible chromatin state. Surprisingly, SET1 is required for DNA methylation in the frq promoter, indicating a dependence on H3K4me for DNA methylation. The data support a model where SET1 is needed for proper regulation by modulating chromatin at frq.	[Raduwan, Hamidah; Isola, Allison L.; Belden, William J.] Rutgers State Univ, Dept Biochem & Microbiol, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick	Belden, WJ (corresponding author), Rutgers State Univ, Dept Biochem & Microbiol, 76 Lipman Dr, New Brunswick, NJ 08901 USA.	belden@aesop.rutgers.edu		Isola, Allison/0000-0003-3633-9084; Raduwan, Hamidah/0000-0002-4939-7809	National Institutes of Health [P01GM068087, R01GM101378]; School of Environmental and Biological Science at Rutgers University; Charles and Joanna Busch Memorial Fund; James D. Macmillan Graduate Student Fellowship; NIEHS Center for Environmental Exposure and Disease (CEED) [P30ES005022]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM068087, R01GM101378] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); School of Environmental and Biological Science at Rutgers University; Charles and Joanna Busch Memorial Fund; James D. Macmillan Graduate Student Fellowship; NIEHS Center for Environmental Exposure and Disease (CEED); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM101378 (to W.J.B.). This work was also supported by the School of Environmental and Biological Science at Rutgers University and the Charles and Joanna Busch Memorial Fund.; Supported by a James D. Macmillan Graduate Student Fellowship.; W.J.B. is a member of NIEHS Center for Environmental Exposure and Disease (CEED) (Grant P30ES005022).; We thank Dr. Peter Kahn and Dr. Tom Kusch for helpful comments on this manuscript and Dr. Luis Larrondo for luciferase stains and assistance with the data analysis. We are grateful to Dr. Kevin McCluskey at the Fungal Genetics Stock Center who provided deletion strains generated by the Neurospora Knock-out Consortium (supported by National Institutes of Health Grant P01GM068087).	Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; ARONSON BD, 1994, P NATL ACAD SCI USA, V91, P7683, DOI 10.1073/pnas.91.16.7683; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Belden WJ, 2007, GENE DEV, V21, P1494, DOI 10.1101/gad.1551707; Belden WJ, 2007, MOL CELL, V25, P587, DOI 10.1016/j.molcel.2007.01.010; Belden WJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002166; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Brown SA, 2005, SCIENCE, V308, P693, DOI 10.1126/science.1107373; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cheng P, 2005, GENE DEV, V19, P234, DOI 10.1101/gad.1266805; Chiu JC, 2008, GENE DEV, V22, P1758, DOI 10.1101/gad.1682708; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Curtis AM, 2004, J BIOL CHEM, V279, P7091, DOI 10.1074/jbc.M311973200; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Denault DL, 2001, EMBO J, V20, P109, DOI 10.1093/emboj/20.1.109; DiTacchio L, 2011, SCIENCE, V333, P1881, DOI 10.1126/science.1206022; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Dubruille R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000787; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Duong HA, 2011, SCIENCE, V332, P1436, DOI 10.1126/science.1196766; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Etchegaray JP, 2006, J BIOL CHEM, V281, P21209, DOI 10.1074/jbc.M603722200; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Flanagan JF, 2007, J MOL BIOL, V369, P334, DOI 10.1016/j.jmb.2007.03.024; Garceau NY, 1997, CELL, V89, P469, DOI 10.1016/S0092-8674(00)80227-5; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gooch VD, 2008, EUKARYOT CELL, V7, P28, DOI 10.1128/EC.00257-07; Guillaumond F, 2011, FASEB J, V25, P2740, DOI 10.1096/fj.10-178616; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; He Q, 2005, GENE DEV, V19, P1518, DOI 10.1101/gad.1322205; He Q, 2003, EMBO J, V22, P4421, DOI 10.1093/emboj/cdg425; He Q, 2006, GENE DEV, V20, P2552, DOI 10.1101/gad.1463506; Heintzen C, 2007, ADV GENET, V58, P25, DOI 10.1016/S0065-2660(06)58002-2; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Jones MA, 2010, P NATL ACAD SCI USA, V107, P21623, DOI 10.1073/pnas.1014204108; Katada S, 2010, NAT STRUCT MOL BIOL, V17, P1414, DOI 10.1038/nsmb.1961; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee HC, 2010, MOL CELL, V38, P803, DOI 10.1016/j.molcel.2010.04.005; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Lin JM, 2002, NATURE, V420, P816, DOI 10.1038/nature01235; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Liu Y, 2000, P NATL ACAD SCI USA, V97, P234, DOI 10.1073/pnas.97.1.234; LOROS JJ, 1986, GENETICS, V114, P1095; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luo CH, 1998, EMBO J, V17, P1228, DOI 10.1093/emboj/17.5.1228; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Naruse Y, 2004, MOL CELL BIOL, V24, P6278, DOI 10.1128/MCB.24.14.6278-6287.2004; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Querfurth C, 2011, MOL CELL, V43, P713, DOI 10.1016/j.molcel.2011.06.033; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Smith E, 2010, MOL CELL, V40, P689, DOI 10.1016/j.molcel.2010.11.031; Smith KM, 2010, EUKARYOT CELL, V9, P1549, DOI 10.1128/EC.00154-10; Stratmann M, 2012, MOL CELL, V48, P277, DOI 10.1016/j.molcel.2012.08.012; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; Talora C, 1999, EMBO J, V18, P4961, DOI 10.1093/emboj/18.18.4961; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; Venkatasubrahmanyam S, 2007, P NATL ACAD SCI USA, V104, P16609, DOI 10.1073/pnas.0700914104; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	83	32	32	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8380	8390		10.1074/jbc.M112.359935	http://dx.doi.org/10.1074/jbc.M112.359935			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23319591	Green Published, hybrid			2022-12-25	WOS:000316564500037
J	Su, PH; Chen, CC; Chang, YF; Wong, ZR; Chang, KW; Huang, BM; Yang, HY				Su, Peng-Han; Chen, Chih-Cheng; Chang, Ya-Fan; Wong, Zong-Ruei; Chang, Kai-Wei; Huang, Bu-Miin; Yang, Hsi-Yuan			Identification and Cytoprotective Function of a Novel Nestin Isoform, Nes-S, in Dorsal Root Ganglia Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FILAMENT-ASSOCIATED PROTEIN; EPIDERMAL-GROWTH-FACTOR; INTERMEDIATE-FILAMENTS; REACTIVE ASTROCYTES; SYNEMIN ISOFORMS; SPLICE VARIANTS; SENSORY NEURONS; RADIAL GLIA; STEM-CELLS; EXPRESSION	In this study, the first nestin isoform, Nes-S, was identified in neurons of dorsal root ganglia (DRG) of adult rats. Nes-S cannot form filaments by itself in cytoplasmic intermediate filamentfree SW13 cells. Instead, it co-assembles into filaments with vimentin when transfected into vimentin(+) SW13 cells, and with peripherin and neurofilament proteins when transfected into N2a cells. In primary DRG neurons, endogenous Nes-S co-assembles with peripherin and neurofilament proteins. The expression of Nes-S first appears in DRG at postnatal day 5 and persists to adulthood. Among the adult tissues we examined, the expression of Nes-S is restricted to the sensory and motor neurons. Finally, exogenous Nes-S enhances viability when transfected into N2a cells, and knockdown of endogenous Nes-S impairs the survival of DRG neurons in primary cultures. Taken together, Nes-S is a new neuronal intermediate filament protein that exerts a cytoprotective function in mature sensory and motor neurons.	[Su, Peng-Han; Chang, Ya-Fan; Wong, Zong-Ruei; Chang, Kai-Wei; Yang, Hsi-Yuan] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10617, Taiwan; [Chen, Chih-Cheng] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Huang, Bu-Miin] Natl Cheng Kung Univ, Dept Cell Biol & Anat, Tainan 701, Taiwan	National Taiwan University; Academia Sinica - Taiwan; National Cheng Kung University	Yang, HY (corresponding author), Natl Taiwan Univ, Inst Mol & Cellular Biol, 1,Sec 4,Roosevelt Rd, Taipei 10617, Taiwan.	hyhy@ntu.edu.tw	Chen, Chih-Cheng/AAT-1062-2021; Chen, Chih-Cheng/S-7015-2018	Chen, Chih-Cheng/0000-0003-4768-5660; Chen, Chih-Cheng/0000-0003-4768-5660	National Science Council, Executive Yuan, Taiwan [NSC98-2320-B-002-034-MY2]	National Science Council, Executive Yuan, Taiwan(Ministry of Science and Technology, Taiwan)	This work was funded by the National Science Council, Executive Yuan, Taiwan, through Grants NSC98-2320-B-002-034-MY2 (to H.-Y.Y.).	Blechingberg J, 2007, GLIA, V55, P497, DOI 10.1002/glia.20475; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; Chou YH, 2003, MOL BIOL CELL, V14, P1468, DOI 10.1091/mbc.E02-08-0545; DAHLSTRAND J, 1992, J CELL SCI, V103, P589; De Girolamo LA, 2000, J NEUROCHEM, V75, P133, DOI 10.1046/j.1471-4159.2000.0750133.x; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Ernsberger U, 2009, CELL TISSUE RES, V336, P349, DOI 10.1007/s00441-009-0784-z; FERRI GL, 1990, BRAIN RES, V515, P331, DOI 10.1016/0006-8993(90)90618-L; FRIEDMAN B, 1990, J COMP NEUROL, V295, P43, DOI 10.1002/cne.902950105; FRISEN J, 1995, J CELL BIOL, V131, P453, DOI 10.1083/jcb.131.2.453; Goldman R. D., 1990, CELLULAR MOL BIOL IN, P3; Goldman RD, 2012, J STRUCT BIOL, V177, P14, DOI 10.1016/j.jsb.2011.11.017; GRANGER BL, 1980, CELL, V22, P727, DOI 10.1016/0092-8674(80)90549-8; Guerette D, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-164; HEDBERG KK, 1986, EXP CELL RES, V163, P509, DOI 10.1016/0014-4827(86)90081-9; Hendrickson ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018535; Herrmann H, 2000, CURR OPIN CELL BIOL, V12, P79, DOI 10.1016/S0955-0674(99)00060-5; HERRMANN H, 1987, J BIOL CHEM, V262, P1320; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Huang YL, 2009, J BIOCHEM, V146, P307, DOI 10.1093/jb/mvp070; Huang YL, 2009, CELL SIGNAL, V21, P954, DOI 10.1016/j.cellsig.2009.02.005; Huang YL, 2008, BIOCHEM BIOPH RES CO, V377, P361, DOI 10.1016/j.bbrc.2008.09.143; Hyder CL, 2011, J CELL SCI, V124, P1363, DOI 10.1242/jcs.041244; Izmiryan A, 2006, GLIA, V54, P204, DOI 10.1002/glia.20378; Izmiryan A, 2009, EXP CELL RES, V315, P769, DOI 10.1016/j.yexcr.2008.12.009; Jin ZG, 2009, J BIOL CHEM, V284, P8160, DOI 10.1074/jbc.M805632200; JOHNSON EM, 1986, TRENDS NEUROSCI, V9, P33, DOI 10.1016/0166-2236(86)90012-3; Karakesisoglou I, 2000, J CELL BIOL, V149, P195, DOI 10.1083/jcb.149.1.195; Langbein L, 2010, J BIOL CHEM, V285, P36909, DOI 10.1074/jbc.M110.161745; Lee CY, 2003, NEUROL RES, V25, P767, DOI 10.1179/016164103101202156; Lee JH, 2007, J CELL SCI, V120, P2259, DOI 10.1242/jcs.03468; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Leung CL, 2002, TRENDS CELL BIOL, V12, P37, DOI 10.1016/S0962-8924(01)02180-8; Leung CL, 2001, J CELL SCI, V114, P3409; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; Liu W, 2012, J CELL BIOCHEM, V113, P3186, DOI 10.1002/jcb.24195; Lopes JP, 2009, CELL CYCLE, V8, P97, DOI 10.4161/cc.8.1.7506; Marvin NJ, 1998, J CELL SCI, V111, P1951; McLean J, 2008, J NEUROCHEM, V104, P1663, DOI 10.1111/j.1471-4159.2007.05198.x; Michalczyk K, 2005, HISTOL HISTOPATHOL, V20, P665, DOI 10.14670/HH-20.665; Mohseni P, 2011, J NEUROSCI, V31, P11547, DOI 10.1523/JNEUROSCI.4396-10.2011; O'Hare MJ, 2005, J NEUROSCI, V25, P8954, DOI 10.1523/JNEUROSCI.2899-05.2005; Oikawa H, 2010, EXP CELL RES, V316, P940, DOI 10.1016/j.yexcr.2009.10.025; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Pallari HM, 2011, MOL BIOL CELL, V22, P1539, DOI 10.1091/mbc.E10-07-0568; Park D, 2010, STEM CELLS, V28, P2162, DOI 10.1002/stem.541; Park KY, 2000, J MED GENET, V37, P851, DOI 10.1136/jmg.37.11.851; Parry DAD, 2005, ADV PROTEIN CHEM, V70, P113, DOI 10.1016/S0065-3233(04)70005-4; Parry DAD, 2007, EXP CELL RES, V313, P2204, DOI 10.1016/j.yexcr.2007.04.009; PEARSON J, 1983, DEV BIOL, V96, P32, DOI 10.1016/0012-1606(83)90308-1; Perng MD, 2008, MOL BIOL CELL, V19, P4521, DOI 10.1091/mbc.E08-03-0284; Sahlgren CM, 2006, EMBO J, V25, P4808, DOI 10.1038/sj.emboj.7601366; Sahlgren CM, 2003, MOL CELL BIOL, V23, P5090, DOI 10.1128/MCB.23.14.5090-5106.2003; Saito T, 2007, J NEUROCHEM, V102, P133, DOI 10.1111/j.1471-4159.2007.04540.x; SARRIA AJ, 1990, J CELL BIOL, V111, P553, DOI 10.1083/jcb.111.2.553; Steinert PM, 1999, J BIOL CHEM, V274, P9881, DOI 10.1074/jbc.274.14.9881; Su PH, 2011, J ANAT, V218, P311, DOI 10.1111/j.1469-7580.2010.01331.x; Tanaka S, 2004, MOL CELL BIOL, V24, P8834, DOI 10.1128/MCB.24.20.8834-8846.2004; Tian B, 2009, NAT CELL BIOL, V11, P211, DOI 10.1038/ncb1829; Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004; Tong JX, 1996, EXP NEUROL, V138, P45, DOI 10.1006/exnr.1996.0045; Vogelbaum MA, 1998, J NEUROSCI, V18, P8928; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Xiao S, 2008, J NEUROSCI, V28, P1833, DOI 10.1523/JNEUROSCI.3222-07.2008; Xue ZG, 2004, EXP CELL RES, V298, P431, DOI 10.1016/j.yexcr.2004.04.023; YANG HY, 1992, CELL MOTIL CYTOSKEL, V22, P185, DOI 10.1002/cm.970220306; YANG HY, 1985, J CELL BIOL, V100, P620, DOI 10.1083/jcb.100.2.620; Yang HY, 1997, EXP NEUROL, V146, P199, DOI 10.1006/exnr.1997.6518; YANG HY, 1993, J NEUROCYTOL, V22, P558, DOI 10.1007/BF01189043; Yang JF, 2011, NAT NEUROSCI, V14, P324, DOI 10.1038/nn.2747; Yuan Y, 1997, MOL CELL NEUROSCI, V10, P71, DOI 10.1006/mcne.1997.0627; Zhou ZL, 2010, MOL BIOL REP, V37, P2407, DOI 10.1007/s11033-009-9751-8; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	76	14	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8391	8404		10.1074/jbc.M112.408179	http://dx.doi.org/10.1074/jbc.M112.408179			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23319587	hybrid, Green Published			2022-12-25	WOS:000316564500038
J	Gargi, A; Tamilselvam, B; Powers, B; Prouty, MG; Lincecum, T; Eshraghi, A; Maldonado-Arocho, FJ; Wilson, BA; Bradley, KA; Blanke, SR				Gargi, Amandeep; Tamilselvam, Batcha; Powers, Brendan; Prouty, Michael G.; Lincecum, Tommie; Eshraghi, Aria; Maldonado-Arocho, Francisco J.; Wilson, Brenda A.; Bradley, Kenneth A.; Blanke, Steven R.			Cellular Interactions of the Cytolethal Distending Toxins from Escherichia coli and Haemophilus ducreyi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMPYLOBACTER-JEJUNI; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; BACTERIAL TOXIN; CHOLERA-TOXIN; CYCLE ARREST; CELLS; CDTB; ENDOSOMES; CLDT; COMPONENT	The cytolethal distending toxins (CDTs) compose a subclass of intracellularly acting genotoxins produced by many Gram-negative pathogenic bacteria that disrupt the normal progression of the eukaryotic cell cycle. Here, the intoxication mechanisms of CDTs from Escherichia coli (Ec-CDT) and Haemophilus ducreyi (Hd-CDT), which share limited amino acid sequence homology, were directly compared. Ec-CDT and Hd-CDT shared comparable in vitro DNase activities of the CdtB subunits, saturable cell surface binding with comparable affinities, and the requirement for an intact Golgi complex to induce cell cycle arrest. In contrast, disruption of endosome acidification blocked Hd-CDT-mediated cell cycle arrest and toxin transport to the endoplasmic reticulum and nucleus, while having no effects on Ec-CDT. Phosphorylation of the histone protein H2AX, as well as nuclear localization, was inhibited for Hd-CdtB, but not Ec-CdtB, in cells expressing dominant negative Rab7 (T22N), suggesting that Hd-CDT, but not Ec-CDT, is trafficked through late endosomal vesicles. In support of this idea, significantly more Hd-CdtB than Ec-CdtB co-localized with Rab9, which is enriched in late endosomal compartments. Competitive binding studies suggested that Ec-CDT and Hd-CDT bind to discrete cell surface determinants. These results suggest that Ec-CDT and Hd-CDT are transported within cells by distinct pathways, possibly mediated by their interaction with different receptors at the cell surface.	[Gargi, Amandeep; Tamilselvam, Batcha; Powers, Brendan; Prouty, Michael G.; Wilson, Brenda A.; Blanke, Steven R.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Wilson, Brenda A.; Blanke, Steven R.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Lincecum, Tommie] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [Eshraghi, Aria; Maldonado-Arocho, Francisco J.; Bradley, Kenneth A.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Houston System; University of Houston; University of California System; University of California Los Angeles	Blanke, SR (corresponding author), B103 CLSL,601 South Goodwin Ave, Urbana, IL 61801 USA.	sblanke@illinois.edu	Tamilselvam, Batcha/A-8212-2010	Tamilselvam, Batcha/0000-0001-9241-3846	National Institutes of Health [R01GM098756, AI0059095, AI038396, T32DE007296, F31DE022485]; James R. Beck graduate research fellowship; Francis and Harlie Clark graduate student research award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038396, R29AI038396, R21AI059095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F31DE022485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James R. Beck graduate research fellowship; Francis and Harlie Clark graduate student research award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM098756 (to K. A. B.), AI0059095 (to S. R. B.), AI038396 (to B. A. W.), and T32DE007296 and F31DE022485 (to A. E.). This work was also supported by a James R. Beck graduate research fellowship and a Francis and Harlie Clark graduate student research award (to A. G.).	Abrami L, 2005, TRENDS MICROBIOL, V13, P72, DOI 10.1016/j.tim.2004.12.004; Aragon V, 1997, INFECT IMMUN, V65, P3774, DOI 10.1128/IAI.65.9.3774-3780.1997; BAG PK, 1993, FEMS MICROBIOL LETT, V114, P285, DOI 10.1111/j.1574-6968.1993.tb06587.x; BLANKE SR, 2006, MICROBE, V1, P26; BOUZARI S, 1990, FEMS MICROBIOL LETT, V71, P193; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Cao L, 2005, MOL MICROBIOL, V58, P1303, DOI 10.1111/j.1365-2958.2005.04905.x; Cao L, 2008, INFECT IMMUN, V76, P2812, DOI 10.1128/IAI.00126-08; Cao LS, 2006, INFECT IMMUN, V74, P4990, DOI 10.1128/IAI.00697-06; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Cope LD, 1997, P NATL ACAD SCI USA, V94, P4056, DOI 10.1073/pnas.94.8.4056; Cortes-Bratti X, 1999, J CLIN INVEST, V103, P107, DOI 10.1172/JCI3831; Cortes-Bratti X, 2000, INFECT IMMUN, V68, P6903, DOI 10.1128/IAI.68.12.6903-6911.2000; Damek-Poprawa M, 2012, INFECT IMMUN, V80, P2761, DOI 10.1128/IAI.00385-12; Daro E, 1997, J CELL BIOL, V139, P1747, DOI 10.1083/jcb.139.7.1747; DIXON WJ, 1950, ANN MATH STAT, V21, P488, DOI 10.1214/aoms/1177729747; Elwell C, 2001, INFECT IMMUN, V69, P3418, DOI 10.1128/IAI.69.5.3418-3422.2001; Elwell CA, 2000, MOL MICROBIOL, V37, P952, DOI 10.1046/j.1365-2958.2000.02070.x; Eshraghi A, 2010, J BIOL CHEM, V285, P18199, DOI 10.1074/jbc.M110.112912; Frisan T, 2003, CELL MICROBIOL, V5, P695, DOI 10.1046/j.1462-5822.2003.00311.x; Frisk A, 2001, MICROB PATHOGENESIS, V30, P313, DOI 10.1006/mpat.2000.0436; Ganley IG, 2004, MOL BIOL CELL, V15, P5420, DOI 10.1091/mbc.E04-08-0747; Gargi A, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00124; Ge ZM, 2008, CELL MICROBIOL, V10, P1599, DOI 10.1111/j.1462-5822.2008.01173.x; Gelfanova V, 1999, INFECT IMMUN, V67, P6394; Guerra L, 2005, CELL MICROBIOL, V7, P921, DOI 10.1111/j.1462-5822.2005.00520.x; Guerra L, 2009, BBA-MOL CELL RES, V1793, P489, DOI 10.1016/j.bbamcr.2008.11.017; Hassane DC, 2003, INFECT IMMUN, V71, P541, DOI 10.1128/IAI.71.1.541-545.2003; Hu X, 2006, PROTEINS, V62, P421, DOI 10.1002/prot.20767; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; JOHNSON WM, 1988, MICROB PATHOGENESIS, V4, P115, DOI 10.1016/0882-4010(88)90053-8; JOHNSON WM, 1988, MICROB PATHOGENESIS, V4, P103, DOI 10.1016/0882-4010(88)90052-6; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Lee RB, 2003, INFECT IMMUN, V71, P4883, DOI 10.1128/IAI.71.9.4883-4890.2003; LENCER WI, 1995, AM J PHYSIOL-GASTR L, V269, pG548, DOI 10.1152/ajpgi.1995.269.4.G548; Li LQ, 2002, CELL MICROBIOL, V4, P87, DOI 10.1046/j.1462-5822.2002.00174.x; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; Mayer MPA, 1999, INFECT IMMUN, V67, P1227, DOI 10.1128/IAI.67.3.1227-1237.1999; McSweeney LA, 2005, INFECT IMMUN, V73, P2051, DOI 10.1128/IAI.73.4.2051-2060.2005; McSweeney LA, 2004, CELL MICROBIOL, V6, P447, DOI 10.1111/j.1462-5822.2004.00373.x; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Mise K, 2005, INFECT IMMUN, V73, P4846, DOI 10.1128/IAI.73.8.4846-4852.2005; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; MONTECUCCO C, 1994, FEBS LETT, V346, P92, DOI 10.1016/0014-5793(94)00449-8; Nesic D, 2004, NATURE, V429, P429, DOI 10.1038/nature02532; Nesic D, 2005, PLOS PATHOG, V1, P214, DOI 10.1371/journal.ppat.0010028; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Nishikubo S, 2003, J BIOL CHEM, V278, P50671, DOI 10.1074/jbc.M305062200; Nougayrede JP, 2005, TRENDS MICROBIOL, V13, P103, DOI 10.1016/j.tim.2005.01.002; Ohara M, 2004, J BIOCHEM, V136, P409, DOI 10.1093/jb/mvh154; OKUDA J, 1995, MICROB PATHOGENESIS, V18, P167, DOI 10.1016/S0882-4010(95)90022-5; ORLANDI PA, 1993, J BIOL CHEM, V268, P12010; Oswald E, 2005, CURR OPIN MICROBIOL, V8, P83, DOI 10.1016/j.mib.2004.12.011; Pickett CL, 1999, TRENDS MICROBIOL, V7, P292, DOI 10.1016/S0966-842X(99)01537-1; RIEDERER MA, 1994, J CELL BIOL, V125, P573, DOI 10.1083/jcb.125.3.573; Sandvig K, 2005, GENE THER, V12, P865, DOI 10.1038/sj.gt.3302525; SIMPSON JC, 1995, J BIOL CHEM, V270, P20078, DOI 10.1074/jbc.270.34.20078; Smith JL, 2006, CRIT REV MICROBIOL, V32, P227, DOI 10.1080/10408410601023557; Spinosa MR, 2008, J NEUROSCI, V28, P1640, DOI 10.1523/JNEUROSCI.3677-07.2008; Sugai M, 1998, INFECT IMMUN, V66, P5008, DOI 10.1128/IAI.66.10.5008-5019.1998; Sun-Wada GH, 2004, BBA-BIOENERGETICS, V1658, P106, DOI 10.1016/j.bbabio.2004.04.013; Sun-Wada GH, 2003, CELL STRUCT FUNCT, V28, P455, DOI 10.1247/csf.28.455; Thelestam M, 2005, REV PHYSIOL BIOCH P, V152, P111, DOI 10.1007/s10254-004-0030-8; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Wising C, 2010, APMIS, V118, P143, DOI 10.1111/j.1600-0463.2009.02573.x	67	26	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7492	7505		10.1074/jbc.M112.448118	http://dx.doi.org/10.1074/jbc.M112.448118			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23306199	Green Published, hybrid			2022-12-25	WOS:000316455300006
J	Ogata, M; Umemoto, N; Ohnuma, T; Numata, T; Suzuki, A; Usui, T; Fukamizo, T				Ogata, Makoto; Umemoto, Naoyuki; Ohnuma, Takayuki; Numata, Tomoyuki; Suzuki, Akari; Usui, Taichi; Fukamizo, Tamo			A Novel Transition-state Analogue for Lysozyme, 4-O-beta-Tri-N-acetylchitotriosyl Moranoline, Provided Evidence Supporting the Covalent Glycosyl-enzyme Intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGG-WHITE LYSOZYME; FREE-ENERGY CHANGE; SUBSTRATE-BINDING; CATALYSIS; 1-DEOXYNOJIRIMYCIN; HYDROLYSIS; REFINEMENT; INHIBITORS; OLIGOSACCHARIDES; TRANSGLYCOSYLASE	4-O-beta-Di-N-acetylchitobiosyl moranoline (2) and 4-O-beta-tri-N-acetylchitotriosyl moranoline (3) were produced by lysozyme-mediated transglycosylation from the substrates tetra-N-acetylchitotetraose, (GlcNAc)(4), and moranoline, and the binding modes of 2 and 3 to hen egg white lysozyme (HEWL) was examined by inhibition kinetics, isothermal titration calorimetry (ITC), and x-ray crystallography. Compounds 2 and 3 specifically bound to HEWL, acting as competitive inhibitors with K-i values of 2.01 x 10(-5) and 1.84 x 10(-6) M, respectively. From IT Canalysis, the binding of 3 was found to be driven by favorable enthalpy change (Delta H-r degrees), which is similar to those obtained for 2 and (GlcNAc)(4). However, the entropy loss (-T Delta S-r degrees) for the binding of 3 was smaller than those of 2 and (GlcNAc)(4). Thus the binding of 3 was found to be more favorable than those of the others. Judging from the K-d value of 3 (760 nM), the compound appears to have the highest affinity among the lysozyme inhibitors identified to date. X-ray crystal structure of HEWL in a complex with 3 showed that compound 3 binds to subsites -4 to -1 and the moranoline moiety adopts an undistorted C-4(1) chair conformation almost overlapping with the -1 sugar covalently bound to Asp-52 of HEWL (Vocadlo, Davies, G.J., Laine, R., and Withers, S. G. (2001) Nature 412, 835-838). From these results, we concluded that compound 3 serves as a transition-state analogue for lysozyme providing additional evidence supporting the covalent glycosyl-enzyme intermediate in the catalytic reaction.	[Ogata, Makoto; Suzuki, Akari; Usui, Taichi] Shizuoka Univ, Grad Sch Sci & Technol, Dept Biosci, Shizuoka 4228529, Japan; [Umemoto, Naoyuki; Ohnuma, Takayuki; Fukamizo, Tamo] Kinki Univ, Grad Sch Agr, Dept Adv Biosci, Nara 6318505, Japan; [Numata, Tomoyuki] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki 3058566, Japan	Shizuoka University; Kindai University (Kinki University); National Institute of Advanced Industrial Science & Technology (AIST)	Usui, T (corresponding author), 836 Ohya,Suruga Ku, Shizuoka 4228529, Japan.	usui@ipc.shizuoka.ac.jp; fukamizo@nara.kindai.ac.jp	OHNUMA, Takayuki/T-8839-2019; Fukamizo, Tamo/AAY-7251-2020; Numata, Tomoyuki/L-6952-2018	Numata, Tomoyuki/0000-0002-4244-8829; Ogata, Makoto/0000-0002-8319-1265	MEXT (Ministry of Education, Culture, Sports, Science and Technology) [S1101035]	MEXT (Ministry of Education, Culture, Sports, Science and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by "Strategic Project to Support the Formation of Research Bases at Private Universities, Matching Fund Subsidy from MEXT (Ministry of Education, Culture, Sports, Science and Technology), 2011-2015, Grant S1101035.	Barends TRM, 2007, J BIOL CHEM, V282, P17242, DOI 10.1074/jbc.M701444200; Callewaert L, 2010, J BIOSCIENCES, V35, P127, DOI 10.1007/s12038-010-0015-5; CHEETHAM JC, 1992, J MOL BIOL, V224, P613, DOI 10.1016/0022-2836(92)90548-X; CHIPMAN DM, 1968, J BIOL CHEM, V243, P487; Dixon M, 1979, ENZYMES, P138; Dong J, 1999, ACTA CRYSTALLOGR D, V55, P745, DOI 10.1107/S0907444998016047; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fukamizo T, 2000, CURR PROTEIN PEPT SC, V1, P105, DOI 10.2174/1389203003381450; Garcia-Hernandez E, 2003, PROTEIN SCI, V12, P135, DOI 10.1110/ps.0222503; Goto T, 2007, J BIOL CHEM, V282, P27459, DOI 10.1074/jbc.M704555200; Imoto T., 1972, ENZYMES, V7, P665; Jensen HH, 2001, ANGEW CHEM INT EDIT, V40, P3447, DOI 10.1002/1521-3773(20010917)40:18<3447::AID-ANIE3447>3.0.CO;2-8; Johnson L N, 1968, Brookhaven Symp Biol, V21, P120; Kawaguchi T, 1996, BIOSCI BIOTECH BIOCH, V60, P344, DOI 10.1271/bbb.60.344; KUHARA S, 1982, J BIOCHEM-TOKYO, V92, P121, DOI 10.1093/oxfordjournals.jbchem.a133908; Kuroki R, 1997, J BIOL CHEM, V272, P19976, DOI 10.1074/jbc.272.32.19976; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; MALCOLM BA, 1989, P NATL ACAD SCI USA, V86, P133, DOI 10.1073/pnas.86.1.133; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAKAE Y, 1975, J BIOCHEM-TOKYO, V77, P993, DOI 10.1093/oxfordjournals.jbchem.a130825; Ogata M, 2012, BIOSCI BIOTECH BIOCH, V76, P1362, DOI 10.1271/bbb.120119; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PHILLIPS DC, 1966, SCI AM, V215, P78, DOI 10.1038/scientificamerican1166-78; Piens K, 2008, J BIOL CHEM, V283, P21864, DOI 10.1074/jbc.M803057200; Poon DKY, 2007, BIOCHEMISTRY-US, V46, P1759, DOI 10.1021/bi061694c; RUPLEY JA, 1967, P NATL ACAD SCI USA, V57, P496, DOI 10.1073/pnas.57.3.496; SAINTBLANCARD J, 1970, BIOCHIM BIOPHYS ACTA, V220, P300, DOI 10.1016/0005-2744(70)90014-8; SCHINDLER M, 1976, J BIOL CHEM, V251, P4330; SECEMSKI II, 1972, J BIOL CHEM, V247, P4740; SECEMSKI II, 1971, J AM CHEM SOC, V93, P3549; Tanaka A, 1996, BIOSCI BIOTECH BIOCH, V60, P2055, DOI 10.1271/bbb.60.2055; USUI T, 1988, BIOCHIM BIOPHYS ACTA, V953, P179, DOI 10.1016/0167-4838(88)90022-2; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; Weiss MS, 2000, ACTA CRYSTALLOGR D, V56, P952, DOI 10.1107/S0907444900006685; Zechel DL, 2003, J AM CHEM SOC, V125, P14313, DOI 10.1021/ja036833h	37	17	18	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6072	6082		10.1074/jbc.M112.439281	http://dx.doi.org/10.1074/jbc.M112.439281			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23303182	hybrid, Green Published			2022-12-25	WOS:000315820700005
J	Cardenas-Aguayo, MD; Kazim, SF; Grundke-Iqbal, I; Iqbal, K				Cardenas-Aguayo, Maria del Carmen; Kazim, Syed Faraz; Grundke-Iqbal, Inge; Iqbal, Khalid			Neurogenic and Neurotrophic Effects of BDNF Peptides in Mouse Hippocampal Primary Neuronal Cell Cultures	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; PARTIAL AGONISTS; SMALL-MOLECULE; ADULT NEUROGENESIS; DENTATE GYRUS; SPINAL-CORD; IN-VITRO; BRAIN	The level of brain-derived neurotrophic factor (BDNF), a member of the neurotrophin family, is down regulated in Alzheimer's disease (AD), Parkinson's disease (PD), depression, stress, and anxiety; conversely the level of this neurotrophin is increased in autism spectrum disorders. Thus, modulating the level of BDNF can be a potential therapeutic approach for nervous system pathologies. In the present study, we designed five different tetra peptides (peptides B-1 to B-5) corresponding to different active regions of BDNF. These tetra peptides were found to be non-toxic, and they induced the expression of neuronal markers in mouse embryonic day 18 (E18) primary hippocampal neuronal cultures. Additionally, peptide B-5 induced the expression of BDNF and its receptor, TrkB, suggesting a positive feedback mechanism. The BDNF peptides induced only a moderate activation (phosphorylation at Tyr 706) of the TrkB receptor, which could be blocked by the Trk's inhibitor, K252a. Peptide B-3, when combined with BDNF, potentiated the survival effect of this neurotrophin on H2O2-treated E18 hippocampal cells. Peptides B-3 and B-5 were found to work as partial agonists and as partial antagonists competing with BDNF to activate the TrkB receptor in a dose-dependent manner. Taken together, these results suggest that the described BDNF tetra peptides are neurotrophic, can modulate BDNF signaling in a partial agonist/antagonist way, and offer a novel therapeutic approach to neural pathologies where BDNF levels are dysregulated.	[Cardenas-Aguayo, Maria del Carmen; Kazim, Syed Faraz; Grundke-Iqbal, Inge; Iqbal, Khalid] New York State Inst Basic Res Dev Disabil, Dept Neurochem, Staten Isl, NY 10314 USA; [Kazim, Syed Faraz] Suny Downstate Med Ctr, Neural & Behav Sci Grad Program, Brooklyn, NY 11203 USA	Institute for Basic Research in Developmental Disabilities; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Iqbal, K (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Neurochem, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA.	khalid.iqbal.ibr@gmail.com	del Carmen Cardenas-Aguayo, Maria/AAH-5073-2020	del Carmen Cardenas-Aguayo, Maria/0000-0001-9156-2161	New York State Office of People with Developmental Disabilities; EVER NeuroPharma GmbH, Unterach, Austria	New York State Office of People with Developmental Disabilities; EVER NeuroPharma GmbH, Unterach, Austria	Studies described in this article were supported in part by the New York State Office of People with Developmental Disabilities, and a research grant from EVER NeuroPharma GmbH, Unterach, Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adessi C, 2002, CURR MED CHEM, V9, P963, DOI 10.2174/0929867024606731; Ankeny DP, 2001, EXP NEUROL, V170, P85, DOI 10.1006/exnr.2001.7699; Barkats M, 1998, PROG NEUROBIOL, V55, P333, DOI 10.1016/S0301-0082(98)00028-8; Barrett GL, 2000, PROG NEUROBIOL, V61, P205, DOI 10.1016/S0301-0082(99)00056-8; Beck M, 2005, AMYOTROPH LATERAL SC, V6, P100, DOI 10.1080/14660820510028412; Behl C, 2002, FREE RADICAL BIO MED, V33, P182, DOI 10.1016/S0891-5849(02)00883-3; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Blanchard J, 2011, J NEUROPATH EXP NEUR, V70, P1070, DOI 10.1097/NEN.0b013e318236e9ad; Blanchard J, 2010, ACTA NEUROPATHOL, V120, P605, DOI 10.1007/s00401-010-0734-6; Blanchard J, 2010, J ALZHEIMERS DIS, V21, P1185, DOI [10.3233/JAD-2010-100069, 10.3233/JAD-2010-1000069]; Bolognin S, 2012, ACTA NEUROPATHOL, V123, P133, DOI 10.1007/s00401-011-0908-x; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; Cardenas-Aguayo MD, 2003, J HEMATOTH STEM CELL, V12, P735; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chao MV, 2002, NEURON, V33, P9, DOI 10.1016/S0896-6273(01)00573-6; Chohan MO, 2011, NEUROBIOL AGING, V32, P1420, DOI 10.1016/j.neurobiolaging.2009.08.008; Correia CT, 2010, GENES BRAIN BEHAV, V9, P841, DOI 10.1111/j.1601-183X.2010.00627.x; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Counts SE, 2005, J NEUROPATH EXP NEUR, V64, P263, DOI 10.1093/jnen/64.4.263; Eglen R, 2011, PHARMACOL THERAPEUT, V130, P144, DOI 10.1016/j.pharmthera.2011.01.007; Fletcher JM, 2009, BIOORGAN MED CHEM, V17, P2695, DOI 10.1016/j.bmc.2009.02.053; Fryer RH, 1997, EXP NEUROL, V148, P616, DOI 10.1006/exnr.1997.6699; Fumagalli F, 2006, PHARMACOGENOMICS J, V6, P8, DOI 10.1038/sj.tpj.6500337; Fumagalli F, 2006, PHARMACOGENOMICS J, V6, P95, DOI 10.1038/sj.tpj.6500360; GRUNDKEIQBAL I, 1988, MOL BRAIN RES, V4, P43, DOI 10.1016/0169-328X(88)90017-4; Haase G, 1998, J NEUROL SCI, V160, pS97, DOI 10.1016/S0022-510X(98)00207-X; Harper MM, 2009, EXP EYE RES, V89, P538, DOI 10.1016/j.exer.2009.05.013; HOYER D, 1993, TRENDS PHARMACOL SCI, V14, P270, DOI 10.1016/0165-6147(93)90129-8; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kasarskis EJ, 1999, NEUROLOGY, V52, P1427; Lee J, 2000, J MOL NEUROSCI, V15, P99, DOI 10.1385/JMN:15:2:99; Li B, 2010, FEBS LETT, V584, P3359, DOI 10.1016/j.febslet.2010.06.025; Li N, 2010, ACTA PHARMACOL SIN, V31, P265, DOI 10.1038/aps.2010.3; Lieberman JA, 2004, CNS DRUGS, V18, P251, DOI 10.2165/00023210-200418040-00005; Longo FM, 2004, J ALZHEIMERS DIS, V6, pS13; Longo FM, 2007, CURR ALZHEIMER RES, V4, P503, DOI 10.2174/156720507783018316; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Mandel RJ, 2010, CURR OPIN MOL THER, V12, P240; Manfredsson FP, 2012, NEUROBIOL DIS; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Massa F, 2011, P NATL ACAD SCI USA, V108, P6644, DOI 10.1073/pnas.1016928108; Massa SM, 2010, J CLIN INVEST, V120, P1774, DOI 10.1172/JCI41356; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; Molina-Holgado F, 2008, CNS NEUROL DISORD-DR, V7, P110; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Nakagawara A, 2001, CANCER LETT, V169, P107, DOI 10.1016/S0304-3835(01)00530-4; O'Leary PD, 2003, J BIOL CHEM, V278, P25738, DOI 10.1074/jbc.M303209200; PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3; Price RD, 2007, PHARMACOL THERAPEUT, V115, P292, DOI 10.1016/j.pharmthera.2007.03.005; Simmons DA, 2009, P NATL ACAD SCI USA, V106, P4906, DOI 10.1073/pnas.0811228106; Tapia-Arancibia L, 2008, BRAIN RES REV, V59, P201, DOI 10.1016/j.brainresrev.2008.07.007; Tatebayashi Y, 1999, J NEUROSCI, V19, P5245; Tsai SJ, 2007, MED HYPOTHESES, V68, P674, DOI 10.1016/j.mehy.2006.06.019; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Whitty A, 1999, CHEM BIOL, V6, pR107, DOI 10.1016/S1074-5521(99)80034-9; Yang JM, 2009, NAT NEUROSCI, V12, P113, DOI 10.1038/nn.2244; Yang T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003604; Young W, 2009, CELL TRANSPLANT, V18, P951, DOI 10.3727/096368909X471251; Zhang W, 2008, NEUROSCIENCE, V152, P502, DOI 10.1016/j.neuroscience.2007.12.037	61	47	47	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53596	10.1371/journal.pone.0053596	http://dx.doi.org/10.1371/journal.pone.0053596			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320097	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429800062
J	Mastroeni, D; Chouliaras, L; Grover, A; Liang, WS; Hauns, K; Rogers, J; Coleman, PD				Mastroeni, Diego; Chouliaras, Leonidas; Grover, Andrew; Liang, Winnie S.; Hauns, Kevin; Rogers, Joseph; Coleman, Paul D.			Reduced RAN Expression and Disrupted Transport between Cytoplasm and Nucleus; A Key Event in Alzheimer's Disease Pathophysiology	PLOS ONE			English	Article							RNA-POLYMERASE-II; GENE-EXPRESSION; MECHANISMS; CASPASE-3; REGIONS; COMPLEX; IMPORT; EXPORT; HDAC1	Transcription of DNA is essential for cell maintenance and survival; inappropriate localization of proteins that are involved in transcription would be catastrophic. In Alzheimer's disease brains, and in vitro studies, we have found qualitative and quantitative deficits in transport into the nucleus of DNA methyltransferase 1 (DNMT1) and RNA polymerase II (RNA pol II), accompanied by their abnormal sequestration in the cytoplasm. RAN (RAs-related Nuclear protein) knockdown, by siRNA and oligomeric A beta 42 treatment in neurons, replicate human data which indicate that transport disruption in AD may be mechanistically linked to reduced expression of RAN, a pivotal molecule in nucleocytoplasmic transport. In vitro studies also indicate a significant role for oligomeric A beta 42 in the observed phenomena. We propose a model in which reduced transcription regulators in the nucleus and their increased presence in the cytoplasm may lead to many of the cellular manifestations of Alzheimer's disease.	[Mastroeni, Diego; Grover, Andrew; Hauns, Kevin; Rogers, Joseph; Coleman, Paul D.] Banner Sun Hlth Res Inst, LJ Roberts Alzheimers Dis Ctr, Sun City, AZ USA; [Mastroeni, Diego; Chouliaras, Leonidas] Maastricht Univ, Med Ctr, European Grad Sch Neurosci EURON,Sch Mental Hlth, Dept Psychiat & Neuropsychol,Fac Hlth Med & Life, Maastricht, Netherlands; [Liang, Winnie S.] Translat Genom Res Inst, Collaborat Sequencing Ctr, Phoenix, AZ USA	Banner Research; Banner Health; Banner Sun Health Research Institute; Maastricht University; Translational Genomics Research Institute	Coleman, PD (corresponding author), Banner Sun Hlth Res Inst, LJ Roberts Alzheimers Dis Ctr, Sun City, AZ USA.	paul.coleman@bannerhealth.com	Chouliaras, Leonidas/W-8711-2019	Chouliaras, Leonidas/0000-0002-3052-3879	National Institutes of Health (NIH) [RO1 AG036400]; Arizona Alzheimer's Research Center DHS; National Institute of Neurological Disorders and Stroke [U24 NS072026]; National Institute on Aging [P30 AG19610]; Arizona Department of Health Services, Arizona Alzheimer's Research Center [211002]; Arizona Biomedical Research Commission [4001, 0011, 05-901, 1001]; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS072026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG036400, P30AG019610] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arizona Alzheimer's Research Center DHS; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Arizona Department of Health Services, Arizona Alzheimer's Research Center; Arizona Biomedical Research Commission; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH) RO1 AG036400 and Arizona Alzheimer's Research Center DHS Award FY 2012 to PDC. The Brain and Body Donation Program is supported by the National Institute of Neurological Disorders and Stroke (U24 NS072026 National Brain and Tissue Resource for Parkinson's Disease and Related Disorders), the National Institute on Aging (P30 AG19610 Arizona Alzheimer's Disease Core Center), the Arizona Department of Health Services (contract 211002, Arizona Alzheimer's Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011, 05-901 and 1001 to the Arizona Parkinson's Disease Consortium) and the Michael J. Fox Foundation for Parkinson's Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barres V, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-272; Bhaskar K, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-14; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Carre C, 2011, MOL CELL BIOL, V31, P3953, DOI 10.1128/MCB.05442-11; Cotman CW, 2005, J NEUROPATH EXP NEUR, V64, P104, DOI 10.1093/jnen/64.2.104; Curradi M, 2002, MOL CELL BIOL, V22, P3157, DOI 10.1128/MCB.22.9.3157-3173.2002; Czeko E, 2011, MOL CELL, V42, P261, DOI 10.1016/j.molcel.2011.02.033; D'Amelio M, 2011, NAT NEUROSCI, V14, P69, DOI 10.1038/nn.2709; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Desplats P, 2011, J BIOL CHEM, V286, P9031, DOI 10.1074/jbc.C110.212589; Husseman JW, 2001, J NEUROPATH EXP NEUR, V60, P1219, DOI 10.1093/jnen/60.12.1219; Irier HA, 2012, DNA CELL BIOL; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Kim JY, 2010, NAT NEUROSCI, V13, P180, DOI 10.1038/nn.2471; Liang WS, 2008, PHYSIOL GENOMICS, V33, P240, DOI 10.1152/physiolgenomics.00242.2007; Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105; Liang WS, 2007, PHYSIOL GENOMICS, V28, P311, DOI 10.1152/physiolgenomics.00208.2006; Liang WS, 2010, NEUROBIOL AGING, V31, P549, DOI 10.1016/j.neurobiolaging.2008.05.013; Mastroeni D, 2011, NEUROBIOL AGING, V32, P1161, DOI 10.1016/j.neurobiolaging.2010.08.017; Mastroeni D, 2010, NEUROBIOL AGING, V31, P2025, DOI 10.1016/j.neurobiolaging.2008.12.005; Mastroeni D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006617; Miyamoto Y, 2004, J CELL BIOL, V165, P617, DOI 10.1083/jcb.200312008; Muhlhausser P, 2001, EMBO REP, V2, P690, DOI 10.1093/embo-reports/kve168; Patel VP, 2011, INT J CLIN EXP PATHO, V4, P215; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Rodriguez MS, 2004, BIOL CELL, V96, P639, DOI 10.1016/j.biolcel.2004.04.014; Sheffield LG, 2006, J NEUROPATH EXP NEUR, V65, P45, DOI 10.1097/01.jnen.0000195939.40410.08; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012	29	44	45	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53349	10.1371/journal.pone.0053349	http://dx.doi.org/10.1371/journal.pone.0053349			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308199	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429800041
J	Silva, G; Cardoso, BA; Belo, H; Almeida, AM				Silva, Gabriela; Cardoso, Bruno A.; Belo, Helio; Almeida, Antonio Medina			Vorinostat Induces Apoptosis and Differentiation in Myeloid Malignancies: Genetic and Molecular Mechanisms	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; SUBEROYLANILIDE HYDROXAMIC ACID; MYELODYSPLASTIC SYNDROMES; DOWN-REGULATION; CD34(+) CELLS; CANCER-CELLS; SP FAMILY; EXPRESSION; SP1; TRANSCRIPTION	Background: Aberrant epigenetic patterns are central in the pathogenesis of haematopoietic diseases such as myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML). Vorinostat is a HDACi which has produced responses in these disorders. The purpose of this study was to address the functional effects of vorinostat in leukemic cell lines and primary AML and MDS myeloid cells and to dissect the genetic and molecular mechanisms by which it exerts its action. Methodology/Principal Findings: Functional assays showed vorinostat promoted cell cycle arrest, inhibited growth, and induced apoptosis and differentiation of K562, HL60 and THP-1 and of CD33(+) cells from AML and MDS patients. To explore the genetic mechanism for these effects, we quantified gene expression modulation by vorinostat in these cells. Vorinostat increased expression of genes down-regulated in MDS and/or AML (cFOS, COX2, IER3, p15, RAI3) and suppressed expression of genes over-expressed in these malignancies (AXL, c-MYC, Cyclin D1) and modulated cell cycle and apoptosis genes in a manner which would favor cell cycle arrest, differentiation, and apoptosis of neoplastic cells, consistent with the functional assays. Reporter assays showed transcriptional effect of vorinostat on some of these genes was mediated by proximal promoter elements in GC-rich regions. Vorinostat-modulated expression of some genes was potentiated by mithramycin A, a compound that interferes with SP1 binding to GC-rich DNA sequences, and siRNA-mediated SP1 reduction. ChIP assays revealed vorinostat inhibited DNA binding of SP1 to the proximal promoter regions of these genes. These results suggest vorinostat transcriptional action in some genes is regulated by proximal promoter GC-rich DNA sequences and by SP1. Conclusion: This study sheds light on the effects of vorinostat in AML and MDS and supports the implementation of clinical trials to explore the use of vorinostat in the treatment of these diseases.	[Silva, Gabriela; Cardoso, Bruno A.; Belo, Helio; Almeida, Antonio Medina] EPE, Inst Portugues Oncol Lisboa Francisco Gentil, Unidade Invest Patobiol Mol, Lisbon, Portugal; [Silva, Gabriela; Cardoso, Bruno A.; Belo, Helio; Almeida, Antonio Medina] Univ Nova Lisboa, Fac Ciencias Med, CEDOC, P-1200 Lisbon, Portugal	Universidade Nova de Lisboa	Almeida, AM (corresponding author), EPE, Inst Portugues Oncol Lisboa Francisco Gentil, Unidade Invest Patobiol Mol, Lisbon, Portugal.	amalmeida@ipolisboa.min-saude.pt		Silva, Gabriela/0000-0002-4004-9904; Cardoso, Bruno/0000-0002-6521-7257; Almeida, Antonio/0000-0003-4361-0928	Portuguese Association Against Leukemia; IPOLFG Oncology Research Fund; Fundacao para a Ciencia e Tecnologia [SFRH/BPD/46494/2008]; Celgene; Novartis	Portuguese Association Against Leukemia; IPOLFG Oncology Research Fund; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Celgene(Bristol-Myers SquibbCelgene Corporation); Novartis(Novartis)	This study was funded by a research grant from the Portuguese Association Against Leukemia, from the IPOLFG Oncology Research Fund, and a post-doctoral fellowship from "Fundacao para a Ciencia e Tecnologia" (SFRH/BPD/46494/2008) for GS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr AMA receives consulting fees from Celgene and Novartis and is on the board of speakers for Bristol-Meyer Squibb, Shire and Amgen. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Agirre X, 2006, ONCOGENE, V25, P1862, DOI 10.1038/sj.onc.1209236; Almeida AM, 2007, NEW ENGL J MED, V356, P1641, DOI 10.1056/NEJMoa063369; Almeida AM, 2006, NAT MED, V12, P846, DOI 10.1038/nm1410; Arinze IJ, 2003, J BIOL CHEM, V278, P17785, DOI 10.1074/jbc.M209430200; Blundell R.A., 2006, AM J BIOCH BIOTECHNO, V2, P33, DOI DOI 10.3844/AJBBSP.2006.33.40; Breen EC, 2006, TUMOR BIOL, V27, P187, DOI 10.1159/000093022; Bu Y, 2007, J BIOL CHEM, V282, P26725, DOI 10.1074/jbc.M702885200; Capparuccia L, 2009, J CELL SCI, V122, P1723, DOI 10.1242/jcs.030197; Cheng YC, 2007, LEUKEMIA RES, V31, P1403, DOI 10.1016/j.leukres.2007.03.012; Chou CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018087; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; Delgado M Dolores, 2010, Genes Cancer, V1, P605, DOI 10.1177/1947601910377495; Figueroa ME, 2009, BLOOD, V114, P3448, DOI 10.1182/blood-2009-01-200519; Friedbichler K, 2010, BLOOD, V116, P1548, DOI 10.1182/blood-2009-12-258913; Garcia-Manero G, 2008, BLOOD, V111, P1060, DOI 10.1182/blood-2007-06-098061; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Griffiths EA, 2008, SEMIN HEMATOL, V45, P23, DOI 10.1053/j.seminhematol.2007.11.007; Griffiths EA, 2010, EPIGENETICS-US, V5, P590, DOI 10.4161/epi.5.7.12558; Han JW, 2001, J BIOL CHEM, V276, P42084, DOI 10.1074/jbc.M106688200; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hofmann WK, 2002, BLOOD, V100, P3553, DOI 10.1182/blood.V100.10.3553; Jain N, 2009, INT J BIOCHEM CELL B, V41, P72, DOI 10.1016/j.biocel.2008.10.006; Jia ZL, 2007, CANCER RES, V67, P4878, DOI 10.1158/0008-5472.CAN-06-3494; Kelly WK, 2005, J CLIN ONCOL, V23, P3923, DOI 10.1200/JCO.2005.14.167; Lee JH, 2010, P NATL ACAD SCI USA, V107, P14639, DOI 10.1073/pnas.1008522107; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Lieberman HB, 2011, J MOL CELL BIOL, V3, P39, DOI 10.1093/jmcb/mjq039; Liu F, 2006, MOL BIOL CELL, V17, P585, DOI 10.1091/mbc.E05-08-0775; Long XH, 2007, INT J MOL MED, V19, P607; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Mano H, 2006, LEUKEMIA LYMPHOMA, V47, P9, DOI 10.1080/10428190500264231; Marks PA, 2007, ONCOGENE, V26, P1351, DOI 10.1038/sj.onc.1210204; Marsee DK, 2010, AM J CLIN PATHOL, V134, P429, DOI 10.1309/AJCPCRK3MOAOJ6AT; Martin V, 2010, CANCER SCI, V101, P425, DOI 10.1111/j.1349-7006.2009.01413.x; Matarraz S, 2010, CYTOM PART B-CLIN CY, V78B, P154, DOI 10.1002/cyto.b.20513; Mitsiades CS, 2004, P NATL ACAD SCI USA, V101, P540, DOI 10.1073/pnas.2536759100; Mudduluru G, 2010, MOL CANCER RES, V8, P159, DOI 10.1158/1541-7786.MCR-09-0326; Neubauer A, 1997, LEUKEMIA LYMPHOMA, V25, P91, DOI 10.3109/10428199709042499; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pellagatti A, 2005, HEMATOLOGY, V10, P281, DOI 10.1080/10245330500065680; Pellagatti A, 2004, BRIT J HAEMATOL, V125, P576, DOI 10.1111/j.1365-2141.2004.04958.x; Pellagatti A, 2006, BLOOD, V108, P337, DOI 10.1182/blood-2005-12-4769; Lima PSP, 2008, GENET MOL BIOL, V31, P632, DOI 10.1590/S1415-47572008000400005; Petruccelli LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020987; Plass C, 2008, SEMIN ONCOL, V35, P378, DOI 10.1053/j.seminoncol.2008.04.008; Richon VM, 2009, CANCER LETT, V280, P201, DOI 10.1016/j.canlet.2009.01.002; Siegel D, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-31; Silva G, 2006, J IMMUNOL, V177, P1894, DOI 10.4049/jimmunol.177.3.1894; Silva G, 2009, J BIOL CHEM, V284, P29582, DOI 10.1074/jbc.M109.045344; Sleiman SF, 2011, J NEUROSCI, V31, P6858, DOI 10.1523/JNEUROSCI.0710-11.2011; Stintzing S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/214143; Stossi F, 2006, J BIOL CHEM, V281, P16272, DOI 10.1074/jbc.M513405200; Suzuki A, 2010, J BIOL CHEM, V285, P13444, DOI 10.1074/jbc.M109.062430; Suzuki E, 2010, INT J ONCOL, V36, P1299, DOI 10.3892/ijo_00000615; Tsiftsoglou AS, 2009, PHARMACOL THERAPEUT, V122, P264, DOI 10.1016/j.pharmthera.2009.03.001; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Waby JS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-275; Wilson AJ, 2008, MOL BIOL CELL, V19, P4062, DOI 10.1091/mbc.E08-02-0139; Witt O, 2003, BLOOD, V101, P2001, DOI 10.1182/blood-2002-08-2617; Wu YZ, 2007, GENES CELLS, V12, P905, DOI 10.1111/j.1365-2443.2007.01104.x; Yoshima T, 1998, J BIOL CHEM, V273, P25466, DOI 10.1074/jbc.273.39.25466; Yu DCW, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-276; Zeuner A, 2011, CELL DEATH DIFFER, V18, P371, DOI 10.1038/cdd.2010.110	63	53	55	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53766	10.1371/journal.pone.0053766	http://dx.doi.org/10.1371/journal.pone.0053766			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320102	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429800067
J	Subramanyam, MA; Diez-Roux, AV; Pilsner, JR; Villamor, E; Donohue, KM; Liu, YM; Jenny, NS				Subramanyam, Malavika A.; Diez-Roux, Ana V.; Pilsner, J. Richard; Villamor, Eduardo; Donohue, Kathleen M.; Liu, Yongmei; Jenny, Nancy S.			Social Factors and Leukocyte DNA Methylation of Repetitive Sequences: The Multi-Ethnic Study of Atherosclerosis	PLOS ONE			English	Article							SOCIOECONOMIC POSITION; EPIGENETIC DIFFERENCES; PARTICULATE MATTER; GLOBAL METHYLATION; PRENATAL EXPOSURE; PHYSICAL-ACTIVITY; AFRICAN-AMERICAN; SEX-DIFFERENCES; HEALTH; BLOOD	Epigenetic changes are a potential mechanism contributing to race/ethnic and socioeconomic disparities in health. However, there is scant evidence of the race/ethnic and socioeconomic patterning of epigenetic marks. We used data from the Multi-Ethnic Study of Atherosclerosis Stress Study (N = 988) to describe age-and gender-independent associations of race/ethnicity and socioeconomic status (SES) with methylation of Alu and LINE-1 repetitive elements in leukocyte DNA. Mean Alu and Line 1 methylation in the full sample were 24% and 81% respectively. In multivariable linear regression models, African-Americans had 0.27% (p<0.01) and Hispanics 0.20% (p<0.05) lower Alu methylation than whites. In contrast, African-Americans had 0.41% (p<0.01) and Hispanics 0.39% (p<0.01) higher LINE-1 methylation than whites. These associations remained after adjustment for SES. In addition, a one standard deviation higher wealth was associated with 0.09% (p<0.01) higher Alu and 0.15% (p<0.01) lower LINE-1 methylation in age-and gender-adjusted models. Additional adjustment for race/ethnicity did not alter this pattern. No associations were observed with income, education or childhood SES. Our findings, from a large community-based sample, suggest that DNA methylation is socially patterned. Future research, including studies of gene-specific methylation, is needed to understand better the opposing associations of Alu and LINE-1 methylation with race/ethnicity and wealth as well as the extent to which small methylation changes in these sequences may influence disparities in health.	[Subramanyam, Malavika A.] Indian Inst Technol Gandhinagar, Ahmadabad, Gujarat, India; [Diez-Roux, Ana V.; Villamor, Eduardo] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Pilsner, J. Richard] Univ Massachusetts, Div Environm Hlth Sci, Amherst, MA 01003 USA; [Donohue, Kathleen M.] Columbia Univ, Med Ctr, New York, NY USA; [Liu, Yongmei] Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA; [Jenny, Nancy S.] Univ Vermont, Lab Clin Biochem Res, Colchester, VT USA	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Gandhinagar; University of Michigan System; University of Michigan; University of Massachusetts System; University of Massachusetts Amherst; Columbia University; Wake Forest University; University of Vermont	Subramanyam, MA (corresponding author), Indian Inst Technol Gandhinagar, Ahmadabad, Gujarat, India.	Malavika@iitgn.ac.in			National Heart, Lung, and Blood Institute (NHLBI);  [N01 HC-95159];  [N01-HC-95160];  [N01-HC-95161];  [N01-HC-95162];  [N01-HC-95163];  [N01-HC-95164];  [N01-HC-95165];  [N01-HC-95166];  [N01-HC-95167];  [N01-HC-95168];  [N01-HC-95169];  [RR-024156];  [RO1 HL076831];  [R01 HL101161]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095165, N01HC095163, N01HC095167, N01HC095159, N01HC095169, N01HC095168, N01HC095162, N01HC095164, N01HC095161, N01HC095166, N01HC095160] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101161, R01HL076831] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; ; ; ; ; ; ; ; ; ; ; ; ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	MESA is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with MESA investigators. Support is provided by grants and contracts N01 HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169 and RR-024156. MESA Stress Study was supported by RO1 HL076831 and R01 HL101161. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	August KJ, 2011, J GEN INTERN MED, V26, P245, DOI 10.1007/s11606-010-1514-7; Axume J, 2007, EPIGENETICS-US, V2, P66, DOI 10.4161/epi.2.1.4066; Baccarelli A, 2010, EPIDEMIOLOGY, V21, P819, DOI 10.1097/EDE.0b013e3181f20457; Baccarelli A, 2009, AM J RESP CRIT CARE, V179, P572, DOI 10.1164/rccm.200807-1097OC; Bain BJ, 1996, J CLIN PATHOL, V49, P664, DOI 10.1136/jcp.49.8.664; Bernabe E, 2012, COMMUNITY DENT ORAL, V40, P46, DOI 10.1111/j.1600-0528.2011.00633.x; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Borghol N, 2012, INT J EPIDEMIOL, V41, P62, DOI 10.1093/ije/dyr147; Braveman PA, 2010, AM J PUBLIC HEALTH, V100, pS186, DOI 10.2105/AJPH.2009.166082; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Champagne FA, 2010, DEV PSYCHOBIOL, V52, P299, DOI 10.1002/dev.20436; Choi IS, 2007, MODERN PATHOL, V20, P802, DOI 10.1038/modpathol.3800825; Choi SH, 2009, INT J CANCER, V125, P723, DOI 10.1002/ijc.24384; Cleland VJ, 2009, AM J EPIDEMIOL, V170, P1069, DOI 10.1093/aje/kwp271; Coogan PF, 2012, ETHNIC DIS, V22, P198; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; El-Maarri O, 2007, HUM GENET, V122, P505, DOI 10.1007/s00439-007-0430-3; El-Maarri O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016252; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Guerrero-Preston R, 2009, P R HEALTH SCI J, V28, P24; Hajat A, 2010, PSYCHONEUROENDOCRINO, V35, P932, DOI 10.1016/j.psyneuen.2009.12.009; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Janicki-Deverts D, 2012, PSYCHOSOM MED, V74, P728, DOI 10.1097/PSY.0b013e31825e32e8; Kant AK, 2007, PUBLIC HEALTH NUTR, V10, P158, DOI 10.1017/S1368980007246749; Kant AK, 2007, AM J PREV MED, V32, P264, DOI 10.1016/j.amepre.2006.12.011; Keister LA, 2000, ANNU REV SOCIOL, V26, P63, DOI 10.1146/annurev.soc.26.1.63; Kim KY, 2010, ENVIRON HEALTH PERSP, V118, P370, DOI 10.1289/ehp.0901131; MacLennan NK, 2004, PHYSIOL GENOMICS, V18, P43, DOI 10.1152/physiolgenomics.00042.2004; Madrigano J, 2011, ENVIRON HEALTH PERSP, V119, P977, DOI 10.1289/ehp.1002773; McGuinness D, 2012, INT J EPIDEMIOL, V41, P151, DOI 10.1093/ije/dyr215; Nelson HH, 2011, ENVIRON HEALTH PERSP, V119, P1528, DOI 10.1289/ehp.1103423; Niculescu MD, 2011, CURR OPIN CLIN NUTR, V14, P35, DOI 10.1097/MCO.0b013e328340ff7c; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Peters JL, 2011, AM J EPIDEMIOL, V174, P1345, DOI 10.1093/aje/kwr269; Pilsner JR, 2007, AM J CLIN NUTR, V86, P1179, DOI 10.1093/ajcn/86.4.1179; Pilsner JR, 2009, ENVIRON HEALTH PERSP, V117, P1466, DOI 10.1289/ehp.0800497; Pollack CE, 2007, AM J PREV MED, V33, P250, DOI 10.1016/j.amepre.2007.04.033; Rusiecki JA, 2008, ENVIRON HEALTH PERSP, V116, P1547, DOI 10.1289/ehp.11338; Sacks JD, 2011, ENVIRON HEALTH PERSP, V119, P446, DOI 10.1289/ehp.1002255; Shrewsbury V, 2008, OBESITY, V16, P275, DOI 10.1038/oby.2007.35; Stenvinkel P, 2007, J INTERN MED, V261, P488, DOI 10.1111/j.1365-2796.2007.01777.x; Szyf M, 2008, ENVIRON MOL MUTAGEN, V49, P46, DOI 10.1002/em.20357; Tamashiro KLK, 2010, PHYSIOL BEHAV, V100, P560, DOI 10.1016/j.physbeh.2010.04.008; Tao MH, 2011, ALCOHOL, V45, P689, DOI 10.1016/j.alcohol.2010.11.006; Tarantini L, 2009, ENVIRON HEALTH PERSP, V117, P217, DOI 10.1289/ehp.11898; Terry MB, 2008, CANCER EPIDEM BIOMAR, V17, P2306, DOI 10.1158/1055-9965.EPI-08-0312; Villamor E, 2008, J NUTR, V138, P1391, DOI 10.1093/jn/138.7.1391; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Williams DR, 2010, ANN NY ACAD SCI, V1186, P69, DOI 10.1111/j.1749-6632.2009.05339.x; Williams DR, 2009, J BEHAV MED, V32, P20, DOI 10.1007/s10865-008-9185-0; Wright RO, 2010, ENVIRON HEALTH PERSP, V118, P790, DOI 10.1289/ehp.0901429; Wu HC, 2011, EPIGENETICS-US, V6, P76, DOI 10.4161/epi.6.1.13391; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Zhang FF, 2011, EPIGENETICS-US, V6, P623, DOI 10.4161/epi.6.5.15335; Zhang FF, 2011, EPIGENETICS-US, V6, P293, DOI 10.4161/epi.6.3.14378; Zhu ZZ, 2012, INT J EPIDEMIOL, V41, P126, DOI 10.1093/ije/dyq154	58	37	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e54018	10.1371/journal.pone.0054018	http://dx.doi.org/10.1371/journal.pone.0054018			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	069IY	23320117	gold, Green Published, Green Submitted			2022-12-25	WOS:000313429800084
J	Tibolla, G; Pineiro, R; Chiozzotto, D; Mavrommati, I; Wheeler, AP; Norata, GD; Catapano, AL; Maffucci, T; Falasca, M				Tibolla, Gianpaolo; Pineiro, Roberto; Chiozzotto, Daniela; Mavrommati, Ioanna; Wheeler, Ann P.; Norata, Giuseppe Danilo; Catapano, Alberico Luigi; Maffucci, Tania; Falasca, Marco			Class II Phosphoinositide 3-Kinases Contribute to Endothelial Cells Morphogenesis	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; SPHINGOSINE 1-PHOSPHATE; GROWTH-FACTOR; MIGRATION; SPHINGOSINE-1-PHOSPHATE; ANGIOGENESIS; CHOLESTEROL; MECHANISM; DISTINCT; PATHWAY	The question of whether the distinct isoforms of the family of enzymes phosphoinositide 3-kinases (PI3Ks) play redundant roles within a cell or whether they control distinct cellular processes or distinct steps within the same cellular process has gained considerable importance in the recent years due to the development of inhibitors able to selectively target individual isoforms. It is important to understand whether inhibition of one PI3K can result in compensatory effect from other isoform(s) and therefore whether strategies aimed at simultaneously blocking more than one PI3K may be needed. In this study we investigated the relative contribution of distinct PI3K isoforms to endothelial cells (EC) functions specifically regulated by the sphingolipid sphingosine-1-phosphate (S1P) and by high density lipoproteins (HDL), the major carrier of S1P in human plasma. Here we show that a co-ordinated action of different PI3Ks is required to tightly regulate remodelling of EC on Matrigel, a process dependent on cell proliferation, apoptosis and migration. The contribution of each isoform to this process appears to be distinct, with the class II enzyme PI3K-C2 beta and the class IB isoform p110 gamma mainly regulating the S1P- and HDL-dependent EC migration and PI3K-C2 alpha primarily controlling EC survival. Data further indicate that PI3K-C2 beta and p110 gamma control distinct steps involved in cell migration supporting the hypothesis that different PI3Ks regulate distinct cellular processes.	[Tibolla, Gianpaolo; Pineiro, Roberto; Chiozzotto, Daniela; Mavrommati, Ioanna; Norata, Giuseppe Danilo; Maffucci, Tania; Falasca, Marco] Queen Mary Univ London, Inositide Signalling Grp, Ctr Diabet, Barts & London Sch Med & Dent,Blizard Inst, London, England; [Tibolla, Gianpaolo; Norata, Giuseppe Danilo; Catapano, Alberico Luigi] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Tibolla, Gianpaolo; Norata, Giuseppe Danilo] Bassini Hosp, Societa Italiana Studio Aterosclerosi, Ctr Study Atherosclerosis, Cinisello Balsamo, Italy; [Wheeler, Ann P.] Queen Mary Univ London, Blizard Adv Light Microscopy Core Facil, Barts & London Sch Med & Dent, London, England; [Catapano, Alberico Luigi] Ist Ric & Cura Carattere Sci MultiMed, Milan, Italy	University of London; Queen Mary University London; University of Milan; University of London; Queen Mary University London	Falasca, M (corresponding author), Queen Mary Univ London, Inositide Signalling Grp, Ctr Diabet, Barts & London Sch Med & Dent,Blizard Inst, London, England.	m.falasca@qmul.ac.uk	Catapano, alberico/AAC-2827-2019; Norata, Giuseppe Danilo/AAC-2863-2019; Piñeiro, Roberto/AAN-5561-2020; Falasca, Marco/S-4020-2016	Catapano, alberico/0000-0002-7593-2094; Piñeiro, Roberto/0000-0001-9479-139X; Wheeler, Ann/0000-0001-8617-827X; Norata, Giuseppe Danilo/0000-0002-6081-1257; Falasca, Marco/0000-0002-9801-7235	British Heart Foundation [PG/04/033/16906, PG/06/022/20348]; SISA Lombardia; Diabetes UK [BDA:09/0003971]; "Dote Ricerca FSE" Regione Lombardia; University of Milan; Diabetes UK [09/0003971] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); SISA Lombardia; Diabetes UK(Diabetes UK); "Dote Ricerca FSE" Regione Lombardia(Regione Lombardia); University of Milan; Diabetes UK(Diabetes UK)	This work was supported by British Heart Foundation [grant PG/04/033/16906 and grant PG/06/022/20348 to MF] and by SISA Lombardia. D. Chiozzotto was supported by British Heart Foundation [grant PG/04/033/16906 to MF]. T. Maffucci was supported by grant from Diabetes UK [( grant BDA:09/0003971], G. Tibolla was supported by "Dote Ricerca FSE" Regione Lombardia, G. D. Norata and A. L. Catapano were recipients of PUR grant from the University of Milan.	Allende ML, 2003, BLOOD, V102, P3665, DOI 10.1182/blood-2003-02-0460; Arcaro A, 2002, EMBO J, V21, P5097, DOI 10.1093/emboj/cdf512; Argraves KM, 2007, J LIPID RES, V48, P2325, DOI 10.1194/jlr.R700011-JLR200; Calabresi L, 2003, ARTERIOSCL THROM VAS, V23, P1724, DOI 10.1161/01.ATV.0000094961.74697.54; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; Domin J, 1997, BIOCHEM J, V326, P139, DOI 10.1042/bj3260139; Elis W, 2008, MOL CANCER RES, V6, P614, DOI 10.1158/1541-7786.MCR-07-0262; Falasca M, 2007, BIOCHEM SOC T, V35, P211, DOI 10.1042/BST0350211; Falasca M, 2007, J BIOL CHEM, V282, P28226, DOI 10.1074/jbc.M704357200; Falasca M, 2012, BIOCHEM J, V443, P587, DOI 10.1042/BJ20120008; Falasca M, 2009, BBA-MOL CELL RES, V1793, P1795, DOI 10.1016/j.bbamcr.2009.10.003; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Harada K, 2005, MOL CELL BIOL, V25, P11122, DOI 10.1128/MCB.25.24.11122-11130.2005; Heller R, 2008, CARDIOVASC RES, V80, P96, DOI 10.1093/cvr/cvn159; Hla T, 2004, SEMIN CELL DEV BIOL, V15, P513, DOI 10.1016/j.semcdb.2004.05.002; Jamieson S, 2011, BIOCHEM J, V438, P53, DOI 10.1042/BJ20110502; Katso RM, 2006, MOL BIOL CELL, V17, P3729, DOI 10.1091/mbc.E05-11-1083; Kimura T, 2003, ARTERIOSCL THROM VAS, V23, P1283, DOI 10.1161/01.ATV.0000079011.67194.5A; Kontush A, 2007, ARTERIOSCL THROM VAS, V27, P1843, DOI 10.1161/ATVBAHA.107.145672; Kwiterovich PO, 1998, AM J CARDIOL, V82, p13Q; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; Lucke S, 2010, CELL PHYSIOL BIOCHEM, V26, P87, DOI 10.1159/000315109; Maceyka M, 2009, J LIPID RES, V50, pS272, DOI 10.1194/jlr.R800065-JLR200; Madeddu P, 2008, ARTERIOSCL THROM VAS, V28, P68, DOI 10.1161/ATVBAHA.107.145573; Maffucci T, 2005, CANCER RES, V65, P8339, DOI 10.1158/0008-5472.CAN-05-0121; Maffucci T, 2005, J CELL BIOL, V169, P789, DOI 10.1083/jcb.200408005; Matsuo Y, 2007, ATHEROSCLEROSIS, V194, P159, DOI 10.1016/j.atherosclerosis.2006.10.020; Mazza Simona, 2011, Int J Biochem Mol Biol, V2, P168; Mineo C, 2003, J BIOL CHEM, V278, P9142, DOI 10.1074/jbc.M211394200; Morello F, 2009, CARDIOVASC RES, V82, P261, DOI 10.1093/cvr/cvn325; MURUGESAN G, 1994, CIRC RES, V74, P1149, DOI 10.1161/01.RES.74.6.1149; Nofer JR, 2005, TRENDS CARDIOVAS MED, V15, P265, DOI 10.1016/j.tcm.2005.08.005; Norata GD, 2006, J CLIN ENDOCR METAB, V91, P546, DOI 10.1210/jc.2005-1664; Norata GD, 2004, ARTERIOSCL THROM VAS, V24, P871, DOI 10.1161/01.ATV.zhq0504.1403; Rivera R, 2008, REV PHYSIOL BIOCH P, V160, P25, DOI 10.1007/112_0507; Seetharam D, 2006, CIRC RES, V98, P63, DOI 10.1161/01.RES.0000199272.59432.5b; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Yang AH, 2002, BBA-MOL CELL BIOL L, V1582, P197, DOI 10.1016/S1388-1981(02)00172-5; Yatomi Y, 2008, BBA-GEN SUBJECTS, V1780, P606, DOI 10.1016/j.bbagen.2007.10.006; Yoshioka K, 2012, NAT MED, V18, P1560, DOI 10.1038/nm.2928; Zhan B, 2005, ATHEROSCLEROSIS, V178, P199, DOI 10.1016/j.atherosclerosis.2004.08.024	42	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53808	10.1371/journal.pone.0053808	http://dx.doi.org/10.1371/journal.pone.0053808			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320105	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429800070
J	Holmquist, JG; Schmidt-Gengenbach, J; Haultain, SA				Holmquist, Jeffrey G.; Schmidt-Gengenbach, Jutta; Haultain, Sylvia A.			Effects of a Long-Term Disturbance on Arthropods and Vegetation in Subalpine Wetlands: Manifestations of Pack Stock Grazing in Early versus Mid-Season	PLOS ONE			English	Article							GRASSLAND INVERTEBRATES; SPECIES-DIVERSITY; MANAGEMENT; PLANT; TERRESTRIAL; ABUNDANCE; RESPONSES; PATCH; CONSERVATION; ASSEMBLAGES	Conclusions regarding disturbance effects in high elevation or high latitude ecosystems based solely on infrequent, long-term sampling may be misleading, because the long winters may erase severe, short-term impacts at the height of the abbreviated growing season. We separated a) long-term effects of pack stock grazing, manifested in early season prior to stock arrival, from b) additional pack stock grazing effects that might become apparent during annual stock grazing, by use of paired grazed and control wet meadows that we sampled at the beginning and end of subalpine growing seasons. Control meadows had been closed to grazing for at least two decades, and meadow pairs were distributed across Sequoia National Park, California, USA. The study was thus effectively a landscape-scale, long-term manipulation of wetland grazing. We sampled arthropods at these remote sites and collected data on associated vegetation structure. Litter cover and depth, percent bare ground, and soil strength had negative responses to grazing. In contrast, fauna showed little response to grazing, and there were overall negative effects for only three arthropod families. Mid-season and long-term results were generally congruent, and the only indications of lower faunal diversity on mid-season grazed wetlands were trends of lower abundance across morphospecies and lower diversity for canopy fauna across assemblage metrics. Treatment x Season interactions almost absent. Thus impacts on vegetation structure only minimally cascaded into the arthropod assemblage and were not greatly intensified during the annual growing season. Differences between years, which were likely a response to divergent snowfall patterns, were more important than differences between early and mid-season. Reliance on either vegetation or faunal metrics exclusively would have yielded different conclusions; using both flora and fauna served to provide a more integrative view of ecosystem response.	[Holmquist, Jeffrey G.; Schmidt-Gengenbach, Jutta] Univ Calif San Diego, White Mt Res Stn, Bishop, CA USA; [Haultain, Sylvia A.] Sequoia & Kings Canyon Natl Pk, Three Rivers, CA USA	University of California System; University of California San Diego	Holmquist, JG (corresponding author), Univ Calif Los Angeles, Inst Environm & Sustainabil, White Mt Res Ctr, Bishop, CA USA.	jholmquist@ucla.edu	Holmquist, Jeffrey G./H-3188-2011	Holmquist, Jeffrey G./0000-0003-3198-6338	National Park Service [J8R07080005]; NPS [J8C07100004, J8R07070006, J8R07030011]	National Park Service; NPS	This project was supported by the National Park Service (J8R07080005), and the current study built upon earlier work funded by the NPS (J8C07100004, J8R07070006, and J8R07030011); http://www.nps.gov/seki/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; ANDRESEN H, 1990, VEGETATIO, V89, P137, DOI 10.1007/BF00032166; Baines M, 1998, ECOGRAPHY, V21, P74, DOI 10.1111/j.1600-0587.1998.tb00395.x; Bausell R.Barker., 2002, POWER ANAL EXPT RES; Bell JR, 2001, J ZOOL, V255, P377, DOI 10.1017/S0952836901001479; Bestelmeyer Brandon T., 2000, P122; Bestelmeyer BT, 1996, ECOL APPL, V6, P1225, DOI 10.2307/2269603; Bestelmeyer BT, 2001, ECOL APPL, V11, P1123, DOI 10.1890/1051-0761(2001)011[1123:ABISLM]2.0.CO;2; Brathen KA, 2007, ECOSYSTEMS, V10, P773, DOI 10.1007/s10021-007-9058-3; Buckley R, 2004, ENV IMPACTS ECOTOURI, P383; Cardoso P, 2011, BIOL CONSERV, V144, P2647, DOI 10.1016/j.biocon.2011.07.024; Cease AJ, 2012, SCIENCE, V335, P467, DOI 10.1126/science.1214433; Cole D. N., 2004, Environmental impacts of ecotourism, P41, DOI 10.1079/9780851998107.0041; Cole DN, 2004, J RANGE MANAGE, V57, P153, DOI 10.2307/4003913; Cole DN, 1998, J ENVIRON MANAGE, V53, P61, DOI 10.1006/jema.1998.0192; Collins SL, 2006, ECOLOGY, V87, P2058, DOI 10.1890/0012-9658(2006)87[2058:SIOFAG]2.0.CO;2; Cuffney TE, 2007, J N AM BENTHOL SOC, V26, P286, DOI 10.1899/0887-3593(2007)26[286:ATEOTC]2.0.CO;2; DAY TA, 1990, ECOLOGY, V71, P180, DOI 10.2307/1940258; Duffey E, 1974, GRASSLAND ECOLOGY WI; Elliott TL, 2011, ARCT ANTARCT ALP RES, V43, P198, DOI 10.1657/1938-4246-43.2.198; Fahrig L, 1998, ECOSYSTEMS, V1, P197, DOI 10.1007/s100219900015; Feber RE, 1996, J APPL ECOL, V33, P1191, DOI 10.2307/2404698; GIBSON CWD, 1992, ECOGRAPHY, V15, P166, DOI 10.1111/j.1600-0587.1992.tb00020.x; Hatfield RG, 2007, BIOL CONSERV, V139, P150, DOI 10.1016/j.biocon.2007.06.019; Hendricks HH, 2005, PLANT ECOL, V176, P19, DOI 10.1007/s11258-003-0009-6; Hoback WW, 1999, ENTOMOL EXP APPL, V91, P393, DOI 10.1023/A:1003667427454; HOLM S, 1979, SCAND J STAT, V6, P65; Holmquist JG, 2011, ARCT ANTARCT ALP RES, V43, P568, DOI 10.1657/1938-4246-43.4.568; Holmquist JG, 2011, BIOL CONSERV, V144, P518, DOI 10.1016/j.biocon.2010.10.007; Holmquist JG, 2010, WETLANDS, V30, P252, DOI 10.1007/s13157-010-0020-3; Holmquist JG, 1998, OIKOS, V81, P558, DOI 10.2307/3546776; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Jones WM, 2011, BIOL CONSERV, V144, P511, DOI 10.1016/j.biocon.2010.10.005; Kelly Caroline L., 2003, Ecological Management & Restoration, V4, P37, DOI 10.1046/j.1442-8903.2003.00136.x; Kirk R., 2014, EXPT DESIGN PROCEDUR, DOI [10.4135/9781483384733, DOI 10.4135/9781483384733]; Kitti H, 2009, POLAR BIOL, V32, P253, DOI 10.1007/s00300-008-0526-9; Kohler F, 2006, LANDSCAPE ECOL, V21, P281, DOI 10.1007/s10980-005-0144-7; Kohler F, 2004, J VEG SCI, V15, P143, DOI 10.1111/j.1654-1103.2004.tb02249.x; Koricheva J, 2000, OECOLOGIA, V125, P271, DOI 10.1007/s004420000450; Kruess A, 2002, BIOL CONSERV, V106, P293, DOI 10.1016/S0006-3207(01)00255-5; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; LIVINGSTON RJ, 1987, ESTUARIES, V10, P194, DOI 10.2307/1351848; Longino John T., 2000, P186; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Majer JD, 1996, CONSERV BIOL, V10, P65, DOI 10.1046/j.1523-1739.1996.10010065.x; Marty JT, 2005, CONSERV BIOL, V19, P1626, DOI 10.1111/j.1523-1739.2005.00198.x; Mashiri FE, 2008, RANGELAND ECOL MANAG, V61, P368, DOI 10.2111/07-109.1; Mayr S, 2007, TUTOR QUANT METHODS, V3, P51, DOI 10.20982/tqmp.03.2.p051; McClain ME, 2003, ECOSYSTEMS, V6, P301, DOI 10.1007/s10021-003-0161-9; MCCLARAN MP, 1989, RANGELANDS, V11, P3; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; MILCHUNAS DG, 1995, OECOLOGIA, V101, P366, DOI 10.1007/BF00328824; Mitsch W.J., 2007, WETLANDS, V4th ed., DOI DOI 10.1017/CBO9781107415324.004; Monz CA, 2010, ENVIRON MANAGE, V45, P551, DOI 10.1007/s00267-009-9406-5; MORRIS MG, 1979, J APPL ECOL, V16, P77, DOI 10.2307/2402730; MORRIS MG, 1979, J APPL ECOL, V16, P417, DOI 10.2307/2402519; New TR, 1998, INVERTEBRATE SURVEYS; Newsome D., 2004, Environmental impacts of ecotourism, P61, DOI 10.1079/9780851998107.0061; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Oliver I, 1996, ECOL APPL, V6, P594, DOI 10.2307/2269394; Oliver I, 1996, CONSERV BIOL, V10, P99, DOI 10.1046/j.1523-1739.1996.10010099.x; Olofsson J, 2006, J ECOL, V94, P431, DOI 10.1111/j.1365-2745.2006.01100.x; PASTOR J, 1993, ECOLOGY, V74, P467, DOI 10.2307/1939308; Peck J. E., 2010, MULTIVARIATE ANAL CO; Pickett S. T. A., 1985, ECOLOGY NATURAL DIST; Pik AJ, 1999, AUST J ECOL, V24, P555, DOI 10.1046/j.1442-9993.1999.01003.x; Pocock MJO, 2012, SCIENCE, V335, P973, DOI 10.1126/science.1214915; Poos MS, 2012, ECOL INDIC, V18, P82, DOI 10.1016/j.ecolind.2011.10.008; Prieto-Benitez S, 2011, BIOL CONSERV, V144, P683, DOI 10.1016/j.biocon.2010.11.024; Ratkowsky David A., 2008, Australasian Mycologist, V27, P66; RICHARDS IR, 1975, J BRIT GRASSLAND SOC, V30, P187; Savage J, 2011, WETLANDS, V31, P125, DOI 10.1007/s13157-010-0133-8; Seymour CL, 1999, J ARID ENVIRON, V43, P267, DOI 10.1006/jare.1999.0552; Sorensen LI, 2009, ECOSYSTEMS, V12, P830, DOI 10.1007/s10021-009-9260-6; Southwood TRE, 2000, ECOLOGICAL METHODS; STOHLGREN TJ, 1989, ENVIRON MANAGE, V13, P485, DOI 10.1007/BF01867682; Strayer D, 1986, OCCAS PUBL I ECOSYST, V2; Triplehorn C., 2005, BORRER DELONGS INTRO, V7; Underwood AJ, 1997, EXPT ECOLOGY; Vickery JA, 2001, J APPL ECOL, V38, P647, DOI 10.1046/j.1365-2664.2001.00626.x; Waddle TJ, 2013, RIVER RES APPL, V29, P366, DOI 10.1002/rra.1607; WATSON AE, 1994, J LEISURE RES, V26, P372, DOI 10.1080/00222216.1994.11969968; Wettstein W, 1999, J APPL ECOL, V36, P363, DOI 10.1046/j.1365-2664.1999.00404.x; Wiens JA, 1997, OIKOS, V78, P257, DOI 10.2307/3546292; WIENS JA, 1993, OIKOS, V66, P369, DOI 10.2307/3544931; Williams DD., 2006, BIOL TEMPORARY WATER	87	16	17	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e54109	10.1371/journal.pone.0054109	http://dx.doi.org/10.1371/journal.pone.0054109			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308297	gold, Green Submitted, Green Published			2022-12-25	WOS:000313429100128
J	Langridge, AT; Glasson, EJ; Nassar, N; Jacoby, P; Pennell, C; Hagan, R; Bourke, J; Leonard, H; Stanley, FJ				Langridge, Amanda T.; Glasson, Emma J.; Nassar, Natasha; Jacoby, Peter; Pennell, Craig; Hagan, Ronald; Bourke, Jenny; Leonard, Helen; Stanley, Fiona J.			Maternal Conditions and Perinatal Characteristics Associated with Autism Spectrum Disorder and Intellectual Disability	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; MENTAL-RETARDATION; RISK-FACTORS; WESTERN-AUSTRALIA; OBSTETRIC COMPLICATIONS; DEVELOPMENTAL-DISABILITIES; DIAGNOSTIC SUBSTITUTION; HEAD CIRCUMFERENCE; MEDICAL CONDITIONS; POPULATION COHORT	Background: As well as being highly comorbid conditions, autism spectrum disorders (ASD) and intellectual disability (ID) share a number of clinically-relevant phenomena. This raises questions about similarities and overlap in diagnosis and aetiological pathways that may exist for both conditions. Aims: To examine maternal conditions and perinatal factors for children diagnosed with an ASD, with or without ID, and children with ID of unknown cause, compared with unaffected children. Methods: The study population comprised all live singleton births in Western Australia (WA) between January 1984 and December 1999 (N = 383,153). Univariate and multivariate multinomial logistic regression models were applied using a blocked modelling approach to assess the effect of maternal conditions, sociodemographic factors, labour and delivery characteristics and neonatal outcomes. Results: In univariate analyses mild-moderate ID was associated with pregnancy hypertension, asthma, urinary tract infection, some types of ante-partum haemorrhage, any type of preterm birth, elective C-sections, breech presentation, poor fetal growth and need for resuscitation at birth, with all factors showing an increased risk. Severe ID was positively associated with poor fetal growth and need for resuscitation, as well as any labour or delivery complication. In the multivariate analysis no maternal conditions or perinatal factors were associated with an increased risk of ASD without ID. However, pregnancy hypertension and small head circumference were associated with a reduced risk (OR = 0.64, 95% CI: 0.43, 0.94; OR = 0.58, 95% CI: 0.34, 0.96, respectively). For ASD with ID, threatened abortion before 20 weeks gestation and poor fetal growth were associated with an increased risk. Conclusion: Findings show that indicators of a poor intrauterine environment are associated with an elevated risk of ID, while for ASD, and particularly ASD without ID, the associations are much weaker. As such, these findings highlight the importance of accounting for the absence or presence of ID when examining ASD, if we are to improve our understanding of the causal pathways associated with these conditions.	[Langridge, Amanda T.; Glasson, Emma J.; Nassar, Natasha; Jacoby, Peter; Bourke, Jenny; Leonard, Helen; Stanley, Fiona J.] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; [Nassar, Natasha] Univ Sydney, Kolling Inst Med Res, Sydney, NSW 2006, Australia; [Hagan, Ronald] Univ Western Australia, Sch Womens & Infants Hlth, Dept Neonatol, Perth, WA 6009, Australia	Telethon Kids Institute; University of Western Australia; University of Sydney; Kolling Institute of Medical Research; University of Western Australia	Langridge, AT (corresponding author), Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia.	amandal@ichr.uwa.edu.au	Nassar, Natasha/K-3918-2019; Glasson, Emma/H-5339-2013; Pennell, Craig/ABD-6902-2020; Leonard, Helen/A-1010-2013	Glasson, Emma/0000-0003-3996-9049; Pennell, Craig/0000-0002-0937-6165; Leonard, Helen/0000-0001-6405-5834; , Emma/0000-0001-5547-8595; Nassar, Natasha/0000-0002-3720-9655	Australian National Health and Medical Research Council (NHMRC) [572742]; NHMRC [572568, 632955]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	Funding was provided by the Australian National Health and Medical Research Council (NHMRC, http://www.nhmrc.gov.au) Program Grant (572742), NHMRC Research Fellowship (572568 to HL) and NHMRC Career Development Fellowship (632955 to NN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Baird G, 2000, J AM ACAD CHILD PSY, V39, P694, DOI 10.1097/00004583-200006000-00007; Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; Baron-Cohen S, 2009, BRIT J PSYCHIAT, V194, P500, DOI 10.1192/bjp.bp.108.059345; Berger R, 2002, J SOC GYNECOL INVEST, V9, P319, DOI 10.1016/S1071-5576(02)00164-8; Bertrand J, 2001, PEDIATRICS, V108, P1155, DOI 10.1542/peds.108.5.1155; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Bilder D, 2009, PEDIATRICS, V123, P1293, DOI 10.1542/peds.2008-0927; Blair E, 2005, BMC PEDIAT, V5; Boyle CA, 2011, PEDIATRICS, V127, P1034, DOI 10.1542/peds.2010-2989; Broman Sarah H, 1987, Public Health Rep, V102, P55; BRYSON SE, 1988, J AM ACAD CHILD PSY, V27, P418, DOI 10.1097/00004583-198807000-00006; Buchmayer S, 2009, PEDIATRICS, V124, pE817, DOI 10.1542/peds.2008-3582; Burstyn I, 2010, CHRONIC DIS CAN, V30, P125; Camp BW, 1998, EARLY HUM DEV, V50, P159, DOI 10.1016/S0378-3732(97)00034-9; Coo H, 2008, J AUTISM DEV DISORD, V38, P1036, DOI 10.1007/s10803-007-0478-x; Croen LA, 2002, J AUTISM DEV DISORD, V32, P217, DOI 10.1023/A:1015405914950; Croen LA, 2005, ARCH PEDIAT ADOL MED, V159, P151, DOI 10.1001/archpedi.159.2.151; Croen LA, 2002, J AUTISM DEV DISORD, V32, P207, DOI 10.1023/A:1015453830880; Croen LA, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.6.e86; Croen LA, 2011, J NEURODEV DISORD, V3, P307, DOI 10.1007/s11689-011-9093-4; Crowther CA, 2003, JAMA-J AM MED ASSOC, V290, P2669, DOI 10.1001/jama.290.20.2669; Dammann O, 2002, MENT RETARD DEV D R, V8, P46, DOI 10.1002/mrdd.10005; Dammann O, 1997, PEDIATR RES, V42, P1, DOI 10.1203/00006450-199707000-00001; Department of Health and Aged Care, 2001, MEAS REM ACC REM IND; DEYKIN EY, 1980, AM J DIS CHILD, V134, P860, DOI 10.1001/archpedi.1980.02130210044012; Drews CD, 1996, PEDIATRICS, V97, P547; Eaton WW, 2001, J AUTISM DEV DISORD, V31, P279, DOI 10.1023/A:1010743203048; Fombonne E, 2005, J CLIN PSYCHIAT, V66, P3; Gardener H, 2011, PERINATAL NEONATAL R; Gardener H, 2009, BRIT J PSYCHIAT, V195, P7, DOI 10.1192/bjp.bp.108.051672; Gee V, 1994, VALIDATION STUDY W A; Gillberg C, 2002, DEV MED CHILD NEUROL, V44, P296; GILLBERG C, 1983, J AUTISM DEV DISORD, V13, P153, DOI 10.1007/BF01531816; Glasson EJ, 2004, ARCH GEN PSYCHIAT, V61, P618, DOI 10.1001/archpsyc.61.6.618; Glasson EJ, 2008, MED J AUSTRALIA, V188, P288, DOI 10.5694/j.1326-5377.2008.tb01623.x; HAGBERG B, 1983, BRAIN DEV-JPN, V5, P441, DOI 10.1016/S0387-7604(83)80072-2; Hallmayer J, 2011, ARCH GEN PSYCHIAT AR, V2011, P2076; Heber R, 1961, AM J MENTAL DEFICIEN, V64; Holman CDJ, 2008, AUST HEALTH REV, V32, P766, DOI 10.1071/AH080766; Hornig M, 2001, MENT RETARD DEV D R, V7, P200, DOI 10.1002/mrdd.1028; Hou JW, 1998, J INTELL DISABIL RES, V42, P137, DOI 10.1046/j.1365-2788.1998.00104.x; Huleihel Mahmoud, 2004, Reprod Biol Endocrinol, V2, P17, DOI 10.1186/1477-7827-2-17; Hultman CM, 2002, EPIDEMIOLOGY, V13, P417, DOI 10.1097/00001648-200207000-00009; JONAS O, 1989, EUR J EPIDEMIOL, V5, P322, DOI 10.1007/BF00144832; Juul-Dam N, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.4.e63; Kohane IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033224; Larsson HJ, 2005, AM J EPIDEMIOL, V161, P916, DOI 10.1093/aje/kwi123; Leonard H, 2005, SOC SCI MED, V60, P1499, DOI 10.1016/j.socscimed.2004.08.014; Leonard H, 2008, AM J EPIDEMIOL, V167, P103, DOI 10.1093/aje/kwm245; Leonard H, 2006, ANN EPIDEMIOL, V16, P448, DOI 10.1016/j.annepidem.2005.05.002; Leonard H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017875; Leonard H, 2010, RES AUTISM SPECT DIS, V4, P548, DOI 10.1016/j.rasd.2010.01.003; Limperopoulos C, 2008, PEDIATRICS, V121, P758, DOI 10.1542/peds.2007-2158; Mann JR, 2010, J AUTISM DEV DISORD, V40, P548, DOI 10.1007/s10803-009-0903-4; McDermott S, 2000, OBSTET GYNECOL, V96, P113, DOI 10.1016/S0029-7844(00)00823-1; McDermott S, 2001, J FAM PRACTICE, V50, P433; McElrath TF, 2008, AM J EPIDEMIOL, V168, P980, DOI 10.1093/aje/kwn202; MERVIS CA, 1995, PAEDIATR PERINAT EP, V9, P455, DOI 10.1111/j.1365-3016.1995.tb00168.x; Murphy CC, 1998, MENT RETARD DEV D R, V4, P6, DOI 10.1002/(SICI)1098-2779(1998)4:1<6::AID-MRDD3>3.0.CO;2-P; Nassar N, 2009, INT J EPIDEMIOL, V38, P1245, DOI 10.1093/ije/dyp260; O'Roak BJ, 2008, AUTISM RES, V1, P4, DOI 10.1002/aur.3; Petterson B, 2005, ANN HUM BIOL, V32, P237, DOI 10.1080/03014460500075035; Pink B, 2008, SOCIOECONOMIC INDEXE; Pink B., 2006, INFORM PAPER INTRO S; Rapin I, 1997, NEW ENGL J MED, V337, P97, DOI 10.1056/NEJM199707103370206; ROELEVELD N, 1992, PREV MED, V21, P110, DOI 10.1016/0091-7435(92)90010-F; SALONEN JT, 1984, J MENT DEFIC RES, V28, P53; Schieve LA, 2012, RES DEV DISABIL, V33, P467, DOI 10.1016/j.ridd.2011.10.008; Shattuck PT, 2006, PEDIATRICS, V117, P1028, DOI 10.1542/peds.2005-1516; StataCorp, 2019, STATA STAT SOFTWARE; STREISSGUTH AP, 1990, ALCOHOL CLIN EXP RES, V14, P662, DOI 10.1111/j.1530-0277.1990.tb01224.x; Stromme P, 2000, DEV MED CHILD NEUROL, V42, P76, DOI 10.1017/S0012162200000165; Sussmann JE, 2009, BRIT J PSYCHIAT, V194, P224, DOI 10.1192/bjp.bp.106.033134; TAYLOR DJ, 1985, LANCET, V1, P713; Tuovinen S, 2011, ANN MED, V15, P15; VanderWeele TJ, 2012, EPIDEMIOLOGY, V23, P1, DOI 10.1097/EDE.0b013e31823aca5d; Volkmar FR, 2009, J CHILD PSYCHOL PSYC, V50, P108, DOI 10.1111/j.1469-7610.2008.02010.x; Whitehouse AJO, 2011, J AUTISM DEV DISORD, V41, P122, DOI 10.1007/s10803-010-1019-6; Williams K, 2008, CHILD CARE HLTH DEV, V34, P249, DOI 10.1111/j.1365-2214.2007.00796.x; Yeargin-Allsopp M, 2003, JAMA-J AM MED ASSOC, V289, P49, DOI 10.1001/jama.289.1.49; YearginAllsopp M, 1997, DEV MED CHILD NEUROL, V39, P142	84	82	86	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e50963	10.1371/journal.pone.0050963	http://dx.doi.org/10.1371/journal.pone.0050963			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308096	Green Published, gold			2022-12-25	WOS:000313429100004
J	Vivo, M; Ranieri, M; Sansone, F; Santoriello, C; Calogero, RA; Calabro, V; Pollice, A; La Mantia, G				Vivo, Maria; Ranieri, Michela; Sansone, Federica; Santoriello, Cristina; Calogero, Raffaele A.; Calabro, Viola; Pollice, Alessandra; La Mantia, Girolama			Mimicking p14ARF Phosphorylation Influences Its Ability to Restrain Cell Proliferation	PLOS ONE			English	Article							PROTEIN-KINASE-C; ARF TUMOR-SUPPRESSOR; ONCOGENIC STRESS; PKC-ALPHA; P53; P14(ARF); APOPTOSIS; MDM2; STABILIZATION; DEGRADATION	The INK4a/ARF locus on the short arm of chromosome 9 is one of the most frequently altered loci in human cancer. It is generally accepted that ARF is involved in oncogenic checkpoint pathways by sensitizing incipient cancer cells to undergo growth arrest or apoptosis through both p53-dependent and independent pathways. While intensive studies have been focused on ARF activation at the transcriptional level, only recently mechanisms governing ARF turnover have been identified. Here, we show for the first time that p14ARF is a PKC target. Prediction analysis showed many potential phosphorylation sites in PKC consensus sequences within ARF protein, and, among them, the threonine at position 8 was the most conserved. Substitution of this threonine influences both ARF stability and localization. Furthermore, a phosphomimetic ARF mutation reduces the ability to arrest cell growth although the ability to bind MDM2 and stabilize p53 result unaffected. Thus we propose that phosphorylation of ARF in both immortalized and tumor cell lines could be a mechanism to escape ARF surveillance following proliferative and oncogenic stress.	[Vivo, Maria; Ranieri, Michela; Sansone, Federica; Calabro, Viola; Pollice, Alessandra; La Mantia, Girolama] Univ Naples Federico II, Dept Struct & Funct Biol, Naples, Italy; [Santoriello, Cristina] Harvard Univ, Harvard Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Calogero, Raffaele A.] Univ Turin, Dept Comp Sci, Turin, Italy	University of Naples Federico II; Harvard University; University of Turin	Vivo, M (corresponding author), Univ Naples Federico II, Dept Struct & Funct Biol, Naples, Italy.	maria.vivo@unina.it; lamantia@unina.it	Calabro, Viola/H-6156-2013; Calogero, Raffaele/K-9428-2019; Vivo, Maria/S-3390-2017	Calogero, Raffaele/0000-0002-2848-628X; Vivo, Maria/0000-0003-2458-4226; Calabro, Viola/0000-0002-6508-8889; Ranieri, Michela/0000-0002-3833-3594	PRIN (Programmi di ricerca di Rilevante Interesse Nazionale); AIRC (Associazione Italiana Ricerca sul Cancro)	PRIN (Programmi di ricerca di Rilevante Interesse Nazionale); AIRC (Associazione Italiana Ricerca sul Cancro)	This work was supported by grants awarded to GLM from PRIN (Programmi di ricerca di Rilevante Interesse Nazionale) and AIRC (Associazione Italiana Ricerca sul Cancro). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DR, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-22; Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Aslanian A, 2004, GENE DEV, V18, P1413, DOI 10.1101/gad.1196704; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bosco R, 2011, MINI-REV MED CHEM, V11, P185, DOI 10.2174/138955711795049899; Brady CA, 2010, J CELL SCI, V123, P2527, DOI 10.1242/jcs.064501; Breitkreutz D, 2007, J CANCER RES CLIN, V133, P793, DOI 10.1007/s00432-007-0280-3; Calabro V, 1999, ONCOGENE, V18, P2157, DOI 10.1038/sj.onc.1202532; Chen DL, 2010, NATURE, V464, P624, DOI 10.1038/nature08820; Clark PA, 2002, ONCOGENE, V21, P4498, DOI 10.1038/sj.onc.1205558; Colucci-D'Amato GL, 2000, J BIOL CHEM, V275, P19306, DOI 10.1074/jbc.275.25.19306; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; del Arroyo AG, 2007, CELL CYCLE, V6, P2697; DENNING MF, 1995, CELL GROWTH DIFFER, V6, P149; Di Costanzo A, 2009, CELL CYCLE, V8, P1185, DOI 10.4161/cc.8.8.8202; di Tommaso A, 2009, EXP CELL RES, V315, P1326, DOI 10.1016/j.yexcr.2009.01.010; DLUGOSZ AA, 1992, MOL CARCINOGEN, V5, P286, DOI 10.1002/mc.2940050409; Eftmova T, 2002, J BIOL CHEM, V277, P31753, DOI 10.1074/jbc.M205098200; Fagerstrom S, 1996, CELL GROWTH DIFFER, V7, P775; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hashemi J, 2002, CANCER LETT, V180, P211, DOI 10.1016/S0304-3835(02)00027-7; Herkert B, 2010, J CELL BIOL, V188, P905, DOI 10.1083/jcb.200908103; Inoue R, 2005, BIOCHEM BIOPH RES CO, V330, P1314, DOI 10.1016/j.bbrc.2005.03.117; Itahana K, 2008, CANCER CELL, V13, P542, DOI 10.1016/j.ccr.2008.04.002; Jerome-Morais A, 2009, J INVEST DERMATOL, V129, P2365, DOI 10.1038/jid.2009.74; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; Korgaonkar C, 2002, MOL CELL BIOL, V22, P196, DOI 10.1128/MCB.22.1.196-206.2002; Kuo ML, 2004, GENE DEV, V18, P1862, DOI 10.1101/gad.1213904; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Llanos S, 2001, NAT CELL BIOL, V3, P445, DOI 10.1038/35074506; Muniz VP, 2011, MOL CANCER RES, V9, P867, DOI 10.1158/1541-7786.MCR-10-0475; Ozenne P, 2010, INT J CANCER, V127, P2239, DOI 10.1002/ijc.25511; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Pollice A, 2007, ONCOGENE, V26, P5154, DOI 10.1038/sj.onc.1210313; Pollice A, 2004, J BIOL CHEM, V279, P6345, DOI 10.1074/jbc.M310957200; Pollice A, 2008, FEBS LETT, V582, P3257, DOI 10.1016/j.febslet.2008.09.026; Popov N, 2010, EPIGENETICS-US, V5, P685, DOI 10.4161/epi.5.8.12996; Raveh T, 2001, NAT CELL BIOL, V3, P1, DOI 10.1038/35050500; Rodriguez IP, 2004, REV ONCOL, V6, P7; Rodway H, 2004, ONCOGENE, V23, P6186, DOI 10.1038/sj.onc.1207854; Shen J, 2011, BIOCHEM J, V434, P275, DOI 10.1042/BJ20101163; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Shimao Y, 1999, CLIN EXP METASTAS, V17, P351; Shimizu T, 2010, ONCOGENE, V29, P5687, DOI 10.1038/onc.2010.312; Sim ATR, 1999, CELL CALCIUM, V26, P209, DOI 10.1054/ceca.1999.0072; Taneja P, 2007, ONCOGENE, V26, P7457, DOI 10.1038/sj.onc.1210568; Vivo M, 2001, J BIOL CHEM, V276, P14161, DOI 10.1074/jbc.M006845200; Vivo M, 2009, CELL CYCLE, V8, P3545, DOI 10.4161/cc.8.21.9954; Wang S, 2010, FEBS LETT, V584, P3909, DOI 10.1016/j.febslet.2010.08.015; Weber JD, 2000, MOL CELL BIOL, V20, P2517, DOI 10.1128/MCB.20.7.2517-2528.2000; Wheeler DL, 2005, AM J PATHOL, V166, P117, DOI 10.1016/S0002-9440(10)62237-7; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Zhang YP, 2001, CELL GROWTH DIFFER, V12, P175; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	55	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53631	10.1371/journal.pone.0053631	http://dx.doi.org/10.1371/journal.pone.0053631			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308265	Green Submitted, gold, Green Published			2022-12-25	WOS:000313429100098
J	Fang, F; Sun, HY; Zhao, Q; Lin, CT; Sun, YF; Gao, W; Xu, JJ; Zhou, JY; Ge, F; Liu, NF				Fang, Fang; Sun, Hongying; Zhao, Qiang; Lin, Congtian; Sun, Yufang; Gao, Wei; Xu, Juanjuan; Zhou, Junying; Ge, Feng; Liu, Naifa			Patterns of Diversity, Areas of Endemism, and Multiple Glacial Refuges for Freshwater Crabs of the Genus Sinopotamon in China (Decapoda: Brachyura: Potamidae)	PLOS ONE			English	Article							QINGHAI-TIBETAN PLATEAU; PARSIMONY ANALYSIS; HISTORICAL BIOGEOGRAPHY; SPECIES DISTRIBUTIONS; ENVIRONMENTAL NICHE; PLANT DIVERSITY; PHYLOGEOGRAPHY; CONSERVATION; BIODIVERSITY; REGION	Previous research has shown that the geographical distribution patterns of freshwater fishes and amphibians have been influenced by past climatic oscillations in China resulting from Pleistocene glacial activity. However, it remains unknown how these past changes have impacted the present-day distribution of Chinese freshwater crabs. This work describes the diversity and endemism of freshwater crabs belonging to Sinopotamon, a highly speciose genus endemic to China, and evaluates its distribution in terms of topography and past climatic fluctuations. Species diversity within Sinopotamon was found to be concentrated in an area from the northeastern edge of the Yunnan-Guizhou Plateau to the Jiangnan Hills, and three areas of endemism were identified. Multiple regression analysis between current climatic variables and Sinopotamon diversity suggested that regional annual precipitation, minimum temperature in the coldest month, and annual temperature range significantly influenced species diversity and may explain the diversity patterns of Sinopotamon. A comparison of ecological niche models (ENMs) between current conditions and the last glacial maximum (LGM) showed that suitable habitat for Sinopotamon in China severely contracted during the LGM. The coincidence of ENMs and the areas of endemism indicated that southeast of the Daba Mountains, and central and southeastern China, are potential Pleistocene refuges for Sinopotamon. The presence of multiple Pleistocene refuges within the range of this genus could further promote inter- and intraspecific differentiations, and may have led to high Sinopotamon species diversity, a high endemism rate and widespread distribution.	[Fang, Fang; Sun, Hongying; Sun, Yufang; Xu, Juanjuan] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China; [Lin, Congtian] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Zhou, Junying; Ge, Feng] Nanjing Inst Environm Sci, Nanjing, Jiangsu, Peoples R China; [Liu, Naifa] Lanzou Univ, Sch Life Sci, Lanzhou, Peoples R China	Nanjing Normal University; Chinese Academy of Sciences; Institute of Zoology, CAS	Sun, HY (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China.	sunhongying@njnu.edu.cn			National Natural Science Foundation of China [31071902]; Priority Academic Program Development of Jiangsu Higher Education Institutions; National Environmental Protection Public Welfare Science and Technology Research Program of China [201009033]; Nanjing Normal University Innovative Team Project [0319PM0902]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; National Environmental Protection Public Welfare Science and Technology Research Program of China; Nanjing Normal University Innovative Team Project	This work was supported by grants from the National Natural Science Foundation of China (31071902) and the Priority Academic Program Development of Jiangsu Higher Education Institutions to SHY; the National Environmental Protection Public Welfare Science and Technology Research Program of China (201009033) to ZJY & GF; and Nanjing Normal University Innovative Team Project (0319PM0902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderberg M.R., 1973, CLUSTER ANAL APPL; [Anonymous], 2011, R LANG ENV STAT COMP; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; BIRNBAUM ZW, 1951, ANN MATH STAT, V22, P592, DOI 10.1214/aoms/1177729550; Brooks DR, 2003, J BIOGEOGR, V30, P819, DOI 10.1046/j.1365-2699.2003.00848.x; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Chambers J.M., 1992, LINEAR MODELS; Chang J, 1980, HENAN J PREVENTIVE M, V4, P41; Che J, 2010, P NATL ACAD SCI USA, V107, P13765, DOI 10.1073/pnas.1008415107; Chen G.-x., 1980, Acta Zootaxonomica Sinica, V5, P256; Chen L, 2008, PROG NAT SCI, V18, P833, DOI 10.1016/j.pnsc.2008.02.004; Chen Ling, 2004, Zoological Research, V25, P369; Chen YY, 2001, PROG NAT SCI, V11, P411; Cheng Youzhu, 1998, Wuyi Science Journal, V14, P21; Cheng Youzhu, 1998, Wuyi Science Journal, V14, P18; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; CRACRAFT J, 1991, Australian Systematic Botany, V4, P211, DOI 10.1071/SB9910211; Crisp MD, 2001, J BIOGEOGR, V28, P183, DOI 10.1046/j.1365-2699.2001.00524.x; Cumberlidge N, 2011, INTEGR ZOOL, V6, P45, DOI 10.1111/j.1749-4877.2010.00228.x; Cumberlidge N, 2009, BIOL CONSERV, V142, P1665, DOI 10.1016/j.biocon.2009.02.038; DAI A, 1979, Acta Zoologica Sinica, V25, P243; Dai A.-y., 1979, Acta Zootaxonomica Sinica, V4, P122; Dai A.-y., 1986, Sinozoologia, V4, P55; DAI A-Y, 1975, Acta Zoologica Sinica, V21, P257; DAI A-Y, 1988, Acta Zootaxonomica Sinica, V13, P127; DAI AY, 1981, ACTA ZOOL SINICA, V27, P172; Dai AY., 1999, FAUNA SINICA ARTHROP; Dai AY, 1977, CHINESE J ZOOLOGY, V1, P29; Dai CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029329; Debandi G, 2012, AUSTRAL ECOL, V37, P392, DOI 10.1111/j.1442-9993.2011.02295.x; Ding R.H., 1994, FISHES SICHUAN CHINA; Dobson M, 2007, FUND APPL LIMNOL, V168, P271, DOI 10.1127/1863-9135/2007/0168-0271; Dobson M, 2007, FRESHWATER BIOL, V52, P215, DOI 10.1111/j.1365-2427.2006.01648.x; Du Nanshan, 1981, Oceanologia et Limnologia Sinica, V12, P80; Du NS, 1979, J SHANGHAI NORMAL U, V1, P106; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Fattorini S, 2002, J BIOGEOGR, V29, P49, DOI 10.1046/j.1365-2699.2002.00656.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Flanders J, 2011, J BIOGEOGR, V38, P439, DOI 10.1111/j.1365-2699.2010.02411.x; Fox J., 2019, R COMPANION APPL REG, V3rd ed; Gao LM, 2007, MOL ECOL, V16, P4684, DOI 10.1111/j.1365-294X.2007.03537.x; GHERARDI F, 1987, Investigacion Pesquera (Barcelona), V51, P389; Glasby CJ, 1999, J BIOGEOGR, V26, P507, DOI 10.1046/j.1365-2699.1999.00297.x; Gu XH, 1986, CHINESE J ZOOLOGY, V4, P22; HASUMI H, 2004, 1 U TOK CTR CLIM SYS; Hausdorf B, 2002, SYST BIOL, V51, P648, DOI 10.1080/10635150290102320; He PY, 1994, QUATERNARY SEDIMENTA; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Huang XL, 2008, J BIOGEOGR, V35, P230, DOI 10.1111/j.1365-2699.2007.01776.x; Huang XL, 2006, ECOL ENTOMOL, V31, P608, DOI 10.1111/j.1365-2311.2006.00819.x; Huang ZH, 2010, MOL PHYLOGENET EVOL, V56, P273, DOI 10.1016/j.ympev.2010.01.028; Hubert N, 2006, J BIOGEOGR, V33, P1414, DOI 10.1111/j.1365-2699.2006.01518.x; Humphries C.J., 1999, CLADISTIC BIOGEOGRAP; Institute oZiS, 1987, FISH QINL; IUCN (World Conservation Union), 2001, IUCN RED LIST CAT VE; Jesse R, 2011, MOL PHYLOGENET EVOL, V59, P23, DOI 10.1016/j.ympev.2010.12.011; Jezkova T, 2009, J MAMMAL, V90, P306, DOI 10.1644/08-MAMM-A-243.1; Kent M, 2006, PROG PHYS GEOG, V30, P399, DOI 10.1191/0309133306pp489pr; Kreft H, 2010, J BIOGEOGR, V37, P2029, DOI 10.1111/j.1365-2699.2010.02375.x; Legendre L, 1983, NUMERICAL ECOLOGY; Lei FM, 2003, BIODIVERS CONSERV, V12, P239, DOI 10.1023/A:1021928801558; Lei FM, 2007, BIODIVERS CONSERV, V16, P1119, DOI 10.1007/s10531-006-9080-3; Li J. J., 1999, MAR GEOL Q GEOL, V19, P1; Li SH, 2009, MOL ECOL, V18, P622, DOI 10.1111/j.1365-294X.2008.04028.x; Linder HP, 2001, SYST BIOL, V50, P892, DOI 10.1080/106351501753462867; Linder HP, 2001, J BIOGEOGR, V28, P169, DOI 10.1046/j.1365-2699.2001.00527.x; Liu Huan-Zhang, 1998, Acta Zootaxonomica Sinica, V23, P10; Liu M.G., 2010, ATLAS PHYS GEOGRAPHY, V3rd ed.; Lopez-Pujol J, 2011, J BIOGEOGR, V38, P1267, DOI 10.1111/j.1365-2699.2011.02504.x; Marsaglia G., 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i18, DOI 10.18637/JSS.V008.I18]; McAllister Don E., 1994, P155; Medail F, 2009, J BIOGEOGR, V36, P1333, DOI 10.1111/j.1365-2699.2008.02051.x; Morrone JJ, 2005, J BIOGEOGR, V32, P1281, DOI 10.1111/j.1365-2699.2005.01279.x; MORRONE JJ, 1994, SYST BIOL, V43, P438, DOI 10.2307/2413679; Morrone JJ, 2002, J BIOGEOGR, V29, P1095, DOI 10.1046/j.1365-2699.2002.00753.x; MORRONE JJ, 1995, ANNU REV ECOL SYST, V26, P373, DOI 10.1146/annurev.es.26.110195.002105; Morrone Juan J., 2001, Diversity and Distributions, V7, P297, DOI 10.1046/j.1366-9516.2001.00116.x; Murtagh F., 1985, MULTIDIMENSIONAL CLU; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naruse T, 2008, ZOOTAXA, P49, DOI 10.11646/zootaxa.1812.1.3; Nelson G., 1981, SYSTEMATICS BIOGEOGR; Ng Peter K.L., 2008, Raffles Bulletin of Zoology Supplement, V17, P1; Peterson AT, 2008, EVOLUTION, V62, P173, DOI 10.1111/j.1558-5646.2007.00258.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Qian H, 2000, NATURE, V407, P180, DOI 10.1038/35025052; Qiu YX, 2009, MOL PHYLOGENET EVOL, V51, P281, DOI 10.1016/j.ympev.2009.01.016; Quijano-Abril MA, 2006, J BIOGEOGR, V33, P1266, DOI 10.1111/j.1365-2699.2006.01501.x; Raxworthy CJ, 2003, NATURE, V426, P837, DOI 10.1038/nature02205; Revenga C, 2005, PHILOS T ROY SOC B, V360, P397, DOI 10.1098/rstb.2004.1595; Rosen BR, 1988, FOSSILS EARTH HIST A, P437; Samyn Y, 2005, J BIOGEOGR, V32, P1523, DOI 10.1111/j.1365-2699.2005.01295.x; Santos CMD, 2005, J BIOGEOGR, V32, P1284, DOI 10.1111/j.1365-2699.2005.01269.x; Nihei SS, 2006, J BIOGEOGR, V33, P2099, DOI 10.1111/j.1365-2699.2006.01619.x; Shih HT, 2011, SYST BIODIVERS, V9, P1, DOI 10.1080/14772000.2011.554457; Smith B T, 1976, LECT NOTES COMPUTER; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; SOKAL ROBERT R., 1962, TAXON, V11, P33, DOI 10.2307/1217208; Somers MJ, 1998, S AFR J ZOOL, V33, P31; Song G, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-143; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; TAI A-Y, 1975, Acta Zoologica Sinica, V21, P169; Tian B, 2009, J BIOGEOGR, V36, P2148, DOI 10.1111/j.1365-2699.2009.02157.x; Tribsch A, 2004, J BIOGEOGR, V31, P747, DOI 10.1111/j.1365-2699.2004.01065.x; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Wang JA, 2007, CHINESE GEOGRAPHY TU; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; WILKINSON GN, 1973, ROY STAT SOC C-APP, V22, P392; Wilkinson JH, 1965, ALGEBRAIC EIGENVALUE; WILLIAMS TR, 1962, ANN TROP MED PARASIT, V56, P362, DOI 10.1080/00034983.1962.11686133; Wu YQ, 2001, GEOMORPHOLOGY, V36, P203, DOI 10.1016/S0169-555X(00)00057-X; Yang Yu-Hui, 2004, Acta Zoologica Sinica, V50, P193; Zhang DF, 2000, ENVIRON GEOL, V39, P1352, DOI 10.1007/s002540000174; Zhang H, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-21; Zhang R. Z., 1999, ZOOGEOGRAPHY CHINA; Zhang Xiong-Fei, 2004, Acta Genetica Sinica, V31, P1232; ZHAO J, 1990, NATURAL HIST CHINA; Zhu C, 2003, GLOBAL CHANGE SCI; Zou JX, 2008, CRUSTACEANA, V81, P1381, DOI 10.1163/156854008X361076	121	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53143	10.1371/journal.pone.0053143	http://dx.doi.org/10.1371/journal.pone.0053143			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308152	Green Published, Green Submitted, gold			2022-12-25	WOS:000313670100021
J	Lacourpaille, L; Hug, F; Nordez, A				Lacourpaille, Lilian; Hug, Francois; Nordez, Antoine			Influence of Passive Muscle Tension on Electromechanical Delay in Humans	PLOS ONE			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; HUMAN SKELETAL-MUSCLE; ELBOW FLEXOR MUSCLES; GASTROCNEMIUS-MUSCLE; ANKLE JOINT; FORCE TRANSMISSION; ELASTIC PROPERTIES; STIFFNESS; LENGTH	Background: Electromechanical delay is the time lag between onsets of muscle activation and muscle force production and reflects both electro-chemical processes and mechanical processes. The aims of the present study were two-fold: to experimentally determine the slack length of each head of the biceps brachii using elastography and to determine the influence of the length of biceps brachii on electromechanical delay and its electro-chemical/mechanical processes using very high frame rate ultrasound. Methods/Result: First, 12 participants performed two passive stretches to evaluate the change in passive tension for each head of the biceps brachii. Then, they underwent two electrically evoked contractions from 120 to 20 degrees of elbow flexion (0 degrees: full extension), with the echographic probe maintained over the muscle belly and the myotendinous junction of biceps brachii. The slack length was found to occur at 95.5 +/- 6.3 degrees and 95.3 +/- 8.2 degrees of the elbow joint angle for the long and short heads of the biceps brachii, respectively. The electromechanical delay was significantly longer at 120 degrees (16.9 +/- 3.1 ms; p<0.001), 110 degrees (15.0 +/- 3.1 ms; p<0.001) and 100 degrees (12.7 +/- 2.5 ms; p = 0.01) of elbow joint angle compared to 90 degrees (11.1 +/- 1.7 ms). However, the delay between the onset of electrical stimulation and the onset of both muscle fascicles (3.9 +/- 0.2 ms) and myotendinous junction (3.7 +/- 0.3 ms) motion was not significantly affected by the joint angle (p>0.95). Conclusion: In contrast to previous observations on gastrocnemius medialis, the onset of muscle motion and the onset of myotendinous junction motion occurred simultaneously regardless of the length of the biceps brachii. That suggests that the between-muscles differences reported in the literature cannot be explained by different muscle passive tension but instead may be attributable to muscle architectural differences.	[Lacourpaille, Lilian; Hug, Francois; Nordez, Antoine] Univ Nantes, Lab Motricite Interact Performance, EA 4334, Nantes, France	Nantes Universite	Hug, F (corresponding author), Univ Nantes, Lab Motricite Interact Performance, EA 4334, Nantes, France.	francois.hug@univ-nantes.fr	Hug, François/AAV-2415-2020	Hug, François/0000-0002-6432-558X; Lacourpaille, Lilian/0000-0002-9664-8121	European Regional Development Fund (ERDF) [37400]; Association Francaise contre les Myopathie (AFM) [14597]; Region des Pays de la Loire	European Regional Development Fund (ERDF)(European Commission); Association Francaise contre les Myopathie (AFM)(Association Francaise contre les Myopathies); Region des Pays de la Loire(Region Pays de la Loire)	This study was supported by grants from the European Regional Development Fund (ERDF, number 37400), the Association Francaise contre les Myopathie (AFM number 14597) and the Region des Pays de la Loire. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackland DC, 2012, J BIOMECH, V45, P1463, DOI 10.1016/j.jbiomech.2012.02.023; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Catheline S, 1999, J ACOUST SOC AM, V105, P2941, DOI 10.1121/1.426907; Catheline S, 2004, J ACOUST SOC AM, V116, P3734, DOI 10.1121/1.1815075; CAVANAGH PR, 1979, EUR J APPL PHYSIOL, V42, P159, DOI 10.1007/BF00431022; De Groote F, 2010, J BIOMECH, V43, P1876, DOI 10.1016/j.jbiomech.2010.03.022; Debernard L, 2011, CLIN BIOMECH, V26, P836, DOI 10.1016/j.clinbiomech.2011.04.004; Deffieux T, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2378616; Deffieux T, 2008, IEEE T ULTRASON FERR, V55, P2177, DOI 10.1109/TUFFC.917; Dresner MA, 2001, J MAGN RESON IMAGING, V13, P269, DOI 10.1002/1522-2586(200102)13:2<269::AID-JMRI1039>3.3.CO;2-T; Gajdosik RL, 2001, CLIN BIOMECH, V16, P87, DOI 10.1016/S0268-0033(00)00061-9; Hoang PD, 2005, J BIOMECH, V38, P1333, DOI 10.1016/j.jbiomech.2004.05.046; Hug F, 2011, MUSCLE NERVE, V43, P441, DOI 10.1002/mus.21948; Lacourpaille L, J ELECTROMY IN PRESS; Lacourpaille L, 2012, PHYSIOL MEAS, V33, pN19, DOI 10.1088/0967-3334/33/3/N19; Maas H, 2001, J BIOMECH, V34, P927, DOI 10.1016/S0021-9290(01)00055-0; Maas H, 2008, J APPL PHYSIOL, V104, P1557, DOI 10.1152/japplphysiol.01208.2007; Magnusson SP, 1998, SCAND J MED SCI SPOR, V8, P65; Maisetti O, 2012, J BIOMECH, V45, P978, DOI 10.1016/j.jbiomech.2012.01.009; Martin A, 1996, EUR J APPL PHYSIOL, V73, P157, DOI 10.1007/BF00262825; McNair PJ, 2002, CLIN BIOMECH, V17, P536, DOI 10.1016/S0268-0033(02)00062-1; McNair PJ, 2001, MED SCI SPORT EXER, V33, P354, DOI 10.1097/00005768-200103000-00003; MORITANI T, 1987, EUR J APPL PHYSIOL O, V56, P30, DOI 10.1007/BF00696372; Muraoka T, 2004, J APPL PHYSIOL, V96, P540, DOI 10.1152/japplphysiol.01015.2002; Muro M., 1985, BIOMECHANICS A, P86; Murray WM, 2000, J BIOMECH, V33, P943, DOI 10.1016/S0021-9290(00)00051-8; Nordez A, 2008, J BIOMECH, V41, P2305, DOI 10.1016/j.jbiomech.2008.03.033; Nordez A, 2008, INT J SPORTS MED, V29, P414, DOI 10.1055/s-2007-964980; Nordez A, 2010, J APPL PHYSIOL, V108, P1389, DOI 10.1152/japplphysiol.01323.2009; Nordez A, 2009, J APPL PHYSIOL, V106, P1970, DOI 10.1152/japplphysiol.00221.2009; Riemann BL, 2001, J ATHL TRAINING, V36, P369; Sasaki K, 2011, MED SCI SPORT EXER, V43, P1200, DOI 10.1249/MSS.0b013e318209312c; Tanter M, 2008, ULTRASOUND MED BIOL, V34, P1373, DOI 10.1016/j.ultrasmedbio.2008.02.002; Tian M, J APPL PHYS IN PRESS; Valour D, 2003, PFLUG ARCH EUR J PHY, V445, P721, DOI 10.1007/s00424-002-0871-4	35	43	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53159	10.1371/journal.pone.0053159	http://dx.doi.org/10.1371/journal.pone.0053159			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308153	Green Published, Green Submitted, gold			2022-12-25	WOS:000313670100022
J	Li, HR; Olson, M; Lin, GF; Hey, T; Tan, SY; Narva, KE				Li, Huarong; Olson, Monica; Lin, Gaofeng; Hey, Timothy; Tan, Sek Yee; Narva, Kenneth E.			Bacillus thuringiensis Cry34Ab1/Cry35Ab1 Interactions with Western Corn Rootworm Midgut Membrane Binding Sites	PLOS ONE			English	Article							LARVAL MIDGUT; AMINOPEPTIDASE N; DELTA-ENDOTOXIN; TOXIN; RESISTANCE; COLEOPTERA; CADHERIN; SUSCEPTIBILITY; IDENTIFICATION; CHRYSOMELIDAE	Background: Bacillus thuringiensis (Bt) Cry34Ab1/Cry35Ab1 are binary insecticidal proteins that are co-expressed in transgenic corn hybrids for control of western corn rootworm, Diabrotica virgifera virgifera LeConte. Bt crystal (Cry) proteins with limited potential for field-relevant cross-resistance are used in combination, along with non-transgenic corn refuges, as a strategy to delay development of resistant rootworm populations. Differences in insect midgut membrane binding site interactions are one line of evidence that Bt protein mechanisms of action differ and that the probability of receptor-mediated cross-resistance is low. Methodology/Principal Findings: Binding site interactions were investigated between Cry34Ab1/Cry35Ab1 and coleopteran active insecticidal proteins Cry3Aa, Cry6Aa, and Cry8Ba on western corn rootworm midgut brush border membrane vesicles (BBMV). Competitive binding of radio-labeled proteins to western corn rootworm BBMV was used as a measure of shared binding sites. Our work shows that I-125-Cry35Ab1 binds to rootworm BBMV, Cry34Ab1 enhances I-125-Cry35Ab1 specific binding, and that I-125-Cry35Ab1 with or without unlabeled Cry34Ab1 does not share binding sites with Cry3Aa, Cry6Aa, or Cry8Ba. Two primary lines of evidence presented here support the lack of shared binding sites between Cry34Ab1/Cry35Ab1 and the aforementioned proteins: 1) No competitive binding to rootworm BBMV was observed for competitor proteins when used in excess with I-125-Cry35Ab1 alone or combined with unlabeled Cry34Ab1, and 2) No competitive binding to rootworm BBMV was observed for unlabeled Cry34Ab1 and Cry35Ab1, or a combination of the two, when used in excess with I-125-Cry3Aa, or I-125-Cry8Ba. Conclusions/Significance: Combining two or more insecticidal proteins active against the same target pest is one tactic to delay the onset of resistance to either protein. We conclude that Cry34Ab1/Cry35Ab1 are compatible with Cry3Aa, Cry6Aa, or Cry8Ba for deployment as insect resistance management pyramids for in-plant control of western corn rootworm.	[Li, Huarong; Olson, Monica; Lin, Gaofeng; Hey, Timothy; Tan, Sek Yee; Narva, Kenneth E.] Dow AgroSci LLC, Indianapolis, IN USA	Dow Chemical Company	Narva, KE (corresponding author), Dow AgroSci LLC, Indianapolis, IN USA.	knarva@dow.com		Narva, Kenneth/0000-0001-8094-6418				Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; CARROLL J, 1989, BIOCHEM J, V261, P99, DOI 10.1042/bj2610099; Charles JF, 1997, FEMS MICROBIOL LETT, V156, P153, DOI 10.1016/S0378-1097(97)00419-9; Domon B, 2006, SCIENCE, V312, P212, DOI 10.1126/science.1124619; Drees BM, 1999, HDB CORN INSECTS, P66; Ellis RT, 2002, APPL ENVIRON MICROB, V68, P1137, DOI 10.1128/AEM.68.3.1137-1145.2002; Fabrick J, 2009, J BIOL CHEM, V284, P18401, DOI 10.1074/jbc.M109.001651; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gray ME, 2009, ANNU REV ENTOMOL, V54, P303, DOI 10.1146/annurev.ento.54.110807.090434; Heckel DG, 2007, J INVERTEBR PATHOL, V95, P192, DOI 10.1016/j.jip.2007.03.008; Herrero S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-96; Li HR, 2004, BIOCHEM BIOPH RES CO, V323, P52, DOI 10.1016/j.bbrc.2004.08.054; Li HR, 2004, INSECT BIOCHEM MOLEC, V34, P753, DOI 10.1016/j.ibmb.2004.03.010; LI JD, 1991, NATURE, V353, P815, DOI 10.1038/353815a0; Masson L, 2004, BIOCHEMISTRY-US, V43, P12349, DOI 10.1021/bi048946z; Metcalf R. L., 1986, METHODS STUDY PEST D, pvii; Michaels T.E., 1996, U.S. Patent, Patent No. [5,554,534 A, 5554534, 5,554,534]; Moellenbeck DJ, 2001, NAT BIOTECHNOL, V19, P668, DOI 10.1038/90282; NARVA KE, 2002, Patent No. 6372480; Narva KE, 1993, US patent, Patent No. [5186934, 5,186,934]; O'Neal ME, 1999, J ECON ENTOMOL, V92, P1301, DOI 10.1093/jee/92.6.1301; Ochoa-Campuzano C, 2007, BIOCHEM BIOPH RES CO, V362, P437, DOI 10.1016/j.bbrc.2007.07.197; Rajagopal R, 2002, J BIOL CHEM, V277, P46849, DOI 10.1074/jbc.C200523200; Rausell C, 2004, BBA-BIOMEMBRANES, V1660, P99, DOI 10.1016/j.bbamem.2003.11.004; Roush RT, 1998, PHILOS T R SOC B, V353, P1777, DOI 10.1098/rstb.1998.0330; Sayed A, 2007, INSECT MOL BIOL, V16, P591, DOI 10.1111/j.1365-2583.2007.00755.x; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Schnepf H. E., 2007, US Patent, Patent No. [7,309,785, 7309785]; Schnepf HE, 2009, US patent, Patent No. 7524810; Siegfried BD, 2005, J ECON ENTOMOL, V98, P1320, DOI 10.1603/0022-0493-98.4.1320; Song P, 2012, J INVERTEBR PATHOL, V109, P318, DOI 10.1016/j.jip.2012.01.009; Tabashnik BE, 1998, PHILOS T R SOC B, V353, P1751, DOI 10.1098/rstb.1998.0327; Thomson M., 1999, U.S. Patent, Patent No. [5,874,288 A, 5874288]; United States Environmental Protection Agency, 2003, EPA PUBL; US Environmental Protection Agency, CURR PREV REG SECT 3; (US EPA) U. S. Environmental Protection Agency, 1998, ENV PROT AG WHIT PAP; US EPA (U.S. Environmental Protection Agency), 2001, BIOP REG ACT DOC BAC; van Frankenhuyzen K, 2009, J INVERTEBR PATHOL, V101, P1, DOI 10.1016/j.jip.2009.02.009; Walters FS, 2008, APPL ENVIRON MICROB, V74, P367, DOI 10.1128/AEM.02165-07; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; Wright RJ, 2000, J ECON ENTOMOL, V93, P7, DOI 10.1603/0022-0493-93.1.7; Yang YJ, 2007, APPL ENVIRON MICROB, V73, P6939, DOI 10.1128/AEM.01703-07; Zhao J, 2010, INSECT BIOCHEM MOLEC, V40, P113, DOI 10.1016/j.ibmb.2010.01.001	46	36	43	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53079	10.1371/journal.pone.0053079	http://dx.doi.org/10.1371/journal.pone.0053079			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308139	gold, Green Published, Green Submitted			2022-12-25	WOS:000313670100016
J	Tam, JKV; Chow, BKC; Lee, LTO				Tam, Janice K. V.; Chow, Billy K. C.; Lee, Leo T. O.			Structural and Functional Divergence of Growth Hormone-Releasing Hormone Receptors in Early Sarcopterygians: Lungfish and Xenopus	PLOS ONE			English	Article							PEPTIDE HISTIDINE-ISOLEUCINE; MOLECULAR-CLONING; PITUITARY RECEPTOR; GENE-EXPRESSION; IDENTIFICATION; EVOLUTIONARY; COELACANTH; DISCOVERY; RNA	The evolutionary trajectories of growth hormone-releasing hormone (GHRH) receptor remain enigmatic since the discovery of physiologically functional GHRH-GHRH receptor (GHRHR) in non-mammalian vertebrates in 2007. Interestingly, subsequent studies have described the identification of a GHRHR(2) in chicken in addition to the GHRHR and the closely related paralogous receptor, PACAP-related peptide (PRP) receptor (PRPR). In this article, we provide information, for the first time, on the GHRHR in sarcopterygian fish and amphibians by the cloning and characterization of GHRHRs from lungfish (P. dolloi) and X. laevis. Sequence alignment and phylogenetic analyses demonstrated structural resemblance of lungfish GHRHR to their mammalian orthologs, while the X. laevis GHRHR showed the highest homology to GHRHR2 in zebrafish and chicken. Functionally, lungfish GHRHR displayed high affinity towards GHRH in triggering intracellular cAMP and calcium accumulation, while X. laevis GHRHR(2) was able to react with both endogenous GHRH and PRP. Tissue distribution analyses showed that both lungfish GHRHR and X. laevis GHRHR(2) had the highest expression in brain, and interestingly, X. laevis (GHRHR2) also had high abundance in the reproductive organs. These findings, together with previous reports, suggest that early in the Sarcopterygii lineage, GHRHR and PRPR have already established diverged and specific affinities towards their cognate ligands. GHRHR(2), which has only been found in xenopus, zebrafish and chicken hitherto, accommodates both GHRH and PRP.	[Tam, Janice K. V.; Chow, Billy K. C.; Lee, Leo T. O.] Univ Hong Kong, Sch Biol Sci, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong	Lee, LTO (corresponding author), Univ Hong Kong, Sch Biol Sci, Pokfulam, Hong Kong, Peoples R China.	ltolee2@hku.hk	Chow, Billy/D-3064-2009; Lee, Leo T.O./AAB-1581-2021	Chow, Billy/0000-0003-3390-0307; 	Hong Kong Government RGC [7696/ 09M, CRFHKU6/CRF/11G]; Committee on Research [20101159013]	Hong Kong Government RGC; Committee on Research	The present study was supported by the Hong Kong Government RGC grant 7696/ 09M to LTOL, CRFHKU6/CRF/11G to BKCC and the Committee on Research 20101159013 to LTOL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinkmann H, 2004, P NATL ACAD SCI USA, V101, P4900, DOI 10.1073/pnas.0400609101; Cardoso JCR, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-108; DIMALINE R, 1987, BIOCHIM BIOPHYS ACTA, V930, P97, DOI 10.1016/0167-4889(87)90160-1; GAYLINN BD, 1993, MOL ENDOCRINOL, V7, P77, DOI 10.1210/me.7.1.77; Hassan HA, 2001, ARCH BIOCHEM BIOPHYS, V387, P20, DOI 10.1006/abbi.2000.2208; Hoo RLC, 2001, J MOL ENDOCRINOL, V27, P229, DOI 10.1677/jme.0.0270229; Horikawa R, 2001, ENDOCRINOLOGY, V142, P2660, DOI 10.1210/en.142.6.2660; HSIUNG HM, 1993, NEUROPEPTIDES, V25, P1, DOI 10.1016/0143-4179(93)90062-F; Ji YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-263; Lee LTO, 2007, P NATL ACAD SCI USA, V104, P2133, DOI 10.1073/pnas.0611008104; Levy G, 2011, J MOL ENDOCRINOL, V46, P101, DOI 10.1530/JME-10-0065; LIN CJ, 1992, NATURE, V360, P765, DOI 10.1038/360765a0; MATSUBARA S, 1995, ENDOCRINOLOGY, V136, P4147, DOI 10.1210/en.136.9.4147; Mayden RL, 2007, J EXP ZOOL PART B, V308B, P642, DOI 10.1002/jez.b.21175; Mayo KE, 1996, ANN NY ACAD SCI, V805, P184, DOI 10.1111/j.1749-6632.1996.tb17483.x; MAYO KE, 1992, MOL ENDOCRINOL, V6, P1734, DOI 10.1210/me.6.10.1734; Ogino Y, 2009, ENDOCRINOLOGY, V150, P5415, DOI 10.1210/en.2009-0523; Pollet N, 2006, GENOME DYN, V2, P138, DOI 10.1159/000095101; Porter TE, 2006, ENDOCRINOLOGY, V147, P2535, DOI 10.1210/en.2005-1534; Tam JKV, 2007, PEPTIDES, V28, P1920, DOI 10.1016/j.peptides.2007.07.011; Tam JKV, 2011, GEN COMP ENDOCR, V173, P405, DOI 10.1016/j.ygcen.2011.06.003; Tam JKV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019384; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Toogood AA, 2006, ENDOCRINOLOGY, V147, P1838, DOI 10.1210/en.2005-0930; Tse DLY, 2002, ENDOCRINOLOGY, V143, P1327, DOI 10.1210/en.143.4.1327; Wang Y, 2010, DOMEST ANIM ENDOCRIN, V38, P13, DOI 10.1016/j.domaniend.2009.07.008; Wu S, 2008, J MOL ENDOCRINOL, V41, P343, DOI 10.1677/JME-08-0083; Zardoya R, 1997, NATURWISSENSCHAFTEN, V84, P389, DOI 10.1007/s001140050415; Zardoya R, 1996, P NATL ACAD SCI USA, V93, P5449, DOI 10.1073/pnas.93.11.5449	29	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53482	10.1371/journal.pone.0053482	http://dx.doi.org/10.1371/journal.pone.0053482			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308232	Green Published, Green Submitted, gold			2022-12-25	WOS:000313670100044
J	Chen, ZH; Zhao, RJ; Li, RH; Guo, CP; Zhang, GJ				Chen, Zhi-Hong; Zhao, Rui-Jun; Li, Rong-Hui; Guo, Cui-Ping; Zhang, Guo-Jun			Bioluminescence Imaging of DNA Synthetic Phase of Cell Cycle in Living Animals	PLOS ONE			English	Article							VITRO MODEL SYSTEM; IN-VIVO; TOPOISOMERASE-I; HOLLOW FIBERS; CANCER; EXPRESSION; RESISTANCE	Bioluminescence reporter proteins have been widely used in the development of tools for monitoring biological events in living cells. Currently, some assays like flow cytometry analysis are available for studying DNA synthetic phase (S-phase) targeted anti-cancer drug activity in vitro; however, techniques for imaging of in vivo models remain limited. Cyclin A2 is known to promote S-phase entry in mammals. Its expression levels are low during G1-phase, but they increase at the onset of S-phase. Cyclin A2 is degraded during prometaphase by ubiquitin-dependent, proteasome-mediated proteolysis. In this study, we have developed a cyclin A2-luciferase (CYCA-Luc) fusion protein targeted for ubiquitin-proteasome dependent degradation, and have evaluated its utility in screening S-phase targeted anti-cancer drugs. Similar to endogenous cyclin A2, CYCA-Luc accumulates during S-phase and is degraded during G2/M-phase. Using Cdc20 siRNA we have demonstrated that Cdc20 can mediate CYCA-Luc degradation. Moreover, using noninvasive bioluminescent imaging, we demonstrated accumulation of CYCA-Luc in response to 10-hydroxycamptothecin (HCPT), an S-phase targeted anti-cancer drug, in human tumor cells in vivo and in vitro. Our results indicate that a CYCA-Luc fusion reporter system can be used to monitor S-phase of cell cycle, and evaluate pharmacological activity of anti-cancer drug HCPT in real time in vitro and in vivo, and is likely to provide an important tool for screening such drugs.	[Chen, Zhi-Hong; Zhao, Rui-Jun; Li, Rong-Hui; Guo, Cui-Ping; Zhang, Guo-Jun] Shantou Univ, Canc Hosp, Coll Med, Breast Ctr, Shantou, Peoples R China; [Chen, Zhi-Hong] Mudanjiang Med Univ, Heilongjiang Prov Key Lab Canc Prevent & Treatmen, Mudanjiang, Peoples R China; [Zhao, Rui-Jun; Li, Rong-Hui; Guo, Cui-Ping; Zhang, Guo-Jun] Shantou Univ, Coll Med, Canc Res Ctr, Shantou, Peoples R China	Shantou University; Mudanjiang Medical University; Shantou University	Zhang, GJ (corresponding author), Shantou Univ, Canc Hosp, Coll Med, Breast Ctr, Shantou, Peoples R China.	guoj_zhang@yahoo.com	Zhang, Guo-Jun/H-3890-2015	Zhang, Guo-Jun/0000-0001-5182-5887	National Basic Research Project of China [2011CB707705]; National Natural Science Foundation of China [30973377, 31271068]	National Basic Research Project of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partly supported by grants from the National Basic Research Project of China (2011CB707705) and the National Natural Science Foundation of China (30973377 and 31271068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abdel-Aziz W, 2004, BIOCHEM PHARMACOL, V68, P11, DOI 10.1016/j.bcp.2004.03.021; Abdel-Aziz W, 2003, CRIT REV ONCOL HEMAT, V48, P19, DOI 10.1016/S1040-8428(03)00096-9; Arrondeau J, 2010, DISCOV MED, V10, P355; Badr CE, 2011, TRENDS BIOTECHNOL, V29, P624, DOI 10.1016/j.tibtech.2011.06.010; Boni V, 2010, MOL CANCER THER, V9, P2265, DOI 10.1158/1535-7163.MCT-10-0061; Chiarle R, 2001, BREAST CANCER RES, V3, P91; Cho YS, 2003, CLIN CANCER RES, V9, P1171; Close DM, 2011, SENSORS-BASEL, V11, P180, DOI 10.3390/s110100180; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Dong XL, 2012, BIOMED PHARMACOTHER, V66, P70, DOI 10.1016/j.biopha.2011.11.016; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Gong D, 2010, MOL BIOL CELL, V21, P3149, DOI 10.1091/mbc.E10-05-0393; Gross S, 2005, NAT METHODS, V2, P607, DOI 10.1038/NMETH779; Gross S, 2005, CANCER CELL, V7, P5, DOI 10.1016/j.ccr.2004.12.011; Honda A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039249; Kuhling H, 2003, J PATHOL, V199, P424, DOI 10.1002/path.1322; Liao Z, 2008, MOL PHARMACOL, V73, P490, DOI 10.1124/mol.107.041178; Liu WF, 2011, EUR J MED CHEM, V46, P2408, DOI 10.1016/j.ejmech.2011.03.024; Lyons SK, 2006, CANCER RES, V66, P4701, DOI 10.1158/0008-5472.CAN-05-3598; Mateo F, 2009, ONCOGENE, V28, P2654, DOI 10.1038/onc.2009.127; Negrin RS, 2006, NAT REV IMMUNOL, V6, P484, DOI 10.1038/nri1879; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Segurado M, 2009, BIOL CELL, V101, P617, DOI 10.1042/BC20090053; van Leuken R, 2008, BBA-REV CANCER, V1786, P49, DOI 10.1016/j.bbcan.2008.05.002; Wexler EJ, 2000, CLIN CANCER RES, V6, P3361; Willmann JK, 2008, NAT REV DRUG DISCOV, V7, P591, DOI 10.1038/nrd2290; Zhang GJ, 2004, NAT MED, V10, P643, DOI 10.1038/nm1047; Zhang GJ, 2008, NAT PROTOC, V3, P891, DOI 10.1038/nprot.2008.52; Zhang GJ, 2007, NEOPLASIA, V9, P652, DOI 10.1593/neo.07421; Zhang N, 2003, J IMMUNOL, V170, P6307, DOI 10.4049/jimmunol.170.12.6307	30	8	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53291	10.1371/journal.pone.0053291	http://dx.doi.org/10.1371/journal.pone.0053291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301056	Green Submitted, Green Published, gold			2022-12-25	WOS:000313480000047
J	Monsarrat, S; Benhamou, S; Sarrazin, F; Bessa-Gomes, C; Bouten, W; Duriez, O				Monsarrat, Sophie; Benhamou, Simon; Sarrazin, Francois; Bessa-Gomes, Carmen; Bouten, Willem; Duriez, Olivier			How Predictability of Feeding Patches Affects Home Range and Foraging Habitat Selection in Avian Social Scavengers?	PLOS ONE			English	Article							VULTURES GYPS-FULVUS; FOOD SUPPLEMENTATION; ECOLOGICAL TRAPS; BREEDING SUCCESS; SPACE USE; BEHAVIOR; CONSERVATION; POPULATION; SEX; ALBATROSSES	Feeding stations are commonly used to sustain conservation programs of scavengers but their impact on behaviour is still debated. They increase the temporal and spatial predictability of food resources while scavengers have supposedly evolved to search for unpredictable resources. In the Grands Causses (France), a reintroduced population of Griffon vultures Gyps fulvus can find carcasses at three types of sites: 1. "light feeding stations'', where farmers can drop carcasses at their farm (spatially predictable), 2. "heavy feeding stations'', where carcasses from nearby farms are concentrated (spatially and temporally predictable) and 3. open grasslands, where resources are randomly distributed (unpredictable). The impact of feeding stations on vulture's foraging behaviour was investigated using 28 GPS-tracked vultures. The average home range size was maximal in spring (1272 +/- 752 km(2)) and minimal in winter (473 +/- 237 km(2)) and was highly variable among individuals. Analyses of home range characteristics and feeding habitat selection via compositional analysis showed that feeding stations were always preferred compared to the rest of the habitat where vultures can find unpredictable resources. Feeding stations were particularly used when resources were scarce (summer) or when flight conditions were poor (winter), limiting long-ranging movements. However, when flight conditions were optimal, home ranges also encompassed large areas of grassland where vultures could find unpredictable resources, suggesting that vultures did not lose their natural ability to forage on unpredictable resources, even when feeding stations were available. However during seasons when food abundance and flight conditions were not limited, vultures seemed to favour light over heavy feeding stations, probably because of the reduced intraspecific competition and a pattern closer to the natural dispersion of resources in the landscape. Light feeding stations are interesting tools for managing food resources, but don't prevent vultures to feed at other places with possibly high risk of intoxication (poison).	[Monsarrat, Sophie; Benhamou, Simon; Duriez, Olivier] Univ Montpellier 2, Ctr Ecol Fonct & Evolut, CNRS, UMR 5175, Montpellier, France; [Sarrazin, Francois] UPMC, CNRS, MNHN, UMR 7204, Paris, France; [Bessa-Gomes, Carmen] Univ Paris 11, CNRS, UMR 8079, F-91405 Orsay, France; [Bouten, Willem] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; University of Amsterdam	Duriez, O (corresponding author), Univ Montpellier 2, Ctr Ecol Fonct & Evolut, CNRS, UMR 5175, Montpellier, France.	olivier.duriez@cefe.cnrs.fr	Bouten, Willem/G-4383-2018; Sarrazin, Francois/B-7593-2013; Sarrazin, François/AAB-4227-2019; Duriez, Olivier/R-4772-2016	Bouten, Willem/0000-0002-5250-8872; Sarrazin, Francois/0000-0001-5901-4819; Sarrazin, François/0000-0001-5901-4819; Duriez, Olivier/0000-0003-1868-9750; Monsarrat, Sophie/0000-0002-6220-5306; Bessa Gomes, Carmen/0000-0002-3476-0767	ANR [ANR-07-BLAN-0201]	ANR(French National Research Agency (ANR))	Project funded by ANR grant no ANR-07-BLAN-0201, coordinated by F. Sarrazin and C. Bessa-Gomes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrados C, 2002, CR BIOL, V325, P165, DOI 10.1016/S1631-0691(02)01414-2; AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; [Anonymous], 2010, R LANG ENV STAT COMP; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bahat O, 1995, THESIS TEL AVIV U TE; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; BENHAMOU S, 1994, ANIM BEHAV, V47, P1423, DOI 10.1006/anbe.1994.1189; BENHAMOU S, 1989, J THEOR BIOL, V139, P379, DOI 10.1016/S0022-5193(89)80216-4; Benhamou S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014592; Benhamou S, 2010, J WILDLIFE MANAGE, V74, P1353, DOI 10.2193/2009-441; Blondel J, 2010, MEDITERRANEAN REGION; BlSSzquez M., 2009, VULTURES FEEDING STA, P308; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bose M, 2007, ORYX, V41, P503, DOI 10.1017/S0030605307000312; Bose M, 2012, BIRD STUDY IN PRESS; Bose M, 2007, IBIS, V149, P490, DOI 10.1111/j.1474-919X.2007.00674.x; BOUTIN S, 1990, CAN J ZOOL, V68, P203, DOI 10.1139/z90-031; Carrete M, 2005, BIOL CONSERV, V126, P582, DOI 10.1016/j.biocon.2005.06.031; Carrete M, 2006, BIOL LETTERS, V2, P624, DOI 10.1098/rsbl.2006.0498; Cornelis D, 2011, J MAMMAL, V92, P1287, DOI 10.1644/10-MAMM-A-397.1; Cortes-Avizanda A, 2010, BIOL CONSERV, V143, P1707, DOI 10.1016/j.biocon.2010.04.016; Cramp S., 1982, HDB BIRDS EUROPE MID; Deygout C, 2009, ECOL MODEL, V220, P1826, DOI 10.1016/j.ecolmodel.2009.04.030; Donazar JA, 1999, BEHAV ECOL SOCIOBIOL, V45, P55, DOI 10.1007/s002650050539; Dupont H, 2012, J APPL ECOL, V49, P404, DOI 10.1111/j.1365-2664.2012.02111.x; Duriez O, 2012, BIRD STUDY IN PRESS; Fischer AB, 1969, ZOOL JB SYST, V96, P81; Garcia-Ripolles C, 2011, ACTA ORNITHOL, V46, P127, DOI 10.3161/000164511X625892; Gault A, 2006, THESIS U PARIS 6 PAR, P6; Gilbert M, 2007, BIRD CONSERV INT, V17, P63, DOI 10.1017/S0959270906000621; Gilroy JJ, 2007, TRENDS ECOL EVOL, V22, P351, DOI 10.1016/j.tree.2007.03.014; Goss-Custard John D., 1997, P373; Horne JS, 2006, ECOLOGY, V87, P1146, DOI 10.1890/0012-9658(2006)87[1146:STBHRM]2.0.CO;2; Kie JG, 2010, PHILOS T R SOC B, V365, P2221, DOI 10.1098/rstb.2010.0093; Lopez-Bao JV, 2010, ANIM CONSERV, V13, P35, DOI 10.1111/j.1469-1795.2009.00300.x; Margalida A, 2010, EUR J WILDLIFE RES, V56, P673, DOI 10.1007/s10344-010-0366-0; Margalida A, 2010, J APPL ECOL, V47, P931, DOI 10.1111/j.1365-2664.2010.01835.x; Gonzalez L, 2006, BIOL CONSERV, V129, P477, DOI 10.1016/j.biocon.2005.11.014; MERETSKY VJ, 1992, CONDOR, V94, P313, DOI 10.2307/1369205; Meretsky VJ, 1999, J WILDLIFE MANAGE, V63, P107, DOI 10.2307/3802491; Millspaugh JJ, 2006, J WILDLIFE MANAGE, V70, P384, DOI 10.2193/0022-541X(2006)70[384:AORSUU]2.0.CO;2; Mundy P., 1992, VULTURES AFRICA; Nathan R, 2012, J EXP BIOL, V215, P986, DOI 10.1242/jeb.058602; Oro D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004084; Phillips RA, 2007, AQUAT CONSERV, V17, pS6, DOI 10.1002/aqc.906; Pinaud D, 2007, J ANIM ECOL, V76, P9, DOI 10.1111/j.1365-2656.2006.01186.x; Piper S.E., 2004, P341; Piper SE, 1999, BIRD STUDY, V46, P230; Piper SE, 2006, THESSALONIKI, P41; Prakash V, 2003, BIOL CONSERV, V109, P381, DOI 10.1016/S0006-3207(02)00164-7; R Development Core Team, 2012, R LANG ENV STAT COMP; RAPPOLE JH, 1991, J FIELD ORNITHOL, V62, P335; Reddy A, 2007, CURR SCI INDIA, V92, P659; Ridoux V, 1997, ECOLOGY; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Ruxton GD, 2004, J THEOR BIOL, V228, P431, DOI 10.1016/j.jtbi.2004.02.005; Sarrazin F, 1996, IBIS, V138, P315, DOI 10.1111/j.1474-919X.1996.tb04344.x; SARRAZIN F, 1994, AUK, V111, P853; Schoech SJ, 2008, BIOL CONSERV, V141, P162, DOI 10.1016/j.biocon.2007.09.009; Terrasse M., 1994, P479; Terrasse Michel, 2004, P127; Wienecke BC, 2000, DEEP-SEA RES PT II, V47, P2573, DOI 10.1016/S0967-0645(00)00036-9; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Xirouchakis SM, 2009, WILDLIFE BIOL, V15, P37, DOI 10.2981/07-090	64	112	116	1	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53077	10.1371/journal.pone.0053077	http://dx.doi.org/10.1371/journal.pone.0053077			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301024	gold, Green Submitted, Green Published			2022-12-25	WOS:000313480000029
J	Kwan, HT; Chan, DW; Cai, PCH; Mak, CSL; Yung, MMH; Leung, THY; Wong, OGW; Cheung, ANY; Ngan, HYS				Kwan, H. T.; Chan, David W.; Cai, Patty C. H.; Mak, Celia S. L.; Yung, Mingo M. H.; Leung, Thomas H. Y.; Wong, Oscar G. W.; Cheung, Annie N. Y.; Ngan, Hextan Y. S.			AMPK Activators Suppress Cervical Cancer Cell Growth through Inhibition of DVL3 Mediated Wnt/beta-Catenin Signaling Activity	PLOS ONE			English	Article							PROTEIN-KINASE; BETA-CATENIN; BREAST-CANCER; WNT PATHWAY; MAMMALIAN TARGET; LUNG-CANCER; DISHEVELLED OVEREXPRESSION; ANTIDIABETIC DRUG; DIABETIC-PATIENTS; HUMAN COUNTERPART	Recent evidence has suggested that AMPK activators may be applied as therapeutic drugs in suppressing cancer cell growth. However, the molecular mechanism of their suppressive function in cancer cells is still unclear. Here we show that AMPK activators impair cervical cancer cell growth through the reduction of DVL3, a positive regulator in Wnt/beta-catenin signaling and an oncogenic player in cervical cancer tumorigenesis. By western blot and immunohistochemical analyses, we demonstrated that DVL3 was frequently upregulated and significantly associated with elevated beta-catenin (P = 0.009) and CyclinD1 (P = 0.009) expressions in cervical cancer. Enforced expression of DVL3 elevated beta-catenin and augmented cervical cancer cell growth, verifying that DVL3-mediated Wnt/beta-catenin activation is involved in cervical cancer oncogenesis. On the other aspect, we noted that the cervical cancer cell growth was remarkably suppressed by AMPK activators and such cell growth inhibition was in concomitant with the reduction of DVL3 protein level in dose- and time-dependent manners. Besides, impaired mTOR signaling activity also reduced DVL3 expression. In contrast, co-treatment with Compound C (AMPK inhibitor) could significantly abrogate metformin induced DVL3 reduction. In addition, co-treatment with AM114 or MG132 (proteosomal inhibitors) could partially restore DVL3 expression under the treatment of metformin. Further in vivo ubiquitination assay revealed that metformin could reduce DVL3 by ubiquitin/proteasomal degradation. To our knowledge, this is the first report showing the probable molecular mechanisms of that the AMPK activators suppress cervical cancer cell growth by impairing DVL3 protein synthesis via AMPK/mTOR signaling and/or partially promoting the proteasomal degradation of DVL3.	[Kwan, H. T.; Chan, David W.; Cai, Patty C. H.; Mak, Celia S. L.; Yung, Mingo M. H.; Leung, Thomas H. Y.; Ngan, Hextan Y. S.] Univ Hong Kong, LKS Fac Med, Dept Obstet, Hong Kong, Hong Kong, Peoples R China; [Kwan, H. T.; Chan, David W.; Cai, Patty C. H.; Mak, Celia S. L.; Yung, Mingo M. H.; Leung, Thomas H. Y.; Ngan, Hextan Y. S.] Univ Hong Kong, LKS Fac Med, Dept Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Wong, Oscar G. W.; Cheung, Annie N. Y.] Univ Hong Kong, LKS Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Chan, DW (corresponding author), Univ Hong Kong, LKS Fac Med, Dept Obstet, Hong Kong, Hong Kong, Peoples R China.	dwchan@hku.hk; hysngan@hku.hk	YUNG, Mingo Ming Ho/AHB-5775-2022; Wong, Gee Wan/C-4661-2009; Chan, David/O-9896-2018; Cheung, Annie Nga Yin/C-4231-2009	YUNG, Mingo Ming Ho/0000-0003-0903-1164; Chan, David/0000-0002-6951-3467; Cheung, Annie Nga Yin/0000-0002-1584-7568; Ngan, Hextan Y S/0000-0003-3945-159X	Wong Check She Charitable Foundation	Wong Check She Charitable Foundation	This study was supported by Wong Check She Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimova IN, 2009, CELL CYCLE, V8, P909, DOI 10.4161/cc.8.6.7933; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Ben Sahra I, 2010, MOL CANCER THER, V9, P1092, DOI 10.1158/1535-7163.MCT-09-1186; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; Bulut G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027243; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Carretero J, 2007, ONCOGENE, V26, P1616, DOI 10.1038/sj.onc.1209951; Cazzaniga M, 2009, CANCER EPIDEM BIOMAR, V18, P701, DOI 10.1158/1055-9965.EPI-08-0871; Chan DW, 2006, GASTROENTEROLOGY, V131, P1218, DOI 10.1053/j.gastro.2006.07.020; Chen H, 2011, J BIOL CHEM, V286, P14870, DOI 10.1074/jbc.M110.211607; Chung MT, 2009, GYNECOL ONCOL, V112, P646, DOI 10.1016/j.ygyno.2008.10.026; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Dumont FJ, 1995, LIFE SCI, V58, P373, DOI 10.1016/0024-3205(95)02233-3; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Feng ZB, 2011, HUM PATHOL, V42, P659, DOI 10.1016/j.humpath.2010.07.021; Guigas B, 2009, IUBMB LIFE, V61, P18, DOI 10.1002/iub.135; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Herbst Andreas, 2007, Methods Mol Biol, V361, P63; Holloway KR, 2010, P NATL ACAD SCI USA, V107, P9216, DOI 10.1073/pnas.0911325107; Hu TH, 2010, J BIOL CHEM, V285, P13561, DOI 10.1074/jbc.M109.075945; Hutchinson DJ, 2008, AM J HEALTH-SYST PH, V65, P2105, DOI 10.2146/ajhp070627; Ilyas M, 2005, J PATHOL, V205, P130, DOI 10.1002/path.1692; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; Kimura N, 2003, GENES CELLS, V8, P65, DOI 10.1046/j.1365-2443.2003.00615.x; Liu BL, 2009, CELL CYCLE, V8, P2031, DOI 10.4161/cc.8.13.8814; Metcalfe C, 2010, CANCER RES, V70, P6629, DOI 10.1158/0008-5472.CAN-10-1616; Miyazaki K, 2004, J BIOL CHEM, V279, P11327, DOI 10.1074/jbc.M312389200; Miyoshi Y, 1998, CANCER RES, V58, P2524; Mizutani K, 2005, TUMORI J, V91, P546, DOI 10.1177/030089160509100616; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Motoshima H, 2006, J PHYSIOL-LONDON, V574, P63, DOI 10.1113/jphysiol.2006.108324; Nagahata T, 2003, CANCER SCI, V94, P515, DOI 10.1111/j.1349-7006.2003.tb01475.x; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Pereira-Suarez AL, 2002, TUMOR BIOL, V23, P45, DOI 10.1159/000048688; Perez-Plasencia Carlos, 2008, Int Arch Med, V1, P10, DOI 10.1186/1755-7682-1-10; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Proud CG, 1997, BIOCHEM J, V328, P329; Ramachandran I, 2012, ONCOGENE, V31, P2725, DOI 10.1038/onc.2011.455; Sareddy GR, 2009, NEUROCHEM INT, V55, P307, DOI 10.1016/j.neuint.2009.03.016; Shao M, 2009, DEVELOPMENT, V136, P2121, DOI 10.1242/dev.032649; Shen Z, 2002, CLIN CANCER RES, V8, P2085; Szalmas A, 2009, SEMIN CANCER BIOL, V19, P144, DOI 10.1016/j.semcancer.2009.02.011; Takatani T, 2011, MOL CELL ENDOCRINOL, V339, P114, DOI 10.1016/j.mce.2011.04.003; Thomas G, 1997, CURR OPIN CELL BIOL, V9, P782, DOI 10.1016/S0955-0674(97)80078-6; Uematsu K, 2003, ONCOGENE, V22, P7218, DOI 10.1038/sj.onc.1206817; Uematsu K, 2003, CANCER RES, V63, P4547; Uematsu K, 2007, ANTICANCER RES, V27, P4239; Uren A, 2005, CANCER RES, V65, P6199, DOI 10.1158/0008-5472.CAN-05-0455; Vazquez-Martin A, 2009, CELL CYCLE, V8, P3679, DOI 10.4161/cc.8.22.9905; Yu SYM, 2009, TUMOR BIOL, V30, P80, DOI 10.1159/000216843; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500; Zhao Y, 2010, MOL CARCINOGEN, V49, P760, DOI 10.1002/mc.20651; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhou J, 2009, ONCOGENE, V28, P1993, DOI 10.1038/onc.2009.63; Zhuang Yongxian, 2008, J Mol Signal, V3, P18, DOI 10.1186/1750-2187-3-18; ZYLBERBERG B, 1991, PRESSE MED, V20, P1320	60	67	71	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53597	10.1371/journal.pone.0053597	http://dx.doi.org/10.1371/journal.pone.0053597			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301094	Green Published, gold, Green Submitted			2022-12-25	WOS:000313320900087
J	Motrich, RD; Castro, GM; Caputto, BL				Motrich, Ruben D.; Castro, Gonzalo M.; Caputto, Beatriz L.			Old Players with a Newly Defined Function: Fra-1 and c-Fos Support Growth of Human Malignant Breast Tumors by Activating Membrane Biogenesis at the Cytoplasm	PLOS ONE			English	Article							IMMEDIATE-EARLY GENE; PHOSPHOLIPID-SYNTHESIS; TRANSCRIPTION FACTORS; ANTIGEN 1; EXPRESSION; AP-1; JUN; PHOSPHORYLATION; LOCALIZATION; NUCLEAR	A shared characteristic of tumor cells is their exacerbated growth. Consequently, tumor cells demand high rates of phospholipid synthesis required for membrane biogenesis to support their growth. c-Fos, in addition to its AP-1 transcription factor activity, is the only protein known up to date that is capable of activating lipid synthesis in normal and brain tumor tissue. For this latter activity, c-Fos associates to the endoplasmic reticulum (ER) through its N-terminal domain and activates phospholipid synthesis, an event that requires it Basic Domain (BD) (aa 139-159). Fra-1, another member of the FOS family of proteins, is over-expressed in human breast cancer cells and its BD is highly homologous to that of c-Fos with two conservative substitutions in its basic amino acids. Consequently, herein we examined if Fra-1 and/or c-Fos participate in growth of breast cancer cells by activating phospholipid synthesis as found previously for c-Fos in brain tumors. We found both Fra-1 and c-Fos over-expressed in >95% of human ductal breast carcinoma biopsies examined contrasting with the very low or undetectable levels in normal tissue. Furthermore, both proteins associate to the ER and activate phospholipid synthesis in cultured MCF7 and MDA-MB231 breast cancer cells and in human breast cancer samples. Stripping tumor membranes of Fra-1 and c-Fos prior to assaying their lipid synthesis capacity in vitro results in non-activated lipid synthesis levels that are restored to their initial activated state by addition of Fra-1 and/or c-Fos to the assays. In MDA-MB231 cells primed to proliferate, blocking Fra-1 and c-Fos with neutralizing antibodies blocks lipid-synthesis activation and cells do not proliferate. Taken together, these results disclose the cytoplasmic activity of Fra-1 and c-Fos as potential targets for controlling growth of breast carcinomas by decreasing the rate of membrane biogenesis required for growth.	[Motrich, Ruben D.; Castro, Gonzalo M.; Caputto, Beatriz L.] Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Invest Quim Biol Cordoba, Natl Sci & Tech Res Council,Dept Quim Biol, RA-5000 Cordoba, Argentina	National University of Cordoba	Caputto, BL (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Invest Bioquim Clin & Inmunol, Natl Sci & Tech Res Council,Dept Bioquim Clin, Ciudad Univ, RA-5000 Cordoba, Argentina.	bcaputto@fcq.unc.edu.ar		Castro, Gonzalo Manuel/0000-0002-0984-3835; Motrich, Ruben/0000-0002-5772-1285	Agencia Nacional de Promocion Cientifica y Tecnologica; Fondo para la Investigacion Cientifica y Tecnologica (Ministerio de Ciencia y Technologia); Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Fondo para la Investigacion Cientifica y Tecnologica (Ministerio de Ciencia y Technologia); Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba(Secretaria de Ciencia y Tecnologia (SECYT))	This work was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica, Fondo para la Investigacion Cientifica y Tecnologica (Ministerio de Ciencia y Technologia) and Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Pecchio ARA, 2011, MOL BIOL CELL, V22, P4716, DOI 10.1091/mbc.E11-03-0259; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Basbous J, 2007, MOL CELL BIOL, V27, P3936, DOI 10.1128/MCB.01776-06; Belguise K, 2005, ONCOGENE, V24, P1434, DOI 10.1038/sj.onc.1208312; Borioli GA, 2001, BIOCHEM BIOPH RES CO, V280, P9, DOI 10.1006/bbrc.2000.4081; Bussolino DF, 2001, FASEB J, V15, P556; Bussolino DF, 1998, MOL BRAIN RES, V58, P10, DOI 10.1016/S0169-328X(98)00065-5; Caputto BL, 2000, NEUROCHEM RES, V25, P153, DOI 10.1023/A:1007508020173; Casalino L, 2003, MOL CELL BIOL, V23, P4401, DOI 10.1128/MCB.23.12.4401-4415.2003; Gaggiotti MC, 2009, BIOPOLYMERS, V91, P710, DOI 10.1002/bip.21212; Chiappetta G, 2000, CLIN CANCER RES, V6, P4300; Chiappetta G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-17; Chipuk JE, 2003, CANCER CELL, V4, P371, DOI 10.1016/S1535-6108(03)00272-1; COHEN DR, 1988, MOL CELL BIOL, V8, P2063, DOI 10.1128/MCB.8.5.2063; Crespo PM, 2008, J BIOL CHEM, V283, P31163, DOI 10.1074/jbc.M709257200; Debinski W, 2005, MOL CANCER RES, V3, P237; Debinski W, 2011, CANCER BIOL THER, V11, P254, DOI 10.4161/cbt.11.2.13953; Ferrero GO, 2012, ONCOGENE, V31, P3381, DOI 10.1038/onc.2011.510; Fleischmann A, 2000, GENE DEV, V14, P2695, DOI 10.1101/gad.187900; Garbarino-Pico E, 2005, NEUROCHEM INT, V47, P260, DOI 10.1016/j.neuint.2005.04.024; Gil GA, 2004, MOL BIOL CELL, V15, P1881, DOI 10.1091/mbc.e03-09-0705; Gil GA, 2012, NEUROCHEM RES, V37, P1364, DOI 10.1007/s11064-012-0763-8; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Guido ME, 1996, J NEUROSCI RES, V43, P93, DOI 10.1002/jnr.490430112; KOUZARIDES T, 1989, NATURE, V340, P568, DOI 10.1038/340568a0; Kustikova O, 1998, MOL CELL BIOL, V18, P7095, DOI 10.1128/MCB.18.12.7095; Leppa S, 2001, MOL CELL BIOL, V21, P4369, DOI 10.1128/MCB.21.13.4369-4378.2001; Logullo AF, 2011, HISTOPATHOLOGY, V58, P617, DOI 10.1111/j.1365-2559.2011.03785.x; Ma K, 2009, CANCER INVEST, V27, P353, DOI 10.1080/07357900802254008; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; MORGAN JI, 1995, TRENDS NEUROSCI, V18, P66; Nakajima H, 2007, J ANTIBIOT, V60, P682, DOI 10.1038/ja.2007.87; Philips A, 1998, MOL ENDOCRINOL, V12, P973, DOI 10.1210/me.12.7.973; Portal MM, 2007, ONCOGENE, V26, P3551, DOI 10.1038/sj.onc.1210137; Ramos-Nino ME, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-81; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Silvestre DC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009544; Smith LM, 1999, ONCOGENE, V18, P6063, DOI 10.1038/sj.onc.1202989; Song YH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-298; SUZUKI T, 1991, NUCLEIC ACIDS RES, V19, P5537, DOI 10.1093/nar/19.20.5537; Torgerson TR, 1998, J IMMUNOL, V161, P6084; Usui A, 2012, CANCER-AM CANCER SOC, V118, P3387, DOI 10.1002/cncr.26652; YOSHIOKA K, 1995, P NATL ACAD SCI USA, V92, P4972, DOI 10.1073/pnas.92.11.4972; Young MR, 2006, GENE, V379, P1, DOI 10.1016/j.gene.2006.05.001; Young MR, 2002, MOL CELL BIOL, V22, P587, DOI 10.1128/MCB.22.2.587-598.2002; Zajchowski DA, 2001, CANCER RES, V61, P5168; Zerpa GAD, 1999, J NEUROCHEM, V73, P1228, DOI 10.1046/j.1471-4159.1999.0731228.x; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	49	28	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53211	10.1371/journal.pone.0053211	http://dx.doi.org/10.1371/journal.pone.0053211			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301044	Green Published, Green Submitted, gold			2022-12-25	WOS:000313320900068
J	You, X; Liu, F; Zhang, T; Lv, N; Liu, Q; Shan, C; Du, Y; Kong, G; Wang, T; Ye, L; Zhang, X				You, X.; Liu, F.; Zhang, T.; Lv, N.; Liu, Q.; Shan, C.; Du, Y.; Kong, G.; Wang, T.; Ye, L.; Zhang, X.			Hepatitis B virus X protein upregulates Lin28A/Lin28B through Sp-1/c-Myc to enhance the proliferation of hepatoma cells	ONCOGENE			English	Article						hepatitis B virus X protein; Lin28A; Lin28B; proliferation; hepatocellular carcinoma	C-MYC; PROMOTES TRANSFORMATION; LET-7 MICRORNA; MESSENGER-RNA; EXPRESSION; LIN28; BINDING; GROWTH; IDENTIFICATION; ACTIVATION	Hepatitis B virus X protein (HBx) plays critical roles in the pathogenesis of hepatocellular carcinoma (HCC). Here, we were interested in knowing whether the oncogene Lin28A and its homolog Lin28B are involved in the hepatocarcinogenesis mediated by HBx. We showed that the expression levels of Lin28A and Lin28B were increased in clinical HCC tissues, HepG2.2.15 cell line and liver tissues of p21-HBx transgenic mice. Interestingly, the expression levels of HBx were positively associated with those of Lin28A/Lin28B in clinical HCC tissues. Moreover, the overexpression of HBx resulted in the upregulation of Lin28A/Lin28B in hepatoma HepG2/H7402 cell lines by transient transfection, suggesting that HBx was able to upregulate Lin28A and Lin28B. Then, we examined the mechanism by which HBx upregulated Lin28A and Lin28B. We identified that the promoter region of Lin28A regulated by HBx was located at nt -235/-66 that contained Sp-1 binding element. Co-immunoprecipitation showed that HBx was able to interact with Sp-1 in HepG2-X cells. Moreover, chromatin immunoprecipitation (ChIP) demonstrated that HBx could bind to the promoter of Lin28A, which failed to work when Sp-1 was silenced. Electrophoretic mobility shift assay (EMSA) further identified that HBx was able to interact with Sp-1 element in Lin28A promoter via transcription factor Sp-1. In addition, we found that c-Myc was involved in the activation of Lin28B mediated by HBx. In function, Lin28A/Lin28B played important roles in HBx-enhanced proliferation of hepatoma cells in vitro and in vivo. In conclusion, HBx activates Lin28A/Lin28B through Sp-1/c-Myc in hepatoma cells. Lin28A/Lin28B serves as key driver genes in HBx-induced hepatocarcinogenesis.	[You, X.; Zhang, T.; Lv, N.; Shan, C.; Du, Y.; Kong, G.; Wang, T.; Zhang, X.] Nankai Univ, Coll Life Sci, Key Lab Mol Microbiol & Technol, Minist Educ,Dept Canc Res, Tianjin 300071, Peoples R China; [Liu, F.; Liu, Q.; Ye, L.] Nankai Univ, Coll Life Sci, Dept Biochem, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Zhang, X (corresponding author), Nankai Univ, Coll Life Sci, Key Lab Mol Microbiol & Technol, Inst Mol Biol,Minist Educ,Dept Canc Res, 94 Weijin Rd, Tianjin 300071, Peoples R China.	yelihong@nankai.edu.cn; zhangxd@nankai.edu.cn	Zhang, Tao/F-4366-2018; Shan, changliang/L-9029-2016	Zhang, Tao/0000-0002-4749-6774; You, Xiaona/0000-0001-9996-1466	National Basic Research Program of China (973 Program) [2009CB521702]; National Natural Science Foundation of China [81071624, 81272218]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Dr Xiao Yang (from the Genetic Laboratory of Development and Diseases, Institute of Biotechnology, Beijing, People's Republic of China) for kindly providing the HBx transgenic mice. This work was supported in part by National Basic Research Program of China (973 Program, No. 2009CB521702) and National Natural Science Foundation of China (No. 81071624, 81272218).	Abdelrahim M, 2004, CANCER RES, V64, P6740, DOI 10.1158/0008-5472.CAN-04-0713; Ali N, 2011, J VIROL, V85, P12292, DOI 10.1128/JVI.05920-11; Arbuthnot P, 2001, INT J EXP PATHOL, V82, P77, DOI 10.1111/j.1365-2613.2001.iep178.x; Arzumanyan A, 2011, CANCER RES, V71, P3701, DOI 10.1158/0008-5472.CAN-10-3951; Cao DF, 2011, HUM PATHOL, V42, P710, DOI 10.1016/j.humpath.2010.09.007; Carmona S, 2006, MOL THER, V13, P411, DOI 10.1016/j.ymthe.2005.10.013; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Du YM, 2012, J BIOL CHEM, V287, P26302, DOI 10.1074/jbc.M112.342113; Fang H, 2005, MOL BRAIN RES, V136, P1, DOI 10.1016/j.molbrainres.2004.12.024; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Hamano R, 2012, BRIT J CANCER, V106, P1415, DOI 10.1038/bjc.2012.90; Helland A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018064; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; King CE, 2011, ONCOGENE, V30, P4185, DOI 10.1038/onc.2011.131; King CE, 2011, CANCER RES, V71, P4260, DOI 10.1158/0008-5472.CAN-10-4637; Kong GY, 2011, ACTA PHARMACOL SIN, V32, P1173, DOI 10.1038/aps.2011.52; Kong GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019518; Li L, 2012, HEPATOLOGY, V56, P1380, DOI 10.1002/hep.25891; Li WH, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-45; Liang LH, 2010, HEPATOLOGY, V52, P1731, DOI 10.1002/hep.23904; Liu QY, 2011, J BIOL CHEM, V286, P17168, DOI 10.1074/jbc.M110.167783; Michielsen P, 2011, ACTA GASTRO-ENT BELG, V74, P4; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Ng SA, 2011, J GASTROENTEROL, V46, P974, DOI 10.1007/s00535-011-0415-9; Pan L, 2011, MOL CELL BIOCHEM, V355, P257, DOI 10.1007/s11010-011-0862-x; Peng S, 2010, ONCOGENE, V29, P2153, DOI 10.1038/onc.2009.500; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; QADRI I, 1995, P NATL ACAD SCI USA, V92, P1003, DOI 10.1073/pnas.92.4.1003; Qiu CH, 2010, NUCLEIC ACIDS RES, V38, P1240, DOI 10.1093/nar/gkp1071; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Sakurai M, 2012, J STEROID BIOCHEM, V131, P101, DOI 10.1016/j.jsbmb.2011.10.007; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shan CL, 2011, CARCINOGENESIS, V32, P1190, DOI 10.1093/carcin/bgr106; Shan CL, 2010, CELL RES, V20, P563, DOI 10.1038/cr.2010.49; Shona JK, 2009, VIRUS RES, V139, P14, DOI 10.1016/j.virusres.2008.09.006; Sze KMF, 2011, HEPATOLOGY, V53, P1558, DOI 10.1002/hep.24232; Tang H, 2006, CANCER SCI, V97, P977, DOI 10.1111/j.1349-7006.2006.00299.x; Tang H, 2009, HEPATOLOGY, V49, P60, DOI 10.1002/hep.22581; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang Q, 2010, NEOPLASIA, V12, P103, DOI 10.1593/neo.91298; Wang YL, 2004, HEPATOLOGY, V39, P318, DOI 10.1002/hep.20076; Wang YC, 2010, CARCINOGENESIS, V31, P1516, DOI 10.1093/carcin/bgq107; Wu HY, 2011, J AGR FOOD CHEM, V59, P1713, DOI 10.1021/jf1045624; Xu BS, 2009, NUCLEIC ACIDS RES, V37, P4256, DOI 10.1093/nar/gkp372; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang T, 2012, HEPATOLOGY, V56, P2051, DOI 10.1002/hep.25899; Zhang XD, 2005, J MED VIROL, V77, P374, DOI 10.1002/jmv.20466; Zhang XD, 2005, J LAB CLIN MED, V145, P98, DOI 10.1016/j.lab.2004.11.018	52	48	50	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 23	2014	33	4					449	460		10.1038/onc.2012.618	http://dx.doi.org/10.1038/onc.2012.618			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	296VX	23318446				2022-12-25	WOS:000330214600006
J	Ammoun, S; Provenzano, L; Zhou, L; Barczyk, M; Evans, K; Hilton, DA; Hafizi, S; Hanemann, CO				Ammoun, S.; Provenzano, L.; Zhou, L.; Barczyk, M.; Evans, K.; Hilton, D. A.; Hafizi, S.; Hanemann, C. O.			Axl/Gas6/NF kappa B signalling in schwannoma pathological proliferation, adhesion and survival	ONCOGENE			English	Article						Gas6/Axl; NF kappa B; merlin; proliferation/adhesion/survival; schwannoma	RECEPTOR TYROSINE KINASE; NF-KAPPA-B; UBIQUITIN LIGASE CRL4(DCAF1); GROWTH-FACTOR; UP-REGULATION; SOLUBLE FORM; ACTIVATION; EXPRESSION; CELLS; MERLIN	TAM family receptor tyrosine kinases comprising Tyro3 (Sky), Axl, and Mer are overexpressed in some cancers, correlate with multidrug resistance and contribute to tumourigenesis by regulating invasion, angiogenesis, cell survival and tumour growth. Mutations in the gene coding for a tumour suppressor merlin cause development of multiple tumours of the nervous system such as schwannomas, meningiomas and ependymomas occurring spontaneously or as part of a hereditary disease neurofibromatosis type 2. The benign character of merlin-deficient tumours makes them less responsive to chemotherapy. We previously showed that, amongst other growth factor receptors, TAM family receptors (Tyro3, Axl and Mer) are significantly overexpressed in schwannoma tissues. As Axl is negatively regulated by merlin and positively regulated by E3 ubiquitin ligase CRL4DCAF1, previously shown to be a key regulator in schwannoma growth we hypothesized that Axl is a good target to study in merlin-deficient tumours. Moreover, Axl positively regulates the oncogene Yes-associated protein, which is known to be under merlin regulation in schwannoma and is involved in increased proliferation of merlin-deficient meningioma and mesothelioma. Here, we demonstrated strong overexpression and activation of Axl receptor as well as its ligand Gas6 in human schwannoma primary cells compared to normal Schwann cells. We show that Gas6 is mitogenic and increases schwannoma cell-matrix adhesion and survival acting via Axl in schwannoma cells. Stimulation of the Gas6/Axl signalling pathway recruits Src, focal adhesion kinase (FAK) and NFkB. We showed that NFkB mediates Gas6/Axl-mediated overexpression of survivin, cyclin D1 and FAK, leading to enhanced survival, cell-matrix adhesion and proliferation of schwannoma. We conclude that Axl/FAK/Src/NF kappa B pathway is relevant in merlin-deficient tumours and is a potential therapeutic target for schwannoma and other merlin-deficient tumours.	[Ammoun, S.; Provenzano, L.; Zhou, L.; Barczyk, M.; Evans, K.; Hanemann, C. O.] Univ Plymouth, Inst Translat & Stratified Med, Peninsula Sch Med, Plymouth PL68BU, Devon, England; [Ammoun, S.; Provenzano, L.; Zhou, L.; Barczyk, M.; Evans, K.; Hanemann, C. O.] Univ Plymouth, Inst Translat & Stratified Med, Peninsula Sch Dent, Plymouth PL68BU, Devon, England; [Hilton, D. A.] Derriford Hosp, Dept Histopathol, Plymouth PL6 8DH, Devon, England; [Hafizi, S.] Univ Portsmouth, IBBS, Div Pharmacol, Portsmouth, Hants, England	University of Plymouth; University of Plymouth; Derriford Hospital; University of Portsmouth	Ammoun, S (corresponding author), Univ Plymouth, Inst Translat & Stratified Med, Peninsula Sch Med, John Bull Bldg,Tamar Sci Pk,Res Way, Plymouth PL68BU, Devon, England.	sylwia.ammoun@pms.ac.uk	Hafizi, Sassan/W-4424-2019; Hanemann, C Oliver/AAV-6257-2020	Hafizi, Sassan/0000-0002-4539-0888; Hanemann, C Oliver/0000-0002-1951-1025	Children tumour foundation	Children tumour foundation	Work was supported by the Children tumour foundation and Dr Hadwen Trust support. We thank Dr Federiko Roncoroli for providing human tissues and Leanne Turner for technical assistance.	Ammoun S, 2012, ONCOGENE, V31, P1710, DOI 10.1038/onc.2011.357; Ammoun S, 2008, CANCER RES, V68, P5236, DOI 10.1158/0008-5472.CAN-07-5849; Ammoun S, 2012, GLIA, V60, P1721, DOI 10.1002/glia.22391; Ammoun S, 2011, NAT REV NEUROL, V7, P392, DOI 10.1038/nrneurol.2011.82; Ammoun S, 2011, NEURO-ONCOLOGY, V13, P759, DOI 10.1093/neuonc/nor056; Ammoun S, 2010, NEURO-ONCOLOGY, V12, P834, DOI 10.1093/neuonc/noq012; Ammoun S, 2010, NEUROBIOL DIS, V37, P141, DOI 10.1016/j.nbd.2009.09.017; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Boyle K, 2005, NEUROBIOL DIS, V20, P412, DOI 10.1016/j.nbd.2005.03.022; Burchert A, 1998, ONCOGENE, V16, P3177, DOI 10.1038/sj.onc.1201865; Cooper J, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002314; Costa M, 1996, J CELL PHYSIOL, V168, P737, DOI 10.1002/(SICI)1097-4652(199609)168:3<737::AID-JCP27>3.0.CO;2-U; Demarchi F, 2001, J BIOL CHEM, V276, P31738, DOI 10.1074/jbc.M104457200; Du J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015940; Flaiz C, 2009, EXP NEUROL, V218, P137, DOI 10.1016/j.expneurol.2009.04.019; Georgakis GV, 2006, EXP HEMATOL, V34, P1670, DOI 10.1016/j.exphem.2006.07.002; Hafizi S, 2006, CYTOKINE GROWTH F R, V17, P295, DOI 10.1016/j.cytogfr.2006.04.004; Hanemann CO, 2006, NEUROPATH APPL NEURO, V32, P605, DOI 10.1111/j.1365-2990.2006.00769.x; Hanemann CO, 1997, ACTA NEUROPATHOL, V94, P310, DOI 10.1007/s004010050712; Hilton DA, 2009, HISTOPATHOLOGY, V55, P744, DOI 10.1111/j.1365-2559.2009.03440.x; Kaempchen K, 2003, HUM MOL GENET, V12, P1211, DOI 10.1093/hmg/ddg146; Kim H, 2002, MOL CELLS, V14, P108; Kim JY, 2002, BIOCHEM BIOPH RES CO, V296, P1295, DOI 10.1016/S0006-291X(02)02077-6; Kim RJ, 2010, CANCER LETT, V287, P172, DOI 10.1016/j.canlet.2009.06.010; Klein EA, 2007, CELL CYCLE, V6, P1115, DOI 10.4161/cc.6.9.4147; Lee H, 2007, MOL CELL BIOL, V27, P2103, DOI 10.1128/MCB.00572-06; LERNER EC, 1995, J BIOL CHEM, V270, P26802, DOI 10.1074/jbc.270.45.26802; Li RH, 1996, J NEUROSCI, V16, P2012; Li W, 2010, CELL, V140, P477, DOI 10.1016/j.cell.2010.01.029; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Liu WG, 2008, CARCINOGENESIS, V29, P1096, DOI 10.1093/carcin/bgn026; Lu Q, 1999, J CELL BIOL, V144, P519, DOI 10.1083/jcb.144.3.519; Mahadevan D, 2007, ONCOGENE, V26, P3909, DOI 10.1038/sj.onc.1210173; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Ou WB, 2011, ONCOGENE, V30, P1643, DOI 10.1038/onc.2010.555; Rexhepaj R, 2010, CELL PHYSIOL BIOCHEM, V25, P715, DOI 10.1159/000315091; Rosenbaum C, 1998, NEUROBIOL DIS, V5, P55, DOI 10.1006/nbdi.1998.0179; Rosenbaum C, 2000, NEUROBIOL DIS, V7, P483, DOI 10.1006/nbdi.2000.0307; Sakai H, 2010, PEPTIDES, V31, P2216, DOI 10.1016/j.peptides.2010.09.012; Sather S, 2007, BLOOD, V109, P1026, DOI 10.1182/blood-2006-05-021634; Sayan AE, 2012, ONCOGENE, V31, P1493, DOI 10.1038/onc.2011.336; Shiozawa Y, 2010, NEOPLASIA, V12, P116, DOI 10.1593/neo.91384; Stenhoff J, 2004, BIOCHEM BIOPH RES CO, V319, P871, DOI 10.1016/j.bbrc.2004.05.070; Taylor ICA, 1995, ONCOGENE, V11, P2619; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Utermark T, 2005, BRAIN PATHOL, V15, P17; Utermark T, 2003, BRAIN PATHOL, V13, P352; Valverde P, 2005, BIOCHEM BIOPH RES CO, V333, P180, DOI 10.1016/j.bbrc.2005.05.086; Wickremesekera A, 2007, J CLIN NEUROSCI, V14, P1199, DOI 10.1016/j.jocn.2007.05.009; Wu CW, 2002, ANTICANCER RES, V22, P1071; Xiao GH, 2005, MOL CELL BIOL, V25, P2384, DOI 10.1128/MCB.25.6.2384-2394.2005; Yi CL, 2010, GENE DEV, V24, P1673, DOI 10.1101/gad.1964810; Zhao YF, 2012, CANCER INVEST, V30, P287, DOI 10.3109/07357907.2012.657816; Zhou L, 2011, NEOPLASIA, V13, P1101, DOI 10.1593/neo.111060	54	63	65	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 16	2014	33	3					336	346		10.1038/onc.2012.587	http://dx.doi.org/10.1038/onc.2012.587			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	296VR	23318455	Green Published			2022-12-25	WOS:000330214000008
J	Jastrzebska, B; Orban, T; Golczak, M; Engel, A; Palczewski, K				Jastrzebska, Beata; Orban, Tivadar; Golczak, Marcin; Engel, Andreas; Palczewski, Krzysztof			Asymmetry of the rhodopsin dimer in complex with transducin	FASEB JOURNAL			English	Article						G-protein-coupled receptor; heterotrimeric G protein; retinoids; retinal isomerization; membrane protein	PROTEIN-COUPLED RECEPTOR; CRYSTAL-STRUCTURE; VISUAL CYCLE; ACTIVATION; OPSIN; SITE; HETERODIMERIZATION; INTERMEDIATE; DYNAMICS; ARRESTIN	A large body of evidence for G-protein-coupled receptor (GPCR) oligomerization has accumulated over the past 2 decades. The smallest of these oligomers in vivo most likely is a dimer that buries 1000-angstrom(2) intramolecular surfaces and on stimulation forms a complex with heterotrimeric G protein in 2:1 stoichiometry. However, it is unclear whether each of the monomers adopts the same or a different conformation and function after activation of this dimer. With bovine rhodopsin (Rho) and its cognate bovine G-protein transducin (G(t)) as a model system, we used the retinoid chromophores 11-cis-retinal and 9-cis-retinal to monitor each monomer of the dimeric GPCR within a stable complex with nucleotide-free Gt. We found that only 50% of Rho* in the Rho*-G(t) complex is trapped in a Meta II conformation, while 50% evolves toward an opsin conformation and can be regenerated with 9-cis-retinal. We also found that all-trans-retinal can regenerate chromophore-depleted Rho* e complexed with Gt and FAK*TSA peptide containing Lys(296) with the attached all-trans retinoid (m/z of 934.5[MH](+)) was identified by mass spectrometry. Thus, our study shows that each of the monomers contributes unequally to the pentameric (2:1:1:1) complex of Rho dimer and Gt heterotrimer, validating the oligomeric structure of the complex and the asymmetry of the GPCR dimer, and revealing its structural/functional signature. This study provides a clear functional distinction between monomers of family A GPCRs in their oligomeric form.-Jastrzebska, B., Orban, T., Golczak, M., Engel, A., Palczewski, K. Asymmetry of the rhodopsin dimer in complex with transducin. FASEB J. 27, 1572-1584 (2013). www.fasebj.org	[Jastrzebska, Beata; Orban, Tivadar; Golczak, Marcin; Engel, Andreas; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University	Jastrzebska, B (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	bxj27@case.edu; kxp65@case.edu			U.S. National Institutes of Health [EY008061, EY019478]; NATIONAL EYE INSTITUTE [R01EY019478, R29EY008061, R01EY008061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094598] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Leslie T. Webster, Jr. and members of the K. P. laboratory for helpful comments on this manuscript. This work was supported by U.S. National Institutes of Health grants EY008061 and EY019478. K. P. is John Hord Professor of Pharmacology.	ARGOS P, 1982, EUR J BIOCHEM, V128, P565; Baldwin JM, 1997, J MOL BIOL, V272, P144, DOI 10.1006/jmbi.1997.1240; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; BORNANCIN F, 1989, EUR J BIOCHEM, V184, P687, DOI 10.1111/j.1432-1033.1989.tb15068.x; BOWNDS D, 1965, NATURE, V205, P254, DOI 10.1038/205254a0; BOWNDS D, 1967, NATURE, V216, P1178, DOI 10.1038/2161178a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Damian M, 2006, EMBO J, V25, P5693, DOI 10.1038/sj.emboj.7601449; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Fanelli F, 2008, FEBS LETT, V582, P991, DOI 10.1016/j.febslet.2008.02.041; Filipek S, 2004, PHOTOCH PHOTOBIO SCI, V3, P628, DOI 10.1039/b315661c; Filizola M, 2006, J COMPUT AID MOL DES, V20, P405, DOI 10.1007/s10822-006-9053-3; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Garwin GG, 2000, METHOD ENZYMOL, V316, P313; Goc A, 2008, BIOCHEMISTRY-US, V47, P12409, DOI 10.1021/bi8015444; Granzin J, 1998, NATURE, V391, P918, DOI 10.1038/36147; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Heck M, 2003, VISION RES, V43, P3003, DOI 10.1016/j.visres.2003.08.011; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Ianoul A, 2005, NAT CHEM BIOL, V1, P196, DOI 10.1038/nchembio726; Jastrzebska B, 2011, J STRUCT BIOL, V176, P387, DOI 10.1016/j.jsb.2011.08.016; Jastrzebska B, 2011, J BIOL CHEM, V286, P18930, DOI 10.1074/jbc.M111.234583; Jastrzebska B, 2009, FASEB J, V23, P371, DOI 10.1096/fj.07-114835; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; KITO Y, 1968, NATURE, V218, P955, DOI 10.1038/218955a0; Kniazeff J, 2011, PHARMACOL THERAPEUT, V130, P9, DOI 10.1016/j.pharmthera.2011.01.006; Krebs A, 1998, J MOL BIOL, V282, P991, DOI 10.1006/jmbi.1998.2070; KROPF A, 1970, PHOTOCHEM PHOTOBIOL, V12, P249, DOI 10.1111/j.1751-1097.1970.tb06057.x; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lambert NA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115pe12; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Lebon G, 2012, CURR OPIN STRUC BIOL, V22, P482, DOI 10.1016/j.sbi.2012.03.007; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Lodowski DT, 2006, J BIOL CHEM, V281, P16785, DOI 10.1074/jbc.M601327200; MATTHEWS RG, 1963, J GEN PHYSIOL, V47, P215, DOI 10.1085/jgp.47.2.215; Maurice P, 2011, TRENDS PHARMACOL SCI, V32, P514, DOI 10.1016/j.tips.2011.05.006; Modzelewska A, 2006, CELL BIOCHEM BIOPHYS, V46, P1, DOI 10.1385/CBB:46:1:1; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Nakamichi H, 2006, P NATL ACAD SCI USA, V103, P12729, DOI 10.1073/pnas.0601765103; Neri M, 2010, BIOCHEMISTRY-US, V49, P4827, DOI 10.1021/bi100478j; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; Okada Tetsuji, 2006, P243; Orban T, 2012, STRUCTURE, V20, P826, DOI 10.1016/j.str.2012.03.017; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Palczewski K, 2010, TRENDS BIOCHEM SCI, V35, P595, DOI 10.1016/j.tibs.2010.05.002; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Park PSH, 2008, ANNU REV PHARMACOL, V48, P107, DOI 10.1146/annurev.pharmtox.48.113006.094630; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rivero-Muller A, 2010, P NATL ACAD SCI USA, V107, P2319, DOI 10.1073/pnas.0906695106; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Singh P, 2008, J BIOL CHEM, V283, P14053, DOI 10.1074/jbc.M708974200; SPALINK JD, 1983, P NATL ACAD SCI-BIOL, V80, P1887, DOI 10.1073/pnas.80.7.1887; SURYA A, 1995, J BIOL CHEM, V270, P5024, DOI 10.1074/jbc.270.10.5024; Tateyama M, 2004, NAT STRUCT MOL BIOL, V11, P637, DOI 10.1038/nsmb770; Unger VM, 1997, NATURE, V389, P203, DOI 10.1038/38316; Vahedi-Faridi A, 2013, MICROSCOPY-JPN, V62, P95, DOI 10.1093/jmicro/dfs091; Van Hooser JP, 2000, METHOD ENZYMOL, V316, P565; WALD G, 1953, J GEN PHYSIOL, V37, P189, DOI 10.1085/jgp.37.2.189; WALD G, 1957, NATURE, V180, P278, DOI 10.1038/180278a0; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Zhang N, 2013, J CLIN INVEST, V123, P121, DOI 10.1172/JCI66176	71	54	57	0	30	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2013	27	4					1572	1584		10.1096/fj.12-225383	http://dx.doi.org/10.1096/fj.12-225383			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23303210	Green Published			2022-12-25	WOS:000316940800028
J	Banks, SC; Lindenmayer, DB; Wood, JT; McBurney, L; Blair, D; Blyton, MDJ				Banks, Sam C.; Lindenmayer, David B.; Wood, Jeff T.; McBurney, Lachlan; Blair, David; Blyton, Michaela D. J.			Can Individual and Social Patterns of Resource Use Buffer Animal Populations against Resource Decline?	PLOS ONE			English	Article							MOUNTAIN BRUSHTAIL POSSUM; DEER HABITAT SELECTION; SOUTHEASTERN AUSTRALIA; ARBOREAL MARSUPIALS; FUNCTIONAL-RESPONSES; BEHAVIORAL-RESPONSES; ENVIRONMENTAL-CHANGE; TERRITORY QUALITY; REGIME SHIFTS; FORESTS	Species in many ecosystems are facing declines of key resources. If we are to understand and predict the effects of resource loss on natural populations, we need to understand whether and how the way animals use resources changes under resource decline. We investigated how the abundance of arboreal marsupials varies in response to a critical resource, hollow-bearing trees. Principally, we asked what mechanisms mediate the relationship between resources and abundance? Do animals use a greater or smaller proportion of the remaining resource, and is there a change in cooperative resource use (den sharing), as the availability of hollow trees declines? Analyses of data from 160 sites surveyed from 1997 to 2007 showed that hollow tree availability was positively associated with abundance of the mountain brushtail possum, the agile antechinus and the greater glider. The abundance of Leadbeater's possum was primarily influenced by forest age. Notably, the relationship between abundance and hollow tree availability was significantly less than 1: 1 for all species. This was due primarily to a significant increase by all species in the proportional use of hollow-bearing trees where the abundance of this resource was low. The resource-sharing response was weaker and inconsistent among species. Two species, the mountain brushtail possum and the agile antechinus, showed significant but contrasting relationships between the number of animals per occupied tree and hollow tree abundance. The discrepancies between the species can be explained partly by differences in several aspects of the species' biology, including body size, types of hollows used and social behaviour as it relates to hollow use. Our results show that individual and social aspects of resource use are not always static in response to resource availability and support the need to account for dynamic resource use patterns in predictive models of animal distribution and abundance.	[Banks, Sam C.; Lindenmayer, David B.; Wood, Jeff T.; McBurney, Lachlan; Blair, David; Blyton, Michaela D. J.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia	Australian National University	Banks, SC (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia.	Banks@anu.edu.au	Blyton, Michaela/ABA-4463-2021; Lindenmayer, David B/P-7183-2017; Banks, Sam/K-4907-2012	Lindenmayer, David B/0000-0002-4766-4088; Banks, Sam/0000-0003-2415-0057	Hermon Slade Foundation [HSF 08-4]; Australian Research Council; APD fellowship [ARC DP 0984876]	Hermon Slade Foundation; Australian Research Council(Australian Research Council); APD fellowship	This research was supported by grants from the Hermon Slade Foundation (HSF 08-4; www.hermonslade.org.au) and the Australian Research Council (www.arc.gov.au), including an APD fellowship to Sam Banks (ARC DP 0984876). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MA, 1984, AUST J BOT, V32, P205, DOI 10.1071/BT9840205; Aitken KEH, 2008, ECOLOGY, V89, P971, DOI 10.1890/07-0711.1; Banks SC, 2007, CAN J ZOOL, V85, P1065, DOI 10.1139/Z07-094; Banks SC, 2012, MOL ECOL, V21, P673, DOI 10.1111/j.1365-294X.2011.05282.x; Banks SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022952; Banks SC, 2011, P ROY SOC B-BIOL SCI, V278, P2768, DOI 10.1098/rspb.2010.2657; Berger-Tal O, 2011, BEHAV ECOL, V22, P236, DOI 10.1093/beheco/arq224; Beyer HL, 2010, PHILOS T R SOC B, V365, P2245, DOI 10.1098/rstb.2010.0083; Bjorneraas K, 2012, OECOLOGIA, V168, P231, DOI 10.1007/s00442-011-2072-3; Boyce MS, 1999, TRENDS ECOL EVOL, V14, P268, DOI 10.1016/S0169-5347(99)01593-1; Brown J. L., 1964, Wilson Bulletin, V76, P160; Dubois FD, 2005, ECOLOGY, V86, P3, DOI 10.1890/04-0566; Elton C. S., 1927, ANIMAL ECOLOGY; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Fisher DO, 2011, BEHAV ECOL SOCIOBIOL, V65, P593, DOI 10.1007/s00265-010-1060-7; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Franklin JF, 2011, P NATL ACAD SCI USA, V108, P16863, DOI 10.1073/pnas.1114045108; Gibbons P, 2002, BIOL CONSERV, V103, P1, DOI 10.1016/S0006-3207(01)00109-4; Gibbons PL, 2011, AUSTR MAMMALOGY; Godvik IMR, 2009, ECOLOGY, V90, P699, DOI 10.1890/08-0576.1; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hebblewhite M, 2008, J APPL ECOL, V45, P834, DOI 10.1111/j.1365-2664.2008.01466.x; HUGHES JJ, 1994, ECOLOGY, V75, P1397, DOI 10.2307/1937463; Johnson CJ, 2004, J APPL ECOL, V41, P238, DOI 10.1111/j.0021-8901.2004.00899.x; Jones J, 2001, ECOLOGY, V82, P2628, DOI 10.1890/0012-9658(2001)082[2628:ATEOND]2.0.CO;2; KOMDEUR J, 1992, NATURE, V358, P493, DOI 10.1038/358493a0; Lindenmayer DB, 2011, ECOL MONOGR, V81, P557, DOI 10.1890/11-0279.1; Lindenmayer DB, 2006, BIODIVERS CONSERV, V15, P4079, DOI 10.1007/s10531-005-3367-7; Lindenmayer DB, 2011, P NATL ACAD SCI USA, V108, P15887, DOI 10.1073/pnas.1110245108; Lindenmayer DB, 2010, CAN J FOREST RES, V40, P48, DOI 10.1139/X09-185; Lindenmayer DB, 1997, J MAMMAL, V78, P1117, DOI 10.2307/1383054; Lindenmayer DB, 1996, WILDLIFE RES, V23, P343, DOI 10.1071/WR9960343; LINDENMAYER DB, 1990, AUST WILDLIFE RES, V17, P467, DOI 10.1071/WR9900467; Lindenmayer DB, 1997, ECOL APPL, V7, P625, DOI 10.1890/1051-0761(1997)007[0625:DACOTW]2.0.CO;2; LINDENMAYER DB, 1993, FOREST ECOL MANAG, V60, P77, DOI 10.1016/0378-1127(93)90024-H; Lindenmayer DB, 2000, FOREST ECOL MANAG, V134, P189, DOI 10.1016/S0378-1127(99)00257-1; Matthiopoulos J, 2011, ECOLOGY, V92, P583, DOI 10.1890/10-0751.1; McLoughlin PD, 2010, J ANIM ECOL, V79, P4, DOI 10.1111/j.1365-2656.2009.01613.x; Morellet N, 2011, LANDSCAPE ECOL, V26, P999, DOI 10.1007/s10980-011-9624-0; Morris DW, 2011, P ROY SOC B-BIOL SCI, V278, P2401, DOI 10.1098/rspb.2011.0604; Mysterud A, 1998, ECOLOGY, V79, P1435, DOI 10.1890/0012-9658(1998)079[1435:FRIHUA]2.0.CO;2; NEWTON I, 1994, BIOL CONSERV, V70, P265, DOI 10.1016/0006-3207(94)90172-4; Osko TJ, 2004, J WILDLIFE MANAGE, V68, P576, DOI 10.2193/0022-541X(2004)068[0576:MHPIRT]2.0.CO;2; Payne R.W., 2008, GENSTAT FOR WINDOWS; Sih A, 2011, EVOL APPL, V4, P367, DOI 10.1111/j.1752-4571.2010.00166.x; STACEY PB, 1991, AM NAT, V137, P831, DOI 10.1086/285196; Tuomainen U, 2011, BIOL REV, V86, P640, DOI 10.1111/j.1469-185X.2010.00164.x; Wagner T, 2011, J WILDLIFE MANAGE, V75, P1788, DOI 10.1002/jwmg.212; Wauters LA, 2005, EVOL ECOL, V19, P375, DOI 10.1007/s10682-005-8311-5; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004	50	10	11	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53672	10.1371/journal.pone.0053672	http://dx.doi.org/10.1371/journal.pone.0053672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320100	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429800065
J	Kolaj-Robin, O; Noor, MR; O'Kane, SR; Baymann, F; Soulimane, T				Kolaj-Robin, Olga; Noor, Mohamed R.; O'Kane, Sarah R.; Baymann, Frauke; Soulimane, Tewfik			Atypical Features of Thermus thermophilus Succinate: Quinone Reductase	PLOS ONE			English	Article							COLI FUMARATE REDUCTASE; PHOSPHORYLATIVE ELECTRON-TRANSPORT; BACILLUS-SUBTILIS SUCCINATE; MEMBRANE-PROTEIN COMPLEX; ESCHERICHIA-COLI; RESPIRATORY-CHAIN; MENAQUINONE OXIDOREDUCTASE; CRYSTAL-STRUCTURE; CYTOCHROME-B; DEHYDROGENASE	The Thermus thermophilus succinate: quinone reductase (SQR), serving as the respiratory complex II, has been homologously produced under the control of a constitutive promoter and subsequently purified. The detailed biochemical characterization of the resulting wild type (wt-rcII) and His-tagged (rcII-His(8)-SdhB and rcII-SdhB-His(6)) complex II variants showed the same properties as the native enzyme with respect to the subunit composition, redox cofactor content and sensitivity to the inhibitors malonate, oxaloacetate, 3-nitropropionic acid and nonyl-4-hydroxyquinoline-N-oxide (NQNO). The position of the His-tag determined whether the enzyme retained its native trimeric conformation or whether it was present in a monomeric form. Only the trimer exhibited positive cooperativity at high temperatures. The EPR signal of the [2Fe-2S] cluster was sensitive to the presence of substrate and showed an increased rhombicity in the presence of succinate in the native and in all recombinant forms of the enzyme. The detailed analysis of the shape of this signal as a function of pH, substrate concentration and in the presence of various inhibitors and quinones is presented, leading to a model for the molecular mechanism that underlies the influence of succinate on the rhombicity of the EPR signal of the proximal iron-sulfur cluster.	[Kolaj-Robin, Olga; Noor, Mohamed R.; O'Kane, Sarah R.; Soulimane, Tewfik] Univ Limerick, Chem & Environm Sci Dept, Limerick, Ireland; [Kolaj-Robin, Olga; Noor, Mohamed R.; O'Kane, Sarah R.; Soulimane, Tewfik] Univ Limerick, Mat & Surface Sci Inst, Limerick, Ireland; [Baymann, Frauke] AMU, UMR7281, BIP CNRS, Lab Bioenerget & Ingn Prot, Marseille, France	University of Limerick; University of Limerick; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Baymann, F (corresponding author), AMU, UMR7281, BIP CNRS, Lab Bioenerget & Ingn Prot, Marseille, France.	baymann@imm.cnrs.fr; tewfik.soulimane@ul.ie			Science Foundation Ireland [BICF685]; Irish Research Council for Science, Engineering and Technology; French National Center for Scientific Research (CNRS)	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR); French National Center for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the Science Foundation Ireland (BICF685), by the Irish Research Council for Science, Engineering and Technology EMBARK Ulysses Research Visit to France 2009 grants (to TS) and PhD Scholarship (to MN) and by the French National Center for Scientific Research (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKRELL BAC, 1989, ARCH BIOCHEM BIOPHYS, V268, P26, DOI 10.1016/0003-9861(89)90561-4; Azarkina N, 2002, J BACTERIOL, V184, P5339, DOI 10.1128/JB.184.19.5339-5347.2002; BEINERT H, 1975, EUR J BIOCHEM, V54, P185, DOI 10.1111/j.1432-1033.1975.tb04128.x; Christenson A, 2008, BBA-BIOENERGETICS, V1777, P1203, DOI 10.1016/j.bbabio.2008.05.450; Darke PL, 1996, J BIOL CHEM, V271, P7445, DOI 10.1074/jbc.271.13.7445; Gambarelli S, 2004, INORG CHEM, V43, P1441, DOI 10.1021/ic0301167; Grisshammer Reinhard, 2005, Journal of Structural and Functional Genomics, V6, P159, DOI 10.1007/s10969-005-1917-6; GUEST JR, 1981, J GEN MICROBIOL, V122, P171; HAGERHALL C, 1995, BIOCHEMISTRY-US, V34, P11080; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; Hederstedt L, 2002, BBA-BIOENERGETICS, V1553, P74, DOI 10.1016/S0005-2728(01)00231-6; Huang LS, 2006, J BIOL CHEM, V281, P5965, DOI 10.1074/jbc.M511270200; Iverson TM, 1999, SCIENCE, V284, P1961, DOI 10.1126/science.284.5422.1961; Kolaj-Robin O, 2011, BBA-BIOENERGETICS, V1807, P68, DOI 10.1016/j.bbabio.2010.10.009; KOTLYAR AB, 1984, BIOCHIM BIOPHYS ACTA, V784, P24, DOI 10.1016/0167-4838(84)90168-7; KROGER A, 1978, BIOCHIM BIOPHYS ACTA, V505, P129, DOI 10.1016/0304-4173(78)90010-1; KROGER A, 1992, ARCH MICROBIOL, V158, P311, DOI 10.1007/BF00245358; Kurokawa T, 2005, ARCH MICROBIOL, V183, P317, DOI 10.1007/s00203-005-0775-8; Lancaster CRD, 1999, NATURE, V402, P377, DOI 10.1038/46483; LAZAZZERA BA, 1993, GENE DEV, V7, P1993, DOI 10.1101/gad.7.10.1993; Luke KA, 2007, FEBS J, V274, P4023, DOI 10.1111/j.1742-4658.2007.05955.x; Madej MG, 2006, EMBO J, V25, P4963, DOI 10.1038/sj.emboj.7601361; Maklashina E, 1998, J BACTERIOL, V180, P5989, DOI 10.1128/JB.180.22.5989-5996.1998; Matsson M, 2000, BIOCHEMISTRY-US, V39, P8617, DOI 10.1021/bi000271m; Mohanty AK, 2004, PROTEIN EXPRES PURIF, V33, P311, DOI 10.1016/j.pep.2003.10.010; Mooser D, 2005, BBA-BIOENERGETICS, V1708, P262, DOI 10.1016/j.bbabio.2005.03.008; PETERSON J, 1992, J LIPID RES, V33, P1165; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Shimizu H, 2012, J BIOCHEM, V151, P589, DOI 10.1093/jb/mvs051; SMIRNOVA IA, 1995, FEBS LETT, V359, P23, DOI 10.1016/0014-5793(94)01442-4; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Sytkowski AJ, 1998, P NATL ACAD SCI USA, V95, P1184, DOI 10.1073/pnas.95.3.1184; UNDEN G, 1980, BIOCHIM BIOPHYS ACTA, V591, P275, DOI 10.1016/0005-2728(80)90159-0; Wallace BA, 2003, PROTEIN SCI, V12, P875, DOI 10.1110/ps.0229603; WESTENBERG DJ, 1993, J BIOL CHEM, V268, P815; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605; Yeliseev AA, 2005, PROTEIN SCI, V14, P2638, DOI 10.1110/ps.051550305	37	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53559	10.1371/journal.pone.0053559	http://dx.doi.org/10.1371/journal.pone.0053559			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308253	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429100090
J	Zayats, T; Yang, BZ; Xie, PX; Poling, J; Farrer, LA; Gelernter, J				Zayats, Tetyana; Yang, Bao-Zhu; Xie, Pingxing; Poling, James; Farrer, Lindsay A.; Gelernter, Joel			A Complex Interplay between Personality Domains, Marital Status and a Variant in CHRNA5 on the Risks of Cocaine, Nicotine Dependences and Cocaine-Induced Paranoia	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTOR GENES; MESSENGER-RNA EXPRESSION; UNITED-STATES; 5-FACTOR MODEL; SUBSTANCE USE; DRUG-USE; SEMISTRUCTURED ASSESSMENT; ADDICTIVE PERSONALITY; SMOKING INITIATION; COPING STYLES	Background: Personality correlates highly with both cocaine and nicotine dependencies (CD, ND), and their co-morbid psychopathologies. However, little is known about the nature of these relationships. This study examined if environment (marriage) or genetics (a single SNP, CHRNA5*rs16969968) would moderate the correlation of personality with CD, ND and cocaine-induced paranoia (CIP) in African and European Americans (AAs, EAs). Methods: 1432 EAs and 1513 AAs were examined using logistic regression. Personality was assessed by NEO-PI-R, while CD, ND and CIP were diagnosed according to DSM-IV. ND and CD were examined as binary traits and for the analysis of CIP, subjects were divided into 3 groups: (A) Controls with no CIP; (B) CD cases without CIP; and (C) CD cases with CIP. Multiple testing was Bonferroni-corrected. Results: For CD and ND in the EA population, marital status proved to be a significant moderator in their relationship with openness only (OR = 1.90, 95%CI = 1.36-2.64, p = 1.54e-04 and OR = 2.12, 95%CI = 1.52-2.90, p = 4.65e-06 respectively). For CIP, marriage was observed to moderate its correlation with openness and neuroticism (OR = 1.39, 95%CI = 1.18-1.63, p = 7.64e-04 and OR = 1.26, 95%CI = 1.12-1.42, p = 1.27e-03 respectively). The correlations moderated by rs16969968 were those of conscientiousness and CD (OR = 1.62, 95%CI: 1.23-2.12, p = 8.94e-04) as well as CIP (OR = 1.21, 95%CI: 1.11-1.32, p = 4.93e-04 when comparing group A versus group C). No significant interactions were observed in AA population. The Bonferroni-corrected significance threshold was set to be 1.67e-03. Conclusion: The role of personality in CD and CIP may be interceded by both environment and genetics, while in ND by environment only.	[Zayats, Tetyana; Yang, Bao-Zhu; Xie, Pingxing; Poling, James; Gelernter, Joel] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; [Poling, James; Gelernter, Joel] VACT Healthcare Ctr, West Haven, CT USA; [Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Genet & Genom, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Biostat & Epidemiol, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Med, Boston, MA USA; [Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Neurol, Boston, MA USA; [Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Ophthalmol, Boston, MA USA; [Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Genet & Genom, Boston, MA USA; [Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Biostat & Epidemiol, Boston, MA USA; [Gelernter, Joel] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Gelernter, Joel] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	Yale University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Yale University; Yale University	Gelernter, J (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA.	joel.gelernter@yale.edu	Farrer, Lindsay/AAS-1035-2020; Xie, Pingxing/AAK-1965-2020	Poling, James/0000-0002-0133-3136; Farrer, Lindsay/0000-0001-5533-4225; Gelernter, Joel/0000-0002-4067-1859	National Institute on Drug Abuse (NIDA) [R01 DA12690, R01 DA12849, RC2 DA028909, K01 DA24758]; National Institute on Alcohol Abuse and Alcoholism (NIAAA) [R01 AA11330, R01 AA17535]; VA MERIT grant; VA Connecticut MIRECC Center; Brain and Behavior Research NARSAD Young Investigator award; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017535, R01AA011330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012690, K01DA024758, R01DA012849, RC2DA028909] Funding Source: NIH RePORTER	National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); VA MERIT grant; VA Connecticut MIRECC Center; Brain and Behavior Research NARSAD Young Investigator award; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by National Institute on Drug Abuse (NIDA) grants R01 DA12690, R01 DA12849, RC2 DA028909, and K01 DA24758, National Institute on Alcohol Abuse and Alcoholism (NIAAA) grants R01 AA11330 and R01 AA17535, a VA MERIT grant, and the VA Connecticut MIRECC Center, and a Brain and Behavior Research NARSAD Young Investigator award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TJ, 1998, DRUG ALCOHOL DEPEN, V50, P137, DOI 10.1016/S0376-8716(98)00023-4; Baker TB, 2009, NICOTINE TOB RES, V11, P785, DOI 10.1093/ntr/ntp064; Bernstein E, 2005, J ADDICT DIS, V24, P43, DOI 10.1300/J069v24n04_04; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Botwin MD, 1997, J PERS, V65, P107, DOI 10.1111/j.1467-6494.1997.tb00531.x; BRADY KT, 1991, J CLIN PSYCHIAT, V52, P509; Broms U, 2004, NICOTINE TOB RES, V6, P447, DOI 10.1080/14622200410001696637; Brown JS, 2007, DEV PSYCHOL, V43, P1295, DOI 10.1037/0012-1649.43.6.1295; Budney A J, 1993, J Subst Abuse, V5, P117, DOI 10.1016/0899-3289(93)90056-H; Chen LS, 2009, ADDICTION, V104, P1731, DOI 10.1111/j.1360-0443.2009.02697.x; Chen XN, 2009, AM J MED GENET B, V150B, P926, DOI 10.1002/ajmg.b.30919; CHERRY N, 1976, BRIT J PREV SOC MED, V30, P123; Clemmey P, 1997, DRUG ALCOHOL DEPEN, V44, P123, DOI 10.1016/S0376-8716(96)01331-2; Compton WM, 2007, ARCH GEN PSYCHIAT, V64, P566, DOI 10.1001/archpsyc.64.5.566; Costa P.T., 2008, SAGE HDB PERSONALITY, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9, 10.4135/9781849200479.N9]; Cromby J, 2009, THEOR PSYCHOL, V19, P335, DOI 10.1177/0959354309104158; Denissen JJA, 2008, J RES PERS, V42, P1285, DOI 10.1016/j.jrp.2008.04.002; DERBY CA, 1994, AM J PREV MED, V10, P327, DOI 10.1016/S0749-3797(18)30560-9; DIGMAN JM, 1990, ANNU REV PSYCHOL, V41, P417, DOI 10.1146/annurev.psych.41.1.417; Donnellan MB, 2004, J RES PERS, V38, P481, DOI 10.1016/j.jrp.2004.01.001; Epstein DH, 2010, ADDICT BEHAV, V35, P318, DOI 10.1016/j.addbeh.2009.11.003; Erlich PM, 2010, HUM GENET, V128, P491, DOI 10.1007/s00439-010-0876-6; Freathy RM, 2011, INT J EPIDEMIOL, V40, P1617, DOI 10.1093/ije/dyr077; FUNDER DC, 1995, PSYCHOL REV, V102, P652, DOI 10.1037/0033-295X.102.4.652; Garlow SJ, 2007, J PSYCHIATR RES, V41, P530, DOI 10.1016/j.jpsychires.2005.08.008; GOLDBERG LR, 1990, J PERS SOC PSYCHOL, V59, P1216, DOI 10.1037/0022-3514.59.6.1216; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Grant BF, 1997, J STUD ALCOHOL, V58, P464, DOI 10.15288/jsa.1997.58.464; Grucza RA, 2010, ADDICT BIOL, V15, P346, DOI 10.1111/j.1369-1600.2010.00220.x; Grucza RA, 2008, BIOL PSYCHIAT, V64, P922, DOI 10.1016/j.biopsych.2008.04.018; Harwood HJ, 1999, ADDICTION, V94, P631; Heinz AJ, 2009, ADDICT BEHAV, V34, P258, DOI 10.1016/j.addbeh.2008.10.020; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; Johnson EO, 2010, ADDICTION, V105, P2014, DOI 10.1111/j.1360-0443.2010.03074.x; Kandel D, 1997, DRUG ALCOHOL DEPEN, V44, P11, DOI 10.1016/S0376-8716(96)01315-4; Kerr JS, 1996, HUM PSYCHOPHARM CLIN, V11, pS9; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Lee CW, 2007, AM J PUBLIC HEALTH, V97, P1503, DOI 10.2105/AJPH.2005.083527; Lee-Baggley D, 2005, J PERS, V73, P1141, DOI 10.1111/j.1467-6494.2005.00345.x; LIPKUS IM, 1994, HEALTH PSYCHOL, V13, P149, DOI 10.1037/0278-6133.13.2.149; Lips EH, 2010, INT J EPIDEMIOL, V39, P563, DOI 10.1093/ije/dyp288; McCormick RA, 1998, ADDICT BEHAV, V23, P497, DOI 10.1016/S0306-4603(98)00005-7; McCrae R.R., 2002, 5 FACTOR MODEL PERSO; McGue M, 1999, J CONSULT CLIN PSYCH, V67, P394, DOI 10.1037/0022-006X.67.3.394; McKusick D, 1998, HEALTH AFFAIR, V17, P147, DOI 10.1377/hlthaff.17.5.147; Mello NK, 2011, EXP CLIN PSYCHOPHARM, V19, P203, DOI 10.1037/a0023373; Merline AC, 2004, AM J PUBLIC HEALTH, V94, P96, DOI 10.2105/AJPH.94.1.96; Moos RH, 2002, ADDICTION, V97, P75, DOI 10.1046/j.1360-0443.2002.00063.x; Muhuri PK, 2011, AM J DRUG ALCOHOL AB, V37, P155, DOI 10.3109/00952990.2011.553977; NATHAN PE, 1988, J CONSULT CLIN PSYCH, V56, P183, DOI 10.1037/0022-006X.56.2.183; O'Rourke N, 2011, AGING MENT HEALTH, V15, P344, DOI 10.1080/13607863.2010.519324; Orr N, 2008, ADV GENET, V62, P1, DOI 10.1016/S0065-2660(08)00601-9; Perez-Stable EJ, 1998, JAMA-J AM MED ASSOC, V280, P152, DOI 10.1001/jama.280.2.152; Pierucci-Lagha A, 2005, DRUG ALCOHOL DEPEN, V80, P303, DOI 10.1016/j.drugalcdep.2005.04.005; Pierucci-Lagha A, 2007, DRUG ALCOHOL DEPEN, V91, P85, DOI 10.1016/j.drugalcdep.2007.04.014; Quirk SW, 1998, ASSESSMENT, V5, P157, DOI 10.1177/107319119800500206; REVELLE W, 1995, ANNU REV PSYCHOL, V46, P295, DOI 10.1146/annurev.ps.46.020195.001455; Roll JM, 1996, DRUG ALCOHOL DEPEN, V40, P195, DOI 10.1016/0376-8716(96)01219-7; Roll JM, 1997, EXP CLIN PSYCHOPHARM, V5, P263, DOI 10.1037/1064-1297.5.3.263; Saccone NL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001053; Saccone NL, 2009, CANCER RES, V69, P6848, DOI 10.1158/0008-5472.CAN-09-0786; Saccone NL, 2009, AM J MED GENET B, V150B, P453, DOI 10.1002/ajmg.b.30828; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; SATEL SL, 1991, AM J PSYCHIAT, V148, P495; Saucier G., 1996, 5 FACTOR MODEL PERSO; Sherva R, 2008, ADDICTION, V103, P1544, DOI 10.1111/j.1360-0443.2008.02279.x; Sherva R, 2010, NEUROPSYCHOPHARMACOL, V35, P1921, DOI 10.1038/npp.2010.64; Smith RM, 2011, EUR J HUM GENET, V19, P76, DOI 10.1038/ejhg.2010.120; Stevens VL, 2008, CANCER EPIDEM BIOMAR, V17, P3517, DOI 10.1158/1055-9965.EPI-08-0585; Terracciano A, 2004, ADDICTION, V99, P472, DOI 10.1111/j.1360-0443.2004.00687.x; Terracciano A, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-22; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thorne S. L., 2008, Morbidity and Mortality Weekly Report, V57, P1221; Trinidad DR, 2009, NICOTINE TOB RES, V11, P203, DOI 10.1093/ntr/ntn018; US Surgeon General, 1998, MMWR RECOMM REP, V47, pv; van Loon AJM, 2005, EUR J PUBLIC HEALTH, V15, P256, DOI 10.1093/eurpub/cki077; Wang JC, 2009, MOL PSYCHIATR, V14, P501, DOI 10.1038/mp.2008.42; Wang JC, 2009, HUM MOL GENET, V18, P3125, DOI 10.1093/hmg/ddp231; Watson D, 1996, J PERS, V64, P737, DOI 10.1111/j.1467-6494.1996.tb00943.x; Weiss RB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000125; WHITE HR, 1995, ADDICTION, V90, P947, DOI 10.1046/j.1360-0443.1995.9079477.x; Williams DR, 1992, J HLTH SOCIAL BEHAV, V33; Williams PG, 2009, J RES PERS, V43, P777, DOI 10.1016/j.jrp.2009.06.003; Xie P, 2010, NEUROPSYCHOPHARMACOL, V35, P1684, DOI 10.1038/npp.2010.37; Yang BZ, 2005, GENET EPIDEMIOL, V28, P302, DOI 10.1002/gepi.20070; Zhang HP, 2010, NEUROPSYCHOPHARMACOL, V35, P2211, DOI 10.1038/npp.2010.95	87	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e49368	10.1371/journal.pone.0049368	http://dx.doi.org/10.1371/journal.pone.0049368			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	069IS	23308091	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429100001
J	Zhong, P; Agosto, LM; Ilinskaya, A; Dorjbal, B; Truong, R; Derse, D; Uchil, PD; Heidecker, G; Mothes, W				Zhong, Peng; Agosto, Luis M.; Ilinskaya, Anna; Dorjbal, Batsukh; Truong, Rosaline; Derse, David; Uchil, Pradeep D.; Heidecker, Gisela; Mothes, Walther			Cell-to-Cell Transmission Can Overcome Multiple Donor and Target Cell Barriers Imposed on Cell-Free HIV	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; VIROLOGICAL SYNAPSES; PERIPHERAL-BLOOD; IN-VIVO; NEUTRALIZING ANTIBODY; LYMPHOTROPIC-VIRUS; VACCINIA VIRUS; F-ACTIN; SPREAD; TYPE-1	Virus transmission can occur either by a cell-free mode through the extracellular space or by cell-to-cell transmission involving direct cell-to-cell contact. The factors that determine whether a virus spreads by either pathway are poorly understood. Here, we assessed the relative contribution of cell-free and cell-to-cell transmission to the spreading of the human immunodeficiency virus (HIV). We demonstrate that HIV can spread by a cell-free pathway if all the steps of the viral replication cycle are efficiently supported in highly permissive cells. However, when the cell-free path was systematically hindered at various steps, HIV transmission became contact-dependent. Cell-to-cell transmission overcame barriers introduced in the donor cell at the level of gene expression and surface retention by the restriction factor tetherin. Moreover, neutralizing antibodies that efficiently inhibit cell-free HIV were less effective against cell-to-cell transmitted virus. HIV cell-to-cell transmission also efficiently infected target T cells that were relatively poorly susceptible to cell-free HIV. Importantly, we demonstrate that the donor and target cell types influence critically the extent by which cell-to-cell transmission can overcome each barrier. Mechanistically, cell-to-cell transmission promoted HIV spread to more cells and infected target cells with a higher proviral content than observed for cell-free virus. Our data demonstrate that the frequently observed contact-dependent spread of HIV is the result of specific features in donor and target cell types, thus offering an explanation for conflicting reports on the extent of cell-to-cell transmission of HIV.	[Zhong, Peng; Agosto, Luis M.; Truong, Rosaline; Uchil, Pradeep D.; Mothes, Walther] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06520 USA; [Ilinskaya, Anna; Dorjbal, Batsukh; Derse, David; Heidecker, Gisela] Natl Canc Inst Frederick, HIV Drug Resistance Program, Frederick, MD USA	Yale University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Mothes, W (corresponding author), Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06520 USA.	walther.mothes@yale.edu	sourisseau, marion/M-7542-2014	Uchil, Pradeep/0000-0002-7236-858X	National Institutes of Health [R01s CA098727, AI084096]; China Scholarship Council; NATIONAL CANCER INSTITUTE [R01CA098727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084096] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by the National Institutes of Health R01s CA098727 & AI084096 to WM, and a fellowship from the China Scholarship Council-Yale World Scholars in the Biomedical Sciences to PZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abela IA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002634; Agosto LM, 2007, VIROLOGY, V368, P60, DOI 10.1016/j.virol.2007.06.001; Alfsen A, 2005, MOL BIOL CELL, V16, P4267, DOI 10.1091/mbc.E05-03-0192; Bangham CRM, 2003, J GEN VIROL, V84, P3177, DOI 10.1099/vir.0.19334-0; BLACK FL, 1955, J IMMUNOL, V74, P236; Brimacombe CL, 2011, J VIROL, V85, P596, DOI 10.1128/JVI.01592-10; BUBB MR, 1994, J BIOL CHEM, V269, P14869; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Cameron PU, 2010, P NATL ACAD SCI USA, V107, P16934, DOI 10.1073/pnas.1002894107; Carr JM, 1999, VIROLOGY, V265, P319, DOI 10.1006/viro.1999.0047; Casartelli N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000955; Chen P, 2007, J VIROL, V81, P12582, DOI 10.1128/JVI.00381-07; Chukkapalli V, 2008, J VIROL, V82, P2405, DOI 10.1128/JVI.01614-07; Cordeiro JV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008506; CUDMORE S, 1995, NATURE, V378, P636, DOI 10.1038/378636a0; Del Portillo A, 2011, J VIROL, V85, P7169, DOI 10.1128/JVI.00231-11; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Doceul V, 2010, SCIENCE, V327, P873, DOI 10.1126/science.1183173; Flint SJ, 2009, PRINCIPLES VIROLOGY, P40; Ganesh L, 2004, J VIROL, V78, P11980, DOI 10.1128/JVI.78.21.11980-11987.2004; Gousset K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000015; GUPTA P, 1989, J VIROL, V63, P2361, DOI 10.1128/JVI.63.5.2361-2365.1989; Haller C, 2011, EUR J CELL BIOL, V90, P913, DOI 10.1016/j.ejcb.2010.09.010; Hatziioannou T, 2006, SCIENCE, V314, P95, DOI 10.1126/science.1130994; HELENIUS A, 1980, J CELL BIOL, V84, P404, DOI 10.1083/jcb.84.2.404; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; IWASAKI Y, 1975, LAB INVEST, V33, P391; Jin J, 2011, J VIROL, V85, P7672, DOI 10.1128/JVI.00409-11; Jin J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006551; Jin J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000163; Johnson DC, 2002, J VIROL, V76, P1, DOI 10.1128/JVI.76.1.1-8.2002; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Jolly C, 2010, J VIROL, V84, P12185, DOI 10.1128/JVI.01447-10; Josefsson L, 2011, P NATL ACAD SCI USA, V108, P11199, DOI 10.1073/pnas.1107729108; Jouvenet N, 2006, CELL MICROBIOL, V8, P1803, DOI 10.1111/j.1462-5822.2006.00750.x; Jung A, 2002, NATURE, V418, P144, DOI 10.1038/418144a; Kuhl BD, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-115; Lawrence DMP, 2000, J VIROL, V74, P1908, DOI 10.1128/JVI.74.4.1908-1918.2000; LAYNE SP, 1992, VIROLOGY, V189, P695, DOI 10.1016/0042-6822(92)90593-E; Liberatore RA, 2011, P NATL ACAD SCI USA, V108, P18097, DOI 10.1073/pnas.1113694108; Llewellyn GN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001167; Martin N, 2010, J VIROL, V84, P3516, DOI 10.1128/JVI.02651-09; Massanella M, 2009, AIDS, V23, P183, DOI 10.1097/QAD.0b013e32831ef1a3; Mazurov D, 2011, J VIROL, DOI [10.1128/JVI.06993-06911, DOI 10.1128/JVI.06993-06911]; Mazurov D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000788; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; MERZ DC, 1980, J EXP MED, V151, P275, DOI 10.1084/jem.151.2.275; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Mothes W, 2010, J VIROL, V84, P8360, DOI 10.1128/JVI.00443-10; Neagu MR, 2009, J CLIN INVEST, V119, P3035, DOI 10.1172/JCI39354; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Nejmeddine M, 2005, J BIOL CHEM, V280, P29653, DOI 10.1074/jbc.M502639200; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Pais-Correia AM, 2010, NAT MED, V16, P83, DOI 10.1038/nm.2065; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; PHILLIPS DM, 1994, AIDS, V8, P719, DOI 10.1097/00002030-199406000-00001; Platt EJ, 2010, J VIROL, V84, P3106, DOI 10.1128/JVI.01958-09; Richardson MW, 2008, J VIROL, V82, P11117, DOI 10.1128/JVI.01046-08; Rudnicka D, 2009, J VIROL, V83, P6234, DOI 10.1128/JVI.00282-09; Ruprecht CR, 2011, J EXP MED, V208, P439, DOI 10.1084/jem.20101907; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Schindler M, 2005, J VIROL, V79, P5489, DOI 10.1128/JVI.79.9.5489-5498.2005; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; Sigal A, 2011, NATURE, V477, P95, DOI 10.1038/nature10347; Sol-Foulon N, 2007, EMBO J, V26, P516, DOI 10.1038/sj.emboj.7601509; Sourisseau M, 2007, J VIROL, V81, P1000, DOI 10.1128/JVI.01629-06; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Swiggard WJ, 2005, J VIROL, V79, P14179, DOI 10.1128/JVI.79.22.14179-14188.2005; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Vasiliver-Shamis G, 2009, J VIROL, V83, P11341, DOI 10.1128/JVI.01440-09; Vogt VM, 1999, J VIROL, V73, P7050, DOI 10.1128/JVI.73.8.7050-7055.1999; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036	76	95	97	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53138	10.1371/journal.pone.0053138	http://dx.doi.org/10.1371/journal.pone.0053138			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308151	Green Published, gold, Green Submitted			2022-12-25	WOS:000313429100031
J	Kumps, C; Fieuw, A; Mestdagh, P; Menten, B; Lefever, S; Pattyn, F; De Brouwer, S; Sante, T; Schulte, JH; Schramm, A; Van Roy, N; Van Maerken, T; Noguera, R; Combaret, V; Devalck, C; Westermann, F; Laureys, G; Eggert, A; Vandesompele, J; De Preter, K; Speleman, F				Kumps, Candy; Fieuw, Annelies; Mestdagh, Pieter; Menten, Bjorn; Lefever, Steve; Pattyn, Filip; De Brouwer, Sara; Sante, Tom; Schulte, Johannes Hubertus; Schramm, Alexander; Van Roy, Nadine; Van Maerken, Tom; Noguera, Rosa; Combaret, Valerie; Devalck, Christine; Westermann, Frank; Laureys, Genevieve; Eggert, Angelika; Vandesompele, Jo; De Preter, Katleen; Speleman, Frank			Focal DNA Copy Number Changes in Neuroblastoma Target MYCN Regulated Genes	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; N-MYC; TRANSCRIPTIONAL TARGET; ACTIVATING MUTATIONS; THERAPEUTIC TARGET; ALK KINASE; EXPRESSION; MICRORNA; RECEPTOR; REVEALS	Neuroblastoma is an embryonic tumor arising from immature sympathetic nervous system cells. Recurrent genomic alterations include MYCN and ALK amplification as well as recurrent patterns of gains and losses of whole or large partial chromosome segments. A recent whole genome sequencing effort yielded no frequently recurring mutations in genes other than those affecting ALK. However, the study further stresses the importance of DNA copy number alterations in this disease, in particular for genes implicated in neuritogenesis. Here we provide additional evidence for the importance of focal DNA copy number gains and losses, which are predominantly observed in MYCN amplified tumors. A focal 5 kb gain encompassing the MYCN regulated miR-17 similar to 92 cluster as sole gene was detected in a neuroblastoma cell line and further analyses of the array CGH data set demonstrated enrichment for other MYCN target genes in focal gains and amplifications. Next we applied an integrated genomics analysis to prioritize MYCN down regulated genes mediated by MYCN driven miRNAs within regions of focal heterozygous or homozygous deletion. We identified RGS5, a negative regulator of G-protein signaling implicated in vascular normalization, invasion and metastasis, targeted by a focal homozygous deletion, as a new MYCN target gene, down regulated through MYCN activated miRNAs. In addition, we expand the miR-17 similar to 92 regulatory network controlling TGF beta signaling in neuroblastoma with the ring finger protein 11 encoding gene RNF11, which was previously shown to be targeted by the miR-17 similar to 92 member miR-19b. Taken together, our data indicate that focal DNA copy number imbalances in neuroblastoma (1) target genes that are implicated in MYCN signaling, possibly selected to reinforce MYCN oncogene addiction and (2) serve as a resource for identifying new molecular targets for treatment.	[Kumps, Candy; Fieuw, Annelies; Mestdagh, Pieter; Menten, Bjorn; Lefever, Steve; Pattyn, Filip; De Brouwer, Sara; Sante, Tom; Van Roy, Nadine; Van Maerken, Tom; Vandesompele, Jo; De Preter, Katleen; Speleman, Frank] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium; [Schulte, Johannes Hubertus; Schramm, Alexander; Eggert, Angelika] Univ Childrens Hosp Essen, Dept Pediat Oncol & Haematol, Essen, Germany; [Noguera, Rosa] Univ Valencia, Sch Med, Dept Pathol, Valencia, Spain; [Combaret, Valerie] FNCLCC, Ctr Leon Berard, Lab Rech Translat, Lyon, France; [Devalck, Christine] Childrens Univ Hosp, Brussels, Belgium; [Westermann, Frank] German Canc Res Ctr, Dept Tumor Genet, Heidelberg, Germany; [Laureys, Genevieve] Ghent Univ Hosp, Dept Pediat Hematol Oncol, Ghent, Belgium	Ghent University; Ghent University Hospital; University of Duisburg Essen; University of Valencia; UNICANCER; Centre Leon Berard; Helmholtz Association; German Cancer Research Center (DKFZ); Ghent University; Ghent University Hospital	Speleman, F (corresponding author), Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium.	franki.speleman@ugent.be	laureys, genevieve/AAG-2390-2021; Schramm, Alexander/G-5688-2010; speleman, frank/AAR-5184-2020; Eggert, Angelika/AAE-6907-2022; Schulte, Johannes H/G-3981-2010; Vandesompele, Jo/W-3411-2018; Westermann, Frank/F-7509-2013; De Preter, Katleen/I-7135-2013; Schulte, Johannes H./V-2474-2018; Pattyn, Filip/Q-4003-2019; Menten, Björn/B-3072-2013; Pattyn, Filip/A-4164-2015	Schramm, Alexander/0000-0001-7670-7529; speleman, frank/0000-0002-6628-8559; Eggert, Angelika/0000-0003-3476-8184; Vandesompele, Jo/0000-0001-6274-0184; De Preter, Katleen/0000-0002-7726-5096; Pattyn, Filip/0000-0003-0858-6651; Pattyn, Filip/0000-0003-0858-6651; Mestdagh, Pieter/0000-0001-7821-9684; Menten, Bjorn/0000-0001-8182-659X; Schulte, Johannes Hubertus/0000-0003-0671-1201	Institute for the Promotion of Innovation by Science and Technology (IWT-Vlaanderen) [081373]; Fund for Scientific Research Flanders (FWO); "Emmanuel van der Schueren'' grant from the "Vlaamse Liga tegen Kanker''; European Union [037260, 259348]; FWO [G.0198.08]; Belgian program of Interuniversity Poles of Attraction (IUAP); GOA [01G01910]; FOD [NKP_29_014]; IWT [SBO60848]; department of Pathology, Medical School, University of Valencia, Valencia, Spain [RD06/0020/0102, PI10/0015, 396/2009]	Institute for the Promotion of Innovation by Science and Technology (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Fund for Scientific Research Flanders (FWO)(FWO); "Emmanuel van der Schueren'' grant from the "Vlaamse Liga tegen Kanker''; European Union(European Commission); FWO(FWO); Belgian program of Interuniversity Poles of Attraction (IUAP); GOA; FOD; IWT(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); department of Pathology, Medical School, University of Valencia, Valencia, Spain	CK is indebted to the Institute for the Promotion of Innovation by Science and Technology (IWT-Vlaanderen; http://www.iwt.be/) for a predoctoral fellowship (grant number 081373), AF, KD, PM, and FP are supported by the Fund for Scientific Research Flanders (FWO; http://www.fwo.be/). SD is supported by an "Emmanuel van der Schueren'' grant from the "Vlaamse Liga tegen Kanker'' (http://www.tegenkanker.be/). This work was supported by the European Union (STREP-EET project, grant number 037260; http://ec.europa.eu/research/index.cfm), the FWO (grant number: G.0198.08), the Belgian program of Interuniversity Poles of Attraction (IUAP; http://www.belspo.be/belspo/iap/index_en.stm), initiated by the Belgian State, Prime Minister's Office, Science Policy Programming, by the GOA (http://www.ugent.be/nl/onderzoek/financiering/bof/GOA; grant number 01G01910), the FOD (http://www.health.belgium.be/eportal; grant number: NKP_29_014) and the IWT (grant number: SBO60848). This work was also funded by the department of Pathology, Medical School, University of Valencia, Valencia, Spain: RD06/0020/0102 and PI10/0015 (ISCIII & ERDF); 396/2009 (FAECC). The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no259348 (ASSET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azarova AM, 2011, SEMIN CANCER BIOL, V21, P267, DOI 10.1016/j.semcancer.2011.09.005; Azmi P, 2005, EUR J CANCER, V41, P2549, DOI 10.1016/j.ejca.2005.08.020; Azmi PB, 2009, ANTICANCER RES, V29, P2253; Berger M, 2005, BLOOD, V105, P1094, DOI 10.1182/blood-2004-06-2315; Berry T, 2012, CANCER CELL, V22, P117, DOI 10.1016/j.ccr.2012.06.001; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Brouwer S De, 2011, INT J CANC; Buckley PG, 2010, CLIN CANCER RES, V16, P2971, DOI 10.1158/1078-0432.CCR-09-3215; Caren H, 2008, BIOCHEM J, V416, P153, DOI 10.1042/BJ20081834; Caren H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-353; Chen LD, 2010, CANCER RES, V70, P1377, DOI 10.1158/0008-5472.CAN-09-2598; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Chesler L, 2011, SEMIN CANCER BIOL, V21, P245, DOI 10.1016/j.semcancer.2011.09.011; Chiang MF, 2012, BIOMED PHARMACOTHER, V66, P433, DOI 10.1016/j.biopha.2012.03.003; Connor MK, 2004, ONCOGENE, V23, P2089, DOI 10.1038/sj.onc.1207380; De Brouwer S, 2010, CLIN CANCER RES, V16, P4353, DOI 10.1158/1078-0432.CCR-09-2660; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gantier MP, 2012, NUCL ACIDS RES; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Gogada R, 2011, CELL CYCLE, V10, P4128, DOI 10.4161/cc.10.23.18292; Gustafson WC, 2010, ONCOGENE, V29, P1249, DOI 10.1038/onc.2009.512; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Helland A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018064; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Heukamp LC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003967; Hofer-Warbinek R, 2004, CELL DEATH DIFFER, V11, P1317, DOI 10.1038/sj.cdd.4401502; Hogarty MD, 2012, CANCER CELL, V21, P145, DOI 10.1016/j.ccr.2012.01.018; Hogarty MD, 2008, CANCER RES, V68, P9735, DOI 10.1158/0008-5472.CAN-07-6866; Holzel M, 2010, CELL, V142, P218, DOI 10.1016/j.cell.2010.06.004; Hu BS, 2012, WORLD J GASTROENTERO, V18, P3020, DOI 10.3748/wjg.v18.i23.3020; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang GC, 2012, J SURG ONCOL, V105, P420, DOI 10.1002/jso.22033; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Kim M, 2009, CANCER GENET CYTOGEN, V195, P59, DOI 10.1016/j.cancergencyto.2009.06.013; Lefever S, 2009, NUCLEIC ACIDS RES, V37, pD942, DOI 10.1093/nar/gkn777; Li JN, 2011, BIOCHEMISTRY-US, V50, P5566, DOI 10.1021/bi200642e; Loven J, 2010, P NATL ACAD SCI USA, V107, P1553, DOI 10.1073/pnas.0913517107; Lutz W, 1996, ONCOGENE, V13, P803; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Mac SM, 2000, MOL CARCINOGEN, V29, P76, DOI 10.1002/1098-2744(200010)29:2<76::AID-MC4>3.0.CO;2-Y; Manzur M, 2009, TRENDS CARDIOVAS MED, V19, P26, DOI 10.1016/j.tcm.2009.04.002; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Meehan M, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-6; Menges CW, 2009, CELL CYCLE, V8, P2528, DOI 10.4161/cc.8.16.9280; Menten B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-124; Messiaen LM, 2000, HUM MUTAT, V15, P541, DOI 10.1002/1098-1004(200006)15:6<541::AID-HUMU6>3.3.CO;2-E; Mestdagh P, 2010, ONCOGENE, V29, P1394, DOI 10.1038/onc.2009.429; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Meyle KD, 2009, HUM GENET, V126, P499, DOI 10.1007/s00439-009-0715-9; Michels E, 2007, GENE CHROMOSOME CANC, V46, P1098, DOI 10.1002/gcc.20496; Molenaar JJ, 2008, CANCER RES, V68, P2599, DOI 10.1158/0008-5472.CAN-07-5032; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Molenaar JJ, 2012, NAT GENET; Monti S, 2012, CANCER CELL, V22, P359, DOI 10.1016/j.ccr.2012.07.014; Mosse YP, 2008, NATURE; Northcott PA, 2009, CANCER RES, V69, P3249, DOI 10.1158/0008-5472.CAN-08-4710; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Palmer RH, 2009, BIOCHEM J, V420, P345, DOI 10.1042/BJ20090387; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Reiff T, 2011, DEVELOPMENT, V138, P4699, DOI 10.1242/dev.072157; Schonherr C., 2012, ONCOGENE; Schulte JH, 2008, INT J CANCER, V122, P699, DOI 10.1002/ijc.23153; Slack A, 2005, CANCER LETT, V228, P21, DOI 10.1016/j.canlet.2005.01.050; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Stallings RL, 2006, CANCER RES, V66, P3673, DOI 10.1158/0008-5472.CAN-05-4154; Toledo F, 2007, INT J BIOCHEM CELL B, V39, P1476, DOI 10.1016/j.biocel.2007.03.022; Tzoneva G, 2012, CURR TOP MICROBIOL, V360, P163, DOI 10.1007/82_2012_232; van de Wiel MA, 2009, BIOINFORMATICS, V25, P1099, DOI 10.1093/bioinformatics/btp132; Van Maerken T, 2012, BMC RES NOTES UNPUB; Van Maerken T, 2006, CANCER RES, V66, P9646, DOI 10.1158/0008-5472.CAN-06-0792; Vandesompele J, 2005, J CLIN ONCOL, V23, P2280, DOI 10.1200/JCO.2005.06.104; Veeriah S, 2009, P NATL ACAD SCI USA, V106, P9435, DOI 10.1073/pnas.0900571106; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Westermann F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r150; Yang HW, 2001, ONCOGENE, V20, P5075, DOI 10.1038/sj.onc.1204456; Zhu SZ, 2012, CANCER CELL, V21, P362, DOI 10.1016/j.ccr.2012.02.010	78	34	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e52321	10.1371/journal.pone.0052321	http://dx.doi.org/10.1371/journal.pone.0052321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308108	Green Published, Green Submitted, gold			2022-12-25	WOS:000313670100008
J	Andersen, JT; Petersen, M; Jimenez-Solem, E; Broedbaek, K; Andersen, NL; Torp-Pedersen, C; Keiding, N; Poulsen, HE				Andersen, Jon Traerup; Petersen, Morten; Jimenez-Solem, Espen; Broedbaek, Kasper; Andersen, Nadia Lyhne; Torp-Pedersen, Christian; Keiding, Niels; Poulsen, Henrik Enghusen			Clarithromycin in Early Pregnancy and the Risk of Miscarriage and Malformation: A Register Based Nationwide Cohort Study	PLOS ONE			English	Article							DANISH; MULTICENTER; POPULATION	Background: The antibiotic clarithromycin has been associated with fetal loss in animals and a study has found a doubling in the frequency of miscarriages among women using clarithromycin in pregnancy. The aim of the study was to investigate whether clarithromycin use in early pregnancy was associated with an increased risk for miscarriages and major malformations. Methods: We conducted a nationwide cohort study including all women in Denmark with a known conception between 1997 and 2007. The Fertility Database was used to identify all women giving birth and the National Hospital Register was used to identify all women with a record of miscarriage or induced abortion. Prescription data was obtained from the National Prescription Register. The primary outcome was the number of miscarriages and offspring with major congenital malformations among users of clarithromycin compared to non-users. Results: We identified 931 504 pregnancies (705 837 live births, 77 553 miscarriages, and 148 114 induced abortions). 401 women redeemed a prescription of clarithromycin in the first trimester of which 40 (10.0%) experienced a miscarriage and among the live born nine (3.6%) had offspring with malformations. The hazard ratio (HR) of having a miscarriage after exposure to clarithromycin was 1.56 (CI95% 1.14-2.13). There was no increased hazard of having a miscarriage when being exposed to penicillin or erythromycin. There was no increased prevalence (OR = 1.03 (CI95% 0.52-2.00)) of having offspring with malformations after exposure to clarithromycin. Conclusions: We found an increased hazard of miscarriage but no increased prevalance of having offspring with malformations among women redeeming a prescription of clarithromycin in early pregnancy. This is supported by previous studies in animals and humans. However, further research is required to explore the possible effect of treatment indication on the associations found.	[Andersen, Jon Traerup; Petersen, Morten; Jimenez-Solem, Espen; Broedbaek, Kasper; Poulsen, Henrik Enghusen] Rigshosp, Copenhagen Univ Hosp, Lab Clin Pharmacol, DK-2100 Copenhagen, Denmark; [Andersen, Jon Traerup; Petersen, Morten; Jimenez-Solem, Espen; Broedbaek, Kasper; Poulsen, Henrik Enghusen] Bispebjerg Hosp, Dept Clin Pharmacol, DK-2400 Copenhagen, Denmark; [Andersen, Nadia Lyhne] Mental Hlth Ctr Copenhagen, Copenhagen, Denmark; [Torp-Pedersen, Christian] Gentofte Univ Hosp, Dept Cardiol, Hellerup, Denmark; [Torp-Pedersen, Christian; Keiding, Niels; Poulsen, Henrik Enghusen] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen	Andersen, JT (corresponding author), Rigshosp, Copenhagen Univ Hosp, Lab Clin Pharmacol, DK-2100 Copenhagen, Denmark.	jta@rh.dk	Torp-Pedersen, Christian/E-5931-2013; Jimenez-Solem, Espen/B-4207-2012	Jimenez-Solem, Espen/0000-0002-3777-147X; Andersen, Jon/0000-0003-0169-1328; Poulsen, Henrik Enghusen/0000-0003-4242-9924	Danish Agency for Science, Technology and Innovation; P. Carl Petersen Foundation	Danish Agency for Science, Technology and Innovation; P. Carl Petersen Foundation	The study is supported by grants from the Danish Agency for Science, Technology and Innovation (http://en.fi.dk/), and the P. Carl Petersen Foundation (http://www.pcarlp-fond.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott Laboratories, 2010, BIAX PROD INF; Andersen TF, 1999, DAN MED BULL, V46, P263; [Anonymous], 1992, LANCET, V339, P1600, DOI DOI 10.1016/0140-6736(92)91856-4; Bar-Oz B, 2008, EUR J OBSTET GYN R B, V141, P31, DOI 10.1016/j.ejogrb.2008.07.008; Blenstrup LT, 2011, SCAND J PUBLIC HEALT, V39, P79, DOI 10.1177/1403494811399957; Buss L, 2006, ACTA OBSTET GYN SCAN, V85, P467, DOI 10.1080/00016340500494887; Drinkard CR, 2000, PHARMACOEPIDEM DR S, V9, P549, DOI 10.1002/pds.538; Einarson A, 1998, AM J PERINAT, V15, P523, DOI 10.1055/s-2007-994053; European Surveillance of Congenital Anomalies, 2005, EUROCAT GUID 1 3 REF; Gaist D, 1997, DAN MED BULL, V44, P445; Heikkinen T, 2000, BRIT J OBSTET GYNAEC, V107, P770, DOI 10.1111/j.1471-0528.2000.tb13339.x; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Knudsen LB, 1998, DAN MED BULL, V45, P221; Larsen H, 2003, SCAND J PUBLIC HEALT, V31, P12, DOI 10.1080/14034940210134194; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Sorensen H T, 1996, J Med Syst, V20, P57; The Danish National Board of Health, 2004, PROJ VEDR DAT LANDSP; Thorning H, 2004, PROJECT DATA QUALITY; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Witt A, 2003, AM J OBSTET GYNECOL, V188, P816, DOI 10.1067/mob.2003.171	20	114	116	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53327	10.1371/journal.pone.0053327	http://dx.doi.org/10.1371/journal.pone.0053327			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301061	gold, Green Published, Green Submitted			2022-12-25	WOS:000313320900075
J	Chang, HM; Shyu, MK; Tseng, GF; Liu, CH; Chang, HS; Lan, CT; Hsu, WM; Liao, WC				Chang, Hung-Ming; Shyu, Ming-Kwang; Tseng, Guo-Fang; Liu, Chiung-Hui; Chang, Hung-Shuo; Lan, Chyn-Tair; Hsu, Wen-Ming; Liao, Wen-Chieh			Neuregulin Facilitates Nerve Regeneration by Speeding Schwann Cell Migration via ErbB2/3-Dependent FAK Pathway	PLOS ONE			English	Article							NEU DIFFERENTIATION FACTOR; PERIPHERAL-NERVE; PROLIFERATION; RECOVERY; PLASTICITY; KINASE; INJURY; ROLES	Background: Adequate migration of Schwann cells (Sc) is crucial for axon-guidance in the regenerative process after peripheral nerve injury (PNI). Considering neuregulin-erbB-FAK signaling is an essential pathway participating in the regulation of Sc migration during development, the present study is aimed to examine whether neuregulin would exert its beneficial effects on adult following PNI and further determine the potential changes of downstream pathway engaged in neuro-regeneration by both in vitro and in vivo approaches. Methodology and Principal Findings: Cultured RSC96 cells treated with neuregulin were processed for erbB2/3 immunofluorescence and FAK immunoblotings. The potential effects of neuregulin on Sc were assessed by cell adherence, spreading, and migration assays. In order to evaluate the functional significance of neuregulin on neuro-regeneration, the in vivo model of PNI was performed by chronic end-to-side neurorrhaphy (ESN). In vitro studies indicated that after neuregulin incubation, erbB2/3 were not only expressed in cell membranes, but also distributed throughout the cytoplasm and nucleus of RSC96 cells. Activation of erbB2/3 was positively correlated with FAK phosphorylation. Neuregulin also increases Sc adherence, spreading, and migration by 127.2+/-5.0%, 336.8+/-3.0%, and 80.0+/-5.7%, respectively. As for in vivo study, neuregulin significantly accelerates the speed of Sc migration and increases Sc expression in the distal stump of injured nerves. Retrograde labeling and compound muscle action potential recordings (CMAP) also showed that neuregulin successfully facilitates nerve regeneration by eliciting noticeably larger CMAP and promoting quick re-innervation of target muscles. Conclusions: As neuregulin successfully improves axo-glial interaction by speeding Sc migration via the erbB2/3-FAK pathway, therapeutic use of neuregulin may thus serve as a promising strategy to facilitate the progress of nerve regeneration after PNI.	[Chang, Hung-Ming] Taipei Med Univ, Sch Med, Dept Anat, Coll Med, Taipei, Taiwan; [Shyu, Ming-Kwang; Chang, Hung-Shuo] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Tseng, Guo-Fang] Tzu Chi Univ, Dept Anat, Coll Med, Hualien, Taiwan; [Liu, Chiung-Hui] Natl Taiwan Univ, Coll Med, Grad Inst Anat & Cell Biol, Taipei 10764, Taiwan; [Lan, Chyn-Tair; Liao, Wen-Chieh] Chung Shan Med Univ, Dept Anat, Fac Med, Taichung, Taiwan; [Hsu, Wen-Ming] Natl Taiwan Univ Hosp, Dept Surg, Div Pediat Surg, Taipei 100, Taiwan; [Liao, Wen-Chieh] Chung Shan Med Univ Hosp, Dept Pediat, Taichung, Taiwan	Taipei Medical University; National Taiwan University; National Taiwan University Hospital; Tzu Chi University; National Taiwan University; Chung Shan Medical University; National Taiwan University; National Taiwan University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital	Liao, WC (corresponding author), Chung Shan Med Univ, Dept Anat, Fac Med, Taichung, Taiwan.	khrnangel@gmail.com	Liu, Chiung-Hui/K-2974-2016	Liu, Chiung-Hui/0000-0002-2656-2576; HSU, WEN-MING/0000-0002-5145-9538; Liao, Wen Chieh/0000-0001-7848-2124; SHYU, MING-KWANG/0000-0001-9057-4101	 [NSC 99-2320-B-040-002-MY3];  [NSC 101-2320-B-040-003]	; 	This study is supported by the research grants (NSC 99-2320-B-040-002-MY3 and NSC 101-2320-B-040-003) to Dr. H-M Chang and Dr. W-C Liao from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adilakshmi T, 2011, J NEUROSCI, V31, P5106, DOI 10.1523/JNEUROSCI.5635-10.2011; Chen LE, 1998, NEUROCHEM INT, V33, P341, DOI 10.1016/S0197-0186(98)00037-0; Cheng C, 2002, NEUROSCIENCE, V115, P321, DOI 10.1016/S0306-4522(02)00291-9; Chernousov MA, 2000, HISTOL HISTOPATHOL, V15, P593, DOI 10.14670/HH-15.593; Corfas G, 2004, J NEUROSCI, V24, P9250, DOI 10.1523/JNEUROSCI.3649-04.2004; Dezawa Mari, 2000, Acta Anatomica Nipponica, V75, P255; Eckert JM, 2009, GLIA, V57, P1501, DOI 10.1002/glia.20866; Evans GRD, 2001, ANAT RECORD, V263, P396, DOI 10.1002/ar.1120; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fang WK, 2009, AM J CHINESE MED, V37, P945, DOI 10.1142/S0192415X09007363; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; Fricker FR, 2011, FUTUR NEUROL, V6, P809, DOI 10.2217/FNL.11.45; Frostick SP, 1998, MICROSURG, V18, P397, DOI 10.1002/(SICI)1098-2752(1998)18:7<397::AID-MICR2>3.0.CO;2-F; Gambarotta G, 2004, J BIOL CHEM, V279, P48808, DOI 10.1074/jbc.M408374200; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Guertin AD, 2005, J NEUROSCI, V25, P3478, DOI 10.1523/JNEUROSCI.3766-04.2005; Ji Y, 2012, J PROTEOME RES; Joung I, 2010, MOL CELLS, V30, P477, DOI 10.1007/s10059-010-0137-5; Koeppen AH, 2004, J NEUROL SCI, V220, P115, DOI 10.1016/j.jns.2004.03.008; Lemke G, 1996, MOL CELL NEUROSCI, V7, P247, DOI 10.1006/mcne.1996.0019; Liao WC, 2010, NEUROSCIENCE, V171, P934, DOI 10.1016/j.neuroscience.2010.09.036; Liao WC, 2009, J ANAT, V215, P506, DOI 10.1111/j.1469-7580.2009.01135.x; Liu Z, 2011, PEPTIDES, V32, P1244, DOI 10.1016/j.peptides.2011.04.005; Lu MC, 2009, CELL BIOCHEM FUNCT, V27, P186, DOI 10.1002/cbf.1554; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Meintanis S, 2001, GLIA, V34, P39, DOI 10.1002/glia.1038; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Morris JK, 1999, NEURON, V23, P273, DOI 10.1016/S0896-6273(00)80779-5; Newbern J, 2010, SEMIN CELL DEV BIOL, V21, P922, DOI 10.1016/j.semcdb.2010.08.008; PinkasKramarski R, 1996, J BIOL CHEM, V271, P19029, DOI 10.1074/jbc.271.32.19029; Priestley JV, 2007, BRAIN, V130, P895, DOI 10.1093/brain/awm041; Robinson Michael D, 2002, Phys Med Rehabil Clin N Am, V13, P109, DOI 10.1016/S1047-9651(03)00074-3; Schlosshauer B, 2003, BRAIN RES, V963, P321, DOI 10.1016/S0006-8993(02)03930-6; Tseng CY, 2003, J RECONSTR MICROSURG, V19, P331; Vartanian T, 2000, BIOCHEM BIOPH RES CO, V271, P414, DOI 10.1006/bbrc.2000.2624; WEN DZ, 1992, CELL, V69, P559, DOI 10.1016/0092-8674(92)90456-M; Yildiz M, 2011, EUR ARCH OTO-RHINO-L, V268, P1127, DOI 10.1007/s00405-011-1492-3	37	66	69	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53444	10.1371/journal.pone.0053444	http://dx.doi.org/10.1371/journal.pone.0053444			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301073	gold, Green Submitted, Green Published			2022-12-25	WOS:000313320900078
J	Jankanpaa, HJ; Frenkel, M; Zulfugarov, I; Reichelt, M; Krieger-Liszkay, A; Mishra, Y; Gershenzon, J; Moen, J; Lee, CH; Jansson, S				Jankanpaa, Hanna Johansson; Frenkel, Martin; Zulfugarov, Ismayil; Reichelt, Michael; Krieger-Liszkay, Anja; Mishra, Yogesh; Gershenzon, Jonathan; Moen, Jon; Lee, Choon-Hwan; Jansson, Stefan			Non-Photochemical Quenching Capacity in Arabidopsis thaliana Affects Herbivore Behaviour	PLOS ONE			English	Article							INDUCED RESPONSES; PLUTELLA-XYLOSTELLA; JASMONIC ACID; LIGHT; DEFENSE; STRESS; OVIPOSITION; FLUORESCENT; COMPETITION; FITNESS	Under natural conditions, plants have to cope with numerous stresses, including light-stress and herbivory. This raises intriguing questions regarding possible trade-offs between stress defences and growth. As part of a program designed to address these questions we have compared herbivory defences and damage in wild type Arabidopsis thaliana and two "photoprotection genotypes", npq4 and oePsbS, which respectively lack and overexpress PsbS (a protein that plays a key role in qE-type non-photochemical quenching). In dual-choice feeding experiments both a specialist (Plutella xylostella) and a generalist (Spodoptera littoralis) insect herbivore preferred plants that expressed PsbS most strongly. In contrast, although both herbivores survived equally well on each of the genotypes, for oviposition female P. xylostella adults preferred plants that expressed PsbS least strongly. However, there were no significant differences between the genotypes in levels of the 10 most prominent glucosinolates; key substances in the Arabidopsis anti-herbivore chemical defence arsenal. After transfer from a growth chamber to the field we detected significant differences in the genotypes' metabolomic profiles at all tested time points, using GC-MS, but no consistent "metabolic signature'' for the lack of PsbS. These findings suggest that the observed differences in herbivore preferences were due to differences in the primary metabolism of the plants rather than their contents of typical "defence compounds". A potentially significant factor is that superoxide accumulated most rapidly and to the highest levels under high light conditions in npq4 mutants. This could trigger changes in planta that are sensed by herbivores either directly or indirectly, following its dismutation to H2O2.	[Jankanpaa, Hanna Johansson; Mishra, Yogesh; Jansson, Stefan] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden; [Frenkel, Martin; Moen, Jon] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden; [Zulfugarov, Ismayil; Lee, Choon-Hwan] Pusan Natl Univ, Dept Mol Biol, Pusan, South Korea; [Zulfugarov, Ismayil] Azerbaijan Natl Acad Sci, Inst Bot, Baku, Azerbaijan; [Reichelt, Michael; Gershenzon, Jonathan] Max Planck Inst Chem Ecol, Dept Biochem, Jena, Germany; [Krieger-Liszkay, Anja] CEA, Inst Biol & Technol Saclay, Serv Bioenerget Biol Struct & Mecanisme, Gif Sur Yvette, France	Umea University; Umea University; Pusan National University; Azerbaijan National Academy of Sciences (ANAS); Institute of Botany Azerbaijan National Academy of Sciences; Max Planck Society; CEA; UDICE-French Research Universities; Universite Paris Saclay	Jansson, S (corresponding author), Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden.		Gershenzon, Jonathan/K-1331-2013; Jansson, Stefan/A-1119-2009; Mishra, Yogesh/AAI-3004-2021; Zulfugarov, Ismayil/I-2314-2014	Gershenzon, Jonathan/0000-0002-1812-1551; Jansson, Stefan/0000-0002-7906-6891; Zulfugarov, Ismayil/0000-0002-9723-3542; Krieger-Liszkay, Anja/0000-0001-7141-4129	The Swedish Research Council (VR); The Max Planck Society; Agence Nationale de la Recherche [ANR-09-BLAN-0005-01]; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2009-0071776]	The Swedish Research Council (VR)(Swedish Research Council); The Max Planck Society(Max Planck Society); Agence Nationale de la Recherche(French National Research Agency (ANR)); Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	Funders are The Swedish Research Council (VR), The Max Planck Society, Agence Nationale de la Recherche (reference ANR-09-BLAN-0005-01), and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0071776). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 1999, ECOLOGY, V80, P1713, DOI 10.1890/0012-9658(1999)080[1713:IRTHIW]2.0.CO;2; Agrawal AA, 1998, SCIENCE, V279, P1201, DOI 10.1126/science.279.5354.1201; Amiard V, 2007, NEW PHYTOL, V173, P722, DOI 10.1111/j.1469-8137.2006.01954.x; Baldwin IT, 1998, P NATL ACAD SCI USA, V95, P8113, DOI 10.1073/pnas.95.14.8113; Baldwin IT, 1996, ENTOMOLOGIA EXPT APP, V80, P353; Burow M, 2006, J CHEM ECOL, V32, P2333, DOI 10.1007/s10886-006-9149-1; Carvalho RF, 2011, J INTEGR PLANT BIOL, V53, P920, DOI 10.1111/j.1744-7909.2011.01081.x; Chen YG, 2008, ENTOMOL EXP APPL, V126, P244, DOI 10.1111/j.1570-7458.2007.00662.x; Cipollini DF, 2002, OECOLOGIA, V131, P514, DOI 10.1007/s00442-002-0909-5; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Fernandez AP, 2008, CURR OPIN PLANT BIOL, V11, P509, DOI 10.1016/j.pbi.2008.06.002; Frenkel M, 2008, NEW PHYTOL, V180, P545, DOI 10.1111/j.1469-8137.2008.02591.x; Frenkel M, 2007, PHYSIOL PLANTARUM, V129, P455, DOI 10.1111/j.1399-3054.2006.00831.x; Frenkel M, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-12; Fryer MJ, 2002, J EXP BOT, V53, P1249, DOI 10.1093/jexbot/53.372.1249; Gardner SN, 2002, EVOL ECOL RES, V4, P1131; Georgiou CD, 2005, ANAL BIOCHEM, V347, P144, DOI 10.1016/j.ab.2005.09.013; Gilmore AM, 1998, BIOCHEMISTRY-US, V37, P13582, DOI 10.1021/bi981384x; Gohre V, 2012, MOL PLANT MICROBE IN, V25, P1083, DOI 10.1094/MPMI-11-11-0301; Havaux M, 1999, P NATL ACAD SCI USA, V96, P8762, DOI 10.1073/pnas.96.15.8762; Heil M, 2001, EUR J PLANT PATHOL, V107, P137, DOI 10.1023/A:1008793009517; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Hideg E, 2002, PLANT CELL PHYSIOL, V43, P1154, DOI 10.1093/pcp/pcf145; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Jankanpaa HJ, 2012, PLANT CELL ENVIRON, V35, P1824, DOI 10.1111/j.1365-3040.2012.02519.x; Jung C, 2007, PLANT CELL REP, V26, P1053, DOI 10.1007/s00299-007-0311-1; Kalai T, 2002, ARKIVOC, P112, DOI 10.3998/ark.5550190.0003.312; Kariola T, 2005, PLANT CELL, V17, P282, DOI 10.1105/tpc.104.025817; Karpinski S, 2003, CURR OPIN PLANT BIOL, V6, P390, DOI 10.1016/S1369-5266(03)00061-X; Kliebenstein DJ, 2005, CURR OPIN PLANT BIOL, V8, P264, DOI 10.1016/j.pbi.2005.03.002; Kulheim C, 2005, PHYSIOL PLANTARUM, V125, P202, DOI 10.1111/j.1399-3054.2005.00547.x; Kulheim C, 2002, SCIENCE, V297; Li Q, 2000, J CHEM ECOL, V26, P2401, DOI 10.1023/A:1005535129399; Li XP, 2002, P NATL ACAD SCI USA, V99, P15222, DOI 10.1073/pnas.232447699; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Long SP, 2006, PLANT CELL ENVIRON, V29, P315, DOI 10.1111/j.1365-3040.2005.01493.x; Lu YB, 2004, ECOL LETT, V7, P337, DOI 10.1111/j.1461-0248.2004.00582.x; Mahalingam R, 2006, PLANT CELL ENVIRON, V29, P1357, DOI 10.1111/j.1365-3040.2006.01516.x; Mello Marcia O., 2002, Braz. J. Plant Physiol., V14, P71, DOI 10.1590/S1677-04202002000200001; Mewis I, 2006, PHYTOCHEMISTRY, V67, P2450, DOI 10.1016/j.phytochem.2006.09.004; Mubarakshina MM, 2010, J EXP BOT, V61, P3577, DOI 10.1093/jxb/erq171; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Niyogi KK, 2005, J EXP BOT, V56, P375, DOI 10.1093/jxb/eri056; Ratzka A, 2002, P NATL ACAD SCI USA, V99, P11223, DOI 10.1073/pnas.172112899; Roach T, 2012, BIOCH BIOPH IN PRESS; Siemens DH, 2002, ECOLOGY, V83, P505, DOI 10.1890/0012-9658(2002)083[0505:CODITC]2.0.CO;2; Spencer JL, 1996, ENTOMOL EXP APPL, V81, P165, DOI 10.1007/BF00192141; STOCKHOFF BA, 1993, PHYSIOL ENTOMOL, V18, P409, DOI 10.1111/j.1365-3032.1993.tb00615.x; van Kleunen M, 2004, BASIC APPL ECOL, V5, P173, DOI 10.1078/1439-1791-00225; Verhage A, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00047; Wasternack C, 1998, FETT-LIPID, V100, P139	51	28	28	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53232	10.1371/journal.pone.0053232	http://dx.doi.org/10.1371/journal.pone.0053232			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301046	Green Submitted, gold, Green Published			2022-12-25	WOS:000313320900069
J	Ono, M; Tanaka, RJ; Kano, M; Sugiman, T				Ono, Masahiro; Tanaka, Reiko J.; Kano, Manabu; Sugiman, Toshio			Visualising the Cross-Level Relationships between Pathological and Physiological Processes and Gene Expression: Analyses of Haematological Diseases	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; CANONICAL CORRESPONDENCE-ANALYSIS; ACUTE PROMYELOCYTIC LEUKEMIA; MYELODYSPLASTIC SYNDROMES; BREAST-CANCER; MICROARRAY DATA; CELLS; CLASSIFICATION; TRANSLOCATION	The understanding of pathological processes is based on the comparison between physiological and pathological conditions, and transcriptomic analysis has been extensively applied to various diseases for this purpose. However, the way in which the transcriptomic data of pathological cells relate to the transcriptomes of normal cellular counterparts has not been fully explored, and may provide new and unbiased insights into the mechanisms of these diseases. To achieve this, it is necessary to develop a method to simultaneously analyse components across different levels, namely genes, normal cells, and diseases. Here we propose a multidimensional method that visualises the cross-level relationships between these components at three different levels based on transcriptomic data of physiological and pathological processes, by adapting Canonical Correspondence Analysis, which was developed in ecology and sociology, to microarray data (CCA on Microarray data, CCAM). Using CCAM, we have analysed transcriptomes of haematological disorders and those of normal haematopoietic cell differentiation. First, by analysing leukaemia data, CCAM successfully visualised known relationships between leukaemia subtypes and cellular differentiation, and their characteristic genes, which confirmed the relevance of CCAM. Next, by analysing transcriptomes of myelodysplastic syndromes (MDS), we have shown that CCAM was effective in both generating and testing hypotheses. CCAM showed that among MDS patients, high-risk patients had transcriptomes that were more similar to those of both haematopoietic stem cells (HSC) and megakaryocyte-erythroid progenitors ( MEP) than low-risk patients, and provided a prognostic model. Collectively, CCAM reveals hidden relationships between pathological and physiological processes and gene expression, providing meaningful clinical insights into haematological diseases, and these could not be revealed by other univariate and multivariate methods. Furthermore, CCAM was effective in identifying candidate genes that are correlated with cellular phenotypes of interest. We expect that CCAM will benefit a wide range of medical fields.	[Ono, Masahiro] UCL, Immunobiol Unit, Inst Child Hlth, London, England; [Tanaka, Reiko J.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Kano, Manabu] Kyoto Univ, Dept Syst Sci, Kyoto, Japan; [Sugiman, Toshio] Kyoto Univ, Grad Sch Human Environm Studies, Dept Human Coexistence, Kyoto, Japan	University of London; University College London; Imperial College London; Kyoto University; Kyoto University	Ono, M (corresponding author), UCL, Immunobiol Unit, Inst Child Hlth, London, England.	m.ono@ucl.ac.uk	Ono, Masahiro/H-2378-2011; Kano, Manabu/AAH-6448-2020	Ono, Masahiro/0000-0002-9284-7326; Kano, Manabu/0000-0002-2325-1043	EPSRC; BBSRC [BB/J013951/1] Funding Source: UKRI; EPSRC [EP/G007446/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J013951/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/G007446/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	M.O. is a Human Frontier Science Program (HFSP, www.hfsp.org) Long-Term Fellow. R.J.T. is supported by EPSRC (www.epsrc.ac.uk) Career Acceleration Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MK, 2006, IMMUNOL REV, V209, P191, DOI 10.1111/j.0105-2896.2006.00352.x; Balgobind BV, 2011, HAEMATOL-HEMATOL J, V96, P221, DOI 10.3324/haematol.2010.029660; Baty F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-422; BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; Blobel GA, 2000, BLOOD, V95, P745, DOI 10.1182/blood.V95.3.745.003k05_745_755; Burkle A, 2007, BLOOD, V110, P3316, DOI 10.1182/blood-2007-05-089409; Cazzola M, 2011, HAEMATOL-HEMATOL J, V96, P349, DOI 10.3324/haematol.2010.030023; Chiorazzi N, 2011, BLOOD, V117, P1781, DOI 10.1182/blood-2010-07-155663; Cox CV, 2005, STEM CELL REV, V1, P189, DOI 10.1385/SCR:1:3:189; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; Ebert BL, 2008, PLOS MED, V5, P312, DOI 10.1371/journal.pmed.0050035; Faderl S, 2003, CANCER-AM CANCER SOC, V98, P1337, DOI 10.1002/cncr.11664; Fellenberg K, 2001, P NATL ACAD SCI USA, V98, P10781, DOI 10.1073/pnas.181597298; FOURNIER S, 1992, J CLIN INVEST, V89, P1312, DOI 10.1172/JCI115717; Greenacre M, 2008, CORRES ANAL PRACTICE; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Greenberg SA, 2012, GENES IMMUN, V13, P207, DOI 10.1038/gene.2011.61; GRIFFIN JD, 1983, BLOOD, V61, P85; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Hart SM, 2002, HAEMATOLOGICA, V87, P1307; Hubmann R, 2010, BRIT J HAEMATOL, V148, P868, DOI 10.1111/j.1365-2141.2009.08024.x; Iqbal J, 2010, BLOOD, V115, P1026, DOI 10.1182/blood-2009-06-227579; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kishino H, 2000, Genome Inform Ser Workshop Genome Inform, V11, P83; Koury M, 2008, WINTROBES CLIN HEMAT; Kuhn A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-26; Lanasa MC, 2011, LEUKEMIA LYMPHOMA, V52, P1398, DOI 10.3109/10428194.2011.568076; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; Larsson O, 2006, OMICS, V10, P381, DOI 10.1089/omi.2006.10.381; LEBEAU MM, 1983, NEW ENGL J MED, V309, P630, DOI 10.1056/NEJM198309153091103; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Malcovati L, 2005, J CLIN ONCOL, V23, P7594, DOI 10.1200/JCO.2005.01.7038; Martens JHA, 2011, INT J BIOCHEM CELL B, V43, P1413, DOI 10.1016/j.biocel.2011.05.014; McCune B, 1997, ECOLOGY, V78, P2617; Mills KI, 2009, BLOOD, V114, P1063, DOI 10.1182/blood-2008-10-187203; Miura Y, 1998, BLOOD, V92, P2815, DOI 10.1182/blood.V92.8.2815.420k09_2815_2822; Nikpour M, 2010, BRIT J HAEMATOL, V149, P844, DOI 10.1111/j.1365-2141.2010.08174.x; Nolte F, 2010, FUTURE ONCOL, V6, P445, DOI [10.2217/fon.09.175, 10.2217/FON.09.175]; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; NUCIFORA G, 1993, BLOOD, V82, P712; Oksanen J, 2011, TECHNICAL REPORT; PALMER MW, 1993, ECOLOGY, V74, P2215, DOI 10.2307/1939575; Porakishvili N, 2011, BRIT J HAEMATOL, V153, P486, DOI 10.1111/j.1365-2141.2011.08605.x; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Sandberg R, 2005, P NATL ACAD SCI USA, V102, P2052, DOI 10.1073/pnas.0408105102; Schoch C, 2003, BLOOD, V102, P2395, DOI 10.1182/blood-2003-02-0434; Schoch C, 1996, BRIT J HAEMATOL, V94, P493, DOI 10.1046/j.1365-2141.1996.d01-1829.x; Sell S, 2005, STEM CELL REV, V1, P197, DOI 10.1385/SCR:1:3:197; Shaffer AL, 2001, IMMUNITY, V15, P375, DOI 10.1016/S1074-7613(01)00194-7; Shih AH, 2011, SEMIN ONCOL, V38, P613, DOI 10.1053/j.seminoncol.2011.04.013; SMYTH GK, 2004, STAT APPL GENET MOL, V3; Sternberg A, 2005, BLOOD, V106, P2982, DOI 10.1182/blood-2005-04-1543; Sugiman T, 1998, ASIAN J SOC PSYCHOL, V1, P51, DOI DOI 10.1111/1467-839X.00005; Symmans WF, 2010, J CLIN ONCOL, V28, P4111, DOI 10.1200/JCO.2010.28.4273; Szczepanski T, 2003, BEST PRACT RES CL HA, V16, P561, DOI 10.1053/ybeha.2003.285; Tanaka RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019895; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Tzeng J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-179; Valent P, 2009, LEUKEMIA LYMPHOMA, V50, P341, DOI 10.1080/10428190902756107; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wang HW, 2004, NAT GENET, V36, P687, DOI 10.1038/ng1384; Wouters BJ, 2009, BLOOD, V113, P291, DOI 10.1182/blood-2008-04-153239	64	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53544	10.1371/journal.pone.0053544	http://dx.doi.org/10.1371/journal.pone.0053544			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301083	Green Published, Green Submitted, gold			2022-12-25	WOS:000313320900083
J	Rijnkels, M; Freeman-Zadrowski, C; Hernandez, J; Potluri, V; Wang, LG; Li, W; Lemay, DG				Rijnkels, Monique; Freeman-Zadrowski, Courtneay; Hernandez, Joseph; Potluri, Vani; Wang, Liguo; Li, Wei; Lemay, Danielle G.			Epigenetic Modifications Unlock the Milk Protein Gene Loci during Mouse Mammary Gland Development and Differentiation	PLOS ONE			English	Article							BETA-GLOBIN LOCUS; DNA METHYLATION; CHROMATIN-STRUCTURE; TRANSGENIC MICE; HUMAN GENOME; CASEIN GENE; CELL-FATE; TRANSCRIPTION FACTORS; SECRETORY ACTIVATION; REGULATORY ELEMENTS	Background: Unlike other tissues, development and differentiation of the mammary gland occur mostly after birth. The roles of systemic hormones and local growth factors important for this development and functional differentiation are well-studied. In other tissues, it has been shown that chromatin organization plays a key role in transcriptional regulation and underlies epigenetic regulation during development and differentiation. However, the role of chromatin organization in mammary gland development and differentiation is less well-defined. Here, we have studied the changes in chromatin organization at the milk protein gene loci (casein, whey acidic protein, and others) in the mouse mammary gland before and after functional differentiation. Methodology/Principal Findings: Distal regulatory elements within the casein gene cluster and whey acidic protein gene region have an open chromatin organization after pubertal development, while proximal promoters only gain open-chromatin marks during pregnancy in conjunction with the major induction of their expression. In contrast, other milk protein genes, such as alpha-lactalbumin, already have an open chromatin organization in the mature virgin gland. Changes in chromatin organization in the casein gene cluster region that are present after puberty persisted after lactation has ceased, while the changes which occurred during pregnancy at the gene promoters were not maintained. In general, mammary gland expressed genes and their regulatory elements exhibit developmental stage- and tissue-specific chromatin organization. Conclusions/Significance: A progressive gain of epigenetic marks indicative of open/active chromatin on genes marking functional differentiation accompanies the development of the mammary gland. These results support a model in which a chromatin organization is established during pubertal development that is then poised to respond to the systemic hormonal signals of pregnancy and lactation to achieve the full functional capacity of the mammary gland.	[Rijnkels, Monique; Freeman-Zadrowski, Courtneay; Hernandez, Joseph; Potluri, Vani] Baylor Coll Med, USDA ARS, Childrens Nutr Res Ctr, Dept Pediat Nutr, Houston, TX 77030 USA; [Wang, Liguo; Li, Wei] Baylor Coll Med, Dept Mol & Cellular Biol, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA; [Lemay, Danielle G.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA	Baylor College of Medicine; United States Department of Agriculture (USDA); Baylor College of Medicine; University of California System; University of California Davis	Rijnkels, M (corresponding author), Baylor Coll Med, USDA ARS, Childrens Nutr Res Ctr, Dept Pediat Nutr, Houston, TX 77030 USA.	rijnkel@bcm.edu		Lemay, Danielle/0000-0003-3318-0485; Wang, Liguo/0000-0003-2072-4826	National Institute of Health [1R21HD05376, 1R03HD05609]; USDA [6200-51000-048]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA(United States Department of Agriculture (USDA))	This work was supported by grants from National Institute of Health (1R21HD05376, 1R03HD05609) and USDA (6200-51000-048) to MR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2007, BLOOD, V109, P3895, DOI 10.1182/blood-2006-08-040147; Anderson SM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1653; Ausuble F. M., 1987, CURRENT PROTOCOLS MO; Bao L, 2008, NUCLEIC ACIDS RES, V36, pD83, DOI 10.1093/nar/gkm875; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Blakely CM, 2006, CANCER RES, V66, P6421, DOI 10.1158/0008-5472.CAN-05-4235; Bulger M, 2010, DEV BIOL, V339, P250, DOI 10.1016/j.ydbio.2009.11.035; Buser AC, 2007, MOL ENDOCRINOL, V21, P106, DOI 10.1210/me.2006-0297; Casey TM, 2007, J MAMMARY GLAND BIOL, V12, P293, DOI 10.1007/s10911-007-9055-3; Choi YS, 2009, DEV BIOL, V329, P227, DOI 10.1016/j.ydbio.2009.02.032; Clarkson RWE, 2004, BREAST CANCER RES, V6, pR92, DOI 10.1186/bcr754; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; D'Cruz CM, 2002, MOL ENDOCRINOL, V16, P2034, DOI 10.1210/me.2002-0073; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Fata JE, 2007, DEV BIOL, V306, P193, DOI 10.1016/j.ydbio.2007.03.013; Ginger MR, 2003, BREAST CANCER RES, V5, P192, DOI 10.1186/bcr603; Ginger MR, 2001, MOL ENDOCRINOL, V15, P1993, DOI 10.1210/me.15.11.1993; Hemberg M, 2012, NUCL ACIDS RES; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Hovey RC, 2002, J MAMMARY GLAND BIOL, V7, P17, DOI 10.1023/A:1015766322258; Howlin J, 2006, J MAMMARY GLAND BIOL, V11, P283, DOI 10.1007/s10911-006-9024-2; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; JOHNSON ML, 1983, J BIOL CHEM, V258, P805; Jura J, 2005, BBA-GENE STRUCT EXPR, V1727, P58, DOI 10.1016/j.bbaexp.2004.11.008; Kabotyanski EB, 2006, MOL ENDOCRINOL, V20, P2355, DOI 10.1210/me.2006-0160; Kabotyanski EB, 2009, J BIOL CHEM, V284, P22815, DOI 10.1074/jbc.M109.032490; KESHET I, 1986, CELL, V44, P535, DOI 10.1016/0092-8674(86)90263-1; Kestler DP, 2008, MOL MED, V14, P318, DOI 10.2119/2008-00010.Kestler; Kim K, 2010, INT J BIOCHEM CELL B, V42, P1517, DOI 10.1016/j.biocel.2010.05.009; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kimura AP, 2007, MOL CELL BIOL, V27, P6555, DOI 10.1128/MCB.00273-07; Kleinberg D, 2008, J MAMMARY GLAND BIOL, V13, P353, DOI 10.1007/s10911-008-9103-7; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; LaMarca HL, 2008, ENDOCRINOLOGY, V149, P4317, DOI 10.1210/en.2008-0450; LaMarca HL, 2010, STEM CELLS, V28, P535, DOI 10.1002/stem.297; Lee HJ, 2011, STEM CELLS; Lemay DG, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-56; LI BL, 1994, CELL GROWTH DIFFER, V5, P711; LI BL, 1995, MOL CARCINOGEN, V14, P75, DOI 10.1002/mc.2940140203; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; LI S, 1995, MOL CELL BIOL, V15, P2063; LI S, 1994, J BIOL CHEM, V269, P14235; LI S, 1994, MOL ENDOCRINOL, V8, P1328, DOI 10.1210/me.8.10.1328; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maruyama R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001369; Master Stephen R, 2004, Breast Dis, V19, P47; McArthur M, 2001, J MOL BIOL, V313, P27, DOI 10.1006/jmbi.2001.4969; Medina D, 2001, ANN NY ACAD SCI, V952, P23, DOI 10.1111/j.1749-6632.2001.tb02725.x; Millot B, 2003, BIOCHEM J, V372, P41, DOI 10.1042/BJ20021894; Millot B, 2001, BIOCHEM J, V359, P557, DOI 10.1042/0264-6021:3590557; Oakes SR, 2008, J MAMMARY GLAND BIOL, V13, P13, DOI 10.1007/s10911-008-9069-5; Oakes SR, 2008, GENE DEV, V22, P581, DOI 10.1101/gad.1614608; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Platenburg GJ, 1996, TRANSGENIC RES, V5, P421, DOI 10.1007/BF01980207; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Rijnkels M, 2003, GENOMICS, V82, P417, DOI 10.1016/S0888-7543(03)00114-9; Rijnkels M, 2002, J MAMMARY GLAND BIOL, V7, P327, DOI 10.1023/A:1022808918013; Rijnkels M, 2010, J MAMMARY GLAND BIOL, V15, P85, DOI 10.1007/s10911-010-9170-4; ROBINSON GW, 1995, DEVELOPMENT, V121, P2079; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Rosen JM, 1998, BIOCHEM SOC SYMP, P101; Rudolph MC, 2003, J MAMMARY GLAND BIOL, V8, P287, DOI 10.1023/B:JOMG.0000010030.73983.57; Rudolph MC, 2007, PHYSIOL GENOMICS, V28, P323, DOI 10.1152/physiolgenomics.00020.2006; Singh K, 2010, J MAMMARY GLAND BIOL, V15, P101, DOI 10.1007/s10911-010-9164-2; Stein T, 2004, BREAST CANCER RES, V6, pR75, DOI 10.1186/bcr753; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Vafaizadeh V, 2012, FRONT BIOSCI-LANDMRK, V17, P1232, DOI 10.2741/3983; Vanselow J, 2006, J MOL ENDOCRINOL, V37, P463, DOI 10.1677/jme.1.02131; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Wagschal A, 2007, COLD SPRING HARB PRO, V2007; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wang M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-328; Wang ZB, 2009, CURR OPIN GENET DEV, V19, P127, DOI 10.1016/j.gde.2009.02.001; Watson CJ, 2008, SEMIN CELL DEV BIOL, V19, P401, DOI 10.1016/j.semcdb.2008.07.021; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wellberg E, 2010, DEVELOPMENT, V137, P945, DOI 10.1242/dev.041657; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; Whitelaw CBA, 2000, ADV EXP MED BIOL, V480, P147; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; WU C, 1979, CELL, V16, P807, DOI 10.1016/0092-8674(79)90096-5; Xu R, 2007, J BIOL CHEM, V282, P14992, DOI 10.1074/jbc.M610316200; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	88	44	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53270	10.1371/journal.pone.0053270	http://dx.doi.org/10.1371/journal.pone.0053270			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301053	gold, Green Published, Green Submitted			2022-12-25	WOS:000313320900072
J	Zhou, DE; Yang, L; Zheng, LT; Ge, WT; Li, D; Zhang, Y; Hu, XD; Gao, ZB; Xu, JH; Huang, YQ; Hu, HG; Zhang, H; Zhang, H; Liu, MM; Yang, HM; Zheng, L; Zheng, S				Zhou, Donger; Yang, Liu; Zheng, Liangtao; Ge, Weiting; Li, Dan; Zhang, Yong; Hu, Xueda; Gao, Zhibo; Xu, Jinghong; Huang, Yanqin; Hu, Hanguang; Zhang, Hang; Zhang, Hao; Liu, Mingming; Yang, Huanming; Zheng, Lei; Zheng, Shu			Exome Capture Sequencing of Adenoma Reveals Genetic Alterations in Multiple Cellular Pathways at the Early Stage of Colorectal Tumorigenesis	PLOS ONE			English	Article							INACTIVATING MUTATIONS; SOMATIC MUTATIONS; HUMAN BREAST; METHYLATION; FRAMEWORK; CANCERS; HEAD	Most of colorectal adenocarcinomas are believed to arise from adenomas, which are premalignant lesions. Sequencing the whole exome of the adenoma will help identifying molecular biomarkers that can predict the occurrence of adenocarcinoma more precisely and help understanding the molecular pathways underlying the initial stage of colorectal tumorigenesis. We performed the exome capture sequencing of the normal mucosa, adenoma and adenocarcinoma tissues from the same patient and sequenced the identified mutations in additional 73 adenomas and 288 adenocarcinomas. Somatic single nucleotide variations (SNVs) were identified in both the adenoma and adenocarcinoma by comparing with the normal control from the same patient. We identified 12 nonsynonymous somatic SNVs in the adenoma and 42 nonsynonymous somatic SNVs in the adenocarcinoma. Most of these mutations including OR6X1, SLC15A3, KRTHB4, RBFOX1, LAMA3, CDH20, BIRC6, NMBR, GLCCI1, EFR3A, and FTHL17 were newly reported in colorectal adenomas. Functional annotation of these mutated genes showed that multiple cellular pathways including Wnt, cell adhesion and ubiquitin mediated proteolysis pathways were altered genetically in the adenoma and that the genetic alterations in the same pathways persist in the adenocarcinoma. CDH20 and LAMA3 were mutated in the adenoma while NRXN3 and COL4A6 were mutated in the adenocarcinoma from the same patient, suggesting for the first time that genetic alterations in the cell adhesion pathway occur as early as in the adenoma. Thus, the comparison of genomic mutations between adenoma and adenocarcinoma provides us a new insight into the molecular events governing the early step of colorectal tumorigenesis.	[Zhou, Donger; Yang, Liu; Zheng, Liangtao; Ge, Weiting; Li, Dan; Huang, Yanqin; Hu, Hanguang; Zhang, Hang; Zheng, Shu] China Natl Minist Educ, Key Lab Canc Prevent & Intervent, Key Lab Mol Biol Med Sci Zhejiang Prov, Inst Canc, Hangzhou, Zhejiang, Peoples R China; [Zhou, Donger; Yang, Liu; Zheng, Liangtao; Ge, Weiting; Li, Dan; Xu, Jinghong; Huang, Yanqin; Hu, Hanguang; Zhang, Hang; Zheng, Lei; Zheng, Shu] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Yong; Hu, Xueda; Gao, Zhibo; Zhang, Hao; Liu, Mingming; Yang, Huanming] Beijing Genom Inst BGI Shenzhen, Shenzhen, Peoples R China; [Zheng, Lei] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr,Johns Hopkins, Baltimore, MD 21205 USA; [Zheng, Lei] Johns Hopkins Univ, Sch Med, Dept Surg, Sidney Kimmel Comprehens Canc Ctr,Johns Hopkins, Baltimore, MD 21205 USA	Zhejiang University; Beijing Genomics Institute (BGI); Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Zheng, S (corresponding author), China Natl Minist Educ, Key Lab Canc Prevent & Intervent, Key Lab Mol Biol Med Sci Zhejiang Prov, Inst Canc, Hangzhou, Zhejiang, Peoples R China.	lzheng6@jhmi.edu	wei, jiang/GRX-7907-2022; xu, jing/GRR-8698-2022; yang, liu/GVU-8760-2022; GE, Weiting/AAK-5197-2020	GE, Weiting/0000-0002-4769-0251; Zheng, Liangtao/0000-0001-9795-3198	National Natural Science of China Foundation [30973382]; National High Technology Research and Development Program of China [2006AA02A302, 2012AA02A204, 2012AA02A506]; NIH [K23 CA148964-01]; Johns Hopkins University School of Medicine Clinician Scientist Award; NATIONAL CANCER INSTITUTE [R01CA169702, K23CA148964, P30CA006973] Funding Source: NIH RePORTER	National Natural Science of China Foundation(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University School of Medicine Clinician Scientist Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project is supported by the National Natural Science of China Foundation 30973382 and the National High Technology Research and Development Program of China (2006AA02A302,2012AA02A204,2012AA02A506). Lei Zheng is supported by an NIH K23 CA148964-01 and a Johns Hopkins University School of Medicine Clinician Scientist Award. Lei Zheng is an adjunct "Guangji Scholar" at the Second Affiliated Hospital of Zhejiang University School of medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jie He PZ, 2011, CHINESE CANC REGISTR; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kanda M, 2012, GASTROENTEROLOGY, V142, P730, DOI 10.1053/j.gastro.2011.12.042; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kemp Z, 2005, CANCER RES, V65, P11361, DOI 10.1158/0008-5472.CAN-05-2565; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Lovig T, 2002, SCAND J GASTROENTERO, V37, P1184, DOI 10.1080/003655202760373407; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Olivier Magali, 2004, IARC Sci Publ, P247; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Samuels Y, 2004, CELL CYCLE, V3, P1221, DOI 10.4161/cc.3.10.1164; Sancho R, 2010, GASTROENTEROLOGY, V139, P929, DOI 10.1053/j.gastro.2010.05.078; Scheel C, 2007, CANCER RES, V67, P11476, DOI 10.1158/0008-5472.CAN-07-1653; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Thiagalingam S, 1996, NAT GENET, V13, P343, DOI 10.1038/ng0796-343; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Yang G, 1998, J NATL CANCER I, V90, P1661, DOI 10.1093/jnci/90.21.1661	40	31	32	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53310	10.1371/journal.pone.0053310	http://dx.doi.org/10.1371/journal.pone.0053310			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301059	Green Submitted, Green Published, gold			2022-12-25	WOS:000313320900074
J	Zussy, C; Brureau, A; Keller, E; Marchal, S; Blayo, C; Delair, B; Ixart, G; Maurice, T; Givalois, L				Zussy, Charleine; Brureau, Anthony; Keller, Emeline; Marchal, Stephane; Blayo, Claire; Delair, Brice; Ixart, Guy; Maurice, Tangui; Givalois, Laurent			Alzheimer's Disease Related Markers, Cellular Toxicity and Behavioral Deficits Induced Six Weeks after Oligomeric Amyloid-beta Peptide Injection in Rats	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; SOLUBLE-PROTEIN OLIGOMERS; CENTRAL-NERVOUS-SYSTEM; A-BETA; NEUROTROPHIC FACTOR; IN-VITRO; BETA-PROTEIN/A4 DEPOSITS; INDUCED NEUROTOXICITY; MEMORY DEFICITS; APOPTOTIC DEATH	Alzheimer's disease (AD) is a neurodegenerative pathology associated with aging characterized by the presence of senile plaques and neurofibrillary tangles that finally result in synaptic and neuronal loss. The major component of senile plaques is an amyloid-beta protein (A beta). Recently, we characterized the effects of a single intracerebroventricular (icv) injection of A beta fragment (25-35) oligomers (oA beta(25-35)) for up to 3 weeks in rats and established a clear parallel with numerous relevant signs of AD. To clarify the long- term effects of oA beta(25-35) and its potential role in the pathogenesis of AD, we determined its physiological, behavioral, biochemical and morphological impacts 6 weeks after injection in rats. oA beta(25-35) was still present in the brain after 6 weeks. oA beta(25-35) injection did not affect general activity and temperature rhythms after 6 weeks, but decreased body weight, induced short-and long-term memory impairments, increased corticosterone plasma levels, brain oxidative (lipid peroxidation), mitochondrial (caspase-9 levels) and reticulum stress (caspase-12 levels), astroglial and microglial activation. It provoked cholinergic neuron loss and decreased brain-derived neurotrophic factor levels. It induced cell loss in the hippocampic CA subdivisions and decreased hippocampic neurogenesis. Moreover, oA beta(25-35) injection resulted in increased APP expression, A beta(1-42) generation, and increased Tau phosphorylation. In conclusion, this in vivo study evidenced that the soluble oligomeric forms of short fragments of A beta, endogenously identified in AD patient brains, not only provoked long- lasting pathological alterations comparable to the human disease, but may also directly contribute to the progressive increase in amyloid load and Tau pathology, involved in the AD physiopathology.	[Zussy, Charleine; Brureau, Anthony; Keller, Emeline; Marchal, Stephane; Blayo, Claire; Delair, Brice; Ixart, Guy; Maurice, Tangui; Givalois, Laurent] Inserm U710, Mol Mechanisms Neurodegenerat Dementia Lab, Montpellier, France; [Zussy, Charleine; Brureau, Anthony; Keller, Emeline; Marchal, Stephane; Blayo, Claire; Delair, Brice; Ixart, Guy; Maurice, Tangui; Givalois, Laurent] Univ Montpellier 2, Montpellier, France; [Zussy, Charleine; Brureau, Anthony; Keller, Emeline; Marchal, Stephane; Blayo, Claire; Delair, Brice; Ixart, Guy; Maurice, Tangui; Givalois, Laurent] EPHE, F-75006 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE)	Givalois, L (corresponding author), Inserm U710, Mol Mechanisms Neurodegenerat Dementia Lab, Montpellier, France.	lgivalois@univ-montp2.fr	Maurice, Tangui/AAP-2499-2020; MARCHAL, stéphane/M-4324-2017	Maurice, Tangui/0000-0002-4074-6793; MARCHAL, stéphane/0000-0002-1101-7890; Givalois, Laurent/0000-0002-6698-5346	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by annual INSERM funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham I, 2000, J NEUROENDOCRINOL, V12, P486, DOI 10.1046/j.1365-2826.2000.00475.x; Alkam T, 2008, J PHARMACOL EXP THER, V327, P137, DOI 10.1124/jpet.108.141309; Arancibia S, 2008, NEUROBIOL DIS, V31, P316, DOI 10.1016/j.nbd.2008.05.012; Bazan-Peregrino M, 2007, J NEUROSCI RES, V85, P332, DOI 10.1002/jnr.21112; Bertrand J, 2010, NEUROSCIENCE, V168, P323, DOI 10.1016/j.neuroscience.2010.04.009; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Catania C, 2009, MOL PSYCHIATR, V14, P95, DOI 10.1038/sj.mp.4002101; Chavant F, 2010, J PHARMACOL EXP THER, V332, P505, DOI 10.1124/jpet.109.162164; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Cotrufo T, 2003, J NEUROSCI, V23, P3566; DAVIS KL, 1986, AM J PSYCHIAT, V143, P300; Delobette S, 1997, EUR J PHARMACOL, V319, P1, DOI 10.1016/S0014-2999(96)00922-3; Eikelenboom P, 2006, J NEURAL TRANSM, V113, P1685, DOI 10.1007/s00702-006-0575-6; Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882; Geci C, 2007, J NEUROCHEM, V101, P664, DOI 10.1111/j.1471-4159.2006.04415.x; Givalois L, 2004, MOL CELL NEUROSCI, V27, P280, DOI 10.1016/j.mcn.2004.07.002; Givalois L, 2004, ENDOCRINOLOGY, V145, P4737, DOI 10.1210/en.2004-0616; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Goodman YD, 1996, J NEUROCHEM, V66, P1836; Gruden MA, 2007, J NEUROIMMUNOL, V186, P181, DOI 10.1016/j.jneuroim.2007.03.023; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; HERMESLIMA M, 1995, FREE RADICAL BIO MED, V19, P271, DOI 10.1016/0891-5849(95)00020-X; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Jakob-Roetne R, 2009, ANGEW CHEM INT EDIT, V48, P3030, DOI 10.1002/anie.200802808; Kaneko I, 2001, NEUROSCIENCE, V104, P1003, DOI 10.1016/S0306-4522(01)00155-5; Khan A, 2012, MOL CELL BIOCHEM, V369, P55, DOI 10.1007/s11010-012-1368-x; Klementiev B, 2007, NEUROSCIENCE, V145, P209, DOI 10.1016/j.neuroscience.2006.11.060; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; Korolainen MA, 2005, NEUROBIOL DIS, V20, P858, DOI 10.1016/j.nbd.2005.05.021; KRUGERS HJ, 1993, NEUROSCI LETT, V154, P73, DOI 10.1016/0304-3940(93)90174-J; Kubo T, 2002, J NEUROSCI RES, V70, P474, DOI 10.1002/jnr.10391; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Li XK, 2005, NEUROL RES, V27, P218, DOI 10.1179/016164105X35585; Lin F, 2012, ARZNEIMITTELFORSCH, V62, P187, DOI 10.1055/s-0031-1299763; Lin HB, 2009, PSYCHOPHARMACOLOGY, V204, P705, DOI 10.1007/s00213-009-1499-2; LOWY MT, 1993, J NEUROCHEM, V61, P1957, DOI 10.1111/j.1471-4159.1993.tb09839.x; MASUGI F, 1989, METHOD FIND EXP CLIN, V11, P707; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Maurice T, 1996, BRAIN RES, V731, P249, DOI 10.1016/S0006-8993(96)00710-X; Maurice T, 1996, BRAIN RES, V706, P181, DOI 10.1016/0006-8993(95)01032-7; McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.071; MCGEER PL, 1987, NEUROSCI LETT, V79, P195, DOI 10.1016/0304-3940(87)90696-3; Meunier J, 2006, BRIT J PHARMACOL, V149, P998, DOI 10.1038/sj.bjp.0706927; Meunier J, 2004, BRIT J PHARMACOL, V142, P689, DOI 10.1038/sj.bjp.0705835; Millucci L, 2010, CURR PROTEIN PEPT SC, V11, P54, DOI 10.2174/138920310790274626; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Naert G, 2006, NEUROSCIENCE, V139, P779, DOI 10.1016/j.neuroscience.2005.12.028; Nagele RG, 2004, NEUROBIOL AGING, V25, P663, DOI 10.1016/j.neurobiolaging.2004.01.007; Nguyen N, 2009, NEUROCHEM RES, V34, P942, DOI 10.1007/s11064-008-9848-9; Paxinos G., 1998, RAT BRAIN STEROTAXIC; PIKE CJ, 1995, J NEUROCHEM, V64, P253, DOI 10.1046/j.1471-4159.1995.64010253.x; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Rao RV, 2002, J BIOL CHEM, V277, P21836, DOI 10.1074/jbc.M202726200; ROGERS J, 1988, NEUROBIOL AGING, V9, P339, DOI 10.1016/S0197-4580(88)80079-4; Rogers J, 2008, J PERIODONTOL, V79, P1535, DOI 10.1902/jop.2008.080171; Rojo LE, 2008, ARCH MED RES, V39, P1, DOI 10.1016/j.arcmed.2007.10.001; ROZEMULLER JM, 1989, NEUROSCI LETT, V101, P288, DOI 10.1016/0304-3940(89)90547-8; Russo C, 2000, NATURE, V405, P531, DOI 10.1038/35014735; Schindowski K, 2006, AM J PATHOL, V169, P599, DOI 10.2353/ajpath.2006.060002; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sigurdsson EM, 1997, NEUROBIOL AGING, V18, P591, DOI 10.1016/S0197-4580(97)00154-1; STANDAERT DG, 1991, AM J PATHOL, V139, P681; Stepanichev M Yu, 2006, Neurosci Behav Physiol, V36, P101, DOI 10.1007/s11055-005-0167-1; Stepanichev MY, 2004, PHYSIOL BEHAV, V80, P647, DOI 10.1016/j.physbeh.2003.11.003; Stepanichev MY, 2003, BRAIN RES BULL, V61, P197, DOI 10.1016/S0361-9230(03)00118-7; Stepanichev MY, 2003, J NEUROSCI RES, V71, P110, DOI 10.1002/jnr.10469; Sutton ET, 1997, EXP CELL RES, V230, P368, DOI 10.1006/excr.1996.3440; Tekirian TL, 2001, J ALZHEIMERS DIS, V3, P241; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; van de Nes JAP, 1998, ACTA NEUROPATHOL, V96, P129, DOI 10.1007/s004010050872; van de Nes JAP, 2006, ACTA NEUROPATHOL, V111, P126, DOI 10.1007/s00401-005-0018-8; Vanzani MC, 2005, MEDICINA-BUENOS AIRE, V65, P213; Varadarajan S, 2001, J AM CHEM SOC, V123, P5625, DOI 10.1021/ja010452r; Villard V, 2009, NEUROPSYCHOPHARMACOL, V34, P1552, DOI 10.1038/npp.2008.212; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; Walsh DM, 2005, BIOCHEM SOC T, V33, P1087, DOI 10.1042/BST0331087; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang R, 2008, BRAIN RES, V1210, P84, DOI 10.1016/j.brainres.2008.01.104; Watson D, 2005, NEUROL RES, V27, P869, DOI 10.1179/016164105X49436; Yamada K, 2000, PHARMACOL THERAPEUT, V88, P93, DOI 10.1016/S0163-7258(00)00081-4; Yamaguchi Y, 2001, EUR J PHARMACOL, V412, P265, DOI 10.1016/S0014-2999(01)00730-0; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Zussy C, 2011, AM J PATHOL, V179, P315, DOI 10.1016/j.ajpath.2011.03.021	87	82	84	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53117	10.1371/journal.pone.0053117	http://dx.doi.org/10.1371/journal.pone.0053117			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301030	Green Published, gold			2022-12-25	WOS:000313320900062
J	Kambach, DM; Sodi, VL; Lelkes, PI; Azizkhan-Clifford, J; Reginato, MJ				Kambach, D. M.; Sodi, V. L.; Lelkes, P. I.; Azizkhan-Clifford, J.; Reginato, M. J.			ErbB2, FoxM1 and 14-3-3 zeta prime breast cancer cells for invasion in response to ionizing radiation	ONCOGENE			English	Article						ErbB2; FoxM1; 14-3-3 zeta; invasion; reactive oxygen species	MAMMARY EPITHELIAL-CELLS; GROWTH-FACTOR RECEPTOR; CARCINOMA IN-SITU; SIGNALING NETWORK; OXIDATIVE STRESS; FREE-RADICALS; PROGRESSION; SRC; TRANSCRIPTION; RESISTANCE	ErbB2 is frequently highly expressed in premalignant breast cancers, including ductal carcinoma in situ (DCIS); however, little is known about the signals or pathways it contributes to progression into the invasive/malignant state. Radiotherapy is often used to treat early premalignant lesions regardless of ErbB2 status. Here, we show that clinically relevant doses of ionizing radiation (IR)-induce cellular invasion of ErbB2-expressing breast cancer cells, as well as MCF10A cells overexpressing ErbB2. ErbB2-negative breast cancer cells, such as MCF7 and T47D, do not invade following treatment with IR nor do MCF10A cells overexpressing epidermal growth factor receptor. ErbB2 becomes phosphorylated at tyrosine 877 in a dose- and time- dependent manner following exposure to X-rays, and activates downstream signaling cascades including PI3K/Akt. Inhibition of these pathways, as well as inhibition of reactive oxygen species (ROS) with antioxidants, prevents IR-induced invasion. Activation of ErbB2-dependent signaling results in upregulation of the forkhead family transcription factor, FoxM1, and its transcriptional targets, including matrix metalloproteinase 2 (MMP2). Inhibition of FoxM1 by RNA interference prevented induction of invasion by IR, and overexpression of FoxM1 in MCF10A cells was sufficient to promote IR-induced invasion. Moreover, we found that 14-3-3 zeta is also upregulated by IR in cancer cells in a ROS-dependent manner, is required for IR-induced invasion in ErbB2-positive breast cancer cells and together with FoxM1 is sufficient for invasion in ErbB2-negative breast cancer cells. Thus, our data show that IR-mediated activation of ErbB2 and induction of 14-3-3 zeta collaborate to regulate FoxM1 and promote invasion of breast cancer cells and furthermore, may serve as therapeutic targets to enhance radiosensitivity of breast cancers.	[Kambach, D. M.; Sodi, V. L.; Azizkhan-Clifford, J.; Reginato, M. J.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA; [Lelkes, P. I.] Drexel Univ, Sch Biomed Engn, Philadelphia, PA 19102 USA	Drexel University; Drexel University	Azizkhan-Clifford, J (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, 245 N 15th St,NCB Rm 11117, Philadelphia, PA 19102 USA.	jane.clifford@drexelmed.edu; Mauricio.Reginato@drexelmed.edu	Lelkes, Peter I/S-1751-2019; Lelkes, Peter/HGA-2907-2022		Drexel University College of Medicine CURE grants; NATIONAL CANCER INSTITUTE [P30CA056036, R01CA155413] Funding Source: NIH RePORTER	Drexel University College of Medicine CURE grants; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Gieira Jones and Prachi Thanawala for technical support and Dr Gianluca Gallo for the PI3K activating peptide. We would also like to thank Drs Jay Reiff and Jacqueline Emrich and the Radiation Oncology Department at Hahnemann University Hospital for their assistance. This work was supported by Drexel University College of Medicine CURE grants (to MJR).	Ahmad A, 2010, BREAST CANCER RES TR, V122, P337, DOI 10.1007/s10549-009-0572-1; Andarawewa KL, 2007, CANCER RES, V67, P8662, DOI 10.1158/0008-5472.CAN-07-1294; Badache A, 2006, J MAMMARY GLAND BIOL, V11, P13, DOI 10.1007/s10911-006-9009-1; Bektas N, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-42; Bergamaschi A, 2012, ONCOGENE, V31, P39, DOI 10.1038/onc.2011.223; Bergamaschi A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2913; Biscardi JS, 2000, BREAST CANCER RES, V2, P203, DOI 10.1186/bcr55; Bowers G, 2001, ONCOGENE, V20, P1388, DOI 10.1038/sj.onc.1204255; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Carr JR, 2010, CANCER RES, V70, P5054, DOI 10.1158/0008-5472.CAN-10-0545; Chabottaux V, 2007, CLIN EXP METASTAS, V24, P647, DOI 10.1007/s10585-007-9113-7; Contessa JN, 2006, BREAST CANCER RES TR, V95, P17, DOI 10.1007/s10549-005-9023-9; Dai B, 2007, ONCOGENE, V26, P6212, DOI 10.1038/sj.onc.1210443; Danes CG, 2008, CANCER RES, V68, P1760, DOI 10.1158/0008-5472.CAN-07-3177; DiGiovanna MP, 2002, CANCER RES, V62, P6667; Feinendegen LE, 2002, HUM EXP TOXICOL, V21, P85, DOI 10.1191/0960327102ht216oa; Francis RE, 2009, INT J ONCOL, V35, P57, DOI 10.3892/ijo_00000313; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Gemenetzidis E, 2010, CANCER RES, V70, P9515, DOI 10.1158/0008-5472.CAN-10-2173; Giannoni E, 2010, FREE RADICAL BIO MED, V49, P516, DOI 10.1016/j.freeradbiomed.2010.04.025; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Haenssen KK, 2010, J CELL SCI, V123, P1373, DOI 10.1242/jcs.050906; Hebner C, 2008, ANNU REV PATHOL-MECH, V3, P313, DOI 10.1146/annurev.pathmechdis.3.121806.151526; Ishizawar RC, 2007, ONCOGENE, V26, P3503, DOI 10.1038/sj.onc.1210138; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Koo CY, 2012, BBA-GENE REGUL MECH, V1819, P28, DOI 10.1016/j.bbagrm.2011.09.004; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Lagadec C, 2012, STEM CELLS, V30, P833, DOI 10.1002/stem.1058; LAWRENCE TS, 2008, CANC PRINCIPLES PRAC, P307; Leach JK, 2001, CANCER RES, V61, P3894; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Littler DR, 2010, NUCLEIC ACIDS RES, V38, P4527, DOI 10.1093/nar/gkq194; Lu J, 2009, CANCER CELL, V16, P195, DOI 10.1016/j.ccr.2009.08.010; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Marcotte R, 2009, MOL CELL BIOL, V29, P5858, DOI 10.1128/MCB.01731-08; McGovern UB, 2009, MOL CANCER THER, V8, P582, DOI 10.1158/1535-7163.MCT-08-0805; Mendes O, 2007, CLIN EXP METASTAS, V24, P341, DOI 10.1007/s10585-007-9071-0; Millour J, 2010, ONCOGENE, V29, P2983, DOI 10.1038/onc.2010.47; Mori K, 2004, CANCER RES, V64, P7464, DOI 10.1158/0008-5472.CAN-04-1725; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Neal CL, 2010, EXPERT OPIN THER TAR, V14, P1343, DOI 10.1517/14728222.2010.531011; Neal CL, 2009, CANCER RES, V69, P3425, DOI 10.1158/0008-5472.CAN-08-2765; O'Toole TE, 2011, J CELL PHYSIOL, V226, P2965, DOI 10.1002/jcp.22644; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Park HJ, 2009, EMBO J, V28, P2908, DOI 10.1038/emboj.2009.239; Raychaudhuri P, 2011, CANCER RES, V71, P4329, DOI 10.1158/0008-5472.CAN-11-0640; SATO K, 1994, BIOCHEM BIOPH RES CO, V205, P1716, DOI 10.1006/bbrc.1994.2866; SchmidtUllrich RK, 1996, RADIAT RES, V145, P81, DOI 10.2307/3579199; Tan M, 2005, CANCER RES, V65, P1858, DOI 10.1158/0008-5472.CAN-04-2353; Tofilon PJ, 2009, CHEM REV, V109, P2974, DOI 10.1021/cr800504x; Tzivion G, 2006, SEMIN CANCER BIOL, V16, P203, DOI 10.1016/j.semcancer.2006.03.004; Vera-Ramirez L, 2011, CRIT REV ONCOL HEMAT, V80, P347, DOI 10.1016/j.critrevonc.2011.01.004; Xiang B, 2006, METHOD ENZYMOL, V406, P692, DOI 10.1016/S0076-6879(06)06054-X; Yang X, 2012, CANCER GENE THER, V19, P153, DOI 10.1038/cgt.2011.85; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309	56	30	30	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 30	2014	33	5					589	598		10.1038/onc.2012.629	http://dx.doi.org/10.1038/onc.2012.629			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AA5GW	23318431	Green Accepted			2022-12-25	WOS:000331125100007
J	Liu, Y; Raheja, R; Yeh, N; Ciznadija, D; Pedraza, AM; Ozawa, T; Hukkelhoven, E; Erdjument-Bromage, H; Tempst, P; Gauthier, NP; Brennan, C; Holland, EC; Koff, A				Liu, Y.; Raheja, R.; Yeh, N.; Ciznadija, D.; Pedraza, A. M.; Ozawa, T.; Hukkelhoven, E.; Erdjument-Bromage, H.; Tempst, P.; Gauthier, N. P.; Brennan, C.; Holland, E. C.; Koff, A.			TRIM3, a tumor suppressor linked to regulation of p21(Waf1/Cip1)	ONCOGENE			English	Article						glioma; p21; PDGF; stem/progenitor; TRIM3	NEURAL STEM-CELLS; INTEGRATED GENOMIC ANALYSIS; SELF-RENEWAL; CYCLIN D1; ABERRANT EXPRESSION; MALIGNANT GLIOMA; MOUSE MODELS; IN-VIVO; CANCER; DROSOPHILA	The TRIM family of genes is largely studied because of their roles in development, differentiation and host cell antiviral defenses; however, roles in cancer biology are emerging. Loss of heterozygosity of the TRIM3 locus in similar to 20% of human glioblastomas raised the possibility that this NHL-domain containing member of the TRIM gene family might be a mammalian tumor suppressor. Consistent with this, reducing TRIM3 expression increased the incidence of and accelerated the development of platelet-derived growth factor -induced glioma in mice. Furthermore, TRIM3 can bind to the cdk inhibitor p21(WAF1/CIP1). Thus, we conclude that TRIM3 is a tumor suppressor mapping to chromosome 11p15.5 and that it might block tumor growth by sequestering p21 and preventing it from facilitating the accumulation of cyclin D1-cdk4.	[Liu, Y.; Raheja, R.; Yeh, N.; Ciznadija, D.; Hukkelhoven, E.; Erdjument-Bromage, H.; Tempst, P.; Koff, A.] Mem Sloan Kettering Canc Ctr, Programs Mol Biol, New York, NY 10021 USA; [Gauthier, N. P.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Koff, A (corresponding author), Mem Sloan Kettering Canc Ctr, Programs Mol Biol, 1275 York Ave, New York, NY 10021 USA.	a-koff@ski.mskcc.org	Brennan, Cameron/R-7082-2019	Brennan, Cameron/0000-0003-4064-8891; Koff, Andrew/0000-0003-3271-3067; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Tempst, Paul/0000-0002-6680-3987	Memorial Sloan-Kettering Cancer Center Core Grant [P30CA08748]; Brain Tumor Center; Golfers Against Cancer Foundation;  [CA89563]; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA089563] Funding Source: NIH RePORTER	Memorial Sloan-Kettering Cancer Center Core Grant; Brain Tumor Center; Golfers Against Cancer Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Marta Kovatcheva and other members of the Koff lab, Pengbo Zhou (Cornell University Medical School), John Petrini (MSKCC) and Hakim Djaballah (MSKCC) for comments on this manuscript, and Max Chan Liu (The Browning School) for his assistance with Id1 staining and image acquisition. This work was supported by the Memorial Sloan-Kettering Cancer Center Core Grant (P30CA08748) and grants to Andrew Koff (CA89563). Funding was also provided by the Brain Tumor Center (YL, DC) and the Golfers Against Cancer Foundation (AK).	Aaltomaa S, 1999, PROSTATE, V39, P8; Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Aktas H, 1997, MOL CELL BIOL, V17, P3850, DOI 10.1128/MCB.17.7.3850; Arama E, 2000, ONCOGENE, V19, P3706, DOI 10.1038/sj.onc.1203706; Bae DS, 2001, GYNECOL ONCOL, V81, P341, DOI 10.1006/gyno.2001.6196; Baretton GB, 1999, BRIT J CANCER, V80, P546, DOI 10.1038/sj.bjc.6690390; Barrett LE, 2012, CANCER CELL, V21, P11, DOI 10.1016/j.ccr.2011.11.025; Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Boulay JL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-71; Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Broxmeyer HE, 2012, ANN NY ACAD SCI, V1266, P151, DOI 10.1111/j.1749-6632.2012.06509.x; Ceccarelli C, 2001, INT J CANCER, V95, P128; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Charles N, 2010, CELL STEM CELL, V6, P141, DOI 10.1016/j.stem.2010.01.001; Charles NA, 2010, CELL STEM CELL, V6, P6, DOI 10.1016/j.stem.2009.12.005; Chen J, 2012, CELL, V149, P36, DOI 10.1016/j.cell.2012.03.009; Cheung CC, 2010, P NATL ACAD SCI USA, V107, P11883, DOI 10.1073/pnas.1006529107; Cheung TH, 2001, CANCER LETT, V172, P93, DOI 10.1016/S0304-3835(01)00624-3; Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015; Ciznadija D, 2011, CANCER RES, V71, P6174, DOI 10.1158/0008-5472.CAN-11-1031; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Ferrandina G, 2000, INT J ONCOL, V17, P1231; Gao H, 2004, P NATL ACAD SCI USA, V101, P17204, DOI 10.1073/pnas.0407693101; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Herranz H, 2010, EMBO J, V29, P1688, DOI 10.1038/emboj.2010.69; Hukkelhoven E, 2012, J BIOL CHEM, V287, P38523, DOI 10.1074/jbc.M112.366542; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; James MK, 2008, MOL CELL BIOL, V28, P498, DOI 10.1128/MCB.02171-06; Januschke J, 2008, ONCOGENE, V27, P6994, DOI 10.1038/onc.2008.349; Katz AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032453; Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017; Lee J, 2009, EXP MOL MED, V41, P765, DOI 10.3858/emm.2009.41.11.102; Liu Y, 2007, EMBO J, V26, P4683, DOI 10.1038/sj.emboj.7601886; Muraoka RS, 2002, MOL CELL BIOL, V22, P2204, DOI 10.1128/MCB.22.7.2204-2219.2002; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Reichert H, 2011, RESULTS PROBL CELL D, V53, P529, DOI 10.1007/978-3-642-19065-0_21; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Sarbia M, 2000, Recent Results Cancer Res, V155, P15; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; See WL, 2010, ONCOGENE, V29, P1720, DOI 10.1038/onc.2009.465; See WL, 2010, CELL CYCLE, V9, P1562, DOI 10.4161/cc.9.8.11259; Shih AH, 2004, CANCER RES, V64, P4783, DOI 10.1158/0008-5472.CAN-03-3831; Taylor BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003179; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Viglietto G, 2002, CELL CYCLE, V1, P394, DOI 10.4161/cc.1.6.263; Vitucci M, 2011, BRIT J CANCER, V104, P545, DOI 10.1038/sj.bjc.6606031; Winters ZE, 2003, BREAST CANCER RES, V5, pR242, DOI 10.1186/bcr654; Wulczyn FG, 2010, ADV EXP MED BIOL, V700, P85, DOI 10.1007/978-1-4419-7823-3_9; Xu XLL, 2009, CELL, V137, P1018, DOI 10.1016/j.cell.2009.03.051; Yan Q, 2005, MOL BIOL CELL, V16, P2470, DOI 10.1091/mbc.e04-11-1014; Yeh N, 2007, MOL CELL BIOL, V27, P5161, DOI 10.1128/MCB.02431-06	55	39	42	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 16	2014	33	3					308	315		10.1038/onc.2012.596	http://dx.doi.org/10.1038/onc.2012.596			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	296VR	23318451	Green Accepted			2022-12-25	WOS:000330214000005
J	Heinnickel, ML; Alric, J; Wittkopp, T; Yang, WQ; Catalanotti, C; Dent, R; Niyogi, KK; Wollman, FA; Grossman, AR				Heinnickel, Mark L.; Alric, Jean; Wittkopp, Tyler; Yang, Wenqiang; Catalanotti, Claudia; Dent, Rachel; Niyogi, Krishna K.; Wollman, Francis-Andre; Grossman, Arthur R.			Novel Thylakoid Membrane GreenCut Protein CPLD38 Impacts Accumulation of the Cytochrome b(6)f Complex and Associated Regulatory Processes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLAMYDOMONAS-REINHARDTII; ELECTRON-TRANSFER; PHOTOSYSTEM-II; MESSENGER-RNA; ARCHITECTURE; RESOLUTION; CHLORORESPIRATION; PHOTOSYNTHESIS; CHLOROPLAST; DEPRIVATION	Based on previous comparative genomic analyses, a set of nearly 600 polypeptides was identified that is present in green algae and flowering and nonflowering plants but is not present (or is highly diverged) in nonphotosynthetic organisms. The gene encoding one of these "GreenCut" proteins, CPLD38, is in the same operon as ndhL in most cyanobacteria; the NdhL protein is part of a complex essential for cyanobacterial respiration. A cpld38 mutant of Chlamydomonas reinhardtii does not grow on minimal medium, is high light-sensitive under photoheterotrophic conditions, has lower accumulation of photosynthetic complexes, reduced photosynthetic electron flow to P700(+), and reduced photochemical efficiency of photosystem II (Phi PSII); these phenotypes are rescued by a wild-type copy of CPLD38. Single turnover flash experiments and biochemical analyses demonstrated that cytochrome b(6)f function was severely compromised, and the levels of transcripts and polypeptide subunits of the cytochrome b(6)f complex were also significantly lower in the cpld38 mutant. Furthermore, subunits of the cytochrome b(6)f complex in mutant cells turned over much more rapidly than in wild-type cells. Interestingly, PTOX2 and NDA2, two major proteins involved in chlororespiration, were more than 5-fold higher in mutants relative to wild-type cells, suggesting a shift in the cpld38 mutant from photosynthesis toward chlororespiratory metabolism, which is supported by experiments that quantify the reduction state of the plastoquinone pool. Together, these findings support the hypothesis that CPLD38 impacts the stability of the cytochrome b(6)f complex and possibly plays a role in balancing redox inputs to the quinone pool from photosynthesis and chlororespiration.	[Heinnickel, Mark L.; Alric, Jean; Wittkopp, Tyler; Yang, Wenqiang; Catalanotti, Claudia; Grossman, Arthur R.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Dent, Rachel; Niyogi, Krishna K.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Dent, Rachel; Niyogi, Krishna K.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Alric, Jean; Wollman, Francis-Andre] CNRS, Inst Biol Physicochim, UMR 7141, F-75005 Paris, France; [Alric, Jean; Wollman, Francis-Andre] Univ Paris 06, F-75005 Paris, France	Carnegie Institution for Science; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Heinnickel, ML (corresponding author), Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA.	mlh300@stanford.edu	Alric, Jean/E-3538-2013	Alric, Jean/0000-0003-3574-2234	National Science Foundation [MCB0824469, MCB0235878]; Brigitte Berthelemot; Direct For Biological Sciences [0951094] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Brigitte Berthelemot; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by National Science Foundation Grants MCB0824469 and MCB0235878 (to A. R. G.) and by private funds donated by Brigitte Berthelemot.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Battchikova N, 2011, BBA-BIOENERGETICS, V1807, P935, DOI 10.1016/j.bbabio.2010.10.017; Bennoun P, 2001, BBA-BIOENERGETICS, V1506, P133, DOI 10.1016/S0005-2728(01)00190-6; BULTE L, 1992, EUR J BIOCHEM, V204, P327, DOI 10.1111/j.1432-1033.1992.tb16641.x; Catalanotti C, 2012, PLANT CELL, V24, P692, DOI 10.1105/tpc.111.093146; Choquet Y, 1998, P NATL ACAD SCI USA, V95, P4380, DOI 10.1073/pnas.95.8.4380; CHUA NH, 1971, BIOCHIM BIOPHYS ACTA, V245, P277, DOI 10.1016/0005-2728(71)90146-0; Cruz JA, 2001, PLANT PHYSIOL, V127, P1167, DOI 10.1104/pp.127.3.1167; Dent RM, 2005, PLANT PHYSIOL, V137, P545, DOI 10.1104/pp.104.055244; Desplats C, 2009, J BIOL CHEM, V284, P4148, DOI 10.1074/jbc.M804546200; Dussault AA, 2006, BIOL PROCED ONLINE, V8, P1, DOI 10.1251/bpo114; Eberhard S, 2008, ANNU REV GENET, V42, P463, DOI 10.1146/annurev.genet.42.110807.091452; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Friso G, 2004, PLANT CELL, V16, P478, DOI 10.1105/tpc.017814; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Gonzalez-Ballester D, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-24; Grossman AR, 2010, PHOTOSYNTH RES, V106, P3, DOI 10.1007/s11120-010-9555-7; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; HIYAMA T, 1972, BIOCHIM BIOPHYS ACTA, V267, P160, DOI 10.1016/0005-2728(72)90147-8; Houille-Vernes L, 2011, P NATL ACAD SCI USA, V108, P20820, DOI 10.1073/pnas.1110518109; Jans F, 2008, P NATL ACAD SCI USA, V105, P20546, DOI 10.1073/pnas.0806896105; JOLIOT P, 1974, BIOCHIM BIOPHYS ACTA, V357, P267, DOI 10.1016/0005-2728(74)90066-8; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Karpowicz SJ, 2011, J BIOL CHEM, V286, P21427, DOI 10.1074/jbc.M111.233734; KURAS R, 1994, EMBO J, V13, P1019, DOI 10.1002/j.1460-2075.1994.tb06350.x; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Ledford HK, 2004, MOL GENET GENOMICS, V272, P470, DOI 10.1007/s00438-004-1078-5; Lennartz K, 2006, PLANT J, V45, P101, DOI 10.1111/j.1365-313X.2005.02605.x; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Malnoe A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1299; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Miller R, 2010, PLANT PHYSIOL, V154, P1737, DOI 10.1104/pp.110.165159; Nakao M, 2010, NUCLEIC ACIDS RES, V38, pD379, DOI 10.1093/nar/gkp915; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Peltier JB, 2004, J BIOL CHEM, V279, P49367, DOI 10.1074/jbc.M406763200; PIERRE Y, 1995, J BIOL CHEM, V270, P29342, DOI 10.1074/jbc.270.49.29342; Pootakham W, 2010, PLANT PHYSIOL, V153, P1653, DOI 10.1104/pp.110.157875; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Stroebel D, 2003, NATURE, V426, P413, DOI 10.1038/nature02155; Sun Q, 2009, NUCLEIC ACIDS RES, V37, pD969, DOI 10.1093/nar/gkn654; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; WHITE CC, 1978, BIOCHIM BIOPHYS ACTA, V502, P127, DOI 10.1016/0005-2728(78)90137-8; Wykoff DD, 1998, PLANT PHYSIOL, V117, P129, DOI 10.1104/pp.117.1.129; Xiao JW, 2012, PLANT PHYSIOL, V160, P1911, DOI 10.1104/pp.112.204891; YANOFSKY C, 1981, NUCLEIC ACIDS RES, V9, P6647, DOI 10.1093/nar/9.24.6647; YILDIZ FH, 1994, PLANT PHYSIOL, V104, P981, DOI 10.1104/pp.104.3.981	52	22	22	0	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7024	7036		10.1074/jbc.M112.427476	http://dx.doi.org/10.1074/jbc.M112.427476			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23303190	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000316002400024
J	Song, P; Kim, JH; Ghim, J; Yoon, JH; Lee, A; Kwon, Y; Hyun, H; Moon, HY; Choi, HS; Berggren, PO; Suh, PG; Ryu, SH				Song, Parkyong; Kim, Jong Hyun; Ghim, Jaewang; Yoon, Jong Hyuk; Lee, Areum; Kwon, Yonghoon; Hyun, Hyunjung; Moon, Hyo-Youl; Choi, Hueng-Sik; Berggren, Per-Olof; Suh, Pann-Ghill; Ryu, Sung Ho			Emodin Regulates Glucose Utilization by Activating AMP-activated Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; DEPENDENT DIABETES-MELLITUS; RAT SKELETAL-MUSCLE; COMPLEX-I; SIGNALING PATHWAY; ADIPOSE-TISSUE; INSULIN; METFORMIN; CELLS; TRANSPORT	AMP-activated protein kinase has been described as a key signaling protein that can regulate energy homeostasis. Here, we aimed to characterize novel AMP-activated kinase (AMPK)-activating compounds that have a much lower effective concentration than metformin. As a result, emodin, a natural anthraquinone derivative, was shown to stimulate AMPK activity in skeletal muscle and liver cells. Emodin enhanced GLUT4 translocation and [C-14]glucose uptake into the myotube in an AMPK-dependent manner. Also, emodin inhibited glucose production by suppressing the expression of key gluconeogenic genes, such as phosphoenolpyruvate carboxykinase and glucose-6-phosphatase, in hepatocytes. Furthermore, we found that emodin can activate AMPK by inhibiting mitochondrial respiratory complex I activity, leading to increased reactive oxygen species and Ca2+/calmodulin-dependent protein kinase kinase activity. Finally, we confirmed that a single dose administration of emodin significantly decreased the fasting plasma glucose levels and improved glucose tolerance in C57Bl/6J mice. Increased insulin sensitivity was also confirmed after daily injection of emodin for 8 days using an insulin tolerance test and insulin-stimulated PI3K phosphorylation in wild type and high fat diet-induced diabetic mouse models. Our study suggests that emodin regulates glucose homeostasis in vivo by AMPK activation and that this may represent a novel therapeutic principle in the treatment of type 2 diabetic models.	[Song, Parkyong; Kim, Jong Hyun; Ghim, Jaewang; Lee, Areum; Kwon, Yonghoon; Ryu, Sung Ho] Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, Kyungbuk, South Korea; [Yoon, Jong Hyuk] NovaCell Technol Inc, Pohang 790784, Kyungbuk, South Korea; [Hyun, Hyunjung; Berggren, Per-Olof; Ryu, Sung Ho] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang 790784, South Korea; [Moon, Hyo-Youl; Suh, Pann-Ghill] Ulsan Natl Inst Sci & Technol, Sch Nanobiotechnol & Chem Engn, Ulsan 689805, South Korea; [Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju, South Korea; [Berggren, Per-Olof] Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, SE-17177 Stockholm, Sweden	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Ulsan National Institute of Science & Technology (UNIST); Chonnam National University; Karolinska Institutet	Ryu, SH (corresponding author), POSTECH Biotech Ctr, San 31 Hyojadong, Pohang 790784, South Korea.	sungho@postech.ac.kr	Suh, Pann-Ghill/F-3610-2010	Berggren, Per-Olof/0000-0001-8991-413X; Kwon, yonghoon/0000-0002-6232-4305; Moon, Hyo Youl/0000-0001-8207-1301; Ryu, Sung Ho/0000-0003-0913-3048	21C Frontier Functional Proteomics Project [FPR08B1-160]; World Class University Program [R31-2008-000-10105-0]; Korean Ministry of Education, Science and Technology; Ministry of Health and Welfare, Republic of Korea [A111345]; Swedish Research Council; Family Erling-Persson Foundation; Stichting af Jochnick Foundation	21C Frontier Functional Proteomics Project(Ministry of Education, Science & Technology (MEST), Republic of Korea); World Class University Program; Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Swedish Research Council(Swedish Research CouncilEuropean Commission); Family Erling-Persson Foundation; Stichting af Jochnick Foundation	This work was supported by 21C Frontier Functional Proteomics Project Grant FPR08B1-160, World Class University Program Grant R31-2008-000-10105-0 funded by the Korean Ministry of Education, Science and Technology, Korea Health Technology R&D Project Grant A111345 from the Ministry of Health and Welfare, Republic of Korea, the Swedish Research Council, The Family Erling-Persson Foundation, and The Stichting af Jochnick Foundation.	An ZB, 2007, J BIOL CHEM, V282, P26793, DOI 10.1074/jbc.M703701200; Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052; Cha TL, 2005, CANCER RES, V65, P2287, DOI 10.1158/0008-5472.CAN-04-3250; Choi HC, 2008, J BIOL CHEM, V283, P20186, DOI 10.1074/jbc.M803020200; Choi SL, 2001, BIOCHEM BIOPH RES CO, V287, P92, DOI 10.1006/bbrc.2001.5544; Collins QF, 2007, J BIOL CHEM, V282, P30143, DOI 10.1074/jbc.M702390200; DEFRONZO RA, 1995, NEW ENGL J MED, V333, P541, DOI 10.1056/NEJM199508313330902; Feng Y, 2010, BRIT J PHARMACOL, V161, P113, DOI 10.1111/j.1476-5381.2010.00826.x; Fujita Y, 2010, DIABETOLOGIA, V53, P1472, DOI 10.1007/s00125-010-1729-5; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hattori A, 2010, OBESITY, V18, P48, DOI 10.1038/oby.2009.145; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Imanishi Y, 2004, J HEPATOL, V41, P242, DOI 10.1016/j.jhep.2004.04.005; Jahnke GD, 2004, BIRTH DEFECTS RES B, V71, P89, DOI 10.1002/bdrb.20002; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kandror Konstantin V, 2003, Sci STKE, V2003, pPE5, DOI 10.1126/stke.2003.169.pe5; Katz A, 2007, J APPL PHYSIOL, V102, P1671, DOI 10.1152/japplphysiol.01066.2006; Koistinen HA, 2003, DIABETES, V52, P1066, DOI 10.2337/diabetes.52.5.1066; Kumar A, 1998, ONCOGENE, V17, P913, DOI 10.1038/sj.onc.1201998; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Lenaz G, 2006, BBA-BIOENERGETICS, V1757, P1406, DOI 10.1016/j.bbabio.2006.05.007; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Liu YX, 2009, TRANSPL P, V41, P1837, DOI 10.1016/j.transproceed.2009.02.090; Lochhead PA, 2000, DIABETES, V49, P896, DOI 10.2337/diabetes.49.6.896; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Merry TL, 2009, IUBMB LIFE, V61, P479, DOI 10.1002/iub.179; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Musi N, 2001, AM J PHYSIOL-ENDOC M, V280, pE677, DOI 10.1152/ajpendo.2001.280.5.E677; Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074; Oshida K, 2011, J APPL TOXICOL, V31, P790, DOI 10.1002/jat.1637; Park IJ, 2009, ANN NY ACAD SCI, V1171, P538, DOI 10.1111/j.1749-6632.2009.04698.x; Ross RM, 2007, DIABETES, V56, P2885, DOI 10.2337/db07-0745; Sandeep TC, 2005, DIABETES, V54, P872, DOI 10.2337/diabetes.54.3.872; Sandstrom ME, 2006, J PHYSIOL-LONDON, V575, P251, DOI 10.1113/jphysiol.2006.110601; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Somwar R, 2000, DIABETES, V49, P1794, DOI 10.2337/diabetes.49.11.1794; STUMVOLL M, 1995, NEW ENGL J MED, V333, P550, DOI 10.1056/NEJM199508313330903; Su YT, 2005, BIOCHEM PHARMACOL, V70, P229, DOI 10.1016/j.bcp.2005.04.026; Tzeng TF, 2012, PLANTA MED, V78, P943, DOI 10.1055/s-0031-1298626; Tzeng TF, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/781812; Wang CH, 2007, WORLD J GASTROENTERO, V13, P378, DOI 10.3748/wjg.v13.i3.378; Watt MJ, 2006, NAT MED, V12, P541, DOI 10.1038/nm1383; Yang Y, 2007, BIOCHEM BIOPH RES CO, V353, P225, DOI 10.1016/j.bbrc.2006.11.134; Yea K, 2008, J MOL MED-JMM, V86, P211, DOI 10.1007/s00109-007-0269-z; Yi J, 2004, CANCER RES, V64, P108, DOI 10.1158/0008-5472.CAN-2820-2; Zmijewski JW, 2010, J BIOL CHEM, V285, P33154, DOI 10.1074/jbc.M110.143685; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857	52	51	61	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5732	5742		10.1074/jbc.M112.441477	http://dx.doi.org/10.1074/jbc.M112.441477			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23303186	Green Published, hybrid			2022-12-25	WOS:000315342500045
J	Ananthi, S; Prajna, NV; Lalitha, P; Valarnila, M; Dharmalingam, K				Ananthi, Sivagnanam; Prajna, Namperumalsamy Venkatesh; Lalitha, Prajna; Valarnila, Murugesan; Dharmalingam, Kuppamuthu			Pathogen Induced Changes in the Protein Profile of Human Tears from Fusarium Keratitis Patients	PLOS ONE			English	Article							DIFFERENCE GEL-ELECTROPHORESIS; CORNEAL ULCERATION; SERUM ANTIPROTEASES; ETIOLOGIC DIAGNOSIS; PROTEOMIC ANALYSIS; ALPHA-1-ANTITRYPSIN; FLUID; IDENTIFICATION; EXPRESSION; CYSTATINS	Fusarium is the major causative agent of fungal infections leading to corneal ulcer (keratitis) in Southern India and other tropical countries. Keratitis caused by Fusarium is a difficult disease to treat unless antifungal therapy is initiated during the early stages of infection. In this study tear proteins were prepared from keratitis patients classified based on the duration of infection. Among the patients recruited, early infection (n = 35), intermediate (n = 20), late (n = 11), samples from five patients in each group were pooled for analysis. Control samples were a pool of samples from 20 patients. Proteins were separated on difference gel electrophoresis (DIGE) and the differentially expressed proteins were quantified using DeCyder software analysis. The following differentially expressed proteins namely alpha-1-antitrypsin, haptoglobin alpha 2 chain, zinc-alpha-2-glycoprotein, apolipoprotein, albumin, haptoglobin precursor - beta chain, lactoferrin, lacrimal lipocalin precursor, cystatin SA III precursor, lacritin precursor were identified using mass spectrometry. Variation in the expression level of some of the proteins was confirmed using western blot analysis. This is the first report to show stage specific tear protein profile in fungal keratitis patients. Validation of this data using a much larger sample set could lead to clinical application of these findings.	[Ananthi, Sivagnanam; Valarnila, Murugesan] Aravind Eye Care Syst, Aravind Med Res Fdn, Dr G Venkataswamy Eye Res Inst, Madurai, Tamil Nadu, India; [Prajna, Namperumalsamy Venkatesh] Aravind Eye Care Syst, Aravind Eye Hosp, Cornea Clin, Madurai, Tamil Nadu, India; [Lalitha, Prajna] Aravind Eye Care Syst, Aravind Eye Hosp, Dept Microbiol, Madurai, Tamil Nadu, India; [Dharmalingam, Kuppamuthu] Madurai Kamaraj Univ, Sch Biotechnol, Madurai 625021, Tamil Nadu, India	Madurai Kamaraj University	Dharmalingam, K (corresponding author), Madurai Kamaraj Univ, Sch Biotechnol, Madurai 625021, Tamil Nadu, India.	dharmalingam.k@gmail.com		Namperumalsamy, Venkatesh Prajna/0000-0003-2019-4044	Department of Biotechnology, Government of India, New Delhi, India [BT/INF/22/2/2007, BT/PR13879/MED/12/458/2010, BT/PR7592/MED/12/290/2006, BT/HRD/35/03/2010]	Department of Biotechnology, Government of India, New Delhi, India(Department of Biotechnology (DBT) India)	KD thanks the Department of Biotechnology, Government of India, New Delhi, India for grants no. BT/INF/22/2/2007, BT/PR13879/MED/12/458/2010 and BT/PR7592/MED/12/290/2006 for DBT Distinguished Biotechnology Research Professorship BT/HRD/35/03/2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSON M, 1986, J BIOL CHEM, V261, P1282; Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; Ananthi S, 2008, MOL VIS, V14, P500; Ananthi S, 2011, EXP EYE RES, V92, P454, DOI 10.1016/j.exer.2011.03.002; ARORA PK, 1978, NATURE, V274, P589, DOI 10.1038/274589a0; Baker GRC, 2006, ARCH OPHTHALMOL-CHIC, V124, P1451, DOI 10.1001/archopht.124.10.1451; BARKA T, 1991, CURR EYE RES, V10, P25, DOI 10.3109/02713689109007608; BERMAN MB, 1973, INVEST OPHTH VISUAL, V12, P759; BIRGENS HS, 1985, SCAND J HAEMATOL, V34, P326; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREIT SN, 1985, CLIN IMMUNOL IMMUNOP, V35, P363, DOI 10.1016/0090-1229(85)90097-2; Brock JH, 2002, BIOCHEM CELL BIOL, V80, P1, DOI 10.1139/o01-212; CHEVANCE LG, 1976, ARCH OTOLARYNGOL, V102, P363; de Souza GA, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r72; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; ERIE JC, 1993, ARCH OPHTHALMOL-CHIC, V111, P1665, DOI 10.1001/archopht.1993.01090120087027; FULLARD RJ, 1988, CURR EYE RES, V7, P163, DOI 10.3109/02713688808995746; GACHON AM, 1979, EXP EYE RES, V29, P539, DOI 10.1016/0014-4835(79)90154-4; Gachon AMF, 1998, BRIT J OPHTHALMOL, V82, P453, DOI 10.1136/bjo.82.4.453; Gonzales C A, 1996, Ophthalmic Epidemiol, V3, P159, DOI 10.3109/09286589609080122; Good DM, 2007, J PROTEOME RES, V6, P4549, DOI 10.1021/pr070529w; Green-Church KB, 2008, MOL VIS, V14, P456; GUPTA AK, 1988, BRIT J OPHTHALMOL, V72, P390, DOI 10.1136/bjo.72.5.390; Gupta N, 2007, J PROTEOME RES, V6, P3669, DOI 10.1021/pr070223p; Gupta N, 2010, J MED MICROBIOL, V59, P400, DOI 10.1099/jmm.0.016394-0; HAGAN M, 1995, BRIT J OPHTHALMOL, V79, P1024, DOI 10.1136/bjo.79.11.1024; Herber S, 2001, ELECTROPHORESIS, V22, P1838, DOI 10.1002/1522-2683(200105)22:9<1838::AID-ELPS1838>3.0.CO;2-7; Hirai K, 1998, CANCER RES, V58, P2359; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; ISEMURA S, 1991, J BIOCHEM, V110, P648, DOI 10.1093/oxfordjournals.jbchem.a123634; JONES BR, 1975, AM J OPHTHALMOL, V79, P719, DOI 10.1016/0002-9394(75)90730-8; Kanyshkova TG, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1, DOI 10.1023/A:1002817226110; Kawai S, 2002, ANN CLIN BIOCHEM, V39, P56, DOI 10.1258/0004563021901748; KIJLSTRA A, 1994, ADV EXP MED BIOL, V350, P299; Kolte Rajashri A, 2010, J Indian Soc Periodontol, V14, P227, DOI 10.4103/0972-124X.76923; Koo BS, 2005, J PROTEOME RES, V4, P719, DOI 10.1021/pr0498133; Kuriakose T, 1991, Indian J Ophthalmol, V39, P118; KYAWMYINT TO, 1975, CLIN CHIM ACTA, V59, P51, DOI 10.1016/0009-8981(75)90217-X; Langlois MR, 1996, CLIN CHEM, V42, P1589; Lescuyer P, 2007, J PROTEOME RES, V6, P3371, DOI 10.1021/pr0702060; Levin LA, 1996, SURV OPHTHALMOL, V41, P142, DOI 10.1016/S0039-6257(96)80004-X; Li N, 2005, J PROTEOME RES, V4, P2052, DOI 10.1021/pr0501970; Ma PS, 2006, J CELL BIOL, V174, P1097, DOI 10.1083/jcb.200511134; Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3; METZBOUTIGUE MH, 1984, EUR J BIOCHEM, V145, P659, DOI 10.1111/j.1432-1033.1984.tb08607.x; MII S, 1992, ELECTROPHORESIS, V13, P379, DOI 10.1002/elps.1150130177; Molloy MP, 1997, ELECTROPHORESIS, V18, P2811, DOI 10.1002/elps.1150181516; NEUHOFF V, 1985, ELECTROPHORESIS, V6, P427, DOI 10.1002/elps.1150060905; Nichols JJ, 2009, CORNEA, V28, P1109, DOI 10.1097/ICO.0b013e3181a2ad81; Poole TRG, 2002, BRIT J OPHTHALMOL, V86, P941, DOI 10.1136/bjo.86.8.941; PRAUSE JU, 1983, ACTA OPHTHALMOL, V61, P272; Ramachandran B, 2012, J BIOSCIENCES, V37, P617, DOI 10.1007/s12038-012-9245-z; Reitz C, 1998, GRAEF ARCH CLIN EXP, V236, P894, DOI 10.1007/s004170050177; Righetti PG, 2005, CLIN CHIM ACTA, V357, P123, DOI 10.1016/j.cccn.2005.03.018; Russell ST, 2004, BBA-MOL CELL BIOL L, V1636, P59, DOI 10.1016/j.bbalip.2003.12.004; Saijyothi AV, 2010, ELECTROPHORESIS, V31, P3420, DOI 10.1002/elps.201000271; Samudre S, 2011, INVEST OPHTH VIS SCI, V52, P6265, DOI 10.1167/iovs.10-6220; Sanghi S, 2001, J MOL BIOL, V310, P127, DOI 10.1006/jmbi.2001.4748; Sen DK, 1986, PREOCULAR TEAR FILM, P192; SHARP HL, 1976, GASTROENTEROLOGY, V70, P611; Sharp HL, 1975, MODERN TRENDS GASTRO, P140; Sitaramamma T, 1998, Indian Journal of Ophthalmology, V46, P239; Srinivasan M, 2004, Curr Opin Ophthalmol, V15, P321, DOI 10.1097/00055735-200408000-00008; Srinivasan M, 1997, BRIT J OPHTHALMOL, V81, P965, DOI 10.1136/bjo.81.11.965; TADA T, 1991, J HISTOCHEM CYTOCHEM, V39, P1221, DOI 10.1177/39.9.1918940; TALAMO RC, 1975, PEDIATRICS, V56, P91; ter Rahe BSM, 1998, OPHTHALMOLOGICA, V212, P34, DOI 10.1159/000027256; Thomas PA, 2007, CURR OPIN INFECT DIS, V20, P129, DOI 10.1097/QCO.0b013e328017f878; Tomosugi N, 2005, J PROTEOME RES, V4, P820, DOI 10.1021/pr0497576; Tonge R, 2001, PROTEOMICS, V1, P377; Tseng CF, 2004, PROTEOMICS, V4, P2221, DOI 10.1002/pmic.200300787; TWINING SS, 1994, INVEST OPHTH VIS SCI, V35, P458; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; UPADHYAY MP, 1991, AM J OPHTHALMOL, V111, P92, DOI 10.1016/S0002-9394(14)76903-X; Vasanthi Mani, 2007, Indian Journal of Ophthalmology, V55, P27; Whitcher JP, 1997, BRIT J OPHTHALMOL, V81, P622, DOI 10.1136/bjo.81.8.622; YOHAI RA, 1994, SURV OPHTHALMOL, V39, P3, DOI 10.1016/S0039-6257(05)80041-4; Zhou L, 2004, J PROTEOME RES, V3, P410, DOI 10.1021/pr034065n; Zhou L, 2006, ANN ACAD MED SINGAP, V35, P400; Zolg W, 2006, MOL CELL PROTEOMICS, V5, P1720, DOI 10.1074/mcp.R600001-MCP200	80	43	45	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53018	10.1371/journal.pone.0053018	http://dx.doi.org/10.1371/journal.pone.0053018			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308132	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429800025
J	Nguemo, F; Fleischmann, BK; Gupta, MK; Saric, T; Malan, D; Liang, HM; Pfannkuche, K; Bloch, W; Schunkert, H; Hescheler, J; Reppel, M				Nguemo, Filomain; Fleischmann, Bernd K.; Gupta, Manoj K.; Saric, Tomo; Malan, Daniela; Liang, Huamin; Pfannkuche, Kurt; Bloch, Wilhelm; Schunkert, Heribert; Hescheler, Juergen; Reppel, Michael			The L-type Ca2+ Channels Blocker Nifedipine Represses Mesodermal Fate Determination in Murine Embryonic Stem Cells	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; CALCIUM-CHANNEL; CARDIAC MYOCYTES; FUNCTIONAL-PROPERTIES; VERTEBRATE HEART; IN-VITRO; CARDIOMYOCYTES; DIFFERENTIATION; EXPRESSION; CARDIOMYOGENESIS	Dihydropyridines (DHP), which nifedipine is a member of, preferentially block Ca2+ channels of different cell types. Moreover, influx of Ca2+ through L-type Ca2+ channels (LTCCs) activates Ca2+ signaling pathways, which in turn contribute to numerous cellular processes. Although LTCCs are expressed in undifferentiated cells, very little is known about its contributions to the transcriptional regulation of mesodermal and cardiac genes. This study aimed to examine the contribution of LTCCs and the effect of nifedipine on the commitment of pluripotent stem cells toward the cardiac lineage in vitro. The murine embryonic stem (ES, cell line D3) and induced pluripotent stem (iPS, cell clone 09) cells were differentiated into enhanced green fluorescence protein (EGFP) expressing spontaneously beating cardiomyocytes (CMs). Early treatment of differentiating cells with 10 mu M nifedipine led to a significant inhibition of the cardiac mesoderm formation and cardiac lineage commitment as revealed by gene regulation analysis. This was accompanied by the inhibition of spontaneously occurring Ca2+ transient and reduction of LTCCs current density (I-CaL) of differentiated CMs. In addition, nifedipine treatment instigated a pronounced delay of the spontaneous beating embryoid body (EB) and led to a poor surface localization of L-type Ca2+ channel alpha(1C) (Ca(V)1.2) subunits. Contrary late incubation of pluripotent stem cells with nifedipine was without any impact on the differentiation process and did not affect the derived CMs function. Our data indicate that nifedipine blocks the determined path of pluripotent stem cells to cardiomyogenesis by inhibition of mesodermal commitment at early stages of differentiation, thus the proper upkeep Ca2+ concentration and pathways are essentially required for cardiac gene expression, differentiation and function.	[Nguemo, Filomain; Gupta, Manoj K.; Saric, Tomo; Pfannkuche, Kurt; Hescheler, Juergen; Reppel, Michael] Univ Cologne, Inst Neurophysiol, D-50931 Cologne, Germany; [Fleischmann, Bernd K.; Malan, Daniela] Univ Bonn, Life & Brain Ctr, Inst Physiol 1, Bonn, Germany; [Liang, Huamin] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Physiol, Wuhan 430074, Peoples R China; [Bloch, Wilhelm] German Sport Univ Cologne, Dept Mol & Cellular Sport Med, Cologne, Germany; [Schunkert, Heribert; Reppel, Michael] Med Univ Lubeck, Dept Cardiol, D-23538 Lubeck, Germany	University of Cologne; University of Bonn; Huazhong University of Science & Technology; German Sport University Cologne; University of Lubeck	Nguemo, F (corresponding author), Univ Cologne, Inst Neurophysiol, D-50931 Cologne, Germany.	b200028@uni-koeln.de	Saric, Tomo/B-3415-2015	Saric, Tomo/0000-0001-8344-1095; Nguemo, Filomain/0000-0002-2236-6797; Pfannkuche, Kurt Paul/0000-0002-4284-774X	Rosa-Luxemburg Foundation; Federal Ministry of Education and Research in Germany (BMBF) within the research consortium 'Human Heart Models' [01GG0708]	Rosa-Luxemburg Foundation; Federal Ministry of Education and Research in Germany (BMBF) within the research consortium 'Human Heart Models'	This work was supported by Rosa-Luxemburg Foundation through the scholarship offered to Filomain Nguemo and Federal Ministry of Education and Research in Germany (BMBF) within the research consortium 'Human Heart Models' (grant 01GG0708). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif A, 2008, BASIC RES CARDIOL, V103, P514, DOI 10.1007/s00395-008-0729-9; Altomare C, 2010, BASIC RES CARDIOL, V105, P737, DOI 10.1007/s00395-010-0111-6; Best JM, 2012, J MOL CELL CARDIOL, V52, P376, DOI 10.1016/j.yjmcc.2011.08.014; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; D'Ascenzo M, 2006, EUR J NEUROSCI, V23, P935, DOI 10.1111/j.1460-9568.2006.04628.x; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Ebert AM, 2005, P NATL ACAD SCI USA, V102, P17705, DOI 10.1073/pnas.0502683102; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Gollasch M, 1998, FASEB J, V12, P593, DOI 10.1096/fasebj.12.7.593; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Gupta MK, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-98; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Harvey PA, 2011, J CELL BIOL, V194, P355, DOI 10.1083/jcb.201101100; Harvey RP, 2002, NAT REV GENET, V3, P544, DOI 10.1038/nrg843; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; Hescheler J, 1997, CARDIOVASC RES, V36, P149, DOI 10.1016/S0008-6363(97)00193-4; Inagaki N, 2000, J BIOL CHEM, V275, P27165; Ji GJ, 1999, FASEB J, V13, P313, DOI 10.1096/fasebj.13.2.313; JOHNSON GJ, 1986, CIRCULATION, V73, P847, DOI 10.1161/01.CIR.73.4.847; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kleger A, 2010, CIRCULATION, V122, P1823, DOI 10.1161/CIRCULATIONAHA.110.971721; Kolossov E, 2005, FASEB J, V19, P577, DOI 10.1096/fj.03-1451fje; Kolossov E, 2006, J EXP MED, V203, P2315, DOI 10.1084/jem.20061469; Kuryshev YA, 1999, CIRCULATION, V100, P675, DOI 10.1161/01.CIR.100.6.675; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Le Blanc C, 2004, CIRC RES, V95, P300, DOI 10.1161/01.RES.0000138017.76125.8b; Lin S, 2001, AM J PHYSIOL-HEART C, V280, pH1160, DOI 10.1152/ajpheart.2001.280.3.H1160; Linask KL, 2010, STEM CELLS DEV, V19, P1959, DOI 10.1089/scd.2010.0192; MALTSEV VA, 1994, CIRC RES, V75, P233, DOI 10.1161/01.RES.75.2.233; Maruyama R, 2006, AM J PHYSIOL-HEART C, V290, pH1493, DOI 10.1152/ajpheart.00669.2005; Mauritz C, 2008, CIRCULATION, V118, P507, DOI 10.1161/CIRCULATIONAHA.108.778795; Muller-Borer BJ, 2007, P NATL ACAD SCI USA, V104, P3877, DOI 10.1073/pnas.0700416104; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Navedo MF, 2010, AM J PHYSIOL-CELL PH, V298, pC211, DOI 10.1152/ajpcell.00267.2009; Nguemo F, 2009, BASIC RES CARDIOL, V104, P295, DOI 10.1007/s00395-008-0755-7; Ohtani K, 2011, BASIC RES CARDIOL, V106, P5, DOI 10.1007/s00395-010-0139-7; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Pfannkuche K, 2009, CELL PHYSIOL BIOCHEM, V24, P73, DOI 10.1159/000227815; Porter GA, 2003, DEV DYNAM, V227, P280, DOI 10.1002/dvdy.10307; Porter GA, 2002, J BIOL CHEM, V277, P28942, DOI 10.1074/jbc.M203961200; Puceat M, 2005, CELL CALCIUM, V38, P383, DOI 10.1016/j.ceca.2005.06.016; Rajala K, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/383709; Sachinidis A, 2006, CELL PHYSIOL BIOCHEM, V18, P303, DOI 10.1159/000097608; Sasse P, 2007, J GEN PHYSIOL, V130, P133, DOI 10.1085/jgp.200609575; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Stainier DYR, 2001, NAT REV GENET, V2, P39, DOI 10.1038/35047564; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Tsai CT, 2007, CIRC RES, V100, P1476, DOI 10.1161/01.RES.0000268497.93085.e1; Viatchenko-Karpinski S, 1999, P NATL ACAD SCI USA, V96, P8259, DOI 10.1073/pnas.96.14.8259; Wang Y, 2007, J MOL CELL CARDIOL, V42, P1045, DOI 10.1016/j.yjmcc.2007.03.905; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; YATANI A, 1988, AM J PHYSIOL, V254, pH140, DOI 10.1152/ajpheart.1988.254.1.H140; YONEMOCHI H, 1990, CIRCULATION, V81, P1401, DOI 10.1161/01.CIR.81.4.1401; Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885	55	18	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53407	10.1371/journal.pone.0053407	http://dx.doi.org/10.1371/journal.pone.0053407			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320083	Green Submitted, gold, Green Published			2022-12-25	WOS:000313429800047
J	Lieberman, OJ; DeStefano, JJ; Lee, VT				Lieberman, Ori J.; DeStefano, Jeffery J.; Lee, Vincent T.			Detection of Cyclic Diguanylate G-Octaplex Assembly and Interaction with Proteins	PLOS ONE			English	Article							C-DI-GMP; HUMAN-IMMUNODEFICIENCY-VIRUS; G-QUADRUPLEX; STRUCTURAL BASIS; REVERSE-TRANSCRIPTASE; ALLOSTERIC CONTROL; BINDING-PROTEIN; NUCLEIC-ACIDS; GUANOSINE-MONOPHOSPHATE; RESOLUTION STRUCTURE	Bacterial signaling networks control a wide variety of cellular processes including growth, metabolism, and pathogenesis. Bis-(3'-5')-cyclic dimeric guanosine monophosphate (cdiGMP) is a secondary signaling nucleotide that controls cellulose synthesis, biofilm formation, motility and virulence in a wide range of Gram-negative bacterial species. CdiGMP is a dynamic molecule that forms different tertiary structures in vitro, including a trans-monomer, cis-monomer, cis-dimer and G-octaplex (G8). Although the monomer and dimer have been shown to be physiologically relevant in modulating protein activity and transcription, the biological effects of the cdiGMP G8 has not yet been described. Here, we have developed a TLC-based assay to detect radiolabeled cdiGMP G8 formation. Utilizing the radiolabeled cdiGMP G8, we have also shown a novel inhibitory interaction between the cdiGMP G8 and HIV-1 reverse transcriptase and that the cdiGMP G8 does not interact with proteins from Pseudomonas aeruginosa known to bind monomeric and dimeric cdiGMP. These results suggest that the radiolabeled cdiGMP G8 can be used to measure interactions between the cdiGMP G8 and cellular proteins, providing an avenue through which the biological significance of this molecule could be investigated.	[Lieberman, Ori J.; DeStefano, Jeffery J.; Lee, Vincent T.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Lieberman, Ori J.; DeStefano, Jeffery J.; Lee, Vincent T.] Maryland Pathogen Res Inst, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Lee, VT (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	vtlee@umd.edu		Lieberman, Ori/0000-0002-0467-0875; Lee, Vincent T./0000-0002-3593-0318	Maryland Summer Scholarship; University of Maryland-Howard Hughes Medical Institute; National Institute of Health [R21 R21AI096083]; Cystic Fibrosis Foundation; National Institute of General Medicine [GM051140]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI096083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051140, R29GM051140] Funding Source: NIH RePORTER	Maryland Summer Scholarship; University of Maryland-Howard Hughes Medical Institute; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institute of General Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a Maryland Summer Scholarship (OJL), University of Maryland-Howard Hughes Medical Institute Undergraduate Research Fellowship (OJL), National Institute of Health R21 R21AI096083 (VTL) and Cystic Fibrosis Foundation Grant (VTL), and National Institute of General Medicine grant GM051140 (JJD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Barends TRM, 2009, NATURE, V459, P1015, DOI 10.1038/nature07966; Benach J, 2007, EMBO J, V26, P5153, DOI 10.1038/sj.emboj.7601918; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; Brooks TA, 2010, FEBS J, V277, P3459, DOI 10.1111/j.1742-4658.2010.07759.x; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Cahoon LA, 2009, SCIENCE, V325, P764, DOI 10.1126/science.1175653; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006; De N, 2009, J MOL BIOL, V393, P619, DOI 10.1016/j.jmb.2009.08.030; DeStefano JJ, 2008, OLIGONUCLEOTIDES, V18, P133, DOI 10.1089/oli.2008.0103; DeStefano JJ, 2006, NUCLEIC ACIDS RES, V34, P130, DOI 10.1093/nar/gkj426; Donaldson GP, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1299; EGLI M, 1990, P NATL ACAD SCI USA, V87, P3235, DOI 10.1073/pnas.87.8.3235; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fry M, 2007, FRONT BIOSCI-LANDMRK, V12, P4336, DOI 10.2741/2391; Fukuda H, 2002, P NATL ACAD SCI USA, V99, P12685, DOI 10.1073/pnas.152456899; Gatto B, 2009, CURR MED CHEM, V16, P1248, DOI 10.2174/092986709787846640; Gentner M, 2012, J AM CHEM SOC; Habazettl J, 2011, J BIOL CHEM, V286, P14304, DOI 10.1074/jbc.M110.209007; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Horvath MP, 2001, J MOL BIOL, V310, P367, DOI 10.1006/jmbi.2001.4766; Huppert JL, 2010, FEBS J, V277, P3452, DOI 10.1111/j.1742-4658.2010.07758.x; Hurley LH, 2002, NAT REV CANCER, V2, P188, DOI 10.1038/nrc749; Jenal U, 2004, CURR OPIN MICROBIOL, V7, P185, DOI 10.1016/j.mib.2004.02.007; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; JOYCE GF, 1989, GENE, V82, P83, DOI 10.1016/0378-1119(89)90033-4; Kelsey I, 2011, BIOORGANIC MED CHEM; Kendrick S, 2010, PURE APPL CHEM, V82, P1609, DOI 10.1351/PAC-CON-09-09-29; Keniry MA, 2001, BIOPOLYMERS, V56, P123, DOI 10.1002/1097-0282(2000/2001)56:3<123::AID-BIP10010>3.0.CO;2-3; Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185; Kulshina N, 2009, NAT STRUCT MOL BIOL, V16, P1212, DOI 10.1038/nsmb.1701; Lai YT, 2012, NUCL ACID THER; Lee VT, 2007, MOL MICROBIOL, V65, P1474, DOI 10.1111/j.1365-2958.2007.05879.x; LIAW YC, 1990, FEBS LETT, V264, P223, DOI 10.1016/0014-5793(90)80253-F; MACAYA RF, 1993, P NATL ACAD SCI USA, V90, P3745, DOI 10.1073/pnas.90.8.3745; Merighi M, 2007, MOL MICROBIOL, V65, P876, DOI 10.1111/j.1365-2958.2007.05817.x; Michalowski D, 2008, NUCLEIC ACIDS RES, V36, P7124, DOI 10.1093/nar/gkn891; Mills E, 2011, CELL MICROBIOL, V13, P1122, DOI 10.1111/j.1462-5822.2011.01619.x; Minasov G, 2009, J BIOL CHEM, V284, P13174, DOI 10.1074/jbc.M808221200; Muniyappa K, 2000, MOL CELL BIOL, V20, P1361, DOI 10.1128/MCB.20.4.1361-1369.2000; Nakayama S, 2011, CHEM COMMUN, V47, P4766, DOI 10.1039/c0cc05432a; Navarro MVAS, 2009, STRUCTURE, V17, P1104, DOI 10.1016/j.str.2009.06.010; Paeschke K, 2008, NAT STRUCT MOL BIOL, V15, P598, DOI 10.1038/nsmb.1422; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Qin Y, 2008, BIOCHIMIE, V90, P1149, DOI 10.1016/j.biochi.2008.02.020; RANDERATH K, 1964, EXPERIENTIA, V20, P406, DOI 10.1007/BF02147995; Roelofs KG, 2011, P NATL ACAD SCI USA, V108, P15528, DOI 10.1073/pnas.1018949108; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Romling U, 2009, CONTRIB MICROBIOL, V16, P161, DOI 10.1159/000219379; ROSS P, 1985, FEBS LETT, V186, P191, DOI 10.1016/0014-5793(85)80706-7; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; SCHNEIDER DJ, 1995, BIOCHEMISTRY-US, V34, P9599, DOI 10.1021/bi00029a037; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Sissi C, 2011, BIOCHIMIE, V93, P1219, DOI 10.1016/j.biochi.2011.04.018; SMITH FW, 1992, NATURE, V356, P164, DOI 10.1038/356164a0; Smith KD, 2011, P NATL ACAD SCI USA, V108, P7757, DOI 10.1073/pnas.1018857108; Smith KD, 2009, NAT STRUCT MOL BIOL, V16, P1218, DOI 10.1038/nsmb.1702; Sondermann H, 2012, CURR OPIN MICROBIOL, V15, P140, DOI 10.1016/j.mib.2011.12.008; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Zhang ZY, 2006, J AM CHEM SOC, V128, P7015, DOI 10.1021/ja0613714; Zhang ZY, 2004, J AM CHEM SOC, V126, P16700, DOI 10.1021/ja0449832	70	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53689	10.1371/journal.pone.0053689	http://dx.doi.org/10.1371/journal.pone.0053689			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308275	gold, Green Submitted, Green Published			2022-12-25	WOS:000313429100107
J	Sukhdeo, K; Paramban, RI; Vidal, JG; Elia, J; Martin, J; Rivera, M; Carrasco, DR; Jarrar, A; Kalady, MF; Carson, CT; Balderas, R; Hjelmeland, AB; Lathia, JD; Rich, JN				Sukhdeo, Kumar; Paramban, Rosanto I.; Vidal, Jason G.; Elia, Jeanne; Martin, Jody; Rivera, Maricruz; Carrasco, Daniel R.; Jarrar, Awad; Kalady, Matthew F.; Carson, Christian T.; Balderas, Robert; Hjelmeland, Anita B.; Lathia, Justin D.; Rich, Jeremy N.			Multiplex Flow Cytometry Barcoding and Antibody Arrays Identify Surface Antigen Profiles of Primary and Metastatic Colon Cancer Cell Lines	PLOS ONE			English	Article							STEM-CELLS; MESSENGER-RNA; PROTEIN; MICROARRAY; EXPRESSION	Colon cancer is a deadly disease affecting millions of people worldwide. Current treatment challenges include management of disease burden as well as improvements in detection and targeting of tumor cells. To identify disease state-specific surface antigen signatures, we combined fluorescent cell barcoding with high-throughput flow cytometric profiling of primary and metastatic colon cancer lines (SW480, SW620, and HCT116). Our multiplexed technique offers improvements over conventional methods by permitting the simultaneous and rapid screening of cancer cells with reduced effort and cost. The method uses a protein-level analysis with commercially available antibodies on live cells with intact epitopes to detect potential tumor-specific targets that can be further investigated for their clinical utility. Multiplexed antibody arrays can easily be applied to other tumor types or pathologies for discovery-based approaches to target identification.	[Sukhdeo, Kumar; Rivera, Maricruz; Hjelmeland, Anita B.; Rich, Jeremy N.] Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44106 USA; [Sukhdeo, Kumar] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Paramban, Rosanto I.; Vidal, Jason G.; Elia, Jeanne; Martin, Jody; Carson, Christian T.; Balderas, Robert] BD Biosci, San Diego, CA USA; [Carrasco, Daniel R.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Jarrar, Awad; Kalady, Matthew F.] Cleveland Clin, Inst Digest Dis, Dept Colorectal Surg, Cleveland, OH 44106 USA; [Jarrar, Awad; Kalady, Matthew F.] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44106 USA; [Lathia, Justin D.] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University; Harvard University; Brigham & Women's Hospital; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Sukhdeo, K (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44106 USA.	kumar@case.edu; lathiaj@ccf.org; richj@ccf.org	Rich, Jeremy/AAM-1445-2021; Lathia, Justin/AHB-8296-2022	Sukhdeo, Kumar/0000-0001-8725-6081	Pediatric Brain Tumor Foundation of the United States; Brain Tumor Society; Goldhirsh Foundation; James D. McDonnell Foundation; National Institutes of Health [CA112958, CA116659, CA154130]; Pathway to Independence Award [CA157948]; Case Western Reserve Medical Scientist Training Program [T32 GM007250]; National Research Service Award, National Cancer Institute [F30 CA165857]; NATIONAL CANCER INSTITUTE [R01CA116659, R00CA157948, K99CA157948, F30CA165857, R01CA154130] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM088088, T32GM007250] Funding Source: NIH RePORTER	Pediatric Brain Tumor Foundation of the United States; Brain Tumor Society; Goldhirsh Foundation; James D. McDonnell Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Western Reserve Medical Scientist Training Program; National Research Service Award, National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Pediatric Brain Tumor Foundation of the United States, Brain Tumor Society, Goldhirsh Foundation, and James D. McDonnell Foundation. This work was also funded by National Institutes of Health grants CA112958 (JNR), CA116659 (JNR), CA154130 (JNR), Pathway to Independence Award CA157948 (JDL), Case Western Reserve Medical Scientist Training Program T32 GM007250 (KS), and National Research Service Award, National Cancer Institute F30 CA165857 (KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; BRATTAIN MG, 1981, CANCER RES, V41, P1751; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dydensborg AB, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-223; Ellmark P, 2006, PROTEOMICS, V6, P1791, DOI 10.1002/pmic.200500468; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Haraguchi N, 2008, ANN SURG ONCOL, V15, P2927, DOI 10.1245/s10434-008-0074-0; Hewitt RE, 2000, J PATHOL, V192, P446; Hong Y, 2010, CLIN EXP METASTAS, V27, P83, DOI 10.1007/s10585-010-9305-4; Joyce T, 2007, EXPERT OPIN PHARMACO, V8, P895, DOI 10.1517/14656566.8.7.895; Kemper K, 2010, CANCER RES, V70, P719, DOI 10.1158/0008-5472.CAN-09-1820; Ki DH, 2007, INT J CANCER, V121, P2005, DOI 10.1002/ijc.22975; Krutzik PO, 2011, CURRENT PROTOCOLS CY, V55, P63131; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Pascal LE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-246; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sikaroodi M, 2010, CURR MOL MED, V10, P249, DOI 10.2174/156652410790963277; Skrzypczak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013091; Spizzo G, 2011, J CLIN PATHOL, V64, P415, DOI 10.1136/jcp.2011.090274; Stein U, 2009, NAT MED, V15, P59, DOI 10.1038/nm.1889; Velazquez EF, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-2; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Zhou J, 2011, JOVE-J VIS EXP, DOI 10.3791/3322; Zhou J, 2010, J IMMUNOL METHODS, V355, P40, DOI 10.1016/j.jim.2010.01.015	32	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53015	10.1371/journal.pone.0053015	http://dx.doi.org/10.1371/journal.pone.0053015			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308131	Green Published, gold, Green Submitted			2022-12-25	WOS:000313429100023
J	Xia, S; Zhang, Q; Zhu, H; Cheng, YY; Liu, GX; Hu, ZY				Xia, Shuang; Zhang, Qi; Zhu, Huan; Cheng, Yingyin; Liu, Guoxiang; Hu, Zhengyu			Systematics of a Kleptoplastidal Dinoflagellate, Gymnodinium eucyaneum Hu (Dinophyceae), and Its Cryptomonad Endosymbiont	PLOS ONE			English	Article							MARINE DINOFLAGELLATE; GREEN DINOFLAGELLATE; SEQUENCE ALIGNMENT; EVOLUTION; PHYLOGENY; ULTRASTRUCTURE; STRATEGIES; NUCLEAR; IDENTIFICATION; CRYPTOPHYCEAE	New specimens of the kleptoplastidal dinoflagellate Gymnodinium eucyaneum Hu were collected in China. We investigated the systematics of the dinoflagellate and the origin of its endosymbiont based on light morphology and phylogenetic analyses using multiple DNA sequences. Cells were dorsoventrally flattened with a sharply acute hypocone and a hemispherical epicone. The confusion between G. eucyaneum and G. acidotum Nygaard still needs to be resolved. We found that the hypocone was conspicuously larger than the epicone in most G. eucyaneum cells, which differed from G. acidotum, but there were a few cells whose hypocone and epicone were of nearly the same size. In addition, there was only one site difference in the partial nuclear LSU rDNA sequences of a sample from Japan given the name G. acidotum and G. eucyaneum in the present study, which suggest that G. eucyaneum may be a synonym of G. acidotum. Spectroscopic analyses and phylogenetic analyses based on nucleomorph SSU rDNA sequences and chloroplast 23 s rDNA sequences suggested that the endosymbiont of G. eucyaneum was derived from Chroomonas (Cryptophyta), and that it was most closely related to C. coerulea Skuja. Moreover, the newly reported kleptoplastidal dinoflagellates G. myriopyrenoides and G. eucyaneum in our study were very similar, and the taxonomy of kleptoplastidal dinoflagellates was discussed.	[Xia, Shuang; Zhang, Qi; Zhu, Huan; Liu, Guoxiang; Hu, Zhengyu] Chinese Acad Sci, Inst Hydrobiol, Key Lab Algal Biol, Wuhan, Peoples R China; [Xia, Shuang; Zhu, Huan] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Cheng, Yingyin] Chinese Acad Sci, Inst Hydrobiol, Ctr Water Environm & Human Hlth, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Liu, GX (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Algal Biol, Wuhan, Peoples R China.	liugx@ihb.ac.cn	Liu, Guoxiang/L-7413-2019; González, Adela M Gómez/D-2863-2012; Pasanisi, Fabrizio/L-7437-2015; de Simone, Giovanni/D-1767-2011	Liu, Guoxiang/0000-0001-8565-2363; Pasanisi, Fabrizio/0000-0003-4224-7821; de Simone, Giovanni/0000-0001-8567-9881	National Natural Science Foundation of China [30970501, 31270252]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (Grant Nos 30970501 and 31270252). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsanti L, 2009, J PHYCOL, V45, P1304, DOI 10.1111/j.1529-8817.2009.00751.x; BRETT SJ, 1994, PROTOPLASMA, V181, P106, DOI 10.1007/BF01666391; Chen B, 1990, J CHIN ELECT MICRO S, V3, P42; Chesnick JM, 1997, J EUKARYOT MICROBIOL, V44, P314, DOI 10.1111/j.1550-7408.1997.tb05672.x; Daugbjerg N, 2000, PHYCOLOGIA, V39, P302, DOI 10.2216/i0031-8884-39-4-302.1; de Salas MF, 2003, J PHYCOL, V39, P1233, DOI 10.1111/j.0022-3646.2003.03-019.x; Douglas S, 2001, NATURE, V410, P1091, DOI 10.1038/35074092; DOYLE JJ, 1987, TAXON, V36, P715, DOI 10.2307/1221122; FARMER MA, 1990, PROTOPLASMA, V153, P178, DOI 10.1007/BF01354002; FIELDS SD, 1991, J PHYCOL, V27, P525, DOI 10.1111/j.0022-3646.1991.00525.x; Garcia-Cuetos L, 2010, HARMFUL ALGAE, V9, P25, DOI 10.1016/j.hal.2009.07.002; GIBBS SP, 1981, ANN NY ACAD SCI, V361, P193; GILLOTT MA, 1980, J PHYCOL, V16, P558; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; GREENWOOD A D, 1977, British Phycological Journal, V12, P119; Greenwood A. D., 1974, 8 INT C ELECT MICROS, P566; Hansen G, 2005, PHYCOL RES, V53, P169, DOI 10.1111/j.1440-183.2005.00383.x; Hansen G, 2000, J PHYCOL, V36, P394, DOI 10.1046/j.1529-8817.2000.99172.x; Hoef-Emden K, 2002, J MOL EVOL, V55, P161, DOI 10.1007/s00239-002-2313-5; Hoef-Emden K, 2008, J PHYCOL, V44, P985, DOI 10.1111/j.1529-8817.2008.00530.x; HORIGUCHI T, 1991, BOT MAR, V34, P123, DOI 10.1515/botm.1991.34.2.123; Horiguchi T, 2006, PHYCOL RES, V54, P193, DOI 10.1111/j.1440-1835.2006.00426.x; Horiguchi Takeo, 2006, Paleontological Research, V10, P299; HOSHAW RW, 1973, HDB PHYCOLOGICAL MET, P54; Hu H., 1980, KEXUE TONGBAO, V25, P882; Hu H.J., 1983, Chinese Journal of Oceanology and Limnology, V1, P198; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Johnson MD, 2011, PHOTOSYNTH RES, V107, P117, DOI 10.1007/s11120-010-9546-8; Jorgensen MF, 2004, PHYCOL RES, V52, P284; Jorgensen MF, 2004, J PHYCOL, V40, P351, DOI 10.1111/j.1529-8817.2004.03131.x; Kim E, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-73; Kofoid C. A., 1921, Memoirs of the University of California, V5, P1; Kugrens P, 2003, FRESHWATER ALGAE N A, P740; Larsen Jacob, 1992, P427; Lewitus AJ, 1999, J PHYCOL, V35, P303, DOI 10.1046/j.1529-8817.1999.3520303.x; MAIER UG, 1992, BIOSYSTEMS, V28, P69, DOI 10.1016/0303-2647(92)90009-N; MAIER UG, 1994, ENDOCYTOBIOSIS CELL, V10, P129; Minnhagen S, 2008, ENVIRON MICROBIOL, V10, P2411, DOI 10.1111/j.1462-2920.2008.01666.x; Nagai S, 2008, J PHYCOL, V44, P909, DOI 10.1111/j.1529-8817.2008.00544.x; NICHOLS HW, 1965, J PHYCOL, V1, P34, DOI 10.1111/j.1529-8817.1965.tb04552.x; Novarino G, 2003, HYDROBIOLOGIA, V502, P225, DOI 10.1023/B:HYDR.0000004284.12535.25; Nygaard G, 1949, KONGEL DANSKE VIDENS, V7, P263; Park MG, 2008, J PHYCOL, V44, P1154, DOI 10.1111/j.1529-8817.2008.00579.x; Pochon X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029816; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; SCHNEPF E, 1989, PLANT SYST EVOL, V164, P75, DOI 10.1007/BF00940431; SCHNEPF E, 1992, EUR J PROTISTOL, V28, P3, DOI 10.1016/S0932-4739(11)80315-9; Schnepf Eberhard, 1992, P699; SCHOLIN CA, 1994, J PHYCOL, V30, P999, DOI 10.1111/j.0022-3646.1994.00999.x; Shi Z, 1983, HAIYANG YU HUZHAO, V14, P161; SITTE P, 1992, ENDOCYT CELL RES, V8, P223; Skovgaard A, 1998, AQUAT MICROB ECOL, V15, P293, DOI 10.3354/ame015293; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TAYLOR F J R, 1974, Taxon, V23, P229, DOI 10.2307/1218702; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; WHATLEY JM, 1981, NEW PHYTOL, V87, P233, DOI 10.1111/j.1469-8137.1981.tb03195.x; WILCOX LW, 1984, J PHYCOL, V20, P236, DOI 10.1111/j.0022-3646.1984.00236.x; Wisecaver JH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-366; Yamaguchi H, 2011, PROTIST, V162, P650, DOI 10.1016/j.protis.2011.01.002; Yoon HS, 2005, MOL BIOL EVOL, V22, P1299, DOI 10.1093/molbev/msi118; Zhang S., 1989, Acta Hydrobiologica Sinica, V13, P289	62	14	15	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53820	10.1371/journal.pone.0053820	http://dx.doi.org/10.1371/journal.pone.0053820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308288	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429100120
J	El Husseini, D; Boulanger, MC; Fournier, D; Mahmut, A; Bosse, Y; Pibarot, P; Mathieu, P				El Husseini, Diala; Boulanger, Marie-Chloe; Fournier, Dominique; Mahmut, Ablajan; Bosse, Yohan; Pibarot, Philippe; Mathieu, Patrick			High Expression of the Pi-Transporter SLC20A1/Pit1 in Calcific Aortic Valve Disease Promotes Mineralization through Regulation of Akt-1	PLOS ONE			English	Article							MUSCLE-CELL CALCIFICATION; VASCULAR CALCIFICATION; PHOSPHATE; STENOSIS; OSTEOPONTIN; SIGNAL; TRIAL	The regulation of phosphate (Pi) handling is crucial during calcification of the aortic valve. Gene profiling of Pi transporters revealed that VIC culture expresses SLC201A1/Pit1 and SLC20A2/Pit2. On exposure to a mineralizing medium (2 mM Pi), the expression of Pi transporters in VIC culture is increased several folds, with the highest magnitude for SLC20A1. By using siRNAs, we established that silencing SLC20A1 significantly reduced Pi-induced mineralization of VICs. In human pathological specimens, we found that the expression of SCL20A1 was increased in CAVD tissues compared to control non-mineralized aortic valves. Treatment of VIC culture with Pi promoted the loss of mitochondrial membrane potential (Delta psi m) and cytochrome c release within the cytosol, leading to apoptosis. Inhibition of Pi transporters with phosphonoformic acid (PFA) prevented Pi-mediated apoptosis of VICs. Moreover, we discovered that the level of the Akt-1 transcript is diminished in CAVD tissues compared with control valves. Accordingly, treatment with Pi caused a reduction of the Akt-1 transcript in VIC culture, and treatment with PFA or siRNA against SLC20A1 restored the level of Akt-1. Overexpression of Akt-1 (pCMVAkt-1) prevented both Pi-induced apoptosis and mineralization of VIC culture. These results strongly suggest that overexpression of SLC20A1 promotes apoptosis and mineralization by altering the level of Akt-1.	[El Husseini, Diala; Boulanger, Marie-Chloe; Fournier, Dominique; Mahmut, Ablajan; Mathieu, Patrick] Univ Laval, Dept Surg, Res Ctr, Quebec Heart & Lung Inst,GRV,LEMV, Quebec City, PQ, Canada; [Bosse, Yohan; Pibarot, Philippe] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada	Laval University; Quebec Heart & Lung Institute	Mathieu, P (corresponding author), Univ Laval, Dept Surg, Res Ctr, Quebec Heart & Lung Inst,GRV,LEMV, Quebec City, PQ, Canada.	patrick.mathieu@chg.ulaval.ca	Pibarot, Philippe/ABD-5300-2021		HSFC grant; CIHR grants [MOP114893]; Fonds de Recherche en Sante du Quebec (FRSQ)	HSFC grant; CIHR grants(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This work was supported by HSFC grant and CIHR grants MOP114893. D. E.H. is supported by studentship grants from Fonds de Recherche en Sante du Quebec (FRSQ). Y.B. is a research scholar from the Heart and Stroke Foundation of Canada, Ottawa, Ontario, Canada. P.P. holds the Canada Research Chair in Valvular Heart Diseases, Ottawa, Ontario, Canada. P.M. is a research scholar from the Fonds de Recherche en Sante du Quebec, Montreal, Quebec, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck GR, 2000, P NATL ACAD SCI USA, V97, P8352, DOI 10.1073/pnas.140021997; Chan KL, 2010, CIRCULATION, V121, P306, DOI 10.1161/CIRCULATIONAHA.109.900027; Cote N, 2012, J MOL CELL CARDIOL, V52, P1191, DOI 10.1016/j.yjmcc.2012.02.003; Cowell SJ, 2005, NEW ENGL J MED, V352, P2389, DOI 10.1056/NEJMoa043876; Giachelli CM, 2005, CIRC RES, V96, P717, DOI 10.1161/01.RES.0000161997.24797.c0; Giachelli CM, 2001, AM J KIDNEY DIS, V38, pS34, DOI 10.1053/ajkd.2001.27394; Jono S, 2000, CIRC RES, V87, pE10, DOI 10.1161/01.RES.87.7.e10; Lau WL, 2011, ADV CHRONIC KIDNEY D, V18, P105, DOI 10.1053/j.ackd.2010.12.002; Li XW, 2006, CIRC RES, V98, P905, DOI 10.1161/01.RES.0000216409.20863.e7; LoghmanAdham M, 1996, GEN PHARMACOL-VASC S, V27, P305, DOI 10.1016/0306-3623(95)02017-9; Matheny RW, 2009, EXP BIOL MED, V234, P1264, DOI 10.3181/0904-MR-138; Mathieu P, 2007, CAN J CARDIOL, V23, p32B, DOI 10.1016/S0828-282X(07)71008-5; Mune S, 2009, CLIN EXP NEPHROL, V13, P571, DOI 10.1007/s10157-009-0208-0; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Pohjolainen V, 2012, ATHEROSCLEROSIS, V220, P66, DOI 10.1016/j.atherosclerosis.2011.10.003; Proudfoot D, 2001, Z Kardiol, V90 Suppl 3, P43; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Son BK, 2008, J ATHEROSCLER THROMB, V15, P63, DOI 10.5551/jat.E545; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3; Villa-Bellosta R, 2007, ARTERIOSCL THROM VAS, V27, P1030, DOI 10.1161/ATVBAHA.106.132266	20	38	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53393	10.1371/journal.pone.0053393	http://dx.doi.org/10.1371/journal.pone.0053393			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308213	Green Published, gold			2022-12-25	WOS:000313670100037
J	Li, PF; Carter, G; Romero, J; Gower, KM; Watson, J; Patel, NA; Cooper, DR				Li, Pengfei; Carter, Gay; Romero, Jacqueline; Gower, Kathryn M.; Watson, James; Patel, Niketa A.; Cooper, Denise R.			Clk/STY (cdc2-Like Kinase 1) and Akt Regulate Alternative Splicing and Adipogenesis in 3T3-L1 Pre-Adipocytes	PLOS ONE			English	Article							C-BETA-II; SKELETAL-MUSCLE CELLS; PROTEIN-KINASE; ADIPOSE CONVERSION; INSULIN-RESISTANCE; DIFFERENTIATION; PHOSPHORYLATION; ALPHA; TRANSCRIPTION; ADIPONECTIN	The development of adipocytes from their progenitor cells requires the action of growth factors signaling to transcription factors to induce the expression of adipogenic proteins leading to the accumulation of lipid droplets, induction of glucose transport, and secretion of adipokines signaling metabolic events throughout the body. Murine 3T3-L1 pre-adipocytes sequentially express all the proteins necessary to become mature adipocytes throughout an 8-10 day process initiated by a cocktail of hormones. We examined the role of Clk/STY or Clk1, a cdc2-like kinase, in adipogenesis since it is known to be regulated by Akt, a pivotal kinase in development. Inhibition of Clk1 by a specific inhibitor, TG003, blocked alternative splicing of PKC beta II and expression of PPAR gamma 1 and PPAR gamma 2. SiRNA depletion of Clk1 resulted in early expression of PKC beta II and sustained PKC beta I expression. Since Clk1 is a preferred Akt substrate, required for phosphorylation of splicing factors, mutation of Clk1 Akt phosphorylation sites was undertaken. Akt sites on Clk1 are in the serine/arginine-rich domain and not the kinase domain. Mutation of single and multiple sites resulted in dysregulation of PKC beta II, PKC beta I, and PPAR gamma 1&2 expression. Additionally, adipogenesis was blocked as assessed by Oil Red O staining, adiponectin, and Glut1 and 4 expression. Immunofluorescence microscopy revealed that Clk1 triple mutant cDNA, transfected into pre-adipocytes, resulted in excluding SRp40 (SFSR6) from co-localizing to the nucleus with PFS, a perispeckle specific protein. This study demonstrates the role of Akt and Clk1 kinases in the early differentiation of 3T3-L1 cells to adipocytes.	[Li, Pengfei; Romero, Jacqueline; Gower, Kathryn M.; Patel, Niketa A.; Cooper, Denise R.] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33620 USA; [Carter, Gay; Watson, James; Patel, Niketa A.; Cooper, Denise R.] James A Haley Vet Hosp, Res Serv, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital	Cooper, DR (corresponding author), Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33620 USA.	dcooper@health.usf.edu		Patel, Niketa A./0000-0003-4811-8596	Department of Veterans Affairs Merit Review; National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [2RO1 054393, RO1 054393S2]; NIH NIDDK STEP-UP Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054393] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003689] Funding Source: NIH RePORTER	Department of Veterans Affairs Merit Review(US Department of Veterans Affairs); National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH NIDDK STEP-UP Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Department of Veterans Affairs Merit Review (D.R.C., N.A.P.) and National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2RO1 054393 (D.R.C.), NIH NIDDK STEP-UP Award (J.A.R.), and NIH NIDDK RO1 054393S2 (D.R.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudry A, 2006, J CELL SCI, V119, P889, DOI 10.1242/jcs.02792; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Bullock AN, 2009, STRUCTURE, V17, P352, DOI 10.1016/j.str.2008.12.023; CHALFANT CE, 1995, J BIOL CHEM, V270, P13326, DOI 10.1074/jbc.270.22.13326; Chalfant CE, 1998, J BIOL CHEM, V273, P910, DOI 10.1074/jbc.273.2.910; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; Colwill K, 1996, J BIOL CHEM, V271, P24569, DOI 10.1074/jbc.271.40.24569; Duncan PI, 1997, MOL CELL BIOL, V17, P5996, DOI 10.1128/MCB.17.10.5996; DUNCAN PI, 1995, J BIOL CHEM, V270, P21524, DOI 10.1074/jbc.270.37.21524; Fox AH, 2002, CURR BIOL, V12, P13, DOI 10.1016/S0960-9822(01)00632-7; Garcia-Sacristan A, 2005, CELL RES, V15, P495, DOI 10.1038/sj.cr.7290319; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; GREEN H, 1979, J CELL PHYSIOL, V101, P169, DOI 10.1002/jcp.1041010119; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Heiker JT, 2010, BIOL CHEM, V391, P1005, DOI 10.1515/BC.2010.104; HOWELL BW, 1991, MOL CELL BIOL, V11, P568, DOI 10.1128/MCB.11.1.568; Huang H, 2008, J GASTROEN HEPATOL, V23, pS50, DOI 10.1111/j.1440-1746.2007.05284.x; Huang W, 2009, HEPATOLOGY, V49, P1525, DOI 10.1002/hep.22815; Jiang K, 2009, ENDOCRINOLOGY, V150, P2087, DOI 10.1210/en.2008-0818; Kleiman E, 2009, BIOCH BIOPH IN PRESS; Lee K, 1996, J BIOL CHEM, V271, P27299, DOI 10.1074/jbc.271.44.27299; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Mott BT, 2009, BIOORG MED CHEM LETT, V19, P6700, DOI 10.1016/j.bmcl.2009.09.121; Muraki M, 2004, J BIOL CHEM, V279, P24246, DOI 10.1074/jbc.M314298200; Nam SY, 2010, J BIOL CHEM, V285, P31157, DOI 10.1074/jbc.M110.122044; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Patel NA, 2005, J BIOL CHEM, V280, P14302, DOI 10.1074/jbc.M411485200; Patel NA, 2004, MOL ENDOCRINOL, V18, P899, DOI 10.1210/me.2003-0391; Patel NA, 2001, J BIOL CHEM, V276, P22648, DOI 10.1074/jbc.M101260200; Prasad J, 2003, MOL CELL BIOL, V23, P4139, DOI 10.1128/MCB.23.12.4139-4149.2003; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; ROTH MB, 1991, J CELL BIOL, V115, P587, DOI 10.1083/jcb.115.3.587; Shao DL, 1997, J BIOL CHEM, V272, P21473, DOI 10.1074/jbc.272.34.21473; Stark JM, 1998, P NATL ACAD SCI USA, V95, P2163, DOI 10.1073/pnas.95.5.2163; Stark JM, 1999, J BIOL CHEM, V274, P29838, DOI 10.1074/jbc.274.42.29838; Stojdl DF, 1999, BIOCHEM CELL BIOL, V77, P293, DOI 10.1139/bcb-77-4-293; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; YUN B, 1994, GENE DEV, V8, P1160, DOI 10.1101/gad.8.10.1160; Yun SJ, 2008, BIOCHEM BIOPH RES CO, V371, P138, DOI 10.1016/j.bbrc.2008.04.029	39	19	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53268	10.1371/journal.pone.0053268	http://dx.doi.org/10.1371/journal.pone.0053268			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308182	Green Submitted, Green Published, gold			2022-12-25	WOS:000313670100029
J	Laanto, E; Bamford, JKH; Laakso, J; Sundberg, LR				Laanto, Elina; Bamford, Jaana K. H.; Laakso, Jouni; Sundberg, Lotta-Riina			Phage-Driven Loss of Virulence in a Fish Pathogenic Bacterium	PLOS ONE			English	Article							FLAVOBACTERIUM-COLUMNARE; RESISTANT MUTANTS; MARINE VIRUSES; EVOLUTION; MOTILITY; DIVERSITY; ADHESION; DISEASE; BACTERIOPHAGES; SUSCEPTIBILITY	Parasites provide a selective pressure during the evolution of their hosts, and mediate a range of effects on ecological communities. Due to their short generation time, host-parasite interactions may also drive the virulence of opportunistic bacteria. This is especially relevant in systems where high densities of hosts and parasites on different trophic levels (e. g. vertebrate hosts, their bacterial pathogens, and virus parasitizing bacteria) co-exist. In farmed salmonid fingerlings, Flavobacterium columnare is an emerging pathogen, and phage that infect F. columnare have been isolated. However, the impact of these phage on their host bacterium is not well understood. To study this, four strains of F. columnare were exposed to three isolates of lytic phage and the development of phage resistance and changes in colony morphology were monitored. Using zebrafish (Danio rerio) as a model system, the ancestral rhizoid morphotypes were associated with a 25-100% mortality rate, whereas phage-resistant rough morphotypes that lost their virulence and gliding motility (which are key characteristics of the ancestral types), did not affect zebrafish survival. Both morphotypes maintained their colony morphologies over ten serial passages in liquid culture, except for the low-virulence strain, Os06, which changed morphology with each passage. To our knowledge, this is the first report of the effects of phage-host interactions in a commercially important fish pathogen where phage resistance directly correlates with a decline in bacterial virulence. These results suggest that phage can cause phenotypic changes in F. columnare outside the fish host, and antagonistic interactions between bacterial pathogens and their parasitic phage can favor low bacterial virulence under natural conditions. Furthermore, these results suggest that phage-based therapies can provide a disease management strategy for columnaris disease in aquaculture.	[Laanto, Elina; Bamford, Jaana K. H.; Laakso, Jouni; Sundberg, Lotta-Riina] Univ Jyvaskyla, Ctr Excellence Biol Interact, SF-40351 Jyvaskyla, Finland; [Laanto, Elina; Bamford, Jaana K. H.; Laakso, Jouni; Sundberg, Lotta-Riina] Univ Helsinki, Ctr Excellence Biol Interact, FIN-00014 Helsinki, Finland; [Laanto, Elina; Bamford, Jaana K. H.; Sundberg, Lotta-Riina] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Laanto, Elina; Bamford, Jaana K. H.] Univ Jyvaskyla, Nanosci Ctr, Jyvaskyla, Finland; [Laakso, Jouni] Univ Helsinki, Dept Biosci, Helsinki, Finland	University of Jyvaskyla; University of Helsinki; University of Jyvaskyla; University of Jyvaskyla; University of Helsinki	Sundberg, LR (corresponding author), Univ Jyvaskyla, Ctr Excellence Biol Interact, SF-40351 Jyvaskyla, Finland.	lotta-riina.sundberg@jyu.fi	Sundberg, Lotta-Riina/AAW-3125-2020; Laanto, Elina/ABA-8049-2020; Sundberg, Lotta-Riina/N-1551-2014; Laakso, Jouni/I-7794-2013	Sundberg, Lotta-Riina/0000-0003-3510-4398; Sundberg, Lotta-Riina/0000-0003-3510-4398; Laakso, Jouni/0000-0001-8245-9912; Laanto, Elina/0000-0003-4172-3128	Finnish Centre of Excellence Program of the Academy of Finland [1129648, 252411]; Academy of Finland [127500, 125572]; Maj and Tor Nessling Foundation	Finnish Centre of Excellence Program of the Academy of Finland(Academy of Finland); Academy of Finland(Academy of Finland); Maj and Tor Nessling Foundation	This work was supported by Finnish Centre of Excellence Program of the Academy of Finland 2006-2011 CoE in Virus Research (#1129648), and CoE in Biological Interactions 2012-2017(#252411, Johanna Mappes), Academy of Finland grants 127500 (L. R. S.) and 125572 (J.L.), and a grant from the Maj and Tor Nessling Foundation (J.K.H.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedon S.T, 2008, BACTERIOPHAGE ECOLOG; Abedon ST, 2005, EVOL BIOINFORM, V1, P97; ANACKER RL, 1959, J BACTERIOL, V78, P25, DOI 10.1128/JB.78.1.25-32.1959; Antonovics J, 2013, EVOLUTION, V67, P1, DOI 10.1111/j.1558-5646.2012.01793.x; Bader JA, 2005, LETT APPL MICROBIOL, V40, P123, DOI 10.1111/j.1472-765X.2004.01641.x; Bashey F, 2011, OIKOS, V120, P1539, DOI 10.1111/j.1600-0706.2011.19304.x; Bohannan BJM, 2000, ECOL LETT, V3, P362, DOI 10.1046/j.1461-0248.2000.00161.x; Boyd EF, 2002, TRENDS MICROBIOL, V10, P521, DOI 10.1016/S0966-842X(02)02459-9; Brown SP, 2012, TRENDS MICROBIOL, V20, P336, DOI 10.1016/j.tim.2012.04.005; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; Capparelli R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011720; Castillo D, 2012, J FISH DIS, V35, P193, DOI 10.1111/j.1365-2761.2011.01336.x; DARZINS A, 1993, J BACTERIOL, V175, P5934, DOI 10.1128/JB.175.18.5934-5944.1993; Decostere A, 1997, J CLIN MICROBIOL, V35, P322, DOI 10.1128/JCM.35.1.322-324.1997; Dumpala PR, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-26; Ebert D, 1996, PARASITOL TODAY, V12, P96, DOI 10.1016/0169-4758(96)80668-5; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Friman VP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017651; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; HEIERSON A, 1986, J BACTERIOL, V167, P18, DOI 10.1128/jb.167.1.18-24.1986; Hendrix RW, 2002, THEOR POPUL BIOL, V61, P471, DOI 10.1006/tpbi.2002.1590; Holmfeldt K, 2007, APPL ENVIRON MICROB, V73, P6730, DOI 10.1128/AEM.01399-07; Josenhans C, 2002, INT J MED MICROBIOL, V291, P605, DOI 10.1078/1438-4221-00173; King OD, 2007, THEOR POPUL BIOL, V72, P560, DOI 10.1016/j.tpb.2007.08.006; Kunttu HMT, 2011, J APPL MICROBIOL, V111, P1319, DOI 10.1111/j.1365-2672.2011.05149.x; Kunttu HMT, 2012, ENV MICROBIOL REP, V4, P398, DOI 10.1111/j.1758-2229.2012.00342.x; Kunttu HMT, 2009, EPIDEMICS-NETH, V1, P96, DOI 10.1016/j.epidem.2009.04.003; Kunttu HMT, 2009, MICROB PATHOGENESIS, V46, P21, DOI 10.1016/j.micpath.2008.10.001; Laanto E, 2011, APPL ENVIRON MICROB, V77, P7868, DOI 10.1128/AEM.05574-11; Lennon JT, 2008, ECOL LETT, V11, P1178, DOI 10.1111/j.1461-0248.2008.01225.x; Mennerat A, 2010, EVOL BIOL, V37, P59, DOI 10.1007/s11692-010-9089-0; Moyer TR, 2007, DIS AQUAT ORGAN, V76, P39, DOI 10.3354/dao076039; Nakai T, 2002, RES MICROBIOL, V153, P13, DOI 10.1016/S0923-2508(01)01280-3; Olivares-Fuster O, 2011, J FISH DIS, V34, P385, DOI 10.1111/j.1365-2761.2011.01253.x; Ottemann KM, 1997, MOL MICROBIOL, V24, P1109, DOI 10.1046/j.1365-2958.1997.4281787.x; Park SC, 2003, DIS AQUAT ORGAN, V53, P33, DOI 10.3354/dao053033; Pulkkinen K, 2010, P ROY SOC B-BIOL SCI, V277, P593, DOI 10.1098/rspb.2009.1659; Revetta Randy P., 2005, Journal of Water and Health, V3, P83; Rickard AH, 2003, FEMS MICROBIOL LETT, V220, P133, DOI 10.1016/S0378-1097(03)00094-6; Santander J, 2007, ELECTRON J BIOTECHN, V10, P627, DOI 10.2225/vol10-issue4-fulltext-14; Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107; SCHADE SYLVIA Z., 1967, J VIROL, V1, P599; SCHRAG SJ, 1995, TRENDS ECOL EVOL, V10, P319, DOI 10.1016/S0169-5347(00)89118-1; Seger J., 1987, Oxford Surveys in Evolutionary Biology, V4, P182; SHIEH H S, 1980, Microbios Letters, V13, P129; Stern A, 2011, BIOESSAYS, V33, P43, DOI 10.1002/bies.201000071; Suomalainen LR, 2006, DIS AQUAT ORGAN, V70, P55, DOI 10.3354/dao070055; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Zar JH., 2010, BIOSTAT ANAL	53	83	85	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53157	10.1371/journal.pone.0053157	http://dx.doi.org/10.1371/journal.pone.0053157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23308090	gold, Green Published, Green Submitted			2022-12-25	WOS:000313872600064
J	Miura, K; Wakayama, Y; Tanino, M; Orba, Y; Sawa, H; Hatakeyama, M; Tanaka, S; Sabe, H; Mochizuki, N				Miura, K.; Wakayama, Y.; Tanino, M.; Orba, Y.; Sawa, H.; Hatakeyama, M.; Tanaka, S.; Sabe, H.; Mochizuki, N.			Involvement of EphA2-mediated tyrosine phosphorylation of Shp2 in Shp2-regulated activation of extracellular signal-regulated kinase	ONCOGENE			English	Article						Shp2; EphA2; Erk; cancer; LEOPARD syndrome	EPIDERMAL-GROWTH-FACTOR; PHOSPHATASE SHP2; LEOPARD-SYNDROME; EPHA2 RECEPTOR; PATHWAY; CANCER; PROTEIN; TARGET; MECHANISM; CELLS	Shp2 is a positive regulator for Erk activation downstream of receptor tyrosine kinases for growth factors. It has been controversial how Shp2 induces Erk activation. We here demonstrate that EphA2 is responsible for Shp2-mediated Erk activation by phosphorylating Tyr542 and Tyr580 of Shp2 in the cells stimulated with growth factors. In NMuMG mammary epithelial cells stimulated with hepatocyte growth factor (HGF), HGF-dependent Erk phosphorylation was prolonged only in the presence of EphA2. This Erk activation paralleled the phosphorylation of Tyr542/580 of Shp2 and the association of Grb2 with Shp2, suggesting the positive signal involving Grb2 signal to activate Ras-Erk pathway. Immunohistochemical studies of mammary cancer specimens revealed that the cancer progression was associated with both Tyr580 phosphorylation of Shp2 and increased expression of EphA2, which were also correlated with increased Erk phosphorylation. Overexpression of either Shp2Thr468Met (a phosphatase-defective mutant found in Lentigines, Electrocardiographic abnormalities, Ocular hypertelorism, Pulmonary stenosis, Abnormal genitalia, Retardation of growth and sensorineural Deafness (LEOPARD) syndrome) or Shp2Asn308Asp (a phosphatase-active mutant found in Noonan syndrome) with EphA2 exhibited comparable activation of Erk and stronger activation than wild-type Shp2, suggesting the phosphatase-independent Erk activation. Expression of Shp2Thr468Met with Tyr542/580Phe mutations resulted in the suppression of Erk activation. Phosphatase-active and -inactive, and wild-type Shp2s bound equally to Grb2, suggesting that phosphorylation of Tyr542/580 of Shp2 was essential but not sufficient for Shp2-mediated Erk activation. We found that Gab1 (Grb2-associated binder 1) was involved in the mutant Shp2-mediated Erk activation. Zebrafish injected with Shp2Thr468Met mRNA showed cardiac edema, whereas those depleted of EphA2b showed less phenotype, suggesting that EphA2 might partly account for the phenotype of LEOPARD syndrome. Collectively, tyrosine phosphorylation of Shp2 by EphA2 contributes to the phosphatase-independent Shp2-mediated activation of Erk and might be involved in Shp2-associated diseases.	[Miura, K.; Wakayama, Y.; Mochizuki, N.] Natl Cerebral & Cardiovasc Ctr, Dept Cell Biol, Res Inst, Suita, Osaka 5658565, Japan; [Tanino, M.; Tanaka, S.] Hokkaido Univ, Grad Sch Med, Lab Canc Res, Dept Pathol,Kita Ku, Sapporo, Hokkaido, Japan; [Orba, Y.; Sawa, H.] Hokkaido Univ, Dept Mol Pathobiol, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Hatakeyama, M.] Univ Tokyo, Grad Sch Med, Div Microbiol, Bunkyo Ku, Tokyo, Japan; [Sabe, H.] Hokkaido Univ, Grad Sch Med, Dept Mol Biol, Kita Ku, Sapporo, Hokkaido, Japan	National Cerebral & Cardiovascular Center - Japan; Hokkaido University; Hokkaido University; University of Tokyo; Hokkaido University	Miura, K (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Cell Biol, Res Inst, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	miurako@ri.ncvc.go.jp; nmochizu@ri.ncvc.go.jp	Sawa, Hirofumi/AAW-8816-2021; Sabe, Hisataka/GPF-4385-2022; Sawa, Hirofumi/F-6954-2012; Tanaka, Shinya/D-3586-2011	Sawa, Hirofumi/0000-0003-2569-2755; 	Ministry of Education, Science, Sports and Culture of Japan; Ministry of Health, Labor and Welfare of Japan; Takeda Science Foundation; AstraZeneca; Grants-in-Aid for Scientific Research [22240085, 22114002, 22114001, 24590406] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); AstraZeneca(AstraZeneca); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M Matsuda (Kyoto University), T Akagi (KAN Research Institute), T Hirano (Osaka University) and S Kunimoto (Nippon University) for reagents; M Masuda, S Fukuhara and H Fukui for valuable advice; and M Sone, K Hiratomi, M Minamimoto, H Yonekawa, W Koeda and Y Matsuura for technical assistance. This work was supported, in part, by grants from the Ministry of Education, Science, Sports and Culture of Japan; the Ministry of Health, Labor and Welfare of Japan; Takeda Science Foundation; and AstraZeneca Research Grant.	Agazie YM, 2003, MOL CELL BIOL, V23, P7875, DOI 10.1128/MCB.23.21.7875-7886.2003; Araki T, 2003, J BIOL CHEM, V278, P41677, DOI 10.1074/jbc.M306461200; Araujo J, 2010, CANCER TREAT REV, V36, P492, DOI 10.1016/j.ctrv.2010.02.015; Bin Fang W, 2008, J BIOL CHEM, V283, P16017, DOI 10.1074/jbc.M709934200; Brantley-Sieders DM, 2008, J CLIN INVEST, V118, P64, DOI 10.1172/JCI33154; Cai T, 2002, J CELL BIOL, V159, P103, DOI 10.1083/jcb.200205017; Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005; Cha Y, 2010, FEBS LETT, V584, P4241, DOI 10.1016/j.febslet.2010.09.016; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Cleghon V, 1998, MOL CELL, V2, P719, DOI 10.1016/S1097-2765(00)80287-7; Cunnick JM, 2000, J BIOL CHEM, V275, P13842, DOI 10.1074/jbc.275.18.13842; Dance M, 2008, CELL SIGNAL, V20, P453, DOI 10.1016/j.cellsig.2007.10.002; Edouard T, 2007, CELL MOL LIFE SCI, V64, P1585, DOI 10.1007/s00018-007-6509-0; Grossmann KS, 2010, ADV CANCER RES, V106, P53, DOI 10.1016/S0065-230X(10)06002-1; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Ireton RC, 2005, CURR CANCER DRUG TAR, V5, P149, DOI 10.2174/1568009053765780; Jopling C, 2007, PLOS GENET, V3, P2468, DOI 10.1371/journal.pgen.0030225; Lemeer S, 2007, MOL CELL PROTEOMICS, V6, P2088, DOI 10.1074/mcp.M600482-MCP200; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lu W, 2001, MOL CELL, V8, P759, DOI 10.1016/S1097-2765(01)00369-0; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Stewart RA, 2010, DEV CELL, V18, P750, DOI [10.1016/j.devcel.2010.03.009, 10.1016/j.devce1.2010.03.009]; Tartaglia M, 2010, ANN NY ACAD SCI, V1214, P99, DOI 10.1111/j.1749-6632.2010.05790.x; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; Wang YJ, 2002, BIOCHEM BIOPH RES CO, V296, P214, DOI 10.1016/S0006-291X(02)00806-9	30	33	39	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 7	2013	32	45					5292	5301		10.1038/onc.2012.571	http://dx.doi.org/10.1038/onc.2012.571			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	251IS	23318428	hybrid			2022-12-25	WOS:000326922100005
J	Lee, W; VanderVen, BC; Fahey, RJ; Russell, DG				Lee, Wonsik; VanderVen, Brian C.; Fahey, Ruth J.; Russell, David G.			Intracellular Mycobacterium tuberculosis Exploits Host-derived Fatty Acids to Limit Metabolic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL LIPIDS; CHOLESTEROL CATABOLISM; PROPIONATE METABOLISM; METHYLCITRATE CYCLE; BOVIS BCG; VIRULENCE; MACROPHAGES; REQUIRES; GROWTH; PERSISTENCE	Recent data indicate that the nutrients available to Mycobacterium tuberculosis (Mtb) inside its host cell are restricted in their diversity. Fatty acids and cholesterol appear more favored; however, their degradation can result in certain metabolic stresses. Their breakdown can generate propionyl-CoA, which gives rise to potentially toxic intermediates. Detoxification of propionyl-CoA relies on the activity of the methylcitrate cycle, the methylmalonyl pathway, or incorporation of the propionyl-CoA into methyl-branched lipids in the cell wall. The current work explores carbon flux through these pathways, focusing primarily on those pathways responsible for the incorporation of propionyl-CoA into virulence-associated cell wall lipids. Exploiting both genetic and biochemical rescue, we demonstrate that these metabolic pressures are experienced by Mtb inside its host macrophage and that the bacterium accesses host fatty acid stores. The metabolism of these host lipids expands the acetyl-CoA pool and alleviates the pressure from propionyl-CoA. These data have major implications for our appreciation of central metabolism of Mtb during the course of infection.	[Lee, Wonsik; VanderVen, Brian C.; Fahey, Ruth J.; Russell, David G.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14850 USA	Cornell University	Russell, DG (corresponding author), Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14850 USA.	dgr8@cornell.edu	Russell, David G/D-4533-2009; Russell, David G/N-5280-2019	Russell, David G/0000-0002-9748-750X; Russell, David G/0000-0002-9748-750X; VanderVen, Brian/0000-0003-3655-4390	National Institutes of Health [AI 067027, AI080651, HL055936]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080651, R01AI067027] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI 067027, AI080651, and HL055936 (to D. G. R.).	Abramovitch RB, 2011, MOL MICROBIOL, V80, P678, DOI 10.1111/j.1365-2958.2011.07601.x; Beatty WL, 2000, TRAFFIC, V1, P235, DOI 10.1034/j.1600-0854.2000.010306.x; Beatty WL, 2001, EUR J CELL BIOL, V80, P31, DOI 10.1078/0171-9335-00131; Bentrup KHZ, 1999, J BACTERIOL, V181, P7161; Bhatt A, 2007, MOL MICROBIOL, V64, P1442, DOI 10.1111/j.1365-2958.2007.05761.x; Brock M, 2004, EUR J BIOCHEM, V271, P3227, DOI 10.1111/j.1432-1033.2004.04255.x; Chang JC, 2009, J BACTERIOL, V191, P5232, DOI 10.1128/JB.00452-09; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; DUBOS RJ, 1950, J EXP MED, V92, P319, DOI 10.1084/jem.92.4.319; Geisel RE, 2005, J IMMUNOL, V174, P5007, DOI 10.4049/jimmunol.174.8.5007; Gonzalo-Asensio J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003496; Griffin JE, 2012, CHEM BIOL, V19, P218, DOI 10.1016/j.chembiol.2011.12.016; Jain M, 2007, P NATL ACAD SCI USA, V104, P5133, DOI 10.1073/pnas.0610634104; Kaur Devinder, 2009, Adv Appl Microbiol, V69, P23, DOI 10.1016/S0065-2164(09)69002-X; Kim MJ, 2010, EMBO MOL MED, V2, P258, DOI 10.1002/emmm.201000079; Krithika R, 2006, P NATL ACAD SCI USA, V103, P2069, DOI 10.1073/pnas.0507924103; Listenberger LL, 2007, CURR PROTOC CELL BIO, DOI [DOI 10.1002/0471143030.CB2402S35, 10.1002/0471143030.cb2402s35]; Liu KY, 2003, MICROBIOL-SGM, V149, P1829, DOI 10.1099/mic.0.26234-0; Maloney E, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00019; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Miner MD, 2009, INDIAN J EXP BIOL, V47, P407; Minnikin DE, 2002, CHEM BIOL, V9, P545, DOI 10.1016/S1074-5521(02)00142-4; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Munoz-Elias EJ, 2006, MOL MICROBIOL, V60, P1109, DOI 10.1111/j.1365-2958.2006.05155.x; Murry Jeffrey P., 2008, V416, P45, DOI 10.1007/978-1-59745-321-9_4; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Podinovskaia M., 2013, CELL MICROB IN PRESS; RAINWATER DL, 1982, J BACTERIOL, V151, P905, DOI 10.1128/JB.151.2.905-911.1982; Rhoades E, 2003, MOL MICROBIOL, V48, P875, DOI 10.1046/j.1365-2958.2003.03473.x; Rhoades ER, 2005, TUBERCULOSIS, V85, P159, DOI 10.1016/j.tube.2004.10.001; Rohde KH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002769; Rombouts Y, 2011, J BIOL CHEM, V286, P33678, DOI 10.1074/jbc.M111.273920; Rousseau C, 2003, MICROBIOL-SGM, V149, P1837, DOI 10.1099/mic.0.26278-0; Russell DG, 2010, CELL HOST MICROBE, V8, P68, DOI 10.1016/j.chom.2010.06.002; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Savvi S, 2008, J BACTERIOL, V190, P3886, DOI 10.1128/JB.01767-07; SEGAL W, 1956, J BACTERIOL, V72, P132, DOI 10.1128/JB.72.2.132-141.1956; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000545; Trivedi OA, 2005, MOL CELL, V17, P631, DOI 10.1016/j.molcel.2005.02.009; Upton AM, 2007, MICROBIOL-SGM, V153, P3973, DOI 10.1099/mic.0.2007/011726-0; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Venugopal A, 2011, CELL HOST MICROBE, V9, P21, DOI 10.1016/j.chom.2010.12.004; Walters SB, 2006, MOL MICROBIOL, V60, P312, DOI 10.1111/j.1365-2958.2006.05102.x; Yang XX, 2009, BIOCHEMISTRY-US, V48, P3819, DOI 10.1021/bi9005418	48	243	253	2	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6788	6800		10.1074/jbc.M112.445056	http://dx.doi.org/10.1074/jbc.M112.445056			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23306194	Green Published, hybrid			2022-12-25	WOS:000316002400002
J	Korkina, O; Dong, ZW; Marullo, A; Warshaw, G; Symons, M; Ruggieri, R				Korkina, Olga; Dong, Zhiwan; Marullo, Allison; Warshaw, Gregg; Symons, Marc; Ruggieri, Rosamaria			The MLK-related Kinase (MRK) Is a Novel RhoC Effector That Mediates Lysophosphatidic Acid (LPA)-stimulated Tumor Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; MAP KINASE; IN-VITRO; C-JUN; SIGNALING PATHWAY; BREAST-CANCER; SMALL GTPASES; MIGRATION; ACTIVATION; METASTASIS	The small GTPase RhoC is overexpressed in many invasive tumors and is essential for metastasis. Despite its high structural homology to RhoA, RhoC appears to perform functions that are different from those controlled by RhoA. The identity of the signaling components that are differentially regulated by these two GTPases is only beginning to emerge. Here, we show that the MAP3K protein MRK directly binds to the GTP-bound forms of both RhoA and RhoC in vitro. However, siRNA-mediated depletion of MRK in cells phenocopies depletion of RhoC, rather than that of RhoA. MRK depletion, like that of RhoC, inhibits LPA-stimulated cell invasion, while depletion of RhoA increases invasion. We also show that active MRK enhances LPA-stimulated invasion, further supporting a role for MRK in the regulation of invasion. Depletion of either RhoC or MRK causes sustained myosin light chain phosphorylation after LPA stimulation. In addition, activation of MRK causes a reduction in myosin light chain phosphorylation. In contrast, as expected, depletion of RhoA inhibits myosin light chain phosphorylation. We also present evidence that both RhoC and MRK are required for LPA-induced stimulation of the p38 and ERK MAP kinases. In conclusion, we have identified MRK as a novel RhoC effector that controls LPA-stimulated cell invasion at least in part by regulating myosin dynamics, ERK and p38.	[Korkina, Olga; Dong, Zhiwan; Marullo, Allison; Warshaw, Gregg; Symons, Marc; Ruggieri, Rosamaria] Feinstein Inst Med Res, Oncol & Cell Biol Ctr, Manhasset, NY 11030 USA	Northwell Health	Symons, M (corresponding author), Feinstein Inst Med Res, 350 Community Dr, Manhasset, NY 11030 USA.	msymons@nshs.edu; mruggier@nshs.edu			National Institutes of Health [CA100747]; Swim Across America Foundation; Institutional Grant from the Feinstein Institute for Medical Research; NATIONAL CANCER INSTITUTE [R01CA100747] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swim Across America Foundation; Institutional Grant from the Feinstein Institute for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA100747 (to R. R.), a grant from the Swim Across America Foundation (to M. S.), and an Institutional Grant from the Feinstein Institute for Medical Research (to R. R.).	Barrantes ID, 2012, BIOCHEM SOC T, V40, P79, DOI 10.1042/BST20110676; Bellovin DI, 2006, ONCOGENE, V25, P6959, DOI 10.1038/sj.onc.1209682; Bian D, 2006, ONCOGENE, V25, P2234, DOI 10.1038/sj.onc.1209261; Boone B, 2009, J CUTAN PATHOL, V36, P629, DOI 10.1111/j.1600-0560.2008.01117.x; Bravo-Cordero JJ, 2011, CURR BIOL, V21, P635, DOI 10.1016/j.cub.2011.03.039; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chuang YY, 2004, CANCER RES, V64, P8271, DOI 10.1158/0008-5472.CAN-04-2097; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Crabtree GR, 1996, TRENDS BIOCHEM SCI, V21, P418, DOI 10.1016/S0968-0004(96)20027-1; Dietrich KA, 2009, BIOL CHEM, V390, P1063, DOI 10.1515/BC.2009.110; Du Y, 2005, J BIOL CHEM, V280, P42984, DOI 10.1074/jbc.M502671200; Faried A, 2006, EUR J CANCER, V42, P1455, DOI 10.1016/j.ejca.2006.02.012; Fritz G, 2002, BRIT J CANCER, V87, P635, DOI 10.1038/sj.bjc.6600510; Fritz G, 2006, CURR CANCER DRUG TAR, V6, P1, DOI 10.2174/156800906775471752; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Gotoh I, 2001, J BIOL CHEM, V276, P4276, DOI 10.1074/jbc.M008595200; Gross EA, 2002, J BIOL CHEM, V277, P13873, DOI 10.1074/jbc.M111994200; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Hama K, 2004, J BIOL CHEM, V279, P17634, DOI 10.1074/jbc.M313927200; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Ho TTG, 2008, J BIOL CHEM, V283, P21588, DOI 10.1074/jbc.M710033200; Horiuchi A, 2003, LAB INVEST, V83, P861, DOI 10.1097/01.LAB.0000073128.16098.31; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Hutchison N, 2009, CELL SIGNAL, V21, P1522, DOI 10.1016/j.cellsig.2009.05.012; Islam M, 2009, MOL CANCER RES, V7, P1771, DOI 10.1158/1541-7786.MCR-08-0512; Jia ZJ, 2006, BIOL CELL, V98, P337, DOI 10.1042/BC20050088; Kamai T, 2001, BJU INT, V87, P227, DOI 10.1046/j.1464-410x.2001.02030.x; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Katoh K, 2011, J R SOC INTERFACE, V8, P305, DOI 10.1098/rsif.2010.0419; Kitzing TM, 2010, ONCOGENE, V29, P2441, DOI 10.1038/onc.2009.515; Kleer CG, 2005, BREAST CANCER RES TR, V93, P101, DOI 10.1007/s10549-005-4170-6; Kondo T, 2004, PATHOBIOLOGY, V71, P19, DOI 10.1159/000072958; Leung IWL, 1998, J BIOL CHEM, V273, P32408, DOI 10.1074/jbc.273.49.32408; Liu TC, 2000, BIOCHEM BIOPH RES CO, V274, P811, DOI 10.1006/bbrc.2000.3236; Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4; Marinissen MT, 2001, GENE DEV, V15, P535, DOI 10.1101/gad.855801; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Pan CQ, 2012, CELL SIGNAL, V24, P2143, DOI 10.1016/j.cellsig.2012.06.002; PARKS S, 1991, CELL, V64, P447, DOI 10.1016/0092-8674(91)90652-F; Pille JY, 2005, MOL THER, V11, P267, DOI 10.1016/j.ymthe.2004.08.029; Pua TL, 2009, FUTURE ONCOL, V5, P1659, DOI 10.2217/FON.09.120; Radhika V, 2004, J BIOL CHEM, V279, P49406, DOI 10.1074/jbc.M408836200; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; SELF AJ, 1995, METHOD ENZYMOL, V256, P3; Sengupta S, 2004, SEMIN CELL DEV BIOL, V15, P503, DOI 10.1016/j.semcdb.2004.05.003; Shikada Y, 2003, CLIN CANCER RES, V9, P5282; Simpson KJ, 2004, CANCER RES, V64, P8694, DOI 10.1158/0008-5472.CAN-04-2247; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Street CA, 2011, ANTICANCER RES, V31, P3645; Suwa H, 1998, BRIT J CANCER, V77, P147, DOI 10.1038/bjc.1998.23; SYMONS M, 1995, CURR OPIN BIOTECH, V6, P668, DOI 10.1016/0958-1669(95)80110-3; Teramoto H, 1996, J BIOL CHEM, V271, P25731, DOI 10.1074/jbc.271.42.25731; Tosti E, 2004, J BIOL CHEM, V279, P47652, DOI 10.1074/jbc.M409961200; Vacratsis PO, 2000, J BIOL CHEM, V275, P27893; Valster A, 2005, METHODS, V37, P208, DOI 10.1016/j.ymeth.2005.08.001; van Golen KL, 1999, CLIN CANCER RES, V5, P2511; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Vega FM, 2011, J CELL BIOL, V193, P655, DOI 10.1083/jcb.201011038; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wang W, 2008, CLIN CANCER RES, V14, P6804, DOI 10.1158/1078-0432.CCR-07-4820; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Xia DL, 2005, EXP CELL RES, V304, P506, DOI 10.1016/j.yexcr.2004.11.025	73	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5364	5373		10.1074/jbc.M112.414060	http://dx.doi.org/10.1074/jbc.M112.414060			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23319595	Green Published, hybrid			2022-12-25	WOS:000315342500011
J	Zeng, DN; Zhao, JS; Chung, HS; Guan, ZQ; Raetz, CRH; Zhou, P				Zeng, Daina; Zhao, Jinshi; Chung, Hak Suk; Guan, Ziqiang; Raetz, Christian R. H.; Zhou, Pei			Mutants Resistant to LpxC Inhibitors by Rebalancing Cellular Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-DEPENDENT DEACETYLASE; GRAM-NEGATIVE INFECTIONS; FATTY-ACID BIOSYNTHESIS; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; TRANSFER-RNA; ANTIBIOTIC-ACTIVITY; MEMBRANE-PROTEINS; ACTIVE-SITE; IN-VIVO	LpxC, the deacetylase that catalyzes the second and committed step of lipid A biosynthesis in Escherichia coli, is an essential enzyme in virtually all Gram-negative bacteria and is one of the most promising antibiotic targets for treatment of multidrug-resistant Gram-negative infections. Despite the rapid development of LpxC-targeting antibiotics, the potential mechanisms of bacterial resistance to LpxC inhibitors remain poorly understood. Here, we report the isolation and biochemical characterization of spontaneously arising E. coli mutants that are over 200-fold more resistant to LpxC inhibitors than the wild-type strain. These mutants have two chromosomal point mutations that account for resistance additively and independently; one is in fabZ, a dehydratase in fatty acid biosynthesis; the other is in thrS, the Thr-tRNA ligase. For both enzymes, the isolated mutations result in reduced enzymatic activities in vitro. Unexpectedly, we observed a decreased level of LpxC in bacterial cells harboring fabZ mutations in the absence of LpxC inhibitors, suggesting that the biosyntheses of fatty acids and lipid A are tightly regulated to maintain a balance between phospholipids and lipid A. Additionally, we show that the mutation in thrS slows protein production and cellular growth, indicating that reduced protein biosynthesis can confer a suppressive effect on inhibition of membrane biosynthesis. Altogether, our studies reveal a previously unrecognized mechanism of antibiotic resistance by rebalancing cellular homeostasis.	[Zeng, Daina; Zhao, Jinshi; Chung, Hak Suk; Guan, Ziqiang; Raetz, Christian R. H.; Zhou, Pei] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Chung, Hak Suk] Korea Inst Sci & Technol, Ctr Integrated Risk Res, Seoul 136791, South Korea	Duke University; Korea Institute of Science & Technology (KIST)	Zhou, P (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	peizhou@biochem.duke.edu	Guan, Ziqiang/AAE-5110-2019; Zhou, Pei/O-6704-2019	Zhou, Pei/0000-0002-7823-3416; Chung, Hak Suk/0000-0003-1166-9909	National Institutes of Health Grant [GM-51310, AI-055588]; National Institutes of Health Lipid Maps Large Scale Collaborative Grant [GM-069338]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051310, U54GM069338] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Lipid Maps Large Scale Collaborative Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-51310 (to C. R. H. R.) and Grant AI-055588 (to P. Z.).; Supported by National Institutes of Health Lipid Maps Large Scale Collaborative Grant GM-069338.; We thank all members of the Raetz laboratory for stimulating discussions. We are especially grateful to Drs. Xiaofei Liang and Eric Toone for the generous gifts of LpxC inhibitors used in this study, Ali Masoudi for help in the preparation of acyl-ACP, Dr. William T. Doerrler for providing the polyclonal LpxC antibody, and Drs. Michael D. Been and John Hsieh for help in ThrS assay design. The Mass Spectrometry Facility, Department of Biochemistry, Duke University Medical Center, was supported by National Institutes of Health Lipid Maps Large Scale Collaborative Grant GM-069338.	ANDERSON MS, 1993, J BIOL CHEM, V268, P19858; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barb AW, 2008, CURR PHARM BIOTECHNO, V9, P9; Barb AW, 2007, P NATL ACAD SCI USA, V104, P18433, DOI 10.1073/pnas.0709412104; Barb AW, 2007, BIOCHEMISTRY-US, V46, P3793, DOI 10.1021/bi6025165; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bodewits K, 2010, ANTIMICROB AGENTS CH, V54, P3531, DOI 10.1128/AAC.01600-09; Bollenbach T, 2009, CELL, V139, P707, DOI 10.1016/j.cell.2009.10.025; Bovee ML, 2003, BIOCHEMISTRY-US, V42, P15102, DOI 10.1021/bi0355701; Brown MF, 2012, J MED CHEM, V55, P914, DOI 10.1021/jm2014748; Caughlan RE, 2012, ANTIMICROB AGENTS CH, V56, P17, DOI 10.1128/AAC.05417-11; Chung HS, 2010, BIOCHEMISTRY-US, V49, P4126, DOI 10.1021/bi100343e; Clements JM, 2002, ANTIMICROB AGENTS CH, V46, P1793, DOI 10.1128/AAC.46.6.1793-1799.2002; Clementz T, 1997, J BIOL CHEM, V272, P10353; Cole KE, 2011, BIOCHEMISTRY-US, V50, P258, DOI 10.1021/bi101622a; Cosgrove SE, 2002, ARCH INTERN MED, V162, P185, DOI 10.1001/archinte.162.2.185; Dartigalongue C, 2001, J BIOL CHEM, V276, P20866, DOI 10.1074/jbc.M100464200; Evans HL, 2007, CRIT CARE MED, V35, P89, DOI 10.1097/01.CCM.0000251496.61520.75; Fallon EO, 2009, J GERONTOL A-BIOL, V64, P138, DOI 10.1093/gerona/gln020; Guan ZQ, 2011, BBA-MOL CELL BIOL L, V1811, P800, DOI 10.1016/j.bbalip.2011.04.009; Harris A, 1999, CLIN INFECT DIS, V28, P1128, DOI 10.1086/514760; Heath RJ, 1996, J BIOL CHEM, V271, P27795, DOI 10.1074/jbc.271.44.27795; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Jackman JE, 1999, BIOCHEMISTRY-US, V38, P1902, DOI 10.1021/bi982339s; JOHNSON EJ, 1977, J BACTERIOL, V129, P66, DOI 10.1128/JB.129.1.66-70.1977; Kimber MS, 2004, J BIOL CHEM, V279, P52593, DOI 10.1074/jbc.M408105200; Langklotz S, 2011, J BACTERIOL, V193, P1090, DOI 10.1128/JB.01043-10; Ledoux S, 2008, METHODS, V44, P74, DOI 10.1016/j.ymeth.2007.08.001; Lee CJ, 2011, CHEM BIOL, V18, P38, DOI 10.1016/j.chembiol.2010.11.011; Liang XF, 2011, BIOORGAN MED CHEM, V19, P852, DOI 10.1016/j.bmc.2010.12.017; Lu YH, 2011, J BIOL CHEM, V286, P5506, DOI 10.1074/jbc.M110.199265; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; McClerren AL, 2005, BIOCHEMISTRY-US, V44, P16574, DOI 10.1021/bi0518186; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; MOHAN S, 1994, J BIOL CHEM, V269, P32896; Montgomery JI, 2012, J MED CHEM, V55, P1662, DOI 10.1021/jm2014875; NIKAIDO H, 1996, ESCHERICHIA COLI SAL, P29; Ogura T, 1999, MOL MICROBIOL, V31, P833, DOI 10.1046/j.1365-2958.1999.01221.x; Onishi HR, 1996, SCIENCE, V274, P980, DOI 10.1126/science.274.5289.980; Pop-Vicas AE, 2005, CLIN INFECT DIS, V40, P1792, DOI 10.1086/430314; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; Shimohata N, 2002, GENES CELLS, V7, P653, DOI 10.1046/j.1365-2443.2002.00554.x; Slama TG, 2008, CRIT CARE, V12, DOI 10.1186/cc6820; Sorensen MA, 1998, J MOL BIOL, V280, P561, DOI 10.1006/jmbi.1998.1909; Sorensen PG, 1996, J BIOL CHEM, V271, P25898, DOI 10.1074/jbc.271.42.25898; Vorachek-Warren MK, 2002, J BIOL CHEM, V277, P14194, DOI 10.1074/jbc.M200409200; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Wang J, 2011, COLD SH Q B, V76, P183, DOI 10.1101/sqb.2011.76.010835; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Warmus JS, 2012, BIOORG MED CHEM LETT, V22, P2536, DOI 10.1016/j.bmcl.2012.01.140; Wayne P.A, 1997, PERF VOL ANT SUSC FL, Vsixth	53	42	42	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5475	5486		10.1074/jbc.M112.447607	http://dx.doi.org/10.1074/jbc.M112.447607			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23316051	Green Published, hybrid			2022-12-25	WOS:000315342500022
J	Wu, J; Cheng, Z; Reddie, K; Carroll, K; Hammad, LA; Karty, JA; Bauer, CE				Wu, Jiang; Cheng, Zhuo; Reddie, Khalilah; Carroll, Kate; Hammad, Loubna A.; Karty, Jonathan A.; Bauer, Carl E.			RegB Kinase Activity Is Repressed by Oxidative Formation of Cysteine Sulfenic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTER GENE-EXPRESSION; REDOX SWITCHES; SENSOR; AUTOPHOSPHORYLATION; IDENTIFICATION; TRANSDUCTION; REGB/REGA; SYSTEM	RegB/RegA comprise a global redox-sensing signal transduction system utilized by a wide range of proteobacteria to sense environmental changes in oxygen tension. The conserved cysteine 265 in the sensor kinase RegB was previously reported to form an intermolecular disulfide bond under oxidizing conditions that converts RegB from an active dimer into an inactive tetramer. In this study, we demonstrate that a stable sulfenic acid (-SOH) derivative also forms at Cys-265 in vitro and in vivo when RegB is exposed to oxygen. This sulfenic acid modification is reversible and stable in the air. Autophosphorylation assay shows that reduction of the SOH at Cys-265 to a free thiol (SH) can increase RegB kinase activity in vitro. Our results suggest that a sulfenic acid modification at Cys-265 performs a regulatory role in vivo and that it may be the major oxidation state of Cys-265 under aerobic conditions. Cys-265 thus functions as a complex redox switch that can form multiple thiol modifications in response to different redox signals to control the kinase activity of RegB.	[Wu, Jiang; Cheng, Zhuo; Bauer, Carl E.] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA; [Hammad, Loubna A.; Karty, Jonathan A.] Indiana Univ, METACyt Biochem Anal Ctr, Dept Chem, Bloomington, IN 47405 USA; [Reddie, Khalilah] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Carroll, Kate] Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Michigan System; University of Michigan; Scripps Research Institute	Bauer, CE (corresponding author), Indiana Univ, Dept Mol & Cellular Biochem, Simon Hall MSB,212 S Hawthorne Dr, Bloomington, IN 47405 USA.	bauer@indiana.edu	Wu, Jiang/N-3838-2014	Wu, Jiang/0000-0002-9336-457X; Carroll, Kate/0000-0002-7624-9617; Karty, Jonathan/0000-0003-1022-9100	National Institutes of Health [R37 GM040941, R01 GM102187]; Camile Henry Dreyfus Teacher Scholar Award; NATIONAL CANCER INSTITUTE [R01CA174864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102187, R37GM040941] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Camile Henry Dreyfus Teacher Scholar Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R37 GM040941 (to C. E. B.) and Grant R01 GM102187 (to K. S. C.) as well as funding from the Camile Henry Dreyfus Teacher Scholar Award.	Alvarez B, 2010, METHOD ENZYMOL, V473, P117, DOI 10.1016/S0076-6879(10)73005-6; Antelmann H, 2011, ANTIOXID REDOX SIGN, V14, P1049, DOI 10.1089/ars.2010.3400; Bird TH, 1999, J BIOL CHEM, V274, P16343, DOI 10.1074/jbc.274.23.16343; BOYER PD, 1954, J AM CHEM SOC, V76, P4331, DOI 10.1021/ja01646a025; BOYER PD, 1979, CC/LIFE SCI, P14; Charles RL, 2007, MOL CELL PROTEOMICS, V6, P1473, DOI 10.1074/mcp.M700065-MCP200; Cheng Z, 2012, MOL MICROBIOL, V85, P734, DOI 10.1111/j.1365-2958.2012.08135.x; CLAIBORNE A, 1993, FASEB J, V7, P1483, DOI 10.1096/fasebj.7.15.8262333; Elsen S, 2004, MICROBIOL MOL BIOL R, V68, P263, DOI 10.1128/MMBR.68.2.263-279.2004; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; INOUE K, 1995, BIOCHEMISTRY-US, V34, P391, DOI 10.1021/bi00002a002; Kim YJ, 2007, J BACTERIOL, V189, P5617, DOI 10.1128/JB.00443-07; Klomsiri C, 2011, ANTIOXID REDOX SIGN, V14, P1065, DOI 10.1089/ars.2010.3376; Leonard SE, 2011, ANGEW CHEM INT EDIT, V50, P4423, DOI 10.1002/anie.201007871; Leonard SE, 2009, ACS CHEM BIOL, V4, P783, DOI 10.1021/cb900105q; MOSLEY CS, 1994, J BACTERIOL, V176, P7566, DOI 10.1128/JB.176.24.7566-7573.1994; Paget MSB, 2003, ANNU REV GENET, V37, P91, DOI 10.1146/annurev.genet.37.110801.142538; Paulsen CE, 2012, NAT CHEM BIOL, V8, P57, DOI 10.1038/nchembio.736; Paulsen CE, 2009, CHEM BIOL, V16, P217, DOI 10.1016/j.chembiol.2009.01.003; POOLE LB, 1989, J BIOL CHEM, V264, P12330; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Reddie KG, 2008, MOL BIOSYST, V4, P521, DOI 10.1039/b719986d; Saurin AT, 2004, P NATL ACAD SCI USA, V101, P17982, DOI 10.1073/pnas.0404762101; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Seo YH, 2009, P NATL ACAD SCI USA, V106, P16163, DOI 10.1073/pnas.0903015106; SGANGA MW, 1992, CELL, V68, P945, DOI 10.1016/0092-8674(92)90037-D; Swem LR, 2006, J BIOL CHEM, V281, P6768, DOI 10.1074/jbc.M509687200; Swem LR, 2003, EMBO J, V22, P4699, DOI 10.1093/emboj/cdg461; Torchinsky Y. M., 1981, PROPERTIES SH GROUPS; Turell L, 2008, BIOCHEMISTRY-US, V47, P358, DOI 10.1021/bi701520y; Wu J., 2007, BACTERIAL SIGNAL TRA, P131; Wu J, 2008, ADV EXP MED BIOL, V631, P131, DOI 10.1007/978-0-387-78885-2_9; Wu JA, 2010, MBIO, V1, DOI 10.1128/mBio.00272-10	33	36	36	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4755	4762		10.1074/jbc.M112.413492	http://dx.doi.org/10.1074/jbc.M112.413492			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23306201	hybrid, Green Published			2022-12-25	WOS:000315340400024
J	von der Lippe, M; Bullock, JM; Kowarik, I; Knopp, T; Wichmann, M				von der Lippe, Moritz; Bullock, James M.; Kowarik, Ingo; Knopp, Tatjana; Wichmann, Matthias			Human-Mediated Dispersal of Seeds by the Airflow of Vehicles	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; FERAL OILSEED RAPE; AMBROSIA-ARTEMISIIFOLIA; PLANT DISPERSAL; MOTOR-VEHICLES; WIND; MIGRATION; INVASION; BEHAVIOR; MODELS	Human-mediated dispersal is known as an important driver of long-distance dispersal for plants but underlying mechanisms have rarely been assessed. Road corridors function as routes of secondary dispersal for many plant species but the extent to which vehicles support this process remains unclear. In this paper we quantify dispersal distances and seed deposition of plant species moved over the ground by the slipstream of passing cars. We exposed marked seeds of four species on a section of road and drove a car along the road at a speed of 48 km/h. By tracking seeds we quantified movement parallel as well as lateral to the road, resulting dispersal kernels, and the effect of repeated vehicle passes. Median distances travelled by seeds along the road were about eight meters for species with wind dispersal morphologies and one meter for species without such adaptations. Airflow created by the car lifted seeds and resulted in longitudinal dispersal. Single seeds reached our maximum measuring distance of 45 m and for some species exceeded distances under primary dispersal. Mathematical models were fit to dispersal kernels. The incremental effect of passing vehicles on longitudinal dispersal decreased with increasing number of passes as seeds accumulated at road verges. We conclude that dispersal by vehicle airflow facilitates seed movement along roads and accumulation of seeds in roadside habitats. Dispersal by vehicle airflow can aid the spread of plant species and thus has wide implications for roadside ecology, invasion biology and nature conservation.	[von der Lippe, Moritz; Bullock, James M.; Knopp, Tatjana; Wichmann, Matthias] Ctr Ecol & Hydrol, Wallingford, Oxon, England; [von der Lippe, Moritz; Kowarik, Ingo] Tech Univ Berlin, Dept Ecol, Berlin, Germany; [Knopp, Tatjana] Univ Potsdam, Dept Anim Ecol, Potsdam, Germany; [Wichmann, Matthias] Univ Potsdam, Potsdam, Germany	UK Centre for Ecology & Hydrology (UKCEH); Technical University of Berlin; University of Potsdam; University of Potsdam	von der Lippe, M (corresponding author), Ctr Ecol & Hydrol, Wallingford, Oxon, England.	moritz.vdlippe@tu-berlin.de	Bullock, James M/F-9997-2011; Wichmann, Matthias/F-8142-2013	von der Lippe, Moritz/0000-0003-4760-1420	German Academic Exchange Service (DAAD); NERC [NE/B503141/1]; Natural Environment Research Council [NE/B503141/1] Funding Source: researchfish	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	M. von der Lippe and T. Knopp were funded by research grants of the German Academic Exchange Service (DAAD, http://www.daad.de). M. Wichmann and J. Bullock were funded by the NERC research grant NE/B503141/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askew AP, 1997, FUNCT ECOL, V11, P121, DOI 10.1046/j.1365-2435.1997.00049.x; Bonte D, 2012, BIOL REV, V87, P290, DOI 10.1111/j.1469-185X.2011.00201.x; Bullock JM, 2011, OIKOS, V120, P1201, DOI 10.1111/j.1600-0706.2010.19092.x; Bullock JM, 2000, OECOLOGIA, V124, P506, DOI 10.1007/PL00008876; CLIFFORD HT, 1959, J ECOL, V47, P311, DOI 10.2307/2257368; Colbach N, 2001, AGR ECOSYST ENVIRON, V83, P255, DOI 10.1016/S0167-8809(00)00175-4; Crawley MJ, 2004, P ROY SOC B-BIOL SCI, V271, P1909, DOI 10.1098/rspb.2004.2814; Dark SJ, 2004, DIVERS DISTRIB, V10, P1, DOI 10.1111/j.1472-4642.2004.00054.x; ESKRIDGE RE, 1979, J APPL METEOROL, V18, P387, DOI 10.1175/1520-0450(1979)018<0387:HMPIPO>2.0.CO;2; Essl F, 2009, PRESLIA, V81, P119; Garnier A, 2008, BASIC APPL ECOL, V9, P533, DOI 10.1016/j.baae.2007.08.014; Greene DF, 2004, J ECOL, V92, P758, DOI 10.1111/j.0022-0477.2004.00921.x; Hodkinson DJ, 1997, J APPL ECOL, V34, P1484, DOI 10.2307/2405264; Hucho W-H, 2003, AERODYNAMICS ROAD VE; Jongejans E, 2008, PERSPECT PLANT ECOL, V9, P153, DOI 10.1016/j.ppees.2007.09.005; Katul GG, 2005, AM NAT, V166, P368, DOI 10.1086/432589; Kawata M, 2009, ENVIRON SCI POLLUT R, V16, P120, DOI 10.1007/s11356-008-0074-4; Knispel AL, 2010, ENVIRON SCI POLLUT R, V17, P13, DOI 10.1007/s11356-009-0219-0; Kowarik I., 2011, NeoBiota, P49, DOI 10.3897/neobiota.9.1469; Kowarik I, 2007, PERSPECT PLANT ECOL, V8, P207, DOI 10.1016/j.ppees.2007.03.002; Lavoie C, 2007, J BIOGEOGR, V34, P1751, DOI 10.1111/j.1365-2699.2007.01730.x; Lemke A, 2009, J APPL ECOL, V46, P1122, DOI 10.1111/j.1365-2664.2009.01691.x; LONSDALE WM, 1994, BIOL CONSERV, V69, P277, DOI 10.1016/0006-3207(94)90427-8; MATLACK GR, 1987, AM J BOT, V74, P1150, DOI 10.2307/2444151; Morales JM, 2006, ECOLOGY, V87, P1489, DOI 10.1890/0012-9658(2006)87[1489:TEOPDA]2.0.CO;2; Myers JA, 2004, OECOLOGIA, V139, P35, DOI 10.1007/s00442-003-1474-2; Nathan R, 2002, NATURE, V418, P409, DOI 10.1038/nature00844; Niggemann M, 2009, ECOL MODEL, V220, P1339, DOI 10.1016/j.ecolmodel.2009.02.018; Ogle CC, 2000, AUSTRAL ECOL, V25, P539, DOI 10.1046/j.1442-9993.2000.01076.x; Pickering CM, 2011, BIOL INVASIONS, V13, P1869, DOI 10.1007/s10530-011-0006-y; R Development Core Team, 2009, R FDN STAT COMP; Romermann C, 2005, OIKOS, V110, P219, DOI 10.1111/j.0030-1299.2005.13911.x; Russo SE, 2006, ECOLOGY, V87, P3160, DOI 10.1890/0012-9658(2006)87[3160:IABISD]2.0.CO;2; SCHMIDT W, 1989, VEGETATIO, V80, P147, DOI 10.1007/BF00048038; Schurr FM, 2005, J ECOL, V93, P1017, DOI 10.1111/j.1365-2745.2005.01018.x; Solazzo E, 2008, ATMOS ENVIRON, V42, P4918, DOI 10.1016/j.atmosenv.2008.02.032; Soons MB, 2004, ECOLOGY, V85, P3056, DOI 10.1890/03-0522; Soons MB, 2005, DIVERS DISTRIB, V11, P165, DOI 10.1111/j.1366-9516.2005.00148.x; Soons MB, 2008, J ECOL, V96, P581, DOI 10.1111/j.1365-2745.2008.01370.x; Tackenberg O, 2003, PLANT BIOLOGY, V5, P451, DOI 10.1055/s-2003-44789; Tackenberg O, 2003, ECOL MONOGR, V73, P173, DOI 10.1890/0012-9615(2003)073[0173:MLDOPD]2.0.CO;2; Taylor K, 2012, DIVERS DISTRIB, V18, P942, DOI 10.1111/j.1472-4642.2012.00926.x; Vila M, 2001, BIOL CONSERV, V100, P397, DOI 10.1016/S0006-3207(01)00047-7; Vitalos M, 2009, NEOBIOTA-SER, V8, P53; von der Lippe M, 2008, DIVERS DISTRIB, V14, P18, DOI 10.1111/j.1472-4642.2007.00401.x; Von der Lippe M, 2007, CONSERV BIOL, V21, P986, DOI 10.1111/j.1523-1739.2007.00722.x; von der Lippe M, 2007, ECOGRAPHY, V30, P483, DOI 10.1111/j.2007.0906-7590.05072.x; Wichmann MC, 2009, P ROY SOC B-BIOL SCI, V276, P523, DOI 10.1098/rspb.2008.1131; WILCOX DA, 1989, ENVIRON MANAGE, V13, P365, DOI 10.1007/BF01874916; Wilson JRU, 2009, TRENDS ECOL EVOL, V24, P136, DOI 10.1016/j.tree.2008.10.007; Zwaenepoel A, 2006, BASIC APPL ECOL, V7, P83, DOI 10.1016/j.baae.2005.04.003	51	85	93	0	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e52733	10.1371/journal.pone.0052733	http://dx.doi.org/10.1371/journal.pone.0052733			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320077	gold, Green Submitted, Green Published			2022-12-25	WOS:000313429800019
J	Guirao-Rico, S; Aguade, M				Guirao-Rico, Sara; Aguade, Montserrat			Patterns of Nucleotide Diversity at the Regions Encompassing the Drosophila Insulin-Like Peptide (dilp) Genes: Demography vs. Positive Selection in Drosophila melanogaster	PLOS ONE			English	Article							ADAPTIVE PROTEIN EVOLUTION; NATURAL-POPULATIONS; MORPHOMETRICAL TRAITS; MOLECULAR EVOLUTION; LATITUDINAL CLINES; DNA; POLYMORPHISM; GROWTH; SIZE; VARIABILITY	In Drosophila, the insulin-signaling pathway controls some life history traits, such as fertility and lifespan, and it is considered to be the main metabolic pathway involved in establishing adult body size. Several observations concerning variation in body size in the Drosophila genus are suggestive of its adaptive character. Genes encoding proteins in this pathway are, therefore, good candidates to have experienced adaptive changes and to reveal the footprint of positive selection. The Drosophila insulin-like peptides (DILPs) are the ligands that trigger the insulin-signaling cascade. In Drosophila melanogaster, there are several peptides that are structurally similar to the single mammalian insulin peptide. The footprint of recent adaptive changes on nucleotide variation can be unveiled through the analysis of polymorphism and divergence. With this aim, we have surveyed nucleotide sequence variation at the dilp1-7 genes in a natural population of D. melanogaster. The comparison of polymorphism in D. melanogaster and divergence from D. simulans at different functional classes of the dilp genes provided no evidence of adaptive protein evolution after the split of the D. melanogaster and D. simulans lineages. However, our survey of polymorphism at the dilp gene regions of D. melanogaster has provided some evidence for the action of positive selection at or near these genes. The regions encompassing the dilp1-4 genes and the dilp6 gene stand out as likely affected by recent adaptive events.	[Guirao-Rico, Sara; Aguade, Montserrat] Univ Barcelona, Dept Genet, Inst Recerca Biodiversitat, Barcelona, Spain	University of Barcelona	Aguade, M (corresponding author), Univ Barcelona, Dept Genet, Inst Recerca Biodiversitat, Barcelona, Spain.	maguade@ub.edu	Guirao-Rico, Sara/F-4145-2016	Guirao-Rico, Sara/0000-0001-9896-4665; Aguade, Montserrat/0000-0002-3884-7800	Ministerio de Educacion y Ciencia (Spain); Comissio Interdepartamental de Ciencia i Tecnologia, Spain [BFU 2004-02253, BFU 2007-63229]; Comissio Interdepartamental de Recerca i Innovacio Tecnologica, Generalitat de Catalunya, Spain [2005 SGR/00166, 2009 SGR/1287]	Ministerio de Educacion y Ciencia (Spain)(Spanish Government); Comissio Interdepartamental de Ciencia i Tecnologia, Spain; Comissio Interdepartamental de Recerca i Innovacio Tecnologica, Generalitat de Catalunya, Spain(Generalitat de Catalunya)	SG-R was supported by a predoctoral fellowship from Ministerio de Educacion y Ciencia (Spain). This work was supported by grants BFU 2004-02253 and BFU 2007-63229 from Comissio Interdepartamental de Ciencia i Tecnologia, Spain, and grants 2005 SGR/00166 and 2009 SGR/1287 from Comissio Interdepartamental de Recerca i Innovacio Tecnologica, Generalitat de Catalunya, Spain, to MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andolfatto P, 2001, MOL BIOL EVOL, V18, P279, DOI 10.1093/oxfordjournals.molbev.a003804; Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Ashburner M., 1989, DROSOPHILA LAB HDB; Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; Begun DJ, 2000, P NATL ACAD SCI USA, V97, P5960, DOI 10.1073/pnas.97.11.5960; Beisswanger S, 2006, GENETICS, V172, P265, DOI 10.1534/genetics.105.049346; Beisswanger S, 2008, P NATL ACAD SCI USA, V105, P5447, DOI 10.1073/pnas.0710892105; Betancourt AJ, 2002, P NATL ACAD SCI USA, V99, P13616, DOI 10.1073/pnas.212277199; Braverman JM, 2005, GENETICS, V170, P1153, DOI 10.1534/genetics.104.033456; Britton JS, 1998, DEVELOPMENT, V125, P2149; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; CAPY P, 1993, GENET SEL EVOL, V25, P517, DOI 10.1051/gse:19930602; COYNE JA, 1987, GENETICS, V117, P727; DAVID JR, 1975, EXPERIENTIA, V31, P164, DOI 10.1007/BF01990682; DAVID JR, 1982, JPN J GENET, V57, P89, DOI 10.1266/jjg.57.89; Falconer D. S, 1996, INTRO QUANTITATIVE G; Fay JC, 2002, NATURE, V415, P1024, DOI 10.1038/4151024a; Fay JC, 2000, GENETICS, V155, P1405; Giannakou ME, 2007, TRENDS BIOCHEM SCI, V32, P180, DOI 10.1016/j.tibs.2007.02.007; Gibert P, 2004, GENETICA, V120, P165, DOI 10.1023/B:GENE.0000017639.62427.8b; Gilchrist AS, 1999, GENETICS, V153, P1775; Glinka S, 2003, GENETICS, V165, P1269; Glinka S, 2006, MOL BIOL EVOL, V23, P1869, DOI 10.1093/molbev/msl069; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Guirao-Rico S, 2009, MOL BIOL EVOL, V26, P1723, DOI 10.1093/molbev/msp088; Haddrill PR, 2005, GENOME RES, V15, P790, DOI 10.1101/gr.3541005; HASSON E, 1993, GENETICA, V92, P61, DOI 10.1007/BF00057508; Hipfner DR, 1999, BIOESSAYS, V21, P718, DOI 10.1002/(SICI)1521-1878(199909)21:9<718::AID-BIES2>3.0.CO;2-Z; HUDSON RR, 1987, GENETICS, V116, P153; HUDSON RR, 1990, OXFORD SURVEYS EVOLU; Huey RB, 2000, SCIENCE, V287, P308, DOI 10.1126/science.287.5451.308; Hutter S, 2007, GENETICS, V177, P469, DOI 10.1534/genetics.107.074922; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; JAMES AC, 1995, GENETICS, V140, P659; James AC, 1997, GENETICS, V146, P881; Jensen JD, 2005, GENETICS, V170, P1401, DOI 10.1534/genetics.104.038224; Jukes T. H., 1969, MAMMALIAN PROTEIN ME; Kafri R, 2009, CELL, V136, P389, DOI 10.1016/j.cell.2009.01.027; Karan D, 1998, GENET RES, V71, P31, DOI 10.1017/S0016672397003054; Kim Y, 2002, GENETICS, V160, P765; Kim Y, 2010, GENETICS, V184, P571, DOI 10.1534/genetics.109.109447; LACHAISE D, 1988, EVOL BIOL, V22, P159; Larracuente AM, 2008, TRENDS GENET, V24, P114, DOI 10.1016/j.tig.2007.12.001; Li HP, 2006, PLOS GENET, V2, P1580, DOI 10.1371/journal.pgen.0020166; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MADDISON WP, 1992, MACCLADE ANAL PHYLOG; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Moriyama EN, 1996, MOL BIOL EVOL, V13, P261, DOI 10.1093/oxfordjournals.molbev.a025563; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nei M., 1987, MOL EVOLUTIONARY GEN; Noor MAF, 2007, GENETICS, V177, P1417, DOI 10.1534/genetics.107.070672; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Ometto L, 2005, MOL BIOL EVOL, V22, P2119, DOI 10.1093/molbev/msi207; Orengo DJ, 2004, GENETICS, V167, P1759, DOI 10.1534/genetics.104.028969; Orengo DJ, 2007, MOL BIOL EVOL, V24, P1122, DOI 10.1093/molbev/msm032; Orengo DJ, 2010, MOL BIOL EVOL, V27, P153, DOI 10.1093/molbev/msp220; Paaby AB, 2010, MOL ECOL, V19, P760, DOI 10.1111/j.1365-294X.2009.04508.x; PARTRIDGE L, 1987, ANIM BEHAV, V35, P468, DOI 10.1016/S0003-3472(87)80272-5; PREVOSTI A, 1988, P NATL ACAD SCI USA, V85, P5597, DOI 10.1073/pnas.85.15.5597; PREVOSTI A, 1955, COLD SPRING HARB SYM, V20, P294, DOI 10.1101/SQB.1955.020.01.028; Ramos-Onsins SE, 2007, EVOL BIOINFORM, V3, P41; Robertson FW., 1957, J GENET, V55, P428, DOI [10.1007/BF02984061, DOI 10.1007/BF02984061]; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Rychlik W, 1992, OLIGO 4 06 PRIMER AN; Saucedo LJ, 2002, CURR OPIN GENET DEV, V12, P565, DOI 10.1016/S0959-437X(02)00341-6; Singh ND, 2005, GENETICS, V169, P709, DOI 10.1534/genetics.104.032250; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; STALKER HD, 1947, EVOLUTION, V1, P237, DOI 10.2307/2405325; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; TAJIMA F, 1989, GENETICS, V123, P585; Tavare S, 1997, GENETICS, V145, P505; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thornton K, 2006, GENETICS, V172, P1607, DOI 10.1534/genetics.105.048223; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; van't Land J, 1999, J EVOLUTION BIOL, V12, P222, DOI 10.1046/j.1420-9101.1999.00029.x; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Zeng K, 2006, GENETICS, V174, P1431, DOI 10.1534/genetics.106.061432	77	0	0	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53593	10.1371/journal.pone.0053593	http://dx.doi.org/10.1371/journal.pone.0053593			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308258	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429100093
J	Brown, TM; Allen, AE; al-Enezi, J; Wynne, J; Schlangen, L; Hommes, V; Lucas, RJ				Brown, Timothy M.; Allen, Annette E.; al-Enezi, Jazi; Wynne, Jonathan; Schlangen, Luc; Hommes, Vanja; Lucas, Robert J.			The Melanopic Sensitivity Function Accounts for Melanopsin-Driven Responses in Mice under Diverse Lighting Conditions	PLOS ONE			English	Article							ACTION SPECTRUM; GANGLION-CELLS; IN-VIVO; BISTABILITY; PHOTORECEPTORS; HUMANS; VISION; RETINA; SYSTEM; SLEEP	In addition to rods and cones, photoreception in mammals extends to a third retinal cell type expressing the photopigment melanopsin. The influences of this novel opsin are widespread, ranging from pupillary and circadian responses to brightness perception, yet established approaches to quantifying the biological effects of light do not adequately account for melanopsin sensitivity. We have recently proposed a novel metric, the melanopic sensitivity function (V-Z lambda), to address this deficiency. Here, we further validate this new measure with a variety of tests based on potential barriers to its applicability identified in the literature or relating to obvious practical benefits. Using electrophysiogical approaches and pupillometry, initially in rodless+coneless mice, our data demonstrate that under a very wide range of different conditions (including switching between stimuli with highly divergent spectral content) the V-Z lambda function provides an accurate prediction of the sensitivity of melanopsin-dependent responses. We further show that V-Z lambda provides the best available description of the spectral sensitivity of at least one aspect of the visual response in mice with functional rods and cones: tonic firing activity in the lateral geniculate nuclei. Together, these data establish V-Z lambda as an important new approach for light measurement with widespread practical utility.	[Brown, Timothy M.; Allen, Annette E.; al-Enezi, Jazi; Wynne, Jonathan; Lucas, Robert J.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Schlangen, Luc] Philips Lighting, Eindhoven, Netherlands; [Hommes, Vanja] Philips Consumer Lifestyle, Drachten, Netherlands	University of Manchester; Philips; Philips	Lucas, RJ (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	Robert.lucas@manchester.ac.uk		Brown, Timothy/0000-0002-5625-4750; Alenezi, Jazi/0000-0002-0275-5437; Lucas, Robert/0000-0002-1088-8029; Schlangen, Luc/0000-0002-8424-7240; Allen, Annette/0000-0003-0214-7076	European Research Council; Wellcome Trust; Biotechnology and Biological Sciences Research Council (UK); Philips Lighting (the Netherlands); The Cultural Office of the State of Kuwait; BBSRC [BB/I017836/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I017836/1] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Philips Lighting (the Netherlands)(Netherlands Government); The Cultural Office of the State of Kuwait; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Research Council, Wellcome Trust, Biotechnology and Biological Sciences Research Council (UK), Philips Lighting (the Netherlands) and The Cultural Office of the State of Kuwait. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi Y, 2006, ENERG BUILDINGS, V38, P588, DOI 10.1016/j.enbuild.2005.09.005; al Enezi J, 2011, J BIOL RHYTHM, V26, P314, DOI 10.1177/0748730411409719; Allen AE, 2011, J NEUROSCI, V31, P16833, DOI 10.1523/JNEUROSCI.2505-11.2011; Altimus CM, 2008, P NATL ACAD SCI USA, V105, P19998, DOI 10.1073/pnas.0808312105; Bailes HJ, 2010, CELL MOL LIFE SCI, V67, P99, DOI 10.1007/s00018-009-0155-7; Berman S. M., 1990, Lighting Research and Technology, V22, P37; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Brainard GC, 2001, J NEUROSCI, V21, P6405; Brown TM, 2012, CURR BIOL, V22, P1134, DOI 10.1016/j.cub.2012.04.039; Brown TM, 2011, J PHYSIOL-LONDON, V589, P1173, DOI 10.1113/jphysiol.2010.199877; Brown TM, 2011, VISION RES, V51, P280, DOI 10.1016/j.visres.2010.08.010; Brown TM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000558; Cooper HM, 2008, J BIOL RHYTHM, V23, P392, DOI 10.1177/0748730408323064; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; HARRINGTON RE, 1954, J OPT SOC AM, V44, P113, DOI 10.1364/JOSA.44.000113; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; HILLMAN P, 1983, PHYSIOL REV, V63, P668, DOI 10.1152/physrev.1983.63.2.668; Lupi D, 2008, NAT NEUROSCI, V11, P1068, DOI 10.1038/nn.2179; Mawad K, 2008, J BIOL RHYTHM, V23, P387, DOI 10.1177/0748730408323063; MINKE B, 1978, BIOL CYBERN, V30, P33, DOI 10.1007/BF00365481; Mrosovsky N, 2003, CHRONOBIOL INT, V20, P989, DOI 10.1081/CBI-120026043; Mure LS, 2007, J BIOL RHYTHM, V22, P411, DOI 10.1177/0748730407306043; Mure LS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005991; Rahman SA, 2008, ENDOCRINOLOGY, V149, P6125, DOI 10.1210/en.2007-1742; Rollag MD, 2008, J BIOL RHYTHM, V23, P396, DOI 10.1177/0748730408323067; Sexton T, 2012, J BIOL CHEM, V287, P1649, DOI 10.1074/jbc.R111.301226; Sexton TJ, 2012, J BIOL CHEM, V287, P20888, DOI 10.1074/jbc.M111.325969; Shichida Y, 2012, BIOCHEMISTRY; Smallwood PM, 2003, P NATL ACAD SCI USA, V100, P11706, DOI 10.1073/pnas.1934712100; STABELL U, 1981, J OPT SOC AM, V71, P841, DOI 10.1364/JOSA.71.000841; Thapan K, 2001, J PHYSIOL-LONDON, V535, P261, DOI 10.1111/j.1469-7793.2001.t01-1-00261.x; Tsai JW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000125; Vienot F, 2009, J MOD OPTIC, V56, P1433, DOI 10.1080/09500340903151278	34	22	23	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53583	10.1371/journal.pone.0053583	http://dx.doi.org/10.1371/journal.pone.0053583			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301090	Green Submitted, Green Published, gold			2022-12-25	WOS:000313480000069
J	Kovacs, AT; Eckhardt, TH; van Kranenburg, R; Kuipers, OP				Kovacs, Akos T.; Eckhardt, Tom H.; van Kranenburg, Richard; Kuipers, Oscar P.			Functional Analysis of the ComK Protein of Bacillus coagulans	PLOS ONE			English	Article							COMPETENCE TRANSCRIPTION FACTOR; NATURAL GENETIC-TRANSFORMATION; SUBTILIS K-STATE; BIOFILM FORMATION; GENOME SEQUENCE; BINDING-SITE; DNA UPTAKE; EXPRESSION; ACTIVATION; ACID	The genes for DNA uptake and recombination in Bacilli are commonly regulated by the transcriptional factor ComK. We have identified a ComK homologue in Bacillus coagulans, an industrial relevant organism that is recalcitrant for transformation. Introduction of B. coagulans comK gene under its own promoter region into Bacillus subtilis comK strain results in low transcriptional induction of the late competence gene comGA, but lacking bistable expression. The promoter regions of B. coagulans comK and the comGA genes are recognized in B. subtilis and expression from these promoters is activated by B. subtilis ComK. Purified ComK protein of B. coagulans showed DNA-binding ability in gel retardation assays with B. subtilis- and B. coagulans-derived probes. These experiments suggest that the function of B. coagulans ComK is similar to that of ComK of B. subtilis. When its own comK is overexpressed in B. coagulans the comGA gene expression increases 40-fold, while the expression of another late competence gene, comC is not elevated and no reproducible DNA-uptake could be observed under these conditions. Our results demonstrate that B. coagulans ComK can recognize several B. subtilis comK-responsive elements, and vice versa, but indicate that the activation of the transcription of complete sets of genes coding for a putative DNA uptake apparatus in B. coagulans might differ from that of B. subtilis.	[Kovacs, Akos T.; Eckhardt, Tom H.; Kuipers, Oscar P.] Univ Groningen, Mol Genet Grp, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands; [van Kranenburg, Richard] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [Kuipers, Oscar P.] Kluyver Ctr Genom Ind Fermentat, Groningen, Netherlands	University of Groningen; Wageningen University & Research	Kuipers, OP (corresponding author), Univ Groningen, Mol Genet Grp, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands.	o.p.kuipers@rug.nl	Kuipers, Oscar/B-6752-2009; Kovács, Ákos T/A-9433-2015	Kuipers, Oscar/0000-0001-5596-7735; Kovács, Ákos T/0000-0002-4465-1636; van Kranenburg, Richard/0000-0001-5856-1546	SenterNovem [IS044081]	SenterNovem	Part of this work was financially supported by a SenterNovem subsidy IS044081. This project was carried out within the research programme of the Kluyver Centre for Genomics of Industrial Fermentation which is part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abee T, 2011, CURR OPIN BIOTECH, V22, P172, DOI 10.1016/j.copbio.2010.10.016; Albano M, 2005, J BACTERIOL, V187, P2010, DOI 10.1128/JB.187.6.2010-2019.2005; ALBANO M, 1987, J BACTERIOL, V169, P3110, DOI 10.1128/jb.169.7.3110-3117.1987; Ashikaga S, 2000, J BACTERIOL, V182, P2411, DOI 10.1128/JB.182.9.2411-2415.2000; Berka RM, 2002, MOL MICROBIOL, V43, P1331, DOI 10.1046/j.1365-2958.2002.02833.x; Blomqvist T, 2006, APPL ENVIRON MICROB, V72, P6751, DOI 10.1128/AEM.01156-06; Chai YR, 2008, MOL MICROBIOL, V67, P254, DOI 10.1111/j.1365-2958.2007.06040.x; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Chen I, 2006, J BIOL CHEM, V281, P21720, DOI 10.1074/jbc.M604071200; CHUNG YS, 1995, MOL MICROBIOL, V15, P543, DOI 10.1111/j.1365-2958.1995.tb02267.x; Claverys JP, 2006, ANNU REV MICROBIOL, V60, P451, DOI 10.1146/annurev.micro.60.080805.142139; Doron SI, 2008, J CLIN GASTROENTEROL, V42, pS58, DOI 10.1097/MCG.0b013e3181618ab7; Finkel SE, 2001, J BACTERIOL, V183, P6288, DOI 10.1128/JB.183.21.6288-6293.2001; GASSON MJ, 1983, J BACTERIOL, V154, P1; Burgos MJG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-227; Hamoen LW, 1998, GENE DEV, V12, P1539, DOI 10.1101/gad.12.10.1539; HAMOEN LW, 1995, MOL MICROBIOL, V15, P55, DOI 10.1111/j.1365-2958.1995.tb02220.x; Hamoen LW, 2002, NUCLEIC ACIDS RES, V30, P5517, DOI 10.1093/nar/gkf698; Hamoen LW, 2003, MICROBIOL-SGM, V149, P9, DOI 10.1099/mic.0.26003-0; Hoffmann K, 2010, APPL ENVIRON MICROB, V76, P5046, DOI 10.1128/AEM.00660-10; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Joseph P, 2001, FEMS MICROBIOL LETT, V205, P91; Kearns DB, 2005, GENE DEV, V19, P3083, DOI 10.1101/gad.1373905; Koumoutsi A, 2004, J BACTERIOL, V186, P1084, DOI 10.1128/JB.186.4.1084-1096.2004; Kovacs AT, 2010, APPL ENVIRON MICROB, V76, P4085, DOI 10.1128/AEM.03060-09; Kovacs AT, 2009, ENVIRON MICROBIOL, V11, P1911, DOI 10.1111/j.1462-2920.2009.01937.x; Kramer N, 2007, MOL MICROBIOL, V65, P454, DOI 10.1111/j.1365-2958.2007.05799.x; KUNST F, 1995, J BACTERIOL, V177, P2403, DOI 10.1128/jb.177.9.2403-2407.1995; Lewis PJ, 1999, GENE, V227, P101, DOI 10.1016/S0378-1119(98)00580-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; Martin B, 2006, TRENDS MICROBIOL, V14, P339, DOI 10.1016/j.tim.2006.06.007; Mellegard H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024304; Mironczuk AM, 2008, MICROB BIOTECHNOL, V1, P226, DOI 10.1111/j.1751-7915.2008.00023.x; Nijland R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009724; Ogura M, 2002, J BACTERIOL, V184, P2344, DOI 10.1128/JB.184.9.2344-2351.2002; Oomes SJCM, 2007, INT J FOOD MICROBIOL, V120, P85, DOI 10.1016/j.ijfoodmicro.2007.06.013; Palchevskiy V, 2006, J BACTERIOL, V188, P3902, DOI 10.1128/JB.01974-05; Prepiak P, 2007, MOL CELL, V26, P639, DOI 10.1016/j.molcel.2007.05.011; Provvedi R, 2001, MOL MICROBIOL, V40, P634, DOI 10.1046/j.1365-2958.2001.02406.x; Rhee M, 2011, STANDARDS GENOMIC SC, V5; Rhee MS, 2007, PLASMID, V58, P13, DOI 10.1016/j.plasmid.2006.11.006; Sambrook J, 2001, MOL CLONING LAB MANU; Smits WK, 2007, MOL MICROBIOL, V64, P368, DOI 10.1111/j.1365-2958.2007.05662.x; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Smits WK, 2005, MOL MICROBIOL, V56, P604, DOI 10.1111/j.1365-2958.2005.04488.x; Su F, 2011, J BACTERIOL, V193, P6398, DOI 10.1128/JB.06157-11; Su F, 2011, J BACTERIOL, V193, P4563, DOI 10.1128/JB.05378-11; Susanna KA, 2006, MICROBIOL-SGM, V152, P473, DOI 10.1099/mic.0.28357-0; Susanna KA, 2004, J BACTERIOL, V186, P1120, DOI 10.1128/JB.186.4.1120-1128.2004; Susanna KA, 2007, J BACTERIOL, V189, P4718, DOI 10.1128/JB.00281-07; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THORNE CB, 1966, J BACTERIOL, V91, P1012, DOI 10.1128/JB.91.3.1012-1020.1966; Turgay K, 1998, EMBO J, V17, P6730; van Hijum SAFT, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-77; VANSINDEREN D, 1995, MOL MICROBIOL, V15, P455; Veening JW, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.18; Veening JW, 2005, MOL MICROBIOL, V56, P1481, DOI 10.1111/j.1365-2958.2005.04659.x; VENEMA G, 1965, J BACTERIOL, V89, P1250, DOI 10.1128/JB.89.5.1250-1255.1965; Wang QZ, 2011, P NATL ACAD SCI USA, V108, P18920, DOI 10.1073/pnas.1111085108; Woodbury RL, 2006, RES MICROBIOL, V157, P851, DOI 10.1016/j.resmic.2006.07.002; Wydau S, 2006, FEMS MICROBIOL LETT, V257, P32, DOI 10.1111/j.1574-6968.2006.00141.x	63	6	7	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53471	10.1371/journal.pone.0053471	http://dx.doi.org/10.1371/journal.pone.0053471			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301076	Green Submitted, Green Published, gold			2022-12-25	WOS:000313480000060
J	Hosur, V; Cox, ML; Burzenski, LM; Riding, RL; Alley, L; Lyons, BL; Kavirayani, A; Martin, KA; Cox, GA; Johnson, KR; Shultz, LD				Hosur, Vishnu; Cox, Melissa L.; Burzenski, Lisa M.; Riding, Rebecca L.; Alley, Lynn; Lyons, Bonnie L.; Kavirayani, Anoop; Martin, Kimberly A.; Cox, Gregory A.; Johnson, Kenneth R.; Shultz, Leonard D.			Retrotransposon Insertion in the T-cell Acute Lymphocytic Leukemia 1 (Tal1) Gene Is Associated with Severe Renal Disease and Patchy Alopecia in Hairpatches (Hpt) Mice	PLOS ONE			English	Article							SCL GENE; CRITICAL REGULATOR; STEM-CELLS; MOUSE; ABSENCE; HEMATOPOIESIS; LOCUS; EXPRESSION; SCL/TAL-1; SEQUENCES	"Hairpatches" (Hpt) is a naturally occurring, autosomal semi-dominant mouse mutation. Hpt/Hpt homozygotes die in utero, while Hpt/+ heterozygotes exhibit progressive renal failure accompanied by patchy alopecia. This mutation is a model for the rare human disorder "glomerulonephritis with sparse hair and telangiectases" (OMIM 137940). Fine mapping localized the Hpt locus to a 6.7 Mb region of Chromosome 4 containing 62 known genes. Quantitative real time PCR revealed differential expression for only one gene in the interval, T-cell acute lymphocytic leukemia 1 (Tal1), which was highly upregulated in the kidney and skin of Hpt/+ mice. Southern blot analysis of Hpt mutant DNA indicated a new EcoRI site in the Tal1 gene. High throughput sequencing identified an endogenous retroviral class II intracisternal A particle insertion in Tal1 intron 4. Our data suggests that the IAP insertion in Tal1 underlies the histopathological changes in the kidney by three weeks of age, and that glomerulosclerosis is a consequence of an initial developmental defect, progressing in severity over time. The Hairpatches mouse model allows an investigation into the effects of Tal1, a transcription factor characterized by complex regulation patterns, and its effects on renal disease.	[Hosur, Vishnu; Cox, Melissa L.; Burzenski, Lisa M.; Riding, Rebecca L.; Alley, Lynn; Lyons, Bonnie L.; Kavirayani, Anoop; Martin, Kimberly A.; Cox, Gregory A.; Johnson, Kenneth R.; Shultz, Leonard D.] Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Shultz, LD (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	lenny.shultz@jax.org		Kavirayani, Anoop/0000-0003-3874-3101	NIH [HLO77642, CA034196, AR054170, DK057199]; Jackson Laboratory; JDRF; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057199] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jackson Laboratory; JDRF(Juvenile Diabetes Research Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the NIH grants HLO77642, CA034196, AR054170, and DK057199. MC was supported by a fellowship funded by The Jackson Laboratory. VH was supported by a fellowship from the JDRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplan PD, 1997, EMBO J, V16, P2408, DOI 10.1093/emboj/16.9.2408; APLAN PD, 1990, MOL CELL BIOL, V10, P6426, DOI 10.1128/MCB.10.12.6426; Barton LM, 1999, INT J BIOCHEM CELL B, V31, P1193, DOI 10.1016/S1357-2725(99)00082-5; Basu SK, 2011, EMBO J, V30, P3714, DOI 10.1038/emboj.2011.250; BEGLEY CG, 1994, GENE, V138, P93, DOI 10.1016/0378-1119(94)90787-0; Bloor AJC, 2002, J HEMATOTH STEM CELL, V11, P195, DOI 10.1089/152581602753658402; Bockamp E, 2006, BLOOD, V108, P1533, DOI 10.1182/blood-2005-12-012104; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Dekel B, 2004, KIDNEY INT, V65, P1162, DOI 10.1111/j.1523-1755.2004.00489.x; Delabesse E, 2005, MOL CELL BIOL, V25, P5215, DOI 10.1128/MCB.25.12.5215-5225.2005; Elefanty AG, 1998, P NATL ACAD SCI USA, V95, P11897, DOI 10.1073/pnas.95.20.11897; Fishbane S, 2009, CURR OPIN NEPHROL HY, V18, P112, DOI 10.1097/MNH.0b013e328324b672; Gering M, 2003, DEVELOPMENT, V130, P6187, DOI 10.1242/dev.00875; Gering M, 1998, EMBO J, V17, P4029, DOI 10.1093/emboj/17.14.4029; Gottgens B, 2001, GENOME RES, V11, P87, DOI 10.1101/gr.153001; Hall MA, 2003, P NATL ACAD SCI USA, V100, P992, DOI 10.1073/pnas.0237324100; Horie K, 2007, GENETICS, V176, P815, DOI 10.1534/genetics.107.071647; JOHNSON KR, 1992, GENOMICS, V12, P503, DOI 10.1016/0888-7543(92)90441-T; Lecuyer E, 2004, EXP HEMATOL, V32, P11, DOI 10.1016/j.exphem.2003.10.010; Maksakova IA, 2006, PLOS GENET, V2, P1, DOI 10.1371/journal.pgen.0020002; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; Qin CH, 2010, MOL CARCINOGEN, V49, P54, DOI 10.1002/mc.20576; ROBB L, 1995, P NATL ACAD SCI USA, V92, P7075, DOI 10.1073/pnas.92.15.7075; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; SHULTZ LD, 1991, LAB INVEST, V65, P588; Simon D, 2010, HUM MOL GENET, V19, P2015, DOI 10.1093/hmg/ddq083; XIA Y, 1991, P NATL ACAD SCI USA, V88, P11416, DOI 10.1073/pnas.88.24.11416; Yang M, 2011, ADV CHRONIC KIDNEY D, V18, P400, DOI 10.1053/j.ackd.2011.10.001; Zhang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000007	30	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53426	10.1371/journal.pone.0053426	http://dx.doi.org/10.1371/journal.pone.0053426			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301070	gold, Green Published, Green Submitted			2022-12-25	WOS:000313320900077
J	Penicud, K; Behrens, A				Penicud, K.; Behrens, A.			DMAP1 is an essential regulator of ATM activity and function	ONCOGENE			English	Article						DMAP1; ATM; TIP60; double-strand break	HISTONE ACETYLTRANSFERASE COMPLEX; DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; ATAXIA-TELANGIECTASIA; KINASE-ACTIVITY; ACTIVATES ATM; SANT DOMAIN; ACETYLATION; REPAIR; TIP60	The hereditary autosomal recessive disease ataxia telangiectasia (A-T) is caused by mutation in the DNA damage kinase ATM. ATM's main function is to orchestrate DNA repair, thereby maintaining genomic stability. ATM activity is increased in response to several stimuli, including ionising radiation (IR) and hypotonic stress. DNMT1-associated protein 1 (DMAP1) is a member of the TIP60-p400 histone acetyl transferase (HAT) complex, which acetylates histone H4 at lysine 16 (H4K16) to affect chromatin relaxation and modulate ATM activation. Here we demonstrate that DMAP1 is required for both modes of ATM activation. Knockdown of DMAP1 impaired IR-induced ATM activation and consequently resulted in radiosensitivity and impaired the G2/M checkpoint. Moreover, DMAP1 was also required for efficient ATM signalling in response to hypotonic stress. Overexpression of DMAP1 increased IR-induced ATM substrate phosphorylation, suggesting that DMAP1 function is rate limiting for ATM signalling. DMAP1 associated with TIP60-dependent HAT activity, and depletion of DMAP1 reduced H4K16 acetylation in response to DNA damage. Treatment with histone deacetylase inhibitors rescued IR-induced ATM signalling in Dmap1-depleted cells. These results suggest that DMAP1 is a critical regulator of ATM activity and function.	[Penicud, K.; Behrens, A.] Canc Res UK London Res Inst, Mammalian Genet Lab, London WC2A 3LY, England	Cancer Research UK	Behrens, A (corresponding author), Canc Res UK London Res Inst, Mammalian Genet Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	axel.behrens@cancer.org.uk		Behrens, Axel/0000-0002-1557-1143	Experimental HistoPathology Unit, Bioinformatics and Biostatistics; Equipment Park, Biological Resources; FACS Lab in the London Research Institute (CR-UK); ERC [281661 ATMINDDR]; Cancer Research UK; Cancer Research UK [15679] Funding Source: researchfish	Experimental HistoPathology Unit, Bioinformatics and Biostatistics; Equipment Park, Biological Resources(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); FACS Lab in the London Research Institute (CR-UK); ERC(European Research Council (ERC)European Commission); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	Support was given from the Experimental HistoPathology Unit, Bioinformatics and Biostatistics, the Equipment Park, Biological Resources and the FACS Lab in the London Research Institute (CR-UK). We thank Dr Cremona and Dr Kanu for critical reading of the manuscript and the Mammalian Genetics Lab for input and discussions. This work was supported by an ERC grant (281661 ATMINDDR) to AB. The London Research Institute is funded by Cancer Research UK.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Boyer LA, 2004, NAT REV MOL CELL BIO, V5, P158, DOI 10.1038/nrm1314; Boyer LA, 2002, MOL CELL, V10, P935, DOI 10.1016/S1097-2765(02)00634-2; Cai Y, 2003, J BIOL CHEM, V278, P42733, DOI 10.1074/jbc.C300389200; Chun HH, 2004, DNA REPAIR, V3, P1187, DOI 10.1016/j.dnarep.2004.04.010; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Frappart PO, 2006, NEUROMOL MED, V8, P495, DOI 10.1385/NMM:8:4:495; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kim YC, 2009, NAT CELL BIOL, V11, P92, DOI 10.1038/ncb1817; Kuhne M, 2004, CANCER RES, V64, P500, DOI 10.1158/0008-5472.CAN-03-2384; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lukas J, 2004, DNA REPAIR, V3, P997, DOI 10.1016/j.dnarep.2004.03.006; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Negishi M, 2009, GENES CELLS, V14, P1347, DOI 10.1111/j.1365-2443.2009.01352.x; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Sharma GG, 2010, MOL CELL BIOL, V30, P3582, DOI 10.1128/MCB.01476-09; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; SHILOH Y, 1982, EXP CELL RES, V140, P191, DOI 10.1016/0014-4827(82)90169-0; Sun YL, 2007, MOL CELL BIOL, V27, P8502, DOI 10.1128/MCB.01382-07; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Wu JX, 2011, NAT STRUCT MOL BIOL, V18, P761, DOI 10.1038/nsmb.2078	29	18	19	2	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 23	2014	33	4					525	531		10.1038/onc.2012.597	http://dx.doi.org/10.1038/onc.2012.597			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	296VX	23318425	Green Accepted			2022-12-25	WOS:000330214600013
J	Agrawal, B; Czymmek, KJ; Sparks, DL; Bais, HP				Agrawal, Bhavana; Czymmek, Kirk J.; Sparks, Donald L.; Bais, Harsh P.			Transient Influx of Nickel in Root Mitochondria Modulates Organic Acid and Reactive Oxygen Species Production in Nickel Hyperaccumulator Alyssum murale	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; OXIDATIVE STRESS; CYTOCHROME-C; SUBCELLULAR-LOCALIZATION; MALATE-DEHYDROGENASE; SEBERTIA-ACUMINATA; FREE HISTIDINE; NADPH OXIDASE; TOLERANCE; TRANSITION	Mitochondria are important targets of metal toxicity and are also vital for maintaining metal homeostasis. Here, we examined the potential role of mitochondria in homeostasis of nickel in the roots of nickel hyperaccumulator plant Alyssum murale. We evaluated the biochemical basis of nickel tolerance by comparing the role of mitochondria in closely related nickel hyperaccumulator A. murale and non-accumulator Alyssum montanum. Evidence is presented for the rapid and transient influx of nickel in root mitochondria of nickel hyperaccumulator A. murale. In an early response to nickel treatment, substantial nickel influx was observed in mitochondria prior to sequestration in vacuoles in the roots of hyperaccumulator A. murale compared with non-accumulator A. montanum. In addition, the mitochondrial Krebs cycle was modulated to increase synthesis of malic acid and citric acid involvement in nickel hyperaccumulation. Furthermore, malic acid, which is reported to form a complex with nickel in hyperaccumulators, was also found to reduce the reactive oxygen species generation induced by nickel. We propose that the interaction of nickel with mitochondria is imperative in the early steps of nickel uptake in nickel hyperaccumulator plants. Initial uptake of nickel in roots results in biochemical responses in the root mitochondria indicating its vital role in homeostasis of nickel ions in hyperaccumulation.	[Agrawal, Bhavana; Sparks, Donald L.; Bais, Harsh P.] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19716 USA; [Czymmek, Kirk J.] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; [Agrawal, Bhavana; Czymmek, Kirk J.; Sparks, Donald L.; Bais, Harsh P.] Delaware Biotechnol Inst, Newark, DE 19711 USA; [Sparks, Donald L.; Bais, Harsh P.] Ctr Crit Zone Res, Newark, DE 19711 USA	University of Delaware; University of Delaware	Bais, HP (corresponding author), Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19716 USA.	hbais@udel.edu	Rechsteiner, Cynthia/C-5894-2011	Czymmek, Kirk/0000-0002-5471-7395	National Science Foundation Grant EPSCoR	National Science Foundation Grant EPSCoR	This work was supported by National Science Foundation Grant EPSCoR (to H. P. B., K. J. C., and D. L. S.).	Agius SC, 1998, PHYSIOL PLANTARUM, V104, P329, DOI 10.1034/j.1399-3054.1998.1040306.x; Asemaneh T, 2006, PLANTA, V225, P193, DOI 10.1007/s00425-006-0340-y; BAKER A J M, 1989, Biorecovery, V1, P81; Baker AJM, 2000, PHYTOREMEDIATION OF CONTAMINATED SOIL AND WATER, P85; Balk J, 1999, FEBS LETT, V463, P151, DOI 10.1016/S0014-5793(99)01611-7; Balk J, 2001, PLANT CELL, V13, P1803, DOI 10.1105/tpc.13.8.1803; Berazain R, 2007, PLANT SOIL, V293, P99, DOI 10.1007/s11104-007-9227-3; Bhatia NP, 2004, FUNCT PLANT BIOL, V31, P1061, DOI 10.1071/FP03192; Bidwell SD, 2004, PLANT CELL ENVIRON, V27, P705, DOI 10.1111/j.0016-8025.2003.01170.x; Boominathan R, 2003, J BIOTECHNOL, V101, P131, DOI 10.1016/S0168-1656(02)00320-6; Boyd RS, 1998, AM J BOT, V85, P259, DOI 10.2307/2446314; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROOKS RR, 1979, PROC R SOC SER B-BIO, V203, P387, DOI 10.1098/rspb.1979.0005; BROOKS RR, 1981, PHYSIOL PLANTARUM, V51, P167, DOI 10.1111/j.1399-3054.1981.tb02693.x; Callahan DL, 2008, PHYTOCHEMISTRY, V69, P240, DOI 10.1016/j.phytochem.2007.07.001; Chaney RL, 2007, J ENVIRON QUAL, V36, P1429, DOI 10.2134/jeq2006.0514; Chen CY, 2009, CLEAN-SOIL AIR WATER, V37, P304, DOI 10.1002/clen.200800199; de la Fuente V, 2007, PLANT BIOSYST, V141, P170, DOI 10.1080/11263500701401422; Delhaize E, 2004, P NATL ACAD SCI USA, V101, P15249, DOI 10.1073/pnas.0406258101; Douchkov D, 2005, PLANT CELL ENVIRON, V28, P365, DOI 10.1111/j.1365-3040.2005.01273.x; Ermler U, 1998, CURR OPIN STRUC BIOL, V8, P749, DOI 10.1016/S0959-440X(98)80095-X; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Freeman JL, 2004, PLANT CELL, V16, P2176, DOI 10.1105/tpc.104.023036; Gomes RA, 2006, PLANT PHYSIOL BIOCH, V44, P420, DOI 10.1016/j.plaphy.2006.06.002; Hao FS, 2006, PLANT SCI, V170, P151, DOI 10.1016/j.plantsci.2005.08.014; HOMER FA, 1991, PHYTOCHEMISTRY, V30, P2141, DOI 10.1016/0031-9422(91)83602-H; Ingle RA, 2005, BIOMETALS, V18, P627, DOI 10.1007/s10534-005-2999-0; Joo JH, 2001, PLANT PHYSIOL, V126, P1055, DOI 10.1104/pp.126.3.1055; Kaiser J, 2003, SCIENCE, V302, P376, DOI 10.1126/science.302.5644.376; Kerkeb L, 2003, PLANT PHYSIOL, V131, P716, DOI 10.1104/pp102.010686; KERSTEN WJ, 1980, PHYTOCHEMISTRY, V19, P1963, DOI 10.1016/0031-9422(80)83013-5; Kobayashi Y, 2007, PLANT PHYSIOL, V145, P843, DOI 10.1104/pp.107.102335; Kolisek M, 2003, EMBO J, V22, P1235, DOI 10.1093/emboj/cdg122; Kramer U, 2007, FEBS LETT, V581, P2263, DOI 10.1016/j.febslet.2007.04.010; Kramer U, 2000, PLANT PHYSIOL, V122, P1343, DOI 10.1104/pp.122.4.1343; Kramer U, 1996, NATURE, V379, P635, DOI 10.1038/379635a0; Kumar P, 2007, J PLANT NUTR SOIL SC, V170, P796, DOI 10.1002/jpln.200625126; Kupper H, 2001, J EXP BOT, V52, P2291, DOI 10.1093/jexbot/52.365.2291; Kupper H., 2007, METAL IONS LIFE SCI, P31, DOI DOI 10.1002/9780470028131.CH2; LEE J, 1978, PHYTOCHEMISTRY, V17, P1033, DOI 10.1016/S0031-9422(00)94274-2; LEE J, 1977, PHYTOCHEMISTRY, V16, P1503, DOI 10.1016/0031-9422(77)84010-7; McNear DH, 2010, PHYTOCHEMISTRY, V71, P188, DOI 10.1016/j.phytochem.2009.10.023; Mesjasz-Przybylowicz J, 2007, PLANT SOIL, V293, P61, DOI 10.1007/s11104-007-9237-1; MOLLER IM, 1982, PHYSIOL PLANTARUM, V54, P267, DOI 10.1111/j.1399-3054.1982.tb00258.x; Montarges-Pelletier E, 2008, PHYTOCHEMISTRY, V69, P1695, DOI 10.1016/j.phytochem.2008.02.009; Morgunov I, 1998, J BIOL CHEM, V273, P29540, DOI 10.1074/jbc.273.45.29540; Murphey WH, 1969, METHOD ENZYMOL, V8, P145, DOI [10.1016/0076-6879(69)13029-3, DOI 10.1016/0076-6879(69)13029-3]; Noctor G, 2007, TRENDS PLANT SCI, V12, P125, DOI 10.1016/j.tplants.2007.01.005; Ochoa S, 1955, METHODS ENZYMOLOGY, V1; PELOSI P, 1976, AGR BIOL CHEM TOKYO, V40, P1641, DOI 10.1080/00021369.1976.10862273; Perrier N, 2004, CR GEOSCI, V336, P567, DOI 10.1016/j.crte.2003.12.014; Pierrel F, 2007, BIOMETALS, V20, P675, DOI 10.1007/s10534-006-9052-9; Pompeu GB, 2008, SCI AGR, V65, P548, DOI 10.1590/S0103-90162008000500015; Rafelski SM, 2008, NAT REV MOL CELL BIO, V9, P593, DOI 10.1038/nrm2460; Randhawa VK, 2001, CAN J MICROBIOL, V47, P987, DOI 10.1139/cjm-47-11-987; Riesen O, 2005, J PLANT NUTR, V28, P421, DOI 10.1081/PLN-200049153; Romani AMP, 2000, FRONT BIOSCI, V5, pD720, DOI 10.2741/Romani; Sagner S, 1998, PHYTOCHEMISTRY, V47, P339, DOI 10.1016/S0031-9422(97)00593-1; Saito A, 2010, PLANT CELL ENVIRON, V33, P174, DOI 10.1111/j.1365-3040.2009.02068.x; Scorrano L, 1999, J BIOL CHEM, V274, P24657, DOI 10.1074/jbc.274.35.24657; Smart KE, 2007, INT J MASS SPECTROM, V260, P107, DOI 10.1016/j.ijms.2006.08.011; Tappero R, 2007, NEW PHYTOL, V175, P641, DOI 10.1111/j.1469-8137.2007.02134.x; Tesfaye M, 2001, PLANT PHYSIOL, V127, P1836, DOI 10.1104/pp.010376; Veeger C., 1969, METHODS ENZYMOLOGY, VXIII, P81, DOI [https://doi.org/10.1016/0076-6879(69)13020-7, DOI 10.1016/0076-6879(69)13020-7]; Weir IE, 2003, CYTOM PART A, V54A, P109, DOI 10.1002/cyto.a.10054; Xu T, 2001, NAT CELL BIOL, V3, P691, DOI 10.1038/35087000; Zhao JF, 2009, ANAL BIOCHEM, V384, P34, DOI 10.1016/j.ab.2008.09.019	67	22	22	2	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7351	7362		10.1074/jbc.M112.406645	http://dx.doi.org/10.1074/jbc.M112.406645			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23322782	Green Published, hybrid			2022-12-25	WOS:000316002400054
J	Tavecchio, M; Lisanti, S; Lam, A; Ghosh, JC; Martin, NM; O'Connell, M; Weeraratna, AT; Kossenkov, AV; Showe, LC; Altieri, DC				Tavecchio, Michele; Lisanti, Sofia; Lam, Aaron; Ghosh, Jagadish C.; Martin, Nina M.; O'Connell, Michael; Weeraratna, Ashani T.; Kossenkov, Andrew V.; Showe, Louise C.; Altieri, Dario C.			Cyclophilin D Extramitochondrial Signaling Controls Cell Cycle Progression and Chemokine-directed Cell Motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; UNFOLDED PROTEIN RESPONSE; KAPPA-B; STAT3 ACTIVATION; HEXOKINASE-II; CANCER; PATHWAY; CARDIOPROTECTION; TRANSPLANTATION; INACTIVATION	Mitochondria control bioenergetics and cell fate decisions, but how they influence nuclear gene expression is understood poorly. Here, we show that deletion or reduction in the levels of cyclophilin D (CypD, also called Ppif), a mitochondrial matrix peptidyl prolyl isomerase and apoptosis regulator, results in increased cell proliferation and enhanced cell migration and invasion. These responses are associated with extensive transcriptional changes, modulation of a chemokine/chemokine receptor gene signature, and activation of the pleiotropic inflammatory mediator, STAT3. In the absence of CypD, active STAT3 enhances cell proliferation via accelerated entry into S-phase and stimulates autocrine/paracrine cell motility through Cxcl12-Cxcr4-directed chemotaxis. Therefore, CypD directs mitochondria-to-nuclei inflammatory gene expression in normal and tumor cells. This pathway may contribute to malignant traits under conditions of CypD modulation.	[Tavecchio, Michele; Lisanti, Sofia; Lam, Aaron; Ghosh, Jagadish C.; Martin, Nina M.; Altieri, Dario C.] Wistar Inst Anat & Biol, Prostate Canc Discovery & Dev Program, Philadelphia, PA 19104 USA; [O'Connell, Michael; Weeraratna, Ashani T.] Wistar Inst Anat & Biol, Melanoma Res Ctr, Philadelphia, PA 19104 USA; [Weeraratna, Ashani T.] Wistar Inst Anat & Biol, Tumor Microenvironm & Metastasis Program, Philadelphia, PA 19104 USA; [Kossenkov, Andrew V.; Showe, Louise C.] Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, Philadelphia, PA 19104 USA; [Showe, Louise C.; Altieri, Dario C.] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, Philadelphia, PA 19104 USA	The Wistar Institute; The Wistar Institute; The Wistar Institute; The Wistar Institute; The Wistar Institute	Altieri, DC (corresponding author), Wistar Inst Anat & Biol, Ctr Canc, 3601 Spruce St, Philadelphia, PA 19104 USA.	daltieri@wistar.org	O'Connell, Michael/F-9236-2017	Martin, Nina/0000-0002-3361-7037	National Institutes of Health [CA140043, CA78810, CA118005]; Cancer Center Support Grant (CCSG) [CA010815]; NATIONAL CANCER INSTITUTE [R01CA118005, P01CA140043, R01CA078810, P30CA010815] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024693] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant (CCSG); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA140043, CA78810, and CA118005. This work was also supported by Cancer Center Support Grant (CCSG) CA010815 (to The Wistar Institute).	Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bernier M, 2011, J BIOL CHEM, V286, P19270, DOI 10.1074/jbc.M110.200311; Biswas G, 2003, J CELL BIOL, V161, P507, DOI 10.1083/jcb.200211104; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Carreira RS, 2010, AUTOPHAGY, V6, P462, DOI 10.4161/auto.6.4.11553; Chae YC, 2012, CANCER CELL, V22, P331, DOI 10.1016/j.ccr.2012.07.015; Duda DG, 2011, CLIN CANCER RES, V17, P2074, DOI 10.1158/1078-0432.CCR-10-2636; Fujimoto K, 2010, P NATL ACAD SCI USA, V107, P10214, DOI 10.1073/pnas.0914209107; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Ghosh JC, 2010, CANCER RES, V70, P8988, DOI 10.1158/0008-5472.CAN-10-2225; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hausenloy DJ, 2012, BRIT J PHARMACOL, V165, P1235, DOI 10.1111/j.1476-5381.2011.01700.x; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; Hetz C, 2009, MOL CELL, V35, P551, DOI 10.1016/j.molcel.2009.08.021; Heusch G, 2011, CIRC RES, V109, P1302, DOI 10.1161/CIRCRESAHA.111.255604; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kahan BD, 2011, TRANSPL P, V43, P2853, DOI 10.1016/j.transproceed.2011.08.058; Kinnally KW, 2011, BBA-MOL CELL RES, V1813, P616, DOI 10.1016/j.bbamcr.2010.09.013; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Machida K, 2006, J BIOL CHEM, V281, P14314, DOI 10.1074/jbc.M513297200; Malouitre S, 2010, BIOCHEM J, V425, P137, DOI 10.1042/BJ20090332; Mertens C, 2007, CELL, V131, DOI 10.1016/j.cell.2007.10.033; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nefedova Y, 2007, CURR CANCER DRUG TAR, V7, P71, DOI 10.2174/156800907780006887; Nguyen TT, 2011, J BIOL CHEM, V286, P40184, DOI 10.1074/jbc.M111.243469; Phillips D, 2010, J BIOL CHEM, V285, P23532, DOI 10.1074/jbc.C110.152652; Rama I, 2010, NAT REV NEPHROL, V6, P511, DOI 10.1038/nrneph.2010.102; Sansone P, 2012, J CLIN ONCOL, V30, P1005, DOI 10.1200/JCO.2010.31.8907; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Shulga N, 2010, J CELL SCI, V123, P894, DOI 10.1242/jcs.061846; Siegelin MD, 2011, J CLIN INVEST, V121, P1349, DOI 10.1172/JCI44855; Soriano SF, 2002, J EXP MED, V196, P311, DOI 10.1084/jem.20012041; Srinivasan V, 2010, AGING CELL, V9, P933, DOI 10.1111/j.1474-9726.2010.00622.x; Storey John D, 2003, Methods Mol Biol, V224, P149; Szczepanek K, 2012, TRENDS CELL BIOL, V22, P429, DOI 10.1016/j.tcb.2012.05.001; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; To LB, 2011, BLOOD, V118, P4530, DOI 10.1182/blood-2011-06-318220; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhou LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021680	49	37	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5553	5561		10.1074/jbc.M112.433045	http://dx.doi.org/10.1074/jbc.M112.433045			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23303179	Green Published, hybrid			2022-12-25	WOS:000315342500029
J	Jin, R; Zhu, WD; Cao, SB; Chen, R; Jin, H; Liu, Y; Wang, SB; Wang, W; Xiao, GF				Jin, Rui; Zhu, Wandi; Cao, Shengbo; Chen, Rui; Jin, Hui; Liu, Yang; Wang, Shaobo; Wang, Wei; Xiao, Gengfu			Japanese Encephalitis Virus Activates Autophagy as a Viral Immune Evasion Strategy	PLOS ONE			English	Article							NF-KAPPA-B; UNFOLDED PROTEIN RESPONSE; HEPATITIS-C VIRUS; MONITORING AUTOPHAGY; GENE-EXPRESSION; IN-VITRO; INTERFERON; REPLICATION; MACHINERY; INDUCTION	In addition to manipulating cellular homeostasis and survivability, autophagy also plays a crucial role in numerous viral infections. In this study, we discover that Japanese encephalitis virus (JEV) infection results in the accumulation of microtubule-associated protein 1 light chain 3-II (LC3-II) protein and GFP-LC3 puncta in vitro and an increase in autophagosomes/autolysosomes in vivo. The fusion between autophagosomes and lysosomes is essential for virus replication. Knockdown of autophagy-related genes reduced JEV replication in vitro, as indicated by viral RNA and protein levels. We also note that JEV infection in autophagy-impaired cells displayed active caspases cleavage and cell death. Moreover, we find that JEV induces higher type I interferon (IFN) activation in cells deficient in autophagy-related genes as the cells exhibited increased phosphorylation and dimerization of interferon regulatory factor 3 (IRF3) and mitochondrial antiviral signaling protein (MAVS) aggregation. Finally, we find that autophagy is indispensable for efficient JEV replication even in an IFN-defective background. Overall, our studies provide the first description of the mechanism of the autophagic innate immune signaling pathway during JEV infection.	[Jin, Rui; Zhu, Wandi; Chen, Rui; Jin, Hui; Liu, Yang; Wang, Shaobo; Wang, Wei; Xiao, Gengfu] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China; [Cao, Shengbo] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Huazhong Agricultural University	Wang, W (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China.	429166911@qq.com; xiaogf@wh.iov.cn	Wang, Shaobo/AAB-2272-2020	Wang, Wei/0000-0002-8696-9773	National Key Scientific Program (973) [2010CB530100, 2011CB933600]; National Natural Science Foundation of China [31000089]	National Key Scientific Program (973); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Key Scientific Program (973)-(Nos. 2010CB530100 and 2011CB933600) and a grant from the National Natural Science Foundation of China (No. 31000089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014; Chen R, 2011, AUTOPHAGY, V7, P205, DOI 10.4161/auto.7.2.14197; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Criollo A, 2012, CELL CYCLE, V11, P194, DOI 10.4161/cc.11.1.18669; Fujiwara K, 2008, J BIOL CHEM, V283, P388, DOI 10.1074/jbc.M611043200; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; Halfmann Randal, 2008, J Vis Exp, DOI 10.3791/838; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Juang YT, 1998, P NATL ACAD SCI USA, V95, P9837, DOI 10.1073/pnas.95.17.9837; Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Klionsky DJ, 2010, AUTOPHAGY, V6, P438, DOI 10.4161/auto.6.4.12244; Krajewski S, 1999, P NATL ACAD SCI USA, V96, P5752, DOI 10.1073/pnas.96.10.5752; Kudchodkar SB, 2009, REV MED VIROL, V19, P359, DOI 10.1002/rmv.630; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li JH, 2011, J VIROL, V85, P6319, DOI 10.1128/JVI.02627-10; Li JK, 2012, MICROBES INFECT, V14, P159, DOI 10.1016/j.micinf.2011.09.001; Li YM, 2010, J VIROL METHODS, V168, P51, DOI 10.1016/j.jviromet.2010.04.015; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lin RJ, 2006, J VIROL, V80, P5908, DOI 10.1128/JVI.02714-05; Lin RJ, 2004, J GEN VIROL, V85, P521, DOI 10.1099/vir.0.19496-0; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Nazmi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021761; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Shrivastava S, 2011, HEPATOLOGY, V53, P406, DOI 10.1002/hep.24073; Sir D, 2008, HEPATOLOGY, V48, P1054, DOI 10.1002/hep.22464; Takeshita F, 2008, AUTOPHAGY, V4, P67, DOI 10.4161/auto.5055; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Vossen MTM, 2002, IMMUNOGENETICS, V54, P527, DOI 10.1007/s00251-002-0493-1; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Wong J, 2008, J VIROL, V82, P9143, DOI 10.1128/JVI.00641-08; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102	45	63	66	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e52909	10.1371/journal.pone.0052909	http://dx.doi.org/10.1371/journal.pone.0052909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320079	Green Published, gold, Green Submitted			2022-12-25	WOS:000313429800021
J	Bonhomme, CJ; Knopp, KA; Bederka, LH; Angelini, MM; Buchmeier, MJ				Bonhomme, Cyrille J.; Knopp, Kristeene A.; Bederka, Lydia H.; Angelini, Megan M.; Buchmeier, Michael J.			LCMV Glycosylation Modulates Viral Fitness and Cell Tropism	PLOS ONE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; N-LINKED GLYCANS; MEMBRANE-FUSION; ENVELOPE GLYCOPROTEIN; HEMORRHAGIC-FEVER; RECEPTOR-BINDING; HIV-1 GP120; LASSA-VIRUS; WEST-AFRICA; ARENAVIRUS	The glycoprotein (GP) of arenaviruses is glycosylated at 11 conserved N-glycosylation sites. We constructed recombinant lymphocytic choriomeningitis virus (rLCMV) featuring either additions or deletions of these N-glycans to investigate their role in the viral life cycle. N-glycosylation at two sites, T87 and S97, were found to be necessary to rescue rLCMV. Three of nine successfully rescued mutants, S116A, T234A, and S373A, under selective pressures in either epithelial, neuronal, or macrophage cells reverted to WT sequence. Of the seven stable N-glycan deletion mutants, five of these led to altered viral fitness and cell tropism, assessed as growth in either mouse primary cortical neurons or bone marrow derived macrophages. These results demonstrate that the deletion of N-glycans in LCMV GP may confer an advantage to the virus for infection of neurons but a disadvantage in macrophages.	[Bonhomme, Cyrille J.; Knopp, Kristeene A.; Bederka, Lydia H.; Angelini, Megan M.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; [Buchmeier, Michael J.] Univ Calif Irvine, Dept Mol Biol, Irvine, CA 92717 USA; [Buchmeier, Michael J.] Univ Calif Irvine, Dept Biochem, Irvine, CA 92717 USA; [Buchmeier, Michael J.] Univ Calif Irvine, Dept Med, Div Infect Dis, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Buchmeier, MJ (corresponding author), Univ Calif Irvine, Dept Mol Biol, Irvine, CA 92717 USA.	m.buchmeier@uci.edu	Pacific-Southwest, RCE/B-6155-2009	Bederka, Lydia/0000-0002-3006-9979	National Institutes of Health (NIH) Pacific Southwest Regional Center of Excellence [AI-065359]; National Science Foundation [DGE-0638751]; NIH [5T32A1007319-23]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Pacific Southwest Regional Center of Excellence; National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (NIH) grant AI-065359 Pacific Southwest Regional Center of Excellence, National Science Foundation Grant DGE-0638751, and NIH grant 5T32A1007319-23. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham J, 2010, NAT STRUCT MOL BIOL, V17, P438, DOI 10.1038/nsmb.1772; Agnihothram SS, 2009, J VIROL, V83, P9890, DOI 10.1128/JVI.00837-09; AHMED R, 1988, J EXP MED, V167, P1719, DOI 10.1084/jem.167.5.1719; AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Amman BR, 2007, EMERG INFECT DIS, V13, P719, DOI 10.3201/eid1305.061269; Auwerx J, 2008, VIROLOGY, V382, P10, DOI 10.1016/j.virol.2008.09.010; Balzarini J, 2007, NAT REV MICROBIOL, V5, P583, DOI 10.1038/nrmicro1707; Barton LL, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.3.e35; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; Benoit ME, 2011, J NEUROSCI, V31, P3459, DOI 10.1523/JNEUROSCI.3932-10.2011; Beyer WR, 2003, J VIROL, V77, P2866, DOI 10.1128/JVI.77.5.2866-2872.2003; Bonhomme CJ, 2011, VIROLOGY, V409, P223, DOI 10.1016/j.virol.2010.10.011; Bonthius DJ, 2007, ANN NEUROL, V62, P347, DOI 10.1002/ana.21161; BORROW P, 1994, VIROLOGY, V198, P1, DOI 10.1006/viro.1994.1001; Bowden TA, 2009, J VIROL, V83, P8259, DOI 10.1128/JVI.00761-09; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; BUCKLEY SM, 1970, AM J TROP MED HYG, V19, P680, DOI 10.4269/ajtmh.1970.19.680; BUCKLEY SM, 1970, NATURE, V227, P174, DOI 10.1038/227174a0; BURNS JW, 1991, VIROLOGY, V183, P620, DOI 10.1016/0042-6822(91)90991-J; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; Charrel RN, 2008, CURR OPIN MICROBIOL, V11, P362, DOI 10.1016/j.mib.2008.06.001; Charrel RN, 2006, ARCH INTERN MED, V166, P2044, DOI 10.1001/archinte.166.18.2044; COIMBRA TLM, 1994, LANCET, V343, P391, DOI 10.1016/S0140-6736(94)91226-2; DEIBEL R, 1975, JAMA-J AM MED ASSOC, V232, P501, DOI 10.1001/jama.232.5.501; Delgado S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000047; DISIMONE C, 1995, VIROLOGY, V209, P3, DOI 10.1006/viro.1995.1225; DISIMONE C, 1994, VIROLOGY, V198, P455, DOI 10.1006/viro.1994.1057; Emonet S, 2007, EMERG INFECT DIS, V13, P472, DOI 10.3201/eid1303.061141; Emonet SE, 2011, VIROLOGY, V411, P416, DOI 10.1016/j.virol.2011.01.013; Eschli B, 2007, J VIROL, V81, P11650, DOI 10.1128/JVI.00955-07; EVANS CF, 1994, J VIROL, V68, P7367, DOI 10.1128/JVI.68.11.7367-7373.1994; Fischer SA, 2006, NEW ENGL J MED, V354, P2235, DOI 10.1056/NEJMoa053240; Flatz L, 2006, P NATL ACAD SCI USA, V103, P4663, DOI 10.1073/pnas.0600652103; Francois KO, 2011, J BIOL CHEM, V286, P42900, DOI 10.1074/jbc.M111.274456; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; HIRANO N, 1974, ARCH GES VIRUSFORSCH, V44, P298, DOI 10.1007/BF01240618; Igonet S, 2011, P NATL ACAD SCI USA, V108, P19967, DOI 10.1073/pnas.1108910108; JOHNSON KM, 1964, P SOC EXP BIOL MED, V118, P113; Klewitz C, 2007, J GEN VIROL, V88, P2320, DOI 10.1099/vir.0.82950-0; Knoper RC, 2009, VIROLOGY, V391, P232, DOI 10.1016/j.virol.2009.06.015; Lecompte E, 2007, VIROLOGY, V364, P178, DOI 10.1016/j.virol.2007.02.008; Maisner A, 1996, J VIROL, V70, P4973, DOI 10.1128/JVI.70.8.4973-4977.1996; Melanson VR, 2006, J VIROL, V80, P623, DOI 10.1128/JVI.80.2.623-633.2006; Morgado P, 2011, INFECT IMMUN, V79, P4401, DOI 10.1128/IAI.05562-11; Neuman BW, 2005, J VIROL, V79, P3822, DOI 10.1128/JVI.79.6.3822-3830.2005; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; PARODI A S, 1959, Prensa Med Argent, V46, P2242; PARODI A S, 1958, Dia Med, V30, P2300; Paweska JT, 2009, EMERG INFECT DIS, V15, P1598, DOI 10.3201/eid1510.090211; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; Quinones-Kochs MI, 2002, J VIROL, V76, P4199, DOI 10.1128/JVI.76.9.4199-4211.2002; Radoshitzky SR, PLOS ONE, V6; SALVATO M, 1991, J VIROL, V65, P1863, DOI 10.1128/JVI.65.4.1863-1869.1991; Salvato MSCJ, 2005, 8 REP ICTV, P725733; Sanchez AB, 2006, VIROLOGY, V350, P370, DOI 10.1016/j.virol.2006.01.012; Sevilla N, 2006, CURR TOP MICROBIOL, V299, P315; SUGAWARA K, 1988, J GEN VIROL, V69, P537, DOI 10.1099/0022-1317-69-3-537; Sullivan BM, 2011, P NATL ACAD SCI USA, V108, P2969, DOI 10.1073/pnas.1019304108; TESH RB, 1994, AM J TROP MED HYG, V50, P452, DOI 10.4269/ajtmh.1994.50.452; van Opijnen T, 2005, REV MED VIROL, V15, P219, DOI 10.1002/rmv.472; WELSH RM, 1972, J GEN VIROL, V17, P355, DOI 10.1099/0022-1317-17-3-355; WRIGHT KE, 1990, VIROLOGY, V177, P175, DOI 10.1016/0042-6822(90)90471-3; WRIGHT KE, 1989, VIROLOGY, V171, P417, DOI 10.1016/0042-6822(89)90610-7; Wyss DF, 1996, CURR OPIN BIOTECH, V7, P409, DOI 10.1016/S0958-1669(96)80116-9; York J, 2008, J VIROL, V82, P10932, DOI 10.1128/JVI.01140-08	65	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53273	10.1371/journal.pone.0053273	http://dx.doi.org/10.1371/journal.pone.0053273			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308183	Green Published, gold			2022-12-25	WOS:000313429100049
J	Chung, CL; Hsiao, SH; Hsiao, G; Sheu, JR; Chen, WL; Chang, SC				Chung, Chi-Li; Hsiao, Shih-Hsin; Hsiao, George; Sheu, Joen-Rong; Chen, Wei-Lin; Chang, Shi-Chuan			Clinical Importance of Angiogenic Cytokines, Fibrinolytic Activity and Effusion Size in Parapneumonic Effusions	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PLASMINOGEN-ACTIVATOR INHIBITOR-1; PLEURAL EFFUSIONS; FACTOR VEGF; INFECTION; MANAGEMENT; EMPYEMA; PLEURODESIS; GUIDELINE; TURNOVER	Objective: To investigate the relationship among angiogenic cytokines, fibrinolytic activity and effusion size in parapneumonic effusion (PPE) and their clinical importance. Methods: From January 2008 through December 2010, 26 uncomplicated (UPPE) and 38 complicated (CPPE) PPE were studied. Based on chest ultrasonography, there were non-loculated in 30, uni-loculated in 12, and multi-loculated effusions in 22 patients. The effusion size radiological scores, and effusion vascular endothelial growth factor (VEGF), interleukin (IL)-8, plasminogen activator inhibitor type-1 (PAI-1) and tissue type plasminogen activator (tPA) were measured on admission. Treatment outcome and pleural fibrosis, defined as radiological residual pleural thickening (RPT), were assessed at 6-month follow-up. Results: The effusion size and effusion VEGF, IL-8 and PAI-1/tPA ratio were significantly higher in CPPE than in UPPE, and significantly higher in multi-loculated PPE than in non-locualted and uni-loculated PPE, respectively. VEGF (cutoff value 1975 pg/ml) and IL-8 (cutoff value 1937 pg/ml) seemed best to discriminate between UPPE and CPPE. VEGF, IL-8 and effusion size correlated positively with PAI-1/tPA ratio in both UPPE and CPPE. Moreover, the level of VEGF, but not IL-8, correlated positively with effusion size in all patients (r = 0.79, p<0.001) and in UPPE (r = 0.64, p<0.001) and CPPE (r = 0.71, p<0.001) groups. The patients with higher VEGF or greater effusion were prone to have medical treatment failure (n = 10; VEGF, odds ratio 1.01, p = 0.02; effusion size, odds ratio 1.26, p = 0.01). Additionally, ten patients with RPT had larger effusion size and higher levels of VEGF and PAI-1/tPA ratio than did those without. Conclusions: In PPE, VEGF and IL-8 levels are valuable to identify CPPE, and higher VEGF level or larger effusion is associated with decreased fibrinolytic activity, development of pleural loculation and fibrosis, and higher risk of medical treatment failure.	[Chung, Chi-Li; Hsiao, Shih-Hsin] Taipei Med Univ Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan; [Chung, Chi-Li] Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei, Taiwan; [Hsiao, George; Sheu, Joen-Rong; Chen, Wei-Lin] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Hsiao, George; Sheu, Joen-Rong; Chen, Wei-Lin] Taipei Med Univ, Coll Med, Dept Pharmacol, Taipei, Taiwan; [Chang, Shi-Chuan] Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan; [Chang, Shi-Chuan] Natl Yang Ming Univ, Inst Emergency & Crit Care Med, Taipei 112, Taiwan	Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Chang, SC (corresponding author), Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan.	scchang@vghtpe.gov.tw			National Science Council of Taiwan [NSC98-2314-B-038-022-MY2]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a grant from the National Science Council of Taiwan (NSC98-2314-B-038-022-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman C, 2003, CLIN SCI, V105, P601, DOI 10.1042/CS20030115; Bithell TC, 1993, WINTROBES CLIN HEMAT, P566; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; BROADDUS VC, 1994, J IMMUNOL, V152, P2960; Cameron R, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002312.pub3; Castro DJ, 2003, EUR RESPIR J, V21, P952, DOI 10.1183/09031936.03.00099502; Cheng DS, 1999, CHEST, V116, P760, DOI 10.1378/chest.116.3.760; Chung CL, 2008, EUR RESPIR J, V31, P1261, DOI 10.1183/09031936.00122207; Chung CL, 2005, CHEST, V128, P690, DOI 10.1016/S0012-3692(15)50413-3; Colicc GL, 2000, CHEST, V118, P1158, DOI 10.1378/chest.118.4.1158; Davies CWH, 2003, THORAX, V58, pII18, DOI 10.1136/thorax.58.suppl_2.ii18; Davies CWH, 1999, AM J RESP CRIT CARE, V160, P1682, DOI 10.1164/ajrccm.160.5.9903002; Davies HE, 2010, THORAX, V65, P41, DOI 10.1136/thx.2010.137000; Economidou F, 2008, RESP MED, V102, P774, DOI 10.1016/j.rmed.2007.10.021; Ferguson AD, 1996, QJM-MON J ASSOC PHYS, V89, P285; Fukumoto T, 1998, J LEUKOCYTE BIOL, V63, P584, DOI 10.1002/jlb.63.5.584; Guo YBB, 2005, CHEST, V128, P1790, DOI 10.1378/chest.128.3.1790; Huang HC, 1999, CHEST, V115, P751, DOI 10.1378/chest.115.3.751; Idell S, 2001, AM J RESP CRIT CARE, V163, P578, DOI 10.1164/ajrccm.163.2.2005135; IDELL S, 1991, AM REV RESPIR DIS, V144, P187, DOI 10.1164/ajrccm/144.1.187; LEMENSE GP, 1995, CHEST, V107, P1532, DOI 10.1378/chest.107.6.1532; LOMAS DJ, 1993, BRIT J RADIOL, V66, P619, DOI 10.1259/0007-1285-66-787-619; Marchi E, 2012, CHEST, V141, P183, DOI 10.1378/chest.10-3181; Maskell NA, 2005, NEW ENGL J MED, V352, P865, DOI 10.1056/NEJMoa042473; Mohammed KA, 2001, AM J PHYSIOL-LUNG C, V281, pL119, DOI 10.1152/ajplung.2001.281.1.L119; Nasreen N, 1998, AM J RESP CRIT CARE, V158, P971, DOI 10.1164/ajrccm.158.3.9801097; Papaioannou AI, 2010, RESPIRATION, V80, P472, DOI 10.1159/000270913; PEPPER MS, 1991, BIOCHEM BIOPH RES CO, V181, P902, DOI 10.1016/0006-291X(91)91276-I; Rahman NM, 2011, NEW ENGL J MED, V365, P518, DOI 10.1056/NEJMoa1012740; Ribeiro SCC, 2009, RESPIROLOGY, V14, P1188, DOI 10.1111/j.1440-1843.2009.01628.x; Shetty S, 2009, TXB PLEURAL DIS, P101; Teixeira LR, 2011, LUNG CANCER, V74, P392, DOI 10.1016/j.lungcan.2011.04.015; Thickett DR, 1999, THORAX, V54, P707, DOI 10.1136/thx.54.8.707; Wu YD, 2004, AM J PHYSIOL-CELL PH, V286, pC905, DOI 10.1152/ajpcell.00200.2003	34	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53169	10.1371/journal.pone.0053169	http://dx.doi.org/10.1371/journal.pone.0053169			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308155	Green Submitted, gold, Green Published			2022-12-25	WOS:000313429100032
J	Kapoor, N; Pawar, S; Sirakova, TD; Deb, C; Warren, WL; Kolattukudy, PE				Kapoor, Nidhi; Pawar, Santosh; Sirakova, Tatiana D.; Deb, Chirajyoti; Warren, William L.; Kolattukudy, Pappachan E.			Human Granuloma In Vitro Model, for TB Dormancy and Resuscitation	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS INFECTION; NECROSIS-FACTOR-ALPHA; CHRONIC MURINE TUBERCULOSIS; LATENT TUBERCULOSIS; PULMONARY TUBERCULOSIS; IMMUNE-RESPONSE; CELLS; TNF; MICE; TRIACYLGLYCEROL	Tuberculosis (TB) is responsible for death of nearly two million people in the world annually. Upon infection, Mycobacterium tuberculosis (Mtb) causes formation of granuloma where the pathogen goes into dormant state and can live for decades before resuscitation to develop active disease when the immune system of the host is weakened and/or suppressed. In an attempt to better understand host-pathogen interactions, several groups have been developing in vitro models of human tuberculosis granuloma. However, to date, an in vitro granuloma model in which Mtb goes into dormancy and can subsequently resuscitate under conditions that mimic weakening of the immune system has not been reported. We describe the development of a biomimetic in vitro model of human tuberculosis granuloma using human primary leukocytes, in which the Mtb exhibited characteristics of dormant mycobacteria as demonstrated by (1) loss of acid-fastness, (2) accumulation of lipid bodies (3) development of rifampicin-tolerance and (4) gene expression changes. Further, when these micro granulomas were treated with immunosuppressant anti-tumor necrosis factor-alpha monoclonal antibodies (anti-TNF alpha mAbs), resuscitation of Mtb was observed as has been found in humans. In this human in vitro granuloma model triacylglycerol synthase 1deletion mutant (Delta tgs1) with impaired ability to accumulate triacylglycerides (TG), but not the complemented mutant, could not go into dormancy. Deletion mutant of lipY, with compromised ability to mobilize the stored TG, but not the complemented mutant, was unable to come out of dormancy upon treatment with anti-TNF alpha mAbs. In conclusion, we have developed an in vitro human tuberculosis granuloma model that largely exhibits functional features of dormancy and resuscitation observed in human tuberculosis.	[Kapoor, Nidhi; Sirakova, Tatiana D.; Deb, Chirajyoti; Kolattukudy, Pappachan E.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Pawar, Santosh; Warren, William L.] Sanofi Pasteur, Orlando, FL USA	State University System of Florida; University of Central Florida; Sanofi-Aventis	Kolattukudy, PE (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	pk@ucf.edu			U.S. Army, Department of Defense; National Institutes of Health [RO1A1035]; Department of Defense	U.S. Army, Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense)	This project was funded in part by the U.S. Army, Department of Defense and by grant number RO1A1035 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have declared the affiliation of Santosh Pawar and William L. Warren to Sanofi Pasteur in the online manuscript form. Dr. William Warren is employed in Sanofi Pasteur; however, this work, supported by Department of Defense with P.E. Kolattukudy as the Principal Investigator, had nothing to do with the activities of Sanofi Pasteur and there are no financial or intellectual property arrangements with Sanofi Pasteur. Dr. Pawar moved on from Sanofi Pasteur to a non-profit Cancer Research Center. Thus, no conflict of interest exists in either case. This does not alter the authors' adherence to all the PLOS ONE policies and sharing data and materials.	ADAMS LB, 1995, J INFECT DIS, V171, P400, DOI 10.1093/infdis/171.2.400; Aleman M, 2004, INFECT IMMUN, V72, P5150, DOI 10.1128/IAI.72.9.5150-5158.2004; Bean AGD, 1999, J IMMUNOL, V162, P3504; Bekker LG, 2000, INFECT IMMUN, V68, P6954, DOI 10.1128/IAI.68.12.6954-6961.2000; Bergeron A, 1997, J IMMUNOL, V159, P3034; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; Birkness KA, 2007, IMMUNOL CELL BIOL, V85, P160, DOI 10.1038/sj.icb.7100019; Botha T, 2003, J IMMUNOL, V171, P3110, DOI 10.4049/jimmunol.171.6.3110; Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003; Cardona PJ, 2000, SCAND J IMMUNOL, V52, P156, DOI 10.1046/j.1365-3083.2000.00763.x; Clark-Curtiss JE, 1998, CURR TOP MICROBIOL, V225, P57; Clay H, 2008, IMMUNITY, V29, P283, DOI 10.1016/j.immuni.2008.06.011; Daniel J, 2004, J BACTERIOL, V186, P5017, DOI 10.1128/jb.186.15.5017-5030.2004; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Deb C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006077; Dreher D, 2002, AM J RESP CRIT CARE, V165, P1577, DOI 10.1164/rccm.2204010; Ebert EC, 2009, AM J PHYSIOL-GASTR L, V296, pG612, DOI 10.1152/ajpgi.90576.2008; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Garton NJ, 2002, MICROBIOL-SGM, V148, P2951, DOI 10.1099/00221287-148-10-2951; GOLD R, 1994, LAB INVEST, V71, P219; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Heinemann DEH, 1997, SCAND J IMMUNOL, V45, P596, DOI 10.1046/j.1365-3083.1997.d01-435.x; Hernandez J, 2010, IMMUNOL INVEST, V39, P197, DOI 10.3109/08820130903586346; Keane J, 2005, RHEUMATOLOGY, V44, P714, DOI 10.1093/rheumatology/keh567; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Law K, 1996, AM J RESP CRIT CARE, V153, P799, DOI 10.1164/ajrccm.153.2.8564135; Lay G, 2007, J PATHOL, V211, P76, DOI 10.1002/path.2092; Lee J, 2009, YONSEI MED J, V50, P1, DOI 10.3349/ymj.2009.50.1.1; Lin PL, 2010, J IMMUNOL, V185, P15, DOI 10.4049/jimmunol.0903856; Lin PL, 2010, ARTHRITIS RHEUM-US, V62, P340, DOI 10.1002/art.27271; Low KL, 2009, J BACTERIOL, V191, P5037, DOI 10.1128/JB.00530-09; Marino S, 2007, PLOS COMPUT BIOL, V3, P1909, DOI 10.1371/journal.pcbi.0030194; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; Martinez ON, 2001, AM J GASTROENTEROL, V96, P1665; MCCUNE RM, 1956, J EXP MED, V104, P737, DOI 10.1084/jem.104.5.737; Mishra KC, 2008, INFECT IMMUN, V76, P127, DOI 10.1128/IAI.00410-07; Mohan AK, 2004, CLIN INFECT DIS, V39, P295, DOI 10.1086/421494; Mohan VP, 2001, INFECT IMMUN, V69, P1847, DOI 10.1128/IAI.69.3.1847-1855.2001; OZAKI T, 1992, CHEST, V102, P54, DOI 10.1378/chest.102.1.54; Parrish JZ, 2006, CHROMOSOMA, V115, P89, DOI 10.1007/s00412-005-0038-0; Perskvist N, 2002, J IMMUNOL, V168, P6358, DOI 10.4049/jimmunol.168.12.6358; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Pilheu JA, 1997, INT J TUBERC LUNG D, V1, P422; Placido R, 1997, J PATHOL, V181, P31, DOI 10.1002/(SICI)1096-9896(199701)181:1<31::AID-PATH722>3.0.CO;2-G; Plessner HL, 2007, J INFECT DIS, V195, P1643, DOI 10.1086/517519; Puissegur MP, 2007, J IMMUNOL, V178, P3161, DOI 10.4049/jimmunol.178.5.3161; Puissegur MP, 2004, CELL MICROBIOL, V6, P423, DOI 10.1111/j.1462-5822.2004.00371.x; Ramos-Vara JA, 2011, METHODS MOL BIOL, V691, P83, DOI 10.1007/978-1-60761-849-2_5; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Saunders BM, 2000, IMMUNOL CELL BIOL, V78, P334, DOI 10.1046/j.1440-1711.2000.00933.x; Saunders BM, 1999, IMMUNOLOGY, V98, P324; Seiler P, 2003, J INFECT DIS, V188, P1326, DOI 10.1086/378563; Seitzer U, 2003, CELLS TISSUES ORGANS, V174, P110, DOI 10.1159/000071151; Sirakova TD, 2006, MICROBIOL-SGM, V152, P2717, DOI 10.1099/mic.0.28993-0; Taflin C, 2009, AM J PATHOL, V174, P497, DOI 10.2353/ajpath.2009.080580; Tufariello JM, 2003, LANCET INFECT DIS, V3, P578, DOI 10.1016/S1473-3099(03)00741-2; Uppal SS, 2004, CYTOM PART B-CLIN CY, V61B, P20, DOI 10.1002/cyto.b.20018; Wallis RS, 2004, CLIN INFECT DIS, V39, P1254, DOI 10.1086/424455; Wang CZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013594; Wu YE, 2009, J INT MED RES, V37, P1742; Zahrt TC, 2003, MICROBES INFECT, V5, P159, DOI 10.1016/S1286-4579(02)00083-7; 2010, CENT EUR J PUBLIC HL, V18, P237	66	111	118	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53657	10.1371/journal.pone.0053657	http://dx.doi.org/10.1371/journal.pone.0053657			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308269	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429100102
J	Lindstrom, T; Grear, DA; Buhnerkempe, M; Webb, CT; Miller, RS; Portacci, K; Wennergren, U				Lindstrom, Tom; Grear, Daniel A.; Buhnerkempe, Michael; Webb, Colleen T.; Miller, Ryan S.; Portacci, Katie; Wennergren, Uno			A Bayesian Approach for Modeling Cattle Movements in the United States: Scaling up a Partially Observed Network	PLOS ONE			English	Article							FOOT-AND-MOUTH; GREAT-BRITAIN; LIVESTOCK MOVEMENTS; DISEASE SPREAD; DYNAMICS; SHEEP; TRANSMISSION; INVASIONS; KERNEL; HERD	Networks are rarely completely observed and prediction of unobserved edges is an important problem, especially in disease spread modeling where networks are used to represent the pattern of contacts. We focus on a partially observed cattle movement network in the U.S. and present a method for scaling up to a full network based on Bayesian inference, with the aim of informing epidemic disease spread models in the United States. The observed network is a 10% state stratified sample of Interstate Certificates of Veterinary Inspection that are required for interstate movement; describing approximately 20,000 movements from 47 of the contiguous states, with origins and destinations aggregated at the county level. We address how to scale up the 10% sample and predict unobserved intrastate movements based on observed movement distances. Edge prediction based on a distance kernel is not straightforward because the probability of movement does not always decline monotonically with distance due to underlying industry infrastructure. Hence, we propose a spatially explicit model where the probability of movement depends on distance, number of premises per county and historical imports of animals. Our model performs well in recapturing overall metrics of the observed network at the node level (U.S. counties), including degree centrality and betweenness; and performs better compared to randomized networks. Kernel generated movement networks also recapture observed global network metrics, including network size, transitivity, reciprocity, and assortativity better than randomized networks. In addition, predicted movements are similar to observed when aggregated at the state level (a broader geographic level relevant for policy) and are concentrated around states where key infrastructures, such as feedlots, are common. We conclude that the method generally performs well in predicting both coarse geographical patterns and network structure and is a promising method to generate full networks that incorporate the uncertainty of sampled and unobserved contacts.	[Lindstrom, Tom; Wennergren, Uno] Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden; [Lindstrom, Tom] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Grear, Daniel A.; Buhnerkempe, Michael; Webb, Colleen T.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Miller, Ryan S.; Portacci, Katie] US Anim & Plant Hlth Inspect Serv, USDA, Ctr Epidemiol & Anim Hlth, Ft Collins, CO USA	Linkoping University; University of Sydney; Colorado State University; United States Department of Agriculture (USDA)	Wennergren, U (corresponding author), Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden.	uno.wennergren@liu.se	Lindström, Tom/AAX-6492-2020; Lindström, Tom/E-7599-2011; Buhnerkempe, Michael G./N-2411-2019; Miller, Ryan/H-9848-2019	Lindström, Tom/0000-0001-7856-2925; Buhnerkempe, Michael G./0000-0002-5996-8927; Miller, Ryan/0000-0003-3892-0251; Grear, Daniel/0000-0002-5478-1549	Research and Policy for Infectious Disease Dynamics (RAPIDD) Program, Science and Technology Directorate, U.S. Department of Homeland Security; Fogarty International Center, National Institutes of Health; Foreign Animal Disease Modeling Program, Science and Technology Directorate, U.S. Department of Homeland Security [ST-108-000017]; USDA [11-9208-0269-CA11-1, 09-9208-0235-CA]; U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary Services; NIH	Research and Policy for Infectious Disease Dynamics (RAPIDD) Program, Science and Technology Directorate, U.S. Department of Homeland Security; Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Foreign Animal Disease Modeling Program, Science and Technology Directorate, U.S. Department of Homeland Security; USDA(United States Department of Agriculture (USDA)); U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary Services(United States Department of Agriculture (USDA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by the Research and Policy for Infectious Disease Dynamics (RAPIDD) Program, Science and Technology Directorate, U.S. Department of Homeland Security, and Fogarty International Center, National Institutes of Health; Foreign Animal Disease Modeling Program, Science and Technology Directorate, U.S. Department of Homeland Security (Grant ST-108-000017); and USDA Cooperative Agreement 11-9208-0269-CA11-1 and 09-9208-0235-CA. Data was provided by the U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary Services; however, the analyses, views and conclusions contained in this document are those of the authors and should not be interpreted as necessarily representing the regulatory opinions, official policies, either expressed or implied, of the USDA-APHIS-Veterinary Services or the U.S. Department of Homeland Security. USDA APHIS employees are co-authors on this work (RM and KP) and were involved with data collection, manuscript preparation and decision to publish. DHS and NIH funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajardi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019869; Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.2307/176541; Craft Meggan E, 2011, Interdiscip Perspect Infect Dis, V2011, P676949, DOI 10.1155/2011/676949; Edmunds WJ, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-10; Ferguson NM, 2001, NATURE, V413, P542, DOI 10.1038/35097116; Gamerman D, 2006, MARKOV CHAIN MONTE C; Gelman A., 2004, BAYESIAN DATA ANAL; Goh KI, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.017101; Guimera R, 2009, P NATL ACAD SCI USA, V106, P22073, DOI 10.1073/pnas.0908366106; Hakansson N, 2010, ADV COMPLEX SYST, V13, P239, DOI 10.1142/S0219525910002517; Kao RR, 2006, P ROY SOC B-BIOL SCI, V273, P1999, DOI 10.1098/rspb.2006.3505; Kao RR, 2007, J R SOC INTERFACE, V4, P907, DOI 10.1098/rsif.2007.1129; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; Kiss IZ, 2006, J R SOC INTERFACE, V3, P669, DOI 10.1098/rsif.2006.0129; Lindstrom T, 2008, ECOLOGY, V89, P1784, DOI 10.1890/07-1363.1; Lindstrom T, 2012, J R SOC INTERFACE, V9, P1287, DOI 10.1098/rsif.2011.0625; Lindstrom T, 2011, P ROY SOC B-BIOL SCI, V278, P1564, DOI 10.1098/rspb.2010.1902; Lindstrom T, 2011, PREV VET MED, V98, P230, DOI 10.1016/j.prevetmed.2010.11.005; Lindstrom T, 2009, PREV VET MED, V91, P85, DOI 10.1016/j.prevetmed.2009.05.022; Mitchell A, 2005, ANIM SCI, V80, P265, DOI 10.1079/ASC50020265; Ortiz-Pelaez A, 2006, PREV VET MED, V76, P40, DOI 10.1016/j.prevetmed.2006.04.007; Sanson RL, 2005, NEW ZEAL VET J, V53, P223, DOI 10.1080/00480169.2005.36550; Shields DA, 2003, LDPM10801 USDA ERS; Vernon MC, 2009, P ROY SOC B-BIOL SCI, V276, P469, DOI 10.1098/rspb.2008.1009; Webb CR, 2005, PREV VET MED, V68, P3, DOI 10.1016/j.prevetmed.2005.01.003; Woolhouse M, 2001, NATURE, V410, P515, DOI 10.1038/35069250	26	34	34	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53432	10.1371/journal.pone.0053432	http://dx.doi.org/10.1371/journal.pone.0053432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308223	Green Submitted, Green Published, gold			2022-12-25	WOS:000313670100042
J	Xie, GS; Yang, B; Xu, ZD; Li, FC; Guo, K; Zhang, ML; Wang, LQ; Zou, WH; Wang, YT; Peng, LC				Xie, Guosheng; Yang, Bo; Xu, Zhengdan; Li, Fengcheng; Guo, Kai; Zhang, Mingliang; Wang, Lingqiang; Zou, Weihua; Wang, Yanting; Peng, Liangcai			Global Identification of Multiple OsGH9 Family Members and Their Involvement in Cellulose Crystallinity Modification in Rice	PLOS ONE			English	Article							MEMBRANE-ANCHORED ENDO-1,4-BETA-GLUCANASE; SECONDARY CELL-WALL; GLYCOSYL HYDROLASES; CATALYTIC SUBUNIT; POPLAR CELLULASE; EXPRESSION ATLAS; BRASSICA-NAPUS; GENES; KORRIGAN; ENDO-1,4-BETA-D-GLUCANASE	Plant glycoside hydrolase family 9 (GH9) comprises typical endo-beta-1,4-glucanase (EGases, EC3.2.1.4). Although GH9A (KORRIGAN) family genes have been reported to be involved in cellulose biosynthesis in plants, much remains unknown about other GH9 subclasses. In this study, we observed a global gene co-expression profiling and conducted a correlation analysis between OsGH9 and OsCESA among 66 tissues covering most periods of life cycles in 2 rice varieties. Our results showed that OsGH9A3 and B5 possessed an extremely high co-expression with OsCESA1, 3, and 8 typical for cellulose biosynthesis in rice. Using two distinct rice non-GH9 mutants and wild type, we performed integrative analysis of gene expression level by qRT-PCR, cellulase activities in situ and in vitro, and lignocellulose crystallinity index (CrI) in four internodes of stem tissues. For the first time, OsGH9B1, 3, and 16 were characterized with the potential role in lignocellulose crystallinity alteration in rice, whereas OsGH9A3 and B5 were suggested for cellulose biosynthesis. In addition, phylogenetic analysis and gene co-expression comparison revealed GH9 function similarity in Arabidopsis and rice. Hence, the data can provide insights into GH9 function in plants and offer the potential strategy for genetic manipulation of plant cell wall using the five aforementioned novel OsGH9 genes.	[Xie, Guosheng; Yang, Bo; Xu, Zhengdan; Li, Fengcheng; Guo, Kai; Zhang, Mingliang; Wang, Lingqiang; Zou, Weihua; Wang, Yanting; Peng, Liangcai] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Coll Plant Sci & Technol, Biomass & Bioenergy Res Ctr,Coll Life Sci & Techn, Wuhan, Peoples R China; [Xie, Guosheng; Yang, Bo; Xu, Zhengdan; Li, Fengcheng; Guo, Kai; Zhang, Mingliang; Wang, Lingqiang; Zou, Weihua; Wang, Yanting; Peng, Liangcai] Huazhong Agr Univ, Natl Ctr Plant Gene Res Wuhan, Coll Plant Sci & Technol, Biomass & Bioenergy Res Ctr,Coll Life Sci & Techn, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Peng, LC (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Coll Plant Sci & Technol, Biomass & Bioenergy Res Ctr,Coll Life Sci & Techn, Wuhan, Peoples R China.	lpeng@mail.hzau.edu.cn			National 973 pre-project [2010CB134401]; National Transgenic Project [2009ZX08009-119B]; National 111 Project [B08032]; HZAU Changjiang Scholar Promoting Project [52204-07022]	National 973 pre-project(National Basic Research Program of China); National Transgenic Project; National 111 Project; HZAU Changjiang Scholar Promoting Project	The project was supported in part by grants from the National 973 pre-project (2010CB134401), the National Transgenic Project (2009ZX08009-119B), the National 111 Project (B08032), and HZAU Changjiang Scholar Promoting Project (52204-07022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhandari S, 2006, PLANTA, V224, P828, DOI 10.1007/s00425-006-0269-1; Bosch M, 2011, J EXP BOT, V62, P3545, DOI 10.1093/jxb/err045; Burton RA, 2000, PLANT CELL, V12, P691, DOI 10.1105/tpc.12.5.691; Chundawat SPS, 2011, J AM CHEM SOC, V133, P11163, DOI 10.1021/ja2011115; Crowell EF, 2010, CURR OPIN PLANT BIOL, V13, P700, DOI 10.1016/j.pbi.2010.07.005; Davison A, 2005, MOL BIOL EVOL, V22, P1273, DOI 10.1093/molbev/msi107; Delmer DP, 1999, ANNU REV PLANT PHYS, V50, P245, DOI 10.1146/annurev.arplant.50.1.245; Desprez T, 2002, PLANT PHYSIOL, V128, P482, DOI 10.1104/pp.010822; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Harris DM, 2012, P NATL ACAD SCI USA, V109, P4098, DOI 10.1073/pnas.1200352109; Hartati S, 2008, PLANT PHYSIOL, V147, P552, DOI 10.1104/pp.108.116970; Hayashi T, 2005, INT REV CYTOL, V247, P1, DOI 10.1016/S0074-7696(05)47001-1; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Ibatullin FM, 2009, PLANT PHYSIOL, V151, P1741, DOI 10.1104/pp.109.147439; Kaida R, 2009, MOL PLANT, V2, P904, DOI 10.1093/mp/ssp060; Karczmarek A, 2008, MOL PLANT MICROBE IN, V21, P791, DOI 10.1094/MPMI-21-6-0791; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lane DR, 2001, PLANT PHYSIOL, V126, P278, DOI 10.1104/pp.126.1.278; Libertini E, 2004, J MOL EVOL, V58, P506, DOI 10.1007/s00239-003-2571-x; Loopstra CA, 1998, PLANT PHYSIOL, V116, P959, DOI 10.1104/pp.116.3.959; Lopez-Casado G, 2008, CURR OPIN PLANT BIOL, V11, P329, DOI 10.1016/j.pbi.2008.02.010; Maloney VJ, 2010, PLANT BIOTECHNOL J, V8, P294, DOI 10.1111/j.1467-7652.2009.00483.x; Molhoj M, 2002, PLANT CELL PHYSIOL, V43, P1399, DOI 10.1093/pcp/pcf163; Molhoj M, 2001, PLANT PHYSIOL, V127, P674, DOI 10.1104/pp.010269; Molhoj M, 2001, PLANT MOL BIOL, V45, P93, DOI 10.1023/A:1006475908000; Nicol F, 1998, EMBO J, V17, P5563, DOI 10.1093/emboj/17.19.5563; Nobuta K, 2007, NAT BIOTECHNOL, V25, P473, DOI 10.1038/nbt1291; Ohmiya Y, 2000, PLANT J, V24, P147, DOI 10.1046/j.1365-313x.2000.00860.x; Park S, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-10; Park YW, 2003, PLANT J, V33, P1099, DOI 10.1046/j.1365-313X.2003.01696.x; Pear JR, 1996, P NATL ACAD SCI USA, V93, P12637, DOI 10.1073/pnas.93.22.12637; Peng LC, 2000, PLANTA, V211, P406, DOI 10.1007/s004250000301; Peng LC, 2002, SCIENCE, V295, P147, DOI 10.1126/science.1064281; Persson S, 2005, P NATL ACAD SCI USA, V102, P8633, DOI 10.1073/pnas.0503392102; Persson S, 2007, P NATL ACAD SCI USA, V104, P15566, DOI 10.1073/pnas.0706592104; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Robert S, 2005, PLANT CELL, V17, P3378, DOI 10.1105/tpc.105.036228; Ruprecht C, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00023; Scheible WR, 2001, P NATL ACAD SCI USA, V98, P10079, DOI 10.1073/pnas.191361598; Schindelman G, 2001, GENE DEV, V15, P1115, DOI 10.1101/gad.879101; Segal L., 1959, TEXT RES J, V29, P786, DOI [DOI 10.1177/004051755902901003, 10.1177/004051755902901003]; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Szyjanowicz PMJ, 2004, PLANT J, V37, P730, DOI 10.1111/j.1365-313X.2003.02000.x; Takahashi J, 2009, PLANT CELL PHYSIOL, V50, P1099, DOI 10.1093/pcp/pcp062; Tanaka K, 2003, PLANT PHYSIOL, V133, P73, DOI 10.1104/pp.103.022442; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Team RDC, 2009, R LANG ENV STAT COMP; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Urbanowicz BR, 2007, PLANT PHYSIOL, V144, P1693, DOI 10.1104/pp.107.102574; Wang L, 2010, PLANT J, V61, P752, DOI 10.1111/j.1365-313X.2009.04100.x; Wang LQ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-282; Xie GS, 2011, J INTEGR PLANT BIOL, V53, P143, DOI 10.1111/j.1744-7909.2010.01022.x; Xu N, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-58; Yoshida K, 2006, PLANT CELL PHYSIOL, V47, P1541, DOI 10.1093/pcp/pcl020; Zhang JW, 2012, MOL PLANT, V5, P176, DOI 10.1093/mp/ssr084; Zhou HL, 2006, PLANT MOL BIOL, V60, P137, DOI 10.1007/s11103-005-2972-x; Zuo JR, 2000, PLANT CELL, V12, P1137, DOI 10.1105/tpc.12.7.1137	59	47	50	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e50171	10.1371/journal.pone.0050171	http://dx.doi.org/10.1371/journal.pone.0050171			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308094	Green Published, Green Submitted, gold			2022-12-25	WOS:000313670100002
J	Wu, T; Zhang, ZH; Yuan, ZQ; Lo, LJ; Chen, J; Wang, YZ; Peng, JR				Wu, Ting; Zhang, Zhenhai; Yuan, Zhangqin; Lo, Li Jan; Chen, Jun; Wang, Yizhen; Peng, Jinrong			Distinctive Genes Determine Different Intramuscular Fat and Muscle Fiber Ratios of the longissimus dorsi Muscles in Jinhua and Landrace Pigs	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; ADIPOSE TRIGLYCERIDE LIPASE; ACID-BINDING PROTEINS; SKELETAL-MUSCLE; MEAT QUALITY; MICROARRAY ANALYSIS; LIPID-METABOLISM; CARCASS CHARACTERISTICS; LIPOPROTEIN-LIPASE; SUBCUTANEOUS ADIPOCYTES	Meat quality is determined by properties such as carcass color, tenderness and drip loss. These properties are closely associated with meat composition, which includes the types of muscle fiber and content of intramuscular fat (IMF). Muscle fibers are the main contributors to meat mass, while IMF not only contributes to the sensory properties but also to the plethora of physical, chemical and technological properties of meat. However, little is known about the molecular mechanisms that determine meat composition in different pig breeds. In this report we show that Jinhua pigs, a Chinese breed, contains much higher levels of IMF than do Landrace pigs, a Danish breed. We analyzed global gene expression profiles in the longissimus dorsi muscles in Jinhua and Landrace breeds at the ages of 30, 90 and 150 days. Cross-comparison analysis revealed that genes that regulate fatty acid biosynthesis (e.g., fatty acid synthase and stearoyl-CoA desaturase) are expressed at higher levels in Jinhua pigs whereas those that regulate myogenesis (e.g., myogenic factor 6 and forkhead box O1) are expressed at higher levels in Landrace pigs. Among those genes which are highly expressed in Jinhua pigs at 90 days (d90), we identified a novel gene porcine FLJ36031 (pFLJ), which functions as a positive regulator of fat deposition in cultured intramuscular adipocytes. In summary, our data showed that the up-regulation of fatty acid biosynthesis regulatory genes such as pFLJ and myogenesis inhibitory genes such as myostatin in the longissimus dorsi muscles of Jinhua pigs could explain why this local breed produces meat with high levels of IMF.	[Wu, Ting; Yuan, Zhangqin; Lo, Li Jan; Wang, Yizhen; Peng, Jinrong] Zhejiang Univ, Coll Anim Sci, Minist Educ, Key Lab Mol Anim Nutr, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Zhenhai] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY USA; [Chen, Jun] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Columbia University; Zhejiang University	Wang, YZ (corresponding author), Zhejiang Univ, Coll Anim Sci, Minist Educ, Key Lab Mol Anim Nutr, Hangzhou 310003, Zhejiang, Peoples R China.	yzwang@zju.edu.cn; pengjr@zju.edu.cn	Zhang, Zhenhai/GRX-5887-2022	Zhang, Zhenhai/0000-0002-4310-0525; Peng, Jinrong/0000-0002-0793-4848; wang, yizhen/0000-0002-3908-7102	Special Fund for Cultivation and Breeding of New Transgenic Organism [2009ZX08009-144B]; Fundamental Research Funds for the Central Universities	Special Fund for Cultivation and Breeding of New Transgenic Organism; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported financially by the Special Fund for Cultivation and Breeding of New Transgenic Organism (Grant No. 2009ZX08009-144B) and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao WY, 2000, J CELL BIOL, V148, P375, DOI 10.1083/jcb.148.2.375; Bai QF, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-8; Barroso E, 2011, ENDOCRINOLOGY, V152, P1848, DOI 10.1210/en.2010-1468; Bayer S, 2011, APPL MICROBIOL BIOT, V89, P91, DOI 10.1007/s00253-010-2831-9; Bernot D, 2010, J BIOL CHEM, V285, P6508, DOI 10.1074/jbc.M109.078444; CAMERON ND, 1990, MEAT SCI, V27, P227, DOI 10.1016/0309-1740(90)90053-9; Campbell WG, 2001, AM J PHYSIOL-CELL PH, V280, pC763, DOI 10.1152/ajpcell.2001.280.4.C763; Cassano M, 2011, DEVELOPMENT, V138, P4523, DOI 10.1242/dev.070706; Cesar ASM, 2010, GENET MOL RES, V9, P727, DOI 10.4238/vol9-2gmr733; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Chen HB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-64; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; Costabile G, 2011, J ENDOCRINOL INVEST, V34, pE110, DOI [10.3275/7276, 10.1007/BF03347469]; Cotter DG, 2011, J BIOL CHEM, V286, P6902, DOI 10.1074/jbc.M110.192369; Dagher G, 2003, J LIPID RES, V44, P1811, DOI 10.1194/jlr.M300267-JLR200; Dai FW, 2009, S AFR J ANIM SCI, V39, P267; Ding ST, 2000, J ANIM SCI, V78, P2127; Donkor J, 2008, J CLIN ENDOCR METAB, V93, P233, DOI 10.1210/jc.2007-1535; Duggan DJ, 1999, NAT GENET, V21, P10, DOI 10.1038/4434; Edwards LN, 2010, MEAT SCI, V86, P938, DOI 10.1016/j.meatsci.2010.07.020; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Evock-Clover CM, 2002, COMP BIOCHEM PHYS A, V133, P345, DOI 10.1016/S1095-6433(02)00113-7; Femia AP, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-194; Fenton JI, 2009, DIABETES OBES METAB, V11, P343, DOI 10.1111/j.1463-1326.2008.00974.x; Fortin A, 2005, MEAT SCI, V69, P297, DOI 10.1016/j.meatsci.2004.07.011; GarciaMacias JA, 1996, ANIM SCI, V63, P487, DOI 10.1017/S1357729800015381; Gardan D, 2007, COMP BIOCHEM PHYS B, V148, P14, DOI 10.1016/j.cbpb.2007.03.017; Gardan D, 2006, AM J PHYSIOL-ENDOC M, V291, pE372, DOI 10.1152/ajpendo.00482.2005; Gardner KL, 2006, J CELL PHYSIOL, V206, P196, DOI 10.1002/jcp.20449; Geyer CB, 2009, DEV BIOL, V330, P142, DOI 10.1016/j.ydbio.2009.03.020; Gomez-Ruiz A, 2010, J CELL PHYSIOL, V225, P206, DOI 10.1002/jcp.22241; Gray S, 2002, J BIOL CHEM, V277, P34322, DOI 10.1074/jbc.M201304200; Grizard J, 1999, EAAP PUBLIC, P177; Grove KL, 2010, INT J OBESITY, V34, P989, DOI 10.1038/ijo.2010.12; Guo J, 2011, J ANIM SCI, V89, P185, DOI 10.2527/jas.2010-2983; Guo W, 2008, ASIAN AUSTRAL J ANIM, V21, P11, DOI 10.5713/ajas.2008.60256; Hayes AJ, 2001, MATRIX BIOL, V20, P107, DOI 10.1016/S0945-053X(01)00125-1; Inuzuka H, 1999, BBA-GENE STRUCT EXPR, V1447, P199, DOI 10.1016/S0167-4781(99)00161-X; Ishimoto K, 2011, YAKUGAKU ZASSHI, V131, P1189, DOI 10.1248/yakushi.131.1189; Jiang WQ, 2000, J ENDOCRINOL, V165, P457, DOI 10.1677/joe.0.1650457; Jiang YZ, 2011, ANIMAL, V5, P1485, DOI 10.1017/S1751731111000425; Jiang YH, 2010, RES VET SCI, V89, P133, DOI 10.1016/j.rvsc.2010.01.009; Kabaeva Z, 2011, HUM MOL GENET, V20, P3346, DOI 10.1093/hmg/ddr240; Kallio P, 2009, INT J OBESITY, V33, P80, DOI 10.1038/ijo.2008.196; Kaphalia BS, 2001, J BIOCHEM MOL TOXIC, V15, P165, DOI 10.1002/jbt.14; Kaphalia BS, 1997, CHEM RES TOXICOL, V10, P211, DOI 10.1021/tx960079e; Kemp TJ, 2000, GENOMICS, V66, P229, DOI 10.1006/geno.2000.6213; Latorre MA, 2003, ANIM SCI, V77, P33, DOI 10.1017/S1357729800053625; Latorre MA, 2003, MEAT SCI, V65, P1369, DOI 10.1016/S0309-1740(03)00059-7; Lefaucheur L, 2004, J ANIM SCI, V82, P1931; Li ZC, 2010, MOL REPROD DEV, V77, P76, DOI 10.1002/mrd.21111; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez IP, 2005, MOL CELL BIOCHEM, V275, P109, DOI 10.1007/s11010-005-1082-z; Ma J, 2007, J DIABETES COMPLICAT, V21, P28, DOI 10.1016/j.jdiacomp.2006.03.002; Matsakas A, 2009, HISTOL HISTOPATHOL, V24, P611, DOI 10.14670/HH-24.611; Miao ZG, 2009, ANIMAL, V3, P468, DOI 10.1017/S1751731108003613; Miyagawa S, 2010, XENOTRANSPLANTATION, V17, P61, DOI 10.1111/j.1399-3089.2009.00565.x; Mostyn A, 2007, P NUTR SOC, V66, p57A; Naraballobh W, 2010, ARCH TIERZUCHT, V53, P230, DOI 10.5194/aab-53-230-2010; Newcom DW, 2004, J ANIM SCI, V82, P2264; Pannier L, 2010, MEAT SCI, V85, P515, DOI 10.1016/j.meatsci.2010.02.025; Pas MFWT, 2000, J ANIM SCI, V78, P69; Patruno M, 2008, DIFFERENTIATION, V76, P168, DOI 10.1111/j.1432-0436.2007.00189.x; Paturi G, 2010, FOOD RES INT, V43, P856, DOI 10.1016/j.foodres.2009.12.003; Pulawa LK, 2007, DIABETES, V56, pA340; Raj S, 2010, MEAT SCI, V86, P324, DOI 10.1016/j.meatsci.2010.04.037; Reiter SS, 2007, COMP BIOCHEM PHYS D, V2, P200, DOI 10.1016/j.cbd.2007.04.008; Rosell CM, 1996, J AGR FOOD CHEM, V44, P3453, DOI 10.1021/jf9601022; Schmitt B, 2003, PHYSIOL GENOMICS, V15, P148, DOI 10.1152/physiolgenomics.00089.2003; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Serlachius M, 2004, EXP CELL RES, V296, P256, DOI 10.1016/j.yexcr.2004.02.016; Serre C, 2010, J INVEST DERMATOL, V130, pS76; Shan T, 2009, ANIM GENET, V40, P863, DOI 10.1111/j.1365-2052.2009.01927.x; Shan TZ, 2006, J ANIM FEED SCI, V15, P621, DOI 10.22358/jafs/66931/2006; Shan TZ, 2009, J CELL BIOCHEM, V107, P984, DOI 10.1002/jcb.22203; Shen WJ, 2008, DIABETES, V57, pA390; Siders JL, 2001, AM J HUM GENET, V69, P639; Soeno Y, 1998, ZOOL SCI, V15, P217, DOI 10.2108/zsj.15.217; Soni KG, 2004, J BIOL CHEM, V279, P40683, DOI 10.1074/jbc.M400541200; Soranzo N, 2009, BLOOD, V113, P3831, DOI 10.1182/blood-2008-10-184234; Symonds ME, 2004, P NUTR SOC, V63, P397, DOI 10.1079/PNS2004366; Tsai S, 2006, ANIM GENET, V37, P423, DOI 10.1111/j.1365-2052.2006.01460.x; Van den Maagdenberg K, 2007, J ANIM SCI, V85, P952, DOI 10.2527/jas.2006-563; Verner J, 2007, J ANIM BREED GENET, V124, P81, DOI 10.1111/j.1439-0388.2007.00639.x; Wang D, 2009, POULTRY SCI, V88, P2285, DOI 10.3382/ps.2009-00190; Wang HB, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-193; Wang Q, 2007, J MOL BIOL, V367, P630, DOI 10.1016/j.jmb.2007.01.020; Wei L, 2010, J INVEST DERMATOL, V130, pS132; WOOD JD, 1987, ANIM PROD, V44, P488; Wu AL, 2008, ENDOCRINOLOGY, V149, P1407, DOI 10.1210/en.2007-1470; Yang HJ, 2010, AMINO ACIDS, V38, P1333, DOI 10.1007/s00726-009-0342-8; Yuan YA, 2011, MOL CELL BIOCHEM, V348, P77, DOI 10.1007/s11010-010-0640-1; Zhao SH, 2005, GENOMICS, V86, P618, DOI 10.1016/j.ygeno.2005.08.001; Zhao SM, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-6; Zhou GX, 2010, MEAT SCI, V86, P440, DOI 10.1016/j.meatsci.2010.05.031	95	65	69	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53181	10.1371/journal.pone.0053181	http://dx.doi.org/10.1371/journal.pone.0053181			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301040	Green Published, Green Submitted, gold			2022-12-25	WOS:000313480000037
J	Kadnikov, VV; Mardanov, AV; Podosokorskaya, OA; Gavrilov, SN; Kublanov, IV; Beletsky, AV; Bonch-Osmolovskaya, EA; Ravin, NV				Kadnikov, Vitaly V.; Mardanov, Andrey V.; Podosokorskaya, Olga A.; Gavrilov, Sergey N.; Kublanov, Ilya V.; Beletsky, Alexey V.; Bonch-Osmolovskaya, Elizaveta A.; Ravin, Nikolai V.			Genomic Analysis of Melioribacter roseus, Facultatively Anaerobic Organotrophic Bacterium Representing a Novel Deep Lineage within Bacteriodetes/Chlorobi Group	PLOS ONE			English	Article							CELLULOSE-BINDING DOMAIN; ALTERNATIVE COMPLEX-III; RHODOBACTER-CAPSULATUS; RHODOTHERMUS-MARINUS; NITROGEN-FIXATION; RIBOSOMAL-RNA; CYTOCHROME-C; PHYLOGENY; PHOTOSYNTHESIS; CLASSIFICATION	Melioribacter roseus is a moderately thermophilic facultatively anaerobic organotrophic bacterium representing a novel deep branch within Bacteriodetes/Chlorobi group. To better understand the metabolic capabilities and possible ecological functions of M. roseus and get insights into the evolutionary history of this bacterial lineage, we sequenced the genome of the type strain P3M-2(T). A total of 2838 open reading frames was predicted from its 3.30 Mb genome. The whole proteome analysis supported phylum-level classification of M. roseus since most of the predicted proteins had closest matches in Bacteriodetes, Proteobacteria, Chlorobi, Firmicutes and deeply-branching bacterium Caldithrix abyssi, rather than in one particular phylum. Consistent with the ability of the bacterium to grow on complex carbohydrates, the genome analysis revealed more than one hundred glycoside hydrolases, glycoside transferases, polysaccharide lyases and carbohydrate esterases. The reconstructed central metabolism revealed pathways enabling the fermentation of complex organic substrates, as well as their complete oxidation through aerobic and anaerobic respiration. Genes encoding the photosynthetic and nitrogen-fixation machinery of green sulfur bacteria, as well as key enzymes of autotrophic carbon fixation pathways, were not identified. The M. roseus genome supports its affiliation to a novel phylum Ignavibateriae, representing the first step on the evolutionary pathway from heterotrophic ancestors of Bacteriodetes/Chlorobi group towards anaerobic photoautotrophic Chlorobi.	[Kadnikov, Vitaly V.; Mardanov, Andrey V.; Beletsky, Alexey V.; Ravin, Nikolai V.] Russian Acad Sci, Ctr Bioengn, Moscow, Russia; [Podosokorskaya, Olga A.; Gavrilov, Sergey N.; Kublanov, Ilya V.; Bonch-Osmolovskaya, Elizaveta A.] Russian Acad Sci, Winogradsky Inst Microbiol, Moscow, Russia	Research Center of Biotechnology RAS; Russian Academy of Sciences; Research Center of Biotechnology RAS; Russian Academy of Sciences	Ravin, NV (corresponding author), Russian Acad Sci, Ctr Bioengn, Moscow, Russia.	nravin@biengi.ac.ru	Kadnikov, Vitaly V/E-2359-2014; Beletsky, Alexey/AAA-5366-2019; Mardanov, Andrey/S-2294-2016; Kadnikov, Vitaly/AAB-5305-2019; Kublanov, Ilya V/D-2976-2013; Podosokorskaya, Olga/ADN-6642-2022; Ravin, Nikolai V/C-5907-2014	Kadnikov, Vitaly V/0000-0002-3022-9784; Beletsky, Alexey/0000-0002-7611-2354; Mardanov, Andrey/0000-0002-8245-8757; Kadnikov, Vitaly/0000-0002-3022-9784; Kublanov, Ilya V/0000-0002-6845-8873; Ravin, Nikolai/0000-0002-1456-1832	Ministry of Education and Sciences of Russia [11.519.11.2029]; Program "The origin and evolution of biosphere'' of the Russian Academy of Sciences	Ministry of Education and Sciences of Russia; Program "The origin and evolution of biosphere'' of the Russian Academy of Sciences	This work was performed using the scientific equipment of Core Research Facility of Centre 'Bioengineering' RAS and supported by Ministry of Education and Sciences of Russia (contract 11.519.11.2029). The work of V.V.K., A.V.M. and N.V.R. was supported by the Program "The origin and evolution of biosphere'' of the Russian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MWW, 1990, BIOCHIM BIOPHYS ACTA, V1020, P115, DOI 10.1016/0005-2728(90)90044-5; Alexander B, 2002, ARCH MICROBIOL, V178, P131, DOI 10.1007/s00203-002-0432-4; BARRETT EL, 1987, MICROBIOL REV, V51, P192, DOI 10.1128/MMBR.51.2.192-205.1987; Basu P., 2010, MICROBE MAG, V5, P53, DOI DOI 10.1128/MICR0BE.5.53.1; Bayer EA, 2008, CHEM REC, V8, P364, DOI 10.1002/tcr.20160; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Biegel E, 2011, CELL MOL LIFE SCI, V68, P613, DOI 10.1007/s00018-010-0555-8; Biegel E, 2010, P NATL ACAD SCI USA, V107, P18138, DOI 10.1073/pnas.1010318107; Blankenship RE, 1995, ANOXYGENIC PHOTOSYNT, V2, P399, DOI DOI 10.1007/0-306-47954-0; Brun E, 2000, BIOCHEMISTRY-US, V39, P2445, DOI 10.1021/bi992079u; Bryant DA, 2006, TRENDS MICROBIOL, V14, P488, DOI 10.1016/j.tim.2006.09.001; BUCHANAN BB, 1990, PHOTOSYNTH RES, V24, P47, DOI 10.1007/BF00032643; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Crotti LB, 1998, J BASIC MICROB, V38, P181; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Ducluzeau AL, 2008, MOL BIOL EVOL, V25, P1158, DOI 10.1093/molbev/msn062; Ekici S, 2012, BBA-BIOENERGETICS, V1817, P898, DOI 10.1016/j.bbabio.2011.10.011; Garrity G.M., 2001, BERGEYS MANUAL SYSTE, P601; Gilkes NR, 1999, GENETICS BIOCH ECOLO, P24; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Gruber TM, 1998, FEMS MICROBIOL LETT, V162, P53, DOI 10.1016/S0378-1097(98)00102-5; Gupta RS, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-71; Gupta RS, 2004, CRIT REV MICROBIOL, V30, P123, DOI 10.1080/10408410490435133; Henshaw JL, 2004, J BIOL CHEM, V279, P21552, DOI 10.1074/jbc.M401620200; Huxley L, 2011, BBA-BIOENERGETICS, V1807, P85, DOI 10.1016/j.bbabio.2010.08.005; Iino T, 2010, INT J SYST EVOL MICR, V60, P1376, DOI 10.1099/ijs.0.012484-0; Jeong HS, 2000, J BACTERIOL, V182, P1208, DOI 10.1128/JB.182.5.1208-1214.2000; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; Koski LB, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-151; Krieg NR., 2010, BERGEYS MANUAL SYSTE, P25, DOI [10.1007/978-0-387-68572-4_3, DOI 10.1007/978-0-387-68572-4]; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Liu Z, 2012, ISME J IN PRESS; Liu ZF, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00185; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Miroshnichenko ML, 2003, INT J SYST EVOL MICR, V53, P323, DOI 10.1099/ijs.0.02390-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Moreira CG, 2006, J BACTERIOL, V188, P3952, DOI 10.1128/JB.00177-06; Nold SC, 1996, APPL ENVIRON MICROB, V62, P4598, DOI 10.1128/AEM.62.12.4598-4607.1996; OLSEN GJ, 1994, J BACTERIOL, V176, P1, DOI 10.1128/JB.176.1.1-6.1994; Overmann J, 2006, PROKARYOTES, V7, P359, DOI DOI 10.1007/0-387-30747-8_13; PASTER BJ, 1994, J BACTERIOL, V176, P725, DOI 10.1128/jb.176.3.725-732.1994; Pereira MM, 2007, FEBS LETT, V581, P4831, DOI 10.1016/j.febslet.2007.09.008; Perevalova AA, 2008, APPL ENVIRON MICROB, V74, P7620, DOI 10.1128/AEM.00972-08; Pitcher RS, 2002, BIOCHEM SOC T, V30, P653, DOI 10.1042/bst0300653; Podosokorskaya O, 2013, ENV MICROBI IN PRESS; Refojo PN, 2010, BBA-BIOENERGETICS, V1797, P1869, DOI 10.1016/j.bbabio.2010.04.012; Rothery RA, 2008, BBA-BIOMEMBRANES, V1778, P1897, DOI 10.1016/j.bbamem.2007.09.002; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Sazanov LA, 2007, BIOCHEMISTRY-US, V46, P2275, DOI 10.1021/bi602508x; SCHMEHL M, 1993, MOL GEN GENET, V241, P602, DOI 10.1007/BF00279903; Schut GJ, 2009, J BACTERIOL, V191, P4451, DOI 10.1128/JB.01582-08; Shipman JA, 2000, J BACTERIOL, V182, P5365, DOI 10.1128/JB.182.19.5365-5372.2000; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stelter M, 2008, BIOCHEMISTRY-US, V47, P11953, DOI 10.1021/bi800999g; Suen G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018814; Swem LR, 2001, J MOL BIOL, V309, P121, DOI 10.1006/jmbi.2001.4652; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Wahlund TM, 1997, J BACTERIOL, V179, P4859, DOI 10.1128/jb.179.15.4859-4867.1997; WAHLUND TM, 1993, J BACTERIOL, V175, P474, DOI 10.1128/JB.175.2.474-478.1993; Wilson DB, 2009, CELLULOSE, V16, P723, DOI 10.1007/s10570-009-9326-9; WILSON DB, 1992, CRIT REV BIOTECHNOL, V12, P45, DOI 10.3109/07388559209069187; WINTERHALTER C, 1995, MOL MICROBIOL, V15, P431, DOI 10.1111/j.1365-2958.1995.tb02257.x; Xie G, 2007, APPL ENVIRON MICROB, V73, P3536, DOI 10.1128/AEM.00225-07; Yanyushin MF, 2005, BIOCHEMISTRY-US, V44, P10037, DOI 10.1021/bi047267l	69	47	52	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53047	10.1371/journal.pone.0053047	http://dx.doi.org/10.1371/journal.pone.0053047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301019	Green Submitted, gold, Green Published			2022-12-25	WOS:000313320900055
J	Kang, R; Tang, D; Schapiro, NE; Loux, T; Livesey, KM; Billiar, TR; Wang, H; Van Houten, B; Lotze, MT; Zeh, HJ				Kang, R.; Tang, D.; Schapiro, N. E.; Loux, T.; Livesey, K. M.; Billiar, T. R.; Wang, H.; Van Houten, B.; Lotze, M. T.; Zeh, H. J.			The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics	ONCOGENE			English	Article						HMGB1; RAGE; pancreatic cancer; inflammation; mitochondria; ATP	ADVANCED GLYCATION ENDPRODUCTS; GROUP BOX-1 PROTEIN; RAGE; RECEPTOR; CANCER; AUTOPHAGY; MIGRATION; RELEASE; IMMUNE; SIGNAL	Tumor cells require increased adenosine triphosphate (ATP) to support anabolism and proliferation. The precise mechanisms regulating this process in tumor cells are unknown. Here, we show that the receptor for advanced glycation endproducts (RAGE) and one of its primary ligands, high-mobility group box 1 (HMGB1), are required for optimal mitochondrial function within tumors. We found that RAGE is present in the mitochondria of cultured tumor cells as well as primary tumors. RAGE and HMGB1 coordinately enhanced tumor cell mitochondrial complex I activity, ATP production, tumor cell proliferation and migration. Lack of RAGE or inhibition of HMGB1 release diminished ATP production and slowed tumor growth in vitro and in vivo. These findings link, for the first time, the HMGB1-RAGE pathway with changes in bioenergetics. Moreover, our observations provide a novel mechanism within the tumor microenvironment by which necrosis and inflammation promote tumor progression.	[Kang, R.; Tang, D.; Schapiro, N. E.; Loux, T.; Livesey, K. M.; Billiar, T. R.; Lotze, M. T.; Zeh, H. J.] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Dept Surg, Pittsburgh, PA 15219 USA; [Wang, H.] NYU, Sch Med, North Shore Univ Hosp, Manhasset, NY USA; [Van Houten, B.] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Lab Mol & Cell Biol Program, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; New York University; Northwell Health; North Shore University Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Tang, D (corresponding author), Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Dept Surg, 5117 Ctr Ave, Pittsburgh, PA 15219 USA.	tangd2@upmc.edu; lotzemt@upcm.edu; zehh@upmc.edu	Van Houten, Bennett/K-2284-2019; Tang, Daolin/B-2905-2010; Wang, Haichao/K-6310-2012; Kang, Rui/ABD-5291-2021; Wang, Haichao/AAU-2237-2021; Tang, Daolin/ABD-5062-2021	Wang, Haichao/0000-0002-0211-9000; Kang, Rui/0000-0003-2725-1574; Wang, Haichao/0000-0002-0211-9000; Tang, Daolin/0000-0002-1903-6180; Loux, Tara/0000-0002-7531-6363	National Institutes of Health [P01 CA 101944, R01CA160417]; University of Pittsburgh;  [P30CA047904]; NATIONAL CANCER INSTITUTE [R01CA160417, P30CA047904, P01CA101944] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh(University of Pittsburgh); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We dedicate this manuscript to the memory of Angelika Bierhaus, PhD, our friend and benefactor. She was a pioneering RAGE biologist, generous and kind in her dealings with colleagues, who provided us the mice with which we completed this work, and who sadly passed away on 15 April 2012 after a long and courageous battle with cancer. Angelika had a great love of life and she was generous, kind and warm hearted. She was always full of plans for scientific endeavors, even when her disease began to take its toll. She steadfastly denied that she would be defeated, recently celebrating her 50th birthday; however, she was aware that her remaining time was short. She dedicated herself to research, but despite her incredible strength, she was not able to overcome the disease, which tragically took her life. We thank Christine Heiner (University of Pittsburgh. Department of Surgery) for her critical reading of the manuscript. This project was supported by grants from the National Institutes of Health (P01 CA 101944 to MTL, R01CA160417 to DT) and the University of Pittsburgh (DT and HJZ). This project used University of Pittsburgh Cancer Institute shared resources that are supported in part by award P30CA047904. We also thank Dr Donna Stolz and Simon Watkins for providing the confocal microscopy facilities at the Center for Biologic Imaging at University of Pittsburgh School of Medicine.	Alonso M, 2004, J NEUROCHEM, V89, P248, DOI 10.1111/j.1471-4159.2004.02323.x; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Arciuch VGA, 2009, ADV DRUG DELIVER REV, V61, P1234, DOI 10.1016/j.addr.2009.04.025; Bianchi ME, 2009, J LEUKOCYTE BIOL, V86, P573, DOI 10.1189/jlb.1008585; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; DiNorcia J, 2012, J GASTROINTEST SURG, V16, P104, DOI 10.1007/s11605-011-1754-9; Galli S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007541; Gebhardt C, 2008, J EXP MED, V205, P275, DOI 10.1084/jem.20070679; Gefter JV, 2009, CELL TISSUE RES, V337, P79, DOI 10.1007/s00441-009-0791-0; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Huang J, 2012, CANCER RES, V72, P230, DOI 10.1158/0008-5472.CAN-11-2001; Hudson BI, 2008, J BIOL CHEM, V283, P34457, DOI 10.1074/jbc.M801465200; Kang R, 2010, CELL DEATH DIFFER, V17, P666, DOI 10.1038/cdd.2009.149; Kang R., 2012, P NATL ACAD SCI US; Kang R, 2012, P NATL ACAD SCI USA, V109, P7031, DOI 10.1073/pnas.1113865109; Kang R, 2011, ANTIOXID REDOX SIGN, V15, P2175, DOI 10.1089/ars.2010.3378; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Livesey KM, 2012, CANCER RES, V72, P1996, DOI 10.1158/0008-5472.CAN-11-2291; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Mantovani A, 2009, NATURE, V457, P36, DOI 10.1038/457036b; Mitola S, 2006, J IMMUNOL, V176, P12, DOI 10.4049/jimmunol.176.1.12; Orlova VV, 2007, EMBO J, V26, P1129, DOI 10.1038/sj.emboj.7601552; Pagliarini DJ, 2006, TRENDS BIOCHEM SCI, V31, P26, DOI 10.1016/j.tibs.2005.11.005; Palumbo R, 2004, J CELL BIOL, V164, P441, DOI 10.1083/jcb.200304135; Poderoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001443; Praus M, 1999, GENE THER, V6, P227, DOI 10.1038/sj.gt.3300802; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rai V, 2012, J BIOL CHEM, V287, P5133, DOI 10.1074/jbc.M111.277731; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Stumbo AC, 2008, CELL BIOL INT, V32, P235, DOI 10.1016/j.cellbi.2007.08.031; Tang D, 2010, ONCOGENE, V29, P5299, DOI 10.1038/onc.2010.261; Tang DL, 2007, J IMMUNOL, V179, P1236, DOI 10.4049/jimmunol.179.2.1236; Tang DL, 2011, CELL METAB, V13, P701, DOI 10.1016/j.cmet.2011.04.008; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Tang DL, 2010, BBA-GENE REGUL MECH, V1799, P131, DOI 10.1016/j.bbagrm.2009.11.014; Ulloa L, 2002, P NATL ACAD SCI USA, V99, P12351, DOI 10.1073/pnas.192222999; Vakkila J, 2004, NAT REV IMMUNOL, V4, P641, DOI 10.1038/nri1415; Wang SW, 2002, BIOCHEM J, V367, P729, DOI 10.1042/BJ20020752; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Zhang YS, 2012, BIOCHEM PHARMACOL, V84, P1492, DOI 10.1016/j.bcp.2012.09.015	44	159	168	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 30	2014	33	5					567	577		10.1038/onc.2012.631	http://dx.doi.org/10.1038/onc.2012.631			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AA5GW	23318458	Green Accepted			2022-12-25	WOS:000331125100005
J	Little, JL; Serzhanova, V; Izumchenko, E; Egleston, BL; Parise, E; Klein-Szanto, AJ; Loudon, G; Shubina, M; Seo, S; Kurokawa, M; Ochs, MF; Golemis, EA				Little, J. L.; Serzhanova, V.; Izumchenko, E.; Egleston, B. L.; Parise, E.; Klein-Szanto, A. J.; Loudon, G.; Shubina, M.; Seo, S.; Kurokawa, M.; Ochs, M. F.; Golemis, E. A.			A requirement for Nedd9 in luminal progenitor cells prior to mammary tumorigenesis in MMTV-HER2/ErbB2 mice	ONCOGENE			English	Article						breast cancer; HER2; mammary precursor cells; drug resistance	FOCAL ADHESION KINASE; EPITHELIAL-SPECIFIC DISRUPTION; SUBSTRATE LYMPHOCYTE TYPE; DOCKING PROTEIN HEF1; HUMAN-BREAST; TRANSCRIPTOME ANALYSES; ANTIGEN RECEPTOR; CANCER; MOUSE; INTEGRIN	Overexpression of the NEDD9/HEF1/Cas-L scaffolding protein is frequent, and drives invasion and metastasis in breast, head and neck, colorectal, melanoma, lung and other types of cancer. We have examined the consequences of genetic ablation of Nedd9 in the MMTV-HER2/ERBB2/neu mouse mammary tumor model. Unexpectedly, we found that only a limited effect on metastasis in MMTV-neu;Nedd9(-/-) mice compared with MMTV-neu;Nedd9(-/-) mice, but instead a dramatic reduction in tumor incidence (18 versus 80%), and a significantly increased latency until tumor appearance. Orthotopic reinjection and tail-vein injection of cells arising from tumors, coupled with in vivo analysis, indicated tumors arising in MMTV-neu;Nedd9(-/-) mice had undergone mutational selection that overcame the initial requirement for Nedd9. To better understand the defects in early tumor growth, we compared mammary progenitor cell pools from MMTV-neu;Nedd9(-/-) versus MMTV-neu;Nedd9(-/-) mice. The MMTV-neu;Nedd9(-/-) genotype selectively reduced both the number and colony-forming potential of mammary luminal epithelial progenitor cells, while not affecting basal epithelial progenitors. MMTV-neu;Nedd9(-/-) mammospheres had striking defects in morphology and cell polarity. All of these defects were seen predominantly in the context of the HER2/neu oncogene, and were not associated with randomization of the plane of mitotic division, but rather with depressed expression the cell attachment protein FAK, accompanied by increased sensitivity to small molecule inhibitors of FAK and SRC. Surprisingly, in spite of these significant differences, only minimal changes were observed in the gene expression profile of Nedd9(-/-) mice, indicating critical Nedd9-dependent differences in cell growth properties were mediated via post-transcriptional regulation of cell signaling. Coupled with emerging data indicating a role for NEDD9 in progenitor cell populations during the morphogenesis of other tissues, these results indicate a functional requirement for NEDD9 in the growth of mammary cancer progenitor cells.	[Little, J. L.; Serzhanova, V.; Izumchenko, E.; Egleston, B. L.; Klein-Szanto, A. J.; Shubina, M.; Golemis, E. A.] Fox Chase Canc Ctr, Inst Canc Res, Philadelphia, PA 19111 USA; [Parise, E.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Little, J. L.; Loudon, G.] Bryn Mawr Coll, Dept Biol, Bryn Mawr, PA 19010 USA; [Seo, S.; Kurokawa, M.] Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Tokyo, Japan; [Ochs, M. F.] Johns Hopkins Univ, Dept Oncol Informat, Baltimore, MD USA; [Ochs, M. F.] Johns Hopkins Univ, Dept Hlth Sci Informat, Baltimore, MD USA	Fox Chase Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Bryn Mawr College; University of Tokyo; Johns Hopkins University; Johns Hopkins University	Golemis, EA (corresponding author), Fox Chase Canc Ctr, Inst Canc Res, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	EA_Golemis@fccc.edu	Little, Joy/K-1463-2015; Little, Joy/AAY-4795-2021; Egleston, Brian L./P-1000-2019	Egleston, Brian L./0000-0002-1633-799X; Golemis, Erica/0000-0003-3618-3673	Pennsylvania Tobacco Settlement funding; NIH [CA06927, T32 CA009035, F32 CA150553]; Pew Charitable Fund; American Associates, Ben-Gurion University of the Negev; Fox Chase Cancer Center Undergraduate Student Summer Fellowship Program;  [R01s CA63366];  [CA113342];  [U54 CA149147];  [R21 LM009382]; NATIONAL CANCER INSTITUTE [P30CA006927, R01CA063366, U54CA149147, T32CA009035, R01CA113342, R29CA063366, F32CA150553] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R21LM009382] Funding Source: NIH RePORTER	Pennsylvania Tobacco Settlement funding; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable Fund; American Associates, Ben-Gurion University of the Negev; Fox Chase Cancer Center Undergraduate Student Summer Fellowship Program; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We are grateful to Emmanuelle Nicolas (Genotyping and Real-Time-PCR Facility of FCCC), Jianming Pei (Cytogenetics and Chromosome Microarray Analysis Facility of FCCC) and Yue-Sheng Liu (Expression Microarray Facility of FCCC), Anthony Lerro and Jackie Valvardi (Laboratory Animal Facility of FCCC), James Oesterling (Cell Sorting Facility of FCCC), Jin Fang (Cell Culture Facility of FCCC), Catherine Renner (Histopathology Facility), Marina Boushra (from Cornell University), Christiaan Honig (from Germantown Academy) and Nicolas G Day (from St John's College) for technical help. We particularly acknowledge Edna Cukierman for expert advice with analysis of microscopic images. R01s CA63366 and CA113342, a U54 CA149147 subcontract, and Pennsylvania Tobacco Settlement funding (to EAG); and NIH core Grant CA06927 and the Pew Charitable Fund (to Fox Chase Cancer Center) supported this work. JLL was supported by NIH T32 CA009035 and F32 CA150553; EI by the American Associates, Ben-Gurion University of the Negev; EP by the Fox Chase Cancer Center Undergraduate Student Summer Fellowship Program. MFO was supported by R21 LM009382.	Aquino JB, 2009, NEUROSCIENCE, V162, P1106, DOI 10.1016/j.neuroscience.2009.05.035; Astier A, 1997, LEUKEMIA LYMPHOMA, V28, P65, DOI 10.3109/10428199709058332; Astier A, 1997, J BIOL CHEM, V272, P19719, DOI 10.1074/jbc.272.32.19719; Astsaturov I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001083; Baselga J, 2010, ANN ONCOL, V21, P36, DOI 10.1093/annonc/mdq421; Castello-Cros R, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-94; Dadke D, 2006, MOL BIOL CELL, V17, P1204, DOI 10.1091/mbc.E05-03-0237; Dankort DL, 2000, ONCOGENE, V19, P1038, DOI 10.1038/sj.onc.1203272; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dilworth SM, 2002, NAT REV CANCER, V2, P951, DOI 10.1038/nrc946; Fashena SJ, 2002, J CELL SCI, V115, P99; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hao Y, 2010, CURR BIOL, V20, P1809, DOI 10.1016/j.cub.2010.09.032; Izumchenko E, 2009, CANCER RES, V69, P7198, DOI 10.1158/0008-5472.CAN-09-0795; Keller PJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2755; Kong CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022666; Lahlou H, 2007, P NATL ACAD SCI USA, V104, P20302, DOI 10.1073/pnas.0710091104; Law SF, 1996, MOL CELL BIOL, V16, P3327; Law SF, 2000, MOL CELL BIOL, V20, P5184, DOI 10.1128/MCB.20.14.5184-5195.2000; Li BL, 1997, MOL CELL BIOL, V17, P3155, DOI 10.1128/MCB.17.6.3155; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Lifsted T, 1998, INT J CANCER, V77, P640, DOI 10.1002/(SICI)1097-0215(19980812)77:4<640::AID-IJC26>3.0.CO;2-8; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Lo PK, 2012, ONCOGENE, V31, P2614, DOI [10.1038/onc.2011.439, 10.1038/onc.2012.147]; Luo M, 2009, CANCER RES, V69, P466, DOI 10.1158/0008-5472.CAN-08-3078; Manie SN, 1997, J BIOL CHEM, V272, P4230, DOI 10.1074/jbc.272.7.4230; Minegishi M, 1996, J EXP MED, V184, P1365, DOI 10.1084/jem.184.4.1365; Moasser MM, 2007, ONCOGENE, V26, P6469, DOI 10.1038/sj.onc.1210477; Nagashima Takeshi, 2008, Cancer Genomics & Proteomics, V5, P161; O'Neill GM, 2007, CANCER RES, V67, P8975, DOI 10.1158/0008-5472.CAN-07-1328; O'Neill GM, 2001, MOL CELL BIOL, V21, P5094, DOI 10.1128/MCB.21.15.5094-5108.2001; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pontier SM, 2009, J CELL SCI, V122, P207, DOI 10.1242/jcs.040394; Provenzano PP, 2008, AM J PATHOL, V173, P1551, DOI 10.2353/ajpath.2008.080308; Pugacheva EN, 2005, NAT CELL BIOL, V7, P937, DOI 10.1038/ncb1309; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Seo S, 2005, J IMMUNOL, V175, P3492, DOI 10.4049/jimmunol.175.6.3492; Seo S, 2011, CANCER SCI, V102, P2109, DOI 10.1111/j.1349-7006.2011.02066.x; Shults J, 2007, STATA J, V7, P147, DOI 10.1177/1536867X0700700201; Singh MK, 2010, CANCER RES, V70, P8907, DOI 10.1158/0008-5472.CAN-10-0353; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Stingl John, 2005, Methods Mol Biol, V290, P249; Tikhmyanova N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022102; Tikhmyanova N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012369; Tikhmyanova N, 2010, CELL MOL LIFE SCI, V67, P1025, DOI 10.1007/s00018-009-0213-1; Tondeur S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008990; Vaillant F, 2007, STEM CELL REV, V3, P114, DOI 10.1007/s12015-007-0018-2; van Miltenburg MHAM, 2009, FASEB J, V23, P3482, DOI 10.1096/fj.08-123398; van Seventer GA, 2001, EUR J IMMUNOL, V31, P1417, DOI 10.1002/1521-4141(200105)31:5<1417::AID-IMMU1417>3.0.CO;2-C; Vogel T, 2010, CEREB CORTEX, V20, P661, DOI 10.1093/cercor/bhp134; Worthington J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-490	56	18	18	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 23	2014	33	4					411	420		10.1038/onc.2012.607	http://dx.doi.org/10.1038/onc.2012.607			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	296VX	23318423	Green Accepted			2022-12-25	WOS:000330214600002
J	Teoh-Fitzgerald, ML; Fitzgerald, MP; Zhong, W; Askeland, RW; Domann, FE				Teoh-Fitzgerald, M. L.; Fitzgerald, M. P.; Zhong, W.; Askeland, R. W.; Domann, F. E.			Epigenetic reprogramming governs EcSOD expression during human mammary epithelial cell differentiation, tumorigenesis and metastasis	ONCOGENE			English	Article						three-dimensional culture; DNA methylation; experimental lung metastasis; spontaneous metastasis; acinar morphogenesis; laminin-enriched extracellular matrix	EXTRACELLULAR-SUPEROXIDE-DISMUTASE; GENE-EXPRESSION; MATRIX COMPONENTS; DNA METHYLATION; BINDING-SITE; CANCER; GROWTH; INACTIVATION; OVEREXPRESSION; IDENTIFICATION	Expression of the antioxidant enzyme EcSOD in normal human mammary epithelial cells was not recognized until recently. Although expression of EcSOD was not detectable in non-malignant human mammary epithelial cells (HMEC) cultured in conventional two-dimensional (2D) culture conditions, EcSOD protein expression was observed in normal human breast tissues, suggesting that the 2D-cultured condition induces a repressive status of EcSOD gene expression in HMEC. With the use of laminin-enriched extracellular matrix (IrECM), we were able to detect expression of EcSOD when HMEC formed polarized acinar structures in a 3D-culture condition. Repression of the EcSOD-gene expression was again seen when the HMEC acini were sub-cultured as a monolayer, implying that IrECM-induced acinar morphogenesis is essential in EcSOD-gene activation. We have further shown the involvement of DNA methylation in regulating EcSOD expression in HMEC under these cell culture conditions. EcSOD mRNA expression was strongly induced in the 2D-cultured HMEC after treatment with a DNA methyltransferase inhibitor. In addition, epigenetic analyses showed a decrease in the degree of CpG methylation in the EcSOD promoter in the 3D versus 2D-cultured HMEC. More importantly, > 80% of clinical mammary adenocarcinoma samples showed significantly decreased EcSOD mRNA and protein expression levels compared with normal mammary tissues and there is an inverse correlation between the expression levels of EcSOD and the clinical stages of breast cancer. Combined bisulfite restriction analysis analysis of some of the tumors also revealed an association of DNA methylation with the loss of EcSOD expression in vivo. Furthermore, overexpression of EcSOD inhibited breast cancer metastasis in both the experimental lung metastasis model and the syngeneic mouse model. This study suggests that epigenetic silencing of EcSOD may contribute to mammary tumorigenesis and that restoring the extracellular superoxide scavenging activity could be an effective strategy for breast cancer treatment.	[Teoh-Fitzgerald, M. L.; Fitzgerald, M. P.; Domann, F. E.] Univ Iowa, Dept Radiat Oncol, Free Rad & Radiat Biol Program, Iowa City, IA USA; [Zhong, W.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA; [Askeland, R. W.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA	University of Iowa; University of Wisconsin System; University of Wisconsin Madison; University of Iowa	Teoh-Fitzgerald, ML (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	m.teohfitzgerald@unmc.edu; frederick-domann@uiowa.edu		Domann, Frederick/0000-0002-0489-2179	NIH [R01 CA073612, R01 CA115438]; Susan G Komen for the Cure [KG080437]; SFRBM Research Mini-Fellowship; Oberley Seed Grant; Carver Research Program of Excellence in Redox Biology and Medicine; Holden Comprehensive Cancer Center Breast Cancer Research Fund; NATIONAL CANCER INSTITUTE [P30CA086862, R01CA115438, R01CA073612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G Komen for the Cure(Susan G. Komen Breast Cancer Foundation); SFRBM Research Mini-Fellowship; Oberley Seed Grant; Carver Research Program of Excellence in Redox Biology and Medicine; Holden Comprehensive Cancer Center Breast Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Dr James Crapo (National Jewish Medical and Research Center, Denver, CO, USA) for providing antibodies to EcSOD and Dr Michael Henry (Department of Molecular Physiology and Biophysics, University of Iowa, IA, USA) for providing the 4T1 luc cells. We also thank Justin Fishbaugh from the Flow Cytometry Core Facility for assisting with the DCFH assays as well as the Central Microscopy Research Facility. This study was supported by NIH grant R01 CA073612 and R01 CA115438 (FE Domann), Susan G Komen for the Cure grant KG080437 (M Teoh-Fitzgerald), SFRBM Research Mini-Fellowship (M Teoh-Fitzgerald), Oberley Seed Grant (M Teoh-Fitzgerald), and Carver Research Program of Excellence in Redox Biology and Medicine, and by the Holden Comprehensive Cancer Center Breast Cancer Research Fund.	ADACHI T, 1992, ARCH BIOCHEM BIOPHYS, V297, P155, DOI 10.1016/0003-9861(92)90654-F; Behrend L, 2003, BIOCHEM SOC T, V31, P1441; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BLASCHKE RJ, 1994, METHOD ENZYMOL, V245, P535; Case AJ, 2011, FREE RADICAL BIO MED, V50, P448, DOI 10.1016/j.freeradbiomed.2010.11.025; CHEN LH, 1989, CELL REGUL, V1, P45, DOI 10.1091/mbc.1.1.45; Drake JM, 2005, CLIN EXP METASTAS, V22, P674, DOI 10.1007/s10585-006-9011-4; Edovitsky E, 2004, JNCI-J NATL CANCER I, V96, P1219, DOI 10.1093/jnci/djh230; Garbe JC, 2007, CELL CYCLE, V6, P1927, DOI 10.4161/cc.6.15.4519; Gius D, 2006, ANTIOXID REDOX SIGN, V8, P1249, DOI 10.1089/ars.2006.8.1249; Henrotin Y, 2009, ADV CLIN CHEM, V49, P31, DOI 10.1016/S0065-2423(09)49002-4; Hewetson A, 2002, MOL ENDOCRINOL, V16, P2101, DOI 10.1210/me.2002-0064; HICKS CL, 1979, J DAIRY SCI, V62, P529, DOI 10.3168/jds.S0022-0302(79)83285-3; HICKS CL, 1980, J DAIRY SCI, V63, P1199, DOI 10.3168/jds.S0022-0302(80)83065-7; Jolivet G, 2005, J CELL BIOCHEM, V95, P313, DOI 10.1002/jcb.20397; Jones PA, 2002, ONCOGENE, V21, P5358, DOI 10.1038/sj.onc.1205597; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Laukkanen MO, 1999, ARTERIOSCL THROM VAS, V19, P2171, DOI 10.1161/01.ATV.19.9.2171; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Li YZ, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-7; MARKLUND SL, 1984, J CLIN INVEST, V74, P1398, DOI 10.1172/JCI111550; Novak P, 2009, CANCER RES, V69, P5251, DOI 10.1158/0008-5472.CAN-08-4977; Oberley LW, 2005, BIOMED PHARMACOTHER, V59, P143, DOI 10.1016/j.biopha.2005.03.006; OBERLEY LW, 1979, CANCER RES, V39, P1141; OBERLEY LW, 1981, MED HYPOTHESES, V7, P21, DOI 10.1016/0306-9877(81)90018-9; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Raats CJI, 1997, J BIOL CHEM, V272, P26734, DOI 10.1074/jbc.272.42.26734; Rose SL, 2006, GYNECOL ONCOL, V102, P319, DOI 10.1016/j.ygyno.2005.12.025; Shan WH, 2010, FREE RADICAL BIO MED, V49, P2078, DOI 10.1016/j.freeradbiomed.2010.10.691; Svensson RU, 2007, CANCER RES, V67, P10445, DOI 10.1158/0008-5472.CAN-07-1955; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tang XY, 2011, J BIOL CHEM, V286, P13244, DOI 10.1074/jbc.M110.206615; Teodoridis JM, 2004, DRUG RESIST UPDATE, V7, P267, DOI 10.1016/j.drup.2004.06.005; Teoh ML, 2007, CLIN CANCER RES, V13, P7441, DOI 10.1158/1078-0432.CCR-07-0851; Teoh MLT, 2009, CANCER RES, V69, P6355, DOI 10.1158/0008-5472.CAN-09-1195; Teoh-Fitzgerald MLT, 2012, MOL CANCER RES, V10, P40, DOI 10.1158/1541-7786.MCR-11-0501; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; VUKICEVIC S, 1992, EXP CELL RES, V202, P1, DOI 10.1016/0014-4827(92)90397-Q; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Xu R, 2007, J BIOL CHEM, V282, P14992, DOI 10.1074/jbc.M610316200	41	58	62	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 16	2014	33	3					358	368		10.1038/onc.2012.582	http://dx.doi.org/10.1038/onc.2012.582			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	296VR	23318435	Green Accepted			2022-12-25	WOS:000330214000010
J	Wu, J; Patmore, DM; Jousma, E; Eaves, DW; Breving, K; Patel, AV; Schwartz, EB; Fuchs, JR; Cripe, TP; Stemmer-Rachamimov, AO; Ratner, N				Wu, J.; Patmore, D. M.; Jousma, E.; Eaves, D. W.; Breving, K.; Patel, A. V.; Schwartz, E. B.; Fuchs, J. R.; Cripe, T. P.; Stemmer-Rachamimov, A. O.; Ratner, N.			EGFR-STAT3 signaling promotes formation of malignant peripheral nerve sheath tumors	ONCOGENE			English	Article						EGFR; STAT3; sarcoma; MPNST; NF1	GROWTH-FACTOR RECEPTOR; NEUROFIBROMATOSIS TYPE-1; SELF-RENEWAL; MOUSE MODELS; CANCER-CELLS; NF1; TRANSCRIPTION-3; TRANSDUCER; ACTIVATOR; PATHWAY	Malignant peripheral nerve sheath tumors (MPNSTs) develop sporadically or in the context of neurofibromatosis type 1. Epidermal growth factor receptor (EGFR) overexpression has been implicated in MPNST formation, but its precise role and relevant signaling pathways remain unknown. We found that EGFR overexpression promotes mouse neurofibroma transformation to aggressive MPNST (GEM-PNST). Immunohistochemistry demonstrated phosphorylated STAT3 (Tyr705) in both human MPNST and mouse GEM-PNST. A specific JAK2/STAT3 inhibitor FLLL32 delayed MPNST formation in an MPNST xenograft nude mouse model. STAT3 knockdown by shRNA prevented MPNST formation in vivo. Finally, reducing EGFR activity strongly reduced pSTAT3 in vivo. Thus, an EGFR-STAT3 pathway is necessary for MPNST transformation and establishment of MPNST xenografts growth but not for tumor maintenance. Efficacy of the FLLL32 pharmacological inhibitor in delaying MPNST growth suggests that combination therapies targeting JAK/STAT3 might be useful therapeutics.	[Wu, J.; Patmore, D. M.; Jousma, E.; Eaves, D. W.; Breving, K.; Patel, A. V.; Cripe, T. P.; Ratner, N.] Cincinnati Childrens Hosp Med Ctr, Cincinnati Childrens Hosp Res Fdn, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA; [Schwartz, E. B.; Fuchs, J. R.] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA; [Stemmer-Rachamimov, A. O.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Stemmer-Rachamimov, A. O.] Harvard Univ, Sch Med, Boston, MA USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; Ohio State University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Ratner, N (corresponding author), Cincinnati Childrens Hosp, Dept Pediat, Div Exp Hematol & Canc Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	nancy.ratner@cchmc.org		Fuchs, James/0000-0002-8743-6389; RATNER, NANCY/0000-0001-5030-9354	National Institutes of Health [R01 NS28840, P50 NS057531]; Department of Defense New Investigator Award [NF100053]; Ohio State University Comprehensive Cancer Center Pelotonia Idea Grant; American Cancer Society [IRG-67-003-44]; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS057531, R01NS028840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense New Investigator Award(United States Department of Defense); Ohio State University Comprehensive Cancer Center Pelotonia Idea Grant; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr Andre Bernards (Massachusetts General Hospital) and Drs Jiayuh Lin, Pui-Kai Li and Gregory B Lesinski (Ohio State University) for helpful discussions. This work was supported by the National Institutes of Health (R01 NS28840 and P50 NS057531 to NR), and Department of Defense New Investigator Award (NF100053) and an Ohio State University Comprehensive Cancer Center Pelotonia Idea Grant (to JW). The American Cancer Society (IRG-67-003-44) supported JRF.	Banerjee S, 2010, CANCER RES, V70, P1356, DOI 10.1158/0008-5472.CAN-09-2178; Battle T. E., 2002, Current Molecular Medicine (Hilversum), V2, P381, DOI 10.2174/1566524023362456; Beert E, 2011, GENE CHROMOSOME CANC, V50, P1021, DOI 10.1002/gcc.20921; Carroll SL, 2008, GLIA, V56, P1590, DOI 10.1002/glia.20776; Cichowski K, 1999, SCIENCE, V286, P2172, DOI 10.1126/science.286.5447.2172; DeClue JE, 2000, J CLIN INVEST, V105, P1233, DOI 10.1172/JCI7610; Evans DGR, 2002, J MED GENET, V39, P311, DOI 10.1136/jmg.39.5.311; Ferner RE, 2002, CANCER RES, V62, P1573; Ferner RE, 2007, EUR J HUM GENET, V15, P131, DOI 10.1038/sj.ejhg.5201676; Frahm S, 2004, NEUROBIOL DIS, V16, P85, DOI 10.1016/j.nbd.2004.01.006; Frohnert PW, 2003, GLIA, V43, P104, DOI 10.1002/glia.10232; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Guryanova OA, 2011, CANCER CELL, V19, P498, DOI 10.1016/j.ccr.2011.03.004; Joseph NM, 2008, CANCER CELL, V13, P129, DOI 10.1016/j.ccr.2008.01.003; Katz D, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001227; Keizman D, 2009, J NEURO-ONCOL, V94, P383, DOI 10.1007/s11060-009-9862-z; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Li HZ, 2002, CANCER RES, V62, P4507; Lin L, 2010, CANCER RES, V70, P2445, DOI 10.1158/0008-5472.CAN-09-2468; Ling BC, 2005, CANCER CELL, V7, P65, DOI 10.1016/j.ccr.2004.10.016; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; LUETTEKE NC, 1994, GENE DEV, V8, P399, DOI 10.1101/gad.8.4.399; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Miller SJ, 2009, EMBO MOL MED, V1, P236, DOI 10.1002/emmm.200900027; Miller SJ, 2006, CANCER RES, V66, P2584, DOI 10.1158/0008-5472.CAN-05-3330; Perry A, 2002, J NEUROPATH EXP NEUR, V61, P702, DOI 10.1093/jnen/61.8.702; Reilly KM, 2006, CANCER RES, V66, P62, DOI 10.1158/0008-5472.CAN-05-1480; Reilly KM, 2004, P NATL ACAD SCI USA, V101, P13008, DOI 10.1073/pnas.0401236101; Rosenbaum T, 2000, J NEUROSCI RES, V61, P524, DOI 10.1002/1097-4547(20000901)61:5<524::AID-JNR7>3.3.CO;2-Q; Shao H, 2003, CANCER RES, V63, P3923; Sherry MM, 2009, STEM CELLS, V27, P2383, DOI 10.1002/stem.185; Stemmer-Rachamimov AO, 2004, CANCER RES, V64, P3718, DOI 10.1158/0008-5472.CAN-03-4079; Sun Daochun, 2012, Transl Oncogenomics, V5, P1, DOI 10.4137/TOG.S8830; Torres KE, 2011, CLIN CANCER RES, V17, P3943, DOI 10.1158/1078-0432.CCR-11-0193; Tucker T, 2005, NEUROLOGY, V65, P205, DOI 10.1212/01.wnl.0000168830.79997.13; Vigneron A, 2008, CANCER RES, V68, P815, DOI 10.1158/0008-5472.CAN-07-5115; Vogel KS, 1999, SCIENCE, V286, P2176, DOI 10.1126/science.286.5447.2176; Walrath JC, 2009, MAMM GENOME, V20, P214, DOI 10.1007/s00335-009-9179-4; Widemann BC, 2009, CURR ONCOL REP, V11, P322, DOI 10.1007/s11912-009-0045-z; Wu JQ, 2008, CANCER CELL, V13, P105, DOI 10.1016/j.ccr.2007.12.027; Yarden Y, 2001, EUR J CANCER, V37, pS3; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	42	63	68	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 9	2014	33	2					173	180		10.1038/onc.2012.579	http://dx.doi.org/10.1038/onc.2012.579			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	286BY	23318430	Green Accepted			2022-12-25	WOS:000329440700005
J	Thompson, KE; Korbmacher, JP; Hecht, E; Hobi, N; Wittekindt, OH; Dietl, P; Kranz, C; Frick, M				Thompson, Kristin E.; Korbmacher, Jonas P.; Hecht, Elena; Hobi, Nina; Wittekindt, Oliver H.; Dietl, Paul; Kranz, Christine; Frick, Manfred			Fusion-activated cation entry (FACE) via P2X(4) couples surfactant secretion and alveolar fluid transport	FASEB JOURNAL			English	Article						exocytosis; ATII cell; lamellar body; transepithelial ion transport; purinergic	CELLS IN-VITRO; AIR-LIQUID INTERFACE; II CELLS; EPITHELIAL-CELLS; RECEPTOR CHANNELS; RECENT PROGRESS; LUNG FUNCTIONS; ION-TRANSPORT; BALB/C MICE; EXOCYTOSIS	Two fundamental mechanisms within alveoli are essential for lung function: regulated fluid transport and secretion of surfactant. Surfactant is secreted via exocytosis of lamellar bodies (LBs) in alveolar type II (ATII) cells. We recently reported that LB exocytosis results in fusion-activated cation entry (FACE) via P2X(4) receptors on LBs. We propose that FACE, in addition to facilitating surfactant secretion, modulates alveolar fluid transport. Correlative fluorescence and atomic force microscopy revealed that FACE-dependent water influx correlated with individual fusion events in rat primary ATII cells. Moreover, ATII cell monolayers grown at air-liquid interface exhibited increases in short-circuit current (I-sc) on stimulation with ATP or UTP. Both are potent agonists for LB exocytosis, but only ATP activates FACE. ATP, not UTP, elicited additional fusion-dependent increases in Isc. Overexpressing dominant-negative P2X(4) abrogated this effect by similar to 50%, whereas potentiating P2X(4) lead to similar to 80% increase in I-sc. Finally, we monitored changes in alveolar surface liquid (ASL) on ATII monolayers by confocal microscopy. Only stimulation with ATP, not UTP, led to a significant, fusion-dependent, 20% decrease in ASL, indicating apical-to-basolateral fluid transport across ATII monolayers. Our data support the first direct link between LB exocytosis, regulation of surfactant secretion, and transalveolar fluid resorption via FACE.-Thompson, K. E., Korbmacher, J. P., Hecht, E., Hobi, N., Wittekindt, O. H., Dietl, P., Kranz, C., Frick, M. Fusion-activated cation entry (FACE) via P2X(4) couples surfactant secretion and alveolar fluid transport. FASEB J. 27, 1772-1783 (2013). www.fasebj.org	[Thompson, Kristin E.; Korbmacher, Jonas P.; Hecht, Elena; Hobi, Nina; Wittekindt, Oliver H.; Dietl, Paul; Frick, Manfred] Univ Ulm, Inst Gen Physiol, D-89081 Ulm, Germany; [Kranz, Christine] Univ Ulm, Inst Analyt & Bioanalyt Chem, D-89081 Ulm, Germany	Ulm University; Ulm University	Frick, M (corresponding author), Univ Ulm, Inst Gen Physiol, Albert Einstein Allee 11, D-89081 Ulm, Germany.	manfred.frick@uni-ulm.de	Kranz, Christine/F-3838-2014; Frick, Manfred/E-1374-2012	Kranz, Christine/0000-0002-6001-0580; Frick, Manfred/0000-0002-4763-1104; Korbmacher, Jonas/0000-0002-0454-8407	Deutsche Forschungsgemeinschaft (DFG) [D-1402/1-1, D-1422/3-1]; BiU grant [D.5006]; Landesstiftung Baden-Wurtemberg grant [P-LS-Biomat/03]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); BiU grant; Landesstiftung Baden-Wurtemberg grant	The authors thank M. Timmler and T. Felder for technical assistance, in particular for primary alveolar type II cell isolation; and S. Britsch and C. Wiegreffe for access to and support for the Leica SP5 confocal microscope. The authors are especially grateful to F. Wagner and P. Radermacher for their help with the in situ compliance measurements. The authors declare no conflicts of interest. This work was supported by Deutsche Forschungsgemeinschaft (DFG) grants D-1402/1-1 and D-1422/3-1, BiU grant D.5006, and Landesstiftung Baden-Wurtemberg grant P-LS-Biomat/03. K. T. and M. F. designed the study; K. T., J. K., E. H., N. H., O. H. W., and M. F. performed experiments and analyzed data; all authors wrote the manuscript.	Altamirano J, 1998, J GEN PHYSIOL, V112, P145, DOI 10.1085/jgp.112.2.145; Ameen NA, 2003, AM J PHYSIOL-CELL PH, V284, pC429, DOI 10.1152/ajpcell.00261.2002; BASTACKY J, 1995, J APPL PHYSIOL, V79, P1615, DOI 10.1152/jappl.1995.79.5.1615; Berthiaume Y, 2007, RESP PHYSIOL NEUROBI, V159, P350, DOI 10.1016/j.resp.2007.05.010; Borok Z, 1998, AM J RESP CELL MOL, V18, P554, DOI 10.1165/ajrcmb.18.4.2838; Bove PF, 2010, J BIOL CHEM, V285, P34939, DOI 10.1074/jbc.M110.162933; CHEEK JM, 1989, AM J PHYSIOL, V256, pC688, DOI 10.1152/ajpcell.1989.256.3.C688; CLEMENTS JA, 1961, J APPL PHYSIOL, V16, P444, DOI 10.1152/jappl.1961.16.3.444; Davis IC, 2004, AM J PHYSIOL-LUNG C, V286, pL112, DOI 10.1152/ajplung.00218.2003; Dietl P, 2005, ANNU REV PHYSIOL, V67, P595, DOI 10.1146/annurev.physiol.67.040403.102553; Dietl P, 2004, BIOL NEONATE, V85, P299, DOI 10.1159/000078176; Dietl P, 2001, NEWS PHYSIOL SCI, V16, P239; Dietl P, 2012, CELL CALCIUM, V52, P296, DOI 10.1016/j.ceca.2012.04.010; Dobbs LG, 2007, RESP PHYSIOL NEUROBI, V159, P283, DOI 10.1016/j.resp.2007.06.011; Dobbs LG, 1997, AM J PHYSIOL-LUNG C, V273, pL347, DOI 10.1152/ajplung.1997.273.2.L347; DOBBS LG, 1986, AM REV RESPIR DIS, V134, P141; Edwards YS, 2001, COMP BIOCHEM PHYS A, V129, P245, DOI 10.1016/S1095-6433(01)00321-X; Fang XH, 2006, AM J PHYSIOL-LUNG C, V290, pL242, DOI 10.1152/ajplung.00178.2005; Folkesson HG, 2006, AM J RESP CELL MOL, V35, P10, DOI 10.1165/rcmb.2006-0080SF; Frick M, 2001, AM J RESP CELL MOL, V25, P306, DOI 10.1165/ajrcmb.25.3.4493; Haller T, 1999, AM J PHYSIOL-LUNG C, V277, pL893, DOI 10.1152/ajplung.1999.277.5.L893; Haller T, 2004, AM J PHYSIOL-LUNG C, V286, pL1009, DOI 10.1152/ajplung.00342.2003; Haller T, 1998, P NATL ACAD SCI USA, V95, P1579, DOI 10.1073/pnas.95.4.1579; Hecht E, 2012, ANAL CHEM, V84, P5716, DOI 10.1021/ac300775j; Hollenhorst MI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/174306; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Ito Y, 2011, AM J RESP CELL MOL, V45, P938, DOI 10.1165/rcmb.2011-0052OC; Kaczmarek-Hajek K, 2012, PURINERG SIGNAL, V8, P375, DOI 10.1007/s11302-012-9314-7; Kemp PJ, 2004, AM J PHYSIOL-LUNG C, V287, pL460, DOI 10.1152/ajplung.00191.2004; Khakh BS, 1999, J NEUROSCI, V19, P7289, DOI 10.1523/JNEUROSCI.19-17-07289.1999; Mason RJ, 2002, AM J PHYSIOL-LUNG C, V282, pL249, DOI 10.1152/ajplung.00027.2001; Matalon S, 1999, ANNU REV PHYSIOL, V61, P627, DOI 10.1146/annurev.physiol.61.1.627; Matthay MA, 2002, PHYSIOL REV, V82, P569, DOI 10.1152/physrev.00003.2002; Miklavc P, 2012, J CELL SCI, V125, P2765, DOI 10.1242/jcs.105262; Miklavc P, 2011, P NATL ACAD SCI USA, V108, P14503, DOI 10.1073/pnas.1101039108; Miklavc P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010982; Mishra A, 2011, J CELL SCI, V124, P657, DOI 10.1242/jcs.066977; Mizgerd JP, 2004, AM J PHYSIOL-LUNG C, V286, pL1302, DOI 10.1152/ajplung.00353.2003; Moschos SA, 2011, MOL THER, V19, P2163, DOI 10.1038/mt.2011.206; MUALLEM S, 1992, J BIOL CHEM, V267, P17658; NIELSEN S, 1995, P NATL ACAD SCI USA, V92, P1013, DOI 10.1073/pnas.92.4.1013; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Patel AS, 2005, AM J PHYSIOL-LUNG C, V289, pL489, DOI 10.1152/ajplung.00074.2005; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ravasio A, 2011, AM J PHYSIOL-CELL PH, V300, pC1456, DOI 10.1152/ajpcell.00427.2010; Rich PB, 2003, J TRAUMA, V55, P290, DOI 10.1097/01.TA.0000078882.11919.AF; SHANNON JM, 1992, AM J PHYSIOL, V262, pL427, DOI 10.1152/ajplung.1992.262.4.L427; Silberberg SD, 2005, J GEN PHYSIOL, V125, P347, DOI 10.1085/jgp.200409221; Tarran R, 2001, J GEN PHYSIOL, V118, P223, DOI 10.1085/jgp.118.2.223; Tarran R, 2002, J GEN PHYSIOL, V120, P407, DOI 10.1085/jgp.20028599; Tarran Robert, 2004, Proc Am Thorac Soc, V1, P42, DOI 10.1513/pats.2306014; Wang JR, 2007, AM J RESP CELL MOL, V36, P661, DOI 10.1165/rcmb.2006-0410OC; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Wemhoner A, 2006, J BIOMOL SCREEN, V11, P286, DOI 10.1177/1087057105285284; Wirtz HR, 2000, RESP PHYSIOL, V119, P1, DOI 10.1016/S0034-5687(99)00092-4; Wolk KE, 2008, AM J RESP CRIT CARE, V178, P969, DOI 10.1164/rccm.200803-455OC; Worthington EN, 2011, METHODS MOL BIOL, V742, P77, DOI 10.1007/978-1-61779-120-8_5; Yang CX, 2009, AM J PHYSIOL-LUNG C, V297, pL439, DOI 10.1152/ajplung.90268.2008	58	28	28	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2013	27	4					1772	1783		10.1096/fj.12-220533	http://dx.doi.org/10.1096/fj.12-220533			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23307836				2022-12-25	WOS:000316940800045
J	Yu, YT; Mo, YK; Ebenezer, D; Bhattacharyya, S; Liu, H; Sundaravel, S; Giricz, O; Wontakal, S; Cartier, J; Caces, B; Artz, A; Nischal, S; Bhagat, T; Bathon, K; Maqbool, S; Gligich, O; Suzuki, M; Steidl, U; Godley, L; Skoultchi, A; Greally, J; Wickrema, A; Verma, A				Yu, Yiting; Mo, Yongkai; Ebenezer, David; Bhattacharyya, Sanchari; Liu, Hui; Sundaravel, Sriram; Giricz, Orsolya; Wontakal, Sandeep; Cartier, Jessy; Caces, Bennett; Artz, Andrew; Nischal, Sangeeta; Bhagat, Tushar; Bathon, Kathleen; Maqbool, Shahina; Gligich, Oleg; Suzuki, Masako; Steidl, Ulrich; Godley, Lucy; Skoultchi, Art; Greally, John; Wickrema, Amittha; Verma, Amit			High Resolution Methylome Analysis Reveals Widespread Functional Hypomethylation during Adult Human Erythropoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSINE METHYLATION; GENE-EXPRESSION; DNA METHYLATION; DIFFERENTIATION; GATA-1; CANCER; CELLS; PU.1; EPIGENETICS	Differentiation of hematopoietic stem cells to red cells requires coordinated expression of numerous erythroid genes and is characterized by nuclear condensation and extrusion during terminal development. To understand the regulatory mechanisms governing these widespread phenotypic changes, we conducted a high resolution methylomic and transcriptomic analysis of six major stages of human erythroid differentiation. We observed widespread epigenetic differences between early and late stages of erythropoiesis with progressive loss of methylation being the dominant change during differentiation. Gene bodies, intergenic regions, and CpG shores were preferentially demethylated during erythropoiesis. Epigenetic changes at transcription factor binding sites correlated significantly with changes in gene expression and were enriched for binding motifs for SCL, MYB, GATA, and other factors not previously implicated in erythropoiesis. Demethylation at gene promoters was associated with increased expression of genes, whereas epigenetic changes at gene bodies correlated inversely with gene expression. Important gene networks encoding erythrocyte membrane proteins, surface receptors, and heme synthesis proteins were found to be regulated by DNA methylation. Furthermore, integrative analysis enabled us to identify novel, potential regulatory areas of the genome as evident by epigenetic changes in a predicted PU.1 binding site in intron 1 of the GATA1 gene. This intronic site was found to be conserved across species and was validated to be a novel PU.1 binding site by quantitative ChIP in erythroid cells. Altogether, our study provides a comprehensive analysis of methylomic and transcriptomic changes during erythroid differentiation and demonstrates that human terminal erythropoiesis is surprisingly associated with hypomethylation of the genome.	[Yu, Yiting; Mo, Yongkai; Bhattacharyya, Sanchari; Giricz, Orsolya; Wontakal, Sandeep; Cartier, Jessy; Nischal, Sangeeta; Bhagat, Tushar; Bathon, Kathleen; Maqbool, Shahina; Gligich, Oleg; Suzuki, Masako; Steidl, Ulrich; Skoultchi, Art; Greally, John; Verma, Amit] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Ebenezer, David; Liu, Hui; Sundaravel, Sriram; Caces, Bennett; Artz, Andrew; Godley, Lucy; Wickrema, Amittha] Univ Chicago, Dept Med, Chicago, IL 60637 USA	Yeshiva University; Albert Einstein College of Medicine; University of Chicago	Wickrema, A (corresponding author), Univ Chicago, Dept Med, MC2115,5841 South Maryland Ave, Chicago, IL 60637 USA.	awickrem@medicine.bsd.uchicago.edu; amit.verma@einstein.yu.edu	Greally, John/AAF-9540-2019; Suzuki, Masako/ABF-6497-2020	Greally, John/0000-0001-6069-7960; Suzuki, Masako/0000-0003-0605-9225; Sundaravel, Sriram/0000-0003-1638-710X; CARTIER, Jessy/0000-0002-0366-8546	National Institutes of Health [R01HL116336]; Partnership for Cures and Immunooncology Training Program Grant T32 (National Institutes of Health) [CA009173]; Leukemia and Lymphoma society; Department of Defense; Giving Tree Foundation; Searle Family Fund (Chicago Biomedical Consortium); William Deputy Memorial Fund; NATIONAL CANCER INSTITUTE [T32CA009173] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Partnership for Cures and Immunooncology Training Program Grant T32 (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma society(Leukemia and Lymphoma Society); Department of Defense(United States Department of Defense); Giving Tree Foundation; Searle Family Fund (Chicago Biomedical Consortium); William Deputy Memorial Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL116336 (to A. V. and A. W.) and Partnership for Cures and Immunooncology Training Program Grant T32 (National Institutes of Health) CA009173 (to A. V.). This work was also supported by the Leukemia and Lymphoma society (to A. V. and A. W.), the Department of Defense (to A. V.), the Giving Tree Foundation (to A. W.), the Searle Family Fund (Chicago Biomedical Consortium) (to A. W.), and the William Deputy Memorial Fund (to A. W. and A. A.).	Alvarez H, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001356; Arai E, 2011, INT J CLIN EXP PATHO, V4, P58; Baldewijns MML, 2008, BBA-REV CANCER, V1785, P133, DOI 10.1016/j.bbcan.2007.12.002; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Esteller M, 2003, ADV EXP MED BIOL, V532, P39; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Figueroa ME, 2009, BLOOD, V113, P2795, DOI 10.1182/blood-2008-08-172387; Figueroa ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001882; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Kang JA, 2008, J BIOL CHEM, V283, P6997, DOI 10.1074/jbc.M706712200; Khulan B, 2006, GENOME RES, V16, P1046, DOI 10.1101/gr.5273806; Oda M, 2009, NUCLEIC ACIDS RES, V37, P3829, DOI 10.1093/nar/gkp260; Rekhtman N, 2003, MOL CELL BIOL, V23, P7460, DOI 10.1128/MCB.23.21.7460-7474.2003; Seshasayee D, 2000, J BIOL CHEM, V275, P22969, DOI 10.1074/jbc.M002931200; Shearstone JR, 2011, SCIENCE, V334, P799, DOI 10.1126/science.1207306; Stopka T, 2005, EMBO J, V24, P3712, DOI 10.1038/sj.emboj.7600834; Suzuki M, 2006, ONCOGENE, V25, P2477, DOI 10.1038/sj.onc.1209272; Thompson RF, 2008, BIOINFORMATICS, V24, P1161, DOI 10.1093/bioinformatics/btn096; Trowbridge JJ, 2009, CELL STEM CELL, V5, P442, DOI 10.1016/j.stem.2009.08.016; Uddin S, 2004, P NATL ACAD SCI USA, V101, P147, DOI 10.1073/pnas.0307075101; Wickrema A, 2007, ONCOGENE, V26, P6803, DOI 10.1038/sj.onc.1210763; Wontakal SN, 2012, P NATL ACAD SCI USA, V109, P3832, DOI 10.1073/pnas.1121019109; Wontakal SN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001392; Yamamoto ML, 2009, BLOOD, V113, P3363, DOI 10.1182/blood-2008-05-160325	26	33	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8805	8814		10.1074/jbc.M112.423756	http://dx.doi.org/10.1074/jbc.M112.423756			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23306203	Green Published, hybrid			2022-12-25	WOS:000316862200003
J	Ha, JH; Shin, JS; Yoon, MK; Lee, MS; He, F; Bae, KH; Yoon, HS; Lee, CK; Park, SG; Muto, Y; Chi, SW				Ha, Ji-Hyang; Shin, Jae-Sun; Yoon, Mi-Kyung; Lee, Min-Sung; He, Fahu; Bae, Kwang-Hee; Yoon, Ho Sup; Lee, Chong-Kil; Park, Sung Goo; Muto, Yutaka; Chi, Seung-Wook			Dual-site Interactions of p53 Protein Transactivation Domain with Anti-apoptotic Bcl-2 Family Proteins Reveal a Highly Convergent Mechanism of Divergent p53 Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL INTERACTIONS; ACTIVATION DOMAIN; BINDING DOMAIN; TAZ2 DOMAIN; NUCLEAR; COMPLEX; MODULATION; SUBDOMAINS; MUTANT; P300	Molecular interactions between the tumor suppressor p53 and the anti-apoptotic Bcl-2 family proteins play an important role in the transcription-independent apoptosis of p53. The p53 transactivation domain (p53TAD) contains two conserved Phi XX Phi Phi motifs (Phi indicates a bulky hydrophobic residue and X is any other residue) referred to as p53TAD1 (residues 15-29) and p53TAD2 (residues 39-57). We previously showed that p53TAD1 can act as a binding motif for anti-apoptotic Bcl-2 family proteins. In this study, we have identified p53TAD2 as a binding motif for anti-apoptotic Bcl-2 family proteins by using NMR spectroscopy, and we calculated the structures of Bcl-X-L/Bcl-2 in complex with the p53TAD2 peptide. NMR chemical shift perturbation data showed that p53TAD2 peptide binds to diverse members of the anti-apoptotic Bcl-2 family independently of p53TAD1, and the binding between p53TAD2 and p53TAD1 to Bcl-X-L is competitive. Refined structural models of the Bcl-X-L.p53TAD2 and Bcl-2.p53TAD2 complexes showed that the binding sites occupied by p53TAD2 in Bcl-X-L and Bcl-2 overlap well with those occupied by pro-apoptotic BH3 peptides. Taken together with the mutagenesis, isothermal titration calorimetry, and paramagnetic relaxation enhancement data, our structural comparisons provided the structural basis of p53TAD2-mediated interaction with the anti-apoptotic proteins, revealing that Bcl-X-L/Bcl-2, MDM2, and cAMP-response element-binding protein-binding protein/p300 share highly similar modes of binding to the dual p53TAD motifs, p53TAD1 and p53TAD2. In conclusion, our results suggest that the dual-site interaction of p53TAD is a highly conserved mechanism underlying target protein binding in the transcription-dependent and transcription-independent apoptotic pathways of p53.	[Ha, Ji-Hyang; Shin, Jae-Sun; Yoon, Mi-Kyung; Lee, Min-Sung; Bae, Kwang-Hee; Park, Sung Goo; Chi, Seung-Wook] Korea Res Inst Biosci & Biotechnol, Med Prote Res Ctr, Taejon 305806, South Korea; [Ha, Ji-Hyang; Lee, Chong-Kil] Chungbuk Natl Univ, Coll Pharm, Cheongju 361763, South Korea; [He, Fahu; Muto, Yutaka] RIKEN, Syst & Struct Biol Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Yoon, Ho Sup] Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, Singapore 637511, Singapore	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungbuk National University; RIKEN; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Muto, Y (corresponding author), RIKEN, Syst & Struct Biol Ctr, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	ymuto@gsc.riken.jp; swchi@kribb.re.kr	He, Fahu/N-1442-2014; Yoon, Ho Sup/A-2193-2011	Yoon, Ho Sup/0000-0002-8243-3904; Bae, Kwang-Hee/0000-0002-5868-2556	Korean Ministry of Education, Science and Technology [T32221]; National Research Foundation of Korea (NRF); Korea government (MEST) [2011-0016011]	Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	We thank Eun-Hee Kim for help with the NMR data collection and Dr. Eunha Hwang for use of the Auto-iTC<INF>200</INF> Microcalorimeter at Korea Basic Science Institute. This study made use of the NMR facility at Korea Basic Science Institute, which is supported by Advanced MR Technology Program of the Korean Ministry of Education, Science and Technology (T32221).; This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2011-0016011).	Acevedo ML, 2004, MOL CELL, V13, P725, DOI 10.1016/S1097-2765(04)00121-2; Arai M, 2012, J AM CHEM SOC, V134, P3792, DOI 10.1021/ja209936u; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Bharatham N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026014; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; CHANG J, 1995, J BIOL CHEM, V270, P25014, DOI 10.1074/jbc.270.42.25014; Chi SW, 2005, J BIOL CHEM, V280, P38795, DOI 10.1074/jbc.M508578200; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Chipuk JE, 2003, CANCER CELL, V4, P371, DOI 10.1016/S1535-6108(03)00272-1; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Denisov AY, 2003, J BIOL CHEM, V278, P21124, DOI 10.1074/jbc.M301798200; Di Lello P, 2006, MOL CELL, V22, P731, DOI 10.1016/j.molcel.2006.05.007; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Feng HQ, 2009, STRUCTURE, V17, P202, DOI 10.1016/j.str.2008.12.009; Fernandez-Recio J, 2004, J MOL BIOL, V335, P843, DOI 10.1016/j.jmb.2003.10.069; Ferreon JC, 2009, P NATL ACAD SCI USA, V106, P6591, DOI 10.1073/pnas.0811023106; Ha JH, 2011, J AM CHEM SOC, V133, P1244, DOI 10.1021/ja109521f; Hagn F, 2010, J BIOL CHEM, V285, P3439, DOI 10.1074/jbc.M109.065391; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Jenkins LMM, 2009, BIOCHEMISTRY-US, V48, P1244, DOI 10.1021/bi801716h; Jiang P, 2006, MOL CELL BIOL, V26, P9071, DOI 10.1128/MCB.01025-06; Kumar R, 2003, MOL ENDOCRINOL, V17, P1, DOI 10.1210/me.2002-0258; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee CW, 2010, BIOCHEMISTRY-US, V49, P9964, DOI 10.1021/bi1012996; Lee CW, 2009, BIOCHEMISTRY-US, V48, P2115, DOI 10.1021/bi802055v; Lee EF, 2009, ANGEW CHEM INT EDIT, V48, P4318, DOI 10.1002/anie.200805761; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Rajagopalan S, 2010, P NATL ACAD SCI USA, V107, P8587, DOI 10.1073/pnas.1003689107; Rajagopalan S, 2009, J BIOL CHEM, V284, P21728, DOI 10.1074/jbc.M109.006429; Sayan BS, 2006, J BIOL CHEM, V281, P13566, DOI 10.1074/jbc.M512467200; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Shan B, 2012, J BIOL CHEM, V287, P30376, DOI 10.1074/jbc.M112.369793; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Sot B, 2007, J BIOL CHEM, V282, P29193, DOI 10.1074/jbc.M705544200; Tamiola K, 2010, J AM CHEM SOC, V132, P18000, DOI 10.1021/ja105656t; Tomita Y, 2006, J BIOL CHEM, V281, P8600, DOI 10.1074/jbc.M507611200; Uesugi M, 1999, P NATL ACAD SCI USA, V96, P14801, DOI 10.1073/pnas.96.26.14801; Venot C, 1999, ONCOGENE, V18, P2405, DOI 10.1038/sj.onc.1202539; Vise PD, 2005, NUCLEIC ACIDS RES, V33, P2061, DOI 10.1093/nar/gki336; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wong TS, 2009, NUCLEIC ACIDS RES, V37, P6765, DOI 10.1093/nar/gkp750; Wong TS, 2009, NUCLEIC ACIDS RES, V37, P568, DOI 10.1093/nar/gkn974; Xu HB, 2006, BIOCHEM BIOPH RES CO, V341, P938, DOI 10.1016/j.bbrc.2005.12.227; Xu HB, 2009, BIOCHEMISTRY-US, V48, P12159, DOI 10.1021/bi901188s; Zhang HY, 2003, J BIOMOL NMR, V25, P173, DOI 10.1023/A:1022836027055	49	37	37	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7387	7398		10.1074/jbc.M112.400754	http://dx.doi.org/10.1074/jbc.M112.400754			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23316052	hybrid, Green Published			2022-12-25	WOS:000316002400057
J	Hoogendijk, AJ; Pinhancos, SS; van der Poll, T; Wieland, CW				Hoogendijk, Arie J.; Pinhancos, Sandra S.; van der Poll, Tom; Wieland, Catharina W.			AMP-activated Protein Kinase Activation by 5-Aminoimidazole-4-carbox-amide-1-beta-D-ribofuranoside (AICAR) Reduces Lipoteichoic Acid-induced Lung Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INJURY; RECEPTOR; INHIBITION; PNEUMONIA; INFECTION; ADENOSINE; INNATE	Adenosine monophosphate-activated protein (AMP)-activated kinase (AMPK) is a highly conserved kinase that plays a key role in energy homeostasis. Activation of AMPK was shown to reduce inflammation in response to lipolysaccharide in vitro and in vivo. 5-Aminoimidazole-4-carbox-amide-1-beta-D-ribofuranoside (AICAR) is intracellularly converted to the AMP analog ZMP, which activates AMPK. Lipoteichoic acid (LTA) is a major component of the cell wall of Gram-positive bacteria that can trigger inflammatory responses. In contrast to lipopolysaccharide, little is known on the effects of AMPK activation in LTA-triggered innate immune responses. Here, we studied the potency of AMPK activation to reduce LTA-induced inflammation in vitro and in lungs in vivo. Activation of AMPK in vitro reduced cytokine production in the alveolar macrophage cell line MH-S. In vivo, AMPK activation reduced LTA-induced neutrophil influx, as well as protein leak and cytokine/chemokine levels in the bronchoalveolar space. In conclusion, AMPK activation inhibits LTA-induced lung inflammation in mice.	[Hoogendijk, Arie J.; Pinhancos, Sandra S.; van der Poll, Tom; Wieland, Catharina W.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [Hoogendijk, Arie J.; Pinhancos, Sandra S.; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Div Infect Dis, NL-1105 AZ Amsterdam, Netherlands; [Wieland, Catharina W.] Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anesthesiol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Hoogendijk, AJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, Meibergdreef 9,G2-105, NL-1105 AZ Amsterdam, Netherlands.	a.j.hoogendijk@amc.uva.nl		Mimoso Pinhancos, Sandra Sofia/0000-0002-6748-5554				Anderson Robert N, 2005, Natl Vital Stat Rep, V53, P1; Bai AP, 2010, BIOCHEM PHARMACOL, V80, P1708, DOI 10.1016/j.bcp.2010.08.009; Davis KA, 2000, J TRAUMA, V49, P892, DOI 10.1097/00005373-200011000-00017; Fan JS, 2011, J IMMUNOL, V186, P2482, DOI 10.4049/jimmunol.0903634; Gaskin FS, 2007, AM J PHYSIOL-HEART C, V292, pH326, DOI 10.1152/ajpheart.00744.2006; Ginsburg I, 2002, LANCET INFECT DIS, V2, P171, DOI 10.1016/S1473-3099(02)00226-8; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Jhun BS, 2004, BIOCHEM BIOPH RES CO, V318, P372, DOI 10.1016/j.bbrc.2004.04.035; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kim TB, 2007, CLIN EXP ALLERGY, V37, P1709, DOI 10.1111/j.1365-2222.2007.02812.x; Knapp S, 2008, J IMMUNOL, V180, P3478, DOI 10.4049/jimmunol.180.5.3478; Leemans JC, 2002, AM J RESP CRIT CARE, V165, P1445, DOI 10.1164/rccm.2106045; Renckens R, 2007, BLOOD, V109, P1593, DOI 10.1182/blood-2006-05-025197; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Torres A, 2010, AM J RESP CRIT CARE, V181, P782, DOI 10.1164/rccm.201001-0030UP; Uchida T, 2006, AM J RESP CRIT CARE, V173, P1008, DOI 10.1164/rccm.200509-1477OC; van der Poll T, 2008, LANCET INFECT DIS, V8, P32, DOI 10.1016/S1473-3099(07)70265-7; van der Windt GJW, 2011, AM J RESP CELL MOL, V44, P377, DOI 10.1165/rcmb.2010-0158OC; van Zoelen MAD, 2009, AM J PATHOL, V174, P2182, DOI 10.2353/ajpath.2009.080914; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Zajkowicz A, 2011, MECH AGEING DEV, V132, P543, DOI 10.1016/j.mad.2011.09.002; Zhao X, 2008, AM J PHYSIOL-LUNG C, V295, pL497, DOI 10.1152/ajplung.90210.2008; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	23	34	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7047	7052		10.1074/jbc.M112.413138	http://dx.doi.org/10.1074/jbc.M112.413138			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23322781	Green Published, hybrid			2022-12-25	WOS:000316002400026
J	Allman, E; Waters, K; Ackroyd, S; Nehrke, K				Allman, Erik; Waters, Korrie; Ackroyd, Sarah; Nehrke, Keith			Analysis of Ca2+ Signaling Motifs That Regulate Proton Signaling through the Na+/H+ Exchanger NHX-7 during a Rhythmic Behavior in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCINEURIN HOMOLOGOUS PROTEIN; MOLECULAR-CLONING; FUNCTIONAL EXPRESSION; ESSENTIAL COFACTOR; EXTRACELLULAR PH; NERVE-TERMINALS; MOTOR PROGRAM; NA; IDENTIFICATION; CHANNELS	Membrane proton transporters contribute to pH homeostasis but have also been shown to transmit information between cells in close proximity through regulated proton secretion. For example, the nematode intestinal Na+/H+ exchanger NHX-7 causes adjacent muscle cells to contract by transiently acidifying the extracellular space between the intestine and muscle. NHX-7 operates during a Ca2+- dependent rhythmic behavior and contains several conserved motifs for regulation by Ca2+ input, including motifs for calmodulin and phosphatidylinositol 4,5-bisphosphate binding, protein kinase C- and calmodulin-dependent protein kinase type II phosphorylation, and a binding site for calcineurin homologous protein. Here, we tested the idea that Ca2+ input differentiates proton signaling from pH housekeeping activity. Each of these motifs was mutated, and their contribution to NHX-7 function was assessed. These functions included pH recovery from acidification in cells in culture expressing recombinant NHX-7, extracellular acidification measured during behavior in live moving worms, and muscle contraction strength as a result of this acidification. Our data suggest that multiple levels of Ca2+ input regulate NHX-7, whose transport capacity normally exceeds the minimum necessary to cause muscle contraction. Furthermore, extracellular acidification limits NHX-7 proton transport through feedback inhibition, likely to prevent metabolic acidosis from occurring. Our findings are consistent with an integrated network whereby both Ca2+ and pH contribute to proton signaling. Finally, our results obtained by expressing rat NHE1 in Caenorhabditis elegans suggest that a conserved mechanism of regulation may contribute to cell-cell communication or proton signaling by Na+/H+ exchangers in mammals.	[Allman, Erik; Nehrke, Keith] Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Ackroyd, Sarah; Nehrke, Keith] Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14642 USA; [Waters, Korrie] Ohio Univ, Dept Family Med, Athens, OH 45701 USA	University of Rochester; University of Rochester; Ohio University	Nehrke, K (corresponding author), Univ Rochester, Med Ctr, Dept Med, 601 Elmwood Ave, Rochester, NY 14642 USA.	keith_nehrke@urmc.rochester.edu		Allman, Erik/0000-0002-6560-0889; Nehrke, Keith/0000-0001-9697-726X; Ackroyd, Sarah/0000-0001-9070-616X	Ruth L. Kirschstein National Research Service Institutional Award from the National Institutes of Health [GM068411]; National Science Foundation Grant [IOS0919848]; National Institutes of Health Office of Research Infrastructure Program [P40 OD010440]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068411] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Institutional Award from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Grant(National Science Foundation (NSF)); National Institutes of Health Office of Research Infrastructure Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Ruth L. Kirschstein National Research Service Institutional Award GM068411 from the National Institutes of Health (to E. A.). This work was also supported by National Science Foundation Grant IOS0919848 (to K. N.).; We thank Teresa Sherman for technical assistance, Dr. L. Pablo Cid for the extracellular pH sensor, and Dr. Maureen Peters for critical comments. Some strains used in this work were provided by the C. elegans Gene Knockout Consortium and the Caenorhabditis Genetics Center, which is supported by National Institutes of Health Office of Research Infrastructure Program P40 OD010440.	Aharonovitz O, 2000, J CELL BIOL, V150, P213, DOI 10.1083/jcb.150.1.213; Allman E, 2009, AM J PHYSIOL-CELL PH, V297, pC1071, DOI 10.1152/ajpcell.00284.2009; Alper SL, 2002, ANNU REV PHYSIOL, V64, P899, DOI 10.1146/annurev.physiol.64.092801.141759; ARONSON PS, 1982, NATURE, V299, P161, DOI 10.1038/299161a0; Attaphitaya S, 1999, J BIOL CHEM, V274, P4383, DOI 10.1074/jbc.274.7.4383; Baird NR, 1999, J BIOL CHEM, V274, P4377, DOI 10.1074/jbc.274.7.4377; Beg AA, 2008, CELL, V132, P149, DOI 10.1016/j.cell.2007.10.058; BERTRAND B, 1994, J BIOL CHEM, V269, P13703; BORON WF, 1976, J GEN PHYSIOL, V67, P91, DOI 10.1085/jgp.67.1.91; BRENNER S, 1974, GENETICS, V77, P71; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; COBBE SM, 1980, J MOL CELL CARDIOL, V12, P745, DOI 10.1016/0022-2828(80)90077-2; CROLL NA, 1978, J ZOOL, V184, P507; Dal Santo P, 1999, CELL, V98, P757, DOI 10.1016/S0092-8674(00)81510-X; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Diering GH, 2011, MOL BIOL CELL, V22, P2246, DOI 10.1091/mbc.E11-01-0066; Dietrich CJ, 2010, J NEUROSCI, V30, P16044, DOI 10.1523/JNEUROSCI.6364-09.2010; DRAY A, 1995, BRIT J ANAESTH, V75, P125, DOI 10.1093/bja/75.2.125; Espelt MV, 2005, J GEN PHYSIOL, V126, P379, DOI 10.1085/jgp.200509355; FLIEGEL L, 1992, BIOCHEM J, V282, P139, DOI 10.1042/bj2820139; Garbern JY, 2010, BRAIN, V133, P1391, DOI 10.1093/brain/awq071; Goyal S, 2003, AM J PHYSIOL-RENAL, V284, pF467, DOI 10.1152/ajprenal.00352.2002; He PJ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/238080; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Imahashi K, 2007, AM J PHYSIOL-HEART C, V292, pH2237, DOI 10.1152/ajpheart.00855.2006; Ishii S, 2005, J BIOL CHEM, V280, P9083, DOI 10.1074/jbc.M407832200; Issberner U, 1996, NEUROSCI LETT, V208, P191, DOI 10.1016/0304-3940(96)12576-3; IWASAKI K, 1995, P NATL ACAD SCI USA, V92, P10317, DOI 10.1073/pnas.92.22.10317; Jang IS, 2006, J NEUROCHEM, V99, P1224, DOI 10.1111/j.1471-4159.2006.04168.x; Johnson D, 2012, AM J PHYSIOL-CELL PH, V302, pC1045, DOI 10.1152/ajpcell.00411.2011; KRISHTAL OA, 1987, BRAIN RES, V436, P352, DOI 10.1016/0006-8993(87)91678-7; Li SY, 2004, J CLIN INVEST, V114, P1782, DOI 10.1172/JCI200418046; Lin X, 1996, P NATL ACAD SCI USA, V93, P12631, DOI 10.1073/pnas.93.22.12631; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; LIU DWC, 1994, J NEUROSCI, V14, P1953; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; MartinezZaguilan R, 1996, CLIN EXP METASTAS, V14, P176, DOI 10.1007/BF00121214; Mishima M, 2007, J BIOL CHEM, V282, P2741, DOI 10.1074/jbc.M604092200; Nakamura N, 2005, J BIOL CHEM, V280, P1561, DOI 10.1074/jbc.M410041200; Nehrke K, 2008, AM J PHYSIOL-CELL PH, V294, pC333, DOI 10.1152/ajpcell.00303.2007; Nehrke K, 2003, J BIOL CHEM, V278, P44657, DOI 10.1074/jbc.M307351200; Nehrke K, 2002, J BIOL CHEM, V277, P29036, DOI 10.1074/jbc.M203200200; NOEL J, 1995, AM J PHYSIOL-CELL PH, V268, pC283, DOI 10.1152/ajpcell.1995.268.2.C283; Numata M, 1998, J BIOL CHEM, V273, P6951, DOI 10.1074/jbc.273.12.6951; ORLOWSKI J, 1992, J BIOL CHEM, V267, P9331; Pang TX, 2001, J BIOL CHEM, V276, P17367, DOI 10.1074/jbc.M100296200; Pfeiffer J, 2008, CURR BIOL, V18, P297, DOI 10.1016/j.cub.2008.01.054; POUYSSEGUR J, 1984, P NATL ACAD SCI-BIOL, V81, P4833, DOI 10.1073/pnas.81.15.4833; Putney LK, 2003, J BIOL CHEM, V278, P44645, DOI 10.1074/jbc.M308099200; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Rocha MA, 2008, J NEUROCHEM, V106, P231, DOI 10.1111/j.1471-4159.2008.05355.x; ROTIN D, 1989, CANCER RES, V49, P205; ROTIN D, 1989, AM J PHYSIOL, V257, pC1158, DOI 10.1152/ajpcell.1989.257.6.C1158; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; Slepkov ER, 2007, BIOCHEM J, V401, P623, DOI 10.1042/BJ20061062; Teramoto T, 2006, CELL CALCIUM, V40, P319, DOI 10.1016/j.ceca.2006.04.009; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; THOMAS JH, 1990, GENETICS, V124, P855; Tominaga T, 1998, MOL BIOL CELL, V9, P2287, DOI 10.1091/mbc.9.8.2287; Tomura H, 2005, CELL SIGNAL, V17, P1466, DOI 10.1016/j.cellsig.2005.06.002; Trudeau LE, 1999, J NEUROPHYSIOL, V81, P2627, DOI 10.1152/jn.1999.81.6.2627; Urra J, 2008, PFLUG ARCH EUR J PHY, V457, P233, DOI 10.1007/s00424-008-0497-2; Vessey JP, 2005, J NEUROSCI, V25, P4108, DOI 10.1523/JNEUROSCI.5253-04.2005; Vila-Petroff M, 2010, J MOL CELL CARDIOL, V49, P106, DOI 10.1016/j.yjmcc.2009.12.007; Wagner J, 2011, AM J PHYSIOL-CELL PH, V301, pC1389, DOI 10.1152/ajpcell.00139.2011; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; WANG Z, 1993, J BIOL CHEM, V268, P11925; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Xing J, 2010, AM J PHYSIOL-CELL PH, V298, pC274, DOI 10.1152/ajpcell.00394.2009	70	5	8	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5886	5895		10.1074/jbc.M112.434852	http://dx.doi.org/10.1074/jbc.M112.434852			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23319594	Green Published, hybrid			2022-12-25	WOS:000315342500058
J	Martinez-Macias, MI; Cordoba-Canero, D; Ariza, RR; Roldan-Arjona, T				Isabel Martinez-Macias, Maria; Cordoba-Canero, Dolores; Ariza, Rafael R.; Roldan-Arjona, Teresa			The DNA Repair Protein XRCC1 Functions in the Plant DNA Demethylation Pathway by Stimulating Cytosine Methylation (5-meC) Excision, Gap Tailoring, and DNA Ligation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; ARABIDOPSIS-THALIANA; LIGASE-III; GLYCOSYLASE/LYASE ROS1; MOLECULAR-CLONING; SINGLE; DEMETER; DOMAIN; GENE; GENOME	DNA methylation patterns are the dynamic outcome of antagonist methylation and demethylation mechanisms, but the latter are still poorly understood. Active DNA demethylation in plants is mediated by a family of DNA glycosylases typified by Arabidopsis ROS1 (repressor of silencing 1). ROS1 and its homologs remove 5-methylcytosine and incise the sugar backbone at the abasic site, thus initiating a base excision repair pathway that finally inserts an unmethylated cytosine. The DNA 3'-phosphatase ZDP processes some of the incision products generated by ROS1, allowing subsequent DNA polymerization and ligation steps. In this work, we examined the possible role of plant XRCC1 (x-ray cross-complementing group protein 1) in DNA demethylation. We found that XRCC1 interacts in vitro with ROS1 and ZDP and stimulates the enzymatic activity of both proteins. Furthermore, extracts from xrcc1 mutant plants exhibit a reduced capacity to complete DNA demethylation initiated by ROS1. An anti-XRCC1 antibody inhibits removal of the blocking 3'-phosphate in the single-nucleotide gap generated during demethylation and reduces the capacity of Arabidopsis cell extracts to ligate a nicked DNA intermediate. Our results suggest that XRCC1 is a component of plant base excision repair and functions at several stages during active DNA demethylation in Arabidopsis.	[Isabel Martinez-Macias, Maria; Cordoba-Canero, Dolores; Ariza, Rafael R.; Roldan-Arjona, Teresa] Univ Cordoba, Dept Genet, Maimonides Inst Biomed Res IMIBIC, E-14071 Cordoba, Spain	Universidad de Cordoba	Roldan-Arjona, T (corresponding author), Univ Cordoba, Dept Genet, Edif Gregor Mendel,Campus Rabanales S-N, E-14071 Cordoba, Spain.	ge2roarm@uco.es	Martinez Macias, Maria Isabel/ACH-3606-2022; Roldan-Arjona, Teresa/H-5976-2015; Macias, Maria Isabel Martinez/B-4571-2019; Cordoba Canero, Dolores/H-8450-2018	Martinez Macias, Maria Isabel/0000-0001-8611-476X; Roldan-Arjona, Teresa/0000-0003-2842-3956; Macias, Maria Isabel Martinez/0000-0001-8611-476X; Rodriguez Ariza, Rafael/0000-0002-0338-7306; Cordoba Canero, Dolores/0000-0002-9659-4928	Spanish Ministry of Economy and Competitiveness; European Regional Development Fund [BFU2010-18838]; Junta de Andalucia [P07-CVI-02770]	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Regional Development Fund(European Commission); Junta de Andalucia(Junta de Andalucia)	This work was supported by the Spanish Ministry of Economy and Competitiveness and the European Regional Development Fund (Grant BFU2010-18838) and by the Junta de Andalucia (Grant P07-CVI-02770).; Recipient of a Ph. D. fellowship from the Spanish Ministry of Economy and Competitiveness.	Agius F, 2006, P NATL ACAD SCI USA, V103, P11796, DOI 10.1073/pnas.0603563103; Akbari M, 2010, DNA REPAIR, V9, P785, DOI 10.1016/j.dnarep.2010.04.002; Ali AAE, 2009, NUCLEIC ACIDS RES, V37, P1701, DOI 10.1093/nar/gkn1086; Andreuzza S, 2010, DEVELOPMENT, V137, P73, DOI 10.1242/dev.041020; Babiychuk E, 1998, PLANT J, V15, P635, DOI 10.1046/j.1365-313x.1998.00240.x; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; Campalans A, 2005, DNA REPAIR, V4, P826, DOI 10.1016/j.dnarep.2005.04.014; Charbonnel C, 2010, PLANT J, V64, P280, DOI 10.1111/j.1365-313X.2010.04331.x; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Cordoba-Canero Dolores, 2012, Methods Mol Biol, V920, P263, DOI 10.1007/978-1-61779-998-3_18; Cordoba-Canero D, 2011, PLANT J, V68, P693, DOI 10.1111/j.1365-313X.2011.04720.x; Cordoba-Canero D, 2009, PLANT J, V60, P716, DOI 10.1111/j.1365-313X.2009.03994.x; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gehring M, 2009, TRENDS GENET, V25, P82, DOI 10.1016/j.tig.2008.12.001; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Gong ZZ, 2011, CELL RES, V21, P1649, DOI 10.1038/cr.2011.140; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Hays JB, 2002, DNA REPAIR, V1, P579, DOI 10.1016/S1568-7864(02)00093-9; Martinez-Macias MI, 2012, MOL CELL, V45, P357, DOI 10.1016/j.molcel.2011.11.034; Ponferrada-Marin MI, 2012, NUCLEIC ACIDS RES, V40, P11554, DOI 10.1093/nar/gks894; Ponferrada-Marin MI, 2010, J BIOL CHEM, V285, P23030, DOI 10.1074/jbc.M110.124578; Ponferrada-Marin MI, 2009, NUCLEIC ACIDS RES, V37, P4264, DOI 10.1093/nar/gkp390; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5; Mackey ZB, 1997, MOL CELL BIOL, V17, P989, DOI 10.1128/MCB.17.2.989; Mani RS, 2004, BIOCHEMISTRY-US, V43, P16505, DOI 10.1021/bi048615m; Marintchev A, 1999, NAT STRUCT BIOL, V6, P884; Marsin S, 2003, J BIOL CHEM, V278, P44068, DOI 10.1074/jbc.M306160200; Morales-Ruiz T, 2006, P NATL ACAD SCI USA, V103, P6853, DOI 10.1073/pnas.0601109103; Nash RA, 1997, BIOCHEMISTRY-US, V36, P5207, DOI 10.1021/bi962281m; Nazarkina ZK, 2007, DNA REPAIR, V6, P254, DOI 10.1016/j.dnarep.2006.10.002; Ortega-Galisteo AP, 2008, PLANT MOL BIOL, V67, P671, DOI 10.1007/s11103-008-9346-0; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Roldan-Arjona T., 2009, DNA RNA MODIFICATION, P149; Taylor RM, 1998, PLANT J, V14, P75, DOI 10.1046/j.1365-313X.1998.00094.x; Taylor RM, 2002, MOL CELL BIOL, V22, P2556, DOI 10.1128/MCB.22.8.2556-2563.2002; Tebbs RS, 1999, DEV BIOL, V208, P513, DOI 10.1006/dbio.1999.9232; Thompson LH, 2000, MUTAT RES-DNA REPAIR, V459, P1, DOI 10.1016/S0921-8777(99)00058-0; Uchiyama Y, 2008, PLANTA, V227, P1233, DOI 10.1007/s00425-008-0695-3; Vidal AE, 2001, EMBO J, V20, P6530, DOI 10.1093/emboj/20.22.6530; Waterworth WM, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-79; WEI YF, 1995, MOL CELL BIOL, V15, P3206; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Wu YQ, 2001, PLANT MOL BIOL, V46, P161, DOI 10.1023/A:1010679901911; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205; Zhu JH, 2007, CURR BIOL, V17, P54, DOI 10.1016/j.cub.2006.10.059	51	24	30	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5496	5505		10.1074/jbc.M112.427617	http://dx.doi.org/10.1074/jbc.M112.427617			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23316050	Green Published, hybrid			2022-12-25	WOS:000315342500024
J	Turner, J; Bowers, RG; Baylis, M				Turner, Joanne; Bowers, Roger G.; Baylis, Matthew			Two-Host, Two-Vector Basic Reproduction Ratio (R-0) for Bluetongue	PLOS ONE			English	Article							SOUTH-AFRICA; VECTORS; DIPTERA; CERATOPOGONIDAE; VIRUS; TRANSMISSION; TEMPERATURE; INFECTION; ABUNDANCE; LIVESTOCK	Mathematical formulations for the basic reproduction ratio (R-0) exist for several vector-borne diseases. Generally, these are based on models of one-host, one-vector systems or two-host, one-vector systems. For many vector borne diseases, however, two or more vector species often co-occur and, therefore, there is a need for more complex formulations. Here we derive a two-host, two-vector formulation for the R-0 of bluetongue, a vector-borne infection of ruminants that can have serious economic consequences; since 1998 for example, it has led to the deaths of well over 1 million sheep in Europe alone. We illustrate our results by considering the situation in South Africa, where there are two major hosts (sheep, cattle) and two vector species with differing ecologies and competencies as vectors, for which good data exist. We investigate the effects on R-0 of differences in vector abundance, vector competence and vector host preference between vector species. Our results indicate that R-0 can be underestimated if we assume that there is only one vector transmitting the infection (when there are in fact two or more) and/or vector host preferences are overlooked (unless the preferred host is less beneficial or more abundant). The two-host, one-vector formula provides a good approximation when the level of cross-infection between vector species is very small. As this approaches the level of intraspecies infection, a combination of the two-host, one-vector R-0 for each vector species becomes a better estimate. Otherwise, particularly when the level of cross-infection is high, the two-host, two-vector formula is required for accurate estimation of R-0. Our results are equally relevant to Europe, where at least two vector species, which co-occur in parts of the south, have been implicated in the recent epizootic of bluetongue.	[Turner, Joanne; Baylis, Matthew] Univ Liverpool, Inst Infect & Global Hlth, Dept Epidemiol & Populat Hlth, Leahurst, Neston, England; [Bowers, Roger G.] Univ Liverpool, Sch Phys Sci, Dept Math Sci, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool	Turner, J (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Dept Epidemiol & Populat Hlth, Leahurst, Neston, England.	j.turner@liverpool.ac.uk	Baylis, Matthew/S-7694-2019	Baylis, Matthew/0000-0003-0335-187X; Bowers, Roger/0000-0001-8207-297X	Leverhulme Trust [F/0025/AC]; Biotechnology and Biological Sciences Research Council [BB/J015806/1] Funding Source: researchfish; BBSRC [BB/J015806/1] Funding Source: UKRI	Leverhulme Trust(Leverhulme Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by The Leverhulme Trust (http://www.leverhulme.ac.uk) through Research Leadership Award F/0025/AC "Predicting the effects of climate change on infectious diseases of animals", which was awarded to Matthew Baylis. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Koeijer AA, 2007, ECOL CONT VECTOR-BOR, V1, P99; Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386; Fu H, 1999, ARCH VIROL, V144, P747, DOI 10.1007/s007050050540; Garros C, 2011, INFECT GENET EVOL, V11, P1103, DOI 10.1016/j.meegid.2011.04.002; Gubbins S, 2008, J R SOC INTERFACE, V5, P363, DOI 10.1098/rsif.2007.1110; Guis H, 2012, J R SOC INTERFACE, V9, P339, DOI 10.1098/rsif.2011.0255; Hartemink NA, 2009, EPIDEMICS-NETH, V1, P153, DOI 10.1016/j.epidem.2009.05.004; Lopez LF, 2002, CR BIOL, V325, P1073, DOI 10.1016/S1631-0691(02)01534-2; Lord CC, 1996, MED VET ENTOMOL, V10, P19, DOI 10.1111/j.1365-2915.1996.tb00077.x; MACDONALD G, 1955, P ROY SOC MED, V48, P295, DOI 10.1177/003591575504800409; Pessanha JEM, 2011, REV SOC BRAS MED TRO, V44; Meiswinkel R, 2004, VETER ITAL SER, V40, P296; Murty US, 2010, J VECTOR DIS, V47, P26; NEVILL EM, 1978, J S AFR VET ASSOC, V49, P129; Paweska JT, 2002, MED VET ENTOMOL, V16, P10, DOI 10.1046/j.1365-2915.2002.00334.x; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; ROGERS DJ, 1988, PARASITOLOGY, V97, P193, DOI 10.1017/S0031182000066853; Tanga MC, 2011, TROP MED INT HEALTH, V16, P447, DOI 10.1111/j.1365-3156.2011.02726.x; Torina A, 2004, MED VET ENTOMOL, V18, P81, DOI 10.1111/j.0269-283X.2004.00493.x; VENTER GJ, 1994, ONDERSTEPOORT J VET, V61, P327; Venter GJ, 1996, ONDERSTEPOORT J VET, V63, P25; Venter GJ, 1998, MED VET ENTOMOL, V12, P378, DOI 10.1046/j.1365-2915.1998.00116.x; Venter GJ, 1996, ONDERSTEPOORT J VET, V63, P315	23	18	18	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53128	10.1371/journal.pone.0053128	http://dx.doi.org/10.1371/journal.pone.0053128			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308149	Green Submitted, gold, Green Published			2022-12-25	WOS:000313429800030
J	Charoenthongtrakul, S; Gao, LL; Parvatiyar, K; Lee, D; Harhaj, EW				Charoenthongtrakul, Soratree; Gao, Linlin; Parvatiyar, Kislay; Lee, David; Harhaj, Edward W.			RING Finger Protein 11 Targets TBK1/IKKi Kinases to Inhibit Antiviral Signaling	PLOS ONE			English	Article							NF-KAPPA-B; IFN-BETA PRODUCTION; I INTERFERON-PRODUCTION; TUMOR-SUPPRESSOR CYLD; E3 UBIQUITIN LIGASE; RIG-I; NEGATIVE REGULATOR; TRANSCRIPTION FACTORS; INNATE IMMUNITY; RNF11	A key feature of the innate antiviral immune response is a rapid nonspecific response to virus infection largely mediated by the induction and extracellular secretion of type I interferons (IFNs) that restrict virus replication. Cytoplasmic sensors such as RIG-I recognize viral RNA and trigger antiviral signaling pathways that upregulate IFN transcription. However, it remains largely unknown how antiviral signaling is negatively regulated to maintain homeostasis after the elimination of virus. In this report, we have identified the RING domain-containing protein RING finger 11 (RNF11) as a novel negative regulator of innate antiviral signaling. Overexpression of RNF11 downregulated IFN-beta expression and enhanced viral replication whereas siRNA-mediated knockdown of RNF11 suppressed viral replication. RNF11 interacted with the noncanonical IKK kinases TBK1/IKKi and attenuated their Lys63-linked polyubiquitination by blocking interactions with the E3 ligase TRAF3. The inhibitory function of RNF11 was dependent on the ubiquitin-binding adaptor molecule TAX1BP1 which was required for RNF11 to target TBK1/IKKi. Collectively, these results indicate that RNF11 functions together with TAX1BP1 to restrict antiviral signaling and IFN-beta production.	[Charoenthongtrakul, Soratree; Parvatiyar, Kislay; Lee, David] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Gao, Linlin] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Grad Program Canc Biol, Miami, FL 33136 USA; [Harhaj, Edward W.] Sidney Kimmel Comprehens Canc Ctr, Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD USA	University of Miami; University of Miami; Johns Hopkins University; Johns Hopkins Medicine	Harhaj, EW (corresponding author), Sidney Kimmel Comprehens Canc Ctr, Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD USA.	eharhaj1@jhmi.edu	Gao, Linlin/S-8070-2019	Gao, Linlin/0000-0001-7332-3538	NIH [PO1CA128115, RO1GM083143]; NATIONAL CANCER INSTITUTE [P01CA128115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083143] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported by NIH grants PO1CA128115 and RO1GM083143 and institutional support from the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Azmi P, 2005, EUR J CANCER, V41, P2549, DOI 10.1016/j.ejca.2005.08.020; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Bruns AM, 2012, CRIT REV BIOCHEM MOL, V47, P194, DOI 10.3109/10409238.2011.630974; Charoenthongtrakul S, 2011, J VIROL, V85, P6955, DOI 10.1128/JVI.00007-11; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; Connor MK, 2004, ONCOGENE, V23, P2089, DOI 10.1038/sj.onc.1207380; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Cui J, 2012, NAT IMMUNOL, V13, P387, DOI 10.1038/ni.2239; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gao LL, 2011, J BIOL CHEM, V286, P36592, DOI 10.1074/jbc.M111.283762; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Harashima A, 2010, GENE DEV, V24, P2640, DOI 10.1101/gad.1965010; Harhaj EW, 2012, IMMUNOL REV, V246, P107, DOI 10.1111/j.1600-065X.2012.01100.x; Harhaj NS, 2007, VIROLOGY, V362, P99, DOI 10.1016/j.virol.2006.12.020; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Huang J, 2005, EMBO J, V24, P4018, DOI 10.1038/sj.emboj.7600863; Iha H, 2008, EMBO J, V27, P629, DOI 10.1038/emboj.2008.5; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kitching R, 2003, BBA-MOL BASIS DIS, V1639, P104, DOI 10.1016/j.bbadis.2003.07.001; Li HX, 2004, ONCOGENE, V23, P1801, DOI 10.1038/sj.onc.1207319; Li ST, 2011, IMMUNITY, V35, P426, DOI 10.1016/j.immuni.2011.06.014; Li Y, 2009, P NATL ACAD SCI USA, V106, P7945, DOI 10.1073/pnas.0900818106; Liang QM, 2011, J IMMUNOL, V187, P4754, DOI 10.4049/jimmunol.1101704; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Mankouri J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000778; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Nakhaei P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000650; Ng MHJ, 2011, J IMMUNOL, V187, P6473, DOI 10.4049/jimmunol.1100719; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Oliere S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001177; Oshima S, 2009, NATURE, V457, P906, DOI 10.1038/nature07575; Parvatiyar K, 2010, J BIOL CHEM, V285, P14999, DOI 10.1074/jbc.M110.109819; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Santonico E, 2010, ONCOGENE, V29, P5604, DOI 10.1038/onc.2010.294; Sartelet A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002581; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shembade N, 2007, J VIROL, V81, P13735, DOI 10.1128/JVI.01790-07; Shembade N, 2007, EMBO J, V26, P3910, DOI 10.1038/sj.emboj.7601823; Shembade N, 2011, NAT IMMUNOL, V12, P834, DOI 10.1038/ni.2066; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Shembade N, 2009, EMBO J, V28, P513, DOI 10.1038/emboj.2008.285; Subramaniam V, 2003, BRIT J CANCER, V89, P1538, DOI 10.1038/sj.bjc.6601301; van Wijk SJL, 2012, MOL CELL, V47, P797, DOI 10.1016/j.molcel.2012.06.017; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815; Yu YX, 2010, IMMUNITY, V33, P863, DOI 10.1016/j.immuni.2010.11.027; Zhang M, 2012, J EXP MED, V209, P1703, DOI 10.1084/jem.20120024; Zhang MY, 2008, J BIOL CHEM, V283, P18621, DOI 10.1074/jbc.M801451200; Zhao W, 2012, J IMMUNOL, V188, P5311, DOI 10.4049/jimmunol.1103506	62	30	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53717	10.1371/journal.pone.0053717	http://dx.doi.org/10.1371/journal.pone.0053717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308279	Green Published, gold, Green Submitted			2022-12-25	WOS:000313429100111
J	Pena, OM; Afacan, N; Pistolic, J; Chen, C; Madera, L; Falsafi, R; Fjell, CD; Hancock, REW				Pena, Olga M.; Afacan, Nicole; Pistolic, Jelena; Chen, Carol; Madera, Laurence; Falsafi, Reza; Fjell, Christopher D.; Hancock, Robert E. W.			Synthetic Cationic Peptide IDR-1018 Modulates Human Macrophage Differentiation	PLOS ONE			English	Article							ALTERNATIVE ACTIVATION; HUMAN MONOCYTES; M2 MACROPHAGES; POLARIZATION; CELLS; TRANSCRIPTION; RESPONSES	Macrophages play a critical role in the innate immune response. To respond in a rapid and efficient manner to challenges in the micro-environment, macrophages are able to differentiate towards classically (M1) or alternatively (M2) activated phenotypes. Synthetic, innate defense regulators (IDR) peptides, designed based on natural host defence peptides, have enhanced immunomodulatory activities and reduced toxicity leading to protection in infection and inflammation models that is dependent on innate immune cells like monocytes/macrophages. Here we tested the effect of IDR-1018 on macrophage differentiation, a process essential to macrophage function and the immune response. Using transcriptional, protein and systems biology analysis, we observed that differentiation in the presence of IDR-1018 induced a unique signature of immune responses including the production of specific pro and anti-inflammatory mediators, expression of wound healing associated genes, and increased phagocytosis of apoptotic cells. Transcription factor IRF4 appeared to play an important role in promoting this IDR-1018-induced phenotype. The data suggests that IDR-1018 drives macrophage differentiation towards an intermediate M1-M2 state, enhancing anti-inflammatory functions while maintaining certain proinflammatory activities important to the resolution of infection. Synthetic peptides like IDR-1018, which act by modulating the immune system, could represent a powerful new class of therapeutics capable of treating the rising number of multidrug resistant infections as well as disorders associated with dysregulated immune responses.	[Pena, Olga M.; Afacan, Nicole; Pistolic, Jelena; Chen, Carol; Madera, Laurence; Falsafi, Reza; Fjell, Christopher D.; Hancock, Robert E. W.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Hancock, REW (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada.	bob@hancocklab.ubc.ca	Hancock, Robert E. W./E-1145-2013	Hancock, Robert E. W./0000-0001-5989-8503; Fjell, Christopher/0000-0001-6304-2628	Canadian Institutes for Health Research; Cystic Fibrosis Canada; Cystic Fibrosis Canada's Translational Initiative; Canadian Institutes for Health Research Vanier Canada Graduate scholarship; Natural Sciences and Engineering Research Council Canada Graduate Studentship	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada; Cystic Fibrosis Canada's Translational Initiative; Canadian Institutes for Health Research Vanier Canada Graduate scholarship(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council Canada Graduate Studentship(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by funding from the Canadian Institutes for Health Research (www.cihr-irsc.gc.ca) and Cystic Fibrosis Canada (www.cysticfibrosis.ca) (REWH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The only conflict of interest is that peptide IDR-1018, discovered by REWH and colleagues, has been filed for patent protection in multiple jurisdictions, assigned to UBC and licenced to Elanco for Animal Health applications and is also under development as a potential therapeutic for hyperinflammation in Cystic Fibrosis with funding from Cystic Fibrosis Canada's Translational Initiative. The peptide has received Notice of allowance in the United States of America and New Zealand. The authors' confirm that this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.; We would like to thank Danay Maestre-Batlle, who help with some of the technical work. O.M.P. is the recipient of a Canadian Institutes for Health Research Vanier Canada Graduate scholarship; N.J.A is a holder of a Natural Sciences and Engineering Research Council Canada Graduate Studentship and R. E. W. H. is a Canada Research Chair in Genomics and Health.	Achtman AH, 2012, SCI TRANSL MED, V4; Afacan NJ, 2012, CURR PHARM DESIGN, V18, P807, DOI 10.2174/138161212799277617; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Cassetta L, 2011, IMMUNOL RES, V53, P11; DARVEAU RP, 1983, J BACTERIOL, V155, P831, DOI 10.1128/JB.155.2.831-838.1983; del Fresno C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002667; del Fresno C, 2009, J IMMUNOL, V182, P6494, DOI 10.4049/jimmunol.0803350; El Chartouni C, 2010, IMMUNOBIOLOGY, V215, P821, DOI 10.1016/j.imbio.2010.05.031; Escribese MM, 2012, J IMMUNOL IN PRESS; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Ganster RW, 2001, P NATL ACAD SCI USA, V98, P8638, DOI 10.1073/pnas.151239498; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hancock REW, 2012, NAT REV MICROBIOL, V10, P243, DOI 10.1038/nrmicro2745; Jersmann HPA, 2003, CYTOM PART A, V51A, P7, DOI 10.1002/cyto.a.10005; Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Lang R, 2005, IMMUNOBIOLOGY, V210, P63, DOI 10.1016/j.imbio.2005.05.001; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Leidi M, 2009, J IMMUNOL, V182, P4415, DOI 10.4049/jimmunol.0713732; Lolmede K, 2009, J LEUKOCYTE BIOL, V85, P779, DOI 10.1189/jlb.0908579; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nijnik A, 2010, J IMMUNOL, V184, P2539, DOI 10.4049/jimmunol.0901813; Nijnik A, 2009, J IMMUNOL, V183, P5788, DOI 10.4049/jimmunol.0901491; Pena OM, 2011, J IMMUNOL, V186, P7243, DOI 10.4049/jimmunol.1001952; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramos R, 2011, PEPTIDES, V32, P1469, DOI 10.1016/j.peptides.2011.06.005; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; Semple F, 2012, J INNATE IMMUN, V4, P337, DOI 10.1159/000336619; Sica A, 2007, EXPERT OPIN THER TAR, V11, P1219, DOI 10.1517/14728222.11.9.1219; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sierra-Filardi E, 2011, BLOOD, V117, P5092, DOI 10.1182/blood-2010-09-306993; Sierra-Filardi E, 2010, IMMUNOBIOLOGY, V215, P788, DOI 10.1016/j.imbio.2010.05.020; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Steinstraesser LHT, 2012, PLOS ONE IN PRESS; Varin A, 2009, IMMUNOBIOLOGY, V214, P630, DOI 10.1016/j.imbio.2008.11.009; Wieczorek M, 2010, CHEM BIOL, V17, P970, DOI 10.1016/j.chembiol.2010.07.007	47	54	60	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e52449	10.1371/journal.pone.0052449	http://dx.doi.org/10.1371/journal.pone.0052449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308112	gold, Green Submitted, Green Published			2022-12-25	WOS:000313429100011
J	Gabba, M; Abbruzzetti, S; Spyrakis, F; Forti, F; Bruno, S; Mozzarelli, A; Luque, FJ; Viappiani, C; Cozzini, P; Nardini, M; Germani, F; Bolognesi, M; Moens, L; Dewilde, S				Gabba, Matteo; Abbruzzetti, Stefania; Spyrakis, Francesca; Forti, Flavio; Bruno, Stefano; Mozzarelli, Andrea; Javier Luque, F.; Viappiani, Cristiano; Cozzini, Pietro; Nardini, Marco; Germani, Francesca; Bolognesi, Martino; Moens, Luc; Dewilde, Sylvia			CO Rebinding Kinetics and Molecular Dynamics Simulations Highlight Dynamic Regulation of Internal Cavities in Human Cytoglobin	PLOS ONE			English	Article							LIGAND MIGRATION; NITRIC-OXIDE; HUMAN NEUROGLOBIN; TRUNCATED HEMOGLOBIN; OXYGEN-AFFINITY; GLOBIN; BINDING; PROTEIN; MYOGLOBIN; PATHWAYS	Cytoglobin (Cygb) was recently discovered in the human genome and localized in different tissues. It was suggested to play tissue-specific protective roles, spanning from scavenging of reactive oxygen species in neurons to supplying oxygen to enzymes in fibroblasts. To shed light on the functioning of such versatile machinery, we have studied the processes supporting transport of gaseous heme ligands in Cygb. Carbon monoxide rebinding shows a complex kinetic pattern with several distinct reaction intermediates, reflecting rebinding from temporary docking sites, second order recombination, and formation (and dissociation) of a bis-histidyl heme hexacoordinated reaction intermediate. Ligand exit to the solvent occurs through distinct pathways, some of which exploit temporary docking sites. The remarkable change in energetic barriers, linked to heme bis-histidyl hexacoordination by HisE7, may be responsible for active regulation of the flux of reactants and products to and from the reaction site on the distal side of the heme. A substantial change in both protein dynamics and inner cavities is observed upon transition from the CO-liganded to the pentacoordinated and bis-histidyl hexacoordinated species, which could be exploited as a signalling state. These findings are consistent with the expected versatility of the molecular activity of this protein.	[Gabba, Matteo] Forschungszentrum Julich, Inst Complex Syst Mol Biophys ICS 5, D-52425 Julich, Germany; [Abbruzzetti, Stefania; Viappiani, Cristiano] Univ Parma, Dipartimento Fis & Sci Terra, I-43100 Parma, Italy; [Spyrakis, Francesca; Cozzini, Pietro] Univ Parma, Dipartimento Sci Alimenti, I-43100 Parma, Italy; [Spyrakis, Francesca; Cozzini, Pietro] INBB, Rome, Italy; [Forti, Flavio; Javier Luque, F.] Univ Barcelona, Fac Med, Dept Fis Quin, Barcelona 7, Spain; [Forti, Flavio; Javier Luque, F.] Univ Barcelona, Fac Med, Inst Biomed IBUB, Barcelona 7, Spain; [Bruno, Stefano; Mozzarelli, Andrea] Univ Parma, Dipartimento Farm, I-43100 Parma, Italy; [Viappiani, Cristiano] CNR, Ist Nanosci, NEST, I-56100 Pisa, Italy; [Nardini, Marco; Bolognesi, Martino] Univ Milan, Dipartimento BioSci, CNR IBF, Milan, Italy; [Nardini, Marco; Bolognesi, Martino] Univ Milan, CIMAINA, Milan, Italy; [Germani, Francesca; Moens, Luc; Dewilde, Sylvia] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium	Helmholtz Association; Research Center Julich; University of Parma; University of Parma; University of Barcelona; University of Barcelona; University of Parma; Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Milan; University of Milan; University of Antwerp	Viappiani, C (corresponding author), Univ Parma, Dipartimento Fis & Sci Terra, I-43100 Parma, Italy.	cristiano.viappiani@fis.unipr.it	Viappiani, Cristiano/AAC-7579-2019; Bruno, Stefano/A-4582-2011; abbruzzetti, stefania/M-8640-2015; Nardini, Marco/B-7842-2017; abbruzzetti, stefania/AAE-5518-2020; Bolognesi, Martino/B-7924-2017; Luque, F. Javier/L-9652-2014; Mozzarelli, Andrea/C-3615-2014	Viappiani, Cristiano/0000-0001-7470-4770; Bruno, Stefano/0000-0002-7890-2472; abbruzzetti, stefania/0000-0001-7685-8554; Nardini, Marco/0000-0002-3718-2165; abbruzzetti, stefania/0000-0001-7685-8554; Bolognesi, Martino/0000-0002-9253-5170; Luque, F. Javier/0000-0002-8049-3567; Mozzarelli, Andrea/0000-0003-3762-0062; spyrakis, francesca/0000-0002-4016-227X	Italian MiUR [PRIN 2008, 2008BFJ34R, Azione Integrate Italia Spagna 2009 IT10L1M59M]; Ministero degli Affari Esteri, Direzione generale per la promozione del sistema Paese; Fondazione Cariparma; Spanish MCINN [SAF2011-27642, IT2009-0010]; Generalitat de Catalunya [2009-SGR00298]; Xarxa de Recerca en Quimica Teorica i Computacional (XQRTC); Barcelona Supercomputer Center	Italian MiUR(Ministry of Education, Universities and Research (MIUR)); Ministero degli Affari Esteri, Direzione generale per la promozione del sistema Paese; Fondazione Cariparma(Fondazione Cariparma); Spanish MCINN(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Xarxa de Recerca en Quimica Teorica i Computacional (XQRTC); Barcelona Supercomputer Center	This work has been supported by the Italian MiUR (PRIN 2008, 2008BFJ34R, and Azione Integrate Italia Spagna 2009 IT10L1M59M), Ministero degli Affari Esteri, Direzione generale per la promozione del sistema Paese (Progetti di Grande Rilevanza, Italia-Argentina 2011 (a) over cap (sic)"2013), Fondazione Cariparma, the Spanish MCINN (SAF2011-27642, IT2009-0010), the Generalitat de Catalunya (2009-SGR00298), the Xarxa de Recerca en Quimica Teorica i Computacional (XQRTC) and the Barcelona Supercomputer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzetti S, 2001, J NANOSCI NANOTECHNO, V1, P407, DOI 10.1166/jnn.2001.058; Abbruzzetti S, 2007, J PHYS CHEM B, V111, P12582, DOI 10.1021/jp074954o; Abbruzzetti S, 2006, PHOTOCH PHOTOBIO SCI, V5, P1109, DOI 10.1039/b610236k; Abbruzzetti S, 2009, P NATL ACAD SCI USA, V106, P18984, DOI 10.1073/pnas.0905433106; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Bettati S, 1997, J BIOL CHEM, V272, P32050, DOI 10.1074/jbc.272.51.32050; BETTATI S, 2004, ENCY NANOSCIENCE NAN, V9, P81; Bidon-Chanal A, 2007, J AM CHEM SOC, V129, P6782, DOI 10.1021/ja0689987; Boechi L, 2010, PROTEINS, V78, P962, DOI 10.1002/prot.22620; Bolognesi M, 1997, PROG BIOPHYS MOL BIO, V68, P29, DOI 10.1016/S0079-6107(97)00017-5; Bolognesi M, 1999, BIOPHYS J, V77, P1093, DOI 10.1016/S0006-3495(99)76959-6; Bruno S, 2001, PROTEIN SCI, V10, P2401, DOI 10.1110/ps.20501; Brunori M, 2006, FASEB J, V20, P2192, DOI 10.1096/fj.06-6643rev; Brunori M, 2005, P NATL ACAD SCI USA, V102, P8483, DOI 10.1073/pnas.0408766102; Brunori M, 2001, TRENDS BIOCHEM SCI, V26, P209, DOI 10.1016/S0968-0004(01)01824-2; Brunori M, 2001, TRENDS BIOCHEM SCI, V26, P21, DOI 10.1016/S0968-0004(00)01698-4; Burmester T, 2002, MOL BIOL EVOL, V19, P416, DOI 10.1093/oxfordjournals.molbev.a004096; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Case D, 2006, AMBER 9; Cohen J, 2006, BIOPHYS J, V91, P1844, DOI 10.1529/biopbysj.106.085746; de Sanctis D, 2004, BIOCHEM BIOPH RES CO, V316, P1217, DOI 10.1016/j.bbrc.2004.03.007; de Sanctis D, 2004, J MOL BIOL, V336, P917, DOI 10.1016/j.jmb.2003.12.063; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Dewilde S, 2008, METHOD ENZYMOL, V436, P341, DOI 10.1016/S0076-6879(08)36019-4; Dordas C, 2009, PLANT SCI, V176, P433, DOI 10.1016/j.plantsci.2009.01.003; Fago A, 2004, J BIOL CHEM, V279, P44417, DOI 10.1074/jbc.M407126200; Flogel U, 2001, P NATL ACAD SCI USA, V98, P735, DOI 10.1073/pnas.011460298; Fordel E, 2007, GENE, V398, P114, DOI 10.1016/j.gene.2007.03.022; GARCIA AE, 1992, PHYS REV LETT, V68, P2696, DOI 10.1103/PhysRevLett.68.2696; Hamdane D, 2003, J BIOL CHEM, V278, P51713, DOI 10.1074/jbc.M309396200; Hankeln T, 2005, J INORG BIOCHEM, V99, P110, DOI 10.1016/j.jinorgbio.2004.11.009; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hoy JA, 2007, J MOL BIOL, V371, P168, DOI 10.1016/j.jmb.2007.05.029; Kawada N, 2001, J BIOL CHEM, V276, P25318, DOI 10.1074/jbc.M102630200; Kriegl JM, 2002, P NATL ACAD SCI USA, V99, P7992, DOI 10.1073/pnas.082244399; Lechauve C, 2010, FEBS J; Liu XP, 2012, BIOCHEMISTRY-US, V51, P5072, DOI 10.1021/bi300291h; Makino M, 2011, PROTEINS, V79, P1143, DOI 10.1002/prot.22950; Maragliano L, 2010, J AM CHEM SOC, V132, P1010, DOI 10.1021/ja905671x; Nienhaus K, 2004, J BIOL CHEM, V279, P22944, DOI 10.1074/jbc.M401561200; Nishihara Y, 2004, J AM CHEM SOC, V126, P11877, DOI 10.1021/ja038877w; Olson JS, 2007, IUBMB LIFE, V59, P552, DOI 10.1080/15216540701230495; Orlowski S, 2007, J MOL MODEL, V13, P715, DOI 10.1007/s00894-007-0203-x; Pesce A, 2002, EMBO REP, V3, P1146, DOI 10.1093/embo-reports/kvf248; Sawai H, 2003, BIOCHEMISTRY-US, V42, P5133, DOI 10.1021/bi027067e; Schmidt M, 2004, J BIOL CHEM, V279, P8063, DOI 10.1074/jbc.M310540200; Schmidtke P, 2011, BIOINFORMATICS, V27, P3276, DOI 10.1093/bioinformatics/btr550; Scott NL, 2002, BIOCHEMISTRY-US, V41, P6902, DOI 10.1021/bi025609m; SHIBAYAMA N, 1995, J MOL BIOL, V251, P203, DOI 10.1006/jmbi.1995.0427; Shivapurkar N, 2008, CANCER RES, V68, P7448, DOI 10.1158/0008-5472.CAN-08-0565; Smagghe BJ, 2009, BIOPOLYMERS, V91, P1083, DOI 10.1002/bip.21256; Sottini S, 2005, J PHYS CHEM B, V109, P19523, DOI 10.1021/jp0540981; Sottini S, 2005, J PHYS CHEM B, V109, P11411, DOI 10.1021/jp0514224; Steinbach PJ, 2002, BIOPHYS J, V82, P2244, DOI 10.1016/S0006-3495(02)75570-7; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Tetreau C, 2004, BIOPHYS J, V86, P435, DOI 10.1016/S0006-3495(04)74120-X; Trent JT, 2001, J BIOL CHEM, V276, P30106, DOI 10.1074/jbc.C100300200; Trent JT, 2002, J BIOL CHEM, V277, P19538, DOI 10.1074/jbc.M201934200; Vallone B, 2004, P NATL ACAD SCI USA, V101, P17351, DOI 10.1073/pnas.0407633101; Viappiani C, 2004, P NATL ACAD SCI USA, V101, P14414, DOI 10.1073/pnas.0405987101	61	24	26	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e49770	10.1371/journal.pone.0049770	http://dx.doi.org/10.1371/journal.pone.0049770			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308092	Green Published, gold			2022-12-25	WOS:000313670100001
J	Iring, A; Ruisanchez, E; Leszl-Ishiguro, M; Horvath, B; Benko, R; Lacza, Z; Jarai, Z; Sandor, P; Di Marzo, V; Pacher, P; Benyo, Z				Iring, Andras; Ruisanchez, Eva; Leszl-Ishiguro, Miriam; Horvath, Bela; Benko, Rita; Lacza, Zsombor; Jarai, Zoltan; Sandor, Peter; Di Marzo, Vincenzo; Pacher, Pal; Benyo, Zoltan			Role of Endocannabinoids and Cannabinoid-1 Receptors in Cerebrocortical Blood Flow Regulation	PLOS ONE			English	Article							SYMPATHETIC-NERVOUS-SYSTEM; CB1 RECEPTOR; ANANDAMIDE UPTAKE; RAT-BRAIN; ENDOGENOUS CANNABINOIDS; CARDIOVASCULAR FUNCTION; CONSTITUTIVE ACTIVITY; HEMODYNAMIC PROFILE; CARDIAC DYSFUNCTION; VANILLOID RECEPTOR	Background: Endocannabinoids are among the most intensively studied lipid mediators of cardiovascular functions. In the present study the effects of decreased and increased activity of the endocannabinoid system (achieved by cannabinoid-1 (CB1) receptor blockade and inhibition of cannabinoid reuptake, respectively) on the systemic and cerebral circulation were analyzed under steady-state physiological conditions and during hypoxia and hypercapnia (H/H). Methodology/Principal Findings: In anesthetized spontaneously ventilating rats the CB1-receptor antagonist/inverse agonist AM-251 (10 mg/kg, i.v.) failed to influence blood pressure (BP), cerebrocortical blood flow (CoBF, measured by laser-Doppler flowmetry) or arterial blood gas levels. In contrast, the putative cannabinoid reuptake inhibitor AM-404 (10 mg/kg, i.v.) induced triphasic responses, some of which could be blocked by AM-251. Hypertension during phase I was resistant to AM-251, whereas the concomitant CoBF-increase was attenuated. In contrast, hypotension during phase III was sensitive to AM-251, whereas the concomitant CoBF-decrease was not. Therefore, CoBF autoregulation appeared to shift towards higher BP levels after CB1-blockade. During phase II H/H developed due to respiratory depression, which could be inhibited by AM-251. Interestingly, however, the concomitant rise in CoBF remained unchanged after AM-251, indicating that CB1-blockade potentially enhanced the reactivity of the CoBF to H/H. In accordance with this hypothesis, AM-251 induced a significant enhancement of the CoBF responses during controlled stepwise H/H. Conclusion/Significance: Under resting physiological conditions CB1-receptor mediated mechanisms appear to have limited influence on systemic or cerebral circulation. Enhancement of endocannabinoid levels, however, induces transient CB1-independent hypertension and sustained CB1-mediated hypotension. Furthermore, enhanced endocannabinoid activity results in respiratory depression in a CB1-dependent manner. Finally, our data indicate for the first time the involvement of the endocannabinoid system and CB1-receptors in the regulation of the cerebral circulation during H/H and also raise the possibility of their contribution to the autoregulation of CoBF.	[Iring, Andras; Ruisanchez, Eva; Leszl-Ishiguro, Miriam; Horvath, Bela; Benko, Rita; Lacza, Zsombor; Sandor, Peter; Benyo, Zoltan] Semmelweis Univ, Inst Human Physiol & Clin Expt Res, Budapest, Hungary; [Horvath, Bela] Cleveland Clin, Pathol & Lab Med Inst, Cleveland, OH 44106 USA; [Jarai, Zoltan] St Imre Teaching Hosp, Dept Cardiol, Budapest, Hungary; [Di Marzo, Vincenzo] CNR, Inst Biomol Chem, Endocannabinoid Res Grp, Naples, Italy; [Pacher, Pal] NIAAA, NIH, Bethesda, MD USA	Semmelweis University; Cleveland Clinic Foundation; Consiglio Nazionale delle Ricerche (CNR); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Benyo, Z (corresponding author), Semmelweis Univ, Inst Human Physiol & Clin Expt Res, Budapest, Hungary.	benyo.zoltan@med.semmelweis-univ.hu	Pacher, Pal/B-6378-2008; Di Marzo, Vincenzo/AAD-7742-2019; Horvath, Bela/A-7368-2009; Benko, Rita/I-9646-2017	Pacher, Pal/0000-0001-7036-8108; Di Marzo, Vincenzo/0000-0002-1490-3070; Benko, Rita/0000-0001-7740-9128; Benyo, Zoltan/0000-0001-6015-0359; Iring, Andras/0000-0002-3087-4337	Hungarian National Innovation Office [OMFB-00770/2009]; Hungarian Scientific Research Fund [OTKA K-62375, K-101775]; Health Science Council [ETT 427/2009]; National Development Agency [TAMOP-4.2.1.B-09/1/KMR-2010-0001]; EFSD/Servier research grant; Nation Institutes of Health/National Institute on Alcohol Abuse and Alcoholism; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000375] Funding Source: NIH RePORTER	Hungarian National Innovation Office; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Health Science Council; National Development Agency; EFSD/Servier research grant; Nation Institutes of Health/National Institute on Alcohol Abuse and Alcoholism; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by grants from the Hungarian National Innovation Office (OMFB-00770/2009), the Hungarian Scientific Research Fund (OTKA K-62375 and K-101775), the Health Science Council (ETT 427/2009), the National Development Agency (TAMOP-4.2.1.B-09/1/KMR-2010-0001), by an EFSD/Servier research grant, and by the Intramural Research Program of the Nation Institutes of Health/National Institute on Alcohol Abuse and Alcoholism. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Batkai S, 2004, CIRCULATION, V110, P1996, DOI 10.1161/01.CIR.0000143230.23252.D2; Batkai S, 2007, AM J PHYSIOL-HEART C, V293, pH909, DOI 10.1152/ajpheart.00373.2007; BEACONSFIELD P, 1972, LANCET, V2, P1146; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; Benyo Z, 1996, CEREBROVAS BRAIN MET, V8, P326; Bloom AS, 1997, PHARMACOL BIOCHEM BE, V57, P625, DOI 10.1016/S0091-3057(96)00475-3; Buckley NE, 2008, BRIT J PHARMACOL, V153, P309, DOI 10.1038/sj.bjp.0707527; BUSIJA DW, 1984, J PHYSIOL-LONDON, V347, P35, DOI 10.1113/jphysiol.1984.sp015051; Calignano A, 1997, EUR J PHARMACOL, V337, pR1, DOI 10.1016/S0014-2999(97)01297-1; CAVERO I, 1972, RES COMMUN CHEM PATH, V3, P483; Costa B, 2006, BRIT J PHARMACOL, V148, P1022, DOI 10.1038/sj.bjp.0706798; De Petrocellis L, 2000, FEBS LETT, V483, P52, DOI 10.1016/S0014-5793(00)02082-2; DESHMUKH VD, 1972, BRIT J SURG, V59, P897; DOHERTY PA, 1983, J PHARMACOL EXP THER, V227, P508; Duarte JMN, 2012, NEUROCHEM INT, V60, P1, DOI 10.1016/j.neuint.2011.10.019; Ellis EF, 1995, AM J PHYSIOL-HEART C, V269, pH1859, DOI 10.1152/ajpheart.1995.269.6.H1859; ESTRADA U, 1987, LIFE SCI, V41, P79, DOI 10.1016/0024-3205(87)90559-5; Fegley D, 2004, P NATL ACAD SCI USA, V101, P8756, DOI 10.1073/pnas.0400997101; Figley CR, 2011, EUR J NEUROSCI, V33, P577, DOI 10.1111/j.1460-9568.2010.07584.x; Fowler CJ, 2012, TRENDS PHARMACOL SCI, V33, P181, DOI 10.1016/j.tips.2012.01.001; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Gardiner SM, 2002, BRIT J PHARMACOL, V135, P1889, DOI 10.1038/sj.bjp.0704649; Gatley SJ, 1996, EUR J PHARMACOL, V307, P331, DOI 10.1016/0014-2999(96)00279-8; Gebremedhin D, 1999, AM J PHYSIOL-HEART C, V276, pH2085, DOI 10.1152/ajpheart.1999.276.6.H2085; GOPLERUD JM, 1991, AM J PHYSIOL, V260, pH1575, DOI 10.1152/ajpheart.1991.260.5.H1575; GRAHAM JDP, 1973, BRIT J PHARMACOL, V49, P1; Hamel E, 2006, J APPL PHYSIOL, V100, P1059, DOI 10.1152/japplphysiol.00954.2005; Hanlon KE, 2010, METHOD ENZYMOL, V484, P3, DOI [10.1016/B978-0-12-381298-8.00001-0, 10.1016/S0076-6879(10)84001-7]; HARPER AM, 1972, ARCH NEUROL-CHICAGO, V27, P1; Hillard CJ, 1999, FEBS LETT, V459, P277, DOI 10.1016/S0014-5793(99)01253-3; Hortobagyi L, 2007, BRAIN RES, V1131, P129, DOI 10.1016/j.brainres.2006.11.009; Horvath B, 2003, J CEREBR BLOOD F MET, V23, P653, DOI 10.1097/01.WCB.0000071890.63724.C9; Horvath B, 2008, NEUROREPORT, V19, P1601, DOI 10.1097/WNR.0b013e3283129790; Horvath B, 2012, BRIT J PHARMACOL, V165, P2462, DOI 10.1111/j.1476-5381.2011.01381.x; Horvath B, 2012, AM J PATHOL, V180, P432, DOI 10.1016/j.ajpath.2011.11.003; Horvath B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014477; Izzo AA, 2009, TRENDS PHARMACOL SCI, V30, P515, DOI 10.1016/j.tips.2009.07.006; Johns DG, 2007, BRIT J PHARMACOL, V152, P825, DOI 10.1038/sj.bjp.0707419; King AR, 2009, CHEM BIOL, V16, P1045, DOI 10.1016/j.chembiol.2009.09.012; Koehler RC, 2009, TRENDS NEUROSCI, V32, P160, DOI 10.1016/j.tins.2008.11.005; Kopczynska B, 2007, LIFE SCI, V80, P1738, DOI 10.1016/j.lfs.2007.01.062; KOVACH AGB, 1992, J PHYSIOL-LONDON, V449, P183, DOI 10.1113/jphysiol.1992.sp019081; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Kunos G, 2000, PROSTAG OTH LIPID M, V61, P71, DOI 10.1016/S0090-6980(00)00056-3; Kunos G, 2011, BRIT J PHARMACOL, V163, P1423, DOI 10.1111/j.1476-5381.2011.01352.x; Kwolek G, 2005, BRIT J PHARMACOL, V145, P567, DOI 10.1038/sj.bjp.0706195; Lake KD, 1997, HYPERTENSION, V29, P1204, DOI 10.1161/01.HYP.29.5.1204; Lake KD, 1997, J PHARMACOL EXP THER, V281, P1030; Lang WS, 1999, J MED CHEM, V42, P896, DOI 10.1021/jm980461j; LEE JG, 1994, ANESTH ANALG, V79, P58; Leffler CW, 2011, AM J PHYSIOL-HEART C, V301, pH1, DOI 10.1152/ajpheart.00230.2011; LEFFLER CW, 1987, SEMIN PERINATOL, V11, P31; Long JZ, 2011, CHEM REV, V111, P6022, DOI 10.1021/cr200075y; Maccarrone M, 2010, TRENDS BIOCHEM SCI, V35, P601, DOI 10.1016/j.tibs.2010.05.008; Malinowska B, 2001, N-S ARCH PHARMACOL, V364, P562, DOI 10.1007/s00210-001-0498-6; Mathew RJ, 1999, ACTA PSYCHIAT SCAND, V100, P67, DOI 10.1111/j.1600-0447.1999.tb10916.x; MATHEW RJ, 1992, J CEREBR BLOOD F MET, V12, P750, DOI 10.1038/jcbfm.1992.106; Mathew RJ, 2002, PSYCHIAT RES-NEUROIM, V116, P173, DOI 10.1016/S0925-4927(02)00069-0; McLaughlin PJ, 2003, BEHAV PHARMACOL, V14, P583, DOI 10.1097/00008877-200312000-00002; Mechoulam R, 1996, J LIPID MEDIAT CELL, V14, P45, DOI 10.1016/0929-7855(96)01507-6; Montecucco F, 2012, TRENDS PHARMACOL SCI, V33, P331, DOI 10.1016/j.tips.2012.03.002; MOSS IR, 1976, LIFE SCI, V19, P99, DOI 10.1016/0024-3205(76)90379-9; Mukhopadhyay P, 2010, CARDIOVASC RES, V85, P773, DOI 10.1093/cvr/cvp369; Niederhoffer N, 2003, N-S ARCH PHARMACOL, V367, P434, DOI 10.1007/s00210-003-0755-y; Pacher P, 2008, BRIT J PHARMACOL, V153, P252, DOI 10.1038/sj.bjp.0707582; Pacher P, 2005, HANDB EXP PHARMACOL, V168, P599; Pacher P, 2005, AM J PHYSIOL-HEART C, V289, pH533, DOI 10.1152/ajpheart.00107.2005; Pacher P, 2004, J PHYSIOL-LONDON, V558, P647, DOI 10.1113/jphysiol.2004.064824; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pacher P, 2009, SEMIN IMMUNOPATHOL, V31, P63, DOI 10.1007/s00281-009-0145-8; Padley JR, 2003, BRIT J PHARMACOL, V140, P384, DOI 10.1038/sj.bjp.0705422; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Pertwee RG, 2005, LIFE SCI, V76, P1307, DOI 10.1016/j.lfs.2004.10.025; Petrosino S, 2010, CURR OPIN INVEST DR, V11, P51; Pfitzer T, 2004, BRIT J PHARMACOL, V142, P943, DOI 10.1038/sj.bjp.0705874; PHILLIPS RN, 1971, P SOC EXP BIOL MED, V136, P260; Rajesh M, 2012, DIABETES, V61, P716, DOI 10.2337/db11-0477; Ralevic V, 2009, CURR VASC PHARMACOL, V7, P15, DOI 10.2174/157016109787354114; Randall MD, 2004, BRIT J PHARMACOL, V142, P20, DOI 10.1038/sj.bjp.0705725; Randall MD, 2002, PHARMACOL THERAPEUT, V95, P191, DOI 10.1016/S0163-7258(02)00258-9; ROSENKRANTZ H, 1974, TOXICOL APPL PHARM, V28, P18, DOI 10.1016/0041-008X(74)90126-4; Ruisanchez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037798; Sandor P, 1999, NEUROCHEM INT, V35, P237, DOI 10.1016/S0197-0186(99)00067-4; Savinainen JR, 2003, BRIT J PHARMACOL, V140, P1451, DOI 10.1038/sj.bjp.0705577; Schmid K, 2003, N-S ARCH PHARMACOL, V368, P301, DOI 10.1007/s00210-003-0787-3; Schwedt TJ, 2009, LANCET NEUROL, V8, P560, DOI 10.1016/S1474-4422(09)70107-3; Seifert T, 2011, PROG NEUROBIOL, V95, P406, DOI 10.1016/j.pneurobio.2011.09.008; Stein EA, 1998, NEUROPSYCHOPHARMACOL, V19, P481, DOI 10.1016/S0893-133X(98)00043-8; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Toth A, 2009, VITAM HORM, V81, P389, DOI 10.1016/S0083-6729(09)81015-7; van der Stelt M, 2001, J NEUROSCI, V21, P8765, DOI 10.1523/JNEUROSCI.21-22-08765.2001; Vangeison G, 2009, NEUROSCIENTIST, V15, P579, DOI 10.1177/1073858409332405; VARGA K, 1995, EUR J PHARMACOL, V278, P279, DOI 10.1016/0014-2999(95)00181-J; Varga K, 1996, HYPERTENSION, V28, P682, DOI 10.1161/01.HYP.28.4.682; WAGERLE LC, 1986, PEDIATR RES, V20, P131, DOI 10.1203/00006450-198602000-00007; Wagner JA, 2001, EUR J PHARMACOL, V423, P203, DOI 10.1016/S0014-2999(01)01112-8; Zakrzeska A, 2010, BRIT J PHARMACOL, V160, P574, DOI 10.1111/j.1476-5381.2009.00579.x	98	18	19	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53390	10.1371/journal.pone.0053390	http://dx.doi.org/10.1371/journal.pone.0053390			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308211	Green Published, gold, Green Submitted			2022-12-25	WOS:000313670100036
J	Gutig, R; Gollisch, T; Sompolinsky, H; Meister, M				Guetig, Robert; Gollisch, Tim; Sompolinsky, Haim; Meister, Markus			Computing Complex Visual Features with Retinal Spike Times	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; GANGLION-CELLS; STRIATE CORTEX; FEEDFORWARD INHIBITION; SOMATOSENSORY CORTEX; RECEPTIVE-FIELDS; AUDITORY-CORTEX; NEURAL-NETWORKS; EYE-MOVEMENTS; INFORMATION	Neurons in sensory systems can represent information not only by their firing rate, but also by the precise timing of individual spikes. For example, certain retinal ganglion cells, first identified in the salamander, encode the spatial structure of a new image by their first-spike latencies. Here we explore how this temporal code can be used by downstream neural circuits for computing complex features of the image that are not available from the signals of individual ganglion cells. To this end, we feed the experimentally observed spike trains from a population of retinal ganglion cells to an integrate-and-fire model of post-synaptic integration. The synaptic weights of this integration are tuned according to the recently introduced tempotron learning rule. We find that this model neuron can perform complex visual detection tasks in a single synaptic stage that would require multiple stages for neurons operating instead on neural spike counts. Furthermore, the model computes rapidly, using only a single spike per afferent, and can signal its decision in turn by just a single spike. Extending these analyses to large ensembles of simulated retinal signals, we show that the model can detect the orientation of a visual pattern independent of its phase, an operation thought to be one of the primitives in early visual processing. We analyze how these computations work and compare the performance of this model to other schemes for reading out spike-timing information. These results demonstrate that the retina formats spatial information into temporal spike sequences in a way that favors computation in the time domain. Moreover, complex image analysis can be achieved already by a simple integrate-and-fire model neuron, emphasizing the power and plausibility of rapid neural computing with spike times.	[Guetig, Robert] Max Planck Inst Expt Med, D-37075 Gottingen, Germany; [Guetig, Robert; Sompolinsky, Haim] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; [Guetig, Robert; Sompolinsky, Haim] Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, Jerusalem, Israel; [Gollisch, Tim] Univ Med Ctr Gottingen, Dept Ophthalmol, Gottingen, Germany; [Sompolinsky, Haim; Meister, Markus] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Meister, Markus] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Max Planck Society; Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of Gottingen; Harvard University; Harvard University	Gutig, R (corresponding author), Max Planck Inst Expt Med, Hermann Rein Str 3, D-37075 Gottingen, Germany.	guetig@em.mpg.de; meister@caltech.edu	889, CRC/L-1607-2018; Sompolinsky, Haim/ABB-8398-2021	889, CRC/0000-0002-6678-3138; Gollisch, Tim/0000-0003-3998-533X; Meister, Markus/0000-0003-2136-6506	Minerva Foundation; German Research Foundation; Max Planck Society; German Research Foundation [SFB 889]; International Human Frontier Science Program Organization; Israel Science Foundation; Israeli Ministry of Defense; Gatsby Charitable Foundation; National Institutes of Health; NATIONAL EYE INSTITUTE [R01EY014737] Funding Source: NIH RePORTER	Minerva Foundation; German Research Foundation(German Research Foundation (DFG)); Max Planck Society(Max Planck Society); German Research Foundation(German Research Foundation (DFG)); International Human Frontier Science Program Organization(Human Frontier Science Program); Israel Science Foundation(Israel Science Foundation); Israeli Ministry of Defense; Gatsby Charitable Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by the Minerva Foundation and the German Research Foundation (RG); the Max Planck Society, the German Research Foundation SFB 889, and the International Human Frontier Science Program Organization (TG); the Israel Science Foundation, the Israeli Ministry of Defense, and the Gatsby Charitable Foundation (HS); and the National Institutes of Health (MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala-Laurila P, 2011, NAT NEUROSCI, V14, P1309, DOI 10.1038/nn.2927; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; AMTHOR FR, 1989, J COMP NEUROL, V280, P97, DOI 10.1002/cne.902800108; Arabzadeh E, 2006, J NEUROSCI, V26, P9216, DOI 10.1523/JNEUROSCI.1491-06.2006; Arbib M., 1969, IEEE T INFORM THEORY, V15, P738; BARNDEN JA, 1993, IEEE T NEURAL NETWOR, V4, P844, DOI 10.1109/72.248461; Blitz DM, 2005, NEURON, V45, P917, DOI 10.1016/j.neuron.2005.01.033; Boudreau CE, 2005, J NEUROSCI, V25, P7179, DOI 10.1523/JNEUROSCI.1445-05.2005; BRAINARD DH, 1989, COLOR RES APPL, V14, P23, DOI 10.1002/col.5080140107; Burkhardt DA, 1998, VISUAL NEUROSCI, V15, P219, DOI 10.1017/S0952523898152021; Carandini M, 2006, J PHYSIOL-LONDON, V577, P463, DOI 10.1113/jphysiol.2006.118976; Cardin JA, 2007, J NEUROSCI, V27, P10333, DOI 10.1523/JNEUROSCI.1692-07.2007; CARR CE, 1990, J NEUROSCI, V10, P3227; CELEBRINI S, 1993, VISUAL NEUROSCI, V10, P811, DOI 10.1017/S0952523800006052; Chase SM, 2007, P NATL ACAD SCI USA, V104, P5175, DOI 10.1073/pnas.0610368104; Chen CF, 2002, NEURON, V33, P779, DOI 10.1016/S0896-6273(02)00611-6; Chichilnisky EJ, 2002, J NEUROSCI, V22, P2737, DOI 10.1523/JNEUROSCI.22-07-02737.2002; CLELAND BG, 1971, J PHYSIOL-LONDON, V217, P473, DOI 10.1113/jphysiol.1971.sp009581; CLELAND BG, 1976, J PHYSIOL-LONDON, V255, P299, DOI 10.1113/jphysiol.1976.sp011281; Dacey D, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P281; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; Delorme A, 2003, J COMPUT NEUROSCI, V15, P357, DOI 10.1023/A:1027420012134; Delorme A, 2001, NEURAL NETWORKS, V14, P795, DOI 10.1016/S0893-6080(01)00049-1; DEMONASTERIO FM, 1975, J PHYSIOL-LONDON, V251, P167, DOI 10.1113/jphysiol.1975.sp011086; DeWeese MR, 2003, J NEUROSCI, V23, P7940; Freiwald WA, 2010, SCIENCE, V330, P845, DOI 10.1126/science.1194908; FREUND TF, 1989, J COMP NEUROL, V289, P315, DOI 10.1002/cne.902890211; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Gawne TJ, 1996, J NEUROPHYSIOL, V76, P1356, DOI 10.1152/jn.1996.76.2.1356; Geffen MN, 2007, PLOS BIOL, V5, P640, DOI 10.1371/journal.pbio.0050065; Gollisch T, 2008, BIOL CYBERN, V99, P263, DOI 10.1007/s00422-008-0252-y; Gollisch T, 2008, SCIENCE, V319, P1108, DOI 10.1126/science.1149639; Greschner M, 2006, J NEUROPHYSIOL, V96, P2845, DOI 10.1152/jn.01131.2005; Gutig R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000141; Gutig R, 2006, NAT NEUROSCI, V9, P420, DOI 10.1038/nn1643; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Hertz JA, 2018, INTRO THEORY NEURAL; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Hromadka T, 2009, CURR OPIN NEUROBIOL, V19, P430, DOI 10.1016/j.conb.2009.07.009; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; Johansson RS, 2004, NAT NEUROSCI, V7, P170, DOI 10.1038/nn1177; KAPLAN E, 1984, EXP BRAIN RES, V55, P111; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; Liu HS, 2009, NEURON, V62, P281, DOI 10.1016/j.neuron.2009.02.025; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; Masquelier T, 2007, PLOS COMPUT BIOL, V3, P247, DOI 10.1371/journal.pcbi.0030031; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; NODA H, 1975, BRAIN RES, V84, P515, DOI 10.1016/0006-8993(75)90769-6; Olshausen BA, 2005, NEURAL COMPUT, V17, P1665, DOI 10.1162/0899766054026639; Panzeri S, 2001, NEURON, V29, P769, DOI 10.1016/S0896-6273(01)00251-3; Rathbun DL, 2010, J NEUROSCI, V30, P13558, DOI 10.1523/JNEUROSCI.0909-10.2010; Rokem A, 2006, J NEUROPHYSIOL, V95, P2541, DOI 10.1152/jn.00891.2005; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; Roska B, 2003, NAT NEUROSCI, V6, P600, DOI 10.1038/nn1061; Sawtell NB, 2006, J NEUROSCI, V26, P8221, DOI 10.1523/JNEUROSCI.1508-06.2006; Schaefer AT, 2006, PLOS BIOL, V4, P1010, DOI 10.1371/journal.pbio.0040163; Segev R, 2007, J NEUROPHYSIOL, V98, P1380, DOI 10.1152/jn.00395.2007; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shamir M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000286; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stanford TR, 2010, NAT NEUROSCI, V13, P379, DOI 10.1038/nn.2485; Stanley GB, 2012, J NEUROSCI, V32, P9073, DOI 10.1523/JNEUROSCI.4968-11.2012; STONE J, 1974, J NEUROPHYSIOL, V37, P722, DOI 10.1152/jn.1974.37.4.722; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Usrey WM, 2002, PHILOS T ROY SOC B, V357, P1729, DOI 10.1098/rstb.2002.1157; Usrey WM, 2000, J NEUROSCI, V20, P5461, DOI 10.1523/JNEUROSCI.20-14-05461.2000; Van Rullen R, 2001, NEURAL COMPUT, V13, P1255, DOI 10.1162/08997660152002852; VanRullen R, 2005, TRENDS NEUROSCI, V28, P1, DOI 10.1016/j.tins.2004.10.010; Victor JD, 2000, BRAIN RES, V886, P33, DOI 10.1016/S0006-8993(00)02751-7; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; Zhou Y, 2010, NEURON, V65, P706, DOI 10.1016/j.neuron.2010.02.021	79	25	26	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53063	10.1371/journal.pone.0053063	http://dx.doi.org/10.1371/journal.pone.0053063			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301021	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000313320900057
J	Martinez-Palacian, A; del Castillo, G; Suarez-Causado, A; Garcia-Alvaro, M; de la Morena-Frutos, D; Fernandez, M; Roncero, C; Fabregat, I; Herrera, B; Sanchez, A				Martinez-Palacian, Adoracion; del Castillo, Gaelle; Suarez-Causado, Amileth; Garcia-Alvaro, Maria; de la Morena-Frutos, Diego; Fernandez, Margarita; Roncero, Cesareo; Fabregat, Isabel; Herrera, Blanca; Sanchez, Aranzazu			Mouse Hepatic Oval Cells Require Met-Dependent PI3K to Impair TGF-beta-Induced Oxidative Stress and Apoptosis	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; FETAL-RAT HEPATOCYTES; STEM-CELLS; TRANSFORMING GROWTH-FACTOR-BETA-1; SIGNAL-TRANSDUCTION; LIVER-REGENERATION; UP-REGULATION; EXPRESSION; PROLIFERATION; ACTIVATION	We have previously shown that oval cells harboring a genetically inactivated Met tyrosine kinase (Met(-/-) oval cells) are more sensitive to TGF-beta-induced apoptosis than cells expressing a functional Met (Met(flx/flx)), demonstrating that the HGF/Met axis plays a pivotal role in oval cell survival. Here, we have examined the mechanism behind this effect and have found that TGF-beta-induced a mitochondria-dependent apoptotic cell death in Met(flx/flx) and Met(-/-) oval cells, associated with a marked increase in levels of the BH3-only proteins Bim and Bmf. Bmf plays a key role during TGF-beta-mediated apoptosis since knocking down of BMF significantly diminished the apoptotic response in Met(-/-) oval cells. TGF-beta also induced oxidative stress accompanied by NADPH oxidase 4 (Nox4) mRNA up-regulation and decreased protein levels of antioxidant enzymes. Antioxidants inhibit both TGF-beta-induced caspase 3 activity and Bmf up-regulation, revealing an oxidative stress-dependent Bmf regulation by TGF-beta. Notably, oxidative stress-related events were strongly amplified in Met(-/-) oval cells, emphasizing the critical role of Met in promoting survival. Pharmacological inhibition of PI3K did impair HGF- driven protection from TGF-beta-induced apoptosis and increased sensitivity of Met(flx/flx) oval cells to TGF-beta by enhancing oxidative stress, reaching apoptotic indices similar to those obtained in Met(-/-) oval cells. Interestingly, both PI3K inhibition and/ or knockdown itself resulted in caspase-3 activation and loss of viability in Met(flx/flx) oval cells, whereas no effect was observed in Met(-/-) oval cells. Altogether, results presented here provide solid evidences that both paracrine and autocrine HGF/Met signaling requires PI3K to promote mouse hepatic oval cell survival against TGF-beta-induced oxidative stress and apoptosis.	[Martinez-Palacian, Adoracion; del Castillo, Gaelle; Suarez-Causado, Amileth; Garcia-Alvaro, Maria; de la Morena-Frutos, Diego; Fernandez, Margarita; Roncero, Cesareo; Herrera, Blanca; Sanchez, Aranzazu] Univ Complutense, Fac Farm, Dep Bioquim & Biol Mol 2, Inst Invest Sanitaria Hosp Clin San Carlos IdISSC, E-28040 Madrid, Spain; [Fabregat, Isabel] Univ Barcelona, Inst Invest Biomed Bellvitge, Oncol Mol Lab, Barcelona, Spain; [Fabregat, Isabel] Univ Barcelona, Inst Invest Biomed Bellvitge, Dept Ciencies Fisiol 2, Barcelona, Spain	Complutense University of Madrid; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Sanchez, A (corresponding author), Univ Complutense, Fac Farm, Dep Bioquim & Biol Mol 2, Inst Invest Sanitaria Hosp Clin San Carlos IdISSC, E-28040 Madrid, Spain.	munozas@farm.ucm.es	Herrera, Blanca/K-1803-2014; Sánchez, Aránzazu/H-7810-2015; Roncero, Cesáreo/H-9039-2015; Fernández, Margarita/H-9077-2015; Fabregat, Isabel/H-7038-2015	Herrera, Blanca/0000-0002-2415-2055; Sánchez, Aránzazu/0000-0001-9145-6633; Roncero, Cesáreo/0000-0001-7608-8553; Fernández, Margarita/0000-0001-7207-2028; Fabregat, Isabel/0000-0003-0136-8440	Ministry of Education and Science [SAF2006-12025]; Alban scholarship program; Ministry of Education and Science (Spain) [SAF2006-12025]; Ministry of Science and Innovation (Spain) [SAF2009-12477]; CAM-UCM [920359]; BSCH-UCM [920359];  [S2010/BMD-2402]	Ministry of Education and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Alban scholarship program; Ministry of Education and Science (Spain)(Spanish Government); Ministry of Science and Innovation (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CAM-UCM; BSCH-UCM; 	AMP was recipient of a research-training contract (grant SAF2006-12025) from the Ministry of Education and Science. GC was recipient of a research-training contract from the Ministry of Education and Science. ASC was recipient of an Alban scholarship program and then a research assistant contract (grant SAF2009-12477). MGA is recipient of a research assistant contract (grant S2010/BMD-2402). This work has been supported by grants SAF2006-12025 from Ministry of Education and Science (Spain), SAF2009-12477 from Ministry of Science and Innovation (Spain), and 920359 (CAM-UCM, BSCH-UCM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black D, 2007, BIOCHIMIE, V89, P1464, DOI 10.1016/j.biochi.2007.09.001; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; Caja L, 2009, CANCER RES, V69, P7595, DOI 10.1158/0008-5472.CAN-09-1482; Carmona-Cuenca I, 2006, J CELL PHYSIOL, V207, P322, DOI 10.1002/jcp.20568; Carmona-Cuenca I, 2008, J HEPATOL, V49, P965, DOI 10.1016/j.jhep.2008.07.021; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Del Castillo G, 2008, J CELL PHYSIOL, V215, P846, DOI 10.1002/jcp.21370; del Castillo G, 2008, AM J PATHOL, V172, P1238, DOI 10.2353/ajpath.2008.070793; del Castillo G, 2006, EXP CELL RES, V312, P2860, DOI 10.1016/j.yexcr.2006.05.017; Ding W, 2009, HEPATOLOGY, V49, P1277, DOI 10.1002/hep.22743; Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044; Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6; Franklin CC, 2003, FASEB J, V17, P1535, DOI 10.1096/fj.02-0867fje; Freathy C, 2000, HEPATOLOGY, V32, P750, DOI 10.1053/jhep.2000.18329; Giannelli G, 2011, BBA-REV CANCER, V1815, P214, DOI 10.1016/j.bbcan.2010.11.004; Gomez-Quiroz LE, 2008, J BIOL CHEM, V283, P14581, DOI 10.1074/jbc.M707733200; Grotegut S, 2010, INT J ONCOL, V36, P1261, DOI 10.3892/ijo_00000610; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Herrera B, 2004, FREE RADICAL BIO MED, V36, P16, DOI 10.1016/j.freeradbiomed.2003.09.020; Herrera B, 2001, FEBS LETT, V499, P225, DOI 10.1016/S0014-5793(01)02554-6; Herrera B, 2001, FASEB J, V15, P741, DOI 10.1096/fj.00-0267com; Hu ZX, 2010, EUR J PHARMACOL, V645, P23, DOI 10.1016/j.ejphar.2010.07.011; HU ZY, 1993, AM J PATHOL, V142, P1823; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Kannan R, 2004, FREE RADICAL BIO MED, V37, P166, DOI 10.1016/j.freeradbiomed.2004.04.011; Kato H, 2007, HEPATO-GASTROENTEROL, V54, P821; KAYANOKI Y, 1994, J BIOL CHEM, V269, P15488; Kiyono K, 2009, CANCER RES, V69, P8844, DOI 10.1158/0008-5472.CAN-08-4401; Lau CK, 2009, CLIN CANCER RES, V15, P3462, DOI 10.1158/1078-0432.CCR-08-2127; Li H, 2006, AM J NEPHROL, V26, P519, DOI 10.1159/000097368; Li YJ, 2006, J AM SOC NEPHROL, V17, P54, DOI 10.1681/ASN.2005030257; Martinez-Palacian A, 2012, CELL SIGNAL, V24, P505, DOI 10.1016/j.cellsig.2011.09.031; Mates JM, 2000, TOXICOLOGY, V153, P83, DOI 10.1016/S0300-483X(00)00306-1; Mishra L, 2009, HEPATOLOGY, V49, P318, DOI 10.1002/hep.22704; NAKAMURA T, 1985, BIOCHEM BIOPH RES CO, V133, P1042, DOI 10.1016/0006-291X(85)91241-0; Nakamura T, 2010, P JPN ACAD B-PHYS, V86, P588, DOI 10.2183/pjab.86.588; Nguyen LN, 2007, HEPATOLOGY, V45, P31, DOI 10.1002/hep.21466; Niimura M, 2006, NEUROSCI LETT, V407, P136, DOI 10.1016/j.neulet.2006.08.060; OBERHAMMER F, 1991, CANCER RES, V51, P2478; Ohgushi M, 2005, MOL CELL BIOL, V25, P10017, DOI 10.1128/MCB.25.22.10017-10028.2005; Okano J, 2003, BIOCHEM BIOPH RES CO, V309, P298, DOI 10.1016/j.bbrc.2003.04.002; Park DY, 1999, J KOREAN MED SCI, V14, P531, DOI 10.3346/jkms.1999.14.5.531; Park HJ, 2002, HEPATOLOGY, V35, P1360, DOI 10.1053/jhep.2002.33205; Preisegger KH, 1999, LAB INVEST, V79, P103; Ramesh S, 2008, EMBO REP, V9, P990, DOI 10.1038/embor.2008.158; Ramjaun AR, 2007, ONCOGENE, V26, P970, DOI 10.1038/sj.onc.1209852; RUSSELL WE, 1988, P NATL ACAD SCI USA, V85, P5126, DOI 10.1073/pnas.85.14.5126; Sanchez A, 1996, J BIOL CHEM, V271, P7416, DOI 10.1074/jbc.271.13.7416; SANCHEZ A, 1995, J CELL PHYSIOL, V165, P398, DOI 10.1002/jcp.1041650221; Sanchez-Capelo A, 2005, CYTOKINE GROWTH F R, V16, P15, DOI 10.1016/j.cytogfr.2004.11.002; Sancho P, 2009, BBA-MOL CELL RES, V1793, P253, DOI 10.1016/j.bbamcr.2008.09.003; Schmelzle T, 2007, P NATL ACAD SCI USA, V104, P3787, DOI 10.1073/pnas.0700115104; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Schulze-Bergkamen H, 2004, HEPATOLOGY, V39, P645, DOI 10.1002/hep.20138; Shao YP, 2010, CANCER RES, V70, P6670, DOI 10.1158/0008-5472.CAN-09-4471; Tanaka M, 2011, J BIOCHEM, V149, P231, DOI 10.1093/jb/mvr001; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Tsuboi S, 1999, J BIOCHEM-TOKYO, V126, P815, DOI 10.1093/oxfordjournals.jbchem.a022521; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; Valdes-Arzate A, 2009, FREE RADICAL BIO MED, V47, P424, DOI 10.1016/j.freeradbiomed.2009.05.014; Webster CRL, 2001, HEPATOLOGY, V33, P608, DOI 10.1053/jhep.2001.22756; Whelan KA, 2010, MOL BIOL CELL, V21, P3829, DOI 10.1091/mbc.E10-04-0353; Wildey GM, 2003, J BIOL CHEM, V278, P18069, DOI 10.1074/jbc.M211958200; Yamamoto K, 2001, HYPERTENSION, V37, P1341, DOI 10.1161/01.HYP.37.5.1341; Yang JW, 2005, J AM SOC NEPHROL, V16, P68, DOI 10.1681/ASN.2003090795; Yang JW, 2003, AM J PATHOL, V163, P621, DOI 10.1016/S0002-9440(10)63689-9; Yao P, 2004, J HEPATOL, V40, P391, DOI 10.1016/j.jhep.2003.11.001; Yu XJ, 2010, MOL BIOL REP, V37, P2423, DOI 10.1007/s11033-009-9753-6; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	70	22	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53108	10.1371/journal.pone.0053108	http://dx.doi.org/10.1371/journal.pone.0053108			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301029	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000313320900061
J	Nelson, BT; Ding, XS; Boney-Montoya, J; Gerard, RD; Kliewer, SA; Andrews, MT				Nelson, Bethany T.; Ding, Xunshan; Boney-Montoya, Jamie; Gerard, Robert D.; Kliewer, Steven A.; Andrews, Matthew T.			Metabolic Hormone FGF21 Is Induced in Ground Squirrels during Hibernation but Its Overexpression Is Not Sufficient to Cause Torpor	PLOS ONE			English	Article							PANCREATIC TRIACYLGLYCEROL LIPASE; PDK4 GENE-EXPRESSION; BETA-KLOTHO; SKELETAL-MUSCLE; PPAR-ALPHA; INDUCTION; BRAIN; TRANSCRIPTION; PGC-1-ALPHA; FGF-21	Hibernation is a natural adaptation that allows certain mammals to survive physiological extremes that are lethal to humans. Near freezing body temperatures, heart rates of 3-10 beats per minute, absence of food consumption, and depressed metabolism are characteristic of hibernation torpor bouts that are periodically interrupted by brief interbout arousals (IBAs). The molecular basis of torpor induction is unknown, however starved mice overexpressing the metabolic hormone fibroblast growth factor 21 (FGF21) promote fat utilization, reduce body temperature, and readily enter torpor-all hallmarks of mammalian hibernation. In this study we cloned FGF21 from the naturally hibernating thirteen-lined ground squirrel (Ictidomys tridecemlineatus) and found that levels of FGF21 mRNA in liver and FGF21 protein in serum are elevated during hibernation torpor bouts and significantly elevated during IBAs compared to summer active animals. The effects of artificially elevating circulating FGF21 concentrations 50 to 100-fold via adenoviral-mediated overexpression were examined at three different times of the year. This is the first time that a transgenic approach has been used in a natural hibernator to examine mechanistic aspects of hibernation. Surgically implanted transmitters measured various metrics of the hibernation phenotype over a 7-day period including changes in motor activity, heart rate and core body temperature. In April fed-state animals, FGF21 overexpression decreased blood insulin and free fatty acid concentrations, effects similar to those seen in obese mice. However, elevated FGF21 concentrations did not cause torpor in these fed-state animals nor did they cause torpor or affect metabolic parameters in fasted-state animals in March/April, August or October. We conclude that FGF21 is strongly regulated during torpor and IBA but that its overexpression is not sufficient to cause torpor in naturally hibernating ground squirrels.	[Nelson, Bethany T.; Andrews, Matthew T.] Univ Minnesota, Dept Biol, Duluth, MN 55812 USA; [Ding, Xunshan; Boney-Montoya, Jamie; Gerard, Robert D.; Kliewer, Steven A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Minnesota System; University of Minnesota Duluth; University of Texas System; University of Texas Southwestern Medical Center Dallas	Andrews, MT (corresponding author), Univ Minnesota, Dept Biol, Duluth, MN 55812 USA.	mandrews@d.umn.edu			National Institutes of Health (NIH) [5RC2HL101625, 1RL1GM084436]; Robert A. Welch Foundation [I-1558]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RL1GM084436] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health (NIH) grants 5RC2HL101625 to MTA, 1RL1GM084436 to SAK, and Robert A. Welch Foundation Grant I-1558 to SAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrews MT, 2007, BIOESSAYS, V29, P431, DOI 10.1002/bies.20560; Andrews MT, 2009, AM J PHYSIOL-REG I, V296, pR383, DOI 10.1152/ajpregu.90795.2008; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, AM J PHYSIOL-ENDOC M, V297, pE1197, DOI 10.1152/ajpendo.00357.2009; Bauer VW, 2001, AM J PHYSIOL-REG I, V281, pR1186, DOI 10.1152/ajpregu.2001.281.4.R1186; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fisher FM, 2011, ENDOCRINOLOGY, V152, P2996, DOI 10.1210/en.2011-0281; Fukumoto S, 2008, ENDOCR J, V55, P23, DOI 10.1507/endocrj.KR07E-002; Furuyama T, 2003, BIOCHEM J, V375, P365, DOI 10.1042/BJ20030022; Gavrilova O, 1999, P NATL ACAD SCI USA, V96, P14623, DOI 10.1073/pnas.96.25.14623; Geiser F, 1998, AM J PHYSIOL-REG I, V275, pR1627, DOI 10.1152/ajpregu.1998.275.5.R1627; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Gerard RD, 1995, ADENOVIRUS VECTORS D, P285; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Hampton M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027021; Hotta Y, 2009, ENDOCRINOLOGY, V150, P4625, DOI 10.1210/en.2009-0119; Hsuchou H, 2007, PEPTIDES, V28, P2382, DOI 10.1016/j.peptides.2007.10.007; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Jinka TR, 2011, J NEUROSCI, V31, P10752, DOI 10.1523/JNEUROSCI.1240-11.2011; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2008, J CELL PHYSIOL, V215, P1, DOI 10.1002/jcp.21357; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Lyman C.P., 1982, HIBERNATION TORPOR M; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Oishi K, 2010, NEUROENDOCRINOL LETT, V31, P198; Ornitz DM, 2001, GENOME BIOL, V2; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Squire TL, 2003, PHYSIOL GENOMICS, V16, P131, DOI 10.1152/physiolgenomics.00168.2002; Squire TL, 2003, PHYSIOL GENOMICS, V16, P119, DOI 10.1152/physiolgenomics.00167.2002; Suzuki M, 2008, MOL ENDOCRINOL, V22, P1006, DOI 10.1210/me.2007-0313; Tsintzas K, 2006, J PHYSIOL-LONDON, V575, P291, DOI 10.1113/jphysiol.2006.109892; van Breukelen F, 2002, J COMP PHYSIOL B, V172, P355, DOI 10.1007/s00360-002-0256-1; Van Breukelen F, 2001, AM J PHYSIOL-REG I, V281, pR1374, DOI 10.1152/ajpregu.2001.281.5.R1374; Vybiral S, 1997, COMP BIOCHEM PHYS A, V118, P1125, DOI 10.1016/S0300-9629(97)00239-9; WANG LCH, 1988, CRYOBIOLOGY, V25, P355, DOI 10.1016/0011-2240(88)90043-0; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	44	13	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53574	10.1371/journal.pone.0053574	http://dx.doi.org/10.1371/journal.pone.0053574			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301087	gold, Green Published, Green Submitted			2022-12-25	WOS:000313320900084
J	Munugalavadla, V; Mariathasan, S; Slaga, D; Du, C; Berry, L; Del Rosario, G; Yan, Y; Boe, M; Sun, L; Friedman, LS; Chesi, M; Bergsagel, PL; Ebens, A				Munugalavadla, V.; Mariathasan, S.; Slaga, D.; Du, C.; Berry, L.; Del Rosario, G.; Yan, Y.; Boe, M.; Sun, L.; Friedman, L. S.; Chesi, M.; Bergsagel, P. Leif; Ebens, A.			The PI3K inhibitor GDC-0941 combines with existing clinical regimens for superior activity in multiple myeloma	ONCOGENE			English	Article						GDC-0941; PI3K; multiple myeloma; FoxO3A	ORALLY BIOAVAILABLE INHIBITOR; TARGET; IDENTIFICATION; RAPAMYCIN; PATHWAY; GROWTH; POTENT; KINASE	The phosphatidylinositol 3'-kinase (PI3K) pathway is dysregulated in multiple myeloma (MM); we therefore tested a highly selective class I PI3K inhibitor, GDC-0941, for anti-myeloma activity. Functional and mechanistic studies were first performed in MM cell lines, then extended to primary MM patient samples cultured in vitro. GDC-0941 was then assessed as a single agent and in various combinations in myeloma tumor xenograft models. We show p110 alpha and beta are the predominant PI3K catalytic subunits in MM and that a highly selective class I PI3K inhibitor, GDC-0941, has robust activity as a single agent to induce cell cycle arrest and apoptosis of both MM cell lines and patient myeloma cells. Mechanistic studies revealed an induction of cell cycle arrest at G(0)/G(1), with decreased phospho-FoxO1/3a levels, decreased cyclin D1 and c-myc expression, and an increase in the cell cycle inhibitor, p27kip. Induction of apoptosis correlated with increased expression of the pro-apoptotic BH3-only protein BIM, cleaved caspase 3 and cleaved poly (ADP-ribose) polymerase (PARP). In vitro, GDC-0941 synergized with dexamethasone (Dex) and lenalidomide (combination index values of 0.3-0.4 and 0.4-0.8, respectively); in vivo GDC-0941 has anti-myeloma activity and significantly increases the activity of the standard of care agents in several murine xenograft tumor models (additional tumor growth inhibition of 37-53% (Dex) and 22-72% (lenalidomide)). These data provide a clear therapeutic hypothesis for the inhibition of PI3K and provide a rationale for clinical development of GDC-0941 in myeloma.	[Munugalavadla, V.; Mariathasan, S.; Slaga, D.; Du, C.; Berry, L.; Del Rosario, G.; Sun, L.; Friedman, L. S.; Ebens, A.] Genentech Inc, Dept Canc Immunotherapy & Hematol, San Francisco, CA 94080 USA; [Yan, Y.; Boe, M.] Genentech Inc, Dept Oncol Biomarker Dev, San Francisco, CA 94080 USA; [Chesi, M.; Bergsagel, P. Leif] Mayo Clin, Dept Med, Ctr Comprehens Canc, Scottsdale, AZ USA	Roche Holding; Genentech; Roche Holding; Genentech; Mayo Clinic; Mayo Clinic Phoenix	Munugalavadla, V (corresponding author), Genentech Inc, Dept Canc Immunotherapy & Hematol, 1 DNA Way,MS 231C,Room 14-3166, San Francisco, CA 94080 USA.	veerendm@gene.com	Bergsagel, Peter Leif/A-7842-2011; Du, Changchun/AAW-6540-2020	Bergsagel, Peter Leif/0000-0003-1523-7388; 				Anderson KC, 2011, ANNU REV PATHOL-MECH, V6, P249, DOI 10.1146/annurev-pathol-011110-130249; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Baumann P, 2009, EXP CELL RES, V315, P485, DOI 10.1016/j.yexcr.2008.11.007; Chanan-Khan AA, BR J HAEMATOL, V151, P3; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Dib Amel, 2008, J Natl Cancer Inst Monogr, P25, DOI 10.1093/jncimonographs/lgn011; Drexler HG, 2000, LEUKEMIA RES, V24, P681, DOI 10.1016/S0145-2126(99)00195-2; Ebens A, 2010, ASH ANN M, V116, P3001; Feldman ME, CURR TOP MICROBIOL I, V347, P241; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Gera J, 2011, LEUKEMIA LYMPHOMA, V52, P1857, DOI 10.3109/10428194.2011.580478; Harvey R Donald, 2007, Future Oncol, V3, P639, DOI 10.2217/14796694.3.6.639; Hoang B, 2010, BLOOD, V116, P4560, DOI 10.1182/blood-2010-05-285726; Ikeda H, 2010, BLOOD, V116, P1460, DOI 10.1182/blood-2009-06-222943; Ismail SI, 2010, LEUKEMIA RES, V34, P824, DOI 10.1016/j.leukres.2009.11.018; Jou ST, 2002, MOL CELL BIOL, V22, P8580, DOI 10.1128/MCB.22.24.8580-8591.2002; Kawauchi K, 2009, ANTI-CANCER AGENT ME, V9, P1024, DOI 10.2174/187152009789377772; Kawauchi K, 2009, ANTI-CANCER AGENT ME, V9, P550, DOI 10.2174/187152009788451851; Khwaja A, CURR TOP MICROBIOL I, V347, P169; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Kyle RA, 2009, CLIN LYMPHOMA MYELOM, V9, P278, DOI 10.3816/CLM.2009.n.056; Lee T, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000013; McMillin DW, 2009, CANCER RES, V69, P5835, DOI 10.1158/0008-5472.CAN-08-4285; Munugalavadla V, 2010, ASH ANN M, V116, P4084; Munugalavadla V, 2008, MOL CELL BIOL, V28, P7182, DOI 10.1128/MCB.00920-08; O'Brien C, CLIN CANC RES, V16, P3670; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Podar K, 2009, LEUKEMIA, V23, P10, DOI 10.1038/leu.2008.259; Rahmani M, 2009, BLOOD, V114, P4507, DOI 10.1182/blood-2008-09-177881; Rajkurnar SV, 2007, BEST PRACT RES CL HA, V20, P665, DOI 10.1016/j.beha.2007.10.002; Raynaud FI, 2009, MOL CANCER THER, V8, P1725, DOI 10.1158/1535-7163.MCT-08-1200; Yasui H, 2006, BRIT J HAEMATOL, V132, P385, DOI 10.1111/j.1365-2141.2005.05860.x; Zhang J, 2003, ONCOGENE, V22, P6289, DOI 10.1038/sj.onc.1206718; Zhao L, 2004, CLIN CANCER RES, V10, P7994, DOI 10.1158/1078-0432.CCR-04-1087; Zollinger A, 2008, BLOOD, V112, P3403, DOI 10.1182/blood-2007-11-119362	35	31	34	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 16	2014	33	3					316	325		10.1038/onc.2012.594	http://dx.doi.org/10.1038/onc.2012.594			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	296VR	23318440				2022-12-25	WOS:000330214000006
J	Ichim, G; Mola, M; Finkbeiner, MG; Cros, MP; Herceg, Z; Hernandez-Vargas, H				Ichim, G.; Mola, M.; Finkbeiner, M. G.; Cros, M-P; Herceg, Z.; Hernandez-Vargas, H.			The histone acetyltransferase component TRRAP is targeted for destruction during the cell cycle	ONCOGENE			English	Article						APC; Cdc20; Cdh1; TRRAP; mitosis; cell cycle	ANAPHASE-PROMOTING COMPLEX/CYCLOSOME; EARLY MITOTIC DEGRADATION; HAT COFACTOR TRRAP; CHROMATIN; MITOSIS; PROGRESSION; COMPLEX; ACETYLATION; TRANSCRIPTION; CHECKPOINT	Chromosomes are dynamic structures that must be reversibly condensed and unfolded to accommodate mitotic division and chromosome segregation. Histone modifications are involved in the striking chromatin reconfiguration taking place during mitosis. However, the mechanisms that regulate activity and function of histone-modifying factors as cells enter and exit mitosis are poorly understood. Here, we show that the anaphase-promoting complex or cyclosome (APC/C) is involved in the mitotic turnover of TRRAP (TRansformation/tRanscription domain-Associated Protein), a common component of histone acetyltransferase (HAT) complexes, and that the pre-mitotic degradation of TRRAP is mediated by the APC/C ubiquitin ligase activators Cdc20 and Cdh1. Ectopic expression of both Cdh1 and Cdc20 reduced the levels of coexpressed TRRAP protein and induced its ubiquitination. TRRAP overexpression or stabilization induces multiple mitotic defects, including lagging chromosomes, chromosome bridges and multipolar spindles. In addition, lack of sister chromatid cohesion and impaired chromosome condensation were found after TRRAP overexpression or stabilization. By using a truncated form of TRRAP, we show that mitotic delay is associated with a global histone H4 hyperacetylation induced by TRRAP overexpression. These results demonstrate that the chromatin modifier TRRAP is targeted for destruction in a cell cycle-dependent fashion. They also suggest that degradation of TRRAP by the APC/C is necessary for a proper condensation of chromatin and proper chromosome segregation. Chromatin compaction mediated by histone modifiers may represent a fundamental arm for APC/C orchestration of the mitotic machinery.	[Ichim, G.; Mola, M.; Finkbeiner, M. G.; Cros, M-P; Herceg, Z.; Hernandez-Vargas, H.] Int Agcy Res Canc IARC, Epigenet Grp, F-69008 Lyon, Rhone Alpes, France	World Health Organization; International Agency for Research on Cancer (IARC)	Herceg, Z (corresponding author), Int Agcy Res Canc IARC, Epigenet Grp, 150 Rue Albert Thomas, F-69008 Lyon, Rhone Alpes, France.	herceg@iarc.fr; vargash@iarc.fr	Ichim, Gabriel/AAJ-5822-2021	Ichim, Gabriel/0000-0002-8386-7405; Hernandez-Vargas, Hector/0000-0001-6045-2103	Association pour la Recherche sur le Cancer (ARC), France; la Ligue Nationale (Francaise) Contre le Cancer (France); Institut National du Cancer (INCA, France); Association for International Cancer Research (AICR), UK	Association pour la Recherche sur le Cancer (ARC), France(Fondation ARC pour la Recherche sur le Cancer); la Ligue Nationale (Francaise) Contre le Cancer (France)(Ligue nationale contre le cancer); Institut National du Cancer (INCA, France)(Institut National du Cancer (INCA) France); Association for International Cancer Research (AICR), UK	We thank Michael Cole for generous gift of the TRRAP expression vector. This work was supported by the Association pour la Recherche sur le Cancer (ARC), France, la Ligue Nationale (Francaise) Contre le Cancer (France), the Institut National du Cancer (INCA, France) and the Association for International Cancer Research (AICR), UK.	Amador V, 2007, MOL CELL, V27, P462, DOI 10.1016/j.molcel.2007.06.013; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Cummings WJ, 2007, PLOS BIOL, V5, P2145, DOI 10.1371/journal.pbio.0050246; Deran M, 2008, MOL CELL BIOL, V28, P435, DOI 10.1128/MCB.00607-07; Eot-Houllier G, 2008, GENE DEV, V22, P2639, DOI 10.1101/gad.484108; Fu GS, 2007, CELL RES, V17, P608, DOI 10.1038/cr.2007.55; Gabellini D, 2003, EMBO J, V22, P3715, DOI 10.1093/emboj/cdg340; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hayes MJ, 2006, NAT CELL BIOL, V8, P607, DOI 10.1038/ncb1410; Herceg Z, 2001, NAT GENET, V29, P206, DOI 10.1038/ng725; Herceg Z, 2005, CELL CYCLE, V4, P383, DOI 10.4161/cc.4.3.1546; Herceg Z, 2003, NUCLEIC ACIDS RES, V31, P7011, DOI 10.1093/nar/gkg902; Hernandez-Vargas H, 2007, ONCOGENE, V26, P2902, DOI 10.1038/sj.onc.1210102; Kruhlak MJ, 2001, J BIOL CHEM, V276, P38307; Li H, 2004, EMBO J, V23, P4824, DOI 10.1038/sj.emboj.7600479; Murr R, 2007, ONCOGENE, V26, P5358, DOI 10.1038/sj.onc.1210605; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Ono T, 2004, MOL BIOL CELL, V15, P3296, DOI 10.1091/mbc.E04-03-0242; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Ramaswamy V, 2003, MOL CELL BIOL, V23, P9136, DOI 10.1128/MCB.23.24.9136-9149.2003; Robert F, 2006, MOL CELL BIOL, V26, P402, DOI 10.1128/MCB.26.2.402-412.2006; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Schueler MG, 2006, ANNU REV GENOM HUM G, V7, P301, DOI 10.1146/annurev.genom.7.080505.115613; Song L, 2011, CELL CYCLE, V10, P52, DOI 10.4161/cc.10.1.14387; Turnell AS, 2005, NATURE, V438, P690, DOI 10.1038/nature04151; Valls E, 2005, J BIOL CHEM, V280, P42592, DOI 10.1074/jbc.M507407200; Vernarecci S, 2008, MOL CELL BIOL, V28, P988, DOI 10.1128/MCB.01366-07; Wu SM, 2010, GENE DEV, V24, P2531, DOI 10.1101/gad.1984210	30	16	18	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 9	2014	33	2					181	192		10.1038/onc.2012.570	http://dx.doi.org/10.1038/onc.2012.570			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	286BY	23318449				2022-12-25	WOS:000329440700006
J	Sakai, N; Chun, J; Duffield, JS; Wada, T; Luster, AD; Tager, AM				Sakai, Norihiko; Chun, Jerold; Duffield, Jeremy S.; Wada, Takashi; Luster, Andrew D.; Tager, Andrew M.			LPA(1)-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation	FASEB JOURNAL			English	Article						lysophosphatidic acid; Rho GTPases; myocardin-related transcription factor-A; myocardin-related transcription factor-B; serum response factor	TISSUE GROWTH-FACTOR; ENCAPSULATING PERITONEAL SCLEROSIS; TGF-BETA ACTIVATION; PULMONARY-FIBROSIS; MESOTHELIAL CELLS; DIALYSIS PATIENTS; GENE-EXPRESSION; ACTIN DYNAMICS; LUNG FIBROSIS; C-FOS	There has been much recent interest in lysophosphatidic acid (LPA) signaling through one of its receptors, LPA(1), in fibrotic diseases, but the mechanisms by which LPA-LPA(1) signaling promotes pathological fibrosis remain to be fully elucidated. Using a mouse peritoneal fibrosis model, we demonstrate central roles for LPA and LPA(1) in fibroblast proliferation. Genetic deletion or pharmacological antagonism of LPA(1) protected mice from peritoneal fibrosis, blunting the increases in peritoneal collagen by 65.4 and 52.9%, respectively, compared to control animals and demonstrated that peritoneal fibroblast proliferation was highly LPA(1) dependent. Activation of LPA1 on mesothelial cells induced these cells to express connective tissue growth factor (CTGF), driving fibroblast proliferation in a paracrine fashion. Activation of mesothelial cell LPA(1) induced CTGF expression by inducing cytoskeleton reorganization in these cells, causing nuclear translocation of myocardin-related transcription factor (MRTF)-A and MRTF-B. Pharmacological inhibition of MRTF-induced transcription also diminished CTGF expression and fibrosis in the peritoneal fibrosis model, mitigating the increase in peritoneal collagen content by 57.9% compared to controls. LPA(1)-induced cytoskeleton reorganization therefore makes a previously unrecognized but critically important contribution to the profibrotic activities of LPA by driving MRTF-dependent CTGF expression, which, in turn, drives fibroblast proliferation.-Sakai, N., Chun, J., Duffield, J. S., Wada, T., Luster, A. D., Tager, A. M. LPA(1)-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation. FASEB J. 27, 1830-1846 (2013). www.fasebj.org	[Sakai, Norihiko; Luster, Andrew D.; Tager, Andrew M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Immunol & Inflammatory Dis, Boston, MA USA; [Sakai, Norihiko; Luster, Andrew D.; Tager, Andrew M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA USA; [Tager, Andrew M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Pulm & Crit Care Unit, Boston, MA USA; [Chun, Jerold] Scripps Res Inst, Dept Mol Biol, Helen L Dorris Inst Neurol & Psychiat Disorders, La Jolla, CA 92037 USA; [Duffield, Jeremy S.] Univ Washington, Dept Med, Div Nephrol, Seattle, WA 98195 USA; [Duffield, Jeremy S.] Univ Washington, Ctr Lung Biol, Seattle, WA 98195 USA; [Duffield, Jeremy S.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Wada, Takashi] Kanazawa Univ, Fac Med, Inst Med Pharmaceut & Hlth Sci, Div Nephrol,Dept Lab Med, Kanazawa, Ishikawa, Japan	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Scripps Research Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kanazawa University	Tager, AM (corresponding author), Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, 149 13th St,Rm 8301, Charlestown, MA 02129 USA.	amtager@partners.org	Chun, Jerold/Y-4670-2019; Luster, Andrew/ABE-6504-2020	Luster, Andrew/0000-0001-9679-7912	U.S. National Institutes of Health (NIH) [R01-HL095732, R01-HL108975]; Scleroderma Research Foundation; Pulmonary Fibrosis Foundation; Coalition for Pulmonary Fibrosis; Nirenberg Center for Advanced Lung Disease; Japan Society for the Promotion of Science (JSPS) Excellent Young Researcher Overseas Visit Program; NIH [R01-MH051699, R01-DA019674]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108975, R01HL095732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093493, P30DK043351, R01DK084077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019674] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scleroderma Research Foundation; Pulmonary Fibrosis Foundation; Coalition for Pulmonary Fibrosis; Nirenberg Center for Advanced Lung Disease; Japan Society for the Promotion of Science (JSPS) Excellent Young Researcher Overseas Visit Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors gratefully acknowledge support from U.S. National Institutes of Health (NIH) grants R01-HL095732 and R01-HL108975, and Scleroderma Research Foundation, Pulmonary Fibrosis Foundation, Coalition for Pulmonary Fibrosis, and Nirenberg Center for Advanced Lung Disease grants to A.M.T, the Japan Society for the Promotion of Science (JSPS) Excellent Young Researcher Overseas Visit Program to N.S., and NIH grants R01-MH051699 and R01-DA019674 to J.C. The authors also thank B. A. Fontaine for his expert assistance, and Amira Pharmaceuticals (San Diego, CA, USA) for the kind gift of AM095. The authors declare no conflicts of interest.	Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Aroeira LS, 2007, J AM SOC NEPHROL, V18, P2004, DOI 10.1681/ASN.2006111292; Bansal Saurabh, 2010, Adv Perit Dial, V26, P75; Cabello-Verrugio C, 2011, CELL SIGNAL, V23, P449, DOI 10.1016/j.cellsig.2010.10.019; Castelino FV, 2011, ARTHRITIS RHEUM-US, V63, P1405, DOI 10.1002/art.30262; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Contos J.J., 2000, MOL PHARM, V58, P13384; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; Deng XL, 2008, MOL BIOL CELL, V19, P2520, DOI 10.1091/mbc.E07-07-0720; Evelyn CR, 2007, MOL CANCER THER, V6, P2249, DOI 10.1158/1535-7163.MCT-06-0782; Gan L, 2011, BIOCHEM BIOPH RES CO, V409, P7, DOI 10.1016/j.bbrc.2011.04.084; Grassmann A, 2005, NEPHROL DIAL TRANSPL, V20, P2587, DOI 10.1093/ndt/gfi159; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; Grotendorst GR, 2005, FASEB J, V19, P729, DOI 10.1096/fj.04-3217com; Heusinger-Ribeiro J, 2001, J AM SOC NEPHROL, V12, P1853, DOI 10.1681/ASN.V1291853; Higuchi C, 2006, THER APHER DIAL, V10, P372, DOI 10.1111/j.1744-9987.2006.00391.x; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; HJELLE JT, 1989, PERITON DIALYSIS INT, V9, P341; Hoyles RK, 2011, AM J RESP CRIT CARE, V183, P249, DOI 10.1164/rccm.201002-0279OC; IGARASHI A, 1993, MOL BIOL CELL, V4, P637, DOI 10.1091/mbc.4.6.637; Kawaguchi Y, 2000, PERITON DIALYSIS INT, V20, pS43; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; Leask A, 2003, BIOCHEM CELL BIOL, V81, P355, DOI 10.1139/O03-069; Leask A, 2009, J CELL COMMUN SIGNAL, V3, P89, DOI 10.1007/s12079-009-0037-7; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Liu SX, 2011, ARTHRITIS RHEUM-US, V63, P239, DOI 10.1002/art.30074; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Mizutani M, 2010, AM J PHYSIOL-RENAL, V298, pF721, DOI 10.1152/ajprenal.00368.2009; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Muehlich S, 2007, AM J PHYSIOL-CELL PH, V292, pC1732, DOI 10.1152/ajpcell.00552.2006; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Pradere JP, 2007, J AM SOC NEPHROL, V18, P3110, DOI 10.1681/ASN.2007020196; Price MA, 1996, PHILOS T ROY SOC B, V351, P551, DOI 10.1098/rstb.1996.0054; Rigby RJ, 1998, NEPHROL DIAL TRANSPL, V13, P154, DOI 10.1093/ndt/13.1.154; Sawada T, 2002, PHARMACOL RES, V46, P505, DOI 10.1016/S1043661802002281; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Singh I, 2007, J BIOL CHEM, V282, P7833, DOI 10.1074/jbc.M608288200; Small EM, 2010, CIRC RES, V107, P294, DOI 10.1161/CIRCRESAHA.110.223172; STYLIANOU E, 1990, KIDNEY INT, V37, P1563, DOI 10.1038/ki.1990.150; Swaney JS, 2011, J PHARMACOL EXP THER, V336, P693, DOI 10.1124/jpet.110.175901; Tager AM, 2004, AM J RESP CELL MOL, V31, P395, DOI 10.1165/rcmb.2004-0175OC; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Tatter AL, 2011, J IMMUNOL, V187, P6094, DOI 10.4049/jimmunol.1003507; van der Wal JBC, 2007, COLORECTAL DIS, V9, P9, DOI 10.1111/j.1463-1318.2007.01345.x; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Watanabe N, 2007, LIFE SCI, V81, P1009, DOI 10.1016/j.lfs.2007.08.013; Xu MY, 2009, AM J PATHOL, V174, P1264, DOI 10.2353/ajpath.2009.080160; Yoshio Y, 2004, KIDNEY INT, V66, P1677, DOI 10.1111/j.1523-1755.2004.00935.x; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yung S, 2006, PERITON DIALYSIS INT, V26, P162	53	108	110	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2013	27	5					1830	1846		10.1096/fj.12-219378	http://dx.doi.org/10.1096/fj.12-219378			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	134PU	23322166	Green Published			2022-12-25	WOS:000318226100004
J	Kopfmann, S; Hess, WR				Kopfmann, Stefan; Hess, Wolfgang R.			Toxin-Antitoxin Systems on the Large Defense Plasmid pSYSA of Synechocystis sp PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; INHIBITS TRANSLATION; F-PLASMID; CYANOBACTERIUM; SEQUENCE; PROTEIN; BACTERIA; LOCI; CLEAVAGE; DECAY	Bacterial toxin-antitoxin (TA) systems are genetic elements, which are encoded by plasmid as well as chromosomal loci and mediate plasmid and genomic island maintenance through post-segregational killing mechanisms. TA systems exist in surprisingly high numbers in all prokaryotes, but cyanobacterial TA systems have been only very poorly experimentally characterized so far. Cyanobacteria are the only prokaryotes that perform oxygenic photosynthesis. As such, cyanobacteria are of high ecological importance and are considered promising for the production of biofuels. Here, we present the molecular characterization of the sll7003/ssl7004 TA system encoded on plasmid pSYSA of the model cyanobacterium Synechocystis sp. PCC 6803 as involving a Mg2+-dependent RNA endonuclease activity targeting single-stranded RNA regions and demonstrate the functionality of four more TA systems encoded on this 100,749-bp plasmid. Furthermore, one additional type I, one additional type II, and three freestanding TA system components are predicted on pSYSA, all of which appear active judged by their expression. By harboring at least seven simultaneously active TA systems, pSYSA appears as the plasmid most strongly selected for among all plasmids studied in this respect thus far. These results point to a high biological relevance of pSYSA, whose coding capacity is 75% devoted to three distinct clustered regularly interspaced short palindromic repeats (CRISPR) systems mediating antiviral defense.	[Kopfmann, Stefan; Hess, Wolfgang R.] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany	University of Freiburg	Hess, WR (corresponding author), Univ Freiburg, Fac Biol, Schanzlestr 1, D-79104 Freiburg, Germany.	wolfgang.hess@biologie.uni-freiburg.de		Hess, Wolfgang/0000-0002-5340-3423	Deutsche Forschungsgemeinschaft, Bonn [HE 2544/6-1]	Deutsche Forschungsgemeinschaft, Bonn(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft, Bonn, Grant HE 2544/6-1 (to W. R. H.).	Ahidjo BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021738; Al-Attar S, 2011, BIOL CHEM, V392, P277, DOI 10.1515/BC.2011.042; Blower TR, 2012, NUCLEIC ACIDS RES, V40, P6158, DOI 10.1093/nar/gks231; Blower TR, 2011, NAT STRUCT MOL BIOL, V18, P185, DOI 10.1038/nsmb.1981; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Christensen-Dalsgaard M, 2006, MOL MICROBIOL, V62, P397, DOI 10.1111/j.1365-2958.2006.05385.x; Christensen-Dalsgaard M, 2008, METHOD ENZYMOL, V447, P521, DOI 10.1016/S0076-6879(08)02225-8; Daines DA, 2007, J BACTERIOL, V189, P5041, DOI 10.1128/JB.00290-07; Danika T, 2012, DNA RES, V19, P435, DOI 10.1093/dnares/dss024; Fozo EM, 2010, NUCLEIC ACIDS RES, V38, P3743, DOI 10.1093/nar/gkq054; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; GERDES K, 1988, J MOL BIOL, V203, P119, DOI 10.1016/0022-2836(88)90096-4; Hess WR, 2011, CURR OPIN MICROBIOL, V14, P608, DOI 10.1016/j.mib.2011.07.024; JAFFE A, 1985, J BACTERIOL, V163, P841; Jiang Y, 2002, MOL MICROBIOL, V44, P971, DOI 10.1046/j.1365-2958.2002.02921.x; Kaneko T, 2003, DNA RES, V10, P221, DOI 10.1093/dnares/10.5.221; Kaneko T, 1996, DNA Res, V3, P185, DOI 10.1093/dnares/3.3.185; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; Masuda H, 2012, MOL MICROBIOL, V84, P979, DOI 10.1111/j.1365-2958.2012.08068.x; McKenzie JL, 2012, RNA, V18, P1267, DOI 10.1261/rna.031229.111; Miallau L, 2009, J BIOL CHEM, V284, P276, DOI 10.1074/jbc.M805061200; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; Ning DG, 2011, CURR MICROBIOL, V63, P496, DOI 10.1007/s00284-011-0011-5; OGURA T, 1983, P NATL ACAD SCI-BIOL, V80, P4784, DOI 10.1073/pnas.80.15.4784; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Rothenbacher FP, 2012, J BACTERIOL, V194, P3464, DOI 10.1128/JB.00217-12; Schuster CF, 2013, J BACTERIOL, V195, P115, DOI 10.1128/JB.00400-12; Shao YC, 2011, NUCLEIC ACIDS RES, V39, pD606, DOI 10.1093/nar/gkq908; Stazic D, 2011, NUCLEIC ACIDS RES, V39, P4890, DOI 10.1093/nar/gkr037; Steglich C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000173; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Van Melderen L, 2002, INT J MED MICROBIOL, V291, P537; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Wang XX, 2012, NAT CHEM BIOL, V8, P855, DOI 10.1038/NCHEMBIO.1062; Winther KS, 2011, P NATL ACAD SCI USA, V108, P7403, DOI 10.1073/pnas.1019587108; Winther KS, 2009, MOL MICROBIOL, V72, P918, DOI 10.1111/j.1365-2958.2009.06694.x; Xu WD, 1997, PLASMID, V37, P95, DOI 10.1006/plas.1997.1281; Yamaguchi Y, 2009, PROG MOL BIOL TRANSL, V85, P467, DOI 10.1016/S0079-6603(08)00812-X; YANG XY, 1993, J BACTERIOL, V175, P3981, DOI 10.1128/JB.175.13.3981-3991.1993; YANG XY, 1994, PLASMID, V31, P131, DOI 10.1006/plas.1994.1014; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7	44	21	22	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7399	7409		10.1074/jbc.M112.434100	http://dx.doi.org/10.1074/jbc.M112.434100			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23322786	Green Published, hybrid			2022-12-25	WOS:000316002400058
J	Dulce, RA; Yiginer, O; Gonzalez, DR; Goss, G; Feng, N; Zheng, MZ; Hare, JM				Dulce, Raul A.; Yiginer, Omer; Gonzalez, Daniel R.; Goss, Garrett; Feng, Ning; Zheng, Meizi; Hare, Joshua M.			Hydralazine and Organic Nitrates Restore Impaired Excitation-Contraction Coupling by Reducing Calcium Leak Associated with Nitroso-Redox Imbalance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; MYOCARDIAL OXYGEN-CONSUMPTION; XANTHINE-OXIDASE; SARCOPLASMIC-RETICULUM; OXIDATIVE STRESS; HEART-FAILURE; PHOSPHOLAMBAN PHOSPHORYLATION; ISOSORBIDE DINITRATE; S-NITROSYLATION; RABBIT AORTA	Although the combined use of hydralazine and isosorbide dinitrate confers important clinical benefits in patients with heart failure, the underlying mechanism of action is still controversial. We used two models of nitroso-redox imbalance, neuronal NO synthase-deficient (NOS1(-/-)) mice and spontaneously hypertensive heart failure rats, to test the hypothesis that hydralazine (HYD) alone or in combination with nitroglycerin (NTG) or isosorbide dinitrate restores Ca2+ cycling and contractile performance and controls superoxide production in isolated cardiomyocytes. The response to increased pacing frequency was depressed in NOS1(-/-) compared with wild type myocytes. Both sarcomere length shortening and intracellular Ca2+ transient (Delta[Ca2+](i)) responses in NOS1(-/-) cardiomyocytes were augmented by HYD in a dose-dependent manner. NTG alone did not affect myocyte shortening but reduced Delta[Ca2+](i) across the range of pacing frequencies and increased myofilament Ca2+ sensitivity thereby enhancing contractile efficiency. Similar results were seen in failing myocytes from the heart failure rat model. HYD alone or in combination with NTG reduced sarcoplasmic reticulum (SR) leak, improved SR Ca2+ reuptake, and restored SR Ca2+ content. HYD and NTG at low concentrations (1 mu M), scavenged superoxide in isolated cardiomyocytes, whereas in cardiac homogenates, NTG inhibited xanthine oxidoreductase activity and scavenged NADPH oxidase-dependent superoxide more efficiently than HYD. Together, these results revealed that by reducing SR Ca2+ leak, HYD improves Ca2+ cycling and contractility impaired by nitroso-redox imbalance, and NTG enhanced contractile efficiency, restoring cardiac excitation-contraction coupling.	[Dulce, Raul A.; Goss, Garrett; Hare, Joshua M.] Univ Miami, Miller Sch Med, ISCI, Miami, FL 33136 USA; [Yiginer, Omer] Gulhane Mil Med Acad, Haydarpasa Hosp, Dept Cardiol, TR-34668 Istanbul, Turkey; [Yiginer, Omer; Feng, Ning] Johns Hopkins Sch Med, Div Cardiol, Baltimore, MD 21287 USA; [Gonzalez, Daniel R.] Univ Talca, Fac Ciencias Salud, Dept Ciencias Basicas Biomed, Talca 3460000, Chile; [Zheng, Meizi] Univ Maryland, Sch Med, Ctr Integrat Med, Baltimore, MD 21207 USA	University of Miami; Gulhane Military Medical Academy; Istanbul Haydarpasa Numune Training & Research Hospital; Istanbul Haydarpasa Sultan Abdulhamid Training & Research Hospital; Johns Hopkins University; Johns Hopkins Medicine; Universidad de Talca; University System of Maryland; University of Maryland Baltimore	Hare, JM (corresponding author), Biomed Res Bldg BRB,1501 NW 10th Ave,Room 916, Miami, FL 33136 USA.	JHare@med.miami.edu	Yiğiner, Ömer/AAO-2477-2020	GONZALEZ, DANIEL/0000-0002-3437-8998; Goss, Garrett/0000-0002-0155-4334	National Institutes of Health [HL-65455, 5R01AG025017, R01 HL094849]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065455, R01HL094849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-65455, 5R01AG025017, and R01 HL094849 (to J. M. H.).	Amado LC, 2005, J MOL CELL CARDIOL, V39, P531, DOI 10.1016/j.yjmcc.2005.04.008; Antoons G, 2006, J MOL CELL CARDIOL, V40, P350, DOI 10.1016/j.yjmcc.2005.12.002; Barouch LA, 2002, NATURE, V416, P337, DOI 10.1038/416337a; Barouch LA, 2003, J MOL CELL CARDIOL, V35, P637, DOI 10.1016/S0022-2828(03)00079-8; BASSANI RA, 1992, J PHYSIOL-LONDON, V453, P591, DOI 10.1113/jphysiol.1992.sp019246; BAUER JA, 1991, CIRCULATION, V84, P35, DOI 10.1161/01.CIR.84.1.35; Beigi F, 2012, P NATL ACAD SCI USA, V109, P4314, DOI 10.1073/pnas.1113319109; Bergamini C, 2009, EUR J HEART FAIL, V11, P444, DOI 10.1093/eurjhf/hfp042; Burger DE, 2009, CIRCULATION, V120, P1345, DOI 10.1161/CIRCULATIONAHA.108.846402; Cappola TP, 2001, CIRCULATION, V104, P2407, DOI 10.1161/hc4501.098928; Chen CA, 2010, NATURE, V468, P1115, DOI 10.1038/nature09599; Cole RT, 2011, CIRCULATION, V123, P2414, DOI 10.1161/CIRCULATIONAHA.110.012781; Cote CG, 1996, AM J PHYSIOL-LUNG C, V271, pL869, DOI 10.1152/ajplung.1996.271.5.L869; Daiber A, 2005, AM J CARDIOL, V96, p25I, DOI 10.1016/j.amjcard.2005.07.030; Ekelund UEG, 1999, CIRC RES, V85, P437, DOI 10.1161/01.RES.85.5.437; Ellershaw DC, 2001, BRIT J PHARMACOL, V134, P621, DOI 10.1038/sj.bjp.0704302; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; GOGIA H, 1995, J AM COLL CARDIOL, V26, P1575, DOI 10.1016/0735-1097(95)00368-1; Gonzalez DR, 2007, P NATL ACAD SCI USA, V104, P20612, DOI 10.1073/pnas.0706796104; Gonzalez DR, 2010, J BIOL CHEM, V285, P28938, DOI 10.1074/jbc.M110.154948; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GURNEY AM, 1995, BRIT J PHARMACOL, V114, P238, DOI 10.1111/j.1476-5381.1995.tb14931.x; Hare JM, 2005, J CLIN INVEST, V115, P509, DOI 10.1172/JCI200524459; Hare JM, 2004, NEW ENGL J MED, V351, P2112, DOI 10.1056/NEJMe048269; Hare JM, 2008, J AM COLL CARDIOL, V51, P2301, DOI 10.1016/j.jacc.2008.01.068; Harrison CB, 2010, CLIN EXP PHARMACOL P, V37, P429, DOI 10.1111/j.1440-1681.2009.05317.x; Janero DR, 2004, P NATL ACAD SCI USA, V101, P16958, DOI 10.1073/pnas.0406075101; Katori T, 2006, FREE RADICAL BIO MED, V41, P1606, DOI 10.1016/j.freeradbiomed.2006.08.023; Khan SA, 2004, P NATL ACAD SCI USA, V101, P15944, DOI 10.1073/pnas.0404136101; Khan SA, 2003, CIRC RES, V92, P1322, DOI 10.1161/01.RES.0000078171.52542.9E; Kinugawa S, 2005, CIRC RES, V96, P355, DOI 10.1161/01.RES.0000155331.09458.A7; Kohr MJ, 2008, CARDIOVASC RES, V77, P353, DOI 10.1093/cvr/cvm018; Lamberts RR, 2007, J PHYSIOL-LONDON, V582, P695, DOI 10.1113/jphysiol.2007.134486; Layland J, 2002, J PHYSIOL-LONDON, V540, P457, DOI 10.1113/jphysiol.2001.014126; Leiro JM, 2004, INT IMMUNOPHARMACOL, V4, P163, DOI 10.1016/j.intimp.2003.10.004; Miao L, 1997, EUR J PHARMACOL, V321, P201, DOI 10.1016/S0014-2999(96)00946-6; Munzel T, 2005, CIRC RES, V97, P618, DOI 10.1161/01.RES.0000184694.03262.6d; Noman A, 2010, LANCET, V375, P2161, DOI 10.1016/S0140-6736(10)60391-1; O'Rourke B, 1999, CIRC RES, V84, P562, DOI 10.1161/01.RES.84.5.562; ROBAK J, 1988, BIOCHEM PHARMACOL, V37, P837, DOI 10.1016/0006-2952(88)90169-4; Rossman EI, 2004, J MOL CELL CARDIOL, V36, P33, DOI 10.1016/j.yjmcc.2003.09.001; Saavedra WF, 2002, CIRC RES, V90, P297, DOI 10.1161/hh0302.104531; Saraiva RM, 2005, CIRCULATION, V112, P3415, DOI 10.1161/CIRCULATIONAHA.105.557892; Saraiva RM, 2007, NITRIC OXIDE-BIOL CH, V16, P331, DOI 10.1016/j.niox.2006.12.001; Sears CE, 2003, CIRC RES, V92, pE52, DOI 10.1161/01.RES.0000064585.95749.6D; Shannon TR, 2002, CIRC RES, V91, P594, DOI 10.1161/01.RES.0000036914.12686.28; Shinyashiki M, 2004, FREE RADICAL BIO MED, V37, P713, DOI 10.1016/j.freeradbiomed.2004.05.031; Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934; Taylor AL, 2012, J CARD FAIL, V18, P600, DOI 10.1016/j.cardfail.2012.06.526; Terentyev D, 2008, CIRC RES, V103, P1466, DOI 10.1161/CIRCRESAHA.108.184457; THADANI U, 1988, CLIN PHARMACOKINET, V15, P32, DOI 10.2165/00003088-198815010-00003; Tziomalos K, 2009, FRONT BIOSCI-LANDMRK, V14, P237, DOI 10.2741/3243; Vila-Petroff MG, 1999, CIRC RES, V84, P1020, DOI 10.1161/01.RES.84.9.1020; Wang H, 2008, AM J PHYSIOL-CELL PH, V294, pC1566, DOI 10.1152/ajpcell.00367.2007; Wang HL, 2010, J PHYSIOL-LONDON, V588, P2905, DOI 10.1113/jphysiol.2010.192617; Yano M, 2005, J CLIN INVEST, V115, P556, DOI 10.1172/JCI200524159; Zhang YH, 2008, CIRC RES, V102, P242, DOI 10.1161/CIRCRESAHA.107.164798; Zoccali C, 2006, J AM SOC NEPHROL, V17, P1466, DOI 10.1681/ASN.2005090949	58	30	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6522	6533		10.1074/jbc.M112.412130	http://dx.doi.org/10.1074/jbc.M112.412130			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23319593	hybrid, Green Published			2022-12-25	WOS:000315820700045
J	Feng, YQ; Love, RP; Chelico, L				Feng, Yuqing; Love, Robin P.; Chelico, Linda			HIV-1 Viral Infectivity Factor (Vif) Alters Processive Single-stranded DNA Scanning of the Retroviral Restriction Factor APOBEC3G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SMALL-MOLECULE INHIBITION; TYPE-1 VIF; CYTIDINE DEAMINASE; AMINO-ACID; VIRION INCORPORATION; MESSENGER-RNA; REVERSE-TRANSCRIPTASE; ANTIVIRAL ACTIVITY; ENZYME APOBEC3G	APOBEC3G is a retroviral restriction factor that can inhibit the replication of human immunodeficiency virus, type 1 (HIV-1) in the absence of the viral infectivity factor (Vif) protein. Virion-encapsidated APOBEC3G can deaminate cytosine to uracil in viral (-)DNA, which leads to hypermutation and inactivation of the provirus. APOBEC3G catalyzes these deaminations processively on single-stranded DNA using sliding and jumping movements. Vif is thought to primarily overcome APOBEC3G through an interaction that mediates APOBEC3G ubiquitination and results in its proteasomal degradation. However, Vif may also inhibit APOBEC3G mRNA translation, virion encapsidation, and deamination activity. Here we investigated the molecular mechanism of Vif(IIIB)- and Vif(HXB2)-mediated inhibition of APOBEC3G deamination activity. Biochemical assays using a model HIV-1 replication assay and synthetic single-stranded or partially double-stranded DNA substrates demonstrated that APOBEC3G has an altered processive mechanism in the presence of Vif. Specifically, Vif(HXB2) inhibited the jumping and Vif(IIIB) inhibited the sliding movements of APOBEC3G. The absence of such an effect by Vif on degradation-resistant APOBEC3G D128K indicates that a Vif-APOBEC3G interaction mediates this effect. That the partially processive APOBEC3G was less effective at inducing mutagenesis in a model HIV-1 replication assay suggests that Vif co-encapsidation with APOBEC3G can promote sublethal mutagenesis of HIV-1 proviral DNA.	[Feng, Yuqing; Love, Robin P.; Chelico, Linda] Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada	University of Saskatchewan	Chelico, L (corresponding author), Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada.	linda.chelico@usask.ca		Feng, Yuqing/0000-0002-7156-1628; Chelico, Linda/0000-0003-4673-8978; Love, Robin/0000-0002-2509-706X	Canadian Institutes of Health Operating Grant [HOP-111407]; Saskatchewan Health Research Foundation; Canadian Foundation for Innovation; Tri-Link Biotechnologies Research Rewards Program	Canadian Institutes of Health Operating Grant(Canadian Institutes of Health Research (CIHR)); Saskatchewan Health Research Foundation; Canadian Foundation for Innovation(Canada Foundation for Innovation); Tri-Link Biotechnologies Research Rewards Program	This work was supported by Canadian Institutes of Health Operating Grant HOP-111407, a new investigator establishment grant from the Saskatchewan Health Research Foundation, the Canadian Foundation for Innovation, and the Tri-Link Biotechnologies Research Rewards Program.	Albin JS, 2010, J BIOL CHEM, V285, P40785, DOI 10.1074/jbc.M110.173161; Bennett RP, 2008, J BIOL CHEM, V283, P33329, DOI 10.1074/jbc.M803726200; Bernacchi S, 2007, J BIOL CHEM, V282, P26361, DOI 10.1074/jbc.M703122200; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bogerd HP, 2004, P NATL ACAD SCI USA, V101, P3770, DOI 10.1073/pnas.0307713101; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Britan-Rosich E, 2011, J MOL BIOL, V410, P1065, DOI 10.1016/j.jmb.2011.03.058; Browne EP, 2009, VIROLOGY, V387, P313, DOI 10.1016/j.virol.2009.02.026; Bulliard Y, 2009, J VIROL, V83, P12611, DOI 10.1128/JVI.01491-09; Cadima-Couto I, 2011, J NEUROIMMUNE PHARM, V6, P296, DOI 10.1007/s11481-011-9258-7; Camaur D, 1996, J VIROL, V70, P6106, DOI 10.1128/JVI.70.9.6106-6111.1996; Chaipan C, 2013, J VIROL, V87, P444, DOI 10.1128/JVI.00676-12; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chelico L, 2010, J BIOL CHEM, V285, P16195, DOI 10.1074/jbc.M110.107987; Chelico L, 2009, PHILOS T R SOC B, V364, P583, DOI 10.1098/rstb.2008.0195; COFFIN JM, 1997, RETROVIRUSES, P121; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Creighton S, 1995, METHOD ENZYMOL, V262, P232; Feng YQ, 2011, J BIOL CHEM, V286, P11415, DOI 10.1074/jbc.M110.199604; Fouchier RAM, 1996, J VIROL, V70, P8263, DOI 10.1128/JVI.70.12.8263-8269.1996; Gao F, 1996, J VIROL, V70, P7013, DOI 10.1128/JVI.70.10.7013-7029.1996; Goila-Gaur R, 2009, J VIROL, V83, P1156, DOI 10.1128/JVI.01734-08; Golla-Gaur R, 2008, VIROLOGY, V372, P136, DOI 10.1016/j.virol.2007.10.017; Greene WC, 2008, ANTIVIR RES, V80, P251, DOI 10.1016/j.antiviral.2008.08.003; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Henriet S, 2005, J MOL BIOL, V354, P55, DOI 10.1016/j.jmb.2005.09.025; Henriet S, 2009, MICROBIOL MOL BIOL R, V73, P211, DOI 10.1128/MMBR.00040-08; Hu CL, 2010, J VIROL, V84, P11981, DOI 10.1128/JVI.00723-10; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; Huthoff H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000330; Iwatani Y, 2009, P NATL ACAD SCI USA, V106, P19539, DOI 10.1073/pnas.0906652106; Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693; Jern P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000367; Kao S, 2003, J VIROL, V77, P11398, DOI 10.1128/JVI.77.21.11398-11407.2003; Kao S, 2003, J VIROL, V77, P1131, DOI 10.1128/JVI.77.2.1131-1140.2003; Kao Sandra, 2004, Retrovirology, V1, P27, DOI 10.1186/1742-4690-1-27; Karczewski MK, 1996, J VIROL, V70, P494, DOI 10.1128/JVI.70.1.494-507.1996; Kitamura S, 2012, NAT STRUCT MOL BIOL, V19, P1005, DOI 10.1038/nsmb.2378; Lavens D, 2010, NUCLEIC ACIDS RES, V38, P1902, DOI 10.1093/nar/gkp1154; LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x; LOEB DD, 1989, NATURE, V340, P397, DOI 10.1038/340397a0; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mangeat B, 2004, J BIOL CHEM, V279, P14481, DOI 10.1074/jbc.C400060200; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Marin M, 2008, J VIROL, V82, P987, DOI 10.1128/JVI.01078-07; McDougall WM, 2011, J BIOL CHEM, V286, P30655, DOI 10.1074/jbc.M111.269506; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; Mercenne G, 2010, NUCLEIC ACIDS RES, V38, P633, DOI 10.1093/nar/gkp1009; Miller JH, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-81; Nathans R, 2008, NAT BIOTECHNOL, V26, P1187, DOI 10.1038/nbt.1496; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Nguyen KL, 2004, VIROLOGY, V319, P163, DOI 10.1016/j.virol.2003.11.021; Nowarski R, 2008, NAT STRUCT MOL BIOL, V15, P1059, DOI 10.1038/nsmb.1495; Pillai SK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-26; Rausch JW, 2004, INT J BIOCHEM CELL B, V36, P1752, DOI 10.1016/j.biocel.2004.02.016; Sadler HA, 2010, J VIROL, V84, P7396, DOI 10.1128/JVI.00056-10; Santa-Marta M, 2005, J BIOL CHEM, V280, P8765, DOI 10.1074/jbc.M409309200; Schrofelbauer R, 2004, P NATL ACAD SCI USA, V101, P3927, DOI 10.1073/pnas.0307132101; Senavirathne G, 2012, J BIOL CHEM, V287, P15826, DOI 10.1074/jbc.M112.342790; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shlyakhtenko LS, 2012, BIOCHEMISTRY-US, V51, P6432, DOI 10.1021/bi300733d; Simon V, 2005, PLOS PATHOG, V1, P20, DOI 10.1371/journal.ppat.0010006; Smith JL, 2010, J VIROL, V84, P12599, DOI 10.1128/JVI.01437-10; Stanford NP, 2000, EMBO J, V19, P6546, DOI 10.1093/emboj/19.23.6546; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Strebel K, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-55; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; Suspene R, 2006, NUCLEIC ACIDS RES, V34, P4677, DOI 10.1093/nar/gkl555; Uyttendaele I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044143; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Wedekind JE, 2006, J BIOL CHEM, V281, P38122, DOI 10.1074/jbc.C600253200; Xu HZ, 2007, VIROLOGY, V360, P247, DOI 10.1016/j.virol.2006.10.036; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zennou V, 2006, VIROLOGY, V349, P31, DOI 10.1016/j.virol.2005.12.035; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang WY, 2012, NATURE, V481, P376, DOI 10.1038/nature10718; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100; Zuo T, 2012, J VIROL, V86, P5497, DOI 10.1128/JVI.06957-11	83	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6083	6094		10.1074/jbc.M112.421875	http://dx.doi.org/10.1074/jbc.M112.421875			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23316055	Green Published, hybrid			2022-12-25	WOS:000315820700006
J	Xu, AJ; Springer, TA				Xu, Amy J.; Springer, Timothy A.			Mechanisms by which von Willebrand Disease Mutations Destabilize the A2 Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VONWILLEBRAND DISEASE; MULTIMERS; CLEAVAGE; ADHESION; UPDATE; IIA	von Willebrand Factor (VWF) is an ultralong, concatameric, and adhesive glycoprotein. On short time scales, adhesiveness for platelets is activated by elongation of VWF by altered hydrodynamics at sites of hemostasis. Over longer time scales, the length of VWF is regulated by ADAMTS13 (a disintegrin and metalloprotease with a thrombospondin type 1 motif, member 13), cleavage by which in the VWF A2 domain is dependent on elongational force. Patients with von Willebrand disease type 2A present with increased bleeding due to mutations within the VWF A2 domain that enhance cleavage. We tested using temperature and force the hypothesis that von Willebrand disease mutations disrupt A2 force sensing by destabilizing the folded state. Mutations R1597W, M1528V, and E1638K reduced A2 thermal stability by 10-18 degrees C. M1528V and E1638K showed a marked further decrease in stability upon calcium removal. In contrast, R1597W, which resides within the A2 calcium-binding loop, exhibited similar stability in the presence and absence of calcium. Using single molecule optical tweezers and R1597W, we measured the force dependence of unfolding and refolding kinetics. In the presence of calcium, the R1597W mutation slowed the rate of refolding but had no effect on unfolding. The three mutations highlight the calcium-binding loop (R1597W), the hydrophobic core around the vicinal disulfide (M1528V), and hydrogen bonds to the alpha 4-less loop (E1638K), as structural features critically important to the function of A2 as a force sensor in regulating thrombogenic activity in the vasculature.	[Springer, Timothy A.] Childrens Hosp Boston, Program Cellular & Mol Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School	Springer, TA (corresponding author), Childrens Hosp Boston, Program Cellular & Mol Med, 3 Blackfan Circle, Boston, MA 02115 USA.	springer@idi.harvard.edu		Xu, Amy/0000-0001-9650-9458	National Institutes of Health [HL-48675]; Molecular Biophysics and General Medical Sciences Training Grants from NIGMS [T32 GM008313, GM007753]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048675, R01HL108248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, T32GM008313] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Biophysics and General Medical Sciences Training Grants from NIGMS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant HL-48675 (to T. A. S.) and Molecular Biophysics and General Medical Sciences Training Grants T32 GM008313 and GM007753 (from NIGMS; to A. J. X.).	Auton M, 2007, J MOL BIOL, V366, P986, DOI 10.1016/j.jmb.2006.10.067; CHRISTOPHE O, 1994, BLOOD, V83, P3553; Dudko OK, 2008, P NATL ACAD SCI USA, V105, P15755, DOI 10.1073/pnas.0806085105; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Hampshire DJ, 2011, SEMIN THROMB HEMOST, V37, P470, DOI 10.1055/s-0031-1281031; Hassenpflug WA, 2006, BLOOD, V107, P2339, DOI 10.1182/blood-2005-04-1758; HOYER LW, 1980, BLOOD, V55, P1056; Jakobi AJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1385; LAVERGNE JM, 1991, BLOOD COAGUL FIBRIN, V2, P293, DOI 10.1097/00001721-199104000-00012; Luken BM, 2010, BLOOD, V115, P4910, DOI 10.1182/blood-2009-12-257949; LYONS SE, 1992, J BIOL CHEM, V267, P4424; RIBBA AS, 1992, J BIOL CHEM, V267, P23209; Sadler JE, 2006, J THROMB HAEMOST, V4, P2103, DOI 10.1111/j.1538-7836.2006.02146.x; Sadler JE, 2005, ANNU REV MED, V56, P173, DOI 10.1146/annurev.med.56.082103.104713; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; Springer TA, 2011, J THROMB HAEMOST, V9, P130, DOI 10.1111/j.1538-7836.2011.04320.x; TOUMADJE A, 1992, ANAL BIOCHEM, V200, P321, DOI 10.1016/0003-2697(92)90473-K; Wu T, 2010, BLOOD, V115, P370, DOI 10.1182/blood-2009-03-210369; Xu AJ, 2012, P NATL ACAD SCI USA, V109, P3742, DOI 10.1073/pnas.1121261109; Ying JY, 2010, BIOPHYS J, V98, P1685, DOI 10.1016/j.bpj.2009.12.4324; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P9226, DOI 10.1073/pnas.0903679106; Zhang XH, 2009, SCIENCE, V324, P1330, DOI 10.1126/science.1170905; Zhou MY, 2011, BLOOD, V117, P4623, DOI 10.1182/blood-2010-11-321596; Zhou YF, 2011, EMBO J, V30, P4098, DOI 10.1038/emboj.2011.297	25	17	19	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6317	6324		10.1074/jbc.M112.422618	http://dx.doi.org/10.1074/jbc.M112.422618			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23322777	Green Published, hybrid			2022-12-25	WOS:000315820700026
J	Lu, CC; Xu, MF; Wang, Y; Qin, YF; Du, GZ; Wu, W; Han, XM; Ji, C; Yang, YL; Gu, AH; Xia, YK; Song, L; Wang, SL; Wang, XR				Lu, Chuncheng; Xu, Miaofei; Wang, Ying; Qin, Yufeng; Du, Guizhen; Wu, Wei; Han, Xiumei; Ji, Chao; Yang, Yanli; Gu, Aihua; Xia, Yankai; Song, Ling; Wang, Shoulin; Wang, Xinru			Genetic Variants in Meiotic Program Initiation Pathway Genes Are Associated with Spermatogenic Impairment in a Han Chinese Population	PLOS ONE			English	Article							RETINOIC ACID; GERM-CELLS; SEX DETERMINATION; MEIOSIS; IDENTIFICATION	Background: The meiotic program initiation pathway genes (CYP26B1, NANOS1 and STRA8) have been proposed to play key roles in spermatogenesis. Objective: To elucidate the exact role of the genetic variants of the meiosis initiation genes in spermatogenesis, we genotyped the potential functional genetic variants of CYP26B1, NANOS1 and STRA8 genes, and evaluated their effects on spermatogenesis in our study population. Design, Setting, and Participants: In this study, all subjects were volunteers from the affiliated hospitals of Nanjing Medical University between March 2004 and July 2009 (NJMU Infertile Study). Total 719 idiopathic infertile cases were recruited and divided into three groups according to WHO semen parameters: 201 azoospermia patients (no sperm in the ejaculate even after centrifugation), 155 oligozoospermia patients (sperm counts <20x10(6)/ml) and 363 infertility/normozoospermia subjects (sperm counts >20x10(6)/ml). The control group consisted of 383 subjects with normal semen parameters, all of which had fathered at least one child without assisted reproductive technologies. Measurements: Eight single nucleotide polymorphisms (SNPs) in CYP26B1, NANOS1 and STRA8 genes were determined by TaqMan allelic discrimination assay in 719 idiopathic infertile men and 383 healthy controls. Results and Limitations: The genetic variant rs10269148 of STRA8 gene showed higher risk of spermatogenic impairment in the groups of abnormospermia (including azoospermia subgroup and oligozoospermia subgroup) and azoospermia than the controls with odds ratios and 95% confidence intervals of 2.52 (1.29-4.94) and 2.92 (1.41-6.06), respectively (P=0.006, 0.002 respective). Notably, larger sample size studies and in vivo or in vitro functional studies are needed to substantiate the biological roles of these variants. Conclusions: Our results provided epidemiological evidence supporting the involvement of genetic polymorphisms of the meiotic program initiation genes in modifying the risk of azoospermia and oligozoospermia in a Han-Chinese population.	[Lu, Chuncheng; Xu, Miaofei; Wang, Ying; Qin, Yufeng; Du, Guizhen; Wu, Wei; Han, Xiumei; Gu, Aihua; Xia, Yankai; Song, Ling; Wang, Shoulin; Wang, Xinru] Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Lu, Chuncheng; Xu, Miaofei; Wang, Ying; Qin, Yufeng; Du, Guizhen; Wu, Wei; Han, Xiumei; Gu, Aihua; Xia, Yankai; Song, Ling; Wang, Shoulin; Wang, Xinru] Nanjing Med Univ, Sch Publ Hlth, Minist Educ, Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China; [Ji, Chao] Nanjing Med Univ, Affiliated Hosp 1, Dept Dermatol, Nanjing, Jiangsu, Peoples R China; [Yang, Yanli] Nanjing Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Wang, XR (corresponding author), Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	xrwang@njmu.edu.cn	Wang, Xin/AAN-8435-2021; Lang, Ming/HIK-0758-2022; yang, yang/HGT-7999-2022; Yang, Ya-Li/GYU-4320-2022; Wu, Wei/C-4409-2012	Wang, Xin/0000-0002-4457-7376; Wu, Wei/0000-0002-0267-1284	National Basic Research Program of China (973 Program) [2009CB941703]; National Natural Science Foundation of China [30930079, 81100461, 810701297, 30671894]; Jiangsu Natural Science Foundation [BK2011774]; Research Fund for the Doctoral Program of Higher Education of China (RFDP) [20113234120001]; University natural science research project in Jiangsu Province [11KJB330001]; Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Research Fund for the Doctoral Program of Higher Education of China (RFDP)(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); University natural science research project in Jiangsu Province; Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	Funding was provided by grants from National Basic Research Program of China (973 Program) (2009CB941703), the National Natural Science Foundation of China (30930079, 81100461, 810701297 and 30671894), the Jiangsu Natural Science Foundation (BK2011774), Research Fund for the Doctoral Program of Higher Education of China (RFDP) (20113234120001), University natural science research project in Jiangsu Province (11KJB330001) and the Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; Bolcun-Filas E, 2012, INT REV CEL MOL BIO, V298, P179, DOI 10.1016/B978-0-12-394309-5.00005-5; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Brinkworth MH, 2000, MUTAT RES-FUND MOL M, V447, P149, DOI 10.1016/S0027-5107(99)00189-X; Dohle GR, 2005, EUR UROL, V48, P703, DOI 10.1016/j.eururo.2005.06.002; Kocer A, 2009, MOL HUM REPROD, V15, P205, DOI 10.1093/molehr/gap008; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; LI LB, 2008, NATL J ANDROL, V14, P211; MacLean G, 2007, ENDOCRINOLOGY, V148, P4560, DOI 10.1210/en.2007-0492; Mark M, 2008, J CELL SCI, V121, P3233, DOI 10.1242/jcs.035071; Ohta K, 2010, BIOL REPROD, V83, P1056, DOI 10.1095/biolreprod.110.085787; Okabe M, 1998, AM J HUM GENET, V62, P1274, DOI 10.1086/301895; Pawlowski WP, 2007, BIOESSAYS, V29, P511, DOI 10.1002/bies.20578; Revenkova E, 2004, NAT CELL BIOL, V6, P555, DOI 10.1038/ncb1135; Ross AC, 2011, ANNU REV NUTR, V31, P65, DOI 10.1146/annurev-nutr-072610-145127; Saga Y, 2008, DEV GROWTH DIFFER, V50, pS141, DOI 10.1111/j.1440-169X.2008.01009.x; Suzuki A, 2008, GENE DEV, V22, P430, DOI 10.1101/gad.1612708; Swain A, 2006, CURR BIOL, V16, pR507, DOI 10.1016/j.cub.2006.06.009; Tahayato A, 2003, GENE EXPR PATTERNS, V3, P449, DOI 10.1016/S1567-133X(03)00066-8; Trautmann E, 2008, CELL CYCLE, V7, P656, DOI 10.4161/cc.7.5.5482; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; White JA, 1996, J BIOL CHEM, V271, P29922, DOI 10.1074/jbc.271.47.29922; White JA, 2000, P NATL ACAD SCI USA, V97, P6403, DOI 10.1073/pnas.120161397; Wolf G, 2001, NUTR REV, V59, P391, DOI 10.1111/j.1753-4887.2001.tb06968.x	25	7	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53443	10.1371/journal.pone.0053443	http://dx.doi.org/10.1371/journal.pone.0053443			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320086	gold, Green Published, Green Submitted			2022-12-25	WOS:000313429800051
J	Pericolini, E; Alunno, A; Gabrielli, E; Bartoloni, E; Cenci, E; Chow, SK; Bistoni, G; Casadevall, A; Gerli, R; Vecchiarelli, A				Pericolini, Eva; Alunno, Alessia; Gabrielli, Elena; Bartoloni, Elena; Cenci, Elio; Chow, Siu-Kei; Bistoni, Giovanni; Casadevall, Arturo; Gerli, Roberto; Vecchiarelli, Anna			The Microbial Capsular Polysaccharide Galactoxylomannan Inhibits IL-17A Production in Circulating T Cells from Rheumatoid Arthritis Patients	PLOS ONE			English	Article							CRYPTOCOCCUS-NEOFORMANS; MONOCLONAL-ANTIBODY; T(H)17 CELLS; CD4+T CELLS; APOPTOSIS; DISEASE; EXPRESSION; CYTOKINES; METHOTREXATE; AUTOIMMUNITY	The persistence of activated T cells in rheumatoid arthritis (RA) synovium may be attributable to increased homing, increased retention or a possible imbalance between cell proliferation and programmed cell death. Induction of apoptosis may represent a potential therapeutic approach. Galactoxylomannan (GalXM) from the opportunistic fungus Cryptococcus neoformans can interact with T cells and induce T-cell apoptosis through the inhibition of CD45 phosphatase activity. The aim of this study was to determine the effect of GalXM on circulating T cells from patients with RA and the underlying mechanisms. GalXM immunomodulating effect on apoptosis and signal transduction pathway involved in IL-17A production was evaluated on T cells. RA T-cell apoptosis, higher than that of control T cells, was further increased by GalXM through induction of caspase-3 activation. Activated T cells expressing the CD45RO molecule and producing IL-17A were the main target of GalXM-induced apoptosis. GalXM induced consistent impairment of IL-17A production and inhibition of STAT3, which was hyperactivated in RA. In conclusion, GalXM triggered apoptosis of activated memory T cells and interfered with IL-17A production in RA. These data suggest therapeutic targeting of deleterious Th17 cells in RA and other autoimmune diseases.	[Pericolini, Eva; Gabrielli, Elena; Cenci, Elio; Vecchiarelli, Anna] Univ Perugia, Dept Expt Med & Biochem Sci, Microbiol Sect, I-06100 Perugia, Italy; [Alunno, Alessia; Bartoloni, Elena; Gerli, Roberto] Univ Perugia, Dept Clin & Expt Med, Rheumatol Unit, I-06100 Perugia, Italy; [Chow, Siu-Kei; Casadevall, Arturo] Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY USA; [Bistoni, Giovanni] Univ Rome, Dept Plast & Reconstruct Surg, La Sapienza Med Sch, Rome, Italy	University of Perugia; University of Perugia; Yeshiva University; Sapienza University Rome	Gerli, R (corresponding author), Univ Perugia, Dept Clin & Expt Med, Rheumatol Unit, I-06100 Perugia, Italy.	gerlir@unipg.it	Alunno, Alessia/AAC-8842-2022; Pericolini, Eva/AAZ-5848-2021; Bartoloni, Elena/R-5842-2019	Pericolini, Eva/0000-0002-5299-8197; CENCI, ELIO/0000-0003-0752-7262; Bartoloni, Elena/0000-0003-4776-2136; Vecchiarelli, Anna/0000-0002-3185-6720	European Commission: FINSysB Marie Curie Initial Training Network [PITNGA-2008-214004]; National Institutes of Health [AI033774, HL059842, AI033142]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033774, R01AI033142, R37AI033142] Funding Source: NIH RePORTER	European Commission: FINSysB Marie Curie Initial Training Network(European CommissionEuropean Commission Joint Research Centre); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by the European Commission: FINSysB Marie Curie Initial Training Network, PITNGA-2008-214004. AC was supported by National Institutes of Health awards AI033774, HL059842, and AI033142. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Berner B, 2000, ANN RHEUM DIS, V59, P190, DOI 10.1136/ard.59.3.190; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bremer E, 2011, IMMUNOL LETT, V138, P161, DOI 10.1016/j.imlet.2011.04.004; Chen SY, 2011, HUM GENE THER, V22, P145, DOI 10.1089/hum.2009.217; Chiang EY, 2009, NAT MED, V15, P766, DOI 10.1038/nm.1984; Choy EHS, 2002, RHEUMATOLOGY, V41, P1142, DOI 10.1093/rheumatology/41.10.1142; De Jesus M, 2010, VIRULENCE, V1, P500, DOI 10.4161/viru.1.6.13451; De Jesus M, 2010, EUKARYOT CELL, V9, P1018, DOI 10.1128/EC.00268-09; De Jesus M, 2009, J IMMUNOL, V183, P3885, DOI 10.4049/jimmunol.0900449; De Jesus M, 2009, EUKARYOT CELL, V8, P96, DOI 10.1128/EC.00331-08; DEBELDER AN, 1975, CARBOHYD RES, V44, P251, DOI 10.1016/S0008-6215(00)84168-3; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Gabrielli E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043972; Gabrielli E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008187; Gaston JSH, 2008, RHEUMATOLOGY, V47, P8, DOI 10.1093/rheumatology/kem203; Gerli R, 2004, CIRCULATION, V109, P2744, DOI 10.1161/01.CIR.0000131450.66017.B3; Gerli R, 2001, TRENDS IMMUNOL, V22, P72, DOI 10.1016/S1471-4906(00)01829-9; Hot A, 2011, ANN RHEUM DIS, V70, P727, DOI 10.1136/ard.2010.143768; Hwang SY, 2005, MOL CELLS, V19, P180; Islander U, 2011, MOL CELL ENDOCRINOL, V335, P14, DOI 10.1016/j.mce.2010.05.018; JAMES PG, 1992, INFECT IMMUN, V60, P1084, DOI 10.1128/IAI.60.3.1084-1088.1992; Jandus C, 2008, ARTHRITIS RHEUM, V58, P2307, DOI 10.1002/art.23655; Kimura A, 2007, P NATL ACAD SCI USA, V104, P12099, DOI 10.1073/pnas.0705268104; Li X, 2010, BIOCHEM BIOPH RES CO, V397, P131, DOI 10.1016/j.bbrc.2010.05.111; Lin L, 2010, CANCER RES, V70, P2445, DOI 10.1158/0008-5472.CAN-09-2468; Majeti R, 2000, CELL, V103, P1059, DOI 10.1016/S0092-8674(00)00209-9; Mamoune A, 2000, HISTOL HISTOPATHOL, V15, P587, DOI 10.14670/HH-15.587; Marrelli A, 2011, AUTOIMMUN REV; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; MIGLIORATI G, 1993, BLOOD, V81, P1352; Monari C, 2005, J IMMUNOL, V174, P3461, DOI 10.4049/jimmunol.174.6.3461; Monari C, 2009, J IMMUNOL, V183, P191, DOI 10.4049/jimmunol.0804144; MORELAND LW, 1995, ARTHRITIS RHEUM, V38, P1581, DOI 10.1002/art.1780381109; Ogawa Y, 2003, ARTHRITIS RHEUM-US, V48, P3350, DOI 10.1002/art.11322; Peck A, 2009, CLIN IMMUNOL, V132, P295, DOI 10.1016/j.clim.2009.03.522; Peng SL, 2006, RHEUMATOLOGY, V45, P26, DOI 10.1093/rheumatology/kei113; Pericolini E, 2006, CELL MICROBIOL, V8, P267, DOI 10.1111/j.1462-5822.2005.00619.x; Pericolini E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012720; Pericolini E, 2009, J IMMUNOL, V182, P6003, DOI 10.4049/jimmunol.0803833; Perlman Harris, 2001, Current Molecular Medicine (Hilversum), V1, P597, DOI 10.2174/1566524013363429; Raposo BR, 2010, ARTHRITIS RHEUM-US, V62, P2953, DOI 10.1002/art.27729; Raza K, 2005, ARTHRITIS RES THER, V7, pR784, DOI 10.1186/ar1733; Rep MHG, 1997, J CLIN INVEST, V99, P2225, DOI 10.1172/JCI119396; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; Saunders AE, 2010, CELL SIGNAL, V22, P339, DOI 10.1016/j.cellsig.2009.10.003; Spurlock CF, 2011, ARTHRITIS RHEUM-US, V63, P2606, DOI 10.1002/art.30457; Vecchiarelli A, 2011, IMMUNOTHERAPY-UK, V3, P997, DOI [10.2217/IMT.11.86, 10.2217/imt.11.86]; Wang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017766; Zaragoza O, 2009, ADV APPL MICROBIOL, V68, P133, DOI 10.1016/S0065-2164(09)01204-0; Zhang JH, 2000, CELL RES, V10, P205, DOI 10.1038/sj.cr.7290049; Zhang N, 2005, CELL RES, V15, P749, DOI 10.1038/sj.cr.7290345	53	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53336	10.1371/journal.pone.0053336	http://dx.doi.org/10.1371/journal.pone.0053336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308194	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429800039
J	Schwab, J; Hammerschmidt, C; Richter, D; Skerka, C; Matuschka, FR; Wallich, R; Zipfel, PF; Kraiczy, P				Schwab, Jasmin; Hammerschmidt, Claudia; Richter, Dania; Skerka, Christine; Matuschka, Franz-Rainer; Wallich, Reinhard; Zipfel, Peter F.; Kraiczy, Peter			Borrelia valaisiana Resist Complement-Mediated Killing Independently of the Recruitment of Immune Regulators and Inactivation of Complement Components	PLOS ONE			English	Article							ACQUIRING SURFACE PROTEIN-1; HUMAN-FACTOR-H; BURGDORFERI SENSU-LATO; C1 ESTERASE INHIBITOR; SPIELMANII SP-NOV; LYME-DISEASE; FUNCTIONAL-CHARACTERIZATION; SERUM RESISTANCE; CYSTEINE PROTEINASES; C4-BINDING PROTEIN	Spirochetes belonging to the Borrelia (B.) burgdorferi sensu lato complex differ in their resistance to complement-mediated killing, particularly in regard to human serum. In the present study, we elucidate the serum and complement susceptibility of B. valaisiana, a genospecies with the potential to cause Lyme disease in Europe as well as in Asia. Among the investigated isolates, growth of ZWU3 Ny3 was not affected while growth of VS116 and Bv9 was strongly inhibited in the presence of 50% human serum. Analyzing complement activation, complement components C3, C4 and C6 were deposited on the surface of isolates VS116 and Bv9, and similarly the membrane attack complex was formed on their surface. In contrast, no surface-deposited components and no aberrations in cell morphology were detected for serum-resistant ZWU3 Ny3. While further investigating the protective role of bound complement regulators in mediating complement resistance, we discovered that none of the B. valaisiana isolates analyzed bound complement regulators Factor H, Factor H-like protein 1, C4b binding protein or C1 esterase inhibitor. In addition, B. valaisiana also lacked intrinsic proteolytic activity to degrade complement components C3, C3b, C4, C4b, and C5. Taken together, these findings suggest that certain B. valaisiana isolates differ in their capability to resist complement-mediating killing by human serum. The molecular mechanism utilized by B. valaisiana to inhibit bacteriolysis appears not to involve binding of the key host complement regulators of the alternative, classical, and lectin pathways as already known for serum-resistant Lyme disease or relapsing fever borreliae.	[Schwab, Jasmin; Hammerschmidt, Claudia; Kraiczy, Peter] Univ Hosp Frankfurt, Inst Med Microbiol & Infect Control, Frankfurt, Germany; [Richter, Dania; Matuschka, Franz-Rainer] Charite Univ Med Berlin, Inst Pathol, Abt Parasitol, Berlin, Germany; [Skerka, Christine; Zipfel, Peter F.] Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, Jena, Germany; [Wallich, Reinhard] Heidelberg Univ, Inst Immunol, Heidelberg, Germany; [Zipfel, Peter F.] Univ Jena, Jena, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hans Knoll Institute (HKI); Ruprecht Karls University Heidelberg; Friedrich Schiller University of Jena	Kraiczy, P (corresponding author), Univ Hosp Frankfurt, Inst Med Microbiol & Infect Control, Frankfurt, Germany.	Kraiczy@em.uni-frankfurt.de			Deutsche Forschungsgemeinschaft [Kr3383/1-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported, in part, by the Deutsche Forschungsgemeinschaft grant Kr3383/1-2 to PK. The funder had no role in study design, data collection, and decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alitalo A, 2004, J IMMUNOL, V172, P6195, DOI 10.4049/jimmunol.172.10.6195; Alitalo A, 2002, J IMMUNOL, V169, P3847, DOI 10.4049/jimmunol.169.7.3847; Alitalo A, 2001, INFECT IMMUN, V69, P3685, DOI 10.1128/IAI.69.6.3685-3691.2001; Beinrohr L, 2008, TRENDS MOL MED, V14, P511, DOI 10.1016/j.molmed.2008.09.009; Bhide Mangesh R, 2009, BMC Res Notes, V2, P134, DOI 10.1186/1756-0500-2-134; Bhide MR, 2005, FEMS IMMUNOL MED MIC, V43, P165, DOI 10.1016/j.femsim.2004.07.012; Blom AM, 2009, MOL IMMUNOL, V46, P2808, DOI 10.1016/j.molimm.2009.04.025; BOCK SC, 1986, BIOCHEMISTRY-US, V25, P4292, DOI 10.1021/bi00363a018; BRADE V, 1992, IMMUNOBIOLOGY, V185, P453, DOI 10.1016/S0171-2985(11)80087-2; BreitnerRuddock S, 1997, MED MICROBIOL IMMUN, V185, P253, DOI 10.1007/s004300050038; Brooks CS, 2005, J IMMUNOL, V175, P3299, DOI 10.4049/jimmunol.175.5.3299; Collares-Pereira M, 2004, J CLIN MICROBIOL, V42, P1316, DOI 10.1128/JCM.42.3.1316-1318.2004; Dieterich R, 2010, INFECT IMMUN, V78, P4467, DOI 10.1128/IAI.00138-10; Discipio RG, 1996, IMMUNOLOGY, V87, P660, DOI 10.1046/j.1365-2567.1996.478594.x; Diza E, 2004, EMERG INFECT DIS, V10, P1692, DOI 10.3201/eid1009.030439; FUJITA T, 1979, J EXP MED, V150, P267, DOI 10.1084/jem.150.2.267; FUJITA T, 1978, J EXP MED, V148, P1044, DOI 10.1084/jem.148.4.1044; Grosskinsky S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000698; Grosskinsky S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004858; Hammerschmidt C, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/349657; Hartmann K, 2006, MOL MICROBIOL, V61, P1220, DOI 10.1111/j.1365-2958.2006.05318.x; Haupt K, 2007, J INFECT DIS, V196, P124, DOI 10.1086/518509; Heinen S, 2009, BLOOD, V114, P2439, DOI 10.1182/blood-2009-02-205641; Hellwage J, 2001, J BIOL CHEM, V276, P8427, DOI 10.1074/jbc.M007994200; Herzberger P, 2009, INT J MED MICROBIOL, V299, P141, DOI 10.1016/j.ijmm.2008.06.005; Herzberger P, 2007, INFECT IMMUN, V75, P4817, DOI 10.1128/IAI.00532-07; Hovis KM, 2006, INFECT IMMUN, V74, P1967, DOI 10.1128/IAI.74.3.1967-1972.2006; Hunfeld KP, 2000, EUR J CLIN MICROBIOL, V19, P27, DOI 10.1007/s100960050005; Jiang HX, 2001, J EXP MED, V194, P1609, DOI 10.1084/jem.194.11.1609; Jozsi M, 2008, TRENDS IMMUNOL, V29, P380, DOI 10.1016/j.it.2008.04.008; Jusko M, 2012, J IMMUNOL, V188, P2338, DOI 10.4049/jimmunol.1101240; Kenedy MR, 2009, INFECT IMMUN, V77, P2773, DOI 10.1128/IAI.00318-09; Kraiczy P, 2006, MOL IMMUNOL, V43, P31, DOI 10.1016/j.molimm.2005.06.016; Kraiczy P, 2004, J BIOL CHEM, V279, P2421, DOI 10.1074/jbc.M308343200; Kraiczy P, 2003, EUR J IMMUNOL, V33, P697, DOI 10.1002/eji.200323571; Kraiczy P, 2001, EUR J IMMUNOL, V31, P1674, DOI 10.1002/1521-4141(200106)31:6&lt;1674::AID-IMMU1674&gt;3.0.CO;2-2; Kraiczy P, 2001, INFECT IMMUN, V69, P7800, DOI 10.1128/IAI.69.12.7800-7809.2001; Kraiczy P, 2000, IMMUNOBIOLOGY, V201, P406, DOI 10.1016/S0171-2985(00)80094-7; KUHN S, 1995, J IMMUNOL, V155, P5663; Kurtenbach K, 2002, TRENDS MICROBIOL, V10, P74, DOI 10.1016/S0966-842X(01)02298-3; Kurtenbach K, 1998, INFECT IMMUN, V66, P1248, DOI 10.1128/IAI.66.3.1248-1251.1998; Kurtenbach Klaus, 2002, P117, DOI 10.1079/9780851996325.0117; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Marr N, 2007, J INFECT DIS, V195, P585, DOI 10.1086/510913; McDowell JV, 2003, INFECT IMMUN, V71, P3597, DOI 10.1128/IAI.71.6.3597-3602.2003; Metts MS, 2003, INFECT IMMUN, V71, P3587, DOI 10.1128/IAI.71.6.3587-3596.2003; Michel H, 2004, MED MICROBIOL IMMUN, V193, P219, DOI 10.1007/s00430-003-0196-8; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; Pietikainen J, 2010, MOL IMMUNOL, V47, P1299, DOI 10.1016/j.molimm.2009.11.028; Potempa J, 2003, CURR PROTEIN PEPT SC, V4, P397, DOI 10.2174/1389203033487036; Ramu P, 2007, FEBS LETT, V581, P1716, DOI 10.1016/j.febslet.2007.03.049; Rijpkema Sjoerd G. T., 1997, Clin Microbiol Infect, V3, P109; Rooijakkers SHM, 2007, MOL IMMUNOL, V44, P23, DOI 10.1016/j.molimm.2006.06.011; Saito K, 2007, AM J TROP MED HYG, V77, P1124, DOI 10.4269/ajtmh.2007.77.1124; Seling A, 2009, INFECT IMMUN; Seling A, 2010, INFECT IMMUN, V78, P39, DOI 10.1128/IAI.00691-09; Siegel C, 2008, J BIOL CHEM, V283, P34855, DOI 10.1074/jbc.M805844200; Siegel C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013519; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; Stevenson B, 2002, INFECT IMMUN, V70, P5307, DOI 10.1128/IAI.70.9.5307-5311.2002; Strle F, 1997, CLIN INFECT DIS, V25, P273, DOI 10.1086/514551; Terao Y, 2008, J BIOL CHEM, V283, P6253, DOI 10.1074/jbc.M704821200; van Burgel ND, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-43; VanDam AP, 1997, INFECT IMMUN, V65, P1228, DOI 10.1128/IAI.65.4.1228-1236.1997; Wallich R, 2005, INFECT IMMUN, V73, P2351, DOI 10.1128/IAI.73.4.2351-2359.2005; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; WHALEY K, 1976, J EXP MED, V144, P1147, DOI 10.1084/jem.144.5.1147; ZICCARDI RJ, 1981, J IMMUNOL, V126, P1769; Zipfel P.F., 2009, NAT REV IMMUNOL; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620; Zipfel PF, 1999, IMMUNOPHARMACOLOGY, V42, P53, DOI 10.1016/S0162-3109(99)00015-6	71	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53659	10.1371/journal.pone.0053659	http://dx.doi.org/10.1371/journal.pone.0053659			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320099	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429800064
J	Wasil, LR; Tomaszewski, MJ; Hoji, A; Rowe, DT				Wasil, Laura R.; Tomaszewski, Monica J.; Hoji, Aki; Rowe, David T.			The Effect of Epstein-Barr Virus Latent Membrane Protein 2 Expression on the Kinetics of Early B Cell Infection	PLOS ONE			English	Article							GROWTH TRANSFORMATION; IN-VIVO; SURFACE-IMMUNOGLOBULIN; LYMPHOCYTE-ACTIVATION; EPITHELIAL-CELLS; TRANSGENIC MICE; EBV PERSISTENCE; CROSS-LINKING; DNA FRAGMENT; BETA-CATENIN	Infection of human B cells with wild-type Epstein-Barr virus (EBV) in vitro leads to activation and proliferation that result in efficient production of lymphoblastoid cell lines (LCLs). Latent Membrane Protein 2 (LMP2) is expressed early after infection and previous research has suggested a possible role in this process. Therefore, we generated recombinant EBV with knockouts of either or both protein isoforms, LMP2A and LMP2B (D2A, D2B, D2A/D2B) to study the effect of LMP2 in early B cell infection. Infection of B cells with D2A and D2A/D2B viruses led to a marked decrease in activation and proliferation relative to wild-type (wt) viruses, and resulted in higher percentages of apoptotic B cells. D2B virus infection showed activation levels comparable to wt, but fewer numbers of proliferating B cells. Early B cell infection with wt, D2A and D2B viruses did not result in changes in latent gene expression, with the exception of elevated LMP2B transcript in D2A virus infection. Infection with D2A and D2B viruses did not affect viral latency, determined by changes in LMP1/Zebra expression following BCR stimulation. However, BCR stimulation of D2A/D2B cells resulted in decreased LMP1 expression, which suggests loss of stability in viral latency. Long-term outgrowth assays revealed that LMP2A, but not LMP2B, is critical for efficient long-term growth of B cells in vitro. The lowest levels of activation, proliferation, and LCL formation were observed when both isoforms were deleted. These results suggest that LMP2A appears to be critical for efficient activation, proliferation and survival of EBV-infected B cells at early times after infection, which impacts the efficient long-term growth of B cells in culture. In contrast, LMP2B did not appear to play a significant role in these processes, and long-term growth of infected B cells was not affected by the absence of this protein.	[Wasil, Laura R.; Tomaszewski, Monica J.; Hoji, Aki; Rowe, David T.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rowe, DT (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA.	rowe1@pitt.edu		Tomaszewski, Monica Jo/0000-0003-3940-1736	Department of Infectious Diseases and Microbiolgy at the University of Pittsburgh	Department of Infectious Diseases and Microbiolgy at the University of Pittsburgh	All studies in this research article are supported by the Department of Infectious Diseases and Microbiolgy at the University of Pittsburgh. There were no external funding sources that played a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 2005, J VIROL, V79, P1789, DOI 10.1128/JVI.79.3.1789-1802.2005; Altmann M, 2005, PLOS BIOL, V3, P2148, DOI 10.1371/journal.pbio.0030404; Altmann M, 2006, P NATL ACAD SCI USA, V103, P14188, DOI 10.1073/pnas.0605985103; Babcock GJ, 1998, IMMUNITY, V9, P395, DOI 10.1016/S1074-7613(00)80622-6; BEAUFILS P, 1993, EMBO J, V12, P5105, DOI 10.1002/j.1460-2075.1993.tb06205.x; Bishop GA, 2003, CRIT REV IMMUNOL, V23, P149, DOI 10.1615/CritRevImmunol.v23.i3.10; Brielmeier M, 1996, J GEN VIROL, V77, P2807, DOI 10.1099/0022-1317-77-11-2807; Caldwell RG, 2000, J VIROL, V74, P1101, DOI 10.1128/JVI.74.3.1101-1113.2000; Caldwell RG, 1998, IMMUNITY, V9, P405, DOI 10.1016/S1074-7613(00)80623-8; Christian SL, 2002, J IMMUNOL, V169, P758, DOI 10.4049/jimmunol.169.2.758; COUNTRYMAN J, 1985, P NATL ACAD SCI USA, V82, P4085, DOI 10.1073/pnas.82.12.4085; Davies ML, 2010, VIROLOGY, V400, P53, DOI 10.1016/j.virol.2010.01.002; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; Dirmeier U, 2003, CANCER RES, V63, P2982; Dolcetti R, 2007, AUTOIMMUN REV, V7, P96, DOI 10.1016/j.autrev.2007.02.012; Downward J, 1998, CURR OPIN GENET DEV, V8, P49, DOI 10.1016/S0959-437X(98)80061-0; Engels N, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-9; Feederle R, 2000, EMBO J, V19, P3080, DOI 10.1093/emboj/19.12.3080; Fruehling S, 1997, VIROLOGY, V235, P241, DOI 10.1006/viro.1997.8690; Gradoville L, 2002, J VIROL, V76, P5612, DOI 10.1128/JVI.76.11.5612-5626.2002; Grillot DAM, 1996, J EXP MED, V183, P381, DOI 10.1084/jem.183.2.381; GROGAN E, 1987, P NATL ACAD SCI USA, V84, P1332, DOI 10.1073/pnas.84.5.1332; Halder S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007214; HAMMERSCHMIDT W, 1988, CELL, V55, P427, DOI 10.1016/0092-8674(88)90028-1; Joseph AM, 2000, J IMMUNOL, V165, P2975, DOI 10.4049/jimmunol.165.6.2975; Kalla M, 2010, P NATL ACAD SCI USA, V107, P850, DOI 10.1073/pnas.0911948107; Kardava L, 2011, J CLIN INVEST, V121, P2614, DOI 10.1172/JCI45685; KAYE KM, 1993, P NATL ACAD SCI USA, V90, P9150, DOI 10.1073/pnas.90.19.9150; KENNEY S, 1989, J VIROL, V63, P1729, DOI 10.1128/JVI.63.4.1729-1736.1989; Kieff E, 2007, FIELDS VIROLOGY, P2603; Kieff Elliott, 1996, P1109; Kilger E, 1998, EMBO J, V17, P1700, DOI 10.1093/emboj/17.6.1700; KINTNER C, 1981, NATURE, V294, P458, DOI 10.1038/294458a0; Krenauer A, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-21; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; LAUX G, 1988, EMBO J, V7, P769, DOI 10.1002/j.1460-2075.1988.tb02874.x; LENNETTE ET, 1995, EUR J CANCER, V31A, P1875, DOI 10.1016/0959-8049(95)00354-L; LONGNECKER R, 1993, J VIROL, V67, P2006, DOI 10.1128/JVI.67.4.2006-2013.1993; LONGNECKER R, 1993, J VIROL, V67, P5068, DOI 10.1128/JVI.67.8.5068-5074.1993; Longnecker R, 1998, HUMAN TUMOR VIRUSES, P133; Lynch DT, 2002, J GEN VIROL, V83, P1025, DOI 10.1099/0022-1317-83-5-1025; Mancao C, 2007, BLOOD, V110, P3715, DOI 10.1182/blood-2007-05-090142; Maruo S, 2006, P NATL ACAD SCI USA, V103, P19500, DOI 10.1073/pnas.0604919104; Maruo S, 2011, P NATL ACAD SCI USA, V108, P1919, DOI 10.1073/pnas.1019599108; Merchant M, 2000, J VIROL, V74, P9115, DOI 10.1128/JVI.74.19.9115-9124.2000; MERINO R, 1994, EMBO J, V13, P683, DOI 10.1002/j.1460-2075.1994.tb06307.x; MILLER CL, 1995, IMMUNITY, V2, P155, DOI 10.1016/S1074-7613(95)80040-9; MILLER CL, 1994, P NATL ACAD SCI USA, V91, P772, DOI 10.1073/pnas.91.2.772; MILLER CL, 1993, J VIROL, V67, P3087, DOI 10.1128/JVI.67.6.3087-3094.1993; Morrison JA, 2003, J VIROL, V77, P12276, DOI 10.1128/JVI.77.22.12276-12284.2003; Neuhierl B, 2002, P NATL ACAD SCI USA, V99, P15036, DOI 10.1073/pnas.232381299; Nikitin PA, 2010, CELL HOST MICROBE, V8, P510, DOI 10.1016/j.chom.2010.11.004; PATARROYO M, 1986, INT J CANCER, V38, P539, DOI 10.1002/ijc.2910380414; Portis T, 2004, ONCOGENE, V23, P8619, DOI 10.1038/sj.onc.1207905; Portis T, 2004, TRENDS IMMUNOL, V25, P422, DOI 10.1016/j.it.2004.05.009; QU LR, 1992, J VIROL, V66, P3715, DOI 10.1128/JVI.66.6.3715-3724.1992; Rechsteiner MP, 2008, J VIROL, V82, P1739, DOI 10.1128/JVI.01723-07; RICKINSON AB, 1974, INT J CANCER, V14, P704, DOI 10.1002/ijc.2910140603; RICKINSON AB, 1977, INT J CANCER, V19, P775, DOI 10.1002/ijc.2910190606; Rickinson AB, 2007, FIELDS VIROLOGY, V5, P2655; Rovedo M, 2007, J VIROL, V81, P84, DOI 10.1128/JVI.01302-06; ROWE M, 1982, INT J CANCER, V29, P373, DOI 10.1002/ijc.2910290403; SAMPLE J, 1989, J VIROL, V63, P933, DOI 10.1128/JVI.63.2.933-937.1989; Scholle F, 2000, J VIROL, V74, P10681, DOI 10.1128/JVI.74.22.10681-10689.2000; Silva R, 2011, BLOOD, V117, P5870, DOI 10.1182/blood-2010-09-310318; SINCLAIR AJ, 1994, EMBO J, V13, P3321, DOI 10.1002/j.1460-2075.1994.tb06634.x; Speck P, 1999, J GEN VIROL, V80, P2193, DOI 10.1099/0022-1317-80-8-2193; TAKADA K, 1986, J VIROL, V57, P1016, DOI 10.1128/JVI.57.3.1016-1022.1986; TAKADA K, 1984, INT J CANCER, V33, P27, DOI 10.1002/ijc.2910330106; Thorley-Lawson DA, 2001, NAT REV IMMUNOL, V1, P75, DOI 10.1038/35095584; THORLEYLAWSON DA, 1985, J EXP MED, V162, P45, DOI 10.1084/jem.162.1.45; WANG F, 1990, J VIROL, V64, P2309, DOI 10.1128/JVI.64.5.2309-2318.1990; White RE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013979; Young LS, 2003, ONCOGENE, V22, P5108, DOI 10.1038/sj.onc.1206556	74	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e54010	10.1371/journal.pone.0054010	http://dx.doi.org/10.1371/journal.pone.0054010			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308294	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000313429800082
J	Cai, H; Chen, HY; Yi, T; Daimon, CM; Boyle, JP; Peers, C; Maudsley, S; Martin, B				Cai, Huan; Chen, Hongyu; Yi, Tie; Daimon, Caitlin M.; Boyle, John P.; Peers, Chris; Maudsley, Stuart; Martin, Bronwen			VennPlex-A Novel Venn Diagram Program for Comparing and Visualizing Datasets with Differentially Regulated Datapoints	PLOS ONE			English	Article							CEREBRAL-ISCHEMIA; EULER DIAGRAMS; HYPOXIA; EXPRESSION; ASTROCYTES	With the development of increasingly large and complex genomic and proteomic data sets, an enhancement in the complexity of available Venn diagram analytical programs is becoming increasingly important. Current freely available Venn diagram programs often fail to represent extra complexity among datasets, such as regulation pattern differences between different groups. Here we describe the development of VennPlex, a program that illustrates the often diverse numerical interactions among multiple, high-complexity datasets, using up to four data sets. VennPlex includes versatile output features, where grouped data points in specific regions can be easily exported into a spreadsheet. This program is able to facilitate the analysis of two to four gene sets and their corresponding expression values in a user-friendly manner. To demonstrate its unique experimental utility we applied VennPlex to a complex paradigm, i.e. a comparison of the effect of multiple oxygen tension environments (1-20% ambient oxygen) upon gene transcription of primary rat astrocytes. VennPlex accurately dissects complex data sets reliably into easily identifiable groups for straightforward analysis and data output. This program, which is an improvement over currently available Venn diagram programs, is able to rapidly extract important datasets that represent the variety of expression patterns available within the data sets, showing potential applications in fields like genomics, proteomics, and bioinformatics.	[Cai, Huan; Yi, Tie; Daimon, Caitlin M.; Martin, Bronwen] NIA, Metab Unit, NIH, Baltimore, MD 21224 USA; [Chen, Hongyu; Maudsley, Stuart] NIA, Receptor Pharmacol Unit, NIH, Baltimore, MD 21224 USA; [Boyle, John P.; Peers, Chris] Univ Leeds, Leeds Inst Genet Hlth & Therapeut, Inst Cardiovasc Res, Leeds, W Yorkshire, England	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Leeds	Martin, B (corresponding author), NIA, Metab Unit, NIH, Baltimore, MD 21224 USA.	martinbro@mail.nih.gov	chen, hongyu/HHS-4314-2022; Maudsley, Stuart/Q-4782-2019; Boyle, John/N-4868-2016; Maudsley, Stuart/AAV-9929-2021; Cai, Huan/B-6578-2016	Maudsley, Stuart/0000-0002-1868-184X; Cai, Huan/0000-0001-7731-8891; Martin, Bronwen/0000-0002-9185-6925; Peers, Chris/0000-0002-8354-346X	National Institute on Aging, National Institutes of Health; Alzheimers Research UK [ARUK-PPG2011B-1] Funding Source: researchfish	National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	This work was supported by the Intramural Research Program of the National Institute on Aging, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Chadwick W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021638; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Cibella F, 2011, PEDIAT ALLERG IMM-UK, V22, P60, DOI 10.1111/j.1399-3038.2010.01097.x; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; Dallas M, 2007, J NEUROSCI, V27, P3946, DOI 10.1523/JNEUROSCI.5030-06.2007; Fang YC, 2006, J CEREBR BLOOD F MET, V26, P491, DOI 10.1038/sj.jcbfm.9600205; Homuth G, 2012, J ENDOCRINOL, V215, P17, DOI 10.1530/JOE-12-0144; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Kestler HA, 2005, BIOINFORMATICS, V21, P1592, DOI 10.1093/bioinformatics/bti169; Kestler HA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-67; Koehler RC, 2009, TRENDS NEUROSCI, V32, P160, DOI 10.1016/j.tins.2008.11.005; Loinard C, 2012, CIRCULATION, V125, P1014, DOI 10.1161/CIRCULATIONAHA.111.041830; Martin B, 2007, ENDOCRINOLOGY, V148, P4318, DOI 10.1210/en.2007-0161; Martin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036911; Martin B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002398; Maudsley S, 2011, METHODS MOL BIOL, V756, P99, DOI 10.1007/978-1-61779-160-4_5; Ogunshola OO, 2009, CELL MOL LIFE SCI, V66, P3555, DOI 10.1007/s00018-009-0141-0; Oliveros JC, 2007, VENNY INTERACTIVE TO; Peers C, 2007, ESSAYS BIOCHEM, V43, P153, DOI 10.1042/bse0430153; Peers C, 2009, ANN NY ACAD SCI, V1177, P169, DOI 10.1111/j.1749-6632.2009.05026.x; Pirooznia M, 2007, BIOINFORMATION, V1, P420, DOI 10.6026/97320630001420; Schonemeier B, 2008, J NEUROIMMUNOL, V198, P39, DOI 10.1016/j.jneuroim.2008.04.010; Taylor SC, 1999, J BIOL CHEM, V274, P31217, DOI 10.1074/jbc.274.44.31217	25	71	74	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53388	10.1371/journal.pone.0053388	http://dx.doi.org/10.1371/journal.pone.0053388			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308210	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429100061
J	Liu, T; Weng, ZY; Dong, XW; Chen, LJ; Ma, L; Cen, S; Zhou, NM; Hu, YZ				Liu, Tao; Weng, Zhiyong; Dong, Xiaowu; Chen, Linjie; Ma, Ling; Cen, Shan; Zhou, Naiming; Hu, Yongzhou			Design, Synthesis and Biological Evaluation of Novel Piperazine Derivatives as CCR5 Antagonists	PLOS ONE			English	Article							SMALL-MOLECULE CCR5; HIV-1; CORECEPTOR; TAK-220	By using a fragment-assembly strategy and bioisosteric-replacement principle, a series of novel piperazine derivatives were designed, synthesized, and evaluated for their cellular target-effector fusion activities and in vitro antiviral activities against HIV-1. Preliminary structure-activity relationships (SARs) of target compounds were concluded in this study, and five compounds were found to exhibited medium to potent CCR5 fusion activities with IC50 values in low micromolar level. Among evaluated compounds, 23 h was found to be a CCR5 antagonist with an IC50 value of 6.29 mu M and an anti-HIV-1 inhibitor with an IC50 value of 0.44 mu M.	[Liu, Tao; Weng, Zhiyong; Dong, Xiaowu; Hu, Yongzhou] Zhejiang Univ, Coll Pharmaceut Sci, Ecole Normale Super, Joint Lab Med Chem, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Linjie; Zhou, Naiming] Zhejiang Univ, Coll Life Sci, Inst Biochem, Hangzhou 310003, Zhejiang, Peoples R China; [Ma, Ling; Cen, Shan] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China; [Ma, Ling; Cen, Shan] Peking Union Med Coll, Beijing 100021, Peoples R China	Zhejiang University; Zhejiang University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, T (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Ecole Normale Super, Joint Lab Med Chem, Hangzhou 310003, Zhejiang, Peoples R China.	Lt601@zju.edu.cn; znm2000@yahoo.com; Huyz@zju.edu.cn	Zhou, Naiming/AHC-1121-2022		National Nature Science Foundation of China [81072515]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Nature Science Foundation of China (number 81072515). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen LJ, 2010, ANAL BIOCHEM, V407, P180, DOI 10.1016/j.ab.2010.08.018; Coakley E, 2005, CURR OPIN INFECT DIS, V18, P9, DOI 10.1097/00001432-200502000-00003; Combadiere C, 1996, J LEUKOCYTE BIOL, V60, P147, DOI 10.1002/jlb.60.1.147; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dong MX, 2012, BIOORG MED CHEM LETT, V22, P3284, DOI 10.1016/j.bmcl.2012.03.019; Feng DZ, 2007, ORG BIOMOL CHEM, V5, P2690, DOI 10.1039/b707175b; Jiang XH, 2004, BIOORG MED CHEM LETT, V14, P3675, DOI 10.1016/j.bmcl.2004.05.014; Kondru R, 2008, MOL PHARMACOL, V73, P789, DOI 10.1124/mol.107.042101; Nishikawa M, 2005, ANTIMICROB AGENTS CH, V49, P4708, DOI 10.1128/AAC.49.11.4708-4715.2005; Rodger DM, 2008, CLIN INFECT DIS, V47, P236; Takashima K, 2005, ANTIMICROB AGENTS CH, V49, P3474, DOI 10.1128/AAC.49.8.3474-3482.2005; Torre O, 2006, TETRAHEDRON-ASYMMETR, V17, P860, DOI 10.1016/j.tetasy.2006.02.022; Weng ZY, 2011, J CHEM RES, P43, DOI 10.3184/174751911X556828; Yerly S, 1999, LANCET, V354, P729, DOI 10.1016/S0140-6736(98)12262-6	14	10	10	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53636	10.1371/journal.pone.0053636	http://dx.doi.org/10.1371/journal.pone.0053636			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308267	Green Submitted, gold, Green Published			2022-12-25	WOS:000313429100100
J	Pieszek, M; Widmann, A; Gruber, T; Schroger, E				Pieszek, Marika; Widmann, Andreas; Gruber, Thomas; Schroeger, Erich			The Human Brain Maintains Contradictory and Redundant Auditory Sensory Predictions	PLOS ONE			English	Article							MISMATCH NEGATIVITY; MULTISENSORY INTEGRATION; INVOLUNTARY ATTENTION; STIMULUS DEVIANCE; EFFECT SIZE; SOUNDS; TASK; MMN; REPRESENTATIONS; POTENTIALS	Computational and experimental research has revealed that auditory sensory predictions are derived from regularities of the current environment by using internal generative models. However, so far, what has not been addressed is how the auditory system handles situations giving rise to redundant or even contradictory predictions derived from different sources of information. To this end, we measured error signals in the event-related brain potentials (ERPs) in response to violations of auditory predictions. Sounds could be predicted on the basis of overall probability, i.e., one sound was presented frequently and another sound rarely. Furthermore, each sound was predicted by an informative visual cue. Participants' task was to use the cue and to discriminate the two sounds as fast as possible. Violations of the probability based prediction (i.e., a rare sound) as well as violations of the visual-auditory prediction (i.e., an incongruent sound) elicited error signals in the ERPs (Mismatch Negativity [MMN] and Incongruency Response [IR]). Particular error signals were observed even in case the overall probability and the visual symbol predicted different sounds. That is, the auditory system concurrently maintains and tests contradictory predictions. Moreover, if the same sound was predicted, we observed an additive error signal (scalp potential and primary current density) equaling the sum of the specific error signals. Thus, the auditory system maintains and tolerates functionally independently represented redundant and contradictory predictions. We argue that the auditory system exploits all currently active regularities in order to optimally prepare for future events.	[Pieszek, Marika; Widmann, Andreas; Schroeger, Erich] Univ Leipzig, Inst Psychol, D-04109 Leipzig, Germany; [Gruber, Thomas] Univ Osnabruck, Inst Psychol, Osnabruck, Germany	Leipzig University; University Osnabruck	Pieszek, M (corresponding author), Univ Leipzig, Inst Psychol, D-04109 Leipzig, Germany.	marika.pieszek@uni-leipzig.de	Widmann, Andreas/AEN-2370-2022; Schröger, Erich/C-3079-2009; Pieszek, Marika/C-3860-2014	Widmann, Andreas/0000-0003-3664-8581; Schröger, Erich/0000-0002-8321-6629; 	Deutsche Forschungsgemeinschaft (DFG) [SCHR 375/20-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by a Deutsche Forschungsgemeinschaft (DFG) Reinhart-Koselleck grant to ES (SCHR 375/20-1), http://www.dfg.de/foerderung/programme/einzelfoerderung/reinhart_koselleck_projekte/kompakt/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres AJD, 2011, INT J PSYCHOPHYSIOL, V79, P137, DOI 10.1016/j.ijpsycho.2010.09.012; Aoyama A, 2006, BRAIN RES, V1068, P194, DOI 10.1016/j.brainres.2005.11.017; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; Beauchamp MS, 2004, NAT NEUROSCI, V7, P1190, DOI 10.1038/nn1333; Bendixen A, 2008, NEUROIMAGE, V41, P1111, DOI 10.1016/j.neuroimage.2008.03.040; Bendixen A, 2012, INT J PSYCHOPHYSIOL, V83, P120, DOI 10.1016/j.ijpsycho.2011.08.003; Bendixen A, 2009, J NEUROSCI, V29, P8447, DOI 10.1523/JNEUROSCI.1493-09.2009; Besle J, 2005, EXP BRAIN RES, V166, P337, DOI 10.1007/s00221-005-2375-x; Boll S, 2009, PSYCHOPHYSIOLOGY, V46, P645, DOI 10.1111/j.1469-8986.2009.00803.x; Bosch-Bayard J, 2001, CLIN ELECTROENCEPHAL, V32, P47, DOI 10.1177/155005940103200203; Bregman AS, 1990, AUDITORY SCENE ANAL, Vxiii; Brown CR, 2007, INT J PSYCHOPHYSIOL, V65, P122, DOI 10.1016/j.ijpsycho.2007.04.002; Bubic A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00025; Deacon D, 1998, PSYCHOPHYSIOLOGY, V35, P413, DOI 10.1017/S004857729896053X; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Deouell LY, 2007, J PSYCHOPHYSIOL, V21, P188, DOI 10.1027/0269-8803.21.34.188; Deouell LY, 1998, PSYCHOPHYSIOLOGY, V35, P355, DOI 10.1017/S0048577298970287; Dimoska A, 2006, BRAIN COGNITION, V62, P98, DOI 10.1016/j.bandc.2006.03.011; Escera C, 2000, AUDIOL NEURO-OTOL, V5, P151, DOI 10.1159/000013877; Evans A. C., 1993, 3D STAT NEUROANATOMI; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Friston KJ, 2012, INT J PSYCHOPHYSIOL, V83, P248, DOI 10.1016/j.ijpsycho.2011.11.014; Friston KJ, 2009, NEURAL NETWORKS, V22, P1093, DOI 10.1016/j.neunet.2009.07.023; Friston KJ, 2009, PHILOS T R SOC B, V364, P1211, DOI 10.1098/rstb.2008.0300; Froyen D, 2008, NEUROSCI LETT, V430, P23, DOI 10.1016/j.neulet.2007.10.014; Garrido MI, 2008, NEUROIMAGE, V42, P936, DOI 10.1016/j.neuroimage.2008.05.018; Garrido MI, 2009, CLIN NEUROPHYSIOL, V120, P453, DOI 10.1016/j.clinph.2008.11.029; GIARD MH, 1995, J COGNITIVE NEUROSCI, V7, P133, DOI 10.1162/jocn.1995.7.2.133; GIARD MH, 1990, PSYCHOPHYSIOLOGY, V27, P627, DOI 10.1111/j.1469-8986.1990.tb03184.x; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; Gondan M, 2006, BRAIN RES, V1073, P389, DOI 10.1016/j.brainres.2005.12.050; GRATTON G, 1990, ELECTROEN CLIN NEURO, V75, P419, DOI 10.1016/0013-4694(90)90087-Z; Grimm S, 2006, NEUROIMAGE, V32, P275, DOI 10.1016/j.neuroimage.2006.03.032; Gruendler TOJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025591; Horvath J, 2001, COGNITIVE BRAIN RES, V12, P131, DOI 10.1016/S0926-6410(01)00038-6; Luck S.J., 2005, INTRO EVENT RELATED; May PJC, 2010, PSYCHOPHYSIOLOGY, V47, P66, DOI 10.1111/j.1469-8986.2009.00856.x; MILLER J, 1982, COGNITIVE PSYCHOL, V14, P247, DOI 10.1016/0010-0285(82)90010-X; Mittag M, 2011, EXP BRAIN RES, V211, P287, DOI 10.1007/s00221-011-2686-z; Molholm S, 2005, CEREB CORTEX, V15, P545, DOI 10.1093/cercor/bhh155; Molholm S, 2006, J NEUROPHYSIOL, V96, P721, DOI 10.1152/jn.00285.2006; MUMFORD D, 1992, BIOL CYBERN, V66, P241, DOI 10.1007/BF00198477; Naatanen R, 2001, TRENDS NEUROSCI, V24, P283, DOI 10.1016/S0166-2236(00)01790-2; NAATANEN R, 1982, BIOL PSYCHOL, V14, P53, DOI 10.1016/0301-0511(82)90017-5; Naatanen R, 1999, PSYCHOL BULL, V125, P826, DOI 10.1037/0033-2909.125.6.826; Naatanen R, 2011, PSYCHOPHYSIOLOGY, V48, P4, DOI 10.1111/j.1469-8986.2010.01114.x; Nieuwenhuis S, 2004, PSYCHOPHYSIOLOGY, V41, P157, DOI 10.1046/j.1469-8986.2003.00128.x; Nieuwenhuis S, 2011, PSYCHOPHYSIOLOGY, V48, P162, DOI 10.1111/j.1469-8986.2010.01057.x; NOVAK GP, 1990, ELECTROEN CLIN NEURO, V75, P255, DOI 10.1016/0013-4694(90)90105-S; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olejnik S, 2000, CONTEMP EDUC PSYCHOL, V25, P241, DOI 10.1006/ceps.2000.1040; Paavilainen P, 2001, NEUROSCI LETT, V301, P179, DOI 10.1016/S0304-3940(01)01635-4; Patel Salil H, 2005, Int J Med Sci, V2, P147; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Rahne T, 2007, BRAIN RES, V1144, P127, DOI 10.1016/j.brainres.2007.01.074; Rinne T, 2001, NEUROREPORT, V12, P2209, DOI 10.1097/00001756-200107200-00033; Ritter W, 1999, PSYCHOPHYSIOLOGY, V36, P835; Schlogl A, 2007, CLIN NEUROPHYSIOL, V118, P98, DOI 10.1016/j.clinph.2006.09.003; Schroger E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001131; Schroger E, 2007, J PSYCHOPHYSIOL, V21, P138, DOI 10.1027/0269-8803.21.34.138; Schroger E, 1998, PSYCHOPHYSIOLOGY, V35, P755, DOI 10.1111/1469-8986.3560755; Schroger E, 2005, ACTA ACUST UNITED AC, V91, P490; SCHROGER E, 1995, PSYCHOPHYSIOLOGY, V32, P55, DOI 10.1111/j.1469-8986.1995.tb03406.x; Sinkkonen J., 1999, INFORM THEORY BRAIN, P241; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Sussman E, 2003, PSYCHON B REV, V10, P630, DOI 10.3758/BF03196525; Teder-Salejarvi WA, 2002, COGNITIVE BRAIN RES, V14, P106, DOI 10.1016/S0926-6410(02)00065-4; Todorovic A, 2011, J NEUROSCI, V31, P9118, DOI 10.1523/JNEUROSCI.1425-11.2011; Ullsperger P, 2006, INT J PSYCHOPHYSIOL, V59, P3, DOI 10.1016/j.ijpsycho.2005.06.007; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0; Widmann A, 2004, PSYCHOPHYSIOLOGY, V41, P709, DOI 10.1111/j.1469-8986.2004.00208.x; Widmann A, 2007, CEREB CORTEX, V17, P2696, DOI 10.1093/cercor/bhl178; Widmann A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00233; Winkler I, 1996, BRAIN RES, V742, P239, DOI 10.1016/S0006-8993(96)01008-6; Winkler I, 2007, J PSYCHOPHYSIOL, V21, P147, DOI 10.1027/0269-8803.21.34.147; Winkler I, 2009, TRENDS COGN SCI, V13, P532, DOI 10.1016/j.tics.2009.09.003; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P74, DOI 10.1002/(SICI)1097-0193(1996)4:1<74::AID-HBM5>3.0.CO;2-M; Zmigrod S, 2009, PSYCHOL RES-PSYCH FO, V73, P674, DOI 10.1007/s00426-008-0163-5	79	27	27	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53634	10.1371/journal.pone.0053634	http://dx.doi.org/10.1371/journal.pone.0053634			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	069IS	23308266	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429100099
J	Thundyil, J; Manzanero, S; Pavlovski, D; Cully, TR; Lok, KZ; Widiapradja, A; Chunduri, P; Jo, DG; Naruse, C; Asano, M; Launikonis, BS; Sobey, CG; Coulthard, MG; Arumugam, TV				Thundyil, John; Manzanero, Silvia; Pavlovski, Dale; Cully, Tanya R.; Lok, Ker-Zhing; Widiapradja, Alexander; Chunduri, Prasad; Jo, Dong-Gyu; Naruse, Chie; Asano, Masahide; Launikonis, Bradley S.; Sobey, Christopher G.; Coulthard, Mark G.; Arumugam, Thiruma V.			Evidence That the EphA2 Receptor Exacerbates Ischemic Brain Injury	PLOS ONE			English	Article							IN-VITRO; VASCULAR-PERMEABILITY; CEREBRAL-ISCHEMIA; LUNG INJURY; EXPRESSION; EPHRINS; ANGIOGENESIS; MECHANISMS; DISEASE; STROKE	Ephrin (Eph) signaling within the central nervous system is known to modulate axon guidance, synaptic plasticity, and to promote long-term potentiation. We investigated the potential involvement of EphA2 receptors in ischemic stroke-induced brain inflammation in a mouse model of focal stroke. Cerebral ischemia was induced in male C57Bl6/J wild-type (WT) and EphA2-deficient (EphA2(-/-)) mice by middle cerebral artery occlusion (MCAO; 60 min), followed by reperfusion (24 or 72 h). Brain infarction was measured using triphenyltetrazolium chloride staining. Neurological deficit scores and brain infarct volumes were significantly less in EphA2(-/-) mice compared with WT controls. This protection by EphA2 deletion was associated with a comparative decrease in brain edema, blood-brain barrier damage, MMP-9 expression and leukocyte infiltration, and higher expression levels of the tight junction protein, zona occludens-1. Moreover, EphA2(-/-) brains had significantly lower levels of the pro-apoptotic proteins, cleaved caspase-3 and BAX, and higher levels of the anti-apoptotic protein, Bcl-2 as compared to WT group. We confirmed that isolated WT cortical neurons express the EphA2 receptor and its ligands (ephrin-A1-A3). Furthermore, expression of all four proteins was increased in WT primary cortical neurons following 24 h of glucose deprivation, and in the brains of WT mice following stroke. Glucose deprivation induced less cell death in primary neurons from EphA2(-/-) compared with WT mice. In conclusion, our data provide the first evidence that the EphA2 receptor directly contributes to blood-brain barrier damage and neuronal death following ischemic stroke.	[Thundyil, John; Manzanero, Silvia; Pavlovski, Dale; Cully, Tanya R.; Lok, Ker-Zhing; Widiapradja, Alexander; Chunduri, Prasad; Launikonis, Bradley S.; Arumugam, Thiruma V.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Jo, Dong-Gyu] Sungkyunkwan Univ, Sch Pharm, Suwon, South Korea; [Naruse, Chie; Asano, Masahide] Kanazawa Univ, Adv Sci Res Ctr, Div Transgen Anim Sci, Kanazawa, Ishikawa, Japan; [Sobey, Christopher G.] Monash Univ, Dept Pharmacol, Vasc Biol & Immunopharmacol Grp, Clayton, Vic 3168, Australia; [Coulthard, Mark G.] Univ Queensland, Royal Childrens Hosp, Acad Discipline Paediat & Child Hlth, Herston, Qld, Australia; [Coulthard, Mark G.] Royal Childrens Hosp, Paediat Intens Care Unit, Herston, Qld, Australia; [Coulthard, Mark G.] Royal Childrens Hosp, Queensland Childrens Med Res Inst, Herston, Qld, Australia	University of Queensland; Sungkyunkwan University (SKKU); Kanazawa University; Monash University; Royal Children's Hospital Brisbane; University of Queensland; Royal Children's Hospital Brisbane; Royal Children's Hospital Brisbane	Arumugam, TV (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia.	t.arumugam@uq.edu.au	Sobey, Christopher G/A-2786-2008; Chunduri, Prasad/J-2141-2014; Coulthard, Mark G/AAT-7735-2021; Launikonis, Bradley/K-6256-2015; Arumugam, Thiruma Valavan/B-4898-2011; Jo, Dong-Gyu/AAN-9278-2021; Coulthard, Mark Graeme/E-9444-2010; Arumugam, Thiruma/AAG-6958-2019; Cully, Tanya/B-7920-2016	Sobey, Christopher G/0000-0001-6525-9097; Coulthard, Mark G/0000-0001-7400-5582; Launikonis, Bradley/0000-0003-0700-4867; Jo, Dong-Gyu/0000-0003-2271-1076; Coulthard, Mark Graeme/0000-0001-7400-5582; Cully, Tanya/0000-0002-7047-9913; Chunduri, Prasad/0000-0001-7297-7580; Arumugam, Thiruma/0000-0002-3377-0939; Manzanero, Silvia/0000-0002-5294-7082	ARC [FT100100427]	ARC(Australian Research Council)	This work was supported by the ARC Future Fellowship (FT100100427) awarded to TVA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SH, 2000, STROKE, V31, P193, DOI 10.1161/01.STR.31.1.193; Arocho LC, 2011, CELL MOL NEUROBIOL, V31, P1057, DOI 10.1007/s10571-011-9705-2; Baum CL, 2005, DERMATOL SURG, V31, P674; Blits-Huizinga CT, 2004, IUBMB LIFE, V56, P257, DOI 10.1080/15216540412331270076; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Carpenter TC, 2012, AM J RESP CELL MOL, V46, P40, DOI 10.1165/rcmb.2011-0044OC; Cercone MA, 2009, AM J PHYSIOL-LUNG C, V297, pL856, DOI 10.1152/ajplung.00118.2009; Davy A, 2005, DEV DYNAM, V232, P1, DOI 10.1002/dvdy.20200; Du J, 2007, CURR PHARM DESIGN, V13, P2507; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Feiler S, 2011, CEREBROVASC DIS, V32, P289, DOI 10.1159/000328248; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Genander M, 2010, CURR OPIN CELL BIOL, V22, P611, DOI 10.1016/j.ceb.2010.08.005; Goldshmit Y, 2006, BRAIN RES REV, V52, P327, DOI 10.1016/j.brainresrev.2006.04.006; Hafner C, 2004, CLIN CHEM, V50, P490, DOI 10.1373/clinchem.2003.026849; Hafner C, 2005, WORLD J GASTROENTERO, V11, P4024, DOI 10.3748/wjg.v11.i26.4024; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Himanen JP, 2003, TRENDS NEUROSCI, V26, P46, DOI 10.1016/S0166-2236(02)00005-X; Ivanov AI, 2006, IUBMB LIFE, V58, P389, DOI 10.1080/15216540600756004; Kitamura T, 2008, AM J PHYSIOL-CELL PH, V294, pC189, DOI 10.1152/ajpcell.00314.2007; Kuijper S, 2007, TRENDS CARDIOVAS MED, V17, P145, DOI 10.1016/j.tcm.2007.03.003; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Larson J, 2008, AM J PHYSIOL-LUNG C, V295, pL431, DOI 10.1152/ajplung.90256.2008; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; Manaenko A, 2011, J NEUROSCI METH, V195, P206, DOI 10.1016/j.jneumeth.2010.12.013; Naruse-Nakajima C, 2001, MECH DEVELOP, V102, P95, DOI 10.1016/S0925-4773(01)00290-8; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Rohani N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000597; Thundyil J, 2012, NEUROMOL MED, V14, P30, DOI 10.1007/s12017-012-8167-0; Thundyil John, 2010, Exp Transl Stroke Med, V2, P15, DOI 10.1186/2040-7378-2-15; Widiapradja A, 2012, J NEUROCHEM, V122, P321, DOI 10.1111/j.1471-4159.2012.07754.x; Xu HS, 2005, AM J PHYSIOL-RENAL, V288, pF855, DOI 10.1152/ajprenal.00347.2004; Zhou N, 2011, MICROVASC RES, V82, P113, DOI 10.1016/j.mvr.2011.06.005	34	40	43	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53528	10.1371/journal.pone.0053528	http://dx.doi.org/10.1371/journal.pone.0053528			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308246	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429100084
J	Watson, JA; Bryan, K; Williams, R; Popov, S; Vujanic, G; Coulomb, A; Boccon-Gibod, L; Graf, N; Pritchard-Jones, K; O'Sullivan, M				Watson, Jenny A.; Bryan, Kenneth; Williams, Richard; Popov, Sergey; Vujanic, Gordan; Coulomb, Aurore; Boccon-Gibod, Liliane; Graf, Norbert; Pritchard-Jones, Kathy; O'Sullivan, Maureen			miRNA Profiles as a Predictor of Chemoresponsiveness in Wilms' Tumor Blastema	PLOS ONE			English	Article							TAMOXIFEN RESISTANCE; MICRORNAS; CANCER; NEPHROBLASTOMA; CHEMOTHERAPY; TRIAL; GENE	The current SIOP treatment protocol for Wilms' tumor involves pre-operative chemotherapy followed by nephrectomy. Not all patients benefit equally from such chemotherapy. The aim of this study was to generate a miRNA profile of chemo resistant blastemal cells in high risk Wilms' tumors which might serve as predictive markers of therapeutic response at the pre-treatment biopsy stage. We have shown here that unsupervised hierarchical clustering of genome-wide miRNA expression profiles can clearly separate intermediate risk tumors from high risk tumors. A total of 29 miRNAs were significantly differentially expressed between post-treatment intermediate risk and high risk groups, including miRNAs that have been previously linked to chemo resistance in other cancer types. Furthermore, 7 of these 29 miRNAs were already at the pre-treatment biopsy stage differentially expressed between cases ultimately deemed intermediate risk compared to high risk. These miRNA alterations include down-regulation in high risk cases of miR-193a. 5p, miR-27a and the up-regulation of miR-483.5p, miR-628.5p, miR-590.5p, miR-302a and miR-367. The demonstration of such miRNA markers at the pretreatment biopsy stage could permit stratification of patients to more tailored treatment regimens.	[Watson, Jenny A.; O'Sullivan, Maureen] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin, Ireland; [Bryan, Kenneth] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Williams, Richard; Pritchard-Jones, Kathy] UCL Inst Child Hlth, London, England; [Popov, Sergey] Inst Canc Res, Surrey, England; [Vujanic, Gordan] Cardiff Univ, Sch Med, Cardiff, S Glam, Wales; [Coulomb, Aurore; Boccon-Gibod, Liliane] Univ Paris 06, Hop Armand Trousseau, Paris, France; [Graf, Norbert] Univ Saarland, Dept Pediat Oncol & Hematol, Homburg, Germany; [O'Sullivan, Maureen] Our Ladys Childrens Hosp, Dept Pathol, Dublin, Ireland	National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; Royal College of Surgeons - Ireland; University of London; University College London; University of London; Institute of Cancer Research - UK; Cardiff University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Saarland University; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin	O'Sullivan, M (corresponding author), Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin, Ireland.	maureen.osullivan@tcd.ie	Vujanic, Gordan M./AFS-3176-2022; Vujanic, Gordan M./AAW-4712-2020; Graf, Norbert/H-1328-2011; Pritchard-Jones, Kathy/F-4286-2014	Vujanic, Gordan M./0000-0003-0726-6939; Vujanic, Gordan M./0000-0003-0726-6939; Graf, Norbert/0000-0002-2248-323X; Pritchard-Jones, Kathy/0000-0002-2384-9475; O'Sullivan, Maureen/0000-0001-5838-1609; Bryan, Kenneth/0000-0002-9550-8354	Health Research Board (HRB) of Ireland [HRB MRCG 2008/1]	Health Research Board (HRB) of Ireland	This project was funded by the Health Research Board (HRB) of Ireland, grant number: HRB MRCG 2008/1; website: http://www.hrb.ie/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KE, 2010, MOL CANCER THER, V9, P3126, DOI 10.1158/1535-7163.MCT-10-0397; Baltayiannis G, 2008, J BUON, V13, P263; Barroca H, 2010, DIAGN CYTOPATHOL, V38, P477, DOI 10.1002/dc.21221; BECKWITH J B, 1990, Pediatric Pathology, V10, P1; Bhatt K, 2011, AM J PHYSIOL-RENAL, V300, pF602, DOI 10.1152/ajprenal.00727.2010; Bjornsson HT, 2007, JNCI-J NATL CANCER I, V99, P1270, DOI 10.1093/jnci/djm069; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; de Kraker J, 2004, LANCET, V364, P1229, DOI 10.1016/S0140-6736(04)17139-0; Feng DD, 2011, J CELL MOL MED, V15, P2164, DOI 10.1111/j.1582-4934.2010.01213.x; Giovannetti E, 2012, CRIT REV ONCOL HEMAT, V81, P103, DOI 10.1016/j.critrevonc.2011.03.010; Godzinski J, 1998, EUR J PEDIATR SURG, V8, P83, DOI 10.1055/s-2008-1071127; Graf N, 2000, UROL CLIN N AM, V27, P443, DOI 10.1016/S0094-0143(05)70092-6; Isomoto H, 2009, DIGESTION, V79, P2, DOI 10.1159/000167859; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Jesus ABD, 2009, CELL CYCLE, V8, P394; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; LEMERLE J, 1983, J CLIN ONCOL, V1, P604, DOI 10.1200/JCO.1983.1.10.604; Ma N, 2011, MOL CELL ENDOCRINOL, V333, P96, DOI 10.1016/j.mce.2010.11.027; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Rivera MN, 2005, NAT REV CANCER, V5, P699, DOI 10.1038/nrc1696; Saal S, 2009, CURR OPIN NEPHROL HY, V18, P317, DOI 10.1097/MNH.0b013e32832c9da2; Sarkar FH, 2010, DRUG RESIST UPDATE, V13, P57, DOI 10.1016/j.drup.2010.02.001; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Ueda K, 1999, ANTI-CANCER DRUG DES, V14, P115; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Zhao JJ, 2008, J BIOL CHEM, V283, P31079, DOI 10.1074/jbc.M806041200; Zheng TS, 2010, INT J CANCER, V126, P2, DOI 10.1002/ijc.24782; Zirn B, 2006, INT J CANCER, V118, P1954, DOI 10.1002/ijc.21564; ZUPPAN CW, 1991, CANCER-AM CANCER SOC, V68, P385, DOI 10.1002/1097-0142(19910715)68:2<385::AID-CNCR2820680229>3.0.CO;2-T	32	54	59	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53417	10.1371/journal.pone.0053417	http://dx.doi.org/10.1371/journal.pone.0053417			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308219	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429100065
J	Cavallo, A; Priore, P; Gnoni, GV; Papa, S; Zanotti, F; Gnoni, A				Cavallo, Alessandro; Priore, Paola; Gnoni, Gabriele Vincenzo; Papa, Sergio; Zanotti, Franco; Gnoni, Antonio			3,5-Diiodo-L-Thyronine Administration To Hypothyroid Rats Rapidly Enhances Fatty Acid Oxidation Rate and Bioenergetic Parameters in Liver Cells	PLOS ONE			English	Article							CARNITINE PALMITOYLTRANSFERASE-I; MITOCHONDRIAL F0F1-ATP SYNTHASE; THYROID-HORMONE ACTION; GENE-EXPRESSION; CARRIER ACTIVITY; HEPATOCYTES; METABOLISM; 3,5-DIIODOTHYRONINE; DIET; RESPIRATION	Growing evidence shows that, among triiodothyronine derivatives, 3,5 diiodo-L-thyronine (T-2) plays an important role in energy metabolism and fat storage. In the present study, short-term effects of T-2 administration to hypothyroid rats on fatty acid oxidation rate and bioenergetic parameters were investigated. Within 1 h following T-2 injection, state 3 and state 4 respiration rates, which were reduced in hypothyroid mitochondria, were noticeably increased particularly in succinate- with respect to glutamate/malate-energized mitochondria. Maximal respiratory activity, observed when glutamate/malate/succinate were simultaneously present in the respiratory medium, was significantly stimulated by T-2 treatment. A T-2-induced increase in respiratory rates was also observed when palmitoyl-CoA or L-palmitoylcarnitine were used as substrates. No significant change in respiratory control index and ADP/O ratio was observed. The activities of the mitochondrial respiratory chain complexes, especially Complex II, were increased in T-2-treated rats. In the latter, Complex V activities, assayed in both ATP synthesis and hydrolysis direction, were enhanced. The rate of fatty acid oxidation, followed by conversion of [C-14]palmitate to CO2 and ketone bodies, was higher in hepatocytes isolated from T-2-treated rats. This increase occurs in parallel with the raise in the activity of carnitine palmitoyltransferase-I, the rate limiting enzyme of fatty acid beta-oxidation, assayed in situ in digitonin-permeabilized hepatocytes. Overall, these results indicate that T-2 rapidly increases the ability of mitochondria to import and oxidize fatty acids. An emerging idea in the literature is the ability of T-2 to reduce adiposity and dyslipidemia and to prevent the development in liver steatosis. The results of the present study, showing a rapid T-2-induced increase in the ability of mitochondria to import and oxidize fatty acids, may contribute to understand the biochemical mechanisms of T-2-metabolic effects.	[Cavallo, Alessandro; Priore, Paola; Gnoni, Gabriele Vincenzo] Univ Salento, Dept Biol & Environm Sci & Technol, Biochem Lab, Lecce, Italy; [Papa, Sergio] CNR, Inst Biomembranes & Bioenerget, I-70126 Bari, Italy; [Zanotti, Franco; Gnoni, Antonio] Univ Bari Aldo Moro, Dept Basic Med Sci, Bari, Italy	University of Salento; Consiglio Nazionale delle Ricerche (CNR); Universita degli Studi di Bari Aldo Moro	Gnoni, A (corresponding author), Univ Bari Aldo Moro, Dept Basic Med Sci, Bari, Italy.	antonio.gnoni@uniba.it	Gnoni, Antonio/C-8078-2014	Gnoni, Antonio/0000-0001-5071-611X; Papa, Sergio/0000-0002-4417-1763	PRIN	PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was in part supported by PRIN 2007 to G.V. Gnoni. Ministero dell'Istruzione dell'Universita e Ricerca (MIUR) Italy. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Arnold S, 1998, EUR J BIOCHEM, V252, P325, DOI 10.1046/j.1432-1327.1998.2520325.x; Bartlett K, 2004, EUR J BIOCHEM, V271, P462, DOI 10.1046/j.1432-1033.2003.03947.x; Cavallo A, 2011, J BIOENERG BIOMEMBR, V43, P349, DOI 10.1007/s10863-011-9366-3; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Cimmino M, 1996, J ENDOCRINOL, V149, P319, DOI 10.1677/joe.0.1490319; Cioffi F, 2010, CURR OPIN ENDOCRINOL, V17, P402, DOI 10.1097/MED.0b013e32833cf354; Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020; Davis PJ, 1996, THYROID, V6, P497, DOI 10.1089/thy.1996.6.497; de Lange P, 2011, DIABETES, V60, P2730, DOI 10.2337/db11-0207; de Lange P, 2008, ENDOCRINOLOGY, V149, P6462, DOI 10.1210/en.2008-0202; Enriquez JA, 1999, MOL CELL BIOL, V19, P657; Fernandez-Vizarra E, 2008, CURR GENET, V54, P13, DOI 10.1007/s00294-008-0194-x; Ferreira FM, 2003, J BIOCHEM MOL TOXIC, V17, P214, DOI 10.1002/jbt.10081; Geelen MJH, 2005, ANAL BIOCHEM, V347, P1, DOI 10.1016/j.ab.2005.03.032; Giudetti AM, 2005, ENDOCRINOLOGY, V146, P3959, DOI 10.1210/en.2005-0345; Giudetti AM, 2006, BBA-MOL CELL BIOL L, V1761, P484, DOI 10.1016/j.bbalip.2006.03.021; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; Goglia F, 1999, FEBS LETT, V452, P115, DOI 10.1016/S0014-5793(99)00642-0; Goglia F, 2005, BIOCHEMISTRY-MOSCOW+, V70, P164, DOI 10.1007/s10541-005-0097-0; Goglia F, 2002, BIOSCIENCE REP, V22, P17, DOI 10.1023/A:1016056905347; Grasselli E, 2008, EXP BIOL MED, V233, P549, DOI 10.3181/0710-RM-266; Grasselli E, 2011, J HEPATOL, V54, P1230, DOI 10.1016/j.jhep.2010.09.027; Guerrieri F, 1998, J BIOENERG BIOMEMBR, V30, P269, DOI 10.1023/A:1020548904384; GUZMAN M, 1992, BIOCHEM J, V287, P487, DOI 10.1042/bj2870487; HAFNER RP, 1990, BIOCHEM J, V265, P731, DOI 10.1042/bj2650731; Jansen MS, 2000, J BIOL CHEM, V275, P34989, DOI 10.1074/jbc.M001752200; Kashfi K, 2011, BIOCHEM SOC T, V39, P833, DOI 10.1042/BST0390833; Kerner Janos, 2008, Archives of Physiology and Biochemistry, V114, P161, DOI [10.1080/13813450802181062, 10.1080/13813450802181062 ]; Lanni A, 2005, FASEB J, V19, DOI 10.1096/fj.05.3977fje; Leary SC, 1996, GEN COMP ENDOCR, V104, P61, DOI 10.1006/gcen.1996.0141; Lombardi A, 1998, BIOCHEM J, V330, P521, DOI 10.1042/bj3300521; Lombardi A, 2009, AM J PHYSIOL-ENDOC M, V296, pE497, DOI 10.1152/ajpendo.90642.2008; Lombardi A, 2007, FEBS LETT, V581, P5911, DOI 10.1016/j.febslet.2007.11.073; Louet JF, 2001, BIOCHEM SOC T, V29, P310, DOI 10.1042/0300-5127:0290310; Mangiullo R, 2008, BBA-BIOENERGETICS, V1777, P1326, DOI 10.1016/j.bbabio.2008.08.003; Mangiullo R, 2010, BBA-BIOENERGETICS, V1797, P233, DOI 10.1016/j.bbabio.2009.10.009; Mollica MP, 2009, J HEPATOL, V51, P363, DOI 10.1016/j.jhep.2009.03.023; Mracek T, 2005, BBA-GEN SUBJECTS, V1726, P217, DOI 10.1016/j.bbagen.2005.06.011; Nogueira V, 2002, J BIOENERG BIOMEMBR, V34, P55, DOI 10.1023/A:1013822820840; PARADIES G, 1991, BIOCHIM BIOPHYS ACTA, V1070, P180, DOI 10.1016/0005-2736(91)90161-Z; Pejznochova M, 2010, MITOCHONDRION, V10, P321, DOI 10.1016/j.mito.2010.01.006; Priore P, 2007, BBA-MOL CELL BIOL L, V1771, P1299, DOI 10.1016/j.bbalip.2007.08.005; Priore P, 2012, BBA-MOL CELL BIOL L, V1821, P1341, DOI 10.1016/j.bbalip.2012.07.008; Ramsey JJ, 2000, FREE RADICAL BIO MED, V29, P946, DOI 10.1016/S0891-5849(00)00417-2; SAGGERSON ED, 1986, BIOCHEM J, V236, P137, DOI 10.1042/bj2360137; Serviddio G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024084; Siculella L, 2006, J BIOL CHEM, V281, P19072, DOI 10.1074/jbc.M507237200; Silvestri E, 2010, MOL BIOSYST, V6, P2256, DOI 10.1039/c0mb00040j; SOBOLL S, 1993, BIOCHIM BIOPHYS ACTA, V1144, P1, DOI 10.1016/0005-2728(93)90024-A; VEERKAMP JH, 1986, BIOCHEM MED METAB B, V35, P248, DOI 10.1016/0885-4505(86)90080-0; Weitzel JM, 2003, EXP PHYSIOL, V88, P121, DOI 10.1113/eph8802506; Wrutniak-Cabello C, 2001, J MOL ENDOCRINOL, V26, P67, DOI 10.1677/jme.0.0260067; Zhang Y, 2004, J BIOL CHEM, V279, P53963, DOI 10.1074/jbc.M406028200	54	38	39	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e52328	10.1371/journal.pone.0052328	http://dx.doi.org/10.1371/journal.pone.0052328			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308110	Green Published, gold, Green Submitted			2022-12-25	WOS:000313670100009
J	Federighi, G; Macchi, M; Bernardi, R; Scuri, R; Brunelli, M; Durante, M; Traina, G				Federighi, Giuseppe; Macchi, Monica; Bernardi, Rodolfo; Scuri, Rossana; Brunelli, Marcello; Durante, Mauro; Traina, Giovanna			Differentially Expressed Genes in Hirudo medicinalis Ganglia after Acetyl-L-Carnitine Treatment	PLOS ONE			English	Article							ALPHA-ACTININ GENE; L-ACETYLCARNITINE; RAT-BRAIN; AGED RATS; LEECH; HSP90; ALPHA-ACTININ-2; INACTIVATION; POTENTIATION; PROTEINS	Acetyl-L-carnitine (ALC) is a naturally occurring substance that, when administered at supra-physiological concentration, is neuroprotective. It is involved in membrane stabilization and in enhancement of mitochondrial functions. It is a molecule of considerable interest for its clinical application in various neural disorders, including Alzheimer's disease and painful neuropathies. ALC is known to improve the cognitive capability of aged animals chronically treated with the drug and, recently, it has been reported that it impairs forms of non-associative learning in the leech. In the present study the effects of ALC on gene expression have been analyzed in the leech Hirudo medicinalis. The suppression subtractive hybridisation methodology was used for the generation of subtracted cDNA libraries and the subsequent identification of differentially expressed transcripts in the leech nervous system after ALC treatment. The method detects differentially but also little expressed transcripts of genes whose sequence or identity is still unknown. We report that a single administration of ALC is able to modulate positively the expression of genes coding for functions that reveal a lasting effect of ALC on the invertebrate, and confirm the neuroprotective and neuromodulative role of the substance. In addition an important finding is the modulation of genes of vegetal origin. This might be considered an instance of ectosymbiotic mutualism.	[Federighi, Giuseppe; Scuri, Rossana] Univ Pisa, Dipartimento Ric Traslaz & Nuove Tecnol Med & Chi, Pisa, Italy; [Macchi, Monica; Brunelli, Marcello] Univ Pisa, Dipartimento Biol, Pisa, Italy; [Bernardi, Rodolfo; Durante, Mauro] Univ Pisa, Dipartimento Sci Agr Genet Alimentari & Agroambie, Pisa, Italy; [Traina, Giovanna] Univ Perugia, Sez Chim Bromatol Biochim Fisiol & Nutr, Dipartimento Sci Econ Estimat & Alimenti, I-06100 Perugia, Italy	University of Pisa; University of Pisa; University of Pisa; University of Perugia	Traina, G (corresponding author), Univ Perugia, Sez Chim Bromatol Biochim Fisiol & Nutr, Dipartimento Sci Econ Estimat & Alimenti, I-06100 Perugia, Italy.	traina@unipg.it	Durante, Marco/K-1315-2014; Traina, Giovanna/AAR-2179-2020	Durante, Marco/0000-0002-4615-553X; Traina, Giovanna/0000-0001-9996-3584	Sigma-Tau Laboratories (Pomezia, Italy)	Sigma-Tau Laboratories (Pomezia, Italy)	The work was supported by Sigma-Tau Laboratories (Pomezia, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aljamali MN, 2009, INSECT MOL BIOL, V18, P129, DOI 10.1111/j.1365-2583.2009.00863.x; Ando S, 2001, J NEUROSCI RES, V66, P266, DOI 10.1002/jnr.1220; BARNES CA, 1990, NEUROBIOL AGING, V11, P499, DOI 10.1016/0197-4580(90)90110-L; BARSTEAD RJ, 1991, CELL MOTIL CYTOSKEL, V20, P69, DOI 10.1002/cm.970200108; BEGGS AH, 1992, J BIOL CHEM, V267, P9281; BENTON D, 1995, PSYCHOPHARMACOLOGY, V117, P298, DOI 10.1007/BF02246104; Blackshaw SE, 2004, J ANAT, V204, P13, DOI 10.1111/j.1469-7580.2004.00260.x; Bouhamdan M, 2006, J NEUROSCI, V26, P2522, DOI 10.1523/JNEUROSCI.4083-05.2006; BROMM K, 1995, NEUROPSYCHOBIOLOGY, V31, P156, DOI 10.1159/000119186; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Burrell BD, 2008, NEUROBIOL LEARN MEM, V90, P275, DOI 10.1016/j.nlm.2007.11.004; Calabrese V, 2003, AMINO ACIDS, V25, P437, DOI 10.1007/s00726-003-0048-2; Cataldo E, 2005, J COMPUT NEUROSCI, V18, P5, DOI 10.1007/s10827-005-5477-3; Chiechio S, 2002, MOL PHARMACOL, V61, P989, DOI 10.1124/mol.61.5.989; De Grandis Domenico, 2002, Drugs R D, V3, P223, DOI 10.2165/00126839-200203040-00001; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Dixson JD, 2003, J MOL EVOL, V56, P1, DOI 10.1007/s00239-002-2374-5; FYRBERG E, 1990, J CELL BIOL, V110, P1999, DOI 10.1083/jcb.110.6.1999; Gadaleta MN, 1998, BIOCHIMIE, V80, P863, DOI 10.1016/S0300-9084(00)88881-1; GASS P, 1994, NEUROSCI LETT, V182, P188, DOI 10.1016/0304-3940(94)90794-3; Gerges NZ, 2004, J NEUROSCI, V24, P4758, DOI 10.1523/JNEUROSCI.0594-04.2004; GHIRARDI O, 1988, PHYSIOL BEHAV, V44, P769, DOI 10.1016/0031-9384(88)90060-1; HEYE N, 1994, INTENS CARE MED, V20, P282, DOI 10.1007/BF01708966; Kerney R, 2011, P NATL ACAD SCI USA, V108, P6497, DOI 10.1073/pnas.1018259108; Korneev Sergei, 1997, Invertebrate Neuroscience, V3, P185, DOI 10.1007/BF02480373; Kristan WB, 2005, PROG NEUROBIOL, V76, P279, DOI 10.1016/j.pneurobio.2005.09.004; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Li Q, 2008, BRAIN RES, V1228, P43, DOI 10.1016/j.brainres.2008.06.035; Lombardo P, 2004, NEUROSCIENCE, V128, P293, DOI 10.1016/j.neuroscience.2004.06.028; Lombardo P, 2003, PFLUG ARCH EUR J PHY, V445, pR164; Macchi M, 2008, ARCH ITAL BIOL, V146, P205; MADER R, 1988, INT J VITAM NUTR RES, V58, P436; MARK J, 1975, GUIDE VITAMINS, P73; Meador K, 1993, J Geriatr Psychiatry Neurol, V6, P222; MEADOR KJ, 1993, ANN NEUROL, V34, P724, DOI 10.1002/ana.410340516; Michailidis IE, 2007, J NEUROSCI, V27, P5523, DOI 10.1523/JNEUROSCI.4378-06.2007; Mills MA, 2001, HUM MOL GENET, V10, P1335, DOI 10.1093/hmg/10.13.1335; Mineta K, 2003, P NATL ACAD SCI USA, V100, P7666, DOI 10.1073/pnas.1332513100; Nuriya M, 2005, J NEUROCHEM, V95, P544, DOI 10.1111/j.1471-4159.2005.03410.x; ONOFRJ M, 1995, INT J CLIN PHARM RES, V15, P9; Ressler KJ, 2002, J NEUROSCI, V22, P7892; Ristori C, 2006, NEUROSCIENCE, V142, P931, DOI 10.1016/j.neuroscience.2006.07.002; ROSENMUND C, 1995, J NEUROSCI, V15, P2788; Scarpini E, 1997, J Peripher Nerv Syst, V2, P250; Schulz D, 2004, EUR J NEUROSCI, V19, P1373, DOI 10.1111/j.1460-9568.2004.03234.x; Scuri R, 2002, J NEUROPHYSIOL, V88, P2490, DOI 10.1152/jn.01027.2001; Settembre E, 2003, CURR OPIN STRUC BIOL, V13, P739, DOI 10.1016/j.sbi.2003.10.006; Snoeckx LHEH, 2001, PHYSIOL REV, V81, P1461, DOI 10.1152/physrev.2001.81.4.1461; THOMSON AD, 1992, NUTR ALCOHOL, P75; Traina G, 2004, MOL BRAIN RES, V132, P57, DOI 10.1016/j.molbrainres.2004.09.006; Traina G, 2008, MOL NEUROBIOL, V38, P146, DOI 10.1007/s12035-008-8038-8; Traina G, 2006, NEUROCHEM INT, V48, P673, DOI 10.1016/j.neuint.2005.11.005; Traina G, 2011, NUTR DIET SUPPL, V3, P77, DOI 10.2147/NDS.S7119; Traina G, 2011, MOL NEUROBIOL, V44, P1, DOI 10.1007/s12035-011-8189-x; Traina G, 2009, MOL NEUROBIOL, V39, P101, DOI 10.1007/s12035-009-8056-1; Traina G, 2008, NEUROCHEM INT, V53, P244, DOI 10.1016/j.neuint.2008.08.001; Venn AA, 2008, J EXP BOT, V59, P1069, DOI 10.1093/jxb/erm328; Wang ZB, 2003, J FASEB, P439; WELCH WJ, 1982, J BIOL CHEM, V257, P4949; Yasui F, 2002, NEUROSCI LETT, V334, P177, DOI 10.1016/S0304-3940(02)01127-8; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158	61	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53605	10.1371/journal.pone.0053605	http://dx.doi.org/10.1371/journal.pone.0053605			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308261	Green Published, gold, Green Submitted			2022-12-25	WOS:000313670100051
J	Takahashi, T; Suzuki, H; Imai, T; Shibata, S; Tabuchi, Y; Tsuchimoto, K; Okano, H; Hibi, T				Takahashi, Tetsufumi; Suzuki, Hidekazu; Imai, Takao; Shibata, Shinsuke; Tabuchi, Yoshiaki; Tsuchimoto, Kanji; Okano, Hideyuki; Hibi, Toshifumi			Musashi-1 Post-Transcriptionally Enhances Phosphotyrosine-Binding Domain-Containing m-Numb Protein Expression in Regenerating Gastric Mucosa	PLOS ONE			English	Article							TRANSCRIPTION FACTOR MTF-1; METALLOTHIONEIN-I; TRANSLATIONAL REPRESSION; MESSENGER-RNA; CELL-FATE; ISOFORMS; SWITCH; DIFFERENTIATION; SUSCEPTIBILITY; IDENTIFICATION	Objective: Upregulation of the RNA-binding protein Musashi-1 (Msi1) has been shown to occur in rat gastric corpus mucosa after ethanol-induced mucosal injury. However, there is no direct evidence linking Msi1 with gastric regeneration. We examined the process of tissue repair after acute gastric mucosal injury with Msi1-knock-out (KO) mice to clarify the role of Msi1 and Msi1-dependent regulation of m-Numb expression in regenerating gastric mucosa. Methods: Acute gastric injury was induced in Msi1-KO and wild-type ICR mice by administering absolute ethanol. Expression of the splicing variants of m-Numb mRNA and protein in the gastric mucosa were analyzed by quantitative RT-PCR and western blotting, respectively. Results: We demonstrated that phosphotyrosine-binding domain-containing m-Numb expression was significantly upregulated at both the mRNA and protein levels in wild-type mice at 3 h after ethanol-induced acute gastric injury. In contrast, in Msi1-KO mice, the m-Numb protein was expressed weakly, and was associated with delayed regeneration of the injured gastric mucosal epithelium. In the Msi1-KO mouse, the ratio of m-Numb mRNA to total m-Numb mRNA in the heavy polysome fractions was lower than that in the wild-type mouse. Further, we showed that m-Numb-enhancement in gastric mucous cells induced the expression of prostate stem cell antigen and metallothionein-2. Under the m-Numb enhancing condition, the gastric cells exhibited enhanced cell proliferation and were significantly more resistant to H2O2-induced cell death than control cells. Conclusions: Msi1-dependent post-transcriptional enhancement of m-Numb is crucial in gastric epithelial regeneration.	[Takahashi, Tetsufumi; Suzuki, Hidekazu; Hibi, Toshifumi] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan; [Takahashi, Tetsufumi; Tsuchimoto, Kanji] Kitasato Univ, Sch Pharm, Lab Pathophysiol, Div Clin Med, Tokyo, Japan; [Imai, Takao; Shibata, Shinsuke; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan; [Tabuchi, Yoshiaki] Toyama Univ, Life Sci Res Ctr, Div Mol Genet, Toyama 930, Japan	Keio University; Kitasato University; Keio University; University of Toyama	Suzuki, H (corresponding author), Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan.	hsuzuki@a6.keio.jp	Okano, Hideyuki/I-7584-2019; Imai, Takao/L-1232-2013; SUZUKI, HIDEKAZU/S-9376-2019; Shibata, Shinsuke/AAM-6620-2020; Takahashi, Tetsufumi/AAW-1430-2021; Suzuki, Hidekazu/J-4396-2013; Suzuki, Hidekazu/AAO-6330-2020	Suzuki, Hidekazu/0000-0002-8994-6163; Tabuchi, Yoshiaki/0000-0002-6007-6176	Japan Society for the Promotion of Science [22300169]; Funding Program for World-leading Innovative R&D on Science and Technology; Mitsukoshi Health and Welfare Foundation; Smoking Research Foundation; Keio Gijuku Academic Development Funds; Kitasato University Research Grant for Young Researchers;  [24659103]; Grants-in-Aid for Scientific Research [24601016] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Funding Program for World-leading Innovative R&D on Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mitsukoshi Health and Welfare Foundation; Smoking Research Foundation; Keio Gijuku Academic Development Funds; Kitasato University Research Grant for Young Researchers; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science (22300169 to H.S.), Grant-in-Aid for challenging Exploratory Research (24659103 to H.S.), Funding Program for World-leading Innovative R&D on Science and Technology (to H.O.), a Research Fund from Mitsukoshi Health and Welfare Foundation (to H.S.), a grant from the Smoking Research Foundation (to H.S.), Keio Gijuku Academic Development Funds (to H.S.), and a Kitasato University Research Grant for Young Researchers (to T.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu RD, 2009, J BIOL CHEM, V284, P12125, DOI 10.1074/jbc.M809605200; Bani-Yaghoub M, 2007, DEV DYNAM, V236, P696, DOI 10.1002/dvdy.21072; Battelli C, 2006, MOL CELL NEUROSCI, V31, P85, DOI 10.1016/j.mcn.2005.09.003; Charlesworth A, 2006, EMBO J, V25, P2792, DOI 10.1038/sj.emboj.7601159; Corallini S, 2006, REPRODUCTION, V132, P887, DOI 10.1530/REP-06-0062; Del Prete MJ, 2007, RNA, V13, P414, DOI 10.1261/rna.79407; Dho SE, 1999, J BIOL CHEM, V274, P33097, DOI 10.1074/jbc.274.46.33097; Dho SE, 1998, J BIOL CHEM, V273, P9179, DOI 10.1074/jbc.273.15.9179; Gu Z, 2000, ONCOGENE, V19, P1288, DOI 10.1038/sj.onc.1203426; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; ITO S, 1984, SCAND J GASTROENTERO, V19, P87; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; Kawahara H, 2008, J CELL BIOL, V181, P639, DOI 10.1083/jcb.200708004; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Kuo CT, 2006, CELL, V127, P1253, DOI 10.1016/j.cell.2006.10.041; Kuwako K, 2010, NEURON, V67, P407, DOI 10.1016/j.neuron.2010.07.005; Kyriazis GA, 2010, J BIOL CHEM, V285, P6811, DOI 10.1074/jbc.M109.074690; LACY ER, 1984, LAB INVEST, V51, P573; Li SC, 1998, NAT STRUCT BIOL, V5, P1075, DOI 10.1038/4185; Matsuda Y, 2005, DEVELOPMENT, V132, P2783, DOI 10.1242/dev.01853; Mita M, 2008, AM J PHYSIOL-GASTR L, V294, pG877, DOI 10.1152/ajpgi.00251.2007; MOORE R, 1989, LAB INVEST, V60, P237; Muto J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033431; Nagata H, 2006, FEBS LETT, V580, P27, DOI 10.1016/j.febslet.2005.11.041; NAKAMURA M, 1994, NEURON, V13, P67, DOI 10.1016/0896-6273(94)90460-X; Nishimoto Y, 2010, CELL RES, V20, P1083, DOI 10.1038/cr.2010.122; Okabe M, 2001, NATURE, V411, P94, DOI 10.1038/35075094; Okano H, 2002, J CELL SCI, V115, P1355; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; RADTKE F, 1993, EMBO J, V12, P1355, DOI 10.1002/j.1460-2075.1993.tb05780.x; Roegiers F, 2004, CURR OPIN CELL BIOL, V16, P195, DOI 10.1016/j.ceb.2004.02.010; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Sakamoto H, 2008, NAT GENET, V40, P730, DOI 10.1038/ng.152; Tabuchi Y, 2003, DIGESTION, V67, P71, DOI 10.1159/000070396; Tanikawa C, 2012, NAT GENET, V44, P430, DOI 10.1038/ng.1109; Toriya M, 2006, DEV NEUROSCI-BASEL, V28, P142, DOI 10.1159/000090760; Tran CD, 2003, HELICOBACTER, V8, P533, DOI 10.1046/j.1523-5378.2003.00174.x; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; Verdi JM, 1999, P NATL ACAD SCI USA, V96, P10472, DOI 10.1073/pnas.96.18.10472; WESTIN G, 1988, EMBO J, V7, P3763, DOI 10.1002/j.1460-2075.1988.tb03260.x; Zhao Z, 2011, UROL ONCOL, DOI 10.1016/j.urolonc.2011.02.004; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	45	19	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53540	10.1371/journal.pone.0053540	http://dx.doi.org/10.1371/journal.pone.0053540			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308249	Green Published, Green Submitted, gold			2022-12-25	WOS:000313670100047
J	Reimann, K; Krishnamoorthy, G; Wangemann, P				Reimann, Katrin; Krishnamoorthy, Gayathri; Wangemann, Philine			NOS Inhibition Enhances Myogenic Tone by Increasing Rho-Kinase Mediated Ca2+ Sensitivity in the Male but Not the Female Gerbil Spiral Modiolar Artery	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; VASCULAR SMOOTH-MUSCLE; COCHLEAR BLOOD-FLOW; NITRIC-OXIDE; GENDER-DIFFERENCES; CARDIOVASCULAR MEDICINE; MYOSIN PHOSPHATASE; CEREBRAL-ARTERY; K+ CHANNELS; GUINEA-PIGS	Cochlear blood flow regulation is important to prevent hearing loss caused by ischemia and oxidative stress. Cochlear blood supply is provided by the spiral modiolar artery (SMA). The myogenic tone of the SMA is enhanced by the nitric oxide synthase (NOS) blocker L-N-G-Nitro-Arginine (LNNA) in males, but not in females. Here, we investigated whether this gender difference is based on differences in the cytosolic Ca2+ concentration and/or the Ca2+ sensitivity of the myofilaments. Vascular diameter, myogenic tone, cytosolic Ca2+, and Ca2+ sensitivity were evaluated in pressurized SMA segments isolated from male and female gerbils using laser-scanning microscopy and microfluorometry. The gender difference of the LNNA-induced tone was compared, in the same vessel segments, to tone induced by 150 mM K+ and endothelin-1, neither of which showed an apparent gender-difference. Interestingly, LNNA-induced tone in male SMAs was observed in protocols that included changes in intramural pressure, but not when the intramural pressure was held constant. LNNA in male SMAs did not increase the global Ca2+ concentration in smooth muscle cells but increased the Ca2+ sensitivity. This increase in the Ca2+ sensitivity was abolished in the presence of the guanylyl cyclase inhibitor ODQ or by extrinsic application of either the nitric oxide (NO)-donor DEA-NONOate or the cGMP analog 8-pCPT-cGMP. The rho-kinase blocker Y27632 decreased the basal Ca2+ sensitivity and abolished the LNNA-induced increase in Ca2+ sensitivity in male SMAs. Neither LNNA nor Y27632 changed the Ca2+ sensitivity in female SMAs. The data suggest that the gender difference in LNNA-induced tone is based on a gender difference in the regulation of rho-kinase mediated Ca2+ sensitivity. Rho-kinase and NO thus emerge as critical factors in the regulation of cochlear blood flow. The larger role of NO-dependent mechanisms in male SMAs predicts greater restrictions on cochlear blood flow under conditions of impaired endothelial cell function.	[Reimann, Katrin; Krishnamoorthy, Gayathri; Wangemann, Philine] Kansas State Univ, Dept Anat & Physiol, Manhattan, KS 66506 USA; [Reimann, Katrin] Univ Tubingen, Univ Klin Hals Nasen & Ohrenheilkunde, Tubingen, Germany	Kansas State University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Wangemann, P (corresponding author), Kansas State Univ, Dept Anat & Physiol, Manhattan, KS 66506 USA.	wange@vet.ksu.edu	Wangemann, Philine/N-2826-2013	Natarajan, Gayathri/0000-0001-7654-5013; Krishnamoorthy, Gayathri/0000-0002-2208-3244	Kansas State University;  [NIH-R01-DC04280];  [NIH-P20-RR017686]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004280] Funding Source: NIH RePORTER	Kansas State University; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Supported by NIH-R01-DC04280 (to PW). The Confocal Microscopy Core Facility was supported by Kansas State University and NIH-P20-RR017686 (to PW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arain FA, 2009, CIRC J, V73, P1774, DOI 10.1253/circj.CJ-09-0588; ARCHER SL, 1994, P NATL ACAD SCI USA, V91, P7583, DOI 10.1073/pnas.91.16.7583; Balligand JL, 2009, PHYSIOL REV, V89, P481, DOI 10.1152/physrev.00042.2007; Boettcher FA, 2002, J ACOUST SOC AM, V112, P2948, DOI 10.1121/1.1513364; BOLOTINA VM, 1994, NATURE, V368, P850, DOI 10.1038/368850a0; BROWN JN, 1994, AM J PHYSIOL, V266, pH458, DOI 10.1152/ajpheart.1994.266.2.H458; Carvajal JA, 2000, J CELL PHYSIOL, V184, P409, DOI 10.1002/1097-4652(200009)184:3<409::AID-JCP16>3.3.CO;2-B; Chrissobolis S, 2004, STROKE, V35, P2200, DOI 10.1161/01.STR.0000136951.85586.c8; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; de Wit C, 1998, HYPERTENSION, V31, P787, DOI 10.1161/01.HYP.31.3.787; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; Geary GG, 1998, AM J PHYSIOL-HEART C, V275, pH292, DOI 10.1152/ajpheart.1998.275.1.H292; HAYASHI T, 1992, P NATL ACAD SCI USA, V89, P11259, DOI 10.1073/pnas.89.23.11259; Hiroki J, 2005, BIOCHEM BIOPH RES CO, V326, P154, DOI 10.1016/j.bbrc.2004.11.011; Iwasaki S, 1998, ACTA OTO-LARYNGOL, V118, P666; JOHNSTONE B M, 1965, Acta Otolaryngol, V60, P113, DOI 10.3109/00016486509126994; Knot HJ, 1999, AM J PHYSIOL-HEART C, V276, pH961, DOI 10.1152/ajpheart.1999.276.3.H961; Lu DS, 2011, J R SOC INTERFACE, V8, P1379, DOI 10.1098/rsif.2011.0177; Mandala M, 2007, NITRIC OXIDE-BIOL CH, V16, P104, DOI 10.1016/j.niox.2006.06.007; MARAGOS CM, 1991, J MED CHEM, V34, P3242, DOI 10.1021/jm00115a013; McDonald L J, 1995, Adv Pharmacol, V34, P263; PEARSON JD, 1995, J ACOUST SOC AM, V97, P1196, DOI 10.1121/1.412231; Pfitzer G, 2001, J APPL PHYSIOL, V91, P497, DOI 10.1152/jappl.2001.91.1.497; QUIRK WS, 1989, HEARING RES, V41, P53, DOI 10.1016/0378-5955(89)90178-0; Reimann K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025659; ROBERTSON BE, 1993, AM J PHYSIOL, V265, pC299; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Scherer EQ, 2005, BMC EAR NOSE THROAT, V5, DOI 10.1186/1472-6815-5-10; Scherer EQ, 2002, STROKE, V33, P2965, DOI 10.1161/01.STR.0000043673.22993.FD; Schubert R, 2008, CARDIOVASC RES, V77, P8, DOI 10.1016/j.cardiores.2007.07.018; Shimokawa H, 2007, TRENDS PHARMACOL SCI, V28, P296, DOI 10.1016/j.tips.2007.04.006; Si JQ, 2002, HEARING RES, V171, P167, DOI 10.1016/S0378-5955(02)00497-5; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Takaki A, 2008, J EXP MED, V205, P2053, DOI 10.1084/jem.20080106; Thompson J, 2003, CLIN EXP PHARMACOL P, V30, P1, DOI 10.1046/j.1440-1681.2003.03790.x; Van Hove CE, 2009, BRIT J PHARMACOL, V158, P920, DOI 10.1111/j.1476-5381.2009.00396.x; Wangemann P, 1998, HEARING RES, V115, P113, DOI 10.1016/S0378-5955(97)00184-6; Wangemann P, 1998, HEARING RES, V118, P90, DOI 10.1016/S0378-5955(98)00017-3; Wangemann P, 2006, J PHYSIOL-LONDON, V576, P11, DOI 10.1113/jphysiol.2006.112888; Wei JY, 1998, J MOL NEUROSCI, V10, P53, DOI 10.1007/BF02737085; Wellman GC, 1996, CIRC RES, V79, P1024, DOI 10.1161/01.RES.79.5.1024; WING KG, 1953, J COMP PHYSIOL PSYCH, V46, P352, DOI 10.1037/h0058043; Wirth A, 2010, BBA-MOL BASIS DIS, V1802, P1276, DOI 10.1016/j.bbadis.2010.05.002; Yang L, 2007, CIRC RES, V101, P465, DOI 10.1161/CIRCRESAHA.107.156976	45	5	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53655	10.1371/journal.pone.0053655	http://dx.doi.org/10.1371/journal.pone.0053655			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301097	Green Published, Green Submitted, gold			2022-12-25	WOS:000313480000073
J	Vervoort, SJ; Lourenco, AR; van Boxtel, R; Coffer, PJ				Vervoort, Stephin J.; Lourenco, Ana Rita; van Boxtel, Ruben; Coffer, Paul J.			SOX4 Mediates TGF-beta-Induced Expression of Mesenchymal Markers during Mammary Cell Epithelial to Mesenchymal Transition	PLOS ONE			English	Article							BREAST-CANCER; GENE-EXPRESSION; CADHERIN; METASTASIS; DIFFERENTIATION; PROGRESSION; PROTEIN; ACTIVATION; SYNTENIN; PATHWAYS	The epithelial to mensenchymal transition program regulates various aspects of embryonic development and tissue homeostasis, but aberrant activation of this pathway in cancer contributes to tumor progression and metastasis. TGF-beta potently induces an epithelial to mensenchymal transition in cancers of epithelial origin by inducing transcriptional changes mediated by several key transcription factors. Here, we identify the developmental transcription factor SOX4 as a transcriptional target of TGF-beta in immortalized human mammary epithelial cells. SOX4 expression and activity are rapidly induced in the early stages of the TGF-beta-induced epithelial to mensenchymal transition. We demonstrate that conditional activation of Sox4 is sufficient to induce the expression of N-cadherin and additional mesenchymal markers including vimentin and fibronectin, but fails to induce complete EMT as no changes are observed in the expression of E-cadherin and beta-catenin. Moreover, shRNA-mediated knockdown of SOX4 significantly delays TGF-beta-induced mRNA and protein expression of mesenchymal markers. Taken together, these data suggest that TGF-beta-mediated increased expression of SOX4 is required for the induction of a mesenchymal phenotype during EMT in human mammary epithelial cells.	[Vervoort, Stephin J.; Lourenco, Ana Rita; van Boxtel, Ruben; Coffer, Paul J.] Univ Med Ctr, Dept Cell Biol, Utrecht, Netherlands; [Vervoort, Stephin J.; Coffer, Paul J.] Univ Med Ctr, Wilhelmina Childrens Hosp, Div Pediat, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Coffer, PJ (corresponding author), Univ Med Ctr, Dept Cell Biol, Utrecht, Netherlands.	P.J.Coffer@umcutrecht.nl	Vervoort, Stephin/AAP-7854-2020; Coffer, Paul/AAF-7970-2020	van Boxtel, Ruben/0000-0003-1285-2836	"Fundacao para a Ciencia e a Tecnologia" (FCT) fellowship [SFRH/BD/75747/2011]; "Center for Translational Molecular Medicine" CTMM grant	"Fundacao para a Ciencia e a Tecnologia" (FCT) fellowship; "Center for Translational Molecular Medicine" CTMM grant	Ana Rita Lourenco is the recipient of a "Fundacao para a Ciencia e a Tecnologia" (FCT) fellowship (SFRH/BD/75747/2011) - http://www.fct.pt/index.phtml.en. Ruben van Boxtel is supported by a "Center for Translational Molecular Medicine" CTMM grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beekman JM, 2012, ONCOGENE, V31, P2668, DOI 10.1038/onc.2011.445; Beekman JM, 2008, J CELL SCI, V121, P1349, DOI 10.1242/jcs.026401; Bhattaram P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1008; Broos S, 2011, NUCLEIC ACIDS RES, V39, pW74, DOI 10.1093/nar/gkr355; Castillo SD, 2012, CANCER RES, V72, P176, DOI 10.1158/0008-5472.CAN-11-3506; Derynck R, 2007, NAT CELL BIOL, V9, P1000, DOI 10.1038/ncb434; Dy P, 2008, NUCLEIC ACIDS RES, V36, P3101, DOI 10.1093/nar/gkn162; Geijsen N, 2001, SCIENCE, V293, P1136, DOI 10.1126/science.1059157; Giannelli G, 2011, BBA-REV CANCER, V1815, P214, DOI 10.1016/j.bbcan.2010.11.004; Hesling C, 2011, EMBO REP, V12, P665, DOI 10.1038/embor.2011.78; Hulit J, 2007, CANCER RES, V67, P3106, DOI 10.1158/0008-5472.CAN-06-3401; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kuwahara M, 2012, NATURE IMMUNOLOGY; Liao YL, 2008, ONCOGENE, V27, P5578, DOI 10.1038/onc.2008.168; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Liu ZD, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r180; Magnani L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002368; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Panda DK, 2001, J BIOL CHEM, V276, P41229, DOI 10.1074/jbc.M104231200; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Pramoonjago P, 2006, ONCOGENE, V25, P5626, DOI 10.1038/sj.onc.1209566; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Sock E, 2004, MOL CELL BIOL, V24, P6635, DOI 10.1128/mcb.24.15.6635-6644.2004; Su Y, 2012, ONCOGENE, V31, P4484, DOI 10.1038/onc.2011.574; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Tanaka H, 2010, NAT MED, V16, P1414, DOI 10.1038/nm.2236; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; van der Vos KE, 2012, NAT CELL BIOL, V14, P829, DOI 10.1038/ncb2536; Vervoort SJ, 2012, ONCOGENE IN PRESS; Wendt MK, 2011, MOL BIOL CELL, V22, P2423, DOI 10.1091/mbc.E11-04-0306; Xu DK, 2008, J BIOL CHEM, V283, P23567, DOI 10.1074/jbc.M800790200; Zhang JC, 2012, CANCER RES, V72, P4597, DOI 10.1158/0008-5472.CAN-12-1045; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zimmermann P, 2001, MOL BIOL CELL, V12, P339, DOI 10.1091/mbc.12.2.339	43	77	79	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53238	10.1371/journal.pone.0053238	http://dx.doi.org/10.1371/journal.pone.0053238			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301048	Green Submitted, Green Published, gold			2022-12-25	WOS:000313480000041
J	Beilstein, F; Bouchoux, J; Rousset, M; Demignot, S				Beilstein, Frauke; Bouchoux, Julien; Rousset, Monique; Demignot, Sylvie			Proteomic Analysis of Lipid Droplets from Caco-2/TC7 Enterocytes Identifies Novel Modulators of Lipid Secretion	PLOS ONE			English	Article							VIRUS CORE PROTEIN; SEX STEROID ACTION; INTESTINAL LIPOPROTEIN OVERPRODUCTION; POSTPRANDIAL TRIGLYCERIDE-METABOLISM; DIFFERENTIATION-RELATED PROTEIN; SUBNORMAL TESTOSTERONE LEVELS; ACYL-COA SYNTHETASE; 17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE-2; GASTROINTESTINAL-TRACT; INDUCED-STEATOSIS	In enterocytes, the dynamic accumulation and depletion of triacylglycerol (TAG) in lipid droplets (LD) during fat absorption suggests that cytosolic LD-associated TAG contribute to TAG-rich lipoprotein (TRL) production. To get insight into the mechanisms controlling the storage/secretion balance of TAG, we used as a tool hepatitis C virus core protein, which localizes onto LDs, and thus may modify their protein coat and decrease TRL secretion. We compared the proteome of LD fractions isolated from Caco-2/TC7 enterocytes expressing or not hepatitis C virus core protein by a differential proteomic approach (isobaric tag for relative and absolute quantitation (iTRAQ) labeling coupled with liquid chromatography and tandem mass spectrometry). We identified 42 proteins, 21 being involved in lipid metabolism. Perilipin-2/ADRP, which is suggested to stabilize long term-stored TAG, was enriched in LD fractions isolated from Caco-2/TC7 expressing core protein while perilipin-3/TIP47, which is involved in LD synthesis from newly synthesized TAG, was decreased. Endoplasmic reticulum-associated proteins were strongly decreased, suggesting reduced interactions between LD and endoplasmic reticulum, where TRL assembly occurs. For the first time, we show that 17 beta-hydroxysteroid dehydrogenase 2 (DHB2), which catalyzes the conversion of 17-keto to 17 beta-hydroxysteroids and which was the most highly enriched protein in core expressing cells, is localized to LD and interferes with TAG secretion, probably through its capacity to inactivate testosterone. Overall, we identified potential new players of lipid droplet dynamics, which may be involved in the balance between lipid storage and secretion, and may be altered in enterocytes in pathological conditions such as insulin resistance, type II diabetes and obesity.	[Beilstein, Frauke; Bouchoux, Julien; Rousset, Monique; Demignot, Sylvie] Univ Paris 06, UMR S 872, Paris, France; [Beilstein, Frauke; Bouchoux, Julien; Rousset, Monique; Demignot, Sylvie] INSERM, U872, Paris, France; [Beilstein, Frauke; Bouchoux, Julien; Demignot, Sylvie] Ecole Prat Hautes Etud, Lab Pharmacol Cellulaire & Mol, Paris, France; [Beilstein, Frauke; Bouchoux, Julien; Rousset, Monique; Demignot, Sylvie] Univ Paris 05, UMR S 872, Paris, France; [Rousset, Monique; Demignot, Sylvie] Inst Cardiometab & Nutr ICAN, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite	Demignot, S (corresponding author), Univ Paris 06, UMR S 872, Paris, France.	sylvie.demignot@crc.jussieu.fr		Demignot, Sylvie/0000-0001-7149-1992; Beilstein, Frauke/0000-0001-9809-7151	ANRS (Agence Nationale de Recherches sur le Sida et les hepatites, Paris, France); ANRS; INSERM (Institut National de la Sante et de la Recherche Medicale)	ANRS (Agence Nationale de Recherches sur le Sida et les hepatites, Paris, France)(ANRS); ANRS(ANRSFrench National Research Agency (ANR)); INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm))	FB and JB were the recipients of an ANRS (Agence Nationale de Recherches sur le Sida et les hepatites, Paris, France) fellowship. This work was supported by ANRS and INSERM (Institut National de la Sante et de la Recherche Medicale). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abumrad NA, 2012, PHYSIOL REV, V92, P1061, DOI 10.1152/physrev.00019.2011; Adeli K, 2008, CURR OPIN LIPIDOL, V19, P221, DOI 10.1097/MOL.0b013e3282ffaf82; Agledahl I, 2008, SCAND J CLIN LAB INV, V68, P641, DOI 10.1080/00365510801999068; Agledahl I, 2008, ASIAN J ANDROL, V10, P542, DOI 10.1111/j.1745-7262.2008.00387.x; Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; Bellocq D, 2010, STEROIDS, V75, P665, DOI 10.1016/j.steroids.2010.04.003; Blouin CM, 2010, J LIPID RES, V51, P945, DOI 10.1194/jlr.M001016; Bouchoux J, 2011, BIOL CELL, V103, P499, DOI 10.1042/BC20110024; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; Brasaemle DL, 2012, J BIOL CHEM, V287, P2273, DOI 10.1074/jbc.R111.309088; Bulankina AV, 2009, J CELL BIOL, V185, P641, DOI 10.1083/jcb.200812042; CHANTRET I, 1994, J CELL SCI, V107, P213; Chateau D, 2005, J CELL PHYSIOL, V202, P767, DOI 10.1002/jcp.20173; Douglass JD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00025; Duez H, 2008, ATHEROSCLEROSIS SUPP, V9, P33, DOI 10.1016/j.atherosclerosissup.2008.05.013; English MA, 2000, BRIT J CANCER, V83, P550, DOI 10.1054/bjoc.2000.1324; Everett RD, 2006, J VIROL, V80, P7995, DOI 10.1128/JVI.00734-06; Faulds MH, 2012, J ENDOCRINOL, V212, P3, DOI 10.1530/JOE-11-0044; Fujimoto T., 2011, COLD SPRING HARB PER, V3; Gassler N, 2003, HUM PATHOL, V34, P1048, DOI 10.1053/S0046-8177(03)00431-3; Gibbons GF, 2000, BBA-MOL CELL BIOL L, V1483, P37, DOI 10.1016/S1388-1981(99)00182-1; Goodman JM, 2009, J LIPID RES, V50, P2148, DOI 10.1194/jlr.R001446; Harris C, 2011, J BIOL CHEM, V286, P42615, DOI 10.1074/jbc.M111.285148; Hodges BDM, 2010, J LIPID RES, V51, P262, DOI 10.1194/jlr.R003582; Horiguchi Y, 2008, ARCH BIOCHEM BIOPHYS, V479, P121, DOI 10.1016/j.abb.2008.08.020; Kaminsky LS, 2003, DRUG METAB DISPOS, V31, P1520, DOI 10.1124/dmd.31.12.1520; Khan N, 2004, ARCH BIOCHEM BIOPHYS, V429, P50, DOI 10.1016/j.abb.2004.05.023; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Larsson S, 2012, J PROTEOME RES, V11, P1264, DOI 10.1021/pr200957p; Le Gall M, 2007, J CELL PHYSIOL, V213, P834, DOI 10.1002/jcp.21245; Lee B, 2009, BBA-MOL CELL BIOL L, V1791, P1173, DOI 10.1016/j.bbalip.2009.08.002; Lehner R, 2012, ARTERIOSCL THROM VAS, V32, P1087, DOI 10.1161/ATVBAHA.111.241497; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Moeller G, 2009, MOL CELL ENDOCRINOL, V301, P7, DOI 10.1016/j.mce.2008.10.040; Moriya K, 1997, J GEN VIROL, V78, P1527, DOI 10.1099/0022-1317-78-7-1527; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Negro F, 2010, DIGEST DIS, V28, P294, DOI 10.1159/000282105; Ohsaki Y, 2009, BBA-MOL CELL BIOL L, V1791, P399, DOI 10.1016/j.bbalip.2008.10.002; Oikawa E, 1998, J BIOCHEM, V124, P679, DOI 10.1093/oxfordjournals.jbchem.a022165; Olofsson SO, 2009, BBA-MOL CELL BIOL L, V1791, P448, DOI 10.1016/j.bbalip.2008.08.001; Pasdeloup D, 2009, J VIROL, V83, P6610, DOI 10.1128/JVI.02655-08; Pauquai T, 2006, BIOCHEM J, V395, P393, DOI 10.1042/BJ20051359; Pavio N, 2005, ONCOGENE, V24, P6119, DOI 10.1038/sj.onc.1208749; Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com; Petit JM, 2003, AM J GASTROENTEROL, V98, P1150, DOI 10.1016/S0002-9270(03)00106-0; Pfaffl MW, 2003, J STEROID BIOCHEM, V84, P159, DOI 10.1016/S0960-0760(03)00025-6; Poutanen M, 2012, J ENDOCRINOL, V212, P1, DOI 10.1530/JOE-11-0414; Ramalho F, 2003, ANTIVIR RES, V60, P125, DOI 10.1016/j.antiviral.2003.08.007; Robertson MD, 2003, GUT, V52, P834, DOI 10.1136/gut.52.6.834; Saloniemi T, 2012, J ENDOCRINOL, V212, P27, DOI 10.1530/JOE-11-0315; Sano T, 2001, CLIN SCI, V101, P485, DOI 10.1042/CS20010052; Spandl J, 2009, TRAFFIC, V10, P1579, DOI 10.1111/j.1600-0854.2009.00980.x; Targett-Adams P, 2003, J BIOL CHEM, V278, P15998, DOI 10.1074/jbc.M211289200; Uchida A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00026; Vidal R, 2005, J LIPID RES, V46, P258, DOI 10.1194/jlr.M400209-JLR200; Walther Tobias C, 2009, Biochim Biophys Acta, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; Wang XW, 2012, AM J PHYSIOL-ENDOC M, V302, pE740, DOI 10.1152/ajpendo.00533.2011; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; WU L, 1993, J BIOL CHEM, V268, P12964; Xu CS, 2009, DRUG METAB DISPOS, V37, P1539, DOI 10.1124/dmd.109.026989; Yao HB, 2008, J BIOL CHEM, V283, P849, DOI 10.1074/jbc.M706160200; Zehmer JK, 2009, PROTEOMICS, V9, P914, DOI 10.1002/pmic.200800584; Zhang HN, 2011, J PROTEOME RES, V10, P4757, DOI 10.1021/pr200553c; Zhu JB, 2009, J LIPID RES, V50, P1080, DOI 10.1194/jlr.M800555-JLR200	69	37	37	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53017	10.1371/journal.pone.0053017	http://dx.doi.org/10.1371/journal.pone.0053017			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301014	Green Published, gold, Green Submitted			2022-12-25	WOS:000313320900052
J	Phillips, AT; Stauft, CB; Aboellail, TA; Toth, AM; Jarvis, DL; Powers, AM; Olson, KE				Phillips, Aaron T.; Stauft, Charles B.; Aboellail, Tawfik A.; Toth, Ann M.; Jarvis, Donald L.; Powers, Ann M.; Olson, Ken E.			Bioluminescent Imaging and Histopathologic Characterization of WEEV Neuroinvasion in Outbred CD-1 Mice	PLOS ONE			English	Article							EQUINE-ENCEPHALITIS-VIRUS; HEPARAN-SULFATE BINDING; ST-LOUIS ENCEPHALITIS; WESTERN-EQUINE; SINDBIS-VIRUS; ENCEPHALOMYELITIS VIRUS; ALPHAVIRUS REPLICATION; CHIKUNGUNYA VIRUS; INFECTION; EXPRESSION	Western equine encephalitis virus (WEEV; Alphavirus) is a mosquito-borne virus that can cause severe encephalitis in humans and equids. Previous studies have shown that intranasal infection of outbred CD-1 mice with the WEEV McMillan (McM) strain result in high mortality within 4 days of infection. Here in vivo and ex vivo bioluminescence (BLM) imaging was applied on mice intranasally infected with a recombinant McM virus expressing firefly luciferase (FLUC) to track viral neuroinvasion by FLUC detection and determine any correlation between BLM and viral titer. Immunological markers of disease (MCP-1 and IP-10) were measured and compared to wild type virus infection. Histopathology was guided by corresponding BLM images, and showed that neuroinvasion occurred primarily through cranial nerves, mainly in the olfactory tract. Olfactory bulb neurons were initially infected with subsequent spread of the infection into different regions of the brain. WEEV distribution was confirmed by immunohistochemistry as having marked neuronal infection but very few infected glial cells. Axons displayed infection patterns consistent with viral dissemination along the neuronal axis. The trigeminal nerve served as an additional route of neuroinvasion showing significant FLUC expression within the brainstem. The recombinant virus WEEV. McM. FLUC had attenuated replication kinetics and induced a weaker immunological response than WEEV. McM but produced comparable pathologies. Immunohistochemistry staining for FLUC and WEEV antigen showed that transgene expression was present in all areas of the CNS where virus was observed. BLM provides a quantifiable measure of alphaviral neural disease progression and a method for evaluating antiviral strategies.	[Phillips, Aaron T.; Stauft, Charles B.; Aboellail, Tawfik A.; Olson, Ken E.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Toth, Ann M.; Jarvis, Donald L.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA; [Powers, Ann M.] Ctr Dis Control, Div Vector Borne Infect Dis, Ft Collins, CO 80522 USA	Colorado State University; University of Wyoming	Phillips, AT (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	aaron.phillips@colostate.edu	Aboellail, Tawfik/AAB-8990-2019	Aboellail, Tawfik/0000-0003-0989-5333; Jarvis, Donald/0000-0002-8104-7155; Stauft, Charles/0000-0001-5633-2950	National Institutes of Health (NIH) [R01 AI46435]; RMRCE [AI065357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065357, R01AI046435] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RMRCE; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by the National Institutes of Health (NIH) (R01 AI46435) and the RMRCE (AI065357). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brault AC, 2004, INSECT MOL BIOL, V13, P625, DOI 10.1111/j.0962-1075.2004.00521.x; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; Caley IJ, 1997, J VIROL, V71, P3031, DOI 10.1128/JVI.71.4.3031-3038.1997; CALISHER CH, 1994, CLIN MICROBIOL REV, V7, P89, DOI 10.1128/CMR.7.1.89-116.1994; Carpentier PA, 2007, GLIA, V55, P239, DOI 10.1002/glia.20450; CHARLES PC, 1995, VIROLOGY, V208, P662, DOI 10.1006/viro.1995.1197; Contag CH, 1997, PHOTOCHEM PHOTOBIOL, V66, P523, DOI 10.1111/j.1751-1097.1997.tb03184.x; Contag CH, 1995, MOL MICROBIOL, V18, P593, DOI 10.1111/j.1365-2958.1995.mmi_18040593.x; Cook SH, 2003, J VIROL, V77, P5333, DOI 10.1128/JVI.77.9.5333-5338.2003; Del Piero F, 2001, VET PATHOL, V38, P451, DOI 10.1354/vp.38-4-451; FINLEY KH, 1955, NEUROLOGY, V5, P223; Foy BD, 2004, INSECT MOL BIOL, V13, P89, DOI 10.1111/j.1365-2583.2004.00464.x; Foy BD, 2008, ADV EXP MED BIOL, V627, P19, DOI 10.1007/978-0-387-78225-6_2; Gardner CL, 2008, J VIROL, V82, P10634, DOI 10.1128/JVI.01323-08; Gardner CL, 2011, P NATL ACAD SCI USA, V108, P16026, DOI 10.1073/pnas.1110617108; Ghosh S, 2011, NATURE, V472, P217, DOI 10.1038/nature09945; Griffin DE, 2005, CURR TOP MICROBIOL, V289, P57; Griffin DE, 2004, ARCH VIROL, P21; HAHN CS, 1988, P NATL ACAD SCI USA, V85, P5997, DOI 10.1073/pnas.85.16.5997; HARDY JL, 1987, AM J TROP MED HYG, V37, pS18, DOI 10.4269/ajtmh.1987.37.18S; HIGGS S, 1995, INSECT MOL BIOL, V4, P97, DOI 10.1111/j.1365-2583.1995.tb00013.x; HIGGS S, 1993, PARASITOL TODAY, V9, P444, DOI 10.1016/0169-4758(93)90098-Z; HOPKINS TA, 1967, J AM CHEM SOC, V89, P7148, DOI 10.1021/ja01002a076; Inoue Y, 2009, EUR J NUCL MED MOL I, V36, P771, DOI 10.1007/s00259-008-1022-8; Julander JG, 2007, VIROLOGY, V360, P454, DOI 10.1016/j.virol.2006.10.031; Karabatsos N, 1985, AM J TROPICAL MED HY; LILJESTROM P, 1991, BIO-TECHNOL, V9, P1356, DOI 10.1038/nbt1291-1356; Logue CH, 2010, ANTIVIR RES, V87, P195, DOI 10.1016/j.antiviral.2010.04.013; Logue CH, 2009, J GEN VIROL, V90, P1848, DOI 10.1099/vir.0.008656-0; Luker GD, 2002, J VIROL, V76, P12149, DOI 10.1128/JVI.76.23.12149-12161.2002; Meyer KF, 1931, SCIENCE, V74, P227, DOI 10.1126/science.74.1913.227; Nagata LP, 2006, J GEN VIROL, V87, P2353, DOI 10.1099/vir.0.81815-0; Olson KE, 2000, INSECT MOL BIOL, V9, P57, DOI 10.1046/j.1365-2583.2000.00162.x; Patterson M, 2011, VACCINE, V29, P9345, DOI 10.1016/j.vaccine.2011.09.130; Powers AM, 1996, P NATL ACAD SCI USA, V93, P4187, DOI 10.1073/pnas.93.9.4187; RaymsKeller A, 1995, INSECT MOL BIOL, V4, P245, DOI 10.1111/j.1365-2583.1995.tb00030.x; Reed DS, 2005, J INFECT DIS, V192, P1173, DOI 10.1086/444397; REISEN WK, 1995, J MED ENTOMOL, V32, P267, DOI 10.1093/jmedent/32.3.267; Roy CJ, 2009, VIROL J, V6, P13; Ryman KD, 2007, J VIROL, V81, P3563, DOI 10.1128/JVI.02494-06; Ryman KD, 2007, J GEN VIROL, V88, P518, DOI 10.1099/vir.0.82359-0; Ryzhikov A B, 1991, Biomed Sci, V2, P607; Ryzhikov AB, 1995, ARCH VIROL, V140, P2243, DOI 10.1007/BF01323243; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; Steele K., 2007, MED ASPECTS BIOL WAR; Toth AM, 2011, PROTEIN EXPRES PURIF, V80, P274, DOI 10.1016/j.pep.2011.08.002; Vanlandingham DL, 2005, AM J TROP MED HYG, V73, P309; Vogel P, 1996, ARCH PATHOL LAB MED, V120, P164; WOODMAN DR, 1975, INFECT IMMUN, V12, P1006, DOI 10.1128/IAI.12.5.1006-1011.1975; Zaitseva M, 2009, J VIROL, V83, P10437, DOI 10.1128/JVI.01296-09; Zhang YG, 2007, J VIROL, V81, P11246, DOI 10.1128/JVI.01282-07; Ziegler SA, 2011, VECTOR-BORNE ZOONOT, V11, P1471, DOI 10.1089/vbz.2011.0648	53	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53462	10.1371/journal.pone.0053462	http://dx.doi.org/10.1371/journal.pone.0053462			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301074	Green Published, gold, Green Submitted			2022-12-25	WOS:000313320900079
J	Davis, AJ; Lee, KJ; Chen, DJ				Davis, Anthony J.; Lee, Kyung-Jong; Chen, David J.			The N-terminal Region of the DNA-dependent Protein Kinase Catalytic Subunit Is Required for Its DNA Double-stranded Break-mediated Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL STRUCTURE; PHOSPHORYLATION SITES; IDENTIFICATION; PKCS; KU; AUTOPHOSPHORYLATION; REPAIR; REVEALS; COMPLEX; HETERODIMER	DNA-dependent protein kinase (DNA-PK) plays an essential role in the repair of DNA double-stranded breaks (DSBs) mediated by the nonhomologous end-joining pathway. DNA-PK is a holoenzyme consisting of a DNA-binding (Ku70/Ku80) and catalytic (DNA-PKcs) subunit. DNA-PKcs is a serine/threonine protein kinase that is recruited to DSBs via Ku70/80 and is activated once the kinase is bound to the DSB ends. In this study, two large, distinct fragments of DNA-PKcs, consisting of the N terminus (amino acids 1-2713), termed N-PKcs, and the C terminus (amino acids 2714-4128), termed C-PKcs, were produced to determine the role of each terminal region in regulating the activity of DNA-PKcs. N-PKcs but not C-PKcs interacts with the Ku-DNA complex and is required for the ability of DNA-PKcs to localize to DSBs. C-PKcs has increased basal kinase activity compared with DNA-PKcs, suggesting that the N-terminal region of DNA-PKcs keeps basal activity low. The kinase activity of C-PKcs is not stimulated by Ku70/80 and DNA, further supporting that the N-terminal region is required for binding to the Ku-DNA complex and full activation of kinase activity. Collectively, the results show the N-terminal region mediates the interaction between DNA-PKcs and the Ku-DNA complex and is required for its DSB-induced enzymatic activity.	[Davis, Anthony J.; Lee, Kyung-Jong; Chen, David J.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Div Mol Radiat Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, DJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Div Mol Radiat Biol, 2201 Inwood Rd, Dallas, TX 75390 USA.	david.chen@utsouthwestern.edu	Classen, Scott/AAY-8176-2020	Davis, Anthony/0000-0003-0184-3651	National Institutes of Health [CA50519, CA13499]; Cancer Prevention Research Institute of Texas [RP110465]; NATIONAL CANCER INSTITUTE [R01CA050519, P01CA092584, R01CA162804, R37CA050519, R01CA134991] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA50519 and CA13499. This work was also supported by Cancer Prevention Research Institute of Texas Grant RP110465.	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Beamish HJ, 2000, NUCLEIC ACIDS RES, V28, P1506, DOI 10.1093/nar/28.7.1506; Blunt T, 1996, P NATL ACAD SCI USA, V93, P10285, DOI 10.1073/pnas.93.19.10285; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; Cary RB, 1997, P NATL ACAD SCI USA, V94, P4267, DOI 10.1073/pnas.94.9.4267; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; Cui XP, 2005, MOL CELL BIOL, V25, P10842, DOI 10.1128/MCB.25.24.10842-10852.2005; Dix MM, 2012, CELL, V150, P426, DOI 10.1016/j.cell.2012.05.040; Douglas P, 2007, MOL CELL BIOL, V27, P1581, DOI 10.1128/MCB.01962-06; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Gupta S, 2005, NUCLEIC ACIDS RES, V33, P6972, DOI 10.1093/nar/gki990; Gurley KE, 2009, EMBO REP, V10, P87, DOI 10.1038/embor.2008.214; Hammarsten O, 2000, J BIOL CHEM, V275, P1541, DOI 10.1074/jbc.275.3.1541; Hammel M, 2010, J BIOL CHEM, V285, P1414, DOI 10.1074/jbc.M109.065615; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hill R, 2008, DNA REPAIR, V7, P1484, DOI 10.1016/j.dnarep.2008.05.007; Hollick JJ, 2003, BIOORG MED CHEM LETT, V13, P3083, DOI 10.1016/S0960-894X(03)00652-8; Izzard RA, 1999, CANCER RES, V59, P2581; Jin SF, 1997, J BIOL CHEM, V272, P24763, DOI 10.1074/jbc.272.40.24763; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kurimasa A, 1999, MOL CELL BIOL, V19, P3877; Leahy JJJ, 2004, BIOORG MED CHEM LETT, V14, P6083, DOI 10.1016/j.bmcl.2004.09.060; Lee KJ, 2004, DNA REPAIR, V3, P267, DOI 10.1016/j.dnarep.2003.11.005; Lee KJ, 2002, J IMMUNOL, V169, P3413, DOI 10.4049/jimmunol.169.6.3413; Lempiainen H, 2009, EMBO J, V28, P3067, DOI 10.1038/emboj.2009.281; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Ma YM, 2005, J BIOL CHEM, V280, P33839, DOI 10.1074/jbc.M507113200; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Meek K, 2012, NUCLEIC ACIDS RES, V40, P2964, DOI 10.1093/nar/gkr1211; Merkle D, 2002, BIOCHEMISTRY-US, V41, P12706, DOI 10.1021/bi0263558; Mukherjee B, 2006, DNA REPAIR, V5, P575, DOI 10.1016/j.dnarep.2006.01.011; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Peterson RT, 2000, J BIOL CHEM, V275, P7416, DOI 10.1074/jbc.275.10.7416; Rivera-Calzada A, 2005, STRUCTURE, V13, P243, DOI 10.1016/j.str.2004.12.006; Rivera-Calzada A, 2007, EMBO REP, V8, P56, DOI 10.1038/sj.embor.7400847; Shao ZP, 2012, DNA REPAIR, V11, P310, DOI 10.1016/j.dnarep.2011.12.007; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; So SR, 2009, J CELL BIOL, V187, P977, DOI 10.1083/jcb.200906064; Song QZ, 1996, EMBO J, V15, P3238, DOI 10.1002/j.1460-2075.1996.tb00688.x; Spagnolo L, 2006, MOL CELL, V22, P511, DOI 10.1016/j.molcel.2006.04.013; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; West RB, 1998, MOL CELL BIOL, V18, P5908, DOI 10.1128/MCB.18.10.5908; Weterings E, 2004, DNA REPAIR, V3, P1425, DOI 10.1016/j.dnarep.2004.06.003; Williams DR, 2008, STRUCTURE, V16, P468, DOI 10.1016/j.str.2007.12.014; Yajima H, 2006, MOL CELL BIOL, V26, P7520, DOI 10.1128/MCB.00048-06; Young DB, 2005, J BIOL CHEM, V280, P27587, DOI 10.1074/jbc.M411689200	54	35	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7037	7046		10.1074/jbc.M112.434498	http://dx.doi.org/10.1074/jbc.M112.434498			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23322783	Green Published, hybrid			2022-12-25	WOS:000316002400025
J	Esparza, JM; O'Toole, E; Li, LY; Giddings, TH; Kozak, B; Albee, AJ; Dutcher, SK				Esparza, Jessica M.; O'Toole, Eileen; Li, Linya; Giddings, Thomas H., Jr.; Kozak, Benjamin; Albee, Alison J.; Dutcher, Susan K.			Katanin Localization Requires Triplet Microtubules in Chlamydomonas reinhardtii	PLOS ONE			English	Article							BASAL BODY CONNECTOR; FUNCTIONAL GENOMICS; DROSOPHILA SPD-2; EPSILON-TUBULIN; FINE-STRUCTURE; DELTA-TUBULIN; CELL-DIVISION; ALPHA-TUBULIN; WHOLE-GENOME; WILD-TYPE	Centrioles and basal bodies are essential for a variety of cellular processes that include the recruitment of proteins to these structures for both centrosomal and ciliary function. This recruitment is compromised when centriole/basal body assembly is defective. Mutations that cause basal body assembly defects confer supersensitivity to Taxol. These include bld2, bld10, bld12, uni3, vfl1, vfl2, and vfl3. Flagellar motility mutants do not confer sensitivity with the exception of mutations in the p60 (pf19) and p80 (pf15) subunits of the microtubule severing protein katanin. We have identified additional pf15 and bld2 (epsilon-tubulin) alleles in screens for Taxol sensitivity. Null pf15 and bld2 alleles are viable and are not essential genes in Chlamydomonas. Analysis of double mutant strains with the pf15-3 and bld2-6 null alleles suggests that basal bodies in Chlamydomonas may recruit additional proteins beyond katanin that affect spindle microtubule stability. The bld2-5 allele is a hypomorphic allele and its phenotype is modulated by nutritional cues. Basal bodies in bld2-5 cells are missing proximal ends. The basal body mutants show aberrant localization of an epitope-tagged p80 subunit of katanin. Unlike IFT proteins, katanin p80 does not localize to the transition fibers of the basal bodies based on an analysis of the uni1 mutant as well as the lack of colocalization of katanin p80 with IFT74. We suggest that the triplet microtubules are likely to play a key role in katanin p80 recruitment to the basal body of Chlamydomonas rather than the transition fibers that are needed for IFT localization.	[Esparza, Jessica M.; O'Toole, Eileen; Li, Linya; Giddings, Thomas H., Jr.; Kozak, Benjamin; Albee, Alison J.; Dutcher, Susan K.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL)	Dutcher, SK (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.	dutcher@genetics.wustl.edu			National Institutes of Health [GM-32843, RR-00592]; National Institutes of Health Ruth L. Kirschstein National Research Service Award [GM093598]; Siteman Cancer Center Summer Opportunities Program; Ford Foundation Predoctoral fellowship; NIGMS, NIH [GM-32843]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM093598, R01GM032843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Siteman Cancer Center Summer Opportunities Program; Ford Foundation Predoctoral fellowship; NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was funded by 1) National Institutes of Health grants GM-32843 to SKD (www.nih.gov/); 2) National Institutes of Health RR-00592 to Andreas Hoenger; 3) National Institutes of Health Ruth L. Kirschstein National Research Service Award GM093598 to AJA; 4) Siteman Cancer Center Summer Opportunities Program Stipend to BK (http://www.siteman.wustl.edu/summerprogram.aspx); 5) a Ford Foundation Predoctoral fellowship to JME (http://sites.nationalacademies.org/pga/fordfellowships/); and 6) a diversity supplement to GM-32843 to support JME. (The supplement to JME was awarded by NIGMS as a supplement to NIH grant GM-32843.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS GMW, 1982, GENETICS, V100, P579; Azimzadeh J, 2007, J CELL SCI, V120, P2139, DOI 10.1242/jcs.005231; Brazelton WJ, 2001, CURR BIOL, V11, P1591, DOI 10.1016/S0960-9822(01)00485-7; Cheng TS, 2007, EXP CELL RES, V313, P1710, DOI 10.1016/j.yexcr.2007.02.023; CLAES H, 1977, EXP CELL RES, V108, P221, DOI 10.1016/S0014-4827(77)80028-1; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Conduit PT, 2010, CURR BIOL, V20, P2178, DOI 10.1016/j.cub.2010.11.011; Deane JA, 2001, CURR BIOL, V11, P1586, DOI 10.1016/S0960-9822(01)00484-5; Delattre M, 2006, CURR BIOL, V16, P1844, DOI 10.1016/j.cub.2006.07.059; Dent RM, 2005, PLANT PHYSIOL, V137, P545, DOI 10.1104/pp.104.055244; Dix CI, 2007, CURR BIOL, V17, P1759, DOI 10.1016/j.cub.2007.08.065; Doles J, 2010, CANCER RES, V70, P1033, DOI 10.1158/0008-5472.CAN-09-2113; Dupuis-Williams P, 2002, J CELL BIOL, V158, P1183, DOI 10.1083/jcb.200205028; Dutcher SK, 1998, MOL BIOL CELL, V9, P1293, DOI 10.1091/mbc.9.6.1293; Dutcher SK, 2002, MOL BIOL CELL, V13, P3859, DOI 10.1091/mbc.E02-04-0205; DUTCHER SK, 1984, J CELL BIOL, V98, P229, DOI 10.1083/jcb.98.1.229; DUTCHER SK, 1995, METHOD CELL BIOL, V47, P531, DOI 10.1016/S0091-679X(08)60857-2; DUTCHER SK, 1995, METHOD CELL BIOL, V47, P323, DOI 10.1016/S0091-679X(08)60826-2; DUTCHER SK, 1992, GENETICS, V131, P593; Dutcher SK, 2003, TRAFFIC, V4, P443, DOI 10.1034/j.1600-0854.2003.00104.x; Dutcher SK, 2012, G3-GENES GENOM GENET, V2, P15, DOI 10.1534/g3.111.000919; Dymek EE, 2004, EUKARYOT CELL, V3, P870, DOI 10.1128/EC.3.4.870-879.2004; Dymek EE, 2012, J CELL SCI, V125, P3357, DOI 10.1242/jcs.096941; EHLER LL, 1995, GENETICS, V141, P945; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; GAERTIG J, 1995, J CELL BIOL, V129, P1301, DOI 10.1083/jcb.129.5.1301; Geimer S, 2004, J CELL SCI, V117, P2663, DOI 10.1242/jcs.01120; Giansanti MG, 2008, CURR BIOL, V18, P303, DOI 10.1016/j.cub.2008.01.058; Good P, 2005, PERMUTATION PARAMETR; GOODENOUGH UW, 1975, J CELL BIOL, V66, P480, DOI 10.1083/jcb.66.3.480; GROSS CH, 1988, CURR GENET, V13, P503, DOI 10.1007/BF02427756; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0; HOLMES JA, 1989, J CELL SCI, V94, P273; Hsu WB, 2008, EXP CELL RES, V314, P2591, DOI 10.1016/j.yexcr.2008.05.012; HUANG B, 1982, CELL, V29, P745, DOI 10.1016/0092-8674(82)90436-6; Iomini C, 2001, J CELL BIOL, V153, P13, DOI 10.1083/jcb.153.1.13; Iomini C, 2006, CURR BIOL, V16, P1147, DOI 10.1016/j.cub.2006.04.035; Iomini C, 2009, GENETICS, V183, P885, DOI 10.1534/genetics.109.101915; Iyaduri KB, 2004, J CELL BIOL, V45, pA167; Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63; JOHNSON UG, 1968, J CELL BIOL, V38, P403, DOI 10.1083/jcb.38.2.403; Kamiya R, 2002, INT REV CYTOL, V219, P115; Kirk, 1998, VOLVOX SEARCH MOL GE; KOZMINSKI KG, 1995, METHOD CELL BIOL, V47, P263, DOI 10.1016/S0091-679X(08)60819-5; Kremer BE, 2005, MOL BIOL CELL, V16, P4648, DOI 10.1091/mbc.E05-03-0267; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lechtreck KF, 2001, EUR J CELL BIOL, V80, P631, DOI 10.1078/0171-9335-00199; LEDIZET M, 1986, J CELL BIOL, V103, P13, DOI 10.1083/jcb.103.1.13; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Matsuura K, 2004, J CELL BIOL, V165, P663, DOI 10.1083/jcb.200402022; McNally FJ, 1996, J CELL SCI, V109, P561; Miller MS, 2005, MOL BIOL CELL, V16, P3810, DOI 10.1091/mbc.E05-05-0404; Mogensen MM, 2000, J CELL SCI, V113, P3013; Muller-Reichert T, 2003, J MICROSC-OXFORD, V212, P71, DOI 10.1046/j.1365-2818.2003.01250.x; Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046; Njiaju UO, 2012, PHARMACOGENET GENOM, V22, P498, DOI 10.1097/FPC.0b013e328352f436; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; O'Toole E, 2003, MOL BIOL CELL; O'Toole ET, 2007, METHOD CELL BIOL, V79, P125, DOI 10.1016/S0091-679X(06)79005-7; O'Toole ET, 2003, MOL BIOL CELL, V14, P2999, DOI 10.1091/mbc.E02-11-0755; Orr GA, 2003, ONCOGENE, V22, P7280, DOI 10.1038/sj.onc.1206934; Palombella AL, 1998, PLANT PHYSIOL, V117, P455, DOI 10.1104/pp.117.2.455; Pelletier L, 2004, CURR BIOL, V14, P863, DOI 10.1016/j.cub.2004.04.012; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Piasecki BP, 2008, MOL BIOL CELL, V19, P262, DOI 10.1091/mbc.E07-08-0798; Piasecki BP, 2009, MOL BIOL CELL, V20, P368, DOI 10.1091/mbc.E08-09-0900; Preble AM, 2001, GENETICS, V157, P163; Rasi MQ, 2009, MOL BIOL CELL, V20, P379, DOI 10.1091/mbc.E07-10-1007; RINGO DL, 1967, J CELL BIOL, V33, P543, DOI 10.1083/jcb.33.3.543; SALISBURY JL, 1988, J PROTOZOOL, V35, P574; SCHIBLER MJ, 1991, J CELL BIOL, V113, P605, DOI 10.1083/jcb.113.3.605; Sharma N, 2007, J CELL BIOL, V178, P1065, DOI 10.1083/jcb.200704021; Shimogawara K, 1998, GENETICS, V148, P1821; Silflow CD, 2001, J CELL BIOL, V153, P63, DOI 10.1083/jcb.153.1.63; Sizova I, 2001, GENE, V277, P221, DOI 10.1016/S0378-1119(01)00616-3; Srayko M, 2000, GENE DEV, V14, P1072; Steg AD, 2012, MOL CANCER THER, V11, P1587, DOI 10.1158/1535-7163.MCT-11-1058; TAILLON BE, 1992, J CELL BIOL, V119, P1613, DOI 10.1083/jcb.119.6.1613; Umen JG, 2001, GENE DEV, V15, P1652, DOI 10.1101/gad.892101; VALLETTE F, 1989, NUCLEIC ACIDS RES, V17, P723, DOI 10.1093/nar/17.2.723; WALTHER Z, 1994, J CELL BIOL, V126, P175, DOI 10.1083/jcb.126.1.175; WRIGHT RL, 1985, J CELL BIOL, V101, P1903, DOI 10.1083/jcb.101.5.1903; WRIGHT RL, 1989, CELL MOTIL CYTOSKEL, V14, P516, DOI 10.1002/cm.970140409; Xu ML, 2012, CANCER SCI, V103, P821, DOI 10.1111/j.1349-7006.2012.02221.x; Yang PF, 2006, J CELL SCI, V119, P1165, DOI 10.1242/jcs.02811; Yin SH, 2012, PHARM RES-DORDR, V29, P2994, DOI 10.1007/s11095-012-0794-5; Zhang D, 2007, J CELL BIOL, V177, P231, DOI 10.1083/jcb.200612011	89	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53940	10.1371/journal.pone.0053940	http://dx.doi.org/10.1371/journal.pone.0053940			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320108	Green Published, gold, Green Submitted			2022-12-25	WOS:000313429800073
J	Borucki, MK; Allen, JE; Chen-Harris, H; Zemla, A; Vanier, G; Mabery, S; Torres, C; Hullinger, P; Slezak, T				Borucki, Monica K.; Allen, Jonathan E.; Chen-Harris, Haiyin; Zemla, Adam; Vanier, Gilda; Mabery, Shalini; Torres, Clinton; Hullinger, Pamela; Slezak, Tom			The Role of Viral Population Diversity in Adaptation of Bovine Coronavirus to New Host Environments	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; AMINO-ACID-SEQUENCES; HEPARAN-SULFATE; WINTER DYSENTERY; CROSS-PROTECTION; SPIKE PROTEIN; VIRUS; CELL; NUCLEOTIDE; INFECTION	The high mutation rate of RNA viruses enables a diverse genetic population of viral genotypes to exist within a single infected host. In-host genetic diversity could better position the virus population to respond and adapt to a diverse array of selective pressures such as host-switching events. Multiple new coronaviruses, including SARS, have been identified in human samples just within the last ten years, demonstrating the potential of coronaviruses as emergent human pathogens. Deep sequencing was used to characterize genomic changes in coronavirus quasispecies during simulated host-switching. Three bovine nasal samples infected with bovine coronavirus were used to infect human and bovine macrophage and lung cell lines. The virus reproduced relatively well in macrophages, but the lung cell lines were not infected efficiently enough to allow passage of non lab-adapted samples. Approximately 12 kb of the genome was amplified before and after passage and sequenced at average coverages of nearly 950x(454 sequencing) and 38,000x(Illumina). The consensus sequence of many of the passaged samples had a 12 nucleotide insert in the consensus sequence of the spike gene, and multiple point mutations were associated with the presence of the insert. Deep sequencing revealed that the insert was present but very rare in the unpassaged samples and could quickly shift to dominate the population when placed in a different environment. The insert coded for three arginine residues, occurred in a region associated with fusion entry into host cells, and may allow infection of new cell types via heparin sulfate binding. Analysis of the deep sequencing data indicated that two distinct genotypes circulated at different frequency levels in each sample, and support the hypothesis that the mutations present in passaged strains were "selected" from a pre-existing pool rather than through de novo mutation and subsequent population fixation.	[Borucki, Monica K.; Allen, Jonathan E.; Chen-Harris, Haiyin; Zemla, Adam; Vanier, Gilda; Mabery, Shalini; Torres, Clinton; Hullinger, Pamela; Slezak, Tom] Lawrence Livermore Natl Lab, Livermore, CA USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Borucki, MK (corresponding author), Lawrence Livermore Natl Lab, Livermore, CA USA.	borucki2@llnl.gov		Allen, Jonathan/0000-0002-4359-8263	Lawrence Livermore National Laboratory [LDRD 10-LW-020]; Defense Threat Reduction Agency, Transformational Medical Technologies Initiative; U.S. Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]	Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Defense Threat Reduction Agency, Transformational Medical Technologies Initiative(United States Department of DefenseDefense Threat Reduction Agency); U.S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE))	Funding was provided by Lawrence Livermore National Laboratory internal funding (LDRD 10-LW-020) and a grant from the Defense Threat Reduction Agency, Transformational Medical Technologies Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344.	Akaike T, 2000, FASEB J, V14, P1447, DOI 10.1096/fj.14.10.1447; Almeida MS, 2007, J VIROL, V81, P3151, DOI 10.1128/JVI.01939-06; Belouzard S, 2009, P NATL ACAD SCI USA, V106, P5871, DOI 10.1073/pnas.0809524106; Bernard KA, 2000, VIROLOGY, V276, P93, DOI 10.1006/viro.2000.0546; Bertram S, 2011, J VIROL, V85, P13363, DOI 10.1128/JVI.05300-11; Borderia AV, 2011, CURR OPIN VIROL, V1, P643, DOI 10.1016/j.coviro.2011.09.012; Brockway SM, 2004, J VIROL, V78, P11551, DOI 10.1128/JVI.78.21.11551-11562.2004; Cho KO, 2001, ARCH VIROL, V146, P2401, DOI 10.1007/s007050170011; Chouljenko VN, 1998, VIRUS GENES, V17, P33, DOI 10.1023/A:1008048916808; Chouljenko VN, 2001, J GEN VIROL, V82, P2927, DOI 10.1099/0022-1317-82-12-2927; de Haan CAM, 2008, J VIROL, V82, P6078, DOI 10.1128/JVI.00074-08; de Haan CAM, 2005, J VIROL, V79, P14451, DOI 10.1128/JVI.79.22.14451-14456.2005; Devaraj SG, 2007, J BIOL CHEM, V282, P32208, DOI 10.1074/jbc.M704870200; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Elena SF, 2006, EMBO REP, V7, P168, DOI 10.1038/sj.embor.7400636; Gonzaalez JM, 2003, ARCH VIROL, V148, P2207, DOI 10.1007/s00705-003-0162-1; Graham RL, 2010, J VIROL, V84, P3134, DOI 10.1128/JVI.01394-09; Han MG, 2006, J VIROL, V80, P12350, DOI 10.1128/JVI.00402-06; HOFMANN MA, 1990, J VIROL, V64, P4108, DOI 10.1128/JVI.64.9.4108-4114.1990; Jacques A, 2009, IMMUNOLOGY, V128, pe181, DOI 10.1111/j.1365-2567.2008.02946.x; Li WH, 2006, J VIROL, V80, P4211, DOI 10.1128/JVI.80.9.4211-4219.2006; Mcroy WC, 2008, J VIROL, V82, P1414, DOI 10.1128/JVI.01674-07; PARKER MD, 1990, J GEN VIROL, V71, P263, DOI 10.1099/0022-1317-71-2-263; Peng GQ, 2011, P NATL ACAD SCI USA, V108, P10696, DOI 10.1073/pnas.1104306108; Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147; SAIF LJ, 1988, VET REC, V123, P300, DOI 10.1136/vr.123.11.300; SCHULTZE B, 1992, J GEN VIROL, V73, P901, DOI 10.1099/0022-1317-73-4-901; Spillmann D, 2001, BIOCHIMIE, V83, P811, DOI 10.1016/S0300-9084(01)01290-1; STABEL JR, 1995, VET IMMUNOL IMMUNOP, V45, P211, DOI 10.1016/0165-2427(94)05348-V; STCYRCOATS K, 1988, ARCH VIROL, V103, P35, DOI 10.1007/BF01319807; Sun L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030802; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vijgen L, 2005, J VIROL, V79, P1595, DOI 10.1128/JVI.79.3.1595-1604.2005; Vijgen L, 2006, J VIROL, V80, P7270, DOI 10.1128/JVI.02675-05; Watanabe R, 2008, J VIROL, V82, P11985, DOI 10.1128/JVI.01412-08; Woolhouse MEJ, 2006, MICROBE, V1, P511, DOI 10.1128/microbe.1.511.1; Wright CF, 2011, J VIROL, V85, P2266, DOI 10.1128/JVI.01396-10; Zagordi O, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-119; Zagordi O, 2010, NUCLEIC ACIDS RES, V38, P7400, DOI 10.1093/nar/gkq655; Zemla A, 2005, NUCLEIC ACIDS RES, V33, pW111, DOI 10.1093/nar/gki457; Zhang X, 2007, VIROLOGY, V363, P1, DOI 10.1016/j.virol.2007.03.018; ZHANG XM, 1991, VIROLOGY, V183, P397, DOI 10.1016/0042-6822(91)90154-4	43	26	29	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e52752	10.1371/journal.pone.0052752	http://dx.doi.org/10.1371/journal.pone.0052752			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308119	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429100014
J	Weingaertner, IR; Koutnik, S; Ammer, H				Weingaertner, Inka Regine; Koutnik, Sarah; Ammer, Hermann			Chronic Morphine Treatment Attenuates Cell Growth of Human BT474 Breast Cancer Cells by Rearrangement of the ErbB Signalling Network	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; OPIOID RECEPTORS; TYROSINE KINASE; CARCINOMA CELLS; DOWN-REGULATION; EGF RECEPTOR; MECHANISMS; DESENSITIZATION; INHIBITION; RESISTANCE	Background: There is increasing evidence that opioid analgesics may interfere with tumour growth. It is currently thought that these effects are mediated by transactivation of receptor tyrosine kinase (RTK)-controlled ERK1/2 and Akt signalling. The growth of many breast cancer cells is dependent on hyperactive ErbB receptor networks and one of the most successful approaches in antineoplastic therapy during the last decade was the development of ErbB-targeted therapies. However, the response rates of single therapies are often poor and resistance mechanisms evolve rapidly. To date there is no information about the ability of opioid analgesics to interfere with the growth of ErbB-driven cancers. Methods and Principal Findings: Here we demonstrate that ErbB2 overexpressing BT474 human breast cancer cells carry fully functional endogenous mu-opioid receptors. Most interestingly, the acute opioid effects on basal and Heregulin-stimulated ERK1/2 and Akt phosphorylation changed considerably during chronic Morphine treatment. Investigation of the underlying mechanism by the use of protein kinase inhibitors and co-immunoprecipitation studies revealed that chronic Morphine treatment results in rearrangement of the ErbB signalling network leading to dissociation of ERK1/2 from Akt signalling and a switch from ErbB1/ErbB3 to ErbB1/ErbB2-dependent cell growth. In chronically Morphine-treated cells Heregulin-stimulated ERK1/2 signalling is redirected via a newly established PI3K- and metalloproteinase-dependent feedback loop. Together, these alterations result in apoptosis of BT474 cells. A similar switch in Heregulin-stimulated ERK1/2 signalling from an ErbB2-independent to an ErbB2-, PI3K-and metalloproteinase-dependent mechanism was also observed in k-opioid receptor expressing SKBR3 human mammary adenocarcinoma cells. Conclusions and Significance: The present data demonstrate that the ErbB receptor network of human breast cancer cells represents a target for chronic Morphine treatment. Rearrangement of ErbB signalling by chronic Morphine may provide a promising strategy to enhance the sensitivity of breast cancer cells to ErbB-directed therapies and to prevent the development of escape mechanisms.	[Weingaertner, Inka Regine; Koutnik, Sarah; Ammer, Hermann] Univ Munich, Inst Pharmacol Toxicol & Pharm, Munich, Germany	University of Munich	Ammer, H (corresponding author), Univ Munich, Inst Pharmacol Toxicol & Pharm, Munich, Germany.	h.ammer@lmu.de		Ammer, Hermann/0000-0003-4935-0207				Afsharimani B, 2011, CANCER METAST REV, V30, P225, DOI 10.1007/s10555-011-9285-0; Amin DN, 2010, SEMIN CELL DEV BIOL, V21, P944, DOI 10.1016/j.semcdb.2010.08.007; Belcheva MM, 2003, MOL PHARMACOL, V64, P1391, DOI 10.1124/mol.64.6.1391; Brockhoff G, 2001, CYTOMETRY, V44, P338, DOI 10.1002/1097-0320(20010801)44:4<338::AID-CYTO1125>3.0.CO;2-V; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Chen XM, 2000, BIOCHEM BIOPH RES CO, V277, P757, DOI 10.1006/bbrc.2000.3731; Chen YL, 2008, CURR MED CHEM, V15, P772, DOI 10.2174/092986708783955518; DEBLASI A, 1989, TRENDS PHARMACOL SCI, V10, P227, DOI 10.1016/0165-6147(89)90266-6; Eisinger DA, 2002, J NEUROSCI, V22, P10192; Eisinger DA, 2011, MOL PHARMACOL, V79, P326, DOI 10.1124/mol.110.064956; Eisinger DA, 2009, J BIOL CHEM, V284, P34819, DOI 10.1074/jbc.M109.042937; Garrett JT, 2011, P NATL ACAD SCI USA, V108, P5021, DOI 10.1073/pnas.1016140108; Gijsen M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000563; Heiss A, 2009, EXP CELL RES, V315, P2115, DOI 10.1016/j.yexcr.2009.04.002; Hermanto U, 2001, ONCOGENE, V20, P7551, DOI 10.1038/sj.onc.1204964; Johnson E, 2010, J BIOL CHEM, V285, P29491, DOI 10.1074/jbc.M110.136770; Kerros C, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-77; Koltermann A, 2009, J CELL MOL MED, V13, P2122, DOI 10.1111/j.1582-4934.2008.00561.x; Kong A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002881; LASFARGUES EY, 1978, J NATL CANCER I, V61, P967; Law PY, 2000, ANNU REV PHARMACOL, V40, P389, DOI 10.1146/annurev.pharmtox.40.1.389; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Lerdrup M, 2007, MOL BIOL CELL, V18, P3656, DOI 10.1091/mbc.e07-01-0025; Marmor MD, 2004, INT J RADIAT ONCOL, V58, P903, DOI 10.1016/j.ijrobp.2003.06.002; Nahta R, 2006, NAT CLIN PRACT ONCOL, V3, P269, DOI 10.1038/ncponc0509; Nylund G, 2008, DIGEST DIS SCI, V53, P461, DOI 10.1007/s10620-007-9897-y; PRIGENT SA, 1994, EMBO J, V13, P2831, DOI 10.1002/j.1460-2075.1994.tb06577.x; Schulz R, 2004, EUR J PHARMACOL, V500, P487, DOI 10.1016/j.ejphar.2004.07.010; Serra V, 2011, ONCOGENE, V30, P2547, DOI 10.1038/onc.2010.626; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; Tegeder I, 2003, CANCER RES, V63, P1846; Tegeder I, 2004, PHARMACOL REV, V56, P351, DOI 10.1124/pr.56.3.2; Toll L, 1998, NIDA Res Monogr, V178, P440; Warren CM, 2006, CELL SIGNAL, V18, P923, DOI 10.1016/j.cellsig.2005.12.007; Wennstrom S, 1999, MOL CELL BIOL, V19, P4279; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zagon IS, 2007, NEUROPEPTIDES, V41, P441, DOI 10.1016/j.npep.2007.08.002; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	39	14	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53510	10.1371/journal.pone.0053510	http://dx.doi.org/10.1371/journal.pone.0053510			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308242	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429100080
J	Zouikr, I; Tadros, MA; Clifton, VL; Beagley, KW; Hodgson, DM				Zouikr, Ihssane; Tadros, Melissa A.; Clifton, Vicki L.; Beagley, Kenneth W.; Hodgson, Deborah M.			Low Formalin Concentrations Induce Fine-Tuned Responses That Are Sex and Age-Dependent: A Developmental Study	PLOS ONE			English	Article							RAT DORSAL-HORN; SPINAL-CORD; INFANT RATS; NOCICEPTIVE RESPONSES; DIFFERENT INTENSITIES; BEHAVIORAL-RESPONSE; GENDER-DIFFERENCES; INFLAMMATORY PAIN; GONADAL-HORMONES; ANALGESIA	The formalin test is increasingly applied as a model of inflammatory pain using high formalin concentrations (5-15%). However, little is known about the effects of low formalin concentrations on related behavioural responses. To examine this, rat pups were subjected to various concentrations of formalin at four developmental stages: 7, 13, 22, and 82 days of age. At postnatal day (PND) 7, sex differences in flinching but not licking responses were observed with 0.5% formalin evoking higher flinching in males than in females. A dose response was evident in that 0.5% formalin also produced higher licking responses compared to 0.3% or 0.4% formalin. At PND 13, a concentration of 0.8% formalin evoked a biphasic response. At PND 22, a concentration of 1.1% evoked higher flinching and licking responses during the late phase (10-30 min) in both males and females. During the early phase (0-5 min), 1.1% evoked higher licking responses compared to 0.9% or 1% formalin. 1.1% formalin produced a biphasic response that was not evident with 0.9 or 1%. At PND 82, rats displayed a biphasic pattern in response to three formalin concentrations (1.25%, 1.75% and 2.25%) with the presence of an interphase for both 1.75% and 2.25% but not for 1.25%. These data suggest that low formalin concentrations induce fine-tuned responses that are not apparent with the high formalin concentration commonly used in the formalin test. These data also show that the developing nociceptive system is very sensitive to subtle changes in formalin concentrations.	[Zouikr, Ihssane; Hodgson, Deborah M.] Univ Newcastle, Lab Neuroimmunol, Sch Psychol, Newcastle, NSW 2300, Australia; [Tadros, Melissa A.] Univ Newcastle, Sch Biomed Sci & Pharm, Newcastle, NSW 2300, Australia; [Clifton, Vicki L.] Univ Adelaide, Robinson Inst, Adelaide, SA, Australia; [Beagley, Kenneth W.] Queensland Univ Technol, Inst Hlth Biomed Innovat, Brisbane, Qld 4001, Australia	University of Newcastle; University of Newcastle; Robinson Research Institute; University of Adelaide; Queensland University of Technology (QUT)	Zouikr, I (corresponding author), Univ Newcastle, Lab Neuroimmunol, Sch Psychol, Newcastle, NSW 2300, Australia.	Ihssane.zouikr@uon.edu.au	Zouikr, Ihssane/X-9165-2019; Clifton, Vicki/A-1445-2012; Clifton, Vicki/AAV-2749-2021; Hodgson, Deborah/C-1950-2008; Beagley, Kenneth/J-1129-2012	Clifton, Vicki/0000-0002-4892-6748; Clifton, Vicki/0000-0002-4892-6748; Hodgson, Deborah/0000-0002-1522-0212; Beagley, Kenneth/0000-0003-3112-6557	National Health and Medical Research Council(NHMRC) [ARC DP 09787599]	National Health and Medical Research Council(NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a grant from National Health and Medical Research Council(NHMRC; ARC DP 09787599). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT FV, 1995, PAIN, V60, P91, DOI 10.1016/0304-3959(94)00095-V; ALOISI AM, 1995, BRAIN RES, V699, P242, DOI 10.1016/0006-8993(95)00912-A; ALOISI AM, 1994, NEUROSCI LETT, V179, P79, DOI 10.1016/0304-3940(94)90939-3; Aloisi AM, 2000, NEUROSCIENCE, V95, P559; ALOISI AM, 1995, PHYSIOL BEHAV, V58, P603, DOI 10.1016/0031-9384(95)00099-5; Anand KJS, 1999, PHYSIOL BEHAV, V66, P627, DOI 10.1016/S0031-9384(98)00338-2; Barr GA, 1998, PHARMACOL BIOCHEM BE, V60, P329, DOI 10.1016/S0091-3057(97)00602-3; Berkley KJ, 2006, AM J PHYSIOL-REG I, V291, pR241, DOI 10.1152/ajpregu.00287.2006; Bhutta AT, 2001, PHYSIOL BEHAV, V73, P51, DOI 10.1016/S0031-9384(01)00432-2; Butkevich IP, 2007, EUR J PAIN, V11, P888, DOI 10.1016/j.ejpain.2007.02.001; Butkevich IP, 2009, BRAIN RES, V1286, P53, DOI 10.1016/j.brainres.2009.06.055; Chanda ML, 2006, AM J PHYSIOL-REG I, V291, pR335, DOI 10.1152/ajpregu.00902.2005; CODERRE TJ, 1993, PAIN, V54, P43, DOI 10.1016/0304-3959(93)90098-A; Craft RM, 2004, EUR J PAIN, V8, P397, DOI 10.1016/j.ejpain.2004.01.003; Craft RM, 2003, CLIN J PAIN, V19, P175, DOI 10.1097/00002508-200305000-00005; Craft RM, 2003, LIFE SCI, V72, P2675, DOI 10.1016/S0024-3205(03)00178-4; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; Fitzgerald M, 2001, NEUROSCIENTIST, V7, P246, DOI 10.1177/107385840100700309; FITZGERALD M, 1986, DEV BRAIN RES, V24, P261, DOI 10.1016/0165-3806(86)90194-X; FITZGERALD M, 1985, J PHYSIOL-LONDON, V364, P1; Gagliese L, 1999, NEUROBIOL AGING, V20, P699, DOI 10.1016/S0197-4580(99)00061-5; Gaumond I, 2002, BRAIN RES, V958, P139, DOI 10.1016/S0006-8993(02)03661-2; Greenspan JD, 2007, PAIN, V132, pS26, DOI 10.1016/j.pain.2007.10.014; GUY ER, 1992, PAIN, V51, P81, DOI 10.1016/0304-3959(92)90012-Z; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; LaPrairie JL, 2007, PAIN, V132, pS124, DOI 10.1016/j.pain.2007.08.010; Lariviere WR, 2006, J NEUROPHYSIOL, V95, P2889, DOI 10.1152/jn.00608.2005; Lidow MS, 2002, PAIN, V99, P377, DOI 10.1016/S0304-3959(02)00258-0; McCall WD, 1996, NEUROSCI LETT, V208, P45, DOI 10.1016/0304-3940(96)12552-0; MCLAUGHLIN CR, 1990, PHARMACOL BIOCHEM BE, V36, P859, DOI 10.1016/0091-3057(90)90090-5; NADEL L, 1990, ANN NY ACAD SCI, V608, P613, DOI 10.1111/j.1749-6632.1990.tb48912.x; Ocvirk R, 2008, PAIN, V138, P402, DOI 10.1016/j.pain.2008.01.019; Okuda K, 2001, PAIN, V92, P107, DOI 10.1016/S0304-3959(00)00476-0; Perissin L, 2003, LIFE SCI, V72, P897, DOI 10.1016/S0024-3205(02)02344-5; Puig S, 1996, PAIN, V64, P345, DOI 10.1016/0304-3959(95)00121-2; Ren K, 2004, PAIN, V110, P588, DOI 10.1016/j.pain.2004.04.006; RIVEST RW, 1991, EXPERIENTIA, V47, P1026, DOI 10.1007/BF01923338; ROSLAND JH, 1990, PAIN, V42, P235, DOI 10.1016/0304-3959(90)91167-H; SKILLING SR, 1988, J NEUROCHEM, V51, P127, DOI 10.1111/j.1471-4159.1988.tb04845.x; SMULLIN DH, 1990, PAIN, V42, P93, DOI 10.1016/0304-3959(90)91095-Z; Sominsky L, 2012, HORM BEHAV, V62, P345, DOI 10.1016/j.yhbeh.2012.02.005; Teng CJ, 1998, PAIN, V76, P337, DOI 10.1016/S0304-3959(98)00065-7; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Walker SM, 2003, PAIN, V105, P185, DOI 10.1016/S0304-3959(03)00201-X; Walsh MA, 2009, J NEUROPHYSIOL, V101, P1800, DOI 10.1152/jn.90755.2008; WHEELERACETO H, 1990, PAIN, V40, P229, DOI 10.1016/0304-3959(90)90073-M; WHEELERACETO H, 1991, PSYCHOPHARMACOLOGY, V104, P35, DOI 10.1007/BF02244551; YI DK, 1995, PAIN, V60, P257, DOI 10.1016/0304-3959(94)00119-Y	48	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53384	10.1371/journal.pone.0053384	http://dx.doi.org/10.1371/journal.pone.0053384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308208	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429100060
J	Manuel, DG; Rosella, LC; Tuna, M; Bennett, C; Stukel, TA				Manuel, Douglas G.; Rosella, Laura C.; Tuna, Meltem; Bennett, Carol; Stukel, Therese A.			Effectiveness of Community-Wide and Individual High-Risk Strategies to Prevent Diabetes: A Modelling Study	PLOS ONE			English	Article							LIFE-STYLE INTERVENTIONS; COST-EFFECTIVENESS; OBESITY; HEALTH; POPULATIONS; CANADA	Background: Diabetes has been described as one of the most important threats to the health of developed countries. Effective population strategies to prevent diabetes have not been determined but two broad strategies have been proposed: "high-risk'' and "community-wide'' strategies. Methods: We modelled the potential effectiveness of two strategies to prevent 10% of new cases of diabetes in Ontario, Canada over a 5-year period. The 5-year risk of developing physician-diagnosed diabetes was estimated for respondents to the Canadian Community Health Survey 2003 (CCHS 2.1, N = 26 232) using a validated and calibrated diabetes risk tool (Diabetes Population Risk Tool [DPoRT]). We estimated how many cases of diabetes could be prevented using two different strategies: a) a community-wide strategy that would uniformly reduce body mass index (BMI) in the entire population; and b) a high baseline risk strategy using either pharmacotherapy or lifestyle counselling to treat people who have an increased risk of developing diabetes. Results: In 2003, the 5-year risk of developing diabetes was 4.7% (383 600 new diagnosed cases of diabetes in 8 189 000 Ontarians aged 20+) and risk was moderately diffused (0.5%, 3.1% and 17.9% risk in the 1st, 5th (median) and 10th deciles of risk). A 10% reduction in new cases of diabetes would have been achieved under any of the following scenarios: if BMI was 3.5% lower in the entire population; if lifestyle counselling covered 32.2% of high-risk people (371 900 of 1 155 000 people with 5 year diabetes risk greater than 10%); or, if pharmacotherapy covered 65.2% of high-risk people. Conclusions: Prevention using pharmacotherapy alone requires unrealistically high coverage levels to achieve modest population reduction in new diabetes cases. On the other hand, in recent years few jurisdictions have been able to achieve a reduction in BMI at the population level, let alone a reduction of BMI of 3.5%.	[Manuel, Douglas G.; Tuna, Meltem; Bennett, Carol] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Manuel, Douglas G.] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada; [Manuel, Douglas G.] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Manuel, Douglas G.; Rosella, Laura C.; Tuna, Meltem; Bennett, Carol; Stukel, Therese A.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Manuel, Douglas G.; Rosella, Laura C.; Tuna, Meltem; Bennett, Carol; Stukel, Therese A.] Inst Clin Evaluat Sci, Ottawa, ON, Canada; [Manuel, Douglas G.; Rosella, Laura C.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Rosella, Laura C.] Publ Hlth Ontario, Toronto, ON, Canada; [Stukel, Therese A.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Toronto; University of Toronto; University of Toronto	Manuel, DG (corresponding author), Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.	dmanuel@ohri.ca	; Manuel, Doug/D-7100-2014	Stukel, Therese/0000-0002-2951-1360; Bennett, Carol/0000-0002-3033-9860; Manuel, Doug/0000-0003-0912-0845	Simulation Technology for Applied Research, a CIHR New Emerging Team; Population Health Improvement Research Network; Ontario Ministry of Health and Long-term Care [06548]	Simulation Technology for Applied Research, a CIHR New Emerging Team(Canadian Institutes of Health Research (CIHR)); Population Health Improvement Research Network; Ontario Ministry of Health and Long-term Care(Ministry of Health and Long-Term Care, Ontario)	This study was supported by Simulation Technology for Applied Research, a CIHR New Emerging Team [http://www.cihr-irsc.gc.ca], and the Population Health Improvement Research Network [http://www.rrasp-phirn.ca/] that receives funding from the Ontario Ministry of Health and Long-term Care [Grant Number 06548]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertram MY, 2010, DIABETOLOGIA, V53, P875, DOI 10.1007/s00125-010-1661-8; Branca F., 2007, CHALLENGE OBESITY WH; Canadian Agency for Drugs and Technologies in Health (CADTH), 2017, GUID EC EV HLTH TECH; Collins GS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-103; Drummond MF, 2015, METHODS EC EVALUATIO; Gillies CL, 2008, BMJ-BRIT MED J, V336, P1180, DOI 10.1136/bmj.39545.585289.25; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; Goldsmith L, 2004, EC EVALUATION 4 FACE; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; Haby MM, 2006, INT J OBESITY, V30, P1463, DOI 10.1038/sj.ijo.0803469; Jain A, 2005, BMJ-BRIT MED J, V331, P1387, DOI 10.1136/bmj.331.7529.1387; Katzmarzyk PT, 2001, J CLIN EPIDEMIOL, V54, P916, DOI 10.1016/S0895-4356(01)00356-0; Lindstrom J, 2010, PUBLIC HEALTH NUTR, V13, P993, DOI 10.1017/S1368980010000960; Manuel DG, 2010, INT J EPIDEMIOL, V39, P380, DOI 10.1093/ije/dyp373; McAlister FA, 2011, CAN MED ASSOC J, V183, P1007, DOI 10.1503/cmaj.101767; McLaren L, 2010, INT J EPIDEMIOL, V39, P372, DOI 10.1093/ije/dyp315; Noble D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7163; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Paulweber B, 2010, HORM METAB RES, V42, pS3, DOI 10.1055/s-0029-1240928; ROSE G, 1991, J ROY COLL PHYS LOND, V25, P48; Rose G, 2001, B WORLD HEALTH ORGAN, V79, P990; Rose GA, 1992, STRATEGY PREVENTIVE, Vxii; Rosella LC, 2011, J EPIDEMIOL COMMUN H, V65, P613, DOI 10.1136/jech.2009.102244; RUSH B, 2002, CENSUS EC EVALUATION; Swinburn B, 2005, OBES REV, V6, P23, DOI 10.1111/j.1467-789X.2005.00184.x; WHO, 2000, OB PREV MAN GLOB EP	27	6	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e52963	10.1371/journal.pone.0052963	http://dx.doi.org/10.1371/journal.pone.0052963			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308127	Green Published, gold, Green Submitted			2022-12-25	WOS:000313670100014
J	Hahn, C; Lim, HK; Won, WY; Ahn, KJ; Jung, WS; Lee, CU				Hahn, Changtae; Lim, Hyun-Kook; Won, Wang Yeon; Ahn, Kook Jin; Jung, Won-Sang; Lee, Chang Uk			Apathy and White Matter Integrity in Alzheimer's Disease: A Whole Brain Analysis with Tract-Based Spatial Statistics	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; NEUROPSYCHIATRIC SYMPTOMS; PARKINSONS-DISEASE; DEPRESSION; DEMENTIA; ADOLESCENTS; INVENTORY; DIAGNOSIS; REGION; ROBUST	The aim of this study was to investigate the microstructural alterations of white matter (WM) in Alzheimer's disease (AD) patients with apathy and to observe the relationships with the severity of apathy. Sixty drug-naive subjects took part in this study (30 apathetic and 30 nonapathetic subjects with AD). The loss of integrity in WM was compared in AD patients with and without apathy through measurement of fractional anisotropy (FA) using by tract-based spatial statistics (TBSS). In addition, we explored the correlation pattern between FA values and the severity of apathy in AD patients with apathy. The apathy group had significantly reduced FA values (p(corrected)<0.05) in the genu of the corpus callosum compared to the nonapathy group. The severity of apathy was negatively correlated with FA values of the left anterior and posterior cingulum, right superior longitudinal fasciculus, splenium, body and genu of the corpus callosum and bilateral uncinate fasciculusin the apathy group (p(corrected)<0.05). This study was the first to explore FA values in whole brain WM in AD patients with apathy. The findings of these microstructural alterations of WM may be the key to the understanding of underlying neurobiological mechanism and clinical significances of apathy in AD.	[Hahn, Changtae; Lee, Chang Uk] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Psychiat, Seoul, South Korea; [Lim, Hyun-Kook] Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Psychiat, Suwon, South Korea; [Won, Wang Yeon] Catholic Univ Korea, Coll Med, St Paul Hosp, Dept Psychiat, Seoul, South Korea; [Ahn, Kook Jin] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Radiol, Seoul, South Korea; [Jung, Won-Sang] Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Radiol, Suwon, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea	Lee, CU (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Psychiat, Seoul, South Korea.	jihan@catholic.ac.kr			Next Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ007186]; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2012R1A1A2042339]	Next Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant from the Next Generation BioGreen 21 Program (no. PJ007186), Rural Development Administration, Republic of Korea. This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A2042339). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolova LG, 2007, DEMENT GERIATR COGN, V24, P91, DOI 10.1159/000103914; Benoit M, 2011, J NEUROL SCI, V310, P58, DOI 10.1016/j.jns.2011.07.006; Bosch B, 2012, NEUROBIOL AGING, V33, P61, DOI 10.1016/j.neurobiolaging.2010.02.004; Bozzali M, 2011, CURR MED CHEM, V18, P2452, DOI 10.2174/092986711795843263; Brown RG, 2000, TRENDS NEUROSCI, V23, P412, DOI 10.1016/S0166-2236(00)01626-X; Bruen PD, 2008, BRAIN, V131, P2455, DOI 10.1093/brain/awn151; Cacciari C, 2010, J ALZHEIMERS DIS, V20, P501, DOI 10.3233/JAD-2010-1384; Castellon SA, 1998, J NEUROPSYCH CLIN N, V10, P320, DOI 10.1176/jnp.10.3.320; Chilovi BV, 2009, DEMENT GERIATR COGN, V27, P390, DOI 10.1159/000210045; Craig D, 2005, AM J GERIAT PSYCHIAT, V13, P460, DOI 10.1176/appi.ajgp.13.6.460; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008; Duan JH, 2006, SURG RADIOL ANAT, V28, P150, DOI 10.1007/s00276-006-0111-2; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Frye RE, 2010, DEV MED CHILD NEUROL, V52, P760, DOI 10.1111/j.1469-8749.2010.03633.x; Fuh JL, 2005, J NEUROL NEUROSUR PS, V76, P1337, DOI 10.1136/jnnp.2004.056408; Guimaraes HC, 2008, ARQ NEURO-PSIQUIAT, V66, P436, DOI 10.1590/S0004-282X2008000300035; Hoare J, 2010, J NEUROPSYCH CLIN N, V22, P313, DOI 10.1176/appi.neuropsych.22.3.313; Huppi PS, 2006, SEMIN FETAL NEONAT M, V11, P489, DOI 10.1016/j.siny.2006.07.006; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kang SY, 2008, NEUROLOGY, V70, P2386, DOI 10.1212/01.wnl.0000314686.94007.d0; Karlsgodt KH, 2010, J NEUROSCI, V30, P8197, DOI 10.1523/JNEUROSCI.0359-10.2010; Kim JW, 2011, AM J GERIAT PSYCHIAT, V19, P644, DOI 10.1097/JGP.0b013e31820dcc73; Landes AM, 2001, J AM GERIATR SOC, V49, P1700, DOI 10.1046/j.1532-5415.2001.49282.x; Lavretsky H, 2007, AM J GERIAT PSYCHIAT, V15, P386, DOI 10.1097/JGP.0b013e3180325a16; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Likitjaroen Y, 2012, EUR ARCH PSY CLIN N, V262, P341, DOI 10.1007/s00406-011-0234-2; Liu YW, 2011, NEUROBIOL AGING, V32, P1558, DOI 10.1016/j.neurobiolaging.2009.10.006; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; MARIN RS, 1995, J NEUROPSYCH CLIN N, V7, P23; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mendez M.F., 2010, BRAIN BEHAV INTRO BE; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Naik M, 2010, ACTA RADIOL, V51, P662, DOI 10.3109/02841851003709870; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Ota M, 2012, INT J GERIATR PSYCH, V27, P722, DOI 10.1002/gps.2779; Pacheco J, 2009, J NEUROSCI, V29, P6229, DOI 10.1523/JNEUROSCI.0896-09.2009; Palmqvist S, 2011, DEMENT GERIATR COGN, V32, P417, DOI 10.1159/000335778; Poldrack RA, 2007, SOC COGN AFFECT NEUR, V2, P67, DOI 10.1093/scan/nsm006; Reijnders JSAM, 2010, MOVEMENT DISORD, V25, P2318, DOI 10.1002/mds.23268; Reuter-Lorenz PA, 2002, IS CL CO NE, P341; Robert P, 2009, EUR PSYCHIAT, V24, P98, DOI 10.1016/j.eurpsy.2008.09.001; Robert PH, 2002, INT J GERIATR PSYCH, V17, P1099, DOI 10.1002/gps.755; Robert PH, 2010, CNS NEUROSCI THER, V16, P263, DOI 10.1111/j.1755-5949.2009.00132.x; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Starkstein SE, 2006, J NEUROL NEUROSUR PS, V77, P8, DOI 10.1136/jnnp.2005.069575; Starkstein SE, 2001, AM J PSYCHIAT, V158, P872, DOI 10.1176/appi.ajp.158.987.872; Starkstein SE, 2009, J NEUROPSYCH CLIN N, V21, P259, DOI 10.1176/appi.neuropsych.21.3.259; Stricker NH, 2009, NEUROIMAGE, V45, P10, DOI 10.1016/j.neuroimage.2008.11.027; Teipel SJ, 2011, PSYCHIAT RES-NEUROIM, V194, P363, DOI [10.1016/j.pscychresns.2011.05.012, 10.1016/j.pscychresns2011.05.012]; Torrente F, 2011, J ATTEN DISORD, V15, P545, DOI 10.1177/1087054709359887; Vogt BA, 2006, NEUROIMAGE, V29, P452, DOI 10.1016/j.neuroimage.2005.07.048; Zhuang L, 2010, NEUROIMAGE, V53, P16, DOI 10.1016/j.neuroimage.2010.05.068	55	55	56	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53493	10.1371/journal.pone.0053493	http://dx.doi.org/10.1371/journal.pone.0053493			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070BE	23301077	Green Published, Green Submitted, gold			2022-12-25	WOS:000313480000061
J	Mitschke, MM; Hoffmann, LS; Gnad, T; Scholz, D; Kruithoff, K; Mayer, P; Haas, B; Sassmann, A; Pfeifer, A; Kilic, A				Mitschke, Michaela M.; Hoffmann, Linda S.; Gnad, Thorsten; Scholz, Daniela; Kruithoff, Katja; Mayer, Peter; Haas, Bodo; Sassmann, Antonia; Pfeifer, Alexander; Kilic, Ana			Increased cGMP promotes healthy expansion and browning of white adipose tissue	FASEB JOURNAL			English	Article						beige adipocytes; adipokines; obesity	DEPENDENT PROTEIN-KINASE; MITOCHONDRIAL BIOGENESIS; INSULIN-RESISTANCE; FAT-CELL; IN-VITRO; ADIPOCYTES; ACTIVATION; INFLAMMATION; ADIPONECTIN; EXPRESSION	With more than half a billion individuals affected worldwide, obesity has reached pandemic proportions. Development of "brown-like" or "brite" adipocytes within white adipose tissue (WAT) has potential antiobesity and insulin-sensitizing effects. We investigated the role of cyclic GMP (cGMP) signaling, focusing on cGMP-dependent protein kinase I (PKGI) in WAT. PKGI is expressed in murine WAT, primary adipocytes, and 3T3-L1. Treatment of adipocytes with cGMP resulted in increased adipogenesis, with a 54% increase in expression of peroxisome proliferator-activated receptor-gamma. Lentiviral overexpression of PKGI further increased adipogenesis, whereas loss of PKGI significantly reduced adipogenic differentiation. In addition to adipogenic effects, PKGI had an antihypertrophic and anti-inflammatory effect via RhoA phosphorylation and reduction of proinflammatory adipokine expression. Moreover, PKGI induced a 4.3-fold increase in abundance of UCP-1 and the development of a brown-like thermogenic program in primary adipocytes. Notably, treatment of C57BL/6 mice with phosphodiesterase inhibitor sildenafil (12 mg/kg/d) for 7 d caused 4.6-fold increase in uncoupling protein-1 expression and promoted establishment of a brown fat cell-like phenotype ("browning") of WAT in vivo. Taken together, PKGI is a key regulator of cell size, adipokine secretion and browning of white fat depots and thus could be a valuable target in developing novel treatments for obesity.-Mitschke, M. M., Hoffmann, L. S., Gnad, T., Scholz, D., Kruithoff, K., Mayer, P., Haas, B., Sassmann, A., Alexander Pfeifer, A., Kilic, A. Increased cGMP promotes healthy expansion and browning of white adipose tissue. FASEB J. 27, 1621-1630 (2013). www.fasebj.org	[Mitschke, Michaela M.; Hoffmann, Linda S.; Gnad, Thorsten; Scholz, Daniela; Kruithoff, Katja; Haas, Bodo; Pfeifer, Alexander; Kilic, Ana] Univ Bonn, Inst Pharmacol & Toxicol, D-53105 Bonn, Germany; [Pfeifer, Alexander] Univ Bonn, Pharma Ctr, D-53105 Bonn, Germany; [Mayer, Peter; Haas, Bodo] Fed Inst Drugs & Med Devices, Bonn, Germany; [Sassmann, Antonia] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany	University of Bonn; University of Bonn; Max Planck Society	Pfeifer, A (corresponding author), Univ Bonn, Inst Pharmacol & Toxicol, Biomed Ctr, Sigmund Freud Str 25, D-53105 Bonn, Germany.	alexander.pfeifer@uni-bonn.de	Mayer, Peter/HHS-1373-2022	Haas, Bodo/0000-0002-1213-3527	Deutsche Forschungsgemeinschaft (DFG); Forschungskommission der Medizinischen Fakultat der Universitat Bonn (BONFOR)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Forschungskommission der Medizinischen Fakultat der Universitat Bonn (BONFOR)	This work was supported by the Deutsche Forschungsgemeinschaft (DFG). The authors are grateful to Prof. Stefan Offermanns (Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany) for the Adipoq creER(T)<SUP>2</SUP> mice. A. K. and L. S. H. are supported by the Forschungskommission der Medizinischen Fakultat der Universitat Bonn (BONFOR). The authors declare no conflicts of interest.	Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Ayala JE, 2007, DIABETES, V56, P1025, DOI 10.2337/db06-0883; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Burkhardt M, 2000, J BIOL CHEM, V275, P33536, DOI 10.1074/jbc.M005670200; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chen BY, 2011, J ENDOCRINOL INVEST, V34, P742, DOI 10.3275/7727; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FORTE LR, 1992, AM J PHYSIOL, V263, pC607, DOI 10.1152/ajpcell.1992.263.3.C607; Francis S. H., 2011, PHARMACOL REV, V62, P525; Francis SH, 2011, HANDB EXP PHARMACOL, V204, P47, DOI [10.1007/978-3-642-17969-3_2, 10.1007/978-3-642-13443-2_4]; Frontini A, 2010, CELL METAB, V11, P253, DOI 10.1016/j.cmet.2010.03.004; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Haas B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000511; Hara Y, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001227; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; Hofmann Franz, 2009, V191, P137, DOI 10.1007/978-3-540-68964-5_8; Ishii-Yonemoto T, 2010, AM J PHYSIOL-ENDOC M, V298, pE930, DOI 10.1152/ajpendo.00320.2009; Jennissen K, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002867; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Karastergiou K, 2010, MOL CELL ENDOCRINOL, V318, P69, DOI 10.1016/j.mce.2009.11.011; Katafuchi T, 2010, PEPTIDES, V31, P1906, DOI 10.1016/j.peptides.2010.06.025; Kiskinis E, 2007, EMBO J, V26, P4831, DOI 10.1038/sj.emboj.7601908; Koh EH, 2010, AM J PHYSIOL-ENDOC M, V298, pE846, DOI 10.1152/ajpendo.00008.2010; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Leiss V, 2011, DIABETES, V60, P148, DOI 10.2337/db10-0595; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Lutz SZ, 2011, DIABETES, V60, P1566, DOI 10.2337/db10-0760; Miyashita K, 2009, DIABETES, V58, P2880, DOI 10.2337/db09-0393; Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007; Nikolic D. M., 2010, OBESITY SILVER SPRIN, V19, P784; Nishikimi T, 2009, REGUL PEPTIDES, V153, P56, DOI 10.1016/j.regpep.2008.10.010; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Noguchi M, 2007, J BIOL CHEM, V282, P29574, DOI 10.1074/jbc.M705972200; Nozaki M, 2007, BIOCHEM BIOPH RES CO, V364, P33, DOI 10.1016/j.bbrc.2007.09.084; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Pfeifer A, 1999, Rev Physiol Biochem Pharmacol, V135, P105, DOI 10.1007/BFb0033671; Pfeifer A, 2001, P NATL ACAD SCI USA, V98, P11450, DOI 10.1073/pnas.201415498; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; Sassmann A, 2010, GENESIS, V48, P618, DOI 10.1002/dvg.20665; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Sawada N, 2001, BIOCHEM BIOPH RES CO, V280, P798, DOI 10.1006/bbrc.2000.4194; Schlossmann Jens, 2009, V191, P163, DOI 10.1007/978-3-540-68964-5_9; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Shen WL, 2011, BRIT J PHARMACOL, V162, P1213, DOI 10.1111/j.1476-5381.2010.01134.x; Shore A, 2010, DIABETOLOGIA, V53, P1164, DOI 10.1007/s00125-010-1701-4; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tateya S, 2011, DIABETES, V60, P2792, DOI 10.2337/db11-0255; Valtcheva N, 2009, J BIOL CHEM, V284, P556, DOI 10.1074/jbc.M806161200; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Zhang XD, 2010, BIOCHEM BIOPH RES CO, V396, P1054, DOI 10.1016/j.bbrc.2010.05.064	56	100	103	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2013	27	4					1621	1630		10.1096/fj.12-221580	http://dx.doi.org/10.1096/fj.12-221580			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23303211				2022-12-25	WOS:000316940800032
J	Doshi, R; Ali, A; Shi, W; Freeman, EV; Fagg, LA; van Veen, HW				Doshi, Rupak; Ali, Anam; Shi, Wilma; Freeman, Elizabeth V.; Fagg, Lisa A.; van Veen, Hendrik W.			Molecular Disruption of the Power Stroke in the ATP-binding Cassette Transport Protein MsbA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG ABC TRANSPORTER; ESCHERICHIA-COLI MSBA; ALTERNATING ACCESS; P-GLYCOPROTEIN; RESISTANCE; DOMAINS; COMPLEX; ENERGY; SWITCH; CYCLE	ATP-binding cassette transporters affect drug pharmacokinetics and are associated with inherited human diseases and impaired chemotherapeutic treatment of cancers and microbial infections. Current alternating access models for ATP-binding cassette exporter activity suggest that ATP binding at the two cytosolic nucleotide-binding domains provides a power stroke for the conformational switch of the two membrane domains from the inward-facing conformation to the outward-facing conformation. In outward-facing crystal structures of the bacterial homodimeric ATP-binding cassette transporters MsbA from Gram-negative bacteria and Sav1866 from Staphylococcus aureus, two transmembrane helices (3 and 4) in the membrane domains have their cytoplasmic extensions in close proximity, forming a tetrahelix bundle interface. In biochemical experiments on MsbA from Escherichia coli, we show for the first time that a robust network of inter-monomer interactions in the tetrahelix bundle is crucial for the transmission of nucleotide-dependent conformational changes to the extracellular side of the membrane domains. Our observations are the first to suggest that modulation of tetrahelix bundle interactions in ATP-binding cassette exporters might offer a potent strategy to alter their transport activity.	[Doshi, Rupak; Ali, Anam; Shi, Wilma; Freeman, Elizabeth V.; Fagg, Lisa A.; van Veen, Hendrik W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Cambridge	van Veen, HW (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	hwv20@cam.ac.uk	van Veen, Hendrik W./A-4162-2008	van Veen, Hendrik W./0000-0002-9658-8077	Biotechnology and Biological Sciences Research Council; Cambridge Commonwealth and Overseas Trust; Charter Studentship; Croucher Foundation; Biotechnology and Biological Sciences Research Council [BB/I002383/1] Funding Source: researchfish; BBSRC [BB/I002383/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cambridge Commonwealth and Overseas Trust; Charter Studentship; Croucher Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council. Recipient of Cambridge Commonwealth and Overseas Trust scholarships and the Charter Studentship. Recipient of a scholarship from the Croucher Foundation.	Aittoniemi J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000762; Borbat PP, 2007, PLOS BIOL, V5, P2211, DOI 10.1371/journal.pbio.0050271; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dean M, 2001, J BIOENERG BIOMEMBR, V33, P475, DOI 10.1023/A:1012823120935; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Doerrler WT, 2001, J BIOL CHEM, V276, P11461, DOI 10.1074/jbc.C100091200; Doshi R, 2011, BIOCHEM SOC T, V39, P807, DOI 10.1042/BST0390807; Doshi R, 2010, PROTEINS, V78, P2867, DOI 10.1002/prot.22813; Eckford PDW, 2008, J BIOL CHEM, V283, P12840, DOI 10.1074/jbc.M708274200; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gutmann DAP, 2010, TRENDS BIOCHEM SCI, V35, P36, DOI 10.1016/j.tibs.2009.07.009; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Loo TW, 2010, BIOCHEM BIOPH RES CO, V395, P436, DOI 10.1016/j.bbrc.2010.04.057; Marquez B, 2011, CURR DRUG TARGETS, V12, P600, DOI 10.2174/138945011795378504; McDevitt CA, 2008, FEBS J, V275, P4354, DOI 10.1111/j.1742-4658.2008.06578.x; Mehmood S, 2012, P NATL ACAD SCI USA, V109, P10832, DOI 10.1073/pnas.1204067109; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Oancea G, 2009, P NATL ACAD SCI USA, V106, P5551, DOI 10.1073/pnas.0811260106; Reuter G, 2003, J BIOL CHEM, V278, P35193, DOI 10.1074/jbc.M306226200; Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615; Sauna ZE, 2007, MOL CANCER THER, V6, P13, DOI 10.1158/1535-7163.MCT-06-0155; Schaedler TA, 2012, J BIOL CHEM, V287, P27682, DOI 10.1074/jbc.M112.372334; Seeger MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037845; Seeger MA, 2009, BBA-PROTEINS PROTEOM, V1794, P725, DOI 10.1016/j.bbapap.2008.12.004; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Velamakanni S, 2008, BIOCHEMISTRY-US, V47, P9300, DOI 10.1021/bi8006737; Venter H, 2008, BIOCHEM PHARMACOL, V75, P866, DOI 10.1016/j.bcp.2007.10.022; Vigano C, 2002, FEBS LETT, V530, P197, DOI 10.1016/S0014-5793(02)03485-3; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Ward A, 2009, J STRUCT BIOL, V165, P169, DOI 10.1016/j.jsb.2008.11.006; Weng JW, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.056432; Woebking B, 2005, J BACTERIOL, V187, P6363, DOI 10.1128/JB.187.18.6363-6369.2005; Woebking B, 2008, BIOCHEMISTRY-US, V47, P10904, DOI 10.1021/bi800778d; Zhou ZM, 1998, J BIOL CHEM, V273, P12466, DOI 10.1074/jbc.273.20.12466; Zolnerciks JK, 2007, FASEB J, V21, P3937, DOI 10.1096/fj.07-8610com; Zou P, 2009, J MOL BIOL, V393, P574, DOI 10.1016/j.jmb.2009.08.051	39	31	32	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6801	6813		10.1074/jbc.M112.430074	http://dx.doi.org/10.1074/jbc.M112.430074			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23306205	Green Published, hybrid			2022-12-25	WOS:000316002400003
J	Wang, HY; He, LF; Ma, F; Regan, MM; Balk, SP; Richardson, AL; Yuan, X				Wang, Hongyun; He, Lingfeng; Ma, Fen; Regan, Meredith M.; Balk, Steven P.; Richardson, Andrea L.; Yuan, Xin			SOX9 Regulates Low Density Lipoprotein Receptor-related Protein 6 (LRP6) and T-cell Factor 4 (TCF4) Expression and Wnt/beta-catenin Activation in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY STEM-CELLS; AUTOSOMAL SEX REVERSAL; SRY-RELATED GENE; BETA-CATENIN; CHONDROCYTE DIFFERENTIATION; INTESTINAL EPITHELIUM; CAMPOMELIC DYSPLASIA; TRANSCRIPTION FACTOR; GLAND DEVELOPMENT; WNT PROTEINS	Gene expression profiling has identified breast cancer (BCa) subtypes, including an aggressive basal-like (BL) subtype. The molecular signals underlying the behavior observed in BL-BCa group are largely unknown, although recent results indicate a prevalent increase in Wnt/beta-catenin activity. Our immunohistochemistry study confirmed that SOX9, one of the BL-BCa signature genes, was expressed by most BL-BCa, and its expression correlated with indicators of poor prognosis. Importantly, BCa gene expression profiling strongly associated SOX9 with the expression of Wnt/beta-catenin pathway components, LRP6 and TCF4. In cancer cell lines, SOX9 silencing reduced cell proliferation and invasion, LRP6 and TCF4 transcription, and decreased Wnt/beta-catenin activation. SOX9 expression was also increased by Wnt, indicating that SOX9 is at the center of a positive feedback loop that enhances Wnt/beta-catenin signaling. Consistently, SOX9 overexpression in BCa cell lines and transgenic SOX9 expression in breast epithelium caused increased LRP6 and TCF4 expression and Wnt/beta-catenin activation. These results identify SOX9-mediated Wnt/beta-catenin activation as one of the molecular mechanisms underlying aberrant Wnt/beta-catenin activity in BCa, especially in the BL-BCa subgroup.	[Wang, Hongyun; He, Lingfeng; Ma, Fen; Balk, Steven P.; Yuan, Xin] Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Dept Med, Boston, MA 02215 USA; [Regan, Meredith M.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Richardson, Andrea L.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Richardson, AL (corresponding author), Dana Farber Canc Inst, 450 Brookline Ave,Smith 936A, Boston, MA 02215 USA.	arichardson@partners.org; xyuan@bidmc.harvard.edu			National Institutes of Health [R01 DK079962]; Dana-Farber/Harvard SPORE in Prostate Cancer Grant [P50 CA 090381]; Dana-Farber/Harvard SPORE in Breast Cancer Grant [CA089393]; Breast Cancer Research Foundation; Department of Defense [W81XWH-08-1-0160]; NATIONAL CANCER INSTITUTE [P50CA090381, P50CA089393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana-Farber/Harvard SPORE in Prostate Cancer Grant; Dana-Farber/Harvard SPORE in Breast Cancer Grant; Breast Cancer Research Foundation; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R01 DK079962 (to X. Y.); the Dana-Farber/Harvard SPORE in Prostate Cancer Grant P50 CA 090381 (to S. P. B.) and Dana-Farber/Harvard SPORE in Breast Cancer Grant CA089393 (to A. L. R.), the Breast Cancer Research Foundation (to A. L. R.), and Department of Defense Postdoctoral Award W81XWH-08-1-0160 (to H. W.).	Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Blache P, 2004, J CELL BIOL, V166, P37, DOI 10.1083/jcb.200311021; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Brisken C, 2000, GENE DEV, V14, P650; BUHLER TA, 1993, DEV BIOL, V155, P87, DOI 10.1006/dbio.1993.1009; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; de Crombrugghe B, 2000, MATRIX BIOL, V19, P389, DOI 10.1016/S0945-053X(00)00094-9; De Santa Barbara P, 1998, MOL CELL BIOL, V18, P6653, DOI 10.1128/MCB.18.11.6653; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; GAVIN BJ, 1992, MOL CELL BIOL, V12, P2418, DOI 10.1128/MCB.12.5.2418; Geyer FC, 2011, MODERN PATHOL, V24, P209, DOI 10.1038/modpathol.2010.205; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Hatsell S, 2003, J MAMMARY GLAND BIOL, V8, P145, DOI 10.1023/A:1025944723047; Hennighausen L, 1995, J CELL BIOCHEM, V59, P463, DOI 10.1002/jcb.240590407; Imbert A, 2001, J CELL BIOL, V153, P555, DOI 10.1083/jcb.153.3.555; Jonsson M, 2000, EUR J CANCER, V36, P242, DOI 10.1016/S0959-8049(99)00276-2; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; Kouros-Mehr H, 2006, DEV DYNAM, V235, P3404, DOI 10.1002/dvdy.20978; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Lindvall C, 2006, J BIOL CHEM, V281, P35081, DOI 10.1074/jbc.M607571200; Lindvall C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005813; Liu CC, 2010, P NATL ACAD SCI USA, V107, P5136, DOI 10.1073/pnas.0911220107; Lu XS, 2008, BREAST CANCER RES TR, V108, P191, DOI 10.1007/s10549-007-9596-6; Matros E, 2005, BREAST CANCER RES TR, V91, P179, DOI 10.1007/s10549-004-7603-8; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; Muller P, 2010, BREAST CANCER RES TR, V120, P317, DOI 10.1007/s10549-009-0381-6; Nakopoulou L, 2006, MODERN PATHOL, V19, P556, DOI 10.1038/modpathol.3800562; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Polakis P, 2000, GENE DEV, V14, P1837; Rakha E, 2009, ARCH PATHOL LAB MED, V133, P860, DOI 10.1043/1543-2165-133.6.860; Roarty K, 2010, CURR OPIN PHARMACOL, V10, P643, DOI 10.1016/j.coph.2010.07.004; Rother K, 2004, ONCOGENE, V23, P3376, DOI 10.1038/sj.onc.1207464; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Schlosshauer PW, 2000, CARCINOGENESIS, V21, P1453, DOI 10.1093/carcin/21.7.1453; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Topol LL, 2009, J BIOL CHEM, V284, P3323, DOI 10.1074/jbc.M808048200; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Wang H, 2008, CANCER RES, V68, P1625, DOI 10.1158/0008-5472.CAN-07-5915; Wang HY, 2007, CANCER RES, V67, P528, DOI 10.1158/0008-5472.CAN-06-1672; Wang ZGC, 2004, CANCER RES, V64, P64, DOI 10.1158/0008-5472.CAN-03-2570; WEBERHALL SJ, 1994, DIFFERENTIATION, V57, P205, DOI 10.1046/j.1432-0436.1994.5730205.x; Yang L, 2011, ONCOGENE, V30, P4437, DOI 10.1038/onc.2011.145; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zhang J, 2010, ONCOGENE, V29, P539, DOI 10.1038/onc.2009.339; Zhou G, 1998, J BIOL CHEM, V273, P14989, DOI 10.1074/jbc.273.24.14989	60	52	56	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6478	6487		10.1074/jbc.M112.419184	http://dx.doi.org/10.1074/jbc.M112.419184			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23306204	hybrid, Green Published			2022-12-25	WOS:000315820700041
J	Ripple, MO; Kim, N; Springett, R				Ripple, Maureen O.; Kim, Namjoon; Springett, Roger			Mammalian Complex I Pumps 4 Protons per 2 Electrons at High and Physiological Proton Motive Force in Living Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; OXIDATIVE-PHOSPHORYLATION; RESPIRATORY-CHAIN; BC(1) COMPLEX; STOICHIOMETRY; MEMBRANE; GRADIENT; NADH; TRANSLOCATION; METABOLISM	Mitochondrial complex I couples electron transfer between matrix NADH and inner-membrane ubiquinone to the pumping of protons against a proton motive force. The accepted proton pumping stoichiometry was 4 protons per 2 electrons transferred (4H(+)/2e(-)) but it has been suggested that stoichiometry may be 3H(+)/2e(-) based on the identification of only 3 proton pumping units in the crystal structure and a revision of the previous experimental data. Measurement of proton pumping stoichiometry is challenging because, even in isolated mitochondria, it is difficult to measure the proton motive force while simultaneously measuring the redox potentials of the NADH/NAD(+) and ubiquinol/ubiquinone pools. Here we employ a new method to quantify the proton motive force in living cells from the redox poise of the bc(1) complex measured using multiwavelength cell spectroscopy and show that the correct stoichiometry for complex I is 4H(+)/2e(-) in mouse and human cells at high and physiological proton motive force.	[Ripple, Maureen O.; Kim, Namjoon; Springett, Roger] Geisel Sch Med Dartmouth, Dept Radiol, Hanover, NH 03755 USA	Dartmouth College	Springett, R (corresponding author), Geisel Sch Med Dartmouth, Dept Radiol, Remsen 319, Hanover, NH 03755 USA.	RSpringett@Dartmouth.edu	Springett, Roger/P-2274-2019		National Institutes of Health [5R21RR25803, R01NS054298]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054298] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by Grants 5R21RR25803 and R01NS054298 from the National Institutes of Health.	Belevich G, 2011, MOL MICROBIOL, V82, P1086, DOI 10.1111/j.1365-2958.2011.07883.x; BROWN GC, 1985, BIOCHEM J, V225, P399, DOI 10.1042/bj2250399; BROWN GC, 1988, BIOCHEM J, V252, P473, DOI 10.1042/bj2520473; Chen RM, 2004, J BIOL CHEM, V279, P26036, DOI 10.1074/jbc.M402710200; COSTA LE, 1984, J BIOL CHEM, V259, P4802; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DEJONGE PC, 1982, BIOCHEM J, V204, P515, DOI 10.1042/bj2040515; Dzbek J, 2008, J BIOL CHEM, V283, P33232, DOI 10.1074/jbc.M802404200; Efremov RG, 2012, BBA-BIOENERGETICS, V1817, P1785, DOI 10.1016/j.bbabio.2012.02.015; Efremov RG, 2011, CURR OPIN STRUC BIOL, V21, P532, DOI 10.1016/j.sbi.2011.07.002; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; FORMAN NG, 1982, J BIOL CHEM, V257, P2908; Gerencser AA, 2012, J PHYSIOL-LONDON, V590, P2845, DOI 10.1113/jphysiol.2012.228387; HALLER T, 1994, ANAL BIOCHEM, V218, P338, DOI 10.1006/abio.1994.1188; HINKLE PC, 1991, BIOCHEMISTRY-US, V30, P3576, DOI 10.1021/bi00228a031; Hirst J, 2010, BIOCHEM J, V425, P327, DOI 10.1042/BJ20091382; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Kim N, 2012, BIOPHYS J, V102, P1194, DOI 10.1016/j.bpj.2012.02.003; Kim N, 2011, BBA-BIOENERGETICS, V1807, P779, DOI 10.1016/j.bbabio.2011.03.008; MOREADITH RW, 1984, J BIOL CHEM, V259, P6215; Moser CC, 2006, BBA-BIOENERGETICS, V1757, P1096, DOI 10.1016/j.bbabio.2006.04.015; MURAOKA S, 1969, BIOCHIM BIOPHYS ACTA, V180, P227, DOI 10.1016/0005-2728(69)90109-1; NICHOLLS DG, 1974, EUR J BIOCHEM, V50, P305, DOI 10.1111/j.1432-1033.1974.tb03899.x; Papa S, 2002, J BIOENERG BIOMEMBR, V34, P1, DOI 10.1023/A:1013863018115; Ransac S, 2008, BBA-BIOENERGETICS, V1777, P1053, DOI 10.1016/j.bbabio.2008.05.003; Ransac S, 2012, BBA-BIOENERGETICS, V1817, P1958, DOI 10.1016/j.bbabio.2012.03.037; Schilling B, 2005, MOL CELL PROTEOMICS, V4, P84, DOI 10.1074/mcp.M400143-MCP200; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shinkarev VP, 2001, BIOCHEMISTRY-US, V40, P12584, DOI 10.1021/bi011334j; VILLALOBO A, 1984, ARCH BIOCHEM BIOPHYS, V233, P417, DOI 10.1016/0003-9861(84)90463-6; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Wikstrom M, 2012, P NATL ACAD SCI USA, V109, P4431, DOI 10.1073/pnas.1120949109; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003	34	42	42	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5374	5380		10.1074/jbc.M112.438945	http://dx.doi.org/10.1074/jbc.M112.438945			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23306206	Green Published, hybrid			2022-12-25	WOS:000315342500012
J	Palstra, AP; Beltran, S; Burgerhout, E; Brittijn, SA; Magnoni, LJ; Henkel, CV; Jansen, HJ; van den Thillart, GEEJM; Spaink, HP; Planas, JV				Palstra, Arjan P.; Beltran, Sergi; Burgerhout, Erik; Brittijn, Sebastiaan A.; Magnoni, Leonardo J.; Henkel, Christiaan V.; Jansen, Hans J.; van den Thillart, Guido E. E. J. M.; Spaink, Herman P.; Planas, Josep V.			Deep RNA Sequencing of the Skeletal Muscle Transcriptome in Swimming Fish	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; RAINBOW-TROUT; GROWTH-HORMONE; LUTEINIZING-HORMONE; PROFILING ANALYSIS; ANDROGEN RECEPTOR; IN-VITRO; EXPRESSION; DIFFERENTIATION; PATHWAY	Deep RNA sequencing (RNA-seq) was performed to provide an in-depth view of the transcriptome of red and white skeletal muscle of exercised and non-exercised rainbow trout (Oncorhynchus mykiss) with the specific objective to identify expressed genes and quantify the transcriptomic effects of swimming-induced exercise. Pubertal autumn-spawning seawater-raised female rainbow trout were rested (n = 10) or swum (n = 10) for 1176 km at 0.75 body-lengths per second in a 6,000-L swim-flume under reproductive conditions for 40 days. Red and white muscle RNA of exercised and non-exercised fish (4 lanes) was sequenced and resulted in 15-17 million reads per lane that, after de novo assembly, yielded 149,159 red and 118,572 white muscle contigs. Most contigs were annotated using an iterative homology search strategy against salmonid ESTs, the zebrafish Danio rerio genome and general Metazoan genes. When selecting for large contigs (>500 nucleotides), a number of novel rainbow trout gene sequences were identified in this study: 1,085 and 1,228 novel gene sequences for red and white muscle, respectively, which included a number of important molecules for skeletal muscle function. Transcriptomic analysis revealed that sustained swimming increased transcriptional activity in skeletal muscle and specifically an up-regulation of genes involved in muscle growth and developmental processes in white muscle. The unique collection of transcripts will contribute to our understanding of red and white muscle physiology, specifically during the long-term reproductive migration of salmonids.	[Palstra, Arjan P.; Magnoni, Leonardo J.; Planas, Josep V.] Univ Barcelona, Fac Biol, Dept Fisiol & Immunol, Barcelona, Spain; [Palstra, Arjan P.; Magnoni, Leonardo J.; Planas, Josep V.] Univ Barcelona, Inst Biomed, Barcelona, Spain; [Beltran, Sergi] Univ Barcelona, Ctr Cient & Tecnol CCiT UB, Unitat Bioinformat, Barcelona, Spain; [Burgerhout, Erik; Brittijn, Sebastiaan A.; van den Thillart, Guido E. E. J. M.; Spaink, Herman P.] Leiden Univ IBL, Inst Biol, Sylvius Lab, Leiden, Netherlands; [Burgerhout, Erik; Brittijn, Sebastiaan A.; Henkel, Christiaan V.; Jansen, Hans J.; van den Thillart, Guido E. E. J. M.; Spaink, Herman P.] ZF Screens, Leiden, Netherlands	University of Barcelona; University of Barcelona; University of Barcelona; Leiden University; Leiden University - Excl LUMC	Palstra, AP (corresponding author), Wageningen UR, Inst Marine Resources & Ecosyst Studies IMARES, Yerseke, Netherlands.	arjan.palstra@wur.nl	Beltran, Sergi/I-3408-2015; Spaink, Herman P./S-3586-2017; Magnoni, Leonardo Julián/A-6275-2011; Burgerhout, Erik/AAI-4527-2020	Beltran, Sergi/0000-0002-2810-3445; Spaink, Herman P./0000-0003-4128-9501; Magnoni, Leonardo Julián/0000-0001-8449-6071; Jansen, Hans/0000-0002-8563-4146; Henkel, Christiaan/0000-0001-9838-8215; Planas, Josep/0000-0002-6525-9617	Ministerio de Ciencia e Innovacion, Spain [AGL2009-07006, CSD2007-0002]; European Commission (REPRO-SWIM) [219971]; European Commission (Glucose Use In Fish) [235581]	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Commission (REPRO-SWIM)(European CommissionEuropean Commission Joint Research Centre); European Commission (Glucose Use In Fish)	This study was supported by grants from the Ministerio de Ciencia e Innovacion, Spain (AGL2009-07006 and CSD2007-0002) to JVP. APP was supported by a Marie Curie Intra-European Fellowship from the European Commission (REPRO-SWIM) with Grant Agreement number 219971. LJM was supported by a Marie Curie International Incoming Fellowship from the European Commission (Glucose Use In Fish) with Grant Agreement number 235581. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong DD, 2005, AM J PHYSIOL-CELL PH, V289, pC853, DOI 10.1152/ajpcell.00093.2005; Ayalon G, 2008, CELL, V135, P1189, DOI 10.1016/j.cell.2008.10.018; Bluthgen Nils, 2005, Genome Inform, V16, P106; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; CHEN XR, 1995, J BIOL CHEM, V270, P18285, DOI 10.1074/jbc.270.31.18285; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conte C, 2009, NUCLEIC ACIDS RES, V37, P5267, DOI 10.1093/nar/gkp550; Coppe A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-635; Cossu G, 1999, EMBO J, V18, P6867, DOI 10.1093/emboj/18.24.6867; Cowling BS, 2008, J CELL BIOL, V183, P1033, DOI 10.1083/jcb.200804077; Duan CM, 2010, GEN COMP ENDOCR, V167, P344, DOI 10.1016/j.ygcen.2010.04.009; Filby AL, 2008, BIOL REPROD, V78, P278, DOI 10.1095/biolreprod.107.063420; Gottsch ML, 2006, MOL CELL ENDOCRINOL, V254, P91, DOI 10.1016/j.mce.2006.04.030; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gundersen K, 2011, BIOL REV, V86, P564, DOI 10.1111/j.1469-185X.2010.00161.x; Gutierrez-Pascual E, 2007, J NEUROENDOCRINOL, V19, P521, DOI 10.1111/j.1365-2826.2007.01558.x; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Hopitzan AA, 2006, MOL BIOL EVOL, V23, P46, DOI 10.1093/molbev/msj004; Hunt LC, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-17; Ibrahim RM, 2008, J ANIM SCI, V86, P1426, DOI 10.2527/jas.2007-0618; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Johnston IA, 2011, J EXP BIOL, V214, P1617, DOI 10.1242/jeb.038620; Klover P, 2009, FASEB J, V23, P3140, DOI 10.1096/fj.08-128215; Lee SJ, 2010, MOL ENDOCRINOL, V24, P1998, DOI 10.1210/me.2010-0127; Lin J, 2009, INT J BIOCHEM CELL B, V41, P1613, DOI 10.1016/j.biocel.2009.02.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magnoni LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031219; McCarthy DJ, 2009, BIOINFORMATICS, V25, P765, DOI 10.1093/bioinformatics/btp053; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miller KM, 2011, SCIENCE, V331, P214, DOI 10.1126/science.1196901; Mommsen Thomas W., 2001, Fish Physiology, V18, P251; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mu YN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-506; NAGAHAMA Y, 1994, INT J DEV BIOL, V38, P217; Namiki M, 1997, J BIOL CHEM, V272, P22046, DOI 10.1074/jbc.272.35.22046; Norbeck LA, 2011, GEN COMP ENDOCR, V173, P270, DOI 10.1016/j.ygcen.2011.06.009; Ordas A, 2011, FISH SHELLFISH IMMUN, V31, P716, DOI 10.1016/j.fsi.2010.08.022; Palstra AP, 2011, FISH PHYSIOL BIOCHEM, V37, P259, DOI 10.1007/s10695-011-9505-0; Palstra AP, 2010, AM J PHYSIOL-REG I, V299, pR486, DOI 10.1152/ajpregu.00109.2010; Palstra AP, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-27; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Planas JV, 2000, BIOL REPROD, V62, P1262, DOI 10.1095/biolreprod62.5.1262; Salem M, 2006, PHYSIOL GENOMICS, V28, P33, DOI 10.1152/physiolgenomics.00114.2006; Salem M, 2006, COMP BIOCHEM PHYS D, V1, P227, DOI 10.1016/j.cbd.2005.12.003; Siriett V, 2006, J CELL PHYSIOL, V206, P255, DOI 10.1002/jcp.20456; Ting HJ, 2002, P NATL ACAD SCI USA, V99, P661, DOI 10.1073/pnas.022469899; TYLER CR, 1991, GEN COMP ENDOCR, V84, P291, DOI 10.1016/0016-6480(91)90052-8; Ueda H, 2011, GEN COMP ENDOCR, V170, P222, DOI 10.1016/j.ygcen.2010.02.003; van Aerle R, 2008, PEPTIDES, V29, P57, DOI 10.1016/j.peptides.2007.10.018; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Videler JJ, 1993, FISH SWIMMING, P254; Vraskou Y, 2011, AM J PHYSIOL-REG I, V300, pR716, DOI 10.1152/ajpregu.00514.2010; Wang H, 2005, GENE, V356, P91, DOI 10.1016/j.gene.2005.03.041; Wang KP, 2008, J BIOL CHEM, V283, P34029, DOI 10.1074/jbc.M803012200; Wang LL, 2010, STEROIDS, V75, P368, DOI 10.1016/j.steroids.2010.01.021; Wilson EM, 2006, J BIOL CHEM, V281, P29962, DOI 10.1074/jbc.M605445200; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; YAMAGUCHI A, 1995, SEMIN CELL BIOL, V6, P165, DOI 10.1006/scel.1995.0023	60	49	50	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53171	10.1371/journal.pone.0053171	http://dx.doi.org/10.1371/journal.pone.0053171			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308156	Green Published, gold			2022-12-25	WOS:000313429800031
J	Veerasamy, M; Phanish, M; Dockrell, MEC				Veerasamy, Mangalakumar; Phanish, Mysore; Dockrell, Mark E. C.			Smad Mediated Regulation of Inhibitor of DNA Binding 2 and Its Role in Phenotypic Maintenance of Human Renal Proximal Tubule Epithelial Cells	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; LOOP-HELIX PROTEINS; TRANSCRIPTION FACTORS; E-CADHERIN; IN-VITRO; FIBROSIS; EXPRESSION; GROWTH; BMP-7; FIBROBLASTS	The basic-Helix-Loop-Helix family (bHLH) of transcriptional factors plays a major role in regulating cellular proliferation, differentiation and phenotype maintenance. The downregulation of one of the members of bHLH family protein, inhibitor of DNA binding 2 (Id2) has been shown to induce de-differentiation of epithelial cells. Opposing regulators of epithelial/mesenchymal phenotype in renal proximal tubule epithelial cells (PTEC), TGF beta 1 and BMP7 also have counter-regulatory effects in models of renal fibrosis. We investigated the regulation of Id2 by these growth factors in human PTECs and its implication in the expression of markers of epithelial versus myofibroblastic phenotype. Cellular Id2 levels were reduced by TGF beta 1 treatment; this was prevented by co-incubation with BMP7. BMP7 alone increased cellular levels of Id2. TGF beta 1 and BMP7 regulated Id2 through Smad2/3 and Smad1/5 dependent mechanisms respectively. TGF beta 1 mediated Id2 suppression was essential for alpha-SMA induction in PTECs. Although Id2 over-expression prevented alpha-SMA induction, it did not prevent E-cadherin loss under the influence of TGF beta 1. This suggests that the loss of gate keeper function of E-cadherin alone may not necessarily result in complete EMT and further transcriptional re-programming is essential to attain mesenchymal phenotype. Although BMP7 abolished TGF beta 1 mediated alpha-SMA expression by restoring Id2 levels, the loss of Id2 was not sufficient to induce alpha-SMA expression even in the context of reduced E-cadherin expression. Hence, a reduction in Id2 is critical for TGF beta 1-induced alpha-SMA expression in this model of human PTECs but is not sufficient in it self to induce alpha-SMA even in the context of reduced E-cadherin.	[Veerasamy, Mangalakumar; Phanish, Mysore; Dockrell, Mark E. C.] St Helier Univ Hosp NHS Trust, S W Thames Inst Renal Res, Carshalton, Surrey, England		Veerasamy, M (corresponding author), St Helier Univ Hosp NHS Trust, S W Thames Inst Renal Res, Carshalton, Surrey, England.	vmangalakumar1@hotmail.com		phanish, mysore/0000-0001-8402-8286; Dockrell, Mark/0000-0003-3771-4464	Southwest Thames Kidney Fund; Genzyme Renal Innovations Program (GRIP)	Southwest Thames Kidney Fund; Genzyme Renal Innovations Program (GRIP)(Sanofi-AventisGenzyme Corporation)	This study was supported by grants from Southwest Thames Kidney Fund and the Genzyme Renal Innovations Program (GRIP). The funders had no role in experimental design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atchley WR, 1997, P NATL ACAD SCI USA, V94, P5172, DOI 10.1073/pnas.94.10.5172; Cao Y, 2009, ONCOGENE, V28, P1089, DOI 10.1038/onc.2008.456; Duband JL, 1995, ACTA ANAT, V154, P63; Dudas PL, 2009, NEPHROL DIAL TRANSPL, V24, P1406, DOI 10.1093/ndt/gfn662; FESTING MFW, 1994, LAB ANIM, V28, P212, DOI 10.1258/002367794780681697; HAY ED, 1995, AM J KIDNEY DIS, V26, P678, DOI 10.1016/0272-6386(95)90610-X; Humphreys BD, AM J PATHOL, V176, P85; IAVARONE A, 1994, GENE DEV, V8, P1270, DOI 10.1101/gad.8.11.1270; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jorda M, 2007, EXP CELL RES, V313, P2389, DOI 10.1016/j.yexcr.2007.04.001; Kaimori A, 2007, J BIOL CHEM, V282, P22089, DOI 10.1074/jbc.M700998200; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kinoshita K, 2007, GUT, V56, P706, DOI 10.1136/gut.2006.092460; Kondo M, 2004, CELL DEATH DIFFER, V11, P1092, DOI 10.1038/sj.cdd.4401467; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Kumar MS, 2003, CIRC RES, V92, P840, DOI 10.1161/01.RES.0000069031.55281.7C; Langlands K, 1997, J BIOL CHEM, V272, P19785, DOI 10.1074/jbc.272.32.19785; Li YJ, 2007, J AM SOC NEPHROL, V18, P449, DOI 10.1681/ASN.2006030236; Li YJ, 2003, J CLIN INVEST, V112, P503, DOI 10.1172/JCI200317913; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Motazed R, 2008, PHARM RES-DORDR, V25, P2440, DOI 10.1007/s11095-008-9551-1; Niculescu-Duvaz I, 2007, NEPHRON EXP NEPHROL, V105, pE108, DOI 10.1159/000100492; Nigten J, 2005, LEUKEMIA, V19, P799, DOI 10.1038/sj.leu.2403699; Norton JD, 2000, J CELL SCI, V113, P3897; Parrinello S, 2001, J BIOL CHEM, V276, P39213, DOI 10.1074/jbc.M104473200; Peinado H, 2004, J CELL SCI, V117, P2827, DOI 10.1242/jcs.01145; Perez-Moreno MA, 2001, J BIOL CHEM, V276, P27424, DOI 10.1074/jbc.M100827200; Phanish MK, 2005, NEPHRON EXP NEPHROL, V100, pE156, DOI 10.1159/000085445; Phanish MK, 2006, BIOCHEM J, V393, P601, DOI 10.1042/BJ20051106; Racusen LC, 1997, J LAB CLIN MED, V129, P318, DOI 10.1016/S0022-2143(97)90180-3; Rastaldi MP, 2002, KIDNEY INT, V62, P137, DOI 10.1046/j.1523-1755.2002.00430.x; Saika S, 2006, AM J PHYSIOL-CELL PH, V290, pC282, DOI 10.1152/ajpcell.00306.2005; SANDERS EJ, 1989, J CELL SCI, V92, P497; Savagner P, 2005, J CELL PHYSIOL, V202, P858, DOI 10.1002/jcp.20188; Veerasamy M, 2009, AM J PHYSIOL-RENAL, V297, pF1238, DOI 10.1152/ajprenal.90539.2008; Vongwiwatana A, 2005, AM J TRANSPLANT, V5, P1367, DOI 10.1111/j.1600-6143.2005.00843.x; Vukicevic S, 1998, J CLIN INVEST, V102, P202, DOI 10.1172/JCI2237; Wang SN, 2006, J AM SOC NEPHROL, V17, P2504, DOI 10.1681/ASN.2006030278; Wang SN, 2003, AM J PHYSIOL-RENAL, V284, pF1006, DOI 10.1152/ajprenal.00382.2002; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zeisberg M, 2005, J BIOL CHEM, V280, P8094, DOI 10.1074/jbc.M413102200; Zeisberg M, 2003, AM J PHYSIOL-RENAL, V285, pF1060, DOI 10.1152/ajprenal.00191.2002; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888	45	19	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e51842	10.1371/journal.pone.0051842	http://dx.doi.org/10.1371/journal.pone.0051842			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320068	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429800010
J	Wheway, J; Obeid, S; Couraud, PO; Combes, V; Grau, GER				Wheway, Julie; Obeid, Stephanie; Couraud, Pierre-Olivier; Combes, Valery; Grau, Georges E. R.			The Brain Microvascular Endothelium Supports T Cell Proliferation and Has Potential for Alloantigen Presentation	PLOS ONE			English	Article							ANTIGEN PRESENTATION; CEREBRAL MALARIA; DENDRITIC CELLS; IN-VITRO; EXPRESSION; PATHOGENESIS; STIMULATION; ACTIVATION; INDUCTION; MOLECULES	Endothelial cells (EC) form the inner lining of blood vessels and are positioned between circulating lymphocytes and tissues. Hypotheses have formed that EC may act as antigen presenting cells based on the intimate interactions with T cells, which are seen in diseases like multiple sclerosis, cerebral malaria (CM) and viral neuropathologies. Here, we investigated how human brain microvascular EC (HBEC) interact with and support the proliferation of T cells. We found HBEC to express MHC II, CD40 and ICOSL, key molecules for antigen presentation and co-stimulation and to take up fluorescently labeled antigens via macropinocytosis. In co-cultures, we showed that HBEC support and promote the proliferation of CD4(+) and CD8(+) T cells, which both are key in CM pathogenesis, particularly following T cell receptor activation and co-stimulation. Our findings provide novel evidence that HBEC can trigger T cell activation, thereby providing a novel mechanism for neuroimmunological complications of infectious diseases.	[Wheway, Julie; Obeid, Stephanie; Combes, Valery; Grau, Georges E. R.] Univ Sydney, Sydney Med Sch, Discipline Pathol, Camperdown, NSW, Australia; [Couraud, Pierre-Olivier] Inst Cochin, Inst Natl Sante & Rech Med, U1016, Paris, France; [Couraud, Pierre-Olivier] CNRS, Unite Mixte Rech 8104, Paris, France; [Couraud, Pierre-Olivier] Univ Paris 05, Paris, France	University of Sydney; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Wheway, J (corresponding author), Univ Sydney, Sydney Med Sch, Discipline Pathol, Camperdown, NSW, Australia.	julie.wheway@sydney.edu.au	Grau, Georges/AGR-7139-2022	Grau, Georges/0000-0002-0442-0462; Combes, Valery/0000-0003-2178-3596	National Health and Medical Research Council of Australia [1009914, 571014, 1028241, 1022368, 571397]; Rebecca L. Cooper Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Rebecca L. Cooper Foundation	The study was funded by the National Health and Medical Research Council of Australia (http://www.nhmrc.gov.au/) project grants 1009914 and 571014 to VC and GEG; 1028241 to JW, VC and GEG; and 1022368 to GEG; fellowship 571397 to JW. Support was also provided through Rebecca L. Cooper Foundation equipment grants (http://www.cooperfoundation.org.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JI, 2009, AM J PATHOL, V175, P685, DOI 10.2353/ajpath.2009.081073; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Biedermann BC, 1999, J IMMUNOL, V162, P7022; BOURDOULOUS S, 1995, EUR J IMMUNOL, V25, P1176, DOI 10.1002/eji.1830250507; BURGER DR, 1981, HUM IMMUNOL, V3, P209, DOI 10.1016/0198-8859(81)90019-7; CHIZZOLINI C, 1990, CLIN EXP IMMUNOL, V79, P95, DOI 10.1111/j.1365-2249.1990.tb05133.x; Cohen JN, 2010, J EXP MED, V207, P681, DOI 10.1084/jem.20092465; Combes V, 2004, JAMA-J AM MED ASSOC, V291, P2542, DOI 10.1001/jama.291.21.2542-b; Coureuil M, 2010, CELL, V143, P1149, DOI 10.1016/j.cell.2010.11.035; Coureuil M, 2009, SCIENCE, V325, P83, DOI 10.1126/science.1173196; GRAU GE, 1986, J IMMUNOL, V137, P2348; HAUSS P, 1995, EUR J IMMUNOL, V25, P2285, DOI 10.1002/eji.1830250826; Hirayasu K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002565; HIRSCHBERG H, 1981, SCAND J IMMUNOL, V14, P545; HIRSCHBERG H, 1981, HUM IMMUNOL, V2, P235, DOI 10.1016/0198-8859(81)90015-X; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Jambou R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001021; Khayyamian S, 2002, P NATL ACAD SCI USA, V99, P6198, DOI 10.1073/pnas.092576699; Klingenberg R, 2005, EUR J IMMUNOL, V35, P1712, DOI 10.1002/eji.200425727; Knolle PA, 1998, CLIN EXP IMMUNOL, V114, P427; Lichtman A., 2007, ENDOTHELIAL BIOMEDIC, P1098; Limmer A, 2000, NAT MED, V6, P1348, DOI 10.1038/82161; Lohse AW, 1996, GASTROENTEROLOGY, V110, P1175, DOI 10.1053/gast.1996.v110.pm8613007; Lou J, 1996, EUR J IMMUNOL, V26, P3107, DOI 10.1002/eji.1830261242; Lou JN, 1997, AM J PATHOL, V151, P1397; MALE D, 1989, J NEUROIMMUNOL, V21, P87, DOI 10.1016/0165-5728(89)90163-X; MALE DK, 1987, IMMUNOLOGY, V60, P453; Manes TD, 2008, J IMMUNOL, V180, P8386, DOI 10.4049/jimmunol.180.12.8386; MonsoHinard C, 1997, IMMUNOLOGY, V92, P53, DOI 10.1046/j.1365-2567.1997.00297.x; MURRAY AG, 1995, J IMMUNOL, V154, P151; Omari KM, 2003, J NEUROIMMUNOL, V134, P166, DOI 10.1016/S0165-5728(02)00423-X; Perez VL, 1998, CELL IMMUNOL, V189, P31, DOI 10.1006/cimm.1998.1362; Pober JS, 1999, IMMUNOL RES, V19, P225, DOI 10.1007/BF02786490; POBER JS, 1982, P NATL ACAD SCI-BIOL, V79, P6641, DOI 10.1073/pnas.79.21.6641; REYNOLDS DJ, 1990, INFECT IMMUN, V58, P3208, DOI 10.1128/IAI.58.10.3208-3216.1990; Rodig N, 2003, EUR J IMMUNOL, V33, P3117, DOI 10.1002/eji.200324270; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Schonbeck U, 2001, CELL MOL LIFE SCI, V58, P4, DOI 10.1007/PL00000776; SHERMAN LA, 1993, ANNU REV IMMUNOL, V11, P385, DOI 10.1146/annurev.immunol.11.1.385; Trickett A, 2003, J IMMUNOL METHODS, V275, P251, DOI 10.1016/S0022-1759(03)00010-3; TURNER RR, 1987, AM J CLIN PATHOL, V87, P569, DOI 10.1093/ajcp/87.5.569; Verma S, 2006, BRAIN BEHAV IMMUN, V20, P449, DOI 10.1016/j.bbi.2005.10.005; Wang XS, 2007, J INTERF CYTOK RES, V27, P329, DOI 10.1089/jir.2006.0154; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582	46	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e52586	10.1371/journal.pone.0052586	http://dx.doi.org/10.1371/journal.pone.0052586			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320074	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429800016
J	Yoneda, T; Kameyama, K; Esumi, K; Daimyo, Y; Watanabe, M; Hata, Y				Yoneda, Taisuke; Kameyama, Katsuro; Esumi, Kazusa; Daimyo, Yohei; Watanabe, Masahiko; Hata, Yoshio			Developmental and Visual Input-Dependent Regulation of the CB1 Cannabinoid Receptor in the Mouse Visual Cortex	PLOS ONE			English	Article							RAT BARREL CORTEX; CRITICAL-PERIOD; SYNAPTIC-TRANSMISSION; GABAERGIC TRANSMISSION; MONOCULAR DEPRIVATION; SOMATOSENSORY CORTEX; CORTICAL CIRCUITS; OCULAR DOMINANCE; DIFFERENT LAYERS; YOUNG MICE	The mammalian visual system exhibits significant experience-induced plasticity in the early postnatal period. While physiological studies have revealed the contribution of the CB1 cannabinoid receptor (CB1) to developmental plasticity in the primary visual cortex (V1), it remains unknown whether the expression and localization of CB1 is regulated during development or by visual experience. To explore a possible role of the endocannabinoid system in visual cortical plasticity, we examined the expression of CB1 in the visual cortex of mice. We found intense CB1 immunoreactivity in layers II/III and VI. CB1 mainly localized at vesicular GABA transporter-positive inhibitory nerve terminals. The amount of CB1 protein increased throughout development, and the specific laminar pattern of CB1 appeared at P20 and remained until adulthood. Dark rearing from birth to P30 decreased the amount of CB1 protein in V1 and altered the synaptic localization of CB1 in the deep layer. Dark rearing until P50, however, did not influence the expression of CB1. Brief monocular deprivation for 2 days upregulated the localization of CB1 at inhibitory nerve terminals in the deep layer. Taken together, the expression and the localization of CB1 are developmentally regulated, and both parameters are influenced by visual experience.	[Yoneda, Taisuke; Kameyama, Katsuro; Esumi, Kazusa; Hata, Yoshio] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Div Integrat Biosci, Yonago, Tottori, Japan; [Daimyo, Yohei; Hata, Yoshio] Tottori Univ, Fac Med, Sch Life Sci, Div Neurobiol, Yonago, Tottori 683, Japan; [Watanabe, Masahiko] Hokkaido Univ, Grad Sch Med, Dept Anat, Sapporo, Hokkaido, Japan	Tottori University; Tottori University; Hokkaido University	Hata, Y (corresponding author), Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Div Integrat Biosci, Yonago, Tottori, Japan.	yhata@med.tottori-u.ac.jp	WATANABE, Masahiko/A-4055-2012; Watanabe, Masahiko/S-3614-2019	WATANABE, Masahiko/0000-0001-5037-7138; Watanabe, Masahiko/0000-0001-5037-7138	Ministry of Education, Culture, Sports, Science and Technology of Japan [22115010];  [10J06736]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas - Mesoscopic Neurocircuitry - from the Ministry of Education, Culture, Sports, Science and Technology of Japan (22115010 to YH) and a Grant-in-Aid for JSPS Research Fellows (10J06736 to TY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodor AL, 2005, J NEUROSCI, V25, P6845, DOI 10.1523/JNEUROSCI.0442-05.2005; Chaves GP, 2008, J NEUROSCI RES, V86, P1626, DOI 10.1002/jnr.21613; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Crozier RA, 2007, P NATL ACAD SCI USA, V104, P1383, DOI 10.1073/pnas.0609596104; Dahlhaus M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005413; Dasilva MA, 2012, PSYCHOPHARMACOLOGY, V219, P835, DOI 10.1007/s00213-011-2412-3; Deshmukh S, 2007, NEUROSCIENCE, V145, P279, DOI 10.1016/j.neuroscience.2006.11.033; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; FOX K, 1992, J NEUROSCI, V12, P1826; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Fukudome Y, 2004, EUR J NEUROSCI, V19, P2682, DOI 10.1111/j.0953-816X.2004.03384.x; Gianfranceschi L, 2003, P NATL ACAD SCI USA, V100, P12486, DOI 10.1073/pnas.1934836100; Gordon JA, 1996, J NEUROSCI, V16, P3274; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hill EL, 2007, J NEUROPHYSIOL, V97, P2580, DOI 10.1152/jn.00603.2006; Huang Y, 2008, J NEUROSCI, V28, P7074, DOI 10.1523/JNEUROSCI.0899-08.2008; Jiang B, 2010, J NEUROSCI, V30, P14261, DOI 10.1523/JNEUROSCI.2979-10.2010; Jiang B, 2010, NEURON, V66, P248, DOI 10.1016/j.neuron.2010.03.021; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Katona I, 1999, J NEUROSCI, V19, P4544; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Liu CH, 2008, NEURON, V58, P340, DOI 10.1016/j.neuron.2008.02.020; Lyckman AW, 2008, P NATL ACAD SCI USA, V105, P9409, DOI 10.1073/pnas.0710172105; Majdan M, 2006, NAT NEUROSCI, V9, P650, DOI 10.1038/nn1674; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; MOWER GD, 1991, DEV BRAIN RES, V58, P151, DOI 10.1016/0165-3806(91)90001-Y; Olsen SR, 2012, NATURE, V483, P47, DOI 10.1038/nature10835; OLSON CR, 1980, EXP BRAIN RES, V39, P17; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; Tropea D, 2006, NAT NEUROSCI, V9, P660, DOI 10.1038/nn1689; Uchigashima M, 2007, J NEUROSCI, V27, P3663, DOI 10.1523/JNEUROSCI.0448-07.2007; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003	35	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53082	10.1371/journal.pone.0053082	http://dx.doi.org/10.1371/journal.pone.0053082			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308141	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429800028
J	Birbach, A				Birbach, Andreas			Use of PB-Cre4 Mice for Mosaic Gene Deletion	PLOS ONE			English	Article							METASTATIC PROSTATE-CANCER; MOUSE PROSTATE; TRANSGENIC ANIMALS; SMOOTH-MUSCLE; MODEL; LEADS; PTEN; EXPRESSION; RECOMBINATION; INACTIVATION	Transgene expression from short promoters in transgenic animals can lead to unwanted transgene expression patterns, often as a byproduct of random integration of the expression cassette into the host genome. Here I demonstrate that the often used PB-Cre4 line (also referred to as "Probasin-Cre''), although expressing exclusively in the male prostate epithelium when transmitted through male mice, can lead to recombination of loxP-flanked alleles in a large variety of tissues when transmitted through female mice. This aberrant Cre activity due to Cre expression in the oocytes leads to different outcomes for maternally or paternally transmitted loxP-flanked alleles: Maternally inherited loxP-flanked alleles undergo recombination very efficiently, making female PB-Cre4 mice an efficient monoallelic "Cre deleter line''. However, paternally inherited loxP-flanked alleles are inefficiently recombined by maternal PB-Cre4, giving rise to mosaic expression patterns in the offspring. This mosaic recombination is difficult to detect with standard genotyping approaches of many mouse lines and should therefore caution researchers using PB-Cre4 to use additional approaches to exclude the presence of recombined alleles. However, mosaic recombination should also be useful in transgenic "knockout'' approaches for mosaic gene deletion experiments.	Med Univ Vienna, Dept Vasc Biol, Ctr Physiol & Pharmacol, Vienna, Austria	Medical University of Vienna	Birbach, A (corresponding author), Med Univ Vienna, Dept Vasc Biol, Ctr Physiol & Pharmacol, Vienna, Austria.	andreas.birbach@gmail.com			Austrian Science Fund FWF [P21919-B13]; Austrian Science Fund (FWF) [P 21919] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was funded by a grant from the Austrian Science Fund FWF (project # P21919-B13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birbach A, 2011, NEOPLASIA, V13, P692, DOI 10.1593/neo.11524; Birbach A, 2009, GENESIS, V47, P757, DOI 10.1002/dvg.20558; Bruxvoort KJ, 2007, CANCER RES, V67, P2490, DOI 10.1158/0008-5472.CAN-06-3028; Francis JC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000995; Giraldo P, 2001, TRANSGENIC RES, V10, P83, DOI 10.1023/A:1008918913249; Houdebine LM, 2002, J BIOTECHNOL, V98, P145, DOI 10.1016/S0168-1656(02)00129-3; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Kelavkar UP, 2006, NEOPLASIA, V8, P510, DOI 10.1593/neo.06202; Ma XQ, 2005, CANCER RES, V65, P5730, DOI 10.1158/0008-5472.CAN-04-4519; Maddison LA, 2004, CANCER RES, V64, P6018, DOI 10.1158/0008-5472.CAN-03-2509; Pearson HB, 2009, CANCER RES, V69, P94, DOI 10.1158/0008-5472.CAN-08-2895; Ratnacaram CK, 2008, P NATL ACAD SCI USA, V105, P2521, DOI 10.1073/pnas.0712021105; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wu XY, 2011, DEV BIOL, V356, P337, DOI 10.1016/j.ydbio.2011.05.659; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Zhang JF, 2000, ENDOCRINOLOGY, V141, P4698, DOI 10.1210/en.141.12.4698; Zhou ZX, 2006, CANCER RES, V66, P7889, DOI 10.1158/0008-5472.CAN-06-0486	20	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53501	10.1371/journal.pone.0053501	http://dx.doi.org/10.1371/journal.pone.0053501			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308238	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429100076
J	den Reijer, PM; Lemmens-den Toom, N; Kant, S; Snijders, SV; Boelens, H; Tavakol, M; Verkaik, NJ; van Belkum, A; Verbrugh, HA; van Wamel, WJB				den Reijer, Paul Martijn; Lemmens-den Toom, Nicole; Kant, Samantha; Snijders, Susan V.; Boelens, Helene; Tavakol, Mehri; Verkaik, Nelianne J.; van Belkum, Alex; Verbrugh, Henri A.; van Wamel, Willem J. B.			Characterization of the Humoral Immune Response during Staphylococcus aureus Bacteremia and Global Gene Expression by Staphylococcus aureus in Human Blood	PLOS ONE			English	Article							GAMMA-HEMOLYSIN; METHICILLIN RESISTANCE; ANTIBODY-RESPONSES; STREAM INFECTIONS; RISK-FACTORS; ENDOCARDITIS; LEUKOCIDIN; PROTEIN; SUPERANTIGENS; HETEROGENEITY	Attempts to develop an efficient anti-staphylococcal vaccine in humans have so far been unsuccessful. Therefore, more knowledge of the antigens that are expressed by Staphylococcus aureus in human blood and induce an immune response in patients is required. In this study we further characterize the serial levels of IgG and IgA antibodies against 56 staphylococcal antigens in multiple serum samples of 21 patients with a S. aureus bacteremia, compare peak IgG levels between patients and 30 non-infected controls, and analyze the expression of 3626 genes by two genetically distinct isolates in human blood. The serum antibody levels were measured using a bead-based flow cytometry technique (xMAPH (R), Luminex corporation). Gene expression levels were analyzed using a microarray (B mu G@s microarray). The initial levels and time taken to reach peak IgG and IgA antibody levels were heterogeneous in bacteremia patients. The antigen SA0688 was associated with the highest median initial-to-peak antibody fold-increase for IgG (5.05-fold) and the second highest increase for IgA (2.07-fold). Peak IgG levels against 27 antigens, including the antigen SA0688, were significantly elevated in bacteremia patients versus controls (P <= 0.05). Expression of diverse genes, including SA0688, was ubiquitously high in both isolates at all time points during incubation in blood. However, only a limited number of genes were specifically up-or downregulated in both isolates when cultured in blood, compared to the start of incubation in blood or during incubation in BHI broth. In conclusion, most staphylococcal antigens tested in this study, including many known virulence factors, do not induce uniform increases in the antibody levels in bacteremia patients. In addition, the expression of these antigens by S. aureus is not significantly altered by incubation in human blood over time. One immunogenic and ubiquitously expressed antigen is the putative iron-regulated ABC transporter SA0688.	[den Reijer, Paul Martijn; Lemmens-den Toom, Nicole; Kant, Samantha; Snijders, Susan V.; Boelens, Helene; Tavakol, Mehri; Verkaik, Nelianne J.; van Belkum, Alex; Verbrugh, Henri A.; van Wamel, Willem J. B.] Erasmus Univ, Med Ctr Rotterdam, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	den Reijer, PM (corresponding author), Erasmus Univ, Med Ctr Rotterdam, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.	p.denreijer@erasmusmc.nl		van Wamel, Willem/0000-0001-9145-9121; Verkaik, Nelianne/0000-0003-2351-2669	department of Medical Microbiology and Infectious Diseases of the Erasmus University Medical Center Rotterdam	department of Medical Microbiology and Infectious Diseases of the Erasmus University Medical Center Rotterdam	The work presented in this paper has been funded internally by the department of Medical Microbiology and Infectious Diseases of the Erasmus University Medical Center Rotterdam. No external funds were acquired for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Brady RA, 2011, INFECT IMMUN, V79, P1797, DOI 10.1128/IAI.00451-10; Chang FY, 2003, MEDICINE, V82, P322, DOI 10.1097/01.md.0000091185.93122.40; Chung MC, 2007, MOL MICROBIOL, V66, P1342, DOI 10.1111/j.1365-2958.2007.05989.x; de Haas CJC, 2004, J EXP MED, V199, P687, DOI 10.1084/jem.20031636; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Dryla A, 2005, CLIN DIAGN LAB IMMUN, V12, P387, DOI 10.1128/CDLI.12.3.387-398.2005; El-Ahdab F, 2005, AM J MED, V118, P225, DOI 10.1016/j.amjmed.2004.12.017; Fowler VG, 2003, ARCH INTERN MED, V163, P2066, DOI 10.1001/archinte.163.17.2066; Gouaux E, 1997, PROTEIN SCI, V6, P2631; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Holtfreter S, 2006, J INFECT DIS, V193, P1275, DOI 10.1086/503048; Holtfreter S, 2010, INT J MED MICROBIOL, V300, P176, DOI 10.1016/j.ijmm.2009.10.002; Jacobsson G, 2010, EUR J CLIN MICROBIOL, V29, P715, DOI 10.1007/s10096-010-0919-x; KAMIO Y, 1993, FEBS LETT, V321, P15, DOI 10.1016/0014-5793(93)80611-W; Kolata J, PROTEOMICS, V11, P3914; Koning S, 2003, J CLIN MICROBIOL, V41, P3017, DOI 10.1128/JCM.41.7.3017-3021.2003; Laupland KB, 2008, J INFECT DIS, V198, P336, DOI 10.1086/589717; LAUTENSCHLAGER S, 1993, CLIN INFECT DIS, V16, P567, DOI 10.1093/clind/16.4.567; Malachowa N, PLOS ONE, V6; Martins TB, 2006, J IMMUNOL METHODS, V316, P97, DOI 10.1016/j.jim.2006.08.007; Otto M, 2010, EXPERT OPIN BIOL TH, V10, P1049, DOI 10.1517/14712598.2010.495115; Piddock LJ, LANCET INFECT DIS; PITTET D, 1995, ARCH INTERN MED, V155, P1177, DOI 10.1001/archinte.155.11.1177; Prat C, 2006, J IMMUNOL, V177, P8017, DOI 10.4049/jimmunol.177.11.8017; Prat C, 2009, J IMMUNOL, V183, P6569, DOI 10.4049/jimmunol.0801523; PREVOST G, 1995, INFECT IMMUN, V63, P4121; Proctor R, VACCINE; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; Sakoulas G, 2008, CLIN INFECT DIS, V46, pS360, DOI 10.1086/533592; Shannon O, 2005, THROMB HAEMOSTASIS, V93, P927, DOI 10.1160/TH04-08-0501; Smith TL, 1999, NEW ENGL J MED, V340, P493, DOI 10.1056/NEJM199902183400701; Spellberg B, SEMIN IMMUNOPATHOL; Thomas D, 2009, INFECT IMMUN, V77, P2043, DOI 10.1128/IAI.01388-08; van Belkum A, 2009, J INFECT DIS, V199, P1820, DOI 10.1086/599119; Verkaik NJ, 2010, EUR J CLIN MICROBIOL, V29, P509, DOI 10.1007/s10096-010-0888-0; Verkaik N, 2008, J IMMUNOL METHODS, V335, P121, DOI 10.1016/j.jim.2008.02.022; Verkaik NJ, 2010, CLIN INFECT DIS, V50, P61, DOI 10.1086/648673; Verkaik NJ, 2009, J INFECT DIS, V199, P625, DOI 10.1086/596743; Verkaik NJ, IMMUNOTHERAPY, V3, P1063; Vytvytska O, 2002, PROTEOMICS, V2, P580, DOI 10.1002/1615-9861(200205)2:5<580::AID-PROT580>3.0.CO;2-G; Wang A, 2007, JAMA-J AM MED ASSOC, V297, P1354, DOI 10.1001/jama.297.12.1354; Wayne P, 2006, M100S116 CLSI; Witney AA, 2005, APPL ENVIRON MICROB, V71, P7504, DOI 10.1128/AEM.71.11.7504-7514.2005; Ziebandt AK, 2010, PROTEOMICS, V10, P1634, DOI 10.1002/pmic.200900313	45	62	62	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53391	10.1371/journal.pone.0053391	http://dx.doi.org/10.1371/journal.pone.0053391			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308212	Green Published, gold, Green Submitted			2022-12-25	WOS:000313429100062
J	Farias, ME; Rascovan, N; Toneatti, DM; Albarracin, VH; Flores, MR; Poire, DG; Collavino, MM; Aguilar, OM; Vazquez, MP; Polerecky, L				Farias, Maria E.; Rascovan, Nicolas; Toneatti, Diego M.; Albarracin, Virginia H.; Flores, Maria R.; Poire, Daniel G.; Collavino, Monica M.; Mario Aguilar, O.; Vazquez, Martin P.; Polerecky, Lubos			The Discovery of Stromatolites Developing at 3570 m above Sea Level in a High-Altitude Volcanic Lake Socompa, Argentinean Andes	PLOS ONE			English	Article							MODERN MARINE STROMATOLITES; AMMONIA-OXIDIZING ARCHAEA; MICROBIAL COMMUNITIES; CUATRO-CIENEGAS; SILICEOUS STROMATOLITES; BACTERIAL DIVERSITY; GUERRERO-NEGRO; ATACAMA DESERT; HIGHBORNE CAY; SEDIMENTS	We describe stromatolites forming at an altitude of 3570 m at the shore of a volcanic lake Socompa, Argentinean Andes. The water at the site of stromatolites formation is alkaline, hypersaline, rich in inorganic nutrients, very rich in arsenic, and warm (20-24 degrees C) due to a hydrothermal input. The stromatolites do not lithify, but form broad, rounded and low-domed bioherms dominated by diatom frustules and aragonite micro-crystals agglutinated by extracellular substances. In comparison to other modern stromatolites, they harbour an atypical microbial community characterized by highly abundant representatives of Deinococcus-Thermus, Rhodobacteraceae, Desulfobacterales and Spirochaetes. Additionally, a high proportion of the sequences that could not be classified at phylum level showed less than 80% identity to the best hit in the NCBI database, suggesting the presence of novel distant lineages. The primary production in the stromatolites is generally high and likely dominated by Microcoleus sp. Through negative phototaxis, the location of these cyanobacteria in the stromatolites is controlled by UV light, which greatly influences their photosynthetic activity. Diatoms, dominated by Amphora sp., are abundant in the anoxic, sulfidic and essentially dark parts of the stromatolites. Although their origin in the stromatolites is unclear, they are possibly an important source of anaerobically degraded organic matter that induces in situ aragonite precipitation. To the best of our knowledge, this is so far the highest altitude with documented actively forming stromatolites. Their generally rich, diverse and to a large extent novel microbial community likely harbours valuable genetic and proteomic reserves, and thus deserves active protection. Furthermore, since the stromatolites flourish in an environment characterized by a multitude of extremes, including high exposure to UV radiation, they can be an excellent model system for studying microbial adaptations under conditions that, at least in part, resemble those during the early phase of life evolution on Earth.	[Farias, Maria E.; Toneatti, Diego M.; Albarracin, Virginia H.; Flores, Maria R.] Consejo Nacl Invest Cient & Tecn, CCT, Planta Piloto Proc Ind Microbiol PROIMI, LIMLA, San Miguel De Tucuman, Tucuman, Argentina; [Rascovan, Nicolas; Vazquez, Martin P.] Inst Agrobiotecnol Rosario INDEAR, Rosario, Santa Fe, Argentina; [Albarracin, Virginia H.] Univ Nacl Tucuman, Fac Ciencias Nat, RA-4000 San Miguel De Tucuman, Tucuman, Argentina; [Albarracin, Virginia H.] Univ Nacl Tucuman, Inst Miguel Lillo, RA-4000 San Miguel De Tucuman, Tucuman, Argentina; [Albarracin, Virginia H.] Max Planck Inst Chem Energy Convers, Mulheim, Germany; [Poire, Daniel G.] Univ Nacl La Plata CONICET, Ctr Invest Geol, La Plata, Buenos Aires, Argentina; [Collavino, Monica M.; Mario Aguilar, O.] Univ Nacl La Plata CONICET, IBBM, La Plata, Buenos Aires, Argentina; [Polerecky, Lubos] Max Planck Inst Marine Microbiol, Bremen, Germany	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de Tucuman; Miguel Lillo Foundation; Universidad Nacional de Tucuman; Max Planck Society; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Max Planck Society	Farias, ME (corresponding author), Consejo Nacl Invest Cient & Tecn, CCT, Planta Piloto Proc Ind Microbiol PROIMI, LIMLA, San Miguel De Tucuman, Tucuman, Argentina.	mefarias2009@gmail.com; lpolerec@mpi-bremen.de	Rascovan, Nicolás/Q-4531-2018; Polerecky, Lubos/E-1134-2014; Albarracín, Virginia Helena/AAO-7847-2020	Rascovan, Nicolás/0000-0002-2129-5878; Polerecky, Lubos/0000-0003-4425-585X; Poire, Daniel G./0000-0003-0966-122X; Farias, Maria Eugenia/0000-0002-2771-8915; Albarracin, Virginia/0000-0002-4316-0720; Collavino, Monica Mariana/0000-0003-4534-2015	Tolar Grande municipality; Argentinean National Council for Science and Technology (CONICET); Argentinean National Fund for Science and Technology (FONCyT) [PICT 1788-1221]; Deutscher Akademischer Austauschdienst (DAAD); Marie Curie fellowship; Max-Planck Society; Biomaris	Tolar Grande municipality; Argentinean National Council for Science and Technology (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Argentinean National Fund for Science and Technology (FONCyT); Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Marie Curie fellowship(European Commission); Max-Planck Society(Max Planck SocietyFoundation CELLEX); Biomaris	We thank the Tolar Grande municipality and people, especially Cacique Sr Cruz, and the members of the Gendarmeria National stationed at the Socompa frontier, for their support during the field campaign, and Veronica Lopez Agosti, Julia Arrouy, Jan Hadidom, Mohammad Al-Najjar, Soledad Cuello and Maria Ines Isla for their indispensable help during the field campaign and in the laboratory. We also thank two anonymous reviewers whose comments helped improve the manuscript.; This work was supported by the Argentinean National Council for Science and Technology (CONICET); Argentinean National Fund for Science and Technology (FONCyT; project number PICT 1788-1221); Deutscher Akademischer Austauschdienst (DAAD); Marie Curie fellowship; the Max-Planck Society; and Biomaris 2010 prize. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Najjar MAA, 2010, ISME J, V4, P440, DOI 10.1038/ismej.2009.121; Allwood AC, 2006, NATURE, V441, P714, DOI 10.1038/nature04764; AWRAMIK SM, 1971, SCIENCE, V174, P825, DOI 10.1126/science.174.4011.825; Baumgartner LK, 2009, ENVIRON MICROBIOL, V11, P2710, DOI 10.1111/j.1462-2920.2009.01998.x; BEBOUT BM, 1995, APPL ENVIRON MICROB, V61, P4215, DOI 10.1128/AEM.61.12.4215-4222.1995; Berelson WM, 2011, GEOBIOLOGY, V9, P411, DOI 10.1111/j.1472-4669.2011.00288.x; Berlanga M, 2009, INT MICROBIOL, V11, P267, DOI 10.2436/20.1501.01.71; BORREGO CM, 1994, PHOTOSYNTH RES, V41, P157, DOI 10.1007/BF02184156; Braissant O, 2010, BIOFILM FORMATION DE; Breitbart M, 2009, ENVIRON MICROBIOL, V11, P16, DOI 10.1111/j.1462-2920.2008.01725.x; BURNE R V, 1987, Palaios, V2, P241, DOI 10.2307/3514674; Burns JA, 2002, MICROBIAL ECOL, V44, P336, DOI 10.1007/s00248-002-1000-9; CABRERA S, 1995, J PHOTOCH PHOTOBIO B, V28, P137, DOI 10.1016/1011-1344(94)07103-U; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chennu A, 2011, INT S TROPH SIGN MIC; Choi JS, 1999, PHOTOCHEM PHOTOBIOL, V70, P95; Costello EK, 2009, APPL ENVIRON MICROB, V75, P735, DOI 10.1128/AEM.01469-08; de Beer D, 1997, LIMNOL OCEANOGR, V42, P1590, DOI 10.4319/lo.1997.42.7.1590; Decho AW, 2010, ECOL ENG, V36, P137, DOI 10.1016/j.ecoleng.2009.01.003; Demergasso C, 2004, FEMS MICROBIOL ECOL, V48, P57, DOI 10.1016/j.femsec.2003.12.013; Dorador C, 2010, FEMS MICROBIOL ECOL, V73, P291, DOI 10.1111/j.1574-6941.2010.00891.x; Dorador C, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000837; DRAVIS JJ, 1983, SCIENCE, V219, P385, DOI 10.1126/science.219.4583.385; Dupraz C, 2005, TRENDS MICROBIOL, V13, P429, DOI 10.1016/j.tim.2005.07.008; Dupraz C, 2009, EARTH-SCI REV, V96, P141, DOI 10.1016/j.earscirev.2008.10.005; Emelyanov VV, 2003, EUR J BIOCHEM, V270, P1599, DOI 10.1046/j.1432-1033.2003.03499.x; Farias ME, 2011, CELL ORIG LIFE EXTRE, V18, P431; Falcon LI, 2007, MICROB ECOL, V54, P363, DOI 10.1007/s00248-007-9240-3; Foster JS, 2011, CELL ORIG LIFE EXTRE, V18, P385; Foster JS, 2009, ISME J, V3, P573, DOI 10.1038/ismej.2008.129; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Futuyma DJ, 2005, NAT HIST, V114, P64; GARCIA HE, 1992, LIMNOL OCEANOGR, V37, P1307, DOI 10.4319/lo.1992.37.6.1307; GARRETT P, 1970, SCIENCE, V169, P171, DOI 10.1126/science.169.3941.171; Garrity G., 2005, BERGEYS MANUAL SYSTE; Goh F, 2009, ISME J, V3, P383, DOI 10.1038/ismej.2008.114; Gramain A, 2011, ENVIRON MICROBIOL, V13, P2105, DOI 10.1111/j.1462-2920.2011.02435.x; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; HALLOY S, 1991, ARCTIC ALPINE RES, V23, P247, DOI 10.2307/1551602; Hoffman P, 1976, STROMATOLITES, V20, P261, DOI DOI 10.1016/S0070-4571(08)71139-7; Holland H. D., 1994, EARLY LIFE EARTH, V84, P237; Houston J, 2003, INT J CLIMATOL, V23, P1453, DOI 10.1002/joc.938; Hu AY, 2010, FRESHWATER BIOL, V55, P2375, DOI 10.1111/j.1365-2427.2010.02454.x; Ionescu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038319; Jones B, 2005, SEDIMENTOLOGY, V52, P1229, DOI 10.1111/j.1365-3091.2005.00739.x; Junier P, 2008, FEMS MICROBIOL ECOL, V64, P141, DOI 10.1111/j.1574-6941.2007.00437.x; Kamp A, 2011, P NATL ACAD SCI USA, V108, P5649, DOI 10.1073/pnas.1015744108; Kano A., 2005, J GEOLOGICAL SOC JAP, V111, P751, DOI [10.5575/geosoc.111.751, DOI 10.5575/GEOSOC.111.751]; Kasting JF, 1991, PALAEOGEOGR PALAEOCL, V97, P125, DOI 10.1016/0031-0182(91)90188-W; Konstantinidis KT, 2006, PHILOS T R SOC B, V361, P1929, DOI 10.1098/rstb.2006.1920; Kowalchuk GA, 2001, ANNU REV MICROBIOL, V55, P485, DOI 10.1146/annurev.micro.55.1.485; Krause-Jensen D, 1998, LIMNOL OCEANOGR, V43, P396, DOI 10.4319/lo.1998.43.3.0396; Kuhl M, 1998, AQUAT MICROB ECOL, V15, P201, DOI 10.3354/ame015201; Lanzen A, 2011, FEMS MICROBIOL ECOL, V77, P577, DOI 10.1111/j.1574-6941.2011.01138.x; LASSEN C, 1992, LIMNOL OCEANOGR, V37, P760, DOI 10.4319/lo.1992.37.4.0760; Lemee L, 1997, TETRAHEDRON, V53, P919, DOI 10.1016/S0040-4020(96)01036-8; Lewis J, 1999, J PLANKTON RES, V21, P343, DOI 10.1093/plankt/21.2.343; Ley RE, 2006, APPL ENVIRON MICROB, V72, P3685, DOI 10.1128/AEM.72.5.3685-3695.2006; LI YH, 1974, GEOCHIM COSMOCHIM AC, V38, P703; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Luccini E, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006580; Lynch RC, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG001961; McKenzie RL, 2003, PHOTOCH PHOTOBIO SCI, V2, P5, DOI 10.1039/b211155c; McQuoid MR, 2002, EUR J PHYCOL, V37, P191, DOI 10.1017/S0967026202003670; Mobberley JM, 2012, ENVIRON MICROBIOL, V14, P82, DOI 10.1111/j.1462-2920.2011.02509.x; Moisander PH, 2006, ENVIRON MICROBIOL, V8, P1721, DOI 10.1111/j.1462-2920.2006.01108.x; Nadeau TL, 1999, AQUAT MICROB ECOL, V20, P231, DOI 10.3354/ame020231; Neilson JW, 2012, EXTREMOPHILES, V16, P553, DOI 10.1007/s00792-012-0454-z; Ng WO, 2003, J BACTERIOL, V185, P1599, DOI 10.1128/JB.185.5.1599-1607.2003; Omoregie EO, 2004, FEMS MICROBIOL ECOL, V47, P305, DOI 10.1016/S0168-6496(03)00301-5; Ordonez OF, 2009, MICROB ECOL, V58, P461, DOI 10.1007/s00248-009-9527-7; Papineau D, 2005, APPL ENVIRON MICROB, V71, P4822, DOI 10.1128/AEM.71.8.4822-4832.2005; Pedley M, 2000, MICROBIAL SEDIMENTS, P179; Pepe-Ranney C, 2012, ENVIRON MICROBIOL, V14, P1182, DOI 10.1111/j.1462-2920.2012.02698.x; Permentier HP, 2000, BBA-BIOENERGETICS, V1460, P338, DOI 10.1016/S0005-2728(00)00200-0; Piacentini RD, 2003, J ATMOS SOL-TERR PHY, V65, P727, DOI 10.1016/S1364-6826(03)00084-1; Playford P.E., 1976, STROMATOLITES, V20, P389, DOI DOI 10.1016/S0070-4571(08)71147-6; Polerecky L, 2007, ENVIRON MICROBIOL, V9, P2007, DOI 10.1111/j.1462-2920.2007.01317.x; Polerecky L, 2009, APPL ENVIRON MICROB, V75, P758, DOI 10.1128/AEM.00819-08; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Qian PY, 2011, ISME J, V5, P507, DOI 10.1038/ismej.2010.112; Raymond J, 2004, MOL BIOL EVOL, V21, P541, DOI 10.1093/molbev/msh047; REID RP, 1995, FACIES, V33, P1, DOI 10.1007/BF02537442; REVSBECH NP, 1986, ADV MICROB ECOL, V9, P293; Ribeiro S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1314; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Sahl JW, 2010, ASTROBIOLOGY, V10, P201, DOI 10.1089/ast.2009.0378; Santos F, 2010, SYST APPL MICROBIOL, V33, P209, DOI 10.1016/j.syapm.2010.02.006; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schmidt SK, 2009, EXTREMOPHILES, V13, P807, DOI 10.1007/s00792-009-0268-9; Schopf JW, 2006, PHILOS T R SOC B, V361, P869, DOI 10.1098/rstb.2006.1834; SODE K, 1991, J BIOTECHNOL, V21, P209, DOI 10.1016/0168-1656(91)90042-T; Souza V, 2006, P NATL ACAD SCI USA, V103, P6565, DOI 10.1073/pnas.0601434103; Souza V, 2012, ASTROBIOLOGY, V12, P641, DOI 10.1089/ast.2011.0675; STANIER RY, 1960, BIOCHIM BIOPHYS ACTA, V41, P478, DOI 10.1016/0006-3002(60)90045-7; Steppe TF, 2002, AQUAT MICROB ECOL, V28, P1, DOI 10.3354/ame028001; Takashima C, 2008, SEDIMENT GEOL, V208, P114, DOI 10.1016/j.sedgeo.2008.06.001; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tian B, 2010, TRENDS MICROBIOL, V18, P512, DOI 10.1016/j.tim.2010.07.007; Visscher PT, 2005, PALAEOGEOGR PALAEOCL, V219, P87, DOI 10.1016/j.palaeo.2004.10.016; Walter M. R., 1976, STROMATOLITES; WALTER MR, 1985, PRECAMBRIAN RES, V29, P149, DOI 10.1016/0301-9268(85)90066-X; WALTER MR, 1972, SCIENCE, V178, P402, DOI 10.1126/science.178.4059.402; Weber M, 2007, ENVIRON SCI TECHNOL, V41, P6210, DOI 10.1021/es070200b; WRIGHT SW, 1991, MAR ECOL PROG SER, V77, P183, DOI 10.3354/meps077183; Zappettini E, 2001, SERV GEOLOGICO MIN A, V26, P65; ZEHR JP, 1989, APPL ENVIRON MICROB, V55, P2522, DOI 10.1128/AEM.55.10.2522-2526.1989	107	78	82	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53497	10.1371/journal.pone.0053497	http://dx.doi.org/10.1371/journal.pone.0053497			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308236	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429100075
J	Risbud, RM; Porter, BE				Risbud, Rashmi M.; Porter, Brenda E.			Changes in MicroRNA Expression in the Whole Hippocampus and Hippocampal Synaptoneurosome Fraction following Pilocarpine Induced Status Epilepticus	PLOS ONE			English	Article							KINASE-II ACTIVITY; CONTROLS DENDRITIC PLASTICITY; ACTIVITY-REGULATED MICRORNA; TRAUMATIC BRAIN-INJURY; NEURONAL CULTURE MODEL; TEMPORAL-LOBE EPILEPSY; IN-VIVO; SEIZURES; MORPHOGENESIS; DECREASE	MicroRNAs regulate protein synthesis by binding non-translated regions of mRNAs and suppressing translation and/or increasing mRNA degradation. MicroRNAs play an important role in the nervous system including controlling synaptic plasticity. Their expression is altered in disease states including stroke, head injury and epilepsy. To better understand microRNA expression changes that might contribute to the development of epilepsy, microRNA arrays were performed on rat hippocampus 4 hours, 48 hours and 3 weeks following an episode of pilocarpine induced status epilepticus. Eighty microRNAs increased at one or more of the time points. No microRNAs decreased at 4 hours, and only a few decreased at 3 weeks, but 188 decreased 48 hours after status epilepticus. The large number of microRNAs with altered expression following status epilepticus suggests that microRNA regulation of translation has the potential to contribute to changes in protein expression during epileptogenesis. We carried out a second set of array's comparing microRNA expression at 48 hours in synaptoneurosome and nuclear fractions of the hippocampus. In control rat hippocampi multiple microRNAs were enriched in the synaptoneurosomal fraction as compared to the nuclear fraction. In contrast, 48 hours after status epilepticus only one microRNA was enriched in the synaptoneurosome fraction. The loss of microRNAs enriched in the synaptoneurosomal fraction implies a dramatic change in translational regulation in synapses 48 hours after status epilepticus.	[Risbud, Rashmi M.; Porter, Brenda E.] Childrens Hosp Philadelphia, Dept Pediat, Div Pediat Neurol, Philadelphia, PA 19104 USA; [Porter, Brenda E.] Univ Penn, Perelman Sch Med, Dept Neurol, Div Pediat Neurol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Porter, BE (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Div Pediat Neurol, Philadelphia, PA 19104 USA.	Brenda2@stanford.edu		Porter, Brenda/0000-0001-6346-7327	NINDS	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NINDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman Naomi, 2005, Appl Bioinformatics, V4, P33, DOI 10.2165/00822942-200504010-00004; Aronica E, 2010, EUR J NEUROSCI, V31, P1100, DOI 10.1111/j.1460-9568.2010.07122.x; Bail S, 2010, RNA, V16, P1032, DOI 10.1261/rna.1851510; Blair RE, 1999, BRAIN RES, V851, P54, DOI 10.1016/S0006-8993(99)02100-9; Blair RE, 2008, EUR J PHARMACOL, V588, P64, DOI 10.1016/j.ejphar.2008.04.021; Booth RFG, 1978, BIOCHEM SOC T, V6, P128, DOI 10.1042/bst0060128; BUTLER LS, 1995, P NATL ACAD SCI USA, V92, P6852, DOI 10.1073/pnas.92.15.6852; Ceman S, 2011, PHARMACOL THERAPEUT, V130, P26, DOI 10.1016/j.pharmthera.2011.01.004; Churn SB, 2000, BRAIN RES, V875, P66, DOI 10.1016/S0006-8993(00)02623-8; Cougot N, 2008, J NEUROSCI, V28, P13793, DOI 10.1523/JNEUROSCI.4155-08.2008; Glanzer J, 2005, P NATL ACAD SCI USA, V102, P16859, DOI 10.1073/pnas.0503783102; Guo DJ, 2012, NEUROBIOL DIS, V45, P348, DOI 10.1016/j.nbd.2011.08.020; Hu K, 2011, NEUROSCI LETT, V488, P252, DOI 10.1016/j.neulet.2010.11.040; Huang YF, 2002, J NEUROSCI, V22, P8422; Jimenez-Mateos EM, 2012, NAT MED, V18, P1087, DOI 10.1038/nm.2834; Jimenez-Mateos EM, 2011, AM J PATHOL, V179, P2519, DOI 10.1016/j.ajpath.2011.07.036; Kim YK, 2011, MOL CELL, V43, P1005, DOI 10.1016/j.molcel.2011.07.031; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Kye MJ, 2007, RNA, V13, P1224, DOI 10.1261/rna.480407; Lambert TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015182; Lee K, 2012, J NEUROSCI, V32, P5678, DOI 10.1523/JNEUROSCI.6471-11.2012; Lippi G, 2011, J CELL BIOL, V194, P889, DOI 10.1083/jcb.201103006; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Lugli G, 2008, J NEUROCHEM, V106, P650, DOI 10.1111/j.1471-4159.2008.05413.x; McKiernan RC, 2012, EXP NEUROL, V237, P346, DOI 10.1016/j.expneurol.2012.06.029; MELLO LEAM, 1993, EPILEPSIA, V34, P985, DOI 10.1111/j.1528-1157.1993.tb02123.x; MULTANI P, 1994, EPILEPSIA, V35, P728, DOI 10.1111/j.1528-1157.1994.tb02503.x; Pichardo-Casas I, 2012, BRAIN RES, V1436, P20, DOI 10.1016/j.brainres.2011.12.001; Poon MM, 2006, J NEUROSCI, V26, P13390, DOI 10.1523/JNEUROSCI.3432-06.2006; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Raol YH, 2006, J NEUROSCI, V26, P11342, DOI 10.1523/JNEUROSCI.3329-06.2006; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Rensing N, 2005, ANN NEUROL, V58, P888, DOI 10.1002/ana.20658; Risbud RM, 2011, BRAIN RES, V1424, P53, DOI 10.1016/j.brainres.2011.09.039; Ross JR, 2011, J NEUROCHEM, V117, P812, DOI 10.1111/j.1471-4159.2011.07233.x; Sano T, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.23; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Song YJ, 2011, BRAIN RES, V1387, P134, DOI 10.1016/j.brainres.2011.02.073; Swann JW, 2000, HIPPOCAMPUS, V10, P617, DOI 10.1002/1098-1063(2000)10:5<617::AID-HIPO13>3.0.CO;2-R; Tsai CA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng052; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Wong M, 2012, NEUROSCIENCE; Zeng LH, 2007, J NEUROSCI, V27, P11604, DOI 10.1523/JNEUROSCI.0983-07.2007	47	69	71	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53464	10.1371/journal.pone.0053464	http://dx.doi.org/10.1371/journal.pone.0053464			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308228	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429100071
J	Shao, Y; Zou, DH; Li, ZD; Wan, L; Qin, ZQ; Liu, NG; Zhang, JH; Zhong, LW; Huang, P; Chen, YJ				Shao, Yu; Zou, Donghua; Li, Zhengdong; Wan, Lei; Qin, Zhiqiang; Liu, Ningguo; Zhang, Jianhua; Zhong, Liangwei; Huang, Ping; Chen, Yijiu			Blunt Liver Injury with Intact Ribs under Impacts on the Abdomen: A Biomechanical Investigation	PLOS ONE			English	Article							FINITE-ELEMENT MODEL; RUPTURE; ORGANS; FORCE	Abdominal trauma accounts for nearly 20% of all severe traffic injuries and can often result from intentional physical violence, from which blunt liver injury is regarded as the most common result and is associated with a high mortality rate. Liver injury may be caused by a direct impact with a certain velocity and energy on the abdomen, which may result in a lacerated liver by penetration of fractured ribs. However, liver ruptures without rib cage fractures were found in autopsies in a series of cases. All the victims sustained punches on the abdomen by fist. Many studies have been dedicated to determining the mechanism underlying hepatic injury following abdominal trauma, but most have been empirical. The actual process and biomechanism of liver injury induced by blunt impact on the abdomen, especially with intact ribs remained, are still inexhaustive. In order to investigate this, finite element methods and numerical simulation technology were used. A finite element human torso model was developed from high resolution CT data. The model consists of geometrically-detailed liver and rib cage models and simplified models of soft tissues, thoracic and abdominal organs. Then, the torso model was used in simulations in which the right hypochondrium was punched by a fist from the frontal, lateral, and rear directions, and in each direction with several impact velocities. Overall, the results showed that liver rupture was primarily caused by a direct strike of the ribs induced by blunt impact to the abdomen. Among three impact directions, a lateral impact was most likely to cause liver injury with a minimum punch speed of 5 m/s (the momentum was about 2.447 kg.m/s). Liver injuries could occur in isolation and were not accompanied by rib fractures due to different material characteristics and injury tolerance.	[Shao, Yu; Zou, Donghua; Li, Zhengdong; Wan, Lei; Qin, Zhiqiang; Liu, Ningguo; Zhang, Jianhua; Huang, Ping; Chen, Yijiu] Minist Justice, Inst Forens Sci, Dept Forens Pathol, Shanghai, Peoples R China; [Shao, Yu] Fudan Univ, Shanghai Med Coll, Dept Forens Sci, Shanghai 200433, Peoples R China; [Zhong, Liangwei] Shanghai Univ Sci & Technol, Coll Mech Engn, Shanghai 201800, Peoples R China	Institute of Forensic Science Ministry of Justice PRC; Fudan University; University of Shanghai for Science & Technology	Huang, P (corresponding author), Minist Justice, Inst Forens Sci, Dept Forens Pathol, Shanghai, Peoples R China.	huangpingifs@gmail.com; yijiuchen@gmail.com	Huang, Ping/L-1193-2019		Key Projects in the National Science & Technology Pillar Program [2012BAK16B02]; National Natural Science Foundation of China [81102300, 81273338]; Science and Technology Commission of Shanghai Municipality [12DZ2271500, 10ZR1431200]; Central Research Institute Public Project of the Scientific Institution of Ministry of Science and Technology [GY1105]	Key Projects in the National Science & Technology Pillar Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Central Research Institute Public Project of the Scientific Institution of Ministry of Science and Technology	Financial support for this work were provided by Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-Year Plan Period, No. 2012BAK16B02, and by programs of the National Natural Science Foundation of China, No. 81102300 and No. 81273338, and by programs of the Science and Technology Commission of Shanghai Municipality, No. 12DZ2271500 and No. 10ZR1431200, also by Central Research Institute Public Project of the Scientific Institution of Ministry of Science and Technology, No. GY1105. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourke J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002200; Bright JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031769; Brock KK, 2005, MED PHYS, V32, P1647, DOI 10.1118/1.1915012; Cronin DS, 2010, MAT PROPERTIES NUMER; de Dios ED, 2011, INT J CRASHWORTHINES, V16, P169, DOI 10.1080/13588265.2010.542335; Gao Z, 2010, ANN BIOMED ENG, V38, P505, DOI 10.1007/s10439-009-9812-0; Grimal Q, 2004, INT J IMPACT ENG, V30, P665, DOI 10.1016/j.ijimpeng.2003.08.002; Kindig M, 2011, TRAFFIC INJ PREV, V12, P377, DOI 10.1080/15389588.2011.583960; Leroy A, 2001, P BBE; Li ZP, 2010, J BIOMECH, V43, P228, DOI 10.1016/j.jbiomech.2009.08.040; Melvin J.W., 1973, SAE TECHNICAL PAPER; Miller K, 2000, J BIOMECH, V33, P367, DOI 10.1016/S0021-9290(99)00196-7; Mollemans W, 2006, LECT NOTES COMPUT SC, V4072, P159; Nava A, 2008, MED IMAGE ANAL, V12, P203, DOI 10.1016/j.media.2007.10.001; Richens D, 2004, EUR J CARDIO-THORAC, V25, P1039, DOI 10.1016/j.ejcts.2004.01.059; Rouhana SW, 2002, ACCIDENTAL INJURY BI, P391; Shigeta K, 2009, DEV NEXT GENERATION; Snedeker JG, 2007, J TRAUMA, V62, P1240, DOI 10.1097/01.ta.0000215531.05677.19; Snedeker JG, 2005, J BIOMECH, V38, P993, DOI 10.1016/j.jbiomech.2004.05.030; Sparks J.L., 2007, BIOMECHANICS BLUNT L; Tseng ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019171; Tungjitkusolmun S, 2002, IEEE T BIO-MED ENG, V49, P3, DOI 10.1109/10.972834; Vock R, 2001, INT J LEGAL MED, V114, P244, DOI 10.1007/s004140000191; Wang LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026490	24	18	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e52366	10.1371/journal.pone.0052366	http://dx.doi.org/10.1371/journal.pone.0052366			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308111	Green Submitted, gold, Green Published			2022-12-25	WOS:000313429100010
J	Acosta, SA; Tajiri, N; Shinozuka, K; Ishikawa, H; Grimmig, B; Diamond, D; Sanberg, PR; Bickford, PC; Kaneko, Y; Borlongan, CV				Acosta, Sandra A.; Tajiri, Naoki; Shinozuka, Kazutaka; Ishikawa, Hiroto; Grimmig, Bethany; Diamond, David; Sanberg, Paul R.; Bickford, Paula C.; Kaneko, Yuji; Borlongan, Cesar V.			Long-Term Upregulation of Inflammation and Suppression of Cell Proliferation in the Brain of Adult Rats Exposed to Traumatic Brain Injury Using the Controlled Cortical Impact Model	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; WHITE-MATTER; ALZHEIMERS-DISEASE; HEAD-INJURY; MICE; NEUROGENESIS; HIPPOCAMPUS; DEPRESSION; DEFICITS; ATROPHY	The long-term consequences of traumatic brain injury (TBI), specifically the detrimental effects of inflammation on the neurogenic niches, are not very well understood. In the present in vivo study, we examined the prolonged pathological outcomes of experimental TBI in different parts of the rat brain with special emphasis on inflammation and neurogenesis. Sixty days after moderate controlled cortical impact injury, adult Sprague-Dawley male rats were euthanized and brain tissues harvested. Antibodies against the activated microglial marker, OX6, the cell cycle-regulating protein marker, Ki67, and the immature neuronal marker, doublecortin, DCX, were used to estimate microglial activation, cell proliferation, and neuronal differentiation, respectively, in the subventricular zone (SVZ), subgranular zone (SGZ), striatum, thalamus, and cerebral peduncle. Stereology-based analyses revealed significant exacerbation of OX6-positive activated microglial cells in the striatum, thalamus, and cerebral peduncle. In parallel, significant decrements in Ki67-positive proliferating cells in SVZ and SGZ, but only trends of reduced DCX-positive immature neuronal cells in SVZ and SGZ were detected relative to sham control group. These results indicate a progressive deterioration of the TBI brain over time characterized by elevated inflammation and suppressed neurogenesis. Therapeutic intervention at the chronic stage of TBI may confer abrogation of these deleterious cell death processes.	[Acosta, Sandra A.; Tajiri, Naoki; Shinozuka, Kazutaka; Ishikawa, Hiroto; Grimmig, Bethany; Sanberg, Paul R.; Bickford, Paula C.; Kaneko, Yuji; Borlongan, Cesar V.] Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA; [Grimmig, Bethany; Bickford, Paula C.] James A Haley Vet Affairs Hosp, Tampa, FL USA; [Diamond, David] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Sanberg, Paul R.] Univ S Florida, Off Res & Innovat, Tampa, FL USA	State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Borlongan, CV (corresponding author), Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA.	cborlong@health.usf.edu	Tajiri, Naoki/K-1230-2012; Kaneko, Yuji/J-6447-2012; Bickford, Paula C/J-5970-2012; Borlongan, Cesar/I-5696-2012	Tajiri, Naoki/0000-0003-2189-662X; Bickford, Paula C/0000-0001-9657-7725; Borlongan, Cesar/0000-0002-2966-9782; Ishikawa, Hiroto/0000-0003-0760-7203; Shinozuka, Kazutaka/0000-0002-6435-4460; Sanberg, Paul/0000-0001-9130-4592	Department of Defense [W81XWH-11-1-0634]; University of South Florida Signature Interdisciplinary Program in Neuroscience funds; University of South Florida and Veterans Administration Reintegration Funds; University of South Florida Neuroscience Collaborative Program; National Institutes of Health [1R01NS071956-01A1]; James and Esther King Biomedical Research Foundation [1KG01-33966]; SanBio Inc.; KMPHC; NeuralStem Inc.; National Institutes of Health, National Institute of Neurological Disorders and Stroke [1R01NS071956-01]; James and Esther King Foundation for Biomedical Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071956] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); University of South Florida Signature Interdisciplinary Program in Neuroscience funds; University of South Florida and Veterans Administration Reintegration Funds; University of South Florida Neuroscience Collaborative Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James and Esther King Biomedical Research Foundation; SanBio Inc.; KMPHC; NeuralStem Inc.; National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); James and Esther King Foundation for Biomedical Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Financial support for this study was through the Department of Defense W81XWH-11-1-0634, the University of South Florida Signature Interdisciplinary Program in Neuroscience funds, the University of South Florida and Veterans Administration Reintegration Funds, and the University of South Florida Neuroscience Collaborative Program. CVB is funded by the National Institutes of Health 1R01NS071956-01A1, James and Esther King Biomedical Research Foundation 1KG01-33966, SanBio Inc., KMPHC and NeuralStem Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CVB is supported by National Institutes of Health, National Institute of Neurological Disorders and Stroke 1R01NS071956-01, Department of Defense W81XWH-11-1-0634, James and Esther King Foundation for Biomedical Research Program, SanBio Inc., KMPHC and NeuralStem Inc. CVB is a PLOS ONE Editorial Board member. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Bye N, 2010, INJURY S1, V41, pS42; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Cernak I, 2005, CELL CYCLE, V4, P1286, DOI 10.4161/cc.4.9.1996; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Dietrich WD, 1999, J NEUROTRAUM, V16, P567, DOI 10.1089/neu.1999.16.567; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Filley CM, 1998, NEUROLOGY, V50, P1535, DOI 10.1212/WNL.50.6.1535; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Glover LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033646; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Gunning-Dixon FM, 2000, NEUROPSYCHOLOGY, V14, P224, DOI 10.1037//0894-4105.14.2.224; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Hayashi T, 2009, BRAIN RES, V1280, P172, DOI 10.1016/j.brainres.2009.05.040; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Ho L, 2012, J ALZHEIMERS DIS, V31, P301, DOI 10.3233/JAD-2012-120598; Holschneider DP, 2011, J NEUROTRAUM, V28, P1909, DOI 10.1089/neu.2011.1978; Iijima T, 1998, J NEUROTRAUM, V15, P277, DOI 10.1089/neu.1998.15.277; Jia X, 2012, J TRAUMA ACUTE CARE; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Laskowitz DT, 2010, J NEUROTRAUM, V27, P1983, DOI 10.1089/neu.2010.1396; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Liu CY, 2008, NEUROSURGERY, V63, pN12, DOI 10.1227/01.NEU.0000339457.01711.3B; Mammis A, 2009, SURG NEUROL, V71, P527, DOI 10.1016/j.surneu.2008.02.040; Mannix RC, 2012, INT J ALZHEIMERS DIS, V2012; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; MAYHEW TM, 1991, EXP PHYSIOL, V76, P639, DOI 10.1113/expphysiol.1991.sp003533; Onyszchuk G, 2009, NEUROSCI LETT, V452, P204, DOI 10.1016/j.neulet.2009.01.049; Parent JM, 2003, NEUROSCIENTIST, V9, P261, DOI 10.1177/1073858403252680; Pluchino S, 2008, BRAIN, V131, P2564, DOI 10.1093/brain/awn198; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Roher AE, 2002, BIOCHEMISTRY-US, V41, P11080, DOI 10.1021/bi026173d; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rovegno M, 2012, MED INTENSIVA, V36, P37, DOI 10.1016/j.medin.2011.06.008; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Starkstein SE, 2005, INT PSYCHOGERIATR, V17, pS93, DOI 10.1017/S1041610205001973; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Yang JS, 2010, J NEUROTRAUM, V27, P1037, DOI 10.1089/neu.2009.1229; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	51	142	144	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53376	10.1371/journal.pone.0053376	http://dx.doi.org/10.1371/journal.pone.0053376			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301065	Green Published, Green Submitted, gold			2022-12-25	WOS:000313480000052
J	Gao, N; Zou, D; Qiao, HL				Gao, Na; Zou, Dan; Qiao, Hai-Ling			Concentration-Dependent Inhibitory Effect of Baicalin on the Plasma Protein Binding and Metabolism of Chlorzoxazone, a CYP2E1 Probe Substrate, in Rats In Vitro and In Vivo	PLOS ONE			English	Article							PHARMACOKINETICS; LIVER; 6-HYDROXYCHLORZOXAZONE; CYTOCHROME-P-450; EXPRESSION; INDUCTION; INJURY; RADIX	Some of the components found in herbs may be inhibitors or inducers of cytochrome P450 enzymes, which may therefore result in undesired herb- drug interactions. As a component extracted from Radix Scutellariae, the direct effect of baicalin on cytochrome P450 has not been investigated sufficiently. In this study, we investigated concentration-dependent inhibitory effect of baicalin on the plasma protein binding and metabolism of chlorzoxazone (CZN), a model CYP2E1 probe substrate, in rats in vitro and in vivo. Animal experiment was a randomized, three-period crossover design. Significant changes in pharmacokinetic parameters of CZN such as C-max, t(1/2) and V-d were observed after treatment with baicalin in vivo (P < 0.05). C-max decreased by 25% and 33%, whereas t(1/2) increased by 34% and 53%, V-d increased by 37% and 50% in 225 mg/kg and 450 mg/kg baicalin-treated rats, respectively. The AUC and CL of CZN were not affected (P > 0.05). Correlation analysis showed that the changes in CZN concentrations and baicalin concentrations were in good correlation (r > 0.99). In vitro experiments, baicalin decreased the formation of 6-OH-chlorzoxazone in a concentration-dependent manner and exhibited a competitive inhibition in rat liver microsomes, with a Ki value of 145.8 mu M. The values of C-max/Ki were 20 and 39 after treatment with baicalin (225 and 450 mg/kg), respectively. Protein binding experiments in vivo showed that the plasma free-fraction (fu) of CZN increased 2.6-fold immediately after baicalin treatment (450 mg/kg) and in vitro showed that baicalin (125-2500 mg/L) increased the unbound CZN from 1.63% to 3.58%. The results indicate that pharmacokinetic changes in CZN are induced by inhibitory effect of baicalin on the plasma protein binding of CZN and CYP2E1 activity.	[Gao, Na; Qiao, Hai-Ling] Zhengzhou Univ, Sch Med, Dept Clin Pharmacol, Zhengzhou, Peoples R China; [Zou, Dan] Henan Med Coll Staff & Workers, Dept Histol & Embryol, Zhengzhou, Peoples R China	Zhengzhou University	Qiao, HL (corresponding author), Zhengzhou Univ, Sch Med, Dept Clin Pharmacol, Zhengzhou, Peoples R China.	qiaohl@zzu.edu.cn			National Natural Science Foundation of China [81041113]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81041113). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek HW, 2006, J PHARM SCI-US, V95, P2452, DOI 10.1002/jps.20698; Chittur SV, 1997, J CHROMATOGR B, V693, P479, DOI 10.1016/S0378-4347(97)00024-8; Christensen H, 2006, J PHARM SCI-US, V95, P2778, DOI 10.1002/jps.20733; Fan L, 2009, EUR J CLIN PHARMACOL, V65, P403, DOI 10.1007/s00228-008-0594-3; GONZALEZ FJ, 1988, PHARMACOL REV, V40, P243; Hou Yan-ning, 2000, Yaoxue Xuebao, V35, P890; Jang SI, 2003, IMMUNOPHARM IMMUNOT, V25, P585, DOI 10.1081/IPH-120026443; Lai MY, 2003, J PHARM PHARMACOL, V55, P205, DOI 10.1211/002235702522; Lai MY, 2004, PLANTA MED, V70, P132, DOI 10.1055/s-2004-815489; Lee KS, 2011, J APPL TOXI IN PRESS; Li CR, 2011, BIOPHARM DRUG DISPOS, V32, P427, DOI 10.1002/bdd.771; Li J, 2012, MED CHEM, V8, P208, DOI 10.2174/157340612800493692; Li Y, 2010, EUR J PHARMACOL, V640, P46, DOI 10.1016/j.ejphar.2010.05.017; Lininger SW, 2000, NATURAL PHARM; McGuffin M., 1997, AM HERBAL PRODUCTS A; Rockich K, 1999, DRUG METAB DISPOS, V27, P1074; Shaik IH, 2011, J PHARM SCI-US, V100, P5281, DOI 10.1002/jps.22708; Srinivas NR, 2010, XENOBIOTICA, V40, P357, DOI 10.3109/00498251003663724; Tang YH, 2006, BIOMED CHROMATOGR, V20, P1116, DOI 10.1002/bmc.655; Tortorici MA, 2006, CRIT CARE MED, V34, P785, DOI 10.1097/01.CCM.0000201899.52739.4F; WAXMAN DJ, 1985, BIOCHEMISTRY-US, V24, P4409, DOI 10.1021/bi00337a023; Zeng MF, 2010, FITOTERAPIA, V81, P490, DOI 10.1016/j.fitote.2010.01.004	22	20	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53038	10.1371/journal.pone.0053038	http://dx.doi.org/10.1371/journal.pone.0053038			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301016	Green Published, Green Submitted, gold			2022-12-25	WOS:000313320900054
J	Luechapanichkul, R; Chen, XW; Taha, HA; Vyas, S; Guan, XY; Freitas, MA; Hadad, CM; Pei, DH				Luechapanichkul, Rinrada; Chen, Xianwen; Taha, Hashem A.; Vyas, Shubham; Guan, Xiaoyan; Freitas, Michael A.; Hadad, Christopher M.; Pei, Dehua			Specificity Profiling of Dual Specificity Phosphatase Vaccinia VH1-related (VHR) Reveals Two Distinct Substrate Binding Modes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; PHOSPHOTYROSINE-CONTAINING PEPTIDES; POTENTIAL FUNCTIONS; LIQUID WATER; ACTIVATION; APOPTOSIS; ERK; JNK; DEPHOSPHORYLATION; IDENTIFICATION	Vaccinia VH1-related (VHR) is a dual specificity phosphatase that consists of only a single catalytic domain. Although several protein substrates have been identified for VHR, the elements that control the in vivo substrate specificity of this enzyme remain unclear. In this work, the in vitro substrate specificity of VHR was systematically profiled by screening combinatorial peptide libraries. VHR exhibits more stringent substrate specificity than classical protein-tyrosine phosphatases and recognizes two distinct classes of Tyr(P) peptides. The class I substrates are similar to the Tyr(P) motifs derived from the VHR protein substrates, having sequences of (D/E/phi)(D/S/N/T/E)(P/I/M/S/A/V) pY(G/A/S/Q) or (D/E/phi)(T/S)(D/E) pY(G/A/S/Q) (where phi is a hydrophobic amino acid and pY is phosphotyrosine). The class II substrates have the consensus sequence of (V/A) P(I/L/M/V/F)X(1-6)pY (where X is any amino acid) with V/A preferably at the N terminus of the peptide. Site-directed mutagenesis and molecular modeling studies suggest that the class II peptides bind to VHR in an opposite orientation relative to the canonical binding mode of the class I substrates. In this alternative binding mode, the Tyr(P) side chain binds to the active site pocket, but the N terminus of the peptide interacts with the carboxylate side chain of Asp(164), which normally interacts with the Tyr(P) + 3 residue of a class I substrate. Proteins containing the class II motifs are efficient VHR substrates in vitro, suggesting that VHR may act on a novel class of yet unidentified Tyr(P) proteins in vivo.	[Luechapanichkul, Rinrada; Chen, Xianwen; Taha, Hashem A.; Vyas, Shubham; Guan, Xiaoyan; Hadad, Christopher M.; Pei, Dehua] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [Freitas, Michael A.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Sch Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Pei, DH (corresponding author), Ohio State Univ, Dept Chem & Biochem, 484 W 12th Ave, Columbus, OH 43210 USA.	pei.3@osu.edu	Freitas, Michael/C-8953-2009; Guan, Xiaoyan/O-9369-2014; Pei, Dehua/P-4594-2016; Guan, Xiaoyan/I-7500-2015	Freitas, Michael/0000-0002-3103-8410; Pei, Dehua/0000-0002-2057-6934; Hadad, Christopher/0000-0003-1211-4315	National Institutes of Health [CA132855, GM062820, 2-U54-NS058183]; Defense Threat Reduction Agency [HDTRA1-11-1-0042]; Ohio Supercomputer Center; Minister of Science and Technology, Thailand; NATIONAL CANCER INSTITUTE [R01CA132855] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311, R01GM062820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS058183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Ohio Supercomputer Center; Minister of Science and Technology, Thailand; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA132855, GM062820, and 2-U54-NS058183. This work was also supported by Defense Threat Reduction Agency Grant HDTRA1-11-1-0042 and the Ohio Supercomputer Center.; Supported by a predoctoral fellowship from the Minister of Science and Technology, Thailand.	Alonso, 2010, EMERGING SIGNALING P, P185; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Alonso A, 2003, NAT IMMUNOL, V4, P44, DOI 10.1038/ni856; Alonso A, 2001, J BIOL CHEM, V276, P4766, DOI 10.1074/jbc.M006497200; Arnoldussen YJ, 2008, CANCER RES, V68, P9255, DOI 10.1158/0008-5472.CAN-08-1224; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bradshaw RA, 1998, TRENDS BIOCHEM SCI, V23, P263, DOI 10.1016/S0968-0004(98)01227-4; Chen XW, 2010, J BIOL CHEM, V285, P31268, DOI 10.1074/jbc.M110.114181; DENU JM, 1995, J BIOL CHEM, V270, P3796, DOI 10.1074/jbc.270.8.3796; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Fogolari F, 2003, BIOPHYS J, V85, P159, DOI 10.1016/S0006-3495(03)74462-2; Garaud M, 2007, J AM CHEM SOC, V129, P5366, DOI 10.1021/ja071275i; Gopishetty B, 2008, ORG LETT, V10, P4605, DOI 10.1021/ol801868a; Hao L, 2007, INT J CANCER, V121, P39, DOI 10.1002/ijc.22597; Hegde R, 2003, J BIOL CHEM, V278, P38699, DOI 10.1074/jbc.M303179200; Henkens R, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-147; Hoyt R, 2007, J IMMUNOL, V179, P3402, DOI 10.4049/jimmunol.179.6.3402; ISHIBASHI T, 1992, P NATL ACAD SCI USA, V89, P12170, DOI 10.1073/pnas.89.24.12170; Jardin C, 2012, J BIOMOL STRUCT DYN, V29, P777, DOI 10.1080/07391102.2012.10507413; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kang TH, 2006, NAT CELL BIOL, V8, P863, DOI 10.1038/ncb1447; Li SW, 2007, ANGEW CHEM INT EDIT, V46, P4751, DOI 10.1002/anie.200700633; Lin YH, 2004, J CELL BIOL, V165, P421, DOI 10.1083/jcb.200311045; Luo R, 2002, J COMPUT CHEM, V23, P1244, DOI 10.1002/jcc.10120; Mahoney MW, 2000, J CHEM PHYS, V112, P8910, DOI 10.1063/1.481505; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rahmouni S, 2006, NAT CELL BIOL, V8, P524, DOI 10.1038/ncb1398; Ren LG, 2011, BIOCHEMISTRY-US, V50, P2339, DOI 10.1021/bi1014453; Schumacher MA, 2002, BIOCHEMISTRY-US, V41, P3009, DOI 10.1021/bi015799l; Sigalov G, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1857811; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Thakkar A, 2006, ANAL CHEM, V78, P5935, DOI 10.1021/ac0607414; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Todd JL, 2002, ONCOGENE, V21, P2573, DOI 10.1038/sj.onc.1205344; Todd JL, 1999, J BIOL CHEM, V274, P13271, DOI 10.1074/jbc.274.19.13271; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200; Vetter SW, 2000, J BIOL CHEM, V275, P2265, DOI 10.1074/jbc.275.4.2265; Walchli S, 2004, J BIOL CHEM, V279, P311, DOI 10.1074/jbc.M307617200; Wang JY, 2011, J BIOL CHEM, V286, P10177, DOI 10.1074/jbc.M110.163295; ZHANG ZY, 1994, BIOCHEMISTRY-US, V33, P2285, DOI 10.1021/bi00174a040; ZHANG ZY, 1993, ANAL BIOCHEM, V211, P7, DOI 10.1006/abio.1993.1224; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200	47	10	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6498	6510		10.1074/jbc.M112.449611	http://dx.doi.org/10.1074/jbc.M112.449611			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23322772	Green Published, hybrid			2022-12-25	WOS:000315820700043
J	Miles, RR; Perry, W; Haas, JV; Mosior, MK; N'Cho, M; Wang, JWJ; Yu, P; Calley, J; Yue, Y; Carter, Q; Han, B; Foxworthy, P; Kowala, MC; Ryan, TP; Solenberg, PJ; Michael, LF				Miles, Rebecca R.; Perry, William; Haas, Joseph V.; Mosior, Marian K.; N'Cho, Mathias; Wang, Jian W. J.; Yu, Peng; Calley, John; Yue, Yong; Carter, Quincy; Han, Bomie; Foxworthy, Patricia; Kowala, Mark C.; Ryan, Timothy P.; Solenberg, Patricia J.; Michael, Laura F.			Genome-wide Screen for Modulation of Hepatic Apolipoprotein A-I (ApoA-I) Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; CENP-F; RISK; ATHEROSCLEROSIS; INHIBITORS; MARKERS; LIPIDS; BLOCK	Control of plasma cholesterol levels is a major therapeutic strategy for management of coronary artery disease (CAD). Although reducing LDL cholesterol (LDL-c) levels decreases morbidity and mortality, this therapeutic intervention only translates into a 25-40% reduction in cardiovascular events. Epidemiological studies have shown that a high LDL-c level is not the only risk factor for CAD; low HDL cholesterol (HDL-c) is an independent risk factor for CAD. Apolipoprotein A-I (ApoA-I) is the major protein component of HDL-c that mediates reverse cholesterol transport from tissues to the liver for excretion. Therefore, increasing ApoA-I levels is an attractive strategy for HDL-c elevation. Using genome-wide siRNA screening, targets that regulate hepatocyte ApoA-I secretion were identified through transfection of 21,789 siRNAs into hepatocytes whereby cell supernatants were assayed for ApoA-I. Approximately 800 genes were identified and triaged using a convergence of information, including genetic associations with HDL-c levels, tissue-specific gene expression, druggability assessments, and pathway analysis. Fifty-nine genes were selected for reconfirmation; 40 genes were confirmed. Here we describe the siRNA screening strategy, assay implementation and validation, data triaging, and example genes of interest. The genes of interest include known and novel genes encoding secreted enzymes, proteases, G-protein-coupled receptors, metabolic enzymes, ion transporters, and proteins of unknown function. Repression of farnesyltransferase (FNTA) by siRNA and the enzyme inhibitor manumycin A caused elevation of ApoA-I secretion from hepatocytes and from transgenic mice expressing hApoA-I and cholesterol ester transfer protein transgenes. In total, this work underscores the power of functional genetic assessment to identify new therapeutic targets.	[Miles, Rebecca R.; Perry, William; Haas, Joseph V.; Mosior, Marian K.; N'Cho, Mathias; Wang, Jian W. J.; Yu, Peng; Calley, John; Yue, Yong; Carter, Quincy; Han, Bomie; Foxworthy, Patricia; Kowala, Mark C.; Ryan, Timothy P.; Solenberg, Patricia J.; Michael, Laura F.] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA	Eli Lilly	Michael, LF (corresponding author), Eli Lilly & Co, Lilly Res Labs, DC0520, Indianapolis, IN 46285 USA.	laura_michael@lilly.com	Han, Bomie/GXH-5054-2022					Ashar HR, 2000, J BIOL CHEM, V275, P30451, DOI 10.1074/jbc.M003469200; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; Cannon CP, 2010, NEW ENGL J MED, V363, P2406, DOI 10.1056/NEJMoa1009744; Cartwright IJ, 1996, BIOCHEM J, V314, P977, DOI 10.1042/bj3140977; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; JOHNSTON PA, 1991, NEURON, V7, P101, DOI 10.1016/0896-6273(91)90078-E; Lindstedt L, 2003, BIOCHEM BIOPH RES CO, V312, P1019, DOI 10.1016/j.bbrc.2003.11.020; McQueen MJ, 2008, LANCET, V372, P224, DOI 10.1016/S0140-6736(08)61076-4; Moskaug JO, 2008, EUR J NUTR, V47, P460, DOI 10.1007/s00394-008-0749-0; Nicholls Stephen J, 2011, Curr Cardiol Rep, V13, P537, DOI 10.1007/s11886-011-0223-0; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Pooley RD, 2008, J CELL SCI, V121, P3413, DOI 10.1242/jcs.032847; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Segal M, 2012, BIOL OPEN, V1, P220, DOI 10.1242/bio.2012307; Sittampalam G. S., 2012, ASSAY GUIDANCE MANUA; Sniderman AD, 2011, CIRC-CARDIOVASC QUAL, V4, P337, DOI 10.1161/CIRCOUTCOMES.110.959247; Steiner G, 2001, AM J CARDIOL, V88, p37N; Sugita M, 2007, ARTERIOSCL THROM VAS, V27, P1390, DOI 10.1161/ATVBAHA.107.140673; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Vergnolle MAS, 2007, CURR BIOL, V17, P1173, DOI 10.1016/j.cub.2007.05.077; Wildsmith KR, 2009, ANAL BIOCHEM, V395, P116, DOI 10.1016/j.ab.2009.07.049	21	11	13	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6386	6396		10.1074/jbc.M112.410092	http://dx.doi.org/10.1074/jbc.M112.410092			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23322769	Green Published, hybrid			2022-12-25	WOS:000315820700033
J	Dong, JH; Otsuki, T; Kato, T; Kohsaka, T; Ike, K; Park, EY				Dong, Jinhua; Otsuki, Takahiro; Kato, Tatsuya; Kohsaka, Tetsuya; Ike, Kazunori; Park, Enoch Y.			Development of Two Murine Antibodies against Neospora caninum Using Phage Display Technology and Application on the Detection of N. caninum	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; INFECTION; TACHYZOITES; ELISA; ABORTIONS; SELECTION; PROTEINS; ANTIGENS; SURFACE; FUSION	Neosporosis, caused by an intracellular parasite, Neospora caninum, is an infectious disease primarily of cattle and dogs. It occurs worldwide and causes huge damages to dairy farms. In this study, we immunized mice with recombinant surface-associated protein 1 of N. caninum (rNcSAG1) and developed two novel monoclonal antibodies, A10 and H3, against NcSAG1 using phage-display technology. Both clones bound to purified rNcSAG1 and the half maximal inhibitory concentrations of A10 and H3 are 50 and 72 nM of rNcSAG1, respectively. In immunofluorescence assays, both A10 and H3 Fabs bound to N. caninum parasites. Direct detection of N. caninum parasites was developed firstly using an enzyme-linked immunosorbent assay (ELISA) with A10 and H3. Binding of A10 and H3 antibodies to rNcSAG1 was also inhibited by some certain anti-N. caninum antibodies in the neosporosis-positive cattle sera, suggesting they might bind to the same epitopes of NcSAG1 with those anti-N. caninum antibodies of bovine. These antibodies were demonstrated to have a potential for monitoring the N. caninum parasites in a dairy farm, which may lead to protect livestock from parasite-infection.	[Dong, Jinhua; Park, Enoch Y.] Shizuoka Univ, Grad Sch Sci & Technol, Biotechnol Lab, Shizuoka, Japan; [Otsuki, Takahiro; Kato, Tatsuya; Park, Enoch Y.] Shizuoka Univ, Fac Agr, Dept Appl Biol Chem, Biotechnol Lab, Shizuoka 4228529, Japan; [Kohsaka, Tetsuya] Shizuoka Univ, Fac Agr, Lab Anim Reprod & Physiol, Shizuoka 4228529, Japan; [Ike, Kazunori] Nippon Vet & Life Univ, Lab Vet Parasitol, Tokyo, Japan	Shizuoka University; Shizuoka University; Shizuoka University	Park, EY (corresponding author), Shizuoka Univ, Grad Sch Sci & Technol, Biotechnol Lab, Shizuoka, Japan.	acypark@ipc.shizuoka.ac.jp	Kato, Tatsuya/E-3095-2010; Park, Enoch/AAU-2614-2020; Dong, Jinhua/D-2510-2015; Kohsaka, Tetsuya/I-1377-2019	Kato, Tatsuya/0000-0001-7990-2557; Dong, Jinhua/0000-0002-7417-1932; Kohsaka, Tetsuya/0000-0001-9093-8243; Park, Enoch Y./0000-0002-7840-1424	Ministry of Education, Culture, Sports, Science and Technology, Japan [22248009]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research (A) grant number 22248009 from the Ministry of Education, Culture, Sports, Science and Technology, Japan. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson R, 2000, PARASITOL TODAY, V16, P110, DOI 10.1016/S0169-4758(99)01604-X; Baszler TV, 1996, J CLIN MICROBIOL, V34, P1423, DOI 10.1128/JCM.34.6.1423-1428.1996; BJERKAS I, 1984, Z PARASITENKD, V70, P271, DOI 10.1007/BF00942230; Bjorkman C, 1999, J VET DIAGN INVEST, V11, P41; Buxton D, 1997, J COMP PATHOL, V117, P1, DOI 10.1016/S0021-9975(97)80062-X; Debache K, 2008, INT J PARASITOL, V38, P1455, DOI 10.1016/j.ijpara.2008.04.001; Dong JH, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-19; Dong J, 2009, ANAL BIOCHEM, V386, P36, DOI 10.1016/j.ab.2008.11.045; Dubey JP, 2007, CLIN MICROBIOL REV, V20, P323, DOI 10.1128/CMR.00031-06; DUBEY JP, 1988, J AM VET MED ASSOC, V193, P1259; DUBEY JP, 1990, J PARASITOL, V76, P127, DOI 10.2307/3282640; Hosseininejad M, 2009, VET PARASITOL, V164, P315, DOI 10.1016/j.vetpar.2009.05.029; Howe DK, 1998, INFECT IMMUN, V66, P5322, DOI 10.1128/IAI.66.11.5322-5328.1998; KOHLER G, 1976, EUR J IMMUNOL, V6, P511, DOI 10.1002/eji.1830060713; Kristensen P, 1998, FOLD DES, V3, P321, DOI 10.1016/S1359-0278(98)00044-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDSAY DS, 1995, AM J VET RES, V56, P1176; LITMAN GW, 1993, MOL BIOL EVOL, V10, P60; Osawa T, 1998, VET PARASITOL, V79, P19, DOI 10.1016/S0304-4017(98)00156-3; Packham AE, 1998, CLIN DIAGN LAB IMMUN, V5, P467, DOI 10.1128/CDLI.5.4.467-473.1998; Reichert JM, 2007, NAT REV DRUG DISCOV, V6, P349, DOI 10.1038/nrd2241; Schier R, 1996, J MOL BIOL, V255, P28, DOI 10.1006/jmbi.1996.0004; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Venturini MC, 1999, INT J PARASITOL, V29, P1705, DOI 10.1016/S0020-7519(99)00143-5; WILLIAMSON RA, 1993, P NATL ACAD SCI USA, V90, P4141, DOI 10.1073/pnas.90.9.4141; YANG WP, 1995, J MOL BIOL, V254, P392, DOI 10.1006/jmbi.1995.0626	26	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53264	10.1371/journal.pone.0053264	http://dx.doi.org/10.1371/journal.pone.0053264			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308179	gold, Green Published, Green Submitted			2022-12-25	WOS:000313429800034
J	Du, LY; Zhao, GY; Sun, SH; Zhang, XJ; Zhou, XJ; Guo, Y; Li, Y; Zhou, YS; Jiang, SB				Du, Lanying; Zhao, Guangyu; Sun, Shihui; Zhang, Xiujuan; Zhou, Xiaojun; Guo, Yan; Li, Ye; Zhou, Yusen; Jiang, Shibo			A Critical HA1 Neutralizing Domain of H5N1 Influenza in an Optimal Conformation Induces Strong Cross-Protection	PLOS ONE			English	Article							RECEPTOR-BINDING DOMAIN; VIRUS HEMAGGLUTININ; MONOCLONAL-ANTIBODIES; IMMUNE-RESPONSES; SURFACE DISPLAY; FC-RECEPTORS; DNA VACCINE; ELICITS; FERRETS; THERAPEUTICS	The highly pathogenic avian influenza (HPAI) H5N1 viruses, especially the laboratory-generated H5N1 mutants, have demonstrated the potential to cross the species barrier and infect mammals and humans. Consequently, the design of an effective and safe anti-H5N1 vaccine is essential. We previously demonstrated that the full-length hemagglutinin 1 (HA1) could induce significant neutralizing antibody response and protection. Here, we intended to identify the critical neutralizing domain (CND) in an optimal conformation that can elicit strong cross-neutralizing antibodies and protection against divergent H5N1 strains. We thus constructed six recombinant proteins covering different regions of HA1 of A/Anhui/1/2005(H5N1), each of which was fused with foldon (Fd) and Fc of human IgG. We found that the critical fragment fused with Fd/Fc (HA-13-263-Fdc, H5 numbering) that could elicit the strongest neutralizing antibody response is located in the N-terminal region of HA1 (residues 13-263), which covers the receptor-binding domain (RBD, residues 112-263). We then constructed three additional recombinants fused with Fd plus His tag (HA-13-263-Fd-His), Fc only (HA-13-263-Fc), and His tag only (HA-13-263-His), respectively. We found that the HA-13-263-Fdc, which formed an oligomeric conformation, induced the strongest neutralizing antibody response and cross-protection against challenges of two tested H5N1 virus strains covering clade 1:A/VietNam/1194/2004 (VN/1194) or clade 2.3.4: A/Shenzhen/406H/06 (SZ/406H), while HA-13-263-Fc dimer and HA-13-263-Fd-His trimer elicited higher neutralizing antibody response and protection than HA-13-263-His monomer. These results suggest that the oligomeric form of the CND containing the RBD can be further developed as an effective and safe vaccine for cross-protection against divergent strains of H5N1 viruses.	[Du, Lanying; Zhang, Xiujuan; Li, Ye; Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA; [Zhao, Guangyu; Sun, Shihui; Zhou, Xiaojun; Guo, Yan; Zhou, Yusen] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Li, Ye] Wenzhou Med Coll, Sch Med Lab Sci, Wenzhou, Zhejiang, Peoples R China; [Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Minist Educ, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Minist Hlth, Shanghai 200433, Peoples R China; [Jiang, Shibo] Fudan Univ, Inst Med Microbiol, Shanghai 200433, Peoples R China	New York Blood Center; Beijing Institute of Microbiology & Epidemiology; Wenzhou Medical University; Fudan University; Fudan University; Fudan University	Zhou, YS (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	yszhou@bmi.ac.cn; sjiang@nybloodcenter.org	Jiang, Shibo/L-4500-2014; Zhang, Xiujuan/AAG-9780-2020	Jiang, Shibo/0000-0001-8283-7135; 	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) of the United States [R03AI088449]; National 973 Basic Research Program of China [2005CB523001]; Chinese Ministry of Science & Technology, Hong Kong, Macau, and Taiwan Collaborative Programs [201200007673]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI088449] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) of the United States; National 973 Basic Research Program of China(National Basic Research Program of China); Chinese Ministry of Science & Technology, Hong Kong, Macau, and Taiwan Collaborative Programs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) of the United States (R03AI088449) to LD, from the National 973 Basic Research Program of China (2005CB523001) to YZ, and from the Chinese Ministry of Science & Technology, Hong Kong, Macau, and Taiwan Collaborative Programs (201200007673) to SJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berns KI, 2012, SCIENCE, V335, P660, DOI 10.1126/science.1217994; Berns KI, 2012, NATURE, V482, P153, DOI DOI 10.1038/482153A; Bodewes R, 2010, J VIROL, V84, P7943, DOI 10.1128/JVI.00549-10; Chen MW, 2008, P NATL ACAD SCI USA, V105, P13538, DOI 10.1073/pnas.0806901105; Chen X, 2010, J BIOL CHEM, V285, P25506, DOI 10.1074/jbc.M110.101170; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Cox RJ, 2011, VACCINE, V29, P8049, DOI 10.1016/j.vaccine.2011.08.042; Du LY, 2008, J IMMUNOL, V180, P948, DOI 10.4049/jimmunol.180.2.948; Du LY, 2007, VACCINE, V25, P2832, DOI 10.1016/j.vaccine.2006.10.031; Du LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016555; Du LY, 2010, BIOCHEM BIOPH RES CO, V397, P580, DOI 10.1016/j.bbrc.2010.05.161; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Faden RR, 2012, SCIENCE, V335, P802, DOI 10.1126/science.1219668; Fouchier R, 2012, NATURE, V481, P257, DOI 10.1038/481257a; Garcia JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007918; Han T, 2011, BIOCHEM BIOPH RES CO, V409, P253, DOI 10.1016/j.bbrc.2011.04.139; He YX, 2005, J IMMUNOL, V174, P4908, DOI 10.4049/jimmunol.174.8.4908; He YX, 2004, BIOCHEM BIOPH RES CO, V324, P773, DOI 10.1016/j.bbrc.2004.09.106; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hessel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016247; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jiang SB, 2010, PROTEIN CELL, V1, P342, DOI 10.1007/s13238-010-0054-6; Khurana S, 2011, J VIROL, V85, P10945, DOI 10.1128/JVI.05406-11; Khurana S, 2011, VACCINE, V29, P5657, DOI 10.1016/j.vaccine.2011.06.014; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; Langley JM, 2011, J INFECT DIS, V203, P1729, DOI 10.1093/infdis/jir172; Le Duc JW, 2012, BIOSECUR BIOTERROR, V10, P153, DOI 10.1089/bsp.2012.0006; Lin SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020052; Loureiro S, 2011, J VIROL, V85, P3010, DOI 10.1128/JVI.01241-10; Maines TR, 2011, VIROLOGY, V413, P139, DOI 10.1016/j.virol.2011.02.015; Martyn JC, 2009, ARCH VIROL, V154, P1129, DOI 10.1007/s00705-009-0423-8; Meier S, 2004, J MOL BIOL, V344, P1051, DOI 10.1016/j.jmb.2004.09.079; Osterholm MT, 2012, SCIENCE, V335, P801, DOI 10.1126/science.1218612; Patel A, 2009, VACCINE, V27, P3083, DOI 10.1016/j.vaccine.2009.03.023; Pleass RJ, 2009, PARASITE IMMUNOL, V31, P529, DOI 10.1111/j.1365-3024.2009.01101.x; Qi Z, 2010, BIOCHEM BIOPH RES CO, V398, P506, DOI 10.1016/j.bbrc.2010.06.109; Santiago FW, 2011, VACCINE, V29, P8888, DOI 10.1016/j.vaccine.2011.09.069; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tambyah PA, 2012, VACCINE, V30, P329, DOI 10.1016/j.vaccine.2011.10.088; Tseng CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035421; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; WEIS WI, 1990, J MOL BIOL, V212, P737, DOI 10.1016/0022-2836(90)90234-D; Weldon WC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012466; Yen HL, 2009, P NATL ACAD SCI USA, V106, P286, DOI 10.1073/pnas.0811052106; Zhang MY, 2009, VACCINE, V27, P857, DOI 10.1016/j.vaccine.2008.11.083; Zhao GY, 2010, VACCINE, V28, P7233, DOI 10.1016/j.vaccine.2010.08.049; Zhou F, 2012, J VIROL, V86, P6970, DOI 10.1128/JVI.06930-11	48	25	26	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53568	10.1371/journal.pone.0053568	http://dx.doi.org/10.1371/journal.pone.0053568			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320093	Green Submitted, gold, Green Published			2022-12-25	WOS:000313429800058
J	How, J; Zhang, A; Phillips, M; Reynaud, A; Lu, SY; Pan, LX; Ho, HT; Yau, YH; Guskov, A; Pervushin, K; Shochat, SG; Eshaghi, S				How, Jonathan; Zhang, Ai; Phillips, Margaret; Reynaud, Aline; Lu, Si Yan; Pan, Lucy Xin; Ho, Hai Ting; Yau, Yin Hoe; Guskov, Albert; Pervushin, Konstantin; Shochat, Susana Geifman; Eshaghi, Said			Comprehensive Analysis and Identification of the Human STIM1 Domains for Structural and Functional Studies	PLOS ONE			English	Article							INTEGRAL MEMBRANE-PROTEINS; HIGH-THROUGHPUT EXPRESSION; CRAC CHANNEL; MECHANISTIC INSIGHTS; ORAI1; PURIFICATION; CRYSTALLIZATION; ACTIVATION; STRATEGY	STIM1 is a Ca2+ sensor within the ER membrane known to activate the plasma membrane store-operated Ca2+ channel upon depletion of its target ion in the ER lumen. This activation is a crucial step to initiate the Ca2+ signaling cascades within various cell types. Human STIM1 is a 77.4 kDa protein consisting of various domains that are involved in Ca2+ sensing, oligomerization, and channel activation and deactivation. In this study, we identify the domains and boundaries in which functional and stable recombinant human STIM1 can be produced in large quantities. To achieve this goal, we cloned nearly 200 constructs that vary in their initial and terminal residues, length and presence of the transmembrane domain, and we conducted expression and purification analyses using these constructs. The results revealed that nearly half of the constructs could be expressed and purified with high quality, out of which 25% contained the integral membrane domain. Further analyses using surface plasmon resonance, nuclear magnetic resonance and a thermostability assay verified the functionality and integrity of these constructs. Thus, we have been able to identify the most stable and well-behaved domains of the hSTIM1 protein, which can be used for future in vitro biochemical and biophysical studies.	[How, Jonathan; Zhang, Ai; Phillips, Margaret; Reynaud, Aline; Lu, Si Yan; Pan, Lucy Xin; Ho, Hai Ting; Yau, Yin Hoe; Guskov, Albert; Pervushin, Konstantin; Shochat, Susana Geifman; Eshaghi, Said] Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Eshaghi, S (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, Singapore 639798, Singapore.	said.eshaghi@ntu.edu.sg	Phillips, Margaret/AAZ-2298-2021; Pervushin, Konstantin/AAJ-6580-2020; Hoe, YAU Yin/A-2817-2011; Guskov, Albert/G-1286-2016	Phillips, Margaret/0000-0003-1654-8583; Pervushin, Konstantin/0000-0002-6393-4340; Hoe, YAU Yin/0000-0001-8136-2393; Guskov, Albert/0000-0003-2340-2216; Zhang, Ai/0000-0001-9372-0266	Nanyang Technological University; National Research Foundation [NRF-CRP4-2008-02]; Biomedical Research Council	Nanyang Technological University(Nanyang Technological University); National Research Foundation; Biomedical Research Council(Agency for Science Technology & Research (A*STAR))	This work was supported by funding from Nanyang Technological University, the National Research Foundation grant NRF-CRP4-2008-02, and the Biomedical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Eshaghi S, 2005, PROTEIN SCI, V14, P676, DOI 10.1110/ps.041127005; Eshaghi Said, 2009, V498, P265, DOI 10.1007/978-1-59745-196-3_17; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Geertsma ER, 2008, P NATL ACAD SCI USA, V105, P5722, DOI 10.1073/pnas.0802190105; Graslund S, 2008, PROTEIN EXPRES PURIF, V58, P210, DOI 10.1016/j.pep.2007.11.008; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Kawasaki T, 2009, BIOCHEM BIOPH RES CO, V385, P49, DOI 10.1016/j.bbrc.2009.05.020; Kim Y, 2011, METHODS, V55, P12, DOI 10.1016/j.ymeth.2011.07.010; Korzeniowski MK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001122; Lecchi P, 1999, ANAL CHEM, V71, P2951, DOI 10.1021/ac981098r; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Muik M, 2011, EMBO J, V30, P1678, DOI 10.1038/emboj.2011.79; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Niegowski D, 2006, INT J BIOL MACROMOL, V39, P83, DOI 10.1016/j.ijbiomac.2006.02.011; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Senisterra GA, 2006, J BIOMOL SCREEN, V11, P940, DOI 10.1177/1087057106294699; Shaw PJ, 2012, J PHYSL; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Yang X, 2012, P NATL ACAD SCI USA, V109, P5657, DOI 10.1073/pnas.1118947109; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842	23	0	0	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53979	10.1371/journal.pone.0053979	http://dx.doi.org/10.1371/journal.pone.0053979			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320111	Green Published, gold			2022-12-25	WOS:000313429800076
J	Mavroeidi, A; Aucott, L; Black, AJ; Fraser, WD; Reid, DM; Macdonald, HM				Mavroeidi, Alexandra; Aucott, Lorna; Black, Alison J.; Fraser, William D.; Reid, David M.; Macdonald, Helen M.			Seasonal Variation in 25(OH) D at Aberdeen (57 degrees N) and Bone Health Indicators- Could Holidays in the Sun and Cod Liver Oil Supplements Alleviate Deficiency?	PLOS ONE			English	Article							VITAMIN-D STATUS; FOOD-FREQUENCY QUESTIONNAIRES; DIETARY ASSESSMENT METHODS; POSTMENOPAUSAL WOMEN; 25-HYDROXYVITAMIN-D LEVELS; WEIGHED RECORDS; MINERAL DENSITY; EXPOSURE; SKIN; OSTEOPOROSIS	Vitamin D has been linked with many health outcomes. The aim of this longitudinal study, was to assess predictors of seasonal variation of 25-hydroxy-vitamin D (25(OH) D) (including use of supplements and holidays in sunny destinations) at a northerly latitude in the UK (57 degrees N) in relation to bone health indicators. 365 healthy postmenopausal women (mean age 62.0 y (SD 1.4)) had 25(OH) D measurements by immunoassay, serum C-telopeptide (CTX), estimates of sunlight exposure (badges of polysulphone film), information regarding holidays in sunny destinations, and diet (from food diaries, including use of supplements such as cod liver oil (CLO)) at fixed 3-monthly intervals over 15 months (subject retention 88%) with an additional 25(OH) D assessment in spring 2008. Bone mineral density (BMD) at the lumbar spine (LS) and dual hip was measured in autumn 2006 and spring 2007 (Lunar I-DXA). Deficiency prevalence (25(OH) D<25 nmol/L) was reduced in women who went on holiday to sunny destinations 3 months prior to their visit, compared to women who did not go on holidays [5.4% vs. 24.6% in Spring (p<0.001) and 3.8% vs. 25.6% in Winter (p = 0.001), respectively]. Similarly deficiency was lower amongst those who took CLO supplements compared to women that did not consume these supplements [2.0% vs. 23.7% in Spring (p = 0.001) and 4.5% vs. 24.8% in winter (p = 0.005), respectively]. There was no seasonal variation in CTX; 25(OH) D predicted a small proportion (1.8% variation) of LS BMD in spring 2007 [unstandardized beta (SE): 0.039 (0.016), p = 0.017]. Seasonal variation of 25(OH) D had little effect on BMD and no effect on CTX. It appears that small increments in vitamin D (e. g. those that can be achieved by cod liver oil supplements of 5 mu g/day) are sufficient to ensure that 25(OH) D is above 25 nmol/L for most people throughout the year. Similarly, holidays in sunny destinations show benefit.	[Mavroeidi, Alexandra; Aucott, Lorna; Black, Alison J.; Reid, David M.; Macdonald, Helen M.] Univ Aberdeen, Musculoskeletal Res Programme, Aberdeen, Scotland; [Fraser, William D.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	University of Aberdeen; University of East Anglia	Macdonald, HM (corresponding author), Univ Aberdeen, Musculoskeletal Res Programme, Aberdeen, Scotland.	h.macdonald@abdn.ac.uk	Mavroeidi, Alexandra/AAW-8827-2020	Aucott, Lorna/0000-0001-6277-7972; Mavroeidi, Alexandra/0000-0001-5213-1596	United Kingdom Food Standards Agency [N05062]	United Kingdom Food Standards Agency	This work was funded by the United Kingdom Food Standards Agency (N05062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bingham SA, 1997, INT J EPIDEMIOL, V26, pS137, DOI 10.1093/ije/26.suppl_1.S137; BINGHAM SA, 1994, BRIT J NUTR, V72, P619, DOI 10.1079/BJN19940064; Cade JE, 2004, NUTR RES REV, V17, P5, DOI 10.1079/NRR200370; Dawson-Hughes B, 2010, OSTEOPOROSIS INT, V21, P1151, DOI 10.1007/s00198-010-1285-3; Department of Health, 1998, NUTR BON HLTH PART R; Engelsen O, 2005, PHOTOCHEM PHOTOBIOL, V81, P1287, DOI 10.1562/2004-11-19-RN-375; Giovannucci E, 2009, ANN EPIDEMIOL, V19, P84, DOI 10.1016/j.annepidem.2007.12.002; Hall LM, 2010, J NUTR, V140, P542, DOI 10.3945/jn.109.115253; Harrison GI, 2002, METHODS, V28, P14, DOI 10.1016/S1046-2023(02)00205-0; Henderson L, 2009, NATL DIET NUTR SURVE, P3; Hill TR, 2007, INT J VITAM NUTR RES, V77, P320, DOI 10.1024/0300-9831.77.5.320; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Hypponen E, 2007, AM J CLIN NUTR, V85, P860, DOI 10.1093/ajcn/85.3.860; Kuchuk NO, 2009, J BONE MINER RES, V24, P693, DOI 10.1359/JBMR.081209; Macdonald HM, 2011, OSTEOPOROSIS INT, V22, P2461, DOI 10.1007/s00198-010-1467-z; Macdonald HM, 2008, BONE, V42, P996, DOI 10.1016/j.bone.2008.01.011; Macdonald HM, 2011, J CLIN ENDOCR METAB, V96, P1677, DOI 10.1210/jc.2010-2032; Macdonald HM, 2006, J BONE MINER RES, V21, P151, DOI 10.1359/JBMR.050906; MacDonald HM, 2005, PUBLIC HEALTH NUTR, V8, P409, DOI 10.1079/PHN2005705; Mavroeidi A, 2010, J STEROID BIOCHEM, V121, P459, DOI 10.1016/j.jsbmb.2010.03.038; Mavroeidi A, 2009, OSTEOPOROSIS INT, V20, P409, DOI 10.1007/s00198-008-0681-4; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; MENDEL CM, 1989, ENDOCR REV, V10, P232, DOI 10.1210/edrv-10-3-232; MetOffice, 2012, UK ACT AN MAPS; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Pasco JA, 2004, J BONE MINER RES, V19, P752, DOI 10.1359/JBMR.040125; Pasco JA, 2001, MED J AUSTRALIA, V175, P401, DOI 10.5694/j.1326-5377.2001.tb143643.x; Powe CE, 2011, J BONE MINER RES, V26, P1609, DOI 10.1002/jbmr.387; Rapuri PB, 2002, J CLIN ENDOCR METAB, V87, P2024, DOI 10.1210/jc.87.5.2024; Rhodes LE, 2010, J INVEST DERMATOL; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Thieden E, 2006, BRIT J DERMATOL, V154, P133, DOI 10.1111/j.1365-2133.2005.06961.x; Zittermann A, 2006, PROG BIOPHYS MOL BIO, V92, P39, DOI 10.1016/j.pbiomolbio.2006.02.001	33	13	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53381	10.1371/journal.pone.0053381	http://dx.doi.org/10.1371/journal.pone.0053381			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308207	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000313429800044
J	Chellappa, V; Taylor, KN; Pedrick, K; Donado, C; Netravali, IA; Haider, K; Cariappa, A; Dalomba, NF; Pillai, S				Chellappa, Vasant; Taylor, Kendra N.; Pedrick, Kathryn; Donado, Carlos; Netravali, Ilka Arun; Haider, Khaleda; Cariappa, Annaiah; Dalomba, Natasha F.; Pillai, Shiv			M89V Sialic Acid Acetyl Esterase (SIAE) and All Other Non-Synonymous Common Variants of This Gene Are Catalytically Normal	PLOS ONE			English	Article							DISEASE	Catalytically defective rare variants of Sialic acid Acetyl Esterase (SIAE) have previously been linked to autoimmunity. Studies presented here confirm that the M89V SIAE protein and all other products of common variant alleles of SIAE are catalytically normal. Although overexpressing transfected non-lymphoid cells secrete small amounts of SIAE that can associate with the cell surface, normal human lymphocytes do not exhibit cell surface SIAE, supporting genetic evidence in mice that indicates that this protein functions in a lymphocyte intrinsic manner. Analyses of the plasma proteome also indicate that SIAE is not secreted in vivo. A re-analysis exclusively of catalytically defective rare variant alleles of SIAE in subjects in which this gene was completely sequenced confirmed an association of SIAE with autoimmunity. A subset of catalytically defective rare variant SIAE alleles has previously been typed in a large genotyping study comparing a diverse group of disease subjects and controls; our re-analysis of this data shows that catalytically defective alleles are enriched in disease subjects. These data suggest that SIAE may be associated with autoimmunity and that further study of catalytically defective rare variant SIAE alleles in terms of autoimmune disease susceptibility is strongly warranted.	[Chellappa, Vasant; Taylor, Kendra N.; Pedrick, Kathryn; Donado, Carlos; Netravali, Ilka Arun; Haider, Khaleda; Cariappa, Annaiah; Dalomba, Natasha F.; Pillai, Shiv] Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Sch Med, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Pillai, S (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Sch Med, Boston, MA 02114 USA.	pillai@helix.mgh.harvard.edu			National Institutes of Health [AI076505, AR058481, AI064930]; Alliance for Lupus Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076505, R01AI064930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [RC1AR058481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funds supporting this study were received from grants from the National Institutes of Health - www.nih.gov (grants AI076505, AR058481 and AI064930) and a grant from the Alliance for Lupus Research (www.lupusresearch.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cariappa A, 2009, J EXP MED, V206, P125, DOI 10.1084/jem.20081399; Higa HH, 1989, J BIOL CHEM, V264; Hirschfield GM, 2012, GENES IMMUN, V13, P328, DOI 10.1038/gene.2011.89; Hunt KA, 2012, NAT GENET, V44, P3, DOI 10.1038/ng.1037; Muthusamy B, 2005, PROTEOMICS, V5, P3531, DOI 10.1002/pmic.200401335; Pillai S, 2012, ANNU REV IMMUNOL, V30, P357, DOI 10.1146/annurev-immunol-020711-075018; Pillai S, 2009, TRENDS IMMUNOL, V30, P488, DOI 10.1016/j.it.2009.07.006; Polanski M, 2006, BIOMARK INSIGHTS, V1, P1; Surolia I, 2010, NATURE, V466, P243, DOI 10.1038/nature09115; Szymanski K, 2011, TISSUE ANTIGENS, V78, P214, DOI 10.1111/j.1399-0039.2011.01703.x	10	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53453	10.1371/journal.pone.0053453	http://dx.doi.org/10.1371/journal.pone.0053453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308225	Green Submitted, gold, Green Published			2022-12-25	WOS:000313429100068
J	Guarnieri, S; Morabito, C; Paolini, C; Boncompagni, S; Pilla, R; Fano-Illic, G; Mariggio, MA				Guarnieri, Simone; Morabito, Caterina; Paolini, Cecilia; Boncompagni, Simona; Pilla, Raffaele; Fano-Illic, Giorgio; Mariggio, Maria A.			Growth Associated Protein 43 Is Expressed in Skeletal Muscle Fibers and Is Localized in Proximity of Mitochondria and Calcium Release Units	PLOS ONE			English	Article							SARCOPLASMIC-RETICULUM; 3-DIMENSIONAL STRUCTURE; PHOSPHOPROTEIN B-50; GENE-EXPRESSION; MAMMALIAN RED; GAP-43; CELLS; BIN1; IDENTIFICATION; NEUROMODULIN	The neuronal Growth Associated Protein 43 (GAP43), also known as B-50 or neuromodulin, is involved in mechanisms controlling pathfinding and branching of neurons during development and regeneration. For many years this protein was classified as neuron-specific, but recent evidences suggest that a) GAP43 is expressed in the nervous system not only in neurons, but also in glial cells, and b) probably it is present also in other tissues. In particular, its expression was revealed in muscles from patients affected by various myopathies, indicating that GAP43 can no-longer considered only as a neuron-specific molecule. We have investigated the expression and subcellular localization of GAP43 in mouse satellite cells, myotubes, and adult muscle (extensor digitorum longus or EDL) using Western blotting, immuno-fluorescence combined to confocal microscopy and electron microscopy. Our in vitro results indicated that GAP43 is indeed expressed in both myoblasts and differentiating myotubes, and its cellular localization changes dramatically during maturation: in myoblasts the localization appeared to be mostly nuclear, whereas with differentiation the protein started to display a sarcomeric-like pattern. In adult fibers, GAP43 expression was evident with the protein labeling forming (in longitudinal views) a double cross striation reminiscent of the staining pattern of other organelles, such as calcium release units (CRUs) and mitochondria. Double immuno-staining and experiments done in EDL muscles fixed at different sarcomere lengths, allowed us to determine the localization, from the sarcomere Z-line, of GAP43 positive foci, falling between that of CRUs and of mitochondria. Staining of cross sections added a detail to the puzzle: GAP43 labeling formed a reticular pattern surrounding individual myofibrils, but excluding contractile elements. This work leads the way to further investigation about the possible physiological and structural role of GAP43 protein in adult fiber function and disease.	[Guarnieri, Simone; Morabito, Caterina; Paolini, Cecilia; Boncompagni, Simona; Fano-Illic, Giorgio; Mariggio, Maria A.] Univ G DAnnunzio, DNI, Chieti, Italy; [Guarnieri, Simone; Morabito, Caterina; Paolini, Cecilia; Boncompagni, Simona; Pilla, Raffaele; Fano-Illic, Giorgio; Mariggio, Maria A.] Univ G DAnnunzio, Ctr Res Ageing CeSI, Chieti, Italy; [Guarnieri, Simone; Morabito, Caterina; Paolini, Cecilia; Boncompagni, Simona; Pilla, Raffaele; Fano-Illic, Giorgio; Mariggio, Maria A.] Univ G DAnnunzio, IIM, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Mariggio, MA (corresponding author), Univ G DAnnunzio, DNI, Chieti, Italy.	mariggio@unich.it	Pilla, Raffaele/I-4459-2019; Mariggiò, Maria Addolorata/T-9047-2017; Fanò-Illic, Giorgio/AAU-5731-2021; Paolini, Cecilia/AAI-4444-2021; Guarnieri, Simone/AAA-5921-2020	Pilla, Raffaele/0000-0002-4326-3279; Mariggiò, Maria Addolorata/0000-0001-5306-7143; Morabito, Caterina/0000-0002-5144-2584; Mariggio, Maria Addolorata/0000-0002-3508-8706; Guarnieri, Simone/0000-0002-2916-2965; Fano Illic, Giorgio/0000-0002-8753-5707	G. d'Annunzio University	G. d'Annunzio University	This work was supported by G. d'Annunzio University research funds to SG and MAM. The authors have no conflicts of interest or financial ties to disclose. No external funding sources were used for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; AIREY JA, 1990, J BIOL CHEM, V265, P14187; Al-Shanti N, 2009, BIOL REV, V84, P637, DOI 10.1111/j.1469-185X.2009.00090.x; ALEXANDER KA, 1987, J BIOL CHEM, V262, P6108; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Boncompagni S, 2009, MOL BIOL CELL, V20, P1058, DOI 10.1091/mbc.E08-07-0783; Butler MH, 1997, J CELL BIOL, V137, P1355, DOI 10.1083/jcb.137.6.1355; CURTIS R, 1992, J CELL BIOL, V116, P1455, DOI 10.1083/jcb.116.6.1455; DACUNHA A, 1990, J CELL BIOL, V111, P209, DOI 10.1083/jcb.111.1.209; DELOULME JC, 1990, J CELL BIOL, V111, P1559, DOI 10.1083/jcb.111.4.1559; Dent EW, 1998, J NEUROBIOL, V35, P287, DOI 10.1002/(SICI)1097-4695(19980605)35:3<287::AID-NEU6>3.0.CO;2-V; Fanzani A, 2007, BIOCHEM BIOPH RES CO, V357, P314, DOI 10.1016/j.bbrc.2007.03.148; FLUCHER BE, 1993, J CELL BIOL, V123, P1161, DOI 10.1083/jcb.123.5.1161; Fugier C, 2011, NAT MED, V17, P720, DOI 10.1038/nm.2374; Gama-Carvalho M, 2001, FEBS LETT, V498, P157, DOI 10.1016/S0014-5793(01)02487-5; Gardner KL, 2006, J CELL PHYSIOL, V206, P196, DOI 10.1002/jcp.20449; HEUB D, 1995, VIRCHOWS ARCH, V426, P69, DOI 10.1007/BF00194700; HEUSS D, 1994, VIRCHOWS ARCH, V425, P101; Heuss D, 1998, NEUROL RES, V20, P360; Korshunova I, 2007, J NEUROCHEM, V100, P1599, DOI 10.1111/j.1471-4159.2006.04316.x; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Ma JJ, 2007, J ORTHOP RES, V25, P1498, DOI 10.1002/jor.20414; Ma JJ, 2005, J ORTHOP RES, V23, P302, DOI 10.1016/j.orthres.2004.08.027; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Morabito C, 2010, FREE RADICAL BIO MED, V48, P579, DOI 10.1016/j.freeradbiomed.2009.12.005; Mosevitsky MI, 2005, INT REV CYTOL, V245, P245, DOI 10.1016/S0074-7696(05)45007-X; Musaro A, 2010, METHODS MOL BIOL, V633, P101, DOI 10.1007/978-1-59745-019-5_8; Neve RL, 1998, J NEUROSCI, V18, P7757; OESTREICHER AB, 1981, BRAIN RES BULL, V6, P145, DOI 10.1016/S0361-9230(81)80040-8; OESTREICHER AB, 1982, J NEUROCHEM, V39, P683, DOI 10.1111/j.1471-4159.1982.tb07947.x; OGATA T, 1985, CELL TISSUE RES, V242, P461; OGATA T, 1985, CELL TISSUE RES, V241, P251, DOI 10.1007/BF00217168; Ohsawa S, 2008, BIOCHEM BIOPH RES CO, V371, P639, DOI 10.1016/j.bbrc.2008.04.056; Salamon M, 2003, J MOL BIOL, V326, P137, DOI 10.1016/S0022-2836(02)01335-9; Schulz RA, 2004, DEV BIOL, V266, P1, DOI 10.1016/j.ydbio.2003.10.008; Shen YP, 2002, J NEUROSCI, V22, P239, DOI 10.1523/JNEUROSCI.22-01-00239.2002; SKENE JHP, 1989, ANNU REV NEUROSCI, V12, P127, DOI 10.1146/annurev.ne.12.030189.001015; Stocker K M, 1992, Perspect Dev Neurobiol, V1, P53; STRITTMATTER SM, 1995, CELL, V80, P445, DOI 10.1016/0092-8674(95)90495-6; Stroffekova K, 2008, PFLUG ARCH EUR J PHY, V455, P873, DOI 10.1007/s00424-007-0344-x; Tjondrokoesoemo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025740; Toussaint A, 2011, ACTA NEUROPATHOL, V121, P253, DOI 10.1007/s00401-010-0754-2; VITKOVIC L, 1988, P NATL ACAD SCI USA, V85, P8296, DOI 10.1073/pnas.85.21.8296; Wechsler-Reya RJ, 1998, MOL CELL BIOL, V18, P566, DOI 10.1128/MCB.18.1.566; Yamaguchi N, 2011, AM J PHYSIOL-CELL PH, V300, pC998, DOI 10.1152/ajpcell.00370.2010; Zhang F, 2000, DEVELOPMENT, V127, P969	46	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53267	10.1371/journal.pone.0053267	http://dx.doi.org/10.1371/journal.pone.0053267			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308181	Green Submitted, gold, Green Published			2022-12-25	WOS:000313429100048
J	Jain, P; Vig, S; Datta, M; Jindel, D; Mathur, AK; Mathur, SK; Sharma, A				Jain, Priyanka; Vig, Saurabh; Datta, Malabika; Jindel, Dinesh; Mathur, Ashok Kumar; Mathur, Sandeep Kumar; Sharma, Abhay			Systems Biology Approach Reveals Genome to Phenome Correlation in Type 2 Diabetes	PLOS ONE			English	Article							DYSTROPHIN-DYSTROGLYCAN COMPLEX; BETA-CELL DYSFUNCTION; WIDE ASSOCIATION DATA; INSULIN-RESISTANCE; COMMON VARIANTS; ADIPOSE-TISSUE; METABOLIC SYNDROME; FUNCTIONAL IMPACT; SKELETAL-MUSCLE; GENE-EXPRESSION	Genome-wide association studies (GWASs) have discovered association of several loci with Type 2 diabetes (T2D), a common complex disease characterized by impaired insulin secretion by pancreatic beta cells and insulin signaling in target tissues. However, effect of genetic risk variants on continuous glycemic measures in nondiabetic subjects mainly elucidates perturbation of insulin secretion. Also, the disease associated genes do not clearly converge on functional categories consistent with the known aspects of T2D pathophysiology. We used a systems biology approach to unravel genome to phenome correlation in T2D. We first examined enrichment of pathways in genes identified in T2D GWASs at genome-wide or lower levels of significance. Genes at lower significance threshold showed enrichment of insulin secretion related pathway. Notably, physical and genetic interaction network of these genes showed robust enrichment of insulin signaling and other T2D pathophysiology related pathways including insulin secretion. The network also overrepresented genes reported to interact with insulin secretion and insulin action targeting antidiabetic drugs. The drug interacting genes themselves showed overrepresentation of insulin signaling and other T2D relevant pathways. Next, we generated genome-wide expression profiles of multiple insulin responsive tissues from nondiabetic and diabetic patients. Remarkably, the differentially expressed genes showed significant overlap with the network genes, with the intersection showing enrichment of insulin signaling and other pathways consistent with T2D pathophysiology. Literature search led our genomic, interactomic, transcriptomic and toxicogenomic evidence to converge on TGF-beta signaling, a pathway known to play a crucial role in pancreatic islets development and function, and insulin signaling. Cumulatively, we find that GWAS genes relate directly to insulin secretion and indirectly, through collaborating with other genes, to insulin resistance. This seems to support the epidemiological evidence that environmentally triggered insulin resistance interacts with genetically programmed beta cell dysfunction to precipitate diabetes.	[Jain, Priyanka; Vig, Saurabh; Datta, Malabika; Sharma, Abhay] CSIR, Funct Genom Unit, CSIR Inst Genom & Integrat Biol, Delhi, India; [Jindel, Dinesh; Mathur, Ashok Kumar] Sawai Man Singh Med Coll, Dept Surg, Jaipur, Rajasthan, India; [Mathur, Sandeep Kumar] Sawai Man Singh Med Coll, Dept Endocrinol, Jaipur, Rajasthan, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); SMS Medical College & Hospital; SMS Medical College & Hospital	Sharma, A (corresponding author), CSIR, Funct Genom Unit, CSIR Inst Genom & Integrat Biol, Delhi, India.	abhaysharma@igib.res.in	Jain, Priyanka/GPT-4181-2022	Jain, Priyanka/0000-0002-2679-1889; Sharma, Abhay/0000-0003-1306-1497; vig, saurabh/0000-0002-0352-987X	Council of Scientific and Industrial Research, Government of India [NWP0032]	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	The research was funded by NWP0032 network project entitled "Diabetes mellitus - New drug discovery R&D, molecular mechanisms and genetic & epidemiological factors" of Council of Scientific and Industrial Research, Government of India (http://rdpp.csir.res.in/csir_acsir/Home.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, NAT GENET, V44, P733, DOI 10.1038/ng.2345; Bajaj M, 2007, DIABETES, V56, P743, DOI 10.2337/db06-0840; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergholdt R, 2012, DIABETES, V61, P954, DOI 10.2337/db11-1263; Berria R, 2006, AM J PHYSIOL-ENDOC M, V290, pE560, DOI 10.1152/ajpendo.00202.2005; Billings LK, ANN NY ACAD SCI, V1212, P59; Bonnycastle LL, 2006, DIABETES, V55, P2534, DOI 10.2337/db06-0178; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r22; Brown ML, 2010, TRENDS ENDOCRIN MET, V21, P441, DOI 10.1016/j.tem.2010.02.008; Califano A, 2012, NAT GENET, V44, P841, DOI 10.1038/ng.2355; Chatr-aryamontri A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S8-S8; Chen T, 2011, J ENDOCRINOL INVEST, V34, P742; Coletta DK, 2011, AM J PHYSIOL-ENDOC M, V301, pE749, DOI 10.1152/ajpendo.00363.2011; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; Davis AP, 2012, DATABASE-OXFORD, DOI 10.1093/database/bar065; Davis AP, 2011, NUCLEIC ACIDS RES, V39, pD1067, DOI 10.1093/nar/gkq813; Diamond-Stanic MK, 2011, BIOCHEM BIOPH RES CO, V405, P439, DOI 10.1016/j.bbrc.2011.01.049; Diaz E, 2011, JOVE-J VIS EXP, DOI 10.3791/2546; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Edlund H, 2001, DIABETES, V50, pS5, DOI 10.2337/diabetes.50.2007.S5; Eyster CA, 2009, VITAM HORM, V80, P193, DOI 10.1016/S0083-6729(08)00608-0; Florez JC, 2008, DIABETOLOGIA, V51, P1100, DOI 10.1007/s00125-008-1025-9; Friedrich N, 2012, J ENDOCRINOL, V215, P29, DOI 10.1530/JOE-12-0120; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gupta D, 2012, CURR DIABETES REV, V8, P76, DOI 10.2174/157339912799424564; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Hayden MR, 2010, OXID MED CELL LONGEV, V3, P290, DOI 10.4161/oxim.3.5.13653; Hinault C, 2011, DIABETES, V60, P1210, DOI 10.2337/db09-1379; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirschhorn JN, 2011, ANNU REV MED, V62, P11, DOI 10.1146/annurev.med.091708.162036; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kim W, 2010, BIOCHEM BIOPH RES CO, V392, P247, DOI 10.1016/j.bbrc.2009.12.115; Klutstein M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-478; Kodama K, 2012, P NATL ACAD SCI USA, V109, P7049, DOI 10.1073/pnas.1114513109; Kolb H, 2012, NAT REV ENDOCRINOL, V8, P183, DOI 10.1038/nrendo.2011.158; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Li HZ, 2012, HUM GENET, V131, P1395, DOI 10.1007/s00439-012-1178-y; Li XM, 2006, J BIOL CHEM, V281, P23748, DOI 10.1074/jbc.M508365200; Lin HM, 2009, J BIOL CHEM, V284, P12246, DOI 10.1074/jbc.M805379200; Lolmede K, 2011, DIABETES METAB, V37, P283, DOI 10.1016/j.diabet.2011.03.002; Lopez D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-282; Luo R, 2012, AM J HUM GENET, V91, P38, DOI 10.1016/j.ajhg.2012.05.011; Lusis AJ, 2008, NAT REV GENET, V9, P819, DOI 10.1038/nrg2468; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Marian AJ, 2012, TRANSL RES, V159, P64, DOI 10.1016/j.trsl.2011.08.001; Martha VS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S7; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Miron M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-333; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Mulvey C, 2005, EUR J CELL BIOL, V84, P867, DOI 10.1016/j.ejcb.2005.06.007; Mulvey C, 2008, MOL MED REP, V1, P297; Newgard CB, 2010, NAT MED, V16, P388, DOI 10.1038/nm0410-388; Nikolajczyk BS, 2011, GENES IMMUN, V12, P239, DOI 10.1038/gene.2011.14; Okamoto Y, 2006, CLIN SCI, V110, P267, DOI 10.1042/CS20050182; Opitz L, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-36; Osier MV, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-124; Oussaief L, 2009, J BIOL CHEM, V284, P23912, DOI 10.1074/jbc.M109.036483; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Palsgaard J, 2012, J BIOL CHEM, V287, P12016, DOI 10.1074/jbc.M111.337048; Patel CJ, 2012, BIOINFORMATICS, V28, pI121, DOI 10.1093/bioinformatics/bts229; Perry JRB, 2009, DIABETES, V58, P1463, DOI 10.2337/db08-1378; PIMENTA W, 1995, JAMA-J AM MED ASSOC, V273, P1855, DOI 10.1001/jama.273.23.1855; Polonsky KS, 1996, NEW ENGL J MED, V334, P777, DOI 10.1056/NEJM199603213341207; Prokopenko I, 2008, TRENDS GENET, V24, P613, DOI 10.1016/j.tig.2008.09.004; Rao AA, 2007, LIPIDS HLTH DIS, V14, P6; Richard AJ, 2011, TRENDS ENDOCRIN MET, V22, P325, DOI 10.1016/j.tem.2011.03.007; Rogers C, 2012, J CLIN ENDOCR METAB, V97, pE329, DOI 10.1210/jc.2011-1033; Roman AA, 2012, ENDOCRINE, V42, P243, DOI 10.1007/s12020-012-9698-8; Rotival M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002367; Shen N, 2011, J BIOL CHEM, V286, P14508, DOI 10.1074/jbc.M110.190165; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Swallow CJ, 2004, CANCER RES, V64, P6402, DOI 10.1158/0008-5472.CAN-04-1117; Szweras M, 2002, J BIOL CHEM, V277, P19991, DOI 10.1074/jbc.M112234200; Tabassum R, 2012, DIABETES IN PRESS; Tan CK, 2011, DIABETES, V60, P464, DOI 10.2337/db10-0801; Tavana O, 2011, CELL CYCLE, V10, P2471, DOI 10.4161/cc.10.15.16741; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Watada H, 2010, ENDOCR J, V57, P185, DOI 10.1507/endocrj.K09E-035; Weiss Ram, 2006, Curr Diab Rep, V6, P182, DOI 10.1007/s11892-006-0032-9; Winckler W, 2007, DIABETES, V56, P685, DOI 10.2337/db06-0202; Winter AG, 2011, BIOINFORMATICS, V27, P1043, DOI 10.1093/bioinformatics/btr062; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013; Yamagata K, 2003, ENDOCR J, V50, P491, DOI 10.1507/endocrj.50.491; You HJ, 2007, CARCINOGENESIS, V28, P2491, DOI 10.1093/carcin/bgm195; Zhong H, 2010, AM J HUM GENET, V86, P581, DOI 10.1016/j.ajhg.2010.02.020	90	34	36	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53522	10.1371/journal.pone.0053522	http://dx.doi.org/10.1371/journal.pone.0053522			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308243	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429100081
J	Womac, DJ; Palanisamy, AP; Eslick, R; Schimpf, DK; Chavin, KD				Womac, Daniel John; Palanisamy, Arun Prathap; Eslick, Rene; Schimpf, Dennis Kenneth; Chavin, Kenneth David			Development of a Mouse Model of Abdominal Cutaneous Flaps for Breast Reconstruction	PLOS ONE			English	Article							DONOR-SITE COMPLICATIONS; ISLAND SKIN FLAP; BODY-WEIGHT; OBESITY; CANCER; RAT; MORTALITY; STAGE; RISK	Autologous tissue transfer, in addition to replacing tissue that was lost during injury or surgery, offers women an excellent option to improve cosmetic appearance and self-confidence following mastectomy due to breast cancer. However, flap necrosis is a complication in obese patients undergoing this procedure. We created a mouse model to study the flap-related complications that leads to decreased flap survival in autologous breast reconstruction. Methods: Left superficial inferior epigastric (SIE) pedicle abdominal-cutaneous flaps were elevated in 8 week-old, obese ob/ob male mice and their lean littermates. Flaps were followed by serial photography. Area of flap necrosis was measured at 7 days. Statistical analysis was performed. Results: Necrosis was observed at the distal margin of the flaps, in both lean and obese groups. Lean left SIE flaps (n = 8) had a total area flap necrosis of 9.1% at 7 days whereas obese left SIE flaps (n = 8) had a total area flap necrosis of 45.5% at 7 days. Obese flaps had a statistically significant increase in necrosis compared to the lean flaps, p = 0.001. Conclusions: There was a significant difference between flap survival in lean and obese SIE pedicle flaps in our mouse model. We have developed the first flap model of obesity utilizing the superficial epigastric pedicle in the mouse. This model is optimal for future studies to dissect out mechanisms that lead to the complications related to flap survival for breast reconstruction, especially in obese subjects.	[Womac, Daniel John; Palanisamy, Arun Prathap; Eslick, Rene; Chavin, Kenneth David] Med Univ S Carolina, Dept Surg, Div Transplant Surg, Charleston, SC 29425 USA; [Schimpf, Dennis Kenneth] Med Univ S Carolina, Dept Surg, Div Plast Surg, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Palanisamy, AP (corresponding author), Med Univ S Carolina, Dept Surg, Div Transplant Surg, Charleston, SC 29425 USA.	arunp@musc.edu	Palanisamy, Arun/I-7712-2019; Palanisamy, Arun/L-2019-2014	Palanisamy, Arun/0000-0002-7793-0682; Palanisamy, Arun/0000-0002-7793-0682	American Cancer Society [RSG-06-262-01-CCE]	American Cancer Society(American Cancer Society)	This study was supported by the American Cancer Society grant titled "Effects of Obesity on Musculocutaneous Flaps Used for Breast Reconstruction", Grant # RSG-06-262-01-CCE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chang DW, 2000, PLAST RECONSTR SURG, V105, P1640, DOI 10.1097/00006534-200004050-00007; Cui YD, 2002, INT J CANCER, V98, P279, DOI 10.1002/ijc.10209; DUNN RM, 1992, PLAST RECONSTR SURG, V90, P319, DOI 10.1097/00006534-199290020-00026; Enger SM, 2004, ARCH SURG-CHICAGO, V139, P954, DOI 10.1001/archsurg.139.9.954; FINSETH F, 1978, PLAST RECONSTR SURG, V61, P412, DOI 10.1097/00006534-197803000-00016; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Harder Y, 2004, J SURG RES, V121, P197, DOI 10.1016/j.jss.2004.03.026; Ingalls AM, 1996, OBES RES, V4, P101, DOI 10.1002/j.1550-8528.1996.tb00519.x; Kroll SS, 1998, PLAST RECONSTR SURG, V102, P1502, DOI 10.1097/00006534-199810000-00024; KROLL SS, 1989, PLAST RECONSTR SURG, V84, P886, DOI 10.1097/00006534-198912000-00003; Lindstrom P, 2007, THESCIENTIFICWORLDJO, V7, P666, DOI 10.1100/tsw.2007.117; Losken A, 2001, PLAST RECONSTR SURG, V107, P1504, DOI 10.1097/00006534-200105000-00032; MCFARLANE R M, 1965, Plast Reconstr Surg, V35, P177, DOI 10.1097/00006534-196502000-00007; Moran SL, 2001, PLAST RECONSTR SURG, V108, P1954, DOI 10.1097/00006534-200112000-00017; OZCAN G, 1991, ANN PLAS SURG, V27, P332, DOI 10.1097/00000637-199110000-00008; Padubidri AN, 1997, ANN PLAS SURG, V39, P500, DOI 10.1097/00000637-199711000-00010; Reyna RE, 2006, AM SURGEON, V72, P764; Selber JC, 2006, ANN PLAS SURG, V56, P492, DOI 10.1097/01.sap.0000210180.72721.4a; Spear SL, 2007, PLAST RECONSTR SURG, V119, P788, DOI 10.1097/01.prs.0000252003.14537.d2; Stoll BA, 1998, INT J OBESITY, V22, P1035, DOI 10.1038/sj.ijo.0800769; Tatlidede S, 2009, J SURG RES, V154, P112, DOI 10.1016/j.jss.2008.05.029; Wingo PA, 2000, CANCER CAUSE CONTROL, V11, P497, DOI 10.1023/A:1008944209648	23	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e52829	10.1371/journal.pone.0052829	http://dx.doi.org/10.1371/journal.pone.0052829			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308122	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429100016
J	Yang, H; Chen, HZ; Liu, ZH; Ma, H; Qin, LH; Jin, RL; Zheng, RJ; Feng, YH; Cui, ZL; Wang, J; Liu, JM; Hu, ZY				Yang, Hua; Chen, Haizhen; Liu, Zhonghua; Ma, Hui; Qin, Lianhua; Jin, Ruiliang; Zheng, Ruijuan; Feng, Yonghong; Cui, Zhenling; Wang, Jie; Liu, Jinming; Hu, Zhongyi			A Novel B-Cell Epitope Identified within Mycobacterium tuberculosis CFP10/ESAT-6 Protein	PLOS ONE			English	Article							PEPTIDE MIMOTOPES; IMMUNOLOGICAL DIAGNOSIS; ANTIBODY-RESPONSES; ANTIGENS; ESAT-6; SERODIAGNOSIS; PATHOGENESIS; PREDICTION; SELECTION; COMPLEX	Background: The 10-kDa culture filtrate protein (CFP10) and 6-kDa early-secreted target antigen (ESAT-6) play important roles in mycobacterial virulence and pathogenesis through a 1:1 complex formation (CFP10/ESAT-6 protein, CE protein), which have been used in discriminating TB patients from BCG-vaccinated individuals. The B-cell epitopes of CFP10 and ESAT-6 separately have been analyzed before, however, the epitopes of the CE protein are unclear and the precise epitope in the positions 40 to 62 of ESAT-6 is still unknown. Methods: In the present study, we searched for the B-cell epitopes of CE protein by using phage-display library biopanning with the anti-CE polyclonal antibodies. The epitopes were identified by sequence alignment, binding affinity and specificity detection, generation of polyclonal mouse sera and detection of TB patient sera. Results: One linear B-cell epitope (KWDAT) consistent with the 162nd-166th sequence of CE and the 57th-61st sequence of ESAT-6 protein was selected and identified. Significantly higher titers of E5 peptide-binding antibodies were found in the sera of TB patients compared with those of healthy individuals. Conclusion: There was a B-cell epitope for CE and ESAT-6 protein in the position 40 to 62 of ESAT-6. E5 peptide may be useful in the serodiagnosis of tuberculosis, which need to be further confirmed by more sera samples.	[Yang, Hua; Liu, Zhonghua; Ma, Hui; Qin, Lianhua; Jin, Ruiliang; Zheng, Ruijuan; Feng, Yonghong; Cui, Zhenling; Wang, Jie; Hu, Zhongyi] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Shanghai Key Lab TB, Shanghai 200092, Peoples R China; [Liu, Jinming] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Dept Resp Med, Shanghai 200092, Peoples R China; [Chen, Haizhen] Shanxi Med Univ, Clin Lab Diagnost, Taiyuan, Peoples R China	Tongji University; Tongji University; Shanxi Medical University	Liu, JM (corresponding author), Tongji Univ, Shanghai Pulm Hosp, Sch Med, Dept Resp Med, Shanghai 200092, Peoples R China.	jinmingliu_sh@hotmail.com; shhuzy@163.com			National Key Project for Infectious Disease [2012ZX10003002-008]; Science and Technology Commission of Shanghai Municipality, Shanghai, PR China [124119a1500]; Fundamental Research Funds for the Central Universities [1511219013]	National Key Project for Infectious Disease; Science and Technology Commission of Shanghai Municipality, Shanghai, PR China(Science & Technology Commission of Shanghai Municipality (STCSM)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grant from the National Key Project for Infectious Disease (No. 2012ZX10003002-008), the Science and Technology Commission of Shanghai Municipality, Shanghai, PR China (No. 124119a1500), and the Fundamental Research Funds for the Central Universities (No. 1511219013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khodari NY, 2011, CLIN VACCINE IMMUNOL, V18, P477, DOI 10.1128/CVI.00405-10; Baassi L, 2009, INT J TUBERC LUNG D, V13, P848; Barenholz A, 2007, J MED MICROBIOL, V56, P579, DOI 10.1099/jmm.0.46920-0; Berthet FX, 1998, MICROBIOL-UK, V144, P3195, DOI 10.1099/00221287-144-11-3195; Chan ED, 2000, TUBERCLE LUNG DIS, V80, P131, DOI 10.1054/tuld.2000.0243; *CHIN ANT ASS, 1995, CHIN LAB SCI PROC DI, P9; Fuchs S, 2003, ANN NY ACAD SCI, V998, P93, DOI 10.1196/annals.1254.011; Ganguly N, 2008, TUBERCULOSIS, V88, P510, DOI 10.1016/j.tube.2008.05.002; Gennaro ML, 2000, CLIN INFECT DIS, V30, pS243, DOI 10.1086/313868; Gershoni JM, 2007, BIODRUGS, V21, P145, DOI 10.2165/00063030-200721030-00002; Gevorkian G, 2005, BIOCHEM J, V387, P411, DOI 10.1042/BJ20041139; Harboe M, 1998, INFECT IMMUN, V66, P717, DOI 10.1128/IAI.66.2.717-723.1998; Hoff ST, 2007, CLIN INFECT DIS, V45, P575, DOI 10.1086/520662; Huang YX, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-538; Khan IH, 2008, CLIN VACCINE IMMUNOL, V15, P433, DOI 10.1128/CVI.00354-07; Kumar G, 2010, ARCH IMMUNOL THER EX, V58, P57, DOI 10.1007/s00005-009-0055-4; Kunnath-Velayudhan S, 2010, P NATL ACAD SCI USA, V107, P14703, DOI 10.1073/pnas.1009080107; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Lightbody KL, 2004, FEMS MICROBIOL LETT, V238, P255, DOI 10.1016/j.femsle.2004.07.043; Nahtman T, 2007, J IMMUNOL METHODS, V328, P1, DOI 10.1016/j.jim.2007.07.015; Pacios LF, 2008, MOL IMMUNOL, V45, P2269, DOI 10.1016/j.molimm.2007.11.022; Prudencio CR, 2010, VACCINE, V28, P5398, DOI 10.1016/j.vaccine.2010.06.021; Renshaw PS, 2002, J BIOL CHEM, V277, P21598, DOI 10.1074/jbc.M201625200; Saha A, 2005, APPL ENVIRON MICROB, V71, P7334, DOI 10.1128/AEM.71.11.7334-7344.2005; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Scala G, 1999, J IMMUNOL, V162, P6155; Sharma A, 2006, CLIN VACCINE IMMUNOL, V13, P1143, DOI 10.1128/CVI.00127-06; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Specter M., 2010, NEW YORKER, V86, P48; Spencer JS, 2004, INFECT IMMUN, V72, P3161, DOI 10.1128/IAI.72.6.3161-3170.2004; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Steingart KR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001062; Tordesillas L, 2009, MOL IMMUNOL, V47, P534, DOI 10.1016/j.molimm.2009.07.028; Ulises HC, 2009, PEPTIDES, V30, P2127, DOI 10.1016/j.peptides.2009.09.019; van Pinxteren LAH, 2000, CLIN DIAGN LAB IMMUN, V7, P155, DOI 10.1128/CDLI.7.2.155-160.2000; Waters WR, 2004, CLIN DIAGN LAB IMMUN, V11, P729, DOI 10.1128/CDLI.11.4.729-735.2004; Weldingh K, 1999, FEMS IMMUNOL MED MIC, V23, P159, DOI 10.1111/j.1574-695X.1999.tb01235.x; Weldingh K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001978; WHO, 2011, COMM SER TESTS DIAGN; World Health Organisation, 2011, WHOHTMTB201116; Wu XQ, 2010, CLIN VACCINE IMMUNOL, V17, P372, DOI [10.1128/CVI.00287-09, 10.3785/j.issn.1006-754X.2010.05.011]; Yang H, 2011, J MED MICROBIOL, V60, P69, DOI 10.1099/jmm.0.025098-0	43	69	70	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e52848	10.1371/journal.pone.0052848	http://dx.doi.org/10.1371/journal.pone.0052848			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308124	Green Published, gold, Green Submitted			2022-12-25	WOS:000313429100018
J	Lei, GS; Zhang, C; Shao, SJ; Jung, HW; Durant, PJ; Lee, CH				Lei, Guang-Sheng; Zhang, Chen; Shao, Shoujin; Jung, Hsin-Wei; Durant, Pamela J.; Lee, Chao-Hung			All-Trans Retinoic Acid in Combination with Primaquine Clears Pneumocystis Infection	PLOS ONE			English	Article							ALVEOLAR MACROPHAGES; CARINII-PNEUMONIA; MYELOID CELLS; SUPPRESSOR-CELLS; ORGANISM BURDEN; DOWN-REGULATION; CANCER-PATIENTS; IMMUNE-SYSTEM; PU.1; EXPRESSION	Pneumocystis pneumonia (PcP) develops in immunocompromised patients. Alveolar macrophages play a key role in the recognition, phagocytosis, and degradation of Pneumocystis, but their number is decreased in PcP. Our study of various inflammatory components during PcP found that myeloid-derived suppressor cells (MDSCs) accumulate in the lungs of mice and rats with Pneumocystis pneumonia (PcP). We hypothesized that treatment with all-trans retinoic acid (ATRA), a metabolite of vitamin A, may effectively control Pneumocystis (Pc) infection by inducing MDSCs to differentiate to AMs. In rodent models of PcP, we found that 5 weeks of ATRA treatment reduced the number of MDSCs in the lungs and increased the number of AMs which cleared Pc infection. We also found that ATRA in combination with primaquine was as effective as the combination of trimethoprim and sulfamethaxazole for treatment of PcP and completely eliminated MDSCs and Pc organisms in the lungs in two weeks. No relapse of PcP was seen after three weeks of the ATRA-primaquine combination treatment. Prolonged survival of Pc-infected animals was also achieved by this regimen. This is the very first successful development of a therapeutic regimen for PcP that combines an immune modulator with an antibiotic, enabling the hosts to effectively defend the infection. Results of our study may serve as a model for development of novel therapies for other infections with MDSC accumulation.	[Lei, Guang-Sheng; Zhang, Chen; Shao, Shoujin; Jung, Hsin-Wei; Durant, Pamela J.; Lee, Chao-Hung] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington	Lee, CH (corresponding author), Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA.	chlee@iupui.edu			National Institutes of Health [R01 AI062259, R03 AI091418]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062259, R03AI091418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by grants R01 AI062259 and R03 AI091418 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhagwat SP, 2010, J IMMUNOL, V184, P497, DOI 10.4049/jimmunol.0901864; Center for Drug Evaluation and Research FDA, 2005, GUID IND EST MAX SAF; CHEN WX, 1992, INT J EXP PATHOL, V73, P709; Eichbaum Q, 1997, BLOOD, V90, P4135, DOI 10.1182/blood.V90.10.4135; EICHBAUM QG, 1994, J EXP MED, V179, P1985, DOI 10.1084/jem.179.6.1985; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gigliotti F, 2006, INFECT IMMUN, V74, P6310, DOI 10.1128/IAI.00668-06; Gomez-Garcia L, 2005, PARASITE IMMUNOL, V27, P395, DOI 10.1111/j.1365-3024.2005.00790.x; GORDIN FM, 1984, ANN INTERN MED, V100, P495, DOI 10.7326/0003-4819-100-4-495; Helweg-Larsen J, 2009, J ANTIMICROB CHEMOTH, V64, P1282, DOI 10.1093/jac/dkp372; Jakubzick C, 2006, J IMMUNOL, V176, P3578, DOI 10.4049/jimmunol.176.6.3578; Kalyoncu U, 2007, SCAND J INFECT DIS, V39, P475, DOI 10.1080/00365540601071867; Komano Y, 2009, ARTHRIT RHEUM-ARTHR, V61, P305, DOI 10.1002/art.24283; Kovacs JA, 2009, JAMA-J AM MED ASSOC, V301, P2578, DOI 10.1001/jama.2009.880; Koziel H, 1998, J CLIN INVEST, V102, P1332, DOI 10.1172/JCI560; Kusmartsev S, 2003, CANCER RES, V63, P4441; Lasbury ME, 2007, J BIOL CHEM, V282, P11009, DOI 10.1074/jbc.M611686200; Lasbury ME, 2011, AM J RESP CELL MOL, V44, P540, DOI 10.1165/rcmb.2009-0367OC; Lasbury ME, 2004, INFECT IMMUN, V72, P2140, DOI 10.1128/IAI.72.4.2140-2147.2004; Lasbury ME, 2003, CLIN DIAGN LAB IMMUN, V10, P293, DOI 10.1128/CDLI.10.2.293-302.2003; Lathers DMR, 2004, CANCER IMMUNOL IMMUN, V53, P422, DOI 10.1007/s00262-003-0459-7; LEE JS, 1993, J CLIN ONCOL, V11, P959, DOI 10.1200/JCO.1993.11.5.959; Lee JM, 2012, INT J CANCER, V131, P741, DOI 10.1002/ijc.26411; Liao CP, 2009, J BIOL CHEM, V284, P8174, DOI 10.1074/jbc.M805787200; LU JJ, 1995, J CLIN MICROBIOL, V33, P2785, DOI 10.1128/JCM.33.10.2785-2788.1995; Martin SI, 2009, AM J TRANSPLANT, V9, pS227, DOI 10.1111/j.1600-6143.2009.02914.x; Mencacci A, 2002, J IMMUNOL, V169, P3180, DOI 10.4049/jimmunol.169.6.3180; Miller RF, 1999, CURR OPIN INFECT DIS, V12, P371, DOI 10.1097/00001432-199908000-00011; Mirza N, 2006, CANCER RES, V66, P9299, DOI 10.1158/0008-5472.CAN-06-1690; Morris A, 2004, EMERG INFECT DIS, V10, P1713, DOI 10.3201/eid1010.030985; MOULTON KS, 1994, MOL CELL BIOL, V14, P4408, DOI 10.1128/MCB.14.7.4408; Nefedova Y, 2007, CANCER RES, V67, P11021, DOI 10.1158/0008-5472.CAN-07-2593; Panopoulos AD, 2002, J BIOL CHEM, V277, P19001, DOI 10.1074/jbc.M112271200; Patatanian E, 2008, J CLIN PHARM THER, V33, P331, DOI 10.1111/j.1365-2710.2008.00935.x; QUEENER SF, 1988, ANTIMICROB AGENTS CH, V32, P807, DOI 10.1128/AAC.32.6.807; Shiohira H, 2010, INT J MOL MED, V26, P393, DOI 10.3892/ijmm_00000478; Slatore CG, 2004, IMMUNOL ALLERGY CLIN, V24, P477, DOI 10.1016/j.iac.2004.03.011; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Swain SD, 2006, AM J PATHOL, V168, P466, DOI 10.2353/ajpath.2006.050724; Terrazas LI, 2001, J IMMUNOL, V167, P5294, DOI 10.4049/jimmunol.167.9.5294; Vale N, 2009, EUR J MED CHEM, V44, P937, DOI 10.1016/j.ejmech.2008.08.011; Voisin MB, 2004, INFECT IMMUN, V72, P5487, DOI 10.1128/IAI.72.9.5487-5492.2004; WAKEFIELD AE, 1990, LANCET, V336, P451, DOI 10.1016/0140-6736(90)92008-6; Wang J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001058; Wright TW, 1999, J CLIN INVEST, V104, P1307, DOI 10.1172/JCI6688; Youn JI, 2011, J LEUKOC BIOL; Zhang C, 2006, INFECT IMMUN, V74, P1857, DOI 10.1128/IAI.74.3.1857-1864.2006; Zhang C, 2012, INFECT IMMUN; Zhang C, 2010, INFECT IMMUN, V78, P1058, DOI 10.1128/IAI.01141-09	49	20	23	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53479	10.1371/journal.pone.0053479	http://dx.doi.org/10.1371/journal.pone.0053479			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308231	gold, Green Submitted, Green Published			2022-12-25	WOS:000313670100043
J	Ramachandran, A; Gangopadhyay, SS; Krishnan, R; Ranpura, SA; Rajendran, K; Ram-Mohan, S; Mulone, M; Gong, EM; Adam, RM				Ramachandran, Aruna; Gangopadhyay, Samudra S.; Krishnan, Ramaswamy; Ranpura, Sandeep A.; Rajendran, Kavitha; Ram-Mohan, Sumati; Mulone, Michelle; Gong, Edward M.; Adam, Rosalyn M.			JunB Mediates Basal- and TGF beta 1-Induced Smooth Muscle Cell Contractility	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; GROWTH-FACTOR-BETA; GENE-EXPRESSION; TRANSFORMING GROWTH-FACTOR-BETA-1; ACTIN; FIBROBLASTS; MODULATION; INDUCTION; REGULATOR; PROTEINS	Smooth muscle contraction is a dynamic process driven by acto-myosin interactions that are controlled by multiple regulatory proteins. Our studies have shown that members of the AP-1 transcription factor family control discrete behaviors of smooth muscle cells (SMC) such as growth, migration and fibrosis. However, the role of AP-1 in regulation of smooth muscle contractility is incompletely understood. In this study we show that the AP-1 family member JunB regulates contractility in visceral SMC by altering actin polymerization and myosin light chain phosphorylation. JunB levels are robustly upregulated downstream of transforming growth factor beta-1 (TGF beta 1), a known inducer of SMC contractility. RNAi-mediated silencing of JunB in primary human bladder SMC (pBSMC) inhibited cell contractility under both basal and TGF beta 1-stimulated conditions, as determined using gel contraction and traction force microscopy assays. JunB knockdown did not alter expression of the contractile proteins alpha-SMA, calponin or SM22 alpha. However, JunB silencing decreased levels of Rho kinase (ROCK) and myosin light chain (MLC20). Moreover, JunB silencing attenuated phosphorylation of the MLC20 regulatory phosphatase subunit MYPT1 and the actin severing protein cofilin. Consistent with these changes, cells in which JunB was knocked down showed a reduction in the F:G actin ratio in response to TGF beta 1. Together these findings demonstrate a novel function for JunB in regulating visceral smooth muscle cell contractility through effects on both myosin and the actin cytoskeleton.	[Ramachandran, Aruna; Gangopadhyay, Samudra S.; Ranpura, Sandeep A.; Mulone, Michelle; Gong, Edward M.; Adam, Rosalyn M.] Boston Childrens Hosp, Urol Dis Res Ctr, Boston, MA USA; [Ramachandran, Aruna; Gangopadhyay, Samudra S.; Ranpura, Sandeep A.; Gong, Edward M.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Krishnan, Ramaswamy; Rajendran, Kavitha; Ram-Mohan, Sumati] Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA; [Krishnan, Ramaswamy] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Adam, RM (corresponding author), Boston Childrens Hosp, Urol Dis Res Ctr, Boston, MA USA.	rosalyn.adam@childrens.harvard.edu			National Institutes of Health (NIH) [R21 DK66412, NIH R01 DK077195]; Edwin Beer Fellowship from the New York Academy of Medicine; AUA Foundation Research Scholar Program; Children's Hospital Boston Office of Fellowship Training; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK066412, R01DK077195] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edwin Beer Fellowship from the New York Academy of Medicine; AUA Foundation Research Scholar Program; Children's Hospital Boston Office of Fellowship Training; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) R21 DK66412, NIH R01 DK077195, Edwin Beer Fellowship from the New York Academy of Medicine, AUA Foundation Research Scholar Program, and the Children's Hospital Boston Office of Fellowship Training. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceves SS, 2010, J ALLERGY CLIN IMMUN, V126, P1198, DOI 10.1016/j.jaci.2010.08.050; Adam RM, 2004, PHYSIOL GENOMICS, V20, P36, DOI 10.1152/physiolgenomics.00181.2004; Akiho H, 2005, GASTROENTEROLOGY, V129, P131, DOI 10.1053/j.gastro.2005.03.049; Avouac J, 2012, ARTHRITIS RHEUM-US, V64, P1642, DOI 10.1002/art.33501; Baskin LS, 1996, LAB INVEST, V75, P157; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Borer JG, 1999, LAB INVEST, V79, P1335; Camoretti-Mercado B, 2003, RESP PHYSIOL NEUROBI, V137, P223, DOI 10.1016/S1569-9048(03)00149-6; Chen SY, 2003, NUCLEIC ACIDS RES, V31, P1302, DOI 10.1093/nar/gkg224; Connelly JT, 2010, NAT CELL BIOL, V12, P711, DOI 10.1038/ncb2074; Fitzgibbon J, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-2; Gervasi M, 2012, J CELL BIOL, V196, P589, DOI 10.1083/jcb.201109045; Grainger DJ, 1998, J CELL SCI, V111, P2977; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; Guo Xia, 2012, World J Biol Chem, V3, P41, DOI 10.4331/wjbc.v3.i3.41; Hocevar BA, 2000, METH MOL B, V142, P97; Hu YB, 2006, LUNG, V184, P33, DOI 10.1007/s00408-005-2560-5; Kim JH, 2005, AM J PHYSIOL-LUNG C, V289, pL511, DOI 10.1152/ajplung.00027.2005; Kropp BP, 1999, J UROLOGY, V162, P1779, DOI 10.1016/S0022-5347(05)68237-7; LAIHO M, 1991, MOL CELL BIOL, V11, P972, DOI 10.1128/MCB.11.2.972; Langlois D, 2010, TRANSGENIC RES, V19, P1069, DOI 10.1007/s11248-010-9379-4; Licht AH, 2010, J CLIN INVEST, V120, P2307, DOI 10.1172/JCI41749; Lien SC, 2006, CELL SIGNAL, V18, P1270, DOI 10.1016/j.cellsig.2005.10.013; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200; Mauviel A, 1996, J BIOL CHEM, V271, P10917, DOI 10.1074/jbc.271.18.10917; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Parekh A, 2009, J UROLOGY, V182, P1210, DOI 10.1016/j.juro.2009.05.002; PERTOVAARA L, 1989, MOL CELL BIOL, V9, P1255, DOI 10.1128/MCB.9.3.1255; Ramachandran A, 2011, AM J PATHOL, V179, P2977, DOI 10.1016/j.ajpath.2011.08.034; Ramachandran A, 2010, AM J PATHOL, V177, P119, DOI 10.2353/ajpath.2010.090772; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Stehr M, 2004, J UROLOGY, V172, P2451, DOI 10.1097/01.ju.0000138084.53577.ca; Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Zderic SA, 2012, J CELL MOL MED, V16, P203, DOI 10.1111/j.1582-4934.2011.01368.x	37	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53430	10.1371/journal.pone.0053430	http://dx.doi.org/10.1371/journal.pone.0053430			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308222	Green Published, gold, Green Submitted			2022-12-25	WOS:000313670100041
J	Stein, ED; White, BP; Mazor, RD; Miller, PE; Pilgrim, EM				Stein, Eric D.; White, Bryan P.; Mazor, Raphael D.; Miller, Peter E.; Pilgrim, Erik M.			Evaluating Ethanol-based Sample Preservation to Facilitate Use of DNA Barcoding in Routine Freshwater Biomonitoring Programs Using Benthic Macroinvertebrates	PLOS ONE			English	Article							PLANT; LIFE	Molecular methods, such as DNA barcoding, have the potential to enhance biomonitoring programs worldwide. Altering routinely used sample preservation methods to protect DNA from degradation may pose a potential impediment to application of DNA barcoding and metagenomics for biomonitoring using benthic macroinvertebrates. Using higher volumes or concentrations of ethanol, requirements for shorter holding times, or the need to include additional filtering may increase cost and logistical constraints to existing biomonitoring programs. To address this issue we evaluated the efficacy of various ethanol-based sample preservation methods at maintaining DNA integrity. We evaluated a series of methods that were minimally modified from typical field protocols in order to identify an approach that can be readily incorporated into existing monitoring programs. Benthic macroinvertebrates were collected from a minimally disturbed stream in southern California, USA and subjected to one of six preservation treatments. Ten individuals from five taxa were selected from each treatment and processed to produce DNA barcodes from the mitochondrial gene cytochrome c oxidase I (COI). On average, we obtained successful COI sequences (i.e. either full or partial barcodes) for between 93-99% of all specimens across all six treatments. As long as samples were initially preserved in 95% ethanol, successful sequencing of COI barcodes was not affected by a low dilution ratio of 2: 1, transfer to 70% ethanol, presence of abundant organic matter, or holding times of up to six months. Barcoding success varied by taxa, with Leptohyphidae (Ephemeroptera) producing the lowest barcode success rate, most likely due to poor PCR primer efficiency. Differential barcoding success rates have the potential to introduce spurious results. However, routine preservation methods can largely be used without adverse effects on DNA integrity.	[Stein, Eric D.; White, Bryan P.; Mazor, Raphael D.] So Calif Coastal Water Res Project, Costa Mesa, CA USA; [Miller, Peter E.] Univ Guelph, Canadian Ctr DNA Barcoding, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Pilgrim, Erik M.] US EPA, Natl Exposure Res Lab, Cincinnati, OH 45268 USA	Southern California Coastal Water Research Project; University of Guelph; United States Environmental Protection Agency	Stein, ED (corresponding author), So Calif Coastal Water Res Project, Costa Mesa, CA USA.	erics@sccwrp.org	Stein, Eric D./A-9362-2008	Stein, Eric D./0000-0002-4729-809X; White, Bryan/0000-0003-4191-3511	Southern California Coastal Water Research Project, general research budget	Southern California Coastal Water Research Project, general research budget	The work was supported by internal agency funding from the Southern California Coastal Water Research Project as part of the general research budget. Molecular analysis was conducted by the Canadian Centre for DNA Barcoding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bainard LD, 2010, J MICROBIOL METH, V82, P124, DOI 10.1016/j.mimet.2010.05.001; Baird DJ, 2011, J N AM BENTHOL SOC, V30, P125, DOI 10.1899/10-013.1; Borisenko AV, 2009, MOL ECOL RESOUR, V9, P27, DOI 10.1111/j.1755-0998.2009.02629.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Flournoy LE, 1996, BIOTECHNIQUES, V20, P657; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gaston GR, 1996, ESTUARIES, V19, P674, DOI 10.2307/1352527; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hauer F. Richard, 1996, P339; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Konig U, 2012, J APPL ICHTHYOL, P1; Merritt RW, 2008, INTRO AQUATIC INSECT, p15 to 37; Meyer CP, 2003, BIOL J LINN SOC, V79, P401, DOI 10.1046/j.1095-8312.2003.00197.x; Morris K, 2012, ANGELES RIVER STATE; Nagy ZT, 2010, ORG DIVERS EVOL, V10, P91, DOI 10.1007/s13127-010-0012-4; Pilgrim EM, 2011, J N AM BENTHOL SOC, V30, P217, DOI 10.1899/10-012.1; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Stoeckle MY, 2008, SCI AM, V299, P82; Sweeney BW, 2011, J N AM BENTHOL SOC, V30, P195, DOI 10.1899/10-016.1; Szinwelski N, 2012, ZOOKEYS, P11, DOI 10.3897/zookeys.196.3130; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Zhou X, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-30	26	47	51	3	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e51273	10.1371/journal.pone.0051273	http://dx.doi.org/10.1371/journal.pone.0051273			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308097	Green Published, Green Submitted, gold			2022-12-25	WOS:000313670100003
J	Doppler, H; Liou, GY; Storz, P				Doeppler, Heike; Liou, Geou-Yarh; Storz, Peter			Downregulation of TRAF2 Mediates NIK-Induced Pancreatic Cancer Cell Proliferation and Tumorigenicity	PLOS ONE			English	Article							NF-KAPPA-B; MULTIPLE-MYELOMA; ACTIVATION; APOPTOSIS; PATHWAY; PROTEIN; ALPHA; IAPS; UBIQUITINATION; DEGRADATION	Background: Increased levels of NF-kappa B are hallmarks of pancreatic ductal adenocarcinoma (PDAC) and both classical and alternative NF-kappa B activation pathways have been implicated. Methodology/Principal Findings: Here we show that activation of the alternative pathway is a source for the high basal NF-kappa B activity in PDAC cell lines. Increased activity of the p52/RelB NF-kappa B complex is mediated through stabilization and activation of NF-kappa B-inducing kinase (NIK). We identify proteasomal downregulation of TNF receptor-associated factor 2 (TRAF2) as a mechanism by which levels of active NIK are increased in PDAC cell lines. Such upregulation of NIK expression and activity levels relays to increased proliferation and anchorage-independent growth, but not migration or survival of PDAC cells. Conclusions/Significance: Rapid growth is one characteristic of pancreatic cancer. Our data indicates that the TRAF2/NIK/NF-kappa B2 pathway regulates PDAC cell tumorigenicity and could be a valuable target for therapy of this cancer.	[Doeppler, Heike; Liou, Geou-Yarh; Storz, Peter] Mayo Clin, Mayo Clin Comprehens Canc Ctr, Dept Canc Biol, Jacksonville, FL 32224 USA	Mayo Clinic	Storz, P (corresponding author), Mayo Clin, Mayo Clin Comprehens Canc Ctr, Dept Canc Biol, Jacksonville, FL 32224 USA.	storz.peter@mayo.edu			AACR [08-20-25-STOR]; National Institutes of Health [CA135102, CA140182, P50CA102701]; Pancreatic Cancer Action Network (PanCAN); Patty Boshell Pancreatic Cancer Foundation; NATIONAL CANCER INSTITUTE [P50CA102701, R21CA135102, R01CA140182] Funding Source: NIH RePORTER	AACR; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pancreatic Cancer Action Network (PanCAN); Patty Boshell Pancreatic Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the AACR (08-20-25-STOR), the National Institutes of Health grants CA135102, CA140182 and P50CA102701 (Mayo Clinic SPORE in Pancreatic Cancer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank our colleagues in the Storz laboratory for helpful discussions and Jenni Bachhofer for help with the manuscript. We also thank the Pancreatic Cancer Action Network (PanCAN) and the Patty Boshell Pancreatic Cancer Foundation for their support.	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Bastea LI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030459; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Chandler NM, 2004, J SURG RES, V118, P9, DOI 10.1016/S0022-4804(03)00354-8; Cowell CF, 2009, J CELL BIOCHEM, V106, P714, DOI 10.1002/jcb.22067; Derudder E, 2003, J BIOL CHEM, V278, P23278, DOI 10.1074/jbc.M300106200; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Nishina T, 2009, BIOCHEM BIOPH RES CO, V388, P96, DOI 10.1016/j.bbrc.2009.07.125; Pan X, 2008, CLIN CANCER RES, V14, P8143, DOI 10.1158/1078-0432.CCR-08-1539; Radutovich N, 2008, METHOD ENZYMOL, V439, P1, DOI 10.1016/S0076-6879(07)00401-6; Schneider G, 2006, EMBO J, V25, P3801, DOI 10.1038/sj.emboj.7601259; Thu YM, 2010, CYTOKINE GROWTH F R, V21, P213, DOI 10.1016/j.cytogfr.2010.06.002; Trauzold A, 2005, FASEB J, V19, P620, DOI 10.1096/fj.04-2984fje; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Wajant H, 2011, FEBS J, V278, P862, DOI 10.1111/j.1742-4658.2011.08015.x; Wang WX, 1999, CLIN CANCER RES, V5, P119; Wharry CE, 2009, CANCER BIOL THER, V8, P1567, DOI 10.4161/cbt.8.16.8961; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676	27	29	29	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53676	10.1371/journal.pone.0053676	http://dx.doi.org/10.1371/journal.pone.0053676			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301098	Green Submitted, Green Published, gold			2022-12-25	WOS:000313480000074
J	Zhou, F; Xue, M; Qin, D; Zhu, XF; Wang, C; Zhu, JZ; Hao, TT; Cheng, L; Chen, XY; Bai, ZQ; Feng, NH; Gao, SJ; Lu, C				Zhou, Feng; Xue, Min; Qin, Di; Zhu, Xiaofei; Wang, Cong; Zhu, Jianzhong; Hao, Tingting; Cheng, Lin; Chen, Xiuying; Bai, Zhiqiang; Feng, Ninghan; Gao, Shou-Jiang; Lu, Chun			HIV-1 Tat Promotes Kaposi's Sarcoma-Associated Herpesvirus (KSHV) vIL-6-Induced Angiogenesis and Tumorigenesis by Regulating PI3K/PTEN/AKT/GSK-3 beta Signaling Pathway	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LYTIC CYCLE REPLICATION; GROWTH-FACTOR; PROTEIN; ACTIVATION; AIDS; INDUCTION; RECEPTOR; CELLS; VGPCR	Kaposi's sarcoma (KS)-associated herpesvirus (KSHV) is etiologically associated with KS, the most common AIDS-related malignancy. KS is characterized by vast angiogenesis and hyperproliferative spindle cells. We have previously reported that HIV-1 Tat can trigger KSHV reactivation and accelerate Kaposin A-induced tumorigenesis. Here, we explored Tat promotion of KSHV vIL-6-induced angiogenesis and tumorigenesis. Tat promotes vIL-6-induced cell proliferation, cellular transformation, vascular tube formation and VEGF production in culture. Tat enhances vIL-6-induced angiogenesis and tumorigenesis of fibroblasts and human endothelial cells in a chicken chorioallantoic membrane (CAM) model. In an allograft model, Tat promotes vIL-6-induced tumorigenesis and expression of CD31, CD34, SMA, VEGF, b-FGF, and cyclin D1. Mechanistic studies indicated Tat activates PI3K and AKT, and inactivates PTEN and GSK-3 beta in vIL-6 expressing cells. LY294002, a specific inhibitor of PI3K, effectively impaired Tat's promotion of vIL-6-induced tumorigenesis. Together, these results provide the first evidence that Tat might contribute to KS pathogenesis by synergizing with vIL-6, and identify PI3K/AKT pathway as a potential therapeutic target in AIDS-related KS patients.	[Zhou, Feng; Lu, Chun] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Zhou, Feng; Lu, Chun] Nanjing Med Univ, Key Lab Pathogen Biol Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Zhou, Feng; Xue, Min; Qin, Di; Zhu, Xiaofei; Hao, Tingting; Cheng, Lin; Chen, Xiuying; Bai, Zhiqiang; Lu, Chun] Nanjing Med Univ, Dept Microbiol & Immunol, Nanjing, Jiangsu, Peoples R China; [Zhou, Feng] Xuzhou Med Coll, Dept Pathogen Biol & Immunol, Xuzhou, Jiangsu, Peoples R China; [Xue, Min] Xuzhou Med Coll, Dept Physiol, Xuzhou, Jiangsu, Peoples R China; [Wang, Cong] Nanjing Med Univ, Affiliated Hosp 1, Dept Pathol, Nanjing, Jiangsu, Peoples R China; [Zhu, Jianzhong] Univ Pittsburgh, Inst Canc, Canc Virol Program, Pittsburgh, PA USA; [Feng, Ninghan] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China; [Gao, Shou-Jiang] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Xuzhou Medical University; Xuzhou Medical University; Nanjing Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Nanjing Medical University; University of Southern California	Lu, C (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	clu@njmu.edu.cn	Gao, Shou-Jiang/B-8641-2012; Feng, Ninghan/ABA-8996-2021; Feng, ninghan/ABB-3726-2021	Lu, Chun/0000-0002-6078-9352; Gao, Shou-Jiang/0000-0001-6194-1742	National Basic Research Program of China (973 Program) [2011CB504803]; National Natural Science Foundation of China [30972619, 81171552, 30900064, 31270199]; Natural Science Foundation of Ministry of Education of Jiangsu Province [10KJA310032, 09KJB310007]; Research Fund for the Doctoral Program of Higher Education of China (New Teacher Fund) [20093234120004]; Natural Science Foundation of Jiangsu Province [BK2010577]; Jiangsu Province's Outstanding Medical Academic Leader Program [RC201178]; China Postdoctoral Science Foundation [2012M511304]; NATIONAL CANCER INSTITUTE [R01CA132637, R01CA124332] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Ministry of Education of Jiangsu Province; Research Fund for the Doctoral Program of Higher Education of China (New Teacher Fund); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Jiangsu Province's Outstanding Medical Academic Leader Program; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Basic Research Program of China (973 Program) (2011CB504803), National Natural Science Foundation of China grants 30972619 and 81171552 to C.L., 30900064 to D.Q., and 31270199 to Z.B.), Natural Science Foundation of Ministry of Education of Jiangsu Province (great project 10KJA310032 to C.L. and grant 09KJB310007 to D.Q.), Research Fund for the Doctoral Program of Higher Education of China (New Teacher Fund, grant 20093234120004 to D.Q.), Natural Science Foundation of Jiangsu Province (BK2010577 to N.F.), Jiangsu Province's Outstanding Medical Academic Leader Program (RC201178 to N.F.), and China Postdoctoral Science Foundation (2012M511304 to Z.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam N, 2009, J VIROL, V83, P5117, DOI 10.1128/JVI.01601-08; Agwale SM, 2002, P NATL ACAD SCI USA, V99, P10037, DOI 10.1073/pnas.152313899; Aoki Y, 1999, BLOOD, V93, P4034, DOI 10.1182/blood.V93.12.4034.412k38_4034_4043; Aranda E, 2009, BIOL RES, V42, P377, DOI [/S0716-97602009000300012, 10.4067/S0716-97602009000300012]; BARILLARI G, 1993, P NATL ACAD SCI USA, V90, P7941, DOI 10.1073/pnas.90.17.7941; BERAL V, 1990, LANCET, V335, P123, DOI 10.1016/0140-6736(90)90001-L; Boykins RA, 1999, J IMMUNOL, V163, P15; Burger R, 1998, BLOOD, V91, P1858, DOI 10.1182/blood.V91.6.1858.1858_1858_1863; Cafaro A, 1999, NAT MED, V5, P643, DOI 10.1038/9488; Cantaluppi V, 2001, AIDS RES HUM RETROV, V17, P965, DOI 10.1089/088922201750290087; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chatterjee M, 2002, SCIENCE, V298, P1432, DOI 10.1126/science.1074883; Chen XY, 2009, NEOPLASIA, V11, P1272, DOI 10.1593/neo.09494; Deng HY, 2002, J VIROL, V76, P8252, DOI 10.1128/JVI.76.16.8252-8264.2002; Deregibus MC, 2002, J BIOL CHEM, V277, P25195, DOI 10.1074/jbc.M200921200; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; ENSOLI B, 1994, NATURE, V371, P674, DOI 10.1038/371674a0; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Gallo RC, 1998, SCIENCE, V282, P1837, DOI 10.1126/science.282.5395.1837; Ganem D, 2010, J CLIN INVEST, V120, P939, DOI 10.1172/JCI40567; Geras-Raaka E, 1998, J EXP MED, V188, P405, DOI 10.1084/jem.188.2.405; Greene Whitney, 2007, Cancer Treat Res, V133, P69; Guo HG, 2004, J VIROL, V78, P9336, DOI 10.1128/JVI.78.17.9336-9342.2004; Harrington W, 1997, LANCET, V349, P774; Jiang BH, 2009, ADV CANCER RES, V102, P19, DOI 10.1016/S0065-230X(09)02002-8; Lei XF, 2010, NAT CELL BIOL, V12, P193, DOI 10.1038/ncb2019; Lempiainen H, 2009, EMBO J, V28, P3067, DOI 10.1038/emboj.2009.281; Martin D, 2011, CANCER CELL, V19, P805, DOI 10.1016/j.ccr.2011.05.005; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; Montaner S, 2007, CELL CYCLE, V6, P438, DOI 10.4161/cc.6.4.3843; Moore PS, 1996, SCIENCE, V274, P1739, DOI 10.1126/science.274.5293.1739; Morris VA, 2008, J VIROL, V82, P8771, DOI 10.1128/JVI.00766-08; Pati S, 2003, J VIROL, V77, P5759, DOI 10.1128/JVI.77.10.5759-5773.2003; Qin D, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-240; Rusnati Marco, 2002, Angiogenesis, V5, P141, DOI 10.1023/A:1023892223074; SELBY MJ, 1989, GENE DEV, V3, P547, DOI 10.1101/gad.3.4.547; Sgarbanti M, 2004, ONCOGENE, V23, P5770, DOI 10.1038/sj.onc.1207707; Suthaus J, 2011, EUR J CELL BIOL, V90, P495, DOI 10.1016/j.ejcb.2010.10.016; Tang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031652; Wan XY, 1999, J VIROL, V73, P8268, DOI 10.1128/JVI.73.10.8268-8278.1999; Wood NH, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-14; Zeng Y, 2007, J VIROL, V81, P2401, DOI 10.1128/JVI.02024-06; Zhu XL, 2011, J MOL BIOL, V410, P1035, DOI 10.1016/j.jmb.2011.03.055; Ziegelbauer JM, 2011, BBA-GENE REGUL MECH, V1809, P623, DOI 10.1016/j.bbagrm.2011.05.003	46	68	75	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53145	10.1371/journal.pone.0053145	http://dx.doi.org/10.1371/journal.pone.0053145			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301033	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000313320900064
J	Bradburne, CE; Verhoeven, AB; Manyam, GC; Chaudhry, SA; Chang, EL; Thach, DC; Bailey, CL; van Hoek, ML				Bradburne, Christopher E.; Verhoeven, Anne B.; Manyam, Ganiraju C.; Chaudhry, Saira A.; Chang, Eddie L.; Thach, Dzung C.; Bailey, Charles L.; van Hoek, Monique L.			Temporal Transcriptional Response during Infection of Type II Alveolar Epithelial Cells with Francisella tularensis Live Vaccine Strain (LVS) Supports a General Host Suppression and Bacterial Uptake by Macropinocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNE-RESPONSE; MURINE MACROPHAGES; MICROARRAY ANALYSIS; RESPIRATORY CHALLENGE; PULMONARY INFECTION; TULAREMIA VACCINE; YERSINIA EFFECTOR; INDUCED APOPTOSIS; HUMAN MONOCYTES; SEVERE SEPSIS	Pneumonic tularemia is caused by inhalation of Francisella tularensis, one of the most infectious microbes known. We wanted to study the kinetics of the initial and early interactions between bacterium and host cells in the lung. To do this, we examined the infection of A549 airway epithelial cells with the live vaccine strain (LVS) of F. tularensis. A549 cells were infected and analyzed for global transcriptional response at multiple time points up to 16 h following infection. At 15 min and 2 h, a strong transcriptional response was observed including cytoskeletal rearrangement, intracellular transport, and interferon signaling. However, at later time points (6 and 16 h), very little differential gene expression was observed, indicating a general suppression of the host response consistent with other reported cell lines and murine tissues. Genes for macropinocytosis and actin/cytoskeleton rearrangement were highly up-regulated and common to the 15 min and 2 h time points, suggesting the use of this method for bacterial entry into cells. We demonstrate macropinocytosis through the uptake of FITC-dextran and amiloride inhibition of Francisella LVS uptake. Our results suggest that macropinocytosis is a potential mechanism of intracellular entry by LVS and that the host cell response is suppressed during the first 2-6 h of infection. These results suggest that the attenuated Francisella LVS induces significant host cell signaling at very early time points after the bacteria's interaction with the cell.	[Bradburne, Christopher E.; Chang, Eddie L.; Thach, Dzung C.] USN, Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC 20375 USA; [Bradburne, Christopher E.] Johns Hopkins Univ, Appl Phys Lab, Asymmetr Operat Dept, Laurel, MD 20723 USA; [Verhoeven, Anne B.; Manyam, Ganiraju C.; Chaudhry, Saira A.; van Hoek, Monique L.] George Mason Univ, Sch Syst Biol, Manassas, VA 20110 USA; [Manyam, Ganiraju C.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Thach, Dzung C.] NIAID, NIH, Bethesda, MD 20892 USA; [Bailey, Charles L.; van Hoek, Monique L.] George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA 20110 USA	United States Department of Defense; United States Navy; Naval Research Laboratory; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; George Mason University; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); George Mason University	van Hoek, ML (corresponding author), George Mason Univ, Discovery Hall,MSN 1H8,10910 Univ Blvd, Manassas, VA 20110 USA.	mvanhoek@gmu.edu	Manyam, Ganiraju/E-9150-2012; van Hoek, Monique/E-1629-2011; Manyam, Ganiraju C/B-5890-2014	Manyam, Ganiraju/0000-0001-6006-8961; van Hoek, Monique/0000-0003-1679-4899; Bradburne, Christopher/0000-0003-4968-8208; Ahmad, Saira/0000-0002-5339-7211	Joint Science and Technology Office for Chemical and Biological Defense/Defense Threat Reduction Agency; U.S. Army Medical Research and Material Command [W81XWH-06-C-0360, HDTRA1-12-C-0039]; National Research Council	Joint Science and Technology Office for Chemical and Biological Defense/Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); U.S. Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Research Council(Consiglio Nazionale delle Ricerche (CNR))	This work was supported through the Joint Science and Technology Office for Chemical and Biological Defense/Defense Threat Reduction Agency and contracted through the U.S. Army Medical Research and Material Command under Contract No. W81XWH-06-C-0360 (to A. B. V., C. L. B., and M. V. H.) and HDTRA1-12-C-0039 (to M. V. H.).; Supported by a fellowship from the National Research Council while at the Center for Bio/Molecular Science and Engineering/United States Naval Research Laboratory and by internal funding from the Asymmetric Operations Department while at Johns Hopkins University/Applied Physics Laboratory.	Ahmad S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-123; Akimana C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011025; Alvord WG, 2007, BRIEF BIOINFORM, V8, P415, DOI 10.1093/bib/bbm043; Andersson H, 2006, J MED MICROBIOL, V55, P1023, DOI 10.1099/jmm.0.46553-0; Asare R, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2010.00145; Belperio JA, 2002, J CLIN INVEST, V110, P1703, DOI 10.1172/JCI200215849; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.2307/1165312; Bolger CE, 2005, J LEUKOCYTE BIOL, V77, P893, DOI 10.1189/jlb.1104637; Butchar JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002924; Chong A, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00138; Clemens DL, 2012, INFECT IMMUN, V80, P952, DOI 10.1128/IAI.05221-11; Clemens DL, 2005, INFECT IMMUN, V73, P5892, DOI 10.1128/IAI.73.9.5892-5902.2005; Cole LE, 2008, J IMMUNOL, V180, P6885, DOI 10.4049/jimmunol.180.10.6885; Cole LE, 2007, INFECT IMMUN, V75, P4127, DOI 10.1128/IAI.01868-06; Cole LE, 2006, J IMMUNOL, V176, P6888, DOI 10.4049/jimmunol.176.11.6888; Cole LE, 2011, J LEUKOCYTE BIOL, V90, P787, DOI 10.1189/jlb.0111014; Cole LE, 2010, J LEUKOCYTE BIOL, V87, P275, DOI 10.1189/jlb.0909619; Craven RR, 2008, INFECT IMMUN, V76, P2833, DOI 10.1128/IAI.00043-08; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; DRABICK JJ, 1994, AM J MED SCI, V308, P83, DOI 10.1097/00000441-199408000-00003; Duits LA, 2002, IMMUNOLOGY, V106, P517, DOI 10.1046/j.1365-2567.2002.01430.x; Elkins KL, 2003, MICROBES INFECT, V5, P135, DOI 10.1016/S1286-4579(02)00084-9; Garcia-Perez BE, 2008, MICROB PATHOGENESIS, V45, P1, DOI 10.1016/j.micpath.2008.01.009; Garcia-Perez BE, 2003, MICROB PATHOGENESIS, V35, P49, DOI 10.1016/S0882-4010(03)00089-5; Hall JD, 2007, INFECT IMMUN, V75, P1034, DOI 10.1128/IAI.01254-06; Han S, 2008, BIOCHEM BIOPH RES CO, V371, P670, DOI 10.1016/j.bbrc.2008.04.092; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hrstka R, 2005, MICROBES INFECT, V7, P619, DOI 10.1016/j.micinf.2004.12.020; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Katz J, 2006, INFECT IMMUN, V74, P2809, DOI 10.1128/IAI.74.5.2809-2816.2006; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; Lai XH, 2001, INFECT IMMUN, V69, P4691, DOI 10.1128/IAI.69.7.4691-4694.2001; Lai XH, 2003, INFECT IMMUN, V71, P4642, DOI 10.1128/IAI.71.8.4642-4646.2003; Lai XH, 2004, MICROB PATHOGENESIS, V37, P225, DOI 10.1016/j.micpath.2004.07.002; Law HT, 2011, SCI REP-UK, V1, DOI 10.1038/srep00192; Li HF, 2006, J LEUKOCYTE BIOL, V80, P766, DOI 10.1189/jlb.0406294; Lindemann SR, 2007, INFECT IMMUN, V75, P3178, DOI 10.1128/IAI.01811-06; Lundequist A, 2011, MOL IMMUNOL, V48, P1753, DOI 10.1016/j.molimm.2011.04.017; MacRedmond R, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-116; Malik M, 2007, J IMMUNOL, V178, P1013, DOI 10.4049/jimmunol.178.2.1013; Mares CA, 2008, INFECT IMMUN, V76, P3001, DOI 10.1128/IAI.00215-08; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Meibom KL, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00140; Meier O, 2002, J CELL BIOL, V158, P1119, DOI 10.1083/jcb.200112067; Nano FE, 2004, J BACTERIOL, V186, P6430, DOI 10.1128/JB.186.19.6430-6436.2004; Nikolsky Y, 2005, DRUG DISCOV TODAY, V10, P653, DOI 10.1016/S1359-6446(05)03420-3; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920; Parsa KVL, 2008, MOL IMMUNOL, V45, P3012, DOI 10.1016/j.molimm.2008.01.011; Parsa KVL, 2006, PLOS PATHOG, V2, P681, DOI 10.1371/journal.ppat.0020071; Pei LM, 2006, MOL ENDOCRINOL, V20, P786, DOI 10.1210/me.2005-0331; Pei LM, 2005, J BIOL CHEM, V280, P29256, DOI 10.1074/jbc.M502606200; Perrin AJ, 2004, CURR BIOL, V14, P806, DOI 10.1016/j.cub.2004.04.033; Rajaram MVS, 2006, J IMMUNOL, V177, P6317, DOI 10.4049/jimmunol.177.9.6317; Rajaram MVS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007919; Ranjard L, 2003, APPL ENVIRON MICROB, V69, P3784, DOI 10.1128/AEM.69.7.3784-3790.2003; RAZAK AA, 1990, BIOL TRACE ELEM RES, V25, P187, DOI 10.1007/BF02990413; Reimers M, 2006, METHOD ENZYMOL, V411, P119, DOI 10.1016/S0076-6879(06)11008-3; Reutershan J, 2006, J CLIN INVEST, V116, P695, DOI 10.1172/JCI27009; Roden JC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-194; Rohmer L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r102; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; SASLAW S, 1961, AM J MED SCI, V241, P689, DOI 10.1097/00000441-196106000-00001; Schmerk CL, 2009, MICROBIOL-SGM, V155, P1498, DOI 10.1099/mic.0.025445-0; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; Sharma J, 2009, J LEUKOCYTE BIOL, V86, P491, DOI 10.1189/jlb.1208728; Shin S, 2008, CELL MICROBIOL, V10, P1209, DOI 10.1111/j.1462-5822.2008.01145.x; Shirey KA, 2008, J IMMUNOL, V181, P4159, DOI 10.4049/jimmunol.181.6.4159; SMYTH GK, 2007, LIMMA LINEAR MODELS; STADTMAN T C, 1989, Biofactors, V2, P35; Stadtman TC, 2002, J BIOL CHEM, V277, P49091, DOI 10.1074/jbc.X200005200; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Telepnev M, 2005, MICROB PATHOGENESIS, V38, P239, DOI 10.1016/j.micpath.2005.02.003; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veiga E, 2005, TRENDS CELL BIOL, V15, P2, DOI 10.1016/j.tcb.2004.11.005; Waag DM, 1996, FEMS IMMUNOL MED MIC, V13, P205, DOI 10.1111/j.1574-695X.1996.tb00238.x; Wehrly TD, 2009, CELL MICROBIOL, V11, P1128, DOI 10.1111/j.1462-5822.2009.01316.x; Wilson JE, 2009, INFECT IMMUN, V77, P4953, DOI 10.1128/IAI.00844-09; Wu TH, 2009, VACCINE, V27, P4684, DOI 10.1016/j.vaccine.2009.05.060	79	14	14	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10780	10791		10.1074/jbc.M112.362178	http://dx.doi.org/10.1074/jbc.M112.362178			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23322778	Green Published, hybrid			2022-12-25	WOS:000317565000056
J	Pan, Q; Tian, Y; Li, XH; Ye, J; Liu, Y; Song, LL; Yang, YT; Zhu, R; He, YH; Chen, L; Chen, WS; Mao, XH; Peng, ZH; Wang, RQ				Pan, Qiong; Tian, Yin; Li, Xiaohuan; Ye, Jun; Liu, Yun; Song, Lili; Yang, Yongtao; Zhu, Rong; He, Yonghong; Chen, Lei; Chen, Wensheng; Mao, Xuhu; Peng, Zhihong; Wang, Rongquan			Enhanced Membrane-tethered Mucin 3 (MUC3) Expression by a Tetrameric Branched Peptide with a Conserved TFLK Motif Inhibits Bacteria Adherence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN INTESTINAL MUCIN; SERUM AMYLOID A3; IN-VITRO; BOVINE COLOSTRUM; EPITHELIAL-CELLS; GENE-EXPRESSION; CARCINOMA CELLS; IV GENE; PROMOTER; TRANSCRIPTION	We investigated whether a synthetic tetrameric branched peptide based on the conserved TFLK motif from mammary-associated serum amyloid A3 (M-SAA3) is more efficient than the monomeric peptide at up-regulating MUC3 expression and examined the possible mechanism(s) and biological significance of this process. We used standard solid-phase methods to synthesize a tetrameric branched peptide (sequence GWLTFL-KAAG) containing a trilysine core, termed the TFLK-containing 10-mer BP. The aberrant expression of transcription factors was analyzed using a transcription factor protein/DNA array. MUC3 and relevant transcription factors were detected using real-time PCR and/or Western blots. The luciferase assay, EMSA, and ChIP assays were used to analyze the activity of the human MUC3 promoter. The bacterial adherence assay was used to evaluate the in vitro inhibition of enteropathogenic Escherichia coli or enterohemorrhage E. coli serotype O157:H7 (EHEC O157:H7) adherence to HT-29-Gal cells after treatment with the TFLK-containing 10-mer BP. In HT-29-Gal cells, the TFLK-containing 10-mer BP induced higher levels of MUC3 expression than the M-SAA3-derived N-terminal 10-mer monomeric peptide, and MUC3 expression was activated through transcriptional mechanisms, including the induction of multiple transcription factors and further binding with their cis-elements between nucleotides -242 and -62 within MUC3 promoter. Interestingly, the TFLK-containing 10-mer BP dramatically inhibited enteropathogenic E. coli and EHEC O157:H7 adherence to the HT-29-Gal cells compared with the controls. This finding suggests a potential therapeutic use for this peptide to prevent gastrointestinal infection.	[Pan, Qiong; Tian, Yin; Li, Xiaohuan; Ye, Jun; Liu, Yun; Song, Lili; Yang, Yongtao; Zhu, Rong; He, Yonghong; Chen, Lei; Chen, Wensheng; Peng, Zhihong; Wang, Rongquan] Third Mil Med Univ, Southwest Hosp, Dept Gastroenterol, Chongqing 400038, Peoples R China; [Mao, Xuhu] Third Mil Med Univ, Dept Clin Microbiol & Immunol, Chongqing 400038, Peoples R China	Army Medical University; Army Medical University	Peng, ZH (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Gastroenterol, Chongqing 400038, Peoples R China.	pengzhh@yahoo.com.cn; rongquanw@hotmail.com		Wang, Rongquan/0000-0001-5307-0086; ye, jun/0000-0002-0631-556X; pan, qiong/0000-0003-1033-3098	National Natural Science Foundation of China [30800519, 81170340]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 30800519 and 81170340.	Bodammer P, 2011, J NUTR, V141, P1056, DOI 10.3945/jn.110.128702; BOHM SK, 1995, BIOCHEM J, V311, P835; Caballero-Franco C, 2007, AM J PHYSIOL-GASTR L, V292, pG315, DOI 10.1152/ajpgi.00265.2006; Chai J, 2012, HEPATOLOGY, V55, P1485, DOI 10.1002/hep.24801; Domenech A, 2012, PROTEIN PEPTIDE LETT, V19, P299, DOI 10.2174/092986612799363217; Edwards PJ, 2009, CURR OPIN DRUG DISC, V12, P899; Erickson RH, 2000, GENE, V258, P77, DOI 10.1016/S0378-1119(00)00422-4; Falciani C, 2007, CHEM BIOL DRUG DES, V69, P216, DOI 10.1111/j.1747-0285.2007.00487.x; Gardiner GE, 2009, FEMS IMMUNOL MED MIC, V55, P404, DOI 10.1111/j.1574-695X.2009.00539.x; Gout S, 2004, EXP CELL RES, V299, P498, DOI 10.1016/j.yexcr.2004.06.008; GUERRANT RL, 1990, REV INFECT DIS, V12, pS41; Gum JR, 2003, J BIOL CHEM, V278, P49600, DOI 10.1074/jbc.M305769200; Gum JR, 1997, BIOCHEM J, V325, P259, DOI 10.1042/bj3250259; Ho NK, 2012, INFECT IMMUN, V80, P2307, DOI 10.1128/IAI.00255-12; Ho SB, 2010, BBA-GEN SUBJECTS, V1800, P629, DOI 10.1016/j.bbagen.2010.03.010; JARVIS KG, 1995, P NATL ACAD SCI USA, V92, P7996, DOI 10.1073/pnas.92.17.7996; Jin ZH, 2010, BIOL PHARM BULL, V33, P370, DOI 10.1248/bpb.33.370; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Larson MA, 2003, BIOCHEM BIOPH RES CO, V300, P531, DOI 10.1016/S0006-291X(02)02901-7; Lieleg O, 2012, BIOMACROMOLECULES, V13, P1724, DOI 10.1021/bm3001292; Linden SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003952; Luu Y, 2010, INT J BIOCHEM CELL B, V42, P996, DOI 10.1016/j.biocel.2010.03.001; Mack DR, 2003, GUT, V52, P827, DOI 10.1136/gut.52.6.827; Mack DR, 2003, PEDIATR RES, V53, P137, DOI 10.1203/01.PDR.0000041517.15440.F3; MACK DR, 1994, BIOCHEM BIOPH RES CO, V199, P1012, DOI 10.1006/bbrc.1994.1330; Mack DR, 1999, AM J PHYSIOL-GASTR L, V276, pG941, DOI 10.1152/ajpgi.1999.276.4.G941; Moller HK, 2011, BRIT J NUTR, V105, P44, DOI 10.1017/S0007114510003168; Pini A, 2010, FASEB J, V24, P1015, DOI 10.1096/fj.09-145474; Playford RJ, 2000, AM J CLIN NUTR, V72, P5; Ponticelli S, 2008, J BIOL CHEM, V283, P34250, DOI 10.1074/jbc.M806607200; Rawal P, 2008, INDIAN J PEDIATR, V75, P917, DOI 10.1007/s12098-008-0192-5; Ruvo M, 2011, CURR MED CHEM, V18, P2429, DOI 10.2174/092986711795843191; Sakai H, 2011, INT IMMUNOPHARMACOL, V11, P1133, DOI 10.1016/j.intimp.2011.02.014; Shekels LL, 2003, BBA-GENE STRUCT EXPR, V1627, P90, DOI 10.1016/S0167-4781(03)00081-2; Shin DS, 2005, J BIOCHEM MOL BIOL, V38, P517; Traber PG, 1996, ANNU REV PHYSIOL, V58, P275, DOI 10.1146/annurev.physiol.58.1.275; VELCICH A, 1995, CELL GROWTH DIFFER, V6, P749	37	18	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5407	5416		10.1074/jbc.M112.408245	http://dx.doi.org/10.1074/jbc.M112.408245			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23316049	hybrid, Green Published			2022-12-25	WOS:000315342500016
J	Kalirai, SS; Bazylinski, DA; Hitchcock, AP				Kalirai, Samanbir S.; Bazylinski, Dennis A.; Hitchcock, Adam P.			Anomalous Magnetic Orientations of Magnetosome Chains in a Magnetotactic Bacterium: Magnetovibrio blakemorei Strain MV-1	PLOS ONE			English	Article							REMANENCE MEASUREMENTS; MOLECULAR-MECHANISMS; PROTEIN; BIOMINERALIZATION; BEAMLINE; MARINE; FE3O4; GENE	There is a good deal of published evidence that indicates that all magnetosomes within a single cell of a magnetotactic bacterium are magnetically oriented in the same direction so that they form a single magnetic dipole believed to assist navigation of the cell to optimal environments for their growth and survival. Some cells of the cultured magnetotactic bacterium Magnetovibrio blakemorei strain MV-1 are known to have relatively wide gaps between groups of magnetosomes that do not seem to interfere with the larger, overall linear arrangement of the magnetosomes along the long axis of the cell. We determined the magnetic orientation of the magnetosomes in individual cells of this bacterium using Fe 2p X-ray magnetic circular dichroism (XMCD) spectra measured with scanning transmission X-ray microscopy (STXM). We observed a significant number of cases in which there are sub-chains in a single cell, with spatial gaps between them, in which one or more sub-chains are magnetically polarized opposite to other sub-chains in the same cell. These occur with an estimated frequency of 4.0 +/- 0.2%, based on a sample size of 150 cells. We propose possible explanations for these anomalous cases which shed insight into the mechanisms of chain formation and magnetic alignment.	[Kalirai, Samanbir S.; Hitchcock, Adam P.] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON, Canada; [Bazylinski, Dennis A.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA	McMaster University; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Hitchcock, AP (corresponding author), McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON, Canada.	aph@mcmaster.ca			Canada Foundation for Innovation (CFI); NSERC; Canadian Institutes of Health Research (CIHR); National Research Council (NRC); University of Saskatchewan; U.S. National Science Foundation (NSF) [EAR-0920718]; Office of Energy Research, Office of Basic Energy Sciences, Materials Sciences Division of the U.S. Department of Energy [DE-AC02-05CH11231]; Division Of Earth Sciences [0920718] Funding Source: National Science Foundation	Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Research Council (NRC); University of Saskatchewan; U.S. National Science Foundation (NSF)(National Science Foundation (NSF)); Office of Energy Research, Office of Basic Energy Sciences, Materials Sciences Division of the U.S. Department of Energy(United States Department of Energy (DOE)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	CLS is supported by the Canada Foundation for Innovation (CFI), NSERC, Canadian Institutes of Health Research (CIHR), National Research Council (NRC) and the University of Saskatchewan. DAB is supported by U.S. National Science Foundation (NSF) grant EAR-0920718. The ALS is supported by the Director, Office of Energy Research, Office of Basic Energy Sciences, Materials Sciences Division of the U.S. Department of Energy, under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ade H, 2008, POLYMER, V49, P643, DOI 10.1016/j.polymer.2007.10.030; Alphandery E, 2009, ACS NANO, V3, P1539, DOI 10.1021/nn900289n; Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; BAZYLINSKI DA, 1995, APPL ENVIRON MICROB, V61, P3232, DOI 10.1128/AEM.61.9.3232-3239.1995; Bazylinski DA, 2012, PROKARYOTES IN PRESS; Bazylinski DA, 2013, INT J SYST EVOL MICR, V63, P1824, DOI 10.1099/ijs.0.044453-0; Bellini S., 1963, PARTICOLARE COMPORTA; BLAKEMORE R, 1975, SCIENCE, V190, P377, DOI 10.1126/science.170679; Dean AJ, 1999, CURR MICROBIOL, V39, P219, DOI 10.1007/s002849900448; Dunin-Borkowski RE, 1998, SCIENCE, V282, P1868, DOI 10.1126/science.282.5395.1868; Dunin-Borkowski RE, 2004, MICROSC RES TECHNIQ, V64, P390, DOI 10.1002/jemt.20098; Faivre D, 2008, CHEM REV, V108, P4875, DOI 10.1021/cr078258w; Faivre D, 2008, AM MINERAL, V93, P463, DOI 10.2138/am.2008.2678; Faivre D, 2007, ANGEW CHEM INT EDIT, V46, P8495, DOI 10.1002/anie.200700927; Faivre D, 2010, BIOPHYS J, V99, P1268, DOI 10.1016/j.bpj.2010.05.034; Frankel RB, 1997, BIOPHYS J, V73, P994, DOI 10.1016/S0006-3495(97)78132-3; FRANKEL RB, 1983, BIOCHIM BIOPHYS ACTA, V763, P147, DOI 10.1016/0167-4889(83)90038-1; FRANKEL RB, 1984, ANNU REV BIOPHYS BIO, V13, P85; Grunberg K, 2001, APPL ENVIRON MICROB, V67, P4573, DOI 10.1128/AEM.67.10.4573-4582.2001; GUERINOT ML, 1994, ANNU REV MICROBIOL, V48, P743, DOI 10.1146/annurev.mi.48.100194.003523; Hanzlik M, 2002, J MAGN MAGN MATER, V248, P258, DOI 10.1016/S0304-8853(02)00353-0; Hitchcock AP, 2012, HDB NANOSCOPY, V2; Howells M., 2007, SCI MICROSCOPY, P835, DOI [10.1007/978-0-387-49762-4_13, DOI 10.1007/978-0-387-49762-4_13]; Kalirai SS, 2012, CHEM GEOL, V300, P14, DOI 10.1016/j.chemgeo.2012.01.005; Katzmann E, 2011, MOL MICROBIOL, V82, P1316, DOI 10.1111/j.1365-2958.2011.07874.x; Kaznatcheev KV, 2007, NUCL INSTRUM METH A, V582, P96, DOI 10.1016/j.nima.2007.08.083; Klumpp S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033562; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Komelli A, 2007, ANNU REV BIOCHEM, V76, P351, DOI 10.1146/annurev.biochem.74.082803.133444; Lam KP, 2010, CHEM GEOL, V270, P110, DOI 10.1016/j.chemgeo.2009.11.009; Lang C, 2007, MACROMOL BIOSCI, V7, P144, DOI 10.1002/mabi.200600235; LOWENSTAM HA, 1981, SCIENCE, V211, P1126, DOI 10.1126/science.7008198; MOSKOWITZ BM, 1988, J MAGN MAGN MATER, V73, P273, DOI 10.1016/0304-8853(88)90093-5; NAKAMURA C, 1995, J BIOL CHEM, V270, P28392; PENNINGA I, 1995, J MAGN MAGN MATER, V149, P279, DOI 10.1016/0304-8853(95)00078-X; Salje J, 2010, NAT REV MICROBIOL, V8, P683, DOI 10.1038/nrmicro2425; Scheffel A, 2006, NATURE, V440, P110, DOI 10.1038/nature04382; Skinner HCW, 2005, TREATISE ON GEOCHEMISTRY, VOL 8: BIOGEOCHEMISTRY, P117; Smith MJ, 2006, BIOPHYS J, V91, P1098, DOI 10.1529/biophysj.106.085167; SODHI RNS, 1984, J ELECTRON SPECTROSC, V34, P363, DOI 10.1016/0368-2048(84)80050-X; Sonkaria S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034189; Stohr J., 2006, MAGNETISM FUNDAMENTA; Vincent JFV, 2009, P I MECH ENG H, V223, P919, DOI 10.1243/09544119JEIM561; Warwick T, 2004, AIP CONF PROC, V705, P458, DOI 10.1063/1.1757833; Winklhofer M, 2007, BIOPHYS J, V92, P661, DOI 10.1529/biophysj.106.093823	45	23	23	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53368	10.1371/journal.pone.0053368	http://dx.doi.org/10.1371/journal.pone.0053368			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308202	Green Published, gold			2022-12-25	WOS:000313429800042
J	Li, Q; Li, YM; Han, S; Liu, YZ; Song, DX; Hao, D; Wang, JJ; Qu, YH; Zheng, YX				Li Qiang; Li Yumei; Han Sheng; Liu Yingzi; Song Dongxue; Hao Dake; Wang Jiajia; Qu Yanhong; Zheng Yuxia			Optimization of Fermentation Conditions and Properties of an Exopolysaccharide from Klebsiella sp H-207 and Application in Adsorption of Hexavalent Chromium	PLOS ONE			English	Article							POLYSACCHARIDE; CULTURE	The novel exopolysaccharide HZ-7 is produced by Klebsiella sp. H-207, and its fermentation conditions were optimized by response surface methodology (RSM). In this study, the optimized medium consisted of sucrose 31.93 g/L, KNO3 2.17 g/L and K2HPO4 5.47 g/L; while the optimized culture conditions consisted of seed age 13 h, with an inoculum size of 10.6% and incubation temperature of 28.9 degrees C. A maximum HZ-7 yield of about 15.05 g/L was achieved under the optimized conditions using RSM and single-factor experiments. Next the exopolysaccharide HZ-7 was partially purified and characterized. The resulting product showed good properties, such as high concentration of uronic acid (41.67%), low average molecular weight (about 1.94x10(5) Da) and porous surface structure, were very advantageous to biosorption. Therefore HZ-7 was applied to absorb hexavalent chromium (Cr(VI)). The maximum adsorption efficiency (99.2%) which was obtained at an initial pH of 1.0 along with an initial Cr(VI) concentration of 20 mg/L, was not affected by ordinary metal ions and temperature. These data suggest Klebsiella sp. H-207 exopolysaccharide will be promising potential for industrial application.	[Li Qiang; Li Yumei; Song Dongxue; Hao Dake; Zheng Yuxia] Univ Jinan, Sch Med & Life Sci, Jinan, Peoples R China; [Li Qiang; Han Sheng; Wang Jiajia; Qu Yanhong] Univ Jinan, Sch Chem & Chem Engn, Jinan, Peoples R China; [Liu Yingzi] Shandong Police Coll, Dept Criminal Sci & Technol, Jinan, Peoples R China	University of Jinan; University of Jinan; Shandong Police College	Li, Q (corresponding author), Univ Jinan, Sch Med & Life Sci, Jinan, Peoples R China.	chm_lq@ujn.edu.cn; mls_liym@ujn.edu.cn	LIU, YING/GZL-7252-2022		National Natural Science Foundation of China [31100088]; Ministry of Public security of the People's Republic of China [2010YYCXSDST054]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Public security of the People's Republic of China	This work was supported by National Natural Science Foundation of China (Project No. 31100088), and Application and Innovation Program from the Ministry of Public security of the People's Republic of China (Project No. 2010YYCXSDST054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borgio JF, 2009, AFR J BIOTECHNOL, V8, P5454; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chaplin M F, 1986, CARBOHYDRATE ANAL PR, P129; Cui JD, 2012, J AGR FOOD CHEM, V60, P4865, DOI 10.1021/jf3006273; Dai J, 2012, INT J ENV RES PUB HE, V9, P1757, DOI 10.3390/ijerph9051757; Dermlim W, 1999, APPL MICROBIOL BIOT, V52, P698, DOI 10.1007/s002530051581; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Feng XL, 1995, CHINESE J BIOCH PHAR, V5, P210; Ferreira SLC, 2007, ANAL CHIM ACTA, V597, P179, DOI 10.1016/j.aca.2007.07.011; Freire-Nordi CS, 2005, PROCESS BIOCHEM, V40, P2215, DOI 10.1016/j.procbio.2004.09.003; Freitas F, 2011, TRENDS BIOTECHNOL, V29, P388, DOI 10.1016/j.tibtech.2011.03.008; Freitas F, 2010, PROCESS BIOCHEM, V45, P297, DOI 10.1016/j.procbio.2009.09.020; Ghosh M, 2009, WATER ENVIRON RES, V81, P160, DOI 10.2175/106143008X325818; Iyer A, 2005, MAR POLLUT BULL, V50, P340, DOI 10.1016/j.marpolbul.2004.11.012; Jaehrig SC, 2008, LWT-FOOD SCI TECHNOL, V41, P868, DOI 10.1016/j.lwt.2007.06.004; JAMES BR, 1995, ENVIRON SCI TECHNOL, V29, P2377, DOI 10.1021/es00009a033; Kantar C, 2011, CHEMOSPHERE, V82, P1489, DOI 10.1016/j.chemosphere.2011.01.009; Khuri AI, 2010, WIRES COMPUT STAT, V2, P128, DOI 10.1002/wics.73; Kiran B, 2008, BIOCHEM ENG J, V38, P47, DOI 10.1016/j.bej.2007.06.007; Kong JY, 1998, J MAR BIOTECHNOL, V6, P99; Kumar AS, 2007, J BASIC MICROB, V47, P103, DOI 10.1002/jobm.200610203; Lin YC, 2012, CHEM ENG J, V181, P479, DOI 10.1016/j.cej.2011.12.005; Llamas I, 2010, MAR DRUGS, V8, P2240, DOI 10.3390/md8082240; Manna B, 1996, LETT APPL MICROBIOL, V138, P605; MORIN A, 1998, POLYSACCHARIDES STRU, P275; MOZZI F, 1995, MILCHWISSENSCHAFT, V50, P186; Prasertsan P, 2008, CARBOHYD POLYM, V71, P468, DOI 10.1016/j.carbpol.2007.06.017; Satpute SK, 2010, BIOTECHNOL ADV, V28, P436, DOI 10.1016/j.biotechadv.2010.02.006; Sun SS, 2011, BIORESOURCE TECHNOL, V102, P6153, DOI 10.1016/j.biortech.2011.03.005; Yoon S, 2012, BIOPROC BIOSYST ENG, V35, P167, DOI 10.1007/s00449-011-0620-1; Yuksekdag ZN, 2008, BRAZ ARCH BIOL TECHN, V51, P581, DOI 10.1590/S1516-89132008000300019	31	14	20	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53542	10.1371/journal.pone.0053542	http://dx.doi.org/10.1371/journal.pone.0053542			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320092	Green Submitted, gold, Green Published			2022-12-25	WOS:000313429800057
J	Xu, BS; Schones, DE; Wang, YM; Liang, HJ; Li, GH				Xu, Beisi; Schones, Dustin E.; Wang, Yongmei; Liang, Haojun; Li, Guohui			A Structural-Based Strategy for Recognition of Transcription Factor Binding Sites	PLOS ONE			English	Article							PROTEIN-DNA INTERACTIONS; STRUCTURE-BASED PREDICTION; SACCHAROMYCES-CEREVISIAE; ENERGY FUNCTION; ALL-ATOM; REGULATORY PROTEINS; TARGET SITES; SPECIFICITY; COMPLEXES; PROFILES	Scanning through genomes for potential transcription factor binding sites (TFBSs) is becoming increasingly important in this post-genomic era. The position weight matrix (PWM) is the standard representation of TFBSs utilized when scanning through sequences for potential binding sites. However, many transcription factor (TF) motifs are short and highly degenerate, and methods utilizing PWMs to scan for sites are plagued by false positives. Furthermore, many important TFs do not have well-characterized PWMs, making identification of potential binding sites even more difficult. One approach to the identification of sites for these TFs has been to use the 3D structure of the TF to predict the DNA structure around the TF and then to generate a PWM from the predicted 3D complex structure. However, this approach is dependent on the similarity of the predicted structure to the native structure. We introduce here a novel approach to identify TFBSs utilizing structure information that can be applied to TFs without characterized PWMs, as long as a 3D complex structure (TF/DNA) exists. This approach utilizes an energy function that is uniquely trained on each structure. Our approach leads to increased prediction accuracy and robustness compared with those using a more general energy function. The software is freely available upon request.	[Xu, Beisi; Li, Guohui] Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Lab Mol Modeling & Design, Dalian, Liaoning, Peoples R China; [Xu, Beisi] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Xu, Beisi] Univ Tennessee, Ctr Hlth Sci, Ctr Integrat & Translat Gen, Memphis, TN 38163 USA; [Schones, Dustin E.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA; [Wang, Yongmei] Univ Memphis, Dept Chem, Memphis, TN 38152 USA; [Liang, Haojun] Univ Sci & Technol China, Dept Polymer Sci & Engn, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; City of Hope; Beckman Research Institute of City of Hope; University of Memphis; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Li, GH (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Lab Mol Modeling & Design, Dalian, Liaoning, Peoples R China.	ghli@dicp.ac.cn	Liang, Haojun/F-5960-2010; Xu, Beisi/C-8560-2009; Wang, Yongmei/B-7071-2008	Xu, Beisi/0000-0003-0099-858X; Wang, Yongmei/0000-0002-7418-9489	National Sciences Foundation of China [31070641]; National 973 Program of China [2012CB721000]; SKLMRD; DICP, CAS (Chinese Academy of Sciences)	National Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Program of China(National Basic Research Program of China); SKLMRD; DICP, CAS (Chinese Academy of Sciences)	GL thanks the fundings supported by the National Sciences Foundation of China (no. 31070641) and National 973 Program of China (no. 2012CB721000) and start-up funding from SKLMRD and DICP, CAS (Chinese Academy of Sciences). The funders offered most of the costs of study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius P, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000916; Alamanova D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-225; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernard B, 2009, PROTEINS, V76, P115, DOI 10.1002/prot.22323; Carroll SB, 2001, NATURE, V409, P1102, DOI 10.1038/35059227; Chen CY, 2008, P NATL ACAD SCI USA, V105, P2527, DOI 10.1073/pnas.0712188105; Chen CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030446; Cherry JM, 1997, NATURE, V387, P67, DOI 10.1038/387s067; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Donald JE, 2007, NUCLEIC ACIDS RES, V35, P1039, DOI 10.1093/nar/gkl1103; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elnitski L, 2006, GENOME RES, V16, P1455, DOI 10.1101/gr.4140006; Endres RG, 2004, PROTEINS, V57, P262, DOI 10.1002/prot.20199; Angarica VE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-436; Gao M, 2008, NUCLEIC ACIDS RES, V36, P3978, DOI 10.1093/nar/gkn332; Gao M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000341; Hieb AR, 2007, J MOL BIOL, V372, P619, DOI 10.1016/j.jmb.2007.06.061; Huang N, 2005, J MOL BIOL, V345, P265, DOI 10.1016/j.jmb.2004.10.042; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Jagannathan V, 2006, NUCLEIC ACIDS RES, V34, pD90, DOI 10.1093/nar/gkj049; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kim R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S13; Kono H, 1999, PROTEINS, V35, P114, DOI 10.1002/(SICI)1097-0134(19990401)35:1<114::AID-PROT11>3.0.CO;2-T; Kussell E, 2002, P NATL ACAD SCI USA, V99, P5343, DOI 10.1073/pnas.072665799; Liu X, 2001, Pac Symp Biocomput, P127; Liu ZJ, 2008, PROTEINS, V72, P1114, DOI 10.1002/prot.22002; Liu ZJ, 2005, NUCLEIC ACIDS RES, V33, P546, DOI 10.1093/nar/gki204; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Mandel-Gutfreund Y, 2001, Pac Symp Biocomput, P139; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Morozov AV, 2005, NUCLEIC ACIDS RES, V33, P5781, DOI 10.1093/nar/gki875; Paillard G, 2004, STRUCTURE, V12, P113, DOI 10.1016/j.str.2003.11.022; Parisien M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032647; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Ponomarenko JV, 2000, NUCLEIC ACIDS RES, V28, P205, DOI 10.1093/nar/28.1.205; Robertson TA, 2007, PROTEINS, V66, P359, DOI 10.1002/prot.21162; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Selvaraj S, 2002, J MOL BIOL, V322, P907, DOI 10.1016/S0022-2836(02)00846-X; Siggers TW, 2007, NUCLEIC ACIDS RES, V35, P1085, DOI 10.1093/nar/gkl1155; Siggers TW, 2005, J MOL BIOL, V345, P1027, DOI 10.1016/j.jmb.2004.11.010; Skolnick J, 2006, CURR OPIN STRUC BIOL, V16, P166, DOI 10.1016/j.sbi.2006.02.004; Tjong H, 2007, NUCLEIC ACIDS RES, V35, P1465, DOI 10.1093/nar/gkm008; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Vlieghe D, 2006, NUCLEIC ACIDS RES, V34, pD95, DOI 10.1093/nar/gkj115; Wang GL, 2005, NUCLEIC ACIDS RES, V33, pW94, DOI 10.1093/nar/gki402; Xu BS, 2009, PROTEINS, V76, P718, DOI 10.1002/prot.22384; Zhang C, 2005, J MED CHEM, V48, P2325, DOI 10.1021/jm049314d; Zhang C, 2004, PROTEIN SCI, V13, P400, DOI 10.1110/ps.03348304; Zhao H, 2010, BIOINFORMATICS; Zhou HY, 2003, PROTEIN SCI, V12, P2121, DOI 10.1002/pro.122121; Zhou Y, 2006, CELL BIOCHEM BIOPHYS, V46, P165, DOI 10.1385/CBB:46:2:165; Zhu J, 1999, BIOINFORMATICS, V15, P607, DOI 10.1093/bioinformatics/15.7.607; Zhu X, 2012, J PHYS CHEM B, V116, P13672, DOI 10.1021/jp3084887	56	33	34	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e52460	10.1371/journal.pone.0052460	http://dx.doi.org/10.1371/journal.pone.0052460			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320072	gold, Green Submitted, Green Published			2022-12-25	WOS:000313429800015
J	Beltrami, S; Branchetti, E; Sariyer, IK; Otte, J; Weaver, M; Gordon, J				Beltrami, Sarah; Branchetti, Emanuela; Sariyer, Ilker K.; Otte, Jessica; Weaver, Michael; Gordon, Jennifer			Neurofibromatosis Type 2 Tumor Suppressor Protein, NF2, Induces Proteasome-Mediated Degradation of JC Virus T-Antigen in Human Glioblastoma	PLOS ONE			English	Article							WNT SIGNALING PATHWAY; CONTACT INHIBITION; GENE-PRODUCT; SIMIAN-VIRUS-40 LARGE; CELL-PROLIFERATION; BINDING PROTEIN; TRANSGENIC MICE; MOUSE MODEL; MERLIN; GROWTH	Neurofibromatosis type 2 protein (NF2) has been shown to act as tumor suppressor primarily through its functions as a cytoskeletal scaffold. However, NF2 can also be found in the nucleus, where its role is less clear. Previously, our group has identified JC virus (JCV) tumor antigen (T-antigen) as a nuclear binding partner for NF2 in tumors derived from JCV T-antigen transgenic mice. The association of NF2 with T-antigen in neuronal origin tumors suggests a potential role for NF2 in regulating the expression of the JCV T-antigen. Here, we report that NF2 suppresses T-antigen protein expression in U-87 MG human glioblastoma cells, which subsequently reduces T-antigen-mediated regulation of the JCV promoter. When T-antigen mRNA was quantified, it was determined that increasing expression of NF2 correlated with an accumulation of T-antigen mRNA; however, a decrease in T-antigen at the protein level was observed. NF2 was found to promote degradation of ubiquitin bound T-antigen protein via a proteasome dependent pathway concomitant with the accumulation of the JCV early mRNA encoding T-antigen. The interaction between T-antigen and NF2 maps to the FERM domain of NF2, which has been shown previously to be responsible for its tumor suppressor activity. Co-immunoprecipitation assays revealed a ternary complex among NF2, T-antigen, and the tumor suppressor protein, p53 within a glioblastoma cell line. Further, these proteins were detected in various degrees in patient tumor tissue, suggesting that these associations may occur in vivo. Collectively, these results demonstrate that NF2 negatively regulates JCV T-antigen expression by proteasome-mediated degradation, and suggest a novel role for NF2 as a suppressor of JCV T-antigen-induced cell cycle regulation.	[Beltrami, Sarah; Branchetti, Emanuela; Sariyer, Ilker K.; Otte, Jessica; Gordon, Jennifer] Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA; [Beltrami, Sarah; Branchetti, Emanuela; Sariyer, Ilker K.; Otte, Jessica; Gordon, Jennifer] Temple Univ, Sch Med, Ctr Neurovirol, Philadelphia, PA USA; [Beltrami, Sarah] Temple Univ, Sch Med, Biomed Neurosci Grad Program, Philadelphia, PA USA; [Weaver, Michael] Temple Univ, Sch Med, Dept Neurosurg, Philadelphia, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Gordon, J (corresponding author), Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA.	jennifer.gordon@temple.edu	Sariyer, Ilker/AAE-7677-2020		National Institutes of Health under a Ruth L. Kirchstein National Research Service Award [1T32MH079785]; Comprehensive NeuroAIDS Center (CNAC NIMH) at Temple University School of Medicine [P30MH092177]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH092177, T32MH079785] Funding Source: NIH RePORTER	National Institutes of Health under a Ruth L. Kirchstein National Research Service Award; Comprehensive NeuroAIDS Center (CNAC NIMH) at Temple University School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This investigation was sponsored by the National Institutes of Health under a Ruth L. Kirchstein National Research Service Award (1T32MH079785) providing support to Sarah Beltrami. This study utilized services offered by core facilities of the Comprehensive NeuroAIDS Center (CNAC NIMH Grant Number P30MH092177) at Temple University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare DA, 2005, CANCER RES, V65, P8090, DOI 10.1158/0008-5472.CAN-05-2312; Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; Benkirane M, 1997, EMBO J, V16, P611, DOI 10.1093/emboj/16.3.611; Bhattacharyya R, 2007, ONCOGENE, V26, P7628, DOI 10.1038/sj.onc.1210576; Bosco EE, 2010, ONCOGENE, V29, P2540, DOI 10.1038/onc.2010.20; Chang Z, 2009, J NEURO-ONCOL, V91, P265, DOI 10.1007/s11060-008-9721-3; Cole BK, 2008, MOL CELL BIOL, V28, P1274, DOI 10.1128/MCB.01139-07; EVANS DGR, 1992, Q J MED, V84, P603; Gan DD, 2001, ONCOGENE, V20, P4864, DOI 10.1038/sj.onc.1204670; Gordon J, 2000, ONCOGENE, V19, P4840, DOI 10.1038/sj.onc.1203849; Gronholm M, 2005, MOL CELL NEUROSCI, V28, P683, DOI 10.1016/j.mcn.2004.11.014; Houshmandi SS, 2009, MOL CELL BIOL, V29, P1472, DOI 10.1128/MCB.01392-08; Ikeda K, 1999, J NEUROSURG, V91, P85, DOI 10.3171/jns.1999.91.1.0085; Johnson KC, 2002, ONCOGENE, V21, P5990, DOI 10.1038/sj.onc.1205693; Kalamarides M, 2011, ACTA NEUROPATHOL, V123, P369; Kim H, 2004, J BIOL CHEM, V279, P7812, DOI 10.1074/jbc.M305526200; Kissil JL, 2003, MOL CELL, V12, P841, DOI 10.1016/S1097-2765(03)00382-4; Kressel M, 2002, HUM MOL GENET, V11, P2269, DOI 10.1093/hmg/11.19.2269; Krynska B, 2000, VIROLOGY, V274, P65, DOI 10.1006/viro.2000.0450; Krynska B, 1997, J CELL BIOCHEM, V67, P223, DOI 10.1002/(SICI)1097-4644(19971101)67:2<223::AID-JCB7>3.0.CO;2-Z; Lassak A, 2002, J BIOL CHEM, V277, P17231, DOI 10.1074/jbc.M110885200; Lau YKI, 2008, CANCER RES, V68, P5733, DOI 10.1158/0008-5472.CAN-08-0190; Lee H, 2007, MOL CELL BIOL, V27, P2103, DOI 10.1128/MCB.00572-06; Li W, 2010, CELL, V140, P477, DOI 10.1016/j.cell.2010.01.029; Lopez-Lago MA, 2009, MOL CELL BIOL, V29, P4235, DOI 10.1128/MCB.01578-08; Lu ZM, 2010, CELL CYCLE, V9, P2342, DOI 10.4161/cc.9.12.11988; Mamidipudi V, 2004, MOL CELL BIOL, V24, P6788, DOI 10.1128/MCB.24.15.6788-6798.2004; Mani T, 2011, MOL CELL BIOL, V31, P1983, DOI 10.1128/MCB.00609-10; MARTUZA RL, 1988, NEW ENGL J MED, V318, P684, DOI 10.1056/NEJM198803173181106; McClatchey AI, 2005, GENE DEV, V19, P2265, DOI 10.1101/gad.1335605; McClatchey AI, 1998, GENE DEV, V12, P1121, DOI 10.1101/gad.12.8.1121; McClatchey AI, 2003, NAT REV CANCER, V3, P877, DOI 10.1038/nrc1213; Morales FC, 2010, NEURO-ONCOLOGY, V12, P528, DOI 10.1093/neuonc/nop060; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Morrison H, 2007, CANCER RES, V67, P520, DOI 10.1158/0008-5472.CAN-06-1608; Muranen T, 2005, ONCOGENE, V24, P1150, DOI 10.1038/sj.onc.1208283; Okada T, 2005, J CELL BIOL, V171, P361, DOI 10.1083/jcb.200503165; PADGETT BL, 1976, J INFECT DIS, V133, P686, DOI 10.1093/infdis/133.6.686; Poulin DL, 2004, J VIROL, V78, P8245, DOI 10.1128/JVI.78.15.8245-8253.2004; Riddick G, 2011, NAT REV NEUROL, V7, P439, DOI 10.1038/nrneurol.2011.100; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Sariyer IK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014630; Scoles DR, 2006, HUM MOL GENET, V15, P1059, DOI 10.1093/hmg/ddl021; Sekido Y, 2011, PATHOL INT, V61, P331, DOI 10.1111/j.1440-1827.2011.02666.x; Seo GJ, 2008, J VIROL, V82, P9823, DOI 10.1128/JVI.01144-08; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Shimazu T, 2006, ONCOGENE, V25, P7391, DOI 10.1038/sj.onc.1209731; Shollar D, 2004, ONCOGENE, V23, P5459, DOI 10.1038/sj.onc.1207728; Staib C, 1996, VIROLOGY, V219, P237, DOI 10.1006/viro.1996.0241; Stettner MR, 2009, J GEN VIROL, V90, P2005, DOI 10.1099/vir.0.011072-0; Trofatter J A, 1993, Cell, V75, P826; Trojanek J, 2006, J CELL PHYSIOL, V206, P35, DOI 10.1002/jcp.20425; Tsukita S, 1997, CURR OPIN CELL BIOL, V9, P70, DOI 10.1016/S0955-0674(97)80154-8; Uleri Elena, 2011, Genes Cancer, V2, P728, DOI 10.1177/1947601911424578; White MK, 2005, BRAIN RES REV, V50, P69, DOI 10.1016/j.brainresrev.2005.04.007; Xiao GH, 2005, MOL CELL BIOL, V25, P2384, DOI 10.1128/MCB.25.6.2384-2394.2005; Yu YJ, 2005, J VIROL, V79, P6882, DOI 10.1128/JVI.79.11.6882-6889.2005	57	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53447	10.1371/journal.pone.0053447	http://dx.doi.org/10.1371/journal.pone.0053447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308224	gold, Green Submitted, Green Published			2022-12-25	WOS:000313429100067
J	Dastidar, EG; Dzeyk, K; Krijgsveld, J; Malmquist, NA; Doerig, C; Scherf, A; Lopez-Rubio, JJ				Dastidar, Eeshita G.; Dzeyk, Kristina; Krijgsveld, Jeroen; Malmquist, Nicholas A.; Doerig, Christian; Scherf, Artur; Lopez-Rubio, Jose-Juan			Comprehensive Histone Phosphorylation Analysis and Identification of Pf14-3-3 Protein as a Histone H3 Phosphorylation Reader in Malaria Parasites	PLOS ONE			English	Article							MUTUALLY EXCLUSIVE EXPRESSION; PLASMODIUM-FALCIPARUM; MASS-SPECTROMETRY; MODIFICATION PATTERNS; STRUCTURAL BASIS; GENE-REGULATION; GENOME-WIDE; I-TASSER; CHROMATIN; ACETYLATION	The important role of histone posttranslational modifications, particularly methylation and acetylation, in Plasmodium falciparum gene regulation has been established. However, the role of histone phosphorylation remains understudied. Here, we investigate histone phosphorylation utilizing liquid chromatography and tandem mass spectrometry to analyze histones extracted from asexual blood stages using two improved protocols to enhance preservation of PTMs. Enrichment for phosphopeptides lead to the detection of 14 histone phospho-modifications in P. falciparum. The majority of phosphorylation sites were observed at the N-terminal regions of various histones and were frequently observed adjacent to acetylated lysines. We also report the identification of one novel member of the P. falciparum histone phosphosite binding protein repertoire, Pf14-3-3I. Recombinant Pf14-3-3I protein bound to purified parasite histones. In silico structural analysis of Pf14-3-3 proteins revealed that residues responsible for binding to histone H3 S10ph and/or S28ph are conserved at the primary and the tertiary structure levels. Using a battery of H3 specific phosphopeptides, we demonstrate that Pf14-3-3I preferentially binds to H3S28ph over H3S10ph, independent of modification of neighbouring residues like H3S10phK14ac and H3S28phS32ph. Our data provide key insight into histone phosphorylation sites. The identification of a second member of the histone modification reading machinery suggests a widespread use of histone phosphorylation in the control of various nuclear processes in malaria parasites.	[Dastidar, Eeshita G.; Malmquist, Nicholas A.; Scherf, Artur; Lopez-Rubio, Jose-Juan] Inst Pasteur, Biol Host Parasite Interact Unit, Paris, France; [Dastidar, Eeshita G.; Malmquist, Nicholas A.; Scherf, Artur; Lopez-Rubio, Jose-Juan] CNRS, Unite Rech Associe 2581, Paris, France; [Dzeyk, Kristina; Krijgsveld, Jeroen] European Mol Biol Lab, Prote Core Facil, D-69012 Heidelberg, Germany; [Doerig, Christian] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); Monash University	Scherf, A (corresponding author), Inst Pasteur, Biol Host Parasite Interact Unit, Paris, France.	artur.scherf@pasteur.fr; jjlopez@pasteur.fr	Scherf, Artur/A-9674-2014; Doerig, Christian/Q-9900-2019; lopez-rubio, jose juan/A-4509-2014	Krijgsveld, Jeroen/0000-0001-7549-9326; Doerig, Christian/0000-0002-3188-094X; Malmquist, Nicholas/0000-0003-2822-8245; Scherf, Artur/0000-0003-2411-3328; lopez-rubio, jose juan/0000-0002-0555-1122	European Union [215281]	European Union(European Commission)	EGD benefits from a PhD fellowship funded by the European Union Framework Program 7 Marie Curie Initial Training Network "Intervention strategies against malaria (InterMalTraining)", contract number 215281. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Al-Khedery B, 1999, MOL BIOCHEM PARASIT, V102, P117, DOI 10.1016/S0166-6851(99)00090-0; Andrews KT, 2012, CURR PHARM DES; Bartfai R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001223; Barth TK, 2010, TRENDS BIOCHEM SCI, V35, P618, DOI 10.1016/j.tibs.2010.05.006; Berger SL, 2010, COLD SH Q B, V75, P23, DOI 10.1101/sqb.2010.75.044; Bodenmiller B, 2007, NAT METHODS, V4, P231, DOI 10.1038/nmeth1005; Brokx SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014827; CARY C, 1994, PARASITOL RES, V80, P255, DOI 10.1007/BF00932684; Cherblanc F, 2012, FUTURE MED CHEM, V4, P425, DOI [10.4155/fmc.12.7, 10.4155/FMC.12.7]; Cui LW, 2010, EUKARYOT CELL, V9, P1138, DOI 10.1128/EC.00036-10; Cui L, 2007, ANTIMICROB AGENTS CH, V51, P488, DOI 10.1128/AAC.01238-06; Dastidar EG, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-5; Di Girolamo F, 2008, PROTEOMICS, V8, P2500, DOI 10.1002/pmic.200700763; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Flueck C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000569; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Healy S, 2011, DISCOV MED, V11, P349; Iqbal J, 2010, ANN NY ACAD SCI, V1192, P238, DOI 10.1111/j.1749-6632.2010.05388.x; Issar N, 2009, MICROBES INFECT, V11, P403, DOI 10.1016/j.micinf.2008.12.010; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krebs JE, 2007, MOL BIOSYST, V3, P590, DOI 10.1039/b703923a; Kutateladze TG, 2011, CELL, V146, DOI 10.1016/j.cell.2011.08.022; Lalle M, 2011, J BIOL CHEM, V286, P1227, DOI 10.1074/jbc.M110.194613; LANZER M, 1992, NUCLEIC ACIDS RES, V20, P3051, DOI 10.1093/nar/20.12.3051; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Llinas M, 2008, TRENDS PARASITOL, V24, P551, DOI 10.1016/j.pt.2008.08.010; Lopez-Rubio JJ, 2007, MOL MICROBIOL, V66, P1296, DOI 10.1111/j.1365-2958.2007.06009.x; Lopez-Rubio JJ, 2009, CELL HOST MICROBE, V5, P179, DOI 10.1016/j.chom.2008.12.012; MacDonald N, 2005, MOL CELL, V20, P199, DOI 10.1016/j.molcel.2005.08.032; Marchini FK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025381; Miao J, 2006, GENE, V369, P53, DOI 10.1016/j.gene.2005.10.022; Otto TD, 2010, MOL MICROBIOL, V76, P12, DOI 10.1111/j.1365-2958.2009.07026.x; Paul G, 2009, GENOMICS, V94, P287, DOI 10.1016/j.ygeno.2009.07.004; Perez-Toledo K, 2009, NUCLEIC ACIDS RES, V37, P2596, DOI 10.1093/nar/gkp115; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Salcedo-Amaya AM, 2009, P NATL ACAD SCI USA, V106, P9655, DOI 10.1073/pnas.0902515106; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Trelle MB, 2009, J PROTEOME RES, V8, P3439, DOI 10.1021/pr9000898; Truong AB, 2002, PROTEINS, V49, P321, DOI 10.1002/prot.10210; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; Walter W, 2008, MOL CELL BIOL, V28, P2840, DOI 10.1128/MCB.01457-07; Winter S, 2008, CELL CYCLE, V7, P1336, DOI 10.4161/cc.7.10.5946; Winter S, 2008, EMBO J, V27, P88, DOI 10.1038/sj.emboj.7601954; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	53	28	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53179	10.1371/journal.pone.0053179	http://dx.doi.org/10.1371/journal.pone.0053179			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308157	Green Published, gold, Green Submitted			2022-12-25	WOS:000313429100033
J	Perez-Faginas, P; Aranda, MT; Garcia-Lopez, MT; Infantes, L; Fernandez-Carvajal, A; Gonzalez-Ros, JM; Ferrer-Montiel, A; Gonzalez-Muniz, R				Perez-Faginas, Paula; Teresa Aranda, M.; Teresa Garcia-Lopez, M.; Infantes, Lourdes; Fernandez-Carvajal, Asia; Manuel Gonzalez-Ros, Jose; Ferrer-Montiel, Antonio; Gonzalez-Muniz, Rosario			Highly Functionalized 1,2-Diamino Compounds through Reductive Amination of Amino Acid-Derived beta-Keto Esters	PLOS ONE			English	Article							ASYMMETRIC-SYNTHESIS; EFFICIENT SYNTHESIS; ALPHA; HYDROGENATION; DIPEPTIDES; ALDEHYDES; CATALYST; HYDRIDE; POTENT; ROUTE	1,2-Diamine derivatives are valuable building blocks to heterocyclic compounds and important precursors of biologically relevant compounds. In this respect, amino acid-derived beta-keto esters are a suitable starting point for the synthesis of beta,gamma-diamino ester derivatives through a two-step reductive amination procedure with either simple amines or alpha-amino esters. AcOH and NaBH3CN are the additive and reducing agents of choice. The stereoselectivity of the reaction is still an issue, due to the slow imine-enamine equilibria through which the reaction occurs, affording mixtures of diastereoisomers that can be chromatographically separated. Transformation of the beta,gamma-diamino esters into pyrrolidinone derivatives allows the configuration assignment of the linear compounds, and constitutes an example of their potential application in the generation of molecular diversity.	[Perez-Faginas, Paula; Teresa Aranda, M.; Teresa Garcia-Lopez, M.; Gonzalez-Muniz, Rosario] CSIC, Inst Quim Med, E-28006 Madrid, Spain; [Infantes, Lourdes] CSIC, Inst Quim Fis Rocasolano, Madrid, Spain; [Fernandez-Carvajal, Asia; Manuel Gonzalez-Ros, Jose; Ferrer-Montiel, Antonio] Univ Miguel Hernandez, Inst Biol Mol & Celular, Elche, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Medica (IQM); CSIC - Instituto de Quimica Organica General (IQOG); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Universidad Miguel Hernandez de Elche	Gonzalez-Muniz, R (corresponding author), CSIC, Inst Quim Med, Juan Cierva 3, E-28006 Madrid, Spain.	rosario.gonzalezmuniz@iqm.csic.es	Gonzalez-Muñiz, Rosario/L-9074-2014; Ferrer-Montiel, Antonio/C-3072-2015; Infantes, Lourdes/P-7566-2014; Carvajal, Asia Fernandez/G-8877-2015	Gonzalez-Muñiz, Rosario/0000-0001-8833-4328; Ferrer-Montiel, Antonio/0000-0002-2973-6607; Infantes, Lourdes/0000-0001-6932-4212; Gonzalez Ros, Jose Manuel/0000-0002-4804-6855; Fernandez-Carvajal, Asia/0000-0003-2741-1427	Spanish Ministry of Science and Innovation [SAF2009-09323]; Consolider-Ingenio CSD (Spanish Ion Channel Initiative) [2008-00005]; Consolider-Ingenio CSD (Crystallization Factory) [CSD2006-00015]; Consejo Superior de Investigaciones Cientificas (CSIC); ESF; Program Junta para la Ampliacion de Estudios	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consolider-Ingenio CSD (Spanish Ion Channel Initiative); Consolider-Ingenio CSD (Crystallization Factory); Consejo Superior de Investigaciones Cientificas (CSIC); ESF(European Commission); Program Junta para la Ampliacion de Estudios	This work was supported by the Spanish Ministry of Science and Innovation, SAF2009-09323 and Consolider-Ingenio CSD 2008-00005 (Spanish Ion Channel Initiative) and CSD2006-00015 (Crystallization Factory). P.P.-F. and M. T. A. thank the Consejo Superior de Investigaciones Cientificas (CSIC) for a JAE-predoc fellowship and a JAEdoc contract, respectively, both from the Program Junta para la Ampliacion de Estudios co-financed by the ESF. The funders had no role in study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	Abdel-Magid AF, 2006, ORG PROCESS RES DEV, V10, P971, DOI 10.1021/op0601013; AbdelMagid AF, 1996, J ORG CHEM, V61, P3849, DOI 10.1021/jo960057x; Belot S, 2008, CHEM COMMUN, P4694, DOI 10.1039/b810789k; Bisol TB, 2011, J ORG CHEM, V76, P948, DOI 10.1021/jo102267h; Bunlaksananusorn T, 2005, SYNLETT, P2682, DOI 10.1055/s-2005-917108; Busscher GF, 2010, TETRAHEDRON-ASYMMETR, V21, P1709, DOI 10.1016/j.tetasy.2010.04.013; Cimarelli C, 1996, J ORG CHEM, V61, P5557, DOI 10.1021/jo960107y; Davies SG, 2012, ORG LETT, V14, P218, DOI 10.1021/ol203011u; DEVANT RM, 1988, TETRAHEDRON LETT, V29, P2307, DOI 10.1016/S0040-4039(00)86044-X; Fellah M, 2010, J ORG CHEM, V75, P7803, DOI 10.1021/jo101668k; Fitch DM, 2005, ORG LETT, V7, P5521, DOI 10.1021/ol052371w; Gautier FM, 2011, ORG BIOMOL CHEM, V9, P7860, DOI 10.1039/c1ob05965c; Gomez S, 2002, ADV SYNTH CATAL, V344, P1037, DOI 10.1002/1615-4169(200212)344:10<1037::AID-ADSC1037>3.0.CO;2-3; GOMEZMONTERREY I, 1993, TETRAHEDRON LETT, V34, P3593, DOI 10.1016/S0040-4039(00)73644-6; Hoang CT, 2009, J ORG CHEM, V74, P4177, DOI 10.1021/jo900324d; Iden HS, 2008, J COMB CHEM, V10, P691, DOI 10.1021/cc8001052; Kim HO, 1997, SYNTHETIC COMMUN, V27, P2505, DOI 10.1080/00397919708004114; KIM S, 1985, J ORG CHEM, V50, P1927, DOI 10.1021/jo00211a028; Kuhl A, 2005, AMINO ACIDS, V29, P89, DOI 10.1007/s00726-005-0212-y; Lee HS, 2001, J ORG CHEM, V66, P3597, DOI 10.1021/jo001534l; Lee OY, 2009, ORG LETT, V11, P3302, DOI 10.1021/ol901111g; Lelais G, 2004, BIOPOLYMERS, V76, P206, DOI 10.1002/bip.20088; Lenin R, 2007, ARKIVOC, P204, DOI 10.3998/ark.5550190.0008.d23; Li XH, 2007, J AM CHEM SOC, V129, P14152, DOI 10.1021/ja076155p; MANSOUR TS, 1990, SYNTHETIC COMMUN, V20, P773, DOI 10.1080/00397919008052321; MartinMartinez M, 1997, J MED CHEM, V40, P3402, DOI 10.1021/jm9703247; NARDELLI M, 1983, COMPUT CHEM, V7, P95, DOI 10.1016/0097-8485(83)85001-3; Nardelli M., 1995, J APPL CRYSTALLOGR, V28, P659, DOI [10.1107/s0021889895007138, 10.1107/S0021889895007138, DOI 10.1107/S0021889895007138]; Nugent TC, 2006, ADV SYNTH CATAL, V348, P1289, DOI 10.1002/adsc.200606073; Nugent TC, 2011, ADV SYNTH CATAL, V353, P2085, DOI 10.1002/adsc.201100250; Nugent TC, 2007, EUR J ORG CHEM, V2007, P3863, DOI 10.1002/ejoc.200700345; Nugent TC, 2010, ADV SYNTH CATAL, V352, P753, DOI 10.1002/adsc.200900719; Patino-Molina R, 2000, LETT PEPT SCI, V7, P143; Patino-Molina R, 1999, TETRAHEDRON, V55, P15001, DOI 10.1016/S0040-4020(99)00957-6; Patino-Molina R, 2007, SYNTHESIS-STUTTGART, P1047, DOI 10.1055/s-2007-965962; SETOI H, 1989, CHEM PHARM BULL, V37, P1126; Shibata I, 1998, SYNLETT, P1081; Sridharan V, 2007, SYNLETT, P881, DOI 10.1055/s-2007-973862; Theberge CR, 2003, TETRAHEDRON, V59, P1521, DOI 10.1016/S0040-4020(03)00052-8; Tripathi RP, 2008, CURR ORG CHEM, V12, P1093, DOI 10.2174/138527208785740283; Wang C, 2010, ANGEW CHEM INT EDIT, V49, P7548, DOI 10.1002/anie.201002944; Wen JJ, 1997, J PEPT RES, V49, P3; Xu DQ, 1997, TETRAHEDRON-ASYMMETR, V8, P1445, DOI 10.1016/S0957-4166(97)00160-2; Zivec M, 2009, CURR MED CHEM, V16, P2289, DOI 10.2174/092986709788453113	44	4	4	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53231	10.1371/journal.pone.0053231	http://dx.doi.org/10.1371/journal.pone.0053231			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308167	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429100042
J	Wondimu, Z; Omrani, S; Ishikawa, T; Javed, F; Oikawa, Y; Virtanen, I; Juronen, E; Ingerpuu, S; Patarroyo, M				Wondimu, Zenebech; Omrani, Shahin; Ishikawa, Taichi; Javed, Fawad; Oikawa, Yuko; Virtanen, Ismo; Juronen, Erkki; Ingerpuu, Sulev; Patarroyo, Manuel			A Novel Monoclonal Antibody to Human Laminin alpha 5 Chain Strongly Inhibits Integrin-Mediated Cell Adhesion and Migration on Laminins 511 and 521	PLOS ONE			English	Article							HUMAN LUNG-CARCINOMA; RESTRICTED DISTRIBUTION; BASEMENT-MEMBRANES; BINDING-SITE; EXPRESSION; IDENTIFICATION; MOLECULE; ISOFORMS; DOMAIN; ALPHA-5-LAMININS	Laminins, a large family of alpha beta gamma heterotrimeric proteins mainly found in basement membranes, are strong promoters of adhesion and migration of multiple cell types, such as tumor and immune cells, via several integrin receptors. Among laminin alpha (LM alpha) chains, alpha 5 displays the widest tissue distribution in adult life and is synthesized by most cell types. Here, we have generated and characterized five novel monoclonal antibodies (mAbs) to the human LM alpha 5 chain to further study the biological relevance of alpha 5 laminins, such as laminins 511 (alpha 5 beta 1 gamma 1) and 521 (alpha 5 beta 2 gamma 1). As detected by ELISA, immunohistochemistry, immunoprecipitation and Western blotting, each antibody displayed unique properties when compared to mAb 4C7, the prototype LM alpha 5 antibody. Of greatest interest, mAb 8G9, but not any other antibody, strongly inhibited alpha 3 beta 1/alpha 6 beta 1 integrin-mediated adhesion and migration of glioma, melanoma, and carcinoma cells on laminin-511 and, together with mAb 4C7, on laminin-521. Accordingly, mAb 8G9 abolished the interaction of soluble alpha 3 beta 1 integrin with immobilized laminins 511 and 521. Binding of mAb 8G9 to laminin-511 was unaffected by the other mAbs to the LMa5 chain but largely hindered by mAb 4E10 to a LM beta 1 chain epitope near the globular domain of laminin-511. Thus, mAb 8G9 defines a novel epitope localized at or near the integrin-binding globular domain of the LM alpha 5 chain, which is essential for cell adhesion and migration, and identifies a potential therapeutic target in malignant and inflammatory diseases.	[Wondimu, Zenebech; Omrani, Shahin; Ishikawa, Taichi; Javed, Fawad; Oikawa, Yuko; Patarroyo, Manuel] Karolinska Inst, Dept Dent Med, Stockholm, Sweden; [Virtanen, Ismo] Univ Helsinki, Inst Biomed Anat, Helsinki, Finland; [Juronen, Erkki] Univ Tartu, Inst Biomed, EE-50090 Tartu, Estonia; [Ingerpuu, Sulev] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia	Karolinska Institutet; University of Helsinki; University of Tartu; University of Tartu	Patarroyo, M (corresponding author), Karolinska Inst, Dept Dent Med, Stockholm, Sweden.	Manuel.Patarroyo@ki.se	Javed, Fawad/A-6608-2012; Ishikawa, Taichi/AAU-4916-2021	Javed, Fawad/0000-0002-9253-1989; Ishikawa, Taichi/0000-0002-6229-0379	Karolinska Institutet; Cancerfonden	Karolinska Institutet(Karolinska Institutet); Cancerfonden(Swedish Cancer Society)	The present work was supported by Karolinska Institutet and Cancerfonden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; CHANDRASEKARAN EV, 1979, CANCER RES, V39, P870; Chia J, 2007, AM J PATHOL, V170, P2135, DOI 10.2353/ajpath.2007.060709; Church HJ, 1998, BIOCHEM J, V332, P491, DOI 10.1042/bj3320491; Doi M, 2002, J BIOL CHEM, V277, P12741, DOI 10.1074/jbc.M111228200; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; ENGVALL E, 1986, J CELL BIOL, V103, P2457, DOI 10.1083/jcb.103.6.2457; Falk M, 1999, MATRIX BIOL, V18, P557, DOI 10.1016/S0945-053X(99)00047-5; Ferletta M, 1999, J CELL SCI, V112, P1; Geberhiwot T, 2000, MATRIX BIOL, V19, P163, DOI 10.1016/S0945-053X(00)00056-1; Genersch E, 2003, EUR J CELL BIOL, V82, P105, DOI 10.1078/0171-9335-00297; Gorfu G, 2008, J LEUKOCYTE BIOL, V84, P701, DOI 10.1189/jlb.0108048; Gu YC, 1999, BLOOD, V93, P2533, DOI 10.1182/blood.V93.8.2533.408k22_2533_2542; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ido H, 2006, MATRIX BIOL, V25, P112, DOI 10.1016/j.matbio.2005.10.003; Kawataki T, 2007, EXP CELL RES, V313, P3819, DOI 10.1016/j.yexcr.2007.07.038; Kikkawa Y, 1998, J BIOL CHEM, V273, P15854, DOI 10.1074/jbc.273.25.15854; Kikkawa Y, 2000, J CELL SCI, V113, P869; Kikkawa Y, 2007, J BIOL CHEM, V282, P14853, DOI 10.1074/jbc.M611706200; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lee SP, 1998, BLOOD, V92, P2951, DOI 10.1182/blood.V92.8.2951.420k30_2951_2958; Li J, 2003, EMBO J, V22, P2400, DOI 10.1093/emboj/cdg239; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; Maatta M, 2001, J HISTOCHEM CYTOCHEM, V49, P711; Miner JH, 1999, INT J BIOCHEM CELL B, V31, P811, DOI 10.1016/S1357-2725(99)00030-8; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; MINER JH, 1995, J BIOL CHEM, V270, P28523, DOI 10.1074/jbc.270.48.28523; Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685; Miner JH, 1998, J CELL BIOL, V143, P1713, DOI 10.1083/jcb.143.6.1713; Nigatu A, 2006, THROMB HAEMOSTASIS, V95, P85, DOI 10.1160/TH05-04-0281; Nishiuchi R, 2006, MATRIX BIOL, V25, P189, DOI 10.1016/j.matbio.2005.12.001; Oikawa Y, 2011, EXP CELL RES, V317, P1119, DOI 10.1016/j.yexcr.2010.12.019; Parsons SF, 1999, BEST PRACT RES CL HA, V12, P729, DOI 10.1053/beha.1999.0050; Patarroyo M, 2002, SEMIN CANCER BIOL, V12, P197, DOI 10.1016/S1044-579X(02)00023-8; Petajaniemi N, 2002, J HISTOCHEM CYTOCHEM, V50, P1113, DOI 10.1177/002215540205000813; Plopper GE, 1998, BREAST CANCER RES TR, V51, P57, DOI 10.1023/A:1006086218174; Pouliot N, 2000, EXP CELL RES, V261, P360, DOI 10.1006/excr.2000.5065; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; Salo S, 2009, INT J CANCER, V125, P1814, DOI 10.1002/ijc.24532; Sasaki T, 2001, FEBS LETT, V509, P181, DOI 10.1016/S0014-5793(01)03167-2; Scheele S, 2007, J MOL MED, V85, P825, DOI 10.1007/s00109-007-0182-5; Sime W, 2009, J IMMUNOL, V183, P4657, DOI 10.4049/jimmunol.0901738; Sorokin LM, 1997, DEV BIOL, V189, P285, DOI 10.1006/dbio.1997.8668; Tani T, 1999, EXP CELL RES, V248, P115, DOI 10.1006/excr.1999.4399; Taniguchi Y, 2009, J BIOL CHEM, V284, P7820, DOI 10.1074/jbc.M809332200; Tiger CF, 1997, J BIOL CHEM, V272, P28590, DOI 10.1074/jbc.272.45.28590; TIMPL R, 1979, J BIOL CHEM, V254, P9933; Tran M, 2008, CANCER RES, V68, P2885, DOI 10.1158/0008-5472.CAN-07-6160; Udani M, 1998, J CLIN INVEST, V101, P2550, DOI 10.1172/JCI1204; Virtanen I, 2000, EXP CELL RES, V257, P298, DOI 10.1006/excr.2000.4883; Wondimu Z, 2004, BLOOD, V104, P1859, DOI 10.1182/blood-2004-01-0396; Yamashita H, 2010, J CELL PHYSIOL, V223, P541, DOI 10.1002/jcp.22107	52	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53648	10.1371/journal.pone.0053648	http://dx.doi.org/10.1371/journal.pone.0053648			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308268	gold, Green Submitted, Green Published			2022-12-25	WOS:000313429100101
J	Iorio, RA; Del Duca, S; Calamelli, E; Pula, C; Lodolini, M; Scamardella, F; Pession, A; Ricci, G				Iorio, Rosa Anna; Del Duca, Stefano; Calamelli, Elisabetta; Pula, Chiara; Lodolini, Magda; Scamardella, Fortuna; Pession, Andrea; Ricci, Giampaolo			Citrus Allergy from Pollen to Clinical Symptoms	PLOS ONE			English	Article							EICOSANOID-LIKE SUBSTANCES; LIPID-TRANSFER PROTEINS; FOOD ALLERGY; PROFILIN CIT-S-2; MAJOR ALLERGENS; IGE; REACTIVITY; PCR; SENSITIZATION; ANAPHYLAXIS	Allergy to citrus fruits is often associated with pollinosis and sensitization to other plants due to a phenomenon of cross-reactivity. The aims of the present study were to highlight the cross-reactivity among citrus and the major allergenic pollens/fruits, throughout clinical and molecular investigations, and to evaluate the sensitization frequency to citrus fruits in a population of children and adults with pollinosis. We found a relevant percentage of sensitisation (39%) to citrus fruits in the patients recruited and in all of them the IgE-mediated mechanism has been confirmed by the positive response to the prick-to-prick test. RT-PCR experiments showed the expression of Cit s 1, Cit s 3 and a profilin isoform, already described in apple, also in Citrus clementine pollen. Data of multiple sequence alignments demonstrated that Citrus allergens shared high percentage identity values with other clinically relevant species (i.e. Triticum aestivum, Malus domestica), confirming the possible cross-allergenicity citrus/grasses and citrus/apple. Finally, a novelty of the present work has been the expression of two phospholipaseA2 isoforms (PLA2 alpha and beta) in Citrus as well as in Triticum pollens; being PLA2 able to generate proinflammatory factors, this enzyme could participate in the activation of the allergenic inflammatory cascade.	[Iorio, Rosa Anna; Del Duca, Stefano] Univ Bologna, Dept Biol Earth & Environm Sci, Bologna, Italy; [Calamelli, Elisabetta; Pula, Chiara; Pession, Andrea; Ricci, Giampaolo] Univ Bologna, Womens Childrens & Adolescents Hlth Gozzadini Chi, Dept Pediat Allergol, Bologna, Italy; [Lodolini, Magda; Scamardella, Fortuna] Maggiore Hosp, Lab Anal Unit, Bologna, Italy	University of Bologna; University of Bologna; AUSL di Bologna	Del Duca, S (corresponding author), Univ Bologna, Dept Biol Earth & Environm Sci, Bologna, Italy.	stefano.delduca@unibo.it	Calamelli, Elisabetta/AAL-8143-2021; Del Duca, Stefano/K-5980-2017; Pession, Andrea/O-3200-2013	Del Duca, Stefano/0000-0002-5981-520X; Pession, Andrea/0000-0002-0379-9562; CALAMELLI, ELISABETTA/0000-0002-7809-5543; Calamelli, Elisabetta/0000-0003-4888-0839	Programma Operativo Regionale (POR FESR) of Regione Calabria "My Darling Clementine": un prodotto salutistico nuovo e innovativo dalle clementine e dal limone di Calabria''	Programma Operativo Regionale (POR FESR) of Regione Calabria "My Darling Clementine": un prodotto salutistico nuovo e innovativo dalle clementine e dal limone di Calabria''	This work was supported by the Programma Operativo Regionale (POR FESR 2007-2013) of Regione Calabria "My Darling Clementine": un prodotto salutistico nuovo e innovativo dalle clementine e dal limone di Calabria''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER BR, 1991, CLIN EXP ALLERGY, V21, P683, DOI 10.1111/j.1365-2222.1991.tb03196.x; Ahrazem O, 2006, INT ARCH ALLERGY IMM, V139, P96, DOI 10.1159/000090384; Ahrazem O, 2005, INT ARCH ALLERGY IMM, V137, P201, DOI 10.1159/000086332; Asero R, 2008, CLIN EXP ALLERGY, V38, P1033, DOI 10.1111/j.1365-2222.2008.02980.x; BAGNI N, 1981, PLANT PHYSIOL, V68, P727, DOI 10.1104/pp.68.3.727; Behrendt H, 2001, INT ARCH ALLERGY IMM, V124, P121, DOI 10.1159/000053688; Bohle B, 2007, ALLERGY, V62, P3, DOI 10.1111/j.1398-9995.2006.01258.x; Bolhaar STHP, 2005, J ALLERGY CLIN IMMUN, V116, P1080, DOI 10.1016/j.jaci.2005.07.004; Botton A, 2002, PLANT SCI, V163, P993, DOI 10.1016/S0168-9452(02)00271-6; Crespo JF, 2006, MOL NUTR FOOD RES, V50, P282, DOI 10.1002/mnfr.200500200; D'Amato G, 2010, J INVEST ALLERG CLIN, V20, P95; Ebo DG, 2007, INT ARCH ALLERGY IMM, V144, P39, DOI 10.1159/000102612; Enrique E, 2004, J INVEST ALLERG CLIN, V14, P335; Eriksson NE, 2003, ALLERGOL INT, V52, P199; Garcia BE, 2011, J INVEST ALLERG CLIN, V21, P162; Glaspole IN, 2007, ANN ALLERG ASTHMA IM, V98, P286, DOI 10.1016/S1081-1206(10)60720-X; Gunawan H, 2008, INT ARCH ALLERGY IMM, V147, P276, DOI 10.1159/000144035; Hyun TK, 2011, PLANT OMICS, V4, P428; Ibanez MD, 2004, J ALLERGY CLIN IMMUN, V113, P175, DOI 10.1016/j.jaci.2003.10.059; Iorio RA, 2012, AMINO ACIDS, V42, P1007, DOI 10.1007/s00726-011-1043-7; Kader JC, 1996, ANNU REV PLANT PHYS, V47, P627, DOI 10.1146/annurev.arplant.47.1.627; Kim HJ, 2011, PLANT CELL, V23, P94, DOI 10.1105/tpc.110.074799; Knekt P, 2000, EUR J CLIN NUTR, V54, P415, DOI 10.1038/sj.ejcn.1600974; Krishnan Kannan, 2009, Biophys Rev, V1, P71, DOI 10.1007/s12551-009-0010-y; Kumar R, 2006, ASIAN PAC J ALLERGY, V24, P191; Le Marchand L, 2000, JNCI-J NATL CANCER I, V92, P154, DOI 10.1093/jnci/92.2.154; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez DEQ, 2006, J INVEST ALLERG CLIN, V16, P140; Lopez-Torrejon G, 2005, ALLERGY, V60, P1424, DOI 10.1111/j.1398-9995.2005.00903.x; Mari A, 2001, INT ARCH ALLERGY IMM, V125, P57, DOI 10.1159/000053797; Marzban G, 2005, PLANT SCI, V169, P387, DOI 10.1016/j.plantsci.2005.03.027; Mills ENC, 2007, ALLERGY, V62, P717, DOI 10.1111/j.1398-9995.2007.01425.x; ORTOLANI C, 1989, J ALLERGY CLIN IMMUN, V83, P683, DOI 10.1016/0091-6749(89)90083-3; Paris R, 2009, TREE GENET GENOMES, V5, P81, DOI 10.1007/s11295-008-0177-6; Pignataro V, 2010, J AGR FOOD CHEM, V58, P7239, DOI 10.1021/jf1006825; Radauer C, 2004, PLANT FOOD ALLERGENS, P105; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ricci G, 2005, MOL IMMUNOL, V42, P1251, DOI 10.1016/j.molimm.2004.11.011; Sampson HA, 1999, J ALLERGY CLIN IMMUN, V103, P717, DOI 10.1016/S0091-6749(99)70411-2; Sampson HA, 2004, J ALLERGY CLIN IMMUN, V113, P805, DOI 10.1016/j.jaci.2004.03.014; SLOAN AE, 1986, J ALLERGY CLIN IMMUN, V78, P127, DOI 10.1016/0091-6749(86)90002-3; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANREE R, 1992, INT ARCH ALLERGY IMM, V98, P97, DOI 10.1159/000236171; Wilkins TA, 1996, ISOLATION RNA PLANT, P21; Yan JW, 2012, MOL BIOL REP, V39, P1831, DOI 10.1007/s11033-011-0925-9	45	14	15	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53680	10.1371/journal.pone.0053680	http://dx.doi.org/10.1371/journal.pone.0053680			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308273	Green Published, gold, Green Submitted			2022-12-25	WOS:000313670100052
J	Li, E; Yue, F; Chang, Q; Guo, XN; He, XP; Zhang, BR				Li, Ee; Yue, Feng; Chang, Qi; Guo, Xuena; He, Xiuping; Zhang, Borun			Deletion of Intragenic Tandem Repeats in Unit C of FLO1 of Saccharomyces cerevisiae Increases the Conformational Stability of Flocculin under Acidic and Alkaline Conditions	PLOS ONE			English	Article							YEAST FLOCCULATION; CELL-SURFACE; GENE FLO1; EXPRESSION; BREWERS; PHENOTYPE; STRAINS; PROTEIN	Flocculation is an attractive property for Saccaromyces cerevisiae, which plays important roles in fermentation industry and environmental remediation. The process of flocculation is mediated by a family of cell surface flocculins. As one member of flocculins, Flo1 is characterized by four families of repeats (designated as repeat units A, B, C and D) in the central domain. It is generally accepted that variation of repeat unit A in length in Flo1 influences the degree of flocculation or specificity for sugar recognization. However, no reports were observed for other repeat units. Here, we compared the flocculation ability and its sensitivity to environmental factors between yeast strain YSF1 carrying the intact FLO1 gene and yeast strains carrying the derived forms of FLO1 with partial or complete deletion of repeats in unit C. No obvious differences in flocculation ability and specificity of carbohydrate recognition were observed among these yeast strains, which indicates the truncated flocculins can stride across the cell wall and cluster the N-terminal domain on the surface of yeast cells as the intact Flo1 thereby improving intercellular binding. However, yeast strains with the truncated flocculins required more mannose to inhibit completely the flocculation, displayed broad tolerance of flocculation to pH fluctuation, and the fewer the repeats in unit C, the stronger adaptability of flocculation to pH change, which was not relevant to the position of deletion. This suggests that more stable active conformation is obtained for flocculin by deletion the repeat unit C in the central domain of Flo1, which was validated further by the higher hydrophobicity on the surface of cells of YSF1c with complete deletion of unit C under neutral and alkaline conditions and the stabilization of GFP conformation by fusion with flocculin with complete deletion of unit C in the central domain.	[Li, Ee; Yue, Feng; Chang, Qi; Guo, Xuena; He, Xiuping; Zhang, Borun] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China; [Li, Ee; Yue, Feng; Chang, Qi] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	He, XP (corresponding author), Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China.	hexp@im.ac.cn			National Natural Science Foundation of China [30970087]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant number 30970087, http://nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 1997, METHODS YEAST GENETI; Bauer FF, 2010, APPL MICROBIOL BIOT, V88, P31, DOI 10.1007/s00253-010-2783-0; Bester MC, 2006, CURR GENET, V49, P375, DOI 10.1007/s00294-006-0068-z; Bizzarri R, 2009, ANAL BIOANAL CHEM, V393, P1107, DOI 10.1007/s00216-008-2515-9; Ehrmann MA, 2001, LETT APPL MICROBIOL, V32, P230, DOI 10.1046/j.1472-765X.2001.00892.x; Fidalgo M, 2006, P NATL ACAD SCI USA, V103, P11228, DOI 10.1073/pnas.0601713103; Govender P, 2008, APPL ENVIRON MICROB, V74, P6041, DOI 10.1128/AEM.00394-08; [何秀萍 He Xiuping], 2002, [微生物学报, Acta Microbiologica Sinica], V42, P242; Jin YL, 2000, J AM SOC BREW CHEM, V58, P108; Kobayashi O, 1998, J BACTERIOL, V180, P6503, DOI 10.1128/JB.180.24.6503-6510.1998; Kobayashi O, 1999, CURR GENET, V36, P256, DOI 10.1007/s002940050498; Li Ee, 2012, Weishengwu Xuebao, V52, P69; Liu N, 2007, FEMS YEAST RES, V7, P1362, DOI 10.1111/j.1567-1364.2007.00294.x; Lo WS, 1996, J BACTERIOL, V178, P7144, DOI 10.1128/jb.178.24.7144-7151.1996; Ma K, 2009, BIORESOURCE TECHNOL, V100, P2289, DOI 10.1016/j.biortech.2008.11.010; Machado MD, 2008, BIORESOURCE TECHNOL, V99, P2107, DOI 10.1016/j.biortech.2007.05.047; MASY CL, 1992, CAN J MICROBIOL, V38, P1298, DOI 10.1139/m92-214; Patelakis SJJ, 1998, LETT APPL MICROBIOL, V26, P279; Sambrook J, 2001, MOL CLONING LAB MANU; Sato M, 2001, J AM SOC BREW CHEM, V59, P130; Sieiro C, 1997, FEMS MICROBIOL LETT, V146, P109, DOI 10.1016/S0378-1097(96)00462-4; Soares EV, 2000, BIOTECHNOL LETT, V22, P1827, DOI 10.1023/A:1005665427163; STRATFORD M, 1991, YEAST, V7, P559, DOI 10.1002/yea.320070604; STRATFORD M, 1989, YEAST, V5, P441; TEUNISSEN AWRH, 1993, YEAST, V9, P1, DOI 10.1002/yea.320090102; Van Holle A, 2012, APPL MICROBIOL BIOT, V93, P1221, DOI 10.1007/s00253-011-3502-1; Veelders M, 2010, P NATL ACAD SCI USA, V107, P22511, DOI 10.1073/pnas.1013210108; Verstrepen KJ, 2006, MOL MICROBIOL, V60, P5, DOI 10.1111/j.1365-2958.2006.05072.x; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Verstrepen KJ, 2004, NAT REV MICROBIOL, V2, P533, DOI 10.1038/nrmicro927; Verstrepen KJ, 2003, APPL MICROBIOL BIOT, V61, P197, DOI 10.1007/s00253-002-1200-8; WATARI J, 1994, YEAST, V10, P211, DOI 10.1002/yea.320100208; WATARI J, 1991, AGR BIOL CHEM TOKYO, V55, P1547, DOI 10.1080/00021369.1991.10870834	34	7	12	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53428	10.1371/journal.pone.0053428	http://dx.doi.org/10.1371/journal.pone.0053428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308221	Green Published, Green Submitted, gold			2022-12-25	WOS:000313670100040
J	Blaber, SP; Hill, CJ; Webster, RA; Say, JM; Brown, LJ; Wang, SC; Vesey, G; Herbert, BR				Blaber, Sinead P.; Hill, Cameron J.; Webster, Rebecca A.; Say, Jana M.; Brown, Louise J.; Wang, Shih-Chang; Vesey, Graham; Herbert, Benjamin Ross			Effect of Labeling with Iron Oxide Particles or Nanodiamonds on the Functionality of Adipose-Derived Mesenchymal Stem Cells	PLOS ONE			English	Article							MARROW STROMAL CELLS; MAGNETIC-RESONANCE; IN-VITRO; RAT MODEL; PROLIFERATION; TRACKING; ISCHEMIA; DELIVERY; INHIBIT; BINDING	Stem cells are increasingly the focus of translational research as well as having emerging roles in human cellular therapy. To support these uses there is a need for improved methods for in vivo cell localization and tracking. In this study, we examined the effects of cell labeling on the in vitro functionality of human adipose-derived mesenchymal stem cells. Our results provide a basis for future in vivo studies investigating implanted cell fate and longevity. In particular, we investigated the effects of two different particles: micron-sized (similar to 0.9 mu m) fluorescently labeled ( Dragon Green) superparamagnetic iron oxide particles (M-SPIO particles); and, carboxylated nanodiamonds of similar to 0.25 mu m in size. The effects of labeling on the functionality of adipose-derived MSCs were assessed by in vitro morphology, osteogenic and adipogenic differentiation potential, CD marker expression, cytokine secretion profiling and quantitative proteomics of the intra-cellular proteome. The differentiation and CD marker assays for stem-like functionality were not altered upon label incorporation and no secreted or intra-cellular protein changes indicative of stress or toxicity were detected. These in vitro results indicate that the M-SPIO particles and nanodiamonds investigated in this study are biocompatible with MSCs and therefore would be suitable labels for cell localization and tracking in vivo.	[Blaber, Sinead P.; Hill, Cameron J.; Webster, Rebecca A.; Say, Jana M.; Brown, Louise J.; Herbert, Benjamin Ross] Macquarie Univ, Dept Chem & Biomol Sci, N Ryde, NSW, Australia; [Blaber, Sinead P.; Webster, Rebecca A.; Vesey, Graham; Herbert, Benjamin Ross] Regeneus Ltd, Gordon, NSW, Australia; [Say, Jana M.] Macquarie Univ, Dept Phys & Astron, N Ryde, NSW, Australia; [Wang, Shih-Chang] Univ Sydney, Westmead Hosp, Dept Radiol, Westmead, NSW 2145, Australia	Macquarie University; Macquarie University; University of Sydney	Herbert, BR (corresponding author), Macquarie Univ, Dept Chem & Biomol Sci, N Ryde, NSW, Australia.	Benjamin.Herbert@mq.edu.au		herbert, ben/0000-0003-4697-8197; Brown, Louise/0000-0001-8592-2431	Macquarie University; MQ Research Excellence Scholarship; MQ Research Excellence International Scholarship	Macquarie University; MQ Research Excellence Scholarship; MQ Research Excellence International Scholarship	Regeneus Ltd paid for some of the consumables used in the experiments detailed in this manuscript. Macquarie University post-graduate research funding also contributed to purchasing consumables used in the experiments detailed in this manuscript. the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SPB is supported by a MQ Research Excellence Scholarship and JMS is supported by an MQ Research Excellence International Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Ben-Ami E, 2011, AUTOIMMUN REV, V10, P410, DOI 10.1016/j.autrev.2011.01.005; Billinton N, 2001, ANAL BIOCHEM, V291, P175, DOI 10.1006/abio.2000.5006; Blaber SP, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-172; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Chang YR, 2008, NAT NANOTECHNOL, V3, P284, DOI 10.1038/nnano.2008.99; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; DAVIES G, 1976, PROC R SOC LON SER-A, V348, P285, DOI 10.1098/rspa.1976.0039; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; DYER HB, 1965, J CHEM PHYS, V42, P1898, DOI 10.1063/1.1696224; Fang CY, 2011, SMALL, V7, P3363, DOI 10.1002/smll.201101233; Grillon F, 2012, STEM CELLS TRANSLATI; Gruber A, 1997, SCIENCE, V276, P2012, DOI 10.1126/science.276.5321.2012; Guthi JS, 2010, MOL PHARMACEUT, V7, P32, DOI 10.1021/mp9001393; Heymer A, 2008, BIOMATERIALS, V29, P1473, DOI 10.1016/j.biomaterials.2007.12.003; Hinds KA, 2003, BLOOD, V102, P867, DOI 10.1182/blood-2002-12-3669; Jendelova P, 2003, MAGNET RESON MED, V50, P767, DOI 10.1002/mrm.10585; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Kalish R, 1997, DIAM RELAT MATER, V6, P516, DOI 10.1016/S0925-9635(96)00657-7; Kim DH, 2007, CELL TRANSPLANT, V16, P1007, DOI 10.3727/000000007783472381; Kinnaird T, 2005, CIRC RES, V97, pE51; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Lee JH, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/35/355102; Malik S, 1998, P NATL ACAD SCI USA, V95, P2192, DOI 10.1073/pnas.95.5.2192; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Nohroudi K, 2010, CELL TRANSPLANT, V19, P431, DOI 10.3727/096368909X484699; Oh JY, 2008, STEM CELLS, V26, P1047, DOI 10.1634/stemcells.2007-0737; Parkin J, 2001, LANCET, V357, P1777, DOI 10.1016/S0140-6736(00)04904-7; Rand SC, 1994, DIAMOND LASERS, P235; Say Jana M, 2011, Biophys Rev, V3, P171, DOI 10.1007/s12551-011-0056-5; Schrand AM, 2009, CRIT REV SOLID STATE, V34, P18, DOI 10.1080/10408430902831987; Shapiro EM, 2004, P NATL ACAD SCI USA, V101, P10901, DOI 10.1073/pnas.0403918101; Stroh A, 2009, MOL IMAGING, V8, P166, DOI 10.2310/7290.2009.00017; Tang JM, 2006, EUR J CARDIO-THORAC, V30, P353, DOI 10.1016/j.ejcts.2006.02.070; Th'ng JPH, 2005, J BIOL CHEM, V280, P27809, DOI 10.1074/jbc.M501627200; Timmers L, 2008, STEM CELL RES, V1, P129, DOI 10.1016/j.scr.2008.02.002; Tremblay F, 2009, J BIOL CHEM, V284, P8136, DOI 10.1074/jbc.M809535200; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Uccelli A, 2010, CURR OPIN IMMUNOL, V22, P768, DOI 10.1016/j.coi.2010.10.012; Vaijayanthimala V, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/42/425103; van Buul GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017001; Walczak P, 2008, STROKE, V39, P1569, DOI 10.1161/STROKEAHA.107.502047; Wang JY, 2004, MOL CELL BIOL, V24, P6084, DOI 10.1128/MCB.24.13.6084-6093.2004; WEISSKOFF RM, 1994, MAGNET RESON MED, V31, P601, DOI 10.1002/mrm.1910310605; WELCH WJ, 1992, PHYSIOL REV, V72, P1063, DOI 10.1152/physrev.1992.72.4.1063; Zaitsev A.M., 2001, OPTICAL PROPERTIES D, DOI 10.1007/978-3-662-04548-0; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	54	44	44	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52997	10.1371/journal.pone.0052997	http://dx.doi.org/10.1371/journal.pone.0052997			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301012	Green Submitted, Green Published, gold			2022-12-25	WOS:000313480000024
J	Chevallier, A; Mialot, A; Petit, JM; Fernandez-Salguero, P; Barouki, R; Coumoul, X; Beraneck, M				Chevallier, Aline; Mialot, Antoine; Petit, Jean-Maurice; Fernandez-Salguero, Pedro; Barouki, Robert; Coumoul, Xavier; Beraneck, Mathieu			Oculomotor Deficits in Aryl Hydrocarbon Receptor Null Mouse	PLOS ONE			English	Article							INFANTILE NYSTAGMUS SYNDROME; NUCLEAR TRANSLOCATOR; DIOXIN NEUROTOXICITY; CORTICAL-NEURONS; EYE-MOVEMENTS; MICE LACKING; AH RECEPTOR; BRAIN-STEM; RAT-BRAIN; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN	The Aryl hydrocarbon Receptor or AhR, a ligand-activated transcription factor, is known to mediate the toxic and carcinogenic effects of various environmental pollutants such as 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD). Recent studies in Caenorhabditis elegans and Drosophila melanogaster show that the orthologs of the AhR are expressed exclusively in certain types of neurons and are implicated in the development and the homeostasis of the central nervous system. While physiological roles of the AhR were demonstrated in the mammalian heart, liver and gametogenesis, its ontogenic expression and putative neural functions remain elusive. Here, we report that the constitutive absence of the AhR in adult mice (AhR-/-) leads to abnormal eye movements in the form of a spontaneous pendular horizontal nystagmus. To determine if the nystagmus is of vestibular, visual, or cerebellar origin, gaze stabilizing reflexes, namely vestibulo-ocular and optokinetic reflexes (VOR and OKR), were investigated. The OKR is less effective in the AhR-/- mice suggesting a deficit in the visuo-motor circuitry, while the VOR is mildly affected. Furthermore, the AhR is expressedin the retinal ganglion cells during the development, however electroretinograms revealed no impairment of retinal cell function. The structure of the cerebellum of the AhR-/- mice is normal which is compatible with the preserved VOR adaptation, a plastic process dependent on cerebellar integrity. Finally, intoxication with TCDD of control adults did not lead to any abnormality of the oculomotor control. These results demonstrate that the absence of the AhR leads to acquired central nervous system deficits in the adults. Given the many common features between both AhR mouse and human infantile nystagmus syndromes, the AhR-/- mice might give insights into the developmental mechanisms which lead to congenital eye disorders.	[Chevallier, Aline; Barouki, Robert; Coumoul, Xavier] Ctr Univ St Peres, INSERM, UMR S 747, Paris, France; [Mialot, Antoine; Beraneck, Mathieu] Ctr Univ St Peres, UMR 8194, CNRS, Ctr Etud Sensori Motricite, Paris, France; [Barouki, Robert] Hop Necker Enfants Malad, AP HP, Paris, France; [Fernandez-Salguero, Pedro] Univ Extramadura, Extramadura, Spain; [Chevallier, Aline; Mialot, Antoine; Petit, Jean-Maurice; Barouki, Robert; Coumoul, Xavier; Beraneck, Mathieu] Univ Paris 05, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Coumoul, X (corresponding author), Ctr Univ St Peres, INSERM, UMR S 747, Paris, France.	xavier.coumoul@parisdescartes.fr; mathieu.beraneck@parisdescartes.fr	Fernandez-Salguero, Pedro M./J-8437-2014; Chevallier, Aline/O-5939-2014; COUMOUL, Xavier/AAR-3649-2020	Fernandez-Salguero, Pedro M./0000-0003-2839-5027; COUMOUL, Xavier/0000-0003-2928-9648; Beraneck, Mathieu/0000-0003-2722-0532	CNES (Centre National d'Etudes Spatiales); CNRS (Centre National de Recherche Scientifique); INSERM (Institut National de la Sante et de la Recherche Medicale); MESR (Ministere de l'enseignement superieur et de la recherche); Universite Paris Descartes	CNES (Centre National d'Etudes Spatiales)(Centre National D'etudes Spatiales); CNRS (Centre National de Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); MESR (Ministere de l'enseignement superieur et de la recherche)(Ministry of Research, France); Universite Paris Descartes	This work was funded by the CNES (Centre National d'Etudes Spatiales); CNRS (Centre National de Recherche Scientifique); INSERM (Institut National de la Sante et de la Recherche Medicale); the MESR (Ministere de l'enseignement superieur et de la recherche; Bourse doctorale, Aline Chevallier); the Universite Paris Descartes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi RV, 2002, BRIT J OPHTHALMOL, V86, P1152, DOI 10.1136/bjo.86.10.1152; Akahoshi Eiichi, 2006, Environ Health, V5, P24, DOI 10.1186/1476-069X-5-24; Barouki R, 2007, FEBS LETT, V581, P3608, DOI 10.1016/j.febslet.2007.03.046; Beraneck M, 2008, J NEUROPHYSIOL, V100, P945, DOI 10.1152/jn.90319.2008; Beraneck M, 2007, J NEUROPHYSIOL, V98, P1549, DOI 10.1152/jn.00590.2007; Boyden ES, 2003, NEURON, V39, P1031, DOI 10.1016/S0896-6273(03)00562-2; Butler RA, 2001, GENE, V278, P223, DOI 10.1016/S0378-1119(01)00724-7; Buttner U, 1988, Rev Oculomot Res, V2, P3; Calabrese DR, 2006, JARO-J ASSOC RES OTO, V7, P151, DOI 10.1007/s10162-006-0031-1; Collins LL, 2008, TOXICOL SCI, V103, P125, DOI 10.1093/toxsci/kfn017; Emmons RB, 1999, DEVELOPMENT, V126, P3937; Fernandez M, 2010, J NEUROCHEM, V115, P897, DOI 10.1111/j.1471-4159.2010.06974.x; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; Frohman EM, 2005, LANCET NEUROL, V4, P111, DOI 10.1016/S1474-4422(05)00992-0; Gohlke JM, 2009, REPROD TOXICOL, V28, P321, DOI 10.1016/j.reprotox.2009.05.067; Hahn ME, 2002, CHEM-BIOL INTERACT, V141, P131, DOI 10.1016/S0009-2797(02)00070-4; Huang MYY, 2011, ANN NY ACAD SCI, V1233, P285, DOI 10.1111/j.1749-6632.2011.06150.x; Huang X, 2004, DEVELOPMENT, V131, P819, DOI 10.1242/dev.00959; Hufner Katharina, 2011, Front Neurol, V2, P60, DOI 10.3389/fneur.2011.00060; Iwashita M, 2001, NEUROSCI RES, V39, P299, DOI 10.1016/S0168-0102(00)00228-5; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Kim MD, 2006, GENE DEV, V20, P2806, DOI 10.1101/gad.1459706; Lin CH, 2008, J NEUROCHEM, V104, P1415, DOI 10.1111/j.1471-4159.2007.05098.x; Lin CH, 2009, J NEUROCHEM, V111, P777, DOI 10.1111/j.1471-4159.2009.06364.x; McLean RJ, 2009, EXPERT OPIN PHARMACO, V10, P1805, DOI 10.1517/14656560902978446; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; Oommen BS, 2008, BRAIN RES, V1193, P57, DOI 10.1016/j.brainres.2007.11.053; Petersen SL, 2000, J COMP NEUROL, V427, P428, DOI 10.1002/1096-9861(20001120)427:3<428::AID-CNE9>3.0.CO;2-P; Sanchez-Martin FJ, 2011, J NEUROCHEM, V118, P153, DOI 10.1111/j.1471-4159.2011.07291.x; Sartor MA, 2009, ENVIRON HEALTH PERSP, V117, P1139, DOI 10.1289/ehp.0800485; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Stahl JS, 2004, VISION RES, V44, P3401, DOI 10.1016/j.visres.2004.09.011; Strupp M, 2011, DTSCH ARZTEBL INT, V108, P197, DOI 10.3238/arztebl.2011.0197; Tan MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032330; Traber GL, 2012, INVEST OPHTH VIS SCI, V53, P5737, DOI 10.1167/iovs.12-10137; van Alphen B, 2010, INVEST OPHTH VIS SCI, V51, P623, DOI 10.1167/iovs.09-4072; van der Spuy J, 2004, J BIOL CHEM, V279, P48038, DOI 10.1074/jbc.M407871200; Williamson MA, 2005, TOXICOL SCI, V83, P340, DOI 10.1093/toxsci.kfi031	38	32	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53520	10.1371/journal.pone.0053520	http://dx.doi.org/10.1371/journal.pone.0053520			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301081	Green Published, Green Submitted, gold			2022-12-25	WOS:000313480000062
J	Sieber, MW; Jaenisch, N; Brehm, M; Guenther, M; Linnartz-Gerlach, B; Neumann, H; Witte, OW; Frahm, C				Sieber, Matthias W.; Jaenisch, Nadine; Brehm, Martin; Guenther, Madlen; Linnartz-Gerlach, Bettina; Neumann, Harald; Witte, Otto W.; Frahm, Christiane			Attenuated Inflammatory Response in Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Knock-Out Mice following Stroke	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; RESIDENT MICROGLIA; POSTISCHEMIC BRAIN; DENDRITIC CELLS; IMMUNE-SYSTEM; CUTTING EDGE; MACROPHAGES; DAMAGE; PATHOPHYSIOLOGY; ACTIVATION	Background: Triggering receptor expressed on myeloid cells-2 (TREM2) is a microglial surface receptor involved in phagocytosis. Clearance of apoptotic debris after stroke represents an important mechanism to re-attain tissue homeostasis and thereby ensure functional recovery. The role of TREM2 following stroke is currently unclear. Methods and Results: As an experimental stroke model, the middle cerebral artery of mice was occluded for 30 minutes with a range of reperfusion times (duration of reperfusion: 6 h/12 h/24 h/2 d/7 d/28 d). Quantitative PCR (qPCR) revealed a greatly increased transcription of TREM2 after stroke. We subsequently analyzed the expression of pro-inflammatory cytokines, chemokines and their receptors in TREM2-knockout (TREM2-KO) mice via qPCR. Microglial activation (CD68, Iba1) and CD3-positive T-cell invasion were analyzed via qPCR and immunohistochemistry. Functional consequences of TREM2 knockout were assessed by infarct volumetry. The acute inflammatory response (12 h reperfusion) was very similar between TREM2-KO mice and their littermate controls. However, in the sub-acute phase (7 d reperfusion) following stroke, TREM2-KO mice showed a decreased transcription of pro-inflammatory cytokines TNF alpha, IL-1 alpha and IL-1 beta, associated with a reduced microglial activity (CD68, Iba1). Furthermore, TREM2-KO mice showed a reduced transcription of chemokines CCL2 (MCP1), CCL3 (MIP1 alpha) and the chemokine receptor CX3CR1, followed by a diminished invasion of CD3-positive T-cells. No effect on the lesion size was observed. Conclusions: Although we initially expected an exaggerated pro-inflammatory response following ablation of TREM2, our data support a contradictory scenario that the sub-acute inflammatory reaction after stroke is attenuated in TREM2-KO mice. We therefore conclude that TREM2 appears to sustain a distinct inflammatory response after stroke.	[Sieber, Matthias W.; Jaenisch, Nadine; Brehm, Martin; Guenther, Madlen; Witte, Otto W.; Frahm, Christiane] Jena Univ Hosp, Hans Berger Dept Neurol, Jena, Germany; [Linnartz-Gerlach, Bettina; Neumann, Harald] Univ Hosp Bonn, Inst Reconstruct Neurobiol, Neural Regenerat Grp, Bonn, Germany	Friedrich Schiller University of Jena; University of Bonn	Frahm, C (corresponding author), Jena Univ Hosp, Hans Berger Dept Neurol, Jena, Germany.	christiane.frahm@med.uni-jena.de	Witte, Otto/P-4127-2018; Linnartz-Gerlach, Bettina/B-9428-2011; Neumann, Harald/A-9718-2010	Witte, Otto/0000-0003-2101-4105; Linnartz-Gerlach, Bettina/0000-0003-4485-684X; Neumann, Harald/0000-0002-5071-5202	European Union (STREP, FP6, 'Age-dependent inflammatory response after stroke' - ARGES) [LSHB-CT-2006-018936]; Jena centre for systems biology of ageing - Jenage [BMBF 0315581]; Deutsche Forschungsgemeinschaft [KFO177, SFB704, FOR1336]; Hertie-Foundation	European Union (STREP, FP6, 'Age-dependent inflammatory response after stroke' - ARGES); Jena centre for systems biology of ageing - Jenage; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hertie-Foundation	This project was supported by the European Union (STREP, FP6, 'Age-dependent inflammatory response after stroke' - ARGES [LSHB-CT-2006-018936]) and is part of the research program of the Jena centre for systems biology of ageing - Jenage (BMBF 0315581). The Neural Regeneration Group at the University Bonn LIFE & BRAIN Center is supported by the Hertie-Foundation and the Deutsche Forschungsgemeinschaft (KFO177, SFB704, FOR1336). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amantea D, 2009, FEBS J, V276, P13, DOI 10.1111/j.1742-4658.2008.06766.x; Barnum CJ, 2011, EXP NEUROL, V229, P198, DOI 10.1016/j.expneurol.2011.02.016; Bouchon A, 2001, J EXP MED, V194, P1111, DOI 10.1084/jem.194.8.1111; Charles JF, 2008, INFECT IMMUN, V76, P2439, DOI 10.1128/IAI.00115-08; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Denes A, 2007, J CEREBR BLOOD F MET, V27, P1941, DOI 10.1038/sj.jcbfm.9600495; Denes A, 2011, CEREBROVASC DIS, V32, P517, DOI 10.1159/000332205; FASSBENDER K, 1994, J NEUROL SCI, V122, P135, DOI 10.1016/0022-510X(94)90289-5; Fisher Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010830; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Hughes PM, 2002, J CEREBR BLOOD F MET, V22, P308, DOI 10.1097/00004647-200203000-00008; Ito H, 2012, EUR J IMMUNOL, V42, P176, DOI 10.1002/eji.201141679; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kim SW, 2007, J NEUROSCI RES, V85, P1252, DOI 10.1002/jnr.21236; Kunz A, 2010, BEST PRACT RES-CLIN, V24, P495, DOI 10.1016/j.bpa.2010.10.001; Linnartz B, 2010, INT J ALZHEIMERS DIS, V2010; Macrez R, 2011, LANCET NEUROL, V10, P471, DOI 10.1016/S1474-4422(11)70066-7; Melchior B, 2010, ASN NEURO, V2, P157, DOI 10.1042/AN20100010; Minami M, 2003, LIFE SCI, V74, P321, DOI 10.1016/j.lfs.2003.09.019; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Neumann H, 2007, J NEUROIMMUNOL, V184, P92, DOI 10.1016/j.jneuroim.2006.11.032; Noda Mariko, 2012, Int J Alzheimers Dis, V2012, P891087, DOI 10.1155/2012/891087; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Schilling M, 2005, EXP NEUROL, V196, P290, DOI 10.1016/j.expneurol.2005.08.004; Seno H, 2009, P NATL ACAD SCI USA, V106, P256, DOI 10.1073/pnas.0803343106; Sieber MW, 2010, NEUROBIOL AGING, V31, P654, DOI 10.1016/j.neurobiolaging.2008.05.023; Sieber MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026288; Sieber MW, 2010, ANAL BIOCHEM, V401, P303, DOI 10.1016/j.ab.2010.03.007; Stefano L, 2009, J NEUROCHEM, V110, P284, DOI 10.1111/j.1471-4159.2009.06130.x; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Takahashi K, 2007, PLOS MED, V4, P675, DOI 10.1371/journal.pmed.0040124; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; Vexler ZS, 2006, CLIN NEUROSCI RES, V6, P293, DOI 10.1016/j.cnr.2006.09.008; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Wang X, 2004, ACTA NEUROCHIR SUPPL, V89, P49; Yenari MA, 2010, NEUROTHERAPEUTICS, V7, P378, DOI 10.1016/j.nurt.2010.07.005	37	96	106	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52982	10.1371/journal.pone.0052982	http://dx.doi.org/10.1371/journal.pone.0052982			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301011	Green Submitted, gold, Green Published			2022-12-25	WOS:000313480000023
J	Kwak, MK; Johnson, DT; Zhu, CF; Lee, SH; Ye, DW; Luong, R; Sun, ZJ				Kwak, Mi Kyung; Johnson, Daniel T.; Zhu, Chunfang; Lee, Suk Hyung; Ye, Ding-Wei; Luong, Richard; Sun, Zijie			Conditional Deletion of the Pten Gene in the Mouse Prostate Induces Prostatic Intraepithelial Neoplasms at Early Ages but a Slow Progression to Prostate Tumors	PLOS ONE			English	Article							SUPPRESSOR GENE; ANDROGEN RECEPTOR; TRANSGENIC MOUSE; CANCER; CELL; PTEN/MMAC1; MICE; INACTIVATION; APOPTOSIS; MUTATION	The PTEN tumor suppressor gene is frequently inactivated in human prostate cancer. Using Osr1 (odd skipped related 1)-Cre mice, we generated a novel conditional Pten knockout mouse strain, Pten(LoxP):Osr1-Cre. Conditional biallelic and monoallelic Pten knockout mice were viable. Deletion of Pten expression was detected in the prostate of Pten(LoxP/LoxP):Osr1-Cre mice as early as 2 weeks of age. Intriguingly, Pten(LoxP/LoxP):Osr1-Cre mice develop high-grade prostatic intraepithelial neoplasms (PINs) with high penetrance as early as one-month of age, and locally invasive prostatic tumors after 12-months of age. Pten(LoxP/+):Osr1-Cre mice show only mild oncogenic changes after 8-weeks of age. Castration of Pten(LoxP/LoxP):Osr1-Cre mice shows no significant regression of prostate tumors, although a shift of androgen receptor (AR) staining from the nuclei to cytoplasm is observed in Pten null tumor cells of castrated mice. Enhanced Akt activity is observed in Pten null tumor cells of castrated Pten(LoxP/LoxP):Osr1-Cre. This study provides a novel mouse model that can be used to investigate a primary role of Pten in initiating oncogenic transformation in the prostate and to examine other genetic and epigenetic changes that are required for tumor progression in the mouse prostate.	[Kwak, Mi Kyung; Johnson, Daniel T.; Zhu, Chunfang; Lee, Suk Hyung; Sun, Zijie] Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA; [Kwak, Mi Kyung; Johnson, Daniel T.; Zhu, Chunfang; Lee, Suk Hyung; Sun, Zijie] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Luong, Richard] Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA 94305 USA; [Ye, Ding-Wei] Fudan Univ, Dept Urol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China	Stanford University; Stanford University; Stanford University; Fudan University	Sun, ZJ (corresponding author), Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA.	zsun@stanford.edu		Johnson, Daniel/0000-0003-4669-037X	Public Health Service from the National Cancer Institute [CA-070297, CA-151623]; NATIONAL CANCER INSTITUTE [R01CA151623, R01CA070297, R29CA070297] Funding Source: NIH RePORTER	Public Health Service from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Public Health Service grants CA-070297 and CA-151623 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Backman SA, 2004, P NATL ACAD SCI USA, V101, P1725, DOI 10.1073/pnas.0308217100; Bonneau D, 2000, HUM MUTAT, V16, P109, DOI 10.1002/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0; Cairns P, 1997, CANCER RES, V57, P4997; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Gao H, 2006, P NATL ACAD SCI USA, V103, P14477, DOI 10.1073/pnas.0606836103; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Grieshammer U, 2008, GENESIS, V46, P69, DOI 10.1002/dvg.20366; Kasper S, 2008, STEM CELL REV, V4, P193, DOI 10.1007/s12015-008-9033-1; Kishimoto H, 2003, CELL STRUCT FUNCT, V28, P11; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li PF, 2001, J BIOL CHEM, V276, P20444, DOI 10.1074/jbc.M010226200; Ma XQ, 2005, CANCER RES, V65, P5730, DOI 10.1158/0008-5472.CAN-04-4519; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Matusik RJ, 2008, DIFFERENTIATION, V76, P682, DOI 10.1111/j.1432-0436.2008.00276.x; McMenamin ME, 1999, CANCER RES, V59, P4291; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Nardella C, 2011, CURR TOP MICROBIOL, V347, P135, DOI 10.1007/82_2010_62; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Sharma M, 2002, J BIOL CHEM, V277, P30935, DOI 10.1074/jbc.M201919200; Shen MM, 2007, CANCER RES, V67, P6535, DOI 10.1158/0008-5472.CAN-07-1271; Stambolic V, 2000, CANCER RES, V60, P3605; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Stiles B, 2004, DEV BIOL, V273, P175, DOI 10.1016/j.ydbio.2004.06.008; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Suzuki H, 1998, CANCER RES, V58, P204; Wang SI, 1998, CLIN CANCER RES, V4, P811; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7	34	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53476	10.1371/journal.pone.0053476	http://dx.doi.org/10.1371/journal.pone.0053476			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308230	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429800053
J	Alhaddad, H; Khan, R; Grahn, RA; Gandolfi, B; Mullikin, JC; Cole, SA; Gruffydd-Jones, TJ; Haggstrom, J; Lohi, H; Longeri, M; Lyons, LA				Alhaddad, Hasan; Khan, Razib; Grahn, Robert A.; Gandolfi, Barbara; Mullikin, James C.; Cole, Shelley A.; Gruffydd-Jones, Timothy J.; Haggstrom, Jens; Lohi, Hannes; Longeri, Maria; Lyons, Leslie A.			Extent of Linkage Disequilibrium in the Domestic Cat, Felis silvestris catus, and Its Breeds	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; GENOME-WIDE ASSOCIATION; GENETIC DIVERSITY; PIG BREEDS; DEVON REX; MUTATIONS; SEQUENCE; MICROSATELLITES; ANCESTRY; PATTERNS	Domestic cats have a unique breeding history and can be used as models for human hereditary and infectious diseases. In the current era of genome-wide association studies, insights regarding linkage disequilibrium (LD) are essential for efficient association studies. The objective of this study is to investigate the extent of LD in the domestic cat, Felis silvestris catus, particularly within its breeds. A custom illumina GoldenGate Assay consisting of 1536 single nucleotide polymorphisms (SNPs) equally divided over ten 1 Mb chromosomal regions was developed, and genotyped across 18 globally recognized cat breeds and two distinct random bred populations. The pair-wise LD descriptive measure (r(2)) was calculated between the SNPs in each region and within each population independently. LD decay was estimated by determining the non-linear least-squares of all pair-wise estimates as a function of distance using established models. The point of 50% decay of r(2) was used to compare the extent of LD between breeds. The longest extent of LD was observed in the Burmese breed, where the distance at which r(2) approximate to 0.25 was similar to 380 kb, comparable to several horse and dog breeds. The shortest extent of LD was found in the Siberian breed, with an r(2) approximate to 0.25 at approximately 17 kb, comparable to random bred cats and human populations. A comprehensive haplotype analysis was also conducted. The haplotype structure of each region within each breed mirrored the LD estimates. The LD of cat breeds largely reflects the breeds' population history and breeding strategies. Understanding LD in diverse populations will contribute to an efficient use of the newly developed SNP array for the cat in the design of genome-wide association studies, as well as to the interpretation of results for the fine mapping of disease and phenotypic traits.	[Alhaddad, Hasan; Khan, Razib; Grahn, Robert A.; Gandolfi, Barbara; Lyons, Leslie A.] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA; [Mullikin, James C.] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Cole, Shelley A.] Texas Biomed Res Inst, Dept Genet, San Antonio, TX USA; [Gruffydd-Jones, Timothy J.] Univ Bristol, Sch Vet Sci, Feline Ctr, Bristol BS18 7DU, Avon, England; [Haggstrom, Jens] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden; [Lohi, Hannes] Univ Helsinki, Dept Vet Biosci, Res Programs Unit, Helsinki, Finland; [Lohi, Hannes] Folkhalsan Res Ctr, Helsinki, Finland; [Longeri, Maria] Univ Milan, Dipartimento Sci Vet & Sanita Pubbl, Milan, Italy	University of California System; University of California Davis; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Texas Biomedical Research Institute; University of Bristol; Swedish University of Agricultural Sciences; University of Helsinki; Folkhalsan Research Center; University of Milan	Lyons, LA (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA.	lalyons@ucdavis.edu	Longeri, Maria/L-1557-2017; Lohi, Hannes/F-4596-2011	Longeri, Maria/0000-0001-7863-1855; Lohi, Hannes/0000-0003-1087-5532; Lyons, Leslie/0000-0002-1628-7726; Alhaddad, Hasan/0000-0001-7904-2913; Haggstrom, Jens/0000-0003-3402-023X	National Center for Research Resources (NCRR) [R24 RR016094, C06 RR13556]; Office of Research Infrastructure Programs/OD [R24OD010928]; Center for Companion Animal Health (CCAH) at the University of California Davis; George and Phyllis Miller Feline Health Fund of the San Francisco Foundation; National Human Genome Research Institute, National Institutes of Health; Finnish Cat Association; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR016094, C06RR013556] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200330] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010928] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs/OD; Center for Companion Animal Health (CCAH) at the University of California Davis; George and Phyllis Miller Feline Health Fund of the San Francisco Foundation; National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Finnish Cat Association; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was supported by funding from the National Center for Research Resources (NCRR) R24 RR016094 and is currently supported by the Office of Research Infrastructure Programs/OD R24OD010928, the Center for Companion Animal Health (CCAH) at the University of California Davis and the George and Phyllis Miller Feline Health Fund of the San Francisco Foundation. This research was also supported in part by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health. Genotyping was conducted in facilities constructed with support from Research Facilities Improvement Program Grant Number C06 RR13556 from the NCRR. HL's contribution was funded by the Finnish Cat Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Bach LH, 2012, CYTOGENET GENOME RES, V137, P7, DOI 10.1159/000339416; Bach LH, 2010, ANAL FGF5 CONSTRUCTI; Badke YM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-24; Bannasch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009632; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beaumont M, 2001, MOL ECOL, V10, P319, DOI 10.1046/j.1365-294x.2001.01196.x; BLAXTER A, 1986, VET REC, V118, P619, DOI 10.1136/vr.118.22.619; CFA, 1993, CAT FANC ASS CAT ENC; Corbin LJ, 2010, ANIM GENET, V41, P8, DOI 10.1111/j.1365-2052.2010.02092.x; DOW SW, 1987, J AM VET MED ASSOC, V191, P1563; Driscoll CA, 2007, SCIENCE, V317, P519, DOI 10.1126/science.1139518; Drogemuller C, 2007, ANIM GENET, V38, P218, DOI 10.1111/j.1365-2052.2007.01590.x; Farnir F, 2000, GENOME RES, V10, P220, DOI 10.1101/gr.10.2.220; Filler S, 2012, J HERED; Fox Jr J., 2015, APPL REGRESSION ANAL; Gandolfi B, 2010, MAMM GENOME, V21, P509, DOI 10.1007/s00335-010-9290-6; Gillespie J. H., 2004, POPULATION GENETICS; Gray MM, 2009, GENETICS, V181, P1493, DOI 10.1534/genetics.108.098830; Heath S, 2001, VET REC, V149, P660; HEDRICK PW, 1987, GENETICS, V117, P331; HILL WG, 1988, THEOR POPUL BIOL, V33, P54, DOI 10.1016/0040-5809(88)90004-4; Johnson G, 1991, BENGAL CAT; Karlsson EK, 2008, NAT REV GENET, V9, P713, DOI 10.1038/nrg2382; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kehler JS, 2007, J HERED, V98, P555, DOI 10.1093/jhered/esm072; Kurushima JD, 2012, ANIM GENET; Kurushima JD, 2011, GENETIC ANAL DOMESTI; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lipinski MJ, 2008, GENOMICS, V91, P12, DOI 10.1016/j.ygeno.2007.10.009; LUTZ TA, 1995, VET CLIN N AM-SMALL, V25, P527, DOI 10.1016/S0195-5616(95)50051-8; Lykkjen S, 2010, ANIM GENET, V41, P111, DOI 10.1111/j.1365-2052.2010.02117.x; Lyons LA, 2005, ANIM GENET, V36, P119, DOI 10.1111/j.1365-2052.2005.01253.x; Lyons LA, 2010, TOP COMPANION ANIM M, V25, P203, DOI 10.1053/j.tcam.2010.09.002; Marroni F, 2011, TREE GENET GENOMES, V7, P1011, DOI 10.1007/s11295-011-0391-5; McCue ME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002451; McEvoy BP, 2010, AM J HUM GENET, V87, P297, DOI 10.1016/j.ajhg.2010.07.008; McRae AF, 2002, GENETICS, V160, P1113; Meadows JRS, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-61; Menotti-Raymond M, 2003, CYTOGENET GENOME RES, V102, P272, DOI 10.1159/000075762; Menotti-Raymond M, 2003, J HERED, V94, P95, DOI 10.1093/jhered/esg008; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; Menotti-Raymond M, 2008, SOURCEBOOK MODELS BI, P221; Menotti-Raymond MA, 2005, J FORENSIC SCI, V50, P1061, DOI 10.1520/JFS2004317; Menotti-Raymond M, 2008, GENOMICS, V91, P1, DOI 10.1016/j.ygeno.2007.08.008; Menotti-Raymond M, 2009, GENOMICS, V93, P305, DOI 10.1016/j.ygeno.2008.11.004; Morris D, 1997, CAT WORLD FELINE ENC; Mullikin JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-406; NODEN DM, 1986, J CRAN GENET DEV BIO, P249; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Pontius JU, 2007, GENOME RES, V17, P1675, DOI 10.1101/gr.6380007; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Randi E, 2001, MOL BIOL EVOL, V18, P1679, DOI 10.1093/oxfordjournals.molbev.a003956; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; ROBINSON R, 1969, GENETICA, V40, P597, DOI 10.1007/BF01787384; ROBINSON R, 1993, J HERED, V84, P170, DOI 10.1093/oxfordjournals.jhered.a111311; Robinson R, 1991, GENETICS CAT BREEDER; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Sutter NB, 2004, GENOME RES, V14, P2388, DOI 10.1101/gr.3147604; Uimari P, 2011, J ANIM SCI, V89, P609, DOI 10.2527/jas.2010-3249; Vigne JD, 2004, SCIENCE, V304, P259, DOI 10.1126/science.1095335; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Warnes GR, 2003, R NEWS, V3, P9; Weir B. S., 1996, GENETIC DATA ANAL; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451	68	46	46	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53537	10.1371/journal.pone.0053537	http://dx.doi.org/10.1371/journal.pone.0053537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308248	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429100086
J	Bonekamp, NA; Grille, S; Cardoso, MJ; Almeida, M; Aroso, M; Gomes, S; Magalhaes, AC; Ribeiro, D; Islinger, M; Schrader, M				Bonekamp, Nina A.; Grille, Sandra; Cardoso, Maria Joao; Almeida, Monica; Aroso, Miguel; Gomes, Silvia; Magalhaes, Ana Cristina; Ribeiro, Daniela; Islinger, Markus; Schrader, Michael			Self-Interaction of Human Pex11p beta during Peroxisomal Growth and Division	PLOS ONE			English	Article							DYNAMIN-LIKE PROTEIN-1; MEMBRANE-PROTEIN; DOCOSAHEXAENOIC ACID; BIOGENESIS DISORDERS; MAMMALIAN-CELLS; MOLECULAR-BASIS; PEX11 PROTEINS; CDNA CLONING; FISSION; PROLIFERATION	Pex11 proteins are involved in membrane elongation and division processes associated with the multiplication of peroxisomes. Human Pex11p beta has recently been linked to a new disorder affecting peroxisome morphology and dynamics. Here, we have analyzed the exact membrane topology of Pex11p beta. Studies with an epitope-specific antibody and protease protection assays show that Pex11p beta is an integral membrane protein with two transmembrane domains flanking an internal region exposed to the peroxisomal matrix and N-and C-termini facing the cytosol. A glycine-rich internal region within Pex11p beta is dispensable for peroxisome membrane elongation and division. However, we demonstrate that an amphipathic helix (Helix 2) within the first N-terminal 40 amino acids is crucial for membrane elongation and self-interaction of Pex11p beta. Interestingly, we find that Pex11p beta self-interaction strongly depends on the detergent used for solubilization. We also show that N-terminal cysteines are not essential for membrane elongation, and that putative N-terminal phosphorylation sites are dispensable for Pex11p beta function. We propose that self-interaction of Pex11p beta regulates its membrane deforming activity in conjunction with membrane lipids.	[Bonekamp, Nina A.; Grille, Sandra; Cardoso, Maria Joao; Almeida, Monica; Aroso, Miguel; Gomes, Silvia; Magalhaes, Ana Cristina; Ribeiro, Daniela; Islinger, Markus; Schrader, Michael] Univ Aveiro, Ctr Cell Biol, P-3800 Aveiro, Portugal; [Bonekamp, Nina A.; Grille, Sandra; Cardoso, Maria Joao; Almeida, Monica; Aroso, Miguel; Gomes, Silvia; Magalhaes, Ana Cristina; Ribeiro, Daniela; Islinger, Markus; Schrader, Michael] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Schrader, Michael] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England	Universidade de Aveiro; Universidade de Aveiro; University of Exeter	Schrader, M (corresponding author), Univ Aveiro, Ctr Cell Biol, Campus Univ Santiago, P-3800 Aveiro, Portugal.	m.schrader@exeter.ac.uk	Almeida, Mónica/B-4486-2018; Bonekamp, Nina/AAX-3670-2020; Ribeiro, Daniela/I-7825-2013	Almeida, Mónica/0000-0001-5734-4021; Ribeiro, Daniela/0000-0003-3397-0460; Fernandes Gomes, Silvia Catarina/0000-0001-8473-4420; Magalhaes, Ana/0000-0002-3988-3280; Aroso, Miguel/0000-0002-3118-0185; Ribeiro Cardoso, Maria Joao/0000-0002-2215-7768; Bonekamp, Nina/0000-0001-9748-8089	Portuguese Foundation for Science and Technology (FCT); FEDER [PTDC/BIA-BCM/099613/2008, SFRH/BD/37647/2007, SFRH/BD/45427/2008, SFRH/BD/80542/2011, SFRH/BD/48722/2008, SFRH/BD/81223/2011, SFRH/BPD/77619/2011, SFRH/BPD/74428/2010]; CRUP/DAAD (ACCOES INTEGRADAS) [A-29/11]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FEDER(European Commission); CRUP/DAAD (ACCOES INTEGRADAS)	This work was supported by the Portuguese Foundation for Science and Technology (FCT) and FEDER (PTDC/BIA-BCM/099613/2008 to M. S., SFRH/BD/37647/2007 to N. A. B., SFRH/BD/45427/2008 to M. J. C., SFRH/BD/80542/2011 to M. Almeida, SFRH/BD/48722/2008 to M. Aroso, SFRH/BD/81223/2011 to A. G., SFRH/BPD/77619/2011 to D. R., SFRH/BPD/74428/2010 to M. I.) and CRUP/DAAD (ACCOES INTEGRADAS 2010, A-29/11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe I, 1998, BIOCHEM BIOPH RES CO, V252, P529, DOI 10.1006/bbrc.1998.9684; Abe I, 1998, FEBS LETT, V431, P468, DOI 10.1016/S0014-5793(98)00815-1; Camoes F, 2009, J INHERIT METAB DIS, V32, P163, DOI 10.1007/s10545-008-1018-3; Cepinska MN, 2011, TRAFFIC, V12, P925, DOI 10.1111/j.1600-0854.2011.01198.x; Delille Hannah K, 2011, Commun Integr Biol, V4, P51, DOI 10.4161/cib.4.1.13647; Delille HK, 2010, J CELL SCI, V123, P2750, DOI 10.1242/jcs.062109; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Ebberink MS, 2010, J MED GENET, V47, P608, DOI 10.1136/jmg.2009.074302; Ebberink MS, 2012, J MED GENET, V49, P307, DOI 10.1136/jmedgenet-2012-100778; Ferdinandusse S, 2001, J LIPID RES, V42, P1987; Ferdinandusse S, 2007, HUM MUTAT, V28, P904, DOI 10.1002/humu.20535; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Hu JP, 2010, INT REV CEL MOL BIO, V279, P79, DOI 10.1016/S1937-6448(10)79003-1; Islinger M, 2012, HISTOCHEM CELL BIOL, V137, P547, DOI 10.1007/s00418-012-0941-4; Itoyama A, 2012, J CELL SCI, V125, P589, DOI 10.1242/jcs.087452; Ivashchenko O, 2011, MOL BIOL CELL, V22, P1440, DOI 10.1091/mbc.E10-11-0919; Joshi S, 2012, MOL BIOL CELL, V23, P1307, DOI 10.1091/mbc.E11-09-0782; Kalbfleisch T, 2007, TRAFFIC, V8, P1687, DOI 10.1111/j.1600-0854.2007.00661.x; Knoblach B, 2010, J BIOL CHEM, V285, P6670, DOI 10.1074/jbc.M109.094805; Kobayashi S, 2007, EXP CELL RES, V313, P1675, DOI 10.1016/j.yexcr.2007.02.028; Koch A, 2005, MOL BIOL CELL, V16, P5077, DOI 10.1091/mbc.E05-02-0159; Koch A, 2004, J CELL SCI, V117, P3995, DOI 10.1242/jcs.01268; Koch A, 2003, J BIOL CHEM, V278, P8597, DOI 10.1074/jbc.M211761200; Koch J, 2012, J CELL SCI, V125, P3813, DOI 10.1242/jcs.102178; Koch Johannes, 2011, Biomol Concepts, V2, P353; Koch J, 2010, J CELL SCI, V123, P3389, DOI 10.1242/jcs.064907; Li XL, 2003, J BIOL CHEM, V278, P17012, DOI 10.1074/jbc.M212031200; Li XL, 2002, MOL CELL BIOL, V22, P4358, DOI 10.1128/MCB.22.12.4358-4365.2002; Li XL, 2002, MOL CELL BIOL, V22, P8226, DOI 10.1128/MCB.22.23.8226-8240.2002; Lingard MJ, 2006, J CELL SCI, V119, P1961, DOI 10.1242/jcs.02904; Lizard G, 2012, J ALZHEIMERS DIS, V29, P241, DOI 10.3233/JAD-2011-111163; LUERS G, 1993, J CELL BIOL, V121, P1271, DOI 10.1083/jcb.121.6.1271; Marshall PA, 1996, J CELL BIOL, V135, P123, DOI 10.1083/jcb.135.1.123; Motley AM, 2007, J CELL BIOL, V178, P399, DOI 10.1083/jcb.200702167; Nuttall JM, 2011, CURR OPIN CELL BIOL, V23, P421, DOI 10.1016/j.ceb.2011.05.005; Opalinski L, 2011, EMBO J, V30, P5, DOI 10.1038/emboj.2010.299; Ribeiro D, 2012, HISTOL HISTOPATHOL, V27, P661, DOI 10.14670/HH-27.661; Schrader M, 1996, ANN NY ACAD SCI, V804, P669, DOI 10.1111/j.1749-6632.1996.tb18660.x; Schrader M, 1996, EUR J CELL BIOL, V69, P24; SCHRADER M, 1994, EUR J CELL BIOL, V64, P281; Schrader M, 2012, BBA-MOL BASIS DIS, V1822, P1343, DOI 10.1016/j.bbadis.2011.12.014; Schrader M, 1998, J BIOL CHEM, V273, P29607, DOI 10.1074/jbc.273.45.29607; Schrader M, 2007, BIOESSAYS, V29, P1105, DOI 10.1002/bies.20659; Schrader M, 2006, INT REV CYTOL, V255, P237, DOI 10.1016/S0074-7696(06)55005-3; Schrader M, 2012, HISTOCHEM CELL BIOL, V138, P541, DOI 10.1007/s00418-012-1010-8; Serasinghe MN, 2008, EXP CELL RES, V314, P3494, DOI 10.1016/j.yexcr.2008.09.009; Steinberg SJ, 2006, BBA-MOL CELL RES, V1763, P1733, DOI 10.1016/j.bbamcr.2006.09.010; Tanaka A, 2003, BIOCHEM BIOPH RES CO, V300, P819, DOI 10.1016/S0006-291X(02)02936-4; Thoms S, 2005, FEBS J, V272, P5169, DOI 10.1111/j.1742-4658.2005.04939.x; van der Zand A, 2012, CELL, V149, P397, DOI 10.1016/j.cell.2012.01.054; Wanders RJA, 2006, BBA-MOL CELL RES, V1763, P1707, DOI 10.1016/j.bbamcr.2006.08.010; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Waterham HR, 2012, BBA-MOL BASIS DIS, V1822, P1430, DOI 10.1016/j.bbadis.2012.04.006	53	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53424	10.1371/journal.pone.0053424	http://dx.doi.org/10.1371/journal.pone.0053424			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308220	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429100066
J	Chen, M; He, MA; Min, XW; Pan, A; Zhang, XM; Yao, P; Li, XL; Liu, YW; Yuan, J; Chen, WH; Zhou, L; Fang, WM; Liang, Y; Wang, YJ; Miao, XP; Lang, MJ; Zhang, P; Li, DF; Guo, H; Yang, HD; Hu, FB; Wu, TC				Chen, Mu; He, Meian; Min, Xinwen; Pan, An; Zhang, Xiaomin; Yao, Ping; Li, Xiulou; Liu, Yuewei; Yuan, Jing; Chen, Weihong; Zhou, Li; Fang, Weimin; Liang, Yuan; Wang, Youjie; Miao, Xiaoping; Lang, Mingjian; Zhang, Peng; Li, Dongfeng; Guo, Huan; Yang, Handong; Hu, Frank B.; Wu, Tangchun			Different Physical Activity Subtypes and Risk of Metabolic Syndrome in Middle-Aged and Older Chinese People	PLOS ONE			English	Article							TAI CHI EXERCISE; CARDIOVASCULAR-DISEASE; ADULTS; HEALTH; TRIAL; ASSOCIATION; STATEMENT; STRESS; WOMEN	Background: The prevalence of metabolic syndrome (MetS) is growing rapidly in China. Tai chi and dancing are common types of exercise among middle-aged and elderly Chinese. It remains unclear whether these activities are associated with a lower risk of MetS. Methodology/Principal Findings: A total of 15,514 individuals (6,952 men, 8,562 women) aged 50 to 70 years from the Dongfeng-Tongji Cohort in Shiyan, China participated in a cross-sectional study. Physical activity and other lifestyle factors were assessed with semi-structured questionnaires during face-to-face interviews. MetS was defined by the current National Cholesterol Education Program/Adult treatment Panel III criteria for Asian Americans. The prevalence of MetS was 33.2% in the study population. In the multivariable-adjusted logistic regression analyses, total physical activity levels were monotonically associated with a lower odds of MetS [OR 0.75 comparing extreme quintiles, 95% confidence interval (CI) 0.66-0.86, P<0.001]. Compared with non-exercisers in a specific exercise type, jogging (OR 0.82, 95% CI 0.68-1.00, P = 0.046), tai chi (OR 0.72, 95% CI 0.60-0.88, P<0.001), and dancing (OR 0.56, 95% CI 0.47-0.67, P<0.001) were associated with significantly lower odds of MetS. Furthermore, each 1-h/week increment in tai chi and dancing was associated with a 5% (95% CI 2%-9%) and a 9% (95% CI 6%, 12%) lower risk of MetS. Conclusions/Significance: Jogging, tai chi and dancing are associated with a significantly lower risk of having MetS in middle-aged and older Chinese. Future intervention studies should consider the role of jogging, tai chi and dancing in preventing MetS.	[Chen, Mu; He, Meian; Zhang, Xiaomin; Yao, Ping; Liu, Yuewei; Yuan, Jing; Chen, Weihong; Zhou, Li; Fang, Weimin; Liang, Yuan; Wang, Youjie; Miao, Xiaoping; Guo, Huan; Wu, Tangchun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE Key Lab Environm & Hlth, Wuhan 430074, Hubei, Peoples R China; [Chen, Mu; Pan, An; Li, Xiulou; Lang, Mingjian; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Chen, Mu; Pan, An; Li, Xiulou; Lang, Mingjian; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Min, Xinwen; Zhang, Peng; Li, Dongfeng; Yang, Handong] Dongfeng Motor Corp, Dongfeng Cent Hosp, Shiyan, Hubei, Peoples R China; [Min, Xinwen; Zhang, Peng; Li, Dongfeng; Yang, Handong] Hubei Univ Med, Shiyan, Hubei, Peoples R China	Huazhong University of Science & Technology; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Dongfeng Motor; Hubei University of Medicine	Hu, FB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	frank.hu@channing.harvard.edu; wut@mails.tjmu.edu.cn	Liu, Yuewei/J-5147-2019; Pan, An/C-5572-2011; Zhang, Xiaomin/GVT-8927-2022; Chen, Mu/L-8745-2014; miao, xiaoping/C-4336-2011; Chen, Weihong/D-2177-2011; Zhang, Xiaomin/F-3206-2018	Liu, Yuewei/0000-0001-5970-4262; Pan, An/0000-0002-1089-7945; Chen, Mu/0000-0003-2743-1014; miao, xiaoping/0000-0002-6818-9722; Chen, Weihong/0000-0001-8689-7311; Min, Xinwen/0000-0002-8429-6560; Li, Dongfeng/0000-0003-2583-1727	Huazhong University of Science and Technology Foundation for Educational Development and Research; National Basic Research Program [2011CB503800]	Huazhong University of Science and Technology Foundation for Educational Development and Research; National Basic Research Program(National Basic Research Program of China)	This work was supported by Huazhong University of Science and Technology Foundation for Educational Development and Research and the National Basic Research Program grant 2011CB503800. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Blake Holly, 2012, Curr Aging Sci, V5, P19; Chen SC, 2010, J ALTERN COMPLEM MED, V16, P1153, DOI 10.1089/acm.2009.0560; Ford ES, 2005, DIABETES CARE, V28, P1769, DOI 10.2337/diacare.28.7.1769; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Hu FB, 2011, OBES REV, V12, P552, DOI 10.1111/j.1467-789X.2011.00863.x; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Irwin MR, 2007, J AM GERIATR SOC, V55, P511, DOI 10.1111/j.1532-5415.2007.01109.x; Kinder LS, 2004, PSYCHOSOM MED, V66, P316, DOI 10.1097/01.psy.0000124755.91880.f4; King DE, 2003, MED SCI SPORT EXER, V35, P575, DOI 10.1249/01.MSS.0000058440.28108.CC; Laaksonen DE, 2002, DIABETES CARE, V25, P1612, DOI 10.2337/diacare.25.9.1612; Li FZ, 2012, NEW ENGL J MED, V366, P511, DOI 10.1056/NEJMoa1107911; Liu Q, 2011, LANCET, V377, P2064, DOI 10.1016/S0140-6736(11)60167-0; Ma G, 2008, OBES REV, V9, P113, DOI 10.1111/j.1467-789X.2007.00451.x; Muntner P, 2005, AM J PUBLIC HEALTH, V95, P1631, DOI 10.2105/AJPH.2004.044743; Ng SW, 2009, SOC SCI MED, V68, P1305, DOI 10.1016/j.socscimed.2009.01.035; Pachucki MA, 2011, AM J PUBLIC HEALTH, V101, P2170, DOI 10.2105/AJPH.2011.300282; Raikkonen K, 2002, METABOLISM, V51, P1573, DOI 10.1053/meta.2002.36301; Rennie KL, 2003, INT J EPIDEMIOL, V32, P600, DOI 10.1093/ije/dyg179; Strassel JK, 2011, ALTERN THER HEALTH M, V17, P50; Wang CC, 2010, NEW ENGL J MED, V363, P743, DOI 10.1056/NEJMoa0912611; Wang CC, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-23; Wang F, 2012, INT J EPIDEMIOL; Wang LD, 2005, LANCET, V366, P1821, DOI 10.1016/S0140-6736(05)67344-8; West J, 2004, ANN BEHAV MED, V28, P114, DOI 10.1207/s15324796abm2802_6; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Yeh GY, 2011, ARCH INTERN MED, V171, P750, DOI 10.1001/archinternmed.2011.150; Yu ZJ, 2009, CIRCULATION, V119, P2969, DOI 10.1161/CIRCULATIONAHA.108.833574	30	27	30	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53258	10.1371/journal.pone.0053258	http://dx.doi.org/10.1371/journal.pone.0053258			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	069IS	23308175	Green Published, gold, Green Submitted			2022-12-25	WOS:000313429100046
J	Huang, Y; Zhen, ZL; Song, YY; Zhu, Q; Wang, S; Liu, J				Huang, Yi; Zhen, Zonglei; Song, Yiying; Zhu, Qi; Wang, Song; Liu, Jia			Motor Training Increases the Stability of Activation Patterns in the Primary Motor Cortex	PLOS ONE			English	Article							INFERIOR TEMPORAL CORTEX; OBJECT REPRESENTATIONS; NEURONAL POPULATION; FINGER MOVEMENTS; FUNCTIONAL MRI; VISUAL FORMS; TIME-COURSE; MONKEY; PLASTICITY; ALTERS	Learning to be skillful is an endowed talent of humans, but neural mechanisms underlying behavioral improvement remain largely unknown. Some studies have reported that the mean magnitude of neural activation is increased after learning, whereas others have instead shown decreased activation. In this study, we used functional magnetic resonance imaging (fMRI) to investigate learning-induced changes in the neural activation in the human brain with a classic motor training task. Specifically, instead of comparing the mean magnitudes of activation before and after training, we analyzed the learning-induced changes in multi-voxel spatial patterns of neural activation. We observed that the stability of the activation patterns, or the similarity of the activation patterns between the even and odd runs of the fMRI scans, was significantly increased in the primary motor cortex (M1) after training. By contrast, the mean magnitude of neural activation remained unchanged. Therefore, our study suggests that learning shapes the brain by increasing the stability of the activation patterns, therefore providing a new perspective in understanding the neural mechanisms underlying learning.	[Huang, Yi; Zhen, Zonglei; Song, Yiying; Zhu, Qi; Wang, Song; Liu, Jia] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Liu, Jia] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China	Beijing Normal University; Chinese Academy of Sciences; Institute of Psychology, CAS	Liu, J (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	liujia@bnu.edu.cn	Zhen, Zonglei/GPG-1239-2022; Zhu, Qi/AAW-9090-2021	Zhu, Qi/0000-0002-0993-3400; Liu, Jia/0000-0003-0383-0934; Wang, Song/0000-0002-4476-1915	National Natural Science Foundation of China [31230031, 91132703, 30800295, 31100808]; National Basic Research Program of China [2010CB833903]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This study was funded by the National Natural Science Foundation of China (31230031, 91132703, 30800295, 31100808) and the National Basic Research Program of China (2010CB833903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker CI, 2002, NAT NEUROSCI, V5, P1210, DOI 10.1038/nn960; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Ben Hamed S, 2007, J NEUROPHYSIOL, V98, P327, DOI 10.1152/jn.00760.2006; Buchel C, 1999, SCIENCE, V283, P1538, DOI 10.1126/science.283.5407.1538; Dechent P, 2003, HUM BRAIN MAPP, V18, P272, DOI 10.1002/hbm.10084; Dinstein I, 2012, NEURON, V75, P981, DOI 10.1016/j.neuron.2012.07.026; Dinstein I, 2011, NEURON, V70, P1218, DOI 10.1016/j.neuron.2011.04.018; Doyon J, 2002, P NATL ACAD SCI USA, V99, P1017, DOI 10.1073/pnas.022615199; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; GEORGOPOULOS AP, 1988, J NEUROSCI, V8, P2928; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Ghose GM, 2002, J NEUROPHYSIOL, V87, P1867, DOI 10.1152/jn.00690.2001; Gillebert CR, 2009, J COGNITIVE NEUROSCI, V21, P1054, DOI 10.1162/jocn.2009.21089; Hazeltine E, 1997, BRAIN, V120, P123, DOI 10.1093/brain/120.1.123; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Jiang X, 2007, NEURON, V53, P891, DOI 10.1016/j.neuron.2007.02.015; KARNI A, 1995, NATURE, V377, P155; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Kourtzi Z, 2005, PLOS BIOL, V3, P1317, DOI 10.1371/journal.pbio.0030204; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Kriegeskorte N, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.004.2008; Landau SM, 2004, NEUROIMAGE, V22, P211, DOI 10.1016/j.neuroimage.2004.01.003; Li S, 2012, CEREB CORTEX, V22, P2322, DOI 10.1093/cercor/bhr309; LOGOTHETIS NK, 1995, CEREB CORTEX, V5, P270, DOI 10.1093/cercor/5.3.270; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Miller KJ, 2009, J NEUROSCI, V29, P3132, DOI 10.1523/JNEUROSCI.5506-08.2009; MIYASHITA Y, 1993, NEUROPSYCHOLOGIA, V31, P1119, DOI 10.1016/0028-3932(93)90036-Y; Mukai I, 2007, J NEUROSCI, V27, P11401, DOI 10.1523/JNEUROSCI.3002-07.2007; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Op De Beeck HP, 2007, NEUROSCIENCE, V145, P775, DOI 10.1016/j.neuroscience.2006.12.058; Op de Beeck H.P., 2010, TRENDS COGN SCI, V14, P22; Op de Beeck HP, 2008, CEREB CORTEX, V18, P1676, DOI 10.1093/cercor/bhm196; Op de Beeck HP, 2006, J NEUROSCI, V26, P13025, DOI 10.1523/JNEUROSCI.2481-06.2006; Peissig JJ, 2007, CEREB CORTEX, V17, P1323, DOI 10.1093/cercor/bhl043; Pouget A, 2000, NAT REV NEUROSCI, V1, P125, DOI 10.1038/35039062; Quiroga RQ, 2008, TRENDS COGN SCI, V12, P87, DOI 10.1016/j.tics.2007.12.003; Raiguel S, 2006, J NEUROSCI, V26, P6589, DOI 10.1523/JNEUROSCI.0457-06.2006; SAKAI K, 1994, NEUROREPORT, V5, P829, DOI 10.1097/00001756-199403000-00023; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Schurger A, 2010, SCIENCE, V327, P97, DOI 10.1126/science.1180029; Sheinberg DL, 2002, PERCEPTUAL LEARNING, P95; Sigman M, 2005, NEURON, V46, P823, DOI 10.1016/j.neuron.2005.05.014; Song YY, 2012, J NEUROSCI, V32, P12277, DOI 10.1523/JNEUROSCI.1874-12.2012; Song YY, 2010, J NEUROSCI, V30, P9869, DOI 10.1523/JNEUROSCI.0140-10.2010; Swisher JD, 2010, J NEUROSCI, V30, P325, DOI 10.1523/JNEUROSCI.4811-09.2010; Toni I, 1998, NEUROIMAGE, V8, P50, DOI 10.1006/nimg.1998.0349; Ungerleider LG, 2002, NEUROBIOL LEARN MEM, V78, P553, DOI 10.1006/nlme.2002.4091; Visser RM, 2011, J NEUROSCI, V31, P12021, DOI 10.1523/JNEUROSCI.2178-11.2011; Xiong JH, 2009, NEUROIMAGE, V45, P75, DOI 10.1016/j.neuroimage.2008.11.016; Xue G, 2010, SCIENCE, V330, P97, DOI 10.1126/science.1193125; Yotsumoto Y, 2008, NEURON, V57, P827, DOI 10.1016/j.neuron.2008.02.034; Zhang JX, 2010, J NEUROSCI, V30, P14127, DOI 10.1523/JNEUROSCI.2204-10.2010; Zhang JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040390	53	37	37	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53555	10.1371/journal.pone.0053555	http://dx.doi.org/10.1371/journal.pone.0053555			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308252	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429100089
J	Ribeiro, RF; Potratz, FF; Pavan, BMM; Forechi, L; Lugon, F; Lima, M; Fiorim, J; Fernandes, AA; Vassallo, DV; Stefanon, I				Ribeiro, Rogerio Faustino, Jr.; Potratz, Felipe F.; Pavan, Brunella M. M.; Forechi, Ludimila; Lugon, Filipe; Lima, Moulin; Fiorim, Jonaina; Fernandes, Aurelia Araujo; Vassallo, Dalton Valentim; Stefanon, Ivanita			Carvedilol Prevents Ovariectomy-Induced Myocardial Contractile Dysfunction in Female Rat	PLOS ONE			English	Article							ADRENERGIC-RECEPTOR BLOCKADE; HORMONE REPLACEMENT THERAPY; CONVERTING-ENZYME-ACTIVITY; HEART-FAILURE; GENDER-DIFFERENCES; OXIDATIVE STRESS; POSTMENOPAUSAL WOMEN; ANTIOXIDANT ACTIVITY; CARDIAC-FUNCTION; REACTIVE OXYGEN	Carvedilol has beneficial effects on cardiac function in patients with heart failure but its effect on ovariectomy-induced myocardial contractile dysfunction remains unclear. Estrogen deficiency induces myocardial contractile dysfunction and increases cardiovascular disease risk in postmenopausal women. Our aim was to investigate whether carvedilol, a beta receptor blocker, would prevent ovariectomy-induced myocardial contractile dysfunction. Female rats (8 weeks old) that underwent bilateral ovariectomy were randomly assigned to receive daily treatment with carvedilol (OVX+CAR, 20 mg/kg), placebo (OVX) and SHAM for 58 days. Left ventricle papillary muscle was mounted for isometric tension recordings. The inotropic response to Ca2+ (0.62 to 3.75 mM) and isoproterenol (Iso 10(-8) to 10(-2) M) were assessed. Expression of calcium handling proteins was measured by western blot analysis. Carvedilol treatment in the OVX animals: prevented weight gain and slight hypertrophy, restored the reduced positive inotropic responses to Ca2+ and isoproterenol, prevented the reduction in SERCA2a expression, abolished the increase in superoxide anion production, normalized the increase in p22(phox) expression, and decreased serum angiotensin converting enzyme (ACE) activity. This study demonstrated that myocardial contractile dysfunction and SERCA2a down regulation were prevented by carvedilol treatment. Superoxide anion production and NADPH oxidase seem to be involved in this response.	[Ribeiro, Rogerio Faustino, Jr.; Potratz, Felipe F.; Pavan, Brunella M. M.; Forechi, Ludimila; Lugon, Filipe; Lima, Moulin; Fiorim, Jonaina; Fernandes, Aurelia Araujo; Vassallo, Dalton Valentim; Stefanon, Ivanita] Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, Brazil; [Vassallo, Dalton Valentim] EMESCAM, Dept Physiol Sci, Vitoria, Brazil	Universidade Federal do Espirito Santo; Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria	Ribeiro, RF (corresponding author), Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, Brazil.	rogeriofaustinoribeiro@hotmail.com	Ribeiro, Rogerio/F-7116-2012; Stefanon, Ivanita/J-4729-2014; Vassallo, Dalton/K-8289-2016	Ribeiro, Rogerio/0000-0002-9725-3869; Stefanon, Ivanita/0000-0003-2638-5183; Vassallo, Dalton/0000-0002-4463-4174; Forechi, Ludimila/0000-0002-6657-0503	National Council for Scientific and Technological Development (CNPq, Brazil); Espirito Santo Research Foundation (FAPES/FUNCITEC, Brazil)	National Council for Scientific and Technological Development (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Espirito Santo Research Foundation (FAPES/FUNCITEC, Brazil)	This work was supported by grants from The National Council for Scientific and Technological Development (CNPq, Brazil) and the Espirito Santo Research Foundation (FAPES/FUNCITEC, Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akki A, 2009, J MOL CELL CARDIOL, V47, P15, DOI 10.1016/j.yjmcc.2009.04.004; Barki-Harrington L, 2003, CIRCULATION, V108, P1611, DOI 10.1161/01.CIR.0000092166.30360.78; Bartholomeu JB, 2008, J MOL CELL CARDIOL, V45, P240, DOI 10.1016/j.yjmcc.2008.05.011; Blumenfeld JD, 1999, AM J HYPERTENS, V12, P451, DOI 10.1016/S0895-7061(99)00005-9; Brittsan AG, 2000, J MOL CELL CARDIOL, V32, P2131, DOI 10.1006/jmcc.2000.1270; BUHLER FR, 1972, NEW ENGL J MED, V287, P1209, DOI 10.1056/NEJM197212142872401; Bupha-Intr T, 2006, AM J PHYSIOL-HEART C, V291, pH1101, DOI 10.1152/ajpheart.00660.2005; Bupha-Intr T, 2009, J APPL PHYSIOL, V107, P1105, DOI 10.1152/japplphysiol.00407.2009; Cherednichenko G, 2004, CIRC RES, V94, P478, DOI 10.1161/01.RES.0000115554.65513.7C; Dandona P, 2007, J HYPERTENS, V25, P731, DOI 10.1097/HJH.0b013e3280127948; Dantas APV, 2004, CARDIOVASC RES, V61, P22, DOI 10.1016/j.cardiores.2003.10.010; De Mello WC, 2011, REGUL PEPTIDES, V166, P9, DOI 10.1016/j.regpep.2010.10.003; Domenighetti AA, 2005, HYPERTENSION, V46, P426, DOI 10.1161/01.HYP.0000173069.53699.d9; Farrell SR, 2010, AM J PHYSIOL-HEART C, V299, pH36, DOI 10.1152/ajpheart.00299.2010; Fiorim J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017117; Fischer M, 2002, CARDIOVASC RES, V53, P672, DOI 10.1016/S0008-6363(01)00479-5; Freshour JR, 2002, AM J PHYSIOL-HEART C, V283, pH1997, DOI 10.1152/ajpheart.01054.2001; Gallagher PE, 1999, HYPERTENSION, V33, P323, DOI 10.1161/01.HYP.33.1.323; GILL JS, 1995, EUR J PHARM-ENVIRON, V292, P337, DOI 10.1016/0926-6917(95)90042-X; Giuberti K, 2007, ARCH MED RES, V38, P170, DOI 10.1016/j.arcmed.2006.09.015; Goldhaber JI, 1996, AM J PHYSIOL-HEART C, V271, pH823, DOI 10.1152/ajpheart.1996.271.3.H823; Gomes A, 2006, BIOORGAN MED CHEM, V14, P4568, DOI 10.1016/j.bmc.2006.02.023; Kadambi VJ, 1996, J CLIN INVEST, V97, P533, DOI 10.1172/JCI118446; KANEKO M, 1989, AM J PHYSIOL, V257, pH804, DOI 10.1152/ajpheart.1989.257.3.H804; Koitabashi N, 2005, BIOCHEM BIOPH RES CO, V328, P116, DOI 10.1016/j.bbrc.2004.12.139; Koss KL, 1997, BASIC RES CARDIOL, V92, P17, DOI 10.1007/BF00794064; Koss KL, 1996, CIRC RES, V79, P1059, DOI 10.1161/01.RES.79.6.1059; KUKREJA RC, 1991, CIRC RES, V69, P1003, DOI 10.1161/01.RES.69.4.1003; Li JM, 2002, HYPERTENSION, V40, P477, DOI 10.1161/01.HYP.0000032031.30374.32; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Louis A, 2001, EUR J HEART FAIL, V3, P381, DOI 10.1016/S1388-9842(01)00149-0; MICHELAKIS AM, 1972, J CLIN ENDOCR METAB, V34, P386, DOI 10.1210/jcem-34-2-386; Murphy E, 2011, CIRC RES, V109, P687, DOI 10.1161/CIRCRESAHA.110.236687; Nickenig G, 2000, CIRCULATION, V102, P1828; Paigel AS, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-54; Palomeque J, 2006, AM J PHYSIOL-HEART C, V290, pH96, DOI 10.1152/ajpheart.00324.2005; Palomeque J, 2009, CIRC RES, V105, P1204, DOI 10.1161/CIRCRESAHA.109.204172; PINES A, 1993, AM J CARDIOL, V72, P240, DOI 10.1016/0002-9149(93)90171-8; PRELEVIC GM, 1994, MATURITAS, V20, P37, DOI 10.1016/0378-5122(94)90099-X; PROUDLER AJ, 1995, LANCET, V346, P89, DOI 10.1016/S0140-6736(95)92114-1; Remme WJ, 2007, J AM COLL CARDIOL, V49, P963, DOI 10.1016/j.jacc.2006.10.059; Ribeiro RF, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-53; Ribeiro RF, 2012, CELL PHYSIOL BIOCHEM, V30, P1, DOI 10.1159/000339041; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rueckschloss U, 2010, EXP GERONTOL, V45, P788, DOI 10.1016/j.exger.2010.05.002; Sartorio CL, 2007, HYPERTENSION, V50, P919, DOI 10.1161/HYPERTENSIONAHA.107.093450; SCHEUER J, 1987, CIRC RES, V61, P12, DOI 10.1161/01.RES.61.1.12; Serneri GGN, 2001, CIRC RES, V88, P961, DOI 10.1161/hh0901.089882; Shenoy V, 2009, PEPTIDES, V30, P2309, DOI 10.1016/j.peptides.2009.09.005; Shlipak MG, 2003, AM HEART J, V146, P870, DOI 10.1016/S0002-8703(03)00412-5; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; Simoes MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018730; Stamler JS, 1998, NAT STRUCT BIOL, V5, P247, DOI 10.1038/nsb0498-247; Stanley WC, 2012, CIRC RES, V110, P764, DOI [10.1161/CIRCRESAHA.111.253104, 10.1161/circresaha.111.253104]; Sumino H, 2003, HYPERTENS RES, V26, P53; Sun YL, 2005, CHEST, V128, P1812, DOI 10.1378/chest.128.3.1812; Wattanapermpool J, 1999, AM J PHYSIOL-HEART C, V277, pH467, DOI 10.1152/ajpheart.1999.277.2.H467; Wei S, 2000, J AM COLL CARDIOL, V36, P276, DOI 10.1016/S0735-1097(00)00671-9; Wiggers GA, 2008, AM J PHYSIOL-HEART C, V295, pH1033, DOI 10.1152/ajpheart.00430.2008; Yue TL, 1998, EUR J PHARMACOL, V345, P61, DOI 10.1016/S0014-2999(98)00053-3; Zhou L, 2007, EUR J PHARMACOL, V567, P186, DOI 10.1016/j.ejphar.2007.03.047; Zhuang XF, 2009, J INT MED RES, V37, P1354, DOI 10.1177/147323000903700510; Zima AV, 2006, CARDIOVASC RES, V71, P310, DOI 10.1016/j.cardiores.2006.02.019	63	23	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53226	10.1371/journal.pone.0053226	http://dx.doi.org/10.1371/journal.pone.0053226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308166	Green Published, gold, Green Submitted			2022-12-25	WOS:000313429100041
J	Boves, TJ; Buehler, DA; Sheehan, J; Wood, PB; Rodewald, AD; Larkin, JL; Keyser, PD; Newell, FL; George, GA; Bakermans, MH; Evans, A; Beachy, TA; McDermott, ME; Perkins, KA; White, M; Wigley, TB				Boves, Than J.; Buehler, David A.; Sheehan, James; Wood, Petra Bohall; Rodewald, Amanda D.; Larkin, Jeffrey L.; Keyser, Patrick D.; Newell, Felicity L.; George, Gregory A.; Bakermans, Marja H.; Evans, Andrea; Beachy, Tiffany A.; McDermott, Molly E.; Perkins, Kelly A.; White, Matthew; Wigley, T. Bently			Emulating Natural Disturbances for Declining Late-Successional Species: A Case Study of the Consequences for Cerulean Warblers (Setophaga cerulea)	PLOS ONE			English	Article							FOREST MANAGEMENT; BIRD COMMUNITIES; ECOLOGICAL TRAPS; GRASSLAND BIRDS; AGE STRUCTURE; HABITAT USE; SURVIVAL; POPULATION; CONSERVATION; RESPONSES	Forest cover in the eastern United States has increased over the past century and while some late-successional species have benefited from this process as expected, others have experienced population declines. These declines may be in part related to contemporary reductions in small-scale forest interior disturbances such as fire, windthrow, and treefalls. To mitigate the negative impacts of disturbance alteration and suppression on some late-successional species, strategies that emulate natural disturbance regimes are often advocated, but large-scale evaluations of these practices are rare. Here, we assessed the consequences of experimental disturbance (using partial timber harvest) on a severely declining late-successional species, the cerulean warbler (Setophaga cerulea), across the core of its breeding range in the Appalachian Mountains. We measured numerical (density), physiological (body condition), and demographic (age structure and reproduction) responses to three levels of disturbance and explored the potential impacts of disturbance on source-sink dynamics. Breeding densities of warblers increased one to four years after all canopy disturbances (vs. controls) and males occupying territories on treatment plots were in better condition than those on control plots. However, these beneficial effects of disturbance did not correspond to improvements in reproduction; nest success was lower on all treatment plots than on control plots in the southern region and marginally lower on light disturbance plots in the northern region. Our data suggest that only habitats in the southern region acted as sources, and interior disturbances in this region have the potential to create ecological traps at a local scale, but sources when viewed at broader scales. Thus, cerulean warblers would likely benefit from management that strikes a landscape-level balance between emulating natural disturbances in order to attract individuals into areas where current structure is inappropriate, and limiting anthropogenic disturbance in forests that already possess appropriate structural attributes in order to maintain maximum productivity.	[Boves, Than J.; Buehler, David A.; Keyser, Patrick D.; Beachy, Tiffany A.] Univ Tennessee, Dept Forestry Wildlife & Fisheries, Knoxville, TN USA; [Sheehan, James; George, Gregory A.; McDermott, Molly E.; Perkins, Kelly A.] W Virginia Univ, W Virginia Cooperat Fish & Wildlife Res Unit, Div Forestry & Nat Resources, Morgantown, WV 26506 USA; [Wood, Petra Bohall] W Virginia Univ, US Geol Survey, W Virginia Cooperat Fish & Wildlife Res Unit, Morgantown, WV 26506 USA; [Rodewald, Amanda D.; Newell, Felicity L.; Bakermans, Marja H.] Ohio State Univ, Sch Environm & Nat Resources, Columbus, OH 43210 USA; [Larkin, Jeffrey L.; Evans, Andrea; White, Matthew] Indiana Univ Penn, Dept Biol, Indiana, PA 15705 USA; [Wigley, T. Bently] Natl Council Air & Stream Improvement Inc, Clemson, SC USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; West Virginia University; United States Department of the Interior; United States Geological Survey; West Virginia University; University System of Ohio; Ohio State University; Pennsylvania State System of Higher Education (PASSHE); Indiana University of Pennsylvania	Boves, TJ (corresponding author), Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA.	tboves@illinois.edu	Rodewald, Amanda D/I-6308-2016; Newell, Felicity L/ABC-8690-2021	Rodewald, Amanda D/0000-0002-6719-6306; Newell, Felicity L./0000-0002-7944-8603; Bakermans, Marja/0000-0002-4879-7771	Department of Forestry, Wildlife, and Fisheries at the University of Tennessee; United States Geological Survey West Virginia Cooperative Fish and Wildlife Research Unit; School of the Environment and Natural Resources at Ohio State University; Department of Biology at Indiana University of Pennsylvania; Tennessee Wildlife Resources Agency; Ohio Division of Wildlife; Kentucky Department of Fish and Wildlife Resources; West Virginia Division of Natural Resources Wildlife Diversity Program; U.S. Fish and Wildlife Service; National Council for Air and Stream Improvement, Inc.; National Fish and Wildlife Foundation [2005-0064-000, 2006-0042-000, 2007-0004-000, 2008-0009-000]; Nature Conservancy (through a USFWS Habitat Conservation Plan planning grant with the Tennessee Wildlife Resources Agency); MeadWestvaco Corporation; U.S. Forest Service	Department of Forestry, Wildlife, and Fisheries at the University of Tennessee; United States Geological Survey West Virginia Cooperative Fish and Wildlife Research Unit; School of the Environment and Natural Resources at Ohio State University; Department of Biology at Indiana University of Pennsylvania; Tennessee Wildlife Resources Agency; Ohio Division of Wildlife; Kentucky Department of Fish and Wildlife Resources; West Virginia Division of Natural Resources Wildlife Diversity Program; U.S. Fish and Wildlife Service(US Fish & Wildlife Service); National Council for Air and Stream Improvement, Inc.; National Fish and Wildlife Foundation; Nature Conservancy (through a USFWS Habitat Conservation Plan planning grant with the Tennessee Wildlife Resources Agency); MeadWestvaco Corporation; U.S. Forest Service(United States Department of Agriculture (USDA)United States Forest Service)	This research was funded and supported by the Department of Forestry, Wildlife, and Fisheries at the University of Tennessee; the United States Geological Survey West Virginia Cooperative Fish and Wildlife Research Unit; the School of the Environment and Natural Resources at Ohio State University; the Department of Biology at Indiana University of Pennsylvania; Tennessee Wildlife Resources Agency; Ohio Division of Wildlife; Kentucky Department of Fish and Wildlife Resources; West Virginia Division of Natural Resources Wildlife Diversity Program; U.S. Fish and Wildlife Service; National Council for Air and Stream Improvement, Inc.; National Fish and Wildlife Foundation (grant numbers 2005-0064-000, 2006-0042-000, 2007-0004-000, and 2008-0009-000); The Nature Conservancy (through a USFWS Habitat Conservation Plan planning grant with the Tennessee Wildlife Resources Agency); MeadWestvaco Corporation; and U.S. Forest Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams MD, 2003, BIOSCIENCE, V53, P927, DOI 10.1641/0006-3568(2003)053[0927:WHATWO]2.0.CO;2; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; [Anonymous], 1989, AM THEIR FORESTS HIS; Artman Vanessa L., 2005, Studies in Avian Biology, V30, P127; Askins RA, 1999, STUD AVIAN BIOL-SER, P60; Bakermans MH, 2009, BIOL CONSERV, V142, P2476, DOI 10.1016/j.biocon.2009.05.018; Bakermans MH, 2009, FOREST ECOL MANAG, V258, P224, DOI 10.1016/j.foreco.2009.04.010; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; BirdLife International, 2010, IUCN RED LIST THREAT; Bormann F.H., 1979, PATTERN PROCESS FORE, DOI DOI 10.1007/978-1-4612-6232-9; Braun E., 1942, ECOL MONOG, V12, P413, DOI 10.2307/1943039; Brawn JD, 2001, ANNU REV ECOL SYST, V32, P251, DOI 10.1146/annurev.ecolsys.32.081501.114031; Buehler DA, 2008, J WILDLIFE MANAGE, V72, P646, DOI 10.2193/2006-339; Buehler DA, 2006, J WILDLIFE MANAGE, V70, P1763, DOI 10.2193/0022-541X(2006)70[1763:PCWHUI]2.0.CO;2; Chalfoun AD, 2012, AUK, V129, P589, DOI 10.1525/auk.2012.129.4.589; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; DeLong SC, 1996, BIODIVERS CONSERV, V5, P1191, DOI 10.1007/BF00051571; Doligez B, 2008, ECOLOGY, V89, P1436, DOI 10.1890/07-0113.1; DWERNYCHUK LW, 1972, CAN J ZOOLOG, V50, P559, DOI 10.1139/z72-076; Edler AU, 2010, BIOL J LINN SOC, V99, P384, DOI 10.1111/j.1095-8312.2009.01354.x; Evans KL, 2009, OIKOS, V118, P774, DOI 10.1111/j.1600-0706.2008.17226.x; Fenneman N.M., 1938, PHYSIOGRAPHY E US; Fralish JS, 2003, US FOR SERV T R NC, V234, P1; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Gardali T, 2003, AUK, V120, P1188, DOI 10.1642/0004-8038(2003)120[1188:JAASOS]2.0.CO;2; George G.A., 2009, THESIS W VIRGINIA U; Girvan MK, 2007, AVIAN CONSERV ECOL, V2; Gram WK, 2003, CONSERV BIOL, V17, P1324, DOI 10.1046/j.1523-1739.2003.02171.x; Greenberg CH, 2003, SOUTHEAST NAT, V2, P591, DOI 10.1656/1528-7092(2003)002[0591:SAOGMI]2.0.CO;2; Hamel P.B., 2000, BIRDS N AM ONLINE; Hamel Paul B., 2007, U S Forest Service General Technical Report SRS, V101, P364; Harrison XA, 2011, J ANIM ECOL, V80, P4, DOI 10.1111/j.1365-2656.2010.01740.x; HINES J E, 1989, U S Fish and Wildlife Service Fish and Wildlife Technical Report, P1; Hollander FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025703; Holmes SB, 2007, FOREST ECOL MANAG, V238, P280, DOI 10.1016/j.foreco.2006.10.022; Howell S. N, 1997, IDENTIFICATION GUIDE; HUTTO RL, 1995, CONSERV BIOL, V9, P1041, DOI [10.1046/j.1523-1739.1995.9051041.x, 10.1046/j.1523-1739.1995.9051033.x-i1]; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Jones J, 2004, AUK, V121, P15, DOI 10.1642/0004-8038(2004)121[0015:MEOSAP]2.0.CO;2; Jones J, 2001, ECOLOGY, V82, P2628, DOI 10.1890/0012-9658(2001)082[2628:ATEOND]2.0.CO;2; Labocha MK, 2012, J ORNITHOL, V153, P1, DOI 10.1007/s10336-011-0706-1; Lampila P, 2005, CONSERV BIOL, V19, P1537, DOI 10.1111/j.1523-1739.2005.00201.x; Liker A, 2008, J ANIM ECOL, V77, P789, DOI 10.1111/j.1365-2656.2008.01402.x; Long JN, 2009, FOREST ECOL MANAG, V257, P1868, DOI 10.1016/j.foreco.2008.12.019; LORIMER CG, 1994, J FOREST, V92, P33; LORIMER CG, 1980, ECOLOGY, V61, P1169, DOI 10.2307/1936836; MacDougall AS, 2005, ECOLOGY, V86, P42, DOI 10.1890/04-0669; Menzel JM, 1985, AM MIDL NAT, V151, P355; Miller GW, 2006, FOREST ECOL MANAG, V224, P241, DOI 10.1016/j.foreco.2005.12.035; Morrison RIG, 2007, J AVIAN BIOL, V38, P479, DOI 10.1111/j.2007.0908-8857.03934.x; NEWTON SF, 1993, J ZOOL, V229, P561, DOI 10.1111/j.1469-7998.1993.tb02657.x; Noon BR, 2001, WILDLIFE 2001 POPULA, P441; Oliarnyk CJ, 1996, WILSON BULL, V108, P673; OLIVER CD, 1981, FOREST ECOL MANAG, V3, P153; PARKER G R, 1989, Natural Areas Journal, V9, P5; Pelicice FM, 2008, CONSERV BIOL, V22, P180, DOI 10.1111/j.1523-1739.2007.00849.x; Perera A. H., 2004, EMULATING NATURAL FO; Powell LA, 2007, CONDOR, V109, P949, DOI 10.1650/0010-5422(2007)109[949:AVODPU]2.0.CO;2; Powell LL, 2010, CONDOR, V112, P800, DOI 10.1525/cond.2010.100152; Reed J. Michael, 1999, Current Ornithology, V15, P189; Robertson BA, 2007, CONDOR, V109, P109, DOI 10.1650/0010-5422(2007)109[109:ISHFAE]2.0.CO;2; Rodewald AD, 2008, J ANIM ECOL, V77, P83, DOI 10.1111/j.1365-2656.2007.01313.x; Sauer J.R., 2008, N AM BREEDING BIRD S; Schamber JL, 2009, J AVIAN BIOL, V40, P49, DOI 10.1111/j.1600-048X.2008.04462.x; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Seymour RS, 2002, FOREST ECOL MANAG, V155, P357, DOI 10.1016/S0378-1127(01)00572-2; Short KC, 2003, ECOLOGICAL RESTORATION OF SOUTHWESTERN PONDEROSA PINE FORESTS, P286; SPIES TA, 1994, ECOL APPL, V4, P555, DOI 10.2307/1941957; Stephens SE, 2004, BIOL CONSERV, V115, P101, DOI 10.1016/S0006-3207(03)00098-3; Streby HM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00187.1; Strong TF, 1997, NE238 USDA FOR SERV; U.S. Fish and Wildlife Service, 2007, IND BAT MYO IN PRESS; U.S. Fish and Wildlife Service, 2008, BIRDS CONS CONC; Vanderwel MC, 2007, CONSERV BIOL, V21, P1230, DOI 10.1111/j.1523-1739.2007.00756.x; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; Vickery PD, 1999, STUD AVIAN BIOL, P2; Vitz AC, 2011, CONDOR, V113, P400, DOI 10.1525/cond.2011.100023; Weldon AJ, 2005, ECOLOGY, V86, P1422, DOI 10.1890/04-0913; WILSON A., 1811, AM ORNITHOLOGY, V3; Wood PB, 2005, WILDLIFE SOC B, V33, P851, DOI 10.2193/0091-7648(2005)33[851:CWUORC]2.0.CO;2; Wood PB, 2006, CONDOR, V108, P154, DOI 10.1650/0010-5422(2006)108[0154:CWAAOR]2.0.CO;2; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405; Ziolkowski Jr D.J., 2010, BIRD POPULATIONS, V10, P90; [No title captured]	85	18	18	2	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e52107	10.1371/journal.pone.0052107	http://dx.doi.org/10.1371/journal.pone.0052107			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308104	Green Published, gold, Green Submitted			2022-12-25	WOS:000313670100006
J	Shin, J; Lee, SH; Kwon, MC; Yang, DK; Seo, HR; Kim, J; Kim, YY; Im, SK; Abel, ED; Kim, KT; Park, WJ; Kong, YY				Shin, Juhee; Lee, Seok Hong; Kwon, Min-Chul; Yang, Dong Kwon; Seo, Ha-Rim; Kim, Jaetaek; Kim, Yoon-Young; Im, Sun-Kyoung; Abel, Evan Dale; Kim, Kyong-Tai; Park, Woo Jin; Kong, Young-Yun			Cardiomyocyte Specific Deletion of Crif1 Causes Mitochondrial Cardiomyopathy in Mice	PLOS ONE			English	Article							CR6-INTERACTING FACTOR-1 INTERACTS; COMPLEX-I; RESPIRATORY-CHAIN; DISEASE; PROTEIN; DISORDERS; RECEPTOR; HEART; CHLORAMPHENICOL; BIOGENESIS	Mitochondria are key organelles dedicated to energy production. Crif1, which interacts with the large subunit of the mitochondrial ribosome, is indispensable for the mitochondrial translation and membrane insertion of respiratory subunits. To explore the physiological function of Crif1 in the heart, Crif1(f/f) mice were crossed with Myh6-cre/Esr1 transgenic mice, which harbor cardiomyocyte-specific Cre activity in a tamoxifen-dependent manner. The tamoxifen injections were given at six weeks postnatal, and the mutant mice survived only five months due to hypertrophic heart failure. In the mutant cardiac muscles, mitochondrial mass dramatically increased, while the inner structure was altered with lack of cristae. Mutant cardiac muscles showed decreased rates of oxygen consumption and ATP production, suggesting that Crif1 plays a critical role in the maintenance of both mitochondrial structure and respiration in cardiac muscles.	[Shin, Juhee; Kwon, Min-Chul; Seo, Ha-Rim; Kim, Yoon-Young; Im, Sun-Kyoung; Kong, Young-Yun] Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea; [Shin, Juhee; Kim, Yoon-Young; Im, Sun-Kyoung; Kim, Kyong-Tai] Pohang Univ Sci & Technol, Dept Life Sci, Pohang, Kyungbuk, South Korea; [Lee, Seok Hong; Kim, Jaetaek] Chung Ang Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul 156756, South Korea; [Yang, Dong Kwon; Park, Woo Jin] Gwangju Inst Sci & Technol, Global Res Lab, Kwangju, South Korea; [Yang, Dong Kwon; Park, Woo Jin] Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju, South Korea; [Abel, Evan Dale] Univ Utah, Sch Med, Program Mol Med, Salt Lake City, UT USA	Seoul National University (SNU); Pohang University of Science & Technology (POSTECH); Chung Ang University; Chung Ang University Hospital; Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Utah System of Higher Education; University of Utah	Kong, YY (corresponding author), Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea.	ykong@snu.ac.kr	Kim, Jaetaek/AAE-7147-2020	Kim, Jaetaek/0000-0001-5247-0408; KIM, KYONG-TAI/0000-0001-7292-2627; Abel, E. Dale/0000-0001-5290-0738	National Research Foundation of Korea [2012-0000121]; Bio and Medical Technology Development Program of National Research Foundation [2011-0019269]; Korean Government [NRF-M1AXA002-2011-0028413]; National Research Foundation of Korea Grant	National Research Foundation of Korea(National Research Foundation of Korea); Bio and Medical Technology Development Program of National Research Foundation(National Research Foundation of Korea); Korean Government(Korean Government); National Research Foundation of Korea Grant(National Research Foundation of Korea)	This work was supported by grants from the Basic Science Research Program through the National Research Foundation of Korea (2012-0000121); the Bio and Medical Technology Development Program (2011-0019269) of National Research Foundation funded by the Korean Government; and the National Research Foundation of Korea Grant funded by the Korean Government (NRF-M1AXA002-2011-0028413). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADOUTTE A, 1972, Journal of Cell Biology, V54, P8, DOI 10.1083/jcb.54.1.8; Antozzi C, 1997, CARDIOVASC RES, V35, P184, DOI 10.1016/S0008-6363(97)00141-7; Barrientos A, 2002, GENE, V286, P53, DOI 10.1016/S0378-1119(01)00803-4; Boudina S, 2005, CIRCULATION, V112, P2686, DOI 10.1161/CIRCULATIONAHA.105.554360; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720; Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700; Chung HK, 2003, J BIOL CHEM, V278, P28079, DOI 10.1074/jbc.M212835200; CLARKWAL.GD, 1967, J CELL BIOL, V34, P1, DOI 10.1083/jcb.34.1.1; Cramer WA, 2006, ANNU REV BIOCHEM, V75, P769, DOI 10.1146/annurev.biochem.75.103004.142756; Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391; Holmgren D, 2003, EUR HEART J, V24, P280, DOI 10.1016/S0195-668X(02)00387-1; Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4; Kim SJ, 2012, CELL METAB, V16, P274, DOI 10.1016/j.cmet.2012.06.012; Kirby DM, 2008, TWIN RES HUM GENET, V11, P395, DOI 10.1375/twin.11.4.395; Kwon MC, 2008, EMBO J, V27, P642, DOI 10.1038/sj.emboj.7601986; Kwon MC, 2009, J BIOL CHEM, V284, P33634, DOI 10.1074/jbc.M109.059840; Lee SH, 2009, J MOL CELL CARDIOL, V46, P596, DOI 10.1016/j.yjmcc.2008.12.021; LENK R, 1971, J CELL BIOL, V49, P541, DOI 10.1083/jcb.49.2.541; Lev D, 2004, PEDIATR CARDIOL, V25, P443, DOI 10.1007/s00246-003-0490-7; Li CH, 2005, J BIOL CHEM, V280, P26193, DOI 10.1074/jbc.M501371200; LIPTON JH, 1977, BIOCHIM BIOPHYS ACTA, V477, P264, DOI 10.1016/0005-2787(77)90051-X; MarinGarcia J, 1997, PEDIATR CARDIOL, V18, P251, DOI 10.1007/s002469900169; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Park KC, 2005, MOL ENDOCRINOL, V19, P12, DOI 10.1210/me.2004-0107; Pfeffer G, 2011, ANN MED; Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2; Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170; Smith R, 2007, NEW ENGL J MED, V356, P271, DOI 10.1056/NEJMra061360; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Suh JH, 2008, MOL ENDOCRINOL, V22, P33, DOI 10.1210/me.2007-0194; Sumegi B, 1988, J Mol Recognit, V1, P19, DOI 10.1002/jmr.300010105; VEKSLER VI, 1987, BIOCHIM BIOPHYS ACTA, V892, P191, DOI 10.1016/0005-2728(87)90174-5; Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314; Wallace DC, 2009, GENE DEV, V23, P1714, DOI 10.1101/gad.1784909	41	14	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53577	10.1371/journal.pone.0053577	http://dx.doi.org/10.1371/journal.pone.0053577			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308255	Green Published, Green Submitted, gold			2022-12-25	WOS:000313670100048
J	Agim, ZS; Esendal, M; Briollais, L; Uyan, O; Meschian, M; Martinez, LAM; Ding, YM; Basak, AN; Ozcelik, H				Agim, Zeynep Sena; Esendal, Melda; Briollais, Laurent; Uyan, Ozgun; Meschian, Mehran; Martinez, Luis Antonio Mendoza; Ding, Yongmei; Basak, A. Nazli; Ozcelik, Hilmi			Discovery, Validation and Characterization of Erbb4 and Nrg1 Haplotypes Using Data from Three Genome-Wide Association Studies of Schizophrenia	PLOS ONE			English	Article							NEUREGULIN 1; BIPOLAR DISORDER; GENE; SUSCEPTIBILITY; METAANALYSIS; INVOLVEMENT; PHENOTYPES; GENOTYPES; SUPPORT	Schizophrenia is one of the most common and complex neuropsychiatric disorders, which is contributed both by genetic and environmental exposures. Recently, it is shown that NRG1-mediated ErbB4 signalling regulates many important cellular and molecular processes such as cellular growth, differentiation and death, particularly in myelin-producing cells, glia and neurons. Recent association studies have revealed genomic regions of NRG1 and ERBB4, which are significantly associated with risk of developing schizophrenia; however, inconsistencies exist in terms of validation of findings between distinct populations. In this study, we aim to validate the previously identified regions and to discover novel haplotypes of NRG1 and ERBB4 using logistic regression models and Haploview analyses in three independent datasets from GWAS conducted on European subjects, namely, CATIE, GAIN and nonGAIN. We identified a significant 6-kb block in ERBB4 between chromosome locations 212,156,823 and 212,162,848 in CATIE and GAIN datasets (p = 0.0206 and 0.0095, respectively). In NRG1, a significant 25-kb block, between 32,291,552 and 32,317,192, was associated with risk of schizophrenia in all CATIE, GAIN, and nonGAIN datasets (p = 0.0005, 0.0589, and 0.0143, respectively). Fine mapping and FastSNP analysis of genetic variation located within significantly associated regions proved the presence of binding sites for several transcription factors such as SRY, SOX5, CEPB, and ETS1. In this study, we have discovered and validated haplotypes of ERBB4 and NRG1 in three independent European populations. These findings suggest that these haplotypes play an important role in the development of schizophrenia by affecting transcription factor binding affinity.	[Agim, Zeynep Sena; Uyan, Ozgun; Basak, A. Nazli] Bogazici Univ, Mol Biol & Genet Dept, Neurodegenerat Res Lab, Istanbul, Turkey; [Esendal, Melda; Meschian, Mehran; Martinez, Luis Antonio Mendoza; Ding, Yongmei; Ozcelik, Hilmi] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Fred A Litwin Ctr Canc Genet, Toronto, ON M5G 1X5, Canada; [Briollais, Laurent] Mt Sinai Hosp, Prosserman Ctr Hlth Res, Toronto, ON M5G 1X5, Canada	Bogazici University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Ozcelik, H (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Fred A Litwin Ctr Canc Genet, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	ozcelik@lunenfeld.ca	Agim, Zeynep Sena/L-8142-2019; Briollais, Laurent/A-2941-2013	Agim, Zeynep Sena/0000-0002-8699-9884; 	Suna and Inan Kirac Foundation; Scientific and Technological Research Council of Turkey [SBAG 109S075]; Bogazici University Research Funds [BAP 6055]; National Institute of Mental Health (NIMH) [N01MH900001, MH074027]; Genomics Research Branch at NIMH; Genetic Association Information Network (GAIN); NIMH Schizophrenia Genetics Initiative [U01s: MH46276, MH46289, MH46318]; MGS Part 1 (MGS1) [R01s: MH67257, MH59588, MH59571, MH59565, MH59587, MH60870, MH59566, MH59586, MH61675, MH60879]; MGS Part 2 (MGS2) [R01s: MH67257, MH59588, MH59571, MH59565, MH59587, MH60870, MH59566, MH59586, MH61675, MH60879];  [MGS U01s: MH79469];  [MH79470]; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH046276, U01MH079469, U01MH046289, Z01MH900001, R01MH067257, R01MH060879, R01MH059571, U01MH079470, R01MH059588, R01MH074027] Funding Source: NIH RePORTER	Suna and Inan Kirac Foundation; Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Bogazici University Research Funds(Bogazici University); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Genomics Research Branch at NIMH; Genetic Association Information Network (GAIN); NIMH Schizophrenia Genetics Initiative; MGS Part 1 (MGS1); MGS Part 2 (MGS2); ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by Suna and Inan Kirac Foundation, by The Scientific and Technological Research Council of Turkey (SBAG 109S075) and by Bogazici University Research Funds (BAP 6055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The principal investigators of the CATIE trial, Jeffrey A. Lieberman, T. Scott Stroup, and Joseph P. McEvoy, received the funding from the National Institute of Mental Health (NIMH; N01MH900001) along with MH074027 (PI P. F. Sullivan). Funding support for the companion studies, Genome-Wide Association Study of Schizophrenia (GAIN) and Molecular Genetics of Schizophrenia - nonGAIN Sample (MGS_nonGAIN), was provided by Genomics Research Branch at NIMH (see below), and the genotyping and analysis of samples was provided through the Genetic Association Information Network (GAIN) and under the MGS U01s: MH79469 and MH79470. Assistance with data cleaning was provided by the National Center for Biotechnology Information. Samples and associated phenotype data for the MGS GWAS study were collected under the following grants: NIMH Schizophrenia Genetics Initiative U01s: MH46276 (C. R. Cloninger), MH46289 (C. Kaufmann), and MH46318 (M. T. Tsuang); and MGS Part 1 (MGS1) and Part 2 (MGS2) R01s: MH67257 (N. G. Buccola), MH59588 (B. J. Mowry), MH59571 (P. V. Gejman), MH59565 (Robert Freedman), MH59587 (F. Amin), MH60870 (W. F. Byerley), MH59566 (D. W. Black), MH59586 (J. M. Silverman), MH61675 (D. F. Levinson), and MH60879 (C. R. Cloninger). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton ES, 2004, NAT NEUROSCI, V7, P1319, DOI 10.1038/nn1345; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benzel I, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-31; Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.3.CO;2-L; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; Gong YG, 2009, SCHIZOPHR RES, V111, P109, DOI 10.1016/j.schres.2009.03.017; Hahn CG, 2006, NAT MED, V12, P824, DOI 10.1038/nm1418; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lachman HM, 2006, AM J MED GENET B, V141B, P102, DOI 10.1002/ajmg.b.30242; Li DW, 2006, HUM MOL GENET, V15, P1995, DOI 10.1093/hmg/ddl122; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lu CL, 2010, NEUROSCI LETT, V481, P120, DOI 10.1016/j.neulet.2010.06.067; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Munafo MR, 2006, MOL PSYCHIATR, V11, P539, DOI 10.1038/sj.mp.4001817; Nicodemus KK, 2006, MOL PSYCHIATR, V11, P1062, DOI 10.1038/sj.mp.4001878; Norton N, 2006, AM J MED GENET B, V141B, P96, DOI 10.1002/ajmg.b.30236; Petryshen TL, 2005, MOL PSYCHIATR, V10, P366, DOI 10.1038/sj.mp.4001608; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Silberberg G, 2006, AM J MED GENET B, V141B, P142, DOI 10.1002/ajmg.b.30275; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Sullivan PF, 2008, MOL PSYCHIATR, V13, P570, DOI 10.1038/mp.2008.25; Thomson PA, 2007, MOL PSYCHIATR, V12, P94, DOI 10.1038/sj.mp.4001889; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; Walker RM, 2010, NEUROSCI LETT, V478, P9, DOI 10.1016/j.neulet.2010.04.056; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236	28	39	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53042	10.1371/journal.pone.0053042	http://dx.doi.org/10.1371/journal.pone.0053042			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301017	Green Published, gold, Green Submitted			2022-12-25	WOS:000313480000026
J	Chtarto, A; Bockstael, O; Gebara, E; Vermoesen, K; Melas, C; Pythoud, C; Levivier, M; De Witte, O; Luthi-Carter, R; Clinkers, R; Tenenbaum, L				Chtarto, Abdelwahed; Bockstael, Olivier; Gebara, Elias; Vermoesen, Katia; Melas, Catherine; Pythoud, Catherine; Levivier, Marc; De Witte, Olivier; Luthi-Carter, Ruth; Clinkers, Ralph; Tenenbaum, Liliane			An Adeno-Associated Virus-Based Intracellular Sensor of Pathological Nuclear Factor-kappa B Activation for Disease-Inducible Gene Transfer	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; SPONTANEOUS RECURRENT SEIZURES; VIRAL VECTOR SEROTYPE-1; CENTRAL-NERVOUS-SYSTEM; TRANSGENE EXPRESSION; IN-VIVO; STATUS EPILEPTICUS; MAMMALIAN-CELLS; KAINIC ACID; DOPAMINERGIC-NEURONS	Stimulation of resident cells by NF-kappa B activating cytokines is a central element of inflammatory and degenerative disorders of the central nervous system (CNS). This disease-mediated NF-kappa B activation could be used to drive transgene expression selectively in affected cells, using adeno-associated virus (AAV)-mediated gene transfer. We have constructed a series of AAV vectors expressing GFP under the control of different promoters including NF-kappa B -responsive elements. As an initial screen, the vectors were tested in vitro in HEK-293T cells treated with TNF-alpha. The best profile of GFP induction was obtained with a promoter containing two blocks of four NF-kappa B -responsive sequences from the human JCV neurotropic polyoma virus promoter, fused to a new tight minimal CMV promoter, optimally distant from each other. A therapeutical gene, glial cell line-derived neurotrophic factor (GDNF) cDNA under the control of serotype 1-encapsidated NF-kappa B -responsive AAV vector (AAV-NF) was protective in senescent cultures of mouse cortical neurons. AAV-NF was then evaluated in vivo in the kainic acid (KA)-induced status epilepticus rat model for temporal lobe epilepsy, a major neurological disorder with a central pathophysiological role for NF-kappa B activation. We demonstrate that AAV-NF, injected in the hippocampus, responded to disease induction by mediating GFP expression, preferentially in CA1 and CA3 neurons and astrocytes, specifically in regions where inflammatory markers were also induced. Altogether, these data demonstrate the feasibility to use disease-activated transcription factor-responsive elements in order to drive transgene expression specifically in affected cells in inflammatory CNS disorders using AAV-mediated gene transfer.	[Chtarto, Abdelwahed; Bockstael, Olivier; Melas, Catherine; De Witte, Olivier] ULB, Lab Expt Neurosurg, Brussels, Belgium; [Chtarto, Abdelwahed; Bockstael, Olivier; Melas, Catherine] ULB, IRIBHM, Fac Med, Brussels, Belgium; [Gebara, Elias; Luthi-Carter, Ruth] Ecole Polytech Fed Lausanne, Brain & Mind Inst, CH-1015 Lausanne, Switzerland; [Vermoesen, Katia; Clinkers, Ralph] Vrije Univ Brussel, Fac Med & Pharm, Ctr Neurosci C4F, Dept Pharmaceut Chem & Drug Anal, Brussels, Belgium; [Pythoud, Catherine; Levivier, Marc; Tenenbaum, Liliane] Univ Lausanne Hosp, Dept Clin Neurosci, Lausanne, Switzerland	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Ecole Polytechnique Federale de Lausanne; Vrije Universiteit Brussel; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Chtarto, A (corresponding author), ULB, Lab Expt Neurosurg, Brussels, Belgium.	achtarto@ulb.ac.be	Tenenbaum, Liliane/O-5917-2016; Tenenbaum, Liliane/AAW-5685-2021	Tenenbaum, Liliane/0000-0003-4619-9660; Tenenbaum, Liliane/0000-0003-4619-9660; Gebara, Elias/0000-0003-4389-6604	FNRS- Televie [7.4.593.08 F]; "Credit aux chercheurs'' from the Belgian National Research Foundation [1.5.093.08]; Fonds National de la Recherche Scientifique Medicale [7.4.536.09 F]; "Region Bruxelles-Capitale'' (SOIB) grant REGAVEC; Swiss National Research Foundation (FNS) [FN31003A-127177]; Agency for Innovation by Science and Technology (IWT Vlaanderen); Research Foundation Flanders (FWO Vlaanderen).	FNRS- Televie(Fonds de la Recherche Scientifique - FNRS); "Credit aux chercheurs'' from the Belgian National Research Foundation; Fonds National de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); "Region Bruxelles-Capitale'' (SOIB) grant REGAVEC; Swiss National Research Foundation (FNS)(Swiss National Science Foundation (SNSF)); Agency for Innovation by Science and Technology (IWT Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Foundation Flanders (FWO Vlaanderen).(FWO)	This work was supported by FNRS- Televie: grant number: 7.4.593.08 F. "Credit aux chercheurs'' from the Belgian National Research Foundation: grant number: 1.5.093.08, "Fonds National de la Recherche Scientifique Medicale'' grant number 7.4.536.09 F. "Region Bruxelles-Capitale'' (SOIB) grant REGAVEC 2007-10, Swiss National Research Foundation (FNS) grant number: FN31003A-127177, Agency for Innovation by Science and Technology (IWT Vlaanderen), and Research Foundation Flanders (FWO Vlaanderen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaansen J, 2007, ANN RHEUM DIS, V66, P1143, DOI 10.1136/ard.2006.064519; Afione SA, 1996, J VIROL, V70, P3235, DOI 10.1128/JVI.70.5.3235-3241.1996; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; Bhakar AL, 2002, J NEUROSCI, V22, P8466; Blits B, 2010, J NEUROSCI METH, V185, P257, DOI 10.1016/j.jneumeth.2009.10.009; Bockstael O, 2012, HUM GENE THER, V23, P742, DOI 10.1089/hum.2011.216; BOSHART M, 1985, CELL, V41, P521, DOI 10.1016/S0092-8674(85)80025-8; Bouilleret V, 1999, NEUROSCIENCE, V89, P717, DOI 10.1016/S0306-4522(98)00401-1; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Caba E, 2004, ACTA NEUROPATHOL, V108, P173, DOI 10.1007/s00401-004-0876-5; Carlsen H, 2002, J IMMUNOL, V168, P1441, DOI 10.4049/jimmunol.168.3.1441; CAVALHEIRO EA, 1991, EPILEPSIA, V32, P778, DOI 10.1111/j.1528-1157.1991.tb05533.x; Channavajhala PL, 2005, BIOCHEM BIOPH RES CO, V334, P1214, DOI 10.1016/j.bbrc.2005.07.009; Chtarto A, 2003, GENE THER, V10, P84, DOI 10.1038/sj.gt.3301838; Davidson BL, 2000, P NATL ACAD SCI USA, V97, P3428, DOI 10.1073/pnas.050581197; Depino AM, 2003, EUR J NEUROSCI, V18, P2731, DOI 10.1111/j.1460-9568.2003.03014.x; EGGERMONT J, 1993, EMBO J, V12, P2539, DOI 10.1002/j.1460-2075.1993.tb05909.x; Emborg ME, 2009, NEUROBIOL DIS, V36, P303, DOI 10.1016/j.nbd.2009.07.022; Fluri DA, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-75; Fu HY, 2003, MOL THER, V8, P911, DOI 10.1016/j.ymthe.2003.08.021; Gemma C, 2002, J NEUROSCI, V22, P6114; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Haberman RP, 2000, J VIROL, V74, P8732, DOI 10.1128/JVI.74.18.8732-8739.2000; Haberman RP, 2002, MOL THER, V6, P495, DOI 10.1006/mthe.2002.0701; Hellier JL, 1998, EPILEPSY RES, V31, P73, DOI 10.1016/S0920-1211(98)00017-5; Howard DB, 2008, VIROLOGY, V372, P24, DOI 10.1016/j.virol.2007.10.007; Jakobsson J, 2004, EUR J NEUROSCI, V19, P761, DOI 10.1111/j.0953-816X.2003.03147.x; Jankowsky JL, 2000, LEARN MEMORY, V7, P400, DOI 10.1101/lm.32600; Kaltschmidt B, 2005, BBA-MOL CELL RES, V1745, P287, DOI 10.1016/j.bbamcr.2005.05.009; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Koerber JT, 2009, MOL THER, V17, P2088, DOI 10.1038/mt.2009.184; LACAILLE JC, 1987, J NEUROSCI, V7, P1979; Lesuisse C, 2002, J CEREBR BLOOD F MET, V22, P935, DOI 10.1097/00004647-200208000-00005; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Lock M, 2010, HUM GENE THER, V21, P1273, DOI 10.1089/hum.2009.223; LOTHMAN EW, 1990, EPILEPSY RES, V6, P110, DOI 10.1016/0920-1211(90)90085-A; Lubin FD, 2007, J NEUROCHEM, V103, P1381, DOI 10.1111/j.1471-4159.2007.04863.x; Lubin FD, 2005, NEUROSCIENCE, V133, P969, DOI 10.1016/j.neuroscience.2005.03.028; Majores M, 2004, EPILEPSY RES, V60, P173, DOI 10.1016/j.eplepsyres.2004.07.002; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; McCarty DM, 2003, GENE THER, V10, P2112, DOI 10.1038/sj.gt.3302134; McCarty DM, 2001, GENE THER, V8, P1248, DOI 10.1038/sj.gt.3301514; Melas C, 2008, HUM GENE THER; Oprica M, 2003, J CELL MOL MED, V7, P127, DOI 10.1111/j.1582-4934.2003.tb00211.x; Patel JR, 2008, EXP NEUROL, V213, P93, DOI 10.1016/j.expneurol.2008.05.007; Phillips MI, 2002, HYPERTENSION, V39, P651, DOI 10.1161/hy0202.103472; RANGANATHAN PN, 1993, NUCLEIC ACIDS RES, V21, P1959, DOI 10.1093/nar/21.8.1959; Ravizza T, 2011, NEUROSCI LETT, V497, P223, DOI 10.1016/j.neulet.2011.02.040; Reimsnider S, 2007, MOL THER, V15, P1504, DOI 10.1038/sj.mt.6300227; Rong YQ, 1996, J NEUROCHEM, V67, P662; Sheppard PW, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-276; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Somera-Molina KC, 2009, BRAIN RES, V1282, P162, DOI 10.1016/j.brainres.2009.05.073; STAFSTROM CE, 1992, DEV BRAIN RES, V65, P227, DOI 10.1016/0165-3806(92)90184-X; Strathdee CA, 1999, GENE, V229, P21, DOI 10.1016/S0378-1119(99)00045-1; Tansey MG, 2010, NEUROBIOL DIS, V37, P510, DOI 10.1016/j.nbd.2009.11.004; Tarkowski E, 2003, BRAIN RES BULL, V61, P255, DOI 10.1016/S0361-9230(03)00088-1; Taymans JM, 2007, HUM GENE THER, V18, P195, DOI 10.1089/hum.2006.178; Turrin NP, 2004, NEUROBIOL DIS, V16, P321, DOI 10.1016/j.nbd.2004.03.010; Van der Perren A, 2011, GENE THER, V18, P517, DOI 10.1038/gt.2010.179; Verma IM, 2004, ANN RHEUM DIS, V63, P57, DOI 10.1136/ard.2004.028266; Vermoesen K, 2012, EPILEPSIA, V53, P870, DOI 10.1111/j.1528-1167.2012.03436.x; Vermoesen K, 2010, EPILEPSY RES, V90, P164, DOI 10.1016/j.eplepsyres.2010.04.001; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Vezzani A, 2011, EXP NEUROL; Vincent P, 2009, NEUROSCIENCE, V158, P309, DOI 10.1016/j.neuroscience.2008.02.066; Williams PA, 2009, J NEUROSCI, V29, P2103, DOI 10.1523/JNEUROSCI.0980-08.2009; Wollebo HS, 2011, J NEUROIMMUNOL, V233, P46, DOI 10.1016/j.jneuroim.2010.11.013; ZABEL U, 1993, EMBO J, V12, P201, DOI 10.1002/j.1460-2075.1993.tb05646.x; Zala D, 2005, NEUROBIOL DIS, V20, P785, DOI 10.1016/j.nbd.2005.05.017; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938; Zolotukhin S, 1996, J VIROL, V70, P4646, DOI 10.1128/JVI.70.7.4646-4654.1996	72	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53156	10.1371/journal.pone.0053156	http://dx.doi.org/10.1371/journal.pone.0053156			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301037	Green Published, gold			2022-12-25	WOS:000313480000035
J	Erdoes, G; Balmer, ML; Slack, E; Kocsis, I; Lehmann, LE; Eberle, B; Stuber, F; Book, M				Erdoes, Gabor; Balmer, Maria L.; Slack, Emma; Kocsis, Istvan; Lehmann, Lutz E.; Eberle, Balthasar; Stueber, Frank; Book, Malte			CD62L (L-Selectin) Shedding for Assessment of Perioperative Immune Sensitivity in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass	PLOS ONE			English	Article							OPEN-HEART-SURGERY; LEUKOCYTE ADHESION MOLECULE-1; INFLAMMATORY RESPONSE; CORONARY REVASCULARIZATION; NOSOCOMIAL INFECTIONS; MONOCYTE ACTIVATION; EXPRESSION; NEUTROPHILS; COMPLEMENT; INTERLEUKIN-8	Objective: To investigate the suitability of blood granulocyte and monocyte sensitivity, as measured by the quantity of different agonists required to induce CD62L shedding, for assessment of perioperative immune changes in patients undergoing cardiac surgery with cardiopulmonary bypass. Methods: Patients scheduled for aortocoronary bypass grafting or for valve surgery were included in this prospective observational study. Blood samples were drawn before anesthesia induction, directly after surgery and 48 hours after anesthesia induction. We determined the concentration of two different inflammatory stimuli - lipoteichoic acid (LTA) and tumor necrosis factor alpha (TNF) - required to induce shedding of 50% of surface CD62L from blood granulocytes and monocytes. In parallel monocyte surface human leukocyte antigen (HLA)-DR, and plasma interleukin (IL)-8, soluble (s)CD62L, soluble (s)Toll-like receptor (TLR)-2 and ADAM17 quantification were used to illustrate perioperative immunomodulation. Results: 25 patients were enrolled. Blood granulocytes and monocytes showed decreased sensitivity to the TLR 2/6 agonist Staphylococcus aureus LTA immediately after surgery (p = 0.001 and p = 0.004 respectively). In contrast, granulocytes (p = 0.01), but not monocytes (p = 0.057) displayed a decreased postoperative sensitivity to TNF. We confirmed the presence of a systemic inflammatory response and a decreased immune sensitivity in the post-surgical period by measuring significant increases in the perioperative plasma concentration of IL-8 (p <= 0.001) and sTLR (p = 0.004), and decreases in monocyte HLA-DR (p<0.001), plasma sCD62L (p<0.001). In contrast, ADAM17 plasma levels did not show significant differences over the observation period (p = 0.401). Conclusions: Monitoring granulocyte and monocyte sensitivity using the "CD62L shedding assay'' in the perioperative period in cardiac surgical patients treated with the use of cardiopulmonary bypass reveals common changes in sensitivity to TLR2/6 ligands and to TNF stimulus. Further long-term follow-up studies will address the predictive value of these observations for clinical purposes.	[Erdoes, Gabor; Lehmann, Lutz E.; Eberle, Balthasar; Stueber, Frank; Book, Malte] Univ Hosp Bern, Inselspital, Univ Dept Anesthesiol & Pain Therapy, CH-3010 Bern, Switzerland; [Balmer, Maria L.; Slack, Emma] Univ Bern, Dept Clin Res, Maurice E Muller Labs, Bern, Switzerland; [Slack, Emma] Swiss Fed Inst Technol, Dept Microbiol, Zurich, Switzerland; [Kocsis, Istvan] Semmelweis Univ, Dept Anesthesiol & Intens Care, H-1085 Budapest, Hungary	University of Bern; University Hospital of Bern; University of Bern; Swiss Federal Institutes of Technology Domain; ETH Zurich; Semmelweis University	Erdoes, G (corresponding author), Univ Hosp Bern, Inselspital, Univ Dept Anesthesiol & Pain Therapy, CH-3010 Bern, Switzerland.	gabor.erdoes@insel.ch	Balmer, Maria Luisa/AAB-8993-2021; Slack, Emma/AAD-5837-2019; Balmer, Maria L/A-8546-2013; Erdoes, Gabor/J-5742-2014; Kocsis, István/O-2025-2017; Slack, Emma/B-1612-2016	Balmer, Maria Luisa/0000-0003-0356-6352; Slack, Emma/0000-0002-2473-1145; Erdoes, Gabor/0000-0002-6742-1016; Slack, Emma/0000-0002-2473-1145				Argyris M, 2006, EUR J CARDIO-THORAC, V29, P456, DOI 10.1016/j.ejcts.2005.12.035; Ascione R, 2000, ANN THORAC SURG, V69, P1198, DOI 10.1016/S0003-4975(00)01152-8; Asimakopoulos G, 1998, ANN THORAC SURG, V66, P2135, DOI 10.1016/S0003-4975(98)00727-9; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Blume ED, 1997, CIRCULATION, V96, P352; Day RB, 2012, CELL MOL LIFE SCI, V69, P1415, DOI 10.1007/s00018-011-0870-8; Diegeler A, 2000, CIRCULATION, V102, P95; Docke WD, 2005, CLIN CHEM, V51, P2341, DOI 10.1373/clinchem.2005.052639; Falagas ME, 2006, J THORAC CARDIOV SUR, V132, P481, DOI 10.1016/j.jtcvs.2006.05.019; Finn A, 1977, PERFUSION, V13, P322; GIBBON J H Jr, 1954, Minn Med, V37, P171; GRIFFIN JD, 1990, J IMMUNOL, V145, P576; Gu YJ, 1998, ANN THORAC SURG, V65, P420, DOI 10.1016/S0003-4975(97)01127-2; Hambsch J, 2002, ANESTHESIOLOGY, V96, P1078, DOI 10.1097/00000542-200205000-00009; Hamers LAC, 2011, EUR J CARDIO-THORAC, V40, P372, DOI 10.1016/j.ejcts.2010.11.063; Hazama Shiro, 2004, Ann Thorac Cardiovasc Surg, V10, P90; Ilton MK, 1999, J THORAC CARDIOV SUR, V118, P930, DOI 10.1016/S0022-5223(99)70064-4; KAWAMURA T, 1993, CAN J ANAESTH, V40, P1016, DOI 10.1007/BF03009470; Kollef MH, 1997, CHEST, V112, P666, DOI 10.1378/chest.112.3.666; Li Y, 2006, BLOOD, V108, P2275, DOI 10.1182/blood-2006-02-005827; Mazzone A, 2003, PERFUSION-UK, V18, P3, DOI 10.1191/0267659103pf622oa; MORISSET R, 1977, CAN MED ASSOC J, V116, P279; Pavelkova M, 2006, PHYSIOL RES, V55, P165, DOI 10.33549/physiolres.930662; PEKNA M, 1994, ANN THORAC SURG, V58, P421, DOI 10.1016/0003-4975(94)92219-5; Pillay J, 2007, INJURY, V38, P1365, DOI 10.1016/j.injury.2007.09.016; Pillay J, 2012, J CLIN INVEST, V122, P327, DOI 10.1172/JCI57990; Raby AC, 2009, J IMMUNOL, V183, P506, DOI 10.4049/jimmunol.0802909; Raja Shahzad G, 2005, Asian Cardiovasc Thorac Ann, V13, P382; Ryan T, 1997, CRIT CARE MED, V25, P2009, DOI 10.1097/00003246-199712000-00018; SCHUTT C, 1988, IMMUNOL LETT, V19, P321, DOI 10.1016/0165-2478(88)90162-9; SPERTINI O, 1991, LEUKEMIA, V5, P300; SPERTINI O, 1992, J IMMUNOL METHODS, V156, P115, DOI 10.1016/0022-1759(92)90017-N; Videm V, 2004, SCAND J IMMUNOL, V59, P25, DOI 10.1111/j.0300-9475.2004.01351.x; von Bernuth H, 2006, PEDIATRICS, V118, P2498, DOI 10.1542/peds.2006-1845; Wan IYP, 2004, J THORAC CARDIOV SUR, V127, P1624, DOI 10.1016/j.jtcvs.2003.10.043; Wehlin L, 2005, SCAND CARDIOVASC J, V39, P78, DOI 10.1080/14017430410004623; Wehlin L, 2004, EUR J CARDIO-THORAC, V25, P35, DOI 10.1016/S1010-7940(03)00652-3; Zhao L C, 2001, Dev Immunol, V8, P267, DOI 10.1155/2001/91831	38	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53045	10.1371/journal.pone.0053045	http://dx.doi.org/10.1371/journal.pone.0053045			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301018	Green Published, Green Submitted, gold			2022-12-25	WOS:000313480000027
J	Tuerkcan, S; Richly, MU; Alexandrou, A; Masson, JB				Tuerkcan, Silvan; Richly, Maximilian U.; Alexandrou, Antigoni; Masson, Jean-Baptiste			Probing Membrane Protein Interactions with Their Lipid Raft Environment Using Single-Molecule Tracking and Bayesian Inference Analysis	PLOS ONE			English	Article							GPI-ANCHORED PROTEINS; PLASMA-MEMBRANE; EPSILON-TOXIN; CLOSTRIDIUM-PERFRINGENS; TRANSIENT CONFINEMENT; OXIDE NANOPARTICLES; CHOLESTEROL; DIFFUSION; MICRODOMAINS; RECEPTOR	The statistical properties of membrane protein random walks reveal information on the interactions between the proteins and their environments. These interactions can be included in an overdamped Langevin equation framework where they are injected in either or both the friction field and the potential field. Using a Bayesian inference scheme, both the friction and potential fields acting on the epsilon-toxin receptor in its lipid raft have been measured. Two types of events were used to probe these interactions. First, active events, the removal of cholesterol and sphingolipid molecules, were used to measure the time evolution of confining potentials and diffusion fields. Second, passive rare events, de-confinement of the receptors from one raft and transition to an adjacent one, were used to measure hopping energies. Lipid interactions with the epsilon-toxin receptor are found to be an essential source of confinement. epsilon-toxin receptor confinement is due to both the friction and potential field induced by cholesterol and sphingolipids. Finally, the statistics of hopping energies reveal sub-structures of potentials in the rafts, characterized by small hopping energies, and the difference of solubilization energy between the inner and outer raft area, characterized by higher hopping energies.	[Tuerkcan, Silvan; Richly, Maximilian U.; Alexandrou, Antigoni] Ecole Polytech, CNRS, INSERM U696, Lab Opt & Biosci, F-91128 Palaiseau, France; [Tuerkcan, Silvan; Masson, Jean-Baptiste] Inst Pasteur, Paris, France; [Tuerkcan, Silvan; Masson, Jean-Baptiste] CNRS, URA 2171, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Polytechnique de Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Alexandrou, A (corresponding author), Ecole Polytech, CNRS, INSERM U696, Lab Opt & Biosci, F-91128 Palaiseau, France.	antigoni.alexandrou@polytechnique.edu; jbmasson@pasteur.fr		masson, jean-baptiste/0000-0002-5484-9056; Alexandrou, Antigoni/0000-0003-3727-6863	Delegation Generale pour l'Armement (DGA); Centre de competences en Nanosciences C'Nano Ile-de-France; Fondation de France; ANR Piribio; Bayer Science and Education Foundation	Delegation Generale pour l'Armement (DGA); Centre de competences en Nanosciences C'Nano Ile-de-France; Fondation de France(Fondation de France); ANR Piribio(French National Research Agency (ANR)); Bayer Science and Education Foundation	This work was supported by the Delegation Generale pour l'Armement (DGA), Centre de competences en Nanosciences C'Nano Ile-de-France, Fondation de France, ANR Piribio, Bayer Science and Education Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HJ, 2010, BIOPHYS J, V99, P834, DOI 10.1016/j.bpj.2010.04.072; Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643; Anderson HA, 2000, NAT IMMUNOL, V1, P156, DOI 10.1038/77842; Beaurepaire E, 2004, NANO LETT, V4, P2079, DOI 10.1021/nl049105g; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Casanova D, 2007, J AM CHEM SOC, V129, P12592, DOI 10.1021/ja0731975; Cole AR, 2004, NAT STRUCT MOL BIOL, V11, P797, DOI 10.1038/nsmb804; Cover T.M, 2006, WILEY SERIES TELECOM; Dietrich C, 2002, BIOPHYS J, V82, P274, DOI 10.1016/S0006-3495(02)75393-9; Dorca-Arevalo J, 2012, VET MICROBIOL, V157, P179, DOI 10.1016/j.vetmic.2011.12.020; Garcia-Saez AJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706162200; Giaume D, 2008, LANGMUIR, V24, P11018, DOI 10.1021/la8015468; GOINS B, 1986, BIOPHYS J, V49, P849, DOI 10.1016/S0006-3495(86)83714-6; Ivie SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017787; Jacobson K, 1999, TRENDS CELL BIOL, V9, P87, DOI 10.1016/S0962-8924(98)01495-0; Kenworthy AK, 2000, MOL BIOL CELL, V11, P1645, DOI 10.1091/mbc.11.5.1645; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; London M, 2004, J BIOL CHEM, V279, P9997, DOI 10.1074/jbc.M309992200; Lundbaek JA, 2004, J GEN PHYSIOL, V123, P599, DOI 10.1085/jgp.200308996; Masson JB, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.048103; MAYOR S, 1994, SCIENCE, V264, P1948, DOI 10.1126/science.7516582; Mayor S, 2004, TRAFFIC, V5, P231, DOI 10.1111/j.1600-0854.2004.00172.x; MOURITSEN OG, 1993, ANNU REV BIOPH BIOM, V22, P145, DOI 10.1146/annurev.bb.22.060193.001045; Murase K, 2004, BIOPHYS J, V86, P4075, DOI 10.1529/biophysj.103.035717; Petit L, 1997, J BACTERIOL, V179, P6480, DOI 10.1128/jb.179.20.6480-6487.1997; Popoff MR, 2011, FEBS J, V278, P4602, DOI 10.1111/j.1742-4658.2011.08145.x; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Richly MU, 2012, HYDRODYNAMIC F UNPUB; Rinia HA, 2001, FEBS LETT, V501, P92, DOI 10.1016/S0014-5793(01)02636-9; ROTHBERG KG, 1990, J CELL BIOL, V111, P2931, DOI 10.1083/jcb.111.6.2931; SAKO Y, 1994, J CELL BIOL, V125, P1251, DOI 10.1083/jcb.125.6.1251; Schutz GJ, 2000, EMBO J, V19, P892, DOI 10.1093/emboj/19.5.892; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Sheets ED, 1997, BIOCHEMISTRY-US, V36, P12449, DOI 10.1021/bi9710939; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Suzuki K, 2005, BIOPHYS J, V88, P3659, DOI 10.1529/biophysj.104.048538; Tilley SJ, 2006, CURR OPIN STRUC BIOL, V16, P230, DOI 10.1016/j.sbi.2006.03.008; Turkcan S, 2012, BIOPHYS J, V102, P2299, DOI 10.1016/j.bpj.2012.03.072; Turkcan S, 2012, BIOPHYS J, V102, P2288, DOI 10.1016/j.bpj.2012.01.063; van Zanten TS, 2009, P NATL ACAD SCI USA, V106, P18557, DOI 10.1073/pnas.0905217106; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Voisinne G, 2010, BIOPHYS J, V98, P596, DOI 10.1016/j.bpj.2009.10.051; Xu XL, 2000, BIOCHEMISTRY-US, V39, P843, DOI 10.1021/bi992543v; ZWANZIG R, 1988, P NATL ACAD SCI USA, V85, P2029, DOI 10.1073/pnas.85.7.2029	46	0	0	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53073	10.1371/journal.pone.0053073	http://dx.doi.org/10.1371/journal.pone.0053073			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301023	gold, Green Published			2022-12-25	WOS:000313480000028
J	Wang, YH; Engel, MS; Rafael, JA; Dang, K; Wu, HY; Wang, Y; Xie, Q; Bu, WJ				Wang, Yanhui; Engel, Michael S.; Rafael, Jose A.; Dang, Kai; Wu, Haoyang; Wang, Ying; Xie, Qiang; Bu, Wenjun			A Unique Box in 28S rRNA Is Shared by the Enigmatic Insect Order Zoraptera and Dictyoptera	PLOS ONE			English	Article							SECONDARY-STRUCTURE MODEL; PHYLOGENETIC ANALYSIS; SEQUENCE ALIGNMENT; COMPENSATORY MUTATIONS; MOLECULAR PHYLOGENY; NUCLEOTIDE-SEQUENCE; BAYESIAN-INFERENCE; EVIDENCE CONVERGE; SMALL-SUBUNIT; ALIGNED 18S	The position of the Zoraptera remains one of the most challenging and uncertain concerns in ordinal-level phylogenies of the insects. Zoraptera have been viewed as having a close relationship with five different groups of Polyneoptera, or as being allied to the Paraneoptera or even Holometabola. Although rDNAs have been widely used in phylogenetic studies of insects, the application of the complete 28S rDNA are still scattered in only a few orders. In this study, a secondary structure model of the complete 28S rRNAs of insects was reconstructed based on all orders of Insecta. It was found that one length-variable region, D3-4, is particularly distinctive. The length and/or sequence of D3-4 is conservative within each order of Polyneoptera, but it can be divided into two types between the different orders of the supercohort, of which the enigmatic order Zoraptera and Dictyoptera share one type, while the remaining orders of Polyneoptera share the other. Additionally, independent evidence from phylogenetic results support the clade (Zoraptera+Dictyoptera) as well. Thus, the similarity of D3-4 between Zoraptera and Dictyoptera can serve as potentially valuable autapomorphy or synapomorphy in phylogeny reconstruction. The clades of (Plecoptera+Dermaptera) and ((Grylloblattodea+Mantophasmatodea)+(Embiodea+Phasmatodea)) were also recovered in the phylogenetic study. In addition, considering the other studies based on rDNAs, this study reached the highest congruence with previous phylogenetic studies of Holometabola based on nuclear protein coding genes or morphology characters. Future comparative studies of secondary structures across deep divergences and additional taxa are likely to reveal conserved patterns, structures and motifs that can provide support for major phylogenetic lineages.	[Wang, Yanhui; Dang, Kai; Wu, Haoyang; Wang, Ying; Xie, Qiang; Bu, Wenjun] Nankai Univ, Coll Life Sci, Inst Entomol, Tianjin 300071, Peoples R China; [Engel, Michael S.] Nat Hist Museum, Div Entomol Paleoentomol, London SW7 5BD, England; [Engel, Michael S.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Rafael, Jose A.] INPA, Manaus, Amazonas, Brazil	Nankai University; Natural History Museum London; University of Kansas; Institute Nacional de Pesquisas da Amazonia	Xie, Q (corresponding author), Nankai Univ, Coll Life Sci, Inst Entomol, Tianjin 300071, Peoples R China.	qiangxie@nankai.edu.cn; wenjunbu@nankai.edu.cn	Engel, Michael S/C-5461-2012; Rafael, Jose/ABD-8405-2021	Engel, Michael S/0000-0003-3067-077X; Rafael, Jose/0000-0002-0170-0514; Xie, Qiang/0000-0001-6376-8808	National Science Foundation of China [J0930005, 30970350, 30725005]; U.S. National Science Foundation grant [DEB-0542909]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [472237/2009-8]; Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM) [Edital 016/2006, Proc. 1437/2007]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Science Foundation grant(National Science Foundation (NSF)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)(Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM))	This work was supported by the National Science Foundation of China (grant numbers J0930005, 30970350, 30725005). The participation of Michael S. Engel was supported by U.S. National Science Foundation grant DEB-0542909. Jose A. Rafael was financially supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), grant number 472237/2009-8 and Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM) by the financial support to the Project PRONEX, Edital 016/2006, Proc. 1437/2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amako D, 1996, J MOL EVOL, V43, P469, DOI 10.1007/BF02337519; Andrew DR, 2011, ARTHROPOD STRUCT DEV, V40, P289, DOI 10.1016/j.asd.2011.02.001; Arillo A, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3539[1:RCIBAN]2.0.CO;2; Bethoux O., 2002, ZOOTAXA, V96, P1, DOI DOI 10.11646/ZOOTAXA.96.1.1; Beutel RG, 2001, J ZOOL SYST EVOL RES, V39, P177, DOI 10.1046/j.1439-0469.2001.00155.x; Beutel Rolf G., 2006, Arthropod Systematics & Phylogeny, V64, P3; Beutel RG, 2011, CLADISTICS, V27, P341, DOI 10.1111/j.1096-0031.2010.00338.x; Bonneton F, 2006, INSECT MOL BIOL, V15, P351, DOI 10.1111/j.1365-2583.2006.00654.x; Boudreaux H. B., 1979, ARTHROPOD PHYLOGENY; Buckley TR, 2000, INSECT MOL BIOL, V9, P565, DOI 10.1046/j.1365-2583.2000.00220.x; Burki F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000790; Carmean D, 1992, MOL PHYLOGENET EVOL, V1, P270, DOI 10.1016/1055-7903(92)90002-X; Caterino MS, 2000, ANNU REV ENTOMOL, V45, P1, DOI 10.1146/annurev.ento.45.1.1; Chalwatzis N, 1996, ANN ENTOMOL SOC AM, V89, P788, DOI 10.1093/aesa/89.6.788; CLARK CG, 1984, NUCLEIC ACIDS RES, V12, P6197, DOI 10.1093/nar/12.15.6197; Crampton G. C., 1938, Psyche Cambridge Mass, V45, P165, DOI 10.1155/1938/18939; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davis RB, 2010, P ROY SOC B-BIOL SCI, V277, P1597, DOI 10.1098/rspb.2009.2299; DERIJK P, 1995, J MOL EVOL, V41, P366, DOI 10.1007/BF01215184; DIXON MT, 1993, MOL BIOL EVOL, V10, P256; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; ELLIS RE, 1986, NUCLEIC ACIDS RES, V14, P2345, DOI 10.1093/nar/14.5.2345; Engel M. S., 2000, Acta Geologica Hispanica, V35, P149; Engel MS, 2004, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2004)431<0001:ANRCIB>2.0.CO;2; Engel MS, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)362<0001:TFMZI>2.0.CO;2; Gillespie J, 2004, INSECT MOL BIOL, V13, P495, DOI 10.1111/j.0962-1075.2004.00509.x; Gillespie JJ, 2006, INSECT MOL BIOL, V15, P657, DOI 10.1111/j.1365-2583.2006.00689.x; Gillespie JJ, 2005, J MOL EVOL, V61, P114, DOI 10.1007/s00239-004-0246-x; Gillespie JJ, 2005, INSECT MOL BIOL, V14, P625, DOI 10.1111/j.1365-2583.2005.00591.x; Grimaldi David, 2005, pi; Gutell RR, 2002, CURR OPIN STRUC BIOL, V12, P301, DOI 10.1016/S0959-440X(02)00339-1; GUTELL RR, 1985, PROG NUCLEIC ACID RE, V32, P155, DOI 10.1016/S0079-6603(08)60348-7; Gutell RR, 2000, J MOL BIOL, V300, P791, DOI 10.1006/jmbi.2000.3900; Hall T, BIOEDIT VERSION 7 1; HAMILTON KGA, 1981, CAN ENTOMOL, V113, P953, DOI 10.4039/Ent113953-11; HANCOCK JM, 1988, MOL BIOL EVOL, V5, P393; Handlirsch A, 1908, FOSSILEN INSEKTEN PH; HASSOUNA N, 1984, NUCLEIC ACIDS RES, V12, P3563, DOI 10.1093/nar/12.8.3563; Hennig W., 1953, Beitraege zur Entomologie Berlin, V3, P1; Hennig W., 1981, INSECT PHYLOGENY; Hennig W., 1969, STAMMESGESCHICHTE IN; Hickson RE, 2000, MOL BIOL EVOL, V17, P530, DOI 10.1093/oxfordjournals.molbev.a026333; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ishiwata K, 2011, MOL PHYLOGENET EVOL, V58, P169, DOI 10.1016/j.ympev.2010.11.001; Jobb G., 2011, TREEFINDER VERSION M; Johnson KP, 2000, MOL PHYLOGENET EVOL, V14, P141, DOI 10.1006/mpev.1999.0682; Kjer Karl M., 2006, Arthropod Systematics & Phylogeny, V64, P35; KJER KM, 1994, BBA-GENE STRUCT EXPR, V1217, P147, DOI 10.1016/0167-4781(94)90028-0; KJER KM, 1995, MOL PHYLOGENET EVOL, V4, P314, DOI 10.1006/mpev.1995.1028; Kjer KM, 2004, SYST BIOL, V53, P506, DOI 10.1080/10635150490445922; Klass KD, 2002, SCIENCE, V296, P1456, DOI 10.1126/science.1069397; KRISTENSEN N P, 1975, Zeitschrift fuer Zoologische Systematik und Evolutionsforschung, V13, P1; Kristensen N.P., 1991, P125; KRISTENSEN NP, 1981, ANNU REV ENTOMOL, V26, P135, DOI 10.1146/annurev.en.26.010181.001031; Kristensen NP, 1995, ZOOL BEITR, V36, P83; Kukalova-Peck J., 1991, P141; KUKALOVAPECK J, 1993, SYST ENTOMOL, V18, P333, DOI 10.1111/j.1365-3113.1993.tb00670.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letsch HO, 2012, P ROY SOC B-BIOL SCI, V279, P3282, DOI 10.1098/rspb.2012.0744; Letsch HO, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-146; Letsch HO, 2010, MOL BIOL EVOL, V27, P2507, DOI 10.1093/molbev/msq140; Letsch HO, 2009, MOL PHYLOGENET EVOL, V53, P758, DOI 10.1016/j.ympev.2009.07.033; Longhorn SJ, 2010, MOL PHYLOGENET EVOL, V55, P846, DOI 10.1016/j.ympev.2010.03.024; LYAL CHC, 1985, SYST ENTOMOL, V10, P145; Maddison W, MESQUITE MODULAR SYS; Mallatt JM, 2004, MOL PHYLOGENET EVOL, V31, P178, DOI 10.1016/j.ympev.2003.07.013; Mallatt J, 2006, MOL PHYLOGENET EVOL, V40, P772, DOI 10.1016/j.ympev.2006.04.021; Martynov A. V., 1925, Zeitschrift fuer Morphologie und Oekologie der Tiere Berlin, V4, P465, DOI 10.1007/BF00408465; McKenna DD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011887; Meusemann K, 2010, MOL BIOL EVOL, V27, P2451, DOI 10.1093/molbev/msq130; Minet J., 1986, CAHIERS LIAISON OPIE, V20, P23; Misof B, 2006, J EXP ZOOL PART B, V306B, P70, DOI 10.1002/jez.b.21040; Misof B, 2007, ZOOLOGY, V110, P409, DOI 10.1016/j.zool.2007.08.003; Morgan MJ, 2010, MOL PHYLOGENET EVOL, V56, P305, DOI 10.1016/j.ympev.2010.03.032; Nagaswamy U, 2000, NUCLEIC ACIDS RES, V28, P375, DOI 10.1093/nar/28.1.375; Niehuis O, 2012, CURR BIOL, V22, P1309, DOI 10.1016/j.cub.2012.05.018; PASHLEY DP, 1993, MOL PHYLOGENET EVOL, V2, P132, DOI 10.1006/mpev.1993.1013; Philippe H, 2011, NATURE, V470, P255, DOI 10.1038/nature09676; Plazzi F, 2011, MOL PHYLOGENET EVOL, V58, P304, DOI 10.1016/j.ympev.2010.12.005; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rafael Jost A., 2008, Transactions of the Kansas Academy of Science, V111, P193, DOI 10.1660/0022-8443-111.3.193; Rahle W, 1970, ZOOL JB ABT ANAT ONT, V87, P248; Rasnitsyn AP, 1998, ZOOL ANZ, V237, P185; Reineke A, 1998, INSECT MOL BIOL, V7, P95, DOI 10.1046/j.1365-2583.1998.71048.x; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Richards O.W., 1977, IMMS GEN TXB ENTOMOL; Roeding F, 2007, MOL PHYLOGENET EVOL, V45, P942, DOI 10.1016/j.ympev.2007.09.002; Rokas A, 2006, PLOS BIOL, V4, P1899, DOI 10.1371/journal.pbio.0040352; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schnare MN, 1996, J MOL BIOL, V256, P701, DOI 10.1006/jmbi.1996.0119; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SHAROV AG, 1968, T PALEONTOL I ACAD S, V118, P1; Simmons MP, 2004, MOL PHYLOGENET EVOL, V31, P874, DOI 10.1016/j.ympev.2003.10.008; Simon S, 2009, MOL BIOL EVOL, V26, P2719, DOI 10.1093/molbev/msp191; Smithers C.N., 1991, P410; Snodgrass RE, 1935, PRINCIPLES INSECTA M; Talavera G, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-315; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor DJ, 2009, STRUCTURE, V17, P1591, DOI 10.1016/j.str.2009.09.015; Terry MD, 2005, CLADISTICS, V21, P240, DOI 10.1111/j.1096-0031.2005.00062.x; Thomas MA, 2000, P NATL ACAD SCI USA, V97, P13178, DOI 10.1073/pnas.230296997; von Reumont BM, 2012, MOL BIOL EVOL, V29, P1031, DOI 10.1093/molbev/msr270; von Reumont BM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-119; Wheeler WC, 2001, CLADISTICS, V17, P113, DOI [10.1006/clad.2000.0147, 10.1111/j.1096-0031.2001.tb00115.x]; Whitfield JB, 2008, ANNU REV ENTOMOL, V53, P449, DOI 10.1146/annurev.ento.53.103106.093304; Whitfield JB, 2007, TRENDS ECOL EVOL, V22, P258, DOI 10.1016/j.tree.2007.01.012; Whiting MF, 2003, NATURE, V421, P264, DOI 10.1038/nature01313; Whiting MF, 1997, SYST BIOL, V46, P1, DOI 10.1093/sysbio/46.1.1; Wiegmann BM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-34; Willmann R, 2004, ASSEMBLING THE TREE OF LIFE, P330; Witek A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-345; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia X, 2000, DATA ANAL MOL BIOL E, P276; Xie Q, 2005, MOL PHYLOGENET EVOL, V34, P448, DOI 10.1016/j.ympev.2004.10.015; Xie Q, 2008, MOL PHYLOGENET EVOL, V47, P463, DOI 10.1016/j.ympev.2008.01.024; Xie Q, 2011, PROTEIN CELL, V2, P161, DOI 10.1007/s13238-011-1017-2; Xie Q, 2009, MOL PHYLOGENET EVOL, V50, P310, DOI 10.1016/j.ympev.2008.10.025; Yoshizawa K, 2005, MOL PHYLOGENET EVOL, V37, P572, DOI 10.1016/j.ympev.2005.05.008; Yoshizawa K, 2001, SYST ENTOMOL, V26, P1, DOI 10.1046/j.1365-3113.2001.00133.x; Yoshizawa K, 2011, TAXA P JAPANESE SOC, V30, P17; Yoshizawa K, 2007, SYST ENTOMOL, V32, P197, DOI 10.1111/j.1365-3113.2007.00379.x; Yoshizawa K, 2011, SYST ENTOMOL, V36, P377, DOI 10.1111/j.1365-3113.2011.00572.x; Yoshizawa K, 2010, SYST ENTOMOL, V35, P199, DOI 10.1111/j.1365-3113.2010.00526.x; Zhou JF, 2011, BIOINFORMATICS, V27, P1255, DOI 10.1093/bioinformatics/btr140	124	28	30	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53679	10.1371/journal.pone.0053679	http://dx.doi.org/10.1371/journal.pone.0053679			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301099	gold, Green Published			2022-12-25	WOS:000313480000075
J	Xu, XH; Wang, F; Chen, H; Sun, W; Zhang, XS				Xu, Xiao Hui; Wang, Fang; Chen, Hao; Sun, Wei; Zhang, Xian Sheng			Transcript Profile Analyses of Maize Silks Reveal Effective Activation of Genes Involved in Microtubule-Based Movement, Ubiquitin-Dependent Protein Degradation, and Transport in the Pollination Process	PLOS ONE			English	Article							POLLEN-TUBE GROWTH; VITRO STYLAR MATRIX; ZEA-MAYS-L; PISTIL INTERACTIONS; ARABIDOPSIS POLLEN; IN-VITRO; SELF-INCOMPATIBILITY; RECEPTOR KINASES; REPRODUCTIVE DEVELOPMENT; EXPRESSION PROFILES	Pollination is the first crucial step of sexual reproduction in flowering plants, and it requires communication and coordination between the pollen and the stigma. Maize (Zea mays) is a model monocot with extraordinarily long silks, and a fully sequenced genome, but little is known about the mechanism of its pollen-stigma interactions. In this study, the dynamic gene expression of silks at four different stages before and after pollination was analyzed. The expression profiles of immature silks (IMS), mature silks (MS), and silks at 20 minutes and 3 hours after pollination (20MAP and 3HAP, respectively) were compared. In total, we identified 6,337 differentially expressed genes in silks (SDEG) at the four stages. Among them, the expression of 172 genes were induced upon pollination, most of which participated in RNA binding, processing and transcription, signal transduction, and lipid metabolism processes. Genes in the SDEG dataset could be divided into 12 time-course clusters according to their expression patterns. Gene Ontology (GO) enrichment analysis revealed that many genes involved in microtubule-based movement, ubiquitin-mediated protein degradation, and transport were predominantly expressed at specific stages, indicating that they might play important roles in the pollination process of maize. These results add to current knowledge about the pollination process of grasses and provide a foundation for future studies on key genes involved in the pollen-silk interaction in maize.	[Xu, Xiao Hui; Wang, Fang; Chen, Hao; Sun, Wei; Zhang, Xian Sheng] Shandong Agr Univ, Coll Life Sci, Shandong Key Lab Crop Biol, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Zhang, XS (corresponding author), Shandong Agr Univ, Coll Life Sci, Shandong Key Lab Crop Biol, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	zhangxs@sdau.edu.cn	zhang, xian/GYA-0290-2022	Xu, Xiaohui/0000-0002-3823-0122	Major Research Plan from the Ministry of Science and Technology of China [2013CB945100]	Major Research Plan from the Ministry of Science and Technology of China	This work is supported by the Major Research Plan from the Ministry of Science and Technology of China (no. 2013CB945100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AM, 2010, PLANT PHYSIOL, V154, P1347, DOI 10.1104/pp.110.162172; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Becker JD, 2003, PLANT PHYSIOL, V133, P713, DOI 10.1104/pp.103.028241; Boavida LC, 2011, PLANT PHYSIOL, V155, P2066, DOI 10.1104/pp.110.169813; Chae K, 2007, J BIOL CHEM, V282, P33845, DOI 10.1074/jbc.M703997200; CHEUNG AY, 1995, CELL, V82, P383, DOI 10.1016/0092-8674(95)90427-1; Davidson RM, 2011, PLANT GENOME-US, V4, P191, DOI 10.3835/plantgenome2011.05.0015; Dobritsa AA, 2009, SEX PLANT REPROD, V22, P167, DOI 10.1007/s00497-009-0101-8; Dong J, 2005, PLANT PHYSIOL, V138, P778, DOI 10.1104/pp.105.063388; Dresselhaus T, 2011, ANN BOT-LONDON, V108, P727, DOI 10.1093/aob/mcr017; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; DUPUIS I, 1990, PLANT SCI, V70, P11, DOI 10.1016/0168-9452(90)90026-K; ELLEMAN CJ, 1992, NEW PHYTOL, V121, P413, DOI 10.1111/j.1469-8137.1992.tb02941.x; Foster J, 2008, SEX PLANT REPROD, V21, P143, DOI 10.1007/s00497-008-0074-z; Gambino G, 2008, PHYTOCHEM ANALYSIS, V19, P520, DOI 10.1002/pca.1078; Gu TS, 1998, P NATL ACAD SCI USA, V95, P382, DOI 10.1073/pnas.95.1.382; Hennig L, 2004, PLANT PHYSIOL, V135, P1765, DOI 10.1104/pp.104.043182; HESLOPHARRISON Y, 1984, ACTA BOT NEERL, V33, P81, DOI 10.1111/j.1438-8677.1984.tb01774.x; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hiscock SJ, 2008, NEW PHYTOL, V179, P286, DOI 10.1111/j.1469-8137.2008.02457.x; HISCOCK SJ, 1994, PLANTA, V193, P377, DOI 10.1007/BF00201816; Hiscock SJ, 2002, SEX PLANT REPROD, V15, P65, DOI 10.1007/s00497-002-0143-7; Holdaway-Clarke TL, 2003, NEW PHYTOL, V159, P539, DOI 10.1046/j.1469-8137.2003.00847.x; Honys D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r85; Honys D, 2003, PLANT PHYSIOL, V132, P640, DOI 10.1104/pp.103.020925; Hua ZH, 2006, PLANT CELL, V18, P2531, DOI 10.1105/tpc.106.041061; Huang J, 2006, PLANT J, V46, P780, DOI 10.1111/j.1365-313X.2006.02735.x; HULSKAMP M, 1995, PLANT J, V8, P703, DOI 10.1046/j.1365-313X.1995.08050703.x; Johnson MA, 2003, TRENDS PLANT SCI, V8, P97, DOI 10.1016/S1360-1385(03)00009-8; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; KANDASAMY MK, 1994, DEVELOPMENT, V120, P3405; Kasahara RD, 2005, PLANT CELL, V17, P2981, DOI 10.1105/tpc.105.034603; Kiesselbach T.A., 1999, STRUCTURE REPROD COR; Kim HU, 2002, PLANT MOL BIOL, V50, P1, DOI 10.1023/A:1016077014583; Kim S, 2003, P NATL ACAD SCI USA, V100, P16125, DOI 10.1073/pnas.2533800100; Kim ST, 2006, PLANT PHYSIOL, V142, P1397, DOI 10.1104/pp.106.086801; Krichevsky A, 2007, DEV BIOL, V303, P405, DOI 10.1016/j.ydbio.2006.12.003; Lausser A, 2010, J EXP BOT, V61, P673, DOI 10.1093/jxb/erp330; LAVITHIS M, 1995, SEX PLANT REPROD, V8, P289, DOI 10.1007/BF00229386; Li MN, 2007, PLANT PHYSIOL, V144, P1797, DOI 10.1104/pp.107.101600; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lord EM, 2003, J EXP BOT, V54, P47, DOI 10.1093/jxb/54.380.47; Ma J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r181; MACCIONI RB, 1995, PHYSIOL REV, V75, P835, DOI 10.1152/physrev.1995.75.4.835; Makkena S, 2012, J EXP BOT, V63, P5545, DOI 10.1093/jxb/ers209; Michard E, 2011, SCIENCE, V332, P434, DOI 10.1126/science.1201101; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mudgil Y, 2004, PLANT PHYSIOL, V134, P59, DOI 10.1104/pp.103.029553; Muschietti J, 1998, PLANT CELL, V10, P319, DOI 10.1105/tpc.10.3.319; MUSCHIETTI J, 1994, PLANT J, V6, P321, DOI 10.1046/j.1365-313X.1994.06030321.x; Otsu CT, 2004, J EXP BOT, V55, P1643, DOI 10.1093/jxb/erh195; Palanivelu R, 2003, CELL, V114, P47, DOI 10.1016/S0092-8674(03)00479-3; Park SY, 2000, PLANT CELL, V12, P151, DOI 10.1105/tpc.12.1.151; Pina C, 2005, PLANT PHYSIOL, V138, P744, DOI 10.1104/pp.104.057935; Pruitt RE, 2000, P NATL ACAD SCI USA, V97, P1311, DOI 10.1073/pnas.97.3.1311; Qin Y, 2009, PLOS GENET, V5, DOI [10.1371/journal.pgen.1000621, 10.1109/BMEI.2009.5304794]; Quiapim AC, 2009, PLANT PHYSIOL, V149, P1211, DOI 10.1104/pp.108.131573; Renak D, 2012, SEX PLANT REPROD, V25, P39, DOI 10.1007/s00497-011-0178-8; RUBINSTEIN AL, 1995, P NATL ACAD SCI USA, V92, P3086, DOI 10.1073/pnas.92.8.3086; Sakai N, 2004, INT J BIOCHEM CELL B, V36, P776, DOI 10.1016/S1357-2725(03)00263-2; Samuel MA, 2008, PLANT PHYSIOL, V147, P2084, DOI 10.1104/pp.108.123380; Samuel MA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011338; Samuel MA, 2009, PLANT CELL, V21, P2655, DOI 10.1105/tpc.109.069740; Sanchez AM, 2004, PLANT CELL, V16, pS98, DOI 10.1105/tpc.017806; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Sijacic P, 2004, NATURE, V429, P302, DOI 10.1038/nature02523; Sousa E, 2008, PLANT CELL, V20, P3050, DOI 10.1105/tpc.108.058826; Steinebrunner I, 2003, PLANT PHYSIOL, V131, P1638, DOI 10.1104/pp.102.014308; Stone SL, 1999, SCIENCE, V286, P1729, DOI 10.1126/science.286.5445.1729; Stone SL, 2003, PLANT CELL, V15, P885, DOI 10.1105/tpc.009845; Sutovsky P, 2001, J CELL SCI, V114, P1665; Swanson R, 2005, SEX PLANT REPROD, V18, P163, DOI 10.1007/s00497-005-0009-x; Swanson R, 2004, ANNU REV GENET, V38, P793, DOI 10.1146/annurev.genet.38.072902.092356; Tan XY, 2010, PLANT CELL PHYSIOL, V51, P635, DOI 10.1093/pcp/pcq029; Tang WH, 2004, PLANT J, V39, P343, DOI 10.1111/j.1365-313X.2004.02139.x; Tang WH, 2002, PLANT CELL, V14, P2277, DOI 10.1105/tpc.003103; Theodoulou FL, 2000, BBA-BIOMEMBRANES, V1465, P79, DOI [10.1016/S0005-2736(00)00132-2, 10.1199/tab.0153]; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tung CW, 2005, PLANT PHYSIOL, V138, P977, DOI 10.1104/pp.105.060558; TWELL D, 1989, MOL GEN GENET, V217, P240, DOI 10.1007/BF02464887; Updegraff EP, 2009, SEX PLANT REPROD, V22, P197, DOI 10.1007/s00497-009-0104-5; Wang Y, 2008, PLANT PHYSIOL, V148, P1201, DOI 10.1104/pp.108.126375; Wei LQ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-338; Wiborg J, 2008, BIOCHEM J, V413, P447, DOI 10.1042/BJ20071568; Wolters-Arts M, 2002, PLANT CELL ENVIRON, V25, P513, DOI 10.1046/j.1365-3040.2002.00827.x; Wolters-Arts M, 1998, NATURE, V392, P818, DOI 10.1038/33929; WU HM, 1995, CELL, V82, P395, DOI 10.1016/0092-8674(95)90428-X; Xu XH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-294; Zhang XR, 1998, PLANT MOL BIOL REP, V16, P301, DOI 10.1023/A:1007540610933; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18830, DOI 10.1073/pnas.0705874104; Zinkl GM, 2000, ANN BOT-LONDON, V85, P15, DOI 10.1006/anbo.1999.1066	91	12	12	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53545	10.1371/journal.pone.0053545	http://dx.doi.org/10.1371/journal.pone.0053545			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301084	Green Published, Green Submitted, gold			2022-12-25	WOS:000313480000064
J	Mastropasqua, T; Turatto, M				Mastropasqua, Tommaso; Turatto, Massimo			Perceptual Grouping Enhances Visual Plasticity	PLOS ONE			English	Article							ORIENTATION; ATTENTION; SPECIFICITY; CORTEX; DISCRIMINATION; IMPROVEMENT; MODULATION; RESPONSES	Visual perceptual learning, a manifestation of neural plasticity, refers to improvements in performance on a visual task achieved by training. Attention is known to play an important role in perceptual learning, given that the observer's discriminative ability improves only for those stimulus feature that are attended. However, the distribution of attention can be severely constrained by perceptual grouping, a process whereby the visual system organizes the initial retinal input into candidate objects. Taken together, these two pieces of evidence suggest the interesting possibility that perceptual grouping might also affect perceptual learning, either directly or via attentional mechanisms. To address this issue, we conducted two experiments. During the training phase, participants attended to the contrast of the task-relevant stimulus (oriented grating), while two similar task-irrelevant stimuli were presented in the adjacent positions. One of the two flanking stimuli was perceptually grouped with the attended stimulus as a consequence of its similar orientation (Experiment 1) or because it was part of the same perceptual object (Experiment 2). A test phase followed the training phase at each location. Compared to the task-irrelevant no-grouping stimulus, orientation discrimination improved at the attended location. Critically, a perceptual learning effect equivalent to the one observed for the attended location also emerged for the task-irrelevant grouping stimulus, indicating that perceptual grouping induced a transfer of learning to the stimulus (or feature) being perceptually grouped with the task-relevant one. Our findings indicate that no voluntary effort to direct attention to the grouping stimulus or feature is necessary to enhance visual plasticity.	[Mastropasqua, Tommaso; Turatto, Massimo] Univ Trento, Ctr Mind Brain Sci, Rovereto, Italy; [Turatto, Massimo] Univ Trento, Dept Cognit Sci & Educ, Rovereto, Italy	University of Trento; University of Trento	Turatto, M (corresponding author), Univ Trento, Ctr Mind Brain Sci, Rovereto, Italy.	massimo.turatto@unitn.it			"Ministero dell'Istruzione dell' Universita e della Ricerca"	"Ministero dell'Istruzione dell' Universita e della Ricerca"(Ministry of Education, Universities and Research (MIUR))	This work was supported by a grant from the "Ministero dell'Istruzione dell' Universita e della Ricerca" to Massimo Turatto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg KC, 2009, VISION RES, V49, P2087, DOI 10.1016/j.visres.2009.05.020; AHISSAR M, 1993, P NATL ACAD SCI USA, V90, P5718, DOI 10.1073/pnas.90.12.5718; Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; BALL K, 1982, SCIENCE, V218, P697, DOI 10.1126/science.7134968; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; BAYLIS GC, 1992, PERCEPT PSYCHOPHYS, V51, P145, DOI 10.3758/BF03212239; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Crist RE, 1997, J NEUROPHYSIOL, V78, P2889, DOI 10.1152/jn.1997.78.6.2889; de-Wit LH, 2011, J VISION, V11, DOI 10.1167/11.4.13; Dinse HR, 2003, SCIENCE, V301, P91, DOI 10.1126/science.1085423; Dosher BA, 1998, P NATL ACAD SCI USA, V95, P13988, DOI 10.1073/pnas.95.23.13988; DRIVER J, 1989, J EXP PSYCHOL HUMAN, V15, P448, DOI 10.1037/0096-1523.15.3.448; Driver J, 2001, COGNITION, V80, P61, DOI 10.1016/S0010-0277(00)00151-7; EGLY R, 1994, J EXP PSYCHOL GEN, V123, P161, DOI 10.1037/0096-3445.123.2.161; FAHLE M, 1995, VISION RES, V35, P3003, DOI 10.1016/0042-6989(95)00044-Z; Fahle M, 2002, PERCEPTUAL LEARNING; FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Gilbert CD, 2009, J PHYSIOL-LONDON, V587, P2743, DOI 10.1113/jphysiol.2009.171488; Gutnisky DA, 2009, CURR BIOL, V19, P555, DOI 10.1016/j.cub.2009.01.063; Jeter PE, 2010, VISION RES, V50, P1928, DOI 10.1016/j.visres.2010.06.016; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Karni A, 1997, CURR OPIN NEUROBIOL, V7, P530, DOI 10.1016/S0959-4388(97)80033-5; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kimchi R, 2009, PROG BRAIN RES, V176, P15, DOI 10.1016/S0079-6123(09)17602-1; Lamy D, 2006, PERCEPT PSYCHOPHYS, V68, P17, DOI 10.3758/BF03193652; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; Marr D., 1982, VISION COMPUTATIONAL; Masson MEJ, 2011, BEHAV RES METHODS, V43, P679, DOI 10.3758/s13428-010-0049-5; Moore CM, 1997, J EXP PSYCHOL HUMAN, V23, P339, DOI 10.1037/0096-1523.23.2.339; Neisser U., 1967, COGNITIVE PSYCHOL; Nishina S, 2007, J VISION, V7, DOI 10.1167/7.13.2; Otto TU, 2010, PSYCHOL SCI, V21, P1058, DOI 10.1177/0956797610376074; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; ROCK I, 1990, SCI AM, V263, P84, DOI 10.1038/scientificamerican1290-84; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Sasaki Y, 2010, NAT REV NEUROSCI, V11, P53, DOI 10.1038/nrn2737; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; SCHOUPS AA, 1995, J PHYSIOL-LONDON, V483, P797, DOI 10.1113/jphysiol.1995.sp020623; Seitz AR, 2009, NEURON, V61, P700, DOI 10.1016/j.neuron.2009.01.016; Seitz AR, 2003, NATURE, V422, P36, DOI 10.1038/422036a; SHIU LP, 1992, PERCEPT PSYCHOPHYS, V52, P582, DOI 10.3758/BF03206720; Wannig A, 2011, NAT NEUROSCI, V14, P1243, DOI 10.1038/nn.2910; Wertheimer M, 1923, PSYCHOL FORSCH, V4, P301, DOI 10.1007/BF00410640; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Xiao LQ, 2008, CURR BIOL, V18, P1922, DOI 10.1016/j.cub.2008.10.030; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004	47	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53683	10.1371/journal.pone.0053683	http://dx.doi.org/10.1371/journal.pone.0053683			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	067UP	23301100	Green Submitted, Green Published, gold			2022-12-25	WOS:000313320900088
J	Nishi, M; Sakai, Y; Akutsu, H; Nagashima, Y; Quinn, G; Masui, S; Kimura, H; Perrem, K; Umezawa, A; Yamamoto, N; Lee, SW; Ryo, A				Nishi, M.; Sakai, Y.; Akutsu, H.; Nagashima, Y.; Quinn, G.; Masui, S.; Kimura, H.; Perrem, K.; Umezawa, A.; Yamamoto, N.; Lee, S. W.; Ryo, A.			Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors	ONCOGENE			English	Article						cancer stem cell; reprogramming factors; oncogenesis; MCF-10A; p16INK4a	EXPRESSION; PHOSPHORYLATION; IMMORTALIZATION; IDENTIFICATION; MARKER; SOX2	Cancer stem cells (CSCs), a small and elusive population of undifferentiated cancer cells within tumors that drive tumor growth and recurrence, are believed to resemble normal stem cells. Although surrogate markers have been identified and compelling CSC theoretical models abound, actual proof for the existence of CSCs can only be had retrospectively. Hence, great store has come to be placed in isolating CSCs from cancers for in-depth analysis. On the other hand, although induced pluripotent stem cells (iPSCs) hold great promise for regenerative medicine, concern exists over the inadvertent co-transplantation of partially or undifferentiated stem cells with tumorigenic capacity. Here we demonstrate that the introduction of defined reprogramming factors (OCT4, SOX2, Klf4 and c-Myc) into MCF-10A nontumorigenic mammary epithelial cells, followed by partial differentiation, transforms the bulk of cells into tumorigenic CD44(+)/CD24(low) cells with CSC properties, termed here as induced CSC-like-10A or iCSCL-10A cells. These reprogrammed cells display a malignant phenotype in culture and form tumors of multiple lineages when injected into immunocompromised mice. Compared with other transformed cell lines, cultured iCSCL-10A cells exhibit increased resistance to the chemotherapeutic compounds, Taxol and Actinomycin D, but higher susceptibility to the CSC-selective agent Salinomycin and the Pin1 inhibitor Juglone. Restored expression of the cyclin-dependent kinase inhibitor p16INK4a abrogated the CSC properties of iCSCL-10A cells, by inducing cellular senescence. This study provides some insight into the potential oncogenicity that may arise via cellular reprogramming, and could represent a valuable in vitro model for studying the phenotypic traits of CSCs per se.	[Nishi, M.; Sakai, Y.; Quinn, G.; Ryo, A.] Yokohama City Univ, Sch Med, Dept Microbiol, Yokohama, Kanagawa 2360004, Japan; [Akutsu, H.; Umezawa, A.] Natl Res Inst Child Hlth & Dev, Dept Reprod Biol, Tokyo, Japan; [Nagashima, Y.] Yokohama City Univ, Sch Med, Dept Mol Pathol, Yokohama, Kanagawa 2360004, Japan; [Masui, S.] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan; [Kimura, H.] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan; [Perrem, K.] CSIRO, Dickson, ACT, Australia; [Yamamoto, N.] Natl Univ Singapore, Dept Microbiol, Singapore 117548, Singapore; [Lee, S. W.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA USA; [Lee, S. W.] Harvard Univ, Sch Med, Charlestown, MA USA	Yokohama City University; National Center for Child Health & Development - Japan; Yokohama City University; Kyoto University; National Institute of Infectious Diseases (NIID); Commonwealth Scientific & Industrial Research Organisation (CSIRO); National University of Singapore; Harvard University; Massachusetts General Hospital; Harvard University	Ryo, A (corresponding author), Yokohama City Univ, Sch Med, Dept Microbiol, Kanazawa Ku, 3-9 Fuku Ura, Yokohama, Kanagawa 2360004, Japan.	aryo@yokohama-cu.ac.jp	Nagashima, Yoji/AAA-2591-2021	Masui, Shinji/0000-0001-7417-0019	Japan Health Sciences Foundation; Uehara Memorial Foundation; Takeda Science Foundation; NATIONAL CANCER INSTITUTE [P01CA080058] Funding Source: NIH RePORTER	Japan Health Sciences Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A Kondo, T Taniguchi, Y Kojima, Y Watanabe, M Tanaka and N Sakurai for technical assistance and discussion. This work was in part supported by Grant-in-Aid for Scientific Research on Innovative Areas and the Japan Health Sciences Foundation, and grants from the Uehara Memorial Foundation and Takeda Science Foundation to AR.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Bhat-Nakshatri P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-411; Carette JE, 2010, BLOOD, V115, P4039, DOI 10.1182/blood-2009-07-231845; Chen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033544; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Clark AT, 2007, STEM CELL REV, V3, P49, DOI 10.1007/s12015-007-0002-x; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Cowell JK, 2005, CANCER GENET CYTOGEN, V163, P23, DOI 10.1016/j.cancergencyto.2005.04.019; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Desbaillets I, 2000, EXP PHYSIOL, V85, P645, DOI 10.1017/S0958067000021047; Dey D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005329; Dick JE, 2009, NAT BIOTECHNOL, V27, P44, DOI 10.1038/nbt0109-44; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Lengerke C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-42; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Liu MR, 2009, P NATL ACAD SCI USA, V106, P19035, DOI 10.1073/pnas.0910009106; Lu PJ, 2002, J BIOL CHEM, V277, P2381, DOI 10.1074/jbc.C100228200; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Miyoshi N, 2010, P NATL ACAD SCI USA, V107, P40, DOI 10.1073/pnas.0912407107; Moretto-Zita M, 2010, P NATL ACAD SCI USA, V107, P13312, DOI 10.1073/pnas.1005847107; Nishi M, 2011, J BIOL CHEM, V286, P11593, DOI 10.1074/jbc.M110.187989; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Ryo A, 2005, CLIN CANCER RES, V11, P7523, DOI 10.1158/1078-0432.CCR-05-0457; Sarig R, 2010, J EXP MED, V207, P2127, DOI 10.1084/jem.20100797; Scaffidi P, 2011, NAT CELL BIOL, V13, P1051, DOI 10.1038/ncb2308; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Singh SK, 2003, CANCER RES, V63, P5821; SOULE HD, 1990, CANCER RES, V50, P6075; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Utikal J, 2009, J CELL SCI, V122, P3502, DOI 10.1242/jcs.054783; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; Werbowetski-Ogilvie TE, 2009, NAT BIOTECHNOL, V27, P91, DOI 10.1038/nbt.1516; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	44	79	81	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 30	2014	33	5					643	652		10.1038/onc.2012.614	http://dx.doi.org/10.1038/onc.2012.614			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AA5GW	23318426	Green Accepted			2022-12-25	WOS:000331125100012
J	Wen, W; Peng, C; Kim, MO; Jeong, CH; Zhu, F; Yao, K; Zykova, T; Ma, W; Carper, A; Langfald, A; Bode, AM; Dong, Z				Wen, W.; Peng, C.; Kim, M. O.; Jeong, C. Ho; Zhu, F.; Yao, K.; Zykova, T.; Ma, W.; Carper, A.; Langfald, A.; Bode, A. M.; Dong, Z.			Knockdown of RNF2 induces apoptosis by regulating MDM2 and p53 stability	ONCOGENE			English	Article						RNF2; PcG; p53; MDM2; ubiquitination	DEVELOPMENTAL REGULATORS; POLYCOMB COMPLEXES; CELL-PROLIFERATION; BREAST-CANCER; EZH2; ENHANCER; BMI-1; METHYLATION; PROTEINS; TARGET	RNF2, also known as Ring1B/Ring2, is a component of the polycomb repression complex 1. RNF2 is highly expressed in many tumors, suggesting that it might have an oncogenic function, but the mechanism is unknown. Here, we show that knockdown of RNF2 significantly inhibits both cell proliferation and colony formation in soft agar, and induces apoptosis in cancer cells. Knockdown of RNF2 in HCT116 p53(+/+) cells resulted in significantly more apoptosis than was observed in RNF2 knockdown HCT116 p53(-/-) cells, indicating that RNF2 knockdown-induced apoptosis is partially dependent on p53. Various p53-targeted genes were increased in RNF2 knockdown cells. Further studies revealed that in RNF2 knockdown cells, the p53 protein level was increased, the half-life of p53 was prolonged and p53 ubiquitination was decreased. In contrast, cells overexpressing RNF2 showed a decreased p53 protein level, a shorter p53 half-life and increased p53 ubiquitination. Importantly, we found that RNF2 directly binds with both p53 and MDM2 and promotes MDM2-mediated p53 ubiquitination. RNF2 overexpression could also increase the half-life of MDM2 and inhibit its ubiquitination. The regulation on p53 and MDM2 stability by RNF2 was also observed during the etoposide-induced DNA damage response. These results provide a possible mechanism explaining the oncogenic function of RNF2, and because RNF2 is important for cancer cell survival and proliferation, it might be an ideal target for cancer therapy or prevention.	[Wen, W.; Peng, C.; Kim, M. O.; Jeong, C. Ho; Zhu, F.; Yao, K.; Zykova, T.; Ma, W.; Carper, A.; Langfald, A.; Bode, A. M.; Dong, Z.] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Wen, W.] Fourth Mil Med Univ, Dept Immunol, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Kim, M. O.] Kyungpook Natl Univ, Ctr Lab Anim Resources, Taegu, South Korea	University of Minnesota System; Air Force Military Medical University; Kyungpook National University	Dong, Z (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu	温, 家琦/GYV-3177-2022; ZHU, Feng/C-1303-2010	Zhu, Feng/0000-0003-1172-0102	Hormel Foundation; National Institutes of Health [CA077646, CA027502, CA111536, CA120388, R37CA081064, ES017548]; National Natural Sciences Foundation of China [81171924]; NATIONAL CANCER INSTITUTE [R37CA081064, R01CA077646, P01CA027502, R01CA111536, R01CA120388, R01CA111356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	Hormel Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Dr Bert Vogelstein (Johns Hopkins Oncology Center) for the HCT116 p53<SUP>+/+</SUP>, HCT116 p53<SUP>-/-</SUP> cells, Dr Seongman Kang (Korea University, South Korea) for the pCDNA3-Xpress-RNF2 plasmid. We also thank Dr Yibin Deng at The Hormel Institute for very helpful discussion and advice. We thank Tonya M Poorman for help submitting our manuscript. This work was supported by The Hormel Foundation and National Institutes of Health Grants CA077646, CA027502, CA111536, CA120388, R37CA081064, ES017548 and the National Natural Sciences Foundation of China (No. 81171924).	Alajez NM, 2009, CELL DEATH DIFFER, V16, P1469, DOI 10.1038/cdd.2009.85; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Fujii S, 2008, J BIOL CHEM, V283, P17324, DOI 10.1074/jbc.M800224200; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Jagani Z, 2010, CANCER RES, V70, P5528, DOI 10.1158/0008-5472.CAN-09-4229; Kalushkova A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011483; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee SJ, 2001, FEBS LETT, V503, P61, DOI 10.1016/S0014-5793(01)02689-8; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Levine SS, 2004, TRENDS BIOCHEM SCI, V29, P478, DOI 10.1016/j.tibs.2004.07.007; Liu L, 2006, ONCOGENE, V25, P4370, DOI 10.1038/sj.onc.1209454; Lund AH, 2004, CURR OPIN CELL BIOL, V16, P239, DOI 10.1016/j.ceb.2004.03.010; Ougolkov AV, 2008, CLIN CANCER RES, V14, P6790, DOI 10.1158/1078-0432.CCR-08-1013; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Sanchez-Beato M, 2006, MODERN PATHOL, V19, P684, DOI 10.1038/modpathol.3800577; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Tao WK, 1999, P NATL ACAD SCI USA, V96, P6937, DOI 10.1073/pnas.96.12.6937; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Yang XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005011	29	43	47	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 23	2014	33	4					421	428		10.1038/onc.2012.605	http://dx.doi.org/10.1038/onc.2012.605			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	296VX	23318437	Green Accepted			2022-12-25	WOS:000330214600003
J	Jin, L; Craven, RJ				Jin, L.; Craven, R. J.			The Rak/Frk tyrosine kinase associates with and internalizes the epidermal growth factor receptor	ONCOGENE			English	Article						signaling; tyrosine kinase; Rak; Frk; EGFR; SH2; SH3	CELL LUNG-CANCER; CLINICAL-RESPONSE; BREAST-CANCER; PROTEIN; EGFR; MUTATIONS; FAMILY; RAK; ENDOCYTOSIS; ACTIVATION	Src is the founding member of a diverse family of intracellular tyrosine kinases, and Src has a key role in promoting cancer growth, in part, through its association with receptor tyrosine kinases. However, some Src-related proteins have widely divergent physiological roles, and these proteins include the Rak/Frk tyrosine kinase (Frk stands for Fyn-related kinase), which inhibits cancer cell growth and suppresses tumorigenesis. Rak/Frk phosphorylates and stabilizes the Pten tumor suppressor, protecting it from degradation, and Rak/Frk associates with the retinoblastoma (Rb) tumor suppressor. However, the role of Rak/Frk in receptor-mediated signaling is largely unknown. Here, we demonstrate that Rak/Frk associates with epidermal growth factor receptor (EGFR), increasing in activity and EGFR binding after EGF stimulation, when it decreases the pool of EGFR present at the plasma membrane. EGFR-Rak binding is direct, requires the SH2 and SH3 domains of Rak/Frk for efficient complex formation and is not dependent on the Grb2 adaptor protein. EGFR mutations are associated with increased EGFR activity and tumorigenicity, and we found that Rak/Frk associates preferentially with an EGFR exon 19 mutant, EGFR Delta 747-749/A750P, compared with wild-type EGFR. Furthermore, Rak/Frk inhibited mutant EGFR phosphorylation at an activating site and dramatically decreased the levels of EGFR Delta 747-749/A750P from the plasma membrane. Taken together, the results suggest that Rak/Frk inhibits EGFR signaling in cancer cells and has elevated activity against EGFR exon 19 mutants.	[Jin, L.; Craven, R. J.] Univ Kentucky, Lucille P Markey Canc Ctr, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA	University of Kentucky	Craven, RJ (corresponding author), Univ Kentucky, Med Ctr, Dept Mol & Biomed Pharmacol, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA.	rolf.craven@uky.edu			Kentucky Lung Cancer Research Program, cycle 9	Kentucky Lung Cancer Research Program, cycle 9	This work was supported by the Kentucky Lung Cancer Research Program, cycle 9. We thank Drs Gengxian Shi and Doug Andres for advice and reagents, Mary Gail Engle of the University of Kentucky Imaging Core Facility for expertise in microscopy and Woodrow Friend for reading of the manuscript.	Arteaga CL, 2003, EXP CELL RES, V284, P122, DOI 10.1016/S0014-4827(02)00104-0; Berclaz G, 2000, INT J CANCER, V85, P889; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Brauer PM, 2010, BBA-REV CANCER, V1806, P66, DOI 10.1016/j.bbcan.2010.02.003; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; CANCE WG, 1994, CELL GROWTH DIFFER, V5, P1347; CANCE WG, 1993, INT J CANCER, V54, P571, DOI 10.1002/ijc.2910540409; Chandrasekharan S, 2002, MOL CELL BIOL, V22, P5235, DOI 10.1128/MCB.22.14.5235-5247.2002; CRAVEN RJ, 1995, CANCER RES, V55, P3969; Crudden G, 2005, TUMOR BIOL, V26, P142, DOI 10.1159/000086485; Emlet DR, 1997, J BIOL CHEM, V272, P4079, DOI 10.1074/jbc.272.7.4079; Furukawa M, 2007, DNA CELL BIOL, V26, P178, DOI 10.1089/dna.2006.0573; Ganti AK, 2010, CANCER INVEST, V28, P515, DOI 10.3109/07357900903476760; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Georgescu Maria-Magdalena, 2010, Genes Cancer, V1, P1170, DOI 10.1177/1947601911407325; Giubellino A, 2008, EXPERT OPIN THER TAR, V12, P1021, DOI 10.1517/14728222.12.8.1021 ; Goeze A, 2002, J PATHOL, V196, P8, DOI 10.1002/path.1009; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Haegebarth A, 2006, MOL CELL BIOL, V26, P4949, DOI 10.1128/MCB.01901-05; Hsu JM, 2011, NAT CELL BIOL, V13, P174, DOI 10.1038/ncb2158; Jin GA, 2011, LUNG CANCER, V71, P115, DOI 10.1016/j.lungcan.2010.10.002; Katso RM, 2006, MOL BIOL CELL, V17, P3729, DOI 10.1091/mbc.E05-11-1083; Keilhack H, 1998, J BIOL CHEM, V273, P24839, DOI 10.1074/jbc.273.38.24839; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; LEE J, 1994, GENE, V138, P247, DOI 10.1016/0378-1119(94)90817-6; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li X, 2012, ONCOGENE, V31, P4372, DOI 10.1038/onc.2011.608; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Meyer T, 2003, INT J CANCER, V104, P139, DOI 10.1002/ijc.10925; Oberg-Welsh C, 1998, GROWTH FACTORS, V16, P111; OKUTANI T, 1994, J BIOL CHEM, V269, P31310; Padron D, 2007, CANCER RES, V67, P7695, DOI 10.1158/0008-5472.CAN-07-0484; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Palka-Hamblin HL, 2010, J CELL SCI, V123, P236, DOI 10.1242/jcs.053264; Rivera F, 2008, ANTI-CANCER DRUG, V19, P99, DOI 10.1097/CAD.0b013e3282f23287; Sequist LV, 2008, ANNU REV MED, V59, P429, DOI 10.1146/annurev.med.59.090506.202405; Serfas MS, 2003, ONCOL RES, V13, P409; SMITHGALL TE, 1995, J PHARMACOL TOX MET, V34, P125, DOI 10.1016/1056-8719(95)00082-7; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Tanos B, 2006, J BIOL CHEM, V281, P32714, DOI 10.1074/jbc.M603126200; THUVESON M, 1995, BIOCHEM BIOPH RES CO, V209, P582, DOI 10.1006/bbrc.1995.1540; Yim EK, 2009, CANCER CELL, V15, P304, DOI 10.1016/j.ccr.2009.02.012; Zheng Y, 2012, J BIOL CHEM, V287, P148, DOI 10.1074/jbc.M111.298117; Zheng Y, 2010, MOL CELL BIOL, V30, P4280, DOI 10.1128/MCB.00024-10	45	8	8	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 16	2014	33	3					326	335		10.1038/onc.2012.589	http://dx.doi.org/10.1038/onc.2012.589			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	296VR	23318459	Green Submitted			2022-12-25	WOS:000330214000007
J	Debbabi, M; Kroviarski, Y; Bournier, O; Gougerot-Pocidalo, MA; El-Benna, J; Dang, PMC				Debbabi, Maya; Kroviarski, Yolande; Bournier, Odile; Gougerot-Pocidalo, Marie-Anne; El-Benna, Jamel; Dang, Pham My-Chan			NOXO1 phosphorylation on serine 154 is critical for optimal NADPH oxidase 1 assembly and activation	FASEB JOURNAL			English	Article						reactive oxygen species; NOX1; p22(PHOX); NOXA1; inflammation	PROTEIN-KINASE-C; RESPIRATORY BURST OXIDASE; COLON EPITHELIAL-CELLS; GASTROINTESTINAL-TRACT; NEUTROPHIL ACTIVATION; SUPEROXIDE-PRODUCTION; P47(PHOX); P67(PHOX); P22(PHOX); BINDING	Reactive oxygen species (ROS) production by NADPH oxidase 1 (NOX1), which is mainly expressed in colon epithelial cells, requires the membrane-bound component p22(PHOX) and the cytosolic partners NOX organizer 1 (NOXO1), NOX activator 1 (NOXA1), and Rac1. Contrary to that of its phagocyte counterpart NOX2, the molecular basis of NOX1 regulation is not clear. Because NOXO1 lacks the phosphorylated region found in its homolog p47(PHOX), the current view is that NOX1 activation occurs without NOXO1 phosphorylation. Here, however, we demonstrate that phorbol myristate acetate (PMA) stimulates NOXO1 phosphorylation in a transfected human embryonic kidney (HEK) 293 epithelial cell model via protein kinase C and identify Ser-154 as the major phosphorylated site. Endogenous NOXO1 from T84 colon epithelial cells was also phosphorylated, suggesting that NOXO1 phosphorylation is physiologically relevant. In transfected HEK-293 cells, PMA-induced phosphorylation on Ser-154 enhanced NOXO1 binding to NOXA1 (+97%) and to the p22(PHOX) C-terminal region (+384%), increased NOXO1 colocalization with p22(PHOX), and allowed optimal ROS production by NOX1 as demonstrated by the use of S154A and S154D mutants compared with that by wild-type NOXO1 (P<0.05). Pulldown experiments revealed that phosphorylation on Ser-154 was sufficient to markedly enhance NOXO1 binding to NOXA1, which in turn acts as a molecular switch, allowing optimal interaction of NOXO1 with p22(PHOX). This study unexpectedly revealed that full assembly and activation of NOX1 is a tightly regulated process in which NOXO1 phosphorylation on Ser-154 is the initial trigger.-Debbabi, M., Kroviarski, Y., Bournier, O., Gougerot-Pocidalo, M.-A., El-Benna, J., Dang, P. M.-C. NOXO1 phosphorylation on serine 154 is critical for optimal NADPH oxidase 1 assembly and activation. FASEB J. 27, 1733-1748 (2013). www.fasebj.org	[Debbabi, Maya; Kroviarski, Yolande; Bournier, Odile; Gougerot-Pocidalo, Marie-Anne; El-Benna, Jamel; Dang, Pham My-Chan] INSERM, Ctr Rech Biomed Bichat Beaujon CRB3, U773, F-75018 Paris, France; [Debbabi, Maya; Kroviarski, Yolande; Bournier, Odile; Gougerot-Pocidalo, Marie-Anne; El-Benna, Jamel; Dang, Pham My-Chan] Univ Paris 07, UMR 773, Paris, France; [Debbabi, Maya] Univ Paris 11, Orsay, France; [Kroviarski, Yolande; Bournier, Odile; Gougerot-Pocidalo, Marie-Anne] Ctr Hosp Univ Xavier Bichat, AP HP, CIB Phenogen, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Dang, PMC (corresponding author), INSERM, Fac Med Xavier Bichat, U773, 16 Rue Henri Huchard, F-75018 Paris, France.	my-chan.dang@inserm.fr			Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; French Research Ministry	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); French Research Ministry(Ministry of Research, France)	The authors thank Dr. Samira Benadda (Institut Claude Bernard-IFR2 Site Bichat, Paris, France) for confocal microscopy analysis and Dr. Francoise Braut for measurement of ROS by DCF-mediated fluorescence. This work was supported by Institut National de la Sante et de la Recherche Medicale and Centre National de la Recherche Scientifique. M. D. is the recipient of fellowships from the French Research Ministry.	Ago T, 1999, J BIOL CHEM, V274, P33644, DOI 10.1074/jbc.274.47.33644; Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; BABIOR BM, 1973, J CLIN INVEST, V52, P741, DOI 10.1172/JCI107236; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Cheng GJ, 2005, GENE, V356, P118, DOI 10.1016/j.gene.2005.03.008; Cheng GJ, 2004, J BIOL CHEM, V279, P4737, DOI 10.1074/jbc.M305968200; Dahan I, 2002, J BIOL CHEM, V277, P8421, DOI 10.1074/jbc.M109778200; Dang PMC, 2001, P NATL ACAD SCI USA, V98, P3001, DOI 10.1073/pnas.061029698; Dutta S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010478; ELBENNA J, 1994, J BIOL CHEM, V269, P23431; ElBenna J, 1997, J BIOL CHEM, V272, P17204, DOI 10.1074/jbc.272.27.17204; Fontayne A, 2002, BIOCHEMISTRY-US, V41, P7743, DOI 10.1021/bi011953s; Geiszt M, 2003, J BIOL CHEM, V278, P20006, DOI 10.1074/jbc.M301289200; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Kroviarski Y, 2010, FASEB J, V24, P2077, DOI 10.1096/fj.09-147629; Kuwano Y, 2008, FREE RADICAL BIO MED, V45, P1642, DOI 10.1016/j.freeradbiomed.2008.08.033; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lewis EM, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.030643; Nakano Y, 2007, BIOCHEM J, V403, P97, DOI 10.1042/BJ20060819; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Quinn MT, 2006, CLIN SCI, V111, P1, DOI 10.1042/cs20060059; Raad H, 2009, FASEB J, V23, P1011, DOI 10.1096/fj.08-114553; Regier DS, 2000, J BIOL CHEM, V275, P28406, DOI 10.1074/jbc.M004703200; Rokutan K, 2008, SEMIN IMMUNOPATHOL, V30, P315, DOI 10.1007/s00281-008-0124-5; Rokutan K, 2006, ANTIOXID REDOX SIGN, V8, P1573, DOI 10.1089/ars.2006.8.1573; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; Takeya R, 2003, J BIOL CHEM, V278, P25234, DOI 10.1074/jbc.M212856200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Ueyama T, 2006, MOL CELL BIOL, V26, P2160, DOI 10.1128/MCB.26.6.2160-2174.2006; Yamamoto A, 2007, BIOCHEM BIOPH RES CO, V352, P560, DOI 10.1016/j.bbrc.2006.11.060	31	32	32	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2013	27	4					1733	1748		10.1096/fj.12-216432	http://dx.doi.org/10.1096/fj.12-216432			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23322165				2022-12-25	WOS:000316940800042
J	Zindel, R; Ofek, M; Minz, D; Palevsky, E; Zchori-Fein, E; Aebi, A				Zindel, Renate; Ofek, Maya; Minz, Dror; Palevsky, Eric; Zchori-Fein, Einat; Aebi, Alexandre			The role of the bacterial community in the nutritional ecology of the bulb mite Rhizoglyphus robini (Acari: Astigmata: Acaridae)	FASEB JOURNAL			English	Article						symbiont; chitin digestion; DGGE; 16S rRNA pyrosequencing	CLAPAREDE ACARI; GUT BACTERIA; DIVERSITY; CHITINASE; INSECTS; PLANTS; RHIZOSPHERE; MANAGEMENT; SYMBIONTS; LYSOZYME	The biology of many arthropods can only be understood when their associated microbiome is considered. The nutritional requirements of the bulb mite Rhizoglyphus robini Claparede (Acari: Astigmata: Acaridae) in the laboratory have been shown to be very easily satisfied, and in the field the mites prefer fungus-infected over uninfected plants. To test whether symbiotic bacteria facilitate the survival of R. robini on a temporarily nutritionally unbalanced diet, we investigated the composition of its microbiome. Using 454 pyrosequencing of 16S rRNA gene fragments, 3 genera were found to dominate the bacterial community: Myroides (41.4%), Serratia (11.4%), and Alcaligenes (4.5%); the latter 2 are known to include chitinase-producing species. Laboratory experiments demonstrated that mite fecundity is significantly higher (2 times) on fungus than on controls (sterilized potato dextrose agar and filter paper). Also, when mite homogenate was applied to a chitin layer, the halo produced through degradation was clearly visible, while the saline control did not produce a halo. We thus concluded that R. robini utilizes fungal chitin, at least to a certain extent, as a food source with the help of its associated bacteria. This information supports the general concept of multigenome organisms and the involvement of bacteria in the mite's nutritional ecology.-Zindel, R., Ofek, M., Minz, D., Palevsky, E., Zchori-Fein, E., Aebi, A. The role of the bacterial community in the nutritional ecology of the bulb mite Rhizoglyphus robini (Acari: Astigmata: Acaridae). FASEB J. 27, 1488-1497 (2013). www.fasebj.org	[Zindel, Renate; Aebi, Alexandre] Agroscope Reckenholz Tanikon, Res Stn ART, CH-8046 Zurich, Switzerland; [Ofek, Maya; Minz, Dror] Agr Res Org, Inst Soil Water & Environm Sci, IL-50250 Bet Dagan, Israel; [Palevsky, Eric; Zchori-Fein, Einat] Agr Res Org, Newe Yaar Res Ctr, Dept Entomol, Ramat Yishay, Israel	Swiss Federal Research Station Agroscope; Swiss Federal Research Station for Agroecology & Agriculture; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Zindel, R (corresponding author), Agroscope Reckenholz Tanikon, Res Stn ART, Reckenholzstr 191, CH-8046 Zurich, Switzerland.	zirena@bluewin.ch		Palevsky, Eric/0000-0002-4958-8920; Minz, Dror/0000-0001-6746-9151	European Cooperation in Science and Technology-Secretariat for Education and Research (COST-SER) [C08AE0109]; COST Action [FA0701]	European Cooperation in Science and Technology-Secretariat for Education and Research (COST-SER); COST Action(European Cooperation in Science and Technology (COST))	This article was supported by European Cooperation in Science and Technology-Secretariat for Education and Research (COST-SER) project C08AE0109 to A. A., part of COST Action FA0701. The authors thank Shira Gal and Netta Moses-Daube for help and support in the laboratory in Israel, and Steven Bacon, Mario Waldburger, Irene Banziger, and Franco Widmer in the laboratory in Switzerland. The authors also thank Max Kolton and Pilar Junier for their assistance and advice on experiments involving chitin and two anonymous reviewers for comments and suggestions to improve the manuscript.	Andreotti R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-6; Annamalai N, 2011, ANN MICROBIOL, V61, P801, DOI 10.1007/s13213-011-0198-5; Arakane Y, 2010, CELL MOL LIFE SCI, V67, P201, DOI 10.1007/s00018-009-0161-9; BANDI C, 1994, P ROY SOC B-BIOL SCI, V257, P43, DOI 10.1098/rspb.1994.0092; Berg G, 2005, FEMS MICROBIOL ECOL, V51, P215, DOI 10.1016/j.femsec.2004.08.006; Bextine B, 2004, CURR MICROBIOL, V48, P327, DOI 10.1007/s00284-003-4178-2; BOWMAN CE, 1982, COMP BIOCHEM PHYS B, V72, P551, DOI 10.1016/0305-0491(82)90505-3; BRURBERG MB, 2001, RRD MICROBIOL 1, V5, P187; CHAO A, 1984, SCAND J STAT, V11, P265; CHILDS M, 1981, COMP BIOCHEM PHYS B, V70, P615, DOI 10.1016/0305-0491(81)90305-9; CHRISTIAS C, 1975, APPL MICROBIOL, V29, P250, DOI 10.1111/1741-5705.00031; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Dharne MS, 2008, BRAZ J MICROBIOL, V39, P397, DOI 10.1590/S1517-838220080002000035; Diaz A, 2000, EXP APPL ACAROL, V24, P85, DOI 10.1023/A:1006304300657; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Erban T, 2008, EXP APPL ACAROL, V44, P199, DOI 10.1007/s10493-008-9138-x; Faramarzi M. A., 2009, Biotechnology, V8, P93; Feldhaar H, 2009, INT J MED MICROBIOL, V299, P1, DOI 10.1016/j.ijmm.2008.05.010; Frohlich DR, 1999, MOL ECOL, V8, P1683, DOI 10.1046/j.1365-294x.1999.00754.x; GERSON U, 1991, EXP APPL ACAROL, V12, P103, DOI 10.1007/BF01204403; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Gottlieb Y, 2006, APPL ENVIRON MICROB, V72, P3646, DOI 10.1128/AEM.72.5.3646-3652.2006; Grunwald S, 2010, SYST APPL MICROBIOL, V33, P25, DOI 10.1016/j.syapm.2009.10.002; Gunduz EA, 2009, P ROY SOC B-BIOL SCI, V276, P987, DOI 10.1098/rspb.2008.1476; Hanuny T., 2008, Bulletin OILB/SROP, V32, P71; Harichova J, 2006, BIOLOGIA, V61, P663, DOI 10.2478/s11756-006-0138-1; Hariprasad P, 2011, CROP PROT, V30, P1606, DOI 10.1016/j.cropro.2011.02.032; Hudson HJ, 1986, FUNGAL BIOL; Jaffe K, 2001, CAN J ZOOL, V79, P1120, DOI 10.1139/cjz-79-6-1120; Jin FL, 2011, INT J MOL SCI, V12, P3055, DOI 10.3390/ijms12053055; Jones RT, 2010, ISME J, V4, P223, DOI 10.1038/ismej.2009.111; Kleespies RG, 2008, BIOCONTROL SCI TECHN, V18, P439, DOI 10.1080/09583150802011618; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MANSON D C M, 1972, Acarologia (Paris), V13, P621; McBride MJ, 2009, APPL ENVIRON MICROB, V75, P6864, DOI 10.1128/AEM.01495-09; McBride MJ, 2004, J BACTERIOL, V186, P2295, DOI 10.1128/JB.186.8.2295-2302.2004; McCall C, 2001, VET IMMUNOL IMMUNOP, V78, P231, DOI 10.1016/S0165-2427(00)00258-0; MONREAL J, 1969, CAN J MICROBIOL, V15, P689, DOI 10.1139/m69-122; Mrazek J, 2008, FOLIA MICROBIOL, V53, P229, DOI 10.1007/s12223-008-0032-z; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; O'Neil SE, 2006, CLIN EXP ALLERGY, V36, P831, DOI 10.1111/j.1365-2222.2006.02497.x; OKABE K, 1990, APPL ENTOMOL ZOOL, V25, P397, DOI 10.1303/aez.25.397; OKABE K, 1991, APPL ENTOMOL ZOOL, V26, P129, DOI 10.1303/aez.26.129; Okabe K, 2001, EXP APPL ACAROL, V25, P493, DOI 10.1023/A:1011843407167; Oliver KM, 2006, P ROY SOC B-BIOL SCI, V273, P1273, DOI 10.1098/rspb.2005.3436; ORDENTLICH A, 1988, PHYTOPATHOLOGY, V78, P84; Reichenbach H, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P939, DOI 10.1007/0-387-30746-x_37; Sabree ZL, 2009, P NATL ACAD SCI USA, V106, P19521, DOI 10.1073/pnas.0907504106; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seo WT, 2010, J KOREAN SOC APPL BI, V53, P493, DOI 10.3839/jksabc.2010.075; SIEPEL H, 1993, SOIL BIOL BIOCHEM, V25, P1491, DOI 10.1016/0038-0717(93)90004-U; Smrz J, 2010, SYMBIOSIS, V52, P33, DOI 10.1007/s13199-010-0099-6; Snyder AK, 2010, P ROY SOC B-BIOL SCI, V277, P2389, DOI 10.1098/rspb.2010.0364; Someya N, 2011, MICROBES ENVIRON, V26, P7, DOI 10.1264/jsme2.ME10149; Soukalova H, 2008, INTEGRATIVE ACAROLOG, P374; Spiteller D, 2000, BIOL CHEM, V381, P755, DOI 10.1515/BC.2000.096; Srivastava Shilpi, 2011, Toxicol Int, V18, P111, DOI 10.4103/0971-6580.84262; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teixeira LCRS, 2010, ISME J, V4, P989, DOI 10.1038/ismej.2010.35; Tripathi AK, 2002, RES MICROBIOL, V153, P579, DOI 10.1016/S0923-2508(02)01371-2; Vaidya R, 2003, BIOTECHNOL LETT, V25, P715, DOI 10.1023/A:1023406630791; Wang H, 2011, J APPL MICROBIOL, V110, P1390, DOI 10.1111/j.1365-2672.2011.05001.x; Wong CNA, 2011, ENVIRON MICROBIOL, V13, P1889, DOI 10.1111/j.1462-2920.2011.02511.x; Wooddy Mark W., 1993, International Journal of Acarology, V19, P345; Zaspel JM, 2008, ANN ENTOMOL SOC AM, V101, P1050, DOI 10.1603/0013-8746-101.6.1050; Zilber-Rosenberg I, 2008, FEMS MICROBIOL REV, V32, P723, DOI 10.1111/j.1574-6976.2008.00123.x; Zindel R, 2011, J APPL ECOL, V48, P864, DOI 10.1111/j.1365-2664.2011.01984.x	68	26	28	0	52	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2013	27	4					1488	1497		10.1096/fj.12-216242	http://dx.doi.org/10.1096/fj.12-216242			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23307835	Green Submitted			2022-12-25	WOS:000316940800021
J	Rilla, K; Oikari, S; Jokela, TA; Hyttinen, JMT; Karna, R; Tammi, RH; Tammi, MI				Rilla, Kirsi; Oikari, Sanna; Jokela, Tiina A.; Hyttinen, Juha M. T.; Karna, Riikka; Tammi, Raija H.; Tammi, Markku I.			Hyaluronan Synthase 1 (HAS1) Requires Higher Cellular UDP-GlcNAc Concentration than HAS2 and HAS3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; MESANGIAL CELLS; DOWN-REGULATION; N-ACETYLHEXOSAMINES; CHONDROITIN SULFATE; MONOCYTE ADHESION; MAMMALIAN-CELLS; O-GLCNACYLATION; GROWTH-FACTOR; IN-VIVO	Mammals have three homologous genes encoding proteins with hyaluronan synthase activity (Has1-3), all producing an identical polymer from UDP-N-acetylglucosamine and UDP-glucuronic acid. To compare the properties of these isoenzymes, COS-1 cells, with minor endogenous hyaluronan synthesis, were transfected with human Has1-3 isoenzymes. HAS1 was almost unable to secrete hyaluronan or form a hyaluronan coat, in contrast to HAS2 and HAS3. This failure of HAS1 to synthesize hyaluronan was compensated by increasing the cellular content of UDP-N-acetyl glucosamine by similar to 10-fold with 1 mM glucosamine in the growth medium. Hyaluronan synthesis driven by HAS2 was less affected by glucosamine addition, and HAS3 was not affected at all. Glucose-free medium, leading to depletion of the UDP-sugars, markedly reduced hyaluronan synthesis by all HAS isoenzymes while raising its concentration from 5 to 25 mM had a moderate stimulatory effect. The results indicate that HAS1 is almost inactive in cells with low UDPsugar supply, HAS2 activity increases with UDP-sugars, and HAS3 produces hyaluronan at high speed even with minimum substrate content. Transfected Has2 and particularly Has3 consumed enough UDP-sugars to reduce their content in COS-1 cells. Comparison of different human cell types revealed similar to 50-fold differences in the content of UDP-N-acetylhexosamines and UDP-glucuronic acid, correlating with the expression level of Has1, suggesting cellular coordination between Has1 expression and the content of UDP-sugars.	[Rilla, Kirsi] Univ Eastern Finland, Inst Biomed, FIN-70211 Kuopio, Finland; Univ Eastern Finland, Inst Dent, FIN-70211 Kuopio, Finland; Univ Eastern Finland, Bioctr Kuopio, FIN-70211 Kuopio, Finland; Univ Eastern Finland, Ctr Canc, FIN-70211 Kuopio, Finland	University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland	Rilla, K (corresponding author), Univ Eastern Finland, Inst Biomed, POB 1627, FIN-70211 Kuopio, Finland.	kirsi.rilla@uef.fi	Jokela, Tiina/O-9206-2015; Tammi, Markku/AAQ-7878-2021	Jokela, Tiina/0000-0002-7521-3866; Rilla, Kirsi/0000-0002-7862-5727; Hyttinen, Juha/0000-0002-3414-4032	Academy of Finland; Sigrid Juselius Foundation; EVO (Erityisvaltionosuus) Funds of Kuopio University Hospital; North-Savo Cancer Foundation; Cancer Center of Eastern Finland	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); EVO (Erityisvaltionosuus) Funds of Kuopio University Hospital; North-Savo Cancer Foundation; Cancer Center of Eastern Finland	This work was supported by funds from the Academy of Finland (to M.I.T.), Sigrid Juselius Foundation (to R.H.T. and M.I.T.), EVO (Erityisvaltionosuus) Funds of Kuopio University Hospital (to M.I.T.), the North-Savo Cancer Foundation (to K.R.), and the Cancer Center of Eastern Finland.	BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brinck J, 1999, EXP CELL RES, V252, P342, DOI 10.1006/excr.1999.4645; CLARRIS BJ, 1968, EXP CELL RES, V49, P181, DOI 10.1016/0014-4827(68)90530-2; Dunlop ME, 1996, KIDNEY INT, V50, P40, DOI 10.1038/ki.1996.284; Erikstrup C, 2001, EUR J ENDOCRINOL, V145, P193, DOI 10.1530/eje.0.1450193; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hiltunen ELJ, 2002, CANCER RES, V62, P6410; Hubbard C, 2012, J MOL BIOL, V418, P21, DOI 10.1016/j.jmb.2012.01.053; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Itano N, 1999, CANCER RES, V59, P2499; Jacobson A, 2000, BIOCHEM J, V348, P29, DOI 10.1042/0264-6021:3480029; Jokela TA, 2008, CONNECT TISSUE RES, V49, P115, DOI 10.1080/03008200802148439; Jokela TA, 2008, J BIOL CHEM, V283, P7666, DOI 10.1074/jbc.M706001200; Jokela TA, 2011, J BIOL CHEM, V286, P33632, DOI 10.1074/jbc.M111.265637; Jones S, 2001, KIDNEY INT, V59, P1739, DOI 10.1046/j.1523-1755.2001.0590051739.x; Kakizaki I, 2004, J BIOL CHEM, V279, P33281, DOI 10.1074/jbc.M405918200; Knudson Cheryl B., 2003, Birth Defects Research, V69, P174, DOI 10.1002/bdrc.10013; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kultti A, 2010, J BIOL CHEM, V285, P22899, DOI 10.1074/jbc.M109.088435; Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002; LAURENT TC, 1986, CIBA F SYMP, V124, P9; MAHADEVAN P, 1995, DIABETOLOGIA, V38, P298, DOI 10.1007/s001250050285; Meyer K, 1934, J BIOL CHEM, V107, P629; Mine S, 2006, ENDOCR J, V53, P761, DOI 10.1507/endocrj.K05-119; PREHM P, 1983, BIOCHEM J, V211, P181, DOI 10.1042/bj2110181; Rabina J, 2001, GLYCOCONJUGATE J, V18, P799, DOI 10.1023/A:1021107602535; REED RK, 1988, ACTA PHYSIOL SCAND, V134, P405, DOI 10.1111/j.1748-1716.1988.tb08508.x; Ren J, 2009, J BIOL CHEM, V284, P16621, DOI 10.1074/jbc.M806430200; Rilla K, 2005, J BIOL CHEM, V280, P31890, DOI 10.1074/jbc.M504736200; Rilla K, 2008, J HISTOCHEM CYTOCHEM, V56, P901, DOI 10.1369/jhc.2008.951665; Sainio A, 2010, GLYCOBIOLOGY, V20, P1117, DOI 10.1093/glycob/cwq076; Schwientek T, 1996, J BIOL CHEM, V271, P3398; Shen DL, 2012, J BIOL CHEM, V287, P15395, DOI 10.1074/jbc.M111.310664; Spicer AP, 1999, BIOCHEM SOC T, V27, P109, DOI 10.1042/bst0270109; Spicer AP, 1998, J BIOL CHEM, V273, P1923, DOI 10.1074/jbc.273.4.1923; Stuhlmeier KM, 2007, BBA-GEN SUBJECTS, V1770, P121, DOI 10.1016/j.bbagen.2006.07.001; Takeda M, 2001, METABOLISM, V50, P789, DOI 10.1053/meta.2001.24207; Tammi RH, 2008, SEMIN CANCER BIOL, V18, P288, DOI 10.1016/j.semcancer.2008.03.005; Thompson CB, 2010, MOL CANCER THER, V9, P3052, DOI 10.1158/1535-7163.MCT-10-0470; Tien JYL, 2005, DEV DYNAM, V233, P130, DOI 10.1002/dvdy.20328; Tomiya N, 2001, ANAL BIOCHEM, V293, P129, DOI 10.1006/abio.2001.5091; Uchiyama T, 2005, BIOCHEM BIOPH RES CO, V327, P927, DOI 10.1016/j.bbrc.2004.12.092; Vigetti D, 2012, J BIOL CHEM, V287, P35544, DOI 10.1074/jbc.M112.402347; Vigetti D, 2009, J BIOL CHEM, V284, P30684, DOI 10.1074/jbc.M109.040386; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; WALDMAN BC, 1990, BIOCHEMISTRY-US, V29, P44, DOI 10.1021/bi00453a006; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; Wilkinson TS, 2006, J CELL PHYSIOL, V206, P378, DOI 10.1002/jcp.20468; Yoshida M, 2000, J BIOL CHEM, V275, P497, DOI 10.1074/jbc.275.1.497; ZHU XY, 1990, J BIOL CHEM, V265, P14250	52	77	78	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5973	5983		10.1074/jbc.M112.443879	http://dx.doi.org/10.1074/jbc.M112.443879			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23303191	hybrid, Green Published			2022-12-25	WOS:000315342500065
J	Irandoust, M; Zarate, JA; Hubeek, I; van Beek, EM; Schornagel, K; Broekhuizen, AJF; Akyuz, M; van de Loosdrecht, AA; Delwel, R; Valk, PJ; Sonneveld, E; Kearns, P; Creutzig, U; Reinhardt, D; de Bont, ESJM; Coenen, EA; van den Heuvel-Eibrink, MM; Zwaan, CM; Kaspers, GJL; Cloos, J; van den Berg, TK				Irandoust, Mahban; Zarate, Julian Alvarez; Hubeek, Isabelle; van Beek, Ellen M.; Schornagel, Karin; Broekhuizen, Aart J. F.; Akyuz, Mercan; van de Loosdrecht, Arjan A.; Delwel, Ruud; Valk, Peter J.; Sonneveld, Edwin; Kearns, Pamela; Creutzig, Ursula; Reinhardt, Dirk; de Bont, Eveline S. J. M.; Coenen, Eva A.; van den Heuvel-Eibrink, Marry M.; Zwaan, C. Michel; Kaspers, Gertjan J. L.; Cloos, Jacqueline; van den Berg, Timo K.			Engagement of SIRP alpha Inhibits Growth and Induces Programmed Cell Death in Acute Myeloid Leukemia Cells	PLOS ONE			English	Article							SIGNAL-REGULATORY-PROTEIN; INTEGRIN-ASSOCIATED PROTEIN; GENE-EXPRESSION; VALPROIC ACID; IN-VITRO; DRUG RESISTANCE; STEM-CELLS; CD47; RECEPTOR; ANTIBODY	Background: Recent studies show the importance of interactions between CD47 expressed on acute myeloid leukemia (AML) cells and the inhibitory immunoreceptor, signal regulatory protein-alpha (SIRP alpha) on macrophages. Although AML cells express SIRP alpha, its function has not been investigated in these cells. In this study we aimed to determine the role of the SIRP alpha in acute myeloid leukemia. Design and Methods: We analyzed the expression of SIRP alpha, both on mRNA and protein level in AML patients and we further investigated whether the expression of SIRP alpha on two low SIRP alpha expressing AML cell lines could be upregulated upon differentiation of the cells. We determined the effect of chimeric SIRP alpha expression on tumor cell growth and programmed cell death by its triggering with an agonistic antibody in these cells. Moreover, we examined the efficacy of agonistic antibody in combination with established antileukemic drugs. Results: By microarray analysis of an extensive cohort of primary AML samples, we demonstrated that SIRP alpha is differentially expressed in AML subgroups and its expression level is dependent on differentiation stage, with high levels in FAB M4/M5 AML and low levels in FAB M0-M3. Interestingly, AML patients with high SIRP alpha expression had a poor prognosis. Our results also showed that SIRP alpha is upregulated upon differentiation of NB4 and Kasumi cells. In addition, triggering of SIRP alpha with an agonistic antibody in the cells stably expressing chimeric SIRP alpha, led to inhibition of growth and induction of programmed cell death. Finally, the SIRP alpha-derived signaling synergized with the activity of established antileukemic drugs. Conclusions: Our data indicate that triggering of SIRP alpha has antileukemic effect and may function as a potential therapeutic target in AML.	[Irandoust, Mahban; Hubeek, Isabelle; Broekhuizen, Aart J. F.; Akyuz, Mercan; Kaspers, Gertjan J. L.; Cloos, Jacqueline] Vrije Univ Amsterdam, Dept Pediat Hematol Oncol, Med Ctr, Amsterdam, Netherlands; [Irandoust, Mahban; Hubeek, Isabelle; van de Loosdrecht, Arjan A.; Cloos, Jacqueline] Vrije Univ Amsterdam, Dept Hematol, Med Ctr, Amsterdam, Netherlands; [Zarate, Julian Alvarez; van Beek, Ellen M.; Schornagel, Karin; van den Berg, Timo K.] Univ Amsterdam, Acad Med Ctr, Sanquin Res & Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Delwel, Ruud; Valk, Peter J.] Erasmus Univ, Dept Hematol, Med Ctr, Rotterdam, Netherlands; [Sonneveld, Edwin] DCOG, The Hague, Netherlands; [Kearns, Pamela] Univ Birmingham, Sch Canc Sci, Birmingham, W Midlands, England; [Creutzig, Ursula; Reinhardt, Dirk] Hannover Med Sch, Dept Pediat Hematol Oncol, Hannover, Germany; [de Bont, Eveline S. J. M.] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Coenen, Eva A.; van den Heuvel-Eibrink, Marry M.; Zwaan, C. Michel] Erasmus MC Sophia Childrens Hosp, Dept Pediat Hematol Oncol, Rotterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Dutch Childhood Oncology Group; University of Birmingham; Hannover Medical School; University of Groningen; Erasmus University Rotterdam; Erasmus MC	van den Berg, TK (corresponding author), Univ Amsterdam, Acad Med Ctr, Sanquin Res & Landsteiner Lab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	t.k.vandenberg@sanquin.nl	Valk, Peter/AAX-2823-2020; Reinhardt, Dirk/N-7003-2016; Kearns, Pamela/AAD-6011-2021; Reinhardt, Dirk/D-3939-2011; van den Berg, Timo K/AAC-2479-2022; Kaspers, Gertjan/ABC-5334-2020	Reinhardt, Dirk/0000-0002-7027-4483; Reinhardt, Dirk/0000-0003-4313-9056; Kaspers, Gertjan/0000-0001-7716-8475; Cloos, Jacqueline/0000-0001-9150-8026; Kearns, Pamela/0000-0003-2756-5813	KiKa, Children Cancer Free(stichting Kinderen Kankervrij)	KiKa, Children Cancer Free(stichting Kinderen Kankervrij)	This study was supported by KiKa, Children Cancer Free(stichting Kinderen Kankervrij). website: http://kika.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 1998, J IMMUNOL, V161, P1853; Alblas J, 2005, MOL CELL BIOL, V25, P7181, DOI 10.1128/MCB.25.16.7181-7192.2005; Alcalay M, 2003, J CLIN INVEST, V112, P1751, DOI 10.1172/JCI17595; Balgobind BV, 2011, HAEMATOL-HEMATOL J, V96, P221, DOI 10.3324/haematol.2010.029660; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; BENNETT JM, 1985, ANN INTERN MED, V103, P620, DOI 10.7326/0003-4819-103-4-620; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Carter BZ, 2003, BLOOD, V102, P4179, DOI 10.1182/blood-2003-03-0960; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Chao MP, 2012, CURR OPIN IMMUNOL, V24, P225, DOI 10.1016/j.coi.2012.01.010; Chao MP, 2012, NAT REV CANCER, V12, P58, DOI 10.1038/nrc3171; Chao MP, 2011, CANCER RES, V71, P1374, DOI 10.1158/0008-5472.CAN-10-2238; Chao MP, 2010, CELL, V142, P699, DOI 10.1016/j.cell.2010.07.044; CHOMIENNE C, 1990, BLOOD, V76, P1710; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; DAMOISEAUX JGMC, 1989, J LEUKOCYTE BIOL, V46, P556, DOI 10.1002/jlb.46.6.556; de Vries HE, 2002, J IMMUNOL, V168, P5832, DOI 10.4049/jimmunol.168.11.5832; Edris B, 2012, P NATL ACAD SCI US; Fukunaga A, 2004, J IMMUNOL, V172, P4091, DOI 10.4049/jimmunol.172.7.4091; Galbaugh T, 2010, MOL CANCER RES, V8, P1413, DOI 10.1158/1541-7786.MCR-10-0130; Goldstone AH, 2001, BLOOD, V98, P1302, DOI 10.1182/blood.V98.5.1302; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Goyama S, 2011, INT J HEMATOL, V94, P126, DOI 10.1007/s12185-011-0858-z; Gozzini A, 2005, ANN HEMATOL, V84, P54, DOI 10.1007/s00277-005-0006-z; Han X, 2000, J BIOL CHEM, V275, P37984, DOI 10.1074/jbc.M002334200; Hann I. M., 2004, Annals of Hematology, V83, pS108; Hann IM, 1997, BLOOD, V89, P2311, DOI 10.1182/blood.V89.7.2311; Hatherley D, 2007, J BIOL CHEM, V282, P14567, DOI 10.1074/jbc.M611511200; Heemskerk MHM, 1999, CELL IMMUNOL, V195, P10, DOI 10.1006/cimm.1999.1520; Hubeek I, 2008, ONCOL REP, V19, P1517; Isenberg JS, 2008, AM J PATHOL, V173, P1100, DOI 10.2353/ajpath.2008.080237; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Jiang PH, 1999, J BIOL CHEM, V274, P559, DOI 10.1074/jbc.274.2.559; Kaspers GJL, 2007, HAEMATOLOGICA, V92, P1519, DOI 10.3324/haematol.11203; Kaspers GJL, 1999, ADV EXP MED BIOL, V457, P415; KASPERS GJL, 1994, BRIT J CANCER, V70, P1047, DOI 10.1038/bjc.1994.446; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Kircher B, 2009, EUR J HAEMATOL, V83, P48, DOI 10.1111/j.1600-0609.2009.01242.x; Larizza L, 2005, LEUKEMIA LYMPHOMA, V46, P247, DOI 10.1080/10428190400007565; Liu SJ, 2007, J PHARMACOL EXP THER, V321, P953, DOI 10.1124/jpet.106.118406; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Martens JHA, 2010, FEBS LETT, V584, P2662, DOI 10.1016/j.febslet.2010.04.002; Maxhimer JB, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000139; Metzeler KH, 2008, BLOOD, V112, P4193, DOI 10.1182/blood-2008-02-134411; Nagahara M, 2010, CLIN CANCER RES, V16, P4625, DOI 10.1158/1078-0432.CCR-10-0349; Olek A, 1996, NUCLEIC ACIDS RES, V24, P5064, DOI 10.1093/nar/24.24.5064; Ravindranath Y, 2003, CURR OPIN ONCOL, V15, P23, DOI 10.1097/00001622-200301000-00004; Roos D, 1986, Methods Enzymol, V132, P250; Rowe JM, 2004, BLOOD, V103, P479, DOI 10.1182/blood-2003-05-1686; Saginario C, 1998, MOL CELL BIOL, V18, P6213, DOI 10.1128/MCB.18.11.6213; Seiffert M, 1999, BLOOD, V94, P3633, DOI 10.1182/blood.V94.11.3633.423k01_3633_3643; Seiffert M, 2001, BLOOD, V97, P2741, DOI 10.1182/blood.V97.9.2741; Soto-Pantoja DR, 2012, AUTOPHAGY, V8, P1628, DOI 10.4161/auto.21562; Tsai RK, 2008, J CELL BIOL, V180, P989, DOI 10.1083/jcb.200708043; Uno S, 2007, ONCOL REP, V17, P1189; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; van Beek EM, 2005, J IMMUNOL, V175, P7781, DOI 10.4049/jimmunol.175.12.7781; Vernon-Wilson EF, 2000, EUR J IMMUNOL, V30, P2130; WARRELL RP, 1993, NEW ENGL J MED, V329, P177, DOI 10.1056/NEJM199307153290307; Willingham S. B., 2012, P NATL ACAD SCI US; Wouters BJ, 2009, BLOOD, V113, P3088, DOI 10.1182/blood-2008-09-179895; Zhao XW, 2011, P NATL ACAD SCI USA, V108, P18342, DOI 10.1073/pnas.1106550108	63	13	18	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e52143	10.1371/journal.pone.0052143	http://dx.doi.org/10.1371/journal.pone.0052143			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320069	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429800011
J	Hariharan, N; Ikeda, Y; Hong, C; Alcendor, RR; Usui, S; Gao, SM; Maejima, Y; Sadoshima, J				Hariharan, Nirmala; Ikeda, Yoshiyuki; Hong, Chull; Alcendor, Ralph R.; Usui, Soichiro; Gao, Shumin; Maejima, Yasuhiro; Sadoshima, Junichi			Autophagy Plays an Essential Role in Mediating Regression of Hypertrophy during Unloading of the Heart	PLOS ONE			English	Article							FOXO TRANSCRIPTION FACTORS; CARDIAC-HYPERTROPHY; IN-VIVO; HEMODYNAMIC STRESS; PRESSURE-OVERLOAD; DISTINCT ROLES; EXPRESSION; MYOCYTES; GROWTH; CELLS	Autophagy is a bulk degradation mechanism for cytosolic proteins and organelles. The heart undergoes hypertrophy in response to mechanical load but hypertrophy can regress upon unloading. We hypothesize that autophagy plays an important role in mediating regression of cardiac hypertrophy during unloading. Mice were subjected to transverse aortic constriction (TAC) for 1 week, after which the constriction was removed (DeTAC). Regression of cardiac hypertrophy was observed after DeTAC, as indicated by reduction of LVW/BW and cardiomyocyte cross-sectional area. Indicators of autophagy, including LC3-II expression, p62 degradation and GFP-LC3 dots/cell, were significantly increased after DeTAC, suggesting that autophagy is induced. Stimulation of autophagy during DeTAC was accompanied by upregulation of FoxO1. Upregulation of FoxO1 and autophagy was also observed in vitro when cultured cardiomyocytes were subjected to mechanical stretch followed by incubation without stretch (de-stretch). Transgenic mice with cardiac-specific overexpression of FoxO1 exhibited smaller hearts and upregulation of autophagy. Overexpression of FoxO1 in cultured cardiomyocytes significantly reduced cell size, an effect which was attenuated when autophagy was inhibited. To further examine the role of autophagy and FoxO1 in mediating the regression of cardiac hypertrophy, beclin1+/- mice and cultured cardiomyocytes transduced with adenoviruses harboring shRNA-beclin1 or shRNA-FoxO1 were subjected to TAC/stretch followed by DeTAC/de-stretch. Regression of cardiac hypertrophy achieved after DeTAC/de-stretch was significantly attenuated when autophagy was suppressed through downregulation of beclin1 or FoxO1. These results suggest that autophagy and FoxO1 play an essential role in mediating regression of cardiac hypertrophy during mechanical unloading.	[Hariharan, Nirmala; Ikeda, Yoshiyuki; Hong, Chull; Alcendor, Ralph R.; Usui, Soichiro; Gao, Shumin; Maejima, Yasuhiro; Sadoshima, Junichi] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Cell Biol & Mol Med, Cardiovasc Res Inst, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Sadoshima, J (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Cell Biol & Mol Med, Cardiovasc Res Inst, 185 S Orange Ave, Newark, NJ 07103 USA.	sadoshju@umdnj.edu	Hariharan, Nirmala/J-6736-2013; USUI, Soichiro/GQH-4849-2022; Maejima, Yasuhiro/AAG-5580-2020	Usui, Soichiro/0000-0003-1752-8082; Sadoshima, Junichi/0000-0003-3724-4132	United States Public Health Service [HL59139, HL67724, HL69020, HL91469, HL102738, AG27211]; Foundation of Leducq Transatlantic Network of Excellence; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091469, R01HL102738, P01HL059139, R01HL112330, P01HL069020, R01HL067724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG027211] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Foundation of Leducq Transatlantic Network of Excellence; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by United States Public Health Service grants HL59139, HL67724, HL69020, HL91469, HL102738, AG27211 and the Foundation of Leducq Transatlantic Network of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Depre C, 1998, NAT MED, V4, P1269, DOI 10.1038/3253; Evans-Anderson HJ, 2008, CIRC RES, V102, P686, DOI 10.1161/CIRCRESAHA.107.163428; Friddle CJ, 2000, P NATL ACAD SCI USA, V97, P6745, DOI 10.1073/pnas.100127897; Hariharan N, 2010, CIRC RES, V107, P1470, DOI 10.1161/CIRCRESAHA.110.227371; Iwai-Kanai E, 2008, AUTOPHAGY, V4, P322, DOI 10.4161/auto.5603; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Matsuda T, 2008, P NATL ACAD SCI USA, V105, P20900, DOI 10.1073/pnas.0808315106; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Morisco C, 2003, AM J PHYSIOL-HEART C, V284, pH1043, DOI 10.1152/ajpheart.00990.2002; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Ni YG, 2006, CIRCULATION, V114, P1159, DOI 10.1161/CIRCULATIONAHA.106.637124; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sengupta A, 2009, J BIOL CHEM, V284, P28319, DOI 10.1074/jbc.M109.024406; Skurk C, 2005, J BIOL CHEM, V280, P20814, DOI 10.1074/jbc.M500528200; Su HB, 2010, CARDIOVASC RES, V85, P253, DOI 10.1093/cvr/cvp287; Zafeiridis A, 1998, CIRCULATION, V98, P656, DOI 10.1161/01.CIR.98.7.656; Zhai PY, 2007, J BIOL CHEM, V282, P33181, DOI 10.1074/jbc.M705133200; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	24	67	71	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e51632	10.1371/journal.pone.0051632	http://dx.doi.org/10.1371/journal.pone.0051632			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308102	Green Published, gold			2022-12-25	WOS:000313429100007
J	Rugani, T; Diaci, J; Hladnik, D				Rugani, Tihomir; Diaci, Jurij; Hladnik, David			Gap Dynamics and Structure of Two Old-Growth Beech Forest Remnants in Slovenia	PLOS ONE			English	Article							NATURAL FORESTS; REPLACEMENT; PATTERNS; LIGHT	Context: Due to a long history of intensive forest exploitation, few European beech (Fagus sylvatica L.) old-growth forests have been preserved in Europe. Material and Methods: We studied two beech forest reserves in southern Slovenia. We examined the structural characteristics of the two forest reserves based on data from sample plots and complete inventory obtained from four previous forest management plans. To gain a better understanding of disturbance dynamics, we used aerial imagery to study the characteristics of canopy gaps over an 11-year period in the Kopa forest reserve and a 20-year period in the Gorjanci forest reserve. Results: The results suggest that these forests are structurally heterogeneous over small spatial scales. Gap size analysis showed that gaps smaller than 500 m(2) are the dominant driving force of stand development. The percentage of forest area in canopy gaps ranged from 3.2 to 4.5% in the Kopa forest reserve and from 9.1 to 10.6% in the Gorjanci forest reserve. These forests exhibit relatively high annual rates of coverage by newly established (0.15 and 0.25%) and closed (0.08 and 0.16%) canopy gaps. New gap formation is dependant on senescent trees located throughout the reserve. Conclusion: We conclude that these stands are not even-sized, but rather unevenly structured. This is due to the fact that the disturbance regime is characterized by low intensity, small-scale disturbances.	[Rugani, Tihomir; Diaci, Jurij; Hladnik, David] Univ Ljubljana, Biotech Fac, Dept Forestry & Renewable Forest Resources, Ljubljana, Slovenia	University of Ljubljana	Rugani, T (corresponding author), Univ Ljubljana, Biotech Fac, Dept Forestry & Renewable Forest Resources, Ljubljana, Slovenia.	tihomir.rugani@bf.uni-lj.si			Novo mesto Regional Unit of the Slovenia Forestry Service; Slovenian Ministry of Agriculture, Forestry, and Food [V4-0346]; Programme research group Forest, Forestry, and Renewable Forest Resources	Novo mesto Regional Unit of the Slovenia Forestry Service; Slovenian Ministry of Agriculture, Forestry, and Food; Programme research group Forest, Forestry, and Renewable Forest Resources	We would like to thank the Novo mesto Regional Unit of the Slovenia Forestry Service for all the data and support they provided.; Field research and manuscript preparation was partly funded by the Slovenian Ministry of Agriculture, Forestry, and Food through project grant (project V4-0346) and by the Programme research group Forest, Forestry, and Renewable Forest Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, FOREST MANAGEMENT PL; [Anonymous], 2010, FOREST MANAGEMENT PL; Aszalos R, 2003, STUDY GAP CHARACTERI, P1; Battles JJ, 2000, ECOL APPL, V10, P760, DOI 10.1890/1051-0761(2000)010[0760:GDFFDA]2.0.CO;2; Borrmann K, 1996, ALLG FORST JAGDZTG, V23, P5; Christensen M, 2005, FOREST ECOL MANAG, V210, P267, DOI 10.1016/j.foreco.2005.02.032; Christensen M, 2006, ECO B, V52, P1; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; Commarmot Brigitte, 2005, Forest Snow and Landscape Research, V79, P45; Dale M.R.T., 1999, SPATIAL PATTERN ANAL; Drossler L., 2005, Journal of Forest Science, V51, P446; Drossler VL, 2007, ALLG FORST JAGDZTG, V178, P121; Ellenberg H., 2010, OKOLOGISCHER DYNAMIS; Ellenberg H, 1996, VEGETATION MITTELEUR; Emborg J, 1998, FOREST ECOL MANAG, V106, P83, DOI 10.1016/S0378-1127(97)00299-5; FAO, 2010, GLOBAL FOREST RESOUR; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Fueldner K, 1995, FORSTARCHIV, V66, P235; Kenderes K, 2009, ECOSCIENCE, V16, P39, DOI 10.2980/16-1-3178; Korpel S., 1995, URWALDER WESTKARPATE; Kotar M, 1993, ZBORNIK GOZDARSTVA L, V42, P121; Kral K, 2010, FOREST ECOL MANAG, V260, P2196, DOI 10.1016/j.foreco.2010.09.020; Kucbel S, 2010, EUR J FOREST RES, V129, P249, DOI 10.1007/s10342-009-0322-2; Leibundgut H., 1982, EUROPAISCHE URWALDER; Leibundgut H., 1959, SCHWEIZERISCHE Z FOR, V110, P111; Lemoine D, 2002, ANN FOR SCI, V59, P761, DOI 10.1051/forest:2002062; LERTZMAN KP, 1992, ECOLOGY, V73, P657, DOI 10.2307/1940772; LORIMER CG, 1989, CAN J FOREST RES, V19, P651, DOI 10.1139/x89-102; Manning DB, 2003, GAP STUDIES WEBER ST, P1; Marinsek A., 2004, Zbornik Gozdarstva in Lesarstva, P31; Mlinkk D., 1980, GOZDNI REZERVATI SLO; Nagel TA, 2008, CAN J FOREST RES, V38, P2728, DOI 10.1139/X08-110; PENTTINEN A, 1992, FOREST SCI, V38, P806; Peters R., 1997, BEECH FORESTS; Piovesan G, 2005, J VEG SCI, V16, P13, DOI 10.1111/j.1654-1103.2005.tb02334.x; Pommerening A, 2002, FORESTRY, V75, P305, DOI 10.1093/forestry/75.3.305; Pontailler JY, 1997, FOREST ECOL MANAG, V98, P1, DOI 10.1016/S0378-1127(97)00073-X; Prusa E., 1985, BOHMISCHEN MAHRISCHE; Puhek V, 1993, ZBORNIK GOZDARSTVA L, V42, P155; Puhek V, 1998, PROCJENA STRUKTURNIH; RUNKLE JR, 1982, ECOLOGY, V63, P1533, DOI 10.2307/1938878; Schutz JP, 2011, ANN FOREST SCI, V68, P1105, DOI 10.1007/s13595-011-0126-7; Sharma M, 2002, FOREST ECOL MANAG, V168, P163, DOI 10.1016/S0378-1127(01)00737-X; SZWAGRZYK J, 1993, J VEG SCI, V4, P469, DOI 10.2307/3236074; Tabaku V., 1999, Forstarchiv, V70, P87; THOMPSON HR, 1956, ECOLOGY, V37, P391, DOI 10.2307/1933159; von Oheimb G, 2005, FOREST ECOL MANAG, V212, P253, DOI 10.1016/j.foreco.2005.03.033; Waser LT, 2011, REMOTE SENS ENVIRON, V115, P76, DOI 10.1016/j.rse.2010.08.006; Yamamoto S, 1999, PLANT ECOL, V140, P167, DOI 10.1023/A:1009713002039; Zeibig Andre, 2005, Forest Snow and Landscape Research, V79, P69; Zingg A, 1994, MIXED STANDS RES PLO, P69	51	48	52	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e52641	10.1371/journal.pone.0052641	http://dx.doi.org/10.1371/journal.pone.0052641			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308115	Green Published, gold, Green Submitted			2022-12-25	WOS:000313429100012
J	Sullivan, JT; Brown, SD; Ronson, CW				Sullivan, John T.; Brown, Steven D.; Ronson, Clive W.			The NifA-RpoN Regulon of Mesorhizobium loti Strain R7A and Its Symbiotic Activation by a Novel LacI/GalR-Family Regulator	PLOS ONE			English	Article							RHIZOBIUM-ETLI; BRADYRHIZOBIUM-JAPONICUM; NITROGEN-FIXATION; KLEBSIELLA-PNEUMONIAE; SEQUENCE-ANALYSIS; GENE-EXPRESSION; PROTEIN; LEGUMINOSARUM; GENOME; ISLAND	Mesorhizobium loti is the microsymbiont of Lotus species, including the model legume L. japonicus. M. loti differs from other rhizobia in that it contains two copies of the key nitrogen fixation regulatory gene nifA, nifA1 and nifA2, both of which are located on the symbiosis island ICEMlSym(R7A). M. loti R7A also contains two rpoN genes, rpoN1 located on the chromosome outside of ICEMlSym(R7A) and rpoN2 that is located on ICEMlSym(R7A). The aims of the current work were to establish how nifA expression was activated in M. loti and to characterise the NifA-RpoN regulon. The nifA2 and rpoN2 genes were essential for nitrogen fixation whereas nifA1 and rpoN1 were dispensable. Expression of nifA2 was activated, possibly in response to an inositol derivative, by a novel regulator of the LacI/GalR family encoded by the fixV gene located upstream of nifA2. Other than the well-characterized nif/fix genes, most NifA2-regulated genes were not required for nitrogen fixation although they were strongly expressed in nodules. The NifA-regulated nifZ and fixU genes, along with nifQ which was not NifA-regulated, were required in M. loti for a fully effective symbiosis although they are not present in some other rhizobia. The NifA-regulated gene msi158 that encodes a porin was also required for a fully effective symbiosis. Several metabolic genes that lacked NifA-regulated promoters were strongly expressed in nodules in a NifA2-dependent manner but again mutants did not have an overt symbiotic phenotype. In summary, many genes encoded on ICEMlSym(R7A) were strongly expressed in nodules but not free-living rhizobia, but were not essential for symbiotic nitrogen fixation. It seems likely that some of these genes have functional homologues elsewhere in the genome and that bacteroid metabolism may be sufficiently plastic to adapt to loss of certain enzymatic functions.	[Sullivan, John T.; Brown, Steven D.; Ronson, Clive W.] Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand	University of Otago	Ronson, CW (corresponding author), Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand.	Clive.Ronson@otago.ac.nz	Brown, Steven D/A-6792-2011	Brown, Steven D/0000-0002-9281-3898; Ronson, Clive/0000-0002-2217-9676	Marsden Fund; University of Otago	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); University of Otago	This work was supported by a grant from the Marsden Fund administered by the Royal Society of New Zealand and grants from the University of Otago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 1970, MANUAL PRACTICAL STU; Antoine R, 2000, J BACTERIOL, V182, P5902, DOI 10.1128/JB.182.20.5902-5905.2000; Barnett MJ, 2001, P NATL ACAD SCI USA, V98, P9883, DOI 10.1073/pnas.161294798; BATUT J, 1985, MOL GEN GENET, V199, P232, DOI 10.1007/BF00330264; Bauer E, 1998, J BACTERIOL, V180, P3853, DOI 10.1128/JB.180.15.3853-3863.1998; Baumberger IC, 2003, MOL PLANT MICROBE IN, V16, P342, DOI 10.1094/MPMI.2003.16.4.342; Becker A, 1995, MOL GEN GENET, V249, P487, DOI 10.1007/BF00290574; Benhassine T, 2007, FEMS MICROBIOL LETT, V271, P20, DOI 10.1111/j.1574-6968.2007.00699.x; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Buchko GW, 2009, BBA-PROTEINS PROTEOM, V1794, P627, DOI 10.1016/j.bbapap.2009.01.002; Capela D, 2001, P NATL ACAD SCI USA, V98, P9877, DOI 10.1073/pnas.161294398; Clark SRD, 2001, MOL GEN GENET, V264, P623, DOI 10.1007/s004380000348; Cotton MS, 2009, J AM CHEM SOC, V131, P4558, DOI 10.1021/ja807525m; DAVID M, 1987, J BACTERIOL, V169, P2239, DOI 10.1128/jb.169.5.2239-2244.1987; Dombrecht B, 2005, MOL MICROBIOL, V55, P1207, DOI 10.1111/j.1365-2958.2005.04457.x; Dombrecht B, 2002, MOL GENET GENOMICS, V267, P820, DOI 10.1007/s00438-002-0715-0; Dombrecht B, 2001, MOL PLANT MICROBE IN, V14, P426, DOI 10.1094/MPMI.2001.14.3.426; Dombrecht B, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-12-research0076; FELLAY R, 1989, GENE, V76, P215, DOI 10.1016/0378-1119(89)90162-5; Finan TM, 2001, P NATL ACAD SCI USA, V98, P9889, DOI 10.1073/pnas.161294698; FISCHER HM, 1994, MICROBIOL REV, V58, P352, DOI 10.1128/MMBR.58.3.352-386.1994; Freiberg C, 1997, NATURE, V387, P394, DOI 10.1038/387394a0; Fukami-Kobayashi K, 2003, MOL BIOL EVOL, V20, P267, DOI 10.1093/molbev/msg038; Fumeaux C, 2011, MICROBIOL-SGM, V157, P2745, DOI 10.1099/mic.0.049999-0; Gil F, 2009, MICROBIOL-SGM, V155, P2490, DOI 10.1099/mic.0.027433-0; Giraud E, 2007, SCIENCE, V316, P1307, DOI 10.1126/science.1139548; Gonzalez V, 2006, P NATL ACAD SCI USA, V103, P3834, DOI 10.1073/pnas.0508502103; Gonzalez V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-r36; HARRIS GS, 1990, J BIOL CHEM, V265, P15909; Hauser F, 2007, MOL GENET GENOMICS, V278, P255, DOI 10.1007/s00438-007-0246-9; Hernandez JA, 2008, P NATL ACAD SCI USA, V105, P11679, DOI 10.1073/pnas.0803576105; HIRSCH PR, 1984, PLASMID, V12, P139, DOI 10.1016/0147-619X(84)90059-3; Hong HD, 2006, J BIOL CHEM, V281, P7568, DOI 10.1074/jbc.M512365200; Hubber A, 2004, MOL MICROBIOL, V54, P561, DOI 10.1111/j.1365-2958.2004.04292.x; Hussain AKMA, 1999, PLANT CELL PHYSIOL, V40, P894, DOI 10.1093/oxfordjournals.pcp.a029619; Kaneko T, 2000, DNA RES, V7, P331, DOI 10.1093/dnares/7.6.331; Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189; KLIPP W, 1989, MOL GEN GENET, V216, P293, DOI 10.1007/BF00334368; KULLIK I, 1991, J BACTERIOL, V173, P1125, DOI 10.1128/jb.173.3.1125-1138.1991; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LIU YN, 1990, MOL GEN GENET, V220, P433, DOI 10.1007/BF00391750; Lucas S, 2011, COMPLETE SEQUE UNPUB; Martinez M, 2004, J BACTERIOL, V186, P6586, DOI 10.1128/JB.186.19.6586-6594.2004; Masson-Boivin C, 2009, TRENDS MICROBIOL, V17, P458, DOI 10.1016/j.tim.2009.07.004; Michiels J, 1998, J BACTERIOL, V180, P1729, DOI 10.1128/JB.180.7.1729-1740.1998; Michiels J, 1998, J BACTERIOL, V180, P3620, DOI 10.1128/JB.180.14.3620-3628.1998; MURPHY PJ, 1988, P NATL ACAD SCI USA, V85, P9133, DOI 10.1073/pnas.85.23.9133; Nguyen CC, 1995, FEBS LETT, V377, P98, DOI 10.1016/0014-5793(95)01344-X; Nukui N, 2006, APPL ENVIRON MICROB, V72, P4964, DOI 10.1128/AEM.02745-05; Poggio S, 2006, J BIOL CHEM, V281, P27205, DOI 10.1074/jbc.M601735200; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Ramsay JP, 2006, MOL MICROBIOL, V62, P723, DOI 10.1111/j.1365-2958.2006.05396.x; Reeve W, 2010, STAND GENOMIC SCI, V2, P347, DOI 10.4056/sigs.852027; RONSON CW, 1987, J BACTERIOL, V169, P2424, DOI 10.1128/jb.169.6.2424-2431.1987; RONSON CW, 1987, NUCLEIC ACIDS RES, V15, P7921, DOI 10.1093/nar/15.19.7921; RUVKUN GB, 1981, NATURE, V289, P85, DOI 10.1038/289085a0; Salazar E, 2010, APPL ENVIRON MICROB, V76, P4510, DOI 10.1128/AEM.02007-09; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCOTT KF, 1983, DNA-J MOLEC CELL BIO, V2, P149, DOI 10.1089/dna.1983.2.149; Simon HM, 1996, J BACTERIOL, V178, P2975, DOI 10.1128/jb.178.10.2975-2977.1996; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Sullivan JT, 1998, P NATL ACAD SCI USA, V95, P5145, DOI 10.1073/pnas.95.9.5145; Sullivan JT, 2002, J BACTERIOL, V184, P3086, DOI 10.1128/JB.184.11.3086-3095.2002; SULLIVAN JT, 1995, P NATL ACAD SCI USA, V92, P8985, DOI 10.1073/pnas.92.19.8985; Sullivan JT, 2001, MICROBIOL-SGM, V147, P1315, DOI 10.1099/00221287-147-5-1315; Tejima K, 2003, SOIL SCI PLANT NUTR, V49, P239, DOI 10.1080/00380768.2003.10410003; Uchiumi T, 2004, J BACTERIOL, V186, P2439, DOI 10.1128/JB.186.8.2439-2448.2004; WEICKERT MJ, 1992, J BIOL CHEM, V267, P15869; Wozniak RAF, 2010, NAT REV MICROBIOL, V8, P552, DOI 10.1038/nrmicro2382; Young JPW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r34	71	26	27	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53762	10.1371/journal.pone.0053762	http://dx.doi.org/10.1371/journal.pone.0053762			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308282	gold, Green Published, Green Submitted			2022-12-25	WOS:000313429100114
J	Wynne, JW; Di Rubbo, A; Shiell, BJ; Beddome, G; Cowled, C; Peck, GR; Huang, J; Grimley, SL; Baker, ML; Michalski, WP				Wynne, James W.; Di Rubbo, Antonio; Shiell, Brian J.; Beddome, Gary; Cowled, Christopher; Peck, Grantley R.; Huang, Jing; Grimley, Samantha L.; Baker, Michelle L.; Michalski, Wojtek P.			Purification and Characterisation of Immunoglobulins from the Australian Black Flying Fox (Pteropus alecto) Using Anti-Fab Affinity Chromatography Reveals the Low Abundance of IgA	PLOS ONE			English	Article							NIPAH VIRUS-INFECTION; NECROSIS-FACTOR-ALPHA; IMMUNE-RESPONSE; HENDRA VIRUS; FRUIT BATS; EQUINE MORBILLIVIRUS; GENE REPERTOIRE; HUMAN MONOCYTES; FC-RECEPTOR; EBOLA-VIRUS	There is now an overwhelming body of evidence that implicates bats in the dissemination of a long list of emerging and re-emerging viral agents, often causing illnesses or death in both animals and humans. Despite this, there is a paucity of information regarding the immunological mechanisms by which bats coexist with highly pathogenic viruses. Immunoglobulins are major components of the adaptive immune system. Early studies found bats may have quantitatively lower antibody responses to model antigens compared to conventional laboratory animals. To further understand the antibody response of bats, the present study purified and characterised the major immunoglobulin classes from healthy black flying foxes, Pteropus alecto. We employed a novel strategy, where IgG was initially purified and used to generate anti-Fab specific antibodies. Immobilised anti-Fab specific antibodies were then used to capture other immunoglobulins from IgG depleted serum. While high quantities of IgM were successfully isolated from serum, IgA was not. Only trace quantities of IgA were detected in the serum by mass spectrometry. Immobilised ligands specific to IgA (Jacalin, Peptide M and staphylococcal superantigen-like protein) also failed to capture P. alecto IgA from serum. IgM was the second most abundant serum antibody after IgG. A survey of mucosal secretions found IgG was the dominant antibody class rather than IgA. Our study demonstrates healthy P. alecto bats have markedly less serum IgA than expected. Higher quantities of IgG in mucosal secretions may be compensation for this low abundance or lack of IgA. Knowledge and reagents developed within this study can be used in the future to examine class-specific antibody response within this important viral host.	[Wynne, James W.; Di Rubbo, Antonio; Shiell, Brian J.; Beddome, Gary; Cowled, Christopher; Peck, Grantley R.; Huang, Jing; Grimley, Samantha L.; Baker, Michelle L.; Michalski, Wojtek P.] CSIRO, Anim Food & Hlth Sci, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Huang, Jing] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China	Commonwealth Scientific & Industrial Research Organisation (CSIRO); East China Normal University	Michalski, WP (corresponding author), CSIRO, Anim Food & Hlth Sci, Australian Anim Hlth Lab, Geelong, Vic, Australia.	wojtek.michalski@csiro.au	Cowled, Christopher JE/H-5308-2013; Baker, Michelle/AAX-9171-2020; Peck, Grantley/H-2318-2013; Michalski, Wojtek/H-3544-2013; Wynne, James W/H-7957-2013; Baker, Michelle L/C-9694-2013	Cowled, Christopher JE/0000-0002-1969-9371; Baker, Michelle/0000-0002-7993-9971; Wynne, James W/0000-0001-6846-757X; Baker, Michelle L/0000-0002-7993-9971	CSIRO; Australian Biosecurity Cooperative Research Centre	CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Australian Biosecurity Cooperative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This research was funded mainly by CSIRO. The Australian Biosecurity Cooperative Research Centre provided a student stipend for ADR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Baker K, 2010, MUCOSAL IMMUNOL, V3, P324, DOI 10.1038/mi.2010.15; Baker ML, 2010, IMMUNOGENETICS, V62, P173, DOI 10.1007/s00251-010-0425-4; BJORCK L, 1984, J IMMUNOL, V133, P969; BRANDTZAEG P, 1974, NATURE, V252, P418, DOI 10.1038/252418a0; Burrows PD, 1997, ADV IMMUNOL, V65, P245, DOI 10.1016/S0065-2776(08)60744-0; Butler JE, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P1763, DOI 10.1016/B978-012491543-5/50107-8; Butler JE, 2011, DEV COMP IMMUNOL, V35, P273, DOI 10.1016/j.dci.2010.08.011; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; CHAKRABORTY AK, 1984, DEV COMP IMMUNOL, V8, P415, DOI 10.1016/0145-305X(84)90048-X; Chua KB, 1999, LANCET, V354, P1257, DOI 10.1016/S0140-6736(99)04299-3; Clayton BA, 2012, ZOONOSES PU IN PRESS; Cowled C, 2011, DEV COMP IMMUNOL, V35, P7, DOI 10.1016/j.dci.2010.07.006; Crameri G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008266; FERNANDES FRC, 1995, J INVEST ALLERG CLIN, V5, P151; Field H, 1999, EMERG INFECT DIS, V5, P438, DOI 10.3201/eid0503.990316; Deza FG, 2007, DEV COMP IMMUNOL, V31, P596, DOI 10.1016/j.dci.2006.09.005; GREGORY RL, 1987, J IMMUNOL METHODS, V99, P101, DOI 10.1016/0022-1759(87)90037-8; Hall L.S., 2000, FLYING FOXES FRUIT B; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Hansen JD, 2005, P NATL ACAD SCI USA, V102, P6919, DOI 10.1073/pnas.0500027102; HATTEN BA, 1968, J IMMUNOL, V101, P141; HSU E, 1985, J IMMUNOL, V135, P1998; Hurley WL, 2011, NUTRIENTS, V3, P442, DOI 10.3390/nu3040442; Johansen FE, 2000, SCAND J IMMUNOL, V52, P240; Kuzmin Ivan V, 2011, Emerg Health Threats J, V4, P7159, DOI 10.3402/ehtj.v4i0.7159; Langley R, 2005, J IMMUNOL, V174, P2926, DOI 10.4049/jimmunol.174.5.2926; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Leroy EM, 2009, VECTOR-BORNE ZOONOT, V9, P723, DOI 10.1089/vbz.2008.0167; Lydyard P, 2004, IMMUNOLOGY; Marsh GA, 2012, PLOS PATHOG IN PRESS; Mbawuike IN, 1999, J IMMUNOL, V162, P2530; McColl KA, 2002, AUST VET J, V80, P636, DOI 10.1111/j.1751-0813.2002.tb10973.x; Middleton DJ, 2007, J COMP PATHOL, V136, P266, DOI 10.1016/j.jcpa.2007.03.002; NIKOLOVA EB, 1995, J LEUKOCYTE BIOL, V57, P875, DOI 10.1002/jlb.57.6.875; Nishihara H, 2006, P NATL ACAD SCI USA, V103, P9929, DOI 10.1073/pnas.0603797103; Nor MNM, 2000, REV SCI TECH OIE, V19, P160; NORHAGEN G, 1989, J CLIN IMMUNOL, V9, P279, DOI 10.1007/BF00918659; Page M, 2009, PURIFICATION IGG USI; Papenfuss AT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-261; Peel AJ, 2012, PLOS ONE, V7; Penno M, 2012, COMP 2D DIGE ANAL DE; Petraityte R, 2009, VIRUS RES, V145, P92, DOI 10.1016/j.virusres.2009.06.013; Prowse S, 2000, ANZCCART NEWS, V13, P7; Salvador-Morales C, 2006, MOL IMMUNOL, V43, P193, DOI 10.1016/j.molimm.2005.02.006; Sambrook J, 2001, MOL CLONING LAB MANU; Sandin C, 2002, J IMMUNOL, V169, P1357, DOI 10.4049/jimmunol.169.3.1357; Shiell BJ, 2002, J VIROL METHODS, V102, P27, DOI 10.1016/S0166-0934(01)00441-4; SULKIN SE, 1966, AM J TROP MED HYG, V15, P418, DOI 10.4269/ajtmh.1966.15.418; Swanepoel R, 1996, EMERG INFECT DIS, V2, P321, DOI 10.3201/eid0204.960407; Uren TK, 2005, EUR J IMMUNOL, V35, P180, DOI 10.1002/eji.200425492; van Egmond M, 2001, TRENDS IMMUNOL, V22, P205, DOI 10.1016/S1471-4906(01)01873-7; Williamson MM, 1998, AUST VET J, V76, P813, DOI 10.1111/j.1751-0813.1998.tb12335.x; Williamson MM, 2000, J COMP PATHOL, V122, P201, DOI 10.1053/jcpa.1999.0364; WILTON JMA, 1978, CLIN EXP IMMUNOL, V34, P423; Wolf HM, 1996, CLIN EXP IMMUNOL, V105, P537, DOI 10.1046/j.1365-2249.1996.d01-793.x; WOLF HM, 1994, BLOOD, V83, P1278; Wong S, 2007, REV MED VIROL, V17, P67, DOI 10.1002/rmv.520; Yoshida M, 2006, J CLIN INVEST, V116, P2142, DOI 10.1172/JCI27821; Young PL, 1996, EMERG INFECT DIS, V2, P239, DOI 10.3201/eid0203.960315	61	14	14	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e52930	10.1371/journal.pone.0052930	http://dx.doi.org/10.1371/journal.pone.0052930			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308125	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429100020
J	Zhang, JL; Zheng, QC; Li, ZQ; Zhang, HX				Zhang, Ji-Long; Zheng, Qing-Chuan; Li, Zheng-Qiang; Zhang, Hong-Xing			How Does (E)-2-(Acetamidomethylene)succinate Bind to Its Hydrolase? From the Binding Process to the Final Result	PLOS ONE			English	Article							MESORHIZOBIUM-LOTI MAFF303099; FIXING SYMBIOTIC BACTERIUM; 4-PYRIDOXIC ACID DEHYDROGENASE; MOLECULAR-DYNAMICS SIMULATIONS; GENE IDENTIFICATION; FREE-ENERGIES; PLP CATABOLISM; PYRIDOXAL; ENZYME; DENSITY	The binding of (E)-2-(acetamidomethylene)succinate (E-2AMS) to E-2AMS hydrolase is crucial for biological function of the enzyme and the last step reaction of vitamin B-6 biological degradation. In the present study, several molecular simulation methods, including molecular docking, conventional molecular dynamics (MD), steered MD (SMD), and free energy calculation methods, were properly integrated to investigate the detailed binding process of E-2AMS to its hydrolase and to assign the optimal enzyme-substrate complex conformation. It was demonstrated that the substrate binding conformation with trans-form amide bond is energetically preferred conformation, in which E-2AMS's pose not only ensures hydrogen bond formation of its amide oxygen atom with the vicinal oxyanion hole but also provides probability of the hydrophobic interaction between its methyl moiety and the related enzyme's hydrophobic cavity. Several key residues, Arg146, Arg167, Tyr168, Arg179, and Tyr259, orientate the E-2AMS's pose and stabilize its conformation in the active site via the hydrogen bond interaction with E-2AMS. Sequentially, the binding process of E-2AMS to E-2AMS hydrolase was studied by SMD simulation, which shows the surprising conformational reversal of E-2AMS. Several important intermediate structures and some significant residues were identified in the simulation. It is stressed that Arg146 and Arg167 are two pivotal residues responsible for the conformational reversal of E-2AMS in the binding or unbinding. Our research has shed light onto the full binding process of the substrate to E-2AMS hydrolase, which could provide more penetrating insight into the interaction of E-2AMS with the enzyme and would help in the further exploration on the catalysis mechanism.	[Zhang, Ji-Long; Zheng, Qing-Chuan; Zhang, Hong-Xing] Jilin Univ, Inst Theoret Chem, State Key Lab Theoret & Computat Chem, Changchun, Jilin, Peoples R China; [Zhang, Ji-Long; Li, Zheng-Qiang] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130023, Jilin, Peoples R China	Jilin University; Jilin University	Zhang, HX (corresponding author), Jilin Univ, Inst Theoret Chem, State Key Lab Theoret & Computat Chem, Changchun, Jilin, Peoples R China.	zhanghx@mail.jlu.edu.cn			Natural Science Foundation of China [21173096, 20903045, 20973076]; Specialized Research Fund for the Doctoral Program of Higher Education [20110061110018]; Specialized Fund for the Basic Research of Jilin University [201003044]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Specialized Fund for the Basic Research of Jilin University(Jilin University)	This work is supported by the Natural Science Foundation of China (Grant Nos. 21173096, 20903045, and 20973076), Specialized Research Fund for the Doctoral Program of Higher Education (Grant No. 20110061110018), and the Specialized Fund for the Basic Research of Jilin University (Grant No. 201003044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, AMBER 10; [Anonymous], 2008, DISC STUD 2 5; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Combs G.F., 2008, VITAMINS FUNDAMENTAL; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Darve E, 2001, J CHEM PHYS, V115, P9169, DOI 10.1063/1.1410978; den Otter WK, 2000, J CHEM PHYS, V112, P7283, DOI 10.1063/1.481329; Dunn G, 2005, J MOL BIOL, V346, P253, DOI 10.1016/j.jmb.2004.11.033; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Funami J, 2005, BBA-PROTEINS PROTEOM, V1753, P234, DOI 10.1016/j.bbapap.2005.08.026; Ge F, 2008, J BIOCHEM, V143, P603, DOI 10.1093/jb/mvn010; Henin J, 2004, J CHEM PHYS, V121, P2904, DOI 10.1063/1.1773132; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; James W., 1990, ANDREWS DIS SKIN, V66, P984; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; McCulloch KM, 2010, BIOCHEMISTRY-US, V49, P1226, DOI 10.1021/bi901812p; McCulloch KM, 2009, BIOCHEMISTRY-US, V48, P4139, DOI 10.1021/bi900149f; MIEHLICH B, 1989, CHEM PHYS LETT, V157, P200, DOI 10.1016/0009-2614(89)87234-3; Mukherjee T, 2008, BIOCHEMISTRY-US, V47, P6233, DOI 10.1021/bi8004158; Mukherjee T, 2007, BIOORG CHEM, V35, P458, DOI 10.1016/j.bioorg.2007.07.003; Mukherjee T, 2007, BIOCHEMISTRY-US, V46, P13606, DOI 10.1021/bi701439j; Mukherjee T, 2011, BBA-PROTEINS PROTEOM, V1814, P1585, DOI 10.1016/j.bbapap.2011.06.018; Park SY, 2008, J MOL BIOL, V376, P1426, DOI 10.1016/j.jmb.2007.12.062; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rodriguez-Gomez D, 2004, J CHEM PHYS, V120, P3563, DOI 10.1063/1.1642607; RODWELL VW, 1958, J BIOL CHEM, V233, P1548; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; SNELL E, 1971, COMPREHENSIVE BIOCH, V21; Snell EE, 1944, J BIOL CHEM, V154, P313; Toukmaji AY, 1996, COMPUT PHYS COMMUN, V95, P73, DOI 10.1016/0010-4655(96)00016-1; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Yokochi N, 2006, ARCH BIOCHEM BIOPHYS, V452, P1, DOI 10.1016/j.abb.2006.06.002; Yoshikane Y, 2008, J BIOL CHEM, V283, P1120, DOI 10.1074/jbc.M708061200; Yuan B, 2008, J NUTR SCI VITAMINOL, V54, P185, DOI 10.3177/jnsv.54.185; Yuan BQ, 2006, J BIOSCI BIOENG, V102, P504, DOI 10.1263/jbb.102.504; Yuan BQ, 2004, FEMS MICROBIOL LETT, V234, P225, DOI 10.1016/j.femsle.2004.03.031; Zhang JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039546; Zhang JL, 2010, CHEM PHYS LETT, V484, P338, DOI 10.1016/j.cplett.2009.12.022; Zhang JL, 2010, J PHYS CHEM B, V114, P7383, DOI 10.1021/jp9113078	45	11	11	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53811	10.1371/journal.pone.0053811	http://dx.doi.org/10.1371/journal.pone.0053811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308285	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429100117
J	Wu, L; Runkle, C; Jin, HJ; Yu, J; Li, J; Yang, X; Kuzel, T; Lee, C; Yu, J				Wu, L.; Runkle, C.; Jin, H-J; Yu, J.; Li, J.; Yang, X.; Kuzel, T.; Lee, C.; Yu, J.			CCN3/NOV gene expression in human prostate cancer is directly suppressed by the androgen receptor	ONCOGENE			English	Article						androgen receptor; polycomb EZH2; NOV; CCN3	DIFFERENTIAL EXPRESSION; CCN PROTEINS; NOV; TRANSCRIPTION; MECHANISM; POLYCOMB; GROWTH; INHIBITION; REPRESSION; CASTRATION	Androgen receptor (AR) has essential roles during prostate cancer progression. With genome-wide AR-binding sites mapped to high resolution, studies have recently reported AR as a transcriptional repressor. How AR inhibits gene expression and how this contributes to prostate cancer, however, are incompletely understood. Through meta-analysis of microarray data, here we nominate nephroblastoma overexpressed (NOV) as a top androgen-repressed gene. We show that NOV is directly suppressed by androgen through the AR. AR occupies the NOV enhancer and communicates with the NOV promoter through DNA looping. AR activation recruits the polycomb group protein EZH2, which subsequently catalyzes histone H3 lysine 27 tri-methylation around the NOV promoter, thus leading to repressive chromatin remodeling and epigenetic silencing. Concordantly, AR and EZH2 inhibition synergistically restored NOV expression. NOV is downregulated in human prostate cancer wherein AR and EZH2 are upregulated. Functionally, NOV inhibits prostate cancer cell growth in vitro and in vivo. NOV reconstitution reverses androgen-induced cell growth and NOV knockdown drives androgen-independent cell growth. In addition, NOV expression is restored by hormone-deprivation therapies in mice and prostate cancer patients. Therefore, using NOV as a model gene we gained further understanding of the mechanisms underlying AR-mediated transcriptional repression. Our findings establish a tumor-suppressive role of NOV in prostate cancer and suggest that one important, but previously underestimated, manner by which AR contributes to prostate cancer progression is through inhibition of key tumor-suppressor genes.	[Wu, L.; Runkle, C.; Jin, H-J; Yu, J.; Li, J.; Kuzel, T.; Yu, J.] Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, Dept Med, Chicago, IL 60611 USA; [Yang, X.; Kuzel, T.; Lee, C.; Yu, J.] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Yu, J (corresponding author), Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Div Hematol Oncol,Dept Med, 303 E Super St Lurie 5-117, Chicago, IL 60611 USA.	jindan-yu@northwestern.edu	WU, Longtao/G-6477-2014	WU, Longtao/0000-0003-3463-4127; Jin, Hongjian/0000-0003-3833-7170	NIH [P50CA090386, U54CA143869, K99/R00CA129565, R01HG005119]; US Department of Defense [W81XWH-09-1-0193]; Research Scholar Award from the American Cancer Society [RSG-12-085-01]; NATIONAL CANCER INSTITUTE [P30CA062203, P50CA090386, U54CA143869, K99CA129565, R01CA172384, R00CA129565] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005119] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); Research Scholar Award from the American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Dr Bernard Perbal (University of Paris) for the K19M anti-NOV antibody, Dr Kurt Engeland (Universitatsfrauenklinik Leipzig) for the NOV constructs, Dr Raymond Bergan for the PC-3M cells, and Dr Stephen Plymate for AR overexpression constructs. We are also grateful to Jonathan Zhao and Jung Kim for technical assistance. This work was supported by funding from the NIH P50CA090386 (to CL, JY), U54CA143869 pilot project (to JY), K99/R00CA129565 (to JY), R01HG005119 (to JY), the US Department of Defense W81XWH-09-1-0193 (to JY) and the Research Scholar Award RSG-12-085-01 (to JY) from the American Cancer Society.	Bao BY, 2008, PROSTATE, V68, P839, DOI 10.1002/pros.20749; Benini S, 2005, ONCOGENE, V24, P4349, DOI 10.1038/sj.onc.1208620; Best CJM, 2005, CLIN CANCER RES, V11, P6823, DOI 10.1158/1078-0432.CCR-05-0585; Bohlig L, 2008, CELL CYCLE, V7, P1254, DOI 10.4161/cc.7.9.5812; Cai CM, 2011, CANCER CELL, V20, P457, DOI 10.1016/j.ccr.2011.09.001; Fu CT, 2004, J BIOL CHEM, V279, P36943, DOI 10.1074/jbc.M403952200; Fukunaga-Kalabis M, 2008, ONCOGENE, V27, P2552, DOI 10.1038/sj.onc.1210896; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Jiang WG, 2004, ENDOCR-RELAT CANCER, V11, P781, DOI 10.1677/erc.1.00825; JOLIOT V, 1992, MOL CELL BIOL, V12, P10, DOI 10.1128/MCB.12.1.10; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Kimura A, 2010, J BIOL CHEM, V285, P32704, DOI 10.1074/jbc.M110.141804; Lamont KR, 2011, MOL ENDOCRINOL, V25, P897, DOI 10.1210/me.2010-0469; Lanzino M, 2010, NUCLEIC ACIDS RES, V38, P5351, DOI 10.1093/nar/gkq278; Lin BY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006589; Liu YN, 2008, MOL CELL BIOL, V28, P7096, DOI 10.1128/MCB.00449-08; Maillard M, 2001, J CLIN PATHOL-MOL PA, V54, P275, DOI 10.1136/mp.54.4.275; MARTINERIE C, 1992, ONCOGENE, V7, P2529; Massie CE, 2011, EMBO J, V30, P2719, DOI 10.1038/emboj.2011.158; McCallum L, 2009, BLOOD REV, V23, P79, DOI 10.1016/j.blre.2008.07.002; McCallum L, 2006, BLOOD, V108, P1716, DOI 10.1182/blood-2006-04-016113; Ohgawara T, 2011, J CELL COMMUN SIGNAL, V5, P291, DOI 10.1007/s12079-011-0133-3; Ouellet V, 2011, AM J PATHOL, V178, P2377, DOI 10.1016/j.ajpath.2011.01.033; Perbal B, 2008, J CELL COMMUN SIGNAL, V2, P3, DOI 10.1007/s12079-008-0028-0; Sin WC, 2009, J BIOL CHEM, V284, P29935, DOI 10.1074/jbc.M109.042630; Vallacchi V, 2008, CANCER RES, V68, P715, DOI 10.1158/0008-5472.CAN-07-2103; Verras M, 2007, CANCER RES, V67, P967, DOI 10.1158/0008-5472.CAN-06-3552; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wang XD, 2007, DIFFERENTIATION, V75, P219, DOI 10.1111/j.1432-0436.2006.00135.x; Welsbie DS, 2009, CANCER RES, V69, P958, DOI 10.1158/0008-5472.CAN-08-2216; Yu J, 2010, ONCOGENE, V29, P5370, DOI 10.1038/onc.2010.269; Yu J, 2007, CANCER CELL, V12, P419, DOI 10.1016/j.ccr.2007.10.016; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zhao JC, 2012, GENOME RES, V22, P322, DOI 10.1101/gr.131508.111; Zuo GW, 2010, HISTOL HISTOPATHOL, V25, P795, DOI 10.14670/HH-25.795	38	36	38	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 23	2014	33	4					504	513		10.1038/onc.2012.602	http://dx.doi.org/10.1038/onc.2012.602			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	296VX	23318417	Green Accepted			2022-12-25	WOS:000330214600011
J	Vaites, LP; Lian, Z; Lee, EK; Yin, B; DeMicco, A; Bassing, CH; Diehl, JA				Vaites, L. P.; Lian, Z.; Lee, E. K.; Yin, B.; DeMicco, A.; Bassing, C. H.; Diehl, J. A.			ATM deficiency augments constitutively nuclear cyclin D1-driven genomic instability and lymphomagenesis	ONCOGENE			English	Article						cyclin D1T286A; ATM; genomic instability; lymphoma; c-Myc	C-MYC; D1 PHOSPHORYLATION; DNA; REPLICATION; P53; ACTIVATION; EXPRESSION; OVEREXPRESSION; PROTEOLYSIS; DELETION	Cyclin D1 deregulation is implicated in the genesis of multiple human cancers. Importantly, nuclear cyclin D1 retention during S-phase promotes DNA re-replication and subsequent genomic instability, providing a direct correlation between aberrant cyclin D1/CDK4 activity, transcriptional regulation and double strand DNA break (DSB) induction. Together, these molecular events catalyze the genomic instability necessary for neoplastic transformation. Given that replication-associated DNA damage is central to cyclin D1-driven neoplasia, inactivation of critical checkpoint mediators should augment cyclin D1-dependent tumorigenesis in vivo. To interrogate potential synergy between constitutively nuclear cyclin D1 expression and impaired DSB-induced checkpoint integrity, Ataxia Telangiectasia Mutated (ATM)-deficient mice harboring the Em-D1T286A transgene were generated and evaluated for tumor onset. Em-D1T286A/ATM -/- mice exhibit dramatically accelerated incidence of both B-and T-cell lymphomas relative to Em-D1T286A or ATM -/- control cohorts. Lymphomas exhibit clonal chromosomal alterations distinct from ATM -/- mice, which typically acquire translocations involving the Tcra/d locus during V(D)J recombination, and instead harbor alterations at the c-Myc locus. Collectively, these findings reveal an intricate relationship wherein nuclear cyclin D1/CDK4 drives genomic instability in the absence of ATM function and clonal selection of cells harboring alterations within the murine c-Myc locus, ultimately facilitating transformation and tumor formation.	[Vaites, L. P.; Lian, Z.; Lee, E. K.; Diehl, J. A.] Univ Penn, Leonard & Madlyn Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Vaites, L. P.; Lian, Z.; Lee, E. K.; Diehl, J. A.] Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA; [Yin, B.; DeMicco, A.; Bassing, C. H.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Diehl, JA (corresponding author), Univ Penn, Leonard & Madlyn Abramson Family Canc Res Inst, 438 BRB 2 3,421 Curie Blvd, Philadelphia, PA 19104 USA.	adiehl@mail.med.upenn.edu	Lian, Zhaorui/AAW-2379-2020		NIH [CA93237]; NATIONAL CANCER INSTITUTE [R01CA093237] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors wish to thank Margarita Romero for excellent technical assistance and maintenance of the mouse colony, Dr Eric Brown for providing ATM+/- mice for colony generation and insightful comments on the work, the AFCRI histology core for assistance with tissue paraffin embedding and sectioning, and Dr Priya Aggarwal for assistance with flow cytometry and cytogenetic techniques. This work was supported by a grant from the NIH (CA93237) (JAD).	Aggarwal P, 2007, GENE DEV, V21, P2908, DOI 10.1101/gad.1586007; Aggarwal P, 2010, CANCER CELL, V18, P329, DOI 10.1016/j.ccr.2010.08.012; Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Ghosh M, 2006, MOL CELL BIOL, V26, P5270, DOI 10.1128/MCB.02137-05; Girard-Reydet C, 2004, GENE, V332, P129, DOI 10.1016/j.gene.2004.02.031; Gladden AB, 2006, ONCOGENE, V25, P998, DOI 10.1038/sj.onc.1209147; Gostissa M, 2009, NATURE, V462, P803, DOI 10.1038/nature08633; Greiner TC, 2006, P NATL ACAD SCI USA, V103, P2352, DOI 10.1073/pnas.0510441103; Hakim O, 2012, NATURE, V484, P69, DOI 10.1038/nature10909; Hemmer S, 2001, AM J PATHOL, V158, P1355, DOI 10.1016/S0002-9440(10)64086-2; Jares P, 2008, BRIT J HAEMATOL, V142, P149, DOI 10.1111/j.1365-2141.2008.07124.x; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Lin DI, 2008, ONCOGENE, V27, P1231, DOI 10.1038/sj.onc.1210738; Liyanage M, 2000, BLOOD, V96, P1940, DOI 10.1182/blood.V96.5.1940.h8001940_1940_1946; Lowndes NF, 2005, CURR BIOL, V15, pR99, DOI 10.1016/j.cub.2005.01.029; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; Monni O, 1999, BRIT J HAEMATOL, V104, P665, DOI 10.1046/j.1365-2141.1999.01257.x; MOTOKURA T, 1991, NATURE, V350, P512, DOI 10.1038/350512a0; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nagy B, 2003, BRIT J HAEMATOL, V120, P434, DOI 10.1046/j.1365-2141.2003.04121.x; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Norio P, 2005, MOL CELL, V20, P575, DOI 10.1016/j.molcel.2005.10.029; Pontano LL, 2008, MOL CELL BIOL, V28, P7245, DOI 10.1128/MCB.01085-08; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; SERRANO M, 1995, SCIENCE, V267, P249, DOI 10.1126/science.7809631; Slotta-Huspenina J, 2012, HAEMATOL-HEMATOL J, V97, P1422, DOI 10.3324/haematol.2011.055715; Walker DR, 1999, ONCOGENE, V18, P211, DOI 10.1038/sj.onc.1202298; WITHERS DA, 1991, MOL CELL BIOL, V11, P4846, DOI 10.1128/MCB.11.10.4846; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; Zha S, 2010, J EXP MED, V207, P1369, DOI 10.1084/jem.20100285; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhou J, 2002, P NATL ACAD SCI USA, V99, P13693, DOI 10.1073/pnas.212392399	38	14	14	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2014	33	1					129	133		10.1038/onc.2012.577	http://dx.doi.org/10.1038/onc.2012.577			5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	282YU	23318439	Green Accepted			2022-12-25	WOS:000329212000014
J	Sun, DF; Yu, F; Ma, YT; Zhao, R; Chen, X; Zhu, J; Zhang, CY; Chen, JN; Zhang, JF				Sun, Defang; Yu, Feng; Ma, Yutao; Zhao, Ran; Chen, Xi; Zhu, Jie; Zhang, Chen-Yu; Chen, Jiangning; Zhang, Junfeng			MicroRNA-31 Activates the RAS Pathway and Functions as an Oncogenic MicroRNA in Human Colorectal Cancer by Repressing RAS p21 GTPase Activating Protein 1 (RASA1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAYS; EXPRESSION; TARGET; METASTASIS; PROGNOSIS; INVASION; BREAST; STAGE; KRAS; MUTATION	MicroRNAs (miRNAs) are known to play a vital role in colorectal cancer. We found a widespread disruption in miRNA expression during colorectal tumorigenesis using microarray and quantitative RT-PCR analysis; of the 161 miRNAs altered in colorectal cancer compared with normal adjacent tissue samples, miR-31 was the most significantly dysregulated. We identified candidate targets of miR-31 using bioinformatics approaches and validated RAS p21 GTPase activating protein 1 (RASA1) as a direct target. First, we found an inverse correlation between miR-31 and RASA1 protein levels in vivo. Second, in vitro evidence demonstrated that RASA1 expression was significantly decreased by treatment with pre-miR-31-LV, whereas anti-miR-31-LV treatment increased RASA1 protein levels. Third, a luciferase reporter assay confirmed that miR-31 directly recognizes a specific location within the 3'-untranslated region of RASA1 transcripts. Furthermore, the biological consequences of miR-31 targeting RASA1 were examined by the cell proliferation assay in vitro and by the immunodeficient mouse xenograft tumor model in vivo. Taken together, our results demonstrate for the first time that miR-31 plays a significant role in activating the RAS signaling pathway through the inhibition of RASA1 translation, thereby improving colorectal cancer cell growth and stimulating tumorigenesis.	[Sun, Defang; Yu, Feng; Ma, Yutao; Zhao, Ran; Chen, Xi; Zhu, Jie; Zhang, Chen-Yu; Chen, Jiangning; Zhang, Junfeng] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Sch Life Sci, State Key Lab Analyt Chem Life Sci, Nanjing 210093, Jiangsu, Peoples R China	Nanjing University	Chen, JN (corresponding author), Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Sch Life Sci, State Key Lab Analyt Chem Life Sci, 22 Hankou Rd, Nanjing 210093, Jiangsu, Peoples R China.	jnchen@nju.edu.cn; jfzhang@nju.edu.cn			National Science Fund for Distinguished Young Scholars [81025019]; National Basic Research Program of China Grant [2012CB517603]; National Natural Science Foundation of China [31070722, 31271013, 31071232, 31170751, 31200695, 51173076, 91129712, 81102489]; Key Project of the Chinese Ministry of Education Grant [108059]; Ph.D. Programs Foundation of the Ministry of Education of China Grant [20100091120020]; NSFC [J1103512]; Fundamental Research Funds for the Central Universities	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Basic Research Program of China Grant(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of the Chinese Ministry of Education Grant; Ph.D. Programs Foundation of the Ministry of Education of China Grant(Ministry of Education, China); NSFC(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Science Fund for Distinguished Young Scholars Grant 81025019, the National Basic Research Program of China Grant 2012CB517603, National Natural Science Foundation of China Grants 31070722, 31271013, 31071232, 31170751, 31200695, 51173076, 91129712, and 81102489, Key Project of the Chinese Ministry of Education Grant 108059, the Ph.D. Programs Foundation of the Ministry of Education of China Grant 20100091120020, NSFC J1103512, the Fundamental Research Funds for the Central Universities.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Buday L, 2008, BBA-REV CANCER, V1786, P178, DOI 10.1016/j.bbcan.2008.05.001; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Denhardt DT, 1996, BIOCHEM J, V318, P729, DOI 10.1042/bj3180729; Donovan S, 2002, BBA-REV CANCER, V1602, P23, DOI 10.1016/S0304-419X(01)00041-5; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Downward J, 1998, CURR OPIN GENET DEV, V8, P49, DOI 10.1016/S0959-437X(98)80061-0; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fakih MM, 2010, CLIN COLORECTAL CANC, V9, P22, DOI 10.3816/CCC.2010.n.003; Fang JY, 2005, LANCET ONCOL, V6, P322, DOI 10.1016/S1470-2045(05)70168-6; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; Hu XL, 2009, MOL CANCER RES, V7, P511, DOI 10.1158/1541-7786.MCR-08-0107; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu CJ, 2010, CANCER RES, V70, P1635, DOI 10.1158/0008-5472.CAN-09-2291; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Nishida N, 2012, ANN SURG ONCOL, V19, P3065, DOI 10.1245/s10434-012-2246-1; Orom UA, 2006, GENE, V372, P137, DOI 10.1016/j.gene.2005.12.031; Parsons BL, 2009, BIOMARK MED, V3, P757, DOI 10.2217/BMM.09.95; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Shenouda SK, 2009, CANCER METAST REV, V28, P369, DOI 10.1007/s10555-009-9188-5; Simi L, 2008, AM J CLIN PATHOL, V130, P247, DOI 10.1309/LWDY1AXHXUULNVHQ; Taguchi A, 2008, CANCER RES, V68, P5540, DOI 10.1158/0008-5472.CAN-07-6460; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Veerla S, 2009, INT J CANCER, V124, P2236, DOI 10.1002/ijc.24183; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang CJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-616; Wang CJ, 2009, DIS MARKERS, V26, P27, DOI [10.3233/DMA-2009-0601, 10.1155/2009/921907]; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yabuta N, 2000, GENOMICS, V63, P263, DOI 10.1006/geno.1999.6065; Yamashita S, 2012, ONCOLOGY-BASEL, V82, P205, DOI 10.1159/000336809; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	53	136	150	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9508	9518		10.1074/jbc.M112.367763	http://dx.doi.org/10.1074/jbc.M112.367763			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23322774	Green Published, hybrid			2022-12-25	WOS:000316862200066
J	Paladini, RD; Wei, G; Kundu, A; Zhao, QP; Bookbinder, LH; Keller, GA; Shepard, HM; Frost, GI				Paladini, Rudolph D.; Wei, Ge; Kundu, Anirban; Zhao, Qiping; Bookbinder, Louis H.; Keller, Gilbert A.; Shepard, H. Michael; Frost, Gregory I.			Mutations in the Catalytic Domain of Human Matrix Metalloproteinase-1 (MMP-1) That Allow for Regulated Activity through the Use of Ca2+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SKIN COLLAGENASE; MAMMALIAN COLLAGENASES; LIVER FIBROSIS; RAT UTERUS; BINDING; BETA; ENVIRONMENTS; PURIFICATION; SPECIFICITY; INHIBITION	Conditionally active proteins regulated by a physiological parameter represent a potential new class of protein therapeutics. By systematically creating point mutations in the catalytic and linker domains of human MMP-1, we generated a protein library amenable to physiological parameter-based screening. Mutants screened for temperature-sensitive activity had mutations clustered at or near amino acids critical for metal binding. One mutant, GVSK (Gly(159) to Val, Ser(208) to Lys), contains mutations in regions of the catalytic domain involved in calcium and zinc binding. The in vitro activity of GVSK at 37 degrees C in high Ca2+ (10 mM) was comparable with MMP-1 (wild type), but in low Ca2+ (1 mM), there was an over 10-fold loss in activity despite having similar kinetic parameters. Activity decreased over 50% within 15 min and correlated with the degradation of the activated protein, suggesting that GVSK was unstable in low Ca2+. Varying the concentration of Zn2+ had no effect on GVSK activity in vitro. As compared with MMP-1, GVSK degraded soluble collagen I at the high but not the low Ca2+ concentration. In vivo, MMP-1 and GVSK degraded collagen I when perfused in Zucker rat ventral skin and formed higher molecular weight complexes with alpha 2-macroglobulin, an inhibitor of MMPs. In vitro and in vivo complex formation and subsequent enzyme inactivation occurred faster with GVSK, especially at the low Ca2+ concentration. These data suggest that the activity of the human MMP-1 mutant GVSK can be regulated by Ca2+ both in vitro and in vivo and may represent a novel approach to engineering matrix-remodeling enzymes for therapeutic applications.	[Paladini, Rudolph D.; Wei, Ge; Kundu, Anirban; Zhao, Qiping; Bookbinder, Louis H.; Keller, Gilbert A.; Shepard, H. Michael; Frost, Gregory I.] Halozyme Therapeut Inc, San Diego, CA 92121 USA	Halozyme	Paladini, RD (corresponding author), Halozyme Therapeut Inc, 11388 Sorrento Valley Rd, San Diego, CA 92121 USA.	rpaladini@halozyme.com						Bedair H, 2007, J APPL PHYSIOL, V102, P2338, DOI 10.1152/japplphysiol.00670.2006; BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I; Butler GS, 2009, BIOCHEMISTRY-US, V48, P10830, DOI 10.1021/bi901656f; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Chua F, 2005, AM J RESP CELL MOL, V33, P9, DOI 10.1165/rcmb.2005-0062TR; CLARK IM, 1989, BIOCHEM J, V263, P201, DOI 10.1042/bj2630201; EDWARDS DR, 1987, EMBO J, V6, P1899, DOI 10.1002/j.1460-2075.1987.tb02449.x; EISEN AZ, 1970, J LAB CLIN MED, V75, P258; EISEN AZ, 1971, P NATL ACAD SCI USA, V68, P248, DOI 10.1073/pnas.68.1.248; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Gill SE, 2011, BIOL EXTRACELL MATR, P1, DOI 10.1007/978-3-642-16861-1_1; Grinnell F, 1998, J INVEST DERMATOL, V110, P771, DOI 10.1046/j.1523-1747.1998.00192.x; GROSS J, 1962, P NATL ACAD SCI USA, V48, P1014, DOI 10.1073/pnas.48.6.1014; Hadler-Olsen E, 2011, FEBS J, V278, P28, DOI 10.1111/j.1742-4658.2010.07920.x; HOUSLEY TJ, 1993, J BIOL CHEM, V268, P4481; Igawa T, 2010, NAT BIOTECHNOL, V28, P1203, DOI 10.1038/nbt.1691; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; Iimuro Y, 2003, GASTROENTEROLOGY, V124, P445, DOI 10.1053/gast.2003.50063; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Iyer S, 2006, J MOL BIOL, V362, P78, DOI 10.1016/j.jmb.2006.06.079; JEFFREY JJ, 1970, BIOCHEMISTRY-US, V9, P268, DOI 10.1021/bi00804a012; Kaar JL, 2008, ACTA BIOMATER, V4, P1411, DOI 10.1016/j.actbio.2008.03.010; Maskos K, 2005, BIOCHIMIE, V87, P249, DOI 10.1016/j.biochi.2004.11.019; NAGAI Y, 1966, BIOCHEMISTRY-US, V5, P3123, DOI 10.1021/bi00874a007; Nagase H, 1997, BIOL CHEM, V378, P151; Neumann U, 2004, ANAL BIOCHEM, V328, P166, DOI 10.1016/j.ab.2003.12.035; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; SELTZER JL, 1976, ARCH BIOCHEM BIOPHYS, V173, P355, DOI 10.1016/0003-9861(76)90270-8; TAWFIK DS, 1994, PROTEIN ENG, V7, P431, DOI 10.1093/protein/7.3.431; TOLLEFSEN T, 1980, J PERIODONTAL RES, V15, P96, DOI 10.1111/j.1600-0765.1980.tb00263.x; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; WELGUS HG, 1983, J BIOL CHEM, V258, P4162; WERB Z, 1974, BIOCHEM J, V139, P359, DOI 10.1042/bj1390359; Yamamoto T, 1999, J INVEST DERMATOL, V112, P456, DOI 10.1046/j.1523-1747.1999.00528.x; Zeisberg M, 2005, METH MOLEC MED, V117, P261; Zhang YN, 1997, J BIOL CHEM, V272, P1444, DOI 10.1074/jbc.272.3.1444	37	4	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6629	6639		10.1074/jbc.M112.364729	http://dx.doi.org/10.1074/jbc.M112.364729			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23322779	hybrid, Green Published			2022-12-25	WOS:000315820700062
J	Momeni, MH; Payne, CM; Hansson, H; Mikkelsen, NE; Svedberg, J; Engstrom, A; Sandgren, M; Beckham, GT; Stahlberg, J				Momeni, Majid Haddad; Payne, Christina M.; Hansson, Henrik; Mikkelsen, Nils Egil; Svedberg, Jesper; Engstrom, Ake; Sandgren, Mats; Beckham, Gregg T.; Stahlberg, Jerry			Structural, Biochemical, and Computational Characterization of the Glycoside Hydrolase Family 7 Cellobiohydrolase of the Tree-killing Fungus Heterobasidion irregulare	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULE; TRICHODERMA-REESEI CELLOBIOHYDROLASE; PHANEROCHAETE-CHRYSOSPORIUM; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; ENDOGLUCANASE I; BIOMASS RECALCITRANCE; PROCESSIVE CELLULASE; FILAMENTOUS FUNGUS; HUMICOLA-INSOLENS	Root rot fungi of the Heterobasidion annosum complex are the most damaging pathogens in temperate forests, and the recently sequenced Heterobasidion irregulare genome revealed over 280 carbohydrate-active enzymes. Here, H. irregulare was grown on biomass, and the most abundant protein in the culture filtrate was identified as the only family 7 glycoside hydrolase in the genome, which consists of a single catalytic domain, lacking a linker and carbohydrate-binding module. The enzyme, HirCel7A, was characterized biochemically to determine the optimal conditions for activity. HirCel7A was crystallized and the structure, refined at 1.7 angstrom resolution, confirms that HirCel7A is a cellobiohydrolase rather than an endoglucanase, with a cellulose-binding tunnel that is more closed than Phanerochaete chrysosporium Cel7D and more open than Hypocrea jecorina Cel7A, suggesting intermediate enzyme properties. Molecular simulations were conducted to ascertain differences in enzyme-ligand interactions, ligand solvation, and loop flexibility between the family 7 glycoside hydrolase cellobiohydrolases from H. irregulare, H. jecorina, and P. chrysosporium. The structural comparisons and simulations suggest significant differences in enzyme-ligand interactions at the tunnel entrance in the -7 to -4 binding sites and suggest that a tyrosine residue at the tunnel entrance of HirCel7A may serve as an additional ligand-binding site. Additionally, the loops over the active site in H. jecorina Cel7A are more closed than loops in the other two enzymes, which has implications for the degree of processivity, endo- initiation, and substrate dissociation. Overall, this study highlights molecular level features important to understanding this biologically and industrially important family of glycoside hydrolases.	[Momeni, Majid Haddad; Hansson, Henrik; Mikkelsen, Nils Egil; Svedberg, Jesper; Sandgren, Mats; Stahlberg, Jerry] Swedish Univ Agr Sci, Dept Mol Biol, SE-75124 Uppsala, Sweden; [Payne, Christina M.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Beckham, Gregg T.] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA; [Payne, Christina M.] Univ Kentucky, Dept Chem & Mat Engn, Lexington, KY 40506 USA; [Engstrom, Ake] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Beckham, Gregg T.] Colorado Sch Mines, Dept Chem Engn, Golden, CO 80401 USA	Swedish University of Agricultural Sciences; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; University of Kentucky; Uppsala University; Colorado School of Mines	Beckham, GT (corresponding author), Natl Renewable Energy Lab, Natl Bioenergy Ctr, 1617 Cole Blvd,MS 3322 Golden, Golden, CO 80401 USA.	gregg.beckham@nrel.gov; jerry.stahlberg@molbio.slu.se	Payne, Christina M/C-7338-2011; Momeni, Majid Haddad/AAB-1857-2021; Hansson, Henrik/D-4467-2013; Payne, Christina/ABE-8330-2020; Stahlberg, Jerry/D-4163-2013	Payne, Christina M/0000-0001-5264-0964; Momeni, Majid Haddad/0000-0001-9653-1380; Payne, Christina/0000-0001-5264-0964; Stahlberg, Jerry/0000-0003-4059-8580; Hansson, Henrik/0000-0002-6003-2982; Sandgren, Mats/0000-0002-2358-4534	Faculty for Natural Resources and Agriculture at the Swedish University of Agricultural Sciences through the research program "MicroDrivE"; Department of Energy Office of the Biomass Program; National Institute of Computational Science Kraken cluster under National Science Foundation Extreme Science and Engineering Discovery Environment (XSEDE) Grant [MCB090159]; National Renewable Energy Laboratory Computational Sciences Center; Department of Energy Efficiency and Renewable Energy [DE-AC36-08GO28308]	Faculty for Natural Resources and Agriculture at the Swedish University of Agricultural Sciences through the research program "MicroDrivE"; Department of Energy Office of the Biomass Program(United States Department of Energy (DOE)); National Institute of Computational Science Kraken cluster under National Science Foundation Extreme Science and Engineering Discovery Environment (XSEDE) Grant; National Renewable Energy Laboratory Computational Sciences Center; Department of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE))	This work was supported in part by the Faculty for Natural Resources and Agriculture at the Swedish University of Agricultural Sciences through the research program "MicroDrivE." This work was also supported by funds from the Department of Energy Office of the Biomass Program (to C. M. P. and G. T. B.). Computer time for this research was provided by the National Institute of Computational Science Kraken cluster under National Science Foundation Extreme Science and Engineering Discovery Environment (XSEDE) Grant MCB090159 and the National Renewable Energy Laboratory Computational Sciences Center supported by the Department of Energy Efficiency and Renewable Energy under Contract DE-AC36-08GO28308.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beckham GT, 2011, CURR OPIN BIOTECH, V22, P231, DOI 10.1016/j.copbio.2010.11.005; Beckham GT, 2011, J PHYS CHEM B, V115, P4118, DOI 10.1021/jp1106394; Beckham GT, 2010, BIOPHYS J, V99, P3773, DOI 10.1016/j.bpj.2010.10.032; Beckham GT, 2010, J PHYS CHEM B, V114, P1447, DOI 10.1021/jp908810a; Boisset C, 2000, APPL ENVIRON MICROB, V66, P1444, DOI 10.1128/AEM.66.4.1444-1452.2000; Bu LT, 2012, J BIOL CHEM, V287, P24807, DOI 10.1074/jbc.M112.365510; Bu LT, 2011, J BIOL CHEM, V286, P18161, DOI 10.1074/jbc.M110.212076; Bu LT, 2009, J PHYS CHEM B, V113, P10994, DOI 10.1021/jp904003z; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Cruys-Bagger N, 2012, J BIOL CHEM, V287, P18451, DOI 10.1074/jbc.M111.334946; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fox JM, 2012, BIOCHEMISTRY-US, V51, P442, DOI 10.1021/bi2011543; Grassick A, 2004, EUR J BIOCHEM, V271, P4495, DOI 10.1111/j.1432-1033.2004.04409.x; Grigoriev I. V., 2011, NUCLEIC ACIDS RES, P1; Gruno M, 2004, BIOTECHNOL BIOENG, V86, P503, DOI 10.1002/bit.10838; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Harrison MJ, 1998, EUR J BIOCHEM, V256, P119, DOI 10.1046/j.1432-1327.1998.2560119.x; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horn SJ, 2006, FEBS J, V273, P491, DOI 10.1111/j.1742-4658.2005.05079.x; Horn SJ, 2006, P NATL ACAD SCI USA, V103, P18089, DOI 10.1073/pnas.0608909103; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Ilmen M, 1997, APPL ENVIRON MICROB, V63, P1298; Jalak J, 2012, J BIOL CHEM, V287, P28802, DOI 10.1074/jbc.M112.381624; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; King AJ, 2010, P NATL ACAD SCI USA, V107, P5345, DOI 10.1073/pnas.0914228107; Kleywegt GJ, 1997, J MOL BIOL, V272, P383, DOI 10.1006/jmbi.1997.1243; Koivula A, 1998, FEBS LETT, V429, P341, DOI 10.1016/S0014-5793(98)00596-1; KREMER SM, 1992, EUR J BIOCHEM, V205, P133, DOI 10.1111/j.1432-1033.1992.tb16760.x; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Lin YC, 2011, J AM CHEM SOC, V133, P16617, DOI 10.1021/ja206692g; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Mackenzie LF, 1998, BIOCHEM J, V335, P409, DOI 10.1042/bj3350409; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPherson A, 1982, PREPARATION ANAL PRO; Medie FM, 2012, NAT REV MICROBIOL, V10, P227, DOI 10.1038/nrmicro2729; Munoz IG, 2001, J MOL BIOL, V314, P1097, DOI 10.1006/jmbi.2000.5180; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nimlos MR, 2012, J BIOL CHEM, V287, P20603, DOI 10.1074/jbc.M112.358184; Olson A, 2012, NEW PHYTOL, V194, P1001, DOI 10.1111/j.1469-8137.2012.04128.x; Parkkinen T, 2008, PROTEIN SCI, V17, P1383, DOI 10.1110/ps.034488.108; Payne CM, 2012, J BIOL CHEM, V287, P36322, DOI 10.1074/jbc.M112.402149; Payne CM, 2011, J BIOL CHEM, V286, P41028, DOI 10.1074/jbc.M111.297713; Sammond DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048615; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stahlberg J, 1996, J MOL BIOL, V264, P337, DOI 10.1006/jmbi.1996.0644; STAHLBERG J, 1993, BIOCHIM BIOPHYS ACTA, V1157, P107, DOI 10.1016/0304-4165(93)90085-M; Stals I, 2004, GLYCOBIOLOGY, V14, P713, DOI 10.1093/glycob/cwh080; STENLID J, 1985, CAN J BOT, V63, P2268, DOI 10.1139/b85-322; Sulzenbacher G, 1996, BIOCHEMISTRY-US, V35, P15280, DOI 10.1021/bi961946h; Taylor CB, 2012, J BIOL CHEM, V287, P3147, DOI 10.1074/jbc.M111.270389; Textor LC, 2013, FEBS J, V280, P56, DOI 10.1111/febs.12049; Ubhayasekera W, 2005, FEBS J, V272, P1952, DOI 10.1111/j.1742-4658.2005.04625.x; UZCATEGUI E, 1991, J BIOTECHNOL, V19, P271, DOI 10.1016/0168-1656(91)90064-3; van Aalten DMF, 2000, P NATL ACAD SCI USA, V97, P5842, DOI 10.1073/pnas.97.11.5842; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; Woodward S, 1998, HETEROBASIDION ANNOS, P589; Yakovlev I, 2012, APPL MICROBIOL BIOT, V95, P979, DOI 10.1007/s00253-012-4206-x	63	57	60	0	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5861	5872		10.1074/jbc.M112.440891	http://dx.doi.org/10.1074/jbc.M112.440891			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23303184	Green Published, hybrid			2022-12-25	WOS:000315342500056
J	Xu, L; Go, EP; Finney, J; Moon, H; Lantz, M; Rebecchi, K; Desaire, H; Mure, M				Xu, Li; Go, Eden P.; Finney, Joel; Moon, HeeJung; Lantz, Mason; Rebecchi, Kathryn; Desaire, Heather; Mure, Minae			Post-translational Modifications of Recombinant Human Lysyl Oxidase-like 2 (rhLOXL2) Secreted from Drosophila S2 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME-ACTIVITY; GLYCOPROTEINS; COFACTOR; PROTEIN; LOXL2; PROPEPTIDE; CANCER; ACID; SITE	Human lysyl oxidase-like 2 (hLOXL2) is highly up-regulated in metastatic breast cancer cells and tissues and induces epithelial-to-mesenchymal transition, the first step of metastasis/invasion. hloxl2 encodes four N-terminal scavenger receptor cysteine-rich domains and the highly conserved C-terminal lysyl oxidase (LOX) catalytic domain. Here, we assessed the extent of the post-translational modifications of hLOXL2 using truncated recombinant proteins produced in Drosophila S2 cells. The recombinant proteins are soluble, in contrast to LOX, which is consistently reported to require 2-6 M urea for solubilization. The recombinant proteins also show activity in tropoelastin oxidation. After phenylhydrazine derivatization and trypsin digestion, we used mass spectrometry to identify peptides containing the derivatized lysine tyrosylquinone cross-link at Lys-653 and Tyr-689, as well as N-linked glycans at Asn-455 and Asn-644. Disruption of N-glycosylation by site-directed mutagenesis or tunicamycin treatment completely inhibited secretion so that only small quantities of inclusion bodies were detected. The N-glycosylation site at Asn-644 in the LOX catalytic domain is not conserved in human LOX (hLOX), although the LOX catalytic domain of hLOX shares similar to 50% identity and similar to 70% homology with hLOXL2. The catalytic domain of hLOX was not secreted from S2 cells using the same expression system. These results suggest that the N-glycan at Asn-644 of hLOXL2 enhances the solubility and stability of the LOX catalytic domain.	[Xu, Li; Go, Eden P.; Finney, Joel; Moon, HeeJung; Lantz, Mason; Rebecchi, Kathryn; Desaire, Heather; Mure, Minae] Univ Kansas, Dept Chem, Lawrence, KS 66045 USA	University of Kansas	Desaire, H (corresponding author), Univ Kansas, Dept Chem, MRB, 2030 Becker Dr,Rm 220D, Lawrence, KS 66045 USA.	hdesaire@ku.edu; mmure@ku.edu	Finney, Joel/AAD-3773-2021	Finney, Joel/0000-0002-3755-8425	National Institutes of Health [P20 RR015563, GM079446-02, AHA0765445Z, RO1RR026061]; National Science Foundation (NSF) [CAREER MCB-0747377, CAREER CHE-0645120]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015563, R01RR026061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079446] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P20 RR015563 Project 3 (to M.M., Center of Biomedical Research Excellence for Cancer Experimental Therapeutics), GM079446-02 (to M.M.), AHA0765445Z (to M.M.), and RO1RR026061 (to H.D.). This work was also supported by National Science Foundation (NSF) Grants CAREER MCB-0747377 (to M.M.) and CAREER CHE-0645120 (to H.D.).	Aumiller JJ, 2003, GLYCOBIOLOGY, V13, P497, DOI 10.1093/glycob/cwg051; Barker HE, 2011, CANCER RES, V71, P1561, DOI 10.1158/0008-5472.CAN-10-2868; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; BEDELLHOGAN D, 1993, J BIOL CHEM, V268, P10345; Bollinger JA, 2005, BIOCHEMISTRY-US, V44, P11708, DOI 10.1021/bi0504310; CRONSHAW AD, 1995, BIOCHEM J, V306, P279, DOI 10.1042/bj3060279; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Fabini G, 2001, J BIOL CHEM, V276, P28058, DOI 10.1074/jbc.M100573200; Go EP, 2007, ANAL CHEM, V79, P1708, DOI 10.1021/ac061548c; Grimsby JL, 2010, J CELL BIOCHEM, V111, P1231, DOI 10.1002/jcb.22845; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Irungu J, 2007, ANAL CHEM, V79, P3065, DOI 10.1021/ac062100e; Jourdan-Le Saux C, 1999, J BIOL CHEM, V274, P12939; Kim YK, 2005, BIOTECHNOL BIOENG, V92, P452, DOI 10.1002/bit.20605; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Marchal I, 2001, BIOL CHEM, V382, P151, DOI 10.1515/BC.2001.023; Moreno-Bueno G, 2011, EMBO MOL MED, V3, P528, DOI 10.1002/emmm.201100156; Mure M, 2003, J AM CHEM SOC, V125, P6113, DOI 10.1021/ja0214274; Palamakumbura AH, 2002, ANAL BIOCHEM, V300, P245, DOI 10.1006/abio.2001.5464; Panchenko MV, 1996, J BIOL CHEM, V271, P7113, DOI 10.1074/jbc.271.12.7113; Payne SL, 2007, J CELL BIOCHEM, V101, P1338, DOI 10.1002/jcb.21371; Peng L, 2009, CARCINOGENESIS, V30, P1660, DOI 10.1093/carcin/bgp178; Rebecchi KR, 2011, ANAL CHEM, V83, P8484, DOI 10.1021/ac2017037; Rodriguez HM, 2010, J BIOL CHEM, V285, P20964, DOI 10.1074/jbc.M109.094136; SHAH MA, 1993, J BIOL CHEM, V268, P11573; Smith-Mungo LI, 1998, MATRIX BIOL, V16, P387, DOI 10.1016/S0945-053X(98)90012-9; Stanley P., 2009, ESSENTIALS GLYCOBIOL; TANG SS, 1983, J BIOL CHEM, V258, P4331; Uzel MI, 2001, J BIOL CHEM, V276, P22537, DOI 10.1074/jbc.M102352200; Vora SR, 2010, BIOCHEMISTRY-US, V49, P2962, DOI 10.1021/bi902218p; Wang SX, 1997, J BIOL CHEM, V272, P28841, DOI 10.1074/jbc.272.46.28841; Wang SX, 1996, SCIENCE, V273, P1078, DOI 10.1126/science.273.5278.1078	32	28	29	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5357	5363		10.1074/jbc.C112.421768	http://dx.doi.org/10.1074/jbc.C112.421768			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23319596	hybrid, Green Published			2022-12-25	WOS:000315342500010
J	Attoub, S; Arafat, K; Gelaude, A; Al Sultan, MA; Bracke, M; Collin, P; Takahashi, T; Adrian, TE; De Wever, O				Attoub, Samir; Arafat, Kholoud; Gelaude, An; Al Sultan, Mahmood Ahmed; Bracke, Marc; Collin, Peter; Takahashi, Takashi; Adrian, Thomas E.; De Wever, Olivier			Frondoside A Suppressive Effects on Lung Cancer Survival, Tumor Growth, Angiogenesis, Invasion, and Metastasis	PLOS ONE			English	Article							CUCUMARIA-FRONDOSA; SEA-CUCUMBER; TRITERPENE GLYCOSIDE; PANCREATIC-CANCER; NATURAL-PRODUCTS; DRUG DEVELOPMENT; EXTRACT	A major challenge for oncologists and pharmacologists is to develop less toxic drugs that will improve the survival of lung cancer patients. Frondoside A is a triterpenoid glycoside isolated from the sea cucumber, Cucumaria frondosa and was shown to be a highly safe compound. We investigated the impact of Frondoside A on survival, migration and invasion in vitro, and on tumor growth, metastasis and angiogenesis in vivo alone and in combination with cisplatin. Frondoside A caused concentration-dependent reduction in viability of LNM35, A549, NCI-H460-Luc2, MDA-MB-435, MCF-7, and HepG2 over 24 hours through a caspase 3/7-dependent cell death pathway. The IC50 concentrations (producing half-maximal inhibition) at 24 h were between 1.7 and 2.5 mu M of Frondoside A. In addition, Frondoside A induced a time- and concentration-dependent inhibition of cell migration, invasion and angiogenesis in vitro. Frondoside A (0.01 and 1 mg/kg/day i.p. for 25 days) significantly decreased the growth, the angiogenesis and lymph node metastasis of LNM35 tumor xenografts in athymic mice, without obvious toxic side-effects. Frondoside A (0.1-0.5 mu M) also significantly prevented basal and bFGF induced angiogenesis in the CAM angiogenesis assay. Moreover, Frondoside A enhanced the inhibition of lung tumor growth induced by the chemotherapeutic agent cisplatin. These findings identify Frondoside A as a promising novel therapeutic agent for lung cancer.	[Attoub, Samir; Arafat, Kholoud; Al Sultan, Mahmood Ahmed] UAE Univ, Fac Med & Hlth Sci, Dept Pharmacol & Therapeut, Al Ain, U Arab Emirates; [Gelaude, An; Bracke, Marc; De Wever, Olivier] Univ Hosp, Lab Expt Canc Res, Ghent, Belgium; [Collin, Peter] Coastside Bio Resources, Stonington, ME USA; [Takahashi, Takashi] Nagoya Univ, Grad Sch Med, Div Mol Carcinogenesis, Ctr Neurol Dis & Canc, Nagoya, Aichi 4648601, Japan; [Adrian, Thomas E.] UAE Univ, Fac Med & Hlth Sci, Dept Physiol, Al Ain, U Arab Emirates	United Arab Emirates University; Ghent University; Ghent University Hospital; Nagoya University; United Arab Emirates University	Attoub, S (corresponding author), UAE Univ, Fac Med & Hlth Sci, Dept Pharmacol & Therapeut, Al Ain, U Arab Emirates.	samir.attoub@uaeu.ac.ae	Takahashi, Takashi/I-7262-2014; Attoub, Samir/N-6852-2018; Collin, Peter D/AAG-6923-2020; de wever, olivier/J-3094-2013	Takahashi, Takashi/0000-0003-0615-7001; Collin, Peter D/0000-0003-1636-8806; de wever, olivier/0000-0002-5453-760X; Adrian, Thomas/0000-0002-5051-1111	FMHS [NP/08/27]; UAE University grant [01-04-8-11/09]; Terry Fox Fund for Cancer Research; UAEU-NRF [21MO72]; Maine Technology Institute, Gardiner, Maine, USA; National Cancer Institute, RAPID Program	FMHS; UAE University grant; Terry Fox Fund for Cancer Research; UAEU-NRF; Maine Technology Institute, Gardiner, Maine, USA; National Cancer Institute, RAPID Program	This work was financially supported by the FMHS grant number NP/08/27 (SA), the UAE University grant under a contract no. 01-04-8-11/09 (SA), the Terry Fox Fund for Cancer Research (SA and TA), the UAEU-NRF 09/10 grant number 21MO72 (SA), and the Maine Technology Institute, Gardiner, Maine, USA, and the National Cancer Institute, RAPID Program (PC). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Marzouqi N, 2011, EUR J PHARMACOL, V668, P25, DOI 10.1016/j.ejphar.2011.06.023; Aminin DL, 2008, J MED FOOD, V11, P443, DOI 10.1089/jmf.2007.0530; Aminin DL, 2009, J PROTEOMICS, V72, P886, DOI 10.1016/j.jprot.2009.04.004; Dempke WCM, 2010, LUNG CANCER, V67, P257, DOI 10.1016/j.lungcan.2009.10.012; Derycke L, 2006, CLIN EXP METASTAS, V23, P187, DOI 10.1007/s10585-006-9029-7; GIRARD M, 1990, CAN J CHEM, V68, P11, DOI 10.1139/v90-003; Hait WN, 2010, NAT REV DRUG DISCOV, V9, P253, DOI 10.1038/nrd3144; HARRISHOOKER SA, 1983, J CELL PHYSIOL, V114, P302, DOI 10.1002/jcp.1041140308; Janakiram NB, 2010, CANCER PREV RES, V3, P82, DOI 10.1158/1940-6207.CAPR-09-0112; Jin JO, 2009, FEBS LETT, V583, P697, DOI 10.1016/j.febslet.2009.01.010; Korpanty Grzegorz, 2011, J Thorac Dis, V3, P19, DOI 10.3978/j.issn.2072-1439.2010.11.11; Kozaki K, 2000, CANCER RES, V60, P2535; Kuno T., 2012, Journal of Biophysical Chemistry, V3, P156, DOI 10.4236/jbpc.2012.32018; Li X, 2008, ANN NY ACAD SCI, V1138, P181, DOI 10.1196/annals.1414.025; Ma X, BREAST CANC RES TREA; Mann J, 2002, NAT REV CANCER, V2, P143, DOI 10.1038/nrc723; Molinski TF, 2009, NAT REV DRUG DISCOV, V8, P69, DOI 10.1038/nrd2487; Roginsky AB, 2010, PANCREAS, V39, P646, DOI 10.1097/MPA.0b013e3181c72baf; Spira A, 2004, NEW ENGL J MED, V350, P379, DOI 10.1056/NEJMra035536	19	44	47	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53087	10.1371/journal.pone.0053087	http://dx.doi.org/10.1371/journal.pone.0053087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308143	Green Published, gold			2022-12-25	WOS:000313429800029
J	Hornus, S; Levy, B; Lariviere, D; Fourmentin, E				Hornus, Samuel; Levy, Bruno; Lariviere, Damien; Fourmentin, Eric			Easy DNA Modeling and More with GraphiteLifeExplorer	PLOS ONE			English	Article							MUTL; CELLS	The GraphiteLifeExplorer tool enables biologists to reconstruct 3D cellular complexes built from proteins and DNA molecules. Models of DNA molecules can be drawn in an intuitive way and assembled to proteins or others globular structures. Real time navigation and immersion offer a unique view to the reconstructed biological machinery.	[Hornus, Samuel; Levy, Bruno] Inria Nancy Grand Est, Equipe ALICE, Villers Les Nancy, France; [Lariviere, Damien; Fourmentin, Eric] Fourmentin Guilbert Sci Fdn, Noisy Le Grand, France		Hornus, S (corresponding author), Inria Nancy Grand Est, Equipe ALICE, Villers Les Nancy, France.	samuel.hornus@inria.fr; damien.lariviere@fourmentinguilbert.org		Lariviere, Damien/0000-0002-0892-5118; Levy, Bruno/0000-0002-7007-3219	European Research Council [GOOD- SHAPE FP7-ERC-StG-205693]; Fourmentin-Guilbert Scientific Foundation	European Research Council(European Research Council (ERC)European Commission); Fourmentin-Guilbert Scientific Foundation	This work was partially funded by the European Research Council (GOOD- SHAPE FP7-ERC-StG-205693)(http://erc.europa.eu/starting-grants/). This work was partially funded by the Fourmentin-Guilbert Scientific Foundation which had a role in software design, software test, decision to publish, and preparation of the manuscript (http://www.fourmentinguilbert.org/?set_language = en).	Ahrends R, 2006, NUCLEIC ACIDS RES, V34, P3169, DOI 10.1093/nar/gkl407; Alber F, 2008, ANNU REV BIOCHEM, V77, P443, DOI 10.1146/annurev.biochem.77.060407.135530; Boissonnat JD, 2005, GRAPH MODELS, V67, P405, DOI 10.1016/j.gmod.2005.01.004; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Foley J.D., 1995, COMPUTER GRAPHICS PR; Goodsell D. S., 2009, MACHINERY LIFE; Goodsell DS, 2009, BIOCHEM MOL BIOL EDU, V37, P325, DOI 10.1002/bmb.20345; Goodsell DS, 2007, PLOS BIOL, V5, P2759, DOI 10.1371/journal.pbio.0050308; Grant JA, 1996, J COMPUT CHEM, V17, P1653, DOI 10.1002/(SICI)1096-987X(19961115)17:14<1653::AID-JCC7>3.0.CO;2-K; Harold FM, 2005, MICROBIOL MOL BIOL R, V69, P544, DOI 10.1128/MMBR.69.4.544-564.2005; Harold FM, 2007, CURR OPIN MICROBIOL, V10, P591, DOI 10.1016/j.mib.2007.07.003; Johnson GT, 2011, STRUCTURE, V19, P293, DOI 10.1016/j.str.2010.12.023; Junier I, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000678; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kreyszig E., 1991, DIFFERENTIAL GEOMETR; Loriot S, 2010, BIOINFORMATICS, V26, P1127, DOI 10.1093/bioinformatics/btq083; Lu X-J, 2009, NATURE PROTOCOLS, V3, P1213; Macke TJ, 1998, ACS SYM SER, V682, P379; McGill G, 2008, CELL, V133, P1127, DOI 10.1016/j.cell.2008.06.013; Rappsilber J, 2011, J STRUCT BIOL, V173, P530, DOI 10.1016/j.jsb.2010.10.014; Russel D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001244; Sacho EJ, 2008, MOL CELL, V29, P112, DOI 10.1016/j.molcel.2007.10.030; Schofield MJ, 2001, J BIOL CHEM, V276, P28291, DOI 10.1074/jbc.M103148200; Schwede T, 2009, STRUCTURE, V17, P151, DOI 10.1016/j.str.2008.12.014; Tarini M, 2006, IEEE T VIS COMPUT GR, V12, P1237, DOI 10.1109/TVCG.2006.115; Thiel A, 2012, PLOS GENET, V8, P564, DOI 10.1371/journal.pgen.1002672; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Vendeville A, 2011, FEMS MICROBIOL REV, V35, P395, DOI 10.1111/j.1574-6976.2010.00254.x; Walter T, 2010, NAT METHODS, V7, pS26, DOI [10.1038/nmeth.1431, 10.1038/NMETH.1431]; Wang WP, 2008, ACM T GRAPHIC, V27, DOI 10.1145/1330511.1330513; Winkler I, 2011, J BIOL CHEM, V286, P17326, DOI 10.1074/jbc.M110.187641; Zheng GH, 2009, NUCLEIC ACIDS RES, V37, pW240, DOI 10.1093/nar/gkp358	32	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53609	10.1371/journal.pone.0053609	http://dx.doi.org/10.1371/journal.pone.0053609			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308263	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429100096
J	Huang, YJ; Yin, XR; Zhu, CQ; Wang, WW; Grierson, D; Xu, CJ; Chen, KS				Huang, Yuji; Yin, Xueren; Zhu, Changqing; Wang, Weiwei; Grierson, Donald; Xu, Changjie; Chen, Kunsong			Standard Addition Quantitative Real-Time PCR (SAQPCR): A Novel Approach for Determination of Transgene Copy Number Avoiding PCR Efficiency Estimation	PLOS ONE			English	Article							GENE; PLANTS; ASSAY; EXPRESSION; ETHYLENE; RICE; DNA	Quantitative real-time polymerase chain reaction (qPCR) has been previously applied to estimate transgene copy number in transgenic plants. However, the results can be erroneous owing to inaccurate estimation of PCR efficiency. Here, a novel qPCR approach, named standard addition qPCR (SAQPCR), was devised to accurately determine transgene copy number without the necessity of obtaining PCR efficiency data. The procedures and the mathematical basis for the approach are described. A recombinant plasmid harboring both the internal reference gene and the integrated target gene was constructed to serve as the standard DNA. It was found that addition of suitable amounts of standard DNA to test samples did not affect PCR efficiency, and the guidance for selection of suitable cycle numbers for analysis was established. Samples from six individual T-0 tomato (Solanum lycopersicum) plants were analyzed by SAQPCR, and the results confirmed by Southern blot analysis. The approach produced accurate results and required only small amounts of plant tissue. It can be generally applied to analysis of different plants and transgenes. In addition, it can also be applied to zygosity analysis.	[Huang, Yuji; Yin, Xueren; Zhu, Changqing; Wang, Weiwei; Grierson, Donald; Xu, Changjie; Chen, Kunsong] Zhejiang Univ, Lab Fruit Qual Biol, State Agr Minist Lab Hort Plant Growth Dev & Qual, Hangzhou 310058, Zhejiang, Peoples R China; [Grierson, Donald] Univ Nottingham, Sch Biosci, Plant & Crop Sci Div, Loughborough, Leics, England	Zhejiang University; University of Nottingham	Xu, CJ (corresponding author), Zhejiang Univ, Lab Fruit Qual Biol, State Agr Minist Lab Hort Plant Growth Dev & Qual, Hangzhou 310058, Zhejiang, Peoples R China.	chjxu@zju.edu.cn	Yin, Xue-ren/B-3893-2008; Xu, Changjie/D-2656-2009	Yin, Xue-ren/0000-0002-1282-4432; 	National Basic Research Program of China (973 Program) [2011CB100600]; Program of International Science and Technology Cooperation [2011DFB31580]; National Natural Science Foundation of China [31030052]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Program of International Science and Technology Cooperation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program) [2011CB100600]; the Program of International Science and Technology Cooperation [2011DFB31580] and the National Natural Science Foundation of China [31030052]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar T, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng106; Bar T, 2012, NUCLEIC ACIDS RES, V40, P1395, DOI 10.1093/nar/gkr778; Beltran J, 2009, IN VITRO CELL DEV-PL, V45, P48, DOI 10.1007/s11627-008-9159-5; Bruno AK, 2004, J EXP BOT, V55, P2541, DOI 10.1093/jxb/erh273; Bubner B, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-14; Bubner B, 2004, PLANT CELL REP, V23, P263, DOI 10.1007/s00299-004-0859-y; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Canel C, 1996, PLANT MOL BIOL, V31, P143, DOI 10.1007/BF00020613; Casu RE, 2012, PLANT CELL REP, V31, P167, DOI 10.1007/s00299-011-1150-7; Chen Kun-Song, 2004, Yichuan, V26, P529; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; HAMILTON AJ, 1991, P NATL ACAD SCI USA, V88, P7434, DOI 10.1073/pnas.88.16.7434; HAMILTON AJ, 1990, NATURE, V346, P284, DOI 10.1038/346284a0; Harris D. C., 2006, QUANTITATIVE CHEM AN; Ingham DJ, 2001, BIOTECHNIQUES, V31, P132, DOI 10.2144/01311rr04; Karlen Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-131; Li ZW, 2004, PLANT MOL BIOL REP, V22, P179, DOI 10.1007/BF02772725; Liu WH, 2002, ANAL BIOCHEM, V302, P52, DOI 10.1006/abio.2001.5530; Mason Giovanna, 2002, BMC Biotechnol, V2, P20, DOI 10.1186/1472-6750-2-20; Miyao A, 2003, PLANT CELL, V15, P1771, DOI 10.1105/tpc.012559; Omar AA, 2008, BIOTECHNOL PROGR, V24, P1241, DOI 10.1002/btpr.62; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sambrook J, 2001, MOL CLONING LAB MANU; Sha Y, 2004, THEOR APPL GENET, V108, P306, DOI 10.1007/s00122-003-1423-9; Song P, 2002, PLANT CELL REP, V20, P948, DOI 10.1007/s00299-001-0432-x; Tichopad A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng122; Wang Wei-Wei, 2011, Yichuan, V33, P1017, DOI 10.3724/SP.J.1005.2011.01017; Yang L, 2007, BIOL PLANTARUM, V51, P541, DOI 10.1007/s10535-007-0117-6; Yang LT, 2005, PLANT CELL REP, V23, P759, DOI 10.1007/s00299-004-0881-0; Yi CX, 2008, ANAL BIOCHEM, V375, P150, DOI 10.1016/j.ab.2007.11.022	30	10	11	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53489	10.1371/journal.pone.0053489	http://dx.doi.org/10.1371/journal.pone.0053489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308234	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429100074
J	Islam, MA; Lutken, H; Haugslien, S; Blystad, DR; Torre, S; Rolcik, J; Rasmussen, SK; Olsen, JE; Clarke, JL				Islam, M. Ashraful; Lutken, Henrik; Haugslien, Sissel; Blystad, Dag-Ragnar; Torre, Sissel; Rolcik, Jakub; Rasmussen, Soren K.; Olsen, Jorunn E.; Clarke, Jihong Liu			Overexpression of the AtSHI Gene in Poinsettia, Euphorbia pulcherrima, Results in Compact Plants	PLOS ONE			English	Article							ARABIDOPSIS GYNOECIUM DEVELOPMENT; SHI FAMILY GENES; AUXIN BIOSYNTHESIS; GIBBERELLIN METABOLISM; TRANSCRIPTIONAL REGULATION; STEM ELONGATION; FLOWERING TIME; EXPRESSION; THALIANA; GROWTH	Euphorbia pulcherrima, poinsettia, is a non-food and non-feed vegetatively propagated ornamental plant. Appropriate plant height is one of the most important traits in poinsettia production and is commonly achieved by application of chemical growth retardants. To produce compact poinsettia plants with desirable height and reduce the utilization of growth retardants, the Arabidopsis SHORT INTERNODE (AtSHI) gene controlled by the cauliflower mosaic virus 35S promoter was introduced into poinsettia by Agrobacterium-mediated transformation. Three independent transgenic lines were produced and stable integration of transgene was verified by PCR and Southern blot analysis. Reduced plant height (21-52%) and internode lengths (31-49%) were obtained in the transgenic lines compared to control plants. This correlates positively with the AtSHI transcript levels, with the highest levels in the most dwarfed transgenic line (TL1). The indole-3-acetic acid (IAA) content appeared lower (11-31% reduction) in the transgenic lines compared to the wild type (WT) controls, with the lowest level (31% reduction) in TL1. Total internode numbers, bract numbers and bract area were significantly reduced in all transgenic lines in comparison with the WT controls. Only TL1 showed significantly lower plant diameter, total leaf area and total dry weight, whereas none of the AtSHI expressing lines showed altered timing of flower initiation, cyathia abscission or bract necrosis. This study demonstrated that introduction of the AtSHI gene into poinsettia by genetic engineering can be an effective approach in controlling plant height without negatively affecting flowering time. This can help to reduce or avoid the use of toxic growth retardants of environmental and human health concern. This is the first report that AtSHI gene was overexpressed in poinsettia and transgenic poinsettia plants with compact growth were produced.	[Islam, M. Ashraful; Haugslien, Sissel; Blystad, Dag-Ragnar; Clarke, Jihong Liu] Bioforsk Norwegian Inst Agr & Environm Res, As, Norway; [Lutken, Henrik; Rasmussen, Soren K.] Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, Frederiksberg, Denmark; [Torre, Sissel; Olsen, Jorunn E.] Norwegian Univ Life Sci, Dept Plant & Environm Sci, As, Norway; [Rolcik, Jakub] Palacky Univ, CR-77147 Olomouc, Czech Republic	Bioforsk; University of Copenhagen; Norwegian University of Life Sciences; Palacky University Olomouc	Clarke, JL (corresponding author), Bioforsk Norwegian Inst Agr & Environm Res, As, Norway.	jihong.liu-clarke@bioforsk.no	Lütken, Henrik/F-9449-2014; Clarke, Jihong Liu/J-1278-2014; Rasmussen, Soren K./F-6728-2014	Lütken, Henrik/0000-0003-3719-8324; Rasmussen, Soren K./0000-0001-6169-2504; Blystad, Dag-Ragnar/0000-0001-5490-3334	Danish grant "Joint Proof-of-Concept Fund"; Research Council of Norway [KMB 199398/I10]	Danish grant "Joint Proof-of-Concept Fund"; Research Council of Norway(Research Council of Norway)	This research was supported by the Danish grant "Joint Proof-of-Concept Fund" to Professor Soren K Rasmussen and the Research Council of Norway grant KMB 199398/I10 to Dr Jihong Liu Clarke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascough GD, 2008, S AFR J BOT, V74, P357, DOI 10.1016/j.sajb.2008.01.012; Chandler S, 2007, CRIT REV PLANT SCI, V26, P169, DOI 10.1080/07352680701429381; Cheng YF, 2006, GENE DEV, V20, P1790, DOI 10.1101/gad.1415106; Clarke JL, 2008, PLANT CELL REP, V27, P1027, DOI 10.1007/s00299-008-0526-9; Clifford SC, 2004, HORTSCIENCE, V39, P383, DOI 10.21273/HORTSCI.39.2.383; Coles JP, 1999, PLANT J, V17, P547, DOI 10.1046/j.1365-313X.1999.00410.x; Curtis IS, 2005, PLANTA, V222, P957, DOI 10.1007/s00425-005-0037-7; de Castro VL, 2004, INT J ENVIRON HEAL R, V14, P371, DOI 10.1080/09603120400004055; Dijkstra C, 2008, PLANT CELL REP, V27, P463, DOI 10.1007/s00299-007-0471-z; Ecke IP, 2004, ECKE POINSETTIA MANU, P1; Ecke P, 1990, POINSETTIA MANUAL, P1; Eklund DM, 2010, PLANT CELL, V22, P349, DOI 10.1105/tpc.108.064816; Eklund DM, 2010, DEVELOPMENT, V137, P1275, DOI 10.1242/dev.039594; Eriksson S, 2006, PLANT CELL, V18, P2172, DOI 10.1105/tpc.106.042317; Fleet CM, 2005, CURR OPIN PLANT BIOL, V8, P77, DOI 10.1016/j.pbi.2004.11.015; Fridborg I, 1999, PLANT CELL, V11, P1019, DOI 10.1105/tpc.11.6.1019; Fridborg I, 2001, PLANT PHYSIOL, V127, P937, DOI 10.1104/pp.010388; Fujita T, 2008, EVOL DEV, V10, P176, DOI 10.1111/j.1525-142X.2008.00225.x; Hong JK, 2010, GENES GENOM, V32, P309, DOI 10.1007/s13258-010-0011-z; Islam MA, 2012, SCI HORTIC-AMSTERDAM, V147, P136, DOI 10.1016/j.scienta.2012.08.034; Izawa T, 2002, GENE DEV, V16, P2006, DOI 10.1101/gad.999202; Kim SG, 2010, PLANT MOL BIOL, V74, P337, DOI 10.1007/s11103-010-9677-5; KOORNNEEF M, 1985, PHYSIOL PLANTARUM, V65, P33, DOI 10.1111/j.1399-3054.1985.tb02355.x; Kuusk S, 2002, DEVELOPMENT, V129, P4707; Kuusk S, 2006, PLANT J, V47, P99, DOI 10.1111/j.1365-313X.2006.02774.x; Lee M, 1997, NAT BIOTECHNOL, V15, P178; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutken H, 2012, PLANT CELL REP, V31, P1141, DOI 10.1007/s00299-012-1265-5; Lutken H, 2010, PLANT BIOTECHNOL J, V8, P211, DOI 10.1111/j.1467-7652.2009.00478.x; Mata DA, 2009, HORTSCIENCE, V44, P702, DOI 10.21273/HORTSCI.44.3.702; MOE R, 1992, SCI HORTIC-AMSTERDAM, V50, P127, DOI 10.1016/S0304-4238(05)80015-9; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Muller R, 2011, THESIS U COPENHAGEN; Mutasa-Gottgens E, 2009, J EXP BOT, V60, P1979, DOI 10.1093/jxb/erp040; Nemhauser JL, 2000, DEVELOPMENT, V127, P3877; O'Neill DP, 2002, PLANT PHYSIOL, V130, P1974, DOI 10.1104/pp.010587; Pencik A, 2009, TALANTA, V80, P651, DOI 10.1016/j.talanta.2009.07.043; Petty LM, 2001, ACTA HORTIC, P87, DOI 10.17660/ActaHortic.2001.560.9; Potera C, 2007, NAT BIOTECHNOL, V25, P963, DOI 10.1038/nbt0907-963; Rademacher W, 2000, ANNU REV PLANT PHYS, V51, P501, DOI 10.1146/annurev.arplant.51.1.501; Ross JJ, 1998, J PLANT GROWTH REGUL, V17, P141, DOI 10.1007/PL00007027; Ross JJ, 2000, PLANT J, V21, P547, DOI 10.1046/j.1365-313x.2000.00702.x; Sakamoto T, 2003, NAT BIOTECHNOL, V21, P909, DOI 10.1038/nbt847; Sambrook J., 2002, MOL CLONING LAB MANU; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Sohlberg JJ, 2006, PLANT J, V47, P112, DOI 10.1111/j.1365-313X.2006.02775.x; Sorensen MT, 2006, INT J ANDROL, V29, P129, DOI 10.1111/j.1365-2605.2005.00629.x; Staldal V, 2008, NEW PHYTOL, V180, P798, DOI 10.1111/j.1469-8137.2008.02625.x; Staldal V, 2012, PLANT MOL BIOL, V78, P545, DOI 10.1007/s11103-012-9888-z; Stavang JA, 2005, PLANT PHYSIOL, V138, P2344, DOI 10.1104/pp.105.063149; Stavang JA, 2009, PLANT J, V60, P589, DOI 10.1111/j.1365-313X.2009.03983.x; Taiz L., 2010, PLANT PHYSIOL, P545; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Wolbang CM, 2004, PLANT PHYSIOL, V134, P769, DOI 10.1104/pp.103.030460; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Zawaski C, 2011, NEW PHYTOL, V191, P678, DOI 10.1111/j.1469-8137.2011.03742.x; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306; Zhao YD, 2010, ANNU REV PLANT BIOL, V61, P49, DOI 10.1146/annurev-arplant-042809-112308; Zhu LH, 2008, PLANT CELL REP, V27, P289, DOI 10.1007/s00299-007-0462-0	61	15	20	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53377	10.1371/journal.pone.0053377	http://dx.doi.org/10.1371/journal.pone.0053377			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308204	gold, Green Published, Green Submitted			2022-12-25	WOS:000313429100059
J	Okoshi, R; Shu, CL; Ihara, S; Fukui, Y				Okoshi, Rintaro; Shu, Chung-Li; Ihara, Sayoko; Fukui, Yasuhisa			Scattering of MCF7 Cells by Heregulin beta-1 Depends on the MEK and p38 MAP Kinase Pathway	PLOS ONE			English	Article							TIGHT JUNCTIONS; BREAST-CANCER; E-CADHERIN; ADHERENS JUNCTIONS; SIGNALING PATHWAY; EPITHELIAL-CELLS; GROWTH-FACTOR; ADHESION; RAC; MOLECULES	Heregulin (HRG) beta 1 signaling promotes scattering of MCF7 cells by inducing breakdown of adherens and tight junctions. Here, we show that stimulation with HRG-beta 1 causes the F-actin backbone of junctions to destabilize prior to the loss of adherent proteins and scattering of the cells. The adherent proteins dissociate and translocate from cell-cell junctions to the cytosol. Moreover, using inhibitors we show that the MEK1 pathway is required for the disappearance of F-actin from junctions and p38 MAP kinase activity is essential for scattering of the cells. Upon treatment with a p38 MAP kinase inhibitor, adherens junction complexes immediately reassemble, most likely in the cytoplasm, and move to the plasma membrane in cells dissociated by HRG-beta 1 stimulation. Subsequently, tight junction complexes form, most likely in the cytoplasm, and move to the plasma membrane. Thus, the p38 MAP kinase inhibitor causes a re-aggregation of scattered cells, even in the presence of HRG-beta 1. These results suggest that p38 MAP kinase signaling to adherens junction proteins regulates cell aggregation, providing a novel understanding of the regulation of cell-cell adhesion.	[Okoshi, Rintaro; Shu, Chung-Li; Fukui, Yasuhisa] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan; [Ihara, Sayoko] Univ Tokyo, Grad Sch Agr & Life Sci, Div Appl Biol Chem, Tokyo, Japan; [Fukui, Yasuhisa] Hoshi Univ, Lab Signal Transduct, Tokyo 142, Japan	National Health Research Institutes - Taiwan; University of Tokyo; Hoshi University	Fukui, Y (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan.	990412@nhri.org.tw	Fukui, Yasuhisa/E-8806-2010		Japan's Ministry of Education, Culture, Sports, Science and Technology [20013044]; National Institute of Biomedical Innovation, Japan; National Health Research Institutes, Taiwan	Japan's Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation, Japan(National Institute of Biomedical Innovation); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by grants-in-aid from Japan's Ministry of Education, Culture, Sports, Science and Technology, #20013044; a grant from the National Institute of Biomedical Innovation, Japan; and a grant from the National Health Research Institutes, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 2001, MOL BIOL CELL, V12, P847, DOI 10.1091/mbc.12.4.847; Breuleux M, 2007, CELL MOL LIFE SCI, V64, P2358, DOI 10.1007/s00018-007-7120-0; Burgess AW, 2008, GROWTH FACTORS, V26, P263, DOI 10.1080/08977190802312844; Comoglio PM, 1996, GENES CELLS, V1, P347, DOI 10.1046/j.1365-2443.1996.37037.x; Edme N, 2002, J CELL SCI, V115, P2591; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fukata M, 2001, MOL CELL BIOL, V21, P2165, DOI 10.1128/MCB.21.6.2165-2183.2001; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Grotegut S, 2006, EMBO J, V25, P3534, DOI 10.1038/sj.emboj.7601213; Hamburger AW, 2008, J MAMMARY GLAND BIOL, V13, P225, DOI 10.1007/s10911-008-9077-5; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hutcheson IR, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1754; Kamei T, 1999, ONCOGENE, V18, P6776, DOI 10.1038/sj.onc.1203114; Khwaja A, 1998, J BIOL CHEM, V273, P18793, DOI 10.1074/jbc.273.30.18793; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Lozano E, 2008, J CELL SCI, V121, P933, DOI 10.1242/jcs.016121; Lynch EA, 2006, MOL BIOL CELL, V17, P2236, DOI 10.1091/mbc.E05-08-0779; McNeil C, 1998, J NATL CANCER I, V90, P882, DOI 10.1093/jnci/90.12.882; Niessen CM, 2008, BBA-BIOMEMBRANES, V1778, P562, DOI 10.1016/j.bbamem.2007.12.015; Niessen CM, 2007, J INVEST DERMATOL, V127, P2525, DOI 10.1038/sj.jid.5700865; Oka T, 2007, J BIOL CHEM, V282, P2011, DOI 10.1074/jbc.M605153200; Paris L, 2008, BBA-BIOMEMBRANES, V1778, P646, DOI 10.1016/j.bbamem.2007.08.004; Paumelle R, 2000, MOL BIOL CELL, V11, P3751, DOI 10.1091/mbc.11.11.3751; Paumelle R, 2002, ONCOGENE, V21, P2309, DOI 10.1038/sj.onc.1205297; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; Russell AJ, 2003, J CELL SCI, V116, P3543, DOI 10.1242/jcs.00663; Soldati C, 2008, J NEUROSCI RES, V86, P1044, DOI 10.1002/jnr.21557; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Tsukita S, 1999, TRENDS CELL BIOL, V9, P268, DOI 10.1016/S0962-8924(99)01578-0; Tsukita S, 1999, CURR OPIN CELL BIOL, V11, P628, DOI 10.1016/S0955-0674(99)00016-2; Vadlamudi R, 1999, ONCOGENE, V18, P7253, DOI 10.1038/sj.onc.1203163; Xu QY, 2003, ONCOGENE, V22, P5537, DOI 10.1038/sj.onc.1206796; Yonezawa M, 2009, DIGESTION, V80, P215, DOI 10.1159/000229775	36	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53298	10.1371/journal.pone.0053298	http://dx.doi.org/10.1371/journal.pone.0053298			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308187	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429100051
J	Sapsutthipas, S; Tsuchiya, N; Pathipavanich, P; Ariyoshi, K; Sawanpanyalert, P; Takeda, N; Isarangkura-na-ayuthaya, P; Kameoka, M				Sapsutthipas, Sompong; Tsuchiya, Naho; Pathipavanich, Panita; Ariyoshi, Koya; Sawanpanyalert, Pathom; Takeda, Naokazu; Isarangkura-na-ayuthaya, Panasda; Kameoka, Masanori			CRF01_AE-Specific Neutralizing Activity Observed in Plasma Derived from HIV-1-Infected Thai Patients Residing in Northern Thailand: Comparison of Neutralizing Breadth and Potency between Plasma Derived from Rapid and Slow Progressors	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODY; FUSION INHIBITOR; ENV CLONES; INFECTION; HIV-1; GP41; DIVERSITY; RESPONSES; SELECTION	Background: Development of a protective vaccine against human immunodeficiency virus type 1 (HIV-1) is an important subject in the field of medical sciences; however, it has not yet been achieved. Potent and broadly neutralizing antibodies are found in the plasma of some HIV-1-infected patients, whereas such antibody responses have failed to be induced by currently used vaccine antigens. In order to develop effective vaccine antigens, it is important to reveal the molecular mechanism of how strong humoral immune responses are induced in infected patients. As part of such studies, we examined the correlation between the anti-HIV-1 neutralizing antibody response and disease progression. Methodology/Principal Findings: We evaluated the anti-HIV-1 neutralizing activity of plasma derived from 33 rapid and 34 slow progressors residing in northern Thailand. The level of neutralizing activity varied considerably among plasmas, and no statistically significant differences in the potency and breadth of neutralizing activities were observed overall between plasma derived from rapid and slow progressors; however, plasma of 4 slow progressors showed neutralizing activity against all target viruses, whereas none of the plasma of rapid progressors showed such neutralizing activity. In addition, 21% and 9% of plasmas derived from slow and rapid progressors inhibited the replication of more than 80% of CRF01_AE Env-recombinant viruses tested, respectively. Neutralization of subtype B and C Env-recombinant viruses by the selected plasma was also examined; however, these plasma samples inhibited the replication of only a few viruses tested. Conclusions/Significance: Although no statistically significant differences were observed in the potency and breadth of anti-HIV-1 neutralizing activities between plasma derived from rapid and slow progressors, several plasma samples derived from slow progressors neutralized CRF01_AE Env-recombinant viruses more frequently than those from rapid progressors. In addition, plasma derived from HIV-1-infected Thai patients showed CRF01_AE-specific neutralizing activity.	[Sapsutthipas, Sompong; Takeda, Naokazu; Kameoka, Masanori] Thailand Japan Res Collaborat Ctr Emerging & Reem, Nonthaburi, Thailand; [Tsuchiya, Naho; Ariyoshi, Koya] Nagasaki Univ, Inst Trop Med, Nagasaki 852, Japan; [Pathipavanich, Panita] Lampang Hosp, Lampang, Thailand; [Sawanpanyalert, Pathom; Isarangkura-na-ayuthaya, Panasda] Minist Publ Hlth, Dept Med Sci, Natl Inst Hlth, Nonthaburi, Thailand; [Takeda, Naokazu; Kameoka, Masanori] Osaka Univ, Microbial Dis Res Inst, Osaka, Japan; [Kameoka, Masanori] Kobe Univ, Grad Sch Hlth Sci, Dept Int Hlth, Kobe, Hyogo, Japan	Nagasaki University; Ministry of Public Health - Thailand; Osaka University; Kobe University	Kameoka, M (corresponding author), Thailand Japan Res Collaborat Ctr Emerging & Reem, Nonthaburi, Thailand.	mkameoka@port.kobe-u.ac.jp		Kameoka, Masanori/0000-0001-5525-9915	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) by the Ministry of Education, Culture, Sports, Science and Technology of Japan; Department of Medical Sciences, Ministry of Public Health of Thailand	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) by the Ministry of Education, Culture, Sports, Science and Technology of Japan; Department of Medical Sciences, Ministry of Public Health of Thailand	This work was supported by the program of the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) by the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the research budget of the Department of Medical Sciences, Ministry of Public Health of Thailand. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo MA, 2010, AIDS RES HUM RETROV, V26, P5, DOI 10.1089/aid.2009.0150; BARBAS CF, 1993, J MOL BIOL, V230, P812, DOI 10.1006/jmbi.1993.1203; Bjorndal A, 1997, J VIROL, V71, P7478; Boonchawalit S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027098; CAO YZ, 1995, NEW ENGL J MED, V332, P201, DOI 10.1056/NEJM199501263320401; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Doria-Rose NA, 2009, J VIROL, V83, P188, DOI 10.1128/JVI.01583-08; Euler Z, 2012, J VIROL, V86, P2045, DOI 10.1128/JVI.06091-11; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Girard MP, 2011, VACCINE, V29, P6191, DOI [10.1016/j.vaccine.2011.08.031, 10.1016/j.vaccine.2011.06.085]; Gnanakaran S, 2007, J VIROL, V81, P4886, DOI 10.1128/JVI.01954-06; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Kinomoto M, 2005, J VIROL, V79, P5996, DOI 10.1128/JVI.79.10.5996-6004.2005; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Mascola JR, 1996, AIDS RES HUM RETROV, V12, P1319, DOI 10.1089/aid.1996.12.1319; Montefiori DC, 1996, J INFECT DIS, V173, P60, DOI 10.1093/infdis/173.1.60; Piantadosi A, 2009, J VIROL, V83, P10269, DOI 10.1128/JVI.01149-09; Pilgrim AK, 1997, J INFECT DIS, V176, P924, DOI 10.1086/516508; PURTSCHER M, 1994, AIDS RES HUM RETROV, V10, P1651, DOI 10.1089/aid.1994.10.1651; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Utachee P, 2009, MICROBES INFECT, V11, P334, DOI 10.1016/j.micinf.2008.12.008; Utachee P, 2009, AIDS RES HUM RETROV, V25, P229, DOI 10.1089/aid.2008.0232; Vaine M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013916; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659	32	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53920	10.1371/journal.pone.0053920	http://dx.doi.org/10.1371/journal.pone.0053920			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308290	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429100122
J	Si, YL; de Boer, WF; Gong, P				Si, Yali; de Boer, Willem F.; Gong, Peng			Different Environmental Drivers of Highly Pathogenic Avian Influenza H5N1 Outbreaks in Poultry and Wild Birds	PLOS ONE			English	Article							SPREAD; VIRUS; PERSISTENCE; EUROPE	A large number of highly pathogenic avian influenza (HPAI) H5N1 outbreaks in poultry and wild birds have been reported in Europe since 2005. Distinct spatial patterns in poultry and wild birds suggest that different environmental drivers and potentially different spread mechanisms are operating. However, previous studies found no difference between these two outbreak types when only the effect of physical environmental factors was analysed. The influence of physical and anthropogenic environmental variables and interactions between the two has only been investigated for wild bird outbreaks. We therefore tested the effect of these environmental factors on HPAI H5N1 outbreaks in poultry, and the potential spread mechanism, and discussed how these differ from those observed in wild birds. Logistic regression analyses were used to quantify the relationship between HPAI H5N1 outbreaks in poultry and environmental factors. Poultry outbreaks increased with an increasing human population density combined with close proximity to lakes or wetlands, increased temperatures and reduced precipitation during the cold season. A risk map was generated based on the identified key factors. In wild birds, outbreaks were strongly associated with an increased Normalized Difference Vegetation Index (NDVI) and lower elevation, though they were similarly affected by climatic conditions as poultry outbreaks. This is the first study that analyses the differences in environmental drivers and spread mechanisms between poultry and wild bird outbreaks. Outbreaks in poultry mostly occurred in areas where the location of farms or trade areas overlapped with habitats for wild birds, whereas outbreaks in wild birds were mainly found in areas where food and shelters are available. The different environmental drivers suggest that different spread mechanisms might be involved: HPAI H5N1 spread to poultry via both poultry and wild birds, whereas contact with wild birds alone seems to drive the outbreaks in wild birds.	[Si, Yali; Gong, Peng] Tsinghua Univ, Key Lab Earth Syst Modeling, Minist Educ, Beijing 100084, Peoples R China; [Si, Yali; Gong, Peng] Tsinghua Univ, Ctr Earth Syst Sci, Beijing 100084, Peoples R China; [de Boer, Willem F.] Wageningen Univ, Resource Ecol Grp, NL-6700 AP Wageningen, Netherlands	Tsinghua University; Tsinghua University; Wageningen University & Research	Si, YL (corresponding author), Tsinghua Univ, Key Lab Earth Syst Modeling, Minist Educ, Beijing 100084, Peoples R China.	siyali82@gmail.com	Si, Yali/B-3573-2012; Gong, Peng/AAM-1516-2021	Si, Yali/0000-0001-7107-9850; Gong, Peng/0000-0003-1513-3765	National High Technology Programme of China [2009AA12200101]; Fund for Talents of Tsinghua [553407001]	National High Technology Programme of China; Fund for Talents of Tsinghua	This research is supported by the National High Technology Programme of China (Grant No. 2009AA12200101) and the Fund for Talents of Tsinghua (Grant No. 553407001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, APPL LINEAR STAT MOD; Cardona CJ, 2009, COMP IMMUNOL MICROB, V32, P255, DOI 10.1016/j.cimid.2008.01.001; Fang LQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002268; Farnsworth ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032729; Ge E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029617; Gilbert M, 2006, EMERG INFECT DIS, V12, P227, DOI 10.3201/eid1202.050640; Gilbert M, 2012, SPAT SPATIO-TEMPORAL, V3, P173, DOI 10.1016/j.sste.2012.01.002; Lam TTY, 2012, ECOL LETT, V15, P24, DOI 10.1111/j.1461-0248.2011.01703.x; OIE, 2009, HIGHLY PATHOGENIC AV; Ottaviani D, 2010, ECOHEALTH, V7, P226, DOI 10.1007/s10393-010-0316-z; Pittman M, 2008, ZOONOSES PUBLIC HLTH, V55, P29, DOI 10.1111/j.1863-2378.2007.01087.x; Reperant LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000854; Si YL, 2010, ECOL SOC, V15, DOI 10.5751/es-03622-150326; Si YL, 2009, GEOSPATIAL HEALTH, V4, P65, DOI 10.4081/gh.2009.211; STALLKNECHT DE, 1990, AVIAN DIS, V34, P406, DOI 10.2307/1591428; Ward M, 2008, VET RES COMMUN, V32, P627, DOI 10.1007/s11259-008-9064-8; Williams RAJ, 2011, GEOSPATIAL HEALTH, V5, P247, DOI 10.4081/gh.2011.177	17	51	52	1	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53362	10.1371/journal.pone.0053362	http://dx.doi.org/10.1371/journal.pone.0053362			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308201	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429100057
J	Umhau, JC; George, DT; Heaney, RP; Lewis, MD; Ursano, RJ; Heilig, M; Hibbeln, JR; Schwandt, ML				Umhau, John C.; George, David T.; Heaney, Robert P.; Lewis, Michael D.; Ursano, Robert J.; Heilig, Markus; Hibbeln, Joseph R.; Schwandt, Melanie L.			Low Vitamin D Status and Suicide: A Case-Control Study of Active Duty Military Service Members	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; D SUPPLEMENTATION; D DEFICIENCY; DEPRESSION; SYMPTOMS; ASSOCIATION; SAMPLE; RISK	Objective: Considering that epidemiological studies show that suicide rates in many countries are highest in the spring when vitamin D status is lowest, and that low vitamin D status can affect brain function, we sought to evaluate if a low level of 25-hydroxyvitamin D [25(OH)D] could be a predisposing factor for suicide. \Method: We conducted a prospective, nested, case-control study using serum samples stored in the Department of Defense Serum Repository. Participants were previously deployed active duty US military personnel (2002-2008) who had a recent archived serum sample available for analysis. Vitamin D status was estimated by measuring 25(OH) D levels in serum samples drawn within 24 months of the suicide. Each verified suicide case (n = 495) was matched to a control (n = 495) by rank, age and sex. We calculated odds ratio of suicide associated with categorical levels (octiles) of 25(OH) D, adjusted by season of serum collection. Findings: More than 30% of all subjects had 25(OH) D values below 20 ng/mL. Although mean serum 25(OH) D concentrations did not differ between suicide cases and controls, risk estimates indicated that subjects in the lowest octile of season-adjusted 25(OH) D(<15.5 ng/mL) had the highest risk of suicide, with subjects in the subsequent higher octiles showing approximately the same level of decreased risk (combined odds ratio compared to lowest octile = 0.49; 95% C.I.: 0.315-0.768). Conclusions: Low vitamin D status is common in active duty service members. The lowest 25(OH) D levels are associated with an increased risk for suicide. Future studies could determine if additional sunlight exposure and vitamin D supplementation might reduce suicide by increasing 25(OH) D levels.	[Umhau, John C.; George, David T.; Heilig, Markus; Hibbeln, Joseph R.; Schwandt, Melanie L.] NIAAA, NIH, Bethesda, MD USA; [Heaney, Robert P.] Creighton Univ, Med Ctr, Osteoporosis Res Ctr, Omaha, NE USA; [Lewis, Michael D.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med, Bethesda, MD 20814 USA; [Ursano, Robert J.] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Creighton University; Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA	Umhau, JC (corresponding author), NIAAA, NIH, Bethesda, MD USA.	umhau@jhu.edu	Schwandt, Melanie L/L-9866-2016; Ursano, Robert J/ABE-6533-2020	Heilig, Markus/0000-0003-2706-2482; Ursano, Robert/0000-0002-1861-9173	Division of Intramural Basic and Clinical Research; NIAAA; NIH; Defense Advanced projects Agency, Arlington, Virginia; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000115, ZIAAA000213] Funding Source: NIH RePORTER	Division of Intramural Basic and Clinical Research; NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced projects Agency, Arlington, Virginia; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The Division of Intramural Basic and Clinical Research, NIAAA and NIH supported this study and were responsible for design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, and approval of the manuscript. The Defense Advanced projects Agency, Arlington, Virginia, gave a grant to support this work.	Andersen NE, 2010, J INT SOC SPORT NUTR, V7, DOI 10.1186/1550-2783-7-38; Annweiler C, 2010, NEUROLOGY, V74, P27, DOI 10.1212/WNL.0b013e3181beecd3; Bertone-Johnson ER, 2011, AM J CLIN NUTR, V94, P1104, DOI 10.3945/ajcn.111.017384; BREWERTON TD, 1988, PSYCHIAT RES, V23, P257, DOI 10.1016/0165-1781(88)90016-9; Dantzer R, 2011, PSYCHONEUROENDOCRINO, V36, P426, DOI 10.1016/j.psyneuen.2010.09.012; Deisenhammer EA, 2009, J CLIN PSYCHIAT, V70, P19, DOI 10.4088/JCP.07m03904; Havaki-Kontaxaki B J, 2010, Psychiatriki, V21, P324; Heaney RP, 2003, AM J CLIN NUTR, V77, P204, DOI 10.1093/ajcn/77.1.204; Heaney RP, 2012, N ENGL J MED; Hedelin M, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-38; Hoang MT, 2011, MAYO CLIN PROC, V86, P1050, DOI 10.4065/mcp.2011.0208; Holick MF, 2010, NUTR HEALTH SER, P1, DOI 10.1007/978-1-60327-303-9; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Jaddou HY, 2011, EUR ARCH PSYCHIAT CL; Jorde R, 2008, J INTERN MED, V264, P599, DOI 10.1111/j.1365-2796.2008.02008.x; Kjaergaard M, 2011, PSYCHIAT RES, V190, P221, DOI 10.1016/j.psychres.2011.06.024; Kuningas M, 2009, NEUROBIOL AGING, V30, P466, DOI 10.1016/j.neurobiolaging.2007.07.001; Lam RW, 2000, J CLIN PSYCHIAT, V61, P30, DOI 10.4088/JCP.v61n0108; Lappe J, 2008, J BONE MINER RES, V23, P741, DOI 10.1359/jbmr.080102; Lappe JM, 2006, J AM COLL NUTR, V25, P395, DOI 10.1080/07315724.2006.10719551; Lewis MD, 2011, J CLIN PSYCHIAT; Lindqvist D, 2011, ACTA PSYCHIAT SCAND, V124, P52, DOI 10.1111/j.1600-0447.2010.01655.x; Mann JJ, 2003, NAT REV NEUROSCI, V4, P819, DOI 10.1038/nrn1220; May HT, 2010, AM HEART J, V159, P1037, DOI 10.1016/j.ahj.2010.03.017; McCann JC, 2008, FASEB J, V22, P982, DOI 10.1096/fj.07-9326rev; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Platz EA, 2004, CANCER CAUSE CONTROL, V15, P255, DOI 10.1023/B:CACO.0000024245.24880.8a; Postolache TT, 2010, J AFFECT DISORDERS, V121, P88, DOI 10.1016/j.jad.2009.05.015; Preti A, 1998, PSYCHIAT RES, V78, P9, DOI 10.1016/S0165-1781(97)00154-6; Snellman G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007747; Wang YT, 2009, AM J EPIDEMIOL, V170, P88, DOI 10.1093/aje/kwp086	31	50	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e51543	10.1371/journal.pone.0051543	http://dx.doi.org/10.1371/journal.pone.0051543			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072KP	23308099	Green Published, gold			2022-12-25	WOS:000313670100004
J	Cui, HY; Gao, HB; Cui, XL; Zhao, Y; Shi, XM; Li, QL; Yan, S; Gao, M; Wang, M; Liu, CJ; Wang, YF				Cui, Hongyu; Gao, Hongbo; Cui, Xianlan; Zhao, Yan; Shi, Xingming; Li, Qiaoling; Yan, Shuai; Gao, Ming; Wang, Mei; Liu, Changjun; Wang, Yunfeng			Avirulent Marek's Disease Virus Type 1 Strain 814 Vectored Vaccine Expressing Avian Influenza (AI) Virus H5 Haemagglutinin Induced Better Protection Than Turkey Herpesvirus Vectored AI Vaccine	PLOS ONE			English	Article							INFECTIOUS BURSAL DISEASE; BACTERIAL ARTIFICIAL CHROMOSOME; NEWCASTLE-DISEASE; RECOMBINANT HERPESVIRUS; MATERNAL ANTIBODIES; SEQUENCE-ANALYSIS; GLYCOPROTEIN-B; FOWLPOX VIRUS; IBDV VP2; HA GENE	Background: Herpesvirus of turkey (HVT) as a vector to express the haemagglutinin (HA) of avian influenza virus (AIV) H5 was developed and its protection against lethal Marek's disease virus (MDV) and highly pathogenic AIV (HPAIV) challenges was evaluated previously. It is well-known that avirulemt MDV type 1 vaccines are more effective than HVT in prevention of lethal MDV infection. To further increase protective efficacy against HPAIV and lethal MDV, a recombinant MDV type 1 strain 814 was developed to express HA gene of HPAIV H5N1. Methodology/Principal Findings: A recombinant MDV-1 strain 814 expressing HA gene of HPAIV H5N1 virus A/goose/Guangdong/3/96 at the US2 site (rMDV-HA) was developed under the control of a human CMV immediate-early promoter. The HA expression in the rMDV-HA was tested by immunofluorescence and Western blot analyses, and in vitro and in vivo growth properties of rMDV-HA were also analyzed. Furthermore, we evaluated and compared the protective immunity of rMDV-HA and previously constructed rHVT-HA against HPAIV and lethal MDV. Vaccination of chickens with rMDV-HA induced 80% protection against HPAIV, which was better than the protection rate by rHVT-HA (66.7%). In the animal study with MDV challenge, chickens immunized with rMDV-HA were completely protected against virulent MDV strain J-1 whereas rHVT-HA only induced 80% protection with the same challenge dose. Conclusions/Significance: The rMDV-HA vaccine was more effective than rHVT-HA vaccine for protection against lethal MDV and HPAIV challenges. Therefore, avirulent MDV type 1 vaccine is a better vector than HVT for development of a recombinant live virus vaccine against virulent MDV and HPAIV in poultry.	[Cui, Hongyu; Gao, Hongbo; Zhao, Yan; Shi, Xingming; Li, Qiaoling; Yan, Shuai; Gao, Ming; Wang, Mei; Liu, Changjun; Wang, Yunfeng] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Avian Infect Dis, Harbin, Peoples R China; [Cui, Xianlan] Hlth Anim Lab, Dept Primary Ind Pk Water & Environm, Hobart, Tas, Australia	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Wang, YF (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Avian Infect Dis, Harbin, Peoples R China.	yfwang@hvri.ac.cn	Gao, Hongbo/AHE-9262-2022; Cui, Xianlan/N-1734-2017	Cui, Xianlan/0000-0002-5029-1286	State Key Laboratory of Veterinary Biotechnology as Basic Research Programs of China [SKLVBP201212]; Basic Scientific Research Operation Cost of State-leveled Public Welfare Scientific Research Courtyard [0302012009]	State Key Laboratory of Veterinary Biotechnology as Basic Research Programs of China; Basic Scientific Research Operation Cost of State-leveled Public Welfare Scientific Research Courtyard	The study was supported by a grant from the State Key Laboratory of Veterinary Biotechnology as Basic Research Programs of China (SKLVBP201212) and the Basic Scientific Research Operation Cost of State-leveled Public Welfare Scientific Research Courtyard (0302012009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Baigent SJ, 2006, J GEN VIROL, V87, P769, DOI 10.1099/vir.0.81498-0; Bublot M, 2007, J COMP PATHOL, V137, pS81, DOI 10.1016/j.jcpa.2007.04.017; Capua I, 2000, AVIAN PATHOL, V29, P289, DOI 10.1080/03079450050118403; Capua I, 2009, REV SCI TECH OIE, V28, P245, DOI 10.20506/rst.28.1.1861; Capua I, 2000, VET REC, V147, P751; Chen HL, 2009, SCI CHINA SER C, V52, P419, DOI 10.1007/s11427-009-0068-6; Cui HY, 2009, J VIROL METHODS, V156, P66, DOI 10.1016/j.jviromet.2008.10.021; Cui Hongyu, 2008, Sheng Wu Gong Cheng Xue Bao, V24, P569, DOI 10.1016/S1872-2075(08)60028-X; Cui SJ, 2008, J VET DIAGN INVEST, V20, P567, DOI 10.1177/104063870802000505; DARTEIL R, 1995, VIROLOGY, V211, P481, DOI 10.1006/viro.1995.1430; Gao HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022549; Ge JY, 2007, J VIROL, V81, P150, DOI 10.1128/JVI.01514-06; Heckert RA, 1996, AVIAN DIS, V40, P770, DOI 10.2307/1592296; Jiang Y, 2007, ANTIVIR RES, V75, P234, DOI 10.1016/j.antiviral.2007.03.009; Lee LF, 2008, VACCINE, V26, P1887, DOI 10.1016/j.vaccine.2008.01.046; Li YQ, 2011, VACCINE, V29, P8257, DOI 10.1016/j.vaccine.2011.08.115; Liu Ai-ling, 2009, Chinese Journal of Virology, V25, P368; Liu ChaoNan, 2006, Scientia Agricultura Sinica, V39, P412; Liu JX, 2011, J VIROL, V85, P10989, DOI 10.1128/JVI.05420-11; Luschow D, 2001, VACCINE, V19, P4249, DOI 10.1016/S0264-410X(01)00167-0; MORGAN RW, 1993, AVIAN DIS, V37, P1032, DOI 10.2307/1591910; MORGAN RW, 1992, AVIAN DIS, V36, P858, DOI 10.2307/1591544; Nayak B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006509; Oveissi S, 2010, COMP IMMUNOL MICROB, V33, P491, DOI 10.1016/j.cimid.2009.08.004; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; Pavlova SP, 2009, VACCINE, V27, P5085, DOI 10.1016/j.vaccine.2009.06.048; Prandini F, 2008, ZOOTECNICA INT, P40; Reddy SK, 1996, VACCINE, V14, P469, DOI 10.1016/0264-410X(95)00242-S; ROSS LJN, 1993, J GEN VIROL, V74, P371, DOI 10.1099/0022-1317-74-3-371; Sakaguchi M, 1998, VACCINE, V16, P472, DOI 10.1016/S0264-410X(97)80001-1; Schat K.A, 2008, DIS POULTRY, P452; Schroer D, 2009, AVIAN DIS, V53, P190, DOI 10.1637/8416-072308-Reg.1; Schumacher D, 2000, J VIROL, V74, P11088, DOI 10.1128/JVI.74.23.11088-11098.2000; Shi Wei-song, 2008, Chinese Journal of Virology, V24, P117; Spatz SJ, 2007, VIRUS GENES, V35, P753, DOI 10.1007/s11262-007-0157-1; Swayne DE, 2000, VACCINE, V18, P1088, DOI 10.1016/S0264-410X(99)00369-2; TARNOWSKI BI, 1991, BIOTECH HISTOCHEM, V66, P296, DOI 10.3109/10520299109109990; Tong K, 1984, ACTA VET ZOOTECHNICA, V15, P109; Tsukamoto K, 1999, VIROLOGY, V257, P352, DOI 10.1006/viro.1999.9641; Tsukamoto K, 2002, J VIROL, V76, P5637, DOI 10.1128/JVI.76.11.5637-5645.2002; Van Kerkhove MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014582; Veits J, 2003, J GEN VIROL, V84, P3343, DOI 10.1099/vir.0.19570-0; Veits J, 2006, P NATL ACAD SCI USA, V103, P8197, DOI 10.1073/pnas.0602461103; WEBSTER RG, 1991, VACCINE, V9, P303, DOI 10.1016/0264-410X(91)90055-B; WITTER RL, 1991, AVIAN DIS, V35, P877, DOI 10.2307/1591624; WITTER RL, 1987, AVIAN DIS, V31, P752, DOI 10.2307/1591027; Xia CY, 2000, CHINESE J VET SCI TE, V30, P24; Yun Shui-li, 2009, Chinese Journal of Virology, V25, P430; ZELNIK V, 1995, J GEN VIROL, V76, P2903, DOI 10.1099/0022-1317-76-11-2903; Zhou XM, 2010, VACCINE, V28, P3990, DOI 10.1016/j.vaccine.2010.03.021	51	26	30	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53340	10.1371/journal.pone.0053340	http://dx.doi.org/10.1371/journal.pone.0053340			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301062	Green Published, Green Submitted, gold			2022-12-25	WOS:000313480000050
J	Fowler, ML; Li, A				Fowler, Michelle L.; Li, Andrea			Effects of Texture Component Orientation on Orientation Flow Visibility for 3-D Shape Perception	PLOS ONE			English	Article							3-DIMENSIONAL SHAPE; SURFACE ORIENTATION; IDEAL OBSERVERS; SIMPLE CELLS; SELECTIVITY; SUPPRESSION; MECHANISMS; NEURONS; DISCRIMINATION; LIMITATIONS	In images of textured 3-D surfaces, orientation flows created by the texture components parallel to the surface slant play a critical role in conveying the surface slant and shape. This study examines the visibility of these orientation flows in complex patterns. Specifically, we examine the effect of orientation of neighboring texture components on orientation flow visibility. Complex plaids consisting of gratings equally spaced in orientation were mapped onto planar and curved surfaces. The visibility of the component that creates the orientation flows was quantified by measuring its contrast threshold (CT) while varying the combination of neighboring components present in the pattern. CTs were consistently lowest only when components closest in orientation to that of the orientation flows were subtracted from the pattern. This finding suggests that a previously reported frequency-selective cross-orientation suppression mechanism involved with the perception of 3-D shape from texture is affected by proximity in orientation of concurrent texture components.	[Fowler, Michelle L.] CUNY, Grad Ctr, Neuropsychol Doctoral Subprogram, New York, NY USA; [Li, Andrea] Queens Coll, Dept Psychol, Flushing, NY 11367 USA	City University of New York (CUNY) System; City University of New York (CUNY) System; Queens College NY (CUNY)	Li, A (corresponding author), Queens Coll, Dept Psychol, Flushing, NY 11367 USA.	andrea.li@qc.cuny.edu			National Institutes of Health (NIH) [R15 EY018951]; NIH [R01 EY 13312]; City University of New York PSC- CUNY Research Award Program [PSC-63642-00-41]; NATIONAL EYE INSTITUTE [R15EY018951, R01EY013312] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); City University of New York PSC- CUNY Research Award Program; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health (NIH) R15 EY018951 to AL, NIH R01 EY 13312 to Q. Zaidi, and a grant from the City University of New York PSC- CUNY Research Award Program (PSC-63642-00-41) to AL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey CK, 2002, J VISION, V2, P66, DOI 10.1167/2.1.5; ALBRECHT DG, 1991, VISUAL NEUROSCI, V7, P531, DOI 10.1017/S0952523800010336; Bajcsy R., 1976, COMPUT GRAPHICS IMAG, V5, P52, DOI DOI 10.1016/S0146-664X(76)80005-6; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; CAMPBELL FW, 1966, J PHYSIOL-LONDON, V187, P437, DOI 10.1113/jphysiol.1966.sp008101; Carandini M, 1997, J NEUROSCI, V17, P8621; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2547, DOI 10.1152/jn.00693.2001; CUMMING BG, 1993, VISION RES, V33, P827, DOI 10.1016/0042-6989(93)90201-7; CUTTING JE, 1984, J EXP PSYCHOL GEN, V113, P198, DOI 10.1037/0096-3445.113.2.198; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; Delahunt PB, 2008, J VISION, V8, DOI 10.1167/8.3.5; FIELD DJ, 2004, J VIS, V4, pA283; GEISLER WS, 1991, J NEUROPHYSIOL, V66, P334, DOI 10.1152/jn.1991.66.1.334; GIBSON JJ, 1950, AM J PSYCHOL, V63, P367, DOI 10.2307/1418003; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P427, DOI 10.1017/S095252380001124X; Knill DC, 1998, VISION RES, V38, P1683, DOI 10.1016/S0042-6989(97)00325-8; KNILL DC, 1992, J OPT SOC AM A, V9, P1449, DOI 10.1364/JOSAA.9.001449; Knill DC, 1998, VISION RES, V38, P2635, DOI 10.1016/S0042-6989(97)00415-X; Knill DC, 1998, VISION RES, V38, P1655, DOI 10.1016/S0042-6989(97)00324-6; Li A, 2004, J VISION, V4, P860, DOI 10.1167/4.10.3; Li A, 2003, VISION RES, V43, P2741, DOI 10.1016/j.visres.2003.07.001; Li A, 2001, J OPT SOC AM A, V18, P2430, DOI 10.1364/JOSAA.18.002430; Li A, 2001, VISION RES, V41, P1519, DOI 10.1016/S0042-6989(01)00021-9; Li A, 2000, VISION RES, V40, P217, DOI 10.1016/S0042-6989(99)00169-8; Li A, 2008, VISION RES, V48, P244, DOI 10.1016/j.visres.2007.11.009; Li A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008333; MORRONE MC, 1982, PROC R SOC SER B-BIO, V216, P335, DOI 10.1098/rspb.1982.0078; Olshausen BA, 2005, NEURAL COMPUT, V17, P1665, DOI 10.1162/0899766054026639; Petrov Y, 2005, J NEUROSCI, V25, P8704, DOI 10.1523/JNEUROSCI.2871-05.2005; Priebe NJ, 2006, NAT NEUROSCI, V9, P552, DOI 10.1038/nn1660; Roeber U, 2008, J VIS, V8, p[1, 15]; SAKAI K, 1995, J OPT SOC AM A, V12, P1208, DOI 10.1364/JOSAA.12.001208; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; Series P, 2004, NAT NEUROSCI, V7, P1129, DOI 10.1038/nn1321; SILLITO AM, 1979, J PHYSIOL-LONDON, V289, P33, DOI 10.1113/jphysiol.1979.sp012723; THOMAS JP, 1979, J OPT SOC AM, V69, P652, DOI 10.1364/JOSA.69.000652; TODD JT, 1987, J EXP PSYCHOL HUMAN, V13, P242, DOI 10.1037/0096-1523.13.2.242; TURNER MR, 1991, BIOL CYBERN, V65, P215, DOI 10.1007/BF00206219; Zaidi Q, 2002, VISION RES, V42, P815, DOI 10.1016/S0042-6989(01)00233-4; Zaidi Q, 2006, VISUAL NEUROSCI, V23, P323, DOI 10.1017/S0952523806233170	41	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53556	10.1371/journal.pone.0053556	http://dx.doi.org/10.1371/journal.pone.0053556			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301085	Green Published, gold			2022-12-25	WOS:000313480000065
J	Langer, N; Pedroni, A; Jancke, L				Langer, Nicolas; Pedroni, Andreas; Jaencke, Lutz			The Problem of Thresholding in Small-World Network Analysis	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; COMPLEX BRAIN NETWORKS; MULTI CHANNEL EEG; FUNCTIONAL CONNECTIVITY; ANATOMICAL NETWORKS; PERMUTATION TESTS; CORTICAL NETWORKS; WHOLE-BRAIN; EFFICIENCY	Graph theory deterministically models networks as sets of vertices, which are linked by connections. Such mathematical representation of networks, called graphs are increasingly used in neuroscience to model functional brain networks. It was shown that many forms of structural and functional brain networks have small-world characteristics, thus, constitute networks of dense local and highly effective distal information processing. Motivated by a previous small-world connectivity analysis of resting EEG-data we explored implications of a commonly used analysis approach. This common course of analysis is to compare small-world characteristics between two groups using classical inferential statistics. This however, becomes problematic when using measures of inter-subject correlations, as it is the case in commonly used brain imaging methods such as structural and diffusion tensor imaging with the exception of fibre tracking. Since for each voxel, or region there is only one data point, a measure of connectivity can only be computed for a group. To empirically determine an adequate small-world network threshold and to generate the necessary distribution of measures for classical inferential statistics, samples are generated by thresholding the networks on the group level over a range of thresholds. We believe that there are mainly two problems with this approach. First, the number of thresholded networks is arbitrary. Second, the obtained thresholded networks are not independent samples. Both issues become problematic when using commonly applied parametric statistical tests. Here, we demonstrate potential consequences of the number of thresholds and non-independency of samples in two examples (using artificial data and EEG data). Consequently alternative approaches are presented, which overcome these methodological issues.	[Langer, Nicolas; Jaencke, Lutz] Univ Zurich, Inst Psychol, Div Neuropsychol, Zurich, Switzerland; [Langer, Nicolas] Childrens Hosp, Dept Med, Div Dev Med, Labs Cognit Neurosci, Boston, MA 02115 USA; [Langer, Nicolas] Harvard Univ, Sch Med, Boston, MA USA; [Pedroni, Andreas] Univ Basel, Dept Psychol, Div Social & Affect Neurosci, Basel, Switzerland; [Pedroni, Andreas] Univ Basel, Dept Psychol, Ctr Econ Psychol, Basel, Switzerland; [Jaencke, Lutz] Int Normal Aging & Plast Imaging Ctr, Zurich, Switzerland	University of Zurich; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Basel; University of Basel	Langer, N (corresponding author), Univ Zurich, Inst Psychol, Div Neuropsychol, Zurich, Switzerland.	nicolas.langer@childrens.harvard.edu	Jäncke, Lutz/D-2910-2013	Jäncke, Lutz/0000-0003-2110-9067				Berger VW, 2000, STAT MED, V19, P1319, DOI 10.1002/(SICI)1097-0258(20000530)19:10<1319::AID-SIM490>3.0.CO;2-0; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Butts CT, 2009, SCIENCE, V325, P414, DOI 10.1126/science.1171022; Cohen J., 1969, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Court JH, 2003, SECTION1 GENERAL OVE; Edgington E. S., 1995, RANDOMIZATION TESTS; Fallani FD, 2010, BRAIN TOPOGR, V23, P214, DOI 10.1007/s10548-010-0133-2; Fisher R.A., 1935, THE DESIGN OF EXPERI; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Hanggi J, 2011, J NEUROSCI, V31, P5816, DOI 10.1523/JNEUROSCI.0964-10.2011; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Jancke L, 2012, J COGNITIVE NEUROSCI, V24, P1447, DOI 10.1162/jocn_a_00227; Jancke L, 2011, J NEUROPSYCHOL, V5, P178, DOI 10.1111/j.1748-6653.2011.02004.x; Langer N, 2012, HUM BRAIN MAPP, V33, P1393, DOI 10.1002/hbm.21297; Langer N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009208; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Manly BFJ, 1997, RANDOMIZATION BOOTST; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Micheloyannis S, 2006, NEUROSCI LETT, V402, P273, DOI 10.1016/j.neulet.2006.04.006; Micheloyannis S, 2009, HUM BRAIN MAPP, V30, P200, DOI 10.1002/hbm.20492; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Opsahl T, 2009, STRUCTURE AND EVOLUT; Opsahl T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.168702; Opsahl T, 2009, SOC NETWORKS, V31, P155, DOI 10.1016/j.socnet.2009.02.002; Palva JM, 2010, P NATL ACAD SCI USA, V107, P7580, DOI 10.1073/pnas.0913113107; Palva S, 2010, NEUROIMAGE, V49, P3257, DOI 10.1016/j.neuroimage.2009.11.031; Pitman EJG, 1938, BIOMETRIKA, V29, P322, DOI 10.1093/biomet/29.3-4.322; PITMAN EJG, 1937, ROYAL STAT SOC S, V4, P119; Richiardi J, 2011, PROC IEEE WORKSHOP O; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2009, HUM BRAIN MAPP, V30, P403, DOI 10.1002/hbm.20517; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Smit DJA, 2008, HUM BRAIN MAPP, V29, P1368, DOI 10.1002/hbm.20468; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Sporns O., 2010, NETWORKS BRAIN; Stam CJ, 2010, J NEUROL SCI, V289, P128, DOI 10.1016/j.jns.2009.08.028; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; von Bastian CC, 2012, CORTEX IN PRESS; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027	44	74	76	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53199	10.1371/journal.pone.0053199	http://dx.doi.org/10.1371/journal.pone.0053199			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301043	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000313480000039
J	Soylemez, E; de Boer, MP; Sae-Ueng, U; Evilevitch, A; Stewart, TA; Nyman, M				Soylemez, Emrecan; de Boer, Maarten P.; Sae-Ueng, Udom; Evilevitch, Alex; Stewart, Tom A.; Nyman, May			Photocatalytic Degradation of Bacteriophages Evidenced by Atomic Force Microscopy	PLOS ONE			English	Article							WATER; INACTIVATION; COLIFORM; VIRUSES	Methods to supply fresh water are becoming increasingly critical as the world population continues to grow. Small-diameter hazardous microbes such as viruses (20-100 nm diameter) can be filtered by size exclusion, but in this approach the filters are fouled. Thus, in our research, we are investigating an approach in which filters will be reusable. When exposed to ultraviolet (UV) illumination, titanate materials photocatalytically evolve (OH)-O-center dot and O2(center dot-) radicals, which attack biological materials. In the proposed approach, titanate nanosheets are deposited on a substrate. Viruses adsorb on these nanosheets and degrade when exposed to UV light. Using atomic force microscopy (AFM), we image adsorbed viruses and demonstrate that they are removed by UV illumination in the presence of the nanosheets, but not in their absence.	[Soylemez, Emrecan; de Boer, Maarten P.] Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA; [Sae-Ueng, Udom; Evilevitch, Alex] Carnegie Mellon Univ, Dept Phys, Pittsburgh, PA 15213 USA; [Stewart, Tom A.; Nyman, May] Sandia Natl Labs, Albuquerque, NM 87185 USA	Carnegie Mellon University; Carnegie Mellon University; United States Department of Energy (DOE); Sandia National Laboratories	de Boer, MP (corresponding author), Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA.	mpdebo@andrew.cmu.edu	Soylemez, Emrecan/ABA-7415-2020; Soylemez, Emrecan/M-5564-2016; Evilevitch, Alex/P-3103-2014; de Boer, Maarten P/C-1525-2013	Soylemez, Emrecan/0000-0003-4827-2606; Soylemez, Emrecan/0000-0003-4827-2606; Evilevitch, Alex/0000-0002-0245-9574; de Boer, Maarten P/0000-0003-1574-9324	Laboratory Directed Research and Development (LDRD) program at Sandia National Laboratories; United States Department of Energy [DEAC04-94AL85000]	Laboratory Directed Research and Development (LDRD) program at Sandia National Laboratories; United States Department of Energy(United States Department of Energy (DOE))	This work was supported by the Laboratory Directed Research and Development (LDRD) program at Sandia National Laboratories. Sandia is a multiprogram laboratory operated by Sandia Corporation, a Lockheed-Martin Company, for the United States Department of Energy under Contract No. DEAC04-94AL85000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Development of the titanate photocatalysts used in the study, as well as their adhesion to substrates, was supported by the Laboratory Directed Research and Development (LDRD) program at Sandia National Laboratories. Sandia is a multiprogram laboratory operated by Sandia Corporation, a Lockheed-Martin Company, for the United States Department of Energy under Contract No. DEAC04-94AL85000. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Synthesis and application of the catalytic materials is the subject of a provisional patent application assigned serial number 61/577,349.	[Anonymous], 2006, INT WORKSH NAN WADC; BRADLEY SM, 1992, INORG CHEM, V31, P1181, DOI 10.1021/ic00033a012; Carp O, 2004, PROG SOLID STATE CH, V32, P33, DOI 10.1016/j.progsolidstchem.2004.08.001; Casey WH, 2006, CHEM REV, V106, P1, DOI 10.1021/cr040095d; Cho M, 2005, APPL ENVIRON MICROB, V71, P270, DOI 10.1128/AEM.71.1.270-275.2005; Chong MN, 2010, WATER RES, V44, P2997, DOI 10.1016/j.watres.2010.02.039; Cik G, 2006, CHEMOSPHERE, V63, P1419, DOI 10.1016/j.chemosphere.2005.10.017; Coleman HM, 2005, CHEM ENG J, V113, P55, DOI 10.1016/j.cej.2005.07.015; Dubrovin EV, 2008, LANGMUIR, V24, P13068, DOI 10.1021/la8022612; Evilevitch A, 2003, P NATL ACAD SCI USA, V100, P9292, DOI 10.1073/pnas.1233721100; Evilevitch A, 2011, J MOL BIOL, V405, P18, DOI 10.1016/j.jmb.2010.10.039; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Fujishima A., 2000, J PHOTOCHEM PHOTOB C, V1, P1, DOI DOI 10.1016/S1389-5567(00)00002-2; Garcia R, 1999, PHYS REV B, V60, P4961, DOI 10.1103/PhysRevB.60.4961; Gogniat G, 2006, FEMS MICROBIOL LETT, V258, P18, DOI 10.1111/j.1574-6968.2006.00190.x; GREY IE, 1987, J SOLID STATE CHEM, V66, P7, DOI 10.1016/0022-4596(87)90215-5; Herrmann JM, 2000, CR ACAD SCI II C, V3, P417, DOI 10.1016/S1387-1609(00)01137-3; Hillie T, 2007, NAT NANOTECHNOL, V2, P663, DOI 10.1038/nnano.2007.350; Kuznetsov YG, 2011, BACTERIOPHAGE, V1, P164; Kuznetsov YG, 2011, MICROBIOL MOL BIOL R, V75, P268, DOI 10.1128/MMBR.00041-10; Liga MV, 2011, WATER RES, V45, P535, DOI 10.1016/j.watres.2010.09.012; MATSUNAGA T, 1985, FEMS MICROBIOL LETT, V29, P211, DOI 10.1111/j.1574-6968.1985.tb00864.x; Ostendorf F, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/30/305705; Pan JH, 2010, J MATER CHEM, V20, P4512, DOI 10.1039/b925523k; Silhavy T.J., 1984, EXPT GENE FUSIONS; Skorb EV, 2011, PHOTOCH PHOTOBIO SCI, V10, P1974, DOI 10.1039/c1pp05195d; Stewart TA, 2011, APPL CATAL B-ENVIRON, V105, P69, DOI 10.1016/j.apcatb.2011.03.036; Stewart TA, 2009, ENVIRON SCI TECHNOL, V43, P5416, DOI 10.1021/es803683t; Sun DD, 2003, WATER RES, V37, P3452, DOI 10.1016/S0043-1354(03)00228-8; VESENKA J, 1993, BIOPHYS J, V65, P992, DOI 10.1016/S0006-3495(93)81171-8; WATTS RJ, 1995, WATER RES, V29, P95, DOI 10.1016/0043-1354(94)E0122-M; Woan K, 2009, ADV MATER, V21, P2233, DOI 10.1002/adma.200802738; Wong MS, 2009, J CHEM TECHNOL BIOT, V84, P158, DOI 10.1002/jctb.2002	33	6	6	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53601	10.1371/journal.pone.0053601	http://dx.doi.org/10.1371/journal.pone.0053601			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301095	Green Submitted, Green Published, gold			2022-12-25	WOS:000313480000071
J	Stegen, C; Yakova, Y; Henaff, D; Nadjar, J; Duron, J; Lippe, R				Stegen, Camille; Yakova, Yordanka; Henaff, Daniel; Nadjar, Julien; Duron, Johanne; Lippe, Roger			Analysis of Virion-Incorporated Host Proteins Required for Herpes Simplex Virus Type 1 Infection through a RNA Interference Screen	PLOS ONE			English	Article							CELLULAR-PROTEINS; GENE-EXPRESSION; MESSENGER-RNA; IDENTIFICATION; INHIBITION; TRANSPORT; GLYCOPROTEINS; REPLICATION; ADENOVIRUS; PARTICLES	Viruses are strictly dependent on cells to propagate and many incorporate host proteins in their viral particles, but the significance of this incorporation is poorly understood. Recently, we performed the first comprehensive characterization of the mature herpes simplex virus type 1 (HSV-1) in which up to 49 distinct cellular proteins were identified by mass spectrometry. In the present study, we sought to identify if these cellular factors are relevant for the HSV-1 life cycle. To this end, we performed a small interfering RNA functional screen and found that 15 of these host proteins altered HSV-1 proliferation in cell culture, without any significant effect on cell viability. Moreover, the siRNA used had no negative consequences for Adenovirus type 5 propagation (with one exception) indicating that the modulation was specific for HSV-1 and not merely due to unhealthy cells. The positive host proteins include several Rab GTPases and other intracellular transport components as well as proteins involved in signal transduction, gene regulation and immunity. Remarkably, in most cases when virions were depleted for one of the above proteins, they replicated more poorly in subsequent infections in wild type cells. This highlights for the first time that both the cellular and virion-associated pools of many of these proteins actively contribute to viral propagation. Altogether, these findings underscore the power and biological relevance of combining proteomics and RNA interference to identify novel host-pathogen interactions.	[Stegen, Camille; Yakova, Yordanka; Henaff, Daniel; Nadjar, Julien; Duron, Johanne; Lippe, Roger] Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ, Canada	Universite de Montreal	Lippe, R (corresponding author), Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ, Canada.	roger.lippe@umontreal.ca		Lippe, Roger/0000-0001-5066-3070	Canadian Institutes of Health Research [MOP 82921]; Canada Frederick Banting and Charles Best studentship from the CIHR	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Frederick Banting and Charles Best studentship from the CIHR	This work was funded by a grant from the Canadian Institutes of Health Research (MOP 82921). YY was supported by a Canada Frederick Banting and Charles Best studentship from the CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACE CI, 1989, J VIROL, V63, P2260, DOI 10.1128/JVI.63.5.2260-2269.1989; Angus AGN, 2010, J GEN VIROL, V91, P122, DOI 10.1099/vir.0.015909-0; Baldick CJ, 1996, J VIROL, V70, P6097, DOI 10.1128/JVI.70.9.6097-6105.1996; Bechtel JT, 2005, J VIROL, V79, P4952, DOI 10.1128/JVI.79.8.4952-4964.2005; Bhuyan PK, 2004, J VIROL, V78, P10276, DOI 10.1128/JVI.78.19.10276-10281.2004; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; CAMPADELLI G, 1993, P NATL ACAD SCI USA, V90, P2798, DOI 10.1073/pnas.90.7.2798; Cantin R, 2005, J VIROL, V79, P6577, DOI 10.1128/JVI.79.11.6577-6587.2005; CHEUNG P, 1991, J VIROL, V65, P1893, DOI 10.1128/JVI.65.4.1893-1904.1991; Clement C, 2008, MOL VIS, V14, P1209; Clemente R, 2010, J VIROL, V84, P3562, DOI 10.1128/JVI.02274-09; Dasgupta A, 2001, J GEN VIROL, V82, P1561, DOI 10.1099/0022-1317-82-7-1561; del Rio T, 2005, J VIROL, V79, P3903, DOI 10.1128/JVI.79.7.3903-3919.2005; Delboy MG, 2008, J VIROL, V82, P3381, DOI 10.1128/JVI.02296-07; Desai P, 1998, J VIROL, V72, P7563, DOI 10.1128/JVI.72.9.7563-7568.1998; Dohner K, 2002, MOL BIOL CELL, V13, P2795, DOI 10.1091/mbc.01-07-0348; Dry I, 2008, J VIROL, V82, P5390, DOI 10.1128/JVI.00094-08; Durand LO, 2008, J VIROL, V82, P10591, DOI 10.1128/JVI.01242-08; Dziuba N, 2012, AIDS RES HUM RETROV, V28, P1329, DOI 10.1089/aid.2011.0358; Eckstein A, 2010, ANTIVIR RES, V88, P86, DOI 10.1016/j.antiviral.2010.08.002; Eisfeld AJ, 2011, J VIROL, V85, P6117, DOI 10.1128/JVI.00378-11; English L, 2009, NAT IMMUNOL, V10, P480, DOI 10.1038/ni.1720; Gurer C, 2002, J VIROL, V76, P4666, DOI 10.1128/JVI.76.9.4666-4670.2002; HAY J, 1977, J ANTIMICROB CHEMOTH, V3, P63, DOI 10.1093/jac/3.suppl_A.63; Indran SV, 2011, J VIROL, V85, P5213, DOI 10.1128/JVI.02605-10; Johannsen E, 2004, P NATL ACAD SCI USA, V101, P16286, DOI 10.1073/pnas.0407320101; Karasneh GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025252; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Kattenhorn LM, 2004, J VIROL, V78, P11187, DOI 10.1128/JVI.78.20.11187-11197.2004; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kramer T, 2011, J VIROL, V85, P6427, DOI 10.1128/JVI.02253-10; Krauss O, 2002, J GEN VIROL, V83, P2347, DOI 10.1099/0022-1317-83-10-2347; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Lam Q, 1996, EMBO J, V15, P2575, DOI 10.1002/j.1460-2075.1996.tb00615.x; Le LP, 2004, MOL IMAGING, V3, P105, DOI 10.1162/1535350041464874; Lippe R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00181; LODISH HF, 1980, CELL, V19, P161, DOI 10.1016/0092-8674(80)90397-9; Loret S, 2008, J VIROL, V82, P8605, DOI 10.1128/JVI.00904-08; Loret S, 2012, J GEN VIROL, V93, P624, DOI 10.1099/vir.0.039776-0; Luxton GWG, 2005, P NATL ACAD SCI USA, V102, P5832, DOI 10.1073/pnas.0500803102; Maric M, 2011, J VIROL, V85, P9667, DOI 10.1128/JVI.05314-11; Moerdyk-Schauwecker M, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-166; Naji S, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015313; Ott DE, 2008, REV MED VIROL, V18, P159, DOI 10.1002/rmv.570; Radtke K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000991; Sarma N, 2008, J VIROL, V82, P6600, DOI 10.1128/JVI.00137-08; Shaw ML, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000085; Sodeik B, 1997, J CELL BIOL, V136, P1007, DOI 10.1083/jcb.136.5.1007; Sokolskaja E, 2004, J VIROL, V78, P12800, DOI 10.1128/JVI.78.23.12800-12808.2004; SPEAR GT, 1995, J IMMUNOL, V155, P4376; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Turcotte S, 2005, J VIROL, V79, P8847, DOI 10.1128/JVI.79.14.8847-8860.2005; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; WEINHEIMER SP, 1992, J VIROL, V66, P258, DOI 10.1128/JVI.66.1.258-269.1992; Wu ZT, 2009, J VIROL, V83, P6652, DOI 10.1128/JVI.00260-09; Zenner HL, 2011, J VIROL, V85, P8012, DOI 10.1128/JVI.00500-11; Zhang CW, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-242; Zhang YQ, 2008, CLIN EXP DERMATOL, V33, P56, DOI 10.1111/j.1365-2230.2007.02543.x; Zhe R, 2008, ARCH VIROL, V153, P1401, DOI 10.1007/s00705-008-0110-1; Zhou Q, 2012, VIRUS RES; Zhu FX, 2005, J VIROL, V79, P800, DOI 10.1128/JVI.79.2.800-811.2005	62	45	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53276	10.1371/journal.pone.0053276	http://dx.doi.org/10.1371/journal.pone.0053276			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301054	Green Published, Green Submitted, gold			2022-12-25	WOS:000313480000045
J	Wanisch, K; Kovac, S; Schorge, S				Wanisch, Klaus; Kovac, Stjepana; Schorge, Stephanie			Tackling Obstacles for Gene Therapy Targeting Neurons: Disrupting Perineural Nets with Hyaluronidase Improves Transduction	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; RAT-BRAIN; VECTOR; GLYCOSAMINOGLYCANS; EXPRESSION; ADULT; MICROENVIRONMENT; GLYCOPROTEINS; POLYCATIONS; INTEGRATION	Gene therapy has been proposed for many diseases in the nervous system. In most cases for successful treatment, therapeutic vectors must be able to transduce mature neurons. However, both in vivo, and in vitro, where preliminary characterisation of viral particles takes place, transduction of neurons is typically inefficient. One possible explanation is that the extracellular matrix (ECM), forming dense perineural nets (PNNs) around neurons, physically blocks access to the cell surface. We asked whether co-administration of lentiviral vectors with an enzyme that disrupts the ECM could improve transduction efficiency. Using hyaluronidase, an enzyme which degrades hyaluronic acid, a high molecular weight molecule of the ECM with mainly a scaffolding function, we show that in vitro in mixed primary cortical cultures, and also in vivo in rat cortex, hyaluronidase co-administration increased the percentage of transduced mature, NeuN-positive neurons. Moreover, hyaluronidase was effective at doses that showed no toxicity in vitro based on propidium iodide staining of treated cultures. Our data suggest that limited efficacy of neuronal transduction is partly due to PNNs surrounding neurons, and further that co-applying hyaluronidase may benefit applications where efficient transduction of neurons in vitro or in vivo is required.	[Wanisch, Klaus; Kovac, Stjepana; Schorge, Stephanie] UCL, Inst Neurol, Dept Clin & Expt Epilepsy, London, England; [Kovac, Stjepana] Univ Munster, Dept Neurol, Munster, Germany	University of London; University College London; University of Munster	Wanisch, K (corresponding author), UCL, Inst Neurol, Dept Clin & Expt Epilepsy, London, England.	klaus.wanisch@gmx.de; s.schorge@ucl.ac.uk	Schorge, Stephanie/C-8515-2009	Schorge, Stephanie/0000-0003-1541-5148	Wellcome Trust [086882/Z/08/Z]; Medical Research Council UK; stipend from the Deutsche Forschungsgemeinschaft [KO-3878/1-1]; Worshipful Company of Pewterers UK; Fellowship from the Royal Society [UF090203]; MRC [MR/K000608/1] Funding Source: UKRI; Medical Research Council [MR/K000608/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); stipend from the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Worshipful Company of Pewterers UK; Fellowship from the Royal Society; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	KW is funded by the Wellcome Trust (086882/Z/08/Z) and by the Medical Research Council UK. SK was supported by a stipend from the Deutsche Forschungsgemeinschaft (KO-3878/1-1). SS is funded by a fellowship by the Worshipful Company of Pewterers UK, and by a Fellowship from the Royal Society (UF090203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abordo-Adesida E, 2005, HUM GENE THER, V16, P741, DOI 10.1089/hum.2005.16.741; Batra RK, 1997, J BIOL CHEM, V272, P11736, DOI 10.1074/jbc.272.18.11736; BIGNAMI A, 1992, INT J DEV NEUROSCI, V10, P45, DOI 10.1016/0736-5748(92)90006-L; BRAUER K, 1982, J HIRNFORSCH, V23, P701; BRUCKNER G, 1993, GLIA, V8, P183, DOI 10.1002/glia.440080306; Deepa SS, 2006, J BIOL CHEM, V281, P17789, DOI 10.1074/jbc.M600544200; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Favre D, 2000, GENE THER, V7, P1417, DOI 10.1038/sj.gt.3301256; Forster E, 2001, DEVELOPMENT, V128, P3029; Fuentealba RA, 2009, J BIOL CHEM, V284, P34045, DOI 10.1074/jbc.M109.021030; Ganesh S, 2009, CANCER GENE THER, V16, P383, DOI 10.1038/cgt.2008.90; Girish KS, 2007, LIFE SCI, V80, P1921, DOI 10.1016/j.lfs.2007.02.037; Guo A, 2010, BRAIN RES, V1366, P1, DOI 10.1016/j.brainres.2010.09.099; Hagenfeld D, 2010, J CELL BIOCHEM, V111, P858, DOI 10.1002/jcb.22772; Johansen JL, 2010, J NEUROCHEM, V115, P209, DOI 10.1111/j.1471-4159.2010.06917.x; John N, 2006, MOL CELL NEUROSCI, V31, P774, DOI 10.1016/j.mcn.2006.01.011; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Karra D, 2010, J NEUROSCI, V30, P6171, DOI 10.1523/JNEUROSCI.0183-10.2010; Kochlamazashvili G, 2010, NEURON, V67, P116, DOI 10.1016/j.neuron.2010.05.030; Lander C, 1998, J NEUROSCI, V18, P174; Li MJ, 2010, J NEUROSCI METH, V189, P56, DOI 10.1016/j.jneumeth.2010.03.019; Liehl B, 2007, GENE THER, V14, P1330, DOI 10.1038/sj.gt.3302988; Maleski M, 1997, GLIA, V20, P193, DOI 10.1002/(SICI)1098-1136(199707)20:3<193::AID-GLIA3>3.0.CO;2-9; MANNING JS, 1971, APPL MICROBIOL, V22, P1162, DOI 10.1128/AEM.22.6.1162-1163.1971; MARGOLIS RK, 1975, BIOCHEMISTRY-US, V14, P4797, DOI 10.1021/bi00693a004; MARGOLIS RU, 1974, BIOCHEMISTRY-US, V13, P2849, DOI 10.1021/bi00711a011; Meyer K, 1934, J BIOL CHEM, V107, P629; Moon LDF, 2003, J NEUROSCI RES, V71, P23, DOI 10.1002/jnr.10449; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; Neeves KB, 2007, BRAIN RES, V1180, P121, DOI 10.1016/j.brainres.2007.08.050; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PETERS A, 1985, J COMP NEUROL, V234, P218, DOI 10.1002/cne.902340208; Piedrahita D, 2010, J NEUROSCI, V30, P13966, DOI 10.1523/JNEUROSCI.3637-10.2010; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Srinivasan C, 2009, J CONTROL RELEASE, V136, P62, DOI 10.1016/j.jconrel.2009.01.022; Sykova E, 1997, ADV NEUROL, V73, P121; Thorne RG, 2006, P NATL ACAD SCI USA, V103, P5567, DOI 10.1073/pnas.0509425103; Toole BP, 1990, CURR OPIN CELL BIOL, V2, P839, DOI 10.1016/0955-0674(90)90081-O; TOYOSHIMA K, 1969, VIROLOGY, V38, P414, DOI 10.1016/0042-6822(69)90154-8; VERNA JM, 1989, INT J DEV NEUROSCI, V7, P389, DOI 10.1016/0736-5748(89)90060-9; Wanisch K, 2009, MOL THER, V17, P1316, DOI 10.1038/mt.2009.122; WEISSMANN B, 1954, J AM CHEM SOC, V76, P1753, DOI 10.1021/ja01636a010; White E, 2011, HUM GENE THER; Yanez-Munoz RJ, 2006, NAT MED, V12, P348, DOI 10.1038/nm1365; Yang P, 2010, ACTA PHARMACOL SIN, V31, P531, DOI 10.1038/aps.2010.35; Zhao Y, 2008, HUM GENE THER, V19, P475, DOI 10.1089/hum.2007.119; Zhu SS, 2009, BRAIN RES, V1250, P49, DOI 10.1016/j.brainres.2008.11.013; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	49	8	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53269	10.1371/journal.pone.0053269	http://dx.doi.org/10.1371/journal.pone.0053269			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301052	Green Published, gold, Green Submitted			2022-12-25	WOS:000313480000044
J	Bienhold, C; Ristova, PP; Wenzhofer, F; Dittmar, T; Boetius, A				Bienhold, Christina; Ristova, Petra Pop; Wenzhoefer, Frank; Dittmar, Thorsten; Boetius, Antje			How Deep-Sea Wood Falls Sustain Chemosynthetic Life	PLOS ONE			English	Article							EASTERN MEDITERRANEAN SEA; MOSBY MUD VOLCANO; COMPLEX BACTERIAL COMMUNITIES; DISSOLVED ORGANIC-CARBON; COLD-SEEP COMMUNITIES; HYDROTHERMAL-VENT; IN-SITU; SULFATE REDUCTION; WHALE-FALL; GEN. NOV.	Large organic food falls to the deep sea - such as whale carcasses and wood logs - are known to serve as stepping stones for the dispersal of highly adapted chemosynthetic organisms inhabiting hot vents and cold seeps. Here we investigated the biogeochemical and microbiological processes leading to the development of sulfidic niches by deploying wood colonization experiments at a depth of 1690 m in the Eastern Mediterranean for one year. Wood-boring bivalves of the genus Xylophaga played a key role in the degradation of the wood logs, facilitating the development of anoxic zones and anaerobic microbial processes such as sulfate reduction. Fauna and bacteria associated with the wood included types reported from other deep-sea habitats including chemosynthetic ecosystems, confirming the potential role of large organic food falls as biodiversity hot spots and stepping stones for vent and seep communities. Specific bacterial communities developed on and around the wood falls within one year and were distinct from freshly submerged wood and background sediments. These included sulfate-reducing and cellulolytic bacterial taxa, which are likely to play an important role in the utilization of wood by chemosynthetic life and other deep-sea animals.	[Bienhold, Christina; Ristova, Petra Pop; Wenzhoefer, Frank; Boetius, Antje] Alfred Wegener Inst Polar & Marine Res, HGF MPG Grp Deep Sea Ecol & Technol, Bremerhaven, Germany; [Bienhold, Christina; Ristova, Petra Pop; Wenzhoefer, Frank; Boetius, Antje] Max Planck Inst Marine Microbiol, Bremen, Germany; [Dittmar, Thorsten] Carl von Ossietzky Univ Oldenburg, Max Planck Res Grp Marine Geochem, Inst Chem & Biol Marine Environm, D-26111 Oldenburg, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Max Planck Society; Carl von Ossietzky Universitat Oldenburg; Max Planck Society	Bienhold, C (corresponding author), Alfred Wegener Inst Polar & Marine Res, HGF MPG Grp Deep Sea Ecol & Technol, Bremerhaven, Germany.	cbienhol@mpi-bremen.de	Boetius, Antje/D-5459-2013; Dittmar, Thorsten/L-7796-2013	Boetius, Antje/0000-0003-2117-4176; Dittmar, Thorsten/0000-0002-3462-0107; Bienhold, Christina/0000-0003-2269-9468	EU [GOCE-CT-2005-511234, 226354]	EU(European Commission)	This work contributed to the GDRE DIWOOD of CNRS and MPG, to the ESF EUROCORES EURODEEP project CHEMECO and the CoML project CHESS, as well as to the EU 6th FP HERMES (GOCE-CT-2005-511234) and the 7th FP HERMIONE (grant agreement no. 226354). Additional funds came from the DFG and the Max Planck Society to A. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baco AR, 2003, MAR ECOL PROG SER, V260, P109, DOI 10.3354/meps260109; Baco AR, 1999, MAR ECOL PROG SER, V182, P137, DOI 10.3354/meps182137; Ballard RD, 2001, AM J ARCHAEOL, V105, P607, DOI 10.2307/507409; Becker PT, 2009, CAH BIOL MAR, V50, P343; BENNER R, 1984, APPL ENVIRON MICROB, V47, P998, DOI 10.1128/AEM.47.5.998-1004.1984; Bernardino AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033515; Bernardino AF, 2010, DEEP-SEA RES PT I, V57, P708, DOI 10.1016/j.dsr.2010.03.004; Bienhold C, 2012, ISME J, V6, P724, DOI 10.1038/ismej.2011.140; Boggemann M, 2012, MAR BIODIVERS, V42, P47, DOI 10.1007/s12526-011-0091-2; Boetius A, 1996, MAR ECOL PROG SER, V140, P239, DOI 10.3354/meps140239; Borchert H, 2008, BAYRISCHE LANDESANST, V65, P51; Borda E, 2012, ZOOL SCR, V41, P307, DOI 10.1111/j.1463-6409.2012.00529.x; BORSHEIM KY, 1990, APPL ENVIRON MICROB, V56, P352; Bowman J., 2006, PROKARYOTES, P677, DOI DOI 10.1007/0-387-30747-8_26; BURDIGE DJ, 1992, GEOPHYS RES LETT, V19, P1851, DOI 10.1029/92GL02159; Cardinale M, 2004, APPL ENVIRON MICROB, V70, P6147, DOI 10.1128/AEM.70.10.6147-6156.2004; Carere CR, 2008, INT J MOL SCI, V9, P1342, DOI 10.3390/ijms9071342; de Beer D, 2006, LIMNOL OCEANOGR, V51, P1315, DOI 10.4319/lo.2006.51.3.1315; Deming JW, 1997, MICROSC RES TECHNIQ, V37, P162, DOI 10.1002/(SICI)1097-0029(19970415)37:2<162::AID-JEMT4>3.0.CO;2-Q; Desbruyeres D., 2006, HDB DEEP SEA HYDROTH; DISTEL DL, 1991, APPL ENVIRON MICROB, V57, P2376, DOI 10.1128/AEM.57.8.2376-2382.1991; Distel DL, 2002, INT J SYST EVOL MICR, V52, P2261, DOI 10.1099/00207713-52-6-2261; Distel DL, 1997, BIOL BULL, V192, P253, DOI 10.2307/1542719; Distel DL, 2000, NATURE, V403, P725, DOI 10.1038/35001667; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Duperron S, 2008, ENVIRON MICROBIOL, V10, P433, DOI 10.1111/j.1462-2920.2007.01465.x; Dupont J, 2009, MYCOL RES, V113, P1351, DOI 10.1016/j.mycres.2009.08.015; Dupre S, 2007, DEEP-SEA RES PT I, V54, P1146, DOI 10.1016/j.dsr.2007.03.007; Fagervold SK, 2012, FEMS MICROBIOL ECOL; Fang JS, 2006, FEMS MICROBIOL ECOL, V57, P429, DOI 10.1111/j.1574-6941.2006.00126.x; Felden J, 2010, LIMNOL OCEANOGR, V55, P2366, DOI 10.4319/lo.2010.55.6.2366; Felden J, BIOGEOCHEMICAL UNPUB; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Foucher JP, 2009, OCEANOGRAPHY, V22, P92, DOI 10.5670/oceanog.2009.11; Fukunaga Y, 2009, J GEN APPL MICROBIOL, V55, P267, DOI 10.2323/jgam.55.267; Gaudron SM, 2010, MAR ENVIRON RES, V70, P1, DOI 10.1016/j.marenvres.2010.02.002; Gebruk AV, 2003, SARSIA, V88, P394, DOI 10.1080/00364820310003190; GIBBS PE, 1987, NEW ZEAL J ZOOL, V14, P135, DOI 10.1080/03014223.1987.10422691; Glover AG, 2005, MAR ECOL-EVOL PERSP, V26, P223, DOI 10.1111/j.1439-0485.2005.00060.x; GLUD RN, 1994, DEEP-SEA RES PT I, V41, P1767; Goffredi SK, 2010, ENVIRON MICROBIOL, V12, P344, DOI 10.1111/j.1462-2920.2009.02072.x; Gontharet S, 2007, DEEP-SEA RES PT II, V54, P1292, DOI 10.1016/j.dsr2.2007.04.007; GOODAY A, 1984, SARSIA, V69, P45, DOI 10.1080/00364827.1984.10420588; Grasshoff K., 1999, METHODS SEAWATER ANA; Grunke S, 2011, GEOBIOLOGY, V9, P330, DOI 10.1111/j.1472-4669.2011.00281.x; Hall POJ, 2007, LIMNOL OCEANOGR, V52, P19, DOI 10.4319/lo.2007.52.1.0019; Huber JA, 2010, FEMS MICROBIOL ECOL, V73, P538, DOI 10.1111/j.1574-6941.2010.00910.x; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Jeroschewski P, 1996, ANAL CHEM, V68, P4351, DOI 10.1021/ac960091b; Johansen JE, 1999, INT J SYST BACTERIOL, V49, P1231, DOI 10.1099/00207713-49-3-1231; JOHNSON KS, 1986, SCIENCE, V231, P1139, DOI 10.1126/science.231.4742.1139; JORGENSEN BB, 1978, GEOMICROBIOL J, V1, P11; Jorgensen BB, 2007, NAT REV MICROBIOL, V5, P770, DOI 10.1038/nrmicro1745; Joye SB, 2004, CHEM GEOL, V205, P219, DOI 10.1016/j.chemgeo.2003.12.019; Kallmeyer J, 2004, LIMNOL OCEANOGR-METH, V2, P171, DOI 10.4319/lom.2004.2.171; Khelaifia S, 2011, INT J SYST EVOL MICR, V61, P2706, DOI 10.1099/ijs.0.028670-0; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Knittel K, 2003, GEOMICROBIOL J, V20, P269, DOI 10.1080/01490450303896; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Kretschmar EI, 2008, INT BIODETER BIODEGR, V61, P69, DOI 10.1016/j.ibiod.2007.07.004; Kudenov Jerry D., 1995, P207; Laurent MCZ, 2009, MAR ENVIRON RES, V67, P83, DOI 10.1016/j.marenvres.2008.11.006; Le Bris N, 2006, MAR CHEM, V98, P167, DOI 10.1016/j.marchem.2005.08.008; LESCHINE SB, 1995, ANNU REV MICROBIOL, V49, P399, DOI 10.1146/annurev.mi.49.100195.002151; Levin LA, 2009, DEEP-SEA RES PT II, V56, P449, DOI 10.1016/j.dsr2.2008.05.032; Lichtschlag A, 2010, LIMNOL OCEANOGR, V55, P931, DOI 10.4319/lo.2009.55.2.0931; Loncke L, 2004, MAR PETROL GEOL, V21, P669, DOI 10.1016/j.marpetgeo.2004.02.004; Lorion J, 2012, CAH BIOL MAR, V53, P77; Lorion J, 2009, P ROY SOC B-BIOL SCI, V276, P177, DOI 10.1098/rspb.2008.1101; Luther GW, 2001, NATURE, V410, P813, DOI 10.1038/35071069; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Macavoy SE, 2008, J SHELLFISH RES, V27, P153, DOI 10.2983/0730-8000(2008)27[153:CPIBHI]2.0.CO;2; Madigan M.T., 2006, BROCK BIOL MICROORGA; MEYERREIL LA, 1983, MAR BIOL, V77, P247, DOI 10.1007/BF00395813; MILLERO FJ, 1988, LIMNOL OCEANOGR, V33, P269, DOI 10.4319/lo.1988.33.2.0269; Oksanen J., 2013, R PACKAGE VERSION 2, P292; Olu-Le Roy K, 2004, DEEP-SEA RES PT I, V51, P1915, DOI 10.1016/j.dsr.2004.07.004; Pailleret M, 2007, MAR ECOL-EVOL PERSP, V28, P233, DOI 10.1111/j.1439-0485.2006.00149.x; Palacios C, 2006, CAH BIOL MAR, V47, P415; Palacios C, 2009, MICROB ECOL, V58, P737, DOI 10.1007/s00248-009-9538-4; Ramette A, 2009, APPL ENVIRON MICROB, V75, P2495, DOI 10.1128/AEM.02409-08; RASMUSSEN H, 1992, MAR ECOL PROG SER, V81, P289, DOI 10.3354/meps081289; REICHENBACH H, 2006, PROKARYOTES HDB BIOL, P00549, DOI DOI 10.1007/0-387-30747-8_20; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; REVSBECH NP, 1986, ADV MICROB ECOL, V9, P293; RICE ME, 1985, P BIOL SOC WASH, V98, P54; RICE ME, 1969, AM ZOOL, V9, P803; Ritt B, 2011, MAR BIOL, V158, P1187, DOI 10.1007/s00227-011-1679-6; Rouse G. W., 2001, POLYCHAETES; Ruehland C, 2010, ENVIRON MICROBIOL, V12, P2312, DOI 10.1111/j.1462-2920.2010.02256.x; Sibuet M, 1998, DEEP-SEA RES PT II, V45, P517, DOI 10.1016/S0967-0645(97)00074-X; Smith CR, 2003, OCEANOGR MAR BIOL, V41, P311; SMITH CR, 1989, NATURE, V341, P27, DOI 10.1038/341027a0; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Southward EC, 2008, J SHELLFISH RES, V27, P139, DOI 10.2983/0730-8000(2008)27[139:TMOBSI]2.0.CO;2; Stubbins A, 2012, LIMNOL OCEANOGR-METH, V10, P347, DOI 10.4319/lom.2012.10.347; Treude T, 2003, MAR ECOL PROG SER, V264, P1, DOI 10.3354/meps264001; Treude T, 2009, MAR ECOL PROG SER, V382, P1, DOI 10.3354/meps07972; TURNER RD, 1973, SCIENCE, V180, P1377, DOI 10.1126/science.180.4093.1377; Tyler PA, 2007, MAR ECOL PROG SER, V343, P151, DOI 10.3354/meps06832; Ward ME, 2003, CAN J ZOOL, V81, P582, DOI 10.1139/Z03-034; WATERBURY JB, 1983, SCIENCE, V221, P1401, DOI 10.1126/science.221.4618.1401; Wenzhofer F, 2000, MAR CHEM, V69, P43, DOI 10.1016/S0304-4203(99)00091-2; Wenzhofer F, 2002, DEEP-SEA RES PT I, V49, P1255, DOI 10.1016/S0967-0637(02)00025-0; Wilson DB, 2011, CURR OPIN MICROBIOL, V14, P259, DOI 10.1016/j.mib.2011.04.004; WOLFF T, 1979, SARSIA, V64, P117, DOI 10.1080/00364827.1979.10411373; Yang JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006085; Yi H, 2007, INT J SYST EVOL MICR, V57, P151, DOI 10.1099/ijs.0.64525-0; [No title captured]	110	96	99	2	141	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53590	10.1371/journal.pone.0053590	http://dx.doi.org/10.1371/journal.pone.0053590			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301092	Green Submitted, Green Published, gold			2022-12-25	WOS:000313320900086
J	Gu, BJ; Baird, PN; Vessey, KA; Skarratt, KK; Fletcher, EL; Fuller, SJ; Richardson, AJ; Guymer, RH; Wiley, JS				Gu, Ben J.; Baird, Paul N.; Vessey, Kirstan A.; Skarratt, Kristen K.; Fletcher, Erica L.; Fuller, Stephen J.; Richardson, Andrea J.; Guymer, Robyn H.; Wiley, James S.			A rare functional haplotype of the P2RX4 and P2RX7 genes leads to loss of innate phagocytosis and confers increased risk of age-related macular degeneration	FASEB JOURNAL			English	Article						drusen; microglia; scavenger receptor	RETINAL-PIGMENT EPITHELIUM; EXTRACELLULAR ATP; APOPTOTIC CELLS; P2X(7) RECEPTOR; SCAVENGER RECEPTOR; BRUCHS MEMBRANE; P2X7 RECEPTOR; POLYMORPHISM; MICROGLIA; BRAIN	Age-related macular degeneration (AMD) is a leading cause of blindness in Western countries and is diagnosed by the clinical appearance of yellow subretinal deposits called drusen. Genetic changes in immune components are clearly implicated in the pathology of this disease. We have previously shown that the purinergic receptor P2X7 can act as a scavenger receptor, mediating phagocytosis of apoptotic cells and insoluble debris. We performed a genetic association study of functional polymorphisms in the P2RX7 and P2RX4 genes in a cohort of 744 patients with AMD and 557 age-matched Caucasian control subjects. The P2X4 Tyr315Cys variant was 2-fold more frequent in patients with AMD compared to control subjects, with the minor allele predicting susceptibility to disease. Pairwise linkage disequilibrium was observed between Tyr315Cys in the P2RX4 gene and Gly150Arg in the P2RX7 gene, and these two minor alleles formed a rare haplotype that was overrepresented in patients with AMD (n=17) compared with control subjects (n=3) (odds ratio 4.05, P=0.026). Expression of P2X7 (wild type or variant 150Arg) in HEK293 cells conferred robust phagocytosis toward latex beads, whereas coexpression of the P2X7 150Arg with P2X4 315Cys variants almost completely inhibited phagocytic capacity. Fresh human monocytes harboring this heterozygous 150Arg-315Cys haplotype showed 40% reduction in bead phagocytosis. In the primate eye, immunohistochemistry indicated that P2X7 and P2X4 receptors were coexpressed on microglia and macrophages, but neither receptor was seen on retinal pigment epithelial cells. These results demonstrate that a haplotype including two rare variants in P2RX7 and P2RX4 confers a functional interaction between these two variant receptors that impairs the normal scavenger function of macrophages and microglia. Failure of this P2X7-mediated phagocytic pathway may impair removal of subretinal deposits and predispose individuals toward AMD.-Gu, B. J., Baird, P. N., Vessey, K. A., Skarratt, K. K., Fletcher, E. L., Fuller, S. J., Richardson, A. J., Guymer, R. H., Wiley, J. S. A rare functional haplotype of the P2RX4 and P2RX7 genes leads to loss of innate phagocytosis and confers increased risk of age related macular degeneration. FASEB J. 27, 1479-1487 (2013). www.fasebj.org	[Gu, Ben J.; Wiley, James S.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia; [Vessey, Kirstan A.; Fletcher, Erica L.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3010, Australia; [Baird, Paul N.; Richardson, Andrea J.; Guymer, Robyn H.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, East Melbourne, Vic, Australia; [Skarratt, Kristen K.; Fuller, Stephen J.; Wiley, James S.] Univ Sydney, Nepean Hosp, Nepean Clin Sch, Penrith, NSW, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; Nepean Hospital; University of Sydney	Wiley, JS (corresponding author), Univ Melbourne, Florey Neurosci Inst, Parkville, Vic 3010, Australia.	james.wiley@florey.edu.au	Skarratt, Kristy/AAN-1479-2020; Fletcher, Erica/E-6364-2012; Fuller, Stephen/W-6646-2019	Fletcher, Erica/0000-0001-9412-9523; Fuller, Stephen/0000-0003-4637-7391; Vessey, Kirstan/0000-0003-1031-1964; Wiley, James/0000-0001-9421-4154; Skarratt, Kristy/0000-0003-4971-2773; Gu, Ben/0000-0001-5500-4453; Baird, Paul/0000-0002-1305-3502; Guymer, Robyn/0000-0002-9441-4356	Australian National Health and Medical Research Council (NHMRC) [1048082, 633275, 566814, 529905, 1028444]; Centre for Clinical Research Excellence [529923]; American Health Assistance Foundation; Macular Degeneration Research grant; Australian Research Council [FT120100581]; Centre for Eye Research Australia	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Centre for Clinical Research Excellence; American Health Assistance Foundation; Macular Degeneration Research grant; Australian Research Council(Australian Research Council); Centre for Eye Research Australia	This study was supported by Australian National Health and Medical Research Council (NHMRC) project grants 1048082, 633275, and 566814; Centre for Clinical Research Excellence grant 529923 (Translational Clinical Research in Major Eye Diseases); an American Health Assistance Foundation, Macular Degeneration Research grant to E. L. F.; Australian Research Council Future Fellowship FT120100581 to B.J.G.; NHMRC Practitioner Fellowship 529905 to R. H. G.; and NHMRC Senior Research Fellowship 1028444 to P.N.B. Centre for Eye Research Australia receives operational infrastructure support from the Victorian government.	Anderson CM, 2006, TRENDS NEUROSCI, V29, P257, DOI 10.1016/j.tins.2006.03.003; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Antonio LS, 2011, BRIT J PHARMACOL, V163, P1069, DOI 10.1111/j.1476-5381.2011.01303.x; Baird PN, 2006, INVEST OPHTH VIS SCI, V47, P4194, DOI 10.1167/iovs.05-1285; Baird PN, 2009, CLIN EXP OPHTHALMOL, V37, P814, DOI 10.1111/j.1442-9071.2009.02136.x; Buschini E, 2011, PROG NEUROBIOL, V95, P14, DOI 10.1016/j.pneurobio.2011.05.011; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Finneman SC, 2001, J EXP MED, V194, P1289, DOI 10.1084/jem.194.9.1289; Finnemann SC, 2002, P NATL ACAD SCI USA, V99, P3842, DOI 10.1073/pnas.052025899; Finnemann SC, 1999, J EXP MED, V190, P861, DOI 10.1084/jem.190.6.861; Fletcher EL, 2010, OPTOMETRY VISION SCI, V87, P269, DOI 10.1097/OPX.0b013e3181c9132b; Gerszten RE, 2012, NEW ENGL J MED, V366, P1734, DOI 10.1056/NEJMcibr1200164; Gu BJ, 2011, J IMMUNOL, V187, P2365, DOI 10.4049/jimmunol.1101178; Gu BJ, 2010, BLOOD, V115, P1621, DOI 10.1182/blood-2009-11-251744; Gu BJ, 2009, AM J PHYSIOL-CELL PH, V297, pC430, DOI 10.1152/ajpcell.00079.2009; Gu BJ, 2001, J BIOL CHEM, V276, P11135, DOI 10.1074/jbc.M010353200; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; Guymer R, 1999, PROG RETIN EYE RES, V18, P59, DOI 10.1016/S1350-9462(98)00012-3; Hoppe G, 2001, INVEST OPHTH VIS SCI, V42, P2714; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Karala AR, 2010, J MOL BIOL, V396, P883, DOI 10.1016/j.jmb.2009.12.014; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; KILLINGSWORTH MC, 1990, EYE, V4, P613, DOI 10.1038/eye.1990.86; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Monif M, 2010, INT J BIOCHEM CELL B, V42, P1753, DOI 10.1016/j.biocel.2010.06.021; Newman EA, 2001, J NEUROSCI, V21, P2215, DOI 10.1523/JNEUROSCI.21-07-02215.2001; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Okumura M, 2011, FEBS J, V278, P1137, DOI 10.1111/j.1742-4658.2011.08039.x; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Puthussery T, 2009, J COMP NEUROL, V513, P430, DOI 10.1002/cne.21964; Qureshi OS, 2007, J CELL SCI, V120, P3838, DOI 10.1242/jcs.010348; Richardson AJ, 2006, J LAB CLIN MED, V147, P290, DOI 10.1016/j.lab.2006.01.005; Stokes L, 2011, HYPERTENSION, V58, P1086, DOI 10.1161/HYPERTENSIONAHA.111.176180; Stokes L, 2010, FASEB J, V24, P2916, DOI 10.1096/fj.09-150862; Stokes L, 2009, EUR J IMMUNOL, V39, P986, DOI 10.1002/eji.200838818; Sugiyama T, 2010, INVEST OPHTH VIS SCI, V51, P3236, DOI 10.1167/iovs.09-4192; Swaroop A, 2009, ANNU REV GENOM HUM G, V10, P19, DOI 10.1146/annurev.genom.9.081307.164350; Ting AYC, 2009, CURR OPIN OPHTHALMOL, V20, P369, DOI 10.1097/ICU.0b013e32832f8016; Wiley JS, 2011, TISSUE ANTIGENS, V78, P321, DOI 10.1111/j.1399-0039.2011.01780.x; Wiley JS, 2012, PURINERG SIGNAL, V8, P579, DOI 10.1007/s11302-012-9308-5; Wixey JA, 2009, J NEUROIMMUNOL, V212, P35, DOI 10.1016/j.jneuroim.2009.04.016; Young MT, 2010, TRENDS BIOCHEM SCI, V35, P83, DOI 10.1016/j.tibs.2009.09.006; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598	45	49	51	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2013	27	4					1479	1487		10.1096/fj.12-215368	http://dx.doi.org/10.1096/fj.12-215368			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23303206				2022-12-25	WOS:000316940800020
J	Unoki, M; Masuda, A; Dohmae, N; Arita, K; Yoshimatsu, M; Iwai, Y; Fukui, Y; Ueda, K; Hamamoto, R; Shirakawa, M; Sasaki, H; Nakamura, Y				Unoki, Motoko; Masuda, Akiko; Dohmae, Naoshi; Arita, Kyohei; Yoshimatsu, Masanori; Iwai, Yukiko; Fukui, Yoshinori; Ueda, Koji; Hamamoto, Ryuji; Shirakawa, Masahiro; Sasaki, Hiroyuki; Nakamura, Yusuke			Lysyl 5-Hydroxylation, a Novel Histone Modification, by Jumonji Domain Containing 6 (JMJD6)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINE METHYLTRANSFERASE; METHYLATION; RECEPTOR; RNA; H3	JMJD6 is reported to hydroxylate lysyl residues of a splicing factor, U2AF65. In this study, we found that JMJD6 hydroxylates histone lysyl residues. In vitro experiments showed that JMJD6 has a binding affinity to histone proteins and hydroxylates multiple lysyl residues of histone H3 and H4 tails. Using JMJD6 knock-out mouse embryos, we revealed that JMJD6 hydroxylates lysyl residues of histones H2A/H2B and H3/H4 in vivo by amino acid composition analysis. 5-Hydroxylysine was detected at the highest level in histones purified from murine testis, which expressed JMJD6 at a significantly high level among various tissues examined, and JMJD6 overexpression increased the amount of 5-hydroxylysine in histones in human embryonic kidney 293 cells. These results indicate that histones are additional substrates of JMJD6 in vivo. Because 5-hydroxylation of lysyl residues inhibited N-acetylation and N-methylation by an acetyltransferase and a methyltransferase, respectively, in vitro, histone 5-hydroxylation may have important roles in epigenetic regulation of gene transcription or chromosomal rearrangement.	[Unoki, Motoko; Sasaki, Hiroyuki] Kyushu Univ, Med Inst Bioregulat, Div Epigenet, Dept Mol Genet, Fukuoka 8128582, Japan; [Unoki, Motoko; Ueda, Koji] RIKEN, Ctr Genom Med, Inst Phys & Chem Res, Lab Biomarker Dev, Tokyo 1088639, Japan; [Masuda, Akiko; Dohmae, Naoshi] RIKEN, Biomol Characterizat Team, Saitama 3510198, Japan; [Arita, Kyohei] Kyoto Univ, Grad Sch Engn, Kyoto 6158510, Japan; [Yoshimatsu, Masanori; Hamamoto, Ryuji; Shirakawa, Masahiro; Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo 1088639, Japan; [Iwai, Yukiko; Fukui, Yoshinori] Kyushu Univ, Med Inst Bioregulat, Dept Immunobiol & Neurosci, Div Immunogenet, Fukuoka 8128582, Japan; [Hamamoto, Ryuji; Nakamura, Yusuke] Univ Chicago, Ctr Personalized Therapeut, Sect Hematol Oncol, Chicago, IL 60637 USA	Kyushu University; RIKEN; RIKEN; Kyoto University; University of Tokyo; Kyushu University; University of Chicago	Unoki, M (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Epigenet, Dept Mol Genet,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	unokim@bioreg.kyushu-u.ac.jp	Arita, Kyohei/AAJ-6402-2020; Hamamoto, Ryuji/AAF-9600-2019; Dohmae, Naoshi/C-2040-2011; Unoki, Motoko/X-3285-2019	Arita, Kyohei/0000-0002-9762-8405; Hamamoto, Ryuji/0000-0002-2632-1334; Dohmae, Naoshi/0000-0002-5242-9410; Unoki, Motoko/0000-0002-9629-3818; Fukui, Yoshinori/0000-0003-2335-8745	JSPS KAKENHI [22700867]; Kyushu University; Grants-in-Aid for Scientific Research [22680064, 24113711] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kyushu University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant 22700867 and Kyushu University interdisciplinary programs in education and projects in research development.	Bose Jens, 2004, J Biol, V3, P15, DOI 10.1186/jbiol10; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Han G, 2012, J CELL BIOCHEM, V113, P1663, DOI 10.1002/jcb.24035; Hong X, 2010, P NATL ACAD SCI USA, V107, P14568, DOI 10.1073/pnas.1008832107; Kunisaki Y, 2004, BLOOD, V103, P3362, DOI 10.1182/blood-2003-09-3245; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Mantri M, 2011, CHEMBIOCHEM, V12, P531, DOI 10.1002/cbic.201000641; Masuda A, 2010, ANAL CHEM, V82, P8939, DOI 10.1021/ac101718x; Myllyla R, 2007, J CELL PHYSIOL, V212, P323, DOI 10.1002/jcp.21036; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; Unoki M, 2009, BIOCHEM PHARMACOL, V78, P1279, DOI 10.1016/j.bcp.2009.05.035; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6	17	101	102	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6053	6062		10.1074/jbc.M112.433284	http://dx.doi.org/10.1074/jbc.M112.433284			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23303181	hybrid, Green Published			2022-12-25	WOS:000315820700003
J	Bult, W; Kroeze, SGC; Elschot, M; Seevinck, PR; Beekman, FJ; de Jong, HWAM; Uges, DRA; Kosterink, JGW; Luijten, PR; Hennink, WE; Schip, ADV; Bosch, JLHR; Nijsen, JFW; Jans, JJM				Bult, Wouter; Kroeze, Stephanie G. C.; Elschot, Mattijs; Seevinck, Peter R.; Beekman, Freek J.; de Jong, Hugo W. A. M.; Uges, Donald R. A.; Kosterink, Jos G. W.; Luijten, Peter R.; Hennink, Wim E.; Schip, Alfred D. van Het; Bosch, J. L. H. Ruud; Nijsen, J. Frank W.; Jans, Judith J. M.			Intratumoral Administration of Holmium-166 Acetylacetonate Microspheres: Antitumor Efficacy and Feasibility of Multimodality Imaging in Renal Cancer	PLOS ONE			English	Article							POLY(L-LACTIC ACID) MICROSPHERES; CELL CARCINOMA; RADIOFREQUENCY ABLATION; RADIONUCLIDE THERAPY; SPECT; TUMORS; SURVIVAL; PINHOLE; KIDNEY; RADIOEMBOLIZATION	Purpose: The increasing incidence of small renal tumors in an aging population with comorbidities has stimulated the development of minimally invasive treatments. This study aimed to assess the efficacy and demonstrate feasibility of multimodality imaging of intratumoral administration of holmium-166 microspheres ((HoAcAcMS)-Ho-166). This new technique locally ablates renal tumors through high-energy beta particles, while the gamma rays allow for nuclear imaging and the paramagnetism of holmium allows for MRI. Methods: (HoAcAcMS)-Ho-166 were administered intratumorally in orthotopic renal tumors (Balb/C mice). Post administration CT, SPECT and MRI was performed. At several time points (2 h, 1, 2, 3, 7 and 14 days) after MS administration, tumors were measured and histologically analyzed. Holmium accumulation in organs was measured using inductively coupled plasma mass spectrometry. Results: (HoAcAcMS)-Ho-166 were successfully administered to tumor bearing mice. A striking near-complete tumor-control was observed in (HoAcAcMS)-Ho-166 treated mice (0.10 +/- 0.01 cm(3) vs. 4.15 +/- 0.3 cm(3) for control tumors). Focal necrosis and inflammation was present from 24 h following treatment. Renal parenchyma outside the radiated region showed no histological alterations. Post administration CT, MRI and SPECT imaging revealed clear deposits of (HoAcAcMS)-Ho-166 in the kidney. Conclusions: Intratumorally administered (HoAcAcMS)-Ho-166 has great potential as a new local treatment of renal tumors for surgically unfit patients. In addition to strong cancer control, it provides powerful multimodality imaging opportunities.	[Bult, Wouter; Elschot, Mattijs; de Jong, Hugo W. A. M.; Luijten, Peter R.; Schip, Alfred D. van Het; Nijsen, J. Frank W.] Univ Med Ctr Utrecht, Dept Radiol & Nucl Med, Imaging Div, Utrecht, Netherlands; [Bult, Wouter; Uges, Donald R. A.; Kosterink, Jos G. W.] Univ Groningen, Univ Med Ctr Groningen, Dept Hosp & Clin Pharm, NL-9713 AV Groningen, Netherlands; [Kroeze, Stephanie G. C.; Bosch, J. L. H. Ruud; Jans, Judith J. M.] Univ Med Ctr Utrecht, Dept Urol, Utrecht, Netherlands; [Kroeze, Stephanie G. C.; Jans, Judith J. M.] Univ Med Ctr Utrecht, Expt Oncol Lab, Utrecht, Netherlands; [Seevinck, Peter R.] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [Beekman, Freek J.] Milabs, Utrecht, Netherlands; [Beekman, Freek J.] Delft Univ Technol, Fac Sci Appl, Sect Radiat Detect & Med Imaging, Delft, Netherlands; [Hennink, Wim E.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Pharmaceut, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; University of Groningen; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Delft University of Technology; Utrecht University	Nijsen, JFW (corresponding author), Univ Med Ctr Utrecht, Dept Radiol & Nucl Med, Imaging Div, Utrecht, Netherlands.	f.nijsen@umcutrecht.nl	Elschot, Mattijs/AAD-4362-2021; Nijsen, Frank/C-2839-2018; Hennink, Wim/O-8632-2016	Elschot, Mattijs/0000-0002-8056-9103; Nijsen, Frank/0000-0001-7625-2253; Jans, Judith/0000-0003-0960-6263; Kosterink, Jos/0000-0001-8358-765X	Foundation for Advancement of Research in Hospital Pharmacy University Medical Center Groningen (Stichting OZG); Dutch technology foundation STW [06069]	Foundation for Advancement of Research in Hospital Pharmacy University Medical Center Groningen (Stichting OZG); Dutch technology foundation STW(Technologiestichting STW)	This work was supported by the Foundation for Advancement of Research in Hospital Pharmacy University Medical Center Groningen (Stichting OZG) and the Dutch technology foundation STW (grant number 06069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolch WE, 1999, J NUCL MED, V40, p11S; Branderhorst W, 2010, PHYS MED BIOL, V55, P2023, DOI 10.1088/0031-9155/55/7/015; Bult W, 2009, PHARM RES-DORDR, V26, P1371, DOI 10.1007/s11095-009-9848-8; Bult W, 2012, PHARM RES-DORDR, V29, P827, DOI 10.1007/s11095-011-0610-7; Coldwell D, 2012, AM J CLIN ONCOL-CANC, V35, P167, DOI 10.1097/COC.0b013e3181f47923; D'Asseler Y, 2009, Q J NUCL MED MOL IM, V53, P343; de Wit TC, 2006, PHYS MED BIOL, V51, P4773, DOI 10.1088/0031-9155/51/19/004; Forrer F, 2007, CANCER BIOTHER RADIO, V22, P40, DOI 10.1089/cbr.2006.353; Gao W, 2010, CANCER BIOTHER RADIO, V25, P215, DOI 10.1089/cbr.2008.0596; Gervais DA, 2005, AM J ROENTGENOL, V185, P64, DOI 10.2214/ajr.185.1.01850064; Hendricks JSM, 2005, LAUR052675 LOS AL NA, P1; Heuer R, 2010, EUR UROL, V57, P223, DOI 10.1016/j.eururo.2009.10.023; Hollingsworth JM, 2006, JNCI-J NATL CANCER I, V98, P1331, DOI 10.1093/jnci/djj362; Hung AJ, 2012, BJU INT, V109, P1398, DOI 10.1111/j.1464-410X.2011.10648.x; Kerkhof EM, 2011, BJU INT, V107, P63, DOI 10.1111/j.1464-410X.2010.09458.x; Kutikov A, 2010, J CLIN ONCOL, V28, P311, DOI 10.1200/JCO.2009.22.4816; Lane BR, 2010, CANCER-AM CANCER SOC, V116, P3119, DOI 10.1002/cncr.25184; Lin WY, 2000, J NUCL MED, V41, P1892; Ljungberg B, 2010, EUR UROL, V58, P398, DOI 10.1016/j.eururo.2010.06.032; Luboldt Wolfgang, 2009, Current Drug Delivery, V6, P255; MacKie S, 2011, J UROLOGY, V185, P285, DOI 10.1016/j.juro.2010.09.001; MADRAZO A, 1969, AM J PATHOL, V54, P507; Muto G, 2011, EUR UROL, V60, P173, DOI 10.1016/j.eururo.2011.04.028; Nijsen JFW, 1999, EUR J NUCL MED, V26, P699, DOI 10.1007/s002590050440; O'Donoghue J, 2004, CANCER BIOTHER RADIO, V19, P378, DOI 10.1089/1084978041425025; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Arrontes D, 2008, J UROLOGY, V179, P857, DOI 10.1016/j.juro.2007.10.048; Seevinck PR, 2007, ANTI-CANCER AGENT ME, V7, P317, DOI 10.2174/187152007780618153; Seevinck PR, 2012, INT J RADIAT ONCOL, V83, pE437, DOI 10.1016/j.ijrobp.2011.12.085; Smits MLJ, 2012, LANCET ONCOL, V13, P1025, DOI 10.1016/S1470-2045(12)70334-0; Smits MLJ, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-70; Tian JH, 1996, J NUCL MED, V37, P958; van der Have F, 2008, IEEE T MED IMAGING, V27, P960, DOI 10.1109/TMI.2008.924644; van der Have F, 2009, J NUCL MED, V50, P599, DOI 10.2967/jnumed.108.056606; Vanhove C, 2009, EUR J NUCL MED MOL I, V36, P1049, DOI 10.1007/s00259-009-1062-8; Vente MAD, 2008, EUR J NUCL MED MOL I, V35, P1259, DOI 10.1007/s00259-008-0747-8; Vente MAD, 2009, EUR RADIOL, V19, P951, DOI 10.1007/s00330-008-1211-7; Zielhuis SW, 2007, BIOMATERIALS, V28, P4591, DOI 10.1016/j.biomaterials.2007.07.012; Zielhuis SW, 2005, BIOMATERIALS, V26, P925, DOI 10.1016/j.biomaterials.2004.03.028	39	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e52178	10.1371/journal.pone.0052178	http://dx.doi.org/10.1371/journal.pone.0052178			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320070	Green Published, gold, Green Submitted			2022-12-25	WOS:000313429800012
J	Perea-Martinez, I; Nagai, T; Chaudhari, N				Perea-Martinez, Isabel; Nagai, Takatoshi; Chaudhari, Nirupa			Functional Cell Types in Taste Buds Have Distinct Longevities	PLOS ONE			English	Article							RAT CIRCUMVALLATE PAPILLAE; RECEPTOR-CELLS; LINEAGE RELATIONSHIPS; ALPHA-GUSTDUCIN; POPULATIONS; EXPRESSION; STEM; RENEWAL; IMMUNOREACTIVITY; EPITHELIUM	Taste buds are clusters of polarized sensory cells embedded in stratified oral epithelium. In adult mammals, taste buds turn over continuously and are replenished through the birth of new cells in the basal layer of the surrounding non-sensory epithelium. The half-life of cells in mammalian taste buds has been estimated as 8-12 days on average. Yet, earlier studies did not address whether the now well-defined functional taste bud cell types all exhibit the same lifetime. We employed a recently developed thymidine analog, 5-ethynil-2'-deoxyuridine (EdU) to re-evaluate the incorporation of newly born cells into circumvallate taste buds of adult mice. By combining EdU-labeling with immunostaining for selected markers, we tracked the differentiation and lifespan of the constituent cell types of taste buds. EdU was primarily incorporated into basal extragemmal cells, the principal source for replenishing taste bud cells. Undifferentiated EdU-labeled cells began migrating into circumvallate taste buds within 1 day of their birth. Type II (Receptor) taste cells began to differentiate from EdU-labeled precursors beginning 2 days after birth and then were eliminated with a half-life of 8 days. Type III (Presynaptic) taste cells began differentiating after a delay of 3 days after EdU-labeling, and they survived much longer, with a half-life of 22 days. We also scored taste bud cells that belong to neither Type II nor Type III, a heterogeneous group that includes mostly Type I cells, and also undifferentiated or immature cells. A non-linear decay fit described these cells as two sub-populations with half-lives of 8 and 24 days respectively. Our data suggest that many post-mitotic cells may remain quiescent within taste buds before differentiating into mature taste cells. A small number of slow-cycling cells may also exist within the perimeter of the taste bud. Based on their incidence, we hypothesize that these may be progenitors for Type III cells.	[Perea-Martinez, Isabel; Chaudhari, Nirupa] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA; [Nagai, Takatoshi] Keio Univ, Sch Med, Dept Biol, Yokohama, Kanagawa 223, Japan; [Chaudhari, Nirupa] Univ Miami, Miller Sch Med, Program Neurosci, Miami, FL 33136 USA	University of Miami; Keio University; University of Miami	Chaudhari, N (corresponding author), Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA.	nchaudhari@med.miami.edu	Nagai, Takatoshi/L-1162-2013		National Institutes of Health/National Institute on Deafness and Other Communication Disorders (NIH/NIDCD) [R01 DC6308]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006308] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Deafness and Other Communication Disorders (NIH/NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health/National Institute on Deafness and Other Communication Disorders (NIH/NIDCD) grant R01 DC6308 (NC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano-Miyoshi M, 2008, J MOL HISTOL, V39, P193, DOI 10.1007/s10735-007-9151-0; Bartel DL, 2006, J COMP NEUROL, V497, P1, DOI 10.1002/cne.20954; BEIDLER LM, 1965, J CELL BIOL, V27, P263, DOI 10.1083/jcb.27.2.263; Boughter JD, 1997, J NEUROSCI, V17, P2852; BURNS ER, 1976, ANAT REC, V184, P265, DOI 10.1002/ar.1091840302; Chaudhari N, 2010, J CELL BIOL, V190, P285, DOI 10.1083/jcb.201003144; Cho YK, 1998, CHEM SENSES, V23, P735, DOI 10.1093/chemse/23.6.735; Clapp TR, 2004, J COMP NEUROL, V468, P311, DOI 10.1002/cne.10963; Cohn ZJ, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-72; CONGER AD, 1969, RADIAT RES, V37, P31, DOI 10.2307/3572749; DeFazio RA, 2006, J NEUROSCI, V26, P3971, DOI 10.1523/JNEUROSCI.0515-06.2006; DELAY RJ, 1986, J COMP NEUROL, V253, P242, DOI 10.1002/cne.902530210; Dvoryanchikov G, 2012, CHEM SENSES, V37; Dvoryanchikov G, 2009, J COMP NEUROL, V517, P1, DOI 10.1002/cne.22152; FARBMAN AI, 1980, CELL TISSUE KINET, V13, P349, DOI 10.1111/j.1365-2184.1980.tb00474.x; Gaillard D, 2011, GENESIS, V49, P295, DOI 10.1002/dvg.20731; GANCHROW JR, 1993, MICROSC RES TECHNIQ, V26, P106, DOI 10.1002/jemt.1070260204; Hamamichi R, 2006, NEUROSCIENCE, V141, P2129, DOI 10.1016/j.neuroscience.2006.05.061; Ichimori Y, 2009, ARCH HISTOL CYTOL, V72, P91, DOI 10.1679/aohc.72.91; Kim JW, 2006, CHEM SENSES, V31, P213, DOI 10.1093/chemse/bjj021; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Miura H, 2005, CHEM SENSES, V30, P367, DOI 10.1093/chemse/bji031; MURRAY R G, 1969, Journal of Ultrastructure Research, V27, P444, DOI 10.1016/S0022-5320(69)80043-2; MURRAY RG, 1993, MICROSC RES TECHNIQ, V26, P209, DOI 10.1002/jemt.1070260304; Okubo T, 2009, STEM CELLS, V27, P442, DOI 10.1634/stemcells.2008-0611; Packard D S Jr, 1973, Differentiation, V1, P397, DOI 10.1111/j.1432-0436.1973.tb00137.x; Pumplin DW, 1997, J COMP NEUROL, V378, P389, DOI 10.1002/(SICI)1096-9861(19970217)378:3<389::AID-CNE7>3.0.CO;2-#; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Stone LM, 2002, J NEUROSCI, V22, P4522, DOI 10.1523/JNEUROSCI.22-11-04522.2002; STONE LM, 1995, P NATL ACAD SCI USA, V92, P1916, DOI 10.1073/pnas.92.6.1916; Sullivan JM, 2010, EUR J NEUROSCI, V31, P1549, DOI 10.1111/j.1460-9568.2010.07184.x; TAKEDA M, 1977, ARCH HISTOL JAPON, V40, P243, DOI 10.1679/aohc1950.40.243; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Taniguchi R, 2005, ARCH HISTOL CYTOL, V68, P243, DOI 10.1679/aohc.68.243; Thirumangalathu S, 2009, DEVELOPMENT, V136, P1519, DOI 10.1242/dev.029090; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Wang H, 2009, J COMP NEUROL, V512, P384, DOI 10.1002/cne.21899; Yang RB, 2000, J COMP NEUROL, V424, P205, DOI 10.1002/1096-9861(20000821)424:2<205::AID-CNE2>3.0.CO;2-F; Yee CL, 2001, J COMP NEUROL, V440, P97, DOI 10.1002/cne.1372; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0	40	111	114	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53399	10.1371/journal.pone.0053399	http://dx.doi.org/10.1371/journal.pone.0053399			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320081	gold, Green Published, Green Submitted			2022-12-25	WOS:000313429800045
J	Quesada, V; Sarmiento-Manus, R; Gonzalez-Bayon, R; Hricova, A; Ponce, MR; Micol, JL				Quesada, Victor; Sarmiento-Manus, Raquel; Gonzalez-Bayon, Rebeca; Hricova, Andrea; Ponce, Maria Rosa; Micol, Jose Luis			PORPHOBILINOGEN DEAMINASE Deficiency Alters Vegetative and Reproductive Development and Causes Lesions in Arabidopsis	PLOS ONE			English	Article							MG-PROTOPORPHYRIN IX; RNA-SYNTHESIS LEADS; GENE-EXPRESSION; SALICYLIC-ACID; ANTISENSE RNA; CELL-DEATH; TETRAPYRROLE BIOSYNTHESIS; UROPORPHYRINOGEN DECARBOXYLASE; SUBCELLULAR-LOCALIZATION; ACQUIRED-RESISTANCE	The Arabidopsis rugosa1 (rug1) mutant has irregularly shaped leaves and reduced growth. In the absence of pathogens, leaves of rug1 plants have spontaneous lesions reminiscent of those seen in lesion-mimic mutants; rug1 plants also express cytological and molecular markers associated with defence against pathogens. These rug1 phenotypes are made stronger by dark/light transitions. The rug1 mutant also has delayed flowering time, upregulation of the floral repressor FLOWERING LOCUS C (FLC) and downregulation of the flowering promoters FT and SOC1/AGL20. Vernalization suppresses the late flowering phenotype of rug1 by repressing FLC. Microarray analysis revealed that 280 nuclear genes are differentially expressed between rug1 and wild type; almost a quarter of these genes are involved in plant defence. In rug1, the auxin response is also affected and several auxin-responsive genes are downregulated. We identified the RUG1 gene by map-based cloning and found that it encodes porphobilinogen deaminase (PBGD), also known as hydroxymethylbilane synthase, an enzyme of the tetrapyrrole biosynthesis pathway, which produces chlorophyll, heme, siroheme and phytochromobilin in plants. PBGD activity is reduced in rug1 plants, which accumulate porphobilinogen. Our results indicate that Arabidopsis PBGD deficiency impairs the porphyrin pathway and triggers constitutive activation of plant defence mechanisms leading to leaf lesions and affecting vegetative and reproductive development.	[Quesada, Victor; Sarmiento-Manus, Raquel; Gonzalez-Bayon, Rebeca; Hricova, Andrea; Ponce, Maria Rosa; Micol, Jose Luis] Univ Miguel Hernandez, Inst Bioingn, Elche, Spain	Universidad Miguel Hernandez de Elche	Micol, JL (corresponding author), Univ Miguel Hernandez, Inst Bioingn, Campus Elche, Elche, Spain.	jlmicol@umh.es	Ponce, María Rosa/C-8203-2014; Hricova, Andrea/Z-5792-2019; Gonzalez-Bayon, Rebeca/I-4605-2012; Micol, José Luis/B-4832-2010; Sarmiento, Raquel/L-3129-2017	Ponce, María Rosa/0000-0003-0770-4230; Hricova, Andrea/0000-0001-5879-0912; Micol, José Luis/0000-0002-0396-1750; quesada, victor/0000-0002-0965-8680; Sarmiento, Raquel/0000-0001-6929-8034; Gonzalez-Bayon, Rebeca/0000-0002-9939-0795	Ministerio de Economia y Competitividad of Spain [BIO2008-04075, BFU2011-22825]; Generalitat Valenciana [Prometeo/2009/112]; European Research Training Network [HPRN-CT-2002-00267 (DAGOLIGN)]	Ministerio de Economia y Competitividad of Spain(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); European Research Training Network	This work was supported by research grants to JLM from the Ministerio de Economia y Competitividad of Spain (BIO2008-04075 and BFU2011-22825), the Generalitat Valenciana (Prometeo/2009/112) and the European Research Training Network HPRN-CT-2002-00267 (DAGOLIGN). RSM is indebted to the Ministerio de Ciencia e Innovacion of Spain for her Ph.D. scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Peral MM, 2006, DEVELOPMENT, V133, P3755, DOI 10.1242/dev.02554; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; BATTERSBY AR, 1979, J CHEM SOC CHEM COMM, P1155, DOI 10.1039/c39790001155; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berna G, 1999, GENETICS, V152, P729; Clark AM, 1999, PLANT CELL PHYSIOL, V40, P69, DOI 10.1093/oxfordjournals.pcp.a029476; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dangl JL, 1996, PLANT CELL, V8, P1793, DOI 10.1105/tpc.8.10.1793; DIETRICH RA, 1994, CELL, V77, P565, DOI 10.1016/0092-8674(94)90218-6; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Gong ZZ, 2001, PLANT PHYSIOL, V126, P363, DOI 10.1104/pp.126.1.363; GOUGH SP, 1979, CARLSBERG RES COMMUN, V44, P403, DOI 10.1007/BF02906189; GREENBERG JT, 1994, CELL, V77, P551, DOI 10.1016/0092-8674(94)90217-8; Guan Y, 2004, PLANT PHYSIOL, V135, P1346, DOI 10.1104/pp.104.039370; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; He YH, 2002, PLANT CELL, V14, P805, DOI 10.1105/tpc.010422; Hricova A, 2006, PLANT PHYSIOL, V141, P942, DOI 10.1104/pp.106.080069; Hu GS, 1998, PLANT CELL, V10, P1095, DOI 10.1105/tpc.10.7.1095; Huang MS, 2010, AM J BOT, V97, P357, DOI 10.3732/ajb.0900233; Huang MS, 2009, MOL PLANT, V2, P773, DOI 10.1093/mp/ssp029; Ishikawa A, 2001, PLANT J, V27, P89, DOI 10.1046/j.1365-313x.2001.01058.x; JONES RM, 1994, BIOCHEM J, V299, P895, DOI 10.1042/bj2990895; JORDAN PM, 1979, J CHEM SOC CHEM COMM, P204, DOI 10.1039/c39790000204; Kant S, 2009, PLANT SIGNAL BEHAV, V4, P1174, DOI 10.4161/psb.4.12.10043; KOCH E, 1990, PLANT CELL, V2, P437, DOI 10.1105/tpc.2.5.437; KRUSE E, 1995, EMBO J, V14, P3712, DOI 10.1002/j.1460-2075.1995.tb00041.x; KUC J, 1982, BIOSCIENCE, V32, P854, DOI 10.2307/1309008; Kumar AM, 2000, PLANT PHYSIOL, V122, P49, DOI 10.1104/pp.122.1.49; Lermontova I, 2006, PLANT J, V48, P499, DOI 10.1111/j.1365-313X.2006.02894.x; Libault M, 2007, MOL PLANT MICROBE IN, V20, P900, DOI 10.1094/MPMI-20-8-0900; LIM SH, 1994, PLANT MOL BIOL, V26, P863, DOI 10.1007/BF00028854; Lin CSY, 2011, CLIN NEUROPHYSIOL, V122, P2336, DOI 10.1016/j.clinph.2011.07.036; Lindberg RLP, 1996, NAT GENET, V12, P195, DOI 10.1038/ng0296-195; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorrain S, 2003, TRENDS PLANT SCI, V8, P263, DOI 10.1016/S1360-1385(03)00108-0; Lu H, 2003, PLANT CELL, V15, P2408, DOI 10.1105/tpc.015412; MALAMY J, 1990, SCIENCE, V250, P1002, DOI 10.1126/science.250.4983.1002; Martinez C, 2004, PLANT J, V37, P209, DOI 10.1046/j.1365-313X.2003.01954.x; METRAUX JP, 1990, SCIENCE, V250, P1004, DOI 10.1126/science.250.4983.1004; Meyers BC, 2002, PLANT J, V32, P77, DOI 10.1046/j.1365-313X.2002.01404.x; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Miller JD, 1999, PLANT PHYSIOL, V120, P1015, DOI 10.1104/pp.120.4.1015; Mochizuki N, 2008, P NATL ACAD SCI USA, V105, P15184, DOI 10.1073/pnas.0803245105; Mochizuki N, 2010, TRENDS PLANT SCI, V15, P488, DOI 10.1016/j.tplants.2010.05.012; Mock HP, 1999, J BIOL CHEM, V274, P4231, DOI 10.1074/jbc.274.7.4231; Mock HP, 1997, PLANT PHYSIOL, V113, P1101, DOI 10.1104/pp.113.4.1101; Moeder W, 2008, PLANT SIGNAL BEHAV, V3, P764, DOI 10.4161/psb.3.10.6545; Molina A, 1999, PLANT J, V17, P667, DOI 10.1046/j.1365-313X.1999.00420.x; Moulin M, 2005, BIOCHEM SOC T, V33, P737, DOI 10.1042/BST0330737; Moulin M, 2008, P NATL ACAD SCI USA, V105, P15178, DOI 10.1073/pnas.0803054105; Papenbrock J, 2001, PLANT J, V28, P41, DOI 10.1046/j.1365-313X.2001.01126.x; Penninckx IAMA, 1996, PLANT CELL, V8, P2309, DOI 10.1105/tpc.8.12.2309; Ponce MR, 1998, PLANT J, V14, P497, DOI 10.1046/j.1365-313X.1998.00146.x; Quesada V, 1999, FEBS LETT, V461, P101, DOI 10.1016/S0014-5793(99)01426-X; Quesada V, 2011, PLANT J, V68, P738, DOI 10.1111/j.1365-313X.2011.04726.x; Robles P, 2001, MOL GENET GENOMICS, V266, P12, DOI [10.1007/s004380100353, 10.1007/s004380100535]; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Smyth Gordon K, 2003, Methods Mol Biol, V224, P111; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; Sticher L, 1997, ANNU REV PHYTOPATHOL, V35, P235, DOI 10.1146/annurev.phyto.35.1.235; Strand A, 2003, NATURE, V421, P79, DOI 10.1038/nature01204; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Tanaka Ryouichi, 2011, Arabidopsis Book, V9, pe0145, DOI 10.1199/tab.0145; Tanaka T, 2004, PLANT J, V37, P139, DOI 10.1046/j.1365-313X.2003.01946.x; TERRAS FRG, 1993, FEBS LETT, V316, P233, DOI 10.1016/0014-5793(93)81299-F; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; UKNES S, 1992, PLANT CELL, V4, P645, DOI 10.1105/tpc.4.6.645; Vandeputte O, 2005, APPL ENVIRON MICROB, V71, P1169, DOI 10.1128/AEM.71.3.1169-1177.2005; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Weigel RR, 2005, PLANT CELL, V17, P1279, DOI 10.1105/tpc.104.027441; Weymann K, 1995, PLANT CELL, V7, P2013, DOI 10.1105/tpc.7.12.2013; WITTY M, 1993, PLANT PHYSIOL, V103, P139, DOI 10.1104/pp.103.1.139; Witty M, 1996, PLANTA, V199, P557, DOI 10.1007/BF00195187; Woodson JD, 2011, CURR BIOL, V21, P897, DOI 10.1016/j.cub.2011.04.004; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083	82	25	29	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53378	10.1371/journal.pone.0053378	http://dx.doi.org/10.1371/journal.pone.0053378			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308205	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429800043
J	Almenara, DP; de Moura, JP; Scarabotto, CP; Zingali, RB; Winter, CE				Almenara, Daniela P.; de Moura, Joselene P.; Scarabotto, Cristiane P.; Zingali, Russolina B.; Winter, Carlos E.			The Molecular and Structural Characterization of Two Vitellogenins from the Free-Living Nematode Oscheius tipulae	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; YOLK PROTEINS; SEQUENCE; PRECURSOR; INSECT; EVOLUTION; BINDING; GENE; IDENTIFICATION; LIPOVITELLIN	This paper describes the purification of yolk proteins, which are important for the reproduction of egg-laying animals, and the structural characterization of two vitellogenins, VT1 and OTI-VIT-6, of the nematode Oscheius tipulae. O. tipulae is an alternative model organism to its relative, the widely used Caenorhabditis elegans, and is a good model to understand reproduction in insect parasitic nematodes of the genus Heterorhabditis. The native purified O. tipulae vitellogenin is composed of three polypeptides (VT1, VT2 and VT3), whereas in C. elegans, vitellogenin is composed of four polypeptides. The gene (Oti-vit-1) encoding yolk polypeptide VT1 has been recently identified in the genome of O. tipulae. Immunoblotting and N-terminal sequencing confirmed that VT1 is indeed coded by Oti-vit-1. Utilizing the same experimental approaches, we showed that the polypeptides VT2 and VT3 are derived from the proteolytic processing of the C-and N-terminal portions of the precursor OTI-VIT-6, respectively. We also showed that the recombinant polypeptide (P40), corresponding to the N-terminal sequence of OTI-VIT-6, preferentially interacts with a 100-kDa polypeptide found in adult worm extracts, as we have previously shown for the native vitellins of O. tipulae. Using the putative nematode vitellogenin amino acid sequences available in the UniProtKB database, we constructed a phylogenetic tree and showed that the O. tipulae vitellogenins characterized in this study are orthologous to those of the Caenorhabditis spp. Together, these results represent the first structural and functional comparative study of nematode yolk proteins outside the Caenorhabditis genus and provide insight into the evolution of these lipoproteins within the Nematode Phylum.	[Almenara, Daniela P.; de Moura, Joselene P.; Scarabotto, Cristiane P.; Winter, Carlos E.] Univ Sao Paulo, Dept Parasitol, Inst Biomed Sci, Sao Paulo, Brazil; [Zingali, Russolina B.] Inst Med Biochem UFRJ CCS Bloco H, Lab Prote & Prot & Peptide Microsequencing, Rio De Janeiro, Brazil	Universidade de Sao Paulo	Winter, CE (corresponding author), Univ Sao Paulo, Dept Parasitol, Inst Biomed Sci, Sao Paulo, Brazil.	cewinter@icb.usp.br	Winter, Carlos E./A-3085-2008; Zingali, Russolina/G-4862-2012	Winter, Carlos E./0000-0002-0055-2484; Zingali, Russolina/0000-0003-3156-6923	CNPq; FAPESP	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by FAPESP (http://www.fapesp.br/en/) and CNPq (http://www.cnpq.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn IY, 2006, GENOME, V49, P1007, DOI 10.1139/G06-045; Akamine RN, 2008, J MOL EVOL, V67, P278, DOI 10.1007/s00239-008-9147-8; Almenara DP, 2009, THESIS U SAO PAULO; Anderson TA, 1998, STRUCT FOLD DES, V6, P895, DOI 10.1016/S0969-2126(98)00091-4; Babin PJ, 1999, J MOL EVOL, V49, P150, DOI 10.1007/PL00006528; Berriot-Varoqueaux N, 2000, ANNU REV NUTR, V20, P663, DOI 10.1146/annurev.nutr.20.1.663; BLUMENTHAL T, 1984, J MOL BIOL, V174, P1, DOI 10.1016/0022-2836(84)90361-9; Branicky R, 2001, GENETICS, V159, P997; BYRNE BM, 1989, PROG BIOPHYS MOL BIO, V53, P33, DOI 10.1016/0079-6107(89)90005-9; Chen JS, 1997, J MOL EVOL, V44, P440, DOI 10.1007/PL00006164; Cheon HM, 2001, INSECT BIOCHEM MOLEC, V31, P753, DOI 10.1016/S0965-1748(01)00068-6; Choi Byung-Kwon, 2009, V462, P181, DOI 10.1007/978-1-60327-115-8_12; Crompton D.W.T., 1989, P9; Felix M.-A., 2006, OSCHEIUS TIPULAE WOR, DOI [DOI 10.1895/WORMBOOK.1.119.1, 10.1895/wormbook.1.119.1]; Felix MA, 2012, 959 NEMATODE GENOMES; GERBERHUBER S, 1987, NUCLEIC ACIDS RES, V15, P4737, DOI 10.1093/nar/15.12.4737; GLASS WF, 1981, ANAL BIOCHEM, V115, P219, DOI 10.1016/0003-2697(81)90549-2; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; Grant Barth D, 2006, WormBook, P1; Hagedorn HH, 1998, ADV INSECT PHYSIOL, V27, P335, DOI 10.1016/S0065-2806(08)60015-6; Harris Todd W., 2006, V351, P31; HEWICK RM, 1981, J BIOL CHEM, V256, P7990; Hiramatsu N, 2002, J EXP ZOOL, V292, P11, DOI 10.1002/jez.1138; Jira W, 1998, CHEM PHYS LIPIDS, V91, P1, DOI 10.1016/S0009-3084(97)00095-9; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; KIMBLE J, 1983, DEV BIOL, V96, P189, DOI 10.1016/0012-1606(83)90322-6; Komatsu M, 1996, COMP BIOCHEM PHYS B, V113, P561, DOI 10.1016/0305-0491(95)02079-9; LAFLEUR GJ, 1995, J MOL EVOL, V41, P505, DOI 10.1007/BF00160323; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li AK, 2003, J BIOL CHEM, V278, P2799, DOI 10.1074/jbc.M205067200; Mann CJ, 1999, J MOL BIOL, V285, P391, DOI 10.1006/jmbi.1998.2298; Motola DL, 2006, CELL, V124, P1209, DOI 10.1016/j.cell.2006.01.037; Nakamura A, 1999, BIOCHEM BIOPH RES CO, V264, P580, DOI 10.1006/bbrc.1999.1549; Nico JA, 2009, THESIS U SAO PAULO; PAN ML, 1969, SCIENCE, V165, P393, DOI 10.1126/science.165.3891.393; Roebroek AJM, 2004, J BIOL CHEM, V279, P53442, DOI 10.1074/jbc.M407152200; Rottiers V, 2006, DEV CELL, V10, P473, DOI 10.1016/j.devcel.2006.02.008; Sappington TW, 2002, REPRO BIOL, V12, P69; Sappington TW, 2002, REPROD BIOL INVERTEB, VXII A, P235; Schneider WJ, 1996, INT REV CYTOL, V166, P103, DOI 10.1016/S0074-7696(08)62507-3; Sellers JA, 2005, J BIOL CHEM, V280, P13902, DOI 10.1074/jbc.M500769200; Serino JC, 2008, COMP BIOCHEM PHYS B, V151, P330, DOI 10.1016/j.cbpb.2008.07.017; SHARROCK WJ, 1992, J MOL BIOL, V226, P903, DOI 10.1016/0022-2836(92)90642-W; SHARROCK WJ, 1990, J BIOL CHEM, V265, P14422; SHARROCK WJ, 1984, J MOL BIOL, V174, P419, DOI 10.1016/0022-2836(84)90329-2; SHARROCK WJ, 1983, DEV BIOL, V96, P182, DOI 10.1016/0012-1606(83)90321-4; Shibata Y, 2003, SCIENCE, V302, P1779, DOI 10.1126/science.1087167; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Smolenaars MMW, 2007, J LIPID RES, V48, P489, DOI 10.1194/jlr.R600028-JLR200; SPIETH J, 1985, NUCLEIC ACIDS RES, V13, P7129, DOI 10.1093/nar/13.19.7129; SULSTON JE, 1974, GENETICS, V77, P95; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Telfer WH, 2002, REPRO BIOL, V12, P29; Thompson JR, 2002, BIOCHEMISTRY-US, V41, P9398, DOI 10.1021/bi025674w; Tong Y, 2004, GENE, V328, P25, DOI 10.1016/j.gene.2003.12.001; VANHETSCHIP FD, 1987, J MOL BIOL, V196, P245, DOI 10.1016/0022-2836(87)90688-7; Villeneuve P, 2002, J NEUROCHEM, V82, P783, DOI 10.1046/j.1471-4159.2002.00988.x; Wang H, 2000, GENE, V256, P303, DOI 10.1016/S0378-1119(00)00376-0; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wheeler JR, 2005, TOXICOL MECH METHOD, V15, P293, DOI 10.1080/15376520590968789; Winter CE, 2002, REPRO BIOL, V12, P1; Winter CE, 1996, MOL BIOL EVOL, V13, P674, DOI 10.1093/oxfordjournals.molbev.a025628; WINTER CE, 1992, COMP BIOCHEM PHYS B, V103, P189, DOI 10.1016/0305-0491(92)90430-Y; Wood W.B., 1988, Cold Spring Harbor Monograph Series, V17, P1	64	6	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53460	10.1371/journal.pone.0053460	http://dx.doi.org/10.1371/journal.pone.0053460			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308227	gold, Green Submitted, Green Published			2022-12-25	WOS:000313429100070
J	Culver, JC; Vadakkan, TJ; Dickinson, ME				Culver, James C.; Vadakkan, Tegy J.; Dickinson, Mary E.			A Specialized Microvascular Domain in the Mouse Neural Stem Cell Niche	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; VASCULAR NICHE; SUBVENTRICULAR ZONE; ENDOTHELIAL-CELLS; STEM/PROGENITOR CELLS; SELF-RENEWAL; BONE-MARROW; HUMAN BRAIN; ADULT; NEUROGENESIS	The microenvironment of the subependymal zone (SEZ) neural stem cell niche is necessary for regulating adult neurogenesis. In particular, signaling from the microvasculature is essential for adult neural stem cell maintenance, but microvascular structure and blood flow dynamics in the SEZ are not well understood. In this work, we show that the mouse SEZ constitutes a specialized microvascular domain defined by unique vessel architecture and reduced rates of blood flow. Additionally, we demonstrate that hypoxic conditions are detectable in the ependymal layer that lines the ventricle, and in a subpopulation of neurons throughout the SEZ and striatum. Together, these data highlight previously unidentified features of the SEZ neural stem cell niche, and further demonstrate the extent of microvascular specialization in the SEZ microenvironment.	[Culver, James C.; Vadakkan, Tegy J.; Dickinson, Mary E.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA	Baylor College of Medicine	Dickinson, ME (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA.	mdickins@bcm.edu			NIH [P20 EB007076, U54 CA149196, T32 HL007676]; Optical Imaging and Vital Microscopy Core (OIVM) at BCM; NATIONAL CANCER INSTITUTE [U54CA149196] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097520, T32HL007676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P20EB007076] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Optical Imaging and Vital Microscopy Core (OIVM) at BCM; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the following NIH grants: P20 EB007076, U54 CA149196, and T32 HL007676 (http://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Joshua S. Goldberg for sharing immunostaining protocols, and to members of the Dickinson lab for critical reading of the manuscript. We also acknowledge support from the Optical Imaging and Vital Microscopy Core (OIVM) at BCM.	Ables JL, 2011, NAT REV NEUROSCI, V12, P269, DOI 10.1038/nrn3024; Adamo L, 2009, NATURE, V459, P1131, DOI 10.1038/nature08073; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Andreu-Agullo C, 2009, NAT NEUROSCI, V12, P1514, DOI 10.1038/nn.2437; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; De Visscher G, 2006, NAT PROTOC, V1, P2162, DOI 10.1038/nprot.2006.332; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; DOWELL RT, 1992, AM J PHYSIOL, V262, pR666, DOI 10.1152/ajpregu.1992.262.4.R666; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Goldberg JS, 2009, REGEN MED, V4, P879, DOI [10.2217/rme.09.61, 10.2217/RME.09.61]; Gomez-Gaviro MV, 2012, P NATL ACAD SCI USA, V109, P1317, DOI 10.1073/pnas.1016199109; Gomez-Gaviro MV, 2012, J CARDIOVASC TRANSL; Gotts JE, 2005, EXP NEUROL, V194, P139, DOI 10.1016/j.expneurol.2005.02.001; Gotts JE, 2005, J NEUROSCI RES, V80, P160, DOI 10.1002/jnr.20434; Gurkan UA, 2008, ANN BIOMED ENG, V36, P1978, DOI 10.1007/s10439-008-9577-x; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hamilton LK, 2009, NEUROSCIENCE, V164, P1044, DOI 10.1016/j.neuroscience.2009.09.006; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kazanis I, 2010, J NEUROSCI, V30, P9771, DOI 10.1523/JNEUROSCI.0700-10.2010; Kokovay E, 2012, CELL STEM CELL, V11, P220, DOI 10.1016/j.stem.2012.06.016; Lacar B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031960; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; Li WL, 2008, DEV NEUROBIOL, V68, P1474, DOI 10.1002/dneu.20674; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; MILLER B, 1993, EXP NEUROL, V124, P326, DOI 10.1006/exnr.1993.1203; Mirzadeh Z., 2010, J VIS EXP; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Miyamoto N, 2009, NEUROSCIENCE, V162, P525, DOI 10.1016/j.neuroscience.2009.05.004; Mobley AK, 2009, J CELL SCI, V122, P1842, DOI 10.1242/jcs.043257; Moreno-Manzano V, 2010, J BIOL CHEM, V285, P1333, DOI 10.1074/jbc.M109.008326; Nakagomi N, 2009, STEM CELLS, V27, P2185, DOI 10.1002/stem.161; Neubauer JA, 2004, J APPL PHYSIOL, V96, P367, DOI 10.1152/japplphysiol.00831.2003; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Ohura Norihiko, 2003, J Atheroscler Thromb, V10, P304; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; QUINN B, 1995, NEUROSCI LETT, V184, P169, DOI 10.1016/0304-3940(94)11198-R; Rakic P, 2003, GLIA, V43, P19, DOI 10.1002/glia.10244; Ramirez-Castillejo C, 2006, NAT NEUROSCI, V9, P331, DOI 10.1038/nn1657; Rodriguez-Jimenez FJ, 2012, STEM CELLS; Roitbak T, 2008, J CEREBR BLOOD F MET, V28, P1530, DOI 10.1038/jcbfm.2008.38; Roitbak T, 2011, CELL MOL NEUROBIOL, V31, P119, DOI 10.1007/s10571-010-9561-5; ROSENBLUM WI, 1977, STROKE, V8, P103, DOI 10.1161/01.STR.8.1.103; RUDOLPH AM, 1967, CIRC RES, V21, P163, DOI 10.1161/01.RES.21.2.163; San Martin N, 2011, STEM CELLS, V29, P1064, DOI 10.1002/stem.654; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; SARIN SK, 1990, AM J PHYSIOL, V258, pG365, DOI 10.1152/ajpgi.1990.258.3.G365; Sawada M, 2000, J CEREBR BLOOD F MET, V20, P112, DOI 10.1097/00004647-200001000-00015; Seidel S, 2010, BRAIN, V133, P983, DOI 10.1093/brain/awq042; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Stallcup WB, 2002, J NEUROCYTOL, V31, P423, DOI 10.1023/A:1025731428581; Tabrizchi R, 2000, J PHARMACOL TOX MET, V44, P375, DOI 10.1016/S1056-8719(00)00123-4; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; TORACK RM, 1976, J NEUROPATH EXP NEUR, V35, P385, DOI 10.1097/00005072-197607000-00001; Tormos KV, 2010, J CELL MOL MED, V14, P795, DOI 10.1111/j.1582-4934.2010.01031.x; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Varia MA, 1998, GYNECOL ONCOL, V71, P270, DOI 10.1006/gyno.1998.5163; Wang L, 2007, EXP EYE RES, V84, P108, DOI 10.1016/j.exer.2006.09.005; Wheaton WW, 2011, AM J PHYSIOL-CELL PH, V300, pC385, DOI 10.1152/ajpcell.00485.2010; Whitman MC, 2009, J COMP NEUROL, V516, P94, DOI 10.1002/cne.22093; Winkler IG, 2010, BLOOD, V116, P375, DOI 10.1182/blood-2009-07-233437; Zhu CL, 2009, J CEREBR BLOOD F MET, V29, P342, DOI 10.1038/jcbfm.2008.124	77	33	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53546	10.1371/journal.pone.0053546	http://dx.doi.org/10.1371/journal.pone.0053546			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308251	gold, Green Published, Green Submitted			2022-12-25	WOS:000313429100088
J	Garcia-Montojo, M; Dominguez-Mozo, M; Arias-Leal, A; Garcia-Martinez, A; De las Heras, V; Casanova, I; Faucard, R; Gehin, N; Madeira, A; Arroyo, R; Curtin, F; Alvarez-Lafuente, R; Perron, H				Garcia-Montojo, Marta; Dominguez-Mozo, Maria; Arias-Leal, Ana; Garcia-Martinez, Angel; De las Heras, Virginia; Casanova, Ignacio; Faucard, Raphael; Gehin, Nadege; Madeira, Alexandra; Arroyo, Rafael; Curtin, Francois; Alvarez-Lafuente, Roberto; Perron, Herve			The DNA Copy Number of Human Endogenous Retrovirus-W (MSRV-Type) Is Increased in Multiple Sclerosis Patients and Is Influenced by Gender and Disease Severity	PLOS ONE			English	Article							REAL-TIME PCR; MOLECULAR CHARACTERIZATION; PROCESSED PSEUDOGENES; REVERSE-TRANSCRIPTASE; ENVELOPE PROTEIN; EXPRESSION; PARTICLES; ORIGIN; ENV; SEQUENCES	Background: Multiple Sclerosis is an autoimmune disease more prevalent in women than in men. Multiple Sclerosis Associated Retrovirus element (MSRV) is a member of type-W endogenous retrovirus family (HERV-W), known to be associated to MS. Most HERVs are unable to replicate but MSRV expression associated with reverse-transcriptase activity in MS would explain reported DNA copy number increase in MS patients. A potential link between HERV-W copies on chromosome X and gender differential prevalence has been suggested. The present study addresses MSRV-type DNA load in relation with the gender differences and clinical status in MS and healthy controls. Results: 178 MS patients (62.9% women) and 124 controls (56.5% women) were included. MSRV env load (copies/pg of DNA) was analyzed by real time qPCR with specific primers and probe for its env gene, in DNA from peripheral blood mononuclear cells (PBMCs). MSRV load was more elevated in MS patients than in controls (p = 4.15e-7). MS women presented higher MSRV load than control women (p = 0.009) and MS men also had higher load than control men (p = 2.77e-6). Besides, women had higher levels than men, both among patients (p = 0.007) and controls (p = 1.24e-6). Concordantly, EDSS and MSSS scores were higher among female patients with an elevated MSRV load (p = 0.03 and p = 0.04, respectively). Conclusions: MSRV increases its copy number in PBMC of MS patients and particularly in women with high clinical scores. This may explain causes underlying the higher prevalence of MS in women. The association with the clinical severity calls for further investigations on MSRV load in PBMCs as a biomarker for MS.	[Garcia-Montojo, Marta; Dominguez-Mozo, Maria; Arias-Leal, Ana; Garcia-Martinez, Angel; De las Heras, Virginia; Casanova, Ignacio; Arroyo, Rafael; Alvarez-Lafuente, Roberto] Hosp Clin San Carlos, Inst Invest Sanitaria, Multiple Sclerosis Unit, Madrid, Spain; [Faucard, Raphael; Gehin, Nadege; Madeira, Alexandra; Curtin, Francois; Perron, Herve] Geneuro Innovat, Lyon, France	Hospital Clinico San Carlos	Garcia-Montojo, M (corresponding author), Hosp Clin San Carlos, Inst Invest Sanitaria, Multiple Sclerosis Unit, Madrid, Spain.	mgarciamon.hcsc@salud.madrid.org	Alvarez-Lafuente, Roberto/AAJ-9980-2020; Perron, Herve/AAN-5887-2020	Perron, Herve/0000-0002-2551-7685; Dominguez-Mozo, Maria Inmaculada/0000-0001-9236-5717; Alvarez-Lafuente, Roberto/0000-0002-3132-1486; Garcia-Montojo, Marta/0000-0003-0664-3480	Fundacion para la Investigacion Biomedica-Hospital Clinico San Carlos; Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (Feder) [CP07/00273]; REEM: Red Espanola de Esclerosis Multiple [RETICS-REEM RD07/0060]; Geneuro; Instituto de Salud Carlos III-Fondo Investigaciones Sanitarias FIS [09/02074]; Fundacion Mutua Madrilena; Fundacion LAIR; Geneuro Innovation	Fundacion para la Investigacion Biomedica-Hospital Clinico San Carlos; Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (Feder)(European Commission); REEM: Red Espanola de Esclerosis Multiple; Geneuro; Instituto de Salud Carlos III-Fondo Investigaciones Sanitarias FIS; Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Fundacion LAIR; Geneuro Innovation	MGM, MDM and AAL are recipients of a contract of "Fundacion para la Investigacion Biomedica-Hospital Clinico San Carlos". RAL is recipient of a research contract of the Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (Feder) (CP07/00273). AGM is recipient of a technician contract from "REEM: Red Espanola de Esclerosis Multiple" (RETICS-REEM RD07/0060; www.reem.es.) This work was supported by Geneuro and by grants from: Instituto de Salud Carlos III-Fondo Investigaciones Sanitarias FIS (09/02074), "Fundacion Mutua Madrilena", and "Fundacion LAIR". All of the funders but Geneuro had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RF, NG, AM, FC and HP are employees of Geneuro and MGM received honoraria from this company for scientific consultancy. The study has been funded in part by Geneuro Innovation, a company developing therapies and diagnostic tools for diseases associated with the expression of human endogenous retroviruses, with a primary focus on the Nervous System diseases and Multiple Sclerosis. There are no patents, further products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], DATA BASE OF GENOME; [Anonymous], ENSEMBL GENOME BROWS; Antony JM, 2004, NAT NEUROSCI, V7, P1088, DOI 10.1038/nn1319; Antony JM, 2006, AIDS RES HUM RETROV, V22, P1253, DOI 10.1089/aid.2006.22.1253; Brudek T, 2007, J NEUROIMMUNOL, V187, P147, DOI 10.1016/j.jneuroim.2007.04.003; Brudek T, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-104; Christensen T, 2000, ACTA NEUROL SCAND, V101, P229, DOI 10.1034/j.1600-0404.2000.101004229.x; Cossburn M, 2012, MULT SCLER J, V18, P45, DOI 10.1177/1352458511417479; de Villiers JNP, 2006, METAB BRAIN DIS, V21, P163, DOI 10.1007/s11011-006-9016-3; Deb-Rinker P, 1999, GENOMICS, V61, P133, DOI 10.1006/geno.1999.5946; Dolei A, 2002, NEUROLOGY, V58, P471, DOI 10.1212/WNL.58.3.471; Ebers GC, 2004, LANCET, V363, P1773, DOI 10.1016/S0140-6736(04)16304-6; Emerson JJ, 2004, SCIENCE, V303, P537, DOI 10.1126/science.1090042; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Feschotte C, 2012, NAT REV GENET, V13, P283, DOI 10.1038/nrg3199; Firouzi R, 2003, J NEUROVIROL, V9, P79, DOI 10.1080/13550280390173328; Garson JA, 2009, AIDS RES HUM RETROV, V25, P377, DOI 10.1089/aid.2008.0270; Greer JM, 2011, J NEUROIMMUNOL, V234, P7, DOI 10.1016/j.jneuroim.2011.03.003; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Herrera BM, 2008, NEUROLOGY, V71, P799, DOI 10.1212/01.wnl.0000312377.50395.00; Komurian-Pradel F, 1999, VIROLOGY, V260, P1, DOI 10.1006/viro.1999.9792; Krokki O, 2011, MULT SCLER J, V17, P133, DOI 10.1177/1352458510384012; Kurtzke JF, 1983, NEUROLOGY, P33; Laska MJ, 2012, J VIROL, V86, P3713, DOI 10.1128/JVI.06723-11; Laufer G, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-37; Lleo A, 2008, AUTOIMMUN REV, V7, P626, DOI 10.1016/j.autrev.2008.06.009; Mameli G, 2008, J NEUROVIROL, V14, P73, DOI 10.1080/13550280701801107; Mameli G, 2007, J GEN VIROL, V88, P264, DOI 10.1099/vir.0.81890-0; Mameli G, 2009, J VIROL METHODS, V161, P98, DOI 10.1016/j.jviromet.2009.05.024; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Nowak J, 2003, J NEUROVIROL, V9, P112, DOI 10.1080/13550280390173355; Orton SM, 2006, LANCET NEUROL, V5, P932, DOI 10.1016/S1474-4422(06)70581-6; Otowa T, 2006, NEUROSCI LETT, V408, P226, DOI 10.1016/j.neulet.2006.09.004; Pavlicek A, 2002, GENOME RES, V12, P391, DOI 10.1101/gr.216902; Pennell LM, 2012, J AUTOIMMUN, V38, pJ282, DOI 10.1016/j.jaut.2011.11.013; Perron H, 2001, VIROLOGY, V287, P321, DOI 10.1006/viro.2001.1045; PERRON H, 1989, RES VIROLOGY, V140, P551, DOI 10.1016/S0923-2516(89)80141-4; PERRON H, 1991, LANCET, V337, P862, DOI 10.1016/0140-6736(91)92579-Q; PERRON H, 1997, ACTA NEUROL SCAND  S, V169, P22; Perron H, 2012, MULT SCLER; Perron H, 2010, CLIN REV ALLERG IMMU, V39, P51, DOI 10.1007/s12016-009-8170-x; Perron H, 2009, J NEUROL SCI, V286, P65, DOI 10.1016/j.jns.2009.04.034; Petersen T, 2009, J NEUROIMMUNOL, V215, P108, DOI 10.1016/j.jneuroim.2009.08.015; Ramagopalan SV, 2009, NEUROLOGY, V73, P602, DOI 10.1212/WNL.0b013e3181af33cf; Roebke C, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-69; Rolland A, 2006, J IMMUNOL, V176, P7636, DOI 10.4049/jimmunol.176.12.7636; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; Ruprecht K, 2006, J NEUROVIROL, V12, P65, DOI 10.1080/13550280600614973; Sadovnick AD, 2009, J NEUROL SCI, V286, P1, DOI 10.1016/j.jns.2009.09.005; Sotgiu S, 2006, MULT SCLER J, V12, P698, DOI 10.1177/1352458506070773; Sotgiu S, 2002, NEUROLOGY, V59, P1071, DOI 10.1212/WNL.59.7.1071; Sutkowski N, 2001, IMMUNITY, V15, P579, DOI 10.1016/S1074-7613(01)00210-2; Tai AK, 2008, MULT SCLER J, V14, P1175, DOI 10.1177/1352458508094641; Tai AK, 2009, J CLIN VIROL, V46, P47, DOI 10.1016/j.jcv.2009.05.019; Turner G, 2001, CURR BIOL, V11, P1531, DOI 10.1016/S0960-9822(01)00455-9; Wang PJ, 2004, TRENDS ENDOCRIN MET, V15, P79, DOI 10.1016/j.tem.2004.01.007	56	48	51	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53623	10.1371/journal.pone.0053623	http://dx.doi.org/10.1371/journal.pone.0053623			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308264	gold, Green Submitted, Green Published			2022-12-25	WOS:000313429100097
J	Gray, C; Li, ML; Reynolds, CM; Vickers, MH				Gray, Clint; Li, Minglan; Reynolds, Clare M.; Vickers, Mark H.			Pre-Weaning Growth Hormone Treatment Reverses Hypertension and Endothelial Dysfunction in Adult Male Offspring of Mothers Undernourished during Pregnancy	PLOS ONE			English	Article							CHRONIC MATERNAL UNDERNUTRITION; LOW-PROTEIN DIET; BLOOD-PRESSURE; GAP-JUNCTIONS; NITRIC-OXIDE; DEPENDENT HYPERPOLARIZATION; DOUBLE-BLIND; GUINEA-PIG; FACTOR-I; RAT	Maternal undernutrition results in elevated blood pressure (BP) and endothelial dysfunction in adult offspring. However, few studies have investigated interventions during early life to ameliorate the programming of hypertension and vascular disorders. We have utilised a model of maternal undernutrition to examine the effects of pre-weaning growth hormone (GH) treatment on BP and vascular function in adulthood. Female Sprague-Dawley rats were fed either a standard control diet (CON) or 50% of CON intake throughout pregnancy (UN). From neonatal day 3 until weaning (day 21), CON and UN pups received either saline (CON-S, UN-S) or GH (2.5 ug/g/day)(CON-GH, UN-GH). All dams were fed ad libitum throughout lactation. Male offspring were fed a standard diet until the end of the study. Systolic blood pressure (SBP) was measured at day 150 by tail cuff plethysmography. At day 160, intact mesenteric vessels mounted on a pressure myograph. Responses to pressure, agonist-induced constriction and endothelium-dependent vasodilators were investigated to determine vascular function. SBP was increased in UN-S groups and normalised in UN-GH groups (CON-S 121 +/- 2 mmHg, CON-GH 115 +/- 3, UN-S 146 +/- 3, UN-GH 127 +/- 2). Pressure mediated dilation was reduced in UN-S offspring and normalised in UN-GH groups. Vessels from UN-S offspring demonstrated a reduced constrictor response to phenylephrine and reduced vasodilator response to acetylcholine (ACh). Furthermore, UN-S offspring vessels displayed a reduced vasodilator response in the presence of L-NG-Nitroarginine Methyl Ester (L-NAME), carbenoxolone (CBX), L-NAME and CBX, Tram-34 and Apamin. UN-GH vessels showed little difference in responses when compared to CON and significantly increased vasodilator responses when compared to UN-S offspring. Pre-weaning GH treatment reverses the negative effects of maternal UN on SBP and vasomotor function in adult offspring. These data suggest that developmental cardiovascular programming is potentially reversible by early life GH treatment and that GH can reverse the vascular adaptations resulting from maternal undernutrition.	[Gray, Clint; Li, Minglan; Reynolds, Clare M.; Vickers, Mark H.] Univ Auckland, Liggins Inst & Gravida, Natl Ctr Growth & Dev, Auckland 1, New Zealand	University of Auckland	Gray, C (corresponding author), Univ Auckland, Liggins Inst & Gravida, Natl Ctr Growth & Dev, Auckland 1, New Zealand.	c.gray@auckland.ac.nz		Reynolds, Clare/0000-0001-5782-6303; Vickers, Mark/0000-0003-4876-9356; Li, Minglan/0000-0002-3095-7490	National Research Centre of Growth & development (NRCGD); Capex; Liggins Institute; University of Auckland; Gravida: National Centre for Growth and Development	National Research Centre of Growth & development (NRCGD); Capex; Liggins Institute; University of Auckland; Gravida: National Centre for Growth and Development	Minglan Li was supported by a National Research Centre of Growth & development (NRCGD) doctoral training grant. Clint Gray received equipment grant support from Capex, Liggins Institute and University of Auckland. This work was funded by Gravida: National Centre for Growth and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves J G, 1999, J Perinatol, V19, P593; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Boger RH, 1996, J CLIN INVEST, V98, P2706, DOI 10.1172/JCI119095; Brawley L., 2003, Archives of Physiology and Biochemistry, V111, P23, DOI 10.1076/apab.111.1.23.15138; Chadha PS, 2011, J PHARMACOL EXP THER, V336, P701, DOI 10.1124/jpet.110.165795; Chaytor AT, 1998, J PHYSIOL-LONDON, V508, P561, DOI 10.1111/j.1469-7793.1998.561bq.x; Chaytor AT, 1999, J PHYSIOL-LONDON, V520, P539, DOI 10.1111/j.1469-7793.1999.00539.x; CHEN GF, 1992, CIRC RES, V70, P257, DOI 10.1161/01.RES.70.2.257; Coleman HA, 2001, J PHYSIOL-LONDON, V531, P359, DOI 10.1111/j.1469-7793.2001.0359i.x; Connors BW, 2012, EPILEPSY CURR, V12, P66, DOI 10.5698/1535-7511-12.2.66; Edwards G, 1999, BRIT J PHARMACOL, V128, P1788, DOI 10.1038/sj.bjp.0703009; Egecioglu E, 2005, AM J PHYSIOL-ENDOC M, pE317; Fazio S, 1997, EUR HEART J, V18, P340; Franco MDP, 2002, CARDIOVASC RES, V56, P145, DOI 10.1016/S0008-6363(02)00508-4; Gangula PRR, 2004, BIOL REPROD, V71, P1739, DOI 10.1095/biolreprod.104.031369; GIBBONS GH, 1994, NEW ENGL J MED, V330, P1431; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Goto K, 2002, CLIN EXP PHARMACOL P, V29, P595, DOI 10.1046/j.1440-1681.2002.03689.x; Hadoke PWF, 2006, J ENDOCRINOL, V188, P435, DOI 10.1677/joe.1.06506; Howie GJ, 2012, BRIT J NUTR, V108, P298, DOI 10.1017/S000711451100554X; Isgaard J, 1998, EUR HEART J, V19, P1704, DOI 10.1053/euhj.1998.1123; Jackson AA, 2002, CLIN SCI, V103, P633, DOI 10.1042/cs1030633; Juszczak GR, 2009, PROG NEURO-PSYCHOPH, V33, P181, DOI 10.1016/j.pnpbp.2008.12.014; Kansui Y, 2008, CELL CALCIUM, V44, P135, DOI 10.1016/j.ceca.2007.11.012; Kenny LC, 2002, BRIT J PHARMACOL, V136, P1085, DOI 10.1038/sj.bjp.0704817; Khan AS, 2002, CARDIOVASC RES, V54, P25, DOI 10.1016/S0008-6363(01)00533-8; Kwong WY, 2000, DEVELOPMENT, V127, P4195; Laborie C, 2011, J NEUROENDOCRINOL, V23, P711, DOI 10.1111/j.1365-2826.2011.02159.x; Li JM, 2004, AM J PHYSIOL-REG I, V287, pR1014, DOI 10.1152/ajpregu.00124.2004; Li J, 2009, J NUTR, V139, P447, DOI 10.3945/jn.108.097451; Longobardi S, 2000, GROWTH HORM IGF RES, V10, P242, DOI 10.1054/ghir.2000.0160; LUCAS A, 1991, CIBA F SYMP, V156, P38; McCallum RW, 2002, CLIN ENDOCRINOL, V57, P11, DOI 10.1046/j.1365-2265.2002.01559.x; MONCADA S, 1991, P NATL ACAD SCI USA, V88, P2166, DOI 10.1073/pnas.88.6.2166; MULVANY MJ, 1984, HYPERTENSION, V6, P13; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Murphy ME, 1995, J PHYSIOL-LONDON, V489, P723, DOI 10.1113/jphysiol.1995.sp021086; Nystrom Henrik C, 2005, BMC Physiol, V5, P17, DOI 10.1186/1472-6793-5-17; Ozaki T, 2001, J PHYSIOL-LONDON, V530, P141, DOI 10.1111/j.1469-7793.2001.0141m.x; Pladys P, 2004, PEDIATR RES, V55, P1042, DOI 10.1203/01.PDR.0000127012.37315.36; ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O; Rossoni G, 1999, J CARDIOVASC PHARM, V34, P454, DOI 10.1097/00005344-199909000-00021; Rozental R, 2001, METH MOL B, V154, P447; Sas T, 1999, J CLIN ENDOCR METAB, V84, P3064, DOI 10.1210/jc.84.9.3064; Schilling T, 2007, PFLUG ARCH EUR J PHY, V454, P559, DOI 10.1007/s00424-007-0232-4; Schreuder MF, 2006, J HYPERTENS, V24, P1337, DOI 10.1097/01.hjh.0000234114.33025.fd; Sherman RC, 1998, CLIN SCI, V94, P373, DOI 10.1042/cs0940373; Stankevicius E, 2011, JPET; TAKEZAWA H, 1994, AM J PHYSIOL-REG I, V267, pR1250, DOI 10.1152/ajpregu.1994.267.5.R1250; Tivesten A, 2001, GROWTH HORM IGF RES, V11, P187, DOI 10.1054/ghir.2001.0202; Torrens C, 2006, HYPERTENSION, V47, P982, DOI 10.1161/01.HYP.0000215580.43711.d1; Torrens C, 2009, BRIT J NUTR, V101, P27, DOI 10.1017/S0007114508988760; Torrens C, 2009, HYPERTENSION, V53, P661, DOI 10.1161/HYPERTENSIONAHA.108.122820; Verhelst J, 2009, EUR J ENDOCRINOL, V161, pS41, DOI 10.1530/EJE-09-0291; Vickers MH, 2005, ENDOCRINOLOGY, V146, P4211, DOI 10.1210/en.2005-0581; Vickers MH, 2002, J ENDOCRINOL, V175, P615, DOI 10.1677/joe.0.1750615; Vickers MH, 2001, ENDOCRINOLOGY, V142, P3964, DOI 10.1210/en.142.9.3964; Whitesall SE, 2004, AM J PHYSIOL-HEART C, V286, pH2408, DOI 10.1152/ajpheart.01089.2003; Wolfe D, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.07.033; Woodall SM, 1996, J ENDOCRINOL, V150, P231, DOI 10.1677/joe.0.1500231; Woodall SM, 1996, PEDIATR RES, V40, P438, DOI 10.1203/00006450-199609000-00012; Wulff H, 2001, J BIOL CHEM, V276, P32040, DOI 10.1074/jbc.M105231200; YANG RH, 1995, CIRCULATION, V92, P262, DOI 10.1161/01.CIR.92.2.262	63	40	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53505	10.1371/journal.pone.0053505	http://dx.doi.org/10.1371/journal.pone.0053505			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308239	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429100077
J	Shukla, S; Sharma, H; Abbas, A; MacLennan, GT; Fu, PF; Danielpour, D; Gupta, S				Shukla, Sanjeev; Sharma, Haripaul; Abbas, Ata; MacLennan, Gregory T.; Fu, Pingfu; Danielpour, David; Gupta, Sanjay			Upregulation of SATB1 Is Associated with Prostate Cancer Aggressiveness and Disease Progression	PLOS ONE			English	Article							DNA-BINDING PROTEIN; EPITHELIAL-MESENCHYMAL TRANSITION; GENE-EXPRESSION; CARCINOMA CELLS; NUCLEAR-MATRIX; E-CADHERIN; RICH; REGION; DIFFERENTIATION; OVEREXPRESSION	Disease aggressiveness remains a critical factor to the progression of prostate cancer. Transformation of epithelial cells to mesenchymal lineage, associated with the loss of E-cadherin, offers significant invasive potential and migration capability. Recently, Special AT-rich binding protein (SATB1) has been linked to tumor progression. SATB1 is a cell-type restricted nuclear protein, which functions as a tissue-specific organizer of DNA sequences during cellular differentiation. Our results demonstrate that SATB1 plays significant role in prostate tumor invasion and migration and its nuclear localization correlates with disease aggressiveness. Clinical specimen analysis showed that SATB1 was predominantly expressed in the nucleus of high-grade tumors compared to low-grade tumor and benign tissue. A progressive increase in the nuclear levels of SATB1 was observed in cancer tissues compared to benign specimens. Similarly, SATB1 protein levels were higher in a number of prostate cancer cells viz. HPV-CA-10, DU145, DUPro, PC-3, PC-3M, LNCaP and C4-2B, compared to non-tumorigenic PZ-HPV-7 cells. Nuclear expression of SATB1 was higher in biologically aggressive subclones of prostate cancer cells with their respective parental cell lines. Furthermore, ectopic SATB1 transfection conferred increased cell motility and invasiveness in immortalized human prostate epithelial PZ-HPV-7 cells which correlated with the loss of E-cadherin expression. Consequently, knockdown of SATB1 in highly aggressive human prostate cancer PC-3M cells inhibited invasiveness and tumor growth in vivo along with increase in E-cadherin protein expression. Our findings demonstrate that SATB1 has ability to promote prostate cancer aggressiveness through epithelial-mesenchymal transition.	[Shukla, Sanjeev; Sharma, Haripaul; Abbas, Ata; Gupta, Sanjay] Case Western Reserve Univ, Dept Urol, Cleveland, OH 44106 USA; [Shukla, Sanjeev; Sharma, Haripaul; Abbas, Ata; MacLennan, Gregory T.; Gupta, Sanjay] Univ Hosp Case, Med Ctr, Cleveland, OH USA; [MacLennan, Gregory T.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Fu, Pingfu] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Danielpour, David] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Fu, Pingfu; Danielpour, David; Gupta, Sanjay] Case Comprehens Canc Ctr, Div Gen Med Sci, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Gupta, S (corresponding author), Case Western Reserve Univ, Dept Urol, Cleveland, OH 44106 USA.	sanjay.gupta@case.edu	Fu, Pingfu/O-5415-2019	Fu, Pingfu/0000-0002-2334-5218; Gupta, Sanjay/0000-0002-9492-3249; MacLennan, Gregory T./0000-0003-0089-449X; Abbas, Ata/0000-0001-8272-1853	United States Public Health Service [RO1CA115491]; Endowment funds; NATIONAL CANCER INSTITUTE [R01CA115491] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Endowment funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by United States Public Health Service Grants RO1CA115491 and Endowment funds to SG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JD, 2000, GENE DEV, V14, P521; American Cancer Society, 2011, CANC FACTS FIG 2011; Barboro P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040617; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Chen HX, 2011, J DERMATOL SCI, V64, P39, DOI 10.1016/j.jdermsci.2011.06.007; CUNNINGHAM JM, 1994, BLOOD, V84, P1298; GINGRICH JR, 1991, J UROLOGY, V146, P915, DOI 10.1016/S0022-5347(17)37960-0; Glynne R, 2000, IMMUNOL REV, V176, P216; Gong FR, 2011, NUCLEIC ACIDS RES, V39, P4640, DOI 10.1093/nar/gkr023; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hsiao W, 2010, J UROLOGY, V184, P512, DOI 10.1016/j.juro.2010.04.010; Iorns E, 2010, JNCI-J NATL CANCER I, V102, P1284, DOI 10.1093/jnci/djq243; Kim JH, 2007, CANCER RES, V67, P8229, DOI 10.1158/0008-5472.CAN-07-1297; Kuo TC, 2010, BIOCHEM PHARMACOL, V80, P1093, DOI 10.1016/j.bcp.2010.06.003; LaTulippe E, 2002, CANCER RES, V62, P4499; Li QQ, 2011, CELL DEATH DIFFER, V18, P16, DOI 10.1038/cdd.2010.103; Li QQ, 2010, CANCER SCI, V101, P80, DOI 10.1111/j.1349-7006.2009.01372.x; Lu XM, 2010, ONCOL REP, V24, P981, DOI 10.3892/or_00000945; Meng WJ, 2012, INT J COLORECTAL DIS, V27, P143, DOI 10.1007/s00384-011-1302-9; NAKAGOMI K, 1994, MOL CELL BIOL, V14, P1852, DOI 10.1128/MCB.14.3.1852; Notani D, 2010, METHODS MOL BIOL, V647, P317, DOI 10.1007/978-1-60761-738-9_20; Notani D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000296; Ramakrishnan M, 2000, MOL CELL BIOL, V20, P868, DOI 10.1128/MCB.20.3.868-877.2000; Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709; Selinger CI, 2011, J THORAC ONCOL, V6, P1179, DOI 10.1097/JTO.0b013e31821b4ce0; STEPHENSON RA, 1992, J NATL CANCER I, V84, P951, DOI 10.1093/jnci/84.12.951; Sun J, 2012, CANCER RES, V72, DOI 10.1158/1538-7445.AM2012-1561; Szemes M, 2006, NEUROCHEM RES, V31, P237, DOI 10.1007/s11064-005-9012-8; Thompson EW, 2008, CLIN EXP METASTAS, V25, P591, DOI 10.1007/s10585-008-9189-8; Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; Veveris-Lowe TL, 2005, ENDOCR-RELAT CANCER, V12, P631, DOI 10.1677/erc.1.00958; Wells A, 2008, CLIN EXP METASTAS, V25, P621, DOI 10.1007/s10585-008-9167-1; Yanagisawa J, 1996, CANCER RES, V56, P457; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zhang C, 2011, PROSTATE, V71, P157, DOI 10.1002/pros.21231; Zhao Xiao-lan, 2011, Sichuan Da Xue Xue Bao Yi Xue Ban, V42, P82; Zhao XD, 2010, ORL-J OTO-RHIN-LARYN, V72, P1, DOI 10.1159/000264777; Zhou Lai-Yong, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P534	39	34	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53527	10.1371/journal.pone.0053527	http://dx.doi.org/10.1371/journal.pone.0053527			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308245	Green Published, gold, Green Submitted			2022-12-25	WOS:000313429100083
J	Zhao, XY; Wang, ZM; Zhang, JY; Hua, JM; He, W; Zhu, SK				Zhao, Xinyu; Wang, ZiMian; Zhang, Junyi; Hua, Jianming; He, Wei; Zhu, Shankuan			Estimation of Total Body Skeletal Muscle Mass in Chinese Adults: Prediction Model by Dual-Energy X-Ray Absorptiometry	PLOS ONE			English	Article							ADIPOSE-TISSUE INFILTRATION; LEG MUSCLE; MEN; AGE; RESISTANCE; STRENGTH; GENDER; INDEX	Background: There are few reports on total body skeletal muscle mass (SM) in Chinese. The objective of this study is to establish a prediction model of SM for Chinese adults. Methodology: Appendicular lean soft tissue (ALST) was measured by dual energy X-ray absorptiometry (DXA) and SM by magnetic resonance image (MRI) in 66 Chinese adults (52 men and 14 women). Images of MRI were segmented into compartments including intermuscular adipose tissue (IMAT) and IMAT-free SM. Regression was used to fit the prediction model SM = c + k x ALST. Age and gender were adjusted in the fitted model. The piece-wise linear function was performed to further explore the effect of age on SM. 'Leave-One-Out Cross Validation' was utilized to evaluate the prediction performance. The significance of observed differences between predicted and actual SM was tested by t test and the level of agreement was assessed by the method of Bland and Altman. Results: Men had greater ALST and IMAT-free SM than women. ALST was the primary predictor and highly correlated with IMAT-free SM (R-2 = 0.94, SEE = 1.11 kg, P < 0.001). Age was an additional predictor (SM prediction model with age adjusted R-2 = 0.95, SEE = 1.05 kg, P < 0.001). There was a piece-wise linear relationship between age and IMAT-free SM: IMAT-free SM = 1.21 x ALST-0.98, (Age <45 years) and IMAT-free SM = 1.21 x ALST-0.98-0.04x (Age=45), (Age >= 45years). The prediction performance of this age-adjusted model was good due to 'Leave-One-Out Cross Validation'. No significant difference between measured and predicted IMAT-free SM was detected. Conclusion: Previous SM prediction model developed in multi-ethnic groups underestimated SM by 2.3% and 3.4% for Chinese men and women. A new prediction model by DXA has been established to predict SM in Chinese adults.	[Zhao, Xinyu; He, Wei; Zhu, Shankuan] Zhejiang Univ, Sch Publ Hlth, Chron Dis Res Inst, Obes & Body Composit Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Zhao, Xinyu; Wang, ZiMian] Columbia Univ, Coll Phys & Surg, St Lukes Roosevelt Hosp Ctr, Obes Res Ctr, New York, NY 10027 USA; [Zhang, Junyi] Columbia Univ, Dept Stat, New York, NY USA; [Hua, Jianming] Zhejiang Univ, Affiliated Hosp 2, Dept Radiol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhu, Shankuan] Zhejiang Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Columbia University; Mount Sinai St. Luke's; Mount Sinai West; Columbia University; Zhejiang University; Zhejiang University	Wang, ZM (corresponding author), Columbia Univ, Coll Phys & Surg, St Lukes Roosevelt Hosp Ctr, Obes Res Ctr, New York, NY 10027 USA.	zw28@columbia.edu; zsk@zju.edu.cn	He, Wei/C-8441-2015; Zhang, Junyi/HDN-7815-2022	He, Wei/0000-0003-0161-3274; 	China Medical Board [10-014]; China Scholarship Council [2011632118]	China Medical Board; China Scholarship Council(China Scholarship Council)	This study is supported by China Medical Board (No. 10-014) Research Project (2011) and China Scholarship Council (No. 2011632118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belsley DA, 2005, WILEY SERIES PROBABI; BEMBEN M G, 1991, Medicine and Science in Sports and Exercise, V23, P1302; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bogin B, 2008, INT J EPIDEMIOL, V37, P201, DOI 10.1093/ije/dym254; CLEMENT FJ, 1974, J GERONTOL, V29, P423, DOI 10.1093/geronj/29.4.423; Cook RD, 1982, RESIDUALS INFLUENCE; Deurenberg P, 1999, INT J OBESITY, V23, P537, DOI 10.1038/sj.ijo.0800868; EFRON B, 1983, J AM STAT ASSOC, V78, P316, DOI 10.2307/2288636; Eveleth P.B., 1976, WORLDWIDE VARIATION, V8; Eveleth PB, 1990, WORLDWIDE VARIATION; Forbes G, 1987, HUMAN BODY COMPOSITI; FULLER NJ, 1992, CLIN PHYSIOL, V12, P253, DOI 10.1111/j.1475-097X.1992.tb00831.x; Gallagher D, 2005, AM J CLIN NUTR, V81, P903, DOI 10.1093/ajcn/81.4.903; Gallagher D, 1997, J APPL PHYSIOL, V83, P229, DOI 10.1152/jappl.1997.83.1.229; Goel MS, 2004, JAMA-J AM MED ASSOC, V292, P2860, DOI 10.1001/jama.292.23.2860; Hamill PVV, 1973, DHEW PUBLICATION 11, V11; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P52, DOI 10.1093/ajcn/52.1.52; HEYMSFIELD SB, 1995, J GERONTOL A-BIOL, V50, P23; HURLEY BF, 1995, J GERONTOL A-BIOL, V50, P41; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Kehayias JJ, 1997, AM J CLIN NUTR, V66, P904, DOI 10.1093/ajcn/66.4.904; Kim J, 2004, J APPL PHYSIOL, V97, P655, DOI 10.1152/japplphysiol.00260.2004; Kim J, 2002, AM J CLIN NUTR, V76, P378, DOI 10.1093/ajcn/76.2.378; Lauderdale DS, 2000, INT J OBESITY, V24, P1188, DOI 10.1038/sj.ijo.0801365; Lear SA, 2009, J CLIN ENDOCR METAB, V94, P4696, DOI 10.1210/jc.2009-1030; Levine JA, 2000, J APPL PHYSIOL, V88, P452, DOI 10.1152/jappl.2000.88.2.452; LEXELL J, 1986, J NEUROL SCI, V72, P211, DOI 10.1016/0022-510X(86)90009-2; Lin YC, 2004, APPL ERGON, V35, P173, DOI 10.1016/j.apergo.2004.01.004; Lukasaki HC, 2005, HUMAN BODY COMPOSITI, P203; Malina R.M., 1996, HUMAN BODY COMPOSITI, P217; Miljkovic I, 2009, J CLIN ENDOCR METAB, V94, P2735, DOI 10.1210/jc.2008-2541; Miljkovic-Gacic I, 2008, AM J CLIN NUTR, V87, P1590, DOI 10.1093/ajcn/87.6.1590; Ross R, 1996, CAN J PHYSIOL PHARM, V74, P778, DOI 10.1139/cjpp-74-6-778; Ryan AS, 2002, OBES RES, V10, P336, DOI 10.1038/oby.2002.47; Shen W, 2003, OBES RES, V11, P217, DOI 10.1038/oby.2003.34; Shih R, 2000, J APPL PHYSIOL, V89, P1380, DOI 10.1152/jappl.2000.89.4.1380; Silva AM, 2010, AM J HUM BIOL, V22, P76, DOI 10.1002/ajhb.20956; Snyder WS, 1975, REPORT TASK GROUP RE; Song MY, 2004, AM J CLIN NUTR, V79, P874; Song MY, 2002, J APPL PHYSIOL, V92, P2285, DOI 10.1152/japplphysiol.01066.2001; TSENG BS, 1995, J GERONTOL A-BIOL, V50, P113; Visser M, 1999, J APPL PHYSIOL, V87, P1513, DOI 10.1152/jappl.1999.87.4.1513; Wang W, 1999, J APPL PHYSIOL, V87, P1163, DOI 10.1152/jappl.1999.87.3.1163; Wang ZM, 1996, J APPL PHYSIOL, V80, P824, DOI 10.1152/jappl.1996.80.3.824; WANG ZM, 1992, AM J CLIN NUTR, V56, P19, DOI 10.1093/ajcn/56.1.19	45	18	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53561	10.1371/journal.pone.0053561	http://dx.doi.org/10.1371/journal.pone.0053561			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308254	Green Published, gold			2022-12-25	WOS:000313429100091
J	Hoekstra, EJ; Mesman, S; de Munnik, WA; Smidt, MP				Hoekstra, Elisa J.; Mesman, Simone; de Munnik, Willem A.; Smidt, Marten P.			LMX1B Is Part of a Transcriptional Complex with PSPC1 and PSF	PLOS ONE			English	Article							MESENCEPHALIC DOPAMINERGIC-NEURONS; LIM-HOMEODOMAIN PROTEINS; NAIL-PATELLA-SYNDROME; ISTHMIC ORGANIZER; WNT1 EXPRESSION; DIFFERENTIATION; CELLS; RNA; PARASPECKLES; PROGENITORS	The LIM homeodomain transcription factor Lmx1b is essential for the development of the isthmic organizer and mesodiencephalic dopaminergic neurons. The uncoupling of Pitx3 and Th expression, in the Lmx1b null mutant, suggests that Lmx1b may act as a positional activator of the mdDA domain, eventually leading to properly differentiating mdDA neurons. In this study, we aimed to elucidate how Lmx1b functions mechanistically in this developmental process, by searching for molecular interactors of Lmx1b at the protein level. Initially, affinity-purification of LMX1B-HIS overexpressed protein in MN9D dopaminergic cells followed by mass-spectrometry analysis, resulted in the identification of PSPC1 protein as a possible binding partner of LMX1B. Subsequent immunoprecipitation experiments revealed an interaction between LMX1B and PSPC1 in a larger protein complex also containing PSF. This complex was observed in vitro and in vivo, and we hypothesize that, via PSF and PSPC1, LMX1B may be part of the previously identified Nurr1 transcriptional complex wherein interaction with the co-repressor PSF and the transcription factor Pitx3 is needed to drive expression of Nurr1 target genes in specifying the dopaminergic phenotype. Furthermore, we identified GRLF1, DHX9, MYO1C, HSP70 and TMPO as potential LMX1B interactors. DHX9 and GRLF1 are highly expressed in the developing mdDA neuronal field, and GRLF1 and MYO1C have both been linked to neurite outgrowth. The identification of these proteins suggests that Lmx1b may act directly in the transcriptional activation of Nurr1 target genes and be involved in other processes like neurite outgrowth as well.	[Hoekstra, Elisa J.; Mesman, Simone; de Munnik, Willem A.; Smidt, Marten P.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosci & Pharmacol, Utrecht, Netherlands; [Hoekstra, Elisa J.; Mesman, Simone; Smidt, Marten P.] Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; University of Amsterdam	Smidt, MP (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosci & Pharmacol, Utrecht, Netherlands.	m.p.smidt@uva.nl		Mesman, Simone/0000-0002-9728-5828; Smidt, Marten/0000-0002-8815-747X	VICI-grant [865.09.002]; TI Pharma grant (The Netherlands) [T5-207]	VICI-grant; TI Pharma grant (The Netherlands)	This work was supported by a VICI-grant (no. 865.09.002 to M.P. Smidt) and by a TI Pharma grant (no. T5-207, The Netherlands) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KA, 2000, DEVELOPMENT, V127, P1857; Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; Barberis D, 2005, J CELL SCI, V118, P4689, DOI 10.1242/jcs.02590; Berger R, 1996, GENOME RES, V6, P361, DOI 10.1101/gr.6.5.361; Bond CS, 2009, J CELL BIOL, V186, P637, DOI 10.1083/jcb.200906113; Bose A, 2004, MOL CELL BIOL, V24, P5447, DOI 10.1128/MCB.24.12.5447-5458.2004; Brandstaetter H, 2012, J CELL SCI; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; Burbach JPH, 2003, ANN NY ACAD SCI, V991, P61; CHOI HK, 1991, BRAIN RES, V552, P67, DOI 10.1016/0006-8993(91)90661-E; Fox AH, 2005, MOL BIOL CELL, V16, P5304, DOI 10.1091/mbc.E05-06-0587; Guo C, 2007, DEVELOPMENT, V134, P317, DOI 10.1242/dev.02745; Hermanson E, 2003, EXP CELL RES, V288, P324, DOI 10.1016/S0014-4827(03)00216-7; Jacobs FMJ, 2009, DEVELOPMENT, V136, P531, DOI 10.1242/dev.029769; Jeon CY, 2010, J CELL PHYSIOL, V224, P786, DOI 10.1002/jcp.22184; Kuwahara S, 2006, BIOL REPROD, V75, P352, DOI 10.1095/biolreprod.106.051136; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Li JZ, 1999, P NATL ACAD SCI USA, V96, P709, DOI 10.1073/pnas.96.2.709; Lin W, 2009, DEV BIOL, V333, P386, DOI 10.1016/j.ydbio.2009.07.006; Marini M, 2005, EUR J HUM GENET, V13, P789, DOI 10.1038/sj.ejhg.5201405; Marini M, 2003, INT J MOL MED, V12, P79; Metzakopian E, 2012, DEVELOPMENT, V139, P2625, DOI 10.1242/dev.081034; Myojin R, 2004, BIOL REPROD, V71, P926, DOI 10.1095/biolreprod.104.028159; Nagel F, 2008, J NEUROCHEM, V105, P853, DOI 10.1111/j.1471-4159.2007.05204.x; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; SHERR EH, 1993, J CELL BIOL, V120, P1405, DOI 10.1083/jcb.120.6.1405; Smidt MP, 2000, NAT NEUROSCI, V3, P337, DOI 10.1038/73902; Smidt MP, 2003, EUR J PHARMACOL, V480, P75, DOI 10.1016/j.ejphar.2003.08.094; Tzchori I, 2009, DEVELOPMENT, V136, P1375, DOI 10.1242/dev.026476; Yan CH, 2011, J NEUROSCI, V31, P12413, DOI 10.1523/JNEUROSCI.1077-11.2011; Zhao Y, 2007, P NATL ACAD SCI USA, V104, P13182, DOI 10.1073/pnas.0705464104; Zou PJ, 2003, J BIOL CHEM, V278, P2636, DOI 10.1074/jbc.M210217200	32	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53122	10.1371/journal.pone.0053122	http://dx.doi.org/10.1371/journal.pone.0053122			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308148	Green Published, Green Submitted, gold			2022-12-25	WOS:000313670100019
J	Wang, JF; Hu, MG; Xu, CD; Christakos, G; Zhao, Y				Wang, Jin-Feng; Hu, Mao-Gui; Xu, Cheng-Dong; Christakos, George; Zhao, Yu			Estimation of Citywide Air Pollution in Beijing	PLOS ONE			English	Article							PARTICULATE MATTER; SOURCE APPORTIONMENT; AMBIENT AIR; PM2.5; PM10; PARTICLES; QUALITY; ATMOSPHERE; ILLNESS	There has been discrepancies between the daily air quality reports of the Beijing municipal government, observations recorded at the U. S. Embassy in Beijing, and Beijing residents' perceptions of air quality. This study estimates Beijing's daily area PM2.5 mass concentration by means of a novel technique SPA (Single Point Areal Estimation) that uses data from the single PM2.5 observation station of the U. S Embassy and the 18 PM10 observation stations of the Beijing Municipal Environmental Protection Bureau. The proposed technique accounts for empirical relationships between different types of observations, and generates best linear unbiased pollution estimates (in a statistical sense). The technique extends the daily PM2.5 mass concentrations obtained at a single station (U. S. Embassy) to a citywide scale using physical relations between pollutant concentrations at the embassy PM2.5 monitoring station and at the 18 official PM10 stations that are evenly distributed across the city. Insight about the technique's spatial estimation accuracy (uncertainty) is gained by means of theoretical considerations and numerical validations involving real data. The technique was used to study citywide PM2.5 pollution during the 423-day period of interest (May 10, 2010 to December 6, 2011). Finally, a freely downloadable software library is provided that performs all relevant calculations of pollution estimation.	[Wang, Jin-Feng; Hu, Mao-Gui; Xu, Cheng-Dong; Zhao, Yu] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China; [Christakos, George] San Diego State Univ, Dept Geog, San Diego, CA 92182 USA; [Zhao, Yu] Cent S Univ, Sch Geosci & Infophys, Changsha, Hunan, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; California State University System; San Diego State University; Central South University	Wang, JF (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China.	wangjf@lreis.ac.cn	Hu, Maogui/N-7105-2013; xu, chengdong/O-8200-2017	Hu, Maogui/0000-0002-7671-7863; xu, chengdong/0000-0002-9266-7309; Wang, Jinfeng/0000-0002-6687-9420; Christakos, George/0000-0002-1865-5764	NSFC [41023010, 41271404]; MOST [2012CB955503, 2011AA120305]; CAS [XDA05090102]; Yongqian Chair Professorship (Zhejiang University, China)	NSFC(National Natural Science Foundation of China (NSFC)); MOST; CAS(Chinese Academy of Sciences); Yongqian Chair Professorship (Zhejiang University, China)	This study was supported by the following grants: NSFC (41023010; 41271404), MOST (2012CB955503; 2011AA120305) and CAS (XDA05090102). George Christakos was supported by a Yongqian Chair Professorship (Zhejiang University, China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto H, 2003, SCIENCE, V302, P1716, DOI 10.1126/science.1092666; Bayraktar H, 2010, STOCH ENV RES RISK A, V24, P57, DOI 10.1007/s00477-008-0299-2; BJ-EPB, 2011, BEIJ MUN ENV PROT BU; Brook JR, 1997, J AIR WASTE MANAGE, V47, P2, DOI 10.1080/10473289.1997.10464407; Christakos G, 1998, ATMOS ENVIRON, V32, P2845, DOI 10.1016/S1352-2310(98)00407-5; Fu BJ, 2008, SCIENCE, V321, P611, DOI 10.1126/science.1162213; Gomiscek B, 2004, ATMOS ENVIRON, V38, P3917, DOI 10.1016/j.atmosenv.2004.03.056; Guzman F, 1996, SCIENCE, V271, P1040, DOI 10.1126/science.271.5252.1040; Isaaks E.H., 1989, ISA; Jerrett M, 2007, STOCH ENV RES RISK A, V21, P511, DOI 10.1007/s00477-007-0133-2; Kaiser J, 2000, SCIENCE, V289, P22, DOI 10.1126/science.289.5476.22; Kaiser J, 1997, SCIENCE, V276, P33, DOI 10.1126/science.276.5309.33; Kumar N, 2009, ATMOS ENVIRON, V43, P1153, DOI 10.1016/j.atmosenv.2008.10.055; Kumar R, 2006, ENVIRON MONIT ASSESS, V119, P191, DOI 10.1007/s10661-005-9022-7; Lelieveld J, 2002, SCIENCE, V298, P794, DOI 10.1126/science.1075457; Li CS, 2002, AEROSOL SCI TECH, V36, P469, DOI 10.1080/027868202753571287; Lundgren DA, 1996, AEROSOL SCI TECH, V25, P353, DOI 10.1080/02786829608965401; Maraziotis E, 2008, GLOBAL NEST J, V10, P123; Marcazzan GM, 2001, ATMOS ENVIRON, V35, P4639, DOI 10.1016/S1352-2310(01)00124-8; Marshall JD, 2008, ATMOS ENVIRON, V42, P1359, DOI 10.1016/j.atmosenv.2007.08.012; MEP-PRC, 1996, GB30951996 MEPPRC, P2; Nel A, 2005, SCIENCE, V308, P804, DOI 10.1126/science.1108752; Ostro B., 2004, OUTDOOR AIR POLLUTIO; Pandey P, 2012, B ENVIRON CONTAM TOX, V88, P265, DOI 10.1007/s00128-011-0466-x; Pyne S, 2002, SCIENCE, V295, P1994; Reis BY, 2007, PLOS MED, V4, P1019, DOI 10.1371/journal.pmed.0040210; Song Y, 2007, J HAZARD MATER, V146, P124, DOI 10.1016/j.jhazmat.2006.11.058; Tiwari S, 2012, AEROSOL AIR QUAL RES, V12, P20, DOI 10.4209/aaqr.2011.06.0075; US-Embassy-in-Beijing, 2011, US EMB BEIJ AIR QUAL; van de Kassteele J, 2006, STOCH ENV RES RISK A, V21, P183, DOI 10.1007/s00477-006-0055-4; Wang HL, 2008, J ENVIRON SCI, V20, P1323, DOI 10.1016/S1001-0742(08)62228-7; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024498; Wang Y, 2005, ATMOS ENVIRON, V39, P3771, DOI 10.1016/j.atmosenv.2005.03.013; WHO-Europe, 2006, AIR QUAL GUID GLOB U; Wiwanitkit V, 2008, STOCH ENV RES RISK A, V22, P437, DOI 10.1007/s00477-007-0149-7; XinHuaNet, 2011, CHIN US EXP EXPL BEI; Zheng M, 2005, ATMOS ENVIRON, V39, P3967, DOI 10.1016/j.atmosenv.2005.03.036	37	139	148	2	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53400	10.1371/journal.pone.0053400	http://dx.doi.org/10.1371/journal.pone.0053400			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23894665	gold, Green Published			2022-12-25	WOS:000313429800046
J	Wennstrom, M; Surova, Y; Hall, S; Nilsson, C; Minthon, L; Bostrom, F; Hansson, O; Nielsen, HM				Wennstrom, Malin; Surova, Yulia; Hall, Sara; Nilsson, Christer; Minthon, Lennart; Bostrom, Fredrik; Hansson, Oskar; Nielsen, Henrietta M.			Low CSF Levels of Both alpha-Synuclein and the alpha-Synuclein Cleaving Enzyme Neurosin in Patients with Synucleinopathy	PLOS ONE			English	Article							MULTIPLE-SYSTEM ATROPHY; HUMAN CEREBROSPINAL-FLUID; HUMAN KALLIKREIN 6; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; LEWY BODIES; SERINE-PROTEASE; NEURODEGENERATIVE DISORDERS; SUBSTRATE-SPECIFICITY; DIAGNOSTIC-CRITERIA	Neurosin is a protease that in vitro degrades alpha-synuclein, the main constituent of Lewy bodies found in brains of patients with synucleinopathy including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Several studies have reported reduced cerebrospinal fluid (CSF) levels of alpha-synuclein in synucleinopathy patients and recent data also proposes a significant role of alpha-synuclein in the pathophysiology of Alzheimer's disease (AD). To investigate potential links between neurosin and its substrate alpha-synuclein in vivo we used a commercially available sandwich ELISA and an in-house developed direct ELISA to quantify CSF levels of alpha-synuclein and neurosin in patients diagnosed with DLB, PD and PD dementia (PDD) versus AD patients and non-demented controls. We found that patients with synucleinopathy displayed lower CSF levels of neurosin and alpha-synuclein compared to controls and AD patients. In contrast, AD patients demonstrated significantly increased CSF alpha-synuclein but similar neurosin levels compared to non-demented controls. Further, CSF neurosin and alpha-synuclein concentrations were positively associated in controls, PD and PDD patients and both proteins were highly correlated to CSF levels of phosphorylated tau in all investigated groups. We observed no effect of gender or presence of the apolipoprotein E epsilon 4 allele on neither neurosin or alpha-synuclein CSF levels. In concordance with the current literature our study demonstrates decreased CSF levels of alpha-synuclein in synucleinopathy patients versus AD patients and controls. Importantly, decreased alpha-synuclein levels in patients with synucleinopathy appear linked to low levels of the alpha-synuclein cleaving enzyme neurosin. In contrast, elevated levels of alpha-synuclein in AD patients were not related to any altered CSF neurosin levels. Thus, altered CSF levels of alpha-synuclein and neurosin in patients with synucleinopathy versus AD may not only mirror disease-specific neuropathological mechanisms but may also serve as fit candidates for future biomarker studies aiming at identifying specific markers of synucleinopathy.	[Wennstrom, Malin; Minthon, Lennart; Nielsen, Henrietta M.] Lund Univ, Dept Clin Sci Malmo, Mol Memory Res Unit, Skane Univ Hosp,Wellenberg Lab, Malmo, Sweden; [Surova, Yulia; Hall, Sara; Hansson, Oskar] Lund Univ, Dept Clin Sci Lund, Neurol Clin, Skane Univ Hosp, Malmo, Sweden; [Nilsson, Christer; Minthon, Lennart; Bostrom, Fredrik; Hansson, Oskar] Lund Univ, Dept Clin Sci Malmo, Clin Memory Res Unit, Memory Clin,Skane Univ Hosp, Malmo, Sweden; [Nielsen, Henrietta M.] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Mayo Clinic	Nielsen, HM (corresponding author), Lund Univ, Dept Clin Sci Malmo, Mol Memory Res Unit, Skane Univ Hosp,Wellenberg Lab, Malmo, Sweden.	nielsen.henrietta@mayo.edu	Hansson, Oskar/A-7134-2013; Nielsen, Henrietta M/B-1746-2013	Hansson, Oskar/0000-0001-8467-7286; Brundin, Lena/0000-0002-8327-6242; Bay-Richter, Cecilie/0000-0002-2254-4020; Nielsen, Henrietta M/0000-0001-9664-7068	Swedish Dementia Foundation; Swedish Alzheimer Foundation; Swedish Research Council; Gamla tjanarinnor; Torsten and Ragnar Soderberg Foundation; Swedish Society of Medicine; Skane County Council; Lund University; Swedish Brain Power	Swedish Dementia Foundation; Swedish Alzheimer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Gamla tjanarinnor; Torsten and Ragnar Soderberg Foundation; Swedish Society of Medicine; Skane County Council; Lund University; Swedish Brain Power	The Swedish Dementia Foundation (H.M.N.), the Swedish Alzheimer Foundation (H.M.N., O.H.), the Swedish Research Council (O.H.), Gamla tjanarinnor (H.M.N., O.H.), Torsten and Ragnar Soderberg Foundation (O.H.), the Swedish Society of Medicine (O.H.), the regional agreement on medical training and clinical research (A. L. F.) between the Skane County Council and Lund University (L. M., M. W., H.M.N., O.H.) and Swedish Brain Power (L. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelo PF, 2006, J BIOL CHEM, V281, P3116, DOI 10.1074/jbc.M510096200; Anisowicz A, 1996, MOL MED, V2, P624, DOI 10.1007/BF03401646; Ashby EL, 2010, BRAIN RES, V1363, P1, DOI 10.1016/j.brainres.2010.09.017; Bayani J, 2012, CLIN CHEM LAB MED, V50, P211, DOI 10.1515/CCLM.2011.750; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Cheng FR, 2011, J CHEM NEUROANAT, V42, P242, DOI 10.1016/j.jchemneu.2010.12.001; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Diamandis EP, 2000, CLIN BIOCHEM, V33, P369, DOI 10.1016/S0009-9120(00)00145-4; Diamandis EP, 2000, CLIN BIOCHEM, V33, P663, DOI 10.1016/S0009-9120(00)00185-5; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Gai WP, 1998, LANCET, V352, P547, DOI 10.1016/S0140-6736(05)79256-4; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; Jensen PH, 1999, J BIOL CHEM, V274, P25481, DOI 10.1074/jbc.274.36.25481; Kasai T, 2008, NEUROSCI LETT, V436, P52, DOI 10.1016/j.neulet.2008.02.057; Kasuga K, 2010, J NEUROL NEUROSUR PS, V81, P608, DOI 10.1136/jnnp.2009.197483; Kawakami F, 2011, FEBS J, V278, P4895, DOI 10.1111/j.1742-4658.2011.08389.x; Kim CY, 2008, J NEUROCHEM, V107, P303, DOI 10.1111/j.1471-4159.2008.05612.x; Larson ME, 2012, J NEUROSCI, V32, P10253, DOI 10.1523/JNEUROSCI.0581-12.2012; Little SP, 1997, J BIOL CHEM, V272, P25135, DOI 10.1074/jbc.272.40.25135; Magklara A, 2003, BIOCHEM BIOPH RES CO, V307, P948, DOI 10.1016/S0006-291X(03)01271-3; McKeith Ian G, 2003, Semin Clin Neuropsychiatry, V8, P46; McKeith IG, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P417; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Menendez-Gonzalez M, 2008, J ALZHEIMERS DIS, V14, P59; Mitsui S, 2002, ANN NY ACAD SCI, V977, P216, DOI 10.1111/j.1749-6632.2002.tb04818.x; Mollenhauer B, 2008, EXP NEUROL, V213, P315, DOI 10.1016/j.expneurol.2008.06.004; Mollenhauer B, 2011, LANCET NEUROL, V10, P230, DOI 10.1016/S1474-4422(11)70014-X; Mollenhauer B, 2010, BIOMARK MED, V4, P683, DOI 10.2217/BMM.10.90; Mukaetova-Ladinska E.B., 2010, INT J ALZHEIMERS DIS; Nielsen HM, 2010, ALZHEIMERS DEMENT S1, V6, P363; Ogawa K, 2000, PSYCHIAT CLIN NEUROS, V54, P419, DOI 10.1046/j.1440-1819.2000.00731.x; Ohrfelt A, 2009, NEUROSCI LETT, V450, P332, DOI 10.1016/j.neulet.2008.11.015; Okui A, 2001, NEUROREPORT, V12, P1345, DOI 10.1097/00001756-200105250-00011; Pampalakis G, 2004, BIOCHEM BIOPH RES CO, V320, P54, DOI 10.1016/j.bbrc.2004.04.205; Parnetti L, 2011, MOVEMENT DISORD, V26, P1428, DOI 10.1002/mds.23670; Reesink FE, 2010, J ALZHEIMERS DIS, V22, P87, DOI 10.3233/JAD-2010-100186; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Shi M, 2011, ANN NEUROL, V69, P570, DOI 10.1002/ana.22311; Spencer B, 2012, MOL THERAPY J AM SOC; Spies PE, 2009, J ALZHEIMERS DIS, V16, P363, DOI 10.3233/JAD-2009-0955; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spillantini MG, 2000, ANN NY ACAD SCI, V920, P16; Takeda A, 1998, AM J PATHOL, V152, P367; Tatebe H, 2010, NEUROSCI RES, V67, P341, DOI 10.1016/j.neures.2010.04.008; Tateno F, 2011, ALZHEIMER DIS ASS DI; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Trojanowski JQ, 2007, NEUROPATH APPL NEURO, V33, P615, DOI 10.1111/j.1365-2990.2007.00907.x; Wakabayashi K, 1998, NEUROSCI LETT, V249, P180, DOI 10.1016/S0304-3940(98)00407-8; Waxman EA, 2011, J NEUROSCI, V31, P7604, DOI 10.1523/JNEUROSCI.0297-11.2011; Wennstrom M, 2012, J ALZHEIMERS DIS, V29, P125, DOI [10.3233/JAD-2011-111655, 10.3233/JAD-2012-111655]; Yamashiro K, 1997, BBA-GENE STRUCT EXPR, V1350, P11, DOI 10.1016/S0167-4781(96)00187-X	58	133	135	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53250	10.1371/journal.pone.0053250	http://dx.doi.org/10.1371/journal.pone.0053250			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308173	gold, Green Published, Green Submitted			2022-12-25	WOS:000313429800033
J	Li, RM; Xie, W; Wang, SL; Wu, QJ; Yang, NN; Yang, X; Pan, HP; Zhou, XM; Bai, LY; Xu, BY; Zhou, XG; Zhang, YJ				Li, Rumei; Xie, Wen; Wang, Shaoli; Wu, Qingjun; Yang, Nina; Yang, Xin; Pan, Huipeng; Zhou, Xiaomao; Bai, Lianyang; Xu, Baoyun; Zhou, Xuguo; Zhang, Youjun			Reference Gene Selection for qRT-PCR Analysis in the Sweetpotato Whitefly, Bemisia tabaci (Hemiptera: Aleyrodidae)	PLOS ONE			English	Article							REAL-TIME PCR; RT-PCR; HOUSEKEEPING GENES; QUANTITATIVE PCR; Q-BIOTYPE; EXPRESSION; RNA; NORMALIZATION; QUANTIFICATION; SUSCEPTIBILITY	Background: Accurate evaluation of gene expression requires normalization relative to the expression of reliable reference genes. Expression levels of "classical" reference genes can differ, however, across experimental conditions. Although quantitative real-time PCR (qRT-PCR) has been used extensively to decipher gene function in the sweetpotato whitefly Bemisia tabaci, a world-wide pest in many agricultural systems, the stability of its reference genes has rarely been validated. Results: In this study, 15 candidate reference genes from B. tabaci were evaluated using two Excel-based algorithms geNorm and Normfinder under a diverse set of biotic and abiotic conditions. At least two reference genes were selected to normalize gene expressions in B. tabaci under experimental conditions. Specifically, for biotic conditions including host plant, acquisition of a plant virus, developmental stage, tissue (body region of the adult), and whitefly biotype, ribosomal protein L29 was the most stable reference gene. In contrast, the expression of elongation factor 1 alpha, peptidylprolyl isomerase A, NADH dehydrogenase, succinate dehydrogenase complex subunit A and heat shock protein 40 were consistently stable across various abiotic conditions including photoperiod, temperature, and insecticide susceptibility. Conclusion: Our finding is the first step toward establishing a standardized quantitative real-time PCR procedure following the MIQE (Minimum Information for publication of Quantitative real time PCR Experiments) guideline in an agriculturally important insect pest, and provides a solid foundation for future RNA interference based functional study in B. tabaci.	[Li, Rumei; Zhou, Xiaomao; Bai, Lianyang] Hunan Agr Univ, Inst Pesticide, Changsha, Hunan, Peoples R China; [Li, Rumei; Xie, Wen; Wang, Shaoli; Wu, Qingjun; Yang, Nina; Yang, Xin; Pan, Huipeng; Xu, Baoyun; Zhang, Youjun] Chinese Acad Agr Sci, Dept Plant Protect, Inst Vegetables & Flowers, Beijing 100193, Peoples R China; [Pan, Huipeng; Zhou, Xuguo] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	Hunan Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; University of Kentucky	Zhou, XG (corresponding author), Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA.	xuguozhou@uky.edu; zhangyj@mail.caas.net.cn	Zhang, Youjun/AAY-7948-2020; Yang, Xin/AAG-5375-2020	Zhang, Youjun/0000-0003-3508-6695; 	National Science Fund for Distinguished Young Scholars [31025020]; 973 Program [2013CB127602]; National Natural Science Foundation of China [30900153]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Science Fund for Distinguished Young Scholars (31025020), the 973 Program (2013CB127602), and the National Natural Science Foundation of China (No. 30900153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chapuis MP, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-7; Chu D, 2006, FLA ENTOMOL, V89, P168, DOI 10.1653/0015-4040(2006)89[168:TIOTEQ]2.0.CO;2; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; de Boer ME, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-54; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Feng YT, 2010, PEST MANAG SCI, V66, P313, DOI 10.1002/ps.1877; Ghanim M, 1998, VIROLOGY, V240, P295, DOI 10.1006/viro.1997.8937; Ghanim M, 2009, PEST MANAG SCI, V65, P939, DOI 10.1002/ps.1795; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Hornakova D, 2010, ANAL BIOCHEM, V397, P118, DOI 10.1016/j.ab.2009.09.019; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Inbar M, 2008, ANNU REV ENTOMOL, V53, P431, DOI 10.1146/annurev.ento.53.032107.122456; Jiang HB, 2010, MOL BIOL REP, V37, P1019, DOI 10.1007/s11033-009-9803-0; Jiu M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000182; Jones DR, 2003, EUR J PLANT PATHOL, V109, P195, DOI 10.1023/A:1022846630513; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Kylee J, 2011, PLOS ONE, V6; Langnaese K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-53; Lu ZC, 2011, J EXP BIOL, V214, P764, DOI 10.1242/jeb.047415; Luo Chen, 2002, Acta Entomologica Sinica, V45, P759; Mahadav A, 2009, INSECT BIOCHEM MOLEC, V39, P668, DOI 10.1016/j.ibmb.2009.08.002; Olsvik PA, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-21; Pan HP, 2011, J ECON ENTOMOL, V104, P978, DOI 10.1603/EC11009; Perring TM, 2001, CROP PROT, V20, P725, DOI 10.1016/S0261-2194(01)00109-0; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Shen GM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-76; Shen YM, 2010, ANAL BIOCHEM, V405, P224, DOI 10.1016/j.ab.2010.06.029; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Tatsumi K, 2008, BIOCHEM BIOPH RES CO, V374, P106, DOI 10.1016/j.bbrc.2008.06.103; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tunbridge EM, 2011, BIOL PSYCHIAT, V69, P173, DOI 10.1016/j.biopsych.2010.05.023; Upadhyay SK, 2011, J BIOSCIENCES, V36, P153, DOI 10.1007/s12038-011-9009-1; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Willems E, 2006, INT J DEV BIOL, V50, P627, DOI 10.1387/ijdb.052130ew; Wu JB, 2006, PLANT DIS, V90, P1359, DOI 10.1094/PD-90-1359C; Xie W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035181; Xie W, 2011, PEST MANAG SCI, V67, P87, DOI 10.1002/ps.2037; Xu J, 2010, B ENTOMOL RES, V100, P359, DOI 10.1017/S0007485310000015; Zhou X, 2006, GENE, V376, P47, DOI 10.1016/j.gene.2006.02.002	53	156	166	3	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53006	10.1371/journal.pone.0053006	http://dx.doi.org/10.1371/journal.pone.0053006			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308130	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429800024
J	Lee, HY; Seo, JS; Cho, JH; Jung, H; Kim, JK; Lee, JS; Rhee, S; Choi, YD				Lee, Han Yong; Seo, Ju-Seok; Cho, Jang Hee; Jung, Harin; Kim, Ju-Kon; Lee, Jong Seob; Rhee, Sangkee; Choi, Yang Do			Oryza sativa COI Homologues Restore Jasmonate Signal Transduction in Arabidopsis coi1-1 Mutants	PLOS ONE			English	Article							METHYL JASMONATE; TRANSCRIPTION FACTOR; ACID BIOSYNTHESIS; MALE-STERILITY; GENE ENCODES; PROTEINS; DEFENSE	CORONATINE INSENSITIVE 1 (COI1) encodes an E3 ubiquitin ligase complex component that interacts with JAZ proteins and targets them for degradation in response to JA signaling. The Arabidopsis genome has a single copy of COI1, but the Oryza sativa genome has three closely related COI homologs. To examine the functions of the three OsCOIs, we used yeast two-hybrid assays to examine their interactions with JAZ proteins and found that OsCOIs interacted with OsJAZs and with JAZs, in a coronatine dependent manner. We also tested whether OsCOI1a and OsCOI1b could complement Arabidopsis coi1-1 mutants and found that overexpression of either gene in the coi1-1 mutant resulted in restoration of JA signal transduction and production of seeds, indicating successful complementation. Although OsCOI2 interacted with a few OsJAZs, we were not able to successfully complement the coi1-1 mutant with OsCOI2. Molecular modeling revealed that the three OsCOIs adopt 3D structures similar to COI1. Structural differences resulting from amino acid variations, especially among amino acid residues involved in the interaction with coronatine and JAZ proteins, were tested by mutation analysis. When His-391 in OsCOI2 was substituted with Tyr-391, OsCOI2 interacted with a wider range of JAZ proteins, including OsJAZ1, 2, 5 similar to 9 and 11, and complemented coi1-1 mutants at a higher frequency than the other OsCOIs and COI1. These results indicate that the three OsCOIs are orthologues of COI1 and play key roles in JA signaling.	[Lee, Han Yong; Seo, Ju-Seok; Cho, Jang Hee; Rhee, Sangkee; Choi, Yang Do] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Jung, Harin; Kim, Ju-Kon] Myongji Univ, Sch Biotechnol & Environm Engn, Yongin, South Korea; [Lee, Jong Seob] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea	Seoul National University (SNU); Myongji University; Seoul National University (SNU)	Rhee, S (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	srheesnu@snu.ac.kr; choiyngd@snu.ac.kr			Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea through the National Center for GM Crops [PJ008053, PJ007971]	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea through the National Center for GM Crops	This work was supported by a grant from the Next-Generation BioGreen 21 Program (project nos. PJ008053 to YDC and PJ007971 to JKK), Rural Development Administration, Republic of Korea through the National Center for GM Crops. A graduate research assistantship to HYL, JSS and HJ from the Brain Korea 21 project of the MOEST is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta IF, 2010, JASMONATES ARABIDOPS, P1; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Carpenter CD, 1998, METH MOL B, V82, P85; Cheong JJ, 2003, TRENDS GENET, V19, P409, DOI 10.1016/S0168-9525(03)00138-0; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chini A, 2009, FEBS J, V276, P4682, DOI 10.1111/j.1742-4658.2009.07194.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; FEYS BJF, 1994, PLANT CELL, V6, P751, DOI 10.1105/tpc.6.5.751; Ishiguro S, 2001, PLANT CELL, V13, P2191, DOI 10.1105/tpc.13.10.2191; Katsir L, 2008, CURR OPIN PLANT BIOL, V11, P428, DOI 10.1016/j.pbi.2008.05.004; Kim EH, 2009, PLANT PHYSIOL, V149, P1751, DOI 10.1104/pp.108.134684; Koo AJK, 2009, PHYTOCHEMISTRY, V70, P1571, DOI 10.1016/j.phytochem.2009.07.018; McConn M, 1996, PLANT CELL, V8, P403, DOI 10.1105/tpc.8.3.403; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Park JH, 2002, PLANT J, V31, P1, DOI 10.1046/j.1365-313X.2002.01328.x; Sanders PM, 2000, PLANT CELL, V12, P1041, DOI 10.1105/tpc.12.7.1041; Sasaki Y, 2001, DNA RES, V8, P153, DOI 10.1093/dnares/8.4.153; Seo JS, 2011, PLANT J, V65, P907, DOI 10.1111/j.1365-313X.2010.04477.x; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Shin B, 2002, PLANT J, V30, P23, DOI 10.1046/j.1365-313X.2002.01264.x; Steiner-Lange S, 2003, PLANT J, V34, P519, DOI 10.1046/j.1365-313X.2003.01745.x; Stintzi A, 2000, P NATL ACAD SCI USA, V97, P10625, DOI 10.1073/pnas.190264497; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368; Yang DL, 2012, P NATL ACAD SCI USA, V109, pE1192, DOI 10.1073/pnas.1201616109; Yang XY, 2007, PLANT CELL REP, V26, P219, DOI 10.1007/s00299-006-0229-z; Ye M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036214	28	70	92	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e52802	10.1371/journal.pone.0052802	http://dx.doi.org/10.1371/journal.pone.0052802			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320078	Green Submitted, gold, Green Published			2022-12-25	WOS:000313429800020
J	Zhu, JY; Yang, P; Zhang, Z; Wu, GX; Yang, B				Zhu, Jia-Ying; Yang, Pu; Zhang, Zhong; Wu, Guo-Xing; Yang, Bin			Transcriptomic Immune Response of Tenebrio molitor Pupae to Parasitization by Scleroderma guani	PLOS ONE			English	Article							GENE-EXPRESSION; HELIOTHIS-VIRESCENS; INNATE IMMUNITY; PIERIS-RAPAE; RECOGNITION PROTEINS; MOLECULAR-CLONING; TRICHOPLUSIA-NI; STORAGE PROTEIN; ENZYME-ACTIVITY; VENOM PROTEINS	Background: Host and parasitoid interaction is one of the most fascinating relationships of insects, which is currently receiving an increasing interest. Understanding the mechanisms evolved by the parasitoids to evade or suppress the host immune system is important for dissecting this interaction, while it was still poorly known. In order to gain insight into the immune response of Tenebrio molitor to parasitization by Scleroderma guani, the transcriptome of T. molitor pupae was sequenced with focus on immune-related gene, and the non-parasitized and parasitized T. molitor pupae were analyzed by digital gene expression (DGE) analysis with special emphasis on parasitoid-induced immune-related genes using Illumina sequencing. Methodology/Principal Findings: In a single run, 264,698 raw reads were obtained. De novo assembly generated 71,514 unigenes with mean length of 424 bp. Of those unigenes, 37,373 (52.26%) showed similarity to the known proteins in the NCBI nr database. Via analysis of the transcriptome data in depth, 430 unigenes related to immunity were identified. DGE analysis revealed that parasitization by S. guani had considerable impacts on the transcriptome profile of T. molitor pupae, as indicated by the significant up-or down-regulation of 3,431 parasitism-responsive transcripts. The expression of a total of 74 unigenes involved in immune response of T. molitor was significantly altered after parasitization. Conclusions/Significance: obtained T. molitor transcriptome, in addition to establishing a fundamental resource for further research on functional genomics, has allowed the discovery of a large group of immune genes that might provide a meaningful framework to better understand the immune response in this species and other beetles. The DGE profiling data provides comprehensive T. molitor immune gene expression information at the transcriptional level following parasitization, and sheds valuable light on the molecular understanding of the host-parasitoid interaction.	[Zhu, Jia-Ying; Yang, Bin] SW Forestry Univ, Key Lab Forest Disaster Warning & Control Yunnan, Kunming, Peoples R China; [Yang, Pu] Chinese Acad Forestry, Res Inst Resource Insects, Kunming, Peoples R China; [Zhang, Zhong] Taishan Med Univ, Dept Pathogen Biol, Tai An, Shandong, Peoples R China; [Wu, Guo-Xing] Yunnan Agr Univ, Coll Plant Protect, Kunming, Peoples R China	Chinese Academy of Forestry; Research Institute of Resources Insects, CAF; Shandong First Medical University & Shandong Academy of Medical Sciences; Yunnan Agricultural University	Zhu, JY (corresponding author), SW Forestry Univ, Key Lab Forest Disaster Warning & Control Yunnan, Kunming, Peoples R China.	jyzhu001@gmail.com	Yang, Pu/L-1442-2019; Yang, Bin/AAW-9583-2021	Yang, Bin/0000-0002-9290-7288; li, wan feng/0000-0003-0834-5479	Key Project of Chinese Ministry of Education [211171]; Applied Basic Research Programs of Yunnan Province [2010CD063]; National Natural Science Foundation of China [31260449]	Key Project of Chinese Ministry of Education(Ministry of Education, China); Applied Basic Research Programs of Yunnan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Key Project of Chinese Ministry of Education (211171), Applied Basic Research Programs of Yunnan Province (2010CD063), and National Natural Science Foundation of China (31260449). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latief M, 2008, INSECT BIOCHEM MOLEC, V38, P136, DOI 10.1016/j.ibmb.2007.10.001; Agaisse H, 2004, IMMUNOL REV, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; Asgari S, 2004, J INSECT PHYSIOL, V50, P687, DOI 10.1016/j.jinsphys.2004.05.003; Asgari S, 2011, ANNU REV ENTOMOL, V56, P313, DOI 10.1146/annurev-ento-120709-144849; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Axen A, 1997, EUR J BIOCHEM, V247, P614, DOI 10.1111/j.1432-1033.1997.00614.x; Badisco L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017274; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Barat-Houari M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-160; Beckage NE, 2004, ANNU REV ENTOMOL, V49, P299, DOI 10.1146/annurev.ento.49.061802.123324; Benassi V, 2000, ARCH INSECT BIOCHEM, V43, P64, DOI 10.1002/(SICI)1520-6327(200002)43:2&lt;64::AID-ARCH2&gt;3.0.CO;2-I; Burmester T, 1999, EUR J ENTOMOL, V96, P213; Carton Y, 2008, INSECT SCI, V15, P67, DOI 10.1111/j.1744-7917.2008.00188.x; Carvalho RA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-695; Chen Jun, 2000, Chinese Journal of Biological Control, V16, P166; Christensen BM, 2005, TRENDS PARASITOL, V21, P192, DOI 10.1016/j.pt.2005.02.007; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corona M, 2006, INSECT MOL BIOL, V15, P687, DOI 10.1111/j.1365-2583.2006.00695.x; Coudron TA, 1997, COMP BIOCHEM PHYS B, V116, P197, DOI 10.1016/S0305-0491(96)00217-9; COUDRON TA, 1994, ARCH INSECT BIOCHEM, V26, P97, DOI 10.1002/arch.940260204; Coustau C, 1996, INSECT MOL BIOL, V5, P167, DOI 10.1111/j.1365-2583.1996.tb00050.x; Dong K, 1996, ARCH INSECT BIOCHEM, V32, P237, DOI 10.1002/(SICI)1520-6327(1996)32:2&lt;237::AID-ARCH7&gt;3.0.CO;2-V; Doucet D, 2008, ARCH INSECT BIOCHEM, V67, P188, DOI 10.1002/arch.20227; Dziarski R, 2004, MOL IMMUNOL, V40, P877, DOI 10.1016/j.molimm.2003.10.011; Eleftherianos I, 2011, J INNATE IMMUN, V3, P28, DOI 10.1159/000321931; Etebari K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-446; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Fang Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026888; Fearon DT, 1977, NATURE, V388, P323, DOI DOI 10.1038/40967; Feldhaar H, 2008, MICROBES INFECT, V10, P1082, DOI 10.1016/j.micinf.2008.07.010; Hall M, 1999, P NATL ACAD SCI USA, V96, P1965, DOI 10.1073/pnas.96.5.1965; HARA S, 1995, J BIOL CHEM, V270, P29923, DOI 10.1074/jbc.270.50.29923; Hartzer KL, 2005, ARCH INSECT BIOCHEM, V59, P67, DOI 10.1002/arch.20056; HAYAKAWA Y, 1994, J BIOL CHEM, V269, P14536; HOFFMANN JA, 1995, CURR OPIN IMMUNOL, V7, P4, DOI 10.1016/0952-7915(95)80022-0; Hughes Austin L, 2012, Immunogenetics, V64, P549, DOI 10.1007/s00251-012-0610-8; Keeling CI, 2012, INSECT BIOCHEM MOLEC, V42, P525, DOI 10.1016/j.ibmb.2012.03.010; Kraaijeveld AR, 2009, ADV PARASIT, V70, P257, DOI 10.1016/S0065-308X(09)70010-7; KUNKEL JG, 1990, ARCH INSECT BIOCHEM, V13, P117, DOI 10.1002/arch.940130111; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li XR, 2011, INT J BIOL SCI, V7, P848, DOI 10.7150/ijbs.7.848; Lourenco AP, 2009, ARCH INSECT BIOCHEM, V71, P70, DOI 10.1002/arch.20301; Mahadav A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-342; Marmaras VJ, 2009, CELL SIGNAL, V21, P186, DOI 10.1016/j.cellsig.2008.08.014; Moreau SJM, 2005, INSECT BIOCHEM MOLEC, V35, P1209, DOI 10.1016/j.ibmb.2005.07.003; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nappi A, 2009, ADV PARASIT, V70, P99, DOI 10.1016/S0065-308X(09)70004-1; Nicolas E, 1996, DEV COMP IMMUNOL, V20, P175, DOI 10.1016/0145-305X(96)00017-1; Ourth DD, 2005, BIOCHEM BIOPH RES CO, V335, P1085, DOI 10.1016/j.bbrc.2005.07.189; Pal S, 2009, FLY, V3, P121, DOI 10.4161/fly.8827; Pennacchio F, 2006, ANNU REV ENTOMOL, V51, P233, DOI 10.1146/annurev.ento.51.110104.151029; Pick C, 2009, FEBS J, V276, P1930, DOI 10.1111/j.1742-4658.2009.06918.x; Provost B, 2011, INSECT BIOCHEM MOLEC, V41, P582, DOI 10.1016/j.ibmb.2011.03.010; Qin X, 1982, SCI SILVAE SINICAE, V18, P209; Quicke D. L. J., 1997, PARASITIC WASPS; Ribou AC, 2012, P ROY SOC B-BIOL SCI, V279, P2196, DOI 10.1098/rspb.2011.2422; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Scharlaken B, 2008, DEV COMP IMMUNOL, V32, P883, DOI 10.1016/j.dci.2008.01.010; Schlenke TA, 2007, PLOS PATHOG, V3, P1486, DOI 10.1371/journal.ppat.0030158; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Schmidt O, 2006, ARCH INSECT BIOCHEM, V61, P107, DOI 10.1002/arch.20110; Schmidt O, 1989, Subcell Biochem, V15, P91; SHELBY KS, 1994, J GEN VIROL, V75, P2285, DOI 10.1099/0022-1317-75-9-2285; Shelby KS, 1997, INSECT BIOCHEM MOLEC, V27, P263, DOI 10.1016/S0965-1748(96)00095-1; Shelby KS, 1999, J INSECT PHYSIOL, V45, P507, DOI 10.1016/S0022-1910(98)00144-9; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Song KH, 2008, J INSECT PHYSIOL, V54, P1271, DOI 10.1016/j.jinsphys.2008.06.010; Stanley D, 2009, J INNATE IMMUN, V1, P282, DOI 10.1159/000210371; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Takeda T, 2006, PESTIC BIOCHEM PHYS, V86, P15, DOI 10.1016/j.pestbp.2005.11.012; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; TELFER WH, 1991, ANNU REV ENTOMOL, V36, P205, DOI 10.1146/annurev.en.36.010191.001225; Tian YY, 2009, DEV COMP IMMUNOL, V33, P772, DOI 10.1016/j.dci.2009.01.002; Wertheim B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r94; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yu XQ, 2004, DEV COMP IMMUNOL, V28, P891, DOI 10.1016/j.dci.2004.02.005; Yu XQ, 2002, INSECT BIOCHEM MOLEC, V32, P1287, DOI 10.1016/S0965-1748(02)00091-7; Zagrobelny M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-574; Zhang L, 1980, SCI SILVAE SINICAE, V16, P41; Zhang YH, 2012, GENOMICS, V100, P35, DOI 10.1016/j.ygeno.2012.05.002; Zhang ZT, 2012, DEV COMP IMMUNOL, V38, P262, DOI 10.1016/j.dci.2012.05.003; Zhu JY, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/491748; Zhu JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032291; Zhu JY, 2011, J ZHEJIANG UNIV-SC B, V12, P103, DOI 10.1631/jzus.B1000275; Zhu JY, 2009, INSECT SCI, V16, P227, DOI 10.1111/j.1744-7917.2009.01252.x; Zhu JY, 2009, J ZHEJIANG UNIV-SC B, V10, P445, DOI 10.1631/jzus.B0820314; Zou Z, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r177	90	198	208	5	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54411	10.1371/journal.pone.0054411	http://dx.doi.org/10.1371/journal.pone.0054411			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23301042	Green Submitted, Green Published, gold			2022-12-25	WOS:000314759400162
J	Zhu, JF; Zhang, LF; Li, WF; Han, SY; Yang, WH; Qi, LW				Zhu, Jianfeng; Zhang, Lifeng; Li, Wanfeng; Han, Suying; Yang, Wenhua; Qi, Liwang			Reference Gene Selection for Quantitative Real-time PCR Normalization in Caragana intermedia under Different Abiotic Stress Conditions	PLOS ONE			English	Article							RT-PCR; HOUSEKEEPING GENES; TRANSCRIPTION FACTOR; INTERNAL CONTROL; EXPRESSION NORMALIZATION; VALIDATION; ARABIDOPSIS; IDENTIFICATION; DROUGHT; RICE	Quantitative real-time reverse transcription polymerase chain reaction (qPCR), a sensitive technique for gene expression analysis, depends on the stability of the reference genes used for data normalization. Caragana intermedia, a native desert shrub with strong drought-resistance, sand-fixing capacity and high forage value that is widespread in the desert land of west and northwest China, has not been investigated regarding the identification of reference genes suitable for the normalization of qPCR data. In this study, 10 candidate reference genes were analyzed in C. intermedia subjected to different abiotic (osmotic, salt, cold and heat) stresses, in two distinct plant organs (roots and leaves). The expression stability of these genes was assessed using geNorm, NormFinder and BestKeeper algorithms. The best-ranked reference genes differed across the different sets of samples, but UNK2, PP2A and SAND were the most stable across all tested samples. UNK2 and SAND would be appropriate for normalizing gene expression data for salt-treated roots, whereas the combination of UNK2, SAND and EF-1 alpha would be appropriate for salt-treated leaves. UNK1, UNK2 and PP2A would be appropriate for PEG-treated (osmotic) roots, whereas the combination of TIP41 and PP2A was the most suitable for PEG-treated leaves. SAND, PP2A and TIP41 exhibited the most stable expression in heat-treated leaves. In cold-treated leaves, SAND and EF-1 alpha were the most stably expressed. To further validate the suitability of the reference genes identified in this study, the expression levels of DREB1 and DREB2 (homologs of AtDREB1 and AtDREB2) were studied in parallel. This study is the first systematic analysis for the selection of superior reference genes for qPCR in C. intermedia under different abiotic stress conditions, and will benefit future studies on gene expression in C. intermedia and other species of the leguminous genus Caragana.	[Zhu, Jianfeng; Zhang, Lifeng; Li, Wanfeng; Yang, Wenhua; Qi, Liwang] Chinese Acad Forestry, Res Inst Forestry, Cell Biol Lab, Beijing, Peoples R China; [Han, Suying] Chinese Acad Forestry, Res Inst Forest Ecol & Protect, Key Lab, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF	Qi, LW (corresponding author), Chinese Acad Forestry, Res Inst Forestry, Cell Biol Lab, Beijing, Peoples R China.	lwqi@caf.ac.cn	Yang, Pu/L-1442-2019; Yang, Bin/AAW-9583-2021	Yang, Bin/0000-0002-9290-7288; li, wan feng/0000-0003-0834-5479	National Basic Research Program of China [2009CB119106]; National High Technology Research and Development Program of China [2011AA100203]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the National Basic Research Program of China (2009CB119106) and the National High Technology Research and Development Program of China (2011AA100203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; Chi XY, 2012, MOL GENET GENOMICS, V287, P167, DOI 10.1007/s00438-011-0665-5; Coito Joao L, 2012, BMC Res Notes, V5, P220, DOI 10.1186/1756-0500-5-220; Condori Jose, 2011, BMC Res Notes, V4, P392, DOI 10.1186/1756-0500-4-392; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Demidenko NV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019434; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Faccioli P, 2007, PLANT MOL BIOL, V63, P679, DOI 10.1007/s11103-006-9116-9; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Guo WH, 2010, AGROFOREST SYST, V80, P423, DOI 10.1007/s10457-010-9337-4; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Huang JL, 2010, PLANT PHYSIOL, V153, P1526, DOI 10.1104/pp.110.157370; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Kakar K, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-18; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; Klie Maik, 2011, BMC Res Notes, V4, P518, DOI 10.1186/1756-0500-4-518; Koo SC, 2010, PLANT J, V62, P807, DOI 10.1111/j.1365-313X.2010.04192.x; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Mahoney DJ, 2004, PHYSIOL GENOMICS, V18, P226, DOI 10.1152/physiolgenomics.00067.2004; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Migocka M, 2011, MOL BREEDING, V28, P343, DOI 10.1007/s11032-010-9487-0; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Ohdan T, 2005, J EXP BOT, V56, P3229, DOI 10.1093/jxb/eri292; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Perez R, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-79; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Portieles R, 2010, PLANT BIOTECHNOL J, V8, P678, DOI 10.1111/j.1467-7652.2010.00501.x; Qiu JL, 2008, EMBO J, V27, P2214, DOI 10.1038/emboj.2008.147; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Ren XZ, 2010, PLANT J, V63, P417, DOI 10.1111/j.1365-313X.2010.04248.x; Shi SQ, 2010, PLANT CELL ENVIRON, V33, P149, DOI 10.1111/j.1365-3040.2009.02065.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Wang XM, 2011, MOL BIOL REP, V38, P2801, DOI 10.1007/s11033-010-0425-3; Xu ZZ, 2007, PLANT SOIL, V301, P87, DOI 10.1007/s11104-007-9424-0; Zhong HY, 2011, PLANT CELL REP, V30, P641, DOI 10.1007/s00299-010-0992-8	44	198	208	5	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53196	10.1371/journal.pone.0053196	http://dx.doi.org/10.1371/journal.pone.0053196			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301042	gold, Green Published, Green Submitted			2022-12-25	WOS:000313320900067
J	Liu, JY				Liu, J. Y.			Status of Marine Biodiversity of the China Seas	PLOS ONE			English	Review								China's seas cover nearly 5 million square kilometers extending from the tropical to the temperate climate zones and bordering on 32,000 km of coastline, including islands. Comprehensive systematic study of the marine biodiversity within this region began in the early 1950s with the establishment of the Qingdao Marine Biological Laboratory of the Chinese Academy of Sciences. Since that time scientists have carried out intensive multidisciplinary research on marine life in the China seas and have recorded 22,629 species belonging to 46 phyla. The marine flora and fauna of the China seas are characterized by high biodiversity, including tropical and subtropical elements of the Indo-West Pacific warm-water fauna in the South and East China seas, and temperate elements of North Pacific temperate fauna mainly in the Yellow Sea. The southern South China Sea fauna is characterized by typical tropical elements paralleled with the Philippine-New Guinea-Indonesia Coral triangle typical tropical faunal center. This paper summarizes advances in studies of marine biodiversity in China's seas and discusses current research mainly on characteristics and changes in marine biodiversity, including the monitoring, assessment, and conservation of endangered species and particularly the strengthening of effective management. Studies of (1) a tidal flat in a semi-enclosed embayment, (2) the impact of global climate change on a cold-water ecosystem, (3) coral reefs of Hainan Island and Xisha-Nansha atolls, (4) mangrove forests of the South China Sea, (5) a threatened seagrass field, and (6) an example of stock enhancement practices of the Chinese shrimp fishery are briefly introduced. Besides the overexploitation of living resources (more than 12.4 million tons yielded in 2007), the major threat to the biodiversity of the China seas is environmental deterioration (pollution, coastal construction), particularly in the brackish waters of estuarine environments, which are characterized by high productivity and represent spawning and nursery areas for several economically important species. In the long term, climate change is also a major threat. Finally, challenges in marine biodiversity studies are briefly discussed along with suggestions to strengthen the field. Since 2004, China has participated in the Census of Marine Life, through which advances in the study of zooplankton and zoobenthos biodiversity were finally summarized.	Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS	Liu, JY (corresponding author), Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China.	pmilos@usb.ve		Pedrosa Domellof, Fatima/0000-0002-0648-4996	External Cooperation Program of the Chinese Academy of Sciences [GJHZ200808]; Main Direction Program of Knowledge Innovation of the Chinese Academy of Sciences [KZCX2-YW-417, KSCX2-EW-Z-5]; Special funds for science infrastructure of the Ministry of Science and Technology of the People's Republic of China [2006FY110500-4]; Alfred P. Sloan Foundation	External Cooperation Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Main Direction Program of Knowledge Innovation of the Chinese Academy of Sciences(Chinese Academy of Sciences); Special funds for science infrastructure of the Ministry of Science and Technology of the People's Republic of China; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	Dr. Liu received funding for this study from the following organizations: The External Cooperation Program of the Chinese Academy of Sciences (GJHZ200808); Main Direction Program of Knowledge Innovation of the Chinese Academy of Sciences (KZCX2-YW-417), (KSCX2-EW-Z-5); Special funds for science infrastructure of the Ministry of Science and Technology of the People's Republic of China (2006FY110500-4); and The Alfred P. Sloan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, DIVERSITY SPECIES XI; Briggs J, 1974, MARINE ZOOGEOGRAPHY, DOI 10.2307/1442613; Bureau of Fisheries Ministry of Agriculture of China, 2007, CHIN FISH STAT YB; Bureau of Fisheries Ministry of Agriculture of China, 2009, CHIN FISH STAT YB; Chen Q, 2003, LATIN CHINESE NAMES; Cheng J, 2003, LIVING RESOURCES OCE; Department of Marine Geology Institute of Oceanology Chinese Academy of Sciences, 1982, GEOL YELL E CHIN SEA; Fang J, 1996, MAR FISH RES, V17, P95; FUJIAN Marine Environment and Fishery Resources Monitor Center, 2010, MAR BIOD SURV REP QU; Guan BX, 2006, J OCEANOGR, V62, P1, DOI 10.1007/s10872-006-0028-8; Gurjanova E. F., 1958, Bull Inst mar Biol Peking, V1, P1; Huang X, 2007, STUDY SEAGRASS S CHI; HUANG Z, 1994, MARINE SPECIES THEIR; Huang Z. G, 2004, BIODIVERSITY MARINE; Jia X, 2004, FISHERY ECOLOGICAL E; Jin X, 2005, LIVING RESOURCES HAB; Lee YC, 1998, YELLOW SEA ATLAS; Li G, 2004, MARINE ECOLOGY; Li J. J., 2011, J ZHEJIANG OCEAN U N, V30, P381; Liao K., 1999, NATL PHYS ATLAS CHIN; Lin AK, 2008, SATELLITE REMOTE SEN; LIN P, 1999, MANGROVE ECOSYSTEM C; Liu R, 1983, P INT S SED CONT SHE; Liu R, 1991, P 2 INT S MAR SCI YE, P240; Liu R, 2006, J MARINE SCI BIOTECH, V1, P40; Liu R, 1998, P EUR AS WORKSH INV, P351; Liu R. Y., 1963, OCEANOLOGIA LIMNOLOG, V5, P306; Liu R.Y., 1992, ECOLOGY LIVING RESOU, P2; Liu RuiYu, 2011, Biodiversity Science, V19, P614, DOI 10.3724/SP.J.1003.2011.13185; Liu Ruiyu, 2007, P103; Liu RY, 2008, CHECKLIST MARINE BIO; Ng PKL, 2000, RAFFLES B ZOOL, P3; Ning X, 2002, RES EVALUATION AQUAC; Qi Y, 2003, RED TIDES CHINESE CO; SHAW PT, 1994, DEEP-SEA RES PT I, V41, P1663, DOI 10.1016/0967-0637(94)90067-1; Song Haitang, 2003, ACTA OCEANOLOGICA S, V1, P8; Song Haitang, 2006, EC SHRIMP CRAB SPECI, P1; Sun S, 2007, P WORKSH BIOD MARG S, P97; Tang Q, 2006, MARINE BIOL RESOURCE; Ushakov PV, 1955, VESTN AN SSSR+, V56, P14; WANG S., 2005, CHINA SPECIES RED LI, VIII; Wang S, 2009, CHINA SPECIES RED A, V2; Wang S, 1999, CHINA RED DATA BOOK; Wang S, 2009, CHINA SPECIES RED B, V2; Wang S, 2004, CHINA SPECIES RED LI, VI; Wang WQ, 2007, MANGROVES CHINA; WANG Y, 1987, CONT SHELF RES, V7, P329, DOI 10.1016/0278-4343(87)90104-X; Wang Y. S. J., 2012, OCEANOGRAPHY CHINA; Xu G.Z., 1989, ENV RESOURCES DAYA B; Yu Cun-gen, 2009, Marine Fisheries, V31, P27; Yue P. Q., 1998, CHINA RED DATA BOOK; Zhang S., 2007, ECOLOGICAL ENV BIORE; Zheng Q.N., 2006, J GEOPHYS RES OCEANS, V111; Zheng T, 1982, GEOLOGY HUANGHAI DON, P198; Zheng Y., 2003, BIOL RESOURCES ENV E; Zhong Zhenru, 1986, MARINE FIEHERIES, V3, P99; ZHOU D, 1994, OCEANOLOGY CHINA SEA; Zhou M, 2012, OCEANOGRAPHY CHINA; Zhou MJ, 2008, CONT SHELF RES, V28, P1483, DOI 10.1016/j.csr.2007.02.009; Zhuang Q, 1984, STUDIA MARINA SINICA, V22, P79; Zhuang Q., 1981, OCEANOLOGIA LIMNOLOG, V12, P341; Zou R, 1966, OCEANOLOGIA LIMNOLOG, V2, P153; Zuo T., 2003, COMMUNITY STRUCTURE	63	232	256	29	155	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e50719	10.1371/journal.pone.0050719	http://dx.doi.org/10.1371/journal.pone.0050719			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23675523	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429800005
J	Nakamura, K; Aizawa, K; Nakabayashi, K; Kato, N; Yamauchi, J; Hata, K; Tanoue, A				Nakamura, Kazuaki; Aizawa, Kazuko; Nakabayashi, Kazuhiko; Kato, Natsuko; Yamauchi, Junji; Hata, Kenichiro; Tanoue, Akito			DNA Methyltransferase Inhibitor Zebularine Inhibits Human Hepatic Carcinoma Cells Proliferation and Induces Apoptosis	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; CYCLE ARREST; METHYLATION INHIBITOR; CANCER-CELLS; G(1) ARREST; HEPG2 CELLS; IN-VITRO; EXPRESSION; ACTIVATION; INDUCTION	Hepatocellular carcinoma is one of the most common cancers worldwide. During tumorigenesis, tumor suppressor and cancer-related genes are commonly silenced by aberrant DNA methylation in their promoter regions. Zebularine (1-(beta-(D)-ribofuranosyl)- 1,2-dihydropyrimidin-2-one) acts as an inhibitor of DNA methylation and exhibits chemical stability and minimal cytotoxicity both in vitro and in vivo. In this study, we explore the effect and possible mechanism of action of zebularine on hepatocellular carcinoma cell line HepG2. We demonstrate that zebularine exhibits antitumor activity on HepG2 cells by inhibiting cell proliferation and inducing apoptosis, however, it has little effect on DNA methylation in HepG2 cells. On the other hand, zebularine treatment downregulated CDK2 and the phosphorylation of retinoblastoma protein (Rb), and upregulated p21(WAF/CIP1) and p53. We also found that zebularine treatment upregulated the phosphorylation of p44/42 mitogen-activated protein kinase (MAPK). These results suggest that the p44/42 MAPK pathway plays a role in zebularine-induced cell-cycle arrest by regulating the activity of p21(WAF/CIP1) and Rb. Furthermore, although the proapoptotic protein Bax levels were not affected, the antiapoptotic protein Bcl-2 level was downregulated with zebularine treatment. In addition, the data in the present study indicate that inhibition of the double-stranded RNA-dependent protein kinase (PKR) is involved in inducing apoptosis with zebularine. These results suggest a novel mechanism of zebularine-induced cell growth arrest and apoptosis via a DNA methylation-independent pathway in hepatocellular carcinoma.	[Nakamura, Kazuaki; Aizawa, Kazuko; Kato, Natsuko; Yamauchi, Junji; Tanoue, Akito] Natl Res Inst Child Hlth & Dev, Dept Pharmacol, Tokyo, Japan; [Nakabayashi, Kazuhiko; Hata, Kenichiro] Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Tokyo, Japan	National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan	Nakamura, K (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Pharmacol, Tokyo, Japan.	nakamura-kz@ncchd.go.jp		Nakayama, Karina/0000-0001-5426-7446	Takeda Science Foundation (Osaka, Japan); Grant of National Center for Child Health and Development (Tokyo, Japan) [22A-6]	Takeda Science Foundation (Osaka, Japan)(Takeda Science Foundation (TSF)); Grant of National Center for Child Health and Development (Tokyo, Japan)	This work was supported in part by research grants from the Takeda Science Foundation (Osaka, Japan, http://www.takeda-sci.or.jp/index.html), and The Grant of National Center for Child Health and Development (22A-6) (Tokyo, Japan, http://www.ncchd.go.jp/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Amara K, 2010, CANCER SCI, V101, P1722, DOI 10.1111/j.1349-7006.2010.01569.x; Andersen JB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001338; Ben-Kasus T, 2005, BIOCHEM PHARMACOL, V70, P121, DOI 10.1016/j.bcp.2005.04.010; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Billam M, 2010, BREAST CANCER RES TR, V120, P581, DOI 10.1007/s10549-009-0420-3; Calvisi DF, 2007, J CLIN INVEST, V117, P2713, DOI 10.1172/JCI31457; Cheng JC, 2003, J NATL CANCER I, V95, P399, DOI 10.1093/jnci/95.5.399; Cheng JC, 2004, MOL CELL BIOL, V24, P1270, DOI 10.1128/MCB.24.3.1270-1278.2004; Cheng JC, 2004, CANCER CELL, V6, P151, DOI 10.1016/j.ccr.2004.06.023; Dai XY, 2012, CELL PHYSIOL BIOCHEM, V29, P281, DOI 10.1159/000337609; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Dote H, 2005, CLIN CANCER RES, V11, P4571, DOI 10.1158/1078-0432.CCR-05-0050; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fandy TE, 2009, CURR MED CHEM, V16, P2075, DOI 10.2174/092986709788612738; Feinberg AP, 2004, SEMIN CANCER BIOL, V14, P427, DOI 10.1016/j.semcancer.2004.06.005; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Gan LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016916; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Gravina GL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-305; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; Hubina E, 2006, EUR J ENDOCRINOL, V155, P371, DOI 10.1530/eje.1.02213; Hurd PJ, 1999, J MOL BIOL, V286, P389, DOI 10.1006/jmbi.1998.2491; Issa JPJ, 2009, CLIN CANCER RES, V15, P3938, DOI 10.1158/1078-0432.CCR-08-2783; Kobayashi Y, 2011, GENOME RES, V21, P1017, DOI 10.1101/gr.119487.110; Kouroumalis E, 1998, GUT, V42, P442, DOI 10.1136/gut.42.3.442; LEIST M, 1994, J IMMUNOL, V153, P1778; Liedtke C, 2002, HEPATOLOGY, V36, P315, DOI 10.1053/jhep.2002.34615; Lin RK, 2010, J CLIN INVEST, V120, P521, DOI 10.1172/JCI40706; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Marques CJ, 2011, EPIGENETICS-US, V6, P1354, DOI 10.4161/epi.6.11.17993; MICHIELI P, 1994, CANCER RES, V54, P3391; Motomura W, 2005, BIOCHEM BIOPH RES CO, V332, P89, DOI 10.1016/j.bbrc.2005.04.095; Neureiter D, 2007, SCAND J GASTROENTERO, V42, P103, DOI 10.1080/00365520600874198; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Obaya AJ, 2002, CELL MOL LIFE SCI, V59, P126, DOI 10.1007/s00018-002-8410-1; ORRENIUS S, 1989, TRENDS PHARMACOL SCI, V10, P281, DOI 10.1016/0165-6147(89)90029-1; PINTO A, 1993, LEUKEMIA, V7, P51; PROUD CG, 1995, TRENDS BIOCHEM SCI, V20, P241, DOI 10.1016/S0968-0004(00)89025-8; Qu Y, 2010, AM J CLIN PATHOL, V134, P826, DOI 10.1309/AJCPHGQ69FXDFWII; RUSSO T, 1995, J BIOL CHEM, V270, P29386, DOI 10.1074/jbc.270.49.29386; Samali A, 1999, BIOCHEM BIOPH RES CO, V255, P6, DOI 10.1006/bbrc.1998.0139; Samonakis DN, 2002, ONCOL REP, V9, P903; Schwartsmann G, 2000, INVEST NEW DRUG, V18, P83, DOI 10.1023/A:1006388031954; Serfas MS, 1997, CELL GROWTH DIFFER, V8, P951; Shen GX, 2006, CANCER CHEMOTH PHARM, V57, P317, DOI 10.1007/s00280-005-0050-3; Taya Y, 1997, TRENDS BIOCHEM SCI, V22, P14, DOI 10.1016/S0968-0004(96)10070-0; Taylor SS, 2005, CELL, V122, P823, DOI 10.1016/j.cell.2005.09.007; Thomas MB, 2005, J CLIN ONCOL, V23, P2892, DOI 10.1200/JCO.2005.03.196; Tsagarakis NJ, 2011, WORLD J GASTROENTERO, V17, P313, DOI 10.3748/wjg.v17.i3.313; Tsukada Y, 2004, J BIOCHEM, V136, P701, DOI 10.1093/jb/mvh177; Tu YG, 2007, J BIOL CHEM, V282, P11722, DOI 10.1074/jbc.M609623200; WALDMAN T, 1995, CANCER RES, V55, P5187; Wang D, 2012, BIOINFORMATICS, V28, P729, DOI 10.1093/bioinformatics/bts013; Weisenberger DJ, 2004, MOL CANCER RES, V2, P62; Yang XR, 2009, CELL RES, V19, P469, DOI 10.1038/cr.2009.25; Yoo CB, 2004, BIOCHEM SOC T, V32, P910, DOI 10.1042/BST0320910; You BR, 2012, MOL BIOL REP, V39, P9723, DOI 10.1007/s11033-012-1837-z	59	113	118	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e54036	10.1371/journal.pone.0054036	http://dx.doi.org/10.1371/journal.pone.0054036			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	24086366	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429800086
